ASHG 2012 Program Guide - American Society of Human Genetics
ASHG 2012 Program Guide - American Society of Human Genetics
ASHG 2012 Program Guide - American Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ashg.org/<strong>2012</strong>meeting<br />
Discover • Network • Collaborate
whole exome sequencing<br />
– One Test –<br />
More Answers<br />
Developed jointly by the <strong>Human</strong> Genome Sequencing Center<br />
(HGSC), the Department <strong>of</strong> Molecular and <strong>Human</strong> <strong>Genetics</strong><br />
and the Medical <strong>Genetics</strong> Laboratories <strong>of</strong> the Baylor College <strong>of</strong><br />
Medicine, the Whole Genome Sequencing Laboratory (WGL)<br />
applies the power <strong>of</strong> next generation sequencing technology to<br />
clinical genetics in a CLIA high complexity testing laboratory with<br />
clinical interpretation <strong>of</strong> the sequence information. Whole Exome<br />
Sequencing (WES) is poised to change the current paradigm <strong>of</strong><br />
genetic testing for Mendelian disorders, pharmacogenetic traits,<br />
and potentially complex traits. Rather than limiting testing to a<br />
single gene or panel <strong>of</strong> genes and incurring diagnostic delays and<br />
escalating costs, the Whole Exome Sequencing test will sequence<br />
nucleotide by nucleotide, the human exome to the depth <strong>of</strong> coverage<br />
required to achieve a consensus sequence with high accuracy. Point<br />
mutations, small insertions and deletions <strong>of</strong> the exome are routinely<br />
detected by this methodology. The team curating the Whole Exome<br />
Sequencing test focuses the report on on known or predicted<br />
deleterious mutations in genes associated with patient’s clinical<br />
problems; however, significant potentially medically actionable<br />
findings in other genes <strong>of</strong> interest as well as the option for reporting<br />
autosomal recessive carrier status are included in the focused whole<br />
exome report.<br />
One Baylor Plaza, Nab 2015, Houston, Texas 77030 • 713-798-6555<br />
1-800-411-gene (4363) • www.bcmgeneticlabs.org • www.bcm.edu
Welcome to the <strong>ASHG</strong><br />
62 nd Annual Meeting<br />
Name: _____________________________________<br />
Email: _____________________________________
TABLE OF CONTENTS<br />
<strong>2012</strong> <strong>ASHG</strong> Board <strong>of</strong> Directors ................................................................................. 4<br />
Welcome from the President .................................................................................... 5<br />
<strong>2012</strong> <strong>ASHG</strong> <strong>Program</strong> Committee Members ............................................................ 6<br />
Welcome from the <strong>Program</strong> Chair ........................................................................... 7<br />
<strong>2012</strong> <strong>ASHG</strong> Abstract Reviewers ............................................................................... 9<br />
<strong>ASHG</strong> Administrative Offices/Staff ...................................................................... 10<br />
Annual Meeting Support ......................................................................................... 11<br />
Advertisers .............................................................................................................. 12<br />
Schedule <strong>of</strong> Scientific Sessions and Ancillary Events ........................................ 15<br />
Trainee Track: Meeting within the Meeting Schedule ............................................ 29<br />
Education Track ...................................................................................................... 31<br />
Clinical Track .......................................................................................................... 33<br />
Floor Plans and Maps<br />
Moscone Center (Convention Center) .................................................................... 37<br />
San Francisco Marriott Marquis Hotel (Headquarter Hotel) ................................. 39<br />
San Francisco Hotel Locator Map ......................................................................... 41<br />
BART Metro System ............................................................................................... 43<br />
General Information<br />
About the Meeting ................................................................................................ 45<br />
Abstracts/Abstract Search ................................................................................. 45<br />
Invited Sessions .................................................................................................. 45<br />
Plenary Session Presentations (abstract-driven) ............................................... 45<br />
Platform Sessions (abstract-driven) ................................................................... 45<br />
Poster Sessions (abstract-driven) ..................................................................... 46<br />
Mobile App/Mobile Web Site .............................................................................. 46<br />
Social Media ....................................................................................................... 46<br />
Session Tracks .................................................................................................... 46<br />
Registration, Badge and <strong>Program</strong> Pick up<br />
Registration Hours/Fees ..................................................................................... 47<br />
Replacement/Lost/Forgotten Badge .................................................................. 48<br />
Meeting Information, Services and Offices<br />
<strong>ASHG</strong> Office and Meeting Logistics ................................................................... 48<br />
<strong>ASHG</strong> Central/Membership Services ................................................................ 48<br />
Assistance for Attendees .................................................................................... 49<br />
Attire/Dress Code ............................................................................................... 49<br />
Business Center .................................................................................................. 49<br />
Career/Employment Opportunities ..................................................................... 49<br />
Cell Phone/Camera/Recording Policy ................................................................ 49<br />
CME/CEUs .......................................................................................................... 49<br />
Exhibits/Exhibit Registration and Management ................................................. 50<br />
Family/Nursing Mothers Room ........................................................................... 50<br />
First Aid ............................................................................................................... 50<br />
Food Service ....................................................................................................... 50<br />
Housing/Hotels .................................................................................................. 51<br />
Information .......................................................................................................... 51<br />
Internet Access/Cyber Cafè ............................................................................... 51<br />
Luggage Storage and Coat Check ..................................................................... 51
TABLE OF CONTENTS<br />
Message Center/Literature Tables...................................................................... 51<br />
Parking ................................................................................................................ 52<br />
Prayer Room ....................................................................................................... 52<br />
Press Office ........................................................................................................ 52<br />
Registration Management/Registration Help Desk ............................................ 52<br />
Restaurant/City Information Tours and Activities ............................................... 52<br />
Speaker-Presentation/Upload Room ................................................................. 52<br />
Speaker Conflict <strong>of</strong> Interest ................................................................................ 53<br />
Telephone Numbers for <strong>ASHG</strong> On-Site Offices ................................................. 53<br />
Travel and Visitor Information ............................................................................. 53<br />
Transportation/Getting Around .......................................................................... 54<br />
Daily Meeting Highlights and Workshops<br />
Tuesday ................................................................................................................. 55<br />
Wednesday ............................................................................................................. 56<br />
Thursday ................................................................................................................. 58<br />
Friday ...................................................................................................................... 59<br />
Saturday ................................................................................................................. 61<br />
Charles Epstein Trainee Awards for Excellence in<br />
<strong>Human</strong> <strong>Genetics</strong> Research ..................................................................................... 63<br />
<strong>2012</strong> FASEB MARC TRAVEL AWARDEES ............................................................. 66<br />
INVITED, PLATFORM AND AWARD SESSIONS<br />
Session #1 through Session #81 ....................................................................... 68<br />
Poster Sessions ..................................................................................................... 125<br />
Exhibitors ................................................................................................................ 267<br />
Floor Plan <strong>of</strong> Exhibit and Poster Area .................................................................. 271<br />
Alpha Listing <strong>of</strong> Exhibitors .................................................................................... 273<br />
Product and Service Index ................................................................................... 299<br />
Continuing Education (CEU/CME Credits) ......................................................... 325<br />
Speaker and Author Disclosures ......................................................................... 329<br />
Speaker and Author Index .................................................................................... 333<br />
Advertisements ...................................................................................................... 421<br />
3
AMERICAN SOCIETY OF HUMAN GENETICS<br />
DISCOVER • EDUCATE • ADVOCATE<br />
www.ashg.org<br />
The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> (<strong>ASHG</strong>), founded in 1948, is the primary<br />
pr<strong>of</strong>essional membership organization for human genetics specialists worldwide. <strong>ASHG</strong><br />
serves research scientists, health pr<strong>of</strong>essionals, and the public by providing forums to:<br />
• Share research results at Annual Meetings and in The <strong>American</strong> Journal <strong>of</strong><br />
<strong>Human</strong> <strong>Genetics</strong>;<br />
• Advance genetic research by advocating for research support;<br />
• Enhance genetics education by preparing future pr<strong>of</strong>essionals and informing<br />
the public; and<br />
• Promote genetic services and support responsible social and scientific policies.<br />
<strong>ASHG</strong>’s nearly 8,000 members include researchers, academicians, clinicians,<br />
laboratory practice pr<strong>of</strong>essionals, genetic counselors, nurses and others who have<br />
a special interest in the field <strong>of</strong> human genetics. Members <strong>of</strong> <strong>ASHG</strong> entered the<br />
21st century with a commitment to become fluent in the language <strong>of</strong> the genome,<br />
understand human variation, and promote the public health. As we transfer new<br />
knowledge to the next generation <strong>of</strong> genetics pr<strong>of</strong>essionals and the public, we will<br />
translate new ideas into improved clinical practice. Visit the <strong>ASHG</strong> Web site for<br />
additional information: www.ashg.org.<br />
<strong>2012</strong> Board <strong>of</strong> Directors<br />
Mary-Claire King, President<br />
Jeffrey C. Murray, President-Elect Directors:<br />
Brendan Lee, Secretary David M. Altshuler<br />
Ge<strong>of</strong>frey M. Duyk, Treasurer Stylianos E. Antonarakis<br />
Leslie G. Biesecker<br />
Lynn B. Jorde, Past President 2011 Vivian G. Cheung<br />
Roderick R. McInnes, Past President 2010 Nancy J. Cox<br />
Kay E. Davies<br />
David Nelson, Editor Evan E. Eichler<br />
Richard A. Gibbs<br />
Neil J. Risch
WELCOME FROM THE PRESIDENT<br />
Dear Fellow Members <strong>of</strong> <strong>ASHG</strong>,<br />
Welcome to our <strong>2012</strong> Annual Meeting. The theme for our meeting this year is<br />
“The Scientist as a Citizen <strong>of</strong> the World.” This theme was selected for two reasons.<br />
First, this year has been an extraordinarily productive one for human genetics research<br />
based in populations from all parts <strong>of</strong> the world. <strong>Human</strong> genetics is inherently a science<br />
without borders. Now, economic constraints notwithstanding, we have reached a<br />
moment in which the scientific work <strong>of</strong> our field is carried out in very large part by<br />
geneticists from the places <strong>of</strong> origin <strong>of</strong> populations being studied. Some <strong>of</strong> this work<br />
is internationally collaborative, and the projects are true, not token, joint efforts.<br />
Our field owes this rapid democratization in part to the virtually overnight dissemination<br />
<strong>of</strong> next generation sequencing technology, and in part to the cleverness <strong>of</strong> human<br />
geneticists worldwide who exploit this technology by inventively integrating local,<br />
regional, and international capacities. A little outsourcing goes a long way in the right<br />
hands. Results <strong>of</strong> international collaborations are integrated into every session <strong>of</strong><br />
this <strong>ASHG</strong> meeting. I point out this feature <strong>of</strong> our meeting explicitly, because we take<br />
international collaboration so much for granted that we might not notice it otherwise.<br />
We are fortunate in this. It is not the way <strong>of</strong> the world as a whole.<br />
Second, what happens this week in the U.S. will have enormous consequences for us all.<br />
As human geneticists, we are in the privileged position <strong>of</strong> having far more awareness <strong>of</strong><br />
the world than most <strong>of</strong> our fellow citizens (wherever we are originally from), and therefore<br />
the responsibility to try to help the next years be ones <strong>of</strong> progress for our communities.<br />
Collectively, we are many (more than 8000), with considerable intellectual influence,<br />
if not explicit political power, in our communities. We enjoy more autonomy than most in<br />
exercising that influence, in part because we have each other. <strong>ASHG</strong> is both our home<br />
for productive science and for forming friendships that transcend borders. Collaboration<br />
bridges conflict for far more people than those engaged in the science itself.<br />
So welcome to the 62nd <strong>ASHG</strong> Annual Meeting. Enjoy a lovely week in this beautiful city,<br />
greet old friends, make new friends, arrange a post-doc or a sabbatical year in a place not<br />
previously your own, and think <strong>of</strong> fine projects together. It is a great pleasure to see you here.<br />
With all best wishes,<br />
Mary-Claire King<br />
President, <strong>ASHG</strong><br />
5
6 PROGRAM COMMITTEE<br />
THE AMERICAN SOCIETY OF HUMAN GENETICS 62 ND<br />
Annual Meeting<br />
November 6–10, <strong>2012</strong> • San Francisco, California<br />
<strong>ASHG</strong> gratefully acknowledges the expertise, hard work and<br />
dedication <strong>of</strong> the <strong>2012</strong> <strong>Program</strong> Committee<br />
************************************<br />
<strong>Program</strong> Committee<br />
Joel N. Hirschhorn, Chair<br />
Sally A. Camper Andrew S. McCallion<br />
Andrew G. Clark Karen L. Mohlke<br />
Tina M. Cowan Elaine A. Ostrander<br />
Clair A. Francomano Barbara R. Pober<br />
Chris Gunter Nazneen Rahman<br />
Jonathan L. Haines Michael R. Speicher<br />
Gail P. Jarvik Catherine A. Wicklund<br />
Sekar Kathiresan Alexander F. Wilson<br />
Nicolas Katsanis<br />
************************************
WELCOME FROM THE PROGRAM CHAIR<br />
On behalf <strong>of</strong> the <strong>ASHG</strong> <strong>Program</strong> Committee and the Board <strong>of</strong> Directors, welcome to<br />
the <strong>Society</strong>’s 62 nd Annual Meeting in San Francisco! The <strong>2012</strong> <strong>Program</strong> Committee<br />
has developed an exceptional program. This year, we received a record 3845 abstracts,<br />
from which 411 were chosen for plenary/platform oral presentations and over 3400<br />
<strong>of</strong> the remaining abstracts are being presented as scientific posters. In addition, there<br />
are 24 invited scientific sessions, chosen from the 95 proposals submitted this year.<br />
The program committee has worked to assemble an exciting and outstanding scientific<br />
program that balances basic, translational, and clinical research with sessions that<br />
address timely issues. The schedule once again features separate tracks (trainees,<br />
clinical and educational) to help you select the sessions most relevant to your interests.<br />
The meeting begins on Tuesday at 4:00 pm with the Presidential Address “The<br />
Scientist as a Citizen <strong>of</strong> the World” by Mary-Claire King. The address will be streamed<br />
live on the <strong>ASHG</strong> Web site and will be followed by the plenary abstract presentations<br />
with topics including comparative epigenomics, early exome sequencing in complex<br />
traits, large-scale identification <strong>of</strong> enhancers and cis-acting regulators <strong>of</strong> translation,<br />
and integrated genetic and functional studies <strong>of</strong> disease-causing variants (see page<br />
68 for details). Afterwards, we hope you join us to reconnect with friends and colleagues<br />
and make new connections at the Opening Mixer and Trainee Mixer-Within-A-Mixer<br />
starting at 7:00 pm in the San Francisco Marriott Marquis Hotel.<br />
Each day, you will have the opportunity to select from concurrent invited and platform<br />
presentations. Poster presentations will be held on each <strong>of</strong> three afternoons following<br />
the lunch period, and all posters will remain on display throughout the three days.<br />
The final session <strong>of</strong> the day on Wednesday is the invited Presidential Symposium<br />
entitled “Gene Discovery and Patent Law: Present Experience in the US and in Europe.”<br />
Please plan to join us from 4:30 pm until 6:30 pm to discuss the present state <strong>of</strong> gene<br />
patenting. Come prepared with your written questions for the well-known panelists:<br />
Hank Greely, Gert Matthijs, Mark Lemley and Lori Andrews. (See page 81 for further<br />
details).<br />
In response to survey requests from prior meeting attendees, the <strong>Program</strong> Committee<br />
lengthened the lunch break to 90 minutes and added evening workshops in a variety<br />
<strong>of</strong> topics. Workshops will cover interactive browser sessions (UCSC, Galaxy and<br />
Ensembl Browsers), NCBI databases (Sequence Read Archive, GenBank, GEO,<br />
dbSNP, dbVar and dbGaP) and clinical interpretation <strong>of</strong> databases (such as DECIPHER,<br />
7
8 WELCOME FROM THE PROGRAM CHAIR<br />
ISCA, DbVar). In addition, there will be a session on how scientists can use social<br />
media to benefit their career as well as a workshop on Diagnostic Dilemmas, with<br />
presentation <strong>of</strong> rare and unknown cases.<br />
The <strong>Society</strong>’s Board <strong>of</strong> Directors and the <strong>Program</strong> Committee continue to share a<br />
strong commitment for trainee academic development. Therefore, this year, we have<br />
increased the value <strong>of</strong> trainee awards. The awards were also renamed to honor the<br />
late Charles J. Epstein. We continue to <strong>of</strong>fer several events designed to assist our<br />
trainee members in their transition toward pr<strong>of</strong>essional independence. These events<br />
include: (1) the Undergraduate Faculty <strong>Genetics</strong> Education Workshop, (2) the Trainee-<br />
Mentor Luncheon, (3) the Trainee Development <strong>Program</strong> and Networking Reception,<br />
and (4) a Mock NIH Study Section Workshop. Please refer to page 29 for the “trainee<br />
meeting within the meeting” schedule.<br />
The meeting will conclude on Saturday with a special closing symposium entitled,<br />
“ <strong>Human</strong> <strong>Genetics</strong> <strong>2012</strong> and Beyond: Present Progress and Future Frontiers,” from<br />
12:00 pm to 1:00 pm. This symposium will feature a panel <strong>of</strong> five outstanding geneticists<br />
with diverse perspectives: Han Brunner, Hal Dietz, Dian Donnai, Lynn Jorde, and Jay<br />
Shendure. The panel will address exciting advances presented at this year’s meeting<br />
and will discuss the opportunities and challenges for the coming years. Attendees will<br />
have opportunities to ask questions <strong>of</strong> the panelists during the session in person and<br />
through social media. Chris Gunter will also pose relevant questions to attendees via<br />
social media during the meeting, and summarize the responses at the opening <strong>of</strong><br />
the session.<br />
Feedback<br />
To determine whether the programmatic changes implemented were successful, and<br />
to gather suggestions for future meetings, we will be sending an online survey after<br />
the meeting to all attendees. Please take the time to complete the survey and provide<br />
us with valuable feedback that we can consider for future meetings.<br />
Acknowledgments<br />
Developing a program for the <strong>ASHG</strong> Annual Meeting is a complex process, requiring the<br />
coordinated efforts <strong>of</strong> many individuals over thousands <strong>of</strong> person-hours. A description<br />
<strong>of</strong> how the <strong>Program</strong> Committee puts together the scientific content <strong>of</strong> the meeting can<br />
be found on page 327. This past year, I have had the privilege <strong>of</strong> working with a truly<br />
exceptional <strong>Program</strong> Committee — each member generously volunteering his/her<br />
expertise and time to develop an outstanding scientific program. I am also grateful to<br />
the Education, Social Issues, and Awards committees for their valuable contributions<br />
to the meeting. Finally, my deepest appreciation goes to our <strong>ASHG</strong> administrative staff<br />
(with a special note <strong>of</strong> thanks to Peggi McGovern, Pauline Minhinnett, and Dr. Joann<br />
Boughman) for their enthusiastic dedication and tireless work in making our Annual<br />
Meeting the success that it is.<br />
I hope that you enjoy the meeting, and again, a warm welcome to San Francisco!<br />
Joel N. Hirschhorn, MD, PhD<br />
<strong>2012</strong> <strong>Program</strong> Committee Chair<br />
Boston’s Children’s Hospital/Harvard Medical School<br />
Broad Institute
ABSTRACT REVIEWERS<br />
<strong>ASHG</strong> gratefully acknowledges the expertise, hard work and<br />
dedication <strong>of</strong> the <strong>2012</strong> Abstract Reviewers<br />
Kate G. Ackerman Katherine H. Kim<br />
Laura Almasy Jan Korbel<br />
Hans C. Andersson Beth A. Kozel<br />
Stylianos E. Antonarakis Michael Lovett<br />
Dimitrios Avramopoulos Richard Maas<br />
Blake C. Ballif Christa Lese Martin<br />
David R. Beier Rasika A. Mathias<br />
Cecelia A. Bellcross Andy McCallion<br />
Natalie Blagowidow Nazli McDonnell<br />
Joann A. Boughman Karen Mohlke<br />
Sally A. Camper Cynthia Morton<br />
Rita M. Cantor Maximilian Muenke<br />
Kimberly A. Chapman Christopher Newton-Cheh<br />
Andrew Clark Rasmus Nielsen<br />
Gregory M. Cooper Elaine A. Ostrander<br />
Tina M. Cowan Michael J. Parsons<br />
Gregory E. Crawford Robert Pilarski<br />
Dana C. Crawford Robert M. Plenge<br />
Paul de Bakker Barbara R. Pober<br />
Hal Dietz Nazneen Rahman<br />
Michael J. Dougherty Richard Redon<br />
Flavia M. Facio Catherine A. Reiser<br />
Clair A. Francomano Lawrence T. Reiter<br />
Thomas Glover Nathaniel H. Robin<br />
Chris Gunter Noah Rosenberg<br />
Jonathan L. Haines Richa Saxena<br />
Robert Hegele William K. Scott<br />
Joel N. Hirschhorn Michael R. Speicher<br />
Fuki M. Hisama Beth A. Sullivan<br />
Shama Jari Tricia A. Thornton-Wells<br />
Gail P. Jarvik Luk H. Vandenberghe<br />
Sekar Kathiresan Catherine A. Wicklund<br />
Nicholas Katsanis Alexander F. Wilson<br />
Brendan J. Keating Meredith Yeager<br />
9
10<br />
The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />
9650 Rockville Pike, Bethesda, Maryland 20814-3998<br />
Telephone: 301-634-7300 • 1-866-HUM-GENE • Fax: 301-634-7079<br />
E-mail: society@ashg.org or ashgmeetings@ashg.org<br />
<strong>ASHG</strong> Web site: www.ashg.org<br />
Annual Meeting Web site: www.ashg.org/<strong>2012</strong>meeting<br />
Meetings, Registration and Exhibits<br />
Pauline Minhinnett, Director <strong>of</strong> Meetings; paulinem@ashg.org<br />
Peggi McGovern, Senior Meetings Associate/Registrar; pmcgovern@ashg.org<br />
Carrie Morin, Exhibits, Sponsorship and Advertising Manager, cmorin@ashg.org<br />
<strong>ASHG</strong> Administrative Office<br />
Jennifer Hobin, Interim Executive Officer; jhobin@faseb.org<br />
Karen Goodman, Executive Assistant; kgoodman@ashg.org<br />
Education Department<br />
Michael J. Dougherty, Director <strong>of</strong> Education; mdougherty@ashg.org<br />
Katherine Lontok, Education <strong>Program</strong>s Manager; klontok@ashg.org<br />
Information Services<br />
Yimang Chen, Director, Information Technology; ychen@ashg.org<br />
Ray Wolfe, System Support Engineer/Web Site Coordinator; rwolfe@ashg.org<br />
Hubert Zhang, Systems Developer; hzhang@ashg.org<br />
Communications/Media<br />
Cathy Yarbrough, <strong>ASHG</strong> <strong>2012</strong> Communications Consultant; press@ashg.org<br />
Accounting<br />
Chuck Windle, Director <strong>of</strong> Administration and Finance; cwindle@ashg.org<br />
Membership<br />
Mary Shih, Membership Manager; mshih@ashg.org<br />
If you are unsure whom to contact, please e-mail ashgmeetings@ashg.org and your<br />
inquiry will be forwarded to the appropriate person. See page 53 for a list <strong>of</strong> on-site<br />
telephone numbers and <strong>of</strong>fices at the Convention Center during the <strong>2012</strong> <strong>ASHG</strong><br />
Annual Meeting.
ANNUAL MEETING SUPPORT<br />
The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> gratefully acknowledges the<br />
following Annual Meeting supporters<br />
BIOBASE<br />
Galaxy Workshop: Working with High-Throughput Data and Data Visualization<br />
G3: Genes, Genomes, <strong>Genetics</strong><br />
Educational Support<br />
Genzyme Corp.<br />
Cyber Café and WiFi<br />
Life Technologies<br />
Diagnostic Challenges: Review and Discussion <strong>of</strong> Unique Cases (Rare and<br />
Unknown)<br />
Roche<br />
Badge Holders<br />
11
12<br />
ADVERTISERS<br />
Affymetrix, Inc. (Booth 918) Back Cover<br />
<strong>ASHG</strong> Central (<strong>ASHG</strong>/AJHG)<br />
(Booth 913) Alphabetical, end <strong>of</strong> book, Page 421<br />
<strong>ASHG</strong> <strong>2012</strong> Mobile App Alphabetical, end <strong>of</strong> book, Page 422<br />
<strong>ASHG</strong> 2013 Call for Invited Sessions:<br />
Boston (Booth 913) Alphabetical, end <strong>of</strong> book, Page 423<br />
<strong>American</strong> College <strong>of</strong> Medical <strong>Genetics</strong><br />
and Genomics (Booth 318) Alphabetical, end <strong>of</strong> book, Page 424<br />
Association <strong>of</strong> Pr<strong>of</strong>essors <strong>of</strong> <strong>Human</strong><br />
and Medical <strong>Genetics</strong> (APHMG) Alphabetical, end <strong>of</strong> book, Page 425<br />
Baylor College <strong>of</strong> Medicine, Medical<br />
<strong>Genetics</strong> Laboratories (Booth 711) Inside Front Cover<br />
European <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />
Conference 2013 (Booth 219) Alphabetical, end <strong>of</strong> book, Page 426<br />
JAMA Network (Booth 1201) Facing Inside Back Cover<br />
Life Technologies (Booth 601) Inside Back Cover<br />
Natera (Booth 504) Alphabetical, end <strong>of</strong> book, Page 427<br />
RainDance Technologies (Booth 910) Exhibit Hall Floor Plan Banner<br />
Sequenom, Inc. (Booth 519) Alphabetical, end <strong>of</strong> book, Page 428/429<br />
Shire (Booth 600) Exhibits Tab Divider
NOTES
NOTES
SCHEDULE OF SCIENTIFIC SESSIONS AND<br />
ANCILLARY EVENTS<br />
Ancillary and satellite meetings, exhibitor or other special workshops, reunion/university<br />
receptions or meetings <strong>of</strong> editorial boards, committees, etc., are not <strong>of</strong>ficial <strong>ASHG</strong> functions.<br />
Listings in bold face indicate the event is an <strong>ASHG</strong>-sponsored scientific session/event<br />
open only to scientific registrants.<br />
Indicates Trainee-focused events<br />
Indicates Education-focused events<br />
Indicates Clinical-focused events<br />
(*)Asterisk denotes meetings/events that the organizer specified are by invitation or preregistration<br />
only. Otherwise, attendance may be assumed to be open to all registrants on a<br />
first-come, first-served basis.<br />
MONDAY, November 5<br />
*3:00 PM -<br />
8:00 PM<br />
*4:00 PM -<br />
5:45 PM<br />
*6:00 PM -<br />
9:00 PM<br />
*6:00 PM -<br />
9:00 PM<br />
*6:00 PM -<br />
9:00 PM<br />
<strong>ASHG</strong> Board <strong>of</strong> Directors Meeting #1 Marriott Marquis Hotel<br />
Foothill E, 2nd Level<br />
ABMG Finance Committee Meeting Marriott Marquis Hotel<br />
Pacific E, 4th Level<br />
ABMG Accreditation Committee Meeting Marriott Marquis Hotel<br />
Pacific D, 4th Level<br />
ABMG Credentials Committee Meeting Marriott Marquis Hotel<br />
Pacific F, 4th Level<br />
ABMG MOC Committee Meeting Marriott Marquis Hotel<br />
Pacific E, 4th Level<br />
TUESDAY, November 6<br />
*7:30 AM -<br />
4:00 PM<br />
8:00 AM -<br />
5:00 PM<br />
8:00 AM -<br />
4:00 PM<br />
*8:00 AM -<br />
3:00 PM<br />
*8:00 AM -<br />
3:30 PM<br />
*8:00 AM -<br />
4:00 PM<br />
FSH <strong>Society</strong> Facioscapulohumeral Muscular<br />
Dystrophy [FSHD] <strong>2012</strong> International<br />
Research Consortium & Research Planning<br />
Meeting<br />
Marriott Marquis Hotel<br />
Club Room, 2nd Level<br />
Exhibitor Registration Open Moscone Center<br />
South Lobby<br />
Annual Meeting <strong>of</strong> the <strong>Society</strong> <strong>of</strong> Crani<strong>of</strong>acial<br />
<strong>Genetics</strong> and Developmental Biology: Stem<br />
Cells in Crani<strong>of</strong>acial Development and<br />
Disease<br />
<strong>ASHG</strong> Undergraduate Faculty<br />
<strong>Genetics</strong> Education Workshop<br />
(Advance registration required.)<br />
15<br />
UCSF, Parnassus Campus<br />
Health Sciences West, Room<br />
301<br />
Moscone Center<br />
Room 300, Esplanade Level<br />
South<br />
ABMG Board <strong>of</strong> Directors Meeting Marriott Marquis Hotel<br />
Sierra I, 5th Level<br />
ACMG Board Meeting Marriott Marquis Hotel<br />
Sierra A, 5th Level<br />
SCHEDULE
16 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />
*8:30 AM -<br />
2:30 PM<br />
8:30 AM -<br />
3:45 PM<br />
*9:00 AM -<br />
1:00 PM<br />
10:00 AM -<br />
7:00 PM<br />
*10:00 AM -<br />
3:00 PM<br />
11:00 AM -<br />
4:30 PM<br />
*11:00 AM -<br />
1:00 PM<br />
*11:00 AM -<br />
3:00 PM<br />
12:00 PM -<br />
4:00 PM<br />
*12:00 PM -<br />
4:00 PM<br />
1:00 PM -<br />
4:00 PM<br />
1:30 PM -<br />
3:30 PM<br />
2:00 PM -<br />
4:00 PM<br />
4:00 PM -<br />
4:30 PM<br />
4:30 PM -<br />
6:30 PM<br />
*6:45 PM -<br />
9:30 PM<br />
7:00 PM -<br />
8:30 PM<br />
<strong>ASHG</strong> High School Workshop for Local<br />
San Francisco Students and Teachers<br />
(Advance registration required.)<br />
HVP: Getting Ready for the <strong>Human</strong> Phenome<br />
Project (Separate registration required.)<br />
Philippine Genome Center Health <strong>Program</strong><br />
Scientific Advisory Committee Meeting<br />
Moscone Center<br />
Room 303/305, Esplanade<br />
Level South<br />
Marriott Marquis Hotel<br />
Yerba Buena 7, Lower B2<br />
Level<br />
Moscone Center<br />
Room 220, East Mezzanine<br />
Level South<br />
Scientific Registration Open Moscone Center<br />
North Lobby<br />
<strong>ASHG</strong> Board <strong>of</strong> Directors Meeting #2 Moscone Center<br />
Room 222, East Mezzanine<br />
Level South<br />
Speaker Presentation/Upload Room Open<br />
Speakers are required to upload their<br />
presentations here. We recommend uploading<br />
at least 4 hours before your presentation time.<br />
Moscone Center<br />
Room 110, Lower Level<br />
South<br />
<strong>ASHG</strong> Social Issues Committee Meeting Moscone Center<br />
Room 214, East Mezzanine<br />
Level South<br />
<strong>ASHG</strong> <strong>Program</strong> Committee Meeting #1 Moscone Center<br />
Room 224/226, East<br />
Mezzanine Level South<br />
Ataxia-Telangiectasia & Genome Instability<br />
Workshop<br />
For further information contact:<br />
meyn@sickkids.ca<br />
European <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> (ESHG)<br />
Executive Board Meeting<br />
Getting the Most from the <strong>Human</strong> Genome:<br />
Understanding Updates and Improvements in<br />
the Reference Assembly<br />
1st Meeting <strong>of</strong> the International Consortium<br />
for Autosomal Recessive Intellectual Disability<br />
(CARID)<br />
Clinical Utility <strong>of</strong> Whole Exome Sequencing:<br />
Baylor’s Initial Experience<br />
1. <strong>ASHG</strong> Presidential Address: The<br />
Scientist as a Citizen <strong>of</strong> the World<br />
Moscone Center<br />
Room 274/276, West<br />
Mezzanine Level South<br />
Moscone Center<br />
Room 270, West Mezzanine<br />
Level South<br />
Moscone Center<br />
Room 236/238, East<br />
Mezzanine Level South<br />
Moscone Center<br />
Room 272, West Mezzanine<br />
Level South<br />
Moscone Center<br />
Room 310, Esplanade Level<br />
South<br />
Moscone Center<br />
Hall D, Lower Level North<br />
2. Plenary Abstract Presentations Moscone Center<br />
Hall D, Lower Level North<br />
<strong>Genetics</strong> <strong>of</strong> Type 2 Diabetes Meeting Marriott Marquis Hotel<br />
Pacific I, 4th Level<br />
<strong>ASHG</strong> Opening Mixer and Trainee<br />
Mixer-within-a-Mixer (Open to all<br />
scientific registrants.)<br />
Marriott Marquis Hotel<br />
Yerba Buena 7/8/9, Lower<br />
B2 Level
*7:00 PM -<br />
8:00 PM<br />
*7:00 PM -<br />
9:00 PM<br />
SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 17<br />
ACMG Development Committee Meeting Marriott Marquis Hotel<br />
Sierra A, 5th Level<br />
<strong>American</strong> Journal <strong>of</strong> Medical <strong>Genetics</strong><br />
Editorial Board Meeting<br />
WEDNESDAY, November 7<br />
7:00 AM -<br />
5:00 PM<br />
7:00 AM -<br />
5:00 PM<br />
8:00 AM -<br />
10:00 AM<br />
8:00 AM -<br />
4:30 PM<br />
10:00 AM -<br />
4:30 PM<br />
10:00 AM -<br />
4:30 PM<br />
Marriott Marquis Hotel<br />
Golden Gate C2, B2 Level<br />
Scientific Registration Open Moscone Center<br />
North Lobby<br />
Speaker Presentation/Upload Room Open<br />
Speakers are required to upload their<br />
presentations here. We recommend uploading<br />
at least 4 hours before your presentation time.<br />
Moscone Center<br />
Room 110, Lower Level<br />
South<br />
Concurrent Invited Session I (3-10): Moscone Center<br />
3. Implementing Next-Generation<br />
Sequencing as a Clinical Test<br />
4. Assessing the Pathogenicity <strong>of</strong><br />
Genetic Variants: Translating in Vitro<br />
and in Silico Advances to the Clinic<br />
5. Gene Regulatory Change: The Engine<br />
<strong>of</strong> <strong>Human</strong> Evolution?<br />
6. Insights into <strong>Human</strong> Demography and<br />
Selection from Full Genome<br />
Sequencing<br />
7. Age-Related Macular Degeneration—<br />
GWAS and Beyond: Guiding Light for<br />
the Complex Neurodegenerative<br />
Diseases<br />
8. “Yes Virginia, Family Studies Really Are<br />
Useful for Complex Traits in the Next-<br />
Generation Sequencing Era” (session<br />
in honor <strong>of</strong> Dr. Robert Elston’s<br />
contributions to human genetics in the<br />
year <strong>of</strong> his 80th birthday)<br />
9. Surveying Customer Responses to<br />
Personal Genetic Services<br />
10. Metabolism, Metals, and<br />
Neurodegeneration: Toward<br />
Enhanced Understanding <strong>of</strong><br />
Disease Mechanisms and<br />
Rational Therapeutics<br />
Hall D, Lower Level North<br />
Gateway Ballroom 103,<br />
Lower Level South<br />
Room 135, Lower Level<br />
North<br />
Room 134, Lower Level<br />
North<br />
Gateway Ballroom 104,<br />
Lower Level South<br />
Room 124, Lower Level<br />
North<br />
Room 132, Lower Level<br />
North<br />
Room 130, Lower Level<br />
North<br />
Exhibitor Registration Open Moscone Center<br />
South Lobby<br />
Career Resources Open<br />
Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Exhibits Open Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
SCHEDULE
18 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />
10:00 AM -<br />
4:30 PM<br />
10:30 AM -<br />
12:45 PM<br />
12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
1:45 PM<br />
12:45 PM -<br />
2:00 PM<br />
Posters Open Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Concurrent Platform (abstract-driven) Moscone Center<br />
Session A (11-19):<br />
11. <strong>Genetics</strong> <strong>of</strong> Autism Spectrum<br />
Hall D, Lower Level North<br />
Disorders<br />
12. New Methods for Big Data Gateway Ballroom 103,<br />
Lower Level South<br />
13. Cancer <strong>Genetics</strong> I: Rare Variants Room 135, Lower Level<br />
North<br />
14. Quantitation and Measurement <strong>of</strong><br />
Regulatory Oversight by the Cell<br />
15. New Loci for Obesity, Diabetes, and<br />
Related Traits<br />
Room 134, Lower Level<br />
North<br />
Gateway Ballroom 104,<br />
Lower Level South<br />
16. Neuromuscular Disease and Deafness Room 124, Lower Level<br />
North<br />
17. Chromosomes and Disease Room 132, Lower Level<br />
North<br />
18. Prenatal and Perinatal <strong>Genetics</strong> Room 130, Lower Level<br />
North<br />
19. Vascular and Congenital Heart Disease Room 123, Lower Level<br />
North<br />
Lunch Break, Open Viewing for Posters<br />
and Exhibits<br />
<strong>ASHG</strong> Trainee-Mentor<br />
Luncheon (Advance ticket<br />
purchase required.)<br />
<strong>ASHG</strong> Workshop:<br />
Clinical Interpretation<br />
<strong>of</strong> Cytogenomic Arrays:<br />
Tools & Resources (Advance<br />
ticket purchase required.)<br />
<strong>ASHG</strong>/NCBI Workshop:<br />
Discovering Biological<br />
Data at NCBI (Advance<br />
ticket purchase required.)<br />
<strong>Human</strong> Variome Project International<br />
Scientific Advisory Committee Meeting<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
Complete Genomics Workshop: Whole<br />
Genome Sequencing as a Clinical Tool<br />
Roche Workshop: Genetic Diversity Analysis<br />
Using 454 and Nimblegen Sequencing<br />
Solutions<br />
Illumina Workshop: Integrated Tools for Next-<br />
Generation Sequencing & Genotyping<br />
Applications<br />
Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Moscone Center<br />
Room 303/305, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 307, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 270, West Mezzanine<br />
Level South<br />
Moscone Center Room 309,<br />
Esplanade Level South<br />
Moscone Center<br />
Room 236/238, East<br />
Mezzanine Level South<br />
Moscone Center<br />
Room 308, Esplanade Level<br />
South
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
1:15 PM -<br />
2:15 PM<br />
2:15 PM -<br />
4:15 PM<br />
4:30 PM -<br />
6:30 PM<br />
6:30 PM -<br />
7:45 PM<br />
6:30 PM -<br />
8:00 PM<br />
6:30 PM -<br />
8:00 PM<br />
*6:30 PM -<br />
9:30 PM<br />
*6:30 PM -<br />
9:30 PM<br />
6:45 PM -<br />
8:45 PM<br />
SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 19<br />
Affymetrix Workshop: Enabling the Genome<br />
Generation #1: Population-Optimized<br />
Strategies and Genotyping Solutions for<br />
Expanding Our Understanding <strong>of</strong> the Genetic<br />
Variations in Complex Diseases<br />
Agilent Technologies Lunch Workshop: Better<br />
Sequencing, Better World: The Latest in<br />
HaloPlex & SureSelect NGS Target<br />
Enrichment for <strong>Human</strong> Disease Research<br />
<strong>Human</strong> Molecular <strong>Genetics</strong> Editorial Board<br />
Meeting<br />
DNAnexus: Taking the Guesswork and<br />
Complexity Out <strong>of</strong> Genomic Data Analysis<br />
with a Novel Collaborative and Scalable Data<br />
Technology Platform<br />
QIAGEN, Inc. Workshop: New Sample Prep<br />
Solutions & Multiplex Gene Panel Target<br />
Enrichment for Next-Generation Sequencing<br />
Ion Torrent Luncheon Workshop:<br />
Semiconductor Sequencing For All: Ion<br />
Proton and Ion PGM Systems, Ion<br />
AmpliSeq Technology & More<br />
ACMG <strong>Genetics</strong> Review Course Faculty<br />
Meeting<br />
Knome Workshop: Interpreting Whole<br />
Genomes to Understand Disease and Drug<br />
Response: Methods, Tools, and Case Studies<br />
Poster Session I (Wednesday Poster<br />
Authors Present)<br />
20. Invited Presidential Symposium: Gene<br />
Discovery and Patent Law: Present<br />
Experience in the U.S. and in Europe<br />
Ambry <strong>Genetics</strong> Workshop: The Power <strong>of</strong> the<br />
Diagnostic Exome<br />
Cleveland Clinic Genomic Medicine Institute<br />
Reception<br />
Progeny S<strong>of</strong>tware Workshop: How to<br />
integrate Family History into your EMR<br />
Moscone Center<br />
Room 302, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 250, West Mezzanine<br />
Level South<br />
Moscone Center<br />
Room 274/276, West<br />
Mezzanine Level South<br />
Moscone Center<br />
Room 301, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 300, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 310, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 222, East Mezzanine<br />
Level South<br />
Moscone Center<br />
Room 232/234, East<br />
Mezzanine Level South<br />
Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Moscone Center<br />
Hall D, Lower Level North<br />
Moscone Center<br />
Room 307, Esplanade Level<br />
South<br />
Marriott Marquis Hotel<br />
Yerba Buena 1/2, Lower B2<br />
Level<br />
Moscone Center<br />
Room 236/238, East<br />
Mezzanine Level South<br />
ACMG MOC Meeting Marriott Marquis Hotel<br />
Sierra F, 5th Level<br />
ACMG Pr<strong>of</strong>essional Practice and <strong>Guide</strong>lines<br />
Committee Meeting<br />
Canadian College <strong>of</strong> Medical Geneticists:<br />
CIHR Institute <strong>of</strong> <strong>Genetics</strong> Mixer<br />
Marriott Marquis Hotel<br />
Sierra E, 5th Level<br />
Marriott Marquis Hotel<br />
Yerba Buena 5/6, Lower B2<br />
Level<br />
SCHEDULE
20 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />
*6:45 PM -<br />
9:45 PM<br />
*6:45 PM -<br />
10:30 PM<br />
7:00 PM -<br />
10:30 PM<br />
*7:00 PM -<br />
8:30 PM<br />
*7:00 PM -<br />
8:30 PM<br />
7:00 PM -<br />
8:30 PM<br />
*7:00 PM -<br />
8:30 PM<br />
7:00 PM -<br />
9:00 PM<br />
7:00 PM -<br />
9:30 PM<br />
*7:00 PM -<br />
10:00 PM<br />
*7:00 PM -<br />
10:00 PM<br />
*7:00 PM -<br />
10:00 PM<br />
*7:00 PM -<br />
10:00 PM<br />
International Federation <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />
Societies (IFHGS) Executive Board Meeting<br />
Explore Art & Science with Life Technologies<br />
(By invitation only.)<br />
Moscone Center<br />
Room 224/226, East<br />
Mezzanine Level South<br />
San Francisco Museum <strong>of</strong><br />
Modern Art<br />
Agilent Customer Appreciation Event B Restaurant & Bar<br />
720 Howard Street<br />
<strong>ASHG</strong> Interactive Workshop<br />
on the UCSC Genome<br />
Browser for Intermediate/<br />
Advanced Users (Advance<br />
ticket purchase required.)<br />
<strong>ASHG</strong> Workshop: Social<br />
Media + Scientists = Success:<br />
Strategies for Using Social Media to<br />
Benefit Your Research, Your Career<br />
and Your Connections (Advance<br />
ticket purchase required.)<br />
DNASTAR, Inc. Workshop: Cancer Genomics<br />
Data Analysis Using Next-Gen Sequencing: A<br />
Case Study and Workflow<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 310, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 301, Esplanade Level<br />
South<br />
<strong>Human</strong> Mutation Editorial Board Meeting Marriott Marquis Hotel<br />
Nob Hill C/D, Lower B2 Level<br />
Baylor College <strong>of</strong> Medicine <strong>Genetics</strong><br />
Reception<br />
University <strong>of</strong> Michigan, Department <strong>of</strong> <strong>Human</strong><br />
<strong>Genetics</strong> Alumni Gathering<br />
<strong>2012</strong> Stanford University, Department <strong>of</strong><br />
<strong>Genetics</strong> Reunion<br />
ACMG Biochemical <strong>Genetics</strong> Subcommittee<br />
Meeting<br />
Marriott Marquis Hotel<br />
Yerba Buena 10/11/12/13,<br />
Lower B2 Level<br />
Marriott Marquis Hotel<br />
Pacific C, 4th Level<br />
Roe-SF<br />
651 Howard Street<br />
Marriott Marquis Hotel<br />
Sierra B, 5th Level<br />
ACMG Cytogenetics Subcommittee Meeting Marriott Marquis Hotel<br />
Sierra C, 5th Level<br />
ACMG Molecular <strong>Genetics</strong> Subcommittee<br />
Meeting<br />
THURSDAY, November 8<br />
7:00 AM -<br />
4:30 PM<br />
7:00 AM -<br />
5:00 PM<br />
7:00 AM -<br />
8:00 AM<br />
7:30 AM -<br />
5:00 PM<br />
Marriott Marquis Hotel<br />
Sierra A, 5th Level<br />
Posters Open Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Speaker Presentation/Upload Room Open<br />
Speakers are required to upload their<br />
presentations here. We recommend uploading<br />
at least 4 hours before your presentation time.<br />
Moscone Center<br />
Room 110, Lower Level<br />
South<br />
ACMG Education Committee Meeting Moscone Center<br />
Room 222, East Mezzanine<br />
Level South<br />
Scientific Registration Open Moscone Center<br />
North Lobby<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT
8:00 AM -<br />
10:00 AM<br />
8:00 AM -<br />
4:30 PM<br />
10:00 AM -<br />
4:30 PM<br />
10:00 AM -<br />
4:30 PM<br />
10:30 AM -<br />
12:45 PM<br />
SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 21<br />
Concurrent Invited Session II (21-28): Moscone Center<br />
21. Mendelian Randomization: Using<br />
Genetic Variants to Inform Causality in<br />
Observational Epidemiology<br />
22. Common and Rare CNVs: Genesis,<br />
Patterns <strong>of</strong> Variations and <strong>Human</strong><br />
Diseases<br />
23. Advancing Gene Therapy to the<br />
Clinic: Molecular Medicines<br />
Come <strong>of</strong> Age<br />
24. RNA Splicing in <strong>Human</strong> Development,<br />
Diseases and Natural Variation<br />
25. Genomic Medicine: ELSI Goes<br />
Mainstream<br />
26. Model Organism <strong>Genetics</strong>, <strong>Human</strong><br />
Biology and <strong>Human</strong> Disease<br />
27. Next-Generation Sequencing in<br />
Isolated Populations: Opportunities for<br />
Accelerated Gene Discovery in<br />
Complex Traits<br />
28. Transforming Medical Student<br />
Education in <strong>Genetics</strong> and<br />
Genomics: How Do We Improve<br />
Health and Individualize Care<br />
through Medical School Genetic<br />
and Genomic Curricula?<br />
Room 135, Lower Level<br />
North<br />
Hall D, Lower Level North<br />
Gateway Ballroom 104,<br />
Lower Level South<br />
Room 124, Lower Level<br />
North<br />
Room 132, Lower Level<br />
North<br />
Gateway Ballroom 103,<br />
Lower Level South<br />
Room 134, Lower Level<br />
North<br />
Room 130, Lower Level<br />
North<br />
Exhibitor Registration Open Moscone Center<br />
South Lobby<br />
Career Resources Open<br />
Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Exhibits Open Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Concurrent Platform (abstract-driven) Moscone Center<br />
Session B (29-37):<br />
29. Next-Generation Sequencing: Methods Hall D, Lower Level North<br />
and Applications<br />
30. <strong>Genetics</strong> and Intellectual Disability Gateway Ballroom 103,<br />
Lower Level South<br />
31. GWAS from Head to Toe Room 135, Lower Level<br />
North<br />
32. Cardiovascular <strong>Genetics</strong>: GWAS and<br />
Beyond<br />
33. Clinical <strong>Genetics</strong>: Mutations,<br />
Mutations and Syndromes<br />
Room 134, Lower Level<br />
North<br />
Gateway Ballroom 104,<br />
Lower Level South<br />
34. Cancer <strong>Genetics</strong> II: Clinical Translation Room 124, Lower Level<br />
North<br />
SCHEDULE
22 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />
12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:00 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:00 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
35. Ethical, Legal, Social and Policy<br />
Issues<br />
Room 132, Lower Level<br />
North<br />
36. Chipping Away at Autoimmune Disease Room 130, Lower Level<br />
North<br />
37. Metabolic Disease Discoveries Room 123, Lower Level<br />
North<br />
Lunch Break, Open Viewing for Posters<br />
and Exhibits<br />
Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
AJHG Editorial Board Luncheon Moscone Center<br />
Room 224/226, East<br />
Mezzanine Level South<br />
<strong>ASHG</strong> Information and Education Meeting Moscone Center<br />
Room 214, East Mezzanine<br />
Level South<br />
<strong>ASHG</strong> Workshop: Diagnostic<br />
Challenges: Review and Discussion<br />
<strong>of</strong> Unique Cases, Rare and Unknown<br />
Cases (Advance ticket purchase required.)<br />
Association <strong>of</strong> Pr<strong>of</strong>essors <strong>of</strong> <strong>Human</strong> and<br />
Medical <strong>Genetics</strong> (APHMG) and SIGs<br />
Business Meeting and Lunch<br />
Moscone Center<br />
Room 303/305, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 300, Esplanade Level<br />
South<br />
Clinical <strong>Genetics</strong> Editorial Board Meeting Moscone Center<br />
Room 274/276, West<br />
Mezzanine Level South<br />
Genetic Epidemiology Editorial Board Meeting Moscone Center<br />
Room 272, West Mezzanine<br />
Level South<br />
<strong>Human</strong> Variome Project <strong>Genetics</strong> Journal<br />
Editors Meeting<br />
Life Technologies Luncheon Workshop:<br />
Genetic Analysis at the Speed <strong>of</strong> Life<br />
SOLD<br />
OUT<br />
Illumina Workshop: Next-Generation<br />
Sequencing - Implications for the Clinical Lab<br />
Affymetrix Workshop: Enabling the Genome<br />
Generation #2: Next Generation Cytogenetics<br />
Solution for Constitutional and Cancer<br />
Research Applications<br />
Agilent Technologies Lunch Workshop:<br />
Microarrays & Beyond: Advancements in<br />
Cytogenetic Research Technologies -<br />
Maximizing Flexibility and Customization for<br />
Multiple Applications with NGS, FISH, and<br />
Microarrays<br />
Asuragen, Inc. Workshop: Next Generation<br />
Fragile X Testing: New Capabilities in Genetic<br />
Counseling, Reproduction, and Fertility<br />
Planning for Female FMR1 Carriers<br />
Moscone Center<br />
Room 270, West Mezzanine<br />
Level South<br />
Moscone Center<br />
Room 310, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 308, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 307, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 232/234, East<br />
Mezzanine Level South
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
*1:00 PM -<br />
2:00 PM<br />
*1:00 PM -<br />
2:00 PM<br />
1:00 PM -<br />
2:15 PM<br />
2:15 PM -<br />
4:15 PM<br />
4:30 PM -<br />
6:45 PM<br />
*6:45 PM -<br />
8:15 PM<br />
6:45 PM -<br />
8:15 PM<br />
SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 23<br />
BGI Luncheon Workshop: <strong>Human</strong> Disease<br />
Research and Drug Development in the Era <strong>of</strong><br />
Next-Gen Sequencing<br />
BioNano Genomics Workshop: A Game-<br />
Changing Solution for Structural Variation<br />
Detection and Improving Assembly with<br />
Single-Molecule Visualization<br />
RainDance Technologies Workshop: Powering<br />
Recent Advances in <strong>Human</strong> <strong>Genetics</strong><br />
BioDiscovery Nexus CNV Workshop: Recent<br />
CNV Discoveries and Integrated Genomics<br />
from NGS and Microarray Data<br />
ACMG Social, Ethical and Legal Issues<br />
Committee Meeting<br />
Moscone Center<br />
Room 309, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 301, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 236/238, East<br />
Mezzanine Level South<br />
Moscone Center<br />
Room 302, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 220, East Mezzanine<br />
Level South<br />
ACMG Therapeutics Committee Meeting Moscone Center<br />
Room 222, East Mezzanine<br />
Level South<br />
Pacific Biosciences Workshop: Revealing the<br />
Genome through SMRT Biology: Discoveries<br />
and Applications<br />
Poster Session II (Thursday Poster Authors<br />
Present)<br />
Concurrent Platform (abstract-driven)<br />
Session C (38-46):<br />
38. A Sequencing Jamboree: Exomes to<br />
Genomes<br />
Moscone Center<br />
Room 250, West Mezzanine<br />
Level South<br />
Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Moscone Center<br />
Hall D, Lower Level North<br />
39. Admixture and Demography Gateway Ballroom 103,<br />
Lower Level South<br />
40. Analysis <strong>of</strong> Multilocus Systems Room 135, Lower Level<br />
North<br />
41. Genes Underlying Neurological<br />
Disease<br />
Room 134, Lower Level<br />
North<br />
42. Cancer <strong>Genetics</strong> III: Common Variants Gateway Ballroom 104,<br />
Lower Level South<br />
43. <strong>Genetics</strong> <strong>of</strong> Crani<strong>of</strong>acial and<br />
Musculoskeletal Disorders<br />
Room 124, Lower Level<br />
North<br />
44. Tools for Phenotype Analysis Room 132, Lower Level<br />
North<br />
45. Therapy <strong>of</strong> Genetic Disorders Room 130, Lower Level<br />
North<br />
46. Pharmacogenetics: From Discovery to<br />
Implementation<br />
UC Davis Integrative <strong>Genetics</strong> and Genomics<br />
Reception<br />
Room 123, Lower Level<br />
North<br />
Marriott Marquis Hotel<br />
Sierra H, 5th Level<br />
PALB2 Interest Group Meeting Moscone Center<br />
Room 270, West Mezzanine<br />
Level South<br />
SCHEDULE
24 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />
6:45 PM -<br />
9:00 PM<br />
*6:45 PM -<br />
9:30 PM<br />
6:45 PM -<br />
9:45 PM<br />
6:45 PM -<br />
10:00 PM<br />
6:45 PM -<br />
9:45 PM<br />
*7:00 PM -<br />
8:30 PM<br />
7:00 PM -<br />
8:30 PM<br />
7:00 PM -<br />
8:30 PM<br />
*7:00 PM -<br />
9:00 PM<br />
7:00 PM -<br />
9:00 PM<br />
7:00 PM -<br />
9:00 PM<br />
*7:00 PM -<br />
9:30 PM<br />
*7:00 PM -<br />
10:00 PM<br />
7:00 PM -<br />
10:00 PM<br />
*7:00 PM -<br />
8:00 PM<br />
7:30 PM -<br />
9:00 PM<br />
7:30 PM -<br />
9:30 PM<br />
8:30 PM -<br />
10:30 PM<br />
9:00 PM -<br />
11:00 PM<br />
Ion Torrent: Users Group Meeting W Hotel<br />
Great Room I/II<br />
Ingenuity Systems Reception<br />
TBA<br />
(By invitation only.)<br />
Emory University Department <strong>of</strong> <strong>Human</strong><br />
<strong>Genetics</strong> Reception<br />
Marriott Marquis Hotel<br />
Pacific J, 4th Level<br />
Reception for Friends <strong>of</strong> RUCDR Marriott Marquis Hotel<br />
Nob Hill A/B, Lower B2 Level<br />
ENCODE-Epigenomics Common Fund<br />
Tutorial<br />
<strong>ASHG</strong> Interactive Workshop:<br />
Galaxy 101: Data Integration,<br />
Analysis and Sharing (Separate<br />
registration required.)<br />
Association <strong>of</strong> Chinese Geneticists in America<br />
(ACGA) Annual Meeting and Career Workshop<br />
UCLA Medical <strong>Genetics</strong> Training <strong>Program</strong> and<br />
Department <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> Reception<br />
Harvard Medical School <strong>Genetics</strong> Alumni<br />
Reception<br />
Johns Hopkins Institute <strong>of</strong> Genetic Medicine<br />
Alumni Reception<br />
Mount Sinai Department <strong>of</strong> <strong>Genetics</strong> and<br />
Genomic Sciences Alumni Reception<br />
<strong>ASHG</strong> Trainee Development <strong>Program</strong><br />
and Networking: Science and Public<br />
Policy: Why Should Scientists Care<br />
About and Become Active in Public<br />
Policy Involving Science? (Separate<br />
registration required.)<br />
Moscone Center<br />
Room 303/305, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Marriott Marquis Hotel<br />
Golden Gate C1, B2 Level<br />
Marriott Marquis Hotel<br />
Yerba Buena 5/6, Lower B2<br />
Level<br />
Marriott Marquis Hotel<br />
Pacific C, 4th Level<br />
Marriott Marquis Hotel<br />
Pacific H, 4th Level<br />
Marriott Marquis Hotel<br />
Sierra C, 5th Level<br />
Moscone Center<br />
Room 309, Esplanade Level<br />
South<br />
ACMG Lab QA Committee Meeting Marriott Marquis Hotel<br />
Sierra A, 5th Level<br />
23andMe Bar Night at the B B Restaurant & Bar<br />
720 Howard Street<br />
GIANT Consortium Moscone Center<br />
Room 274/276, West<br />
Mezzanine Level South<br />
Ohio State Scarlet & Gray Reception Marriott Marquis Hotel<br />
Nob Hill C/D, Lower B2 Level<br />
University <strong>of</strong> Maryland School <strong>of</strong> Medicine/<br />
<strong>Program</strong> in Personalized and Genomic<br />
Medicine/Institute for Genome Sciences<br />
Reception<br />
University <strong>of</strong> Chicago Department <strong>of</strong> <strong>Human</strong><br />
<strong>Genetics</strong> Dessert & Wine Reception<br />
Marriott Marquis Hotel<br />
Pacific B, 4th Level<br />
Marriott Marquis Hotel<br />
Yerba Buena 10/11, Lower<br />
B2 Level<br />
CHOP/PENN Reunion Marriott Marquis Hotel<br />
Yerba Buena 4, Lower B2 Level<br />
SOLD<br />
OUT
FRIDAY, November 9<br />
7:00 AM -<br />
4:30 PM<br />
7:00 AM -<br />
5:00 PM<br />
7:30 AM -<br />
5:00 PM<br />
8:00 AM -<br />
10:15 AM<br />
8:00 AM -<br />
4:30 PM<br />
10:00 AM -<br />
4:30 PM<br />
10:00 AM -<br />
4:30 PM<br />
10:30 AM -<br />
11:15 AM<br />
11:15 AM -<br />
11:45 AM<br />
11:45 AM -<br />
12:45 PM<br />
12:45 PM -<br />
2:15 PM<br />
SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 25<br />
Posters Open Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Speaker Presentation/Upload Room Open<br />
Speakers are required to upload their<br />
presentations here. We recommend uploading<br />
at least 4 hours before your presentation time.<br />
Moscone Center<br />
Room 110, Lower Level<br />
South<br />
Scientific Registration Open Moscone Center<br />
North Lobby<br />
Concurrent Platform (abstract-driven) Moscone Center<br />
Session D (47-55):<br />
47. Structural and Regulatory Genomic Hall D, Lower Level North<br />
Variation<br />
48. Neuropsychiatric Disorders Gateway Ballroom 103,<br />
Lower Level South<br />
49. Common Variants, Rare Variants, and<br />
Everything in Between<br />
Room 135, Lower Level<br />
North<br />
50. Population <strong>Genetics</strong> Genome-Wide Room 134, Lower Level<br />
North<br />
51. Endless Forms Most Beautiful: Variant<br />
Discovery in Genomic Data<br />
52. Clinical <strong>Genetics</strong>: Complex<br />
Mechanisms and Exome-Discovery<br />
53. From SNP to Function in Complex<br />
Traits<br />
54. Genetic Counseling and Clinical<br />
Testing<br />
55. Mitochondrial Disorders and<br />
Ciliopathies<br />
Gateway Ballroom 104,<br />
Lower Level South<br />
Room 124, Lower Level<br />
North<br />
Room 132, Lower Level<br />
North<br />
Room 130, Lower Level<br />
North<br />
Room 123, Lower Level<br />
North<br />
Exhibitor Registration Open Moscone Center<br />
South Lobby<br />
Career Resources Open<br />
Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Exhibits Open Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
56. Gruber <strong>Genetics</strong> Prize Award<br />
Presentation and Rosalind Franklin<br />
Young Investigator Award<br />
Announcement<br />
57. <strong>ASHG</strong> William Allan Award<br />
Presentation<br />
58. <strong>ASHG</strong> Membership amd Business<br />
Meeting<br />
Lunch Break, Open Viewing for Posters<br />
and Exhibits<br />
Moscone Center<br />
Hall D, Lower Level North<br />
Moscone Center<br />
Hall D, Lower Level North<br />
Moscone Center<br />
Hall D, Lower Level North<br />
Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
SCHEDULE
26 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
12:45 PM -<br />
2:15 PM<br />
*1:00 PM -<br />
2:00 PM<br />
2:15 PM -<br />
4:15 PM<br />
4:30 PM -<br />
6:45 PM<br />
<strong>ASHG</strong> <strong>Program</strong> Committee Meeting #2 Moscone Center<br />
Room 224/226, East<br />
Mezzanine Level South<br />
<strong>ASHG</strong> Mock Study Section<br />
Workshop (Advance ticket<br />
purchase required.)<br />
<strong>ASHG</strong>/Galaxy Interactive<br />
Workshop: Working with<br />
High- Throughput Data and Data<br />
Visualization (Separate advance<br />
registration required.)<br />
NEBNext: Take the Next Step with Your NGS<br />
Library Prep Reagents<br />
QIAGEN, Inc. Workshop: Automated<br />
Solutions for Quality Control and Validation <strong>of</strong><br />
Next-Gen Sequencing<br />
Recent Advances in NGS Technologies for<br />
Rapid Discovery and Direct Clinical<br />
Applications<br />
Fluidigm Workshop: From Sample to<br />
Sequence Ready: Building robust amplicon<br />
libraries for targeted analysis and validation<br />
using the Access Array System<br />
CLC bio Workshop: Medical Resequencing<br />
Pipelines, and Streamlined Amplicon<br />
Sequence from NGS Data<br />
Moscone Center<br />
Room 303/305, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 302, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 300, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 232/234, East<br />
Mezzanine Level South<br />
Moscone Center<br />
Room 307, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 236/238, East<br />
Mezzanine Level South<br />
ISCA Consortium Luncheon Marriott Marquis Hotel<br />
Yerba Buena 1/2, Lower B2<br />
Level<br />
ACMG Economics Committee Meeting Moscone Center<br />
Room 222, East Mezzanine<br />
Level South<br />
Poster Session III (Friday Poster Authors<br />
Present)<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67):<br />
Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
Moscone Center<br />
59. Genome Structure and Variation Hall D, Lower Level North<br />
60. Advances in Neurodegenerative<br />
Disease<br />
61. Missing Heritability, Interactions and<br />
Sequencing<br />
62. Exome Sequencing Uncovers Etiology<br />
<strong>of</strong> Mendelian Disease<br />
63. Transcriptional Regulation, Variation<br />
and Complexity<br />
Gateway Ballroom 103,<br />
Lower Level South<br />
Room 135, Lower Level<br />
North<br />
Room 134, Lower Level<br />
North<br />
Gateway Ballroom 104,<br />
Lower Level South<br />
64. Epigenetics Room 124, Lower Level<br />
North<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT
*7:00 PM -<br />
8:30 PM<br />
*7:00 PM -<br />
8:30 PM<br />
*7:00 PM -<br />
9:00 PM<br />
8:00 PM -<br />
12:00<br />
midnight<br />
SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS 27<br />
65. Advances in Ocular <strong>Genetics</strong> Room 132, Lower Level<br />
North<br />
66. Cancer <strong>Genetics</strong>: Somatic Variants Room 130, Lower Level<br />
North<br />
67. Developmental Insights into <strong>Human</strong><br />
Malformations<br />
Room 123, Lower Level<br />
North<br />
<strong>ASHG</strong> Trainee Awards Committee Meeting Moscone Center<br />
Room 224/226, East<br />
Mezzanine Level South<br />
<strong>ASHG</strong>/Ensembl Interactive<br />
Worshop: Ensembl<br />
Web- Based Genomic Tools<br />
for Intermediate/Advance Users<br />
(Advance ticket purchase required.)<br />
Drama, Discourse and<br />
Genomics: IRBs to IFs—<br />
An Interactive Play (Advance<br />
ticket purchase required.)<br />
UCSF Institute for <strong>Human</strong> <strong>Genetics</strong> and<br />
Medical <strong>Genetics</strong> Reception<br />
SATURDAY, November 10<br />
7:00 AM -<br />
10:30 AM<br />
7:30 AM -<br />
12:00 PM<br />
8:00 AM -<br />
8:20 AM<br />
8:20 AM -<br />
8:40 AM<br />
8:40 AM -<br />
8:45 AM<br />
8:45 AM -<br />
8:55 AM<br />
8:55 AM -<br />
9:20 AM<br />
9:40 AM -<br />
11:40 AM<br />
Speaker Presentation/Upload Room Open<br />
Speakers are required to upload their<br />
presentations here. We recommend uploading<br />
at least 4 hours before your presentation time.<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 300, Esplanade Level<br />
South<br />
Museum <strong>of</strong> the African<br />
Diaspora<br />
685 Mission Street<br />
Moscone Center<br />
Room 110, Lower Level<br />
South<br />
Scientific Registration Open Moscone Center<br />
North Lobby<br />
68. <strong>ASHG</strong> Award for Excellence in <strong>Human</strong><br />
<strong>Genetics</strong> Education<br />
69. <strong>ASHG</strong> Victor A. McKusick Leadership<br />
Award Presentation<br />
70. AJHG C.W. Cotterman Awards<br />
Announcement<br />
71. <strong>ASHG</strong> Charles J. Epstein Trainee<br />
Awards for Excellence in <strong>Human</strong><br />
<strong>Genetics</strong> Research: Announcement<br />
<strong>of</strong> Winners<br />
Moscone Center<br />
Hall D, Lower Level North<br />
Moscone Center<br />
Hall D, Lower Level North<br />
Moscone Center<br />
Hall D, Lower Level North<br />
Moscone Center<br />
Hall D, Lower Level North<br />
72. <strong>ASHG</strong> Curt Stern Award Presentation Moscone Center<br />
Hall D, Lower Level North<br />
Concurrent Invited Session III (73-80): Moscone Center<br />
73. Returning Results from Large-<br />
Scale Sequencing: Where the<br />
Rubber Meets the Road<br />
74. Genomic Approaches to Mendelian<br />
Disorders<br />
75. Emerging Applications <strong>of</strong> Identity by<br />
Descent Segment Detection<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
Gateway Ballroom 103,<br />
Lower Level South<br />
Hall D, Lower Level North<br />
Gateway Ballroom 104,<br />
Lower Level South<br />
SCHEDULE
28 SCHEDULE OF SCIENTIFIC SESSIONS AND ANCILLARY EVENTS<br />
12:00 PM -<br />
1:00 PM<br />
76. The Functional Consequences <strong>of</strong><br />
microRNA Dysregulation in <strong>Human</strong><br />
Disease<br />
77. Centralizing the Deposition and<br />
Curation <strong>of</strong> <strong>Human</strong> Mutations<br />
Room 134, Lower Level<br />
North<br />
Room 132, Lower Level<br />
North<br />
78. Stem Cells and Personalized Medicine Room 135, Lower Level<br />
North<br />
79. Should Noninvasive Prenatal<br />
Diagnosis Augment or Replace<br />
Current Prenatal Screening and<br />
Diagnosis?<br />
80. Selection Signatures and the <strong>Genetics</strong><br />
<strong>of</strong> Autoimmunity and Infectious<br />
Diseases<br />
81. Closing Plenary: <strong>Human</strong> <strong>Genetics</strong> <strong>2012</strong><br />
and Beyond: Present Progress and<br />
Future Frontiers<br />
Room 124, Lower Level<br />
North<br />
Room 130, Lower Level<br />
North<br />
Moscone Center<br />
Hall D, Lower Level North
TUESDAY, November 6<br />
*8:00 AM -<br />
3:00 PM<br />
7:00 PM -<br />
8:30 PM<br />
TRAINEE “MEETING WITHIN THE MEETING” 29<br />
TRAINEE TRACK<br />
Trainee “Meeting within the Meeting”<br />
<strong>ASHG</strong> Undergraduate Faculty <strong>Genetics</strong><br />
Education Workshop (Advance registration<br />
required.)<br />
<strong>ASHG</strong> Opening Mixer and Trainee Mixerwithin-a-Mixer<br />
(Open to all scientific<br />
registrants.)<br />
WEDNESDAY, November 7<br />
10:00 AM -<br />
4:30 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*7:00 PM -<br />
8:30 PM<br />
*7:00 PM -<br />
8:30 PM<br />
Moscone Center<br />
Room 300, Esplanade Level<br />
South<br />
Marriott Marquis Hotel<br />
Yerba Buena 7/8/9, Lower<br />
B2 Level<br />
Career Resources Open Moscone Center Exhibit<br />
Hall, Lower Level South<br />
<strong>ASHG</strong> Trainee-Mentor Luncheon<br />
(Advance ticket purchase required.)<br />
<strong>ASHG</strong> Workshop: Clinical<br />
Interpretation <strong>of</strong> Cytogenomic<br />
Arrays: Tools & Resources<br />
(Advance ticket purchase required.)<br />
<strong>ASHG</strong>/NCBI Workshop: Discovering<br />
Biological Data at NCBI<br />
(Advance ticket purchase required.)<br />
<strong>ASHG</strong> Interactive Workshop on the<br />
UCSC Genome Browser for<br />
Intermediate/Advanced Users<br />
(Advance ticket purchase required.)<br />
<strong>ASHG</strong> Workshop: Social Media +<br />
Scientists = Success: Strategies<br />
for Using Social Media to Benefit Your<br />
Research, Your Career and Your Connections<br />
(Advance ticket purchase required.)<br />
THURSDAY, November 8<br />
10:00 AM -<br />
4:30 PM<br />
*7:00 PM -<br />
8:30 PM<br />
*7:00 PM -<br />
9:30 PM<br />
Moscone Center<br />
Room 303/305, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 307, Esplanade Level<br />
South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 310, Esplanade Level<br />
South<br />
Career Resources Open Moscone Center Exhibit<br />
Hall, Lower Level South<br />
<strong>ASHG</strong> Interactive Workshop:<br />
Galaxy 101: Data Integration,<br />
Analysis and Sharing<br />
(Separate registration required.)<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
<strong>ASHG</strong> Trainee Development <strong>Program</strong> and<br />
Networking: Science and Public Policy:<br />
Why Should Scientists Care About and<br />
Become Active in Public Policy Involving<br />
Science? (Separate registration required.)<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 309, Esplanade Level<br />
South<br />
TRAINEE TRACK
30 TRAINEE “MEETING WITHIN THE MEETING”<br />
FRIDAY, November 9<br />
10:00 AM -<br />
4:30 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*7:00 PM -<br />
8:30 PM<br />
*7:00 PM -<br />
9:00 PM<br />
Career Resources Open Moscone Center<br />
Exhibit Hall, Lower Level<br />
South<br />
<strong>ASHG</strong> Mock Study Section Workshop<br />
(Advance ticket purchase required.)<br />
<strong>ASHG</strong>/Galaxy Interactive Workshop:<br />
Working with High-Throughput Data<br />
and Data Visualization (Separate<br />
advance registration required.)<br />
<strong>ASHG</strong>/Ensembl Interactive Worshop:<br />
Ensembl Web-Based Genomic Tools<br />
for Intermediate/Advance Users<br />
(Advance ticket purchase required.)<br />
Drama, Discourse and Genomics:<br />
IRBs to IFs—An Interactive Play<br />
(Advance ticket purchase required.)<br />
SATURDAY, November 10<br />
8:40 AM -<br />
8:45 AM<br />
8:45 AM -<br />
8:55 AM<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
70. AJHG C.W. Cotterman Awards<br />
Announcement<br />
71. <strong>ASHG</strong> Charles J. Epstein Trainee<br />
Awards for Excellence in <strong>Human</strong><br />
<strong>Genetics</strong> Research: Announcement <strong>of</strong><br />
Winners<br />
Moscone Center<br />
Room 303/305, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 300, Esplanade Level<br />
South<br />
Moscone Center<br />
Hall D, Lower Level North<br />
Moscone Center<br />
Hall D, Lower Level North
TUESDAY, November 6<br />
*8:00 AM -<br />
3:00 PM<br />
EDUCATION TRACK<br />
<strong>ASHG</strong> Undergraduate Faculty <strong>Genetics</strong><br />
Education Workshop (Advance registration<br />
required.)<br />
WEDNESDAY, November 7<br />
8:00 AM -<br />
10:00 AM<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*7:00 PM -<br />
8:30 PM<br />
*7:00 PM -<br />
8:30 PM<br />
EDUCATION TRACK 31<br />
Moscone Center<br />
Room 300, Esplanade Level<br />
South<br />
Concurrent Invited Sessions I (3-10): Moscone Center<br />
3. Implementing <strong>of</strong> Next-Generation<br />
Sequencing as a Clinical Test<br />
9. Surveying Customer Responses to<br />
Personal Genetic Services<br />
<strong>ASHG</strong> Workshop: Clinical<br />
SOLD<br />
OUT<br />
Interpretation <strong>of</strong> Cytogenomic<br />
Arrays: Tools & Resources<br />
(Advance ticket purchase required.)<br />
<strong>ASHG</strong>/NCBI Workshop: Discovering SOLD<br />
OUT<br />
Biological Data at NCBI (Advance<br />
ticket purchase required.)<br />
<strong>ASHG</strong> Interactive Workshop on<br />
SOLD<br />
OUT<br />
the UCSC Genome Browser for<br />
Intermediate/Advanced Users<br />
(Advance ticket purchase required.)<br />
<strong>ASHG</strong> Workshop: Social Media +<br />
SOLD<br />
Scientists = Success: Strategies for<br />
OUT<br />
Using Social Media to Benefit Your<br />
Research, Your Career and Your Connections<br />
(Advance ticket purchase required.)<br />
THURSDAY, November 8<br />
8:00 AM -<br />
10:00 AM<br />
*7:00 PM -<br />
8:30 PM<br />
Hall D, Lower Level North<br />
Room 132, Lower Level<br />
North<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 307, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 310, Esplanade Level<br />
South<br />
Concurrent Invited Session II (21-28): Moscone Center<br />
25. Genomic Medicine: ELSI Goes<br />
Room 132, Lower Level<br />
Mainstream<br />
North<br />
28. Transforming Medical Student<br />
Room 130, Lower Level<br />
Education in <strong>Genetics</strong> and Genomics:<br />
How Do We Improve Health and<br />
Individualize Care through Medical<br />
School Genetic and Genomic Curricula?<br />
North<br />
<strong>ASHG</strong> Interactive Workshop:<br />
Moscone Center<br />
Galaxy 101: Data Integration,<br />
SOLD<br />
OUT<br />
Room 304/306, Esplanade<br />
Analysis and Sharing (Separate<br />
registration required.)<br />
Level South<br />
EDUCATION TRACK
32 EDUCATION TRACK<br />
Friday, November 9<br />
*12:45 PM -<br />
2:15 PM<br />
*12:45 PM -<br />
2:15 PM<br />
*7:00 PM -<br />
8:30 PM<br />
*7:00 PM -<br />
9:00 PM<br />
<strong>ASHG</strong> Mock Study Section Workshop<br />
(Advance ticket purchase required.)<br />
<strong>ASHG</strong>/Galaxy Interactive Workshop:<br />
Working with High-Throughput Data<br />
and Data Visualization (Separate<br />
advance registration required.)<br />
<strong>ASHG</strong>/Ensembl Interactive Worshop:<br />
Ensembl Web-Based Genomic Tools<br />
for Intermediate/Advance Users<br />
(Advance ticket purchase required.)<br />
Drama, Discourse and Genomics:<br />
IRBs to IFs—An Interactive Play<br />
(Advance ticket purchase required.)<br />
Saturday, November 10<br />
9:40 AM -<br />
11:40 AM<br />
Moscone Center<br />
Room 303/305, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Moscone Center<br />
Room 300, Esplanade<br />
Level South<br />
Concurrent Invited Session III (73-80): Moscone Center<br />
77. Centralizing the Deposition and<br />
Curation <strong>of</strong> <strong>Human</strong> Mutations<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
Room 132, Lower Level<br />
North
WEDNESDAY, November 7<br />
8:00 AM -<br />
10:00 AM<br />
10:30 AM -<br />
12:45 PM<br />
*12:45 PM -<br />
2:15 PM<br />
CLINICAL TRACK 33<br />
CLINICAL TRACK CLINICAL TRACK<br />
Concurrent Invited Session I (3-10): Moscone Center<br />
3. Implementing Next-Generation<br />
Sequencing as a Clinical Test<br />
4. Assessing the Pathogenicity <strong>of</strong> Genetic<br />
Variants: Translating in Vitro and in<br />
Silico Advances to the Clinic<br />
10. Metabolism, Metals, and<br />
Neurodegeneration: Toward<br />
Enhanced Understanding <strong>of</strong> Disease<br />
Mechanisms and Rational Therapeutics<br />
Hall D, Lower Level North<br />
Gateway Ballroom 103,<br />
Lower Level South<br />
Room 130, Lower Level<br />
North<br />
Concurrent Platform (abstract-driven) Moscone Center<br />
Session A (11-19):<br />
18. Prenatal and Perinatal <strong>Genetics</strong> Room 130, Lower Level<br />
North<br />
<strong>ASHG</strong> Workshop: Clinical<br />
Interpretation <strong>of</strong> Cytogenomic<br />
Arrays: Tools & Resources<br />
(Advance ticket purchase required.)<br />
THURSDAY, November 8<br />
8:00 AM -<br />
10:00 AM<br />
10:30 AM -<br />
12:45 PM<br />
*12:45 PM -<br />
2:15 PM<br />
Moscone Center<br />
Room 304/306, Esplanade<br />
Level South<br />
Concurrent Invited Session II (21-28): Moscone Center<br />
22. Common and Rare CNVs: Genesis,<br />
Patterns <strong>of</strong> Variations and <strong>Human</strong><br />
Diseases<br />
23. Advancing Gene Therapy to the Clinic:<br />
Molecular Medicines Come <strong>of</strong> Age<br />
25. Genomic Medicine: ELSI Goes<br />
Mainstream<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37):<br />
33. Clinical <strong>Genetics</strong>: Mutations, Mutations<br />
and Syndromes<br />
Hall D, Lower Level North<br />
Gateway Ballroom 104,<br />
Lower Level South<br />
Room 132, Lower Level<br />
North<br />
Moscone Center<br />
Gateway Ballroom 104,<br />
Lower Level South<br />
35. Ethical, Legal, Social and Policy Issues Room 132, Lower Level<br />
North<br />
<strong>ASHG</strong> Workshop: Diagnostic<br />
Challenges: Review and Discussion<br />
<strong>of</strong> Unique Cases, Rare and Unknown<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
Cases (Advance ticket purchase required.)<br />
Moscone Center<br />
Room 303/305, Esplanade<br />
Level South
34 CLINICAL TRACK<br />
4:30 PM -<br />
6:45 PM<br />
Concurrent Platform (abstract-driven) Moscone Center<br />
Session C (38-46):<br />
45. Therapy <strong>of</strong> Genetic Disorders Room 130, Lower Level<br />
North<br />
FRIDAY, November 9<br />
8:00 AM -<br />
10:15 AM<br />
4:30 PM -<br />
6:45 PM<br />
*7:00 PM -<br />
9:00 PM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55):<br />
52. Clinical <strong>Genetics</strong>: Complex<br />
Mechanisms and Exome-Discovery<br />
54. Genetic Counseling and Clinical<br />
Testing<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67):<br />
67. Developmental Insights into <strong>Human</strong><br />
Malformations<br />
Drama, Discourse and Genomics:<br />
IRBs to IFs—An Interactive Play<br />
(Advance ticket purchase required.)<br />
SATURDAY, November 10<br />
9:40 AM -<br />
11:40 AM<br />
Moscone Center<br />
Room 124, Lower Level<br />
North<br />
Room 130, Lower Level<br />
North<br />
Moscone Center<br />
Room 123, Lower Level<br />
North<br />
Moscone Center<br />
Room 300, Esplanade<br />
Level South<br />
Concurrent Invited Session III (73-80): Moscone Center<br />
SOLD<br />
OUT<br />
73. Returning Results from Large-Scale<br />
Sequencing: Where the Rubber Meets<br />
the Road<br />
77. Centralizing the Deposition and<br />
Curation <strong>of</strong> <strong>Human</strong> Mutations<br />
79. Should Noninvasive Prenatal Diagnosis<br />
Augment or Replace Current Prenatal<br />
Screening and Diagnosis?<br />
Gateway Ballroom 103,<br />
Lower Level South<br />
Room 132, Lower Level<br />
North<br />
Room 124, Lower Level<br />
North
floor plans<br />
Moscone Center, 747 Howard Street<br />
Tel: 415-974-4000
floor plans<br />
Marriott Marquis Hotel, 55 Fourth Street<br />
Tel: 415-896-1600<br />
Mission Street<br />
Mission Tunnel<br />
Corridor to<br />
Yerba Buena<br />
Ballroom<br />
Lower B2 Level.<br />
YERBA BUENA BALLROOM<br />
Howard Street<br />
Howard<br />
Street<br />
Loading<br />
Dock<br />
Kitchen<br />
Bake<br />
Shop<br />
Banquet<br />
Office<br />
Assembly<br />
Willow<br />
Walnut<br />
Freight Door 10' x 10.6'<br />
Salon 14<br />
Salon 13<br />
Salon 12<br />
Salon 11<br />
Salon 10<br />
To<br />
Lobby<br />
A<br />
Golden Gate<br />
Registration A<br />
Business<br />
Center<br />
Laurel<br />
Fourth Street<br />
B<br />
Golden Gate<br />
Prefunction Area<br />
Golden Gate<br />
Registration B<br />
Juniper<br />
Yerba Buena Lane<br />
Elevators<br />
Elevators<br />
C3<br />
C2<br />
C1<br />
Shipping<br />
Receiving<br />
Marriott Marquis Hotel, B2 Level<br />
Salon 9 Salon 8 Salon 7<br />
Nob Hill D<br />
Fourth Street<br />
Service Corridor<br />
Yerba Buena<br />
Grand Assembly<br />
Nob Hill C<br />
Nob Hill B<br />
Nob Hill A<br />
Freight<br />
Elevator<br />
Service<br />
Elevator<br />
Fourth Street<br />
Loading Dock<br />
Salon 15 Salon 1<br />
To Golden<br />
Gate Hall<br />
North<br />
Registration<br />
B South A B A<br />
Registration<br />
Yerba Buena Gardens<br />
Marriott Marquis Hotel, Lower B2 Level<br />
Salon 2<br />
Salon 3<br />
Salon 4<br />
Salon 5<br />
Salon 6<br />
Assembly<br />
Elevator
Pacific<br />
(Fourth Floor)<br />
PACIFIC & SIERRA CONFERENCE SUITES<br />
Fourth & Fifth Levels (All conference suites have windows)<br />
F<br />
Pacific<br />
Y<br />
J<br />
Elevator Elevator<br />
Atrium<br />
Full<br />
Service<br />
Health<br />
Club<br />
H<br />
A B C<br />
Marriott Marquis Hotel, Level 3<br />
G<br />
F<br />
E<br />
D<br />
Marriott Marquis Hotel<br />
K<br />
Elevator<br />
J H G<br />
Garden Deck<br />
Pool<br />
Atrium<br />
Whirlpool<br />
A B C<br />
F<br />
E<br />
D<br />
Sierra<br />
(Fifth Floor)<br />
39
Map/HoTEls In asHG<br />
<strong>of</strong>fICIal BloCK<br />
Hotel Questions: <strong>ASHG</strong>’s Official Housing<br />
Bureau: Convention Management Resources:<br />
Tel: 415-979-2272 or 1-800-750-4949. For onsite<br />
questions, visit the Housing Counter located in<br />
the Registration Area, Upper North Lobby.<br />
Marriott Marquis Hotel: 415-896-1600<br />
Courtyard by Marriott: 415-947-0700<br />
Grand Hyatt: 415-398-1234<br />
Hotel nikko: 415-394-1111<br />
Hotel palomar: 415-348-1111<br />
Intercontinental Hotel: 415-616-4500<br />
sir francis Drake Hotel: 415-392-7755<br />
W Hotel: 415-777-5300<br />
Westin Market street Hotel: 415-974-6400
The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />
Hotel Map and Key<br />
Civic Center<br />
BART/Muni<br />
4<br />
7<br />
8 3<br />
5 1<br />
Powell<br />
BART/Muni<br />
1 San Francisco Marriott Marquis<br />
2 Courtyard by Marriott San Francisco Downtown<br />
3 Grand Hyatt San Francisco<br />
4 Hotel Nikko San Francisco<br />
5 Hotel Palomar<br />
6 InterContinental San Francisco<br />
7 Parc 55 Wyndham San Francisco-Union Square<br />
8 Sir Francis Drake Hotel<br />
9 W San Francisco<br />
10 The Westin San Francisco Market Street<br />
BART/Muni Stations<br />
6<br />
Montgomery<br />
BART/Muni<br />
10<br />
Hotel Locator Map<br />
9<br />
Embarcadero<br />
BART/Muni<br />
2<br />
41
Map/san franCIsCo Bay arEa<br />
rapID TransIT (BarT)
San Francisco Bay Area Rapid Transit/BART<br />
43
ABOUT THE MEETING<br />
GENERAL INFORMATION<br />
All events for the 62nd Annual Meeting <strong>of</strong> The <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />
will be held at the Moscone Center (Convention Center), unless otherwise indicated.<br />
The Convention Center is located at 747 Howard Street, San Francisco, CA 94103;<br />
Tel: 415-974-4000. Please see page 49 for telephone numbers and hotels in the <strong>ASHG</strong><br />
<strong>of</strong>ficial housing block.<br />
All Annual Meeting details are available on the <strong>ASHG</strong> <strong>2012</strong> Annual Meeting Web site<br />
at www.ashg.org/<strong>2012</strong>meeting. The Web site will serve as the <strong>of</strong>ficial e-publication<br />
<strong>of</strong> the <strong>2012</strong> Annual Meeting.<br />
Abstracts<br />
Abstracts <strong>of</strong> the plenary, platform and poster presentations may be viewed online only<br />
at the <strong>ASHG</strong> meeting Website (www.ashg.org/<strong>2012</strong>meeting). Abstracts will not<br />
be available in print. NOTE: Speakers in the invited sessions are not required to<br />
provide abstracts.<br />
Abstract Search/Itinerary Planner<br />
For your convenience, abstract search/printing stations will be located in the<br />
Registration Area, North Lobby <strong>of</strong> the Convention Center.<br />
Invited Sessions<br />
The <strong>2012</strong> program is highlighted by 24 invited scientific sessions that have been<br />
scheduled over three concurrent time periods: (1) Wednesday, November 7 from 8:00<br />
am until 10:00 am (see page 69); (2) Thursday, November 8, from 8:00 am until 10:00<br />
am (see page 82); and (3) Saturday, November 10, from 9:40 am until 11:40 am (see<br />
page 119).<br />
Plenary Session Presentations (abstract-driven)<br />
The plenary session includes a diverse set <strong>of</strong> six presentations, selected from the toprated<br />
abstracts submitted for this year’s annual meeting as determined by the <strong>2012</strong><br />
<strong>Program</strong> Committee. These six abstracts have been programmed from 4:30 pm until<br />
6:30 pm on Tuesday. Each author will give a 15-minute presentation, with an additional<br />
five minutes for discussion. The first author listed is the presenting author. See page<br />
68 for a complete description <strong>of</strong> this session.<br />
Platform Sessions (abstract-driven)<br />
The <strong>Program</strong> Committee has assembled 45 abstract-driven platform sessions totaling<br />
405 oral presentations. Each presenting author will give a 10-minute talk followed by<br />
five minutes <strong>of</strong> discussion. There are five sets <strong>of</strong> nine concurrent platform sessions<br />
as follows: (1) Wednesday, November 7 from 10:30 am until 12:45 pm (see page 73);<br />
(2) Thursday, November 8 from 10:30 am until 12:45 pm (see page 86); (3) Thursday,<br />
November 8 from 4:30 pm until 6:45 pm (see page 94); (4) Friday, November 9 from<br />
8:00 am until 10:15 am (see page 101); and (5) Friday, November 9 from 4:30 pm until<br />
6:45 pm (see page 110).<br />
45<br />
GENERAL INFORMATION
46 GENERAL INFORMATION<br />
Poster Sessions (abstract-driven)<br />
To encourage scientific discussions and to facilitate the exchange <strong>of</strong> information,<br />
posters are grouped by related topics, keyword (selected by the first author at the<br />
time <strong>of</strong> abstract submission), and alphabetical order by the last name <strong>of</strong> the first<br />
author. The first author listed is the presenting author. The program number and the<br />
abstract/poster board number are one and the same. It appears in bold print followed<br />
by the abstract title and author names. Each number is followed by a W (Wednesday),<br />
or T (Thursday), or F (Friday)to indicate the day on which authors must be present at<br />
their poster board. Each author is expected to be present for one <strong>of</strong> the two hours<br />
during that day. The posters are expected to remain on the boards for all three poster<br />
sessions. See page 125 for poster mounting/removal schedule and presentation<br />
times. Poster listings begin on page 127.<br />
Mobile App<br />
NEW<br />
Download the <strong>ASHG</strong> <strong>2012</strong> Mobile App to your smartphone (iOS, Android,<br />
and Blackberry platforms). The Mobile App gives you the meeting at your<br />
fingertips wherever you go. Once the App has been downloaded, you do not need an<br />
Internet connection to view information. Please refer to the ad on page 422.<br />
Mobile Web Site<br />
Access the <strong>ASHG</strong> <strong>2012</strong> mobile Web site at http://m.ashg.org and bookmark it on<br />
your Web-enabled mobile device so that you have important meeting information<br />
at your fingertips. The mobile Web site is an alternative option for those attendees<br />
that do not have a smartphone. An Internet connection is required when viewing the<br />
mobile Web site.<br />
Social Media<br />
This year, views <strong>of</strong> the meeting attendees will be followed through<br />
<strong>ASHG</strong>’s social media outlets and will be summarized at the closing<br />
session. Attendees are encouraged to post their thoughts on exciting<br />
scientific or clinical advances they have heard about during the meeting,<br />
and on challenges that the field will face, by using hashtag #<strong>ASHG</strong><strong>2012</strong>.<br />
Questions for the closing panelists can also be sent to Chris Gunler via<br />
twitter @girlscientist or our Facebook page, https://www.facebook.<br />
com/<strong>Genetics</strong><strong>Society</strong>. Follow <strong>ASHG</strong> on Twitter: @<strong>Genetics</strong><strong>Society</strong>.<br />
Please refer to the <strong>ASHG</strong> <strong>2012</strong> Annual Meeting Web site under general information<br />
for the do’s and don’ts <strong>of</strong> Social Media. Remember, everything is tweetable unless a<br />
speaker requests otherwise.<br />
Session Tracks<br />
The schedule once again features separate schedules that list sessions <strong>of</strong> relevance<br />
to Trainees, as well as Education and Clinical tracks. Please look for the following<br />
symbols and refer to page 29, 31 and 33 for the schedules.<br />
Indicates Clinical-focused events<br />
Indicates Education-focused events<br />
Indicates Trainee-focused events
REGISTRATION, BADGE AND PROGRAM PICK UP<br />
GENERAL INFORMATION 47<br />
Scientific meeting registration, badge, program, and bag pickup is located in the North<br />
Upper Lobby <strong>of</strong> the Convention Center and is open during the following hours:<br />
Tuesday, November 6 10:00 am – 7:00 pm<br />
Wednesday, November 7 7:00 am – 5:00 pm<br />
Thursday, November 8 7:00 am – 5:00 pm<br />
Friday, November 9 7:30 am – 5:00 pm<br />
Saturday, November 10 7:30 am – 10:30 am<br />
Exhibitor registration is located in the South Lobby. See page 48 for exhibitor registration<br />
hours.<br />
Registration Fees<br />
The registration fee includes entry to all invited scientific sessions, platform sessions,<br />
award presentations, poster sessions, exhibits, and to the opening mixer. The fee<br />
does not include admission to separate ticketed events and does not include meals<br />
or hotel costs. Registration may be paid by cash, check, money order or credit card<br />
(<strong>American</strong> Express, MasterCard or VISA).<br />
Registration fees are shown in U.S. dollars<br />
After September 4 Starting November 6<br />
<strong>ASHG</strong> Member $500 $600<br />
Nonmember $750 $850<br />
Trainee <strong>ASHG</strong> Member 1 $275 $300<br />
Trainee Non-member 1 $475 $525<br />
Developing Country 2 $350 $400<br />
Guest Registration 3 N/A $125<br />
One-day registration is not available.<br />
1 Trainees may register at the trainee rates for the meeting. Postdoctoral fellows and students working<br />
toward a degree in human genetics or an allied field qualify. Trainees will be asked to provide certain<br />
information to determine eligibility. Trainees who register at the meeting should bring a student ID card or a<br />
letter signed by their department or laboratory head to certify trainee/student/fellow status.<br />
2 Developing Country Delegates may register at this rate if they are from a country that is classified by the<br />
World Bank as lower income or lower-middle income. Identification such as a passport is required.<br />
3 Guest registration will be available on-site only for family members or special guests <strong>of</strong> registered<br />
delegates. Guest registration fee is $125 per guest and includes admission to the Opening Mixer and the<br />
Exhibit Hall. The guest registration does not include access to scientific sessions. In order to register as<br />
a guest, you must be accompanied by a paying scientific registrant. Please go to the Registration Help<br />
Counter located in the Registration Area. Guests will be issued different colored badges from scientific<br />
registrants.<br />
GENERAL INFORMATION
48 GENERAL INFORMATION<br />
Registration Receipt<br />
The back <strong>of</strong> your badge is your registration receipt. Please retain this for your records.<br />
Replacement, Lost or Forgotten Badges<br />
A $5 fee will be charged to registrants for each replacement badge requested i.e.,<br />
to replace badges that are left at home or in hotel rooms, lost or forgotten.<br />
Questions should be directed to the Registration Help Counter. Telephone: 415-978-<br />
3607.<br />
MEETING INFORMATION, SERVICES AND OFFICES<br />
<strong>ASHG</strong> Office and Meeting Logistics – Room 111, Lower Level North<br />
Questions about housing, ancillary meetings, audio-visual, on-site logistics, and lost<br />
and found should be directed to this <strong>of</strong>fice. CME and CEU tracking forms are also<br />
available. Telephone: 415-978-3600. The <strong>of</strong>fice hours are as follows:<br />
Tuesday, November 6 10:00 am – 6:00 pm<br />
Wednesday, November 7 7:00 am – 5:00 pm<br />
Thursday, November 8 7:00 am – 5:00 pm<br />
Friday, November 9 7:00 am – 5:00 pm<br />
Saturday, November 10 7:00 am – 12:30 pm<br />
Membership questions should be directed to the <strong>ASHG</strong> Booth at <strong>ASHG</strong> Central inside<br />
the Exhibit Hall.<br />
<strong>ASHG</strong> Central – Exhibit Hall, Lower Level South<br />
Visit <strong>ASHG</strong> Central to address membership questions, view sample publications,<br />
apply for membership, and to find out more about <strong>ASHG</strong>. Also available in <strong>ASHG</strong><br />
Central will be editors <strong>of</strong> the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> ( AJHG). The AJHG<br />
provides a record <strong>of</strong> research and review relating to heredity in humans, the application<br />
<strong>of</strong> genetic principles in medicine and public policy, and related areas <strong>of</strong> molecular and<br />
cell biology, behavioral, molecular, biochemical, population and clinical genetics. Also<br />
available is additional information on the city <strong>of</strong> Boston, Massachusetts, the site <strong>of</strong><br />
<strong>ASHG</strong>’s 2013 Annual Meeting and register to win a gift from the Boston Convention and<br />
Visitor’s Bureau!<br />
<strong>ASHG</strong> Central is located in booth #913, in the very center <strong>of</strong> the Exhibit Hall! It is<br />
open during exhibit hours and will have comfortable seating, charging stations, Wi-Fi<br />
access, and much more! We hope you stop by to see us while visiting the exhibits<br />
and posters. You can also meet <strong>ASHG</strong> <strong>2012</strong> Board and <strong>Program</strong> Committee members<br />
during poster session hours. Make <strong>ASHG</strong> Central your destination for networking,<br />
plugging in, and for all the <strong>ASHG</strong> information you need!
GENERAL INFORMATION 49<br />
Assistance for Attendees<br />
Registrants with questions regarding special needs for auxiliary requirements<br />
(such as hearing assistance/sign language interpretation), housing,<br />
and transportation should contact the <strong>ASHG</strong> <strong>of</strong>fice in advance by e-mailing<br />
ashgmeetings@ashg.org with your specific request. NOTE: It may not be possible to<br />
accommodate last-minute and on-site requests.<br />
For information on accessibility within San Francisco, visit http://www.acessnca.<br />
com. If you have difficulty in walking long distances, you may want to consider renting<br />
a mobile scooter from Scoot Around. For details or reservations, call 888-441-7575<br />
or visit www.scootaround.com. For a list <strong>of</strong> taxi companies that <strong>of</strong>fer ramp access,<br />
see page 54.<br />
Attire/Dress Code<br />
Attire for the meeting is business casual. Remember to dress in layers and wear<br />
comfortable walking shoes. You may want to carry a small umbrella as San Francisco<br />
can <strong>of</strong>ten have rain showers in November.<br />
Business Center – Lower Level South<br />
The Convention Center has a full-service business center for your convenience. It will<br />
be open from Tuesday through Friday. Hours will be posted outside the entrance. The<br />
business center will provide an array <strong>of</strong> services including copying, printing, faxing,<br />
Internet access, shipping, and <strong>of</strong>fice supplies. Please refer to page 51 for information<br />
on Internet and Wi-Fi access.<br />
Career/Employment Opportunities – Exhibit Hall, Lower Level South<br />
The <strong>ASHG</strong>/FASEB Career Center will operate Wednesday through Friday inside the<br />
Exhibit Hall during exhibit hours. Job seekers and employers should submit their<br />
résumés/job descriptions on 8½” x 11” paper to the <strong>ASHG</strong>/FASEB Career Center<br />
staff for posting on the employment poster boards inside the Exhibit Hall. Employers<br />
may also e-mail job descriptions to careers@faseb.org. Visit the FASEB/Career<br />
Resources Web site at http://careers.faseb.org for details.<br />
Cell Phone/Camera/Recording Policy<br />
Attendees are strictly prohibited from using cameras and all other recording<br />
devices in all meeting session rooms, on the Exhibit Hall floor, and in all poster/<br />
oral presentations. This means that attendees are not permitted to take pictures or<br />
videos <strong>of</strong> speaker slides, posters or exhibit booths. Attendees not adhering to this<br />
policy may be asked to leave the room and will be asked to delete all pictures or<br />
videos already taken, and further action may be taken with repeated or egregious<br />
<strong>of</strong>fenders. When registering, you agreed to adhere to this policy. Please remember to<br />
turn <strong>of</strong>f or place on silent cell phones or other devices before entering meeting rooms.<br />
CMEs and CEUs<br />
Please refer to page 325 for information. Tracking forms are located at the <strong>ASHG</strong><br />
Information Counter in the North Lobby, at <strong>ASHG</strong> Central inside the Exhibit Hall and<br />
at the <strong>Society</strong> Office, Room 111.<br />
GENERAL INFORMATION
50 GENERAL INFORMATION<br />
Exhibits – Exhibit Hall, Lower Level South<br />
Exhibits will be open daily on Wednesday, Thursday and Friday from 10:00 am until<br />
4:30 pm. The Exhibit Hall features hundreds <strong>of</strong> companies from around the world<br />
showing their latest products and services. More information on who is exhibiting can<br />
be found either through an alphabetical listing <strong>of</strong> companies with descriptions starting<br />
on page 269 or a listing by products and services where companies may be located<br />
by keyword beginning on page 299. Your barcoded badge will allow you to enter<br />
contests and request additional information from companies in the Exhibit Hall. For<br />
additional information on other features in the Exhibit Hall, please see page 267.<br />
NOTE: Children under the age <strong>of</strong> 18 may be admitted into the Exhibit Hall only if they<br />
are accompanied by a paid scientific registrant.<br />
Exhibit Registration and Exhibit Management – South Upper Lobby<br />
The Exhibit Management Office and Exhibit Registration are located in the South<br />
Lobby. Exhibitor Registration hours are as follows:<br />
Tuesday, November 6 8:00 am – 5:00 pm<br />
Wednesday, November 7 8:00 am – 4:30 pm<br />
Thursday, November 8 8:00 am – 4:30 pm<br />
Friday, November 9 8:00 am – 4:30 pm<br />
Family/Nursing Mothers Room – Room 203, East Mezzanine Level South<br />
The family room is open during registration hours. The purpose <strong>of</strong> the room is to<br />
give parents and children a place to relax during the convention. Attendees are not<br />
permitted to use this room for babysitting services. Room 218 has also been set aside<br />
for nursing mothers to have privacy.<br />
First Aid – Lower Level (North and South)<br />
There are two locations for first aid rooms. The first is located outside Hall D in the<br />
North building, telephone 415-974-4096 and the second is located outside Hall C<br />
in the South building, telephone 415-974-4090. The First Aid Room is staffed Monday<br />
through Saturday by trained personnel able to handle various medical problems and<br />
emergencies that might arise. If you are witness to a medical emergency inside the<br />
Convention Center, please dial 511 from any house phone, or 415-974-4021 from<br />
your mobile device. The number to call for emergencies outside <strong>of</strong> the Convention<br />
Center is 911.<br />
Food Service – Exhibit Hall, Lower Level<br />
Food concessions will be open in the Exhibit Hall (Wednesday through Friday) during<br />
exhibit and poster hours. Portable food stands will also be available in various areas<br />
throughout the Convention Center, Wednesday through Saturday. The concession<br />
stands will <strong>of</strong>fer a variety <strong>of</strong> “grab and go” foods. Hours will be posted on-site. <strong>ASHG</strong><br />
will provide c<strong>of</strong>fee service each morning outside session rooms and will provide light<br />
lunch refreshments inside the Exhibit Hall during the lunch period on Wednesday,<br />
Thursday and Friday.
GENERAL INFORMATION 51<br />
Housing/Hotels – North Upper Lobby<br />
See page 41 for the hotel locator map. For housing inquiries, visit the housing counter<br />
located in the registration area (Tuesday through Friday). Hours will be posted at the<br />
counter. The on-site telephone number is 415-978-3609. You may also contact the<br />
<strong>of</strong>ficial <strong>ASHG</strong> <strong>2012</strong> Housing Bureau: Telephone: 415-979-2272 or 1800-750-4949;<br />
e-mail ashghousing@cmrus.com. Below is a list <strong>of</strong> <strong>of</strong>ficial <strong>ASHG</strong> hotels.<br />
Marriott Marquis Hotel (Headquarter): 415-896-1600<br />
Courtyard by Marriott: 415-947-0700<br />
Grand Hyatt: 415-398-1234<br />
Hotel Nikko: 415-394-1111<br />
Hotel Palomar: 415-348-1111<br />
Intercontinental Hotel: 415-616-4500<br />
Sir Francis Drake Hotel: 415-392-7755<br />
W Hotel: 415-777-5300<br />
Westin Market Street Hotel: 415-974-6400<br />
We suggest you put the number <strong>of</strong> the hotel you are staying at into your mobile<br />
device/cell phone.<br />
Information – North Upper Lobby<br />
The information counter will be open during registration hours (see page 47).<br />
Telephone: 415-978-3606. Please stop by the information counter to pick up CME<br />
and CEU tracking forms.<br />
Internet (Wi-Fi) Access and Cyber Café<br />
Complimentary Wi-Fi (supported by Genzyme) is available in all public lobbies and<br />
meeting space <strong>of</strong> the Moscone Center. The service is not available inside the Exhibit<br />
Hall and Posters. Attendees who wish to use the Wi-Fi service should bring their own<br />
laptop or PDA with a wireless 802.11/g network card installed. To access this service,<br />
open your browser and set the SSID (wireless network identified) to <strong>ASHG</strong><strong>2012</strong>. You<br />
will need to set your network card to use DHCP. Open a web browser and click the login<br />
button to continue. Technical support will not be provided at the meeting. Remember<br />
to consider the security implications <strong>of</strong> using the wireless network and protect your<br />
laptop accordingly. The Cyber Café is located in the North Building, Lower Concourse<br />
Level and is open during registration hours. Attendees are asked to limit their time to<br />
15 minutes per visit.<br />
Luggage Storage and Coat Check – South Upper Lobby<br />
Facilities for luggage storage and coat check are available Wednesday through<br />
Saturday. This service is complimentary. Please do not take luggage into the session<br />
rooms. All items must be checked in and checked out on the same day. Items should<br />
not be left overnight.<br />
Message Center/Literature Area – South Building, Lower Level<br />
Leaving messages at the message center is the best way to contact another attendee for<br />
whom you do not have more direct contact information. Please note that it is not possible<br />
to page an attendee. Attendees can post fliers advertising social events or upcoming<br />
meetings. Exhibitors are not permitted to display materials in the literature area.<br />
GENERAL INFORMATION
52 GENERAL INFORMATION<br />
Parking<br />
The Convention Center does not have on-site parking. However, there are many parking<br />
garages nearby. View the Convention Center’s parking map at www.moscone.com<br />
to find a nearby parking garage. You can also visit the SFMTA Web site at<br />
www.sfmta.com for information on parking around the city.<br />
Prayer Room – Room 266, West Mezzanine Level South<br />
This room has been set aside for prayer and meditation and will be open during<br />
registration hours.<br />
Press Office – Room 113, Lower Level North<br />
Journalists should go directly to Room 113 to receive a press badge, program<br />
schedule, news releases and other media materials. The Press Office is open T uesday<br />
through Saturday only for registered journalists. For more information about press<br />
registration procedures, policies/guidelines and on-site media events at the <strong>2012</strong><br />
meeting, please contact Cathy Yarbrough at press@ashg.org.<br />
Registration Management/Registration Help Desk – North Upper Lobby<br />
Questions regarding registration should be directed to the Registration Help Desk.<br />
See registration hours listed on page 47. Telephone: 415-978-3607.<br />
Restaurant/City Information/Tours and Activities<br />
San Francisco Travel will provide city information at the permanent counter located in<br />
the South Upper Lobby. City maps and brochures on local attractions are available<br />
in this area.<br />
Not sure where to dine in San Francisco? Contact RESERVATIONS TONIGHT! at<br />
www.reservationstonight.com or call them toll free in the U.S. at 800-392-DINE (3463).<br />
Outside the U.S. call 707-795-4885. Assistance will be available at the Restaurant<br />
Reservations counter located in the Registration Area <strong>of</strong> the North Upper Lobby as<br />
follows:<br />
Wednesday 10:00 am – 5:00 pm<br />
Thursday 10:00 am – 5:00 pm<br />
Friday 10:00 am – 5:00 pm<br />
Speaker-Ready/Presentation Upload Room – Room 110, Lower Level North<br />
The Speaker-Ready/Presentation Upload Room will be open daily as follows:<br />
Tuesday 11:00 am – 4:30 pm<br />
Wednesday 7:00 am – 5:00 pm<br />
Thursday 7:00 am – 5:00 pm<br />
Friday 7:00 am – 5:00 pm<br />
Saturday 7:00 am – 11:00 am<br />
All speakers are required to upload their presentation in advance <strong>of</strong> the session.<br />
We encourage you to do this at least 4 hours before the start <strong>of</strong> your presentation<br />
time. Speakers are not permitted to take their laptop to the lectern for use during<br />
their presentation. On the day <strong>of</strong> presentation, speakers should arrive at the session<br />
room and check in with the audio-visual technicians and moderator about one-half<br />
hour before the scheduled start <strong>of</strong> the session. For speaker questions, please e-mail<br />
the <strong>ASHG</strong> Meeting Management Office at ashgmeetings@ashg.org.
GENERAL INFORMATION 53<br />
A speaker/author index begins on page 333. Names <strong>of</strong> all speakers, presenting authors<br />
and co-authors are listed followed by their session or abstract number(s).<br />
Speaker Conflict <strong>of</strong> Interest: Beginning on page 329 is an alphabetical list <strong>of</strong> invited<br />
session speakers and authors <strong>of</strong> abstracts who have disclosed the existence <strong>of</strong><br />
significant financial interest or other relationships the presenter has with companies or<br />
organizations that may be perceived to bias the presentation. This information allows<br />
the listener/attendee to be fully knowledgeable in evaluating the presentation, and<br />
is required to meet CME and CEU requirements. All speakers will have a conflict <strong>of</strong><br />
interest slide automatically inserted into their presentation. For speakers that indicated<br />
a conflict, the disclosure information you completed during your abstract submission<br />
or completion <strong>of</strong> the online conflict <strong>of</strong> interest form will automatically be used.<br />
Telephone Numbers for <strong>ASHG</strong> On-Site Offices<br />
All <strong>of</strong>fices are located at the Convention Center<br />
<strong>ASHG</strong> Office and Meeting Management, Room 111: 415-978-3600<br />
Exhibitor Registration and Management, South Upper Lobby: 415-978-3605<br />
Convention Center, Moscone Center Main Number: 415-974-4000<br />
First Aid, Moscone North, Lower Level: 415-974-4096<br />
First Aid, Moscone South, Lower Level: 415-974-4090<br />
Housing Counter, North Upper Lobby: 415-978-3609<br />
Information Counter, North Upper Lobby: 415-978-3606<br />
Message Counter, North Upper Lobby: 415-978-3606<br />
Press Office, Room 113: 415-9783614<br />
Registration Help Counter, North Upper Lobby: 415-978-3607<br />
Restaurant Reservations Counter, North Upper Lobby: 415-978-3621<br />
Security (<strong>ASHG</strong> Show Management): 415-978-3620<br />
Security (Convention Center): dial ‘511’ from any house phone<br />
Emergency/Police/Fire: dial ‘511’ from any house phone<br />
Non-emergency: dial ‘4021’ from any house phone<br />
Travel and Visitor Information<br />
San Francisco is famous for its scenic beauty, cultural attractions, diverse communities,<br />
and world-class cuisine. San Francisco’s landmarks include the Golden Gate Bridge,<br />
cable cars, Fisherman’s Wharf, Alcatraz, Chinatown, Union Square, and North Beach.<br />
The San Francisco Travel Visitors Center is located at 900 Market Street (on the<br />
lower level <strong>of</strong> Hallidie Plaza, next to the cable car turn table at Powell and Market<br />
Streets) and is open Monday through Friday from 9:00 am to 5:00 pm.<br />
Tax: Sales tax: 9.5%; Hotel tax: 15% occupancy tax, 1.5% tourism fee and $0.25<br />
commerce fee<br />
Temperature: Average high in November is 64°F or 18°C and average low is 51°F or<br />
10°C; average rain fall is 3 inches (80mm). The golden rule when packing for a trip to<br />
San Francisco is to wear layers! Fog can roll in at any time, and areas near the water<br />
can feel cool.<br />
GENERAL INFORMATION
54 GENERAL INFORMATION<br />
Tipping <strong>Guide</strong>lines: Tipping is expected in the U.S. Below are some guidelines to follow:<br />
• Waiters usually receive 15–20% <strong>of</strong> the bill. In some cases, the tip is automatically<br />
added to your bill. You should always check before adding a gratuity.<br />
• Maids usually receive $1-$2 per room per day. You should leave the tip daily<br />
and not at the end <strong>of</strong> your stay.<br />
• Taxi drivers usually receive 15% <strong>of</strong> the fare.<br />
• Doormen, Skycaps, and porters usually receive $1/bag<br />
Transportation/Getting Around<br />
Bay Area Rapid Transit (BART): BART is the fast, easy, inexpensive way to get to<br />
downtown San Francisco and around the Bay Area. BART operates five routes with<br />
service to 43 stations, including stops at SFO and OAK airports. The closest stations to<br />
<strong>ASHG</strong> <strong>of</strong>ficial hotels are the Powell Street station and the Montgomery Street station.<br />
Visit www.bart.gov for further information and station listings. See Map on page 43.<br />
Cable Cars and Historic Street Cars (operated by MUNI): San Francisco’s vintage<br />
electric streetcars run along the F-line. Stops can be found every few blocks on Market<br />
Street and The Embarcadero between the Castro District and Fisheman’s Wharf (<strong>of</strong>ten<br />
near glass bus stop shelters). The cable streetcars run along Powell Street to Hyde<br />
or Mason. The California street line goes from California and Market to California and<br />
Van Ness (a less crowded option)! If you are unsure what the difference is between<br />
cable cars and streetcars, remember: a street car has a trolley pole connected to an<br />
overhead wire, while a cable car runs on street rails and has no overhead wires.<br />
Parking: View the Convention Center’s parking map at www.moscone.com to find a<br />
nearby parking garage. You can also visit the SFMTA Web site at www.sfmta.com for<br />
information on parking around the city.<br />
San Francisco Municipal Railway (MUNI): MUNI provides transit within the city and<br />
county <strong>of</strong> San Francisco 24 hours a day, seven days a week. You can buy a Visitor<br />
Pass for unlimited rides on MUNI, including cable cars (good for three or seven<br />
consecutive days).<br />
Taxis: Using taxis is a great way to get around quickly. San Francisco can be<br />
challenging with its steep hills and attractions scattered around the city. The average<br />
price for a taxi from the airport is between $40 and $45, plus 15% tip. Regardless <strong>of</strong><br />
what taxi company you select, rates are set for all companies by the San Francisco<br />
Municipal Transportation Agency (SFMTA). Below are some taxi companies that<br />
operate in downtown San Francisco. These companies <strong>of</strong>fer ramped mini vans for<br />
those in wheelchairs or with scooters, advance reservations required:<br />
Checker 415-206-1900<br />
DeSoto 415-970-1300<br />
Luxor 415-282-4141<br />
Regents 415-487-1004<br />
Town Taxi 415-401-8900<br />
Yellow 415-626-2345<br />
Walking: San Francisco is a great city to walk and explore the unique neighborhoods.<br />
All hotels in the <strong>ASHG</strong> hotel block are within a short walk <strong>of</strong> the Convention Center.
DAILY MEETING HIGHLIGHTS 55<br />
DAILY MEETING HIGHLIGHTS AND WORKSHOPS<br />
Tuesday, November 6<br />
Undergraduate Faculty <strong>Genetics</strong> Education Workshop<br />
8:00 am – 3:00 pm, Room 300, Esplanade Level South<br />
This session for undergraduate faculty, organized by the <strong>ASHG</strong> Undergraduate<br />
Subcommittee, covers human genetics content and pedagogies. The goal is to<br />
encourage effective teaching <strong>of</strong> human genetics so that it contributes to improving<br />
the genetic literacy <strong>of</strong> students. Breakfast and lunch will be served. For further<br />
information, contact Katherine Lontok at klontok@ashg.org. The registration fee is<br />
not refundable. Separate advance registration required.<br />
High School Workshop for San Francisco Students and Teachers<br />
8:30 am – 2:30 pm, Room 303/305, Esplanade Level South<br />
The High School Workshop is organized by the <strong>ASHG</strong> Information and Education<br />
Committee. Students and teachers will interact with genetics researchers and learn<br />
about the field <strong>of</strong> human genetics. The workshop will include several inquiry-oriented<br />
genetics lessons on newborn screening, DNA forensics, epigenetics, complex traits,<br />
family history, and malaria/population genetics.<br />
Presidential Address<br />
4:00 pm – 4:30 pm, Hall D, Lower Level North<br />
The Presidential Address, entitled “The Scientist as a Citizen <strong>of</strong> the World” will be<br />
presented by Mary-Claire King. See page 68 for a description <strong>of</strong> this session. This<br />
session will be available for viewing live on the <strong>ASHG</strong> <strong>2012</strong> Meeting Web site at<br />
www.ashg.org/<strong>2012</strong>meeting.<br />
Plenary Abstract Presentations<br />
4:30 pm – 6:30 pm, Hall D, Lower Level North<br />
Six authors will present in this session. Each author will give a 15-minute presentation,<br />
with an additional five minutes for discussion. See page 68 for a description <strong>of</strong> this<br />
session.<br />
Opening Mixer and Trainee Mixer-within-a-Mixer<br />
7:00 pm – 8:30 pm, San Francisco Marriott Marquis Hotel, Yerba Buena 7, Lower<br />
B2 Level<br />
The opening mixer is open to all scientific registrants and registered guests. The<br />
mixer <strong>of</strong>fers a relaxed atmosphere in which attendees can become acquainted and<br />
reacquainted with colleagues. Light snacks, refreshments and a cash bar will be<br />
<strong>of</strong>fered.<br />
Trainees should look for the designated area. Trainees will receive one complimentary<br />
beverage ticket, which will be printed on trainee badges. Please<br />
remember to bring this ticket with you.<br />
For those interested in knowing the results <strong>of</strong> the U.S. general election, large screens<br />
airing the results will be located inside the Opening Mixer Ballroom after the conclusion<br />
<strong>of</strong> the plenary session.<br />
DAILY MEETING HIGHLIGHTS
56 DAILY MEETING HIGHLIGHTS<br />
Wednesday, November 7<br />
Trainee-Mentor Luncheon<br />
12:45 pm – 2:15 pm, Room 303/305, Esplanade Level South<br />
The Trainee-Mentor Luncheon is a wonderful opportunity for trainees (graduate<br />
students, postdoctoral fellows and clinical fellows) in the field <strong>of</strong> human genetics to<br />
meet and talk informally with senior members <strong>of</strong> the <strong>Society</strong> about career options,<br />
goals, and pr<strong>of</strong>essional opportunities. The luncheon is held on the first day <strong>of</strong> the<br />
meeting so that students can continue their discussions with these mentors at other<br />
times during the course <strong>of</strong> the meeting. Lunch will be served. Please see the <strong>ASHG</strong><br />
Meeting Web site (under workshops) for a list <strong>of</strong> mentors. Tickets are non-refundable.<br />
Separate advance registration required and admission is by advance ticket purchase<br />
only.<br />
Discovering Biological Data at NCBI<br />
12:45 pm–2:15 pm, Room 307, Esplanade Level South<br />
Peter Cooper from the National Center for Biotechnology Information (NCBI) will<br />
present this workshop, which will provide both general strategies for finding data at<br />
the NCBI and an introduction to various tools for visualizing and analyzing sequence<br />
data. This workshop will give a basic introduction to using the Entrez system performing<br />
searches, and finding data on human genes. Specific tasks covered include finding<br />
reference sequences, mapping variations, identifying homologous genes, exploring<br />
expression studies, and using My NCBI to save searches and manage data. Tickets are<br />
non-refundable. Separate advance registration required and admission is by advance<br />
ticket purchase only.<br />
Workshop requirements: Registrants must bring a laptop to this session in order to<br />
participate. Laptops should have full battery power and must have a wireless card.<br />
Clinical Interpretation <strong>of</strong> Cytogenomic Arrays: Tools and Resources<br />
12:45 pm – 2:15 pm, Room 304/306, Esplanade Level South<br />
Darrel Waggoner, University <strong>of</strong> Chicago, and Christa Lese Martin, Emory University,<br />
will present this workshop, which is geared for clinical geneticists and residents,<br />
genetic counselors and genetic counseling students, laboratory directors, laboratory<br />
training fellows, and other laboratory personnel. This interactive session will cover<br />
basic information about the differences between the various array platforms and will<br />
discuss strategies for choosing the appropriate platform for your patients, including<br />
issues related to repeating arrays utilizing different platforms. Tickets are nonrefundable.<br />
Separate advance registration required and admission is by advance ticket<br />
purchase only.<br />
Workshop requirements: Registrants must bring a laptop to this session in order to<br />
participate. Laptops should have full battery power and must have a wireless card.<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT
DAILY MEETING HIGHLIGHTS 57<br />
Presidential Symposium<br />
4:30 pm – 6:30 pm, Hall D, Lower Level North<br />
This symposium, organized by Mary-Claire King and entitled “Gene Discovery and<br />
Patent Law: Present Experience in the U.S. and in Europe,” will explore the present<br />
extraordinary pace <strong>of</strong> gene discovery, the question <strong>of</strong> who, if anyone, owns newly discovered<br />
genes will be critical to research and practice in human genetics. This issue<br />
has been before the U.S. Supreme Court and remanded to the Federal District Court<br />
<strong>of</strong> Appeals as Association for Molecular Pathology et al. v. Myriad <strong>Genetics</strong>. In order<br />
to understand the legal issues represented by this case, the role <strong>of</strong> this case in the<br />
larger context <strong>of</strong> legal issues in genetics, and the consequences <strong>of</strong> the decision on<br />
this case for research and services in human genetics, a panel <strong>of</strong> experts will discuss<br />
and educate us on this issue. See page 81 for a list <strong>of</strong> panelists and for a detailed<br />
description <strong>of</strong> this session.<br />
UCSC Genome Browser Interactive Workshop for<br />
Intermediate/ Advanced Users<br />
7:00 pm – 8:30 pm, Room 304/306, Esplanade Level South<br />
Robert Kuhn and Pauline Fujita, University <strong>of</strong> California, Santa Cruz, will present this<br />
interactive workshop on Web-based genomic tools. The workshop will demonstrate<br />
the use <strong>of</strong> Table Browser to access more than five terabytes <strong>of</strong> genomic data in the<br />
UCSC database. Methods for intersecting data between linked tables and filtering<br />
data to access specific subsets <strong>of</strong> large datasets will be covered. Automated program<br />
driven querying <strong>of</strong> data in the public MySQL database will also be demonstrated.<br />
Tickets are non-refundable. Separate advance registration required and admission<br />
is by advance ticket purchase only.<br />
Workshop requirements: Registrants must bring a laptop to this session in order to<br />
participate. Laptops should have full battery power and must have a wireless card.<br />
Social Media + Scientists = Success: Strategies for Using Social<br />
Media to Benefit Your Research, Your Career, and Your Connections<br />
7:00 pm – 8:30 pm, Room 310, Esplanade Level South<br />
This workshop, which is moderated by Jonathan Gitlin, NHGRI, will involve short presentations<br />
from panelists who have extensive experience using social media, followed<br />
by a highly interactive discussion with the audience. The panelists are drawn from<br />
a cross-section <strong>of</strong> the genomics community and include an early-stage researcher<br />
(Daniel MacArthur, Harvard University), a senior faculty investigator and <strong>2012</strong> <strong>Program</strong><br />
Committee Member/former editor for Nature (Chris Gunter, Hudson Alpha), and an<br />
industry representative in the commercial sector (Shirley Wu, 23andMe). The session<br />
will feature a brief “Social Media 101” tutorial and attendees will leave the workshop<br />
armed with knowledge about effective ways to use social media in the context <strong>of</strong> their<br />
genetics/genomics work. Tickets are non-refundable. Separate advance registration<br />
required and admission is by advance ticket purchase only.<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT<br />
DAILY MEETING HIGHLIGHTS
58 DAILY MEETING HIGHLIGHTS<br />
Thursday, November 8<br />
Diagnostic Challenges: Review and Discussion <strong>of</strong> Unique Cases<br />
(Rare and Unknown)<br />
12:45 pm – 2:15 pm, Room 303/305, Esplanade Level South<br />
This event is organized and moderated by Karen W. Gripp, A. I. duPont Hospital for<br />
Children, and Pedro Sanchez, Children’s Hospital Los Angeles/University <strong>of</strong> Southern<br />
California. The session provides an opportunity for registrants to present cases (rare<br />
and unknown) to a panel <strong>of</strong> expert clinical geneticists (see below) for discussion <strong>of</strong><br />
differential diagnosis, treatment and counseling options. The session provides a lively<br />
give-and-take discussion in an informal environment between the audience and the<br />
panel as each case is presented. Audience participation in suggesting diagnosis or<br />
testing is encouraged.<br />
Panelist Area <strong>of</strong> special interest<br />
Margaret Adam Dysmorphology/Teratology<br />
Cynthia Curry Dysmorphology<br />
Bill Dobyns Brain Malformation<br />
Dian Donnai Dysmorphology<br />
Karen Gripp Rasopathies/Dysmorphology<br />
Julie Hoover-Fong Skeletal Dysplasia<br />
Micheil Innes Dysmorphology<br />
Marilyn Jones Crani<strong>of</strong>acial Anomalies<br />
Stephen Kahler Metabolic Disorders<br />
Pedro Sanchez LDDB, Possum Database<br />
Anne Slavotinek Eye Malformation/Diaphragmatic Hernia<br />
Andrea Superti-Furga Skeletal Dysplasia<br />
Alain Verloes Dysmorphology<br />
Each case will be presented using PowerPoint, with a limit <strong>of</strong> six slides and three<br />
minutes per presentation. Best suited are “visuals” with plenty <strong>of</strong> images. Any slides<br />
depicting patient information or images must have the consent <strong>of</strong> the patient.<br />
It is each presenter’s responsibility to obtain consent prior to sharing identifiable<br />
information. The discussion by the expert panel will follow the presentation.<br />
Discussion will be limited to five minutes. Tickets are non-refundable. Separate<br />
advance registration required and admission is by advance ticket purchase only.<br />
Galaxy 101: Data Integration, Analysis and Sharing SOLD<br />
OUT<br />
7:00 pm – 8:30 pm, Room 304/306, Esplanade Level South<br />
Jennifer Hillman-Jackson, Penn State, and Jeremy Goecks, Emory University, will<br />
present this workshop which is an introduction to Galaxy’s basic functionality as an<br />
analysis and data integration framework for accessible, reproducible, and transparent<br />
biomedical research. In this workshop, participants will learn how to use the Galaxy<br />
Web server (http://usegalaxy.org/) to integrate and analyze biomedical data, including<br />
how to (1) load and integrate your own data with data from popular online resources;<br />
(2) perform common analysis/operations on genomic data; and (3) save, share, describe<br />
and publish your analysis and generated datasets. Tickets are non-refundable. Separate<br />
advance registration required and admission is by advance ticket purchase only.<br />
SOLD<br />
OUT
DAILY MEETING HIGHLIGHTS 59<br />
Workshop requirements: Registrants must bring a laptop to this session in order to<br />
participate. Laptops should have full battery power and must have a wireless card.<br />
Trainee Development <strong>Program</strong> and Networking Session<br />
7:00 pm – 9:30 pm, Room 309, Esplanade Level South<br />
This event is organized by the <strong>ASHG</strong> Pr<strong>of</strong>essional Development Committee, and will be<br />
led by Derek Scholes, NHGRI, and Tyrone Spady, FASEB. This year’s program will focus<br />
on science and public policy: Why should scientists care about and become active in<br />
public policy involving science? Consider the effect <strong>of</strong> policy on research and funding,<br />
education/training, and career development. Come take part in a discussion and see how<br />
you might engage with policy in ways that advance research, medicine, education, etc.<br />
A networking session follows the formal program. Tickets are non-refundable. Separate<br />
advance registration required and admission is by advance ticket purchase only.<br />
Friday, November 9<br />
Gruber <strong>Genetics</strong> Prize Presentation and Lecture/Rosalind Franklin Award<br />
Announcement<br />
10:30 am – 11:15 am, Hall D, Lower Level North<br />
The Gruber <strong>Genetics</strong> Prize honors scientists for distinguished contributions in any<br />
realm <strong>of</strong> genetic research. Dr. Douglas Wallace, Children’s Hospital <strong>of</strong> Philadelphia,<br />
will be presented with the <strong>2012</strong> Gruber <strong>Genetics</strong> Prize. An acceptance lecture is<br />
scheduled. The Rosalind Franklin Award winners will also be announced. See page<br />
107 for a description <strong>of</strong> this session and a list <strong>of</strong> past winners.<br />
William Allan Award: Presentation and Lecture<br />
11:15 am – 11:45 am, Hall D, Lower Level North<br />
The William Allan Award is presented annually to recognize substantial and far-reaching<br />
scientific contributions to human genetics, carried out over a sustained period <strong>of</strong><br />
scientific inquiry and productivity. Dr. Uta Francke, Stanford University, will be<br />
presented with the <strong>2012</strong> William Allan Award. An acceptance lecture is scheduled.<br />
See page 108 for a description <strong>of</strong> this session and a list <strong>of</strong> past winners.<br />
<strong>ASHG</strong> Membership/Business Meeting<br />
11:45 am – 12:45 pm, Hall D, Lower Level North<br />
Reports highlighting current <strong>Society</strong> business will be presented. This is an opportunity<br />
for members to learn about recent <strong>ASHG</strong> activities and to provide suggestions to<br />
leaders. There will be a moment <strong>of</strong> silence for those members and colleagues we have<br />
lost in <strong>2012</strong>. Discussion from the floor is encouraged.<br />
Mock Study Section Workshop<br />
12:45 pm – 2:15 pm, Room 303/305, Esplanade Level South<br />
Ron Adkins and Barbara Thomas, from NIH’s Center for Scientific Review, will lead<br />
the session. Did you ever wonder what really happens in study section meetings and<br />
how proposals get discussed? In this workshop, attendees will have the opportunity to<br />
work with NIH staff to learn about the proposal review process, including the typical<br />
dynamics <strong>of</strong> study section deliberations. The NIH streamlining process will be demonstrated,<br />
and the workshop will present examples <strong>of</strong> mistakes applicants commonly<br />
make. Tickets are non-refundable. Separate advance registration required and admission<br />
by advance ticket purchase only.<br />
SOLD<br />
OUT<br />
DAILY MEETING HIGHLIGHTS
60 DAILY MEETING HIGHLIGHTS<br />
Galaxy Advanced Users Workshop: Working with<br />
High-Throughput Data & Data Visualization<br />
12:45 pm – 2:15 pm, Room 304/306, Esplanade Level South<br />
Jennifer Hillman-Jackson, Penn State, and Jeremy Goecks, Emory University, will<br />
present this advanced level interactive workshop on the Galaxy tools. This workshop<br />
builds on the Galaxy 101 workshop, and basic knowledge <strong>of</strong> Galaxy will be helpful.<br />
Galaxy supports integration <strong>of</strong> data from multiple sources, including user-uploaded<br />
data and popular online resources, such as UCSC, BioMart and InterMine as well<br />
as complex bioinformatics analysis. You will learn to use the free public Galaxy Web<br />
server (http://usegalaxy.org/) to analyze NGS data, Galaxy’s visual analytics to iteratively<br />
guide analysis, etc. Tickets are non-refundable. Separate advance registration<br />
required and admission by advance ticket purchase only.<br />
Workshop requirements: Registrants must bring a laptop to this session in order to<br />
participate. Laptops should have full battery power and must have a wireless card.<br />
Ensembl Browser Interactive Workshop for<br />
Intermediate/Advanced Users<br />
7:00 pm – 8:30 pm, Room 304/306, Esplanade Level South<br />
Paul Flicek, Giulietta M. Spudich, and Bert Overduin from the European Bioinformatics<br />
Institute, will lead an interactive workshop on the Ensembl genomic tools<br />
(www.ensembl.org), introducing highlights and new ways <strong>of</strong> integrating information<br />
in the genome browser and analysis <strong>of</strong> variation data. Gene regulation tracks based<br />
on integrated analysis <strong>of</strong> ENCODE and human epigenome data will be explored and<br />
the presenters will also provide some pointers on accessing Ensembl through the<br />
MySQL and Perl APIs. Ensembl provides an infrastructure for genomic information for<br />
over 60 species, from storage to analysis and visualization. The workshop is tailored<br />
to intermediate/advanced users. Tickets are non-refundable. Separate advance registration<br />
required and admission is by advance ticket purchase only.<br />
Workshop requirements: Registrants must bring a laptop to this session in order to<br />
participate. Laptops should have full battery power and must have a wireless card.<br />
An Interactive Play: Drama, Discourse and Genomics: SOLD<br />
OUT<br />
From IRBs to IFs<br />
7:00 pm – 9:00 pm, Room 300, Esplanade Level South<br />
This interactive session weaves audience participation with the premiere <strong>of</strong> an<br />
original new vignette-play that illuminates ethical, psychological, social, legal, and<br />
policy concerns surrounding the sharing <strong>of</strong> information generated by next-generation<br />
sequencing. Between each act <strong>of</strong> the fictionalized play, audience and actors are engaged<br />
in discussion, as the vignettes evolve—from an Institutional Review Board (IRB)<br />
meeting through the informed consent process to the disclosure <strong>of</strong> incidental findings<br />
(IFs). The presenters, Lynn Bush and Karen Rothenberg, delve into controversial ethical<br />
issues and the dramatization is intended to foster a deeper appreciation for potential<br />
conflicts when disclosing genomic information. Tickets are non-refundable.<br />
Separate advance registration required and admission by advance ticket purchase only.<br />
SOLD<br />
OUT<br />
SOLD<br />
OUT
DAILY MEETING HIGHLIGHTS 61<br />
Saturday, November 10<br />
Award for Excellence in <strong>Human</strong> <strong>Genetics</strong> Education: Presentation and Lecture<br />
8:00 am – 8:20 am, Hall D, Lower Level North<br />
This award recognizes outstanding contributions to human genetics education.<br />
Nominees for this award must have made a contribution that is recognized nationally<br />
or internationally as being <strong>of</strong> exceptional quality and great importance to human<br />
genetics education. Dr. Alan Emery, Green Templeton College, University <strong>of</strong> Oxford,<br />
will be presented the <strong>2012</strong> Award for Excellence in <strong>Human</strong> <strong>Genetics</strong> Education. An<br />
acceptance lecture is scheduled. See page 116 for a description <strong>of</strong> this session and<br />
a list <strong>of</strong> past winners.<br />
Victor A. McKusick Leadership Award: Presentation and Lecture<br />
8:20 am – 8:40 am, Hall D, Lower Level North<br />
This award is presented to an individual whose pr<strong>of</strong>essional achievements have<br />
fostered and enriched the development <strong>of</strong> various human genetics disciplines. In 2008<br />
the Leadership Award was renamed to honor the memory <strong>of</strong> Victor A. McKusick (1921-<br />
2008). Dr. Francis Collins, National Institutes <strong>of</strong> Health, will be presented with the <strong>2012</strong><br />
Victor A. McKusick Leadership Award. An acceptance speech is scheduled. See page<br />
117 for a description <strong>of</strong> this session and a list <strong>of</strong> past winners.<br />
C. W. Cotterman Awards Announced<br />
8:40 am – 8:45 am, Hall D, Lower Level North<br />
The C. W. Cotterman Award winners will be announced and presented with certificates.<br />
Each September, the editorial board <strong>of</strong> the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />
selects two articles representing the best papers published in the Journal during the<br />
previous year by pre- or postdoctoral <strong>ASHG</strong> trainees.<br />
Trainee Research Award Winners Announced<br />
8:45 am – 8:55 am, Hall D, Lower Level North<br />
<strong>ASHG</strong> honors excellence in research conducted by predoctoral and postdoctoral<br />
trainees, including genetic counseling trainees, through merit-based awards that recognize<br />
highly competitive abstracts submitted for the Annual Meeting. These awards<br />
were renamed in <strong>2012</strong> to honor the late Charles Epstein. The six winners <strong>of</strong> the Charles<br />
J. Epstein Trainee Awards for Excellence in <strong>Genetics</strong> Research will be announced. See<br />
page 63 for a list <strong>of</strong> the 18 finalists and page 65 for a list <strong>of</strong> the 60 semifinalists.<br />
Curt Stern Award: Presentation and Lecture<br />
8:55 am – 9:20 am, Hall D, Lower Level North<br />
This award is presented yearly for outstanding scientific achievements in human<br />
genetics occurring in the last 10 years. The work may be a single major discovery or<br />
a series <strong>of</strong> contributions on a similar or related topic. This award honors the memory<br />
<strong>of</strong> Curt Stern (1902-1981) as an outstanding and pioneering human geneticist. Dr. Jay<br />
Shendure, University <strong>of</strong> Washington, will be presented the <strong>2012</strong> Curt Stern Award. An<br />
acceptance lecture is scheduled. See page 119 for a description <strong>of</strong> this session and<br />
a list <strong>of</strong> past winners.<br />
DAILY MEETING HIGHLIGHTS
62 DAILY MEETING HIGHLIGHTS<br />
Closing Symposium - <strong>Human</strong> <strong>Genetics</strong> <strong>2012</strong> and Beyond:<br />
Present Progress and Future Frontiers<br />
12:00 pm – 1:00 pm, Hall D, Lower Level North<br />
This year’s annual meeting will conclude with a special symposium that will include<br />
a panel <strong>of</strong> five outstanding geneticists, Han Brunner, Hal Dietz, Dian Donnai, Lynn Jorde,<br />
and Jay Shendure. This session will discuss the most exciting advances and upcoming<br />
challenges in several areas <strong>of</strong> human genetics. Panelists will answer questions<br />
from each other and from the audience. Views <strong>of</strong> the meeting attendees will be followed<br />
through <strong>ASHG</strong>’s social media outlets and will be summarized at the opening <strong>of</strong> the<br />
session. Attendees are encouraged to post their thoughts on exciting scientific or clinical<br />
advances they have heard about during the meeting, and on challenges that the<br />
field will face, by using hashtag #<strong>ASHG</strong><strong>2012</strong> on Twitter or Facebook page (https://<br />
www.facebook.com/<strong>Genetics</strong><strong>Society</strong>).<br />
<strong>ASHG</strong> <strong>2012</strong> MOBILE APP<br />
Download the <strong>ASHG</strong> <strong>2012</strong> Mobile App to your smartphone (iOS, Android, and<br />
Blackberry platforms). Refer to the ad on page 422.<br />
The mobile App brings the meeting to your fingertips wherever you go. Once the App<br />
has been downloaded, you do not need an Internet connection to view information.
DAILY MEETING HIGHLIGHTS 63<br />
<strong>ASHG</strong>/CHARLES J. EPSTEIN TRAINEE AWARDS FOR<br />
EXCELLENCE IN HUMAN GENETICS RESEARCH<br />
<strong>ASHG</strong> honors excellence in research conducted by predoctoral and postdoctoral<br />
trainees, including genetic counseling trainees, through merit-based awards that recognize<br />
highly competitive abstracts submitted for the Annual Meeting. These awards<br />
were renamed in <strong>2012</strong> to honor the late Dr. Charles Epstein.<br />
Congratulations to the 60 semifinalists. Semifinalists were selected based on abstract<br />
score and awarded complimentary registration plus $750 each. Of those semifinalists,<br />
18 finalists (selected by the Awards Committee) received an additional $250. The<br />
finalists’ presentations were reviewed by the <strong>ASHG</strong> Awards Committee and volunteer<br />
judges during the Annual Meeting. Six winners are chosen to receive an additional<br />
$1000 each. See below for the list <strong>of</strong> finalists and semi-finalists. The winners will be<br />
announced on Saturday, November 10 at the Awards session starting at 8:45 am.<br />
Members <strong>of</strong> the Awards Committee are Christopher Pearson, Chair; Goncalo Abecasis,<br />
Georgia Dunston, Maximilian Muenke, Pragna Patel, Sharon Plon; Mary-Claire King,<br />
ex <strong>of</strong>ficio.<br />
Name/Presentation Date & Time Session<br />
Number<br />
Li, Q.<br />
Tuesday, 5:50 pm (Plenary)<br />
Translational cis-regulation <strong>of</strong> gene ...<br />
Xifara, D.<br />
Wednesday, 10:30 am (Platform)<br />
The detection, structure and uses <strong>of</strong> ...<br />
Ordulu, Z.<br />
Wednesday, 10:30 am (Platform)<br />
Lessons learned from next-gen ...<br />
Doyle, A. J.<br />
Wednesday, 10:30 am (Platform)<br />
Heterozygous germline mutations in a ...<br />
O’Roak, B. J.<br />
Wednesday, 11:15 am (Platform)<br />
The discovery and validation <strong>of</strong> genes ...<br />
Powell, W. T.<br />
Wednesday, 11:15 am (Platform)<br />
A long, non-coding RNA from the ...<br />
Kitzman, J. O.<br />
Wednesday, 11:30 am (Platform)<br />
Noninvasive whole-genome<br />
sequencing <strong>of</strong> a ...<br />
<strong>Program</strong><br />
Number<br />
Award<br />
Category<br />
Room<br />
02 5 Postdoctoral Hall D<br />
Lower Level<br />
North<br />
12 16 Predoctoral Gateway<br />
Ballroom<br />
103 Lower<br />
Level South<br />
18 70 Postdoctoral Room 130<br />
Lower Level<br />
North<br />
19 79 Postdoctoral Room 123<br />
Lower Level<br />
North<br />
11 10 Postdoctoral Hall D<br />
Lower Level<br />
North<br />
17 64 Predoctoral Room 132<br />
Lower Level<br />
North<br />
18 74 Predoctoral Room 130<br />
Lower Level<br />
North<br />
TRAINEE AWARDS
64 DAILY MEETING HIGHLIGHTS<br />
Lee, Y.<br />
Wednesday, 12:00 noon (Platform)<br />
Association <strong>of</strong> genetic variation<br />
affecting ...<br />
Delaneau, O.<br />
Thursday, 11:00 am (Platform)<br />
Accurate haplotype estimation using<br />
phase ...<br />
Menelaou, A.<br />
Thursday, 11:15 am (Platform)<br />
An LD-based method for genotype<br />
calling ...<br />
Ruark, E.<br />
Thursday, 11:45 am (Platform)<br />
BRCA1 and BRCA2 mutational<br />
spectrum in a ...<br />
Snyder, M. W.<br />
Thursday, 12:00 noon (Platform)<br />
Methods for noninvasive prenatal ...<br />
Nguyen, K.-D. H.<br />
Thursday, 12:00 noon (Platform)<br />
High exome mutational burden in<br />
58 African ...<br />
Teslovich, T. M.<br />
Thursday, 4:30 pm (Platform)<br />
Whole-exome sequencing <strong>of</strong><br />
10,000 type 2 ...<br />
Tsetskhladze, Z.<br />
Friday, 9:15 am (Platform)<br />
Functional assessment <strong>of</strong> human<br />
coding ...<br />
Segurel, L.<br />
Friday, 10:00 am (Platform)<br />
When ancestry runs deep:<br />
Trans-species ...<br />
Arboleda, V.<br />
Friday, 5:15 pm (Platform)<br />
Domain-specific mutations in<br />
CDKN1C cause ...<br />
Wert, K. J.<br />
Friday, 6:30 pm (Platform)<br />
Gene therapy provides long-term<br />
visual ...<br />
14 40 Postdoctoral Room 134<br />
Lower Level<br />
North<br />
29 90 Postdoctoral Hall D<br />
Lower Level<br />
North<br />
29 91 Predoctoral Hall D<br />
Lower Level<br />
North<br />
34 138 Predoctoral Room 124<br />
Lower Level<br />
North<br />
29 94 Predoctoral Hall D<br />
Lower Level<br />
North<br />
32 121 Predoctoral Room 134<br />
Lower Level<br />
North<br />
38 169 Postdoctoral Hall D<br />
Lower Level<br />
North<br />
53 309 Postdoctoral Room 132<br />
Lower Level<br />
North<br />
50 285 Postdoctoral Room 134<br />
Lower Level<br />
North<br />
62 361 Predoctoral Room 134<br />
Lower Level<br />
North<br />
65 393 Predoctoral Room 132<br />
Lower Level<br />
North
<strong>2012</strong> TRAINEE AWARD SEMIFINALISTS<br />
Arboleda, Valerie, 361<br />
Buchan, Jillian, 220<br />
Carter, Calvin, 404<br />
de Ligt, Joep, 97<br />
Goldlust, Ian, 66<br />
Gorkin, David, 258<br />
Gymrek, Melissa, 333<br />
He, Zongxiao, 93<br />
Kitzman, Jacob, 74<br />
Kuchenbaecker, Karoline, 208<br />
Kulzer, Jennifer, 304<br />
Laurino, Mercy, 144<br />
Lim, Elaine, 11<br />
Maranville, Joseph, 248<br />
Menelaou, Androniki, 91<br />
Bryc, Katarzyna, 178<br />
Campbell, Catarina, 278<br />
Chaki, Moumita, 406<br />
Chu, Audrey, 51<br />
Chutake, Yogesh, 381<br />
Delaneau, Olivier, 90<br />
Doyle, Alexander, 79<br />
Fairfax, Benjamin, 373<br />
Girirajan, Santhosh, 14<br />
Gulsuner, Suleyman, 287<br />
Hibaoui, Youssef, 67<br />
Hung, Christina, 297<br />
Lee, Phil, 352<br />
Lee, Younghee, 40<br />
Li, Quan, 5<br />
GENERAL INFORMATION 65<br />
Predoctoral<br />
Michailidou, Kyriaki, 206<br />
Mullegama, Sureni, 103<br />
Nguyen, Khanh-Dung, 121<br />
Oz-Levi, Danit, 53<br />
Powell, Weston, 64<br />
Rowsey, Ross, 250<br />
Ruark, Elise, 138<br />
Semaka, Alicia, 265<br />
Sidore, Carlo, 177<br />
Snyder, Matthew, 94<br />
Soblet, Julie, 83<br />
Stimpson, Kaitlin, 69<br />
Wert, Katherine, 393<br />
Xifara, Dionysia Kiara, 16<br />
Yang, Wen-Yun, 180<br />
Postdoctoral<br />
Liu, Pengfei, 61<br />
Lloyd, Deborah, 219<br />
Meltz Steinberg, Karyn, 375<br />
Nord, Alex, 407<br />
O’Roak, Brian, 10<br />
Ordulu, Zehra, 70<br />
Pasaniuc, Bogdan, 89<br />
Sebro, Ronnie, 279<br />
Seeley, Andrea, 313<br />
Segurel, Laure, 285<br />
Smith, Robin, 246<br />
Teslovich, Tanya, 169<br />
Tsetskhladze, Zurab, 309<br />
Tuschl, Karin, 167<br />
Wilson Sayres, Melissa, 281<br />
The number next to each name indicates the authors abstract number.<br />
TRAINEE AWARDS
66 GENERAL INFORMATION<br />
<strong>2012</strong> FASEB MARC TRAVEL AWARDEES<br />
Each year, the <strong>ASHG</strong>/FASEB-MARC <strong>Program</strong> sponsors the Minority Travel Awards<br />
to help support the participation <strong>of</strong> faculty/mentors, postdoctoral fellows, and students<br />
from minority institutions and historically black colleges and universities in the United<br />
States. Underrepresented minority faculty, students, and postdoctoral fellows from<br />
majority institutions are also eligible to apply for these travel awards. The MARC travel<br />
awards provide up to $1,650 in funding for travel-related expenses.<br />
Elinette Albino-Rodriguez<br />
Sandra Brown-Ford<br />
Beatrice Monica Bowen<br />
Kristine Lacuesta Bucasas<br />
Calvin Carter<br />
Monique Courtenay<br />
Nadeem Fazal<br />
Michael Gonzalez<br />
Belen Hernandez<br />
James Hicks<br />
Crystal Humphries<br />
Janina Jeff<br />
Zura Liaqat<br />
Nataly Manjarrez-Orduno<br />
Candace Middlebrooks<br />
Maria Nieves-Colon<br />
Alba Pacheco-Torres<br />
Carmen Ramirez<br />
Aisha Rauf<br />
Nicole Restrepo<br />
Marquitta White
68 INVITED AND PLATFORM SESSIONS<br />
Tuesday, November 6<br />
4:00 PM–4:30 PM<br />
SESSION 1 – <strong>ASHG</strong> Presidential Address: The Scientist<br />
as a Citizen <strong>of</strong> the World<br />
Hall D, Lower Level North, Moscone Center<br />
Presenter:<br />
Mary-Claire King<br />
<strong>ASHG</strong> <strong>2012</strong> President,<br />
Univ. <strong>of</strong> Washington<br />
One <strong>of</strong> the most fulfilling features <strong>of</strong> our lives as<br />
scientists is to act as citizens <strong>of</strong> the world. We both<br />
take this citizenship for granted and take its<br />
responsibilities seriously. In one generation, this role<br />
has evolved dramatically, as scientists travel far more<br />
widely and as modern communication tools enable us<br />
to remain in contact with our colleagues worldwide. In<br />
my presidential address, I will specify some elements<br />
<strong>of</strong> the scientific life that lead naturally to world<br />
citizenship. Then I will focus in particular on how the<br />
intellectual structure <strong>of</strong> human genetics enables us to<br />
be particularly effective world citizens. I will also<br />
discuss migration as a force in our lives, as well as in<br />
human evolution, and will try to define the concept <strong>of</strong><br />
“home” for a scientist. Finally, I will suggest that<br />
scientific goals are both practical and idealistic, and<br />
that we should celebrate both.<br />
Tuesday, November 6<br />
4:30 PM–6:30 PM<br />
SESSION 2 – Plenary Abstract Presentations<br />
Hall D, Lower Level North, Moscone Center<br />
Moderator: Joel N. Hirschhorn, <strong>2012</strong> <strong>Program</strong><br />
Committee Chair Boston Children’s Hosp.,<br />
Harvard Med. Sch. and Broad Inst.<br />
1/4:30 A novel molecular and functional mechanism<br />
predisposing to ototoxicity. B. Wollnik, E. Pohl, N.<br />
Offenhäuser, A. Uzumcu, F. J. Kersten, A. K.<br />
Rzadzinska, O. Uyguner, B. Lorente, G. Nürnberg, M.<br />
Emiroglu, H. Kayserili, I. del Castillo, P. Nürnberg, T.<br />
Moser, C. Kubisch, K. P. Steel, P. P. Di Fiore, H.<br />
Kremer, Y. Li.<br />
2/4:50 Genome-wide comparison <strong>of</strong> genetic and<br />
epigenetic regulatory mechanisms in primates. Y.<br />
Gilad, A. Pai, R. Pique-Regi, C. Cain, J. Degner, N.<br />
Lewellen, K. Michelini, J. Pritchard.<br />
3/5:10 Multidisciplinary and translational task force<br />
for neonatal genomics. E. E. Davis, A. Sabo, N. C.<br />
Oien, S. H. Katsanis, H. Cope, K. Sheets, A.<br />
Sadeghpour, K. McDonald, M. Kousi, J. R. Willer, J.<br />
Kim, S. Dugan-Rocha, D. M. Muzny, A. Ashley-Koch,<br />
E. Hauser, M. Hauser, J. Sun, J. Kurtzberg, A. Murtha,<br />
B. Boyd, W. B. Gallentine, R. Goldberg, M. T.<br />
McDonald, R. A. Gibbs, M. Angrist, C. M. Cotten, N.<br />
Katsanis.<br />
4/5:30 Genome-wide identification and functional<br />
analysis <strong>of</strong> distant-acting crani<strong>of</strong>acial enhancers. C.<br />
Attanasio, Y. Zhu, M. J. Blow, A. S. Nord, V. Afzal, B.<br />
Hallgrimsson, D. FitzPatrick, H. Morrison, E. M. Rubin,<br />
L. A. Pennacchio, A. Visel.<br />
5/5:50 Translational cis-regulation <strong>of</strong> gene<br />
expression in human genome: The effect <strong>of</strong> human<br />
single nucleotide polymorphisms.Q . Li, A. Makri, Y.<br />
Lu, L. Marchand, R. Grabs, M. Rousseau, H. Ounissi-<br />
Benkalha1, H. Qu, C. Polychronakos.<br />
6/6:10 Lessons learned from the NHLBI-Exome<br />
Sequencing Project. S. M. Leal on behalf <strong>of</strong> NHLBI<br />
Exome Sequencing Project.<br />
The Opening Mixer and Trainee-Mixer-within-a-Mixer<br />
will follow the plenary session at the Marriott Marquis<br />
Hotel, Yerba Buena Ballroom. For those interested,<br />
large screens will display the U.S. election updates<br />
after the Plenary session has concluded.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Wednesday, November 7<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session I (3-10)<br />
SESSION 3 – Implementing Next-Generation<br />
Sequencing as a Clinical Test<br />
Hall D, Lower Level North, Moscone Center<br />
Moderators: Nazneen Aziz, Col. <strong>of</strong> <strong>American</strong><br />
Pathologists, Lexington, MA; Ira Lubin, Ctr. for Dis.<br />
Control and Prevent.<br />
Next-generation sequencing (NGS) is used widely in<br />
clinical research for the discovery <strong>of</strong> diseaseassociated<br />
genes and the clinical community is<br />
beginning to embrace this technology for diagnostic<br />
testing. The rapid evolution <strong>of</strong> NGS technologies<br />
presents significant opportunities and challenges for<br />
researchers and clinicians for improving health<br />
outcomes; particularly with respect to an increased<br />
emphasis on personalized and preventive medicine.<br />
Adoption <strong>of</strong> NGS in the clinical laboratory setting<br />
requires the adoption <strong>of</strong> many processes and<br />
procedures, such as, the analytic and clinical<br />
validation <strong>of</strong> the test, CLIA/CAP certification, standards<br />
for reference materials for pr<strong>of</strong>iciency testing, and<br />
questions regarding reimbursement and informed<br />
consent. This session will initially review the state <strong>of</strong><br />
NGS in the clinical setting today and what is<br />
anticipated in the near future. This will be followed by<br />
consideration for what is practically needed for clinical<br />
adoption <strong>of</strong> NGS such as regulatory and pr<strong>of</strong>essional<br />
standards, development, availability, and access to<br />
reference materials, and the laboratory pr<strong>of</strong>essional’s<br />
role for ensuring high quality test results that are useful<br />
for informing clinical decision making. This session will<br />
be informative and practical for the researcher and<br />
laboratorians who are considering launching NGS as a<br />
clinical test.<br />
8:00 AM Challenges <strong>of</strong> introducing NGS in the<br />
clinical laboratory. S. Richards. Oregon Hlth. & Sci.<br />
Univ.<br />
8:15 AM Addressing the fundamentals: NGS<br />
validation and implementation in a clinical setting.<br />
M. Hegde. Emory Univ.<br />
8:45 AM Pr<strong>of</strong>iciency testing, quality control and<br />
development <strong>of</strong> reference material for NGS clinical<br />
testing. E. Lyon. Univ. <strong>of</strong> Utah Sch. <strong>of</strong> Med.<br />
9:00 AM Development <strong>of</strong> accreditation standards<br />
for laboratories <strong>of</strong>fering NGS as a clinical test.<br />
N. Aziz. Col. <strong>of</strong> <strong>American</strong> Pathologists, Lexington, MA.<br />
9:30 AM Lessons from the clinic—What’s next? H.<br />
Jacob. Med. Col. <strong>of</strong> Wisconsin.<br />
INVITED AND PLATFORM SESSIONS 69<br />
Wednesday, November 7<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session I (3-10)<br />
SESSION 4 – Assessing the Pathogenicity <strong>of</strong> Genetic<br />
Variants: Translating in Vitro and in Silico Advances to<br />
the Clinic<br />
Gateway Ballroom 103, Lower Level South, Moscone<br />
Center<br />
Moderators: Marc S. Greenblatt, Univ. <strong>of</strong> Vermont;<br />
Sean V. Tavtigian, Univ. <strong>of</strong> Utah<br />
Interpreting which genetic variants are pathogenic and<br />
which are not remains a critical challenge in the<br />
genetics <strong>of</strong> hereditary cancer syndromes and other<br />
inherited disorders. Genetic testing for disorders such<br />
as Lynch syndrome (caused by mutations in DNA<br />
mismatch repair genes) and hereditary breast-ovarian<br />
cancer (BRCA1, BRCA2 genes) <strong>of</strong>ten identifies a<br />
`Variant <strong>of</strong> Uncertain Significance’ (VUS). As DNA<br />
sequencing capacity increases at a furious pace, there<br />
is an ever greater need to have effective methods to<br />
analyze these data. There is a consensus in the field <strong>of</strong><br />
genetic testing that proper classification <strong>of</strong> variants<br />
requires the integration <strong>of</strong> multiple types <strong>of</strong> data.<br />
Some lines <strong>of</strong> evidence are familiar to clinicians (e.g.,<br />
segregation <strong>of</strong> an allele with disease, detailed<br />
phenotype), and others are less familiar (e.g., in vitro<br />
protein functional assays, in silico algorithms based on<br />
gene sequence or protein structure). Ideally, integration<br />
can be done in a quantitative way, such as Bayesian<br />
probabilistic analysis, but qualitative data may be used<br />
if quantitative measurements are not possible. This<br />
session will 1) explore recent advances in applying<br />
and integrating statistical, laboratory, and<br />
computational methods in the classification <strong>of</strong><br />
missense, splice site, and other genetic variants, and<br />
2) report on international collaborations that are using<br />
these methods to classify variants in mismatch repair,<br />
BRCA, and other genes and disseminating validated<br />
conclusions to the cancer genetics community.<br />
8:00 AM Innovative in vitro and in vivo assays to<br />
investigate the function <strong>of</strong> mismatch repair gene<br />
variants in Lynch syndrome. N. de Wind. Leiden<br />
Univ. Med. Ctr., Netherlands.<br />
8:30 AM Analysis <strong>of</strong> splicing abnormalities to<br />
define pathogenic variants in cancer susceptibility<br />
genes. A. B. Spurdle. Queensland Inst. <strong>of</strong> Med. Res.,<br />
Australia.<br />
9:00 AM Integrating in silico with in vitro,<br />
statistical, and phenotype data to classify missense<br />
variants: A paradigm that is ready for translation to<br />
the clinic. S.V. Tavtigian. Univ. <strong>of</strong> Utah.<br />
9:20 AM CAGI: The Critical Assessment <strong>of</strong><br />
Genome Interpretation, a community experiment to<br />
evaluate phenotype prediction. S. E. Brenner. Univ.<br />
<strong>of</strong> California, Berkeley.<br />
9:40 AM International collaborations to establish<br />
standards for classifying genetic variants and to<br />
disseminate results. M. S. Greenblatt. Univ. <strong>of</strong><br />
Vermont.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
70 INVITED AND PLATFORM SESSIONS<br />
Wednesday, November 7<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session I (3-10)<br />
SESSION 5 – Gene Regulatory Change: The Engine <strong>of</strong><br />
<strong>Human</strong> Evolution?<br />
Room 135, Lower Level North, Moscone Center<br />
Moderators: James P. Noonan, Yale Univ. Sch. <strong>of</strong><br />
Med.; Nadav Ahituv, UCSF<br />
What makes us human? Classic human traits, such as<br />
language and sophisticated tool use, are the result <strong>of</strong><br />
physical changes during human evolution, including<br />
increased brain complexity and altered limb<br />
morphology. This session will focus on efforts to<br />
identify evolutionary changes in gene regulation that<br />
produced uniquely human phenotypes. Speakers will<br />
describe novel approaches that are empowering<br />
research in this emerging field, and the insights that<br />
are being gained. Topics to be discussed include: 1)<br />
Computational identification <strong>of</strong> putative gene<br />
regulatory elements that changed extensively during<br />
human evolution; 2) The role <strong>of</strong> repetitive elements in<br />
generating novel regulatory functions; 3) <strong>Human</strong>specific<br />
loss <strong>of</strong> developmental regulatory elements;<br />
4) New methods to link phenotypic and genotypic<br />
variation across closely related species, and the<br />
implications for understanding human-specific<br />
biology and disease; and 5) Identifying humanspecific<br />
developmental regulatory changes by<br />
direct comparisons <strong>of</strong> enhancer function and gene<br />
expression in embryonic human and nonhuman<br />
primate tissues using functional genomics. The<br />
session will illustrate how the synthesis <strong>of</strong> diverse<br />
computational and experimental approaches is<br />
beginning to reveal the genetic basis <strong>of</strong> unique human<br />
biology.<br />
8:00 AM Chromatin pr<strong>of</strong>iling <strong>of</strong> human embryonic<br />
tissues identifies regulatory elements with humanspecific<br />
developmental functions. J. P. Noonan. Yale<br />
Univ. Sch. <strong>of</strong> Med.<br />
8:25 AM Many human accelerated regions are<br />
developmental enhancers. K. S. Pollard. UCSF.<br />
8:50 AM Linking human and mammalian<br />
genotypes to phenotype. G. Bejerano. Stanford Univ.<br />
9:15 AM The role <strong>of</strong> repetitive elements in driving<br />
human and mammalian genome regulation. D.<br />
Odom. Cancer Research UK, Cambridge, U.K.<br />
9:40 AM Evidence <strong>of</strong> regulatory turnover in the<br />
human lineage revealed by comparing mammalian<br />
constraint, human diversity, and biochemical<br />
activity. M. Kellis. MIT.<br />
Wednesday, November 7<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session I (3-10)<br />
SESSION 6 – Insights into <strong>Human</strong> Demography and<br />
Selection from Full Genome Sequencing<br />
Room 134, Lower Level North, Moscone Center<br />
Moderators: Jeffrey M. Kidd, Univ. <strong>of</strong> Michigan; Carlos<br />
D. Bustamante, Stanford Univ.<br />
Next-generation sequencing allows geneticists to<br />
directly test the extent and pattern <strong>of</strong> natural selection<br />
in the human genome. These new genomic data<br />
address previous concerns <strong>of</strong> ascertainment bias and<br />
accurate identification <strong>of</strong> causal alleles. Recently,<br />
population geneticists have proposed multiple, strong<br />
positive sweeps related to diet and immune defense,<br />
pervasive negative selection in and nearby genes, and<br />
adaptation by allele frequency shifts from standing<br />
variation. The proportion <strong>of</strong> the human genome<br />
attributable to these different patterns is currently<br />
under intense debate. Furthermore, selection is<br />
operating on the background <strong>of</strong> complex human<br />
demography, such as long-range continental<br />
migrations and population-specific bottlenecks. This<br />
symposium aims to provide diverse viewpoints on the<br />
different modes <strong>of</strong> selection operating on the human<br />
genome and a discussion <strong>of</strong> how demographic<br />
processes may have constrained evolution in both<br />
recent and ancient human history.<br />
8:00 AM The effect <strong>of</strong> out-<strong>of</strong>-Africa migrations on<br />
the distribution <strong>of</strong> deleterious alleles in diverse<br />
human genomes. B. M. Henn. Stanford Univ.<br />
8:30 AM Genetic adaptations to new<br />
environments in humans. A. Di Rienzo. Univ. <strong>of</strong><br />
Chicago.<br />
9:00 AM Insights into selective sweeps and<br />
diversity from thousands <strong>of</strong> sequenced genomes.<br />
R. Hernandez. UCSF.<br />
9:30 AM A genomic view <strong>of</strong> the demographic and<br />
adaptive history <strong>of</strong> African pygmies. L. Quintana-<br />
Murci. Inst. Pasteur, Paris, France.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Wednesday, November 7<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session I (3-10)<br />
SESSION 7 – Age-Related Macular Degeneration–<br />
GWAS and Beyond: Guiding Light for the Complex<br />
Neurodegenerative Diseases<br />
Gateway Ballroom 104, Lower Level South, Moscone<br />
Center<br />
Moderators: Anand Swaroop, NEI/NIH; Hemin Chin,<br />
NEI/NIH<br />
AMD is a complex multi-factorial neurodegenerative<br />
disease that is a major cause <strong>of</strong> visual impairment in<br />
the elderly. Genetic linkage and genome-wide<br />
association studies (GWAS) have been immensely<br />
successful in identifying genetic susceptibility loci in<br />
AMD and in providing insights into cellular pathways<br />
underlying pathogenesis <strong>of</strong> the disease. Numerous<br />
groups worldwide have validated the strong<br />
association <strong>of</strong> variants at CFH and ARMS2/HTRA1 loci<br />
with AMD risk, and genome-wide association studies<br />
have suggested the involvement <strong>of</strong> complement,<br />
extracellular matrix, angiogenesis and HDL cholesterol<br />
pathways. This session will discuss the current<br />
progress to carry out comprehensive genetic analyses<br />
<strong>of</strong> AMD, highlighting experimental approaches that<br />
may be applicable to other complex traits and<br />
multigenic diseases. The speakers in this session will<br />
provide the current status <strong>of</strong> meta-analysis <strong>of</strong> AMD-<br />
GWAS, targeted resequencing, and whole exome<br />
sequencing efforts to discover or search for rare<br />
causal variants and functional pathways, and<br />
diagnostic/therapeutic implications <strong>of</strong> genetic variants.<br />
Additionally, we will discuss the relevance <strong>of</strong> AMD<br />
genetics for other complex neurodegenerative<br />
diseases and the future <strong>of</strong> genetic studies.<br />
8:00 AM The bigger the better: Searching for<br />
novel loci for age-related macular degeneration in<br />
a large consortium effort. I. Heid. Regensburg Univ.<br />
Med. Ctr., Germany.<br />
8:30 AM From genetic association to causal<br />
alleles by resequencing and exome arrays: The<br />
stage after GWAS. G. Abecasis. Univ. <strong>of</strong> Michigan.<br />
9:00 AM An integrated hypothesis <strong>of</strong> the<br />
development and progression <strong>of</strong> age-related<br />
macular degeneration based upon available genetic<br />
and biological data. G. S. Hageman. Univ. <strong>of</strong> Utah.<br />
9:30 AM An updated recipe for Mendel’s pea<br />
soup. M. A. Pericak-Vance. Univ. <strong>of</strong> Miami Miller Sch.<br />
<strong>of</strong> Med.<br />
INVITED AND PLATFORM SESSIONS 71<br />
Wednesday, November 7<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session I (3-10)<br />
SESSION 8 – “Yes Virginia, Family Studies Really Are<br />
Useful for Complex Traits in the Next-Generation<br />
Sequencing Era” (session in honor <strong>of</strong> Dr. Robert<br />
Elston’s contributions to human genetics in the year<br />
<strong>of</strong> his 80th birthday)<br />
Room 124, Lower Level North, Moscone Center<br />
Moderators: Michael A. Province, Washington Univ. in<br />
St. Louis; Francoise Clerget-Darpoux, INSERM U781,<br />
Univ. Paris V, France.<br />
The pros and cons <strong>of</strong> family designs as NGS targets in<br />
dissecting complex traits are presented. In the linkage<br />
era, family studies were ubiquitous, but they were<br />
largely neglected in the GWAS era, which<br />
concentrated mostly on unrelated subjects. But as<br />
attention now moves from the common to the rare<br />
variants that can only be completely interrogated<br />
through sequencing, it is useful to at least consider<br />
whether the designs that were optimal for GWAS<br />
remain so for NGS studies. Pedigrees seem to have at<br />
least some advantages over studies <strong>of</strong> unrelateds for<br />
studying rare variation. First, it may be easier to<br />
distinguish true rare variant calls from sequence errors<br />
in family designs than it is in unrelated cohorts, since<br />
there is the added dimension <strong>of</strong> pedigree consistency<br />
information, especially for low coverage. Second, a<br />
key statistical challenge to analyzing the phenotype/<br />
genotype correlation with rare variants, is finding<br />
enough copies <strong>of</strong> any one variant allele with which to<br />
make inferences (hence the various collapsing or<br />
burden tests, which combine multiple nearby rare<br />
variants into a single test). For any given very rare<br />
allele, sampling additional unrelateds is an inefficient<br />
strategy to find more copies <strong>of</strong> that allele, whereas<br />
family members <strong>of</strong> allele carriers are much more likely<br />
to be allele carriers themselves. On the other hand, a<br />
disadvantage <strong>of</strong> family designs is that there is a<br />
smaller diversity <strong>of</strong> founder mutations, so less <strong>of</strong> the<br />
overall population <strong>of</strong> alleles is measured per individual.<br />
This session emphasizes the results <strong>of</strong> real sequencing<br />
studies in pedigrees as well as simulation results to<br />
delineate the areas in which family designs <strong>of</strong>fer<br />
advantages and where they <strong>of</strong>fer disadvantages over<br />
sequencing unrelated subjects, such as case-control<br />
designs.<br />
8:00 AM Whole genome sequencing in large<br />
pedigrees for the identification <strong>of</strong> human QTLs. J.<br />
Blangero. Texas Biomed. Res. Inst., Austin.<br />
8:30 AM Linkage and association information<br />
should be considered as complementary and not<br />
redundant. F. Clerget-Darpoux. INSERM U781, Univ.<br />
Paris V, France.<br />
9:00 AM Power to find rare causal variants in<br />
pedigrees. M. A. Province. Washington Univ. in St.<br />
Louis.<br />
9:30 AM Whither human genetics? R. C. Elston.<br />
Case Western Reserve Univ.<br />
Taking Photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
72 INVITED AND PLATFORM SESSIONS<br />
Wednesday, November 7<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session I (3-10)<br />
SESSION 9 – Surveying Customer Responses to<br />
Personal Genetic Services<br />
Room 132, Lower Level North, Moscone Center<br />
Moderator: J. Scott Roberts, Univ. <strong>of</strong> Michigan<br />
This session will feature presentation <strong>of</strong> empirical data<br />
on the responses <strong>of</strong> personal genome testing<br />
consumers to their individual genomic information. Dr.<br />
David Kaufman <strong>of</strong> Johns Hopkins University will<br />
discuss publicly available interpretations <strong>of</strong> individual<br />
whole genome sequence data in light <strong>of</strong> his Center’s<br />
prior work on direct-to-consumer (DTC) testing and<br />
return <strong>of</strong> individual genetic research results. Dr.<br />
Cinnamon Bloss <strong>of</strong> the Scripps Genomic Health<br />
Initiative (SGHI) will present new long-term follow-up<br />
data from the SGHI, including data related to DTC<br />
pharmacogenomic testing and genetic ancestry<br />
testing. Dr. Sandra Lee <strong>of</strong> Stanford University will<br />
describe an anthropological study <strong>of</strong> how the public<br />
integrates information on population genetic variation<br />
in their interpretation <strong>of</strong> individualized genetic risk<br />
information for disease and drug response. The<br />
session will conclude with a panel discussion<br />
moderated by Dr. Scott Roberts <strong>of</strong> the University <strong>of</strong><br />
Michigan, joint PI (with Dr. Robert Green at Brigham<br />
and Women’s Hospital) <strong>of</strong> the Impact <strong>of</strong> Personal<br />
Genomics (PGen) Study. The PGen Study is a<br />
longitudinal survey study examining consumers’<br />
response to personal genome testing, including their<br />
motivations and expectations, risk perceptions, health<br />
behaviors and intentions. Two personal genomics<br />
companies, 23andMe and Pathway Genomics, are<br />
collaborators on the PGen Study, and the closing<br />
panel will feature a discussion that includes company<br />
representatives Dr. Joanna Mountain and Dr. Tanya<br />
Moreno. In this discussion, panelists and audience<br />
members will share their perspectives on the potential<br />
benefits and risks involved in research partnerships<br />
between academicians and personal genomics<br />
companies.<br />
8:00 AM Interpretomics: Using studies <strong>of</strong> DTC<br />
testing and the return <strong>of</strong> research results to shape<br />
the interpretation <strong>of</strong> personal whole genomic<br />
sequence data. D. Kaufman. Genet. and Publ. Policy<br />
Ctr., Johns Hopkins Univ.<br />
8:30 AM Impact <strong>of</strong> DTC genomic testing at longterm<br />
follow-up. C. S. Bloss. Scripps Translational Sci.<br />
Inst. and Scripps Hlth.<br />
9:00 AM Rendering population differences<br />
meaningful: A study <strong>of</strong> consumer interpretation <strong>of</strong><br />
genetic diversity. S. S-J. Lee. Stanford Univ. Med.<br />
Sch.<br />
9:30 AM The role <strong>of</strong> personal genomic testing<br />
companies in research: A panel discussion<br />
featuring industry and academic perspectives.<br />
Panelists: J. Mountain 1 , T. Moreno 2 , J. S. Roberts 3 .<br />
1) 23andMe Inc., Mountain View, CA; 2) Genomics<br />
Corp., San Diego; 3) Univ. <strong>of</strong> Michigan.<br />
Wednesday, November 7<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session I (3-10)<br />
SESSION 10 – Metabolism, Metals, and<br />
Neurodegeneration: Toward Enhanced Understanding<br />
<strong>of</strong> Disease Mechanisms and Rational Therapeutics<br />
Room 130, Lower Level North, Moscone Center<br />
Moderators: Stephen G. Kaler, NICHD/NIH; Susan J.<br />
Hayflick, Oregon Hlth. & Sci. Univ.<br />
This session will focus on the expanding knowledge<br />
concerning the influence <strong>of</strong> inborn errors <strong>of</strong><br />
metabolism and disorders <strong>of</strong> trace metal homeostasis<br />
on neurodegeneration. Increasing numbers <strong>of</strong> clinical<br />
phenotypes and molecular defects are now associated<br />
with disordered metabolism in the central and<br />
peripheral nervous systems. These include Alzheimer<br />
and Parkinson diseases, Menkes and Wilson diseases,<br />
ATP7A-related distal motor neuropathy, acetyl CoA<br />
transporter 1-related hypocupremia, pantothenate<br />
kinase-associated neurodegeneration, infantile<br />
neuroaxonal dystrophy, dystonia-parkinsonism,<br />
Friedreich ataxia, hemochromatosis, and iron sulfur<br />
cluster scaffold myopathy. Expert speakers will discuss<br />
and review translational research advances relevant to<br />
these conditions, as well as emerging data on disease<br />
mechanisms, pathophysiology, and potential novel<br />
remedies.<br />
8:00 AM Alzheimer disease and the metal<br />
hypothesis. R. E. Tanzi. Massachusetts Gen. Hosp.<br />
8:30 AM Neurodegeneration with brain iron<br />
accumulation. S. J. Hayflick. Oregon Hlth. & Sci. Univ.<br />
9:00 AM Friedreich ataxia and diseases <strong>of</strong> iron<br />
sulfur cluster assembly. T. A. Rouault. NICHD/NIH.<br />
9:20 AM Neurodegeneration and disorders <strong>of</strong><br />
copper transport. S. G. Kaler. NICHD/NIH.<br />
9:40 AM Exploring the link between<br />
glucocerebrosidase mutations and Parkinson<br />
disease. E. Sidransky. NHGRI/NIH.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Wednesday, November 7<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session A (11-19)<br />
SESSION 11 – <strong>Genetics</strong> <strong>of</strong> Autism Spectrum Disorders<br />
Hall D, Lower Level North, Moscone Center<br />
Moderators: Fuki M. Hisama, Univ. <strong>of</strong> Washington; Dan<br />
E. Arking, Johns Hopkins Sch. <strong>of</strong> Med.<br />
7/10:30 Genetic epidemiology <strong>of</strong> autism spectrum<br />
disorder in a cohort <strong>of</strong> over 11,000 affected<br />
sibships and half-sibships: Evidence <strong>of</strong> genetic and<br />
maternal environmental effects. N. Risch, T. J.<br />
H<strong>of</strong>fmann, M. Anderson, L. A. Croen, J. Grether, G.<br />
Windham.<br />
8/10:45 Identifying inherited autism mutations using<br />
whole exome sequencing. T. W. Yu, M. H. Chahrour,<br />
M. E. Coulter, S. Jiralerspong, K. Okamura-Ikeda, K.<br />
Schmitz-Abe, G. H. Mochida, J. N. Partlow, R. S. Hill,<br />
M. Al-Saffar, N. M. Mukaddes, A. Hashmi, S. Balkhy,<br />
G. G. Gascon, O. Oner, S. Al-Saad, T. Ben-Omran, L.<br />
Al-Gazali, V. Eapen, C. Stevens, S. Gabriel, K.<br />
Markianos, H. Taniguchi, N. E. Braverman, E. M.<br />
Morrow, C. A. Walsh.<br />
9/11:00 Identical by descent filtering in extended<br />
families reveals novel autism genes detected by<br />
exome sequencing. H. N. Cukier, N. D. Dueker, S. H.<br />
Slifer, J. M. Lee, P. L. Whitehead, E. Lalanne, N. Leyva,<br />
I. Konidari, R. C. Gentry, W. F. Hulme, D. Van Booven,<br />
D. J. Hedges, V. Mayo, S. S. Ramsook, B. A.<br />
Barrionuevo, J. M. Jaworski, M. A. Schmidt, J. L.<br />
Haines, M. L. Cuccaro, J. R. Gilbert, M. A. Pericak-<br />
Vance.<br />
10/11:15 The discovery and validation <strong>of</strong> genes<br />
recurrently disrupted in autism spectrum disorders.<br />
B. J. O’Roak, L. Vives, A. Kumar, I. B. Stanaway, J.<br />
Egertson, E. Turner, C. Lee, G. L. Carvil, I. G. Phelps,<br />
D. R. O’Day, W. Fu, J. Hiatt, B. Martin, N. Krumm, B.<br />
P. Coe, R. Levy, E. Borenstein, D. A. Nickerson, H. C.<br />
Mefford, D. Doherty, J. M. Akey, R. Bernier, E. E.<br />
Eichler, J. A. Shendure.<br />
11/11:30 Rare complete human knockouts:<br />
Population distribution and significant role in<br />
autism spectrum disorders. E. T. Lim, M. J. Daly,<br />
ARRA Autism Sequencing Consortium.<br />
12/11:45 Exome-based discovery <strong>of</strong> CNVs in<br />
simplex autism families. N. Krumm, B. Nelson, S.<br />
Girirajan, M. Dennis, C. Baker, M. Malig, NHLBI Exome<br />
Sequencing Project, A. Quinlan, D. A. Nickerson, E. E.<br />
Eichler.<br />
13/12:00 Delta catenin (CTNND2): <strong>Genetics</strong> and<br />
function <strong>of</strong> a novel autism gene.T . Turner, E. Oh, Y.<br />
Liu, M. X. Sosa, S. Sanders, K. Sharma, D. Moreno-<br />
De-Luca, T. Plona, K. Pike, D. Soppet, M. W. Smith,<br />
M. State, S. W. Cheung, C. Lese Martin, R. Huganir, E.<br />
Cook, N. Katsanis, A. Chakravarti.<br />
INVITED AND PLATFORM SESSIONS 73<br />
14/12:15 Novel hotspots <strong>of</strong> recurrent copy number<br />
variation associated with autism spectrum disorder.<br />
S. Girirajan, M. Y. Dennis, C. Baker, M. M. Malig, B. P.<br />
Coe, C. D. Campbell, K. Mark, T. Vu, C. Alkan, Z.<br />
Cheng, R. Bernier, E. E. Eichler.<br />
15/12:30 Cluster analysis defines subgroups <strong>of</strong><br />
phenotypic expression for autism spectrum<br />
disorders. O. J. Veatch, B. Yaspan, N. Schnetz-<br />
Boutaud, M. A. Pericak-Vance, J. L. Haines.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
74 INVITED AND PLATFORM SESSIONS<br />
Wednesday, November 7<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session A (11-19)<br />
SESSION 12 – New Methods for Big Data<br />
Gateway Ballroom 103, Lower Level South, Moscone<br />
Center<br />
Moderators: Elizabeth Marchani, Univ. <strong>of</strong> Washington;<br />
Rita Cantor-Chiu, UCLA Sch. <strong>of</strong> Med.<br />
16/10:30 The detection, structure and uses <strong>of</strong><br />
haplotype identity in population genetic data.<br />
D. Xifara, I. Mathieson, G. McVean.<br />
17/10:45 Inferring and sequencing the founding<br />
bottleneck <strong>of</strong> Ashkenazim. I. Pe’er, S. Carmi, S.<br />
Mukherjee, N. Parlamee, M. Bowen, K. Hui, V. Joseph,<br />
P. F. Palamara, L. Ozelius, I. Peter, A. Darvasi, K. Offit,<br />
H. Ostrer, J. Cho, L. Clark, G. Atzmon, T. Lencz,<br />
Ashkenazi Genome Consortium.<br />
18/11:00 Statistical methods for association test <strong>of</strong><br />
rare variants using summarized data without<br />
individual-subject information. Q. Zhang, I. Borecki,<br />
M. A. Province.<br />
19/11:15 Testing for rare variant associations in the<br />
presence <strong>of</strong> missing data. P. Livermore Auer, S. Leal,<br />
G. Wang, NHLBI Exome Sequencing Project.<br />
20/11:30 Quantitative trait locus analysis for nextgeneration<br />
sequencing with the functional linear<br />
models. M. Xiong, L. Luo, Y. Zhu.<br />
21/11:45 A rapid and powerful method for proteinprotein<br />
interaction- and pathway-based association<br />
analysis in genome-wide association studies. M. Li,<br />
S. Kwan, H. Gui, P. Sham.<br />
22/12:00 Statistics for X-chromosome association.<br />
U. Ozbek, D. E. Weeks, W. Chen, J. Shaffer, S. M.<br />
Purcell, E. Feingold.<br />
23/12:15 Joint association analysis <strong>of</strong> pleiotropy<br />
SNPs using GWAS summary statistics. R. M. Salem,<br />
J. N. Hirschhorn.<br />
24/12:30 Multivariate regression-based analysis <strong>of</strong><br />
relative abundance data in metagenomics.<br />
O. Libiger, N. J. Schork.<br />
Wednesday, November 7<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session A (11-19)<br />
SESSION 13 – Cancer <strong>Genetics</strong> I: Rare Variants<br />
Room 135, Lower Level North, Moscone Center<br />
Moderators: Ellen L. Goode, Mayo Clin. Col. <strong>of</strong> Med.;<br />
John D. McPherson, Ontario Inst. for Cancer Res.,<br />
Canada<br />
25/10:30 Exome sequencing <strong>of</strong> more than 6,700<br />
samples and the study <strong>of</strong> genetic susceptibility to<br />
common cancer. A. Kiezun, A. McKenna, G. Kryukov,<br />
G. Getz.<br />
26/10:45 Exome sequencing <strong>of</strong> families severely<br />
affected with breast cancer suggests eight new<br />
candidate genes: ATR, BAP1, CHEK1, GEN1,<br />
KANK4, OBSL1, RAD51B and TP53BP1. C. H.<br />
Spurrell, A. M. Thornton, M. K. Lee, S. Casadei, S. Ng,<br />
T. Walsh, J. Shendure, M. C. King.<br />
27/11:00 Rare variants in XRCC2 as breast cancer<br />
susceptibility alleles. F. S. Hilbers, M. C. Völker-<br />
Albert, W. W. Wiegant, M. P. G. Vreeswijk, N.<br />
Hoogerbrugge, J. C. Oosterwijk, J. M. Collee, M. C.<br />
Southey, P. Peterlongo, P. Radice, F. J. Couch, K. Offit,<br />
I. G. Campbell, J. Benitez, C. J. van Asperen, H. van<br />
Attikum, P. Devilee.<br />
28/11:15 HOXB13 is a susceptibility gene for<br />
prostate cancer: Results from the International<br />
Consortium for Prostate Cancer <strong>Genetics</strong>. K.<br />
Cooney, W. Isaacs, J. Xu, E. Lange, L. Lu, S. Zheng,<br />
Z. Wong, L. Cannon-Albright, J. Stanford, E. A.<br />
Ostrander, C. Maier, J. Schleutker, D. Schaid, S.<br />
Thibodeau, G. Cancel-Tassin, F. Wiklund, R. Eeles,<br />
D. Easton, A. Wittemore, G. Giles, W. Catalona, D.<br />
Mandal, W. Foulkes, J. Carpten, D. Seminara on behalf<br />
<strong>of</strong> International Consortium for Prostate Cancer<br />
<strong>Genetics</strong>.<br />
29/11:30 Parkinson disease and melanoma:<br />
A common genetic pathway linked to PARKIN<br />
inactivation. H. Hu, N. Dumaz, S. Lesage, L. Michel,<br />
V. Descamps, S. Mourah, C. Lebbé, N. Basset-Seguin,<br />
M. Bagot, A. Bensussan, L. Deschamps, M.-T. Leccia,<br />
A. Tsalamlal, P. Sivaramakrishna Rachakonda, S.<br />
Klebe, K. Rajive, C. Kannengiesser, A. Couvelard, B.<br />
Grandchamp, L. Thomas, A. Brice, N. Soufir.<br />
30/11:45 Exome sequencing in families at high risk<br />
for lymphoid malignancies. L. R. Goldin, M. L.<br />
McMaster, M. Rotunno, K. B. Jacobs, L. Burdette, M.<br />
Malasky, A. Hutchinson, M. Cullen, J. Boland, M.<br />
Yeager, M. A. Tucker, S. J. Chanock, N. E. Caporaso.<br />
31/12:00 Rare allelic forms <strong>of</strong> PRDM9 associated<br />
with childhood leukemia. J. Hussin, D. Sinnett, F.<br />
Casals, Y. Idaghdour, V. Bruat, V. Saillour, J.-C. Grenier,<br />
J. Healy, T. de Malliard, J.-F. Spinella, M. Lariviere, S.<br />
Busche, G. Gibson, A. Andersson, L. Holmfeldt, J. Ma,<br />
L. Wei, J. Zhang, G. Andelfinger, J. R. Downing, C. M.<br />
Mullighan, P. Awadalla.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Wednesday, November 7<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session A (11-19) (SESSION 13, continued)<br />
32/12:15 De novo mutation <strong>of</strong> the TGF beta family<br />
in early-onset ovarian cancer. I. Tournier, F.<br />
Charbonnier, S. Coutant, K. Walton, R. Marlin, M.<br />
Vezain, J. Tinat, E. Angot, R. Sesboué, J.-C. Sabourin,<br />
D. Vaur, C. Harrison, T. Frebourg.<br />
33/12:30 Somatic activating mutations in PIK3CA<br />
cause progressive segmental overgrowth. M. J.<br />
Lindhurst, V. E. R. Parker, F. Payne, J. C. Sapp, S.<br />
Rudge, J. Harris, A. M. Witkowski, Q. Zhang, M. P.<br />
Groeneveld, C. E. Scott, A. Daly, S. M. Huson, L. L.<br />
Tosi, M. L. Cunningham, T. N. Darling, J. Geer, Z.<br />
Gucev, P. A. Kreiger, V. R. Sutton, M. M. Thacker, C.<br />
Tziotzios, A. K. Dixon, T. Helliwell, S. O’Rahilly, D. B.<br />
Savage, M. J. O. Wakelam, R. K. Semple, I. Barroso,<br />
L. G. Biesecker.<br />
INVITED AND PLATFORM SESSIONS 75<br />
Wednesday, November 7<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session A (11-19)<br />
SESSION 14 – Quantitation and Measurement <strong>of</strong><br />
Regulatory Oversight by the Cell<br />
Room 134, Lower Level North, Moscone Center<br />
Moderators: Richard M. Myers, HudsonAlpha Inst. for<br />
Biotechnol., Huntsville, AL; Jeffrey C. Barrett,<br />
Wellcome Trust Sanger Inst., U.K.<br />
34/10:30 ChipEnrich: Gene set enrichment testing<br />
for ChIP-seq data. R. P. Welch, C. Lee, L. J. Scott, R.<br />
A. Smith, P. Imbriano, M. A. Sartor.<br />
35/10:45 Enhanced exome sequencing to capture<br />
genome-wide common variants. I. C. R. M. Kolder,<br />
K. I. Morley, E. Birney, I. Dunham, J. C. Barrett.<br />
36/11:00 Complete HIV-1 genomes from<br />
sequencing single molecules: Simple and complex<br />
samples. M. P. S. Brown, M. Schaefer, Y. Gao, W.<br />
Kilembe, S. Allen, E. Hunter, E. E. Paxinos.<br />
37/11:15 DeTCT pipeline: A s<strong>of</strong>tware pipeline for<br />
the analysis <strong>of</strong> transcript count data. J. A. Morris, J.<br />
E. Collins, I. Sealy, N. Wali, E. Busch-Netwich, R.<br />
White, D. L. Stemple, J. C. Barrett.<br />
38/11:30 Fast genome-wide QTL association<br />
mapping with pedigrees. H. Zhou, E. M. Sobel, K.<br />
Lange.<br />
39/11:45 Discovering SNPs regulating human gene<br />
expression using allele specific expression from<br />
RNA-seq data. E. Eskin, E. Kang, B. Han, A. J. Lusis,<br />
L. Martin, S. Shiffman.<br />
40/12:00 Association <strong>of</strong> genetic variation affecting<br />
exon skipping to disease susceptibility. Y. Lee, H.<br />
Im, W. Hernandez, N. J. Cox.<br />
41/12:15 Haplotype-based variant detection and<br />
interpretation enables the population-scale analysis<br />
<strong>of</strong> multi-nucleotide sequence variants. E. Garrison,<br />
J. A. Rosenfeld, D. MacArthur, Y. Xue, Z. Iqbal, S.<br />
Balasubramanian, L. Habegger, R. Poplin, M. A.<br />
DePristo, G. Marth, M. B. Gerstein, C. Tyler-Smith,<br />
1000 Genomes Project.<br />
42/12:30 eQTL analysis identifies novel associations<br />
between genotype and gene expression in the<br />
human intestine. B. Kabakchiev, NIDDK IBD <strong>Genetics</strong><br />
Consortium, M. S. Silverberg.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
76 INVITED AND PLATFORM SESSIONS<br />
Wednesday, November 7<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session A (11-19)<br />
SESSION 15 – New Loci for Obesity, Diabetes, and<br />
Related Traits<br />
Gateway Ballroom 104, Lower Level South, Moscone<br />
Center<br />
Moderators: Jose Florez, Massachusetts Gen. Hosp.;<br />
Richa Saxena, Massachusetts Gen. Hosp.<br />
43/10:30 A genome-wide association analysis <strong>of</strong><br />
early-onset severe obesity: The SCOOP project.<br />
E. Wheeler, N. Huang, E. Bochukova, S. Lindsay, J.<br />
Keogh, R. J. F. Loos, N. J. Wareham, S. O’Rahilly, M.<br />
Hurles, I. Barroso, I. S. Farooqi.<br />
44/10:45 Mapping obesity traits using an integrated<br />
`omics’ approach in adipose tissue from female<br />
twins. A. K. Hedman, J. K. Sandling, E. Grundberg, K.<br />
S. Small, E. Meduri, S. Keildson, A. Nica, A. Buil, J. T.<br />
Bell, J. Nisbet, M. Sekowska, A. Wilk, A. Barrett, N.<br />
Hassanali, T.-P. Yang, D. Glass, S.-Y. Shin, L. Parts, N.<br />
Soranzo, R. Durbin, K. Ahmadi, K. T. Zondervan, C. M.<br />
Lindgren, T. D. Spector, E. T. Dermitzakis, M. I.<br />
McCarthy, P. Deloukas for MuTHER Consortium.<br />
45/11:00 Whole exome sequencing identifies<br />
candidate causal genes for severe insulin<br />
resistance. F. Payne, A. Daly, W. Bottomley, E. Raffan,<br />
E. Goncalves Serra, A. Thompson, D. B. Savage, R. K.<br />
Semple, S. O’Rahilly, I. Barroso, UK10K Consortium.<br />
46/11:15 Exome analysis in 8,232 Finnish men<br />
identifies novel loci and low-frequency variants for<br />
insulin processing and secretion. J. R. Huyghe, A.<br />
U. Jackson, M. P. Fogarty, A. Stanáková, H. M.<br />
Stringham, M. L. Buchkovich, C. Fuchsberger, J.<br />
Paananen, P. S. Chines, T. M. Teslovich, J. M. Romm,<br />
H. Ling, I. McMullen, R. Ingersoll, E. W. Pugh, K. F.<br />
Doheny, J. Kuusisto, L. J. Scott, F. S. Collins, G. R.<br />
Abecasis, R. M. Watanabe, M. Boehnke, M. Laakso, K.<br />
L. Mohlke.<br />
47/11:30 Global genomic and transcriptomic<br />
variation in human pancreatic islets reveals novel<br />
loci associated with type 2 diabetes and related<br />
traits. J. Fadista, P. Vikman, I. Mollet, E. O. Laakso, U.<br />
Krus, O. Hansson, L. Groop.<br />
48/11:45 Identification <strong>of</strong> a novel genome-wide<br />
significant association with type 2 diabetes risk in<br />
Mexicans and Mexican <strong>American</strong>s. A. L. Williams, H.<br />
García-Ortiz, M. J. Gómez-Vázquez, C. A. Haiman, A.<br />
Huerta-Chagoya, A. K. Manning, C. Márquez-Luna, H.<br />
Moreno-Macías for SIGMA Type 2 Diabetes<br />
Consortium.<br />
49/12:00 Discovery and fine-mapping <strong>of</strong> type 2<br />
diabetes susceptibility loci through trans-ethnic<br />
meta-analysis. A. Mahajan, J. E. Below, W. Zhang, M.<br />
J. Go, E. Parra, A. P. Morris, AGEN-T2D, DIAGRAM,<br />
MA-T2D and SA-T2D Consortia.<br />
50/12:15 TCF7L2 genetic variation is associated<br />
with impaired incretin effect and lower glucagon. B.<br />
Chamarthi, K. R. Littleton, V. Kaur, L. Chen, A. K.<br />
Manning, M. K. Thomas, M. S. Hudson, J. C. Florez.<br />
51/12:30 Novel locus including FGF21 is associated<br />
with dietary macronutrient intake. A. Y. Chu, T.<br />
Workalemahu, N. P. Paynter, L. M. Rose, F. Giulianini,<br />
CHARGE Nutrition Working Group, Q. Qi, G. C.<br />
Curhan, E. B. Rimm, D. J. Hunter, L. R. Pasquale, P.<br />
M. Ridker, F. B. Hu, D. I. Chasman, L. Qi on behalf <strong>of</strong><br />
DietGen Consortium.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Wednesday, November 7<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session A (11-19)<br />
SESSION 16 – Neuromuscular Disease and Deafness<br />
Room 124, Lower Level North, Moscone Center<br />
Moderators: Anthony Antonellis, Univ. <strong>of</strong> Michigan;<br />
Thomas Glover, Univ. <strong>of</strong> Michigan<br />
52/10:30 The TRK-fused gene is mutated in<br />
hereditary motor and sensory neuropathy with<br />
proximal dominant involvement (HMSN-P). H.<br />
Ishiura, W. Sako, M. Yoshida, T. Kawarai, O. Tanabe, J.<br />
Goto, Y. Takahashi, H. Date, J. Mitsui, B. Ahsan, Y.<br />
Ichikawa, A. Iwata, H. Yoshino, Y. Izumi, K. Fujita, K.<br />
Maeda, S. Goto, H. Koizumi, R. Morigaki, M. Ikemura,<br />
N. Yamauchi, S. Murayama, G. Nicholson, H. Ito, G.<br />
Sobue, M. Nakagawa, R. Kaji, S. Tsuji.<br />
53/10:45 Mutation in the autophagy-related<br />
TECPR2 gene causes hereditary spastic<br />
paraparesis. D. Oz-Levi, B. Ben-Zeev, E. Ruzzo, Y.<br />
Hitomi, A. Gelman, K. Pelak, Y. Anikster, H. Reznik-<br />
Wolf, I. Bar-Joseph, T. Olender, A. Alkelai, M. Weiss, E.<br />
Ben-Asher, D. Ge, K. Shianna, Z. Elazar, D. Goldstein,<br />
E. Pras, D. Lancet.<br />
54/11:00 Spinal muscular atrophy associated with<br />
progressive myoclonic epilepsy is caused by<br />
mutations in ASAH1. J. Melki, J. Zhou, M. Tawk, F. D.<br />
Tiziano, J. Veillet, M. Bayés, F. Nolent, V. Garcia, S.<br />
Servidei, E. Bertini, F. Castro-Giner, Y. Renda, S.<br />
Carpentier, N. Andrieu-Abadie, I. Gut, T. Levade, H.<br />
Topaloglu.<br />
55/11:15 Genetic variants in chromatin modifying<br />
genes cause D4Z4 hypomethylation, DUX4<br />
expression, and contraction-independent<br />
facioscapulohumeral muscular dystrophy (FSHD2).<br />
D. G. Miller, R. J. L. F. Lemmers, L. M. Petek, J. Balog,<br />
P. J. van der Vliet, G. J. Block, J. W. Lim, G. N.<br />
Filippova, A. M. Amell, G. W. E. Santen, B. Bakker, M.<br />
J. Bamshad, S. J. Tapscott, R. Tawil, S. M. van der<br />
Maarel.<br />
56/11:30 Unexpected extension <strong>of</strong> the phenotype<br />
spectrum associated with SMAD3 mutations in<br />
aneurysms-osteoarthritis syndrome. M. Aubart, D.<br />
Gobert, N. Hanna, C. Muti, J. Roume, V. Cusin, B.<br />
Grandchamp, L. Gouya, D. Detains, G. Jondeau, C.<br />
Boileau.<br />
57/11:45 Whole-exome sequencing for autosomal<br />
recessive non-syndromic deafness: 93% <strong>of</strong> known<br />
genes covered and OTOGL and SLITRK6 are novel<br />
genes. M . Tekin, O. Diaz-Horta, D. Duman, J. Foster II,<br />
A. Sirmaci, M. Gonzalez, N. Mahdieh, M. Bonyadi, F.<br />
B. Cengiz, R. Ulloa, S. Zuchner, S. Blanton.<br />
58/12:00 Whole exome sequencing and more to<br />
unravel the genetics and genotype-phenotype<br />
correlations for deafness. H. Kremer, M. Schraders,<br />
C. Zazo Seco, J. Oostrik, I. Feenstra, A. M. M. Oonk,<br />
E. van Beelen, M. van Bers, K. Neveling, J. A. Veltman,<br />
R. J. C. Admiraal, H. P. M. Kunst, R. J. E. Pennings, E.<br />
H. Hoefsloot.<br />
INVITED AND PLATFORM SESSIONS 77<br />
59/12:15 A mutation in Ca2+ binding protein 2,<br />
expressed in cochlear inner hair cells, causes<br />
autosomal recessive hearing impairment.<br />
I . Schrauwen, S. Helfmann, A. Inagaki, F. Wolk,<br />
M. A. Tabatabaiefar, M. M. Picher, M. Sommen,<br />
C. Zazo Seco, H. Kremer, A. Dheedene, C. Claes,<br />
E. Fransen, M. A. Chaleshtori, P. Coucke, A. Lee,<br />
T. Moser, G. Van Camp.<br />
60/12:30 Comprehensive diagnosis for hearing loss<br />
using personal genomics: The first 100 cases.<br />
E . Shearer, E. A. Black-Ziegelbein, M. S. Hildebrand,<br />
A. P. DeLuca, R. W. Eppsteiner, S. E. Scherer,<br />
T. E. Scheetz, T. L. Casavant, R. J. H. Smith.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
78 INVITED AND PLATFORM SESSIONS<br />
Wednesday, November 7<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session A (11-19)<br />
SESSION 17 – Chromosomes and Disease<br />
Room 132, Lower Level North, Moscone Center<br />
Moderators: Christa Lese Martin, Emory Univ.; Blake<br />
Ballif, Signature Genomics, Spokane, WA<br />
61/10:30 Characterization <strong>of</strong> de novo copy-number<br />
variations in two subjects with a constitutional<br />
“CNV mutator” phenotype. P. Liu, K. Walter, K. Writzl,<br />
V. Gelowani, S. Lindsay, C. M. B. Carvalho, M.<br />
Withers, J. Wiszniewska, A. Patel, B. Rautenstrauss,<br />
M. Hurles, J. R. Lupski.<br />
62/10:45 Associations between gene expression<br />
and phenotypes in 16p11.2 rearrangements.<br />
E. Migliavacca, K. Mannik, F. Zufferey, N. D. Beckmann,<br />
L. Harewood, A. Mace, Z. Kutalik, L. Hippolyte, A.<br />
Maillard, V. Siffredi, R. M. Witwicki, G. Didelot, S.<br />
Jacquemont, S. Bergmann, J. S. Beckmann, 16p11.2<br />
European Consortium Collaborators.<br />
63/11:00 De novo triplication can arise from a<br />
duplication <strong>of</strong> the 17p12 region and confers a<br />
severe Charcot-Marie-Tooth, type 1A phenotype.<br />
V. Gelowani, P. Liu, F. Zhang, S. B. Shachar, S. D.<br />
Batish, E. Roney, V. Drory, A. Orr-Urtreger, J. R. Lupski.<br />
64/11:15 A long, non-coding RNA from the Prader-<br />
Willi critical region forms a subnuclear cloud and<br />
recruits transcriptional activating complexes to the<br />
SNORD 116 locus in postnatal neurons. W . T.<br />
Powell, R. Coulson, F. Crary, S. Wong, D. H. Yasui,<br />
J. M. LaSalle.<br />
65/11:30 Molecular analysis <strong>of</strong> patients whose<br />
clinical features overlap the 22q11.2 deletion<br />
syndrome. S. Saitta, T. Busse, D. McDonald-McGinn,<br />
E. Zackai, S. Woyciechowski, J. Garbarini, E.<br />
Goldmuntz, C. Van Ravenswaaij, L. Hoefsloot, B.<br />
Emanuel, D. Driscoll.<br />
66/11:45 Mouse model implicates GNB3copy<br />
number in a novel childhood obesity syndrome.<br />
I. S. Goldlust, K. E. Hermetz, L. M. Catalano, R. A.<br />
Cozad, R. T. Barfield, K. N. Conneely, J. G. Mulle, S.<br />
Dharamrup, M. Hegde, K. Kim, B. Angle, A. Colley, A.<br />
E. Webb, E. C. Thorland, J. Ellison, J. Rosenfeld, B. C.<br />
Ballif, L. G. Shaffer, L. A. Demmer, Unique Rare<br />
Chromosome Support, M. K. Rudd.<br />
67/12:00 Modeling neurogenesis impairment in<br />
Down syndrome using induced pluripotent stem<br />
cells from monozygotic twins discordant for<br />
trisomy 21. Y. Hibaoui, I. Grad, S. R. Sailani, A.<br />
Letourneau, S. Dahoun, S. Gimelli, M. F. Pelte, F.<br />
Béna, S. E. Antonarakis, A. Feki.<br />
68/12:15 Discovery and interpretation <strong>of</strong> balanced<br />
chromosomal aberrations in neurodevelopmental<br />
abnormalities and prenatal diagnostics. M. E.<br />
Talkowski, V. Pillalamarri, I. Blumenthal, C. Hanscom,<br />
Z. Ordulu, J. Rosenfeld, L. G. Shaffer, J. F. Gusella, C.<br />
C. Morton.<br />
69/12:30 Predisposition <strong>of</strong> acrocentric short arm<br />
fusions due to nuclear location, nucleolar<br />
disorganization, and telomere-induced DNA<br />
damage. K. M. Stimpson, L. L. Sullivan, S. Chen, B.<br />
A. Sullivan.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Wednesday, November 7<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session A (11-19)<br />
SESSION 18 – Prenatal and Perinatal <strong>Genetics</strong><br />
Room 130, Lower Level North, Moscone Center<br />
Moderators: Natalie Blagowidow, Harvey Inst. for<br />
<strong>Human</strong> Genet., Baltimore; David Chitayat, Mount Sinai<br />
Hosp., Toronto, Canada<br />
70/10:30 Lessons learned from next-gen<br />
cytogenetics: Whole genome sequence-based<br />
prenatal diagnosis <strong>of</strong> apparently balanced de novo<br />
chromosome rearrangements. Z. Ordulu,<br />
M. Talkowski, V. Pillalamarri, S. Pereira, I. Blumenthal,<br />
C. Hanscom, A. M. Lindgren, N. Hussain, S. Connolly,<br />
L. E. Wilkins-Haug, J. F. Gusella, C. C. Morton.<br />
71/10:45 The use <strong>of</strong> chromosome microarray<br />
analysis as a first-line test in pregnancies with a<br />
priori low risk for detection <strong>of</strong> submicroscopic<br />
chromosomal abnormalities. F. Fiorentino,<br />
S. Napoletano, C. Caiazzo, M. Sessa, S. Bono,<br />
L. Spizzichino, S. Michiorri, A. Gordon, A. Nuccitelli,<br />
G. Rizzo, M. Baldi.<br />
72/11:00 The challenge <strong>of</strong> preconceptional,<br />
preimplantation, and prenatal genetic diagnoses <strong>of</strong><br />
mitochondrial DNA disorders. J. Steffann, S.<br />
Monnot, N. Gigarel, P. Vachin, E. Herzog, P. Burlet,<br />
N. Frydman, A. Benachi, G. Chalouhi, Y. Ville, R.<br />
Frydman, A.-S. Lebre, A. Rotig, D. C. Samuels, C. Elie,<br />
A. Munnich, J.-P. Bonnefont.<br />
73/11:15 The incidence and spectrum <strong>of</strong> genomic<br />
imbalance in products <strong>of</strong> conception: New insights<br />
from SNP microarray analysis <strong>of</strong> 2,400 miscarriage<br />
specimens. B. Levy, S. Sigurjonsson, B. J. Pettersen,<br />
M. K. Maisenbacher, Z. P. Demko, R. Lathi, R. Tao,<br />
V. Aggarwal, M. Rabinowitz.<br />
74/11:30 Noninvasive whole-genome sequencing <strong>of</strong><br />
a human fetus. J. O. Kitzman, M. W. Snyder, M.<br />
Ventura, A. P. Lewis, R. Qiu, L. E. Simmons, H. S.<br />
Gammill, C. E. Rubens, D. A. Santillan, M. K. Santillan,<br />
J. C. Murray, H. K. Tabor, M. J. Bamshad, E. E. Eichler,<br />
J. A. Shendure.<br />
75/11:45 Spina bifida risk is conferred by multiple<br />
polymorphisms in folate one-carbon pathway<br />
genes. D. Gilbert, K. Lazaruk, J. Stein, J. Hardin, J.<br />
Witte, G. Shaw, E. Lammer, N. Marini, J. Rine.<br />
76/12:00 Bioinformatics approach for identifying the<br />
genetic contributions to preeclampsia. A.Uzun,<br />
I. Kurihara, J. Tavormina, R. Cabezas, A. Laliberte,<br />
A. Dewan, E. Triche, J. Padbury.<br />
INVITED AND PLATFORM SESSIONS 79<br />
77/12:15 Antenatal spectrum <strong>of</strong> CHARGE syndrome<br />
in 40 fetuses with CHD7 mutations. M. Legendre,<br />
M. Gonzales, G. Goudefroye, F. Bilan, P. Parisot,<br />
M. J. Perez, M. Bonnière, B. Bessières, J.<br />
Martinovic, A.-L. Delezoide, F. Jossic, C. Fallet-<br />
Bianco, M. Bucourt, J. Tantau, P. Loget, L. Loeuillet,<br />
N. Laurent, B. Leroy, H. Salhi, C. Rouleau, F. Guimiot,<br />
C. Chelin, A. Bazin, C. Alby, A. Kitzis, Y. Ville,<br />
F. Encha-Razavi, B. GilbertDussardier, M. Vekemans,<br />
T. Attié-Bitach, SOFFOET.<br />
78/12:30 Genetic normalization <strong>of</strong> day-3 embryos:<br />
Results from two independent preimplantation<br />
genetic screening laboratories. P. Brezina,<br />
E. Littman, Y. Sun, V. Phan, R. Anchan, A. Barker,<br />
M. Hughes, G. R. Cutting, W. G. Kearns.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
80 INVITED AND PLATFORM SESSIONS<br />
Wednesday, November 7<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session A (11-19)<br />
SESSION 19 – Vascular and Congenital Heart Disease<br />
Room 123, Lower Level North, Moscone Center<br />
Moderators: Amy Roberts, Children’s Hosp. Boston;<br />
Bart L. Loeys, Univ. <strong>of</strong> Antwerp., Belgium<br />
79/10:30 Heterozygous germline mutations in a<br />
prototypical TGF repressor cause Shprintzen-<br />
Goldberg syndrome with aortic aneurysm. A. J.<br />
Doyle, J. J. Doyle, M. E. Lindsay, S. L. Bessling, N.<br />
Huso, D. Schepers, L. Gillis, G. Mortier, L. Van Laer,<br />
D. W. Mohr, M. J. Caulfield, A. F. Scott, C. J. Curry, B.<br />
Loeys, A. S. McCallion, H. C. Dietz.<br />
80/10:45 Loss-<strong>of</strong>-function mutations inTGFB2<br />
cause Loeys-Dietz syndrome: Towards solving the<br />
TGF� paradox in aortic aneurysmal disease.<br />
B. Loeys, M. E. Lindsay, D. Schepers, N. Ajit Bolar,<br />
J. Doyle, E. Gallo, J. Fert-Bober, M. J. E. Kempers,<br />
E. Fishman, Y. Chen, L. Myers, D. Bjeda, G. Oswald,<br />
B. M. Anderlid, M. Y. Yang, E. M. H. F. Bongers,<br />
J. Timmermans, A. C. Braverman, N. Canham,<br />
G. R. Mortier, H. G. Brunner, P. H. Byers, J. Van Eyk,<br />
L. Van Laer, H. Dietz.<br />
81/11:00 Genetic dissection <strong>of</strong> aortic disease in the<br />
Marfan syndrome. F. Ramirez, L. Carta, M. Del Solar,<br />
M. Lindsay, H. Dietz, J. R. Cook.<br />
82/11:15 Bicuspid aortic valve, aortic coarctation<br />
and patent ductus associated with MATR3<br />
disruption in human and mouse. F. Quintero-<br />
Rivera, Q. J. Xi, K. M. Keppler-Noreuil, J. H. Lee, A.<br />
W. Higgins, R. Anchan, A. E. Roberts, G. A. P. Bruns,<br />
R. Berezney, B. D. Gelb, R. V. Lacro, D. J. Harris,<br />
A. Kamp, I. P. Moskowitz, W. Lu, C. C. Morton, J. F.<br />
Gusella, R. L. Maas.<br />
83/11:30 Identification <strong>of</strong> the cause <strong>of</strong> blue rubber<br />
bleb nevus syndrome. J. Soblet, N. Limaye, M.<br />
Cordisco, A. Dompmartin, O. Enjolras, S. Holden, A.<br />
D. Irvine, C. Labrèze, A. Lanoel, P. N. Rieu, S. Syed,<br />
C. J. van der Vleuten, R. Watson, S. J. Fishman, J. B.<br />
Mulliken, L. M. Boon, M. Vikkula.<br />
84/11:45 Identifying genetic determinants <strong>of</strong><br />
congenital heart defect in Down syndrome. M. R.<br />
Sailani, P. Makrythanasis, S. Deutsch, A. Valsesia,<br />
E. Migliavacca, F. Santoni, A. Sharp, C. Serra-Juhe,<br />
S. Vicari, R. Rabionet, Y. Grattau, G. Dembour, A.<br />
Megarbane, R. Touraine, S. Kitsiou, H. Fryssira, C.<br />
Chatzisevastou-Loukidou, E. Kanavakis, G. Merla, L.<br />
Perez-Jurado, X. Estivill, J. Delabar, S. E. Antonarakis.<br />
85/12:00 Transcriptome-wide decreased variation<br />
in gene expression <strong>of</strong> Down syndrome fibroblasts:<br />
Selection or canalization? K. Popadin, A.<br />
Letourneau, F. Santoni, S. E. Antonarakis.<br />
86/12:15 Mutations in OLFML2B within the QT<br />
interval associated region 1q23.3 disturb cardiac<br />
repolarization, predispose to Long-QT syndrome<br />
and to sudden infant death syndrome. A. Pfeufer,<br />
C. Congiu, Z. Schäfer, H. Prucha, M. Vennemann,<br />
I. Sinicina, N. Strutz-Seebohm, H. Kartmann, M.<br />
Schell, E. Kremmer, E. R. Behr, N. H. Bishopric, R. J.<br />
Myerburg, L. Crotti, P. J. Schwartz, A. A. Hicks, P. P.<br />
Pramstaller, W. Rottbauer, S. Kääb, T. Meitinger, M.<br />
Näbauer, M. Cohen, M. Donner, D. T. Mage, H. W.<br />
Mewes, T. Bajanowski, G. Seebohm, M. Ueffing, C. J.<br />
Gloeckner.<br />
87/12:30 The impact <strong>of</strong> inherited genetic variants<br />
associated with lipid pr<strong>of</strong>ile, hypertension, and<br />
coronary artery disease on the risk <strong>of</strong> intracranial<br />
and abdominal aortic aneurysms. F. N. G. van `t<br />
H<strong>of</strong>, Y. M. Ruigrok, A. F. Baas, L. A. L. M. Kiemeney,<br />
S. H. Vermeulen, A. G. Uitterlinden, F. Rivadeneira, A.<br />
H<strong>of</strong>man, G. J. E. Rinkel, P. I. W. de Bakker.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
INVITED AND PLATFORM SESSIONS 81<br />
Wednesday, November 7<br />
4:30 PM–6:30 PM<br />
SESSION 20 – Invited Presidential Symposium: Gene Discovery and Patent Law: Present Experience in the<br />
U.S. and in Europe<br />
Hall D, Lower Level North, Moscone Center<br />
With the present extraordinary pace <strong>of</strong> gene discovery, the question <strong>of</strong> who, if anyone, owns newly discovered<br />
genes will be critical to research and practice in human genetics. This issue was before the U.S. Supreme Court and<br />
remanded to the Federal Circuit Court <strong>of</strong> Appeals as Association for Molecular Pathology et al. v. Myriad <strong>Genetics</strong>,<br />
No. 11-725 where the decision was affirmed. In order to understand the many legal issues represented by this case,<br />
the role <strong>of</strong> this case in the larger context <strong>of</strong> legal issues in genetics, and the consequences <strong>of</strong> the decision on this<br />
case for research and services in human genetics, we have asked a panel <strong>of</strong> experts to educate us.<br />
Hank Greely, Pr<strong>of</strong>essor <strong>of</strong> Law and Director <strong>of</strong> the<br />
Center for Law and Biosciences at Stanford University,<br />
will moderate the panel and present an overview <strong>of</strong><br />
issues on which genetics and the law have come in<br />
contact in the U.S.<br />
Mark Lemley, Pr<strong>of</strong>essor <strong>of</strong> Law and Director <strong>of</strong> the<br />
<strong>Program</strong> in Law, Science, and Technology at Stanford<br />
University, will describe the meaning <strong>of</strong> patents in the<br />
context <strong>of</strong> intellectual property in general and gene<br />
discovery in particular.<br />
Lori Andrews, Pr<strong>of</strong>essor <strong>of</strong> Law at IIT Chicago-Kent<br />
College <strong>of</strong> Law and Fellow <strong>of</strong> the Hastings Institution,<br />
will describe the issues <strong>of</strong> the Myriad case and the<br />
roles <strong>of</strong> lawyers, practitioners and advocates in the<br />
evolution <strong>of</strong> the case.<br />
Gert Matthijs, Pr<strong>of</strong>essor and Head <strong>of</strong> the Laboratory<br />
for Molecular Diagnostics at the Center for <strong>Human</strong><br />
<strong>Genetics</strong> at University <strong>of</strong> Leuven, Belgium, will discuss<br />
the challenge to gene patenting brought to the<br />
European Patent Office by European human<br />
geneticists, the consequences for genetics services <strong>of</strong><br />
the 2008 EPO decisions, and the present issues <strong>of</strong><br />
gene patents in Europe.<br />
We intend these presentations to be educational rather than confrontational. Each speaker will present both their<br />
own views and alternative, opposing points <strong>of</strong> view. Our goal is to understand the complexity <strong>of</strong> these issues<br />
from the legal perspective. Considerable time after the presentations will be devoted to answering questions from<br />
the audience. We hope <strong>ASHG</strong> members will enjoy looking at these questions from a different angle and will find<br />
this perspective useful in their future research.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
82 INVITED AND PLATFORM SESSIONS<br />
Thursday, November 8<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session II (21-28)<br />
SESSION 21 – Mendelian Randomization: Using<br />
Genetic Variants to Inform Causality in Observational<br />
Epidemiology<br />
Room 135, Lower Level North, Moscone Center<br />
Moderators: David M. Evans, Univ. <strong>of</strong> Bristol, U.K.; Lyle<br />
J. Palmer, Univ. <strong>of</strong> Ontario, Canada<br />
A central problem in classical observational<br />
epidemiology concerns whether an association<br />
between a medically relevant exposure and a disease<br />
outcome reflects a causal relationship, or whether the<br />
purported association is a spurious result <strong>of</strong> latent<br />
confounding, bias or reverse causality. For example,<br />
does an inverse correlation between red wine drinking<br />
and heart disease, mean that red wine prevents<br />
heart attacks? The gold standard in proving whether<br />
an association reflects a causal relationship is the<br />
randomized controlled trial (RCT), in which participants<br />
are randomly assigned into groups that differ on<br />
average only in terms <strong>of</strong> their treatment (exposure)<br />
effect. However, RCTs are typically expensive, <strong>of</strong> long<br />
duration and in some cases, ethically or practically<br />
infeasible to implement. Mendelian randomization<br />
is a relatively new methodology that uses genetic<br />
variants that have been robustly associated with<br />
medically relevant exposures from genetic association<br />
studies (e.g. genetic variants related to BMI, smoking,<br />
alcohol etc.) to determine whether these exposures<br />
are truly causally related to disease outcomes. This<br />
session describes the principles behind Mendelian<br />
randomization, explains how Mendelian randomization<br />
can be used in epidemiological and gene expression<br />
studies to assess causality, describes its assumptions<br />
and limitations, and finally discusses extensions and<br />
promising alternatives to the method.<br />
8:00 AM Mendelian randomization: Overcoming<br />
the limitations. G . D. Smith. Univ. <strong>of</strong> Bristol, U.K.<br />
8:30 AM Utilizing multiple variants to improve<br />
Mendelian randomization studies. B . Pierce. Univ.<br />
<strong>of</strong> Chicago.<br />
9:00 AM Application <strong>of</strong> Mendelian randomization<br />
analyses in prospective studies from Denmark.<br />
A. Tybjærg-Hansen. Univ. <strong>of</strong> Copenhagen, Denmark.<br />
9:30 AM Mendelian randomization for HDL levels<br />
and implications for clinical risk prediction.<br />
B. F. Voight. Univ. <strong>of</strong> Pennsylvania Sch. <strong>of</strong> Med.<br />
Thursday, November 8<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session II (21-28)<br />
SESSION 22 – Common and Rare CNVs: Genesis,<br />
Patterns <strong>of</strong> Variations and <strong>Human</strong> Diseases<br />
Hall D, Lower Level North, Moscone Center<br />
Moderators: Chack Yung Yu, Nationwide Children’s<br />
Hosp. and The Ohio State Univ.; Edward J. Hollox,<br />
Univ. <strong>of</strong> Leicester, U.K.<br />
Copy number variation (CNV) is a part <strong>of</strong> human<br />
genomic variation. There are two types <strong>of</strong> CNVs. The<br />
first type is common CNVs that occur at regions with<br />
complex genomic structures and engage genes<br />
involving in gene-environment interactions. The<br />
diversity <strong>of</strong> common CNVs both in terms <strong>of</strong> copy<br />
number and sequence variation is remarkable, yet<br />
because <strong>of</strong> their complex and challenging nature, they<br />
are under-studied. The second type is de novo or<br />
recent CNVs involved deletions and duplications <strong>of</strong><br />
genomic DNA fragments that are rare individually but<br />
moderately frequent collectively, particularly among<br />
subjects with developmental, neurologic and<br />
psychiatric disorders. This session will highlight the<br />
complexity <strong>of</strong> common CNVs and discuss their roles in<br />
immune-mediated and cognitive diseases. In addition,<br />
the session will feature mechanistic studies to<br />
understand the generation <strong>of</strong> CNVs, and illustrate<br />
techniques for the detection and quantification <strong>of</strong><br />
common and rare CNVs.<br />
8:00 AM CNVs engaged in immune complex<br />
handling and autoimmune diseases: Complement<br />
C4 and immunoglobulin Fc-gamma receptors.<br />
C. Y. Yu. Nationwide Children’s Hosp. and The Ohio<br />
State Univ.<br />
8:30 AM <strong>Human</strong> lineage-specific CNVs: DUF 1220<br />
domain copy number linked to cognitive disease<br />
and brain evolution. J. M. Sikela. Univ. <strong>of</strong> Colorado<br />
Sch. <strong>of</strong> Med., Aurora.<br />
8:55 AM TAR: A mixed genomic disorder caused<br />
by a low-frequency regulatory SNP combined with<br />
a 1q21.1 microdeletion. W. H. Ouwehand. Cambridge<br />
Univ. and Wellcome Trust Sanger Inst., Cambridge,<br />
U.K.<br />
9:20 AM Genetic and environmental risk factors<br />
for de novo CNVs. T. W. Glover. Univ. <strong>of</strong> Michigan.<br />
9:40 AM Frequency estimation <strong>of</strong> low-level<br />
somatic mosaicism for pathogenic CNVs.<br />
P. T. Stankiewicz. Baylor Col. <strong>of</strong> Med.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Thursday, November 8<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session II (21-28)<br />
SESSION 23 – Advancing Gene Therapy to the Clinic:<br />
Molecular Medicines Come <strong>of</strong> Age<br />
Gateway Ballroom 104, Lower Level South, Moscone<br />
Center<br />
Moderator: Beverly Davidson, Univ. <strong>of</strong> Iowa<br />
The first evidence for uptake and expression <strong>of</strong><br />
exogenous DNA in mammalian cells occurred in the<br />
60s and 70s, and in 1980 the first experiment was<br />
performed in which patients were given plasmid DNA<br />
expressing protein lacking in their blood cells. Over the<br />
next 25 years researchers focused on improved vector<br />
development and better delivery modalities, along with<br />
more appropriate clinical trial design, to improve<br />
the chances to positively impact disease course in<br />
patients with genetic diseases. In this symposium we<br />
will present exciting advances in gene therapy for the<br />
eye (Jean Bennett), the liver (Kathy High), blood<br />
disorders (Maria-Gracia Roncolo), the leukodystrophies<br />
(Nathalie Cartier), and lysosomal storage diseases<br />
affecting the brain (Beverly Davidson). Data presented<br />
will span from preclinical studies in animal models to<br />
advanced clinical trials in affected individuals using<br />
several vector platforms.<br />
8:00 AM Safety and efficacy <strong>of</strong> AAV-mediated<br />
gene transfer to liver for severe hemophilia B.<br />
K. High. Children’s Hosp. <strong>of</strong> Philadelphia.<br />
8:25 AM Safety and efficacy after AAV2<br />
re- administration in subjects with congenital<br />
blindness due to RPE65 mutations. J. Bennett. Univ.<br />
<strong>of</strong> Pennsylvania.<br />
8:45 AM Advancing gene therapy for ADA-SCID<br />
and beyond. M- G. Roncarolo. Univ. Vita-Salute San<br />
Raffaele., Milan, Italy.<br />
9:10 AM Gene therapy for the leukodystrophies.<br />
N. Cartier. Saint Vincent de Paul Hosp., Paris, France.<br />
9:30 AM AAV gene therapy for childhood onset<br />
neurological disease caused by lysosomal enzyme<br />
deficiencies. B. Davidson. Univ. <strong>of</strong> Iowa.<br />
INVITED AND PLATFORM SESSIONS 83<br />
Thursday, November 8<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session II (21-28)<br />
SESSION 24 – RNA Splicing in <strong>Human</strong> Development,<br />
Diseases and Natural Variation<br />
Room 124, Lower Level North, Moscone Center<br />
Moderators: David E. Symer, The Ohio State Univ.<br />
Comprehen. Cancer Ctr.; Richard A. Padgett, Lerner<br />
Res. Inst., Cleveland<br />
RNA splicing has been identified and studied for<br />
decades, but its roles in normal human biology and in<br />
contributing to human diseases have not been fully<br />
described to date. The presentations in this session<br />
will address the latest breakthroughs in understanding<br />
how RNA splicing and processing contribute to human<br />
development, diseases including various cancers and<br />
neurodegeneration, and natural variation. Also<br />
discussed will be the development <strong>of</strong> animal models<br />
<strong>of</strong> aberrant RNA splicing, and optimization <strong>of</strong> the latest<br />
technologies <strong>of</strong> RNA-seq and bioinformatics analysis<br />
<strong>of</strong> RNA splicing variation.<br />
8:00 AM Functional consequences <strong>of</strong> minor<br />
spliceosomal snRNA mutations in human<br />
development and natural variation. D. E. Symer.<br />
The Ohio State Univ. Comprehen. Cancer Ctr.<br />
8:25 AM Multicopy snRNA genes and<br />
neurodegeneration. S. L. Ackerman. HHMI/The<br />
Jackson Lab., Bar Harbor, ME.<br />
8:50 AM Understanding the chemical mechanisms<br />
and biological implications <strong>of</strong> splicing reactions.<br />
R. A. Padgett. Lerner Res. Inst., Cleveland.<br />
9:15 AM Overlaying RNA maps onto human<br />
disease. R. B. Darnell. HHMI and Rockefeller Univ.<br />
9:40 AM “Seq-ins” the Myotonic Dystrophy Transcriptome.<br />
E. Wang. MIT<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
84 INVITED AND PLATFORM SESSIONS<br />
Thursday, November 8<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session II (21-28)<br />
SESSION 25 – Genomic Medicine: ELSI Goes<br />
Mainstream<br />
Room 132, Lower Level North, Moscone Center<br />
Moderators: Wylie Burke, Univ. <strong>of</strong> Washington; James<br />
P. Evans, Univ. <strong>of</strong> North Carolina at Chapel Hill<br />
Next-generation sequencing <strong>of</strong> the human genome<br />
has the potential to predict disease risk, identify<br />
disease causation, and refine therapeutic interventions.<br />
As research-based sequencing moves into clinical<br />
practice, however, a number <strong>of</strong> ethical and social<br />
questions will enter mainstream practice, and will need<br />
to be addressed in a practical manner to inform best<br />
practices. For example, how do key stakeholders<br />
(patients, providers, researchers, and the public) view<br />
the risks and benefits <strong>of</strong> genome sequencing, and how<br />
can benefits be optimized and risks mitigated? How<br />
do we address children’s rights as well as other family<br />
members’ rights with respect to potentially shared<br />
information learned from sequencing individuals?<br />
Empirical data can contribute to a better<br />
understanding <strong>of</strong> these issues; but what kinds <strong>of</strong> data<br />
are most relevant and how can they be used to inform<br />
practice and policy? How do we navigate the<br />
increasingly blurred line between research and clinical<br />
care? These issues will be discussed and empirical<br />
data presented by a panel <strong>of</strong> experts investigating the<br />
ethical and social issues <strong>of</strong> genome sequencing in a<br />
variety <strong>of</strong> research and patient populations.<br />
8:00 AM Views <strong>of</strong> patients, parents <strong>of</strong> patients,<br />
and clinicians toward whole genome sequencing<br />
for clinical care management. A. A. Lemke. Med.<br />
Col. <strong>of</strong> Wisconsin.<br />
8:30 AM My46: An innovative web-based<br />
approach to managing and returning results from<br />
exome and whole genome sequencing. H. K. Tabor.<br />
Seattle Children’s Hosp.<br />
9:00 AM Returning “actionable” results to family<br />
members in a pancreatic cancer biobank: Views <strong>of</strong><br />
probands and family members. B. Koenig. Sch. <strong>of</strong><br />
Nursing, UCSF.<br />
9:20 AM Approaches and attitudes on return <strong>of</strong><br />
WGS/WES results. K. Ormond. Stanford Univ.<br />
9:40 AM Next steps in development <strong>of</strong> best<br />
practices for use <strong>of</strong> genome sequencing in clinical<br />
care. A. McGuire. Baylor Col. <strong>of</strong> Med.<br />
Thursday, November 8<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session II (21-28)<br />
SESSION 26 – Model Organism <strong>Genetics</strong>, <strong>Human</strong><br />
Biology and <strong>Human</strong> Disease<br />
Gateway Ballroom 103, Lower Level South, Moscone<br />
Center<br />
Moderators: Phil Hieter, Univ. <strong>of</strong> British Columbia; Hal<br />
Dietz, Johns Hopkins Univ. Sch. <strong>of</strong> Med.<br />
Yeast, worms, flies, zebrafish, and mice are key<br />
‘model’ organisms that <strong>of</strong>fer powerful experimental<br />
approaches for the study <strong>of</strong> biological processes<br />
relevant to human biology and disease. The genome<br />
sequencing projects <strong>of</strong> the 1990s reemphasized the<br />
striking extent to which all organisms are built from the<br />
same genes, and highlighted the enormous value <strong>of</strong><br />
model experimental organisms for the study <strong>of</strong><br />
evolutionarily conserved gene function. Few, if any,<br />
processes at the gene level are known to be unique to<br />
humans. Indeed, key aspects <strong>of</strong> most human<br />
disorders can be modeled in experimentally tractable<br />
organisms through the analysis <strong>of</strong> orthologous genes<br />
and pathways, using the genetic, biochemical and cell<br />
biological toolboxes that have been developed in each<br />
model organism. This symposium will accent the<br />
current relevance <strong>of</strong> model organism studies for the<br />
understanding, diagnosis, and treatment <strong>of</strong> human<br />
disease, and anticipate the future role <strong>of</strong> model<br />
organisms in human disease research. We chose to<br />
highlight a diverse set <strong>of</strong> biological processes and<br />
experimental systems to make the point that the<br />
principles <strong>of</strong> cross species analysis <strong>of</strong> basic gene<br />
function extend to the study <strong>of</strong> all human disorders.<br />
8:00 AM Budding yeast: Lessons from yeast<br />
applied to the study <strong>of</strong> human genetic diseases <strong>of</strong><br />
protein traffic. R. Schekman. Univ. <strong>of</strong> California,<br />
Berkeley.<br />
8:30 AM The nematode worm: Mechanisms<br />
regulating aging in worms and man. C. Kenyon.<br />
UCSF.<br />
9:00 AM The zebrafish: Zebrafish heart<br />
development and function. D. Stainier. Max Planck<br />
Inst. for Heart and Lung Res., Bad Nauheim, Germany.<br />
9:30 AM The laboratory mouse: Mouse models <strong>of</strong><br />
glaucoma and retinal ganglion cell loss. S. John.<br />
HHMI/The Jackson Lab., Bar Harbor, ME.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Thursday, November 8<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session II (21-28)<br />
SESSION 27 – Next-Generation Sequencing in Isolated<br />
Populations: Opportunities for Accelerated Gene<br />
Discovery in Complex Traits<br />
Room 134, Lower Level North, Moscone Center<br />
Moderators: William K. Scott, Univ. <strong>of</strong> Miami; Jeffrey R.<br />
O’Connell, Univ. <strong>of</strong> Maryland Baltimore<br />
This session will present recent developments in the<br />
application <strong>of</strong> whole-exome or whole-genome<br />
sequencing (collectively `next-generation sequencing’<br />
or NGS) in samples from genetically isolated<br />
populations. Such populations have long been the<br />
focus <strong>of</strong> gene discovery efforts for complex traits<br />
because <strong>of</strong> the hypothesized reduction in the genetic<br />
complexity <strong>of</strong> the trait, and the enrichment <strong>of</strong> rare<br />
alleles. Prior genome-wide linkage efforts could detect<br />
large genomic regions potentially harboring rare<br />
alleles, while genome-wide association efforts could<br />
detect smaller areas with more common alleles. NGS<br />
allows the direct examination <strong>of</strong> both common and<br />
rare alleles and can be analyzed in both frameworks.<br />
Characterisics <strong>of</strong> isolated population may facilitate the<br />
blending <strong>of</strong> NGS with these prior approaches, by deep<br />
sequencing a small number <strong>of</strong> individuals to use as a<br />
reference panel for imputation within pedigrees or on<br />
the population level, by `filtering’ detected variants<br />
against pedigree relationships (or kinship estimates) in<br />
individuals with the trait. However, since the structure<br />
<strong>of</strong> the population must be taken into account,<br />
application <strong>of</strong> existing reference panels or methods for<br />
these analyses must be done carefully. The speakers<br />
for this session will discuss approaches to using NGS<br />
data for gene discovery for complex traits in isolated<br />
populations, reviewing methodologic approaches<br />
specific to such studies and illustrating their use in<br />
data sets drawn from such populations.<br />
8:00 AM Using low-pass whole genome<br />
sequencing to create a reference population for<br />
genome imputation in an isolated population:<br />
Examples from the SardiNIA study. S. Sanna.<br />
Cittadella Univ. di Monserrato, Italy.<br />
8:30 AM Fine-mapping linkage <strong>of</strong> age-related<br />
traits using whole-exome sequencing in a<br />
midwestern Amish population sample. W. K. Scott.<br />
Univ. <strong>of</strong> Miami.<br />
9:00 AM The many-<strong>of</strong>-few: The power <strong>of</strong> genetic<br />
isolates for discovery and function <strong>of</strong> rare variants.<br />
J. R. O’Connell. Univ. <strong>of</strong> Maryland Baltimore.<br />
9:30 AM Studying rare variants in the Genetic<br />
Research in Isolated Populations program. C. van<br />
Duijn. Erasmus Med. Ctr. Rotterdam, Netherlands.<br />
INVITED AND PLATFORM SESSIONS 85<br />
Thursday, November 8<br />
8:00 AM–10:00 AM<br />
Concurrent Invited Session II (21-28)<br />
SESSION 28 – Transforming Medical Student Education<br />
in <strong>Genetics</strong> and Genomics: How Do We Improve Health<br />
and Individualize Care through Medical School Genetic<br />
and Genomic Curricula?<br />
Room 130, Lower Level North, Moscone Center<br />
Moderators: Joann N. Bodurtha, Johns Hopkins Univ.;<br />
Joan Scott, NCHPEG, Lutherville, MD<br />
This session will provide national perspectives on<br />
integrating genetics and genomics in medical student<br />
education. Controversies, ranging from the marketing<br />
<strong>of</strong> curriculum change to addressing personal<br />
genotyping, and lessons learned will be emphasized.<br />
Challenges in 4-year integration, evaluation, ethical<br />
issues and competing priorities will be included.<br />
Drs. Valle, Burke, and Potocki will describe 3 different<br />
models <strong>of</strong> curriculum development and delivery.<br />
Drs. Demmer and Salari will provide contrasting<br />
experiences in introducing personal genotyping by<br />
students into the curriculum.<br />
8:00 AM Genes to <strong>Society</strong>—3 years <strong>of</strong><br />
implementation. D. Valle. Johns Hopkins Univ.<br />
8:30 AM The Vermont Integrated Curriculum: The<br />
UVM experience. L. Burke. Univ. <strong>of</strong> Vermont Col. <strong>of</strong><br />
Med.<br />
8:55 AM Effecting change: Building a genetics<br />
curriculum that supports the physicians <strong>of</strong><br />
tomorrow. L. Potocki. Baylor Col. <strong>of</strong> Med.<br />
9:20 AM Lessons learned from the introduction <strong>of</strong><br />
personalized genotyping into a medical school<br />
curriculum. L. Demmer. Carolinas Medical Center.<br />
9:40 AM Personal genotyping in a medical school<br />
curriculum on genomics and personalized<br />
medicine. K. Salari. Stanford Univ. Sch. <strong>of</strong> Med.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
86 INVITED AND PLATFORM SESSIONS<br />
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37)<br />
SESSION 29 – Next-Generation Sequencing: Methods<br />
and Applications<br />
Hall D, Lower Level North, Moscone Center<br />
Moderators: John S. Witte, UCSF; Priya Duggal, Johns<br />
Hopkins Bloomberg Sch <strong>of</strong> Publ. Hlth.<br />
88/10:30 The value <strong>of</strong> population-specific reference<br />
panels for genotype imputation in the age <strong>of</strong><br />
whole-genome sequencing. C. Fuchsberger, B.<br />
Howie, M. Laakso, M. Boehnke, G. Abecasis on behalf<br />
<strong>of</strong> <strong>Genetics</strong> <strong>of</strong> Type-2 Diabetes Consortium.<br />
89/10:45 Fast and accurate 1000 Genomes<br />
imputation using summary statistics or lowcoverage<br />
sequencing data. B. Pasaniuc, N. Zaitlen,<br />
G. Bhatia, A. Gusev, N. Patterson, A. L. Price.<br />
90/11:00 Accurate haplotype estimation using<br />
phase informative sequencing reads. O. Delaneau,<br />
J.-F. Zagury, J. Marchini.<br />
91/11:15 An LD-based method for genotype calling<br />
and phasing using low-coverage sequencing reads<br />
and a haplotype scaffold. A. Menelaou, J. Marchini.<br />
92/11:30 Mixed functional linear model for<br />
sequence-based quantitative trait association<br />
studies unifying population and family study<br />
designs. M. Cao, Y. Zhu, M. Xiong.<br />
93/11:45 Rare variant extensions <strong>of</strong> the<br />
transmission disequilibrium test detects<br />
associations with autism exome sequence data. Z.<br />
He, B. O’Roak, J. Smith, G. Wang, M. Kan, S. Hooker,<br />
B. Li, N. Krumm, D. Nickerson, E. Eichler, S. Leal.<br />
94/12:00 Methods for noninvasive prenatal<br />
determination <strong>of</strong> fetal genomes. M. W. Snyder,<br />
J. O. Kitzman, M. Ventura, A. P. Lewis, R. Qiu, L. E.<br />
Simmons, H. S. Gammill, C. E. Rubens, D. A. Santillan,<br />
M. K. Santillan, J. C. Murray, H. K. Tabor, M. J.<br />
Bamshad, E. E. Eichler, J. A. Shendure.<br />
95/12:15 Associating complex traits with rare<br />
variants identified by NGS: Improving power by a<br />
position-dependent kernel approach. U. Bodenh<strong>of</strong>er,<br />
S. Hochreiter.<br />
96/12:30 The Kaiser Permanente/UCSF Genetic<br />
Epidemiology Research Study on Adult Health and<br />
Aging: Demographic and behavioral influences on<br />
telomeres and relationship with all-cause mortality.<br />
C. Schaefer, S. Sciortino, M. Kvale, K. Lapham, J. Lin,<br />
D. Ranatunga, S. Rowell, M. Sadler, S. Miles,<br />
W. McGuire, D. Ludwig, L. Walter, I. Listerman, S. Van<br />
Den Eeden, R. Whitmer, C. Quesenberry, N. Risch,<br />
E. Blackburn.<br />
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37)<br />
SESSION 30 – <strong>Genetics</strong> and Intellectual Disability<br />
Gateway Ballroom 103, Lower Level South, Moscone<br />
Center<br />
Moderators: Roger Reeves, Johns Hopkins Univ.; Heidi<br />
Rehm, Harvard Univ.<br />
97/10:30 Diagnostic exome sequencing in patients<br />
with intellectual disability <strong>of</strong> unknown cause. J. de<br />
Ligt, M. H. Willemsen, B. W. M. van Bon, T. Kleefstra,<br />
H. G. Yntema, T. Kroes, A. T. Vulto-van Silfhout, D. A.<br />
Koolen, P. de Vries, C. Gilissen, A. Hoischen, H.<br />
Scheffer, B. B. A. de Vries, H. G. Brunner,<br />
J. A. Veltman, L. E. L. M. Vissers.<br />
98/10:45 C-terminal deletions <strong>of</strong> the AUTS2 locus<br />
cause distinct syndromic features and cognitive<br />
impairment. E. Voorhoeve, G. Beunders, C. Golzio, L.<br />
Pardo, J. Rosenfeld, M. Talkowski, I. Simonic, A.<br />
Lionel, S. Vergult, R. Pyatt, J. van de Kamp, A. Nieuwint,<br />
M. Weiss, P. Rizzu, D. Posthuma, L. Verwer, H.<br />
Meijers-Heijboer, B. Menten, G. Mortier, S. Scherer,<br />
E. Eichler, S. Girirajan, N. Katsanis, A. Gr<strong>of</strong>fen, E.<br />
Sistermans.<br />
99/11:00 Autism traits in the RASopathies. I. Corbin,<br />
G. Desachy, K. Rauen, L. Weiss.<br />
100/11:15 Identification <strong>of</strong> novel recessive<br />
mutations in genes for intellectual disability. B. De<br />
Vries, J. H. M. Schuurs-Hoeijmakers, A. T. Vulto-van<br />
Silfhout, L. E. L. M. Vissers, J. de Ligt, C. Gilissen,<br />
I. van de Vondervoort, M. T. Greally, C. W. Ockeloen,<br />
M. H. Willemsen, E. M. Bongers, G. Hira, J. Y. Hehir-<br />
Kwa, R. Pfundt, T. Kleefstra, K. Neveling, S. Reinateo,<br />
A. Vitello, P. Failla, D. Greco, M. Fichera, O. Galesi,<br />
B. W. M. van Bon, J. A. Veltman, C. Romano,<br />
M. A. Willemsen, H. G. Brunner, H. van Bokhoven,<br />
A. P. M. de Brouwer.<br />
101/11:30 Causal de novo SNVs, indels and CNVs in<br />
children with undiagnosed developmental<br />
disorders. M. Hurles, M. van Kogelenberg, K. Morley,<br />
T. Fitzgerald, S. Gerety, A. Tivey, S. Gribble, S. Al-Turki,<br />
S. Clayton, C. Wright, J. Barrett, H. Firth, D.<br />
FitzPatrick, N. Carter on behalf <strong>of</strong> DDD Project.<br />
102/11:45 Making headway with the molecular and<br />
clinical definition <strong>of</strong> rare genetic disorders with<br />
intellectual disability. M. H. Willemsen, W. M.<br />
Wissink-Lindhout, L. E. M. Vissers, A. P. M. de<br />
Brouwer, J. H. M. Rensen, N. de Leeuw, R. Pfundt, H.<br />
G. Yntema, J. de Ligt, J. A. Veltman, H. G. Brunner,<br />
H. M. J. Lantman - de Valk, B. C. J. Hamel, H. van<br />
Bokhoven, T. Kleefstra.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37) (SESSION 30, continued)<br />
103/12:00 MBD5 dosage affects multiple<br />
neurodevelopmental pathways in common with<br />
other genetic syndromes. S. V. Mullegama, J. A.<br />
Rosenfeld, C. Orellana, B. W. M. van Bon, E. A.<br />
Repnikova, L. Brick, L. Dupuis, D. J. Stavropoulos, D.<br />
L. Thrush, J. G. Foster, K. Manickam, A. Lin, J. C.<br />
Hodge, M. E. Talkowski, J. F. Gusella, S. Schwartz, S.<br />
Aradhya, R. E. Pyatt, B. B. A. de Vries, R. Mendoza-<br />
Londono, L. G. Shaffer, S. H. Elsea.<br />
104/12:15 Exome sequencing in X-linked<br />
intellectual disability family assess the role <strong>of</strong><br />
the KIAA2022 gene in the etiology <strong>of</strong> intellectual<br />
disability. M. Rio, S. Mouton, AC. Mazery, C. Bole-<br />
Feysot, P. Nitschke, N. Bahi-Buisson, A. Munnich,<br />
L. Colleaux.<br />
105/12:30 Biallelic mutations <strong>of</strong> a ubiquitin-ligaseencoding<br />
gene cause an Ohdo-like intellectual<br />
disability syndrome. G. Borck, B. Dallapiccola, R.<br />
Ramirez-Solis, A. Segref, H. Thiele, A. Edwards, M. J.<br />
Arends, X. Miro, J. K. White, J. Desir, M. Abramowicz,<br />
M. L. Dentici, K. H<strong>of</strong>mann, A. Har-Zahav, E. Ryder, N.<br />
A. Karp, N. J. Ingham, G. Nuernberg, S. Abdelhak, M.<br />
Pasmanik-Chor, O. Konen, R. I. Kelley, M. Shohat, P.<br />
Nuernberg, J. Flint, K. P. Steel, T. Hoppe, C. Kubisch,<br />
D. J. Adams, L. Basel-Vanagaite.<br />
INVITED AND PLATFORM SESSIONS 87<br />
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37)<br />
SESSION 31 – GWAS from Head to Toe<br />
Room 135, Lower Level North, Moscone Center<br />
Moderators: Erik Ingelsson, Karolinska Inst., Sweden;<br />
Nora Franceschini, Univ. <strong>of</strong> North Carolina at Chapel<br />
Hill<br />
106/10:30 Androgenetic alopecia: Identification<br />
<strong>of</strong> four new genetic risk loci and evidence for the<br />
contribution <strong>of</strong> WNT-signaling to its etiology.<br />
S. Heilmann, A. K. Kiefer, N. Kluck, D. Drichel, A. M.<br />
Hillmer, C. Herold, J. Y. Tung, N. Eriksson, S. Redler,<br />
R. C. Betz, R. Li, H. Stefansson, D. R. Nyholt, K. Song,<br />
S. H. Vermeulen, S. Kanoni, G. Dedoussis, N. G.<br />
Martin, L. A. Kiemeney, V. Mooser, K. Stefansson, J. B.<br />
Richards, T. Becker, F. F. Brockschmidt, D. Hinds,<br />
M. M. Nöthen.<br />
107/10:45 A polymorphism in human estrogenrelated<br />
receptor beta is associated with early<br />
indications <strong>of</strong> hearing loss from acoustic overload<br />
in young adult musicians. V. C. Henrich, S. L.<br />
Phillips, S. J. Richter, S. Teglas, R. Morehouse.<br />
108/11:00 Dissection <strong>of</strong> polygenic variation for<br />
human height into individual variants, specific loci<br />
and biological pathways from a GWAS metaanalysis<br />
<strong>of</strong> 250,000 individuals. T. Esko, A. R. Wood,<br />
S. Vedantam, J. Yang, S. Gustaffsson, S. I. Berndt, J.<br />
Karjalainen, H. M. Kang, A. E. Locke, A. Scherag, D.<br />
C. Croteau-Chonka, F. Day, R. Magi, T. Ferreira,<br />
J. Randall, T. W. Winkler, T. Fall, Z. Kutalik, T.<br />
Workalemahu, G. Abecasis, M. E. Goddard, L.<br />
Franke, R. J. F. Loos, M. N. Weedon, E. Ingelsson, P.<br />
M. Visscher, J. N. Hirschhorn, T. M. Frayling, GIANT<br />
Consortium.<br />
109/11:15 Genome-wide association studies metaanalysis<br />
for fracture risk points to loci related to<br />
hormonal and neurological pathways: The GEFOS<br />
Consortium. L. Oei, H. F. Zheng, E. E. Ntzani, C. M.<br />
Nielson, U. Styrkarsdottir, P. M. Ridker, K. K. Tsilidis,<br />
K. Estrada, A. Enneman, A. Vernon-Smith, R. D.<br />
Jackson, S. Trompet, T. Lehtimäki, S. Kaptoge, T. B.<br />
Harris, J. Eriksson, N. Amin, A. Metspalu, P. C. Sham,<br />
E. Evangelou, J. P. A. Ioannidis, G. Thorleifsson, A. G.<br />
Uitterlinden, S. A. Cummings, T. Spector, D. P. Kiel, D.<br />
Chasman, E. Orwoll, J. B. Richards, F. Rivadeneira,<br />
GEFOS Consortium.<br />
110/11:30 Genetic landscape <strong>of</strong> the red blood cell.<br />
J. C. Chambers, P. van der Harst, W. Zhang, I. Mateo<br />
Leach, J. Sehmi, N. Verweij, D. S. Paul, A. Rendon, U.<br />
Elling, H. Allayee, A. Radhakrishnan, J. S. Beckmann,<br />
G. V. Dedoussis, P. Deloukas, A. A. Hicks, S. Sanna,<br />
M. Uda, J. Penninger, C. Gieger, J. S. Kooner, W.<br />
Ouwehand, N. Soranzo, HaemGen RBC Consortium.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
88 INVITED AND PLATFORM SESSIONS<br />
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37) (SESSION 31, continued)<br />
111/11:45 Discovery and fine-mapping <strong>of</strong> serum<br />
protein loci through trans-ethnic meta-analysis. A.<br />
P. Morris, Y. Okada, F. J. A. van Rooij, B. P. Prins, M.<br />
F. Feitosa, M. Karakas, J. Felix, B. Z. Alizadeh, L. A.<br />
Cupples, J. R. B. Perry, N. Franceschini, CHARGE<br />
Consortium Protein Working Group.<br />
112/12:00 The Kaiser Permanente/UCSF Genetic<br />
Epidemiology Research Study on Adult Health<br />
and Aging: A genome-wide association study <strong>of</strong><br />
telomere length in a multi-ethnic cohort <strong>of</strong> 100,000<br />
subjects. M. Kvale, K. Lapham, T. H<strong>of</strong>fmann, S.<br />
Sciortino, L. Walter, Y. Banda, I. Listerman, J. Lin, S.<br />
Hesselson, P. Kwok, E. Blackburn, C. Schaefer, N.<br />
Risch.<br />
113/12:15 Heritability <strong>of</strong> the variation in aging in<br />
two longitudinal family cohort studies: SardiNIA/<br />
Progenia Study and Framingham Heart Study. J.<br />
Bragg-Gresham, S. Sanna, C. Sidore, A. Mulas, F.<br />
Busonero, A. Maschio, M. Urru, F. Reinier, R. Berutti,<br />
M. Marcelli, R. Cusano, M. Oppo, D. Pitzalis, M.<br />
Zoledziewska, A. Angius, C. Jones, A. Cao, M. Uda, S.<br />
Kardia, D. Schlessinger, F. Cucca, G. Abecasis.<br />
114/12:30 Over 250 novel associations with human<br />
morphological traits. N. Eriksson, C. B. Do,<br />
J. Y. Tung, A. K. Kiefer, D. A. Hinds, J. L. Mountain,<br />
U. Francke.<br />
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37)<br />
SESSION 32 – Cardiovascular <strong>Genetics</strong>: GWAS and<br />
Beyond<br />
Room 134, Lower Level North, Moscone Center<br />
Moderators: Cristen J. Willer, Univ. <strong>of</strong> Michigan;<br />
Panagiotis Deloukas, Wellcome Trust Sanger Inst.,<br />
U.K.<br />
115/10:30 Coronary artery disease loci identified in<br />
over 190,000 individuals implicate lipid metabolism<br />
and inflammation as key causal pathways:<br />
Evidence for independent signals in many <strong>of</strong> the<br />
risk loci. S. Kanoni, C. Willenborg, M. Farrall, T. L.<br />
Assimes, J. R. Thompson, E. Ingelsson, D. Saleheen,<br />
J. Erdmann, M. P. Reilly, R. Collins, S. Kathiresan, A.<br />
Hamsten, U. Thorsteinsdottir, J. S. Kooner, J. Danesh,<br />
C. N. A. Palmer, R. Roberts, H. Watkins, H. Schunkert,<br />
N. J. Samani, P. Deloukas for CARDIoGRAMplusC4D<br />
Consortium.<br />
116/10:45 Genome-wide association study in Han<br />
Chinese identifies four new susceptibility loci for<br />
coronary artery disease. D. Gu, X. Lu, L. Wang, S.<br />
Chen, J. Huang, H. Li, X. Yang, Y. Hao, China<br />
Atherosclerosis <strong>Genetics</strong> Consortium.<br />
117/11:00 Discovery <strong>of</strong> 63 novel loci and refinement<br />
<strong>of</strong> known loci associated with lipid levels. C.<br />
Willer, G. R. Abecasis, M. Boehnke, L. A. Cupples, P.<br />
Deloukas, P. W. Franks, S. Gustafsson, E. Ingelsson,<br />
S. Kathiresan, K. L. Mohlke, G. M. Peloso, S. S. Rich,<br />
S. Ripatti, M. Sandhu, E. M. Schmidt, S. Sengupta,<br />
Global Lipids <strong>Genetics</strong> Consortium.<br />
118/11:15 The Kaiser Permanente/UCSF Genetic<br />
Epidemiology Research Study on Adult Health and<br />
Aging: Genome-wide association study <strong>of</strong> plasma<br />
HDL and LDL and treatment response in over<br />
100,000 subjects. T. J. H<strong>of</strong>fmann, M. N. Kvale, Y.<br />
Banda, S. E. Hesselson, L. Walter, S. Sciortino, D. K.<br />
Ranatunga, D. Ludwig, C. Iribarren, R. Grant, P. Kwok,<br />
C. Schaefer, N. Risch.<br />
119/11:30 Genome-wide screen with 1000 Genomes<br />
imputed data identifies 19 new lipid loci and new<br />
variants with stronger effects in previously known<br />
loci. I. Surakka, A.-P. Sarin, R. Mägi, M. Horikoshi, S.<br />
Wiltshire, T. Esko, T. Ferreira, L. Marullo, G.<br />
Thorleifsson, A. Mahajan, S. Hägg, A. Isaacs, M.<br />
Beekman, J. S. Ried, T. W. Winkler, C. P. Nelson, C.<br />
Willenborg, A. Morris, M. I. McCarthy, I. Prokopenko,<br />
S. Ripatti for ENGAGE Consortium.<br />
120/11:45 Rare coding variation and risk for<br />
myocardial infarction: an exome chip study <strong>of</strong><br />
~6,000 cases and controls. R. Do on behalf <strong>of</strong> NHLBI<br />
Exome Sequencing Project - Early Onset Myocardial<br />
Infarction.<br />
121/12:00 High exome mutational burden in 58<br />
African <strong>American</strong>s with persistent extreme blood<br />
pressure. K.-D. H. Nguyen, A. C. Morrison, A. Li,<br />
R. Gibbs, E. Boerwinkle, A. Chakravarti.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37) (SESSION 32, continued)<br />
122/12:15 Chipping a hole-in-one from the FAIRE<br />
way: Use <strong>of</strong> post-GWAS fine-mapping genotyping<br />
arrays for functional variant discovery. A. J. P.<br />
Smith, F. Drenos, P. Howard, C. Giambartolomei, P. J.<br />
Talmud, V. Plagnol, S. E. Humphries.<br />
123/12:30 Strong association <strong>of</strong> one carbon<br />
metabolism genes with stroke and change in postmethionine<br />
load homocysteine levels in the<br />
Framingham Heart and Vitamin Intervention for<br />
Stroke Prevention studies. S. R. Williams, Q. Yang,<br />
F. Chen, X. Liu, K. Keen, P. Jacques, W. M. Chen,<br />
G. Weinstein, F. C. Hsu, A. Beiser, L. Wang,<br />
K. F. Doheny, P. A. Wolf, M. Zilka, J. Selhub,<br />
B. B. Worrall, S. Seshadri, M. M. Sale, Genomics and<br />
Randomized Trials Network (GARNET).<br />
INVITED AND PLATFORM SESSIONS 89<br />
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37)<br />
SESSION 33 – Clinical <strong>Genetics</strong>: Mutations, Mutations<br />
and Syndromes<br />
Gateway Ballroom 104, Lower Level South, Moscone<br />
Center<br />
Moderators: Nathaniel Robin, Univ. <strong>of</strong> Alabama at<br />
Birmingham; Anne Slavotinek, UCSF<br />
124/10:30 Baraitser-Winter syndrome: Delineation<br />
<strong>of</strong> the phenotypic spectrum in a large series <strong>of</strong><br />
molecularly defined patients. A. Verloes, O. A.<br />
Abdul-Rahman, J. Allanson, J. F. Atkin, M. Baraitser, H.<br />
Brunner, N. Chassaing, K. Devriendt, V. Drouin, A. Fry,<br />
J. P. Fryns, F. Giuliano, K. W. Gripp, D. Lacombe, A.<br />
Lin, G. Mancini, M. Marble, M. Nezarati, M. Nowaczyk,<br />
S. Osimani, M. Rossi, C. Rusu, Y. Sznajer, C. Van<br />
Ravenswaaij, J. Masliah, J. B. Rivière, B. W. M. van<br />
Bon, A. Hoischen, W. Dobyns, D. Pilz.<br />
125/10:45 Three novel mutations in MED12 cause<br />
Ohdo syndrome Maat-Kievit-Brunner type. A. T.<br />
Vulto-van Silfhout, A. Hoischen, B. W. M. van Bon,<br />
W. M. Nillesen, C. Gilissen, F. Gao, J. M. Spaeth, B.<br />
C. Hamel, T. Kleefstra, M. A. A. P. Willemsen, H. van<br />
Bokhoven, H. G. Yntema, B. B. A. de Vries, H. G.<br />
Brunner, T. G. Boyer, A. P. M. de Brouwer.<br />
126/11:00 Heterogeneity <strong>of</strong> mutational mechanisms<br />
and modes <strong>of</strong> inheritance in auriculo-condylar<br />
syndrome. C. Gordon, A. Vuillot, A. Omarjee, S. Park,<br />
J. Horst, R. McGowan, E. Tobias, S. García-Miñaúr, M.<br />
Bitner, L. Jakobsen, P. Kroisel, A. Stewart, R. Palmer,<br />
A. Munnich, M. Holder, A. Lin, A. Henderson, L. Basel-<br />
Vanagaite, E. Gerkes, L. Wilson, M. Cunningham, S.<br />
Marlin, S. Lyonnet, J. Amiel.<br />
127/11:15 Genetic heterogeneity <strong>of</strong> Myhre<br />
syndrome. C. Le G<strong>of</strong>f, C. Michot, C. Mahaut,<br />
A. Abhyankar, W. Le G<strong>of</strong>f, V. Serre, A. Afenjar, A.<br />
Brooks, N. Brunetti-Pierri, P. Campeau, A. Destrée,<br />
M. di Rocco, D. Donnai, R. Hennekam, D. Heron, S.<br />
Jacquemont, S. Mansour, S. Marlin, R. McGowan, H.<br />
Murphy, M. Simon, I. Stolte- Dijkstra, J. Tolmie, R.<br />
Touraine, N. Van der Aa, T. Van Essen, A. Verloes, J. L.<br />
Casanova, A. Munnich, V. Cormier-Daire.<br />
128/11:30 Seven novel families with ADCL favor<br />
clinical and molecular homogeneity. C. Bodemer, B.<br />
Callewaert, M. Kempers, E. Bourrat, M. Renard, O.<br />
Vanakker, F. Malfait, J. De Backer, P. J. Coucke, S.<br />
Hadj-Rabia, A. De Paepe.<br />
129/11:45 Comprehensive clinical and molecular<br />
analysis <strong>of</strong> 12 families with type I recessive cutis<br />
laxa. B. Callewaert, C.-T. Su, T. Van Damme, P.<br />
Vlummens, F. Malfait, O. Vanakker, B. Schulz, M. Mac<br />
Neal, E. C. Davis, J. G. H. Lee, A. Salhi, S. Unger, K.<br />
Heimdal, S. De Almeida, U. Kornak, H. Gaspard, J.<br />
L. Bresson, K. Prescott, M. E. Gosendi, S. Mansour,<br />
G. E. Pierard, S. Madan-Khetarpal, F. C. Sciurba, S.<br />
Symoens, P. J. Coucke, L. Van Maldergem, Z. Urban,<br />
A. De Paepe.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
90 INVITED AND PLATFORM SESSIONS<br />
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37) (SESSION 33, continued)<br />
130/12:00 M694V mutation in Armenian-<strong>American</strong>s:<br />
A ten-year retrospective study <strong>of</strong> MEFV mutations<br />
testing for familial Mediterranean fever at UCLA.<br />
F. S. Ong, H. Vakil, Y. Xue, K. H. Shah, J. Z. Kuo, K. E.<br />
Bernstein, D. L. Rimoin, J. I. Rotter, J. L. Deignan, K.<br />
Das, W. W. Grody.<br />
131/12:15 Clinical features <strong>of</strong> individuals with<br />
Floating-Harbor syndrome due to mutations in<br />
SRCAP. S. M. Nikkel, A. Dauber, R. L. Hood, M.<br />
Feingold, M. Connolly, M. J. M. Nowaczyk, S. M.<br />
White, A. Afenjar, F. Brancati, I. Cordeiro, A. Destrée,<br />
F. Forzano, E. M. Honey, D. Héron, C. M. Jacob, S.<br />
G. Kant, U. Kini, E. Kirk, E. Lemos Silveira-Lucas, L.<br />
Silveira Lucas, L. Audi Delaney, B. Santos da Cunha,<br />
V. Mericq, K. Pope, S. Price, J. M. Wit, D. E. Bulman,<br />
K. M. Boycott, FORGE Canada Consortium.<br />
132/12:30 A prospective natural history study <strong>of</strong><br />
DICER1-related familial pleuropulmonary blastoma<br />
syndrome shows incomplete penetrance, pleiotropy<br />
and variable expressivity. D. R. Stewart, L. Doros,<br />
G. Glenn, A. Bauer, G. Williams, A. Carr, J. Ivanovich,<br />
R. Kase, L. Harney, K. A. Schultz, C. P. Kratz, L. P.<br />
Dehner, D. A. Hill, Y. Messinger.<br />
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37)<br />
SESSION 34 – Cancer <strong>Genetics</strong> II: Clinical Translation<br />
Room 124, Lower Level North, Moscone Center<br />
Moderators: Robert Pilarski, The Ohio State Univ.;<br />
Stephen Thibodeau, Mayo Clin.<br />
133/10:30 Clinical implementation <strong>of</strong> a cancer care<br />
model based on comprehensive molecular pr<strong>of</strong>iling<br />
<strong>of</strong> tumor-normal pairs. J. C. Taylor, K. Kaur, S.<br />
Henderson, E. Domingo, A. Cutts, J. Woods, C.<br />
Motley, B. Dougherty, M. Middleton, B. Hassan, Y.<br />
Wang, E. Beasley, M. Naley, I. Tomlinson, A. Schuh,<br />
TSB LifeTech Consortium.<br />
134/10:45 Clinical implementation <strong>of</strong> single<br />
nucleotide polymorphism microarrays in pediatric<br />
cancer and non-malignant hematologic disorders.<br />
X. Lu, Y. Zhao, S. Gurusiddappa, C. Lau, J. Shohet,<br />
P. Rao, K. Rabin, S. E. Plon.<br />
135/11:00 A prospective clinical trial to evaluate<br />
DNA sequencing as a diagnostic tool to guide<br />
cancer therapy. A. M. K. Brown, P. L. Bedard, B. Tran,<br />
J. Dancey, E. Winquist, S. J. Hotte, G. Goss, S. Welch,<br />
T. Zhang, L. Stein, V. Ferretti, S. Watt, W. Jiao, K. Ng,<br />
P. Shaw, B. G. Neel, T. J. Hudson, J. D. McPherson, S.<br />
Kamel-Reid, L. Siu.<br />
136/11:15 Whole genome sequencing <strong>of</strong> a highly<br />
aggressive melanoma identified BRAFL597<br />
mutants associated with sensitivity to MEK<br />
inhibitors. Z. Zhao, K. B. Dahlman, J. Xia, H.<br />
Hutchinson, C. Ng, D. Hucks, P. Jia, M. Atefi, Z. Su,<br />
S. Branch, P. Lyle, D. J. Hicks, V. Bozon, J. A. Glaspy,<br />
J. L. Netterville, C. L. Vnencak-Jones, J. Sosman,<br />
A. Ribas, W. Pao.<br />
137/11:30 Identification <strong>of</strong> novel mechanisms <strong>of</strong><br />
drug resistance in BRCA1-deficient cancer by<br />
exome and RNA sequencing. K. K. Dhillon,<br />
T. Taniguchi.<br />
138/11:45 BRCA1 and BRCA2 mutational spectrum<br />
in a normal population: Implications for clinical<br />
diagnostics and incidental findings. E. Ruark, K.<br />
W. Lau, A. Renwick, E. Ramsay, F. Zhang, S. Seal, N.<br />
Rahman.<br />
139/12:00 Targeted re-sequencing <strong>of</strong> 10 ovarian<br />
cancer candidate genes in 2,240 cases and 355<br />
controls. H. Song, M. Cieck, J. Cunningham, B.<br />
Fridley, E. Dicks, P. Harrington, S. Ramus, S. Gayther,<br />
E. Goode, P. Pharoah.<br />
140/12:15 Enhanced detection <strong>of</strong> low-level mosaic<br />
mutations in RB1 gene in sporadic unilateral RB by<br />
ion torrent semiconductor sequencing: Risk <strong>of</strong><br />
second cancer. Z. Chen, S. Walther, K. Moran,<br />
D. Gerhart, T. Ganguly, A. Ganguly.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37) (SESSION 34, continued)<br />
141/12:30 Risk <strong>of</strong> colorectal cancer for monoallelic<br />
and biallelic MUTYH mutation carriers. A. K. Win, S.<br />
P. Cleary, J. G. Dowty, D. D. Buchanan, J. P. Young, N.<br />
M. Lindor, R. W. Haile, P. A. Newcomb, L. Marchand,<br />
J. L. Hopper, S. Gallinger, M. A. Jenkins, Colon Cancer<br />
Family Registry.<br />
INVITED AND PLATFORM SESSIONS 91<br />
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37)<br />
SESSION 35 – Ethical, Legal, Social and Policy Issues<br />
Room 132, Lower Level North, Moscone Center<br />
Moderators: Maureen Smith, Northwestern Univ.; Neil<br />
Lamb, HudsonAlpha Inst. for Biotechnol., Huntsville,<br />
AL<br />
142/10:30 Newborn screening for cystic fibrosis:<br />
Preliminary results on the false positive experience.<br />
C. J. Barg, F. A. Miller, R. Z. Hayeems, P. Durie, J. C.<br />
Carroll, P. Chakraborty, B. K. Potter, Y. Bombard, K.<br />
Tam, L. Taylor, E. Kerr, C. Davies, J. Milburn, F. Ratjen,<br />
A. Guttmann.<br />
143/10:45 Conflicting views on newborn and infant<br />
genetic screening: Perspectives <strong>of</strong> relatives <strong>of</strong><br />
children with genetic conditions causing<br />
developmental delay and parents <strong>of</strong> healthy<br />
children. S. A. Metcalfe, A. D. Archibald, A. L.<br />
Atkinson, C. Hickerton, S. Lawton, B. J. McClaren,<br />
S. H. Wong.<br />
144/11:00 Do research participants really want to<br />
know? The Seattle Colorectal Cancer Family<br />
Registry experience on the return <strong>of</strong> research<br />
genetic test results. M. Laurino, D. Fisher, W. Grady,<br />
P. Newcomb.<br />
145/11:15 The student-athletes’ knowledge <strong>of</strong><br />
sickle cell trait and the impact <strong>of</strong> mandatory<br />
genetic testing. N. Lovick, L. Mar, M. Treadwell,<br />
J. Youngblom, C. Hartshorne.<br />
146/11:30 Impact <strong>of</strong> direct-to-consumer<br />
pharmacogenomic testing. C. S. Bloss, N. J. Schork,<br />
E. J. Topol.<br />
147/11:45 Impact <strong>of</strong> genomic risk for type 2<br />
diabetes on health behaviors. S. B. Haga, W. Barry,<br />
R. Mills, J. Sullivan, H. F. Willard, L. P. Svetkey,<br />
G. S. Ginsburg.<br />
148/12:00 African <strong>American</strong> attitudes toward exome<br />
and whole genome sequencing. J. Yu, J. Crouch,<br />
S. M. Jamal, H. K. Tabor, M. J. Bamshad.<br />
149/12:15 Personalized health literacy in the age <strong>of</strong><br />
personalized medicine: Results from a deliberative<br />
public engagement exercise. B. J. Wilson, J. C.<br />
Carroll, S. G. Nicholls, S. M. Craigie, H. Etchegary,<br />
D. Castle, B. K. Potter, J. Little, L. Lemyre on behalf <strong>of</strong><br />
Emerging Team in Genomics in Screening.<br />
150/12:30 Dynamics, definitions and discrepancies:<br />
Public perspectives on the systematic collection<br />
and use <strong>of</strong> family health history in routine health<br />
care. H. Etchegary, B. J. Wilson, S. M. Craigie, S. G.<br />
Nicholls, D. Castle, J. C. Carroll, J. Allanson, B. K.<br />
Potter, P. Chakraborty on behalf <strong>of</strong> CIHR Emerging<br />
Team in Genomics in Screening.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
92 INVITED AND PLATFORM SESSIONS<br />
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37)<br />
SESSION 36 – Chipping Away at Autoimmune Disease<br />
Room 130, Lower Level North, Moscone Center<br />
Moderators: Judy H. Cho, Yale Univ.; Soumya<br />
Raychaudhuri, Brigham and Women’s Hosp.<br />
151/10:30 Immunochip: Redefining the genetic<br />
architecture <strong>of</strong> multiple sclerosis. J. McCauley,<br />
International Multiple Sclerosis <strong>Genetics</strong> Consortium.<br />
152/10:45 Dense genotyping <strong>of</strong> candidate genes<br />
indentifies 16 new susceptibility loci in ankylosing<br />
spondylitis. A. Cortes, P. C. Robinson, P. Leo, D. M.<br />
David, M. A. Brown, International <strong>Genetics</strong> <strong>of</strong><br />
Ankylosing Spondylitis and Wellcome Trust Case<br />
Control Consortia.<br />
153/11:00 Dense fine-mapping study identifies<br />
novel disease loci and implicates coding and<br />
non-coding variation in primary biliary cirrhosis<br />
risk. J. Z. Liu, M. A. Almarri, D. J. Gaffney, G. F.<br />
Mells, L. Jostins, H. J. Cordell, S. Ducker, D. Day,<br />
M. A. Heneghan, J. M. Neuberger, P. T. Donaldson,<br />
A. Bathgate, A. Burroughs, M. Davies, D. E. Jones,<br />
G. J. Alexander, J. C. Barrett, R. N. Sandford, C. A.<br />
Anderson, UK PBC Consortium and Wellcome Trust<br />
Case Control Consortium 3.<br />
154/11:15 Fifteen novel psoriasis susceptibility loci:<br />
Disease-specific signals highlight the role <strong>of</strong> innate<br />
immunity. L. C. Tsoi, S. L. Spain, J. Knight, E.<br />
Ellinghaus, P. E. Stuart, F. Capon, J. Ding, Y. Li, T.<br />
Tejasvi, J. E. Gudjonsson, H. M. Kang, A. M. Bowcock,<br />
U. Mrowietz, S. Koks, T. Esko, J. J. Voorhees, M.<br />
Weichenthal, P. Rahman, D. Gladman, C. E. M.<br />
Griffiths, A. Reis, J. Kere, R. P. Nair, A. Franke, J. N. W.<br />
N. Barker, G. R. Abecasis, J. T. Elder, R. C. Trembath,<br />
Genetic Analysis <strong>of</strong> Psoriasis Consortium, Wellcome<br />
Trust Case Control Consortium 2.<br />
155/11:30 MHC fine-mapping in celiac disease<br />
reveals structural basis <strong>of</strong> HLA-gluten interaction.<br />
J. Gutierrez-Achury, G. Trynka, K. A. Hunt, J.<br />
Romanos, D. van Heel, C. Wijmenga, P. I. W. de<br />
Bakker.<br />
156/11:45 Host-microbe interactions shape genetic<br />
risk for inflammatory bowel disease. J. Barrett,<br />
International IBD <strong>Genetics</strong> Consortium.<br />
157/12:00 Sequencing-based and multiplatform<br />
genome-wide association study for multiple<br />
sclerosis and type 1 diabetes in Sardinians. I. Zara,<br />
E. Porcu, M. Zoledziewska, M. Pitzalis, M. Valentini,<br />
A. Mulas, F. Busonero, R. Atzeni, M. Oppo, F. Reinier,<br />
R. Berutti, R. Pilu, F. Deidda, C. Sidore, R. Piras, A. Loi,<br />
S. Sanna, E. Cocco, F. Poddie, G. Farina, G. Rosati,<br />
L. Lianas, G. Cuccuru, G. Zanetti, A. Angius, M. G.<br />
Marrosu, C. M. Jones, G. R. Abecasis, S. Sanna,<br />
F. Cucca.<br />
158/12:15 Admixture mapping for asthma in Latinos<br />
identifies additional heritable risk factors from<br />
genome-wide meta-analysis data. C. R. Gignoux,<br />
D. G. Torgerson, J. M. Galanter, L. A. Roth, C. Eng,<br />
D. Hu, S. Huntsman, R. D. Hernandez, R. A. Mathias,<br />
S. Sen, K. C. Barnes, E. G. Burchard.<br />
159/12:30 Deep exome sequencing <strong>of</strong> psoriasis<br />
identified new association signals contribute by<br />
INDELs, CNVs and rare SNPs. X. Jin, H. Tang, H.<br />
Jiang, D. Cao, H. Shao, Q. Li, J. Shen, L. Song, Y. Shi,<br />
J. Mei, X. Yang, L. Coin, Y. Li, X. Zhang, J. Wang.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Thursday, November 8<br />
10:30 AM–12:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session B (29-37)<br />
SESSION 37 – Metabolic Disease Discoveries<br />
Room 123, Lower Level North, Moscone Center<br />
Moderators: Kimberly Chapman, Children’s Natl. Med.<br />
Ctr.; Hans Andersson, Tulane Univ. Med. Ctr.<br />
160/10:30 Mutations in DDHD2 cause recessive<br />
spastic paraplegia with intellectual disability, thin<br />
corpus callosum and periventricular white matter<br />
hyperintensities. A. P. M. de Brouwer, J. H. M.<br />
Schuurs-Hoeijmakers, E. J. Kamsteeg, S. Ben-Salem,<br />
S. T. de Bot, I. van de Vondervoort, S. Vermeer, J.<br />
Schwartzentruber, B. R. Ali, S. A. Al-Yahyaee, S. Tariq,<br />
T. Pramathan, R. Bayoumi, B. P. van de Warrenburg,<br />
W. M. van den Akker, C. Gilissen, J. A. Veltman, I. M.<br />
Janssen, A. T. Vulto-van Silfhout, S. van der Velde-<br />
Visser, A. Diekstra, C. E. Erasmus, M. A. Willemsen,<br />
L. E. L. M. Vissers, H. van Bokhoven, R. A. Wevers,<br />
L. Al-Gazali, M. T. Geraghty, B. B. A. de Vries.<br />
161/10:45 Lipidomics <strong>of</strong> Gaucher disease:<br />
Substrate composition and nature is dependent on<br />
tissue/region and acid �-glucosidase mutations:<br />
Phenotypic implications. Y. Sun, W. Zhang, Y. Xu,<br />
B. Quinn, N. Dasgupta, B. Liou, K. D. R. Setchell,<br />
G. A. Grabowski.<br />
162/11:00 Sterol precursors induce Niemann-Pick C<br />
disease phenotypes in Smith-Lemli-Opitz syndrome<br />
causing defective LDL-cholesterol utilization that<br />
is corrected by imino-sugars. C. A. Wassif, E. Lloyd-<br />
Evans, L. J. Haslett, I. M. Williams, C. L. Toth, F. D.<br />
Porter, F. M. Platt.<br />
163/11:15 Glucose kinetics in subjects with MELAS<br />
syndrome: Interim results. L. Emrick, A. El-Hattab,<br />
J. Hsu, F. Jarhoor, F. Scaglia, W. Craigen.<br />
164/11:30 Phenylbutyrate therapy for pyruvate<br />
dehydrogenase complex deficiency. R. Ferriero,<br />
E. Lamantea, P. W. Stacpoole, L. Bonafè, B. Lee,<br />
M. Zeviani, N. Brunetti-Pierri.<br />
165/11:45 Etiologies for neurocognitive delays in<br />
argininosuccinic aciduria. A. Erez, S. Nagamani, P.<br />
Campeau, O. Shchelochkov, J. Kho, K. Bissig, Q. Sun,<br />
N. Bryan, S. Cederbaum, B. Lee.<br />
166/12:00 Enzyme substitution therapy for<br />
phenylketonuria delivered orally using a genetically<br />
modified probiotic: Pro<strong>of</strong> <strong>of</strong> principle.<br />
J. Christodoulou, N. Al-Hafid, X.-Z. Tong, K. Carpenter,<br />
V. Wiley, S. Cunningham, I. E. Alexander.<br />
167/12:15 A new inborn error <strong>of</strong> manganese<br />
metabolism caused by mutations in SLC30A10,<br />
a newly identified human manganese transporter.<br />
K. Tuschl, P. T. Clayton, S. M. Gospe, Jr., S. Gulab, S.<br />
Ibrahim, P. Singhi, R. T. Ribeiro, M. S. Zaki, M. Luz del<br />
Rosario, S. Dyack, V. Price, R. A. Wevers, P. B. Mills.<br />
INVITED AND PLATFORM SESSIONS 93<br />
168/12:30 Combined methylmalonic acidemia and<br />
homocystinuria, cblC type: A prospective clinical<br />
protocol focusing on neurologic and<br />
neurodevelopmental parameters in a cohort <strong>of</strong> preschool<br />
children diagnosed on expanded newborn<br />
screening. J. D. Weisfeld-Adams, H. A. Bender, A. M.<br />
Akerstedt, E. Miles-Mason, T. P. Naidich, S. Lipson,<br />
T. Bottiglieri, S. P. Young, G. A. Diaz.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
94 INVITED AND PLATFORM SESSIONS<br />
Thursday, November 8<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session C (38-46)<br />
SESSION 38 – A Sequencing Jamboree: Exomes to<br />
Genomes<br />
Hall D, Lower Level North, Moscone Center<br />
Moderators: Nancy Cox, Univ. <strong>of</strong> Chicago; Orli Bahcall,<br />
Nature <strong>Genetics</strong><br />
169/4:30 Whole-exome sequencing <strong>of</strong> 10,000 type<br />
2 diabetes cases and controls from five major<br />
ancestry groups. T. M. Teslovich, A. P. Morris, P.<br />
Fontanillas, M. A. Rivas, X. Sim, J. Flannick, N. Burtt,<br />
H. Chen, A. G. Day-Williams, A. Mahajan, G. Atzmon,<br />
P. Cingolani, L. Moutsianas, H. M. Highland, T2D-<br />
GENES Consortium.<br />
170/4:45 Rare and low frequency coding variants<br />
are associated with LDL cholesterol levels:<br />
Findings from the NHLBI Exome Sequencing<br />
Project. L. A. Lange, Y. Hu, C. Xue, Z. Tang, C. Bizon,<br />
E. M. Lange, J. D. Smith, E. H. Turner, G. Jun, H.-M.<br />
Kang, K. P. Li, G. M. Peloso, C. L. Wassel, A. P.<br />
Reiner, E. Boerwinkle, B. M. Psaty, C. J. O’Donnell, S.<br />
Kathiresan, K. E. North, D. Lin, G. P. Jarvik, L. A.<br />
Cupples, C. Kooperberg, J. G. Wilson, D. A.<br />
Nickerson, G. R. Abecasis, S. S. Rich, R. P. Tracy, C. J.<br />
Willer on behalf <strong>of</strong> NHLBI Exome Sequencing Project.<br />
171/5:00 Exome sequencing <strong>of</strong> extreme phenotypes<br />
identifies DCTN4 and CAV2 as modifiers <strong>of</strong> chronic<br />
Pseudomonas aeruginosai nfection in cystic<br />
fibrosis. M. J. Emond, T. Louie, J. Emerson, S.<br />
McNamara, W. Zhao, R. A. Mathias, M. R. Knowles, F.<br />
A. Wright, M. J. Reider, H. K. Tabor, D. A. Nickerson, K.<br />
C. Barnes, R. L. Gibson, M. J. Bamshad.<br />
172/5:15 A high resolution study <strong>of</strong> type 2 diabetes<br />
genetic architecture through whole-genome<br />
sequencing <strong>of</strong> 2850 European individuals: The<br />
GoT2D Study. J. Flannick, C. Fuchsberger, K. J.<br />
Gaulton, N. P. Burtt, H. M. Kang, C. Hartl, R. D.<br />
Pearson, GoT2D Consortium.<br />
173/5:30 Mapping quantitative traits with integrated<br />
whole exome/genome/array panel in individuals <strong>of</strong><br />
European descent. X. Sim, M. A. Rivas, A. K.<br />
Manning, A. E. Locke, C. M. Lindgren, GoT2D<br />
Consortium.<br />
174/5:45 Whole genome sequence analyses<br />
describe the genetic architecture <strong>of</strong> complex<br />
traits: The Cohorts for Heart and Aging Research<br />
in Genetic Epidemiology Consortium. A. C.<br />
Morrison, A. Voorman, A. D. Johnson, X. Liu, J. Yu,<br />
A. Li, D. Muzny, F. Yu, K. Rice, G. Zhu, G. Heiss, C.<br />
J. O’Donnell, B. Psaty, L. A. Cupples, R. Gibbs, E.<br />
Boerwinkle.<br />
175/6:00 Genome sequencing and analysis in<br />
autism spectrum disorder. S. Walker, A. Prasad,<br />
L. Lau, B. Thiruvahindrapuram, B. Fernandez,<br />
R. Yuen, C. R. Marshall, E. Fombonne, W. Roberts,<br />
L. Zwaigenbaum, P. Szatmari, S. W. Scherer.<br />
176/6:15 Deep whole genome sequencing in<br />
pedigrees illuminates the contribution <strong>of</strong> low<br />
frequency and private mutations to the genetic<br />
architecture <strong>of</strong> metabolic quantitative traits.<br />
A. K. Manning, A. R. Wood, P. Fontanillas, G. Jun, P.<br />
Cingolani, M. Almeida, C. Fuchsberger, T. D. Dyer, M.<br />
Rivas, K. Gaulton, J. Maller, J. Curran, J. Grunstad,<br />
T. W. Blackwell, T. M. Teslovich, D. M. Lehman, R.<br />
Grossman, J. Laramie, S. E. Lincoln, M. Boehnke, M.<br />
I. McCarthy, T. M. Frayling, R. Sladek, R. Duggirala, J.<br />
Blangero, G. Abecasis, D. Altshuler, T2D-GENES.<br />
177/6:30 Whole genome sequencing <strong>of</strong> 2,100<br />
individuals in the founder Sardinian population.<br />
C. Sidore, S. Sanna, A. Kwong, H. M. Kang,<br />
R. Cusano, M. Pitzalis, M. Zoledziewska, A. Maschio,<br />
F. Busonero, M. Lobina, A. Angius, R. Lyons, B. Terrier,<br />
C. Brennan, R. Atzeni, A. Mulas, M. Dei, M. G. Piras,<br />
S. Lai, F. Reinier, R. Berutti, C. Jones, M. Marcelli, M.<br />
Urru, M. Oppo, D. Schlessinger, G. Abecasis, F. Cucca.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Thursday, November 8<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session C (38-46)<br />
SESSION 39 – Admixture and Demography<br />
Gateway Ballroom 103, Lower Level South, Moscone<br />
Center<br />
Moderators: Katarzyna Bryc, Harvard Univ.; John<br />
Novembre, UCLA<br />
178/4:30 Differential relatedness <strong>of</strong> African<br />
<strong>American</strong>s to populations within West Africa.<br />
K. Bryc, A. Williams, N. Patterson, S. Musani,<br />
M. Sale, W. Chen, J. Divers, M. Ng, D. W. Bowden,<br />
J. G. Wilson, D. Reich.<br />
179/4:45 Fine scale population genetic structure<br />
<strong>of</strong> African <strong>American</strong>s. E. Y. Durand, M. Macpherson,<br />
B. T. Naughton, J. Mountain, C. B. Do.<br />
180/5:00 A model-based approach for analysis <strong>of</strong><br />
spatial structure in genetic data. W. Yang,<br />
J. Novembre, E. Eskin, E. Halperin.<br />
181/5:15 People <strong>of</strong> the British Isles: An analysis <strong>of</strong><br />
the genetic contributions <strong>of</strong> European populations<br />
to a UK control population. S. Leslie, B. Winney,<br />
G. Hellenthal, S. Myers, P. Donnelly, W. Bodmer.<br />
182/5:30 The applicability <strong>of</strong> the Balding-Nichols<br />
model to a dataset <strong>of</strong> over 100,000 Brazilian<br />
individuals. R. V. Rohlfs, A. Bhaskar, V. R. C. Aguiar,<br />
K. Lohmueller, A. M. Castro, A. C. S. Ferreira, F. S. V.<br />
Malta, Y. Song, I. D. Louro, R. Nielsen.<br />
183/5:45 Rare genetic variants in deep sequencing<br />
<strong>of</strong> neutral regions from a homogeneous population<br />
refine models <strong>of</strong> recent explosive human<br />
population growth. A. Keinan, E. Gazave, A.<br />
Coventry, S. Gottipati, D. Chang, L. Ma, D. Muzny,<br />
E. Boerwinkle, C. Sing, R. Gibbs, A. Clark.<br />
184/6:00 Estimating human population sizes using<br />
the coalescent with recombination. S. Sheehan,<br />
K. Harris, Y. S. Song.<br />
185/6:15 Reconstructing historical contributions<br />
to modern gene pools using the sequentially<br />
Markovian coalescent conditional sampling<br />
distribution. A. Platt, J. Novembre.<br />
186/6:30 On the Sardinian ancestry <strong>of</strong> the Tyrolean<br />
Iceman. M. Sikora, M. Carpenter, A. Moreno-Estrada,<br />
B. M. Henn, P. A. Underhill, I. Zara, M. Pitzalis,<br />
C. Sidore, F. Reinier, M. Marcelli, A. Angius, C. Jones,<br />
T. T. Harkins, A. Keller, A. Zink, G. Abecasis, S. Sanna,<br />
F. Cucca, C. D. Bustamante.<br />
INVITED AND PLATFORM SESSIONS 95<br />
Thursday, November 8<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session C (38-46)<br />
SESSION 40 – Analysis <strong>of</strong> Multilocus Systems<br />
Room 135, Lower Level North, Moscone Center<br />
Moderators: Brendan Keating, Univ. <strong>of</strong> Pennsylvania;<br />
Laura Almasy, Texas Biomed. Res. Inst., San Antonio<br />
187/4:30 Gene-based epistasis analysis in genomewide<br />
association studies. L. Ma, A. Brautbar,<br />
E. Boerwinkle, C. F. Sing, A. G. Clark, A. Keinan.<br />
188/4:45 Building human phenotype networks from<br />
shared genetic risk variants. C. Darabos, K. Desai,<br />
M. Giacobini, M. Lupien, J. H. Moore.<br />
189/5:00 Incorporating network dynamics to<br />
prioritize genes through genome-wide association<br />
studies. L. Hou, M. Chen, C. K. Zhang, J. Cho,<br />
H. Zhao.<br />
190/5:15 Large-scale multi-phenotype metaanalysis<br />
evaluates pleiotropic effects at FADS1 and<br />
GIPR loci. V. Lagou, R. Mägi, K. Fischer, M. Akerlund,<br />
I. Surakka, M. Kaakinen, J. S. Ried, A. Mahajan, M.<br />
Horikoshi, L. Marullo, K. Strauch, C. Gieger, S. Ripatti,<br />
A. P. Morris, V. Lyssenko, I. Prokopenko for ENGAGE<br />
(European Network for Genetic and Genomic<br />
Epidemiology) Consortium.<br />
191/5:30 Building and assessing protein-protein<br />
interaction networks from genome-wide<br />
association results in cancer. L. T. Hiraki, A. D. Joshi,<br />
S. Lindstrom, A. T. Chan, S. Chanock, P. Kraft.<br />
192/5:45 A smoothed functional principal<br />
component analysis for pathway analysis with<br />
next-generation sequencing data. J. Zhao, Y. Zhu,<br />
E. Boerwinkle, M. Xiong.<br />
193/6:00 Variants in exons and in transcription<br />
factors affect gene expression in trans. A. Kreimer,<br />
I. Pe’er.<br />
194/6:15 The continuation <strong>of</strong> theory by other<br />
means: ForSim as a forward simulator for improved<br />
understanding <strong>of</strong> the genetic architecture <strong>of</strong><br />
complex traits and its evolution. K. M. Weiss, J. H.<br />
Lee, J. D. Terwilliger, B. W. Lambert.<br />
195/6:30 Incorporating phylogenetic conservation<br />
and pedigree information in tests <strong>of</strong> rare-variant<br />
association. H. Hu, C. D. Huff, H. Coon, S. Guthery,<br />
S. V. Tavtigian, J. C. Roach, Z. Kronenberg, J. Xing,<br />
A. F. A. Smit, G. Glusman, A. K. Holloway, V. Garg,<br />
B. Moore, R. Hubley, W. S. Watkins, H. Li, S. Z.<br />
Montsar<strong>of</strong>f, D. E. Abbott, L. E. Hood, K. S. Pollard,<br />
D. J. Galas, D. Srivastava, M. G. Reese, L. B. Jorde,<br />
M. Yandell.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
96 INVITED AND PLATFORM SESSIONS<br />
Thursday, November 8<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session C (38-46)<br />
SESSION 41 – Genes Underlying Neurological Disease<br />
Room 134, Lower Level North, Moscone Center<br />
Moderators: Stylianos Antonarakis, Univ. <strong>of</strong> Geneva<br />
Med. Sch.; Laurie Ozelius, Mount Sinai Med. Sch.<br />
196/4:30 TMTC4: A novel candidate gene for<br />
callosal development. L. Fernandez, J. Li, M.<br />
Wakahiro, E. Rider, T. Bartman, E. Sherr.<br />
197/4:45 CLK2 missense mutation in a family with<br />
pontocerebellar hypoplasia type 7. V. R. C. Eggens,<br />
Y. Namavar, M. A. Haagmans, K. Fluiter, E. J. Bradley,<br />
P. G. Barth, B. T. Poll-The, F. Baas.<br />
198/5:00 Missense mutations in ITPR1 cause<br />
autosomal dominant congenital nonprogressive<br />
spinocerebellar ataxia. J. Warman Chardon, L.<br />
Huang, M. Carter, K. Friend, T. Dudding, J.<br />
Schwartzentruber, R. Zou, P. Sch<strong>of</strong>ield, S. Douglas,<br />
D. Bulman, K. Boycott.<br />
199/5:15 VPS37A causes a novel form <strong>of</strong> complex<br />
hereditary spastic paraparesis. T. Falik-Zaccai, Y.<br />
Zivony-Elboum, W. Westbroek, D. Savitzki, Y. Shoval,<br />
Y. Anikster, A. Waters, R. Kleta.<br />
200/5:30 Genome-wide association study identifies<br />
two novel susceptibility loci for musician’s<br />
dystonia. K. Lohmann, A. Schmidt, A. Schillert, S.<br />
Winkler, K. Siegesmund, H.-C. Jabusch, M. Kasten,<br />
J. L. Groen, C. Hemmelmann, J. Hagenah, J. Graf,<br />
N. Brüggemann, A. Grünewald, F. Baas, A. Münchau,<br />
K. E. Zeuner, S. Schreiber, G. Deuschl, M. A. J. de<br />
Koning-Tijssen, E. Altenmüller, A. Ziegler, C. Klein.<br />
201/5:45 Autosomal recessive axonal neuropathy<br />
with neuromyotonia: A novel disease entity<br />
caused by mutations in HINT1. J. Baets, M. Zimon,<br />
L. Almeida-Souza, J. Nikodinovic, Y. Parman, E.<br />
Battaloglu, V. Guergueltcheva, I. Tournev, M. Auer-<br />
Grumbach, T. Müller, P. Van Damme, W. N. Löscher,<br />
N. Barisic, Z. Mitrovic, S. C. Previtali, H. Topaloglu,<br />
G. Bernert, A. Beleza-Meireles, S. Todorovic,<br />
B. Ishpekova, K. Peeters, A. F. Hahn, S. Züchner,<br />
V. Timmerman, V. Milic Rasic, A. R. Janecke,<br />
A. Jordanova, P. De Jonghe.<br />
202/6:00 De novo gain <strong>of</strong> function KCNT1 channel<br />
mutations cause seizures and developmental delay<br />
in malignant migrating partial seizures <strong>of</strong> infancy.<br />
G. Barcia, M. R. Fleming, A. Deligniere, V. Gazula,<br />
M. R. Brown, M. Langouet, H. Chen, J. Kronengold,<br />
A. Abhyankar, R. Cilio, P. Nitschke, A. Kaminska, N.<br />
Boddaert, J. L. Casanova, I. Desguerre, A. Munnich,<br />
O. Dulac, L. K. Kaczmarek, L. Colleaux, R. Nabbout.<br />
203/6:15 Investigating the genetic etiology <strong>of</strong><br />
familial epilepsies using next-generation<br />
sequencing. E. K. Ruzzo, E. L. Heinzen, R. Wedel,<br />
K. V. Shianna, I. E. Scheffer, S. F. Berkovic, R. Ottman,<br />
D. B. Goldstein.<br />
204/6:30 Autoregulation <strong>of</strong> the DYT6-gene THAP1.<br />
A. Erogullari, P. Seibler, D. Braunholz, A. Grünewald,<br />
R. Depping, J. Eckhold, A. Rakovic, T. Lohnau, G.<br />
Gillessen-Kaesbach, C. Klein, K. Lohmann, F. J. Kaiser.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Thursday, November 8<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session C (38-46)<br />
SESSION 42 – Cancer <strong>Genetics</strong> III: Common Variants<br />
Gateway Ballroom 104, Lower Level South, Moscone<br />
Center<br />
Moderators: Kathleen Cooney, Univ. <strong>of</strong> Michigan;<br />
Meredith Yeager, NCI/NIH<br />
205/4:30 Identification <strong>of</strong> 23 novel prostate cancer<br />
susceptibility loci using a custom array (the iCOGS)<br />
in an international consortium, PRACTICAL. R.<br />
Eeles, A. Amin Al Olama, S. Benlloch, E. Saunders, D.<br />
Leongamornlert, M. Tymrakiewicz, M. Ghoussaini, C.<br />
Luccarini, J. Dennis, S. Jugurnauth-Little, T. Dadaev,<br />
PROTECT Group, G. Giles, G. Severi, F. Wiklund, H.<br />
Gronberg, C. Haiman, F. Schumacher, B. Henderson,<br />
L. Le Marchand, S. Lindstrom, P. Kraft, D. Hunter,<br />
S. Gapstur, S. Chanock, S. Berndt, PRACTICAL<br />
Consortium, Z. Kote-Jarai, D. Easton.<br />
206/4:45 Large-scale genotyping identifies more<br />
than 40 novel breast cancer susceptibility loci. K.<br />
Michailidou, P. Hall, A. Gonzalez-Neira, M. Ghoussaini,<br />
J. Dennis, R. L. Milne, M. K. Schmidt, J. Chang-<br />
Claude, S. E. Bojesen, M. K. Humphreys, Q. Wang, M.<br />
Garcia-Closas, P. D. P. Pharoah, G. Chenevix-Trench,<br />
A. M. Dunning, J. Benitez, D. F. Easton, Breast Cancer<br />
Association Consortium.<br />
207/5:00 Genome-wide association study in BRCA1<br />
mutation carriers identifies novel loci associated<br />
with breast and ovarian cancer risk. A. C. Antoniou,<br />
X. Wang, L. McGuffog, A. Lee, M. M. Guedet, K. B.<br />
Kuchenbaecker, P. Soucy, J. Simard, K. Offit, D. F.<br />
Easton, G. Chenevix-Trench, F. J. Couch, Consortium<br />
<strong>of</strong> Investigators <strong>of</strong> Modifiers <strong>of</strong> BRCA1/2.<br />
208/5:15 Identification <strong>of</strong> the first locus to modify<br />
breast cancer risk specifically in BRCA2 mutation<br />
carriers. K. Kuchenbaecker, M. Gaudet, J. Vijai,<br />
R. Klein, T. Kirchh<strong>of</strong>f, L. McGuffog, D. Barrowdale,<br />
A. Dunning, A. Lee, P. Hall, F. Couch, J. Simard, D.<br />
Altshuler, D. Easton, G. Chenevix-Trench, A. Antoniou,<br />
K. Offit, Consortium <strong>of</strong> Investigators <strong>of</strong> Modifiers <strong>of</strong><br />
BRCA1/2 (CIMBA) Collaborators.<br />
209/5:30 Fine-scale mapping and functional<br />
analysis <strong>of</strong> the breast cancer 11q13 (CCND1) locus.<br />
M. Ghoussaini, K. B. Meyer, S. Edwards, J. D. French,<br />
K. Michailidou, S. Ahmed, S. Khan, M. J. Maranian,<br />
C. S. Healey, P. D. P. Pharoah, H. Nevanlinna,<br />
M. A. Brown, G. Chenevix-Trench, D. F. Easton,<br />
A. M. Dunning, BCAC.<br />
INVITED AND PLATFORM SESSIONS 97<br />
210/5:45 Three independent loci within the TERT-<br />
CLPTM1L locus associated with telomere length<br />
and risk <strong>of</strong> breast and ovarian cancer. G. Chenevix-<br />
Trench, S. E. Bojesen, K. A. Pooley, S. Johnatty,<br />
J. Beesley, K. Michailidou, J. Tyrer, S. L. Edwards,<br />
H. C. Shen, K. Lawrenson, H. Pickett, M. Stutz, C.<br />
Smart, J. French, P. L. Mai, M. H. Greene, S. Gayther,<br />
R. Reddel, P. D. P. Pharoah, E. L. Goode, A. Berchuk,<br />
D. F. Easton, A. C. Antoniou, A. M. Dunning on behalf<br />
<strong>of</strong> CIMBA, OCAC and BCAC.<br />
211/6:00 Statistical fine mapping <strong>of</strong> regions<br />
containing melanoma susceptibility genes identified<br />
through genome-wide association studies. J. H.<br />
Barrett, J. C. Taylor, M. Brossard, A. M. Goldstein,<br />
P. A. Kanetsky, E. M. Gillanders, J. A. Newton Bishop,<br />
D. T. Bishop, F. Demenais, M. M. Iles, GenoMEL<br />
Consortium.<br />
212/6:15 Combining expression phenotypes with<br />
high density imputation to identify melanoma risk<br />
genes. M. H. Law, G. W. Montgomery, K. M. Brown,<br />
A. E. Cust, N. G. Martin, G. J. Mann, N. K. Hayward,<br />
S. MacGregor, Q-MEGA and AMFS Investigators.<br />
213/6:30 Meta-analysis identifies four new loci for<br />
testicular germ cell tumor. C. C. Chung, Z. Wang,<br />
P. A. Kanetsky, C. Turnbull, K. McGlynn, R. L. Erickson,<br />
M. H. Greene, M. A. T. Hildebrandt, R. I. Skotheim,<br />
C. Kratz, M. B. Cook, F. Schumacher, R. Koster,<br />
M. Yeager, K. B. Jacobs, S. M. Schwartz, D. T. Bishop,<br />
H. K. Gjessing, V. Cortessis, N. Rahman, X. Wu,<br />
S. J. Chanock, K. L. Nathanson.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
98 INVITED AND PLATFORM SESSIONS<br />
Thursday, November 8<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session C (38-46)<br />
SESSION 43 – <strong>Genetics</strong> <strong>of</strong> Crani<strong>of</strong>acial and<br />
Musculoskeletal Disorders<br />
Room 124, Lower Level North, Moscone Center<br />
Moderators: Irini Manoli, NHGRI/NIH; Siddharth<br />
Prakash, Univ. <strong>of</strong> Texas Hlth. Sci. Ctr. at Houston<br />
214/4:30 Next-generation sequencing detects<br />
mutations in ISPD as a common cause <strong>of</strong> Walker-<br />
Warburg syndrome with defective glycosylation <strong>of</strong><br />
dystroglycan. T. Roscioli, E.-J. Kamsteeg, K. Buysse,<br />
I. Maystadt, J. van Reeuwijk, C. van den Elzen, E.<br />
van Beusekom, M. Riemersma, R. Pfundt, L. E. L. M.<br />
Vissers, M. Schraders, M. F. Buckley, H. G. Brunner, H.<br />
Zhou, J. A. Veltman, C. Gilissen, G. M. S. Mancini, M.<br />
A. Willemsen, D. Petkovi Ramada, D. Chitayat, C.<br />
Bennett, E. Sheridan, E. A. J. Peeters, G. M. B. Tan-<br />
Sindhunata, H. Kayserili, O. Abd El-Fattah El-Hashash,<br />
D. L. Stemple, D. J. Lefeber, Y.-Y. Lin, H. van<br />
Bokhoven.<br />
215/4:45 The identification <strong>of</strong> a novel gene<br />
identified by exome sequencing reveals the<br />
upstream components <strong>of</strong> the RAS/MAPK signaling<br />
pathway involved in Noonan syndrome. H. Yntema,<br />
W. Nillesen, J. Paardekooper Overman, M. Bonetti,<br />
J. de Ligt, H. Venselaar, M. Tartaglia, S. G. M. Frints,<br />
L. E. L. M. Vissers, J. den Hertog, I. van der Burgt.<br />
216/5:00 DYNC2H1 mutations are commonly<br />
found in Jeune asphyxating thoracic dysplasia<br />
(JATD) without extraskeletal features while IFT140<br />
mutations cause JATD with renal involvement.<br />
M. Schmidts, H. H. Arts, Z. Yap, E. M. H. F. Boengers,<br />
D. Anthony, M. M. Oud, S. Al-Turki, L. Duijkers,<br />
J. Stalker, J. B. Yntema, A. Hoischen, R. Bogdanovic,<br />
A. Peco Antic, C. Gillisen, H. Kayserili, I. Veltman,<br />
A. Kutkowska, E. J. Kamsteeg, R. C. M. Hennekam,<br />
P. Scambler, P. L. Beales, UK10K Consortium,<br />
N. V. A. M. Knoers, R. Roepman, H. M. Mitchison.<br />
217/5:15 Dominant missense mutations in<br />
ABCC9 cause Cantú syndrome. G. van Haaften,<br />
M. Harakalova, J. J. T. van Harssel, P. Terhal, S. van<br />
Lieshout, K. Duran, I. Renkens, D. J. Amor, L. C.<br />
Wilson, E. P. Kirk, C. L. S. Turner, D. Shears, S. García-<br />
Miñaúr, M. M. Lees, A. Ross, H. Venselaar, G. Vriend,<br />
H. Takanari, M. B. Rook, M. A. G. van der Heyden,<br />
M. E. Swinkels, I. J. Scurr, S. F. Smithson,<br />
N. V. Knoers, J. J. van der Smagt, I. J. Nijman,<br />
W. P. Kloosterman, M. M. van Haelst, E. Cuppen.<br />
218/5:30 Reduced dosage <strong>of</strong> ERF causes complex<br />
craniosynostosis in humans and mice, and links<br />
ERK1/2 signaling to regulation <strong>of</strong> osteogenesis.<br />
S. R. F. Twigg, I. Paraki, S. J. McGowan, M. Allegra,<br />
A. L. Fenwick, V. P. Sharma, E. Vorgia, A. Zaragkoulias,<br />
E. Sadighi Akha, S. J. Knight, H. Lord, T. Lester,<br />
L. Izatt, A. K. Lampe, S. N. Mohammed, F. J. Stewart,<br />
A. Verloes, L. C. Wilson, D. Johnson, S. A. Wall,<br />
P. Hammond, J. Hughes, S. Taylor, G. Mavrothalassitis,<br />
A. O. M. Wilkie.<br />
219/5:45 Mutations in the multidomain protein<br />
MEGF8 identify a new subtype <strong>of</strong> Carpenter<br />
syndrome associated with defective lateralization.<br />
D. L. Lloyd, S. R. Twigg, N. Elcioglu, D. Jenkins, C. D.<br />
O. Cooper, N. Akarsu, E. Taskiran, N. Al-Sannaa, A.<br />
Annagür, G. Gillessen-Kaesbach, I. Stefanova, S. J. L.<br />
Knight, J. A. Goodship, B. Keavney, P. L. Beales, O.<br />
Gileadi, S. McGowan, A. O. M. Wilkie.<br />
220/6:00 Increased frequency <strong>of</strong> FBN1 variants in<br />
adolescent idiopathic scoliosis. J. G. Buchan, D. A.<br />
Alvarado, M. C. Willing, M. B. Dobbs, C. A. Gurnett.<br />
221/6:15 Exome sequencing in idiopathic scoliosis<br />
reveals rare variants in VANGL, a planar cell<br />
polarity gene involved in axial development.<br />
S. Sharma, J. A. Herring, X. Gao, D. Zhang, C. Wise.<br />
222/6:30 Recessive mutations in FKBP10, a PPIase<br />
known to cause type XI OI, extend the phenotype<br />
to a congenital contracture syndrome (Kuskokwim<br />
disease), and cause diminished collagen crosslinking<br />
in matrix. A. M. Barnes, M. Weis, W. A.<br />
Cabral, E. Makareeva, E. L. Mertz, W. Paton,<br />
G. Duncan, C. Trujillo, S. Leikin, D. R. Eyre, S. J. Bale,<br />
J. C. Marini.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Thursday, November 8<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session C (38-46)<br />
SESSION 44 – Tools for Phenotype Analysis<br />
Room 132, Lower Level North, Moscone Center<br />
Moderators: Donna Maglott, NCBI/NIH; Gregory E.<br />
Crawford, Duke Univ.<br />
223/4:30 PRIMUS: Pedigree Reconstruction and<br />
Identification <strong>of</strong> the Maximum Unrelated Set.<br />
J. Staples, D. Nickerson, J. Below.<br />
224/4:45 Pharmacogenoinformatics: Novel<br />
approach <strong>of</strong> in silico drug designing based on<br />
genetic variation <strong>of</strong> MDR1 gene involved in statin<br />
resistance. A. Munshi, M. Sai Babu, A. Venkateswara<br />
Rao, A. Jyothy.<br />
225/5:00 A general, integrated variant prioritization<br />
method for rapid determination <strong>of</strong> disease causing<br />
mutations from next-generation sequencing data.<br />
B. D. O’Fallon, W. Wooderchak-Donahue, P. Bayrak-<br />
Toydemir.<br />
226/5:15 Visually integrating and exploring high<br />
throughput phenome-wide association (PheWAS)<br />
results using PheWAS-view and PhenoGram. S. A.<br />
Pendergrass, S. Dudek, D. C. Crawford, M. D. Ritchie.<br />
227/5:30 PhenoDB: A new web-based tool for the<br />
collection, storage and analysis <strong>of</strong> phenotypic<br />
features. A. Hamosh, J. Hoover-Fong, V. R. Sutton,<br />
N. Sobreira, C. Boehm, F. Schiettecatte, D. Valle.<br />
228/5:45 A novel metabolomics analysis workflow<br />
provides new biological insights into the genetic<br />
basis <strong>of</strong> human metabolic variation. H. Dharuri,<br />
P. Henneman, D. O. Mook-Kanamori, K. Suhre,<br />
K. Willems van Dijk, P. A. C. `t Hoen.<br />
229/6:00 Integration <strong>of</strong> large-scale gene annotation,<br />
electronic medical records, and incidence data to<br />
produce phenotype-specific posterior probabilities<br />
to aid interpretation <strong>of</strong> genome-wide variant data.<br />
I. M. Campbell, S. W. Cheung, A. Patel, S. R. Lalani, P.<br />
Stankiewicz, M. B. Ramocki, J. R. Lupski, C. A. Shaw.<br />
230/6:15 The Kaiser Permanente/UCSF Genetic<br />
Epidemiology Research Study on Adult Health<br />
and Aging: CREX, computerized methodology to<br />
identify health conditions using the EMR for GWAS.<br />
S. Sciortino, L. Walter, D. Ranatunga, L. Shen, D.<br />
Ludwig, J. Kay, L. Sakoda, N. Risch, C. Schaefer.<br />
231/6:30 An informatics approach to analyzing the<br />
incidentalome. M. C. Adams, J. S. Berg, N. Nassar,<br />
C. Bizon, K. Lee, C. P. Schmitt, K. C. Wilhelmsen,<br />
J. P. Evans.<br />
INVITED AND PLATFORM SESSIONS 99<br />
Thursday, November 8<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session C (38-46)<br />
SESSION 45 – Therapy <strong>of</strong> Genetic Disorders<br />
Room 130, Lower Level North, Moscone Center<br />
Moderators: Cynthia J.R. Curry, UCSF; Brunhilde<br />
Wirth, Univ. <strong>of</strong> Cologne, Germany<br />
232/4:30 Pathogenic exon-trapping by SVA<br />
retrotransposon and rescue in Fukuyama muscular<br />
dystrophy. M. Taniguchi, K. Kobayashi, M. Kanagawa,<br />
C. C. Yu, T. Oda, A. Kuga, H. Kurahashi, H. O. Akmen,<br />
S. DiMauro, T. Yokota, S. Takeda, T. Toda.<br />
233/4:45 Hematopoietic stem cell transplantation<br />
for adolescent and adult onset cerebral X-linked<br />
adrenoleukodystrophy. T. Matsukawa, T. Yamamoto,<br />
S. Seo, K. Kumano, M. Ichikawa, Y. Takahashi, H.<br />
Ishiura, J. Mitsui, M. Tanaka, J. Goto, M. Kurokawa,<br />
S. Tsuji.<br />
234/5:00 Treating Pelizaeus-Merzbacher disease<br />
with clinically applicable compounds, curcumin<br />
and chloroquine: Preclinical studies. K. Inoue,<br />
T. Morimura, Y. Numata, L.-H. Yu, L. Gotoh, R.<br />
Yamamoto, N. Inoue, B. Antalfy, K. Deguchi, H. Osaka,<br />
Y. Goto.<br />
235/5:15 Systemic L-threo-dihydroxyphenylserine<br />
corrects neurochemical abnormalities in a mouse<br />
model <strong>of</strong> Menkes disease. S. Kaler, A. Donsante, P.<br />
Sullivan, D. Goldstein, C. Holmes.<br />
236/5:30 Response to VPA therapy in SMA<br />
patients is concordant from blood to neurons and<br />
influenced by CD36. B. Wirth, L. Heesen, I. Hölker,<br />
T. Bauer, J. Schreml, K. Zimmermann, M. Thoenes,<br />
M. Walter, J. Dimos, M. Peitz, O. Brüstle, R. Heller,<br />
L. Garbes.<br />
237/5:45 Melatonin, a new biomarker reflecting<br />
brain serotonin metabolism in individuals with<br />
phenylketonuria: Evaluation <strong>of</strong> large neutral<br />
amino acid therapy by a randomized, double-blind<br />
crossover study. S. Yano, K. Moseley, C. Azen.<br />
238/6:00 Beyond cholesterol: Antioxidant treatment<br />
for patients with Smith-Lemli-Opitz syndrome.<br />
E. Elias, R. Braverman, S. Tong.<br />
239/6:15 Positive effects <strong>of</strong> short course androgen<br />
therapy on the neurodevelopmental outcome<br />
in boys with 47, XXY syndrome at 36 and 72<br />
months <strong>of</strong> age. C. Samango-Sprouse, E. Stapleton,<br />
T. Sadeghin, F. Mitchell, T. Dixon, M. Kingery, A.<br />
Gropman.<br />
240/6:30 A mechanism and treatment strategy for<br />
pregnancy-associated aortic dissection in Marfan<br />
syndrome. J. P. Habashi, N. Huso, D. Bedja, G. Rykiel,<br />
J. J. Doyle, H. C. Dietz.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
100 INVITED AND PLATFORM SESSIONS<br />
Thursday, November 8<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session C (38-46)<br />
SESSION 46 – Pharmacogenetics: From Discovery to<br />
Implementation<br />
Room 123, Lower Level North, Moscone Center<br />
Moderators: Toni Pollin, Univ. <strong>of</strong> Maryland Sch. <strong>of</strong><br />
Med.; Edward Ramos, NHGRI/NIH<br />
241/4:30 Pharmacogenomics, ancestry and clinical<br />
decision making for global populations. E. Ramos,<br />
A. Doumatey, H. Huang, D. Shriner, G. Chen, S. Callier,<br />
J. Zhou, A. Adeyemo, H. Mcleod, C. Rotimi.<br />
242/4:45 Cell line pr<strong>of</strong>iling in oncology (CELLO) as a<br />
discovery platform for systematic identification <strong>of</strong><br />
genetic and genomic biomarkers <strong>of</strong> drug<br />
sensitivity. J. Zhong, H. Niu, J. Cai, S. Middleton, H.<br />
Bian, J. Hakenberg, C. Saisanit, F. Birzele, W.<br />
Berk<strong>of</strong>sky-Fessler, J. Rosinski, N. Sanapareddy, Z.<br />
Albertyn, B. Chen, S. Bader, G. Chen, M. Xia, L.<br />
Vassilev, A. Belousov, L. Essioux.<br />
243/5:00 Screening <strong>of</strong> the TPMT gene before<br />
thiopurine treatment results in a lower leucopenia<br />
occurrence in patient with inflammatory bowel<br />
disease. M. J. H. Coenen, C. J. van Marrewijk, L. J.<br />
J. Derijks, S. H. Vermeulen, O. H. Klungel, A. L. M.<br />
Verbeek, H. Scheffer, B. Franke, H. J. Guchelaar, D. J.<br />
de Jong, TOPIC Study.<br />
244/5:15 PGRNseq: A new sequencing-based<br />
platform for high-throughput pharmacogenomic<br />
implementation and discovery. A. S. Gordon, J. D.<br />
Smith, Q. Xiang, M. L. Metzker, R. A. Gibbs, E. R.<br />
Mardis, D. A. Nickerson, R. S. Fulton, S. E. Scherer.<br />
245/5:30 Genetic variation in the GRK4 gene<br />
associates with susceptibility to hypertension<br />
and response to angiotensin receptor blockade.<br />
M. White, Z. Wang, H. Sanada, M. Yoneda, S. M.<br />
Williams, J. Bartlett, L. Gordon, S. Chen, L. Asico, C.<br />
Escano, V. Villar, C. Zeng, L. Wong, J. Jones, R. Felder,<br />
G. Eisner, P. Jose.<br />
246/5:45 Genome-wide discovery <strong>of</strong> drugdependent<br />
human liver enhancers. R. P. Smith, K.<br />
M. Morrissey, X. Sun, T. J. H<strong>of</strong>fman, K. M. Giacomini,<br />
N. Ahituv.<br />
247/6:00 Genome-wide association study <strong>of</strong><br />
vancomycin pharmacokinetics using a de-identified<br />
biorepository. S. L. Van Driest, T. L. McGregor, Z. Lu,<br />
S. Vear, C. B. Creech, P. J. Kannankeril, K. B. Brothers,<br />
A. Potts, E. Bowton, J. T. Delaney, Y. Bradford, S.<br />
Wilson, L. Olson, D. C. Crawford, B. Saville, D. M.<br />
Roden, J. C. Denny.<br />
248/6:15 Integrating multiple levels <strong>of</strong> phenotypic<br />
information to map genetic determinants <strong>of</strong><br />
glucocorticoid sensitivity. J. Maranville, S. Baxter,<br />
D. Witonsky, A. Di Rienzo.<br />
249/6:30 Common and rare genetic variation<br />
in maturity-onset diabetes <strong>of</strong> the young genes<br />
influence response to interventions for diabetes<br />
prevention. L. Billings, l. Tipton, A. Warner, J. McAteer,<br />
A. Shuldiner, D. Ehrmann, A. Manning, D. Dabelea,<br />
P. Franks, S. Kahn, T. Pollin, W. Knowler, D. Altshuler,<br />
K. Jablonski, J. Florez.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55)<br />
SESSION 47 – Structural and Regulatory Genomic<br />
Variation<br />
Hall D, Lower Level North, Moscone Center<br />
Moderators: Mike Lovett, Washington Univ. in St.<br />
Louis; Greg Elgar, MRC NIMR, London, U.K.<br />
250/8:00 Germline mosaicism does not explain the<br />
maternal age effect on trisomy. R. Rowsey,<br />
B. Murdoch, P. Hunt, C. Dickerson, T. Woodruff,<br />
T. Hassold.<br />
251/8:15 Female meiosis II errors prevalence and<br />
their impact on human embryo viability. A. Kuliev,<br />
Z. Zlatopolsky, I. Kirillova, J. Cieslak-Janzen.<br />
252/8:30 A population isolate reveals enriched<br />
recessive deleterious variants underlying<br />
neurodevelopmental traits. O. Pietiläinen, J.<br />
Suvisaari, W. Hennah, V. Leppä, T. Paunio, M.<br />
Torniainen, S. Ripatti, S. Ala-Mello, K. Rehnström, A.<br />
Tuulio-Henriksson, T. Varilo, J. Tallila, K. Kristiansson,<br />
M. Isohanni, J. Kaprio, J. Eriksson, M. Jarvelin, R.<br />
Durbin, J. Lonnqvist, M. Hurles, H. Stefansson, N.<br />
Freimer, M. Daly, A. Palotie.<br />
253/8:45 The role <strong>of</strong> trans-acting factors on<br />
recombination in oocytes with nondisjoined<br />
chromosomes 21. C. D. Middlebrooks, N.<br />
Mukhopadhyay, S. W. Tinker, E. G. Allen, L. J. H. Bean,<br />
F. Begum, R. Chowdhury, V. Cheung, E. Feingold,<br />
S. L. Sherman.<br />
254/9:00 Large-scale function-based enhancer<br />
discovery. D. E. Dickel, Y. Zhu, A. S. Nord, J. A.<br />
Akiyama, A. Visel, L. A. Pennacchio.<br />
255/9:15 A single enhancer on human chromosome<br />
11 directly controls >1,000 promoters and distal<br />
regulatory elements genome-wide. J . A.<br />
Stamatoyannopoulos, H. Wang, G. J. Cost, H. Quh, Y.<br />
Santago, J. Belton, R. McCord, S. Orlando, S. Neph,<br />
L. Zhang, T. Canfield, E. Giste, R. Sandstrom, R. S.<br />
Hansen, R. E. Thurman, P. D. Gregory, J. Dekker,<br />
F. D. Urnov.<br />
256/9:30 Identification <strong>of</strong> trait- and disease-relevant<br />
genetic polymorphisms in microRNA target sites.<br />
S. Busche, B. Ge, T. Kwan, K. Wong, S.-H. Chen, M.<br />
Georges, D. Ginzinger, T. Pastinen.<br />
257/9:45 Mapping functional p53 response<br />
elements and their variants in human genome.<br />
X. Wang, M. R. Campbell, V. G. Cheung, D. A. Bell.<br />
258/10:00 A SNP associated with skin cancer and<br />
pigmentation disrupts a melanocyte enhancer in an<br />
intron <strong>of</strong> IRF4. D. U. Gorkin, S. K. L<strong>of</strong>tus, D. Lee,<br />
M. A. Beer, W. J. Pavan, A. S. McCallion.<br />
INVITED AND PLATFORM SESSIONS 101<br />
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55)<br />
SESSION 48 – Neuropsychiatric Disorders<br />
Gateway Ballroom 103, Lower Level South, Moscone<br />
Center<br />
Moderators: Dimitrios Avramopoulos, Johns Hopkins<br />
Univ.; Tatiana Foroud, Indiana Univ. Sch. <strong>of</strong> Med.<br />
259/8:00 Genetic and functional abnormalities <strong>of</strong><br />
the melatonin biosynthesis pathway in patients<br />
with bipolar disorder. S. Jamain, B. Etain, A.<br />
Dumaine, F. Bellivier, C. Pagan, L. Francelle, H.<br />
Goubran-Botros, S. Moreno, J. Deshommes, K.<br />
Moustafa, K. Le Dudal, F. Mathieu, C. Henry, J. P.<br />
Kahn, J. M. Launay, T. W. Mühleisen, S. Cichon, T.<br />
Bourgeron, M. Leboyer.<br />
260/8:15 Massively-parallel sequencing <strong>of</strong> the brain<br />
transcriptome reveals differential expression <strong>of</strong><br />
novel genes in bipolar disorder. N. Akula, J. Barb, X.<br />
Jiang, J. Wendland, K. Choi, S. Sen, B. K. Lipska, J. E.<br />
Kleinman, H. C. Bravo, D. T. Chen, P. J. Munson, F. J.<br />
McMahon.<br />
261/8:30 Rare and common gain-<strong>of</strong>-function<br />
alleles <strong>of</strong> the serotonin transporter gene, SLC6A4,<br />
associated with Tourette disorder.P. R. Moya, J. R.<br />
Wendland, A. M. Andrews, L. M. Rubenstein, K. R.<br />
Timpano, G. A. Heiman, J. A. Tischfield, R. A. King,<br />
S. Rammamoorthy, F. J. McMahon, D. L. Murphy.<br />
262/8:45 GLRB is the third major gene-<strong>of</strong>-effect in<br />
hyperekplexia or startle disease. S. K. Chung, A.<br />
Bode, C. A. Hunt, A. Derrick, T. D. Cushion, S. Wood,<br />
C. Drew, O. W. Howells, R. H. Thomas, J. G. Mullins,<br />
J. Lynch, M. I. Rees.<br />
263/9:00 Functional analysis <strong>of</strong> rare chimeric genes<br />
in schizophrenia. C. Rippey, C. Remmers, M. Cahill,<br />
A. Nord, T. Walsh, M. Lee, M. Gasperini, P. Penzes, J.<br />
McClellan, M.-C. King.<br />
264/9:15 Excess homozygosity in the major<br />
histocompatibility complex in schizophrenia.<br />
S. Mukherjee, S. Guha, M. Ikeda, N. Iwata,<br />
A. K. Malhotra, I. Pe’er, A. Darvasi, T. Lencz.<br />
265/9:30 Significant risk <strong>of</strong> new mutations for<br />
Huntington disease: CAG-size specific risk<br />
estimates <strong>of</strong> intermediate allele repeat instability.<br />
A. Semaka, C. Kay, C. Doty, J. A. Collins,<br />
M. R. Hayden.<br />
266/9:45 Mutations in AKT3 lead to<br />
hemimegalencephaly. A. Poduri, G. D. Evrony, X. Cai,<br />
P. C. Elhosary, R. Beroukhim, M. K. Lehtinen, L. B.<br />
Hills, E. L. Heinzen, A. Hill, R. S. Hill, B. J. Barry,<br />
B. F. D. Bourgeois, J. J. Riviello, A. J. Barkovich,<br />
P. M. Black, J. Madsen, K. L. Ligon, C. A. Walsh.<br />
267/10:00 De novo somatic mutations in<br />
components <strong>of</strong> the PI3K-AKT3-mTOR pathway<br />
cause hemimegalencephaly. J. Lee, M. Huynh,<br />
G. Mathern, J. Gleeson.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
102 INVITED AND PLATFORM SESSIONS<br />
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55)<br />
SESSION 49 – Common Variants, Rare Variants, and<br />
Everything in Between<br />
Room 135, Lower Level North, Moscone Center<br />
Moderators: Steve Rich, Univ. <strong>of</strong> Virginia; Rasika<br />
Mathias, Johns Hopkins Univ. Sch. <strong>of</strong> Med.<br />
268/8:00 Minimal differences in single nucleotide<br />
variation calls between blood- and cell line-derived<br />
DNA from the same individuals. C. M. Schafer, N. G.<br />
Campbell, G. Cai, J. S. Sutcliffe, J. D. Buxbaum, K.<br />
Roeder, ARRA Autism Sequencing Consortium.<br />
269/8:15 The impact <strong>of</strong> genetic variation on<br />
diabetes-related quantitative traits from whole<br />
exome sequences: The T2D-GENES Consortium.<br />
H. M. Highland, X. Sim, A. Manning, M. Rivas, G.<br />
Atzmon, S. Choi, B. K. Cornes, J. Dupuis, J. C. Florez,<br />
P. Fontanillas, T. Frayling, E. R. Gamazon, I.-S. Huh,<br />
H. K. Im, J. Kim, Y. J. Kim, C. M. Lindgren, A. E. Locke,<br />
J. B. Meigs, A. P. Morris, N. Palmer, I. Prokopenko,<br />
T. M. Teslovich, T2D-GENES Consortium.<br />
270/8:30 Whole-exome sequencing in multiplex<br />
families identifies novel rare variants in multiple<br />
sclerosis. A. H. Beecham, J. L. McCauley, A.<br />
Hadjixen<strong>of</strong>ontos, P. L. Whitehead, I. Konidari, A.<br />
Aviram, Y. Pasco, S. L. Hauser, J. R. Oksenberg,<br />
D. J. Hedges, J. M. Vance, J. L. Haines, M. A. Pericak-<br />
Vance.<br />
271/8:45 A Mendelian randomization study on<br />
vitamin D status and blood pressure: A metaanalysis<br />
in up to 89,042 individuals. K. S.<br />
Vimaleswaran, D. J. Berry, A. Cavadino, M. R. Järvelin,<br />
E. Hyppönen, D-CarDia Collaboration.<br />
272/9:00 APOE modulates the relationship among<br />
triglycerides, cholesterol, and CHD through<br />
pleiotropy and gene-gene interactions.<br />
T . J. Maxwell, C. M. Ballantyne, J. M. Cheverud,<br />
C. S. Guild, C. E. Ndumele, E. Boerwinkle.<br />
273/9:15 Statistical inference <strong>of</strong> tissue-consistent<br />
and tissue-specific eQTLs. T. Flutre, X. Wen,<br />
J. Pritchard, M. Stephens.<br />
274/9:30 Estimates <strong>of</strong> penetrance for common<br />
pathogenic copy number variations. J. A. Rosenfeld,<br />
B. P. Coe, E. E. Eichler, H. Cuckle, L. G. Shaffer.<br />
275/9:45 Combining Illumina gene expression<br />
microarrays from different tissues: Methodological<br />
aspects. K. Heim, C. Schurmann, A. Schillert,<br />
C. Müller, T. Zeller, C. Herder, J. Kruppa, T. Illig,<br />
G. Homuth, K. Strauch, A. Peters, H. Wallasch<strong>of</strong>ski,<br />
M. Dörr, T. Meitinger, P. S. Wild, S. Blankenberg,<br />
U. Völker, M. Roden, A. Teumer, H. Prokisch, A. Ziegler<br />
on behalf <strong>of</strong> MetaXpress Consortium.<br />
276/10:00 A DNA variant caller adapted to assess<br />
mitochondrial DNA variation in lymphocytes from<br />
1,000 Sardinians. J. Ding, C. Sidore, O. Meirelles,<br />
M. K. Trost, F. Busonero, R. Nagaraja, F. Cucca,<br />
G. R. Abecasis, D. Schlessinger.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55)<br />
SESSION 50 – Population <strong>Genetics</strong> Genome-Wide<br />
Room 134, Lower Level North, Moscone Center<br />
Moderators: Melissa A. Wilson Sayres, Univ. <strong>of</strong><br />
California, Berkeley; Sarah Tishk<strong>of</strong>f, Univ. <strong>of</strong><br />
Pennsylvania<br />
277/8:00 Direct measure <strong>of</strong> human somatic basesubstitution<br />
mutation rate in monozygotic twins.<br />
J. B. Richards, R. Li, A. Montpetit, T. D. Spector, C.<br />
Polychronakos.<br />
278/8:15 Estimating human mutation rate using<br />
autozygosity in a founder population. C. D.<br />
Campbell, J. X. Chong, M. Malig, A. Ko, B. L. Dumont,<br />
L. Han, L. Vives, B. J. O’Roak, P. H. Sudmant,<br />
M. Abney, C. Ober, E. E. Eichler.<br />
279/8:30 The myth <strong>of</strong> random mating: Evidence<br />
<strong>of</strong> ancestry-related assortative mating across 3<br />
generations in Framingham, MA. R. Sebro, G.<br />
Peloso, J. Dupuis, N. Risch.<br />
280/8:45 Combined analysis <strong>of</strong> loss-<strong>of</strong>-function<br />
variants in protein-coding genes from over 16,000<br />
individuals. D. G. MacArthur, M. Lek, K. Shakir, S.<br />
Balasubramanian, E. Lim, B. M. Neale, L. Habegger,<br />
S. Gabriel, P. Sullivan, S. Kathiresan, M. I. McCarthy,<br />
M. Boehnke, S. Purcell, S. A. McCarroll, M. B. Gerstein,<br />
D. Altshuler, M. A. DePristo, M. J. Daly.<br />
281/9:00 Abundant selection explains low diversity<br />
on human Y chromosomes. M. Wilson Sayres, K.<br />
Lohmueller, R. Nielsen.<br />
282/9:15 The genomic geography <strong>of</strong> close relatives<br />
across Europe. P. Ralph, G. Coop.<br />
283/9:30 Evolutionary history and adaptation<br />
inferred from whole-genome sequences <strong>of</strong> diverse<br />
African hunter-gatherers. J. Lachance, B. Vernot,<br />
C. Elbers, B. Ferwerda, A. Froment, J. Bodo, G. Lema,<br />
W. Fu, T. Nyambo, T. Rebbeck, K. Zhang, J. Akey,<br />
S. Tishk<strong>of</strong>f.<br />
284/9:45 Mapping the human genome’s missing<br />
pieces using population admixture. G. Genovese,<br />
R. E. Handsaker, H. Li, N. Altemose, A. M. Lindgren,<br />
K. Chambert, B. Pasaniuc, A. Price, D. Reich, C. C.<br />
Morton, M. R. Pollak, J. G. Wilson, S. A. McCarroll.<br />
285/10:00 When ancestry runs deep: Trans-species<br />
polymorphisms in apes. L. Segurel, E. Leffler, Z. Gao,<br />
S. Pfeifer, A. Auton, O. Venn, L. Stevison, A. Venkat,<br />
J. L. Kelley, J. Kidd, C. Bustamante, R. Bontrop, M.<br />
Hammer, J. Wall, P. Donnelly, G. McVean,<br />
M. Przeworski.<br />
INVITED AND PLATFORM SESSIONS 103<br />
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55)<br />
SESSION 51 – Endless Forms Most Beautiful: Variant<br />
Discovery in Genomic Data<br />
Gateway Ballroom 104, Lower Level South, Moscone<br />
Center<br />
Moderators: Terry Furey, Univ. <strong>of</strong> North Carolina at<br />
Chapel Hill; Deanna Church, NCBI/NIH<br />
286/8:00 Dark matter <strong>of</strong> the diseasome: Annotating<br />
personal genomes for gene regulatory disease risk<br />
alleles. G. Bejerano.<br />
287/8:15 Causal mutation discovery using nextgeneration<br />
sequencing data: Development and<br />
application <strong>of</strong> a pipeline to reduce false positive<br />
calls and to map regions <strong>of</strong> shared homozygosity<br />
and IBD. S. Gulsuner, T. Walsh, A. C. Watts, M. K. Lee,<br />
T. Ozcelik, M. C. King.<br />
288/8:30 A new framework for large-scale genomic<br />
variant discovery and validation using pooled<br />
sequencing data. G. del Angel, M. Carneiro, E. Banks,<br />
R. Poplin, C. Hartl, M. A. DePristo.<br />
289/8:45 Discovery <strong>of</strong> genomic variants from RNAsequencing<br />
data. R. Piskol, G. Ramaswami, J. B. Li.<br />
290/9:00 zCall: A rare variant caller for array-based<br />
genotyping. J. I. Goldstein, A. Crenshaw, J. Carey, G.<br />
Grant, J. Maguire, M. Fromer, C. O’Dushlaine, J. L.<br />
Moran, K. Chambert, C. Stevens, P. Sklar, C. Hultman,<br />
S. Purcell, S. McCarroll, P. F. Sullivan, M. J. Daly, B.<br />
M. Neale, Swedish Schizophrenia Consortium, ARRA<br />
Autism Sequencing Consortium.<br />
291/9:15 Copy number detection and variant<br />
classification in the DDD project. T. W. Fitzgerald,<br />
K. I. Morley, M. van Kogelenberg, E. Bragin,<br />
P. Vijayarangakannan, A. Tivey, S. Clayton, S. Gribble,<br />
C. Wright, D. FitzPatrick, H. Firth, J. Barrett, N. Carter,<br />
M. Hurles.<br />
292/9:30 Removal <strong>of</strong> mapping biases in sequencebased<br />
functional data improves regulatory element<br />
identification at heterozygous variants.<br />
M. Buchkovich, K. L. Mohlke, T. S. Furey.<br />
293/9:45 SNP discovery in diverse human<br />
populations by rapid, very-low-cost next-generation<br />
sequencing <strong>of</strong> reduced representation libraries.<br />
T. F. Cooke, M. C. Yee, M. Muzzio, R. Bell,<br />
O. E. Cornejo, C. D. Bustamante, E. E. Kenny.<br />
294/10:00 HIBAG -- HLA genotype imputation with<br />
attribute bagging. X. Zheng, J. Shen, C. Cox,<br />
J. Wakefield, M. Ehm, M. Nelson, B. Weir.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
104 INVITED AND PLATFORM SESSIONS<br />
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55)<br />
SESSION 52 – Clinical <strong>Genetics</strong>: Complex Mechanisms<br />
and Exome-Discovery<br />
Room 124, Lower Level North, Moscone Center<br />
Moderators: Michael Gambello, Emory Univ.; Antonie<br />
D. Kline, Harvey Inst. for <strong>Human</strong> Genet., Baltimore<br />
295/8:00 Systematic identification <strong>of</strong> causal<br />
mutations in Mendelian disorders using exome<br />
sequence data. M. Lek, N. F. Clarke, L. B. Waddell,<br />
B. Thomas, M. A. DePristo, M. J. Daly, K. N. North,<br />
D. G. MacArthur.<br />
296/8:15 Exome sequencing <strong>of</strong> a large cohort <strong>of</strong><br />
patients with congenital digestive system<br />
disorders. M. Yourshaw, S. F. Nelson, M. G. Martín.<br />
297/8:30 Novel defect in kinetochore assembly<br />
causes short stature and microcephaly <strong>of</strong> postnatal<br />
onset. C. Y. Hung, J. E. Dallman, O. Rittinger,<br />
J. W. Bauer, M. Tekin, O. A. Bodamer.<br />
298/8:45 Mutations in PIGO, a member <strong>of</strong> the GPI<br />
anchor synthesis pathway, cause<br />
hyperphosphatasia with mental retardation<br />
syndrome. P. M. Krawitz, Y. Murakami, J. Hecht, U.<br />
Krüger, S. E. Holder, G. R. Mortier, B. Chiaie, E. Baere,<br />
M. D. Thompson, T. Roscioli, S. Kielbasa, T. Kinoshita,<br />
S. Mundlos, P. N. Robinson, D. Horn.<br />
299/9:00 The 600 kb deletion syndrome at 16p11.2<br />
leads to energy imbalance and neuropsychiatric<br />
disorders. S. Jacquemont, F. Zufferey, E. H. Sherr, N.<br />
D. Beckmann, E. Hanson, A. Maillard, L. Hippolyte, A.<br />
Mace, C. Ferrari, Z. Kutalik, J. Andrieux, R. Bernier, S.<br />
Bouquillon, B. Delobel, W. Andrew-Faucett, R. P. Goin-<br />
Kochel, L. Harewood, S. Lebon, D. H. Ledbetter, C.<br />
Lese-Martin, K. Mannick, D. Martinet, M. B. Ramocki,<br />
S. J. Spence, K. Steinmann, J. Tjernagel, J. E. Spiro,<br />
A. Reymond, W. Chung, J. S. Beckmann on behalf<br />
<strong>of</strong> Simons VIP Consortium, and 16p11.2 European<br />
Consortium.<br />
300/9:15 Ras/MAPK dysregulation caused by MEK2<br />
haploinsufficiency: A novel mechanism for a<br />
RASopathy phenotype. M. J. M. Nowaczyk, B.<br />
Thompson, S. Zeesman, U. Moog, P. A. Sanchez-Lara,<br />
R. Falk, P. Magoulas, L. Brueton, S. M. Ahmudavalli,<br />
J. H. Fong, D. Batista, K. Rauen.<br />
301/9:30 Analysis <strong>of</strong> ESP5400 exomes for results <strong>of</strong><br />
clinical utility in genes for conditions tested as part<br />
<strong>of</strong> newborn screening programs and age-related<br />
macular degeneration. H. K. Tabor, S. M. Jamal,<br />
J. H. Yu, A. S. Gordon, W. S. Post, A. D. Johnson,<br />
T. A. Graubert, D. A. Nickerson, P. L. Auer, M. J.<br />
Bamshad on behalf <strong>of</strong> NHLBI Personal Genomics<br />
Project Team and NHLBI Exome Sequencing Project.<br />
302/9:45 High congenital malformation rates in a<br />
Chernobyl ionizing radiation impacted population<br />
isolate in Ukraine. W. Wertelecki, L. Yevtushok,<br />
N. Zymak-Zakutnia, S. Lachenko.<br />
303/10:00 Somatic mosaicism is responsible for<br />
congenital melanocytic naevus syndrome, and<br />
underpins the associated risk <strong>of</strong> melanoma.<br />
V. A. Kinsler, A. C. Thomas, N. W. Bulstrode,<br />
S. Abu-Amero, K. McKenzie, E. Chanudet, P. Stanier,<br />
E. Healy, N. J. Sebire, G. E. Moore.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55)<br />
SESSION 53 – From SNP to Function in Complex Traits<br />
Room 132, Lower Level North, Moscone Center<br />
Moderators: Praveen Sethupathy, Univ. <strong>of</strong> North<br />
Carolina at Chapel Hill; Aravinda Chakravarti,<br />
McKusick-Nathans Inst. <strong>of</strong> Genet. Med., Baltimore<br />
304/8:00 The type 2 diabetes risk allele <strong>of</strong><br />
rs11603334 increases ARAP1 promoter activity<br />
and is associated with increased ARAP1 mRNA<br />
in pancreatic islets. J. R. Kulzer, M. L. Stitzel, M. A.<br />
Morken, F. S. Collins, K. L. Mohlke.<br />
305/8:15 NOS1AP is the major genetic<br />
electrocardiographic QT-interval regulator.<br />
A. Kapoor, R. B. Sekar, V. Pihur, M. K. Halushka,<br />
G. F. Tomaselli, A. Chakravarti.<br />
306/8:30 A regulatory polymorphism in Csk, a Lyp<br />
binding partner, associates with systemic lupus<br />
erythematosus and affects B cell signaling,<br />
maturation and activation. N. Manjarrez-Orduño,<br />
E. Marasco, S. A. Chung, M. S. Katz, J. F. Kiridly,<br />
K. R. Simpfendorfer, J. Freudenberg, D. H. Ballard,<br />
E. Nashi, T. J. Hopkins, D. S. Cunninghame Graham,<br />
A. T. Lee, M. J. H. Coenen, B. Franke, D. S. Swinkels,<br />
R. Graham, R. P. Kimberly, P. M. Gaffney, T. J. Vyse, T.<br />
W. Behrens, L. A. Criswell, B. Diamond,<br />
P. K. Gregersen.<br />
307/8:45 ITGAM coding variant, rs1143679 (R77H)<br />
that is associated with systemic lupus<br />
erythematosus (SLE) susceptibility affects its<br />
own expression in monocytes and ligand binding<br />
activities in SLE patients. A. K. Maiti, X. Kim-Howard,<br />
P. Motghare, J. M. Anaya, L. Loogers, S. K. Nath.<br />
308/9:00 Loss-<strong>of</strong>-function <strong>of</strong> semaphorins 3C and<br />
3D in Hirschsprung disease. Q. Jiang, K. P. Kilambi,<br />
T. Heanue, M. X. Sosa, Q. Wang, J. J. Gray,<br />
A. L. Kolodkin, D. D. Ginty, A. Chakravarti.<br />
309/9:15 Functional assessment <strong>of</strong> human coding<br />
polymorphisms affecting skin pigmentation using<br />
zebrafish. Z. Tsetskhladze, V. Canfield, K. Ang,<br />
S. Wentzel, K. Reid, A. Berg, S. Johnson,<br />
K. Kawakami, K. Cheng.<br />
310/9:30 Dosage effects <strong>of</strong> 169 Chr21 genes on<br />
early development events in zebrafish. S. Edie,<br />
N. Zaghloul, D. Klinedinst, J. Lebron, N. Katsanis,<br />
R. Reeves.<br />
311/9:45 Two birds, one stone: Epistasis pr<strong>of</strong>iling <strong>of</strong><br />
many single-nucleotide variants in a human gene.<br />
O. Zill, J. Kitzman, J. Shendure, S. Fields.<br />
312/10:00 Discovery and replication <strong>of</strong> pathwaybased<br />
trans-eQTL associations. L. Wiley, W. Bush.<br />
INVITED AND PLATFORM SESSIONS 105<br />
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55)<br />
SESSION 54 – Genetic Counseling and Clinical Testing<br />
Room 130, Lower Level North, Moscone Center<br />
Moderators: Susan Hahn, Univ. <strong>of</strong> Miami, Hussman<br />
Inst. for <strong>Human</strong> Genomics; Andrew Faucett, Geisinger<br />
Hlth. Syst., Danville, PA<br />
313/8:00 Utilization <strong>of</strong> chromosomal microarrays in<br />
pediatrics. A. H. Seeley, C. E. Keegan, C. S.<br />
Remmert, B. A. Tarini.<br />
314/8:15 Maximizing detection and minimizing<br />
noise: The first report <strong>of</strong> large scale whole exome<br />
sequencing data interpretation in a clinical<br />
laboratory. F. Xia, J. Beuten, M. Bainbridge, Z. Niu,<br />
M. Vatta, M. R. Bekheirnia, R. E. Person, M. Hardison,<br />
J. G. Reid, D. P. Sexton, A. C. Hawes, P. A. Pham, M.<br />
Wang, N. Saada, W. Liu, H. Sun, M. Scheel, Y. Ding,<br />
A. Roy, J. Wiszniewska, A. Willis, D. M. Muzny, S. E.<br />
Plon, J. R. Lupski, A. L. Beaudet, R. A. Gibbs, C. M.<br />
Eng, Y. Yang.<br />
315/8:30 Efficient detection <strong>of</strong> causative mutations<br />
for rare diseases: Rethinking clinical practice.<br />
H. Lee, J. Deignan, T. Toy, B. Harry, M. Yourshaw,<br />
P. Taylor, S. Webb, N. Dorrani, K. Das, F. Quintero,<br />
S. Kantarci, D. A. Wong, W. W. Grody, E. Vilain,<br />
S. F. Nelson.<br />
316/8:45 Intentions to receive individual results<br />
from whole-genome sequencing among<br />
participants in the ClinSeq study. B. B. Biesecker,<br />
F. M. Facio, H. Eidem, T. Fisher, S. Brooks, A. Linn,<br />
K. A. Kaphingst, L. G. Biesecker.<br />
317/9:00 Changes to control perceptions following<br />
disclosure <strong>of</strong> APOE-coronary artery disease<br />
associations during genetic susceptibility testing<br />
for Alzheimer’s disease: Findings from the REVEAL<br />
Study. K. Christensen, J. S. Roberts, W. R. Uhlmann,<br />
P. J. Whitehouse, T. O. Obisesan, D. L. Bhatt,<br />
L. A. Cupples, R. C. Green.<br />
318/9:15 Decreased prediction ability <strong>of</strong> common<br />
genetic variants on breast cancer risk with age:<br />
Possible underlying models and impact on risk<br />
prediction. H. Aschard, S. Lindstrom, P. Kraft.<br />
319/9:30 Large-sample size, comprehensive catalog<br />
<strong>of</strong> variants and advanced machine learning<br />
technique boost risk prediction for inflammatory<br />
bowel disease. Z. Wei, W. Wang, J. Bradfield,<br />
E. Frackelton, C. Kim, F. Mentch, R. Baldassano,<br />
H. Hakonarson, International IBD <strong>Genetics</strong><br />
Consortium.<br />
320/9:45 A comparison <strong>of</strong> risk estimates for<br />
complex diseases: Navigenics SNP-based testing<br />
and family history assessment. L. Aiyar, C. Shuman,<br />
R. Hayeems, L. Velsher, S. Wodak, D. Chitayat,<br />
J. Davies.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
106 INVITED AND PLATFORM SESSIONS<br />
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55) (SESSION 54, continued)<br />
321/10:00 Web-based case conferencing: An<br />
effective source <strong>of</strong> cancer genetics training for<br />
community-based clinicians. K. Blazer, J. Weitzel.<br />
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55)<br />
SESSION 55 – Mitochondrial Disorders and Ciliopathies<br />
Room 123, Lower Level North, Moscone Center<br />
Moderators: Catherine E. Keegan, Univ. <strong>of</strong> Michigan;<br />
Mitzi Murray, Univ. <strong>of</strong> Washington<br />
322/8:00 Combination <strong>of</strong> modern and traditional<br />
techniques identify MCKD1 causal frameshift<br />
variants within the MUC1 VNTR. A. Kirby, A. Gnirke,<br />
D. Jaffe, V. Bareová, N. Pochet, B. Blumenstiel, C. Ye,<br />
D. Aird, C. Stevens, J. Robinson, M. Calibi, I. Gat-Viks,<br />
E. Kelliher, R. Daza, M. DeFelice, H. Hlková, J. Sovová,<br />
C. Antignac, M. Guttman, R. Handsaker, K. Lindblad-<br />
Toh, S. Gabriel, P. S. Hart, A. Regev, C. Nusbaum,<br />
S. Kmoch, A. Bleyer, E. Lander, M. Daly.<br />
323/8:15 ARL13B, INPP5E, PDE6D and CEP164<br />
form a functional network involved in Joubert<br />
syndrome and nephronophthisis. S. Seo, M. C.<br />
Humbert, K. Weihbrecht, C. C. Searby, Y. Li, R. M.<br />
Pope, V. C. Sheffield.<br />
324/8:30 Mainzer-Saldino syndrome is a ciliopathy<br />
caused by mutations in the IFT140 gene. I. Perrault,<br />
S. Saunier, S. Hanein, E. Filhol, A. Bizet, F. Collins,<br />
M. Salih, S. Gerber, N. Delphin, E. Silva, V. Baudouin,<br />
M. Oud, N. Shannon, M. Le Merrer, O. Roche, C.<br />
Pietrement, C. Bole-Feysot, P. Nitschke, M. Zahrate, P.<br />
Beales, H. Arts, A. Munnich, J. Kaplan, C. Antignac, V.<br />
Cormier-Daire, J.-M. Rozet.<br />
325/8:45 Mutations in ALDH1B1, which encodes a<br />
mitochondrial protein belonging to the aldehyde<br />
dehydrogenase family, result in hepatic failure and<br />
mitochondrial respiratory chain deficiency. S. Salhi,<br />
V. Serre, M. Beinat, P. Nitschke, O. Bernard, A. Slama,<br />
A. Munnich, A. Rotig.<br />
326/9:00 Targeted exome sequencing <strong>of</strong> 102<br />
patients with clinical evidence <strong>of</strong> mitochondrial<br />
disease. D. S. Lieber, S. E. Calvo, K. Shanahan,<br />
N. G. Slate, S. Liu, S. G. Hershman, N. B. Gold,<br />
B. A. Chapman, M. Borowsky, D. R. Thorburn,<br />
G. T. Berry, J. D. Schmahmann, D. M. Mueller,<br />
K. B. Sims, V. K. Mootha.<br />
327/9:15 Genetic diagnosis <strong>of</strong> mitochondrial<br />
disorders by whole-exome sequencing. C. J. Carroll,<br />
V. Brilhante, P. Isohanni, R. Pöyhönen, L. Euro,<br />
U. Richter, T. Lahtinen, A. Götz, H. Almusa, P. Ellonen,<br />
H. Pihko, B. Battersby, H. Tyynismaa, A. Suomalainen.<br />
328/9:30 Constitutive activation <strong>of</strong> STIM1 causes<br />
tubular aggregate myopathy. J. Laporte, F.<br />
Chevessier, A. Maues de Paula, C. Koch, S. Attarian,<br />
C. Feger, D. Hantaï, P. Laforêt, K. Ghorab, J. M. Vallat,<br />
M. Fardeau, D. Figarella-Branger, J. Pouget, M. Koch,<br />
C. Ebel, N. Levy, B. Eymard, M. Bartoli, J. Bohm.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Friday, November 9<br />
8:00 AM–10:15 AM<br />
Concurrent Platform (abstract-driven)<br />
Session D (47-55) (SESSION 55, continued)<br />
329/9:45 Mutation in PNPT1 gene, which encodes a<br />
mitochondrial polyribonucleotide<br />
nucleotidyltransferase, causes encephalopathy with<br />
choreo-athetotic movements. V. Vedrenne, A.<br />
Gowher, P. De Lonlay, P. Nitschke, V. Serre, N.<br />
Boddaert, C. Altuzarra, A. M. Mager-Heckel, F.<br />
Chretien, N. Entelis, I. Tarassov, A. Munnich, A. Rotig.<br />
330/10:00 Comprehensive analysis <strong>of</strong> 101 nuclear<br />
genes for molecular diagnosis <strong>of</strong> mitochondrial<br />
disorders. R. Bai, J. Higgs, S. F. Suchy, S. Buchholz,<br />
D. Arjona, B. Boggs, C. Chinault, N. Smaoui, S.<br />
Benhamed, J. Compton, Y. Shevchenko, G. Richard,<br />
S. Bale, F. D. Kendall, S. Parikh, A. L. Gropman,<br />
W. Chung, A. Goldstein, S. E. Palmer, J. A. Panzer,<br />
S. W. Yum, M. J. Falk.<br />
INVITED AND PLATFORM SESSIONS 107<br />
Friday, November 9<br />
10:30 AM–11:15 AM<br />
SESSION 56 – Gruber <strong>Genetics</strong> Prize Award<br />
Presentation and Rosalind Franklin Young Investigator<br />
Award Announcement<br />
Hall D, Lower Level North, Moscone Center<br />
The <strong>Genetics</strong> Prize is awarded annually by The Gruber<br />
Foundation. The <strong>Genetics</strong> Prize is presented to a<br />
leading scientist, or up to three, in recognition <strong>of</strong><br />
groundbreaking contributions to any realm <strong>of</strong> genetics<br />
research. The recipient will be presented with a gold<br />
medal and a $500,000 unrestricted cash award.<br />
Recipient:<br />
Douglas Wallace, PhD<br />
Pr<strong>of</strong>. <strong>of</strong> Pathol. and Lab. Med., Univ. <strong>of</strong> Pennsylvania<br />
Ctr. <strong>of</strong> Mitochondrial and Epigenomic Med., Children’s<br />
Hosp. <strong>of</strong> Philadelphia<br />
The <strong>2012</strong> <strong>Genetics</strong> Prize <strong>of</strong> The Gruber Foundation will<br />
be presented to pioneering geneticist Douglas<br />
C. Wallace for the discovery <strong>of</strong> mutations in the<br />
mitochondrial genome and their impact on human<br />
health and disease.<br />
Dr. Wallace will deliver a lecture entitled, “A<br />
Bioenergetic Perspective on Origins, Health, and<br />
Disease”.<br />
Life is the interplay between structure (anatomy),<br />
energy (vital force), and the information to encode<br />
the structural and energetic systems. Classical<br />
Western biomedical thought has taken an anatomical<br />
perspective on disease and a Mendelian perspective<br />
on genetics. However, these perspectives are proving<br />
increasingly inadequate to explain the biological and<br />
genetic basis <strong>of</strong> complex diseases, cancer, and aging.<br />
To augment this classical perspective, we need to<br />
consider the bioenergetics <strong>of</strong> the eukarotic cell which<br />
is centered on the symbiotic bacterium known as the<br />
mitochondrion. The mitochondrion has its own DNA,<br />
the mitochondrial DNA (mtDNA), which encodes the<br />
core cellular energy genes. Mutations in the mtDNA<br />
have been found to cause the full range <strong>of</strong> complex<br />
disease phenotypes, the thousands <strong>of</strong> mtDNAs per<br />
cell provides an alternative explanation for quantitative<br />
genetic traits, and the analysis <strong>of</strong> mtDNA variation<br />
in human populations has <strong>of</strong>fered new insights<br />
into ancient ancestral migrations and adaptation<br />
to alternative environments. The causal role <strong>of</strong><br />
bioenergetic changes in complex disease has been<br />
validated by the introduction <strong>of</strong> mtDNA mutations into<br />
mice which then manifest common complex disease<br />
phenotypes. The recognition <strong>of</strong> the dichotomy<br />
between anatomical-chromosomal genes and<br />
bioenergetic-mtDNA genes has generated new insights<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
108 INVITED AND PLATFORM SESSIONS<br />
Friday, November 9<br />
10:30 AM–11:15 AM (SESSION 56, continued)<br />
into the molecular genetic basis <strong>of</strong> human health and<br />
disease, <strong>of</strong>fered a new perspective on the neutralistselectionist<br />
debate, and provided an explanation for<br />
the force that drives the evolution <strong>of</strong><br />
complex biological forms.<br />
The Gruber <strong>Genetics</strong> Prize has been presented<br />
annually since 2001. Laureates are: Rudolf Jaenisch,<br />
H. Robert Horvitz, David Botstein, Mary-Claire King,<br />
Robert H. Waterston, Elizabeth H. Blackburn, Maynard<br />
V. Olson, Allan C. Spradling, Janet Davison Rowley,<br />
Gerald Fink, Ronald Davis.<br />
Nominations for the 2013 Prize are currently open. The<br />
deadline is December 15, <strong>2012</strong>. For further information<br />
see www.gruberprizes.org.<br />
ROSALIND FRANKLIN YOUNG INVESTIGATOR<br />
AWARDS: Every three years, the Peter and Patricia<br />
Gruber Foundation presents the Rosalind Franklin Young<br />
Investigator Awards to two young women geneticists.<br />
One award is for research in genetics <strong>of</strong> humans and<br />
other mammals, and one award is for research in<br />
genetics <strong>of</strong> other model organisms. The awards are for<br />
career development and are $75,000 over three years.<br />
Winners <strong>of</strong> the Rosalind Franklin Award are in their first<br />
three years in an independent faculty level position<br />
in any area <strong>of</strong> genetics. The winners are selected by<br />
a committee <strong>of</strong> women geneticists, including former<br />
winners <strong>of</strong> the award. The recipients <strong>of</strong> the 2013–2015<br />
Rosalind Franklin Young Investigator Awards are:<br />
Valerie Horsley, PhD,<br />
Assistant Pr<strong>of</strong>essor <strong>of</strong> Molecular, Cellular, and<br />
Developmental Biology at Yale University, for her<br />
studies <strong>of</strong> the epithelial stem cell niche delineated by<br />
mouse genetic models;<br />
and<br />
Mary Gehring, PhD,<br />
Member <strong>of</strong> the Whitehead Institute and Assistant<br />
Pr<strong>of</strong>essor <strong>of</strong> Biology at MIT, for her studies <strong>of</strong><br />
imprinting and epigenetic regulation in Arabidopsis.<br />
Other finalists were Genevieve Konopka, PhD,<br />
Assistant Pr<strong>of</strong>essor <strong>of</strong> Neuroscience at UT<br />
Southwestern and Avital Rodal, PhD, Assistant<br />
Pr<strong>of</strong>essor <strong>of</strong> Biology at Brandeis University.<br />
Friday, November 9<br />
11:15 AM–11:45 AM<br />
SESSION 57 – <strong>ASHG</strong> William Allan Award Presentation<br />
Hall D, Lower Level North, Moscone Center<br />
The William Allan Award is presented annually by<br />
<strong>ASHG</strong> to recognize substantial and far-reaching<br />
scientific contributions to human and medical<br />
genetics, carried out over a lifetime <strong>of</strong> scientific inquiry<br />
and productivity.<br />
Introduction:<br />
Tayfun Özcelik<br />
Bilkent Univ., Ankara, Turkey<br />
Recipient:<br />
Uta Francke, MD<br />
Pr<strong>of</strong>. Em., Stanford Univ. Med. Ctr.<br />
Dr. Francke was chosen for her outstanding and<br />
tireless contributions to human and medical genetics<br />
fields, for her major impact on the study <strong>of</strong> many<br />
human disorders, for the breadth and depth <strong>of</strong> her<br />
applications <strong>of</strong> chromosomal analyses and molecular<br />
studies, and for her innovative uses <strong>of</strong> mouse models<br />
for understanding human genetic disease. The award<br />
recognizes her seminal work which extends back to<br />
the early days <strong>of</strong> medical and human genetics and<br />
includes more than 500 peer-reviewed publications.<br />
Among Francke’s exemplary achievements are<br />
advances in understanding Charcot-Marie-Tooth,<br />
Marfan, Rett, Prader-Willi, Williams, and Wiskott-<br />
Aldrich syndromes, which have had a major impact<br />
on the studying and treatment <strong>of</strong> these disorders.<br />
In essence, her lifetime <strong>of</strong> scientific discoveries and<br />
numerous contributions to the field over the decades<br />
have been far-reaching and have made a significant<br />
impact on advancing both basic and clinical human<br />
genetics. Dr. Francke has been one <strong>of</strong> the most<br />
respected scientists in the genetics community and is<br />
a stellar example <strong>of</strong> a tireless scientist, always seeking<br />
answers to important questions that interested her.<br />
Past Recipients: John Opitz (2011); Jurg Ott (2010);<br />
Hunt Willard (2009); Haig Kazazian (2008); Arthur<br />
Beaudet (2007); Dorothy Warburton (2006); Francis<br />
Collins (2005); Louis Kunkel (2004); David Weatherall<br />
(2003); Albert de La Chapelle (2002); Charles Epstein<br />
(2001); Stephen Warren (1999); Bert Vogelstein<br />
(1998); Philip Leder (1997); Robert Elston (1996);<br />
Kurt Hirschhorn (1995); Douglas Wallace (1994);<br />
Antonio Cao & Michael Kaback (1993); Alec Jeffreys<br />
(1992); Janet Rowley & Alfred Knudson (1991); Kary<br />
Mullis (1990); David Bostein & Ray White (1989); T.<br />
Caspersson (1988); L. L. Cavalli-Sforza (1987); Mary<br />
Lyon (1986); Joseph Goldstein & Michael Brown<br />
(1985); Y. W. Kan (1984); Frank Ruddle (1983);<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Friday, November 9<br />
11:15 AM–11:45 AM (SESSION 57, continued)<br />
Elizabeth Neufield (1982); Patricia Jacobs (1981);<br />
Walter Bodmer (1980); F. Clarke Fraser (1979);<br />
Charles Scriver (1978); Victor McKusick (1977);<br />
Philip Levin and A.S. Wiener (1975); Curt Stern (1974);<br />
Barton Childs (1973); Arno Motulsky (1970);<br />
Jerome Lejeune (1969); Harry Harris (1968);<br />
Vernon Ingram (1967); James Neel (1965);<br />
Newton Morton (1962).<br />
INVITED AND PLATFORM SESSIONS 109<br />
Friday, November 9<br />
11:45 AM–12:45 PM<br />
SESSION 58 – <strong>ASHG</strong> Membership and Business<br />
Meeting<br />
Hall D, Lower Level North, Moscone Center<br />
Reports highlighting current <strong>Society</strong> business will be<br />
presented. This is an opportunity for members to learn<br />
about recent <strong>ASHG</strong> activities and to provide<br />
suggestions to leaders. There will be a moment <strong>of</strong><br />
silence for those members and colleagues we have<br />
lost in <strong>2012</strong>. Discussion from the floor is encouraged.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
110 INVITED AND PLATFORM SESSIONS<br />
Friday, November 9<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67)<br />
SESSION 59 – Genome Structure and Variation<br />
Hall D, Lower Level North, Moscone Center<br />
Moderators: John Moran, Univ. <strong>of</strong> Michigan Med. Sch.;<br />
Ryan Mills, Univ. <strong>of</strong> Michigan Med. Sch.<br />
331/4:30 A map <strong>of</strong> human genetic variation: Update<br />
from the 1000 Genomes Project. F. Yu, 1000<br />
Genomes Consortium.<br />
332/4:45 Towards a whole genome map <strong>of</strong> heritable<br />
copy number variation. S. Aradhya, L. Matyakhina,<br />
D. Pineda Alvarez, D. Riethmaier, A. Fuller, G. Richard,<br />
J. Meck.<br />
333/5:00 Charting the population-scale landscape<br />
<strong>of</strong> short tandem repeat variation in humans.<br />
M . Gymrek, J. Chen, C. O’Dushlaine, M. Daly,<br />
D. Reich, Y. Erlich.<br />
334/5:15 Whole-genome sequencing analysis <strong>of</strong><br />
iPSC lines uncovers lineage-manifested CNVs.<br />
A . E. Urban, A. Abyzov, D. Palejev, L. Rosenberg-<br />
Belmaker, Y. Zhang, J. Mariani, L. Tomasini,<br />
A. Ferrandino, A. Szekely, M. Wilson, M. Haney,<br />
E. Grigorenko, A. Huttner, S. Weissman, M. Gerstein,<br />
F. Vaccarino.<br />
335/5:30 SNP markers identify areas with restricted<br />
recombination suggesting structural variation<br />
across the human genome is widespread.<br />
P. G. Hysi, B. Tamraz, A. Nag, C. Venturini, J. S.<br />
Rahi, T. D. Spector, C. J. Hammond.<br />
336/5:45 Mapping the L1 interactome reveals RISCassociated<br />
helicase MOV10 as a potent inhibitor<br />
<strong>of</strong> retrotransposition. J. Goodier, L. Cheung, H. H.<br />
Kazazian.<br />
337/6:00 FoSTeS/MMBIR replicative repair<br />
mechanisms are error prone: High frequency <strong>of</strong><br />
nucleotide variation at the breakpoint junctions.<br />
C. M. B. Carvalho, M. B. Ramocki, D. Pehlivan,<br />
P. Fang, L. M. Franco, J. W. Belmont, P. J. Hastings,<br />
J. R. Lupski.<br />
338/6:15 Telomere position effect in patients with<br />
subtelomeric deletions. J. Gerfen, M. K. Rudd,<br />
H. Mason-Suares.<br />
339/6:30 De novo CNV formation in mouse<br />
embryonic stem cells occurs in the absence <strong>of</strong><br />
Xrcc4-dependent nonhomologous end joining.<br />
M . F. Arlt, S. Rajendran, S. R. Birkeland,<br />
K. M. McSweeney, T. E. Wilson, T. W. Glover.<br />
Friday, November 9<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67)<br />
SESSION 60 – Advances in Neurodegenerative Disease<br />
Gateway Ballroom 103, Lower Level South, Moscone<br />
Center<br />
Moderators: Jeff Vance, Univ. <strong>of</strong> Miami;<br />
Tricia Thornton-Wells, Vanderbilt Univ.<br />
340/4:30 A genome-wide association study for<br />
cerebrospinal fluid tau and amyloid beta 42 identify<br />
new candidate variants implicated in Alzheimer’s<br />
disease. J. S. K. Kauwe, C. Cruchaga, O. Harari, K.<br />
Mayo, S. Bertelsen, M. Bailey, D. McKean, P. G. Ridge,<br />
T. J. Maxwell, E. Peskind, D. Galasko, A. M. Goate,<br />
ADGC, ADNI, GERAD.<br />
341/4:45 Analysis <strong>of</strong> whole transcriptome specific<br />
to the temporal pole <strong>of</strong> late-onset Alzheimer’s<br />
disease. C. E. Humphries, M. A. Kohli, P. W.<br />
Whitehead, W. F. Hulme, L. Nathanson, D. C. Mash,<br />
M. A. Pericak-Vance, J. R. Gilbert.<br />
342/5:00 Rare variants from high-density exome<br />
genotyping in late-onset Alzheimer’s disease:<br />
Update from Alzheimer’s Disease <strong>Genetics</strong><br />
Consortium. L.-S. Wang, A. C. Naj, C. Cruchaga,<br />
S. Mukherjee, C.-F. Lin, O. Valladares, L. B. Cantwell,<br />
R. Graham, T. Behrens, P. K. Crane, A. M. Goate,<br />
M. A. Pericak-Vance, G. D. Schellenberg, Alzheimer’s<br />
Disease <strong>Genetics</strong> Consortium.<br />
343/5:15 Common variants in ABCA7 and GRIN3B,<br />
HMHA1 and SBNO2, are associated with late-onset<br />
Alzheimer’s disease in African <strong>American</strong>s. C. Reitz,<br />
G. Jun, J. Buros, B. Vardarajan, L.-S. Wang, J. D.<br />
Buxbaum, E. B. Larson, N. Graff-Radford, D. Evans,<br />
N. Ertekin-Taner, M. Logue, C. T. Baldwin, R. C. Green,<br />
L. L. Barnes, L. B. Cantwell, M. D. Fallin, J. Manly,<br />
K. L. Lunetta, M. I. Kamboh, D. A. Bennett, K. Hall,<br />
A. M. Goate, G. S. Byrd, W. A. Kukull, T. M. Foroud,<br />
J. L. Haines, M. A. Pericak-Vance, L. A. Farrer, G.<br />
Schellenberg, R. Mayeux, ADGC Consortium.<br />
344/5:30 Genome-wide association analyses <strong>of</strong><br />
onset age in late-onset Alzheimer disease<br />
demonstrate no strong effect outside <strong>of</strong> the APOE<br />
region. A. C. Naj, Y. S. Park, R. Rajbhandary, K. L.<br />
Hamilton, G. W. Beecham, E. R. Martin, R. Mayeux,<br />
J. L. Haines, L. A. Farrer, G. D. Schellenberg,<br />
M. A. Pericak-Vance, Alzheimer’s Disease <strong>Genetics</strong><br />
Consortium.<br />
345/5:45 Identification by exome analysis <strong>of</strong> the<br />
molecular bases <strong>of</strong> familial idiopathic basal ganglia<br />
calcification not related to SLC20A2 mutation.<br />
G. Nicolas, C. Pottier, D. Maltête, S. Coutant,<br />
A. Rovelet- Lecrux, S. Legallic, Y. Vaschalde,<br />
L. Guyant-Maréchal, J. Augustin, O. Martinaud,<br />
L. Defebvre, P. Krystkowiak, J. Pariente, I. Le Ber,<br />
T. Frebourg, D. Hannequin, D. Campion.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Friday, November 9<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67) (SESSION 60, continued)<br />
346/6:00 Mutations in DNAJ cause autosomal<br />
dominant Parkinson disease in the Mennonite<br />
community. C. Vilarino-Guell, A. Rajput, S. Appel-<br />
Cresswell, B. Shah, I. Yu, C. Thompson, C. Szu Tu, J.<br />
Trinh, M. Encarnacion, D. W. Dickson, A. J. Stoessl, M.<br />
L. Rajput, M. J. Farrer, A. H. Rajput.<br />
347/6:15 C9ORF72 repeat expansion is a risk factor<br />
for Parkinson disease. K. Nuytemans, G. Bademci,<br />
M. M. Kohli, G. Beecham, V. Inchausti, A. Dressen,<br />
L. Wang, J. I. Young, F. Nahab, C. Singer, E. R. Martin,<br />
J. R. Gilbert, M. Benatar, J. L. Haines, W. K. Scott,<br />
S. Zuchner, M. A. Pericak-Vance, J. M. Vance.<br />
348/6:30 Age-dependent penetrance <strong>of</strong> ALS+/-FTD<br />
due to C9orf72 hexanucleotide intronic repeat<br />
expansion mutations. B. N. Smith, S. Topp,<br />
J. Barnwell, A. Al-Chalabi, J. Kirby, P. J. Shaw, H. Pall,<br />
K. E. Morrison, V. de Jong, F. Bass, C. E. Shaw,<br />
C. M. Lewis.<br />
INVITED AND PLATFORM SESSIONS 111<br />
Friday, November 9<br />
4:30 PM–6:45PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67)<br />
SESSION 61 – Missing Heritability, Interactions and<br />
Sequencing<br />
Room 135, Lower Level North, Moscone Center<br />
Moderators: Dana Crawford, Vanderbilt Univ.;<br />
Alkes Price, Harvard Sch. <strong>of</strong> Publ. Hlth.<br />
349/4:30 Empirical and theoretical studies on<br />
genetic variance <strong>of</strong> rare variants for complex traits<br />
using whole genome sequencing in the CHARGE<br />
Consortium. C. Zhu, A. Morrison, J. Reid, C. J.<br />
O’Donnell, B. Psaty, L. A. Cupples, R. Gibbs, E.<br />
Boerwinkle, X. Liu.<br />
350/4:45 Leveraging admixture analysis to resolve<br />
missing and cross-population heritability in GWAS.<br />
N. Zaitlen, A. Gusev, B. Pasaniuc, G. Bhatia, S.<br />
Pollack, A. Tandon, E. Stahl, R. Do, B. Vilhjalmsson, E.<br />
Akylbekova, A. Cupples, M. Fornage, L. Kao, L. Lange,<br />
S. Musani, G. Papanicolaou, J. Rotter, I. Ruczinksi,<br />
D. Siscovick, X. Zhu, S. McCarroll, G. Lettre,<br />
J. Hirschhorn, N. Patterson, D. Reich, J. Wilson,<br />
S. Kathiresan, A. Price, CARe Analysis Core.<br />
351/5:00 Applying a quantitative genetics test <strong>of</strong><br />
evolutionary neutrality to finger ridge-count, a<br />
classical model trait in humans. S. E. Medland,<br />
P. M. Visscher, G. W. Montgomery, D. M. Evans,<br />
N. G. Martin.<br />
352/5:15 Does common variation contribute to the<br />
shared genetic basis for schizophrenia and autism?<br />
P. H. Lee, S. Ripke, S. Santangelo, M. Daly, Psychiatric<br />
GWAS Consortium - Schizophrenia & Autism Working<br />
Group.<br />
353/5:30 Ultrafast genome-wide interaction scan<br />
on case-control data implicates epistatic calcium<br />
channels in bipolar disorder. S. Prabhu, I. Pe’er.<br />
354/5:45 Computational challenges in the analysis<br />
<strong>of</strong> low coverage sequence data in thousands <strong>of</strong><br />
individuals. Y. Luo, L. Jostins, C. A. Anderson, J. C.<br />
Barrett, UK10K, UKIBDGC.<br />
355/6:00 Sparse sequencing <strong>of</strong> 6,000 cases and<br />
6,000 controls from Chinese women for genomewide<br />
association study <strong>of</strong> major depression.<br />
X. Gan, R. Mott, J. Flint, CONVERGE Consortium.<br />
356/6:15 Deep targeted sequencing <strong>of</strong> 12 breast<br />
cancer loci in 4,700 women across four different<br />
ethnicities. P. Kraft, S. Lindstrom, B. Chapman,<br />
G. Chen, C. Chen, O. H<strong>of</strong>man, D. Mirel, C. Haiman.<br />
357/6:30 Population stratification <strong>of</strong> human<br />
disease-associated SNPs, and their relevance to<br />
human disease networks. S. M. Raj, G. E. H<strong>of</strong>fman,<br />
A. G. Clark.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
112 INVITED AND PLATFORM SESSIONS<br />
Friday, November 9<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67)<br />
SESSION 62 – Exome Sequencing Uncovers Etiology <strong>of</strong><br />
Mendelian Disease<br />
Room 134, Lower Level North, Moscone Center<br />
Moderators: Cheryl Maslen, Oregon Hlth. & Sci. Univ.;<br />
Jun Z. Li, Univ <strong>of</strong> Michigan<br />
358/4:30 Loss <strong>of</strong> function mutations in known<br />
human disease genes in 572 exomes. J. Johnston,<br />
K. Lewis, D. Ng, S. Gonsalves, J. Mullikin, L. G.<br />
Biesecker.<br />
359/4:45 The problem <strong>of</strong> multiple plausible<br />
molecular diagnoses in next-generation<br />
sequencing data: The NIH Undiagnosed Diseases<br />
<strong>Program</strong> experience. D. Adams, C. Boerkoel,<br />
K. Fuentes- Fajardo, P. Cherukuri, M. Sincan, C. Toro,<br />
C. Tifft, W. Gahl, T. Markello.<br />
360/5:00 Exome sequencing to identify the cause <strong>of</strong><br />
Mendelian diseases. J. Lupski, C. Gonzaga-<br />
Jauregui, W. Wiszniewski, D. Pehlivan, E. Karaca,<br />
A. Stray- Pedersen, S. Jhangiani, J. Reid, D. Muzny,<br />
R. A. Gibbs, Baylor-Hopkins Center for Mendelian<br />
Genomics.<br />
361/5:15 Domain-specific mutations in CDKN1C<br />
cause two disorders with opposing phenotypes:<br />
The undergrowth disorder IMAGe syndrome or<br />
the overgrowth disorder Beckwith-Wiedemann<br />
syndrome. V. Arboleda, H. Lee, R. Parnaik, A.<br />
Fleming, A. Banerjee, B. Ferraz-de-Souza, E. Delot,<br />
I. A. Rodriguez-Fernandez, D. Braslavsky, I. Bergadá,<br />
E. C. Dell’Angelica, S. F. Nelson, J. A. Martinez-<br />
Agosto, J. C. Achermann, E. Vilain.<br />
362/5:30 SCID newborn screening and exome<br />
sequencing identifies ataxia telangiectasia and low<br />
T cells early in life. J. M. Mallott, A. Kwan, J. Church,<br />
D. Gonzalez, S. Rana, U. Sunderam, R. Srinivasan,<br />
S. E. Brenner, L. F. Tang, F. Lorey, J. Puck.<br />
363/5:45 Identification <strong>of</strong> a new melanocyte<br />
differentiation gene underlying human autosomal<br />
recessive albinism. K. Grønskov, C. M. Dooley,<br />
E. Østergaard, R. N. Kelsh, L. Hansen, M. P. Levesque,<br />
K. Vilhelmsen, D. Stemple, T. Rosenberg.<br />
364/6:00 Exome sequencing results in 230 patients<br />
with severe developmental disorders in the DDD<br />
project. M. van Kogelenberg, K. Morley, T. Fitzgerald,<br />
S. Gerety, A. Tivey, S. Al-Turki, S. Clayton, C. Wright, J.<br />
Barrett, H. Firth, D. FitzPatrick, N. Carter, M. Hurles on<br />
behalf <strong>of</strong> DDD Project.<br />
365/6:15 Genetic etiology <strong>of</strong> isolated congenital<br />
asplenia. A. Bolze, L. Abel, A. Puel, N. Trede,<br />
L. Selleri, J.-L. Casanova.<br />
366/6:30 Whole genome sequencing in two<br />
brothers with heterotaxy reveals BCL9L as a<br />
novel gene associated with autosomal recessive<br />
heterotaxy (HTX6). C. J. Saunders, N. A. Miller,<br />
S. E. Soden, E. Farrow, D. L. Dinwiddie, N. P. Safina,<br />
S. Humphray, P. Saffrey, Z. Kingsbury, J. C. Weir,<br />
J. Betley, R. J. Grocock, J. E. Petrikin, K. P. Hall,<br />
S. F. Kingsmore.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Friday, November 9<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67)<br />
SESSION 63 – Transcriptional Regulation, Variation and<br />
Complexity<br />
Gateway Ballroom 104, Lower Level South, Moscone<br />
Center<br />
Moderators: Barbara Stranger, Brigham and Women’s<br />
Hosp., Harvard Med. Sch; Ross Hardison, Penn State<br />
367/4:30 The complete GENCODE human<br />
annotation: New insights into the functionality <strong>of</strong><br />
transcriptional complexity. J. M. Mudge, A. Frankish,<br />
GENCODE Consortium, T. Hubbard, J. L. Harrow.<br />
368/4:45 Genetic analyses in the Genotype-Tissue<br />
Expression (GTEx) project. K. Ardlie, N. Cox, D.<br />
DeLuca, E. Dermitzakis, B. Foster, G. Getz, R. Guigo,<br />
S. Jewell, D. Koller, J. Liu, J. Londsdale, D. Mash,<br />
M. McCarthy, M. Moser, D. L. Nicolae, A. Nobel, J.<br />
Pritchard, I. Rusyn, J. Thomas, W. Winckler, F. Wright,<br />
J. Zhu, GTEx Consortium.<br />
369/5:00 Characterizing the genetic basis <strong>of</strong><br />
transcriptome diversity in a large RNA sequencing<br />
study. A. Battle, S. Mostafavi, X. Zhu,<br />
S. B. Montgomery, J. B. Potash, M. M. Weissman,<br />
C. Haudenschild, C. McCormick, R. Mei, A. E. Urban,<br />
D. F. Levinson, D. Koller.<br />
370/5:15 Genetic and molecular basis <strong>of</strong> RNA-DNA<br />
sequence differences in humans. V. G. Cheung,<br />
A. Bruzel, L. McDaniel, A. L. Richards, J. M. Toung,<br />
I. X. Wang.<br />
371/5:30 Characterizing gene expression variation<br />
across seven diverse human populations.<br />
A. R. Martin, H. A. Costa, J. M. Kidd, B. M. Henn,<br />
M. C. Yee, F. Grubert, S. B. Montgomery, H. M. Cann,<br />
M. P. Snyder, C. D. Bustamante.<br />
372/5:45 Comparative eQTL analyses within and<br />
between seven tissue types suggest mechanisms<br />
underlying cell type specificity <strong>of</strong> eQTLs.<br />
B. Engelhardt, C. Brown.<br />
373/6:00 Identification <strong>of</strong> novel genetic<br />
determinants <strong>of</strong> induced innate immune responses<br />
and context specific eQTL in human primary<br />
monocytes. B. P. Fairfax, S. Makino, J. C. Knight.<br />
374/6:15 Gene-level and exon-level expression QTL<br />
signals in the UK Brain Expression Consortium<br />
dataset. M. E. Weale, A. Ramasamy, D. Trabzuni,<br />
R. Walker, C. Smith, M. Ryten, J. Hardy, UK Brain<br />
Expression Consortium.<br />
375/6:30 First complete haplotype <strong>of</strong> the human<br />
immunoglobulin heavy chain locus from a single<br />
individual and characterization <strong>of</strong> novel allelic and<br />
structural variation. K. Meltz Steinberg,<br />
C. T. Watson, J. Huddleston, P. H. Sudmant,<br />
R. L. Warren, M. Malig, J. Schein, A. J. Willsey,<br />
J. B. Joy, J. K. Scott, T. Graves, R. K. Wilson,<br />
R. A. Holt, F. Breden, E. E. Eichler.<br />
INVITED AND PLATFORM SESSIONS 113<br />
Friday, November 9<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67)<br />
SESSION 64 – Epigenetics<br />
Room 124, Lower Level North, Moscone Center<br />
Moderators: Bernd Wollnik, Univ <strong>of</strong> Cologne, Germany;<br />
Beth A. Sullivan, Duke Univ.<br />
376/4:30 The epitranscriptome reveals novel<br />
mechanisms <strong>of</strong> RNA regulation and spatiotemporal<br />
dynamics. C. E. Mason, K. Meyer, Y. Saletore, P.<br />
Zumbo, O. Elemento, S. Jaffrey.<br />
377/4:45 Epigenome-wide pr<strong>of</strong>iling <strong>of</strong> circulating<br />
DNA in colorectal cancer. R. Cortese, Y. Li, A. Kwan,<br />
B. Zanke, Z. Zhang, A. Petronis.<br />
378/5:00 Alterations in genomically imprinted<br />
miRNA and snoRNA clusters in a mouse model <strong>of</strong><br />
fetal alcohol spectrum disorders. B. I. Laufer,<br />
K. Mantha, M. L. Kleiber, E. J. Diehl, S. M. F. Addison,<br />
S. M. Singh.<br />
379/5:15 KDM6A escapes X-inactivation and<br />
controls expression <strong>of</strong> reproduction-related<br />
homeobox genes in female ES cells and ovary:<br />
Deficiency may explain embryonic and ovarian<br />
failure in Turner. C. M. Disteche, J. B. Berletch,<br />
X. Deng, D. Nguyen.<br />
380/5:30 Genome-wide scan <strong>of</strong> DNA methylation<br />
in the aging brain and its relation to Alzheimer’s<br />
disease. P. L. De Jager, G. Srivastava, M. L. Eaton, L.<br />
E. Chibnik, B. Keenan, N. Taner, A. Myers,<br />
B. Bernstein, A. Meissner, M. Kellis, D. A. Bennett.<br />
381/5:45 RNA-mediated transcriptional silencing in<br />
Friedreich ataxia. Y. K. Chutake, A. M. Castro,<br />
S. I. Bidichandani.<br />
382/6:00 P53 regulates 5-hydroxymethylcytosinemediated<br />
epigenetic landscape through GADD45A.<br />
Y. Li, Y. Zhu, K. Szulwach, L. Lin, C. Street, H. Wu,<br />
D. Chen, P. Jin.<br />
383/6:15 Maps <strong>of</strong> open chromatin highlight cell<br />
type-specific patterns <strong>of</strong> regulatory sequence<br />
variation at hematological trait loci. C. A. Albers,<br />
D. S. Paul, A. Rendon, K. Voss, J. Stephens, P. van der<br />
Harst, J. C. Chambers, N. Soranzo, W. H. Ouwehand,<br />
P. Deloukas, HaemGen Consortium.<br />
384/6:30 Functional epialleles at an endogenous<br />
human centromere. B. A. Sullivan, K. A. Maloney,<br />
L. L. Sullivan, E. D. Strome, J. Matheny.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
114 INVITED AND PLATFORM SESSIONS<br />
Friday, November 9<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67)<br />
SESSION 65 – Advances in Ocular <strong>Genetics</strong><br />
Room 132, Lower Level North, Moscone Center<br />
Moderators: Erica Davis, Duke Univ. Med. Ctr; Arupa<br />
Ganguly, Univ. <strong>of</strong> Pennsylvania<br />
385/4:30 Rare insertion polymorphisms identified<br />
by exome sequencing may be associated with agerelated<br />
macular degeneration. L. Farrer, J. Kozubek,<br />
M. Schu, J. Farrell, M. Morrison, K. Mayne, D. Morgan,<br />
R. Robinson, A. Swaroop, D. Schaumberg, K.-H. Park,<br />
E. E. Tsironi, G. Silvestri, I.-K.. Kim, R. Chen, C. Huff,<br />
G. Jun, M. deAngelis.<br />
386/4:45 The role <strong>of</strong> SIX6 in primary open-angle<br />
glaucoma. M. Ulmer, B. Whigham, D. Parker, X. Qin,<br />
N. Katsanis, Y. Liu, A. Ashley-Koch, R. R. Allingham,<br />
M. Hauser, NEIGHBOR Consortium Investigators.<br />
387/5:00 Topical ocular sodium 4-phenylbutyrate<br />
rescues glaucoma in a mouse model <strong>of</strong> primary<br />
open angle glaucoma. G. S. Zode, K. E. Bugge,<br />
E. M. Stone, V. C. Sheffield.<br />
388/5:15 Meta-analysis <strong>of</strong> GWAS on corneal<br />
thickness identifies a total <strong>of</strong> 27 associated loci,<br />
including six risk loci for eye disease keratoconus.<br />
S. Macgregor on behalf <strong>of</strong> CCT Consortium.<br />
389/5:30 Mouse models reveal an essential role<br />
for RERE in eye development. B. Kim, Z. Yu, O.<br />
Shchelochkov, M. Justice, B. Lee, D. Scott.<br />
390/5:45 Mutations in the nuclear NAD synthesizing<br />
enzyme NMNAT1 cause autosomal recessive Leber<br />
congenital amaurosis with early-onset severe<br />
macular atrophy and optic atrophy. J. Rozet,<br />
I. Perrault, S. Hanein, X. Zanlonghi, V. Serre,<br />
M. Nicouleau, S. Defoort-Delhemmes, N. Delphin,<br />
L. Fares-Taie, S. Gerber, O. Xerri, C. Edelson,<br />
A. Goldenberg, A. Duncombe, G. Le Meur, C. Hamel,<br />
E. Silva, P. Nitschke, P. Calvas, A. Munnich, O. Roche,<br />
H. Dollfus, J. Kaplan.<br />
391/6:00 RNA-DNA differences in miRNA<br />
transcriptome <strong>of</strong> retina and retinoblastoma.<br />
A. Ganguly, J. Leipzig, J. Richards, J. Purrazzella,<br />
T. Ganguly.<br />
392/6:15 Knock-in <strong>of</strong> human KIAA0649P in to the<br />
mouse Rb1 locus: Modeling the mechanism <strong>of</strong><br />
imprinted RB1 expression in humans. L. Steenpass,<br />
D. Kanber, M. Hiber, K. Buiting, D. Lohmann,<br />
B. Horsthemke.<br />
393/6:30 Gene therapy provides long-term<br />
visual function in a pre-clinical model <strong>of</strong> retinitis<br />
pigmentosa. K. J. Wert, R. J. Davis, S. H. Tsang.<br />
Friday, November 9<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67)<br />
SESSION 66 – Cancer <strong>Genetics</strong>: Somatic Variants<br />
Room 130, Lower Level North, Moscone Center<br />
Moderators: Charis Eng, Cleveland Clinic; Jennelle<br />
Hodge, Mayo Clin.<br />
394/4:30 The genomic landscape <strong>of</strong> childhood pre-<br />
B acute lymphoblastic leukemia. J. Spinella,<br />
R. Vidal, J. Healy, V. Saillour, E. Bareke, C. Richer,<br />
S. Busche, B. Ge, T. Pastinen, D. Sinnett.<br />
395/4:45 Genomic analysis <strong>of</strong> serial chronic<br />
lymphocytic leukemia samples suggests that<br />
epigenetic changes, rather than clonal evolution,<br />
drive progression <strong>of</strong> disease. E. N. Smith,<br />
C. DeBoever, L. Rassenti, E. Ghia, S. Rozenzhak,<br />
P. Shepard, H. Alakus, O. Harismendy, C. Barrett,<br />
T. J. Kipps, K. A. Frazer.<br />
396/5:00 Whole-genome sequencing <strong>of</strong> liver<br />
cancers identifies etiological influences on<br />
mutation patterns and recurrent mutations in<br />
chromatin regulators. A. Fujimoto, Y. Totoki, T. Abe,<br />
K. A. Boroevich, F. Hosoda, H. H. Nguyen, M. Aoki,<br />
N. Hosono, M. Kubo, F. Miya, Y. Arai, H. Takahashi,<br />
T. Shirakihara, M. Nagasaki, T. Shibuya, K. Nakano,<br />
K. Watanabe-Makino, H. Tanaka, H. Nakamura, K.<br />
Chayama, N. Kamatani, S. Miyano, H. Nakagama,<br />
Y. Nakamura, T. Tsunoda, T. Shibata, H. Nakagawa.<br />
397/5:15 Breast cancer evolution revealed by deep<br />
whole-genome sequencing <strong>of</strong> early neoplasias and<br />
their concurrent carcinomas. A. Sidow, D. Kashef-<br />
Haghighi, D. Newburger, Z. Weng, T. Sweeney,<br />
S. Batzoglou, R. West.<br />
398/5:30 Intra-tumor genetic heterogeneity in<br />
cancer tissues: The key to assessing its<br />
significance is the distribution pr<strong>of</strong>ile <strong>of</strong> gene<br />
variants not just their presence in tumors.<br />
B. Gottlieb, C. Alvarado, C. Wang, B. Gharizadeh,<br />
F. Babrzadeh, L. K. Britel, M. Trifiro.<br />
399/5:45 Next generation sequencing and<br />
chromosomal microarray analysis provide novel<br />
insight into the genomic landscape <strong>of</strong> metastatic<br />
breast cancer. M. Li, Y. Wen, E. Fang, Y. Li, P. Chen,<br />
G. Douglas, C. Carmack, K. Osborne.<br />
400/6:00 The 3D topographic mapping <strong>of</strong> genetic<br />
variations in treatment <strong>of</strong> naïve advanced ovarian<br />
cancer.E. Cuppen, M. de Pagter, M. Hoogstraat,<br />
G. Cirkel, J. Kreeftmeijer, C. Lee, E. Levandowsky,<br />
T. Guy, K. Duran, R. `t Slot, T. Jonges, S. van Lieshout,<br />
M. Lolkema, R. Zweemer, M. Koudijs, I. Nijman,<br />
E. Voest, T. Harkins, W. Kloosterman.<br />
401/6:15 Transcriptome sequence analysis <strong>of</strong><br />
human colorectal cancer samples to reveal<br />
functional attributes. H. Ongen, T. F. Ornt<strong>of</strong>t,<br />
B. Oster, L. Romano, A. Planchon, C. L. Andersen,<br />
E. T. Dermitzakis.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Friday, November 9<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67) (SESSION 66, continued)<br />
402/6:30 Regulatory regions are somatic mutation<br />
cold spots in cancer genomes. S. Sunyaev, P. Polak,<br />
M. S. Lawrence, R. E. Thurman, N. Stoletzki, P.<br />
Stojanov, E. Rynes, L. A. Garraway, S. Mirkin, G. Getz,<br />
J. A. Stamatoyannopoulos.<br />
INVITED AND PLATFORM SESSIONS 115<br />
Friday, November 9<br />
4:30 PM–6:45 PM<br />
Concurrent Platform (abstract-driven)<br />
Session E (59-67)<br />
SESSION 67 – Developmental Insights into <strong>Human</strong><br />
Malformations<br />
Room 123, Lower Level North, Moscone Center<br />
Moderators: Lucy Osborne, Univ. <strong>of</strong> Toronto, Canada;<br />
Rhona Schreck, Cedars-Sinai Med Ctr.<br />
403/4:30 TECTONIC3 mutations cause<br />
or<strong>of</strong>aciodigital syndrome type IV (Mohr-Majewski).<br />
S. Thomas, M. Legendre, S. Saunier, B. Bessières,<br />
C. Alby, M. Bonnière, A. Toutain, L. Loeuillet, K.<br />
Szymanska, F. Jossic, D. Gaillard, M. Tahar Yacoubi,<br />
S. Mougou-Zerelli, A. David, M.-A. Barthez, Y. Ville, C.<br />
Bole-Feysot, P. Nitschke, A. Munnich, C. A. Johnson,<br />
F. Encha-Razavi, V. Cormier-Daire, C. Thauvin-Robinet,<br />
M. Vekemans, T. Attié-Bitach.<br />
404/4:45 Abnormal development <strong>of</strong> NG2+PDGFR � +<br />
neural progenitor cells causes neonatal<br />
hydrocephalus in a ciliopathy mouse model. C . S.<br />
Carter, T. W. Vogel, Q. Zhang, T. O. Moninger, D. R.<br />
Thedens, K. M. Keppler-Noreuil, D. Y. Nishimura, C. C.<br />
Searby, K. Bugge, V. C. Sheffield.<br />
405/5:00 Malformation <strong>of</strong> the brain cortex, as the<br />
only expression <strong>of</strong> a ciliopathy, results from<br />
mutation in human Rotatin. G. M. S. Mancini, F. W.<br />
Verheijen.<br />
406/5:15 Whole exome resequencing identifies<br />
mutations in LRRC6 as a novel single-gene cause<br />
<strong>of</strong> primary cliary dyskinesia. M. Chaki, H. Y. Gee, E.<br />
A. Otto, K. Diaz, T. W. Hurd, J. Halbritter, S. J. Allen,<br />
M. B. Zariwala, M. R. Knowles, F. Hildebrandt.<br />
407/5:30 Temporally and spatially resolved<br />
catalogues <strong>of</strong> in vivo forebrain enhancers. A. S.<br />
Nord, L. Taher, J. Akiyama, M. J. Blow, A. Holt, R.<br />
Hosseini, S. Phouanenavong, I. Plajzer-Frick, M.<br />
Shoukry, V. Afzal, E. M. Rubin, I. Ovcharenko, J. L. R.<br />
Rubenstein, L. A. Pennacchio, A. Visel.<br />
408/5:45 SRY regulation <strong>of</strong> the RET gene suggests<br />
a potential role <strong>of</strong> the Y-chromosome gene in<br />
sexual dimorphism in Hirschsprung disease. Y. Li,<br />
Z. L. Tabatabai, M.-M. Garcia-Barceló, P. K. H. Tam,<br />
Y.-F. C. Lau.<br />
409/6:00 MAP3K1 mutations in 46 XY DGDs alter<br />
crosstalk in downstream signal transduction<br />
pathways to cause abnormal human gonadal<br />
development. J. Loke, A. Pearlman, H. Ostrer.<br />
410/6:15 S<strong>of</strong>t tissue aspects <strong>of</strong> the Williams-Beuren<br />
syndrome facial phenotype can be attributed to<br />
GTF2IRD1. S. J. Palmer, C. P. Canales, P. Carmona-<br />
Mora, P. Kaur, P. W. Gunning, E. C. Hardeman.<br />
411/6:30 Notch gain <strong>of</strong> function inhibits<br />
chondrocyte differentiation via Rbpj-dependent<br />
suppression. S. Chen, J. Tao, Y. Bae, M. Jiang, T.<br />
Bertin, Y. Chen, T. Yang, B. Lee.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
116 INVITED AND PLATFORM SESSIONS<br />
Saturday, November 10<br />
8:00 AM–8:20 AM<br />
SESSION 68 – <strong>ASHG</strong> Award for Excellence in <strong>Human</strong><br />
<strong>Genetics</strong> Education<br />
Hall D, Lower Level North, Moscone Center<br />
The <strong>ASHG</strong> Award for Excellence in <strong>Human</strong> <strong>Genetics</strong><br />
Education was established to recognize those who<br />
have made significant contributions <strong>of</strong> exceptional<br />
quality and great importance to human genetics<br />
education.<br />
Introduction:<br />
Kay Davies, Univ. <strong>of</strong> Oxford<br />
Recipient:<br />
Alan E. H. Emery, MD, PhD, DSc<br />
Em. Pr<strong>of</strong>. <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>,<br />
Univ. <strong>of</strong> Edinburgh; Hon. Fellow,<br />
GreenTempleton Col.,<br />
Univ. <strong>of</strong> Oxford<br />
Pr<strong>of</strong>essor Emery is being recognized for his<br />
distinguished work in education through lecturing,<br />
mentoring, establishment <strong>of</strong> programs, and for his<br />
writings, which include over 400 peer-reviewed articles<br />
and 26 books on all aspects <strong>of</strong> human and medical<br />
genetics (as well as poetry and the relationship<br />
between Medicine and Art). Indeed, Pr<strong>of</strong>essor Emery<br />
has been one <strong>of</strong> the most prolific authors <strong>of</strong> important<br />
genetics texts in the world.<br />
His books have covered all aspects <strong>of</strong> medical<br />
genetics, prenatal diagnosis, genetic counseling,<br />
statistics, molecular genetics, and historical<br />
perspectives. His texts including Elements <strong>of</strong> Medical<br />
<strong>Genetics</strong> (general), Methodology in Medical <strong>Genetics</strong><br />
(statistics), Introduction to Recombinant DNA<br />
(molecular genetics) and Principles and Practice <strong>of</strong><br />
Medical <strong>Genetics</strong> with David Rimoin (medical), remain<br />
among the most important texts in their fields. One <strong>of</strong><br />
his textbooks has been republished in twelve editions<br />
and translated into seven languages. Pr<strong>of</strong>essor Emery<br />
was the first to describe a form <strong>of</strong> muscular dystrophy<br />
now referred to as Emery-Dreifuss Muscular Dystrophy<br />
(EDMD or EMD) and the defective protein Emerin is<br />
named after him.<br />
Among his many accolades, Pr<strong>of</strong>essor Emery is a<br />
fellow or honorary fellow in ten different societies,<br />
including the Royal <strong>Society</strong> <strong>of</strong> Medicine and the Royal<br />
<strong>Society</strong> <strong>of</strong> Arts. Emery has also received many<br />
awards, including the Lifetime Achievement Award<br />
from the World Federation <strong>of</strong> Neurology and the<br />
Cockcr<strong>of</strong>t Medal from the University <strong>of</strong> Manchester,<br />
plus several honorary degrees. For many in the field <strong>of</strong><br />
human genetics, Pr<strong>of</strong>essor Emery is simply known as<br />
“the expert.”<br />
Past Recipients: Giovanni Romeo (2011); Thomas<br />
Gelehrter (2010); Bruce Korf (2009); John Carey,<br />
Lynn Jorde & Louisa Stark (2008); Robert Elston<br />
(2007); Roberta Pagon (2006); Joseph McInerney<br />
(2005); Robert Gorlin (2004); Joan Marks (2003); Kurt<br />
Hirschhorn (2002); Charles Scriver (2001); F. Clarke<br />
Fraser (2000); Arno Motulsky (1999); C.C. Li (1998);<br />
Victor McKusick (1997); Barton Childs (1996); Margaret<br />
Thompson (1995).<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Saturday, November 10<br />
8:20 AM–8:40 AM<br />
SESSION 69 – <strong>ASHG</strong> Victor A. McKusick Leadership<br />
Award Presentation<br />
Hall D, Lower Level North, Moscone Center<br />
<strong>ASHG</strong> established this prestigious award in honor <strong>of</strong><br />
Dr. Victor A. McKusick and his inspiring contributions<br />
to the human genetics field. The McKusick Leadership<br />
Award is presented to an individual whose<br />
pr<strong>of</strong>essional achievements have fostered and enriched<br />
the development <strong>of</strong> the field <strong>of</strong> human genetics.<br />
Recipients <strong>of</strong> this award exemplify the enduring<br />
leadership and vision required to ensure that the field<br />
<strong>of</strong> human genetics will flourish and successfully<br />
assimilate into the broader context <strong>of</strong> science,<br />
medicine, and health.<br />
Introduction:<br />
Joann A. Boughman, Univ. Syst. <strong>of</strong> Maryland<br />
Recipient:<br />
Francis S. Collins, MD, PhD<br />
Director, National Institutes <strong>of</strong> Health<br />
Dr. Collins has been named as the <strong>2012</strong> winner in<br />
recognition <strong>of</strong> his extensive achievements in genetics<br />
research, his efforts to advance health science<br />
and technology through policy and education, and<br />
his stellar leadership <strong>of</strong> the genetics community in<br />
mapping the human genome. The revolution that was<br />
dreamed <strong>of</strong> at the start <strong>of</strong> the <strong>Human</strong> Genome Project<br />
is currently being realized. Today’s medical geneticists,<br />
genetic counselors, and other health pr<strong>of</strong>essionals are<br />
increasingly able to identify and test genes associated<br />
with both single-gene and complex disease. Today’s<br />
medical researchers are increasingly able to<br />
investigate treatments and therapies for diseases with<br />
genetic causes. These medical and scientific advances<br />
would not have been possible without Dr. Collin’s<br />
leadership and dedication to studying the molecular<br />
genetics <strong>of</strong> diseases, for the benefit <strong>of</strong> health and<br />
medicine.<br />
During the completion <strong>of</strong> the NIH-based <strong>Human</strong><br />
Genome Project, Dr. Collins served as the Director <strong>of</strong><br />
the National <strong>Human</strong> Genome Research Institute.<br />
However, prior to taking on that leadership role, he<br />
had already contributed much to human genetics. He<br />
took part in the identification <strong>of</strong> the gene for cystic<br />
fibrosis in 1989, the gene for neur<strong>of</strong>ibromatosis in<br />
1990, and the gene for Huntington’s disease in 1993.<br />
His laboratory is known for its past and continuing<br />
focus on the function <strong>of</strong> genes involved in breast<br />
cancer, diabetes, Hutchinson-Gilford progeria<br />
syndrome, and many other conditions. In 2008, Dr.<br />
Collins stepped down from the NHGRI, and less than<br />
INVITED AND PLATFORM SESSIONS 117<br />
year later, he was chosen by President Obama to<br />
serve as the director <strong>of</strong> the National Institutes <strong>of</strong><br />
Health.<br />
Dr. Collins has received many awards for his<br />
achievements in science and technology, including the<br />
Presidential Medal <strong>of</strong> Freedom in November 2007, the<br />
National Medal <strong>of</strong> Science in 2009, and election into<br />
the Institute <strong>of</strong> Medicine and the National Academy <strong>of</strong><br />
Sciences.<br />
Dr. Collins has also made “singing for science” an<br />
emphasis <strong>of</strong> his pr<strong>of</strong>essional career. His efforts in<br />
education and outreach are commended by many.<br />
These efforts include, among many others, creating<br />
clinical partnerships with four historically black<br />
colleges and universities to develop clinical research<br />
degrees and conduct treatment trials among minority<br />
patients, and establishing the National Center for<br />
Advancing Translational Sciences to enhance the<br />
process <strong>of</strong> translating scientific discoveries into new<br />
drugs, diagnostics, and devices. Dr. Collins continues<br />
to play a vital role in the advancement <strong>of</strong> genetics and<br />
medical research and the improvement <strong>of</strong> health and<br />
medicine.<br />
Past Recipients: Leon E. Rosenberg (2011); Charles J.<br />
Epstein (2010); Arno G. Motulsky (2009); Victor A.<br />
McKusick (2008); Walter Nance (2007); David Rimoin<br />
(2006).<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
118 INVITED AND PLATFORM SESSIONS<br />
Saturday, November 10<br />
8:40 AM–8:45 AM<br />
SESSION 70 – AJHG C.W. Cotterman Awards<br />
Announcement<br />
Hall D, Lower Level North, Moscone Center<br />
Presenter: David L. Nelson, Editor, The <strong>American</strong><br />
Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong><br />
Baylor Col. <strong>of</strong> Med<br />
Each September, the editorial board <strong>of</strong> The <strong>American</strong><br />
Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> elects two articles<br />
published in the journal in the previous year that best<br />
represent outstanding scientific contributions to the<br />
field <strong>of</strong> human genetics. Two Cotterman Awards are<br />
given annually. Monetary awards <strong>of</strong> $1000 and a<br />
certificate will be presented to the recipients for the<br />
top two papers published in the Journal during the<br />
previous year on which the first author was either a<br />
pre- or post- doctoral trainee and an <strong>ASHG</strong> member.<br />
Saturday, November 10<br />
8:45 AM–8:55 AM<br />
SESSION 71 – <strong>ASHG</strong> Charles J. Epstein Trainee Awards<br />
for Excellence in <strong>Human</strong> <strong>Genetics</strong> Research:<br />
Announcement <strong>of</strong> Winners<br />
Hall D, Lower Level North, Moscone Center<br />
Presenter: C. E. Pearson, Awards Committee Chair<br />
Hosp. for Sick Children<br />
<strong>ASHG</strong> honors excellence in research conducted by<br />
predoctoral and postdoctoral trainees, including<br />
genetic counseling trainees, through merit-based<br />
awards that recognize highly competitive abstracts<br />
submitted for the Annual Meeting. These awards were<br />
renamed in <strong>2012</strong> to honor the late Dr. Charles Epstein.<br />
60 Semifinalists were selected based on abstract<br />
score and awarded complimentary registration plus<br />
$750 each. Of those semifinalists, 18 finalists (selected<br />
by the Awards Committee) received an additional<br />
$250. The finalists’ presentations were reviewed by the<br />
<strong>ASHG</strong> Awards Committee and volunteer judges during<br />
the Annual Meeting.<br />
Six winners announced today will receive an additional<br />
$1000 each.<br />
Members <strong>of</strong> the Awards Committee are Christopher<br />
Pearson, Chair; Goncalo Abecasis, Georgia Dunston,<br />
Maximilian Muenke, Pragna Patel, Sharon Plon.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Saturday, November 10<br />
8:55 AM–9:20 AM<br />
SESSION 72 – <strong>ASHG</strong> Curt Stern Award Presentation<br />
Hall D, Lower Level North, Moscone Center<br />
The Curt Stern Award is given annually by <strong>ASHG</strong> in<br />
recognition <strong>of</strong> major scientific achievement in human<br />
genetics that has occurred in the last 10 years.<br />
The work could be a single discovery or a series <strong>of</strong><br />
contributions on similar or related topics. This Award<br />
honors the memory <strong>of</strong> Dr. Curt Stern (1902-1981), an<br />
outstanding pioneer in human genetics who served as<br />
<strong>ASHG</strong> president in 1956.<br />
Introduction:<br />
Evan Eichler, Univ. <strong>of</strong> Washington<br />
Recipient:<br />
Jay A. Shendure, MD, PhD<br />
Assoc. Pr<strong>of</strong>., Dept. <strong>of</strong> Genome<br />
Sciences, Univ. <strong>of</strong> Washington<br />
Dr. Shendure was selected for his outstanding<br />
contributions to the broad development and<br />
application <strong>of</strong> exome sequencing and its truly<br />
revolutionary effects on human genetics, as well as for<br />
the development <strong>of</strong> methods for high-throughput<br />
functional analysis <strong>of</strong> non-coding areas <strong>of</strong> DNA. This<br />
work has been - and will continue to be - <strong>of</strong> great<br />
impact to human disease gene discovery and<br />
understanding in clinical genetics. Importantly, these<br />
contributions have permitted individual (particularly<br />
small) clinical and laboratory groups to make<br />
significant contributions to our understanding <strong>of</strong><br />
disease. Most recently, Dr. Shendure and colleagues<br />
non-invasively sequenced the whole genome <strong>of</strong> a<br />
fetus, using DNA from the blood <strong>of</strong> the mother and the<br />
saliva <strong>of</strong> the father. This work will lead to major<br />
changes in prenatal diagnosis as the field moves<br />
toward non-invasive yet comprehensive testing. Dr.<br />
Shendure is one <strong>of</strong> the most promising young<br />
scientists in our genetics community. He will certainly<br />
continue to lead the way in developing techniques that<br />
will have great impact on patients.<br />
Past Recipients: David Altshuler (2011); Vivian Cheung<br />
(2010); David Haussler and James Kent (2009); Evan<br />
Eichler (2008); Jeffrey Murray (2007); Hal Dietz (2006);<br />
Patrick Brown (2005); Neil Risch (2004); David Page<br />
(2003); James Lupski (2002); Daniel Pinkel and Joe<br />
Gray (2001).<br />
INVITED AND PLATFORM SESSIONS 119<br />
Saturday, November 10<br />
9:40 AM–11:40 AM<br />
Concurrent Invited Session III (73-80)<br />
SESSION 73 – Returning Results from Large-Scale<br />
Sequencing: Where the Rubber Meets the Road<br />
Gateway Ballroom 103, Lower Level South, Moscone<br />
Center<br />
Moderators: Leslie G. Biesecker, NHGRI/NIH; Robert<br />
C. Green, Brigham and Women’s Hosp.<br />
Medicine is on the brink <strong>of</strong> a revolution, as large-scale<br />
medical sequencing (LSMS) is now available for<br />
patient care, marking the dawn <strong>of</strong> genomic medicine.<br />
LSMS may be used in patients with a family history or<br />
symptoms <strong>of</strong> a disease for diagnosis or to predict<br />
future health risks for prevention and surveillance.<br />
Developing standards and procedures for the use <strong>of</strong><br />
LSMS in clinical medicine is critical and there is a<br />
need for empiric data to determine how to interpret,<br />
analyze, and return results. A critical question is how<br />
to handle secondary findings from LSMS. Speakers in<br />
this session will share their pioneering research<br />
initiatives that explore the translation <strong>of</strong> LSMS into<br />
meaningful clinical information and the delivery to<br />
patients. The speakers will report on a range <strong>of</strong><br />
studies, including patients ascertained with diseases,<br />
healthy volunteers, adults, and children, research<br />
versus clinical, and rare versus common disease. All <strong>of</strong><br />
the speakers will focus on results, and not just<br />
opinions, to inform the practice <strong>of</strong> genomic medicine<br />
and future research studies on the return <strong>of</strong> results. Dr.<br />
Biesecker will introduce the session and present<br />
ClinSeq, a large cohort LSMS study with return <strong>of</strong><br />
results to subjects. Dr. Green will present the results <strong>of</strong><br />
two efforts to formulate consensus on return <strong>of</strong><br />
incidental findings in LSMS. Dr. Kingsmore will present<br />
experience with neonatal and pediatric diagnosis by<br />
LSMS. Finally, Dr. Veltman will present the results <strong>of</strong><br />
a pilot using LSMS to diagnose genetically<br />
heterogeneous diseases with required return <strong>of</strong> all<br />
medically relevant results.<br />
9:40 AM ClinSeq: A pilot study <strong>of</strong> large-scale<br />
medical sequencing in research and implications<br />
for clinical genomic medicine. L. G. Biesecker.<br />
NHGRI/NIH.<br />
10:10 AM Expert concordance and discordance for<br />
return <strong>of</strong> incidental findings from whole genome<br />
sequencing. R. C. Green. Brigham and Women’s<br />
Hosp.<br />
10:40 AM Using next-generation sequencing for<br />
carrier testing for severe childhood recessive<br />
diseases. S. F. Kingsmore. Children’s Mercy Hosp.,<br />
Kansas City, KS.<br />
11:10 AM Diagnostic implementation <strong>of</strong> exome<br />
sequencing: Results from 500 patients. J. Veltman.<br />
Genomic Disorders Nijmegen, Netherlands.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
120 INVITED AND PLATFORM SESSIONS<br />
Saturday, November 10<br />
9:40 AM–11:40 AM<br />
Concurrent Invited Session III (73-80)<br />
SESSION 74 – Genomic Approaches to Mendelian<br />
Disorders<br />
Hall D, Lower Level North, Moscone Center<br />
Moderators: Jay Shendure, Univ. <strong>of</strong> Washington; David<br />
Valle, Johns Hopkins Univ. Sch. <strong>of</strong> Med.<br />
Although the gene(s) underlying approximately 3,000<br />
Mendelian disorders are known, there are thousands<br />
<strong>of</strong> well-defined or suspected Mendelian disorders for<br />
which the genetic basis remains unknown. The past<br />
three years have been witness to an explosion <strong>of</strong><br />
interest in applying new technologies such as exome<br />
and genome sequencing to identify the genetic basis<br />
<strong>of</strong> Mendelian disorders that have proven intractable to<br />
conventional strategies. In this session, we will<br />
describe the progress as well as current challenges<br />
facing efforts to scale and accelerate the application <strong>of</strong><br />
next-generation technologies to Mendelian disorders,<br />
e.g. the U.S.-based Mendelian Genome Centers as<br />
well as related international efforts. Topics that will be<br />
explored include primary research results from leading<br />
groups in this field; advances and ongoing challenges<br />
in phenotype curation, sequencing technology, and<br />
data analysis; and the broader implications <strong>of</strong> these<br />
efforts for biology and medicine.<br />
9:40 AM Genomic approaches to Mendelian<br />
disorders. D. Valle. Johns Hopkins Univ. Sch. <strong>of</strong> Med.<br />
9:55 AM FORGE Canada: A nation-wide effort to<br />
understand the genomics <strong>of</strong> childhood disorders.<br />
K. Boycott. Children’s Hosp. <strong>of</strong> Eastern Ontario,<br />
Canada.<br />
10:10 AM Current challenges in exome or genomebased<br />
analysis <strong>of</strong> Mendelian disorders. J. Shendure.<br />
Univ. <strong>of</strong> Washington.<br />
10:40 AM Lessons from 500 diagnostic exomes. H.<br />
G. Brunner. Radboud Univ. Nijmegen Med. Ctr.,<br />
Netherlands.<br />
11:10 AM Genes, genomes and the future <strong>of</strong><br />
medicine. R. Lifton. Yale Univ.<br />
Saturday, November 10<br />
9:40 AM–11:40 AM<br />
Concurrent Invited Session III (73-80)<br />
SESSION 75 – Emerging Applications <strong>of</strong> Identity by<br />
Descent Segment Detection<br />
Gateway Ballroom 104, Lower Level South, Moscone<br />
Center<br />
Moderators: Sharon R. Browning, Univ. <strong>of</strong> Washington;<br />
Brian L. Browning, Univ. <strong>of</strong> Washington<br />
Identity by descent (IBD) is fundamental to genetics<br />
and has diverse applications. Recently developed<br />
statistical methods and genome-wide SNP data have<br />
made it possible to detect haplotypes shared<br />
identically by descent between individuals with<br />
common ancestry up to 25-50 generations ago. With<br />
sequence data, shared haplotypes from even more<br />
distant ancestry can be detected. Patterns <strong>of</strong> IBD<br />
segment sharing within and between populations<br />
reveal important population demographic features<br />
including recent effective population size and migration<br />
patterns. IBD segment sharing is directly relevant to<br />
disease gene mapping and estimation <strong>of</strong> heritability.<br />
Individuals who share a genetic basis for a trait are<br />
more likely to have IBD sharing compared to randomly<br />
chosen individuals, and this forms the basis for IBD<br />
mapping and heritability estimation. Analysis <strong>of</strong> data<br />
from extended pedigrees was extremely difficult with<br />
standard linkage approaches, but is now possible<br />
using approaches based on detected IBD segments.<br />
Detected IBD can be present across pedigrees, which<br />
enhances power to detect association with the trait.<br />
Further, in population samples there is potential to<br />
utilize detected IBD segments to improve power to<br />
detect association when multiple variants within a<br />
gene influence the trait. IBD segments can also be<br />
used to greatly improve haplotype phase estimates,<br />
which is critical to understanding the functional<br />
consequence <strong>of</strong> genetic variation. IBD-based longrange<br />
phasing has previously been shown to be<br />
effective in isolated populations such as Iceland, but<br />
recent advances have extended its application to large<br />
outbred populations. In this session, we explore these<br />
exciting new developments.<br />
9:40 AM Sharing by descent, phasing, rare<br />
variants and population structure. A. Kong. deCODE<br />
Genet., Reykjavik, Iceland.<br />
10:10 AM Length distributions <strong>of</strong> identity by<br />
descent reveal fine-scale demographic history.<br />
I. Pe’er. Columbia Univ.<br />
10:40 AM Identity by descent within and between<br />
pedigrees. E. A. Thompson. Univ. <strong>of</strong> Washington.<br />
11:00 AM Using high resolution identity by descent:<br />
From detecting selection to explaining trait<br />
variability. M. Abney. Univ. <strong>of</strong> Chicago.<br />
11:20 AM Extending the limits <strong>of</strong> IBD segment<br />
detection with sequence data and new statistical<br />
methods. B. L. Browning. Univ. <strong>of</strong> Washington.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Saturday, November 10<br />
9:40 AM–11:40 AM<br />
Concurrent Invited Session III (73-80)<br />
SESSION 76 – The Functional Consequences <strong>of</strong><br />
microRNA Dysregulation in <strong>Human</strong> Disease<br />
Room 134, Lower Level North, Moscone Center<br />
Moderators: Cheryl L. Thompson, Case Western<br />
Reserve Univ.; Ahmad Khalil, Case Western Reserve<br />
Univ.<br />
MicroRNAs (miRNAs) are an evolutionarily conserved<br />
class <strong>of</strong> small non-coding RNAs that have been shown<br />
to regulate the expression levels <strong>of</strong> numerous proteincoding<br />
genes. Although integral to animal biology, their<br />
role in human disease has only recently been studied.<br />
Previously, numerous miRNAs have been<br />
demonstrated to be dysregulated in multiple diseases,<br />
including cancer, cardiovascular disease, neurological<br />
disease and many others. However, the exact<br />
functions and mechanisms <strong>of</strong> these miRNAs in human<br />
diseases are yet to be fully elucidated. A number <strong>of</strong><br />
recent studies have now begun to shed light on the<br />
role <strong>of</strong> miRNAs in disease, providing insights into<br />
mechanisms for imitation and progression <strong>of</strong> disease<br />
as well as targets for preventive and therapeutic<br />
intervention. In this session we have assembled a<br />
group <strong>of</strong> world leaders in the field <strong>of</strong> miRNA and<br />
human diseases. The speakers will discuss their latest<br />
research on miRNAs, which will cover a range <strong>of</strong><br />
topics from targets <strong>of</strong> miRNAs, animal models <strong>of</strong><br />
miRNA action as well as the role <strong>of</strong> circulating miRNAs<br />
in diagnostics.<br />
9:40 AM OncomiR-1 in cancer and development:<br />
A tale <strong>of</strong> mice and men. A. Ventura. Sloan-Kettering<br />
Inst.<br />
10:10 AM microRNA reprogramming in cancer:<br />
Mechanisms and consequences. J. Mendell. Univ. <strong>of</strong><br />
Texas Southwestern Med. Ctr.<br />
10:40 AM Exploring circulating miRNAs as bloodbased<br />
diagnostic biomarkers. M. Shapero.<br />
Affymetrix, Santa Clara, CA.<br />
11:10 AM Circulating microRNAs in obesity and<br />
postmenopausal breast cancer. C. L. Thompson.<br />
Case Western Reserve Univ.<br />
INVITED AND PLATFORM SESSIONS 121<br />
Saturday, November 10<br />
9:40 AM–11:40 AM<br />
Concurrent Invited Session III (73-80)<br />
SESSION 77 – Centralizing the Deposition and Curation<br />
<strong>of</strong> <strong>Human</strong> Mutations<br />
Room 132, Lower Level North, Moscone Center<br />
Moderators: Robert L. Nussbaum, UCSF; David H.<br />
Ledbetter, Geisinger Hlth. Syst., Danville, PA<br />
Hundreds <strong>of</strong> thousands <strong>of</strong> disease-causing variants<br />
have been identified in patients with disease, yet only<br />
a small fraction <strong>of</strong> that data, and the interpretation <strong>of</strong><br />
it, is accessible to researchers and clinicians. The<br />
centralization <strong>of</strong> data on human genomic variation is a<br />
critical step in accelerating advances within the field <strong>of</strong><br />
genomic medicine. Such centralization <strong>of</strong> variant data<br />
will not only enable more efficient approaches to data<br />
analysis, but will also ensure the use <strong>of</strong> a uniform set<br />
<strong>of</strong> standards across the many communities<br />
contributing data and intending to use the resources<br />
for research and clinical applications. This session will<br />
highlight groups that have recently joined efforts<br />
to solve this challenge and create a free and useful<br />
human genomic mutation database for the community.<br />
9:40 AM Improving the accuracy <strong>of</strong> variant<br />
identification. D. Church. NLM/NIH.<br />
10:10 AM The ISCA Consortium: Standardization<br />
and sharing <strong>of</strong> structural variation data. C. L.<br />
Martin. Emory Univ. Sch. <strong>of</strong> Med.<br />
10:40 AM Introducing ClinVar. D. Maglott. NCBI,<br />
NLM/NIH.<br />
11:10 AM Community involvement in centralized<br />
mutation curation. H. L. Rehm. Harvard Med. Sch.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
122 INVITED AND PLATFORM SESSIONS<br />
Saturday, November 10<br />
9:40 AM–11:40 AM<br />
Concurrent Invited Session III (73-80)<br />
SESSION 78 – Stem Cells and Personalized Medicine<br />
Room 135, Lower Level North, Moscone Center<br />
Moderator: Stephen H. Tsang, Columbia Univ.<br />
Speakers will discuss applications <strong>of</strong> patient-specific<br />
and disease-specific stem cell lines, including disease<br />
modeling, drug screening, and regenerative medicine.<br />
Panelists will bring experience in clinical genetics,<br />
genetic manipulation in stem cells, and disease<br />
modeling. The FDA has recently approved phase I/II<br />
clinical trials to investigate the safety and efficacy <strong>of</strong><br />
embryonic stem cell-based retinal cell transplantation,<br />
but such therapy requires immunosuppression.<br />
Patient-specific stem cells may <strong>of</strong>fer an alternative to<br />
embryonic stem cells that will skirt the need for<br />
immunosuppressive therapy as well as the social and<br />
political ramifications <strong>of</strong> embryonic stem cell research,<br />
but their utility even extends far beyond such<br />
groundbreaking advances.<br />
9:40 AM Stem cells and personalized medicine in<br />
retinal degenerations. S. H. Tsang. Columbia Univ.<br />
10:10 AM Direct reprogramming to generate<br />
patient-specific stem cells and neurons. M. Wernig.<br />
Stanford Sch. <strong>of</strong> Med.<br />
10:40 AM A chemical approach to controlling cell<br />
fate. S. Ding. UCSF.<br />
11:10 AM Patient-specific stem cells and<br />
cardiovascular genetics. B. Conklin. UCSF.<br />
Saturday, November 10<br />
9:40 AM–11:40 AM<br />
Concurrent Invited Session III (73-80)<br />
SESSION 79 – Should Noninvasive Prenatal Diagnosis<br />
Augment or Replace Current Prenatal Screening and<br />
Diagnosis?<br />
Room 124, Lower Level North, Moscone Center<br />
Moderators: Mark E. Nunes, Kaiser Permanente, San<br />
Diego; Mildred K. Cho, Stanford Univ.<br />
The discovery <strong>of</strong> circulating cell-free fetal nucleic acid<br />
(cffDNA) in maternal blood plasma in 1997 allowed for<br />
the development <strong>of</strong> noninvasive prenatal diagnosis<br />
(NIPD) <strong>of</strong>fered commercially in a medical setting in<br />
North America beginning in October 2011. From the<br />
initial discovery, ethical issues were raised in that<br />
the method could most easily be validated seeking<br />
circulating Y chromosome transcripts. The method<br />
subsequently has been validated for fetal Rh typing<br />
and fetal aneuploidy, but the next-generation<br />
sequencing methods used to analyze cffDNA allow<br />
any Mendelian trait or disorder with a known gene to<br />
be detected by the method. This technology<br />
convergence, coupled with the test being <strong>of</strong>fered at<br />
10-weeks gestation, could provide a level <strong>of</strong> access<br />
and choice in women’s reproductive decision making<br />
unprecedented since the introduction <strong>of</strong> oral<br />
contraception. We will briefly introduce the topic, and<br />
then debate the ethical, legal, and social issues <strong>of</strong><br />
broadening the scope and availability <strong>of</strong> NIPD. The<br />
technique will be placed in the context <strong>of</strong> the history<br />
<strong>of</strong> seeking fetal markers and cells in maternal<br />
circulation. The ethical context will be outlined, with<br />
competing issues <strong>of</strong> autonomy and societal interest.<br />
The legal context, within the current debate<br />
surrounding reproductive freedom, will be discussed.<br />
The possible impact on society and medical practice<br />
will be described.<br />
9:40 AM Lessons from the clinical introduction <strong>of</strong><br />
noninvasive prenatal diagnosis: How we got here.<br />
A. T. Bombard. Sequenom Inc., San Diego.<br />
10:05 AM Cell-free fetal DNA in prenatal diagnosis:<br />
Where we are going? D. Bianchi. Tufts Univ., Boston.<br />
10:30 AM Academia and industry in the<br />
development <strong>of</strong> noninvasive prenatal diagnosis. M.<br />
K. Cho. Stanford Univ.<br />
10:55 AM Ethical and policy implications <strong>of</strong> early<br />
noninvasive prenatal diagnosis. J. S. King. UC<br />
Hastings Col. <strong>of</strong> the Law, San Francisco.<br />
11:20 AM Discussion. M. E. Nunes. Kaiser<br />
Permanente, San Diego.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Saturday, November 10<br />
9:40 AM–11:40 AM<br />
Concurrent Invited Session III (73-80)<br />
SESSION 80 – Selection Signatures and the <strong>Genetics</strong><br />
<strong>of</strong> Autoimmunity and Infectious Diseases<br />
Room 130, Lower Level North, Moscone Center<br />
Moderators: Judy H. Cho, Yale Univ.; Richard A.<br />
Spritz, Univ. <strong>of</strong> Colorado Denver Anschutz Med.<br />
Campus<br />
The overlap <strong>of</strong> autoimmune and infectious disease loci<br />
is one <strong>of</strong> the seminal findings <strong>of</strong> the GWAS era. The<br />
presence <strong>of</strong> a relatively limited and recurring number<br />
<strong>of</strong> major autoimmune and infectious disease-<br />
associated genes and pathways may well correspond<br />
with functional networks that evolved in response to<br />
historically significant infectious pathogens. It may be<br />
speculated that the plethora <strong>of</strong> common functional<br />
polymorphisms identified through GWAS in<br />
autoimmune diseases evolved through positive<br />
selection; in subsequent eras and environmental<br />
conditions, these once beneficial polymorphisms<br />
confer increased susceptibility to autoimmunity.<br />
Support for this concept is provided by the<br />
observation that uncommon, <strong>of</strong>ten highly penetrant,<br />
mutations in overlapping genes and pathways are<br />
INVITED AND PLATFORM SESSIONS 123<br />
associated in infectious diseases such as severe<br />
mycobacterial infections. Predictive functional<br />
networks may be optimized by integration <strong>of</strong><br />
complementary data sources, notably selection<br />
signatures. Novel approaches <strong>of</strong> identifying signatures<br />
<strong>of</strong> positive selection at single and multiple loci will<br />
require integration <strong>of</strong> genetic association data with<br />
biologic data that optimally models relevant selection<br />
conditions.<br />
9:40 AM <strong>Genetics</strong> and Autoimmunity. J. H. Cho.<br />
Yale Univ.<br />
9.55 AM The genetics <strong>of</strong> autoimmunity. R. A.<br />
Spritz. Univ. <strong>of</strong> Colorado Denver.<br />
10:10 AM Selection signatures and mechanisms <strong>of</strong><br />
host-microbe interactions. P. Sabeti. Harvard Univ.<br />
10:40 AM Interactions <strong>of</strong> HLA class I with killer-cell<br />
immunoglobulin-like receptors: Influences on<br />
human disease. P. Parham. Stanford Univ.<br />
11:10 AM Toward a genetic theory <strong>of</strong> infectious<br />
diseases. J.-L. Casanova. Rockefeller Univ.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.<br />
INVITED AND PLATFORM SESSIONS
124 INVITED AND PLATFORM SESSIONS<br />
Saturday, November 10<br />
12:00 NOON–1:00 PM<br />
SESSION 81 – Closing Plenary: <strong>Human</strong> <strong>Genetics</strong> <strong>2012</strong><br />
and Beyond: Present Progress and Future Frontiers<br />
Hall D, Lower Level North, Moscone Center<br />
Moderator: Joel N. Hirschhorn, <strong>2012</strong> <strong>Program</strong><br />
Committee Chair Boston Children’s Hosp.,<br />
Harvard Med. Sch. and Broad Inst.<br />
Presenter: Chris Gunter, HudsonAlpha Inst. for Biotechnol.<br />
Panelists:<br />
Han Brunner<br />
Radboud Univ. Nijmegen<br />
Jay Shendure<br />
Univ. <strong>of</strong> Washington<br />
Dian Donnai<br />
Univ. <strong>of</strong> Manchester<br />
Lynn Jorde<br />
Univ. <strong>of</strong> Utah<br />
Hal Dietz Johns<br />
Hopkins Univ.<br />
An outstanding panel <strong>of</strong> expert human geneticists<br />
with varying perspectives will make will make brief<br />
presentations and then participate in a wide-ranging<br />
discussion on the most exciting advances and<br />
important upcoming challenges in their areas <strong>of</strong><br />
human genetics. Topics will be driven by questions<br />
from the panelists and the audience, but will include<br />
many <strong>of</strong> the following perspectives:<br />
• The importance <strong>of</strong> education for the public,<br />
scientists, and clinicians<br />
• The impact <strong>of</strong> new technology on human genetics<br />
and genomics<br />
• Advances that define biological mechanisms<br />
• Challenges <strong>of</strong> interpretation <strong>of</strong> exome and genome<br />
sequencing<br />
• Translation <strong>of</strong> advances into clinical care<br />
During the course <strong>of</strong> the 62nd Annual Meeting,<br />
registrants are encouraged to post their thoughts on<br />
scientific or clinical advances they have heard about at<br />
the meeting, and on upcoming important challenges<br />
in human genetics, via <strong>ASHG</strong>’s social media outlets<br />
(Twitter, Facebook).<br />
Twitter: Use hashtag #<strong>ASHG</strong><strong>2012</strong><br />
Facebook: https://www.facebook.com/<strong>Genetics</strong><strong>Society</strong><br />
You can also address your comments through Twitter<br />
directly to Chris Gunter, @girlscientist, during the<br />
meeting.<br />
Posts by meeting participants will be followed and<br />
summarized at the beginning <strong>of</strong> the session by Chris<br />
Gunter, <strong>2012</strong> <strong>Program</strong> Committee Member.<br />
After the brief presentations by the panelists, there will<br />
be opportunities for audience members to ask questions<br />
<strong>of</strong> one or more panel members.<br />
At the conclusion <strong>of</strong> the session, the moderator will<br />
provide a brief summary, and the meeting will be<br />
adjourned by the <strong>2012</strong> President, Mary-Claire King.<br />
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
POSTER SESSIONS<br />
Moscone Center, Exhibit Hall, Lower Level South<br />
POSTER SESSIONS 125<br />
The program and abstract/poster board number next to each listing is followed by a W (Wednesday), or<br />
T (Thursday), or F (Friday) to indicate the day on which authors must be present at their poster boards. To<br />
encourage discussion and to facilitate the exchange <strong>of</strong> information, posters are sorted by related topics.<br />
Refer to the schedule below for presentation times and for the poster mounting/removal schedule. Posters<br />
should remain up all three days.<br />
Wednesday, November 7<br />
10:00 am – 10:30 am Authors place posters on boards. Posters should remain up for all three days<br />
10:00 am – 4:30 pm Posters open for viewing<br />
2:15 pm – 4:15 pm Poster Session I (W)<br />
2:15 pm – 3:15 pm (odd poster board numbers; author must be present)<br />
3:15 pm – 4:15 pm (even poster board numbers; author must be present)<br />
Thursday, November 8<br />
7:00 am – 4:30 pm Posters open for viewing<br />
2:15 pm – 4:15 pm Poster Session II (T)<br />
2:15 pm – 3:15 pm (odd poster board numbers; author must be present)<br />
3:15 pm – 4:15 pm (even poster board numbers; author must be present)<br />
Friday, November 9<br />
7:00 am – 4:30 pm Posters open for viewing<br />
2:15 pm – 4:15 pm Poster Session III (F)<br />
2:15 pm – 3:15 pm (odd poster board numbers; author must be present)<br />
3:15 pm – 4:15 pm (even poster board numbers; author must be present)<br />
4:15 pm – 4:30 pm Authors must remove posters<br />
4:30 pm Exhibit Hall and Posters closed<br />
NOTE: For safety reasons, no registrant will be admitted into the Exhibit Hall or poster area for any<br />
reason after 4:30 pm on Friday. No exceptions can be made to this policy.<br />
IMPORTANT: Do not leave materials or belongings under poster boards or in the poster area. <strong>ASHG</strong> is not<br />
responsible for any articles left in the poster area or any other area.<br />
POSTER SESSIONS
126 POSTER SESSIONS<br />
Overview <strong>of</strong> Poster Schedule<br />
The program number and the abstract/poster board number are one and the same.<br />
It appears in bold print followed by the letter W (Wednesday), T (Thursday) or F (Friday).<br />
The title and author names follow. The first author listed is the presenting author.<br />
Please check the addendum for author changes or cancellations.<br />
Abstract/Poster<br />
Board Numbers Session Topic/Title Page<br />
412-600 Genome Structure, Variation and Function ................................ 127<br />
601-655 Pharmacogenetics ...................................................................... 134<br />
656-753 Metabolic Disorders .................................................................... 137<br />
754-804 Therapy for Genetic Disorders .................................................... 140<br />
805-854 Development ............................................................................... 143<br />
855-980 Cytogenetics ............................................................................... 145<br />
981-1279 Cancer <strong>Genetics</strong> ......................................................................... 150<br />
1280-1583 Statistical <strong>Genetics</strong> and Genetic Epidemiology .......................... 162<br />
1584-1715 Cardiovascular <strong>Genetics</strong> ............................................................. 174<br />
1716-1796 Genetic Counseling and Clinical Testing .................................... 180<br />
1797-1850 Ethical, Legal, Social and Policy Issues in <strong>Genetics</strong> .................. 183<br />
1851-1863 <strong>Genetics</strong> Education .................................................................... 185<br />
1864-1877 Health Services Research ........................................................... 186<br />
1878-2369 Complex Traits and Polygenic Disorders .................................... 187<br />
2370-2661 Psychiatric <strong>Genetics</strong>, Neurogenetics and Neurodegeneration ..... 209<br />
2662-2966 Molecular Basis <strong>of</strong> Mendelian Disorders .................................... 221<br />
2967-3034 Prenatal, Perinatal and Reproductive <strong>Genetics</strong> .......................... 234<br />
3035-3250 Clinical <strong>Genetics</strong> and Dysmorphology ........................................ 237<br />
3251-3414 Evolutionary and Population <strong>Genetics</strong> ........................................ 245<br />
3415-3525 Epigenetics ................................................................................. 252<br />
3526-3735 Bioinformatics and Genomic Technology ................................... 256
Genome Structure, Variation and<br />
Function<br />
412W Capture <strong>of</strong> chromosome conformation changes<br />
in breast cancer cell lines. C. Liu, C. Woo, P. Yim, S.<br />
Dong, J. Stevens.<br />
413F Myc-induced anchorage <strong>of</strong> the rDNA intergenic<br />
spacer region to nucleolar matrix modulates growthstimulated<br />
changes in higher-order rDNA architecture.<br />
C. Shiue, A. Nematollahi-Mahani, A. Wright.<br />
414W CENcode: Linear assembly and epigenetic<br />
annotation <strong>of</strong> human centromeres. K. E. Hayden, J.<br />
Kent.<br />
415F Impact <strong>of</strong> genetic variation on genome-wide<br />
epigenetic pr<strong>of</strong>iles and gene expression phenotypes.<br />
A. Reymond, H. Kilpinen, S. Waszak, A. Gschwind, E.<br />
Migliavacca, R. M. Witwicki, S. Raghav, A. Orioli, L.<br />
Romano-Palumbo, M. Wiederkehr, S. Turnherr, D. Hacker,<br />
M. Gutierrez-Arcelus, L. J. Core, J. T. Lis, N. Hernandez, B.<br />
Deplancke, E. T. Dermitzakis.<br />
416W Capturing long-range chromatin interactions<br />
<strong>of</strong> chromatin regulatory elements. N. Heidari, D. H.<br />
Phanstiel, W. Soon, M. P. Snyder.<br />
417F PRDM9 directs genetic recombination away from<br />
functional genomic elements. K. Brick, F. Smagulova, P.<br />
Khil, R. D. Camerini-Otero, G. Petukhova.<br />
418W ATRX interacts with the MRN complex to play<br />
a key role in the replication <strong>of</strong> non-canonical DNA<br />
structures associated with tandem repeats. R. Gibbons,<br />
D. Clynes, C. Jelinska, H. Ayyub, D. R. Higgs.<br />
419F Genome-wide copy number variation analysis<br />
<strong>of</strong> a branchio-oto-renal syndrome cohort identifies<br />
a recombination hotspot associated with an EYA1<br />
deletion and novel candidate genomic regions. F. Alasti,<br />
P. Brophy, B. Darbro, J. Dierdorff, C. Nishimura, B. Cobb,<br />
J. Clarke, M. Hakeman, A. Bassuk, R. J. H. Smith, J. R.<br />
Manak.<br />
420W Delineation <strong>of</strong> the reliability <strong>of</strong> in silico copy<br />
number variation calls from different Illumina SNP<br />
arrays. S. Herms, L. Priebe, F. Degenhardt, M. M.<br />
Noethen, S. Cichon, P. H<strong>of</strong>fmann.<br />
421F The Kaiser Permanente/UCSF Genetic<br />
Epidemiology Research Study on Adult Health and<br />
Aging: Detecting copy number variation in a multiethnic<br />
cohort <strong>of</strong> 100,000. C. Sabatti, Z. Zhang, Y. Banda,<br />
M. Kvale, T. H<strong>of</strong>fman, S. Hesselson, H. Tang, P.-Y. Kwok,<br />
C. Schaefer, N. Risch.<br />
422W Genomic copy number variation affects brain<br />
structure volumes in schizophrenia. T. H. Wassink,<br />
J. Manak, D. Rudd, E. Epping, F. Fleming, G. Zeien, S.<br />
Ziebell, B. C. Ho, N. C. Andreasen.<br />
POSTER SESSIONS 127<br />
423F The use <strong>of</strong> matepair sequencing in the detection<br />
<strong>of</strong> structural variation in patients with ID and/or<br />
congenital anomalies. S. Vergult, E. Van Binsbergen,<br />
T. Sante, S. Nowak, O. Vanakker, S. Janssens, K. Claes,<br />
B. Poppe, N. Van der Aa, F. Roelens, A. De Paepe, F.<br />
Speleman, E. Cuppen, W. Kloosterman, B. Menten.<br />
424W At the crossroads <strong>of</strong> structure and function: SNP<br />
genotypes indexed by copy number yield novel eQTLs.<br />
L. K. Davis, E. R. Gamazon, N. J. Cox.<br />
425F Extensive genetic variation in somatic human<br />
tissues. M. O’Huallachain, K. J. Karczewski, S. Weissman,<br />
A. E. Urban, M. Snyder.<br />
426W Copy number variations in a cohort <strong>of</strong><br />
Brazilian sickle cell anemia patients with and without<br />
cerebrovascular accident. G. Ananina, F. Menaa, M. A.<br />
Bezerra, A. S. Araujo, P. R. S. Cruz, G. P. Gil, F. F. Costa,<br />
M. B. Melo.<br />
427F Prevalence and effects <strong>of</strong> the obesity associated<br />
deletion on chromosome 16p11.2 in the Swedish<br />
Obese Subjects study. J. C. Andersson-Assarsson, S.<br />
Romeo, L. Sjöström, L. M. S. Carlsson.<br />
428W Molecular study <strong>of</strong> the inverted repeats<br />
responsible for triplication <strong>of</strong> the PLP1 locus. C. R.<br />
Beck, C. M. B. Carvalho, J. R. Lupski.<br />
429F Novel sequence-based CNV detection framework<br />
allows fine-mapping <strong>of</strong> the CFH region in 150 Chinese<br />
Singaporeans with age-related macular degeneration.<br />
E. Bellos, L. Coin, T. Y. Wong, C. Y. Cheng, G. Cheung, M.<br />
Hibberd, V. Kumar, S. Davila.<br />
430W Incidental copy-number variants identified by<br />
routine genome testing in a clinical population. P. M.<br />
Boone, Z. T. Soens, I. M. Campbell, P. Stankiewicz, S. W.<br />
Cheung, A. Patel, A. L. Beaudet, S. E. Plon, C. A. Shaw, A.<br />
L. McGuire, J. R. Lupski.<br />
431F Parental age and burden <strong>of</strong> genomic copy<br />
number variation. J. Buizer-Voskamp, H. M. Blauw, M. P.<br />
M. Boks, K. R. Van Eijk, J. H. Veldink, E. A. M. Hennekam,<br />
J. A. S. Vorstman, F. Mulder, H. Tiemeier, A. G. Uitterlinden,<br />
L. A. Kiemeney, L. H. Van den Berg, R. S. Kahn, C. Sabatti,<br />
R. A. Oph<strong>of</strong>f.<br />
432W Genome-wide analyses <strong>of</strong> recurrent genomic<br />
rearrangements: Identification <strong>of</strong> three novel genomic<br />
disorders. P. Dittwald, T. Gambin, P. Szafranski, J. Li,<br />
R. S. Amato, M. Divon, K. Maliszewski, E. E. Dolgado<br />
Bohorquez, L. Elton, A. C.-H. Tsai, D. Scott, S.-H. L.<br />
Kang, A. M. Breman, S. R. Lalani, C. Bacino, W. Bi, A.<br />
Milosavljevic, J. R. Lupski, A. L. Beaudet, C. A. Shaw, A.<br />
Patel, A. Gambin, S. W. Cheung, P. Stankiewicz.<br />
433F DUF1220 domain copy number loss implicated in<br />
1q21-associated microcephaly. L. Dumas, M. O’Bleness,<br />
J. Davis, C. M. Dickens, N. Anderson, J. G. Keeney, J.<br />
Jackson, M. Sikela, A. Raznahan, J. Giedd, J. Rapoport, S.<br />
S. C. Nagamani, A. Erez, N. Brunetti-Pierri, R. Sugalski, J.<br />
R. Lupski, T. Fingerlin, S. W. Cheung, J. M. Sikela.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
128 POSTER SESSIONS<br />
434W Age-related somatic structural changes in the<br />
nuclear genome <strong>of</strong> human blood cells. L. A. Forsberg,<br />
C. Rasi, H. R. Razzaghian, G. Pakalapati, L. Waite, K. S.<br />
Thilbeault, A. Ronowicz, N. E. Wineinger, H. K. Tiwari,<br />
D. Boomsma, M. P. Westerman, J. R. Harris, R. Lyle,<br />
M. Essand, F. Eriksson, T. L. Assimes, C. Iribarren, E.<br />
Strachan, T. P. O’Hanlon, L. G. Rider, F. W. Miller, V.<br />
Giedraitis, L. Lannfelt, M. Ingelsson, A. Piotrowski, N. L.<br />
Pedersen, D. Absher, J. P. Dumanski.<br />
435F Genome-wide scan <strong>of</strong> common copy number<br />
variant regions in post-traumatic stress disorder. G.<br />
Guffanti, A. Aiello, M. Uddin, D. Wildman, S. Galea, K.<br />
Koenen.<br />
436W Genetic variation among somatic cells revealed<br />
by single nucleus sequencing. I. M. Hall, M. L. Lindberg,<br />
J. Piper, K. J. Brennand, F. H. Gage, M. J. McConnell.<br />
437F Structural haplotypes and recent evolution <strong>of</strong> the<br />
human 17q21.31 locus. R. E. Handsaker, L. M. Boettger,<br />
M. C. Zody, S. A. McCarroll.<br />
438W Population genetics <strong>of</strong> haptoglobin and<br />
haptoglobin-related protein: 50 years <strong>of</strong> human copy<br />
number variation. E. Hollox, A. Menard, F. Yang, B. Fu, M.<br />
Sironi, R. Hardwick.<br />
439F Microduplication in 5p15.33 including CLPMT1L<br />
and TERT genes identified in a patient with cleft lip and<br />
palate, cardiopathy and urogenital abnormalities. G.<br />
Izzo, E. L. Freitas, A. C. V. Krepischi, D. R. Bertola, M. R.<br />
Passos-Bueno, C. Rosenberg.<br />
440W Integration <strong>of</strong> microarray and NGS generated<br />
data for copy number analysis. R. Keshavan, S. Verma,<br />
S. Shams.<br />
441F Comparative performance <strong>of</strong> three algorithms<br />
in detecting CNV associated with obesity and nonalcoholic<br />
fatty liver disease. W. Li, J. Littrell, S. Gawrieh,<br />
M. Olivier.<br />
442W Increased rate <strong>of</strong> rare genic copy number<br />
variants in Parkinson’s disease among Ashkenazi<br />
Jews. X. Liu, C. Cheng, S. Kisselev, H. Mejia-Santana, E.<br />
Louis, L. Cote, H. Andrews, C. Waters, B. Ford, S. Frucht,<br />
S. Fahn, K. Marder, J. Lee, L. Clark.<br />
443F A map <strong>of</strong> copy number variation in admixed<br />
populations in Xinjiang. H. Lou, S. Li, R. Fu, X. Pan, L.<br />
Jin, S. Xu.<br />
444W <strong>Human</strong> CNVs and ultraconserved elements: A<br />
rapid progression to mutual exclusivity. R. B. McCole,<br />
C. Y. Fonseka, C.-T. Wu.<br />
445F Prediction <strong>of</strong> 3551 human haploinsufficient<br />
genes. S. Meader, F. Honti, C. Webber.<br />
446W Prioritization <strong>of</strong> copy number variation loci<br />
associated with autism from AutDB: An integrative<br />
multi-study genetic database. I. Menashe, E. C. Larsen,<br />
S. Banerjee-Basu.<br />
447F Copy number variant analysis in a deeply<br />
phenotyped cohort <strong>of</strong> individuals with intellectual<br />
disability. E. Mercier, Y. Qiao, J. Gillis, S. Lewis, E.<br />
Separovic, P. Pavlidis.<br />
448W A novel susceptibility gene, UGT2B17, is<br />
associated with familial ankylosing spondylitis.<br />
D. O’Rielly, M. Uddin, R. Inman, D. Gladman, W.<br />
Maksymowych, R. Yazdani, P. Rahman.<br />
449F Evolution <strong>of</strong> copy number variation in the rhesus<br />
macaque b-defensin region. B. Ottolini, T. Schwarzacher,<br />
C. L. Bevins, J. V. Solnick, G. Doxiadis, E. J. Hollox.<br />
450W Characterization <strong>of</strong> copy number variation<br />
involving the salivary agglutinin gene DMBT1. S. Polley,<br />
D. Hains, E. Hollox.<br />
451F Single exon deletion in PCCA gene in patient with<br />
propionic acidemia highlights challenges to clinical<br />
whole exome CNV analysis. G. Scharer, G. Creadon-<br />
Swindell, E. Spector, C. Coughlin, T. Shaikh.<br />
452W Identifying autism loci using homozygosity<br />
analysis and copy number variation analysis. K. E.<br />
Schmitz-Abe, T. W. Yu, T. K. Kim, R. S. Hill, E. M. Morrow,<br />
M. E. Greenberg, K. Markianos, C. A. Walsh.<br />
453F Rare exonic deletions contribute to autoimmune<br />
diabetes susceptibility. C. Shtir, D. Smith, H. Guo, J.<br />
Barrett, M. Hurles, N. Walker, V. Plagnol, J. Cooper, J.<br />
Howson, O. Burren, S. Rich, J. Todd.<br />
454W An atypical microduplication overlapping the<br />
C2orf27A gene at 2q21.1 co-segregates with Tourette<br />
syndrome in a three generation family. M. Uddin,<br />
D. D. O’Reilly, P. Rahman, T. R. Purchase, H. White, S.<br />
Luscombe, S. J. Moore, T. L. Young, K. A. Hodgkinson.<br />
455F Detection <strong>of</strong> copy number variation from exomes<br />
in the DDD and UK10K projects. P. Vijayarangakannan,<br />
T. Fitzgerald, C. Joyce, S. McCarthy, M. Hurles, DDD and<br />
UK10K Projects.<br />
456W Alterations in RBFOX1: Real finding or red<br />
herring? L. Walters, A. Bailes, L. Erdman, A. McKinney,<br />
S. Ramsey, C. Weber, S. Hashimoto, L. Lamb Thrush, J.<br />
Atkin, G. Herman, S. Hickey, K. Manickam, C. Crowe, S.<br />
Thomas, C. Astbury, J. Gastier-Foster, S. Reshmi, R. E.<br />
Pyatt.<br />
457F Analyses <strong>of</strong> copy number variation reveal<br />
putative susceptibility loci in MTX-induced mouse<br />
neural tube defects. J.-H. Wang, X.-W. Wang, T. Guan,<br />
Q. Xiang, M.-S. Wang, Z. Zhang, Z. Guan, G.-L. Wang,<br />
Z.-Q. Zhu, Q. Xe, G.-N. Li, J. Guo, F. Wang, Z.-G. Wang,<br />
B. Niu, T. Zhang.<br />
458W Large range <strong>of</strong> copy number variation for human<br />
alpha-defensin genes DEFA1 and DEFA3: Lower copy<br />
number is a risk factor for autoimmune diseases.<br />
H. Wang, B. Zhou, Y. L. Wu, S. Bowden, R. H<strong>of</strong>fman,<br />
J. Ahearn, D. Birmingham, B. Rovin, L. Hebert, A.<br />
Schwaderer, D. Hains, C. Y. Yu.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
459F Analysis <strong>of</strong> structural variation in the Genome<br />
<strong>of</strong> the Netherlands project. K. Ye, V. Guryev, W.<br />
Kloosterman, L. Francioli, J. Y. Hehir-Kwa, E. Lameijer,<br />
A. Abdellaoui, J. de Ligt, V. Koval, N. Amin, F. van Dijk,<br />
L. C. Karssen, H. Mei, Genome <strong>of</strong> the Netherlands<br />
Consortium.<br />
460W Copy number variation <strong>of</strong> the Y chromosome<br />
in autism spectrum disorder. R. K. Yuen, E. Kolomietz,<br />
M. Vlasschaert, A. Merkoulovitch, J. R. MacDonald, C. R.<br />
Marshall, S. W. Scherer.<br />
461F Novel method <strong>of</strong> CNV analysis in FcgR locus<br />
and its application to immune-related diseases. A.<br />
Zhernakova, L. Franke, A. Ioan, G. Trynka, K. Fransen,<br />
R. Weersma, S. Rantapää-Dahlqvist, P. Gregersen, C.<br />
Wijmenga, T. Huizinga, R. Toes.<br />
462W An improved diagnostic workflow using SNP<br />
arrays reveals novel insights into CNVs in mental<br />
retardation. X. Zhou, J. M. Wang, B. Wang, J. Wang, T. Ji,<br />
X. Zhang, X. Ma, Y. Jiang.<br />
463F Copy number variation in autism spectrum<br />
disorders. B. Sheppard, C. Ladd-Acosta, B. K. Lee, J.<br />
Bonner, G. Windham, L. Schieve, L. Croen, A. Reynolds,<br />
D. Schendel, C. Newschaffer, M. D. Fallin.<br />
464W Understanding revisions to the human reference<br />
genome and assembly model. D. Church, P. Flicek, T.<br />
Graves, T. Hubbard, V. Schneider, The Genome Reference<br />
Consortium.<br />
465F Evolutionary history and genome organization<br />
<strong>of</strong> DUF1220 protein domains. M. O’Bleness, C. M.<br />
Dickens, D. Albracht, H. Kotkiewicz, T. Graves, R. Wilson,<br />
J. Sikela.<br />
466W Retrotransposition <strong>of</strong> gene transcripts leads<br />
to structural variation in mammalian genomes. A. D.<br />
Ewing, T. Ballinger, D. Earl, D. Haussler.<br />
467F Whole genome sequencing <strong>of</strong> iPS cells<br />
reveals somatic mutation arising at latest stages <strong>of</strong><br />
reprogramming. M. Cortes, J. S. Seo.<br />
468W Possible genomic impact <strong>of</strong> SVA retrotransposon<br />
in humans similar to that in gibbons. T. Hara, Y. Hirai, H.<br />
Hirai, A. Koga.<br />
469F Functional studies <strong>of</strong> tandem repeat variation<br />
in the human genome using multiplexed capture and<br />
high-throughput sequencing. A. Guilmatre, G. Highnam,<br />
D. Mittelman, A. J. Sharp.<br />
470W Meta-analysis with dbGaP data on genome-wide<br />
association studies for Alzheimer’s disease. J. H. Kim.<br />
471F A survey <strong>of</strong> the mutational load in genes<br />
associated with rare Mendelian disorders and autism.<br />
A. R. Rao, S. F. Nelson.<br />
472W Inferring mechanisms <strong>of</strong> indel mutation from<br />
whole genome sequence. I. H. C. Turner, Z. Iqbal, G.<br />
McVean.<br />
POSTER SESSIONS 129<br />
473F A complex rearrangement <strong>of</strong> the OCA2 gene in<br />
two unrelated albino patients. B. Arveiler, E. Lasseaux,<br />
D. Cailley, M. L. Vuillaume, C. Rooryck, A. Rouault, J.<br />
Toutain, D. Lacombe, F. Morice-Picard.<br />
474W A four base pair insertion in WNT16a identified<br />
through exome sequencing is associated with type 2<br />
diabetes. L. Been, M. Fortner, E. Howard, M. Lerner, D.<br />
Brackett, D. Sanghera.<br />
475F Obstetric complication-associated ANXA5<br />
promoter polymorphisms affect gene expression<br />
via DNA secondary structures. H. Inagaki, S. Ota, H.<br />
Nishizawa, H. Miyamura, K. Nakahira, M. Suzuki, S.<br />
Nishiyama, Y. Udagawa, I. Yanagihara, H. Kurahashi.<br />
476W The influence <strong>of</strong> genomic context on mutation<br />
patterns inferred from extremely rare variants. V. M.<br />
Schaibley, M. Zawistowski, D. Wegmann, D. Kessner,<br />
M. G. Ehm, M. R. Nelson, P. L. St. Jean, G. Abecasis, J.<br />
Novembre, S. Zöllner, J. Z. Li.<br />
477F Sequencing the unsequenceable: Expanded CGG<br />
repeats in the human FMR1 gene. P. Hagerman, J. Eid, P.<br />
Peluso, D. Rank, J. Yin, L. Hickey, E. Loomis.<br />
478W Three novel NR5A1 gene mutations in<br />
patients with 46,XY karyotype and disorders <strong>of</strong> sex<br />
development. H. C. Fabbri, J. G. Andrade, A. T. Maciel-<br />
Guerra, G. Guerra-Junior, M. P. de Mello.<br />
479F A deletion and a novel nonsense SRY mutation<br />
in 46,XY Brazilian patients with disorder <strong>of</strong> sex<br />
development. C. S. C. Piveta, B. P. B. Araújo, P. D.<br />
Pereira, F. B. Coeli-Lacchini, A. T. Maciel-Guerra, G.<br />
Guerra-Junior, I. L. Monlleó, M. P. de Mello.<br />
480W Whole genome sequencing in autism identifies<br />
hotspots for germline mutation. J. Michaelson, H.<br />
Zheng, M. Gujral, Y. Shi, D. Malhotra, X. Jin, D. Greer,<br />
A. Bhandari, R. Corominas, A. Peoples, A. Koren, S.<br />
McCarroll, L. Iakoucheva, Y. Li, J. Wang, J. Sebat.<br />
481F Molecular basis <strong>of</strong> male infertility: An Indian<br />
perspective. H. Sharma, R. Prasad, R. Mohan, S. K. Singh.<br />
482W Phase-defined complete HLA genotyping by<br />
amplicon sequencing and read-backed phasing. K.<br />
Hosomichi, T. Hayano, I. Inoue.<br />
483F Characterization <strong>of</strong> sequence variants from the first<br />
direct-to-consumer exome pilot project. A. Shmygelska,<br />
E. Harrington, C. McLean, A. Chowdry, B. Naughton.<br />
484W Targeted sequencing applications and project<br />
design. R. Fulton.<br />
485F Inverted low-copy repeats and genome<br />
instability: A genome-wide analysis. T. Gambin, P.<br />
Dittwald, C. Gonzaga-Jauregui, C. M. B. Carvalho, J. R.<br />
Lupski, A. Gambin, P. Stankiewicz.<br />
486W DNA from 1D to 3D: Effect <strong>of</strong> single nucleotide<br />
change on DNA conformational structure. P. W. Yim, C.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
130 POSTER SESSIONS<br />
Liu, C. Woo, Y. Shi, J. Stevens, S. Dong.<br />
487F Analysis <strong>of</strong> dinucleotide mutation rates and<br />
composition <strong>of</strong> human genome. G. Zhang, D. W. Nebert.<br />
488W The L141R and G153D variations associated with<br />
exfoliation glaucoma do not affect enzymatic functions<br />
<strong>of</strong> the lysyl oxidase-like protein 1. Y. Kim, S. Kim.<br />
489F Exploration <strong>of</strong> HIV susceptibility by exome<br />
sequencing. S. Liu, W. Scott, D. Dykxhoorn.<br />
490W Linkage disequilibrium analysis <strong>of</strong><br />
polymorphisms <strong>of</strong> FRAS1 related extracellular matrix 1<br />
(FREM1). J. F. Tuff, N. Kaplonski, V. Ly, B. Liang, S. Tyler, F.<br />
A. Plummer, M. Luo.<br />
491F Exome sequencing <strong>of</strong> subjects with familial<br />
1q21.1 CNV and variable phenotype. C. Harvard, F. Mo,<br />
F. Tang, Y. Qiao, S. Hamilton, S. Marles, B. McGillivary, C.<br />
Colins, M. E. S. Lewis, P. Pavlidis, E. Rajcan-Separovic.<br />
492W Deep resequencing <strong>of</strong> the NOS2 gene suggests<br />
multiple potential mechanisms underlying the<br />
association <strong>of</strong> several complex diseases with a<br />
common synonymous SNP. L. Wang, J. Santos, A.<br />
Dressen, A. Mehta, M. Pericak-Vance, J. Vance, W. Scott.<br />
493F Characteristics and analysis <strong>of</strong> exonic SNPs and<br />
indels discovered by low-pass and exome sequencing.<br />
J. Schmidt, J. Gollub, J. Barts, C. Davies, B. Wong, R.<br />
Shigeta, G. Hsiao, M. Nitzberg, E. Shell, J. Peete, S. Hsu,<br />
A. Kohli, T. Ha, D. Brown, L. Bellon, T. Webster.<br />
494W Somatic mosaicism in the blood compartment <strong>of</strong><br />
a 115-year-old woman. H. Holstege, D. Sie, W. Pfeiffer,<br />
T. Nicholas, M. A. Miller, T. Harkins, C. Lee, T. Ross, B.<br />
Ylstra, H. Meijers-Heijboer, M. Reinders, G. Holstege, E.<br />
Sistermans, S. Levy.<br />
495F High-resolution melting analysis <strong>of</strong> STAT3 involved<br />
in autosomal dominant hyper IgE syndrome using<br />
bulge-inducing primers to eliminate polymorphisms<br />
and snapback primers for genotyping. M. T. Seipp, N. H.<br />
Augustine, A. Kumanovics, H. R. Hill, C. T. Wittwer.<br />
496W PON-P: Integrated predictor for pathogenicity <strong>of</strong><br />
missense variants. M. Vihinen, A. Olatubosun, J. Väliaho,<br />
J. Härkönen, J. Thusberg.<br />
497F Data submissions to EBI variation archives.<br />
I. Lappalainen, V. Kumanduri, J. Almeida-King, L. Skipper,<br />
J. D. Spalding, M. Maguire, P. Flicek.<br />
498W The power <strong>of</strong> large numbers: frequencies <strong>of</strong> rare<br />
pathogenic mutations in the 23andMe database. E. R.<br />
Chang, D. A. Hinds, N. Eriksson, J. M. Macpherson, C. B.<br />
Do, B. T. Naughton.<br />
499F Finding from CAGI: The Critical Assessment <strong>of</strong><br />
Genome Interpretation, a community experiment to<br />
evaluate phenotype prediction. S. Brenner, S. Repo, J.<br />
Moult, CAGI Participants.<br />
500W Polymorphic regulation <strong>of</strong> gene expression by<br />
the histone demethylase KDM4C. B. L. Gregory, V. G.<br />
Cheung.<br />
501F Mitochondrial sequence variation in twins.<br />
Y. Bouhlal, S. Martinez, H. Gong, K. Dumas, J. T. C. Shieh.<br />
502W Polymorphisms in primer binding site affect<br />
genotyping accuracy <strong>of</strong> FCGR2B rs1050501 in<br />
Caucasians. J. M. Reynolds.<br />
503F Identification <strong>of</strong> rare variants contributing to<br />
pain sensitivity in the normal population: an exome<br />
sequencing study. B. Zhang, F. M. K. Williams, S. Scollen,<br />
D. Coa, Y. Memari, C. Hyde, Y. Shi, J. Harris, I. Harrow, A.<br />
Malarstig, B. Dougherty, R. McEwen, J. C. Stephens, K.<br />
Patel, C. Menni, D. Hodgkiss, G. Surdulescu, W. He, B.<br />
Sidders, D. Ziemek, N. Soranzo, X. Jin, S. B. McMahon, S.<br />
L. John, J. Wang, T. D. Spector.<br />
504W Discovering retrotransposon insertion<br />
polymorphisms associated with human phenotypes by<br />
TIP-chip. T. D. Babatz, D. Avramopoulos, J. D. Boeke, K.<br />
H. Burns.<br />
505F Fork stalling and template switching mechanism<br />
generates a novel rearrangement associated with<br />
incontinentia pigmenti. M. I. Conte, S. Raimo, M.<br />
Paciolla, A. Pescatore, E. Esposito, M. G. Miano, F. Fusco,<br />
M. V. Ursini.<br />
506W The ENCODE effort combining RNA-seq and<br />
RT-PCR-seq allows to catalog thousands <strong>of</strong> novel<br />
lncRNAs. C. Howald, A. Tanzer, J. Chrast, F. Kokocinski,<br />
T. Derrien, N. Walters, J. Manuel Gonzalez, A. Frankish, B.<br />
L. Aken, T. Hourlier, J. Vogel, S. White, S. M. J. Searle, J.<br />
Harrow, T. Hubbard, R. Guigò, A. Reymond.<br />
507F Evolution <strong>of</strong> microRNA-3’UTR interactions and<br />
their impact on whole transcriptome regulation. A. Z.<br />
Pietrzykowski, E. Kruse, N. Kinstlinger, L. Tejeda, S.<br />
Hamza, Y. Wang.<br />
508W Let-7 coordinately downregulates genes on<br />
the amino acid sensing pathway to repress mTOR<br />
and activate neuronal autophagy. A. N. Dubinsky,<br />
S. Djakovic, R. Zahra, C. Hsu, B. E. Morrison, A. R. La<br />
Spada.<br />
509F Deep sequencing <strong>of</strong> hypoxic breast cancer<br />
reveals deregulation <strong>of</strong> non-coding RNAs, non ploy-A<br />
RNAs and natural anti-sense transcripts. H. Choudhri,<br />
C. Camps, J. Shoedel, S. Oikonomopoulos, L. Winchester,<br />
F. Buffa, D. Moralli, E. Volpi, P. Ratcliffe, A. Harris, D. Mole,<br />
J. Ragoussis.<br />
510W Integrative annotation and functional<br />
characterization <strong>of</strong> human long non-coding RNAs in<br />
bladder cancer. W. Tang, L. Prokunina-Olsson.<br />
511F microRNA-xx regulates vascular smooth muscle<br />
cell phenotypes and prevents neointimal formation.<br />
Y. Wang, H. Wang, Y. Liao, P. Tsai, K. Chen, H. Cheng, R.<br />
Lin, S. Juo.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
512W Comparative analysis <strong>of</strong> strand-specific RNA<br />
sequencing approaches. D. Munafo, P. Liu, C. Sumner,<br />
L. Apone, B. Langhorst, E. Yigit, L. Merrill, F. Stewart, E.<br />
Dimalanta, T. Davis.<br />
513F microRNAs modulating the expression <strong>of</strong> FMR1<br />
mRNA: Implications in the pathophysiology <strong>of</strong> FXTAS.<br />
S. Zongaro, R. Hukema, L. Davidovic, S. D’Antoni, M. V.<br />
Catania, R. Willemsen, B. Mari, B. Bardoni.<br />
514W Dysfunction <strong>of</strong> miRNAs biogenesis in association<br />
with neuronal differentiation in focal cortical dysplasia.<br />
S. H. Avansini, F. R. Torres, D. B. Dogini, F. Rogério, A. C.<br />
Coan, R. Secolin, C. S. Rocha, A. F. Costa, A. L. F. Costa,<br />
A. C. S. Piaza, L. A. M. Reis, E. P. L. Oliveira, H. Tedeschi,<br />
L. S. Queiroz, F. Cendes, I. Lopes-Cendes.<br />
515F Genome-wide miRNA signatures <strong>of</strong> human<br />
longevity. A. ElSharawy, A. Keller, F. Flachsbart, A.<br />
Wendschlag, G. Jacobs, N. Kefer, T. Brefort, P. Leidinger,<br />
C. Backes, E. Meese, S. Schreiber, P. Rosenstiel, A.<br />
Franke, A. Nebel.<br />
516W Peripheral blood mononuclear cells microRNAs<br />
predict treatment outcome <strong>of</strong> chronic hepatitis C. E.<br />
Hsi, C. Huang, M. Yu, C. Dai, S. Juo, C. Chou, J. Huang,<br />
W. Chuang.<br />
517F Copy number variation <strong>of</strong> miRNA in individuals<br />
with intellectual disability. Y. Qiao, C. Harvard, E.<br />
Mercier, S. Lewis, P. Pavlidis, E. Rajcan-Separovic.<br />
518W Novel human variation in microRNAs associated<br />
with disease, biomarkers, and drug metabolism. R. Afi<br />
Rawlings-Goss, S. Tishk<strong>of</strong>f.<br />
519F The tale about MIR147B regulate catalase AEI by<br />
one SNP in the 5’- UTR. Z. Wang, B. Wang, K. Zhang, L.<br />
Jin, W. Huang.<br />
520W Inactivation <strong>of</strong> the miR-183/96/182 cluster results<br />
in syndromic retinal degeneration: The miR-183/96/182<br />
cluster is required for normal function <strong>of</strong> the retina and<br />
other sensory organs. S. Xu, S. Lumayag, C. Haldin, C.<br />
Cowan, B. Kovacs, P. Larsen, D. Valle, P. D. Witmer.<br />
521F microRNA analysis in human ocular scleral<br />
tissue. T. Young, X. Luo, F. Hawthorne, S. Feng, P.<br />
Gonzalez.<br />
522W Founder mutation in a transposable element<br />
leads to the identification <strong>of</strong> a long noncoding RNA in a<br />
progressive infantile encephalopathy. A. Henrion Caude,<br />
P. Munier, E. Benko, S. Hanein, E. Westh<strong>of</strong>, N. Boddaert,<br />
I. Desguerre, S. Bandiera, M. Girard, D. Rodriguez, A.<br />
Munnich, M. Fähling, S. Lyonnet, F. Cartault.<br />
523F <strong>Human</strong> single nucleotide polymorphisms<br />
influence non-coding RNA expression. V. Magadi<br />
Gopalaiah, H.-J. Westra, J. Karjalainen, D. V. Zhernakova,<br />
B. Hrdlickova, R. Almeida, A. Zhernakova, M. H. H<strong>of</strong>ker, J.<br />
Fu, S. With<strong>of</strong>f, L. Franke, C. Wijmenga.<br />
524W Identifying source locations for Alu transcripts<br />
within human testes. S. Linker, P. Deininger, D. Hedges.<br />
POSTER SESSIONS 131<br />
525F The genetic basis <strong>of</strong> human drug response<br />
variation. M. Kaganovich, D. Spacek, M. Snyder.<br />
526W Dietary protein regulates gene expression <strong>of</strong><br />
amino acid-degrading enzymes through PPARa. A. V.<br />
Contreras, C. Rangel, V. Ortiz, G. Aleman, B. Palacios, E.<br />
Tejero, N. Torres, A. R. Tovar.<br />
527F Patterns <strong>of</strong> allele-specific gene expression in ten<br />
human tissues. K. R. Kukurba, T. Nance, R. Piskol, M. H.<br />
Tan, J. B. Li, S. B. Montgomery.<br />
528W Gene expression variation in the response <strong>of</strong><br />
human monocyte-derived dendritic cells to LPS and<br />
influenza dNS1 stimulation. M. N. Lee, C. Ye, A. C.<br />
Villani, W. Li, P. I. Chipendo, M. H. Lee, P. L. De Jager, C.<br />
O. Benoist, A. Regev, N. Hacohen.<br />
529F Gene expression pr<strong>of</strong>iling in a large cohort <strong>of</strong><br />
Europeans with Sjögren’s syndrome reveals viral,<br />
immune, and interferon-related pathways. J. A. Ice,<br />
H. Li, J. A. Kelly, I. Adrianto, S. B. Glenn, K. S. Hefner, E.<br />
S. Vista, D. U. Stone, R. Gopalakrishnan, G. D. Houston,<br />
D. M. Lewis, M. D. Rohrer, P. Hughes, J. B. Harley, C. G.<br />
Montgomery, J. Chodosh, J. A. Lessard, J.-M. Anaya,<br />
B. M. Segal, N. L. Rhodus, L. Radfar, M. B. Frank, R. H.<br />
Sc<strong>of</strong>ield, C. J. Lessard, K. Moser Sivils.<br />
530W A normalization procedure for removal <strong>of</strong><br />
residual multiplex PCR amplification bias from ultradeep<br />
sequencing <strong>of</strong> the TCR repertoire. M. J. Rieder,<br />
C. Carlson, A. Sherwood, R. Emerson, C. Desmaris, M.<br />
Chung, J. Parsons, M. LaMadrid-Herrmannsfeldt, D.<br />
Williamson, R. Livingston, H. Robins.<br />
531F Expression QTL analysis <strong>of</strong> a gene expression<br />
signature which predicts advanced non-alcoholic fatty<br />
liver disease. M. Garrett, C. Moylan, J. Gibson, H. Yang,<br />
H. Pang, A. Dellinger, A. Suzuki, H. Tillmann, C. Guy, M.<br />
Abdelmalek, S. Murphy, A. Diehl, M. Hauser, A. Ashley-<br />
Koch.<br />
532W Bead-based method for capturing specific<br />
microRNA in human urine: A non invasive way <strong>of</strong><br />
detecting clinical conditions. M. Rath, T. Xu, C. Trinh, K.<br />
Tran, J. Stevens, A. Shi, M.-P. Gauthier.<br />
533F Experimental depletion and regeneration <strong>of</strong> human<br />
mitochondrial DNA to investigate its role in nuclear<br />
gene regulation. S. Kumar, C. Bellis, M. P. Johnson, H. H.<br />
H. Goring, T. D. Dyer, J. Blangero, J. E. Curran.<br />
534W Primary mitochondrial diseases dysregulate the<br />
transcriptional and post-transcriptional regulatory<br />
systems in a tissue-specific pattern. Z. Zhang, M.<br />
Tsukikawa, E. Polyak, J. Ostrovsky, C. Clarke, E. Place, E.<br />
Rappaport, G. Reiner, M. Yudk<strong>of</strong>f, R. Naviaux, R. Haas, J.<br />
Baur, M. Falk.<br />
535F Genetic variation in expression response to<br />
endoplasmic reticulum stress in human B cells. W.<br />
Bernal, M. Morley, V. Cheung.<br />
536W Dynamic network connectivity mapping <strong>of</strong><br />
T-cell activation in Caucasians and African <strong>American</strong>s<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
132 POSTER SESSIONS<br />
identifies a common set <strong>of</strong> asthma-associated hub<br />
genes. J. Chu, W. Qiu, V. Carey, K. Barnes, C. Ober, F.<br />
Martinez, R. Lemanske, A. Liu, S. London, S. Weiss, B. Raby.<br />
537F Immunity genes and pathways are associated<br />
with human microbiome composition at host body<br />
sites. R. Blekhman, J. Goodrich, K. Huang, R. Bukowski,<br />
Q. Sun, R. E. Ley, D. Gevers, A. G. Clark.<br />
538W Ribosome footprints on Williams syndrome<br />
region genes in the mouse brain. R. Weiss, M. Howard,<br />
L. Dai, J. Korenberg.<br />
539F Regulatory mutations in the 5’UTR <strong>of</strong> NMNAT1,<br />
encoding the nuclear is<strong>of</strong>orm <strong>of</strong> nicotinamide<br />
nucleotide adenylyltransferase 1, cause Leber<br />
congenital amaurosis. F. Coppieters, A. Baert, C. Van<br />
Cauwenbergh, M. Bauwens, S. De Jaegere, T. de Ravel,<br />
F. Meire, N. Abdelmoula Bouayed, L. Florentin-Arar, B. P.<br />
Leroy, E. De Baere.<br />
540W Disruption <strong>of</strong> a cis-acting microRNA site in<br />
FMR1 results in reduced translation <strong>of</strong> an FMRP<br />
reporter. J. Suhl, R. Muddashetty, G. Bassell, S.<br />
Warren.<br />
541F Is the biosynthesis <strong>of</strong> the major phospholipid<br />
class phosphatidylcoline in mammalian cells regulated<br />
by microRNA? K. Hokynar, S. Hänninen, M. Hermansson,<br />
P. Somerharju.<br />
542W Poly(A) binding protein nuclear 1 levels affect<br />
alternative polyadenylation. E. de Klerk, A. Venema, S.<br />
Y. Anvar, J. J. Goeman, O. Hu, J. T. den Dunnen, S. M. van<br />
der Maarel, V. Raz, P. A. C. ‘t Hoen.<br />
543F Identification <strong>of</strong> human RNA editing sites<br />
using publically available RNA-sequencing data.<br />
G. Ramaswami, J. B. Li.<br />
544W <strong>Human</strong> ADAR proteins regulate RNA editing and<br />
gene expression as revealed in systems study. I. Wang,<br />
J. Toung, A. Richards, E. So, Y. Zhao, W. Ankener, J.<br />
Devlin, Y. Liu, V. Cheung.<br />
545F Integrating functional and computational<br />
genomics to develop neuronal regulatory vocabularies.<br />
X. Reed, L. Taher, G. M. Burzynski, C. Fletez-Brant,<br />
D. Lee, D. S. Gary, M. A. Beer, I. Ovcharenko, A. S.<br />
McCallion.<br />
546W Transcriptome genomic analysis using RNA-seq<br />
in three tissues <strong>of</strong> a twin cohort. A. Buil, A. Brown, M.<br />
Davies, A. Viñuela, M. Gallardo, D. Glass, M. Blasco, R.<br />
Durbin, T. D. Spector, E. T. Dermitzakis for EUROBATS<br />
Consortium.<br />
547F The genetics <strong>of</strong> gene expression, splicing and<br />
transcriptional efficiency through poly-A selection<br />
and ribosomal depletion RNA sequencing in humans.<br />
M. Pala, M. Marongiu, A. Mulas, R. Cusano, F. Crobu, F.<br />
Reinier, R. Berutti, M. G. Piras, C. Joens, D. Schlessinger,<br />
G. Abecasis, A. Angius, S. Sanna, F. Cucca, S. B.<br />
Montgomery.<br />
548W Quantification <strong>of</strong> chitinase transcripts in human<br />
tissues. M. Ohno, K. Tsuda, M. Sakaguti, Y. Sugahara, F.<br />
Oyama.<br />
549F Two functional variants in the promoter region <strong>of</strong><br />
UBE2L3 confer risk for systemic lupus erythematosus.<br />
S. Wang, G. B. Wiley, F. Wen, J. Warner, J. Robertson, J.<br />
M. Guthridge, M. Dozmorov, J. D. Wren, J. A. James, P.<br />
M. Gaffney.<br />
550W A 660 kb deletion centromeric to the lamin B1<br />
gene (LMNB1) mimics LMNB1 duplication and causes<br />
adult-onset autosomal dominant leukodystrophy.<br />
E. Giorgio, D. Robyr, E. Di Gregorio, D. Lacerenza, G.<br />
Vaula, A. Brusco, S. E. Antonarakis, A. Brussino.<br />
551F Variation in transcription factor binding among<br />
humans. F. Grubert, M. Kasowski, C. Heffelfinger, M.<br />
Hariharan, A. Asabere, S. Waszak, L. Habegger, J.<br />
Rozowsky, M. Shi, A. Urban, M. Hong, K. Karczewski, W.<br />
Huber, S. Weissman, M. Gerstein, J. Korbel, M. Snyder.<br />
552W Widespread R-loop formation in the human<br />
genome: Implications for epigenetic control and<br />
beyond. Y. Lim, P. Ginno, P. Lott, I. Korf, F. Chedin.<br />
553F Genome-wide transcriptome pr<strong>of</strong>iling reveals the<br />
functional impact <strong>of</strong> rare de novo and recurrent CNVs<br />
in autism spectrum disorders. R. Luo, S. Sanders, Y.<br />
Tian, I. Voineagu, N. Huang, S. Chu, L. Klei, C. Cai, J. Ou,<br />
J. Lowe, M. Hurles, B. Devlin, M. State, D. Geschwind,<br />
ACE Network Consortium.<br />
554W Transcriptional alterations underlying variable<br />
phenotypic expressivity associated with 16p11.2<br />
microdeletion/microduplication syndrome within<br />
multiplex autism families. I. Blumenthal, J. Z. Levin, Y.<br />
Shen, C. Ernst, C. C. Morton, J. F. Gusella, M. E. Talkowski.<br />
555F Differential reduced expression <strong>of</strong> IRS-1 in<br />
visceral and subcutaneous adipose depots in morbidly<br />
obese and type2 diabetic subjects and their correlation<br />
with metabolic pr<strong>of</strong>iles with 2 novel mutations<br />
sequenced in Asian Indians. M. Sharma, K. Luthra, S.<br />
Aggarwal, N. Vikram, A. Misra.<br />
556W Quantitative analysis <strong>of</strong> the human beta cell<br />
transcriptome. A. C. Nica, H. Ongen, J. Irminger, S.<br />
Dupuis, A. Planchon, L. Romano, S. E. Antonarakis, P. A.<br />
Halban, E. T. Dermitzakis.<br />
557F Novel sequence motif regulates pluripotency. Y.<br />
Song, S. Bao, G. Niu, Y. Zhao, H. Zhu.<br />
558W Quantitative expression analysis <strong>of</strong> mouse<br />
chitinases: Acidic mammalian chitinase is the major<br />
transcript in stomach. F. Oyama, M. Ohno, K. Tsuda, M.<br />
Sakaguchi, Y. Sugahara.<br />
559F The Japanese firefly, Luciola cruciata, gene:<br />
Small intron and their insufficiency <strong>of</strong> splicing in CHO<br />
cells. M. Ishii, R. Kojima, S. Fukuda, M. Sakaguchi, Y.<br />
Sugahara, M. Kamaya, F. Oyama.<br />
560W Expression QTL interactions in a cohort <strong>of</strong> 869<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
individuals reveals sex specific, cis-cis, trans-cis and<br />
trans-trans interactions. J. Bryois, A. Buil, D. M. Evans,<br />
D. F. Conrad, S. M. Ring, M. Hurles, P. Deloukas, G. D.<br />
Smith, E. T. Dermitzakis.<br />
561F Tissue-specific effects <strong>of</strong> genetic variation and<br />
DNA methylation on gene regulation. E. T. Dermitzakis,<br />
M. Gutierrez-Arcelus, S. B. Montgomery, T. Lappalainen,<br />
H. Ongen, A. Yurovsky, J. Byrois, A. Buil, T. Giger, L.<br />
Romano, A. Planchon, E. Falconnet, I. Padioleau, C.<br />
Borrel, A. Letourneau, P. Makrythanasis, M. Guipponi, C.<br />
Gehrig, S. E. Antonarakis.<br />
562W Multi-scale integration systematically connects<br />
disease-associated variants to molecular pathology.<br />
K. J. Karczewski, J. T. Dudley, R. Chen, A. J. Butte, M.<br />
Snyder.<br />
563F Analysis <strong>of</strong> primary natural killer cells reveals<br />
multiple novel cell-specific eQTL. S. Makino, B. P.<br />
Fairfax, E. Ng, J. C. Knight.<br />
564W The impact <strong>of</strong> polymorphisms within probe<br />
sequences on expression QTL studies. A. Ramasamy,<br />
D. Trabzuni, R. J. Gibbs, A. Dillman, D. G. Hernandez,<br />
S. Arepalli, R. Walker, C. Smith, A. A. Shabalin, Y. Li, A.<br />
B. Singleton, M. R. Cookson, J. Hardy, M. Ryten, M. E.<br />
Weale, North <strong>American</strong> Brain Expression Consortium and<br />
UK Brain Expression Consortium.<br />
565F PGC-1a regulates TFEB to promote autophagy<br />
lysosome-mediated turnover <strong>of</strong> aggregate-prone<br />
neurodegenerative disease proteins. T. Tsunemi, B. E.<br />
Morrison, T. D. Ashe, A. R. La Spada.<br />
566W The SLE associated TT.A polymorphism<br />
downstream <strong>of</strong> TNFAIP3 demonstrates lower affinity<br />
for NF- B and SATB1 and reduced enhancer activity.<br />
F. Wen, A. K. Templeton, S. Wang, J. M. Guthridge, M. B.<br />
Humphrey, P. M. Gaffney.<br />
567F Transcriptome and genome sequencing<br />
uncovers functional variation in human populations.<br />
T. Lappalainen, M. Sammeth, N. Kurbatova, J. Monlong,<br />
M. Friedländer, M. A. Rivas, T. Wieland, O. Karlberg,<br />
M. Barann, P. A. C. ‘t Hoen, T. Griebel, M. Sultan, D.<br />
MacArthur, E. Lizano, T. Strom, S. Schreiber, H. Lerach, S.<br />
E. Antonarakis, G. J. van Ommen, R. Sudbrak, R. Häsler,<br />
A. Brazma, A.-C. Syvänen, P. Rosenstiel, T. Meitinger,<br />
R. Guigo, I. Gut, X. Estivill, E. T. Dermitzakis, Geuvadis<br />
Consortium.<br />
568W Impact <strong>of</strong> private variants on human<br />
transcriptome architecture. X. Li, K. Karczewski, K.<br />
Smith, K. Kukurba, S. Montgomery.<br />
569F Predicting disease-relevant cis-regulatory<br />
SNPs via tissue-specificity <strong>of</strong> allelic expression and<br />
chromatin state. N. Light, V. Adoue, P. Lundmark, B. Ge,<br />
T. Kwan, A.-C. Syvänen, T. Pastinen.<br />
570W Characterization <strong>of</strong> the basic regulatory<br />
elements involved in the regulation <strong>of</strong> OTC gene<br />
expression in human. O. Luksan, L. Dvorakova,<br />
M. Jirsa.<br />
POSTER SESSIONS 133<br />
571F Regulatory impact <strong>of</strong> alternative polyadenylation<br />
in human B-lymphoblastoid cells. O. K. Yoon, T. Y. Hsu,<br />
J. H. Im, R. B. Brem.<br />
572W Identification <strong>of</strong> a novel CFTR mRNA is<strong>of</strong>orm<br />
in nasal epithelial cells. A. Hinzpeter, A. de Becdelièvre,<br />
E. Bieth, F. Brémont, C. Costa, C. Gameiro, A. Aissat, M.<br />
Goossens, P. Fanen, E. Girodon.<br />
573F Cytokine induced genetic-epigenetic interactions<br />
at autoimmune thyroiditis susceptibility gene variants.<br />
M. Stefan, W. Zang, M. Keddache, Y. Tomer.<br />
574W DMD transcript imbalance regulates dystrophin<br />
levels. P. Spitali, J. C. van den Bergen, B. Wokke, A. A. M.<br />
Janson, R. van den Eijnde, J. J. G. M. Verschuuren, J. T.<br />
den Dunnen, P. A. C. ‘t Hoen, A. Aartsma-Rus.<br />
575F Protein inhibitor <strong>of</strong> activated STAT3 modulates<br />
the activity <strong>of</strong> anterior segment dysgenesis<br />
transcription factors in trabecular meshwork cells.<br />
T. Footz, L. Huang, M. Walter.<br />
576W Statin-induced alternative splicing in HepG2<br />
cells. C. Stormo, M. K. Kringen, O. K. Olstad, J. P. Berg,<br />
A. P. Piehler.<br />
577F Functional RNA editing sites identified by<br />
comparative transcriptome analysis. R. Zhang, G.<br />
Ramaswami, L. P. Keegan, T. Deng, M. A. O’Connell, J.<br />
B. Li.<br />
578W Meta-analysis <strong>of</strong> transcriptome data using<br />
pathway-based approach reveals biologically relevant<br />
asthma genes. T. Mersha, S. Amirisetty, G. Hershey.<br />
579F Whole transcriptome analysis <strong>of</strong> velocardi<strong>of</strong>acial<br />
syndrome using next-generation sequencing. Y. Zhang,<br />
J. Jin, X. Zhu, M. Haney, Y. Kluger, S. Weissman, A. Urban.<br />
580W Genome-wide search for novel human uORFs<br />
and N-terminal protein extensions using ribosomal<br />
footprinting. J. Hampe, C. Fritsch, A. Herrmann, M.<br />
Nothnagel, K. Szafranski, K. Huse, S. Schreiber, M. Platzer,<br />
M. Krawczak, M. Brosch.<br />
581F Variation in protein levels and its genetic<br />
determination in human lymphoblastoid cell lines. L.<br />
Wu, S. I. Candille, Y. Choi, H. Tang, M. Snyder.<br />
582W The impact <strong>of</strong> loss <strong>of</strong> function variants on the<br />
transcriptome. M. A. Rivas, T. Lappalainen, M. Sammeth,<br />
D. G. MacArthur, N. Kurbatova, T. Wieland, M. Lek, T.<br />
Griebel, M. Barann, M. Sultan, J. Carlsson, P. Hoen, T.<br />
Strom, S. Schreiber, H. Lehrach, S. E. Antonarakis, G. van<br />
Ommen, R. Sudbrak, R. Hasler, A. Brazma, A.-C. Syvänen,<br />
P. Rosenstiel, T. Meitinger, R. Guigo, I. Gut, X. Estivill, M. I.<br />
McCarthy, E. T. Dermitzakis, Geuvadis Consortium.<br />
583F Mapping cis and trans regulatory effects across<br />
multiple tissues in twins: The MuTHER Study. K. Small,<br />
E. Grundberg, A. Hedman, A. Nica, A. Buil, S. Keildson,<br />
J. Bell, T. Yang, A. Barrett, J. Nisbet, D. Meduri, S.-Y.<br />
Shin, D. Glass, J. Min, L. Parts, L. Tsaprouni, F. Nestle,<br />
S. O’Rahilly, N. Soranzo, C. M. Lindgren, K. Zondervan,<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
134 POSTER SESSIONS<br />
K. Ahmadi, E. Schadt, K. Stefansson, G. Davey Smith,<br />
M. McCarthy, P. Deloukas, E. Dermitzakis, T. Spector,<br />
MuTHER Consortium.<br />
584W Identifying age- and sex-associated gene<br />
expression pr<strong>of</strong>iles in .7,000 whole-blood samples.<br />
M. J. Peters, R. Joehanes, T. Esko, K. Heim, H. Völzke,<br />
L. Pilling, J. Brody, Y. F. Ramos, B. E. Stranger, M. W.<br />
Christiansen, S. Gharib, R. Hanson, A. H<strong>of</strong>man, J.<br />
Kettunen, D. Levy, P. Munson, C. O’Donnell, B. Psaty, F.<br />
Rivadeneira, A. Suchy-Dicey, A. G. Uitterlinden, H. Westra,<br />
I. Meulenbelt, D. Enquobahrie, T. Frayling, A. Teumer, H.<br />
Prokisch, A. Metspalu, J. B. J. Van Meurs, A. D. Johnson<br />
on behalf <strong>of</strong> CHARGE Gene Expression Working Group.<br />
585F Simplified sample preparation and streamlined<br />
library preparation method for deep sequencing<br />
ribosome protected mRNA fragments. R. Vaidyanathan,<br />
S. Kuersten, A. Radek, S. Swami, D. Vo, L. Penalva.<br />
586W <strong>Genetics</strong> and epigenetic regulation <strong>of</strong> eukaryotic<br />
transcriptome. Y. Wakabayashi, T. Ni, D. Corcoran, W.<br />
Yang, U. Ohler, W. Peng, C. O’Donnell, J. Zhu.<br />
587F Differential protein expression in human-induced<br />
pluripotent and embryonic stem cells. S. Brown-Ford,<br />
M. Pellitteri-Hahn, A. De La Forest, B. Halligan, S. Duncan,<br />
M. Olivier.<br />
588W Understanding the molecular mechanisms<br />
underlying autism spectrum disorders using iPSCderived<br />
neurons. B. A. DeRosa, J. M. Van Baaren, G.<br />
K. Dubey, J. M. Lee, M. L. Cuccaro, J. M. Vance, M. A.<br />
Pericak-Vance, D. M. Dykxhoorn.<br />
589F Whole exome sequencing in familial non-HHT<br />
brain arteriovenous malformations. N. Bendjilali,<br />
L. Tang, D. E. Guo, R. Hernandez, M. Segal, C. E.<br />
McCulloch, S. Inoue, A. Koizumi, W. L. Young, L.<br />
Pawlikowska, H. Kim.<br />
590W The investigation <strong>of</strong> angiotensin converting<br />
enzyme I/D and plasminogen activator inhibitor-1<br />
4G/5G polymorphisms in venous thromboembolism<br />
patients in Turkish patients. H. Salifoglu, H. Kaya, M.<br />
Karkucak, D. Torun, Y. Tunca.<br />
591F Organization <strong>of</strong> alphoid sequence clusters on<br />
human chromosome 21. W. Ziccardi, C. Putonti, J.<br />
Doering.<br />
592W A high-resolution genome-wide map <strong>of</strong> meiotic<br />
double-strand breaks in humans. F. Pratto, K. Brick, P.<br />
Khil, F. Smagulova, G. Petukhova, R. D. Camerini-Otero.<br />
593F Genome-wide scan <strong>of</strong> disease-inversion<br />
association. J. Ma, C. I. Amos.<br />
594W HOXA11 and MMP2 gene expressions in women<br />
with pelvic organ prolapsus. N. Yilmaz, G. Ozaksit, Y. K.<br />
Terzi, S. Yilmaz, B. Budak, O. Aksakal, F. I. Sahin.<br />
595F Large scale whole genome and whole exome<br />
sequencing <strong>of</strong> rhesus monkeys (Macaca mulatta) in<br />
five primate research centers. M. Raveendran, D. Rio<br />
Deiros, G. L. Fawcett, Z. Johnson, N. H. Kalin, R. W.<br />
Wiseman, B. Ferguson, E. Vallender, S. Kanthaswamy, D.<br />
M. Muzny, R. Gibbs, J. Rogers.<br />
596W Whole genome haplotyping by dilution,<br />
amplification and sequencing. F. Kaper, S. Swamy, B.<br />
Klotzle, J. Cottrell, S. Munchel, M. Bibikova, S. Kruglyak,<br />
M. Ronaghi, M. A. Eberle, J. B. Fan.<br />
597F Mechanism and potential diversity <strong>of</strong> T-cell<br />
receptor rearrangement from sequence repertoires.<br />
A. Murugan, T. Mora, A. Walczak, C. Callan.<br />
598W Expression <strong>of</strong> mouse acidic mammalian<br />
chitinase in Escherichia coli and characterization <strong>of</strong> its<br />
properties. A. Kashimura, Y. Kida, M. Ohno, K. Ishikawa,<br />
M. Sakaguchi, F. Oyama.<br />
599F Functional analysis <strong>of</strong> mouse chitinase-like<br />
protein Ym1. Y. Kida, M. Sakaguchi, Y. Sugahara, F.<br />
Oyama.<br />
600F Targeted deep sequencing by mobile element<br />
scanning (ME-Scan) reveals Alu insertions throughout<br />
the genome and around the world. D. J. Witherspoon,<br />
W. S. Watkins, Y. Zhang, J. Xing, M. A. Batzer, L. B. Jorde.<br />
Pharmacogenetics<br />
601T Identification <strong>of</strong> HNRNPA1 as a novel regulator<br />
<strong>of</strong> cholesterol metabolism. C. Yu, E. Theusch, D. A.<br />
Nickerson, K. Lo, M. Kutilova, R. M. Krauss, M. W. Medina.<br />
602T Novel association <strong>of</strong> dual anti-platelet drug<br />
response with a functional variant in PPARG. A. S.<br />
Fisch, J. Liu, J. P. Lewis, L. M. Yerges-Armstrong, J. R.<br />
O’Connell, B. D. Mitchell, R. B. Horenstein, N. Ambulos, K.<br />
Ryan, Q. Gibson, J. Shelton, A. R. Shuldiner.<br />
603T Genetic variations associated with gemcitabine<br />
treatment outcome in pancreatic cancer. L. Li, B.<br />
Fridley, G. Jenkins, E. Carlson, K. Kalari, G. Petersen, R.<br />
McWilliams, L. Wang.<br />
604T Large scale phenotyping using the 1000 Genomes<br />
Project lymphoblastoid cell line panel. D. Spacek, M.<br />
Kaganovich, M. Snyder.<br />
605T The association <strong>of</strong> SLC6A4 with antidepressantinduced<br />
mania: The long and the short <strong>of</strong> it. J. M.<br />
Biernacka, D. L. Walker, J. Geske, S. Winham, S. Crow, M.<br />
Chauhan, S. McElroy, M. Frye.<br />
606T Interactions between polymorphisms in<br />
eicosanoid metabolism genes and vasodilator<br />
responses in humans. L. N. Gordon, C. R. Lee, M.<br />
Pretorius, R. N. Schuck, L. H. Burch, D. C. Zeldin, S. M.<br />
Williams, N. J. Brown.<br />
607T Pharmacogenetics <strong>of</strong> schizophrenia: Predicting<br />
early response to antipsychotic therapy. M. Gupta, S.<br />
Jain, R. Kukreti.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
608T Identification <strong>of</strong> novel polymorphisms associated<br />
with efficiency <strong>of</strong> metformin treatment in type 2<br />
diabetes patients. J. Klovins, L. Tarasova, L. Zarina, V.<br />
Pirags, OPTIMED Consortium.<br />
609T Cholesteryl ester transfer protein polymorphisms,<br />
statin use, and their impact on cholesterol levels and<br />
cardiovascular events. M. Leusink, N. C. Onland-Moret,<br />
F. W. Asselbergs, B. Ding, S. Kotti, N. R. van Zuydam,<br />
A. C. Papp, N. Danchin, L. Donnelly, A. D. Morris, D. I.<br />
Chasman, P. A. F. M. Doevendans, O. H. Klungel, P. M.<br />
Ridker, W. H. van Gilst, T. Simon, F. Nyberg, C. N. A.<br />
Palmer, W. Sadee, P. van der Harst, C. Verstuyft, P. I. W. de<br />
Bakker, A. de Boer, A.-H. Maitland-van der Zee.<br />
610T Association study <strong>of</strong> inflammation-related<br />
genes and depressive disorders and antidepressant<br />
response. M.-W. Lin, Y.-T. Chang, I.-H. Lin, Y.-M. Bai.<br />
611T Are CYP2C9 and VKORC1 polymorphisms<br />
associated with increased bleeding or thrombosis risk<br />
among Blacks receiving warfarin anticoagulation? F.<br />
Mili, T. A. Deans, W. C. Hooper, P. Weinstein, C. Lally, H.<br />
Austin, N. Wenger.<br />
612T Twelve candidate genes and antidepressant<br />
response in obsessive-compulsive disorder. G. Zai, E.<br />
Brandl, J. Deluce, J. L. Kennedy, M. A. Richter.<br />
613T A genome-wide integrative study <strong>of</strong> microRNAs<br />
in human liver. W. Liu, F. Innocenti, E. Gamazon, S.<br />
Mirkov, J. Ramirez, S. Huang, N. Cox, M. Ratain.<br />
614T Protein quantitative trait loci identify novel<br />
proteins predictive for chemotherapeutic induced<br />
phenotypes. A. L. Stark, R. J. Hause, Jr., L. K. Gorsic,<br />
N. N. Antao, S. S. Wong, D. F. Gill, S. H. Chung, S. M.<br />
Delaney, C. D. Brown, K. P. White, R. B. Jones, M. E.<br />
Dolan.<br />
615T Functional genetic variation in RHOA is<br />
associated with the cholesterol-lowering effects <strong>of</strong><br />
statin treatment. E. Theusch, D. Naidoo, F. Bauzon, K.<br />
Stevens, L. Mangravite, Y. L. Kuang, R. M. Krauss, M. W.<br />
Medina.<br />
616T The modulation <strong>of</strong> CYP3A4 expression by the<br />
efflux pump ABCB1 in HepG2 cells. W. Shou, B. Wang,<br />
Z. Wang, J. Shi, W. Huang.<br />
617T Genetic determinants <strong>of</strong> dabigatran plasma levels<br />
and their relation to bleeding. G. Pare, N. Eriksson,<br />
T. Lehr, S. Connolly, J. Eikelboom, M. D. Ezekowitz, T.<br />
Axelsson, S. Haertter, J. Oldgren, P. Reilly, A. Siegbahn,<br />
A.-C. Syvänen, C. Wadelius, M. Wadelius, H. Zimdahl-<br />
Gelling, S. Yusuf, L. Wallentin.<br />
618T Genome-wide study <strong>of</strong> resistant hypertension<br />
using existing genomic data and electronic medical<br />
records. L. Dumitrescu, M. D. Ritchie, J. C. Denny, S. J.<br />
Bielinski, P. Peissig, J. A. Pacheco, M. G. Hayes, G. P.<br />
Jarvik, R. Li, I. J. Kullo, C. G. Chute, R. L. Chisholm, E. B.<br />
Larson, C. A. McCarty, D. M. Roden, M. de Andrade, D. C.<br />
Crawford on behalf <strong>of</strong> eMERGE Network.<br />
POSTER SESSIONS 135<br />
619T Genetic and clinical determinants <strong>of</strong> warfarin<br />
dose: A RE-LY genomics substudy. N. Eriksson, L.<br />
Wallentin, L. Berglund, T. Axelsson, S. Connolly, M.<br />
Ezekowitz, J. Oldgren, P. Guillaume, P. Reilly, A. Siegbahn,<br />
A.-C. Syvänen, C. Wadelius, S. Yusuf, M. Wadelius.<br />
620T The Kaiser Permanente/UCSF Genetic<br />
Epidemiology Research Study on Adult Health and<br />
Aging: A genome-wide association study <strong>of</strong> quetiapineinduced<br />
weight gain derived from electronic medical<br />
records and outpatient pharmacy data. N. Gonzaludo,<br />
S. Sciortino, L. Walter, N. Risch, P. Y. Kwok, C. Schaefer.<br />
621T Genome-wide association analysis <strong>of</strong> pain<br />
reduction in rheumatoid arthritis patients treated with<br />
anti-TNF medication. M. Umicevic Mirkov, H. Scheffer, S.<br />
Krintel, S. H. Vermeulen, J. Johansen, W. Kievit, M. A. F.<br />
van de Laar, P. C. L. van Riel, B. Franke, M. Hetland, M. J.<br />
H. Coenen.<br />
622T A genome-wide association analysis <strong>of</strong><br />
corticosteroid response in asthmatics. Q. Duan, B. E.<br />
Himes, B. Schuemann, K. G. Tantisira, S. T. Weiss.<br />
623T microRNA-based approach expands on genomewide<br />
association study and identifies SNPs important<br />
for response to glucocorticoids in asthma patients.<br />
H. Im, E. R. Gamazon, D. Lenkala, K. Wu, G. Clemmer, S.<br />
T. Weiss, N. J. Cox, K. Tantisira, R. S. Huang.<br />
624T SLC9A9 variant as a novel biomarker <strong>of</strong> response<br />
to interferon beta: Results from a pharmacogenetic<br />
study on Italian, U.S. and French multiple sclerosis<br />
patients. F. Martinelli Boneschi, F. Esposito, E. Lim, P.<br />
Brambilla, M. Sorosina, M. Romeo, M. Rodegher, N.<br />
Bohossian, N. A. Patsopoulos, B. Kenan, V. Martinelli, D.<br />
Brassat, G. Comi, P. De Jager.<br />
625T Polygenic heritability estimates <strong>of</strong> asthma and<br />
treatment-related phenotypes. M. J. McGeachie, E. A.<br />
Stahl, B. E. Himes, S. A. Pendergrass, M. D. Ritchie, R. M.<br />
Plenge, K. G. Tantisira.<br />
626T Web-based phenotyping yields replication <strong>of</strong><br />
genetic associations with sensitivity to warfarin. J. L.<br />
Mountain, A. K. Kiefer, M. Mullins, T. K. Acquaye, C.<br />
B. Marsh, J. A. Johnson, H. L. McLeod, J. Y. Tung, N.<br />
Eriksson, K. E. Barnholt.<br />
627T Follow-up study <strong>of</strong> genetic risk factors for<br />
carbamazepine-induced cutaneous adverse drug<br />
reactions in Japanese population. T. Ozeki, T. Mushiroda,<br />
A. Takahashi, M. Kubo, Y. Shirakata, Z. Ikezawa, M. Iijima,<br />
T. Shiohara, K. Hashimoto, Y. Nakamura.<br />
628T Re-examination <strong>of</strong> the CATIE pharmacogenetics<br />
whole-genome dataset using a run <strong>of</strong> significiant<br />
findings approach, focus on tardive dyskinesia. C. Zai,<br />
V. Gonçalves, A. Tiwari, G. Oh, V. de Luca, D. Mueller, J.<br />
Knight, J. Kennedy.<br />
629T A Bayesian approach to genome-wide genetic<br />
association studies with survival time as outcome.<br />
L. Chien, I. Chang, C. Hsiung.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
136 POSTER SESSIONS<br />
630T IL28B genotypes associated with IFN-induced<br />
virologic response in clinical studies evaluating<br />
eltrombopag treatment in HCV-infected patients with low<br />
platelet counts. M. Chiano, L. Condreay, L. Briley, D. Pulford,<br />
D. Fraser, K. Johansson, D. Briley, E. Harris, S. Bhatti, D.<br />
Theodore, F. Campbell, S. Vasey, M. Arning, C. Spraggs.<br />
631T Mapping the incidentalome: Quantifying<br />
incidental findings generated through a clinical<br />
pharmacogenomics project. K. B. Brothers, M. J.<br />
Westbrook, M. F. Wright, S. L. Van Driest, T. L. McGregor,<br />
J. C. Denny, R. L. Zuvich, E. W. Clayton.<br />
632T The Coriell Personalized Medicine Collaborative<br />
pharmacogenomics appraisal and evidence scoring<br />
sytem. N. Gharani, M. A. Keller, C. A. Stack, T. J.<br />
Schmidlen, R. S. Kasper, J. P. Jarvis, N. P. Gerry, E. S.<br />
Gordon, M. F. Christman.<br />
633T PharmGKB: From pharmacogenomics knowledge<br />
to clinical interpretation and implementation. L. Gong,<br />
M. Whirl-Carrillo, J. M. Hebert, E. M. McDonagh, K.<br />
Sangkuhl, C. F. Thorn, D. Klein, R. B. Altman, T. E. Klein.<br />
634T Development <strong>of</strong> a scoring tool to prioritize clinical<br />
pharmacogenomic testing. S. F. Manzi.<br />
635T Pharmacogenomic research undertaken by<br />
PharmGKB consortia groups. E. M. McDonagh, M. Whirl<br />
Carrillo, L. Gong, J. M. Hebert, K. Sangkuhl, C. F. Thorn,<br />
D. Klein, R. B. Altman, T. E. Klein.<br />
636T Effects <strong>of</strong> CYP2C9 and VKORC1 polymorphisms<br />
on clinical outcomes and warfarin response: Focusing<br />
on personalized medicine. P. C. J. L. Santos, R. A. G.<br />
Soares, C. M. C. Strunz, J. E. Krieger, A. C. Pereira.<br />
637T Performance <strong>of</strong> a biomarker risk algorithm for a<br />
primary prevention trial <strong>of</strong> Alzheimer’s disease. M. W.<br />
Lutz, D. K. Burns, D. G. Crenshaw, A. M. Saunders, A. D.<br />
Roses.<br />
638T A study <strong>of</strong> asthma pharmacogenomics using RNAseq.<br />
B. E. Himes, R. Hu, P. Wagner, D. Chan, B. Klanderman,<br />
R. A. Panettieri Jr., K. Tantisira, S. T. Weiss, Q. Lu.<br />
639T Genetic moderators <strong>of</strong> treatment response<br />
to methylphenidate and guanfacine in children and<br />
adolescents with ADHD. E. L. Nurmi, K. S. Mallya, F.<br />
Whelan, C. P. Laughlin, J. J. McGough, S. K. Loo, R. M.<br />
Bilder, J. T. McCracken.<br />
640T Identifying genes that influence acute ethanol<br />
responsive behaviors in Caenorhabditis elegans. J. T.<br />
Alaimo, A. G. Davies, J. C. Bettinger.<br />
641T Characterization <strong>of</strong> Northeast Asian ADME gene<br />
variation via exome sequencing. D. H. Hovelson, Z. Xue,<br />
S. Rashkin, X. Zhan, M. G. Ehm, A. Yeo, I. J. Jang, I. Ieiri,<br />
J. E. Lee, L. R. Cardon, S. L. Chissoe, G. Abecasis, M. R.<br />
Nelson.<br />
642T Drug metabolizing enzyme genes and nicotine<br />
and cotinine metabolism. A. W. Bergen, H. S. Javitz, M.<br />
Michel, R. Krasnow, D. Nishita, C. N. Lessov-Schlaggar, H.<br />
Hops, N. J. Markward, S. Hall, T. Baker, D. V. Conti, R. F.<br />
Tyndale, N. L. Benowitz, G. E. Swan.<br />
643T Identification <strong>of</strong> a SNP in the UGT1A1 promoter<br />
associated with increased serum bilirubin levels. M. K.<br />
Kringen, A. P. Piehler, R. M. Grimholt, M. S. Opdal, K. B. F.<br />
Haug, P. Urdal.<br />
644T Well-characterized cohorts and exome data:<br />
Investigating antipsychotic pharmacogenomics in<br />
the South African context. B. Drogemoller, D. Niehaus,<br />
G. Wright, B. Chiliza, L. Asmal, L. Koen, R. Emsley, L.<br />
Warnich.<br />
645T Can genetic variation <strong>of</strong> CES1A predict<br />
methylphenidate response in ADHD patients?<br />
A. Cassidy, E. Sizer, D. Rutschow, K. Hogg, J. Berg, D.<br />
Coghill.<br />
646T Whole exome analysis <strong>of</strong> African <strong>American</strong><br />
warfarin pharmacogenomics. R. Daneshjou, K. Aquino-<br />
Michaels, B. Burkley, L. H. Cavallari, J. A. Johnson, N. A.<br />
Johnson, T. E. Klein, K. J. Karczewski, T. Langaee, S. R.<br />
Patel, M. Perera, H. Sagreiya, H. Tang, N. Tatonetti, R. B.<br />
Altman.<br />
647T Survey <strong>of</strong> rare variants in pharmacogenes for<br />
patients with statin-induced myopathy identified in<br />
a biorepository linked to electronic medical records.<br />
M. T. Oetjens, Q. Feng, A. R. Ramirez, E. Bowton, T. Clark,<br />
D. M. Roden, D. C. Crawford, R. A. Wilke.<br />
648T Genetic determinants <strong>of</strong> fetal hemoglobin<br />
response to hydroxyurea. V. A. Sheehan, A. Sabo, J.<br />
R. Crosby, T. A. Howard, D. M. Muzny, B. Davis, A. Li, U.<br />
Nagaswamy, E. Boerwinkle, R. A. Gibbs, R. E. Ware, J. M.<br />
Flannagan.<br />
649T Translating genetic associations to new<br />
medicines. M. G. Ehm, S. L. Chissoe, M. R. Nelson, D.<br />
M. Waterworth, L. C. McCarthy, H. Tipney, T. Pastinen, M.<br />
Saleh, P. Gros, P. Agarwal, M. Lathrop, L. R. Cardon, J. B.<br />
Richards, P. Sanseau.<br />
650T Association <strong>of</strong> CYP3A4 and CYP3A5 genotypes<br />
with treatment-related hyperlipidemy. L. E. Wong-<br />
Ley, L. E. Figuera, R. Ortiz-Orozco, M. Perez-Nuño,<br />
P. Aguiar-Garcia, F. A. Ortega-Gutierrez, A. Nuñez-<br />
Zenteno.ñ<br />
651T Pharmacogenetic investigation <strong>of</strong> diarrhea<br />
in pazopanib-treated patients with renal cell<br />
carcinoma. Z. Xue, L. Huang, C. N. Sternberg, R. A.<br />
Figlin, L. McCann, C. F. Spraggs, C. Carpenter, L. N.<br />
Pandite, C. Xu.<br />
652T Multi-ethnic glutathione S-transferase copy<br />
number pr<strong>of</strong>iling. S. Martis, R. Vijzelaar, J. Sload, H. Mei,<br />
L. Edelmann, R. J. Desnick, S. A. Scott.<br />
653T Pharmacogenomics <strong>of</strong> cardiovascular disease<br />
treatment in subjects from the Lithuanian population.<br />
A. Pranculis, I. Pepalyte˙ , J. Arasimavičius, Z. A.<br />
Kučinskiene˙ , V. Kučinskas.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
654T Systematic functional characterization <strong>of</strong><br />
cytochrome P450 2E1 promoter variants in the Chinese<br />
Han population. S. Qin, L. He.<br />
655T Influence <strong>of</strong> common polymorphisms in<br />
ABCB1 gene on interaction between methadone and<br />
p-glycoprotein. Y. Teng, C. Hung, M. Chiou.<br />
Metabolic Disorders<br />
656T Genetic regulation <strong>of</strong> circulating glycine<br />
concentration in the Finnish population. J. Kettunen, T.<br />
Tukiainen, M. Ala-Korpela, J. Eriksson, O. Raitakari, M. R.<br />
Järvelin, T. Lehtimäki, V. Salomaa, M. Perola, A. Palotie,<br />
S. Ripatti.<br />
657F Functional and physical interaction <strong>of</strong> the<br />
mitochondrial electron transport chain and fatty acid<br />
oxidation and its disruption in fatty acid oxidation<br />
deficient animals. J. Vockley, Y. Wang, E. Goetzman, J.<br />
Palmfeldt, N. Gregersen.<br />
658T Dysregulation <strong>of</strong> central nervous system<br />
sphingolipid metabolism as a unifying mechanism for<br />
neuro-cognitive manifestations <strong>of</strong> Gaucher disease<br />
and HIV infection. A. F. Elias, N. J. Haughey, K. Mackey,<br />
T. Pitman, A. W. Thomas, S. Wakefield, S. P. Yang.<br />
659F Autism spectrum disorders functioning levels<br />
and metabolic alterations. N. Arciniegas, N. Linares, M.<br />
Cabrera-Rios, S. Carlo.<br />
660T Creatine transporter deficiency: Novel mutations<br />
and functional studies. O. Ardon, X. Yin, N. Longo, A.<br />
Shilon-Hadass, G. Gabis, C. H<strong>of</strong>fman, M. Tzadok, G.<br />
Heimer, S. Sadan, B. Ben-Zeev, Y. Anikster.<br />
661F Mice deficient for succinyl-CoA synthetase<br />
exhibit functionally significant mtDNA depletion and<br />
are a model for mitochondrial disease. T. Donti, M. Ge,<br />
K. Eldin, B. Graham.<br />
662T Role <strong>of</strong> medium chain acyl-CoA dehydrogenase<br />
in the metabolism <strong>of</strong> sodium phenylbutyrate.<br />
K. Kormanik, H. Kang, D. Cuebas, B. Scharschmidt, J.<br />
Vockley, A.-W. Mohsen.<br />
663F Common dysfunctional variants <strong>of</strong> ABCG2<br />
decrease extra-renal urate excretion and cause<br />
hyperuricemia. H. Matsuo, T. Takada, A. Nakayama,<br />
T. Shimizu, H. Kasuga, H. Nakashima, T. Nakamura, Y.<br />
Takada, Y. Kawamura, Y. Utsumi, H. Ogata, M. Nakamura,<br />
Y. Sakurai, T. Hosoya, N. Shinomiya, H. Suzuki, K. Ichida.<br />
664T Exploring the phenotype <strong>of</strong> MMACHC deficiency<br />
(cblC) in zebrafish with morpholinos and zinc finger<br />
nuclease targeted mutagenesis. J. L. Sloan, K. Bishop, T.<br />
L. Blake, R. J. Chandler, B. P. Brooks, R. Sood, C. P. Venditti.<br />
665F Comparative study <strong>of</strong> gene expression pr<strong>of</strong>iling<br />
<strong>of</strong> skin fibroblasts <strong>of</strong> Leigh syndrome French Canadian<br />
subjects and controls. J. Tardif, C. Laprise, LSFC<br />
Consortium.<br />
POSTER SESSIONS 137<br />
666T SUCLG1 mutations causing mitochondrial depletion<br />
syndrome with congenital anomalies. H. C. Andersson, M.<br />
Landsverk, T. Yeh, D. Cejas, D. Singh, L. J. Wong.<br />
667F A mouse model <strong>of</strong> mitochondrial complex I<br />
deficiency exhibits progressive cardiac disease and<br />
seizures. W. J. Craigen, T. Donti, Y. C. Lai, S. Ather, X.<br />
Wehrens, B. H. Graham.<br />
668T Enzyme function affected by mutations in the<br />
sucrase-isomaltase gene. J. Huang, Z. Wu, S. Uhrich, C.<br />
R. Scott.<br />
669F Hyperammonemia and urea cycle homeostasis in<br />
methylmalonic acidemia. R. J. Chandler, H. Morizono, P.<br />
J. McGuire, C. P. Venditti.<br />
670T Propionic acidemia: Is there a decreased<br />
in tricarboxylic acid cycle enzyme functions?<br />
K. Chapman, A. Markowitz-Shulman, G. Cunningham,<br />
J. Cabrera-Luque, M. Summar.<br />
671F Cap myopathy: A distinct form <strong>of</strong> congenital<br />
myopathy. S. J. Piteau, G. Smith, S. Ludwin, J. MacKenzie.<br />
672T Mutations in the phospholipid remodeling<br />
gene SERAC1 impair mitochondrial function and<br />
intracellular cholesterol trafficking and cause dystonia<br />
and deafness. E. Morava, S. Wortmann, F. Vaz, T.<br />
Gardeitchik, L. E. L. M. Vissers, J. Schuurs-Hoeijmakers,<br />
R. Rodenburg, A. Grünewald, C. Klein, T. Kozicz, P.<br />
van Hasselt, M. Harakalova, W. Kloosterman, I. Barić,<br />
K. Naess, Z. Krumina, C. Gilissen, H. Bokhoven, J. A.<br />
Veltman, J. A. M. Smeitink, D. J. Lefeber, R. A. Wevers, A.<br />
P. M. de Brouwer.<br />
673F Somatic cell diagnostic studies may miss some<br />
patients with mutations in MMAA and MMAB genes<br />
responsible for isolated methylmalonic aciduria.<br />
L. Dempsey Nunez, M. L. Illson, J. Kent, Q. Huang, A.<br />
Brebner, D. Watkins, B. M. Gilfix, C. Wittwer, D. S. Rosenblatt.<br />
674T The clinical spectrum <strong>of</strong> combined malonic<br />
and methylmalonic aciduria, a defect in the<br />
intramitochondrial fatty-acid-biosynthesis pathway.<br />
I. Manoli, J. L. Sloan, J. J. Johnston, L. Peller, J. C. Sapp,<br />
L. G. Biesecker, C. P. Venditti.<br />
675F Neurochemical pr<strong>of</strong>iles in children with<br />
inborn errors <strong>of</strong> metabolism determined by in vivo<br />
1H-magnetic resonance spectroscopy. W. Al-Hertani,<br />
E. Mason, T. Tam, B. Schmitt, S. Blaser, H. Branson, A.<br />
Schulze.<br />
676T Analyzing functional phenotypes in fibroblasts<br />
from patients with clinically-diagnosed mitochondrial<br />
disease. B. Graham, T. Donti, A. Bessee, W. Craigen, P.<br />
Bonnen.<br />
677F Clinical molecular laboratory analysis <strong>of</strong> the<br />
genes <strong>of</strong> fatty acid oxidation. M. T. Hardison, M.<br />
Landsverk, L. Wong.<br />
678T Fabry disease: Molecular analysis <strong>of</strong> GLA in<br />
females with no family history. D. Doheny, I. Nazarenko,<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
138 POSTER SESSIONS<br />
J. Kim, R. Dobrovolny, R. Desnick.<br />
679F Maple syrup urine disease due to a new point<br />
mutation at BCKDHB in Iranian family. M. Hamid, G. R.<br />
Shariati, A. H. Saberi, M. Mohammadi.<br />
680T Peanut consumption increases levels <strong>of</strong> plasma<br />
very long chain fatty acids in humans. C. T. Lam, D. A.<br />
Wong, S. D. Cederbaum, B. Lim, Y. Qu.<br />
681F Diagnostic testing for multiple treatable<br />
metabolic neurodegenerative disorders by nextgeneration<br />
sequencing. S. van Koningsbruggen, O. R.<br />
Mook, G. Visser, M. A. Haagmans, R. C. Hennekam, G. S.<br />
Salomons, P. Verwaijen, H. R. Waterham, F. A. Wijburg, M.<br />
M. Mannens.<br />
682T Prevalence <strong>of</strong> GNE p.M712T and hereditary<br />
inclusion body myopathy in Sangesar population <strong>of</strong><br />
Northern Iran. H. Khademian, R. Carbajo, E. Mehravar, L.<br />
Sandoval, J. Garcia-Figueroa, Z. Khokher, D. No, Y. Valles-<br />
Ayoub, D. Darvish.<br />
683F Clinical application <strong>of</strong> massively parallel sequencing<br />
for molecular diagnosis <strong>of</strong> genetically heterogeneous<br />
glycogen storage diseases. J. Wang, H. Cui, N.-C. Lee, W.-<br />
L. Hwu, Y. H. Chien, W. J. Craigen, L.-C. Wong, V.-W. Zhang.<br />
684T Findings from the ZOOM genetic screening<br />
study <strong>of</strong> Niemann-Pick disease type C in adults with<br />
neurological and psychiatric signs. P. Bauer, D. J.<br />
Balding, H. H. Klünemann, D. Linden, D. Ory, M. Pineda, J.<br />
Priller, F. Sedel, A. Muller, H. Chadha-Boreham, R. Welford,<br />
D. S. Strasser, J. E. Wraith, M. C. Patterson.<br />
685F Detection <strong>of</strong> mucopolysacchariduria in driedurine<br />
filter paper samples: A useful technique for<br />
regions where transportation <strong>of</strong> liquid samples is<br />
challenging. R. Giugliani, F. Bender, G. Marasca, R.<br />
Guidobono, J. De Mari, M. Burin, G. Civallero.<br />
686T Analysis <strong>of</strong> non-reducing ends <strong>of</strong><br />
glycosaminoglycans for the diagnosis and monitoring<br />
<strong>of</strong> therapy in mucopolysaccharidoses type I and type II.<br />
T. Yuzyuk, E. Schwarz, J. Brown, B. Crawford, M. Pasquali.<br />
687F Rare, bizarre, and complex illnesses with unusual<br />
medical events in patients should be a signal to trigger<br />
a mitochondrial work-up: Clinical decision tree for<br />
mitochondrial disorder workup is provided. A. Perszyk.<br />
688T Clinical re-sequencing <strong>of</strong> 450 genes to diagnose<br />
mitochondrial disorders: Results from the first 119<br />
patients. J. DaRe, V. Vasta, T. Tran, J. Penn, L. Susswein,<br />
J. Booker, S. Hahn.<br />
689F Insulin resistance: Development <strong>of</strong> a clinical<br />
assay for INSR mutation detection. M. Procter, O. Ardon,<br />
A. Carey, H. Amiri, N. Longo, R. Mao.<br />
690T Comparative transcriptome pr<strong>of</strong>iles in<br />
Gaucher disease mice treated with imiglucerase or<br />
velaglucerase alfa. N. Dasgupta, Y.-H. Xu, S. Oh, Y. Sun,<br />
L. Jia, S. Barnes, M. Keddache, G. A. Grabowski.<br />
691F Enzyme replacement therapy started at birth<br />
improves outcome in difficult-to-treat organs in<br />
mucopolysaccharidosis I mice. G. Baldo, F. Mayer, B.<br />
Martinelli, F. Meyer, P. de Oliveira, A. Tavares, L. Meurer, T.<br />
de Carvalho, U. Matte, R. Giugliani.<br />
692T Long-term bone mineral density response<br />
to enzyme replacement therapy in a retrospective<br />
pediatric cohort <strong>of</strong> Gaucher patients. B. Bembi, G.<br />
Ciana, L. Deroma, A. M. Franzil, A. Dardis.<br />
693F Evaluation <strong>of</strong> long-term enzyme replacement<br />
therapy for children with Fabry disease. A. M. Hebert, T.<br />
Taber, L. Lacbawan, M. Banikazemi, O. Goker-Alpan.<br />
694T Combined therapy in a patient with Gaucher<br />
type III. J. Navarrete, P. Galindo, R. Delgado, A. Limon.<br />
695F Biochemical characterization <strong>of</strong> myelin<br />
abnormalities in the corpus callosum in MPS I<br />
dogs. S.-H. Kan, S. Q. Le, J. K. Yee, M. Guzman, N. M.<br />
Ellinwood, P. I. Dickson.<br />
696T Enzyme replacement therapy in a Gaucher type<br />
3 patient: Report <strong>of</strong> a paradigmatic case. F. Vairo, A. D.<br />
Dornelles, S. D. Mittelstadt, M. Wilke, D. Doneda, C. B. O.<br />
Netto, I. V. D. Schwartz.<br />
697F Alteration in liver TGFb expression and signaling<br />
in MPS I canines and the effect <strong>of</strong> enzyme replacement<br />
therapy. M. Vera, S. Q. Le, S. H. Kan, P. I. Dickson.<br />
698T Korean experience with citrin deficiency. B. H.<br />
Lee, Y. M. Kim, G. H. Kim, K. M. Kim, H. W. Yoo.<br />
699F Molecular diagnosis in mitochondrial respiratory<br />
chain deficiency using exome sequencing.<br />
R. Kopajtich, T. B. Haack, B. Haberberger, K. Danhauser,<br />
J. A. Mayr, W. Sperl, U. Ahting, G. F. H<strong>of</strong>fmann, M.<br />
Tesarova, E. Frisch, M. Schülke, I. Wittig, P. Freisinger,<br />
D. Ghezzi, M. Zeviani, A. Rötig, E. Graf, T. M. Strom, T.<br />
Meitinger, H. Prokisch.<br />
700T Occurrence <strong>of</strong> lysosomal storage disorders in<br />
children with hepatomegaly or hepatosplenomegaly:<br />
An institutional experience. M. Mistri, C. Ankeleshwaria,<br />
A. Bavdekar, M. Kamate, C. Datar, F. Sheth, J. Sheth.<br />
701F Exome sequencing reveals that mutations in the<br />
genes encoding aminoacyl tRNA synthetases cause<br />
a variety <strong>of</strong> clinical syndromes. M. T. Geraghty, M. J.<br />
M. Nowaczyk, P. Humphreys, J. Schwartzentruber, C. L.<br />
Beaulieu, A. Smith, L. Huang, J. Majewski, D. E. Bulman,<br />
K. M. Boycott, FORGE Consortium.<br />
702T Novel mutations in the PC gene in patients with<br />
type B pyruvate carboxylase deficiency. E. Oestergaard,<br />
M. Duno, . LB. Møller, H. S. Kalkanoglu-Sivri, A. Dursun,<br />
D. Aliefendioglu, H. Leth, M. Dahl, E. Christensen, F.<br />
Wibrand.<br />
703F Bioinformatics and genotypic evaluation <strong>of</strong> the<br />
IDUA gene and protein in MPS I patients diagnosed in<br />
Colombia, Ecuador and Perú. H. Velasco, J. Gonzalez,<br />
T. Pineda.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
704T A founder mutation causing a severe<br />
methylenetetrahydr<strong>of</strong>olate reductase deficiency in<br />
Bukharian Jews. S. Ben-Shachar, T. Zvi, A. Rolfs, A. B.<br />
Klobus, Y. Yaron, A. Bar-Shira, A. Orr-Urtreger.<br />
705F Somatic cell and molecular studies on an<br />
atypical patient with combined homocystinuria and<br />
methylmalonic aciduria (cblC). A. Brebner, C. Ficicioglu,<br />
D. Watkins, T. Pastinen, D. S. Rosenblatt.<br />
706T Exome sequencing reveals a homozygous ABCD4<br />
mutation in an adolescent with hyperpigmentation,<br />
ischemia, hyperhomocysteinemia, and methylmalonic<br />
aciduria. J. C. Kim, A. Brebner, N. C. Lee, W. L. Hwu, Y.<br />
H. Chien, S. Fahiminiya, J. Majewski, D. Watkins, D. S.<br />
Rosenblatt.<br />
707F Molecular characterization <strong>of</strong> the GALK1 gene<br />
in Filipino patients with non-classical galactosemia.<br />
C. L. T. Silao, K. N. Hernandez, D. M. Canson, S. C.<br />
Estrada.<br />
708T Exome sequencing reveals a frequent Moroccan<br />
founder mutation in SLC19A3 as a new cause <strong>of</strong><br />
early-childhood fatal Leigh syndrome. H. Smeets, M.<br />
Gerards, R. Kamps, I. Boesten, E. Jongen, B. de Koning,<br />
K. Schoonderwoerd, A. Sefiani, I. Ratbi, W. Coppieters, L.<br />
Karim, I. de Coo, B. van den Bosch.<br />
709F SATB2 acts as an activator <strong>of</strong> the UPF3B gene.<br />
P. Leoyklang, K. Suphapeetiporn, C. Srichomthong, S.<br />
Tongkobpetch, H. Dorward, A. R. Cullinane, M. Huizing, W.<br />
A. Gahl, V. Shotelersuk.<br />
710T Low bone strength is a manifestation <strong>of</strong><br />
phenylketonuria in mice and is attenuated by a<br />
glycomacropeptide-based diet. R. D. Blank, P.<br />
Solverson, S. G. Murali, S. J. Litscher, D. M. Ney.<br />
711F Natural history study <strong>of</strong> patients with hereditary<br />
inclusion body myopathy. J. K. De Dios, J. Shrader, G.<br />
Joe, C. Ciccone, A. Mankodi, J. Dastgir, C. Bonnemann,<br />
M. Bevans, D. Draper, J. McKew, M. Huizing, W. A. Gahl,<br />
N. Carrillo-Carrasco.<br />
712T Hepatic carnitine palmitoyltransferase<br />
1A deficiency: Adulthood complications and a<br />
Durango, Mexico founder mutation. N. M. Gallant, N.<br />
Vatanavicharn, D. Salazar, W. R. Wilcox.<br />
713F Basis <strong>of</strong> immune dysregulation in Gaucher<br />
disease. C. Martin, L. Kozhaya, T. Taber, D. Unutmaz, O.<br />
Goker-Alpan.<br />
714T Longitudinal change in brain volumes and<br />
cognitive function in MPS IIIA. I. Nestrasil, K. Delaney,<br />
B. Yund, A. Ahmed, K. Rudser, V. Kovac, P. Haslett, C.<br />
Richard, C. Whitley, E. Shapiro.<br />
715F Is the pr<strong>of</strong>ile <strong>of</strong> medical signs and<br />
symptoms associated with specific genotype in<br />
mucopolysaccharidosis type I? A. Ahmed, R. Cooksley,<br />
C. Whitley, E. Shapiro.<br />
716T Prevalence <strong>of</strong> Fabry disease in patients with<br />
POSTER SESSIONS 139<br />
chronic pain. C. Goizet, V. Dousset, M. Cadenne,<br />
E. Maurat, S. François, C. Blanchard, P. Poulizac, S.<br />
Tabuteau, C. Hubert, S. Laborde, P. Casenave, X. Ferrer,<br />
G. Solé, I. Coupry, F. Bauduer, T. Levade, D. Lacombe.<br />
717F Infantile onset severe phenotype <strong>of</strong> cblG<br />
disorder in a patient and abnormal neurotransmitter<br />
metabolites. R. Jobling, S. Hewson, S. Mercimek-<br />
Mahmutoglu.<br />
718T Abnormal central tegmental tract signal in a<br />
patient with mild glycogen storage disease type 1a.<br />
D. L. Renaud, S. T. Janousek, D. K. Freese, W. F. Schwenk.<br />
719F Mild clinical and atypical somatic cell findings<br />
in a cblF patient detected by expanded newborn<br />
screening. D. Rosenblatt, A. Brebner, I. R. Miousse, J. C.<br />
Kim, M. T. Geraghty, D. Watkins, C. Armour.<br />
720T Fumarase deficiency. Expanding the phenotype. K.<br />
Siriwardena, W. Al-Hertani, J. Kronick, D. Chitayat.<br />
721F Renal growth in isolated methylmalonic acidemia.<br />
P. Kruszka, I. Manoli, J. Sloan, C. P. Venditti.<br />
722T Plasmalogen deficiency in the Pex7 hypomorphic<br />
mouse, a model <strong>of</strong> rhizomelic chondrodysplasia<br />
punctata, causes neonatal lethality associated with<br />
late lung maturational defects. N. Braverman, X. He,<br />
S. Jiralerspong, G. Nimmo, Y. Chen, J. Hacia, A. Moser,<br />
W. Cui.<br />
723F Phenylketonuria and defective metabolism <strong>of</strong><br />
tetrahydrobiopterin. A. Al-Aqeel.<br />
724T Two cases <strong>of</strong> neonatal onset type II citrullinemia<br />
diagnosed by urine organic acids based newborn<br />
screening. Y. Watanabe, K. Tashiro, K. Aoki, T. Inokuchi,<br />
Y. Seki, T. Yanagi, T. Mizuochi, J. Okada, M. Yoshino, T.<br />
Matsuishi.<br />
725F Translational research in newborn screening:<br />
Implementation <strong>of</strong> a consensus data set for the<br />
long-term follow-up <strong>of</strong> patients to improve scientific<br />
understanding and optimize health outcomes. S. Berry,<br />
K. Hassell, A. Brower, Joint Committee <strong>of</strong> NBSTRN Clinical<br />
Centers Workgroup and NCC/RC Long-Term Follow-Up<br />
Workgroup.<br />
726T Newborn screening for infantile Pompe disease:<br />
Report <strong>of</strong> a pilot study in National Center for Child<br />
Health and Development. M. Kosuga, K. Kida, N. Fuji, T.<br />
Okuyama.<br />
727F The identification <strong>of</strong> infants with Fabry, Pompe,<br />
and mucopolysaccharidosis-I from newborn blood<br />
spots. C. R. Scott, S. Elliott, N. Buroker, L. I. Thomas, M.<br />
Glass, F. Turecek, M. H. Gelb.<br />
728T Bare lymphocyte syndrome type III, a novel<br />
mutation in RFXAP and failure to identify with newborn<br />
screening for severe combined immunodeficiency. L.<br />
Randolph, J. Chase, M. Aguilera, J. Siles, J. Church.<br />
729F Standard value <strong>of</strong> urine HVA/VMA ratio in the<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
140 POSTER SESSIONS<br />
early neonatal period to screen for Menkes disease. M.<br />
Yagi, N. Kusunoki, T. Lee, H. Awano, T. Yokota, A. Miwa, A.<br />
Shibata, I. Morioka, Y. Takeshima, K. Iijima.<br />
730T Correlation <strong>of</strong> phenylalanine concentration with<br />
neuropsychiatric symptom scores in phenylketonuria<br />
patients. T. Morgan, N. Owen, A. Bawcom, G. Wey, L.<br />
Ashford, J. Phillips.<br />
731F A rare disease–simple treatment: Sepiapterin<br />
reductase deficiency with a novel mutation. I. M. Zamir,<br />
B. Ben-Zeev, A. Mimouni-Bloch, S. Msilaty-Gross, Y.<br />
Anikster.<br />
732T A phase 2a study to investigate the effects <strong>of</strong><br />
a single dose <strong>of</strong> migalastat HCl, a pharmacological<br />
chaperone, on alpha-Gal A activity in subjects<br />
with Fabry disease. F. K. Johnson, P. N. Mudd, Jr., S.<br />
Sitaraman, R. Winkler, J. Flanagan, R. Khanna, K. J.<br />
Valenzano, D. J. Lockhart, P. Boudes on Behalf <strong>of</strong> Study<br />
AT1001-013 Principal Investigators.<br />
733F A novel drug target site for medium chain acyl-<br />
CoA dehydrogenase deficiency: Implications for future<br />
drug therapy. H. Kang, J. Vockley, A.-W. Mohsen.<br />
734T Immune response against enzyme<br />
replacement therapy alters enzyme distribution in<br />
mucopolysaccharidosis I mice. S. Le, S.-H. Kan, M.<br />
Vera, P. Dicskon.<br />
735F Hepatic gene transfer <strong>of</strong> TFEB results in<br />
clearance <strong>of</strong> mutant alpha-1-antitrypsin. N. Pastore, P.<br />
Piccolo, F. Annunziata, R. M. Sepe, F. Vetrini, D. Palmer, P.<br />
Ng, K. Blomenkamp, J. Teckman, A. Ballabio, N. Brunetti-<br />
Pierri.<br />
736T Neuronal differentiation <strong>of</strong> induced pluripotent<br />
stem cells from Gaucher disease fibroblasts. J. B.<br />
Florer, C. N. Mayhew, Y. Sun, G. A. Grabowski.<br />
737F Resveratrol and bezafibrate both dramatically<br />
induce transcription <strong>of</strong> aspartoacylase: A potential<br />
new treatment for Canavan disease? B. S. Andresen, T.<br />
K. Doktor, J. O. Sass, J. Bastin, F. Djouadi, T. J. Corydon,<br />
E. Christensen, A. M. Lund, H. S. Andersen.<br />
738T The ingestion <strong>of</strong> a high protein diet during<br />
gestation magnifies the in vivo production <strong>of</strong><br />
metabolites in MMA mice in utero. D. Brown, J. Senac,<br />
J. Sloan, I. Manoli, C. Venditti.<br />
739F Danshen extract regulates energy metabolism by<br />
activating the AMPK-SIRT1-PGC-1a. Y. H. Cho, C. R.<br />
Ku, H. Lee, E. J. Lee.<br />
740T Protocols for sick day management and<br />
emergency interventions for mitochondrial disorder<br />
patients are important for family education, treatment<br />
and support. M. Fredrich, A. Perszyk.<br />
741F High fat diet paradoxically improves cold<br />
survival in a mouse model <strong>of</strong> medium-chain acyl-CoA<br />
dehydrogenase deficiency. S. E. McCandless, L. Rice,<br />
C. L. Hoppel.<br />
742T Sapropterin treatment for toddlers with PKU. N.<br />
L. Pallone.<br />
743F Ubiquinol preparations are numerous and<br />
selection <strong>of</strong> appropriate mitochondrial supplement<br />
requires careful scrutiny by family and doctor.<br />
N. Franklin, A. Perszyk.<br />
744T The role <strong>of</strong> N-acetylcysteine in treating<br />
mitochondrial liver disease. A.-K. Niemi, G. M. Enns.<br />
745F Phase 3 study <strong>of</strong> migalastat HCl for Fabry<br />
disease: Stage 1 results. K. Nicholls, C. Feliciani, S.<br />
Shankar, F. Ezgu, S. G. Janmohamed, S. M. Laing, R.<br />
Schroyer, A. C. Bragat, S. Sitaraman, V. Sniukiene, R. E.<br />
Winkler, P. Boudes.<br />
746T Differential risk for Parkinson disease in males<br />
and females with Gaucher disease. D. Elstein, R.<br />
Alcalay, T. Dinur, G. Altarescu, E. Ben-Chetrit, A. Zimran.<br />
747F Potential cluster <strong>of</strong> MPS IV A in Northeast Brazil.<br />
F. Kubaski, A. C. Brusius-Facchin, P. F. V. Medeiros, C. S.<br />
E. Gondim, R. Giugliani, S. Leistner-Segal.<br />
748T Persistent thrombocytopenia in type I Gaucher<br />
disease: Evaluation and management. H. Rosenbaum.<br />
749F Chemotactic factors critical for increased<br />
immunological cell invasion in Gaucher disease mice.<br />
M. K. Pandey, N. A. Jabre, G. A. Grabowski.<br />
750T Systematic screening for treatable inborn errors<br />
<strong>of</strong> metabolism in intellectual disability patients: First<br />
study results. S. Stockler, R. Salvarinova, G. Horvath,<br />
Y. Lillquist, H. Vallance, S. Sinclair, M. Lafek, T. Murphy,<br />
A. Lehman, M. Patel, M. Demos, M. Connolly, C. van<br />
Karnebeek, TIDE BC, Treatable Intellectual Disability<br />
Endeavor in British Columbia.<br />
751F A novel homozygous mutation in EARS2 causing<br />
a fatal multisystem infantile disease. A. Pyle, B.<br />
Talim, H. Griffin, H. Topaloglu, M. Santibanez-Koref, P. F.<br />
Chinnery, R. Horvath.<br />
752T Novel phenotype associated with OPA mutations?<br />
M. Tesarova, V. Stranecky, H. Kratochvilova, Z. Hajkova,<br />
J. Sladkova, J. Spacilova, H. Hansikova, T. Honzik, H.<br />
Hartmannova, L. Noskova, L. Piherova, E. Lalonde, J.<br />
Majewski, S. Kmoch, J. Zeman.<br />
753T Evaluating pain, negative mood, and resilience<br />
in patients affected by Fabry disease. A. M. Lelis, R.<br />
Duran, L. Beckman, J. Garbanati, W. Wilcox, J. Mirocha.<br />
Therapy for Genetic Disorders<br />
754W Comparison <strong>of</strong> the differentiation potential <strong>of</strong><br />
human mesenchymal stem cells and several animal<br />
species. F. Piryaei, M. Ramezani, M. Kadivar, F. Piryaei.<br />
755W Bone marrow-derived cells as a stable source <strong>of</strong><br />
sialic acid for mice with GNE myopathy. M. C. Malicdan,<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
K. Momma, F. Funato, Y. K. Hayashi, I. Nonaka, M.<br />
Huizing, W. Gahl, C. F. Boerkoel, I. Nishino, S. Noguchi.<br />
756W Lysine restricted diet as novel therapy for<br />
pyridoxine dependent epilepsy: First observational<br />
study. C. van Karnebeek, H. Hartmann, S. Jaggawantru,<br />
J. P. Collet, B. Plecko, S. Stockler, Pyridoxine Dependent<br />
Epilepsy Consortium.<br />
757W High-fat diet rescues lethality <strong>of</strong> homozygous<br />
knockin R155H mice with VCP-associated disease.<br />
K. J. Llewellyn, A. Nalbandian, C. Nguyen, V. E. Kimonis.<br />
758W Serin diet relieves symptoms <strong>of</strong> hereditary<br />
sensory and autonomous neuropathy type 1A caused<br />
by a c.992 C.T, p.(Ser331Phe), mutation in SPTLC1.<br />
B. Rautenstrauss, E. Wilichowski, E. Holinski-Feder, T.<br />
Hornemann.<br />
759W Pilot trial <strong>of</strong> high-dose carnitine supplementation<br />
in young, non-dysmorphic males with autism spectrum<br />
disorders. R. Goin-Kochel, F. Scaglia, C. Schaaf, D. Dang,<br />
A. Laakman, K. Nowell, A. L. Beaudet.<br />
760W Results <strong>of</strong> the phase II multicenter, single<br />
arm, phase II controlled trial ‘IEDAT-01’. L. Chessa, V.<br />
Leuzzi, A. Plebani, R. Micheli, A. R. Soresina, I. Quinti, D.<br />
D’Agnano, C. Bozzao, P. Lulli, M. Magnani.<br />
761W Generation and characterisation <strong>of</strong> FRDA mouse<br />
model cell lines. C. Sandi, S. Al-Mahdawi, V. Ezzatizadeh,<br />
S. Virmouni, M. Sandi, M. Pook.<br />
762W Non-penetrance in RP17? An investigation<br />
into the molecular mechanisms underlying retinitis<br />
pigmentosa 17 with the view to developing novel genebased<br />
therapies. A. Pandor, S. Prince, R. Ramesar.<br />
763W Pharmacological evaluation <strong>of</strong> a CNP analogue<br />
for the treatment <strong>of</strong> achondroplasia. F. Lorget, N. Kaci,<br />
J. Peng, C. Benoist-Lasselin, E. Mugniery, T. Oppeneer, D.<br />
Wendt, S. Bullens, S. Bunting, L. Tsuruda, C. O’Neill, F. Di<br />
Rocco, A. Munnich, L. Legeai-Mallet.<br />
764W Role <strong>of</strong> vitamin D in osteoarthritis knee: A six<br />
month double blind, randomized, placebo control trial.<br />
S. R. Nath, D. Sanghi, S. Raj, K. Baghel, A. Mishra.<br />
765W Use <strong>of</strong> the amniotic fluid transcriptome to<br />
identify novel antenatal treatments for fetuses affected<br />
with Down syndrome. F. Guedj, L. Massingham, K.<br />
Johnson, U. Tantravahi, D. Bianchi.<br />
766W Treatment <strong>of</strong> basal cell carcinomas with a<br />
hedgehog pathway inhibitor vismodegib in basal cell<br />
nevus syndrome. A. Treherne, S. Bale, W. Chen, J. R.<br />
Toro.<br />
767W TGFb signaling exerts dimorphic effects on<br />
aortic aneurysm formation and progression in Marfan<br />
syndrome. L. Carta, J. R. Cook, M. Del Solar, E. Chiu, N.<br />
Clayton, C. Nelson, B. Wentworth, F. Ramirez.<br />
768W Safety <strong>of</strong> velaglucerase alafa in type 1 Gaucher<br />
disease patients with anti-imiglucerase antibodies. O.<br />
POSTER SESSIONS 141<br />
Goker-Alpan, G. M. Pastores, B. Rosenbloom, J. Ibrahim,<br />
G. M. Cohn, D. Zahrieh, P. K. Mistry.<br />
769W Safety and tolerability <strong>of</strong> velaglucerase alfa<br />
enzyme replacement therapy in patients aged $65<br />
years with type 1 Gaucher disease: A multicenter, open<br />
label trial. J. Ibrahim, G. M. Pastores, B. Rosenbloom, O.<br />
Goker-Alpan, G. M. Cohn, D. Zahrieh, P. K. Mistry.<br />
770W A double blind, placebo controlled trial <strong>of</strong><br />
minocycline in children with fragile X syndrome. R.<br />
Hagerman, M. J. Leigh, D. V. Nguyen, T. I. Winarni, S.<br />
Rivera, A. Schneider, T. Chechi, D. Hessl.<br />
771W Enhancing suppression <strong>of</strong> nonsense mutations<br />
in Duchenne muscular dystrophy. P. S. Lai, R.<br />
Elangovan, S. K. H. Tay, P. S. Low.<br />
772W Long-term safety <strong>of</strong> migalastat HCl in patients<br />
with Fabry disease. D. P. Germain, R. Giugliani, G. M.<br />
Pastores, K. Nicholls, S. Shankar, R. Schiffmann, D.<br />
Hughes, A. B. Mehta, S. Waldek, A. Jovanovic, K. Benistan,<br />
J. K. Simosky, V. Sniukiene, R. Winkler, P. F. Boudes.<br />
773W Eliglustat, an investigational oral therapy for<br />
Gaucher disease type 1: Phase 2 results after 4 years<br />
<strong>of</strong> treatment. M. J. Peterschmitt, E. Lukina, N. Watman,<br />
M. Dragosky, G. M. Pastores, E. Avila Arreguin, H.<br />
Rosenbaum, A. Zimran, E. Sysoeva, R. Aguzzi, L. H. Ross,<br />
A. C. Puga.<br />
774W Ammonia control in children ages 2 months<br />
through 5 years with urea cycle disorders: Comparison<br />
<strong>of</strong> sodium phenylbutyrate and glycerol phenylbutyrate.<br />
W. Smith, G. Diaz, U. Lichter-Konecki, S. A. Berry, C. O.<br />
Harding, S. E. McCandless, C. LeMons, K. A. Dickinson,<br />
D. Coakley, T. Moors, M. Mokhtarani, B. F. Scharschmidt,<br />
B. Lee.<br />
775W A comprehensive genetic and functional analysis<br />
<strong>of</strong> a large cohort <strong>of</strong> patients with Kabuki syndrome:<br />
Suggestions for therapy. L. Micale, C. Fusco, B. Augello,<br />
M. N. Loviglio, C. Maffeo, M. T. Pellico, L. Zelante, G.<br />
Merla.<br />
776W Differential effects <strong>of</strong> ramipril and losartan<br />
therapy on phenotype in mice model for Marfan<br />
syndrome. B. L. Lima, G. P. Cardozo, G. R. Fernandes, L.<br />
V. Pereira.<br />
777W Curcumin facilitates a transitory cellular stress<br />
response in Trembler-J mice. Y. Okamoto, K. Mehrdad,<br />
D. Pehlivan, W. Wiszniewski, G. Snipes, J. Lupski.<br />
778W Novel therapeutic assays for epidermolysis<br />
bullosa simplex. J. Lacroix, T. Farez, G. Leclerc, A.<br />
Dupérée, J. Powell, C. McCuaig, C. Morin, V. Legendre-<br />
Guillemin, M. Bchetnia, C. Laprise.<br />
779W Sodium butyrate and valproic acid as a splicing<br />
restoring agents in erythroid cells <strong>of</strong> b-thalassaemic<br />
patients. M. Taghizadeh, S. Mansoori Derakhsham, M.<br />
Shekari Khaniani, A. Hoseinpour Pheysi.<br />
780W Bisphosphonate therapy in Hajdu-Cheney<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
142 POSTER SESSIONS<br />
syndrome: Response, suggested protocol and future<br />
directions in treatment. M. D. Irving, W. M. Drake, J.<br />
Pittaway, D. Dafou, M. A. Simpson, R. T. Trembath.<br />
781W A small chemical, TG003, enhances skipping <strong>of</strong><br />
mutated dystrophin exons: The third example revealing<br />
a decrease <strong>of</strong> exonic splicing enhancer density in<br />
common. A. Nishida, Y. Takeshima, N. Kataoka, M. Yagi,<br />
H. Awano, T. Lee, K. Iijima, M. Hagiwara, M. Matsuo.<br />
782W Bezafibrate as treatment option in patients with<br />
mitochondrial complex I deficiency. B. M. Haberberger,<br />
P. Freisinger, V. Strecker, M. Steger, H. Heide, B. F. Müller,<br />
T. Beckhaus, K. Heim, U. Ahting, B. Rolinski, J. Mayr,<br />
A. Rötig, W. Sperl, M. Zeviani, I. Wittig, T. Meitinger, H.<br />
Prokisch.<br />
783W FMF patients homozygous for M694V have<br />
incomplete response to colchicine. H. Yonath, M. Lidar,<br />
N. Shechter, F. Sikron, S. Sadetzki, P. Langevitz, A. Livneh,<br />
E. Pras.<br />
784W CNS administration <strong>of</strong> recombinant human<br />
tripeptidyl peptidase-1 attenuates neurodegeneration,<br />
improves function, and increases lifespan in a canine<br />
model <strong>of</strong> classical late infantile neuronal ceroid<br />
lip<strong>of</strong>uscinosis. B. Vuillemenot, M. Katz, D. Kennedy, J.<br />
Coates, C. Sibigtroth, R. Whiting, F. Wininger, R. Reed,<br />
E. Adams, M. Butt, R. Cahayag, S. Keve, L. Tsuruda, D.<br />
Musson, C. O’Neill.<br />
785W Intrathecal enzyme replacement therapy<br />
improves diffusion tensor imaging abnormalities<br />
and volume loss in the corpus callosum in canine<br />
mucopolysaccharidosis I. P. Dickson, S. Chen, I.<br />
Nestrasil, V. Kovac, J. Jens, S. Q. Le, S.-h. Kan, M. A.<br />
Guzman, J. Provenzale, E. G. Shapiro, C. H. Vite, A.<br />
Mlikotic, N. M. Ellinwood.<br />
786W Enzyme replacement therapy using chemically<br />
modified enzyme markedly enhances therapeutic<br />
efficacies for bone lesions in mucopolysaccharidosis<br />
VII murine model. S. Tomatsu, D. Rowan, J. Grubb, B.<br />
Haupt, A. Montaño.<br />
787W A phase 2 multicenter, open label, switch<br />
over trial to evaluate the safety and efficacy <strong>of</strong><br />
Abcertin®(imiglucerase) in patients with type 1<br />
Gaucher disease previously treated with imiglucerase.<br />
H. W. Yoo, B. H. Lee, J. S. Lee, J. M. Ko, Y. B. Sohn.<br />
788W Results <strong>of</strong> 12 months use <strong>of</strong> taliglucerase alfa<br />
for Gaucher disease in an unselected cohort <strong>of</strong> adult<br />
patients on an Israeli compassionate use program. A.<br />
Zimran, H. Maayan, G. Altaescu, M. Tiomkin, M. Phillips,<br />
D. Elstein.<br />
789W Gaucher disease type 2: Outcomes <strong>of</strong> enzyme<br />
replacement therapy and impact on quality <strong>of</strong> life.<br />
C. Prada, R. Hopkin, L. Bailey, A. Lovell, N. Leslie, G.<br />
Grabowski.<br />
790W Efficiency <strong>of</strong> various antisense oligonucleotides<br />
for correcting ATM pre-mRNA in a patient with ataxiatelangiectasia<br />
with a deep intronic splicing mutation.<br />
S. Cavalieri, E. Pozzi, R. Cavalli, R. A. Gatti, A. Brusco.<br />
791W In utero brain-directed AAV gene therapy results<br />
in rapid, robust, and specific transduction <strong>of</strong> mouse<br />
choroid plexus epithelia. M. Haddad, A. Donsante, S. G.<br />
Kaler.<br />
792W Gene and stem cell treatment for alpha-1<br />
antitrypsin deficiency. B. Feinerman.<br />
793W Identifying motor neuron transduction<br />
efficiencies that are efficacious in SMA mice and<br />
achievable by intrathecal delivery in a large animal<br />
model. S. Cheng, M. Passini.<br />
794W Differential response to exogenous MeCP2 in<br />
mouse models <strong>of</strong> Rett syndrome. J. Young, V. Camarena,<br />
M. Saez, A. Abrams, K. Bayetti, A. Castle, K. Walz.<br />
795W Preclinical trial <strong>of</strong> trauma-induced osteoarthritis<br />
therapy by overexpressing matrix protein and reducing<br />
inflammation by gene-transfer. M. Z. C. Ruan, K. Guse,<br />
A. Erez, B. C. Dawson, Y. Chen, B. Lee.<br />
796W Towards lentiviral gene therapy for the treatment<br />
<strong>of</strong> MNGIE. R. De Coo, M. Stok, R. Yadak, H. Smeets, N.<br />
Van Til, G. Wagemaker.<br />
797W Directing miRNA-regulatory PNAs to breast<br />
cancer cells with synthetic targeting peptides. Y.-Y. Jin,<br />
C.-P. Chen, M. L. Thakur, E. Wickstrom.<br />
798W Effective inhibition <strong>of</strong> human cytomegalovirus gene<br />
expression and lytic replication by DNA-based external<br />
guide sequence. H. Li, X. Jia, L. Sun, T. Zhou, Z. Deng.<br />
799W Oncogenic EGFR allele specific inhibition by<br />
RNA interference for cancer therapy lacking adverse<br />
effects. M. Takahashi, T. Chiyo, T. Okada, H. Hohjoh.<br />
800W Remission induction <strong>of</strong> spinocerebellar ataxia 6<br />
by systems therapy with medicinal herbs. T. Okabe.<br />
801W Disease progression in MPS IIIA (Sanfilippo<br />
syndrome type A) is associated with genotype and age<br />
at diagnosis. C. B. Whitley, I. Nestrasil, K. Delaney, R.<br />
Cooksley, P. Haslett, C. Richard, E. Shapiro.<br />
802W Therapeutic efficacy <strong>of</strong> D-penicillamine<br />
encapsulated alginate/chitosan nanoparticles in rat model<br />
<strong>of</strong> copper toxicity with neurobehavioral impairments.<br />
R. Prasad, A. Pal, S. Attri, B. Thappa, R. Vasishta.<br />
803W High-efficiency gene correction <strong>of</strong> a Parkinson’s<br />
disease associated LRRK2 gene variant in patientderived<br />
iPS cells. B. Schuele, J. Laganiere, S. K. Mak,<br />
B. J. Vu, M. Vangipuram, Y. A. Huang, D. E. Paschon, O.<br />
Macaranas, A. Flierl, R. Sundararajan, P. D. Gregory, F. D.<br />
Urnov, J. W. Langston, H. S. Zhang.<br />
804W Inhibition <strong>of</strong> CTR1 by antisense oligonucleotides<br />
in mouse model for Wilson disease reduces copper<br />
accumulation and improves liver pathology. T. R.<br />
Grossman, P. Lincoln, M. McCaleb.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
Development<br />
805F Genome-wide identification <strong>of</strong> human cardiac<br />
developmental genes located within regions<br />
associated with congenital heart disease. K. D. Ajbro,<br />
T. A. Andersen, M. Bak, J. A. Rosenfeld, K. Møllgård, S. C.<br />
Eliasson, R. R. Jakobsen, E. Bendsen, N. Tommerup, L. G.<br />
Schaffer, K. Lage, l. A. Larsen.<br />
806F Voltage-gated sodium channels are required for<br />
proliferation <strong>of</strong> embryonic myocardium in zebrafish.<br />
J. Bennett, D. Stroud, J. Becker, D. Roden.<br />
807F Modeling early heart development in Down<br />
syndrome using sibling hESC lines. A. Bosman, A.<br />
Letourneau, M. Zuchelli, V. Tohonen, O. Hovatta, S. E.<br />
Antonarakis, M. E. Jaconi.<br />
808F Ofd1 controls dorso-ventral patterning and<br />
axoneme elongation during embryonic brain<br />
development. A. de Angelis, A. D’Angelo, B. Avallone, I.<br />
Piscopo, R. Tammaro, M. Studer, B. Franco.<br />
809F Exome sequencing identifies a single mutation<br />
in the CCDC114 gene as the cause for primary ciliary<br />
dyskinesia in the Volendam population. A. Onoufriadis,<br />
T. Paff, D. Anthony, A. Shoemark, D. Micha, B. Kuit, M.<br />
Schmidts, S. Petridi, R. Wilson, C. Hogg, R. Emes, UK10K,<br />
E. M. K. Chung, G. Pals, H. M. Mitchison.<br />
810F ALDH1A3 loss <strong>of</strong> function causes bilateral<br />
anophthalmia and hypoplasia <strong>of</strong> the optic nerve and<br />
optic chiasm. M. Yahyavi, A. S. De Preux Charles, T. Xiao,<br />
T. Bardakjian, A. Schneider, H. Baier, A. Slavotinek.<br />
811F Differential expression <strong>of</strong> lung function genes by in<br />
utero smoke exposure during human lung development.<br />
S. Sharma, A. Kho, K. Haley, C. Vyhlidal, R. Gaedigk, L.<br />
Kobzik, J. S. Leeder, K. G. Tantisira, S. T. Weiss.<br />
812F The C7orf58 locus is strongly associated with<br />
both bone mineral content and density at the pediatric<br />
distal radius. B. S. Zemel, M. Li, S. Deliard, C. E. Kim,<br />
L. Qu, R. M. Chiavacci, J. M. Lappe, H. J. Kalkwarf, V.<br />
Gilsanz, H. Hakonarson, S. E. Oberfield, J. A. Shepherd,<br />
S. F. A. Grant.<br />
813F A novel GNAI3 gain-<strong>of</strong>-function mutation<br />
associated with auriculo-condylar syndrome in a<br />
Brazilian family. V. L. R. Tavares, T. T. Torres, H. Buermans,<br />
C. Masotti, D. F. Bueno, J. A. Horst, R. M. Zechi-Ceide, M.<br />
L. Cunningham, M. L. Guion-Almeida, M. R. Passos-Bueno.<br />
814F Non-syndromic cleft lip/palate: A disease driven<br />
by deficiency in genomic repair? G. S. Kobayashi, L. A.<br />
Cruz, D. Y. Sunaga, D. F. Bueno, P. Francis-West, A. Kutta,<br />
B. V. P. Almada, S. G. Ferreira, M. Aguena, L. C. Andrade-<br />
Lima, C. F. Menck, M. R. Passos-Bueno.<br />
815F Genetic characterization <strong>of</strong> osteopenia and bone<br />
overgrowth in Marfan syndrome mice. S. Smaldone, J.<br />
R. Cook, M. Del Solar, F. Ramirez.<br />
816F Evaluating the genetic disruption <strong>of</strong> lung hypoplasia<br />
POSTER SESSIONS 143<br />
in a mouse model <strong>of</strong> CDH. S. C. Schecter, J. Wu, D. Miniati.<br />
817F The role <strong>of</strong> FMRP during early steps <strong>of</strong><br />
neurodevelopment. B. Bardoni, L. Davidovic, B. Mari, O.<br />
Khalfallah.<br />
818F rbm24a and rbm24b Are required for normal<br />
somitogenesis and crani<strong>of</strong>acial development and are<br />
essential for Notch signaling. S. Maragh, R. A. Miller, S.<br />
L. Bessling, W. Huang, M. J. Parsons, A. S. McCallion.<br />
819F Kabuki syndrome: Functional analysis <strong>of</strong><br />
MLL2 and KDM6A in vertebrate development. P. Van<br />
Laarhoven, L. Neitzel, E. A. Geiger, E. H. Zackai, K. B.<br />
Artinger, J. E. Ming, T. H. Shaikh.<br />
820F Fibulin-4b is required for cardiovascular and<br />
musculoskeletal development as an antagonist <strong>of</strong><br />
transforming growth factor-beta. Z. Urban, S. M. Khatri,<br />
A. B. Maxfield.<br />
821F Three-dimensional study <strong>of</strong> Ror2-/- and<br />
Wnta5-/- mice crani<strong>of</strong>acial phenotype using two<br />
imaging techniques. S. Beiraghi, V. Leon-Salazar, J.<br />
Zhang, D. Idiyatullin, M. Garwood, A. S. L. Fok, M. Maga,<br />
Y. Yang.<br />
822F Retinal disease gene identification and<br />
generation <strong>of</strong> photoreceptor gene regulatory networks<br />
by ChIP-seq analysis <strong>of</strong> multiple transcription factors.<br />
H. Hao, M. Brooks, M. Seifert, A. Swaroop.<br />
823F Genome-wide ChIP-seq analysis to identify<br />
mouse Foxl2 binding sites in vivo. M. Marongiu, A.<br />
Sbardellati, L. Marcia, A. Meloni, R. Cusano, A. Angius, G.<br />
Fotia, F. Cucca, L. Crisponi.<br />
824F Cc2d2a is required for cilia biogenesis. S. Veleri,<br />
T. J. Foskett, S. H. Manjunath, A. Longo, M. A. English, P.<br />
Liu, J. Lei, C. Gao, R. N. Fariss, R. Sood, R. A. Rachel, P.<br />
Liu, L. Dong, A. Swaroop.<br />
825F Prdm16 is required during mouse crani<strong>of</strong>acial<br />
development. B. C. Bjork, F. Schnutgen, L. Furlan, B.<br />
Nelson, D. R. Beier.<br />
826F Examination <strong>of</strong> lungs and kidneys in a mouse<br />
model <strong>of</strong> osteogenesis imperfecta. E. Carter, S. Doty, N.<br />
Pleshko, C. Raggio.<br />
827F Pathway analysis by quantitative pr<strong>of</strong>iling <strong>of</strong> gene<br />
expression patterns in developing mouse retina. M.<br />
J. Brooks, I. Nasonkin, S. Perez, S. Veleri, J. Roger, M.<br />
Seifert, A. Swaroop.<br />
828F Essential roles <strong>of</strong> FGF ligands in endochondral<br />
and intramembranous bone development. I. H. Hung, D.<br />
M. Ornitz, G. C. Schoenwolf, M. Lewandoski.<br />
829F Taking a different pathway: Notchless plays with<br />
p53 and Wnt during embryogenesis. A. C. Lossie, C.-L.<br />
Lo, J. B. Sherrill.<br />
830F Developmental defects in the retina <strong>of</strong> Pias3<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
144 POSTER SESSIONS<br />
conditional knockout mice. J. E. Roger, H. Breit, D.<br />
Cheng, L. Dong, A. Swaroop.<br />
831F Uncovering the function <strong>of</strong> TMED2 during<br />
trophoblast differentiation. T. Heba, A. Zakariyah, L. A.<br />
Jerome-Majewska.<br />
832F Mouse models <strong>of</strong> neurodevelopmental disorders:<br />
Overlap between FoxG1 and MeCP2. S. A. Adams, R.<br />
Woods, S. Luu, J. M. LaSalle.<br />
833F Comprehensive characterization <strong>of</strong> a zebrafish<br />
model for pseudoxanthoma elasticum. M. J. Hosen, O.<br />
M. Vanakker, A. Willaert, A. Huysseune, P. J. Coucke, A.<br />
De Paepe.<br />
834F Mouse model reveals the role <strong>of</strong> SOX7 in the<br />
development <strong>of</strong> congenital diaphragmatic hernia<br />
associated with recurrent deletions <strong>of</strong> 8p23.1. D. A.<br />
Scott, M. J. Wat, T. F. Beck, A. Hernández-García, Z. Yu,<br />
D. Veenma, M. Garcia, A. M. Holder, J. J. Wat, Y. Chen, C.<br />
A. Mohila, K. P. Lally, M. Dickinson, D. Tibboel, A. de Klein,<br />
B. Lee.<br />
835F Generation and characterization <strong>of</strong> humanized<br />
DUF1220 transgenic mice. J. G. Keeney, N. Anderson, D.<br />
Restrepo, J. M. Sikela.<br />
836F Overexpression <strong>of</strong> Sox9 in keratinocytes changes<br />
hair follicle cycling in mice. Y. Zhang, Z. H. Zheng, Y. Q.<br />
Xu, S. L. Zhou, L. Shi, X. Zhang.<br />
837F Integration <strong>of</strong> BAC transgenesis, evolutionary<br />
conservation, 3C, DNaseHS, and ChIP on chip data<br />
identifies a candidate osteoblast enhancer <strong>of</strong> Bmp2.<br />
E. M. Broeckelmann, S. Pregizer, D. P. Mortlock.<br />
838F The role <strong>of</strong> Filamin b in skeletogenesis and BMP<br />
signaling in mice. J. Zieba, A. Sarukhanov, M. Ivanova, A.<br />
S. Kim, A. E. Merrill, D. Krakow.<br />
839F The role <strong>of</strong> SOX7 in cardiovascular<br />
development. A. Hernández-Garcia, M. Wat, M. Garcia,<br />
T. F. Beck, Z. Yu, R. Schwartz, M. Dickinson, B. Lee, D.<br />
A. Scott.<br />
840F Novel mouse models reveal the role <strong>of</strong> in the<br />
development <strong>of</strong> inner ear phenotypes seen in 1p36<br />
deletions. H. Zaveri, B. J. Kim, O. A. Shchelochkov, F. A.<br />
Pereira, A. K. Groves, J. S. Oghalai, M. Justice, B. Lee, D.<br />
A. Scott.<br />
841F Xenopus laevis, a model for studying<br />
the involvement <strong>of</strong> HDAC6 in a novel form <strong>of</strong><br />
chondrodysplasia. K. Massé, C. Blanchard, D. Simon,<br />
M. Barillot, P. Helwi, C. Durand, P. Babin, A. Tingaud, P.<br />
Thiebaud, N. Thézé, D. Lacombe, B. Arveiler.<br />
842F Genetic interaction between Sox10 and<br />
b1 integrins during enteric nervous system<br />
development. Y. Watanabe, F. Bondon-Broders,<br />
P. Paul-Gilloteaux, B. Prosper, V. Baral, S. Dufour,<br />
N. Bondurand.<br />
843F Mowat-Wilson syndrome associated ZEB2<br />
zinc-finger mutations lead to phenotype-correlated<br />
impairment <strong>of</strong> the transcription factor function.<br />
J. Ghoumid, L. Drévillon, SM. Alavi-Naini, M. Rio, A.<br />
Briand-Suleau, L. Goodwin, P. Raymond, N. Bondurand,<br />
C. Yanicostas, M. Goossens, S. Lyonnet, D. Mowat, N.<br />
Soussi-Yanicostas, J. Amiel, I. Giurgea.<br />
844F Methylation status <strong>of</strong> a vault RNA, VTRNA2-1<br />
(MIR886), is co-segregated with neural tube defects in<br />
Chinese Han families. W. Li, C. Cai.<br />
845F A high frequency <strong>of</strong> genomic disorders in<br />
patients with congenital kidney malformations. S.<br />
Sanna-Cherchi, K. Kiryluk, K. E. Burgess, M. Bodria, M.<br />
G. Sampson, D. Hadley, S. N. Nees, M. Verbitsky, V. J.<br />
Lozanovski, A. Materna-Kiryluk, B. J. Perry, N. Ristoska-<br />
Bojkovska, M. Zaniew, H. Flogelova, K. Drnasin, V. Goj,<br />
R. P. Lifton, L. N. Clark, M. Saraga, A. F. Dominiczak, L.<br />
Gesualdo, Z. Gucev, L. Allegri, A. Latos-Bielenska, D.<br />
Cusi, F. Scolari, V. Tasic, H. Hakonarson, G. M. Ghiggeri,<br />
A. G. Gharavi.<br />
846F Genome-wide screening and proteome analysis<br />
<strong>of</strong> developing mice diastema region. J. Y. Kim, W. J.<br />
Sohn, Y. M. Chae, Y. J. Jin, B. J. Han, Y. K. Lee, J. K. Jung,<br />
S. H. Kim, M. O. Kim, J. Y. Suh, S. Lee.<br />
847F Foxl2, as Sox9, is involved in skeletal<br />
development through its role in cartilage maturation<br />
and bone mineralization. L. Marcia, A. Puddu, M. Lovicu,<br />
R. Piras, D. Schlessinger, A. Forabosco, M. Uda, L.<br />
Crisponi, M. Marongiu.<br />
848F Expression and functional analysis <strong>of</strong> MMACHC<br />
during mammalian development. M. Moreno-Garcia, M.<br />
Pupavac, D. S. Rosenblatt, L. A. Jerome-Majewska.<br />
849F Three novel human VANGL1 gene mutations in<br />
144 Slovakian, Romanian and German patients with<br />
neural tube defects. O. Bartsch, I. Kirmes, A. Thiede, S.<br />
Lechno, H. Gocan, I. S. Florian, T. Haaf, U. Zechner, L.<br />
Sabova, F. Horn.<br />
850F Identification <strong>of</strong> a new ENU-induced mouse<br />
model for neural tube defects. S. Lachance, M. C.<br />
Guyot, M. Justice, Z. Kibar.<br />
851F Involvement <strong>of</strong> sperm microRNAs in unidentified<br />
male factor infertility. M. G. Katz-Jaffe, B. R. McCallie, J.<br />
Stevens, W. B. Schoolcraft.<br />
852F Comparison <strong>of</strong> the osteogenic potential <strong>of</strong> adult<br />
stem cells from different sources. R. Fanganiello, F.<br />
A. A. Ishiy, L. P. Capelo, M. Aguena, D. F. Bueno, B. V. P.<br />
Almada, M. T. Martins, M. R. Passos-Bueno.<br />
853F The NINDS repository’s publicly accessible<br />
collections <strong>of</strong> highly characterized induced pluripotent<br />
stem cells and primary fibroblasts. C. Tarn, K. Fecenko-<br />
Tacka, M. O’Rourke, K. Panckeri, C. Rhoda, S. Heil, K.<br />
Hodges, M. Sutherland, R. Corriveau, M. Self.<br />
854F Deciphering the Hmx1 pathway in the mouse<br />
retina. A. Boulling, D. F. Schorderet.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
Cytogenetics<br />
855W Evaluation <strong>of</strong> vitamin B12 effects on DNA<br />
damage induced by paclitaxel. O. Khabour, K. Alzoubi,<br />
M. Khader.<br />
856T Evaluation <strong>of</strong> vitamin B12 effects on DNA damage<br />
induced by pioglitazone. K. Alzoubi, O. Khabour, N.<br />
Hussain, S. Al-azzam, N. Mhaidat.<br />
857W Cytogenetic study <strong>of</strong> induced pluripotent<br />
stem cells derived from senescent cells <strong>of</strong> elderly<br />
persons. F. Pellestor, L. Lapasset, F. Becker, J.<br />
Puechberty, A. Schneider, S. Taviaux, P. Sarda, J. M.<br />
Lemaitre, G. Lefort.<br />
858T Secondary aneuploidy in samples <strong>of</strong> balanced<br />
chromosomal rearrangements: No increased rate<br />
detected. O. Reish, R. Amiran, A. Kanesky, S. Gerafi, M.<br />
Mashevich.<br />
859W Telomere “loss” in people with Down syndrome<br />
with and without mild cognitive impairment more than<br />
doubles after T-lymphocytes have been frozen in liquid<br />
nitrogen and short-term cultured with PHA. E. Jenkins,<br />
L. Ye, S. Krinsky-McHale, W. Zigman, N. Schupf, W.<br />
Silverman.<br />
860T Study <strong>of</strong> aging consequences in human<br />
mesenchymal stem cells during tandem passages. H.<br />
Pour-Jafari, B. Pourjafari, F. Talebzadeh, A.R. Zamani, M.<br />
Hosseinipanah, H. Fazli.<br />
861W Telomere structure and function in Cornelia<br />
de Lange syndrome preserved despite evidence<br />
for premature aging. A. D. Kline, H. Riethman, K.<br />
Ravichandran, M. Kaur, A. Kimball, I. D. Krantz.<br />
862T Identifying genes associated with hearing loss<br />
through chromosomal translocations. B. B. Currall,<br />
N. G. Robertson, A. M. Lindgren, M. E. Talkowski, C. C.<br />
Morton.<br />
863W An unbalanced whole-arm translocation<br />
der(1;13)(q10;q10) in Burkitt lymphoma. Y. Seok, S. J.<br />
Park, S. J. Kim, E. Y. Lee, J. R. Choi.<br />
864T Two sibs with trisomy 2q 34-qter. Y. Wang, X. He,<br />
Y. Zhou, C. Wang, X. Yang, L. Zhu, Y. Yang, H. Wu, X. Liu,<br />
D. Shrestha, C. Lee, E. Carter, J. Martinez.<br />
865W Subtelomere sequences on human acrocentric<br />
chromosome short arms. S. Baaj, A. Clarke, P.<br />
Thakkar, E. Chan, M. Khan, S. Chawla, J. Leya,<br />
J. Doering.<br />
866T Multiple chromosomal losses and gain including<br />
the deletion <strong>of</strong> 12p13 region defined by cytogenetic<br />
microarray in a case <strong>of</strong> simultaneous T-cell<br />
prolymphocytic leukemia and renal cell carcinoma. J.<br />
Kim, J. Moon, M. Nam, J. Kim, S. Yoon.<br />
867W A case <strong>of</strong> therapy-related acute myeloid<br />
leukemia with t(19;21)(q13.4;q22). M. Nam, J. Moon, J.<br />
Kim, J. Kim, S. Yoon.<br />
POSTER SESSIONS 145<br />
868T Detection <strong>of</strong> donor cells with a clonal<br />
abnormality 20 years after transplantation: Is this<br />
evidence <strong>of</strong> donor cell leukemia? G. Velagaleti, V.<br />
Ortega, D. Means.<br />
869W Xp22.31 duplications: Indistinctly benign or<br />
inconspicuously pathogenic? E. D. Esplin, B. Li, V. Cox,<br />
R. Clark, C. Curry, A. Slavotinek, L. Hudgins.<br />
870T Refining the critical region associated with<br />
Jacobsen syndrome through the identification <strong>of</strong> a<br />
small interstitial deletion at 11q23.4-q24.1 by CGH<br />
array. S. Raskin, H. Salomão, F. R. Faucz, A. Bonalumi, J.<br />
Souza, P. Grossfeld, J. Rosenfeld, V. S. Sotomaior.<br />
871W Triploid-diploid mixoploidy presenting with<br />
gastrointestinal complaints and growth failure. F. I.<br />
Bhamani, G. L. Elsner, M. B. Beg, R. R. Lebel.<br />
872T Trisomy 14 mosaicism in a girl: Clinical<br />
cytogenetic and molecular analysis. R. Cruz-Alcivar, E.<br />
Lieberman, C. Salas, M. P. Navarrete Meneses, C. Cantú,<br />
K. Buiting, C. Durán-McKinster, V. Del Castillo-Ruiz, P.<br />
Pérez-Vera, Alcivar.<br />
873W Low Klinefelter mosaicism in a male with<br />
azoospermia detected by FISH. P. A. Delgado, B.<br />
Crandall, N. Rao, P. Bui, C. A. Tirado.<br />
874T A balanced translocation t(2;16)(q35;q24.1)<br />
associated with limb defects and crani<strong>of</strong>acial<br />
dysmorphism through presumptive misregulation <strong>of</strong><br />
the IHH (Indian hedgehog) gene. A. C. S. Fonseca, S.<br />
Antonini, A. Bonaldi, P. A. Otto, A. M. Vianna-Morgante.<br />
875W Detection <strong>of</strong> parental origin and meiotic error<br />
type in abortions and born alive with aneuploidies. S.<br />
Frias, S. P. Mendoza-Constantino, S. Sánchez, L. Torres,<br />
B. Molina, P. Grether, D. G. Mayén, R. Meléndez, E.<br />
Yokoyama, C. Villarroel, E. Lieberman, V. del Castillo.<br />
876T Non-mosaic trisomy 9: A new case report. T.<br />
Greer, B. Powell, N. Hauser, J. Shen, L. Mahon, R. Owen,<br />
T. Sahoo, A. Anguiano, F. Boyar.<br />
877W A unique phenotype <strong>of</strong> 2q24.3-2q32.1<br />
duplication: Infantile-onset epilepsy without mesomelic<br />
dysplasia. B. Lim, J. Ko, J. Choi, M. Woo, J. Chae.<br />
878T Importance <strong>of</strong> chromosome breakage testing<br />
in Fanconi’s anemia: Involvement <strong>of</strong> specific<br />
chromosomes. V. Mohan, G. Archana, T. Preethi.<br />
879W Collaborative multicenter cytogenetic study <strong>of</strong><br />
microdeletion syndromes: Brazilian Network. M. Riegel,<br />
N. Barcellos, R. Mergener, R. Gus, R. Giugliani, Brazilian<br />
Network Members.<br />
880T Iidentification <strong>of</strong> chromosome aberration<br />
in fragile X syndrome patients in Tamil Nadu<br />
population South India using cytogenetic techniques.<br />
A. Sundramoorthy.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
146 POSTER SESSIONS<br />
881W A defect in the TUSC3 gene is associated<br />
with syndromic intellectual disability. A. Battaglia, L.<br />
Bernardini, S. Loddo, V. Doccini, V. Parisi, A. Novelli, T.<br />
Filippi.<br />
882T An apparently balanced translocation t(5;6)<br />
(q35.2;p22.3) disrupting the CDKAL1 gene in a girl with<br />
clinical features <strong>of</strong> Silver-Russell syndrome. A. Bonaldi,<br />
S. A. S. Fonseca, A. C. S. Fonseca, A. M. Vianna-<br />
Morgante.<br />
883W Report <strong>of</strong> the first case <strong>of</strong> robertsonian<br />
translocation in Down-Turner mosaicism (mos 45, X /<br />
46,XX, 1 21, rob (21;21)(q10;q10)) with clinical evolution.<br />
M. F. Carvalho, E. F. Carvalho, K. M. Carvalho.<br />
884T Copy number variation in imprinted regions:<br />
Narrowing critical imprinted intervals. B. C. Ballif, N. J.<br />
Neill, J. E. Fox, M. Descartes, F. Brewer, T. Stroud, J. B.<br />
Ravnan, L. G. Shaffer, J. A. Rosenfeld.<br />
885W Detection <strong>of</strong> partial tetrasomy 12pter-12p11.22<br />
region by array CGH and FISH in a newborn with<br />
multiple congenital abnormality. S. Ebrahim, D.<br />
Stockton, A. M. Jay, M. Hankerd, D. Schl<strong>of</strong>f, M. Krist<strong>of</strong>ice,<br />
A. N. Mohamed.<br />
886T Duplication Xq28 and deletion <strong>of</strong> SHOX in a family<br />
with short stature, intellectual and developmental<br />
disability. E. F. Andersen, E. E. Baldwin, S. Ellingwood, R.<br />
Smith, A. N. Lamb.<br />
887W Deafness and infertility syndrome: An underdiagnosed<br />
cause <strong>of</strong> hearing loss? U. Aypar, N.<br />
Hoppman-Chaney, D. Babovic-Vuksanovic.<br />
888T Identification <strong>of</strong> 90 first-reported abnormal<br />
chromosome karyotypes in population <strong>of</strong> Eastern<br />
China with G-band and/or C-band banding techniques.<br />
L. Li, S. Zheng, J. Zhang, W. Fan.<br />
889W Genotype-phenotype correlation in individuals<br />
with MEF2C mutations and/or 5q14.3-q15 deletion<br />
syndrome. E. Pallesi-Pocachard, J. Andrieux, A.-M.<br />
Bisgaard Pedersen, A. Carabalona, R. Steensbjerre Moller,<br />
P.-H. Kaad, E. Parrini, D. Heron, B. Keren, B. Benyahia,<br />
M. Walsh, N. Sobreira, D. Batista, V. Malan, A. Represa, T.<br />
Wang, R. Guerrini, M. Kirchh<strong>of</strong>f, C. Cardoso, M. Holder-<br />
Espinasse.<br />
890T Full-blown expression <strong>of</strong> paternally inherited<br />
Fabry disease in a young woman due to complete<br />
skewed X-inactivation <strong>of</strong> a der(X)t(X;Y)(p22.13;p11.2)<br />
mat.ishYp11.3(SRY1). F. Vialard, K. Benistan, C. Beldjord,<br />
S. Heide, D. Molina-Gomes, F. Jabbour, P. De Mazancourt,<br />
D. P. Germain.<br />
891W Whole-genome array-CGH screening in patients<br />
with autosomal dominant sensorineural hearing loss<br />
points to novel susceptibility loci. E. L. Freitas, D. T.<br />
Uehara, V. G. L. Dantas, A. G. Silva, A. C. Krepischi, R. C.<br />
Mingroni-Netto, C. Rosenberg.<br />
892T Comparison <strong>of</strong> HER2/neu gene amplification<br />
assessment by fluorescent in situ hybridization and<br />
immunohistochemistry in Iranian breast cancer<br />
patients. M. Moradi Chaleshtori, Z. Hojati, H. Teimori, S.<br />
H. Ramazi.<br />
893W Array CGH <strong>of</strong> normal karyotype plasma cell<br />
neoplasms reveals hidden recurrent and individual<br />
genomic copy number alternations. G. Tang, H. Zhang,<br />
C. Shaw, P. Hixson, W. Bi, C. Borgan, M. Coyle, D.<br />
Freppon, D. Vo, J. O’Hare, J. Gonzalez Berjon, C. Chang,<br />
S. Cheung, A. Patel.<br />
894T Interstitial duplication/triplication 20q13.2:<br />
Clinical, cytogenetical and genetical characterization.<br />
A. Briand-Suleau, J. Martinovic, L. Tosca, B. Tou, S.<br />
Brisset, J. Bouligand, V. Delattre, I. Giurgea, C. Goumy,<br />
C. Francannet, A. Guiochon-Mantel, A. Benachi, J.<br />
Vermeesch, G. Tachdjian, P. Vago, M. Goossens, C. Métay.<br />
895W Array-based copy-number analysis in patients<br />
associating obesity and developmental delay/learning<br />
disabilities and additional features. C. D’Angelo, I. Kohl,<br />
C. de Castro, C. Kim, D. R. Bertola, C. Lourenço, A.-B.<br />
Perez, C. Koiffmann.<br />
896T Complex genomic reorganization in<br />
microdeletions/microduplications syndromes and<br />
molecular mechanisms for formation. L. Kulikowski,<br />
F. Piazzon, E. Zanardo, R. Dutra, A. Dias, M. Oliveira,<br />
M. Moreira, G. Novo-Filho, M. Basso, C. Negretto, A.<br />
Zandoná, M. Melaragno, C. Kim.<br />
897W Gene mapping in the Finnish national collection<br />
<strong>of</strong> balanced translocations and inversions. T. M.<br />
Luukkonen, M. Pöyhönen, P. Ellonen, S. Lagström, J. H.<br />
Lee, K. O. J. Simola, K. Aittomäki, J. Ignatius, R. Salonen,<br />
A. Palotie, J. D. Terwilliger, T. Varilo.<br />
898T Combined exon array CGH plus SNP genome<br />
analyses for optimized clinical diagnostics. A. Patel, W.<br />
Bi, C. Shaw, S.-H. Kang, A. N. Pursley, S. Lalani, P. Hixson,<br />
T. Gambin, A. C-H. Tsai, H.-G. Bock, M. Descartes, F.<br />
Probst, F. Sacaglia, A. L. Beaudet, J. R. Lupski, C. Eng, S.<br />
W. Cheung, C. Bacino, J. Wiszniewska.<br />
899W Facing current diagnostic challenges in<br />
array copy number analysis. F. B. Piazzon, R. Dutra,<br />
E. Zanardo, A. Dias, M. Moreira, G. Novo-Filho, D.<br />
Christ<strong>of</strong>olini, V. Meloni, M. Oliveira, A. Zandoná-Teixeira,<br />
M. Basso, C. Negretto, C. Moreira-Filho, M. Melaragno, C.<br />
Kim, L. Kulikowski.<br />
900T Genetic analyses <strong>of</strong> Korean patients with<br />
unexplained mental retardation and developmental<br />
delay using the multiple ligation-dependent probe<br />
amplification. S. Shim, S. Sung, S. Park, K. Kang, M. Lee,<br />
S. Lyu, D. Cha, M. Kim.<br />
901W Complex nature <strong>of</strong> apparently balanced<br />
chromosomal rearrangements in patients with autism<br />
spectrum disorder. A. C. Tabet, A. Verloes, M. Pilorge, B.<br />
Benzacken, C. Betancur.<br />
902T The identification <strong>of</strong> submicroscopic gains and<br />
losses at the breakpoints <strong>of</strong> apparently balanced<br />
rearrangements. B. Torchia, J. A. Rosenfeld, L. G. Shaffer.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
903W Complex phenotype associated with 17q21.31<br />
microdeletion. A. Pic-Taylor, H. Dornelles-Wawruk, C.<br />
Rosenberg, A. C. Krepischi, H. P. N. Safatle, I. Ferrari, J.<br />
F. Mazzeu.<br />
904T Association <strong>of</strong> a deletion downstream <strong>of</strong> NKX2-1<br />
with benign hereditary chorea: Transfer <strong>of</strong> a benign<br />
CNV to likely pathogenic category. U. Surti, J. Liao, K.<br />
C<strong>of</strong>fman, J. Hu, M. Sathanoori, S. Yatsenko, S. Madan-<br />
Khetarpal, M. McGuire, A. Rajkovic.<br />
905W Chromosomal microarray analysis in 22q11.2<br />
deletion syndrome: New insight to LCR-mediated<br />
rearrangement. A. Tsai, D. Klepacka, M. Dodge.<br />
906T Array CGH as a first line diagnostic test in place<br />
<strong>of</strong> karyotyping for postnatal referrals: Results from<br />
four years clinical application for over 7,800 patients.<br />
J. W. Ahn, S. Bint, A. Bergbaum, K. Mann, R. P. Hall, C.<br />
Mackie Ogilvie.<br />
907W Identification <strong>of</strong> the critical region for 7q32q34<br />
deletion syndrome in a 1.5 Mb region at 7q32.3q33. T.-<br />
J. Chen, J. H<strong>of</strong>fman, K. Phelan, H. C. Andersson.<br />
908T Clinical implementation <strong>of</strong> whole-genome array<br />
CGH in Korean patients with pediatric neurologic<br />
diseases and multiple congenital anomalies. E. Shin, K.<br />
Lee, B. Eun.<br />
909W Chromosome and segmental imbalances<br />
detected by array CGH in samples <strong>of</strong> product <strong>of</strong><br />
conception: a pilot study. S. Xu, X. Wang, W. Xu, F.<br />
Gong, J. Lee, X. Lu, S. Li.<br />
910T Hemophilia A and trigonocephaly in a male with<br />
a complex chromosome rearrangement involving<br />
chromosomes X and 1. J. Liu, J. Chernos, R. Lamont, R.<br />
Perrier, B. Argiropoulos.<br />
911W Identification <strong>of</strong> cryptic genomic imbalance<br />
in congenital and development abnormalities: An<br />
institutional experience. F. J. Sheth, J. Andrieux, M.<br />
Desai, J. Sheth, T. Mampilly, G. Mampilly, C. Neeradha, J.<br />
Vijayalakshmy, K. Godbole, S. Desai.<br />
912T Lack <strong>of</strong> evidence for biparental inheritance <strong>of</strong><br />
copy number variation contributing to pathogenic<br />
features in a series <strong>of</strong> clinical microarray cases. C.<br />
E. Cottrell, S. Kulkarni, H. Al-Kateb, M. Evenson, S.<br />
Anderson, D. Lamb Thrush, S. Hashimoto, A. K. Bailes, L.<br />
Erdman, A. McKinney, C. Weber, J. Weslow-Schmidt, S.<br />
Ramsey, C. Astbury, S. Reshmi, J. M. Gastier-Foster, R.<br />
E. Pyatt.<br />
913W 7q33 Deletion in a family with intellectual<br />
disability, dysmorphic features and behavioral<br />
changes. A. Fortuna, F. Lopes, S. Sousa, J. Silva, C.<br />
Gomes, P. Maciel.<br />
914T Investigation <strong>of</strong> the parental origin and genomic<br />
mechanisms involved in de novo pathogenic CNVs in<br />
congenital disorders. S. Hayashi, M. Naganawa, D. T.<br />
Uehara, J. Inazawa.<br />
POSTER SESSIONS 147<br />
915W Our experience <strong>of</strong> clinical implementation<br />
<strong>of</strong> whole-genome array CGH as a first-line test in<br />
postnatal cases. V. Malan, J.-M. Lapierrre, M.-C. de<br />
Blois, C. Ozilou, S. Nusbaum, O. Raoul, M. Le Merrer,<br />
A. Harroche, R. Caumes, G. Baujat, F. Cartault, M. Rio,<br />
J. Amiel, S. Lyonnet, V. Cormier-Daire, A. Munnich, M.<br />
Vekemans, S. Romana.<br />
916T Copy number variation in hereditary colorectal<br />
cancer. A. L. Martin, B. A. Talseth-Palmer, D. M. Grice,<br />
G. N. Hannan, R. J. Scott.<br />
917W Using macrocephaly as a quantitative<br />
endophenotype in autism patients to enhance the<br />
identification <strong>of</strong> novel candidate genes. J. Reiner, D.<br />
Moreno-De-Luca, E. B. Kaminsky, D. H. Ledbetter, C. L.<br />
Martin.<br />
918T Study <strong>of</strong> genomic changes in children with<br />
intellectual and developmental disabilities using<br />
chromosomal microarray. P. Sharma, N. Gupta, M. R.<br />
Chowdhury, R. Shukla, M. Ghosh, M. Kabra.<br />
919W Association <strong>of</strong> rare copy number variations and<br />
risk for Alzheimer’s disease. D. Villela, D. Schlesinger, C.<br />
K. Suemoto, L. T. Grinberg, A. C. Krepischi, C. Rosenberg.<br />
920T Coronary artery disease genomics: CNV findings<br />
in the group <strong>of</strong> patients from Lithuania. V. Kucinskas, I.<br />
Pepalyte˙, A. Pranculis, l. Bagdonaite, V. Dzenkeviciute, Z.<br />
Kucinskiene.<br />
921W An unbalanced translocation causing a 21q11.2<br />
deletion in an infertile male. I. Holm, K. Eiklid, C. Hauge,<br />
V. Rønning, H. Wold.<br />
922T Single cell copy number pr<strong>of</strong>iling in a 24-hour<br />
workflow with oligo aCGH. P. Costa, S. Fulmer-Smentek,<br />
A. De Witte.<br />
923W Four new polymorphic CNVs in cohort <strong>of</strong><br />
100 Bulgarian patients with intellectual disability/<br />
congenital malformations and autism. S. P.<br />
Hadjidekova, D. M. Avdjieva-Tzavella, B. B. Rukova, D. V.<br />
Nesheva, R. S. Tincheva, D. I. Toncheva.<br />
924T First detection <strong>of</strong> clonal trisomy 4 cells from 3<br />
cases <strong>of</strong> ossifying renal tumor <strong>of</strong> infancy. J. Liu, M.<br />
Guzman, B. Pawel, D. Pezanowski, J. Roth, G. Halligan, J.<br />
de Chadarévian1.<br />
925W 17p13.3 Microduplication syndrome: Report<br />
<strong>of</strong> additional findings. L. Mutesa, E. Chabchoub, J.-<br />
H. Caberg, A.-C. Hellin, M. Jamar, H. Peeters, G. van<br />
Buggenhout, G. Pierquin, J. Andrieux.<br />
926T Chromosome aberrations among 4617<br />
chromosomal studies at a pediatric Mexican hospital<br />
in 19-year period <strong>of</strong> time. J. M. Aparicio, M. L. Hurtado,<br />
M. P. Barrientos, W. B. San Martin, A. F. Nuñez, R. G. Ruiz,<br />
H. T. Gomez, S. P. Rodriguez, R. M. Zamudio, F. L. Cuellar,<br />
M. A. Cubillo, F. P. Sierra, M. G. Palma, H. O. Chavez, S.<br />
M. Chatelain.<br />
927W Study <strong>of</strong> sodium pertechnetate on bone marrow<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
148 POSTER SESSIONS<br />
cells <strong>of</strong> mice, in vivo: Micronucleus assay. I. Aranha.<br />
928T Cryptic translocactions <strong>of</strong> acrocentrics<br />
chromosomes in normal couples and couples with<br />
aneuploid miscarriages. S. Ramos, O. Castro, B. Molina,<br />
M. Angeles, P. Grether, D. Mayen, S. Frias.<br />
929W A comparative cytogenetic resolution analysis<br />
between classic chromosome aberrations and<br />
cytokinesis-block micronucleus cytome assay.<br />
R. Saraswathy.<br />
930T In vitro assessment <strong>of</strong> genotoxicity and<br />
cytotoxicity <strong>of</strong> methyl mercury chloride. S. Tayel, M.<br />
Naim Bushra, A. Abd Ruboh, S. Hilal, A. El Agwany.<br />
931W The deletion 5q in myelodysplasia: Correlation<br />
<strong>of</strong> cytogenetic, peripheral blood and bone marrow<br />
findings. V. M. Srivastava, S. Yuvarani, U. Sitaram, A.<br />
Nancy, R. Ahmed, A. Abraham, A. Vishwabandya, B.<br />
George, V. Mathews, A. Srivastava.<br />
932T The quality <strong>of</strong> the bone marrow sample for<br />
successful conventional cytogenetic analysis is<br />
important. E. Tegg, E. Raik.<br />
933W Parental interstitial translocation underlie<br />
deletion in Langer-Giedion syndrome. B. Min, M. Seo, T.<br />
Cho, W. Park.<br />
934T Concurrent deletions and duplications at 1p36. M.<br />
Gajecka, J. Karolak, J. Shen, C. Glotzbach, L. G. Shaffer.<br />
935W Multiple structural abnormalities involving 4q33<br />
in a spontaneous abortion. M. B. Sheridan, C. Wigner, D.<br />
A. S. Batista, K. Turner, C. DeScipio.<br />
936T When transmission modifies the complexity <strong>of</strong><br />
familial chromosome rearrangements. V. Gatinois, G.<br />
Lefort, C. Coubes, J. Puechberty, A. Schneider, S. Taviaux,<br />
M. Tournaire, M. Di Nicola, M. Girard, P. Sarda, F. Pellestor.<br />
937W Evidence <strong>of</strong> a trisomy 9 rescue event in amniotic<br />
fluid. L. E. Northrop, M. J. Macera, V. Johbanputra, B.<br />
Levy.<br />
938T Large-scale sequence analysis <strong>of</strong> translocation<br />
breakpoint junctions. B. Weckselblatt, M. K. Rudd.<br />
939W Analysis <strong>of</strong> the nucleotide sequence diversity<br />
within the SUZ12 gene and its pseudogene SUZ12P<br />
as a means to investigate the signature <strong>of</strong> nonallelic<br />
homologous gene conversion. T. Mussotter, J. Vogt, K.<br />
Bengesser, J. Högel, D. N. Cooper, H. Kehrer-Sawatzki.<br />
940T An examination <strong>of</strong> the origin <strong>of</strong> the excess <strong>of</strong><br />
males liveborn with trisomy 21. C. Walker, S. Gandy,<br />
J. Jones, A. Harden, T. Naluai-Cecchini, E. Cheng, S.<br />
Sherman, T. Oliver.<br />
941W Down - Turner mosaicism. L. Martelli, C. G.<br />
Picanço, C. H. P. Grangeiro, C. S. Pereira, R. M. Scaparo,<br />
S. A. Santos, J. Huber, E. S. Ramos.<br />
942T Accurate, precise, and tunable cytogenetics with<br />
next-generation sequencing. M. A. Eberle, T. Royce, F.<br />
Kaper, J. Cottrell, J.-B. Fan.<br />
943W Two new cases <strong>of</strong> interstitial 6q deletion,<br />
associated to microcephaly, corpus callosum<br />
hypoplasia and further brain and cerebellar<br />
malformations. V. Parisi, S. Loddo, L. Travaglini, A.<br />
Ferraris, G. Vitiello, G. Zanni, L. Bernardini, M. L. Di<br />
Sabato, M. C. Digilio, A. Novelli, E. Del Giudice, A. Rossi,<br />
E. Bertini, B. Dallapiccola, E. M. Valente.<br />
944T Ring chromosome 13: An eventual risk for<br />
intellectual disability, surdity, congenital malformations<br />
and leukemia. I. Ben-Abdallah-Bouhjar, H. Hannachi, S.<br />
Mougou-Zerelli, H. Ben-Khelifa, A. Labalme, D. Sanlaville,<br />
H. Elghezal, A. Saad.<br />
945W Use <strong>of</strong> oligo-SNP array for the detection <strong>of</strong><br />
abnormalities in CLL. N. C. Christacos, M. L. Slovak, M.<br />
A. Sanidad, Y. Hsu, J. C. Kelly, P. N. Mowrey, D. M. Jones.<br />
946T Array-based comparative genomic hybridization<br />
identifies unique copy number alterations in diffuse<br />
large B-cell lymphoma subtypes: A review <strong>of</strong> published<br />
microarray data. R. Garcia.<br />
947W Subtype <strong>of</strong> ETV6/ABL1 fusion transcript is<br />
associated with different leukemia phenotype. A. Kwon,<br />
J. Park, J. Lim, Y. Kim, K. Han, S. Lee, H. Kim, W. Min, J.<br />
Kim, M. Kim.<br />
948T Detecting chromosomal inversions using chromatid<br />
painting strategies: Applications. F. A. Ray, E. Zimmerman,<br />
M. N. Cornforth, E. H. Goodwin, J. S. Bedford, S. M. Bailey.<br />
949W Efficacy and implementation <strong>of</strong> a SNP<br />
microarray for the evaluation <strong>of</strong> patients with multiple<br />
myeloma. S. Schwartz, R. D. Burnside, J. McElligott, I.<br />
Gadi, J. Kesler, V. Jaswaney, K. Phillips, J. Tepperberg, B.<br />
Williford, P. Papenhausen.<br />
950T A de novo intragenic deletion <strong>of</strong> AUST2 in a<br />
patient with autism spectrum disorder. S. Kantarci, I. E.<br />
Amarillo, J. David, E. Vilain, X. Li.<br />
951W 22 q 11.2 Syndrome in a group <strong>of</strong> patients who<br />
attended Operation Smile Foundation in Colombia,<br />
between 2005 and <strong>2012</strong>. I. Briceno, J. C. Martinez, A.<br />
Venegas, O. Moreno, M. Sarmiento, S. Bohorquez, M.<br />
Montiel, A. Patino.<br />
952T Incidence <strong>of</strong> mosaicism detected by exontargeted,<br />
high-resolution array comparative genomic<br />
hybridization in 10,362 consecutive cases with special<br />
emphasis on detection <strong>of</strong> complex unbalanced structural<br />
rearrangements. W. Bi, J. Pham, C. Shaw, P. Hixson, A.<br />
Ester, A. Pursley, K. Plunkett, P. L. Magoulas, S.-H. L. Kang, S.<br />
R. Lalani, C. Bacino, P. Stankiewicz, A. Patel, S. W. Cheung.<br />
953W A cryptic derivative chromosome 12 detected by<br />
oligo-SNP array. Z. Dai, N. C. Christacos, S. Schonberg,<br />
J. Kelly, E. Wallenhorst, K. Sullivan, C. Adams, Y. Hsu, H.<br />
Walker, T. Simanivanh, P. Mowrey.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
954T GLUT1 deficiency and chromosome microarray<br />
analysis. A. J. Dawson, A. Mhanni, F. Booth, D. Bernier, M.<br />
Tomiuk, J. Hartley, M. Strecker, K. Hovanes.<br />
955W Clinically relevant mosaic findings in a total <strong>of</strong><br />
9,605 patients and parents by using genome-wide<br />
high resolution SNP array analysis in constitutional<br />
diagnosis. N. de Leeuw, J. Y. Hehir-Kwa, B. H. W. Faas,<br />
T. K. Rinne, M. J. E. Kempers, S. A. de Munnik, N. F.<br />
A. Leijsten, G. C. Machielsen, S. L. J. van Gessel, M.<br />
Wunderink, M. J. G. Banning, R. van Beek, M. del Rosario,<br />
B. B. A. de Vries, D. F. C. M. Smeets, R. Pfundt.<br />
956T Genomic differences between spontaneously<br />
aborted fetuses and live-born children with 45,X<br />
monosomy. J. Domínguez Ortiz, L. Torres, S. Sanchez, V.<br />
del Castillo, L. Orosco, A. Carnevale, P. Grether, D. Mayen,<br />
S. Frias.<br />
957W Characterization <strong>of</strong> a rare 16.25 Mb duplication<br />
<strong>of</strong> Xp21.2p22.2. M. J. Macera, E. Bornstein, V. Aggarwal,<br />
L. Northrop, M. Shirazi, A. Sorbrino, B. Levy, D. Warburton,<br />
V. Jobanputra.<br />
958T Single nucleotide polymorphism-based<br />
microarray comparison for detection <strong>of</strong> constitutional<br />
copy number variation and absence <strong>of</strong> heterozygosity.<br />
H. Mei, S. A. Scott, H. M. Kearney, D. del Gaudio, J. D.<br />
Weisfeld-Adams, M. P. Wasserstein, S. Das, N. Cohen, L.<br />
Edelmann.<br />
959W Atypical copy number abnormalities in patients<br />
with suggestive phenotype <strong>of</strong> 22q11.2 deletion<br />
syndrome. M. C. Molck, T. P. Vieira, I. C. Sgardioli, M.<br />
Simioni, A. C. Xavier, J. Souza, V. L. Gil-da-Silva-Lopes.<br />
960T Mosaicism in live born and spontaneous<br />
abortions with trisomy 13, 18, 21 and monosomy X.<br />
S. Sánchez, P. Grether, D. G. Mayén, B. Molina, M. J.<br />
Zavaleta, J. Domínguez, R. Meléndez, S. Frias.<br />
961W Array-CGH analysis in patients with Goldenhar<br />
syndrome. P. A. C. Santos, E. L. Freitas, H. P. N. Safatle,<br />
C. Rosenberg, I. Ferrari, S. F. Oliveira, J. F. Mazzeu.<br />
962T Complex rearrangements involving five<br />
chromosomes and at least fourteen breaks. J. Wang, B.<br />
Huang, R. Habibian, A. Hajianpour.<br />
963W Trisomy Xp and partial tetrasomy Xq resulted<br />
from gain <strong>of</strong> a rearranged X chromosome in a female<br />
fetus: Pathogenic or not? M. Yiu, Z. Qi, A. Ki, K.<br />
Hashimoto, M. Ernster, J. Yu.<br />
964T A de novo 0.24-Mb microdeletion <strong>of</strong> 16q24.3<br />
encompassing ANKRD11 in a patient with KBG<br />
syndrome. H.-J. Cho, E.-J. Seo, J.-H. Lim, J.-O. Lee, H.-<br />
W. Yoo, C. K. Cheon.<br />
965W The evaluation <strong>of</strong> subtelomeric fluorescent<br />
in situ hybridization analysis <strong>of</strong> idiopathic mental<br />
retardation / multiple congenital anomaly cases. B.<br />
Durmaz, E. Karaca, A. Durmaz, T. Atik, H. Akin, O. Cogulu,<br />
F. Ozkinay.<br />
POSTER SESSIONS 149<br />
966T Mechanism-based analysis <strong>of</strong> human cell lines <strong>of</strong><br />
Prader-Willi syndrome. Z. Tang, D. Berlin, M. Wineburg,<br />
A. MacMillan, D. Altamuro, L. Toji, C. Beiswanger, S.<br />
Madore, N. Gerry.<br />
967W A child with Pitt-Hopkins syndrome and maternal<br />
somatic mosaicism at 18q21.2. K. Doudney, V. Bickley,<br />
M. Robertson, J. Watt, J. Taylor, A. Kidd, P. George.<br />
968T Microarray benefits diagnostic pregnancy loss<br />
studies. D. L. Pickering, B. J. Dave, D. M. Golden, A. A.<br />
Haggerty, D. L. Bishay, R. L. Smith, S. A. Fisher, W. G.<br />
Sanger.<br />
969W Method comparison study <strong>of</strong> the Illumina<br />
InfiniumDx CytoSNP-12 assay for the detection <strong>of</strong><br />
chromosomal abnormalities in DNA extracted from<br />
peripheral blood. M. Porter, R. Golshani, J. Fabian, M.<br />
Harris.<br />
970T A CML case with normal karyotype and positive<br />
BCR/ABL1 fusion. C. A. Tirado, J. W. Boles, J. Ochoa,<br />
R. Collins.<br />
971W Computational methods for detecting wholegenome<br />
triploid samples with Agilent CGH1SNP<br />
arrays. A. Vadapalli, B. J. Peter, A. Ashutosh, J. Ghosh,<br />
B. Curry, A. Rajkovic, U. Surti, S. A. Yatsenko.<br />
972T Genome-wide resolution study <strong>of</strong> CNV<br />
detection by the CytoScan® HD Cytogenetics<br />
Array through a large-scale experiment. Y. S. Wang,<br />
A. H. Roter.<br />
973W A new case <strong>of</strong> inverted duplication with<br />
terminal deletion <strong>of</strong> chromosome 12p characterized<br />
by FISH and SNP array analysis. E. Pipiras,<br />
B. Jeandidier, S. Chantot-Bastaraud, B. Benzacken,<br />
A. Delahaye.<br />
974T GISH analysis <strong>of</strong> genome discrimination in two<br />
interspecific hybrid <strong>of</strong> sweet potato. Z. Li.<br />
975W Latest innovations in oligo FISH enable high<br />
resolution detection <strong>of</strong> chromosomal aberrations.<br />
M. Ruvolo, V. Kulkarni, B. Mullinax, A. Bergstrom Lucas,<br />
P. Tsang, N. Faravashi, A. De Witte, M. Srinivasan,<br />
E. LeProust, S. Fulmer-Smentek.<br />
976T Deletion 2q24.1q24.2 in a boy with<br />
generalized hypotonia and developmental delay:<br />
Further delineation. V. del Castillo, E. Yokoyama,<br />
C. Villarroel, J. L. Castrillo, S. Avila, S. Sánchez, B. Molina,<br />
S. Frías.<br />
977W SNP arrays provide incremental, clinically<br />
significant information for patients undergoing<br />
chromosome microarray testing. V. Aggarwal,<br />
O. Nahum, B. Marmol, K. Anayane-Yeboa, B. Levy.<br />
978T Non-mosaic duplication <strong>of</strong> chromosome<br />
6p in a child, inherited from his mother<br />
with a mosaic unbalanced der(14)t(6;14)<br />
(6pter➞6p22.3::14p13➞14qter). S. M. Bain, J. K.<br />
Nicholl, W. Waters, A. H. Attwood, J. Samuel, T. A.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
150 POSTER SESSIONS<br />
Hocking, S. G. Brown, E. A. Haan, S. Yu.<br />
979W Diagnostic array analysis and the necessity<br />
<strong>of</strong> high quality SNP information. R. Pfundt, J. Hehir-<br />
Kwa, N. Leijsten, S. van Gessel, M. Wunderink,<br />
T. Machielsen, R. van Beek, M. Banning, M. Rosario,<br />
N. de Leeuw.<br />
980T Copy-number variation and UPD(16) mosaicism<br />
in a patient with apple peel intestinal atresia, ocular<br />
anomalies, microcephaly and bone-marrow failure.<br />
F. A. T. de Vries, Y. van Bever, I. M. Appel, H. Kart, L. J. C.<br />
M. van Zutven, H. B. Beverloo.<br />
Cancer <strong>Genetics</strong><br />
981W Tumor suppression in Apc Min/1 mice by the<br />
prostaglandin D 2 receptor PTGDR. H. Lin, A. Kwong, O.<br />
Lee, V. Buslon, S. French, E. Salido.<br />
982T Effects <strong>of</strong> Western-style diet and genetic<br />
predisposition on the protein expression and cancer<br />
susceptibility in normal colonic mucosa. S. Lowndes,<br />
D. Dermadi Bebek, M. Pussila, N. Reyhani, L. Sarantaus,<br />
M. Nyström.<br />
983F The Jackson Laboratory Rare and Orphan<br />
Disease Center. S. Rockwood, C. Lutz, K. Fancher, A.<br />
Picard, M. Sasner, L. Reinholdt, S. Murray, D. Bergstrom,<br />
J. Morgan, L. Donahue, GRS Team.<br />
984W Genetic differences in transcript responses to<br />
low-dose ionizing radiation identify tissue functions<br />
associated with breast cancer susceptibility. A. J.<br />
Wyrobek, F. Marchetti, S. Bhatnagar, N. Duru, J. Han, Z.<br />
Hu, J.-H. Mao, J. W. Gray, A. M. Snijders.<br />
985T Association <strong>of</strong> the HLA-G gene polymorphisms<br />
with cervical cancer risk. T. Chang, Y. Yang, Y. Lee, T.<br />
Chen, S. Chang, W. Lin.<br />
986F Association <strong>of</strong> the HOXB13 G84E variant with<br />
familial, sporadic, and aggressive prostate cancer: The<br />
Mayo Clinic experience. M. S. DeRycke, L. S. Tillmans,<br />
S. K. McDonnell, S. M. Riska, J. Xu, Y. W. Asmann, D. J.<br />
Schaid, S. N. Thibodeau, International Consortium for<br />
Prostate Cancer <strong>Genetics</strong>.<br />
987W The miR-29 family <strong>of</strong> microRNA genes and let-7i<br />
associate with gastric cancer in European populations:<br />
Results from the EPIC-EURGAST study. Y. Espinosa-<br />
Parrilla, X. Muñoz, C. Bonet, N. García, A. Venceslá, E.<br />
Riboli, C. A. González, N. Sala on behalf <strong>of</strong> EPIC Gastric<br />
Cancer Working Group.<br />
988T 3’UTR variation in PTEN and PTENP1 :<br />
Implications for microRNA binding. B. G. Hernandez, C.<br />
LaViolette, T. Begay, J. A. Wilder.<br />
989F Replacement therapy for lung adenocarcinoma<br />
risk in never-smoking women. C. Hsiao, K. Chen, G.<br />
Chang, Y. Tsai, W. Su, Y. Chen, M. Huang, C. Hsiung, C.<br />
Chen, P. Yang, GELAC Study Group.<br />
990W Application <strong>of</strong> molecular diagnostic techniques<br />
on the study done on phosphatase and tensin<br />
homologue deleted on chromosome 10 (PTEN). R. Issa.<br />
991T Validation, fine-mapping, and characterization<br />
<strong>of</strong> six genes related to testicular germ cell tumor in a<br />
large Swedish-Norwegian case-parent, case-control<br />
sample. R. Karlsson, W. Kristiansen, K. E. Andreassen,<br />
E. L. Aschim, R. M. Bremnes, O. Dahl, S. D. Fosså, O.<br />
Klepp, C. W. Langberg, A. Solberg, S. Tretli, P. K. E.<br />
Magnusson, H.-O. Adami, T. B. Haugen, T. Grotmol, F.<br />
Wiklund.<br />
992F Genome-wide germline DNA autosomal copy<br />
number variation analysis in Finnish BRCA1/2-founder<br />
mutation-negative hereditary breast and/or ovarian<br />
cancer individuals. K. M. Kuusisto, O. Akinrinade, M.<br />
Vihinen, S.-L. Sallinen, J. Schleutker.<br />
993W Mediator complex subunit 12 (MED12) mutations<br />
in uterine leiomyosarcomas. M. M. McGuire, M. Jones,<br />
G. Trucco, U. Surti, R. P. Edwards, A. Rajkovic.<br />
994T Association <strong>of</strong> breast cancer risk factors and HLA-G<br />
gene indel 14bp polimorphyms in a Brazilian population.<br />
Y. C. N. Muniz, M. Damiani, L. D. Hausmann, B. S. Almeida,<br />
B. Fernandes, R. T. Simıes, A. R. Marrero, I. R. Souza.<br />
995F Fine-mapping <strong>of</strong> prostate cancer susceptibility<br />
locus 11q13.5. R. Nurminen, R. Lehtonen, T. L. Tammela,<br />
T. Wahlfors, J. Schleutker.<br />
996W Role <strong>of</strong> copy number variants in the nucleotide<br />
excision repair pathway genes and breast cancer risk in<br />
Puerto Rican women. A. Pacheco Torres, J. Matta, J. Dutil.<br />
997T Screening <strong>of</strong> Finnish RAD51C founder mutations<br />
in prostate and colorectal cancer patients. L. M.<br />
Pelttari, R. Nurminen, A. Gylfe, L. Aaltonen, J. Schleutker,<br />
H. Nevanlinna.<br />
998F Exome sequencing in a familial testicular germ<br />
cell tumor kindred. K. A. Schrader, S. Shah, V. Joseph, R.<br />
Murali, R. Rau-Murthy, K. Sarrel, I. Dolgalev, S. Cheguri,<br />
C. Manschreck, N. Socci, A. Viale, A. Heguy, G. Bosl, D.<br />
Feldman, M. Robson, Z. Stadler, K. Offit.<br />
999W SLX4 mutation in hereditary breast cancer.<br />
S. Shah, Y. Kim, I. Ostrovnaya, F. Lach, R. Murali, K.<br />
Schrader, V. Joseph, K. Sarrel, R. Rau-Murthy, N. Hansen,<br />
S. Cheguri, J. Littman, L. Zhang, K. Offit, A. Smogorzewska.<br />
1000T Contribution <strong>of</strong> ARLTS1 to prostate cancer<br />
susceptibility. S. Siltanen, H. Rauhala, T. L. Tammela, P.<br />
Kujala, T. Visakorpi, T. Wahlfors, J. Schleutker.<br />
1001F Meta-analysis <strong>of</strong> 25 prostate cancer associated<br />
SNPs in high-risk prostate cancer families: New<br />
evidence from the International Consortium for<br />
Prostate Cancer <strong>Genetics</strong>. C. Teerlink, S. Thibodeau, D.<br />
Schaid, K. Cooney, E. Lange, C. Maier, J. Stanford, E. A.<br />
Ostrander, J. Schleutker, G. Cancel-Tassin, O. Cussenot,<br />
R. Eeles, D. Easton, W. Isaacs, J. Xu, J. Carpten, J. E.<br />
Bailey-Wilson, F. Wiklund, A. Whittemore, W. Catalona,<br />
W. Foulkes, N. Camp, L. Cannon-Albright, International<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
Consortium for Prostate Cancer <strong>Genetics</strong>.<br />
1002W CDH1 mutations in patients with lobular<br />
carcinoma <strong>of</strong> the breast. A. L. Valente, S. Rummel, C. D.<br />
Shriver, R. E. Ellsworth.<br />
1003T Fine-mapping <strong>of</strong> breast cancer genome-wide<br />
association studies loci in women <strong>of</strong> African ancestry.<br />
Y. Zheng, T. O. Ogundiran, K. L. Nathanson, E. M. John,<br />
A. Hennis, S. Ambs, C. Adebamowo, S. M. Domchek, T.<br />
R. Rebbeck, M. S. Simon, B. Nemesure, S. Y. Wu, M. C.<br />
Leske, Q. Niu, J. Zhang, E. R. Gamazon, N. J. Cox, O. I.<br />
Olopade, D. Huo.<br />
1004F L1 encoded ORF1p facilitates tumorigenesis and<br />
suppresses nucleus accumulation <strong>of</strong> Smad-4 in HepG2<br />
cells. Y. Zhu, F. Feng, X. Gao, J. Yu, M. Hu, F. Zhang, Y.<br />
Wang, Q. Zhang, Y. Guo.<br />
1005W Copy number variation analysis in 222 mutation<br />
negative polyposis patients reveals potential new<br />
candidate genes. S. Aretz, S. Horpaopan, S. Vogt,<br />
I. Spier, A. M. Zink, S. Herms, A. Laner, K. Wöllner, S.<br />
Pasternack, M. Draaken, D. Stienen, S. Uhlhaas, E.<br />
Holinski-Feder, M. M. Nöthen, P. H<strong>of</strong>fmann.<br />
1006T Evaluation <strong>of</strong> the RHINO gene for breast cancer<br />
predisposition in Finnish breast cancer families.<br />
T. Heikkinen, E. Huovari, S. Vilske, C. Blomqvist, J.<br />
Schleutker, A. Kallioniemi, K. Aittomäki, H. Nevanlinna.<br />
1007F A gene-based association approach prioritizes<br />
candidate susceptible genes for chronic myeloid<br />
leukemia. J.-H. Park, H.-H. Won, J.-W. Kim, D. H. Kim,<br />
S.-T. Lee, S. Kim, S.-H. Kim, C. W. Jung.<br />
1008W Proteomic analysis <strong>of</strong> gastric cancer from<br />
individuals <strong>of</strong> Northern Brazil. M. F. Leal, J. Chung, D. Q.<br />
Calcagno, P. P. Assumpção, S. Demachki, I. D. C. G. Silva,<br />
R. Chammas, R. R. Burbano, M. A. C. Smith.<br />
1009T Fine-mapping <strong>of</strong> IL-16 gene and prostate cancer<br />
risk in African <strong>American</strong>s. K. Batai, E. Shah, M. Ruden,<br />
J. Newsome, A. B. Murphy, C. Ahaghotu, R. A. Kittles.<br />
1010F Fas signaling pathway-based analysis <strong>of</strong><br />
genome-wide data and risk <strong>of</strong> gastric cancer. P. L.<br />
Hyland, S.-W. Lin, N. Hu, Z.-Z. Tang, L. Wang, C. Wang, H.<br />
Su, T. Ding, J.-H. Fan, Y.-L. Qiao, X. Xiong, W. Wheeler, C.<br />
Griffen, K. Yu, Z. Wang, L. Burdett, S. J. Chanock, S. M.<br />
Dawsey, M. A. Tucker, N. D. Freedman, A. M. Goldstein, C.<br />
C. Abnet, P. R. Taylor.<br />
1011W Fine-mapping identifies multiple prostate<br />
cancer risk loci at 5p15, one <strong>of</strong> which associates<br />
with TERT expression. Z. Kote-Jarai, E. Saunders,<br />
D. Leongamornlert, M. Tymrakiewicz, T. Dadaev, S.<br />
Jugurnauth-Little, H. Ross-Adams, A. Al-Olama, S.<br />
Benlloch, S. Halim, R. Russel, A. Dunning, D. Neal, F.<br />
Hamdy, J. Donovan, D. Easton, R. Eeles, UK <strong>Genetics</strong><br />
Prostate Cancer Study Collaborators, PRACTICAL<br />
Consortium.<br />
1012T Fine mapping <strong>of</strong> 12q24 shows a promising<br />
association locus for renal cell carcinoma. J. R. Toro,<br />
POSTER SESSIONS 151<br />
S. Han, M. Yeager, L. Moore, M. Purdue, M. Johansson,<br />
G. Scelo, V. Gaborieau, C. Berg, R. Grubb, V. Stevens, M.<br />
Thun, W. Diver, D. Albanes, S. Weinstein, J. Virtamo, L.<br />
Burdett, A. Brisuda, J. McKay, J. Fraumeni, N. Chartterjee,<br />
P. Rosenberg, N. Rothman, P. Brennan, W. H. Chow, M.<br />
Tucker, S. Chanock.<br />
1013F Array CGH analyses in a patient with multifocal<br />
recurrent meningioma. Z. Yilmaz Celik, Y. K. Terzi, N.<br />
Altinors, F. I. Sahin.<br />
1014W Haplotype-resolved sequencing and structural<br />
analysis <strong>of</strong> the HeLa cancer genome. A. C. Adey, J. O.<br />
Kitzman, J. Burton, J. Shendure.<br />
1015T Role <strong>of</strong> somatic mutations in the<br />
etiopathogenesis <strong>of</strong> Maffucci syndrome. M. Amyere,<br />
M. Limaye, N. Mulliken, J. B. Dompmartin, A. Enjorlas, O.<br />
Kaitila, I. Docquier, P.-L. Godfraind, L. M. Boon, M. Vikkula.<br />
1016F Association <strong>of</strong> polymorphisms in NNK<br />
metabolizing genes and lung cancer risk. J. L. Engle,<br />
A. K. Hull, G. Liu, A. S. Berg, C. J. Gallagher, P. Lazarus, J.<br />
E. Muscat.<br />
1017W Myeloproliferative neoplasms and somatic<br />
mosaicism in the 23andMe participant community. D.<br />
A. Hinds, K. E. Barnholt, J. L. Zehnder, A. K. Kiefer, C. B.<br />
Do, N. Eriksson, J. L. Mountain, U. Francke, J. Y. Tung, R.<br />
L. Levine, R. A. Mesa, J. R. Gotlib.<br />
1018T Acute myeloid leukemia associated with<br />
chromosome 6: Clinical and phenotypical implications<br />
in two pediatric patients with chromosome trisomy and<br />
translocation. L. Hurtado-Hernandez, J. M. Aparicio, F. L.<br />
Cuellar, M. A. L. Cubillo, M. A. H. Garrido, S. M. Chatelain.<br />
1019F Correlating genetic alterations from array<br />
comparative genome hybridization and nextgeneration<br />
sequencing with histology and clinical<br />
outcome in melanocytic neoplasms. Y. Liu, Y. Zhou, E.<br />
George.<br />
1020W Molecular pr<strong>of</strong>iling <strong>of</strong> the therapy-resistant<br />
clones in the recurrent embryonal carcinomas <strong>of</strong><br />
the testes based upon FISH and NGS <strong>of</strong> the isolated<br />
chromosomes. R. Malecki, M. Malecki.<br />
1021T Detection <strong>of</strong> large rearrangements in BRCA1<br />
and BRCA2 by microarray-CGH. D. Mancini-DiNardo,<br />
T. Judkins, N. Woolstenhulme, C. Burton, S. Chen, J.<br />
Schoenberger, M. Ryder, A. Murray, M. Balzotti, N. Gutin,<br />
J. Holladay, J. Craft, C. Colvin, J. Trost, L. A. Burbidge, C.<br />
Arnell, E. Rosenthal, B. Roa.<br />
1022F Effect <strong>of</strong> insecticide exposure in the generation<br />
<strong>of</strong> alterations in MLL, a gene associated with acute<br />
lymphoblastic leukemia. M. P. Navarrete Meneses,<br />
M. Betancourt, E. Bonilla, M. Altamirano, A. Reyes,<br />
P. Pérez-Vera.<br />
1023W Genomic analyses <strong>of</strong> paired diagnostic/relapse<br />
childhood acute lymphoblastic leukemias identify<br />
relapse-associated genetic features <strong>of</strong> pathogenetic and<br />
clinical importance. L. Olsson, A. Castor, M. Behrendtz, A.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
152 POSTER SESSIONS<br />
Biloglav, E. Forestier, K. Paulsson, B. Johansson.<br />
1024T Loss <strong>of</strong> chromosomes is the primary event in<br />
near-haploid and low hypodiploid acute lymphoblastic<br />
leukemia. S. Safavi, E. Forestier, I. Golovleva, G. Barbany,<br />
K. H. Nord, A. V. Moorman, C. J. Harrison, B. Johansson,<br />
K. Paulsson.<br />
1025F Detection <strong>of</strong> the t(8;14) chromosomal<br />
rearrangements in paraffin embedded tissue sections<br />
<strong>of</strong> Burkitt lymphoma patients with quantitative<br />
polymerase chain reaction and fluorescence in situ<br />
hybridization methods. N. Selvi, M. Hekimgil, B. Tezcanli<br />
Kaymaz, S. Aktas, N. Ozhan, C. Gunduz, B. Kosova, Y.<br />
Dodurga, N. Topcuoglu.<br />
1026W Molecular changes in Lynch syndrome<br />
associated and sporadic ovarian carcinomas. A.<br />
Tieva, S. Kaur, L. Renkonen-Sinisalo, H. J. Järvinen, J.-P.<br />
Mecklin, R. Bützow, P. Peltomäki.<br />
1027T A comprehensive genetic and epigenetic<br />
study <strong>of</strong> hepatocellular carcinoma with microarrays.<br />
G. Zhang, C. Wu, D. Yu, J. Chang, W. Sun, M. Li, L. Liang,<br />
Y. Li, D. Lin.<br />
1028F Congenital leukemia with insertion <strong>of</strong> MLL into<br />
19p13.3 and a deletion <strong>of</strong> half a megabase <strong>of</strong> 19p13.3:<br />
Case report. H. Al-Kateb, M. Evenson, S. Kulkarni.<br />
1029W Cytogenetic pr<strong>of</strong>iles <strong>of</strong> 370 cases with renal cell<br />
carcinoma: UCLA experience. P. H. Bui, P. N. Rao.<br />
1030T Identifying <strong>of</strong> cryptic genomic alterations by<br />
high-resolution microarrays in LLA-B and LLA-T<br />
Mexican patients. C. Córdova-Fletes, B. Macias-García,<br />
A. Lugo-Trampe, N. Mendez-Ramírez, R. De la Rosa-<br />
Alvarado, H. Gutiérrez-Aguirre, D. Gómez-Almaguer, A.<br />
Hidalgo, R. Salazar-Riojas, P. Ruíz-Flores, P. Villarreal-<br />
Quiroga, O. González-Llano, A. Rojas-Martínez, H.<br />
Decanini-Arcaute, R. Ortiz-López.<br />
1031F An unusual case <strong>of</strong> APL in a 14-year-old girl with<br />
t(15;17)(q22;q21) and t(9;22)(q34;q11.2). V. Jobanputra,<br />
C. Freeman, S. Hussein, M. J. Macera, B. Levy, V. V. Murty,<br />
M. L. Sulis, G. Bhagat.<br />
1032W Integration <strong>of</strong> cytogenetics and FISH studies<br />
for accurate evaluation <strong>of</strong> chromosome abnormalities.<br />
N. Qin, M. Hibbard.<br />
1033T Evaluation <strong>of</strong> FGFR1 gene amplification status<br />
and its association with clinicopathological features in<br />
breast cancer. R. M. Rodrigues-Peres, J. K. Heinrich, L.<br />
O. Z. Sarian.<br />
1034F Large scale identification <strong>of</strong> chromosomal<br />
abnormalities in familial breast and ovarian cancer. H.<br />
W. H. Yin, L. L. Wang, E. Tsui, Y. Elshimali, D. C. Chen.<br />
1035W Homozygous deletions <strong>of</strong> CDKN2A are present<br />
in all dic(9;20)(p13.2;q11.2)-positive BCP ALLs and<br />
may be important for leukemic transformation.<br />
V. Zachariadis, J. Schoumans, G. Barbany, M. Heyman, E.<br />
Forestier, B. Johansson, M. Nordenskjöld, A. Nordgren.<br />
1036T C-MYC and IGH amplification in patients with<br />
intermediate high grade B-cell lymphomas. A. Zaslav,<br />
M. Bellone, F. Lan, T. Mercado, H. Lee, Y. Hu.<br />
1037F Two deletions in the APC gene (an inherited<br />
deletion in exon 1 and a de novo deletion in exon<br />
12) and a de novo MUTYH deletion causing familial<br />
adenomatous polyposis. G. A. Molfetta, O. C. Vincenzi,<br />
J. Huber, A. A. Marques, W. A. Silva, Jr.<br />
1038W Mutation screening in adenomatous polyposis<br />
coli gene in patients clinically diagnosed as familial<br />
adenomatous polyposis. O. C. Vincenzi, G. A. Molfetta,<br />
J. Huber, C. Ayres, W. A. Silva, Jr.<br />
1039T High-precision CNV analysis <strong>of</strong> FFPE samples<br />
with the nCounter Analysis System. G. Geiss.<br />
1040F Germline copy number variation in high-risk<br />
African <strong>American</strong> families with prostate cancer. E.<br />
Ledet, X. Hu, O. Sartor, W. Rayford, M. Li, D. Mandal.<br />
1041W hapLOH: Powerful haplotype-based pr<strong>of</strong>iling <strong>of</strong><br />
allelic imbalance in impure tumor samples. P. Scheet,<br />
R. Xia, S. Vattathil.<br />
1042T Protein tyrosine phosphatase receptor type J is<br />
implicated in lymphomagenesis <strong>of</strong> follicular and diffuse<br />
large B-cell lymphomas. C. A. Aya-Bonilla, M. R. Green,<br />
E. Camilleri, M. Benton, C. Keane, P. Marlton, R. Lea, M. K.<br />
Gandhi, L. R. Griffiths.<br />
1043F Computational techniques to detect BFB in<br />
tumor genomes. S. Zakov, M. Kinsella, V. Bafna.<br />
1044W Evaluation <strong>of</strong> cytogenetic and gene<br />
polymorphic variants in workers occupationally<br />
exposed to silica-stone quarry industry. R.<br />
Chandirasekar, K. Sasikala, B. Lakshman Kumar, R.<br />
Raichel Jacob, H. Kavitha.<br />
1045T Differential expression <strong>of</strong> AURKA and AURKB<br />
genes in bone marrow stromal mesenchymal cells <strong>of</strong><br />
myelodisplastic syndrome: Correlation with G-banding<br />
analysis and FISH. F. M. Oliveira, A. R. Lucena-Araujo,<br />
M. C. Favarin, E. M. Rego, R. P. Falcão, B. P. Simıes, D. T.<br />
Covas, A. M. Fontes.<br />
1046F A new function for the VHL tumor suppressor<br />
protein: Prevention <strong>of</strong> genome instability through<br />
promotion <strong>of</strong> homologous recombinational DNA repair.<br />
M. S. Meyn, J. L. Metcalf, P. S. Bradshaw, M. Komosa, S.<br />
N. Greer, W. Y. Kim, M. Ohh.<br />
1047W A new role for the ATM protein: Homologous<br />
recombination repair <strong>of</strong> DNA damage. P. Bradshaw, M.<br />
Komosa, M. S. Meyn.<br />
1048T A crosstalk between ATM and FA/BRCA proteins<br />
is necessary to preserve DNA integrity during G2/M<br />
phase. L. C. Torres Maldonado, D. Sosa, M. Castañon, A.<br />
Rodriguez, B. Molina, C. Lopez Camarillo, S. Frias.<br />
1049F A dynamic model <strong>of</strong> the FA/BRCA DNA repair<br />
pathway. A. Rodriguez, L. Torres, D. Sosa, E. Cortes, A.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
M. Salazar, R. Ortoz, P. Ostrosky, L. Mendoza, S. Frias.<br />
1050W Fanconi anemia pathway proteins act<br />
together and independently to regulate homologous<br />
recombination and synthesis <strong>of</strong> telomeric DNA in<br />
ALT-immortalized human cells. H. Root, M. Komosa, A.<br />
Larsen, D. Bazett-Jones, M. S. Meyn.<br />
1051T Transcriptome sequencing <strong>of</strong> tumor<br />
subpopulations reveals a spectrum <strong>of</strong> therapeutic<br />
options in squamous cell lung cancer. C. L. Barrett,<br />
R. B. Schwab, H. Jung, B. Crain, D. J. G<strong>of</strong>f, C. H. M.<br />
Jamieson, P. A. Thistlethwaite, O. Harismendy, D. A.<br />
Carson, K. A. Frazer.<br />
1052F A novel bi-allelic MSH2 mutation associated<br />
with constitutional mismatch repair deficiency<br />
syndrome, and review <strong>of</strong> the clinical phenotype. P.-Y. B.<br />
Au, R. Perrier, E. G. Puffenberger, S. Hume, R. Anderson,<br />
L. Lafay-Cousin, D. Strother, B. McInnes, J. Parboosingh,<br />
F. Bernier.<br />
1053W Clinical and histopathologic characteristics<br />
between familial and sporadic melanoma in Barcelona,<br />
Spain. C. Badenas, P. Aguilera, C. Carrera, J. Malvehy, J.<br />
A. Puig-Butille, E. Martinez-Barrios, J. Palou, S. Puig.<br />
1054T A survey <strong>of</strong> stromal responses and their clinical<br />
associations defined by the fibromatosis signature in<br />
different types <strong>of</strong> carcinomas. J. L. Chen, I. Espinosa, A.<br />
Y. Lin, O. Y. Liao, M. van de Rijn, R. B. West.<br />
1055F Anticipation in hereditary paraganglioma and<br />
pheochromocytoma syndromes. H. Druker, D. Malkin,<br />
S. Meyn.<br />
1056W Evaluation <strong>of</strong> mtDNA D-loop polymorphisms<br />
in Iranian breast cancer patients. M. Ghaffarpour, S.<br />
Eslamizadeh, M. Arabzadeh, B. Motahari, N. Moazami, M.<br />
Houshmand.<br />
1057T Does high HERV-K expression participate<br />
in acute leukemia pathogenesis in children?<br />
D. Januszkiewicz-Lewandowska, K. Nowicka, J.<br />
Rembowska, J. Nowak.<br />
1058F SMAD4 loss-<strong>of</strong>-function mutations cause<br />
wide range <strong>of</strong> clinical disorders with unpredictable<br />
age-related penetrance. N. M. Lindor, K. E. Wain, M. S.<br />
Ellingson, J. McDonald, A. D. Gammon, M. E. Roberts, D.<br />
L. Riegert-Johnson.<br />
1059W Automatic endometrial tumor screening for<br />
Lynch syndrome. M. Myers, P. Conrad, J. Rabban, J.<br />
Terdiman, K. Loranger, A. Blanco, L. Chen.<br />
1060T Detection <strong>of</strong> EGFR mutations by TaqMan®<br />
Mutation Detection Assays powered by Competitive<br />
Allele-Specific TaqMan® PCR Technology (castPCR).<br />
N. Normanno, C. Roma, R. Pasquale, A. M. Rachiglio,<br />
C. Esposito, F. Fenizia, M. L. La Porta, A. Iannaccone, F.<br />
Bergantino, S. Costantini, A. Rico, R. Petraroli.<br />
1061F Germline mutations and microsatellite instability<br />
status in a population-based study <strong>of</strong> women with<br />
POSTER SESSIONS 153<br />
ovarian cancer. T. Pal, A. Mohammad, P. Sun, J. Lee, J.<br />
Fulp, Z. Thompson, A. Doty, D. Coppola, S. Nicosia, T.<br />
Sellers, J. McLaughlin, H. Risch, B. Rosen, J. Schildkraut,<br />
S. Narod.<br />
1062W BRCA2 mutations might be detected at a high<br />
rate in a subset <strong>of</strong> cutaneous melanoma patients with<br />
pancreatic cancer in the familial history. N. Soufir, E.<br />
Rouleau, C. Derouet, A. Riffault, H. H. Hu, S. Caputo, P.<br />
Hammel, V. Descamps, N. Basset-Seguin, P. Saiag, A.<br />
Bensussan, M. Bagot, R. Lidereau, B. Grandchamp.<br />
1063T SUFU germline mutation in a patient with Gorlin<br />
syndrome identified by next-generation sequencing. J.<br />
B. Geigl, E. Heitzer, I. Wolf, L. Cerroni, M. R. Speicher.<br />
1064F Li-Fraumeni syndrome: A clinical, genetic, and<br />
epidemiologic cohort study. P. L. Mai, J. A. Peters, L.<br />
Hoskins, F. Walcott, R. Bremer, S. A. Savage.<br />
1065W Early detection <strong>of</strong> cystic pleuropulmonary<br />
blastoma and cystic nephroma in an asymptomatic<br />
child with DICER1 mutation—Screening<br />
considerations. F. Plourde, V. Larouche, N. Ferguson,<br />
M. St-Amant, I. Harvey, N. Taherian, N. Sabbaghian, J. R.<br />
Priest, W. D. Foulkes.<br />
1066T Impact <strong>of</strong> gynecological screening in Lynch<br />
syndrome carriers with an MSH2 mutation. S.<br />
Stuckless, P. Parfrey, L. Dawson, B. Barrett, J. Green.<br />
1067F Evaluation <strong>of</strong> mismatch repair gene sequence<br />
variants in the Colon Cancer Family Registry using<br />
multifactorial likelihood analysis. B. A. Thompson, D.<br />
E. Goldgar, M. Clendenning, R. Walters, M. T. Parsons,<br />
S. Gallinger, R. W. Haile, J. L. Hopper, M. A. Jenkins,<br />
L. LeMarchand, N. M. Lindor, P. A. Newcomb, S. N.<br />
Thibodeau, J. P. Young, D. D. Buchanan, S. V. Tavtigian, A.<br />
B. Spurdle, Colon Cancer Family Registry.<br />
1068W Development <strong>of</strong> a custom targeted AmpliSeq<br />
multiplex sequencing assay for the detection <strong>of</strong> tumorderived<br />
somatic mutations and application as part<br />
<strong>of</strong> a clinical trial. C.-J. Lih, D. J. Sims, M. G. Mehaffey,<br />
M. Dindinger, E. Levandowsky, C. C. Lee, T. T. Harkin, P.<br />
Brzoska, B. Conley, S. Kummar, P. M. Williams.<br />
1069T A 30-year perspective <strong>of</strong> International Fanconi<br />
Anemia Registry. A. D. Auerbach, IFAR Collaboration<br />
Team.<br />
1070F Histology and prognostic markers are powerful<br />
tools for predicting BRCA mutation status. C. D.<br />
Delozier, A. Rahman, T. Liu, C. J. Curry.<br />
1071W Variants <strong>of</strong> uncertain significance in BRCA<br />
testing: Surgical decisions, risk perception, cancer<br />
distress, and evaluation <strong>of</strong> the genetic cancer risk<br />
assessment process. J. O. Culver, C. D. Brinkerh<strong>of</strong>f, J.<br />
Clague, K. Yang, K. E. Singh, S. R. Sand, J. N. Weitzel.<br />
1072T The contribution <strong>of</strong> predisposition<br />
polymorphisms for body size to the inherited risk <strong>of</strong><br />
colorectal cancer. L. Carvajal-Carmona, G. Casey, O.<br />
Sieber, G. Montgomery, J. Young, P. Baird, D. Kerr, R.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
154 POSTER SESSIONS<br />
Houlston, M. Dunlop, I. Tomlinson, Colon Cancer Family<br />
Registry, COGENT Consortium.<br />
1073F The combined effect <strong>of</strong> the functional variants<br />
in cell death pathway genes on cervical cancer. K.<br />
Chattopadhyay, C. Dandara, A. Hazra, A. L. Williamson.<br />
1074W Genetic ancestry is associated to changes in<br />
DNA repair capacity in non-melanoma skin cancer<br />
patients from Puerto Rico. H. J. Diaz-Zabala, L. Morales,<br />
J. Matta, J. Dutil.<br />
1075T Genetic ancestry and breast cancer survival in<br />
U.S. Latinas. L. Fejerman, D. Hu, S. Huntsman, C. Eng, E.<br />
Gonzalez Burchard, E. M. John, M. C. Stern, E. Perez-<br />
Stable, E. Ziv.<br />
1076F Genetic polymorphisms in candidate<br />
inflammation-related genes and risk <strong>of</strong> esophageal<br />
squamous cell carcinoma. A. Golozar, T. Beaty, P. Gravitt,<br />
I. Ruczinski, Y. L. Qiao, J. H. Fan, T. Ding, Z. Z. Tang, A.<br />
Etemadi, N. Hu, S. M. Dawsey, N. D. Freedman, C. C.<br />
Abnet, A. Goldstein, P. R. Taylor.<br />
1077W Frequency <strong>of</strong> VNTR polymorphism in IL-1Ra<br />
gene in colorectal cancer. I. A. Gutíerrez, E. Cortes, A. M.<br />
Puebla, M. P. Gallegos.<br />
1078T Individual ancestry influences the gene<br />
expression pr<strong>of</strong>ile in breast cancer patients <strong>of</strong> admixed<br />
populations. D. Hu, E. Ziv.<br />
1079F Risks <strong>of</strong> colorectal and other cancers following<br />
endometrial cancer in Lynch syndrome. M. A. Jenkins,<br />
N. M. Lindor, R. W. Haile, P. A. Newcomb, L. Le Marchand,<br />
S. Gallinger, J. L. Hopper, A. K. Win.<br />
1080W Prevalence and clinical features <strong>of</strong> HOXB13<br />
mutation carriers in prostate cancer patients from<br />
Germany. C. Maier, J. Xu, S. L. Zheng, M. Luedeke, A. E.<br />
Rinckleb, W. Vogel, S. N. Thibodeau, K. A. Cooney, W. B.<br />
Isaacs on behalf <strong>of</strong> ICPCG.<br />
1081T Histologic types and risk factors in familial lung<br />
cancer cases from Southern Louisiana. D. Mandal,<br />
M. Haskins, A. Bencaz, J. Hutchinson, J. Chambliss, H.<br />
Rothschild, J. E. Bailey-Wilson.<br />
1082F Using an 18 locus genotype to predict risk <strong>of</strong><br />
breast cancer, and the relationship between age,<br />
estrogen receptor status and genetic risk. C. Merrick,<br />
C. Purdie, L. Jordan, C. Palmer, R. Tavendale, A. Ashfield,<br />
P. Quinlan, P. Armory, A. Thompson, J. Berg.<br />
1083W Association between prostate cancer occurrence<br />
and Y-chromosomal STRs. M. Miri Nargesi, A. Nazemi, P.<br />
Amini, P. Ismail, R. Vasudevan, P. Pasalar, A. H. Abdul Razack.<br />
1084T The clinical phenotype <strong>of</strong> endometrial cancer in<br />
women <strong>of</strong> Newfoundland and Labrador with a MSH2<br />
Lynch syndrome mutation. A. H. G. Nichols, L. M.<br />
Dawson, J. Green, E. Dicks, P. Parfrey.<br />
1085F A unique African prostate cancer cohort to<br />
investigate genetic and environmental risk factors <strong>of</strong><br />
aggressive disease within Africa. E. A. Tindall, M. S. R.<br />
Bornman, S. van Zyl, D. C. Petersen, A. M. Segone, L. R.<br />
Monare, P. A. Venter, V. M. Hayes.<br />
1086W Insulin-like growth factor biomarkers<br />
and genetic polymorphisms are associated with<br />
adenomatous polyp risk. C. B. Vaughn, H. Ochs-Balcom,<br />
J. Nie, Z. Chen, C. L. Thompson, L. Li.<br />
1087T An unusual BRCA mutation distribution in a high<br />
risk cancer genetics clinic. A. C. Nelson-Moseke, J. M.<br />
Jeter, H. Cui, D. Roe, S. K. Chambers, C. M. Laukaitis.<br />
1088F Functional characterization <strong>of</strong> the pancreatic<br />
cancer TERT-CLPTM1L risk locus on Chr5p15.33. J. Jia,<br />
A. Thompson, A. Bosley, H. Parikh, Z. Wang, I. Collins, G.<br />
Petersen, C. Westlake, T. Andresson, L. Amundadottir.<br />
1089W A comprehensive approach to evaluating the<br />
impact <strong>of</strong> sequence variants <strong>of</strong> uncertain significance<br />
in 24 breast cancer genes on transcript splicing. S.<br />
Casadei, T. Walsh, C. H. Spurrell, A. M. Thornton, J. B.<br />
Mandell, S. M. Stray, M. K. Lee, M. C. King.<br />
1090T Functional analysis <strong>of</strong> germline TP53 mutations<br />
in lymphocytes from Li-Fraumeni patients reveals a<br />
drastic biological impact <strong>of</strong> missense mutations. J.-M.<br />
Flaman, Y. Zerdoumi, C. Durambure, J. Laury-Andas, G.<br />
Bougeard-Denoyelle, T. Frebourg, French LFS Working<br />
Group.<br />
1091F Investigation <strong>of</strong> the bladder cancer association<br />
within TP63 gene region. Y.-P. Fu, I. Kohaar, J. Earl,<br />
W. Tang, J. D. Figueroa, N. Malats, M. Garcia-Closas,<br />
N. Chatterjee, M. Kogevinas, P. Porter-Gill, D. Baris, D.<br />
Albanes, M. P. Purdue, A. Carrato, A. Tardón, C. Serra, R.<br />
García-Closas, J. Lloreta, A. Johnson, M. Schwenn, M. R.<br />
Karagas, A. Schned, W. R. Diver, S. M. Gapstur, M. Thun,<br />
J. Virtamo, D. T. Silverman, N. Rothman, F. X. Real, L.<br />
Prokunina-Olsson.<br />
1092W Genetic variant as a selection marker for anti-<br />
PSCA immunotherapy <strong>of</strong> bladder cancer. I. Kohaar,<br />
P. Porter-Gill, P. Lenz, Y. P. Fu, A. Mumy, W. Tang, A. B.<br />
Apolo, N. Rothman, D. Baris, A. R. Schned, K. Ylaya, M.<br />
Schwenn, A. Johnson, M. Jones, M. Kida, D. T. Silverman,<br />
S. M. Hewitt, L. E. Moore, L. Prokunina-Olsson.<br />
1093T Tumor microenvironment and genetic<br />
association with colorectal cancer risk. V. Peltekova, M.<br />
Lemire, Q. Trinh, A. Qazi, R. Bielecki, L. Hodgson-Jensen,<br />
D. D’Souza, S. Zandi, T. Chong, R. De Borja, L. Timms, J.<br />
Rangrej, M. Volar, M. Chan-Seng-Yue, T. Beck, J. Kwan, K.<br />
Kozak, C. Ash, L. D. Stein, J. E. Dick, J. D. McPherson, B.<br />
W. Zanke, A. Pollett, S. Gallinger, T. H. Hudson.<br />
1094F Evaluation <strong>of</strong> the functional effects on cell<br />
signaling caused by allelic forms <strong>of</strong> prostate stem cell<br />
antigen. P. Porter-Gill, A. Mumy, W. Tang, I. Kohaar, L.<br />
Prokunina-Olsson.<br />
1095W Discovery and functional characterization <strong>of</strong><br />
somatic mutations in the novel tumor suppressor<br />
DEAR1. J. Reuther, N. Chen, S. Balasenthil, A. Killary.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1096T rs28381943 and rs2032586 SNPs <strong>of</strong> ABCB1<br />
gene may be the reason <strong>of</strong> mRNA stabilization which<br />
may lead to gene overexpression. M. S. Shahbazi,<br />
M. M. Mansoori, M. G. Golalipour, S. A. Alizadeh, A. J.<br />
Jahangirerad, A. T. Tahmasebifar, S. R. K. Khanduzi.<br />
1097F Identification and functional characterization <strong>of</strong><br />
a novel splicing form <strong>of</strong> the TPCN2 gene on 11q13.3<br />
within a region associated with prostate cancer<br />
risk. N. Sikdar, C. Chung, J. Fang, M. Tarway, W. Tang,<br />
S. Mukherjee Dey, S. Ambs, L. Prokunina-Olsson, S.<br />
Chanock.<br />
1098W An integrated analysis <strong>of</strong> genomic variation<br />
and transcriptome sequencing to identify novel<br />
susceptibility genes for breast cancer. E. Wagner, S.<br />
Clare, M. Radovich, Y. Liu, B. Schneider, A. M. Storniolo,<br />
C. He.<br />
1099T Effects <strong>of</strong> breast cancer associated PALB2<br />
c.1592delT founder mutation at the cellular level.<br />
R. Winqvist, J. Nikkilä, K. Pylkäs, H. Peltoketo, B. Xia, H.<br />
Pospiech.<br />
1100F Global correlation <strong>of</strong> expression with prostate<br />
cancer associated variants identifies IRX4 as a<br />
prostate cancer expression trait locus. X. Xu, W. M.<br />
Hussain, N. Kitabayashi, M. A. Rubin, F. Demichelis, R. J.<br />
Klein.<br />
1101W Interplay <strong>of</strong> tumor suppressor genes and<br />
oncogenes in ovarian cancer. M. Zhao, S. Sun, Z. Zhao.<br />
1102T Establishment <strong>of</strong> breast, leiomyosarcoma<br />
and thyroid cancer stem cells derived from carriers<br />
<strong>of</strong> p.R337H TP53 germline mutation within one Li-<br />
Fraumeni syndrome family. L. I. Mambelli, I. Kerkis, F.<br />
Fortes, P. Hainaut, M. I. W. Achatz.<br />
1103F Functional validation using eQTL needs cellspecific<br />
approaches. S. Kim, H.-H. Won, J.-W. Kim, D. H.<br />
Kim, S.-T. Lee, S. Kim, S.-H. Kim, C. W. Jung.<br />
1104W Functional characterization <strong>of</strong> HLA allelotypes<br />
associated with follicular lymphoma risk. F. C. M. Sillé,<br />
L. Conde, C. F. Skibola.<br />
1105T microRNA expression for classification <strong>of</strong><br />
histiocytic sarcomas in dogs. J. Aguirre Hernandez, J. M.<br />
Dobson, T. M. Hoather, D. R. Sargan, F. Constantino-Casas.<br />
1106F Molecular urine assay <strong>of</strong> PCA3, MMP2, MMP9<br />
and KLK3 in men with prostate cancer and benign<br />
prostatic hyperplasia. H. Akin, A. Simsir, F. Hazan, T. R.<br />
Ozdemir, I. Cureklibatir, G. Itirli, C. Gunduz, C. Ozkinay, F.<br />
Ozkinay.<br />
1107W The effect <strong>of</strong> copy number variation in the<br />
phase II detoxification genes, UGT2B17 and UGT2B28,<br />
on colorectal cancer risk. A. Y. Angstadt, A. S. Berg, J.<br />
Zhu, P. Miller, T. J. Hartman, S. M. Lesko, J. E. Muscat, P.<br />
Lazarus, C. J. Gallagher.<br />
1108T Genetic sequence variant in microRNA genes<br />
and survival in non-small cell lung cancer. A.K. Azad,<br />
POSTER SESSIONS 155<br />
X. Qiu, T. Popper, K. Boyd, Q. Kuang, Y.B. Berhane, H.<br />
Henrique, N. Perera, P. Prakruthi, D. Patel, S. Momin, M.<br />
Nakhla, E. Marjan, Z. Chen, D. Cheng, R. Feld, N.B. Leighl,<br />
F.A. Shepherd, M.-S. Tsao, W. Xu, G. Liu, S. Cuffe.<br />
1109F The PROFILE Study: Genetic prostate cancer<br />
risk stratification for targeted screening. E. K. Bancr<strong>of</strong>t,<br />
E. C. Castro, N. Taylor, E. Page, E. Saunders, T. Dadaev, A.<br />
Lee, A. Antoniou, Z. Kote-Jarai, R. Eeles.<br />
1110W Lgr5 expression and its relatedness with<br />
other tumor stem cell markers in human gastric<br />
adenocarcinoma. W. Fan, Y. W. Guo, Y. Y. Xie, Y.S. Li, W.<br />
Chen.<br />
1111T The TP53 16 bp duplication polymorphism is<br />
associated with breast cancer. M. Gallegos, Jr., A.<br />
Gutiérrez, A. Ramos, E. Salas, J. M. Castro, A. M. Puebla,<br />
L. E. Figuera, G. M. Zúñiga.<br />
1112F Statistics <strong>of</strong> cellular evolution in leukemia:<br />
Allelic variations in patient trajectories based on<br />
immune repertoire sequencing. H. Gao, C. Wang, A.<br />
C. Logan, C. D. Bustamante, J. Seok, D. B. Miklos, R. W.<br />
Davis, M. W. Feldman, W. Xiao.<br />
1113W Genetic polymorphisms and colorectal cancer<br />
risk: A systematic review <strong>of</strong> meta-analyses. B. Haerian,<br />
M. Haerian.<br />
1114T NRF2 and sulfiredoxin genetic polymorphisms<br />
and protein expression predict outcome in breast<br />
cancer. J. M. Hartikainen, M. Tengström, V.-M. Kosma, V.<br />
Kinnula, A. Mannermaa, Y. Soini.<br />
1115F Complex tumor genomes inferred from plasma-<br />
DNA and circulating tumor cells <strong>of</strong> patients with<br />
cancer. E. Heitzer, M. Auer, E. M. H<strong>of</strong>fmann, C. Beneken,<br />
M. Pichler, P. Ulz, S. Lax, J. Waldispuehl-Geigl, O.<br />
Mauermann, G. Pristauz, C. Lackner, G. Höfler, F. Eisner,<br />
E. Petru, H. Sill, H. Samonigg, K. Pantel, S. Riethdorf, T.<br />
Bauernh<strong>of</strong>er, J. B. Geigl, M. R. Speicher.<br />
1116W Novel integrative genomics approach for<br />
associating GWAS information with triple negative<br />
breast cancer. C. Hicks, K. Backus, A. Pannuti, L. Miele.<br />
1117T Germline variation in TP53 regulatory network<br />
genes associates with breast cancer survival and<br />
treatment outcome. M. Jamshidi, M. K. Schmidt, T. Dörk,<br />
M. Garcia-Closas, T. Heikkinen, S. Cornelissen, S. van<br />
den Broek, P. Schürmann, A. Meyer, T. W. Park-Simon,<br />
J. Figueroa, M. Sherman, J. Lissowska, G. T. Keong,<br />
A. Irwanto, M. Laakso, S. Hautaniemi, K. Aittomäki, C.<br />
Blomqvist, J. Liu, H. Nevanlinna.<br />
1118F Detection <strong>of</strong> FLT3 internal tandem duplication<br />
and D835 mutations in Iranian patients with acute<br />
myeloid leukemia. L. Kokabee, A. Ahmadzadeh, M.<br />
Kokabee, M. Karimipoor.<br />
1119W Association <strong>of</strong> gastric cancer with Amerindian<br />
ancestry, socioeconomic and nutritional factors and<br />
a gene candidate study in a Latin <strong>American</strong> admixed<br />
population. L. Lacorte, R. Zamudio, G. Soares-Souza,<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
156 POSTER SESSIONS<br />
P. Herrera, L. Cabrera, C. Hooper, J. Cok, J. Combe,<br />
G. Vargas, W. Prado, S. Schneider, M. Rodrigues, S.<br />
Chanock, D. Berg, R. Gilman, E. Tarazona-Santos,<br />
F. Kehdy.<br />
1120T Detection <strong>of</strong> P16 expression and human<br />
papillomavirus in oropharyngeal squamous cell<br />
carcinoma. S. Lai, V. Sandulache, J. Zevallos.<br />
1121F BORIS expression in squamous intraepithelial<br />
lesions and cervical cancer. B. Lazalde, N. Velazquez-<br />
Hernandez, M. Barragán-Hernandez, M. A. Reyes-<br />
Romero.<br />
1122W An informative clinical applicable serum<br />
miRNAs 371-3 and 302/367 test for (germ cell)<br />
cancer patients. L. H. J. Looijenga, A. J. M. Gillis, M. A.<br />
Rijlaarsdam, R. Eini, L. C. J. Dorssers, Y. van der Zwan, C.<br />
M. de Boer, S. J. White.<br />
1123T Gene variants in chemokine and chemokine<br />
receptor with risk <strong>of</strong> prostate cancer in North Indian<br />
cohort. R. D. Mittal, R. K. Mandal.<br />
1124F The regulatory BCL2 promoter polymorphism<br />
(-938C,A) is associated in Iranian women breast cancer<br />
patients. B. Motahari, M. Ghaffarpour, G. H. Javadi, M.<br />
Houshmand.<br />
1125W Type II transmembrane serine protease gene<br />
variants associate with breast cancer. K. M. Nieminen,<br />
J. M. Hartikainen, V. Kataja, V.-M. Kosma, A. Mannermaa.<br />
1126T Prevalence and prognostic impact <strong>of</strong> Ikaros<br />
deletions in childhood acute lymphoblastic leukemia<br />
treated according to NOPHO protocols. I. Ofverholm, A. N.<br />
Tran, G. Barbany, A. Nordgren, M. Heyman, M. Nordenskjöld.<br />
1127F Genotype proline/proline <strong>of</strong> TP53 codon 72<br />
polymorphism is enriched in breast cancer. A. M.<br />
Puebla, A. Gutiérrez, A. Ramos, E. Salas, J. M. Castro, R.<br />
Ramírez, M. P. Gallegos.<br />
1128W 3R/3R genotype <strong>of</strong> TYMS gene is associated<br />
with non response <strong>of</strong> chemotherapy in breast cancer<br />
patients. A. Ramos, E. Salas, J. M. Castro, L. E. Figuera,<br />
A. M. Puebla, M. P. Gallegos.<br />
1129T Characterization <strong>of</strong> breast cancer intrinsic<br />
subtypes in Mexican women using integrative<br />
multiplatform analysis. C. Rangel-Escareño, I. Imaz-<br />
Rosshandler, S. Muñoz-Montero, J. E. Castillo-Fernandez,<br />
A. Hidalgo-Miranda.<br />
1130F International collaborative analysis <strong>of</strong> the<br />
InSiGHT database quantifies unique reports and<br />
redefines the V.U.S. challenge for DNA mismatch repair<br />
genes (MMR). R. P. Raval, L. Baez-Cabrera, J. P. Plazzer,<br />
S. Okochi, F. Macrae, M. Genuardi, T. K. Weber.<br />
1131W Frequency <strong>of</strong> non-DNA-binding Ikaros is<strong>of</strong>orms<br />
in childhood acute lymphoblastic leukemia and relapse<br />
or death risk. A. Reyes-León, R. Juárez-Velázquez,<br />
A. Medrano-Hernández, T. Cuenca-Roldán, C. Salas-<br />
Labadía, P. Navarrete-Meneses, R. Paredes-Aguilera, R.<br />
Rivera-Luna, R. Cárdenas-Cardos, G. López-Hernández,<br />
R. Bernaldez, P. Pérez-Vera.<br />
1132T Gene expression pr<strong>of</strong>ile <strong>of</strong> human telomere and<br />
telomerase complex in gastric cancer. L. C. Santos, F.<br />
Wisnieski, D. Q. Calcagno, M. F. Leal, T. B. Pontes, C. O.<br />
Gigek, E. S. Chen, S. Demachki, P. P. Assumpção, R. R.<br />
Burbano, M. A. C. Smith.<br />
1133F Chemotherapy response in ovarian cancer is<br />
modulated by the DNA encoded microRNA family<br />
miR-17-92a. I. Shapira, A. Lee, M. Oswald, J. Lovecchio,<br />
A. Menzin, J. Whyte, L. Dos Santos, K. Sultan, V. John, K.<br />
Cheng, S. Liang, T. Bradley, D. Budman.<br />
1134W Single-nucleotide polymorphisms in genes<br />
encoding Toll-like receptor -2, -3, -4, and -9 in casecontrol<br />
study with bladder cancer susceptibility in<br />
North Indian population. V. Singh, N. Srivastava, R.<br />
Kapoor, R. D. Mittal.<br />
1135T Clinical impact <strong>of</strong> MMP-3 and TIMP-3 gene<br />
polymorphisms in prostate cancer. P. Srivastava, R.<br />
Kapoor, R. D. Mittal.<br />
1136F Role <strong>of</strong> SOCS3 promoter methylation in the<br />
pathogenesis <strong>of</strong> myeloproliferative neoplasms and<br />
secondary/reactive erythrocytosis/thrombocythemia.<br />
D. Torun, O. Nevruz, M. Akyol, S. Kozan, M. Bahce, S.<br />
Guran, C. Beyan.<br />
1137W Association <strong>of</strong> common polymorphisms in<br />
TNF-a pathway genes and apoptotic genes with risk<br />
and prognosis <strong>of</strong> esophageal cancer. M. Umar, R.<br />
Upadhyay, S. Kumar, U. C. Ghoshal, B. Mittal.<br />
1138T Colon cancer in a 9-year-old female due to<br />
combined inherited EPCAM deletion and hMSH2 missense<br />
mutation leading to tissue-specific bi-allelic loss<br />
<strong>of</strong> expression <strong>of</strong> hMSH2. P. J. Ainsworth, H. H. Li Chang,<br />
H. Levin, D. K. Driman, V. M. Siu, A. E. L. Cairney, N. L.<br />
Scanlan, K. Buckley.<br />
1139F NF1 second hit leads to the upregulation<br />
<strong>of</strong> HLA class II genes and recruitment <strong>of</strong> Tregs in<br />
neur<strong>of</strong>ibromas. E. M. Jouhilahti, S. Peltonen, E. P.<br />
Jokinen, T. Callens, H. Aho, E. Legius, O. Lassila, L.<br />
Messiaen, J. Peltonen.<br />
1140W Genetic screening <strong>of</strong> colorectal cancer<br />
patients for the Lynch syndrome detection in Estonian<br />
population. M. Kask, E. Oitmaa, K. Toome, K. Raime, K.<br />
Vaidla, P. Laidre, J. Jaal, J. Soplepmann, V. Afanasjev, T.<br />
Erm, H. Roomere.<br />
1141T CASP8AP2 and H2AFZ expression as a<br />
prognosis factor in childhood acute lymphoblastic<br />
leukemia. R. Juárez-Velázquez, A. Reyes-León, C.<br />
Salas, R. Paredes, R. Cardenas, G. López-Hernández,<br />
A. Lopez, A. Carnevale, R. Ortiz, R. Bernaldez,<br />
P. Perez-Vera.<br />
1142F Circulating miRNAs as non-invasive blood based<br />
diagnostic biomarkers. R. Duttgupta, R. Jiang, J. Gollub,<br />
T. Stamato, B. C. Getts, K. W. Jones.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1143W Comparison <strong>of</strong> PCR method and RUT test for<br />
detection <strong>of</strong> Helicobacter pylori infection in gastric<br />
tissue. N. Bagheri, L. Salimzadeh, F. Azadegan, G.<br />
Rahimian, A. Taghikhani, M. Hashemzadeh, H. Shirzad.<br />
1144T Lowered PTEN protein dosage predicts for<br />
underlying germline PTEN mutations amongst patients<br />
presenting with thyroid cancer and Cowden-like<br />
phenotypes. J. Ngeow, X. He, J. Mester, J. Lei, T. Romigh,<br />
M. Milas, M. Orl<strong>of</strong>f, C. Eng.<br />
1145F Cellular uterine leiomyomata with<br />
chromosome 1p deletions represent a distinct entity.<br />
J. C. Hodge, A. T. Florin, K. E. Pearce, A. C. Clayton,<br />
E. A. Stewart.<br />
1146W Cancer biomarker research using castPCR<br />
technology. T. Hartshorne, Y. Bao, B. Ching, M.<br />
Mouanoutoua, Y. Wang, D. Keys, S. Desai, J. Stevens.<br />
1147T Naturally missing teeth and ovarian cancer: A<br />
potential genetic link. L. Morford, A. Vu, K. Kirk, M. Gilbey,<br />
G. Falcao-Alencar, M. Sakamoto, D. Fardo, J. Hartsfield Jr.<br />
1148F A meta-analysis <strong>of</strong> genome-wide association<br />
studies to identify prostate cancer susceptibility<br />
loci associated with aggressive and non-aggressive<br />
disease. A. Amin Al Olama, Z. Kote-Jarai, F. R.<br />
Schumacher, F. Wiklund, S. I. Berndt, S. Benlloch, G. G.<br />
Giles, G. Severi, D. E. Neal, F. C. Hamdy, J. L. Donovan, D.<br />
J. Hunter, B. E. Henderson, S. Chanock, H. Gronberg, C.<br />
A. Haiman, P. Kraft, D. F. Easton, R. A. Eeles, PRACTICAL<br />
Consortium.<br />
1149W Identifying genetic modifiers in two p16<br />
melanoma pedigrees. M. H. Bailey, C. Teerlink, J. M.<br />
Farnham, L. Cannon-Albright.<br />
1150T Genome-wide association studies identify four<br />
novel ER-negative specific breast cancer risk loci. F.<br />
J. Couch, M. Garcia-Closas, S. Lindstrom, K. Michailidou,<br />
M. K. Schmidt, M. Brook, N. Orr, S. Slager, D. J. Hunter,<br />
J. Simard, J. Benitez, A. Dunning, M. E. Sherman, G.<br />
Chenevix-Trench, S. J. Chanock, P. Hall, P. Pharoah, C.<br />
Vachon, D. F. Easton, C. A. Haiman, P. Kraft for BPC3,<br />
TNBCC, and BCAC.<br />
1151F cAMP and cGMP signaling may play an<br />
important role in the development <strong>of</strong> prostate cancer.<br />
R. de Alexandre, A. Horvath, A. Manning, D. Carraro, F.<br />
Soares, M. Nesterova, S. Constantine, F. Faucz.<br />
1152W Genome-wide association for multiple myeloma<br />
reveals overlap between variants associated with<br />
susceptibility and survival. E. Dean, D. Hu, P. Bracci, V.<br />
Krepkiy, T. Martin, J. Wolf, E. Ziv.<br />
1153T Genetic risk factors for malignant pleural<br />
mesothelioma: A genome-wide association study. I.<br />
Dianzani, S. Guarrera, M. Betti, G. Fiorito, D. Ferrante,<br />
F. Voglino, G. Cadby, A. Russo, C. Di Gaetano, F. Rosa,<br />
E. Casalone, M. Padoan, M. Giordano, A. Aspesi, C.<br />
Casadio, F. Ardissone, E. Ruffini, P. G. Betta, R. Libener, R.<br />
Guaschino, E. Piccolini, L. Palmer, M. Neri, D. Mirabelli, D.<br />
Ugolini, S. Bonassi, C. Magnani, G. Matullo.<br />
POSTER SESSIONS 157<br />
1154F A region <strong>of</strong> autozygosity at 8q21.3 and lung<br />
cancer risk. M. T. Landi, K. Jacobs, M. Yeager, D.<br />
Albanes, M. Thun, N. E. Caporaso, S. Chanock, J. Shi.<br />
1155W IL28B allelic protein is<strong>of</strong>orms differentially<br />
activate interferon-stimulated genes. A. Mumy, B.<br />
Muchmore, W. Tang, H. Park, F. Sheikh, B. Rehermann, R.<br />
Donnelly, L. Prokunina-Olsson.<br />
1156T Three novel common susceptibility loci for<br />
ovarian cancer identified by GWAS meta-analysis and<br />
replication. S. J. Ramus, P. D. P. Pharoah, Y. Y. Tsai, C. M.<br />
Phelan, A. N. A. Monteiro, S. A. Gayther, J. M. Schildkraut,<br />
T. A. Sellers on behalf <strong>of</strong> Ovarian Cancer Association<br />
Consortium.<br />
1157F Insights into pancreatic cancer etiology from<br />
pathway analysis <strong>of</strong> genome-wide association study<br />
data. P. Wei, H. Tang, D. Li.<br />
1158W Pathway-based analysis <strong>of</strong> genomewide<br />
SNP data reveals new candidate genes for<br />
susceptibility to melanoma. M. Brossard, A. Vaysse,<br />
E. Corda, P. Jeannin, H. Mohamdi, V. Chaudru, N.<br />
Lavielle, B. Bressac-de Paillerets, M. F. Avril, M. Lathrop,<br />
F. Demenais.<br />
1159T Susceptibility loci associated with specific and<br />
shared subtypes <strong>of</strong> lymphoid malignancies. V. Joseph,<br />
T. Kirchh<strong>of</strong>f, J. Brown, K. A. Schrader, A. Dutra-Clarke,<br />
C. Manschreck, N. Hansen, R. Rau-Murthy, K. Sarrel, J.<br />
Przybylo, S. Shah, S. Cheguri, Z. Stadler, L. Zhang, O.<br />
Paltiel, D. Yehuda, A. Viale, C. Portlock, D. Strauss, S. L.<br />
Lipkin, M. Lacher, M. Robson, R. J. Klein, A. Zelenetz,<br />
K. Offit.<br />
1160F Second generation DCEG Reference Set<br />
improves performance <strong>of</strong> genotype imputation.<br />
Z. Wang, K. B. Jacobs, M. Yeager, A. Hutchinson, J.<br />
Sampson, M. Tucker, S. J. Chanock.<br />
1161W Are there genetic variants that confer shared<br />
genetic susceptibility to pancreatic cancer and<br />
melanoma? L. Wu, K. Rabe, G. Petersen.<br />
1162T Oncogenic rewiring by the t(11;19)(q21;p13)<br />
coactivator fusion, CRTC1/MAML2, involves direct<br />
activation <strong>of</strong> the pluripotency factor MYC. A. L. Amelio,<br />
F. X. Schaub, M. Fallahi-Sichani, M. B. Lawani, M. R.<br />
Southern, B. M. Young, L. Wu, F. J. Kaye, J. L. Cleveland,<br />
M. D. Conkright.<br />
1163F Meta-analysis identifies microRNA expression<br />
signature in non-small-cell lung cancer. T. Annilo, U.<br />
Vısa, T. Vooder, R. Kolde, J. Vilo, A. Metspalu.<br />
1164W The effect <strong>of</strong> non-viral magnet assisted<br />
transfection on chronic myeloid leukemia cell line with<br />
downregulated miR-150. T. Balci, C. Birayavci, S. Yilmaz,<br />
Z. O. Dogan Sigva, G. Saydam, C. Gunduz.<br />
1165T The novel resequencing diagnostic microarray:<br />
RDMGGA1.0, can detect at a diagnose level<br />
mutations in patients with breast, ovarian, colon,<br />
skin and multiple cancers. D. Bercovich, Y. Plotsky,<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
158 POSTER SESSIONS<br />
T. Morad, S. Allon-Shalev, AM. Lichanska, LA. Borsuk,<br />
C. Tibbetts.<br />
1166F A new approach for an anti-diabetic drug<br />
metformin in prostate cancer. C. Biray Avci, E. Harman,<br />
S. Yilmaz, Y. Dodurga, C. Gunduz.<br />
1167W mRNA-seq <strong>of</strong> single prostate cancer circulating<br />
tumor cells reveals recapitulation <strong>of</strong> gene expression<br />
and pathways found in prostate cancer. G. Cann, Z.<br />
Gulzar, S. Cooper, M. Tat, R. Li, S. Stuart, S. Luo, M.<br />
Ronaghi, J. Brooks, A. Talasar.<br />
1168T Detection <strong>of</strong> sequences <strong>of</strong> MMTV-like<br />
retroviruses in breast cancer from Mexican women.<br />
A. Cedro-Tanda, I. A. Cordova-Solis, D. J. Arenas-<br />
Aranda, J. Torres-López, F. A. Salamanca-Gomez, C.<br />
Moctezuma-Meza, G. Castelazo-Rodriguez, N. Garcia-<br />
Hernandez.<br />
1169F Expression <strong>of</strong> stem cell gene, Piwil2 and<br />
testis specific genes TSGA10, TEX101 and ODF3<br />
in breast cancer. M. Dianatpour, P. Mehdipour, M.<br />
Miryounesi, S. Savad, F. Yazarlou, M. Mobasheri, M. H.<br />
Modarressi.<br />
1170W PMS2 screening: Could massive parallel<br />
sequencing facilitate gene analysis? J. Duclos, F. Pires,<br />
G. Legrand, C. Colas, J. Lefevre, M. Eyries, C. Wang, Y.<br />
Parc, F. Soubrier, F. Coulet.<br />
1171T FANCD2 immunohistochemical expression is<br />
a prognostic marker in breast cancer. R. Fagerholm,<br />
K. M. Sprott, T. Heikkinen, J. Bartkova, P. Heikkilä, K.<br />
Aittomäki, J. Bartek, D. T. Weaver, C. Blomqvist, H.<br />
Nevanlinna.<br />
1172F Effects <strong>of</strong> cassia extracts on cytotoxicity,<br />
apoptosis and gene expression in HL-60 cells. C.<br />
Gündüz, S. Yilmaz Süslüer, B. Agrap, C. Biray Avci, F.<br />
Lermioglu.<br />
1173W Universal Lynch syndrome screening result<br />
notification: Efficacy affected by method. H. Hampel, I.<br />
Lattimer, W. L. Frankel.<br />
1174T Allele-specific expression imbalances <strong>of</strong> MCC<br />
and reduced susceptibility to colorectal cancer in<br />
schizophrenia. L. He, G. He.<br />
1175F RAD51 polymorphisms and breast cancer risk.<br />
M. Hosseini, M. Houshmand, A. Ebrahimi.<br />
1176W Design and development <strong>of</strong> a next-generation<br />
sequencing assay for multiplex detection <strong>of</strong> somatic<br />
mutations in FFPE tissues. E. B. Jaeger, R. Haigis, M.<br />
Bauer, J. Yeakley, J. Betley, N. Udar.<br />
1177T Genotypic distribution <strong>of</strong> MMP1 (1607, 1G/2G)<br />
promoter in childhood malignant gliomas. P. Kawal, R.<br />
Kumar, A. Chandra, T. N. Dhole, B. K. Ojha.<br />
1178F Antileukemic effect <strong>of</strong> paclitaxel in combination<br />
with metformin in HL-60 cell line. C. Kayabasi, C.<br />
Birayavci, S. Yilmaz Susluer, Z. O. Dogan Sigva, T. Balci,<br />
G. Saydam, C. Gunduz.<br />
1179W The X-linked tumor suppressor TSPX disrupts<br />
the positive feedback loop <strong>of</strong> the viral oncoprotein HBx<br />
in HBV-associated hepatocarcinogenesis. T. Kido, Y.-F.<br />
C. Lau.<br />
1180T Comparison <strong>of</strong> minor groove binding<br />
ligands and known carcinogen blastomogenic,<br />
recombinogenic and mutagenic activity revealed by<br />
SMART in wts/1 hetesozygous flies. K. Kirsanov, E.<br />
Lesovaya, G. Belitsky, M. Yakubovskaya.<br />
1181F GR-mediated regulation <strong>of</strong> gene expression by<br />
standard glucocorticoids and selective glucocorticoid<br />
receptor agonists in lymphoma cells. E. Lesovaya, A.<br />
Yemelyanov, K. Kirsanov, V. Gasanova, M. Yakubovskaya,<br />
I. Budunova.<br />
1182W Sub-cellular localization <strong>of</strong> Y-box protein 1<br />
regulates proliferation, migration and tumorigenicity<br />
in astrocytomas. X. Liu, D. Faury, C. Sollier, N. Gerges,<br />
B. Meehan, Z. Dong, P. Siegel, A. Korshunov, S. Pfister, J.<br />
Rak, N. Jabado.<br />
1183T Integrative analysis <strong>of</strong> TCGA clinical and<br />
genomic data reveals conflicting roles <strong>of</strong> REST<br />
gene expression in recurrent glioblastoma. J.<br />
Madhusoodanan, M. Shekar, J. Su, I. Kupershmidt.<br />
1184F Analysis <strong>of</strong> MRE11/RAD50/NBN genes in<br />
childhood acute lymphoblastic leukemia. J. Nowak,<br />
M. Mosor, I. Ziolkowska-Suchanek, K. Nowicka, D.<br />
Januszkiewicz-Lewandowska.<br />
1185W Validation <strong>of</strong> a prostate cancer metastasis<br />
signature in a FFPE cohort <strong>of</strong> primary tumors. A.<br />
Pearlman, C. Campbell, J. Loke, S. Freedland, Y. Shao,<br />
H. Ostrer.<br />
1186T Molecular characterization <strong>of</strong> small cell<br />
carcinoma <strong>of</strong> the ovary. P. Ramos, M. L. Russell, L.<br />
Nordstrom, S. Smith, M. T. Barrett, T. Holley, E. Lenkiewitz,<br />
J. G. Pressey, J. Farley, S. P. Anthony, G. Hostetter, A. E.<br />
McCullough, K. A. Furge, B. B. Haab, J. M. Trent, H. E.<br />
Cunliffe.<br />
1187F Effects <strong>of</strong> Helicobacter pylori infection on<br />
MGMT and MLH1 promoter methylation status<br />
and microsatellite instability in pediatric and adult<br />
patients. M. L. Ribeiro, M. C. Alvarez, J. C. Santos,<br />
N. M. Maniezzo, M. S. Ladeira, I. C. A. Scaletsky, J.<br />
Pedrazzoli, Jr.<br />
1188W Role <strong>of</strong> novel and GWAS identified PLCE1<br />
genetic variants to gallbladder cancer susceptibility<br />
in north Indian population. K. L. Sharma, S. Misra, A.<br />
Kumar, B. Mittal.<br />
1189T Serum metabolomics and prostate cancer<br />
survival. R. Szulkin, R. Karlsson, A. Heuberger, M. Hong,<br />
C. Broeckling, J. Prenni, J. Prince, F. Wiklund.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1190F Analysis <strong>of</strong> TCGA patient and curated public<br />
genomic data identifies differentially regulated<br />
processes in breast cancer metastases. R. Wisotzkey,<br />
A. Umesh, J. Park, J. Shima, J. Delaney, E. Kelly, E. Chiu,<br />
M. Shekar, I. Kupershmidt.<br />
1191W Extreme breast/ovarian cancer phenotypes<br />
in non BRCA1 and BRCA2 families <strong>of</strong> Greek ancestry.<br />
F. Fostira, A. V. Stavropoulou, I. Konstantopoulou, D.<br />
Yannoukakos.<br />
1192T Modeling carcinogenesis in BRCA1 and BRCA2<br />
heterozygous mammary epithelial cells. M. E. Keith, M.<br />
Tenniswood.<br />
1193F Integrated transcriptional and functional<br />
screening identifies novel regulators <strong>of</strong> lymphoid<br />
lineage determination. E. Laurenti, S. Doulatov, I. Plumb,<br />
M. Doedens, C. April, J. B. Fan, J. Dick.<br />
1194W microRNA in bi<strong>of</strong>luids—robust biomarkers<br />
for disease, toxicology or injury studies: The case<br />
<strong>of</strong> minimally invasive colorectal cancer detection. P.<br />
Mouritzen, T. Blondal, D. Andreasen, N. Tolstrup, M. W.<br />
Teilum, A. Baker, S. J. Nielsen.<br />
1195T Detection <strong>of</strong> KRAS, BRAF, NRAS and PIK3CA<br />
cancer markers by castPCR technology. J. Au-Young,<br />
D. Keys, B. Ching, M. Mouanoutoua, D. Merrill.<br />
1196F Identifying the causes <strong>of</strong> dyskeratosis<br />
congenita: The prototypical telomere biology disorder.<br />
S. A. Savage, N. Giri, B. Ballew, B. P. Alter.<br />
1197W Germline BAP1 mutation: Additional case report<br />
and expanding clinical phenotype. R. Pilarski, C. M.<br />
Cebulla, T. Rich, L. Strong, M. H. Abdel-Rahman.<br />
1198T Detection <strong>of</strong> human breast cancer gene<br />
fusions from RNA-sequencing analysis <strong>of</strong><br />
formalin-fixed paraffin-embedded tissue specimens.<br />
Y. Ma, J. Stephans, R. Ambannavar, J. Jeong, J.<br />
Morlan, A. Dei Rossi, M. Liu, D. Sinicropi, J. Baker,<br />
K. Qu.<br />
1199F Analysis <strong>of</strong> quantitative trait loci (eQTLs) in<br />
pancreatic cancer by RNA sequencing. H. Parikh, J. Jia,<br />
W. Xiao, I. Collins, J. Hoskins, J. Powell, S. Thorgeirsson,<br />
J. Shi, G. Petersen, L. Amundadottir.<br />
1200W Identification <strong>of</strong> fusion transcripts and copy<br />
number variations in acute lymphoblastic leukemia by<br />
next-generation RNA and DNA sequencing. M. Bonin,<br />
C. Schroeder, M. Sturm, U. Pflückhahn, M. Feldhahn,<br />
O. Kohlbacher, H. G. Rammensee, P. Lang, O. Riess, P.<br />
Bauer, M. Walter.<br />
1201T Admixture rate estimation and post-call<br />
correction for complete genomics matched tumornormal<br />
whole genome sequencing data. M. Chen, Z.<br />
Omay, A. Serin, M. Gunel, H. Zhao.<br />
1202F Transcriptome analysis <strong>of</strong> blast cells <strong>of</strong> patients<br />
with acute lymphoblastic leukemia in diagnosis<br />
and relapse. M. A. Chiabai, G. R. Fernandes, L. H. T.<br />
Sakamoto, R. Pogue, R. W. Pereira.<br />
POSTER SESSIONS 159<br />
1203W Comprehensive germline susceptibility variant<br />
discovery in ovarian cancer using exome sequencing<br />
data. L. Ding, K. Johnson, K. Kanchi, M. Mclellan, C. Lu,<br />
Q. Zhang, D. Koboldt, C. Kandoth, T. Graubert, T. Ley, E.<br />
Mardis, R. Wilson.<br />
1204T Whole-exome sequencing <strong>of</strong> four patients with<br />
critera <strong>of</strong> familial hyperplastic polyposis. C. Garrec,<br />
S. Küry, P. Lindenbaum, V. Vidal, F. Airaud, J. Chettrit, E.<br />
Cauchin, J. F. Mosnier, S. Bézieau.<br />
1205F RAD51 paralogs mutation screening in<br />
breast and ovarian cancer families. L. Golmard,<br />
V. Caux-Moncoutier, G. Davy, E. Al Ageeli, B. Poirot,<br />
C. Tirapo, D. Michaux, C. Barbaroux, C. Dubois<br />
d’Enghien, L. Castéra, M.-H. Stern, C. Houdayer, D.<br />
Stoppa-Lyonnet.<br />
1206W MLH1, MSH2 and MSH6 mutations identified by<br />
DNA sequencing and MLPA analysis: Experience from<br />
the Colon Cancer Family Registry. S. R. Gunawardena,<br />
M. S. DeRycke, N. M. Lindor, M. A. Jenkins, J. L.<br />
Hopper, D. D. Buchanan, S. Gallinger, P. Newcomb, L.<br />
LeMarchand, R. W. Haile, S. N. Thibodeau, Colon Cancer<br />
Family Registry.<br />
1207T Whole-exome sequencing <strong>of</strong> a rare case <strong>of</strong><br />
familial childhood acute lymphoblastic leukemia. J.<br />
Healy, C. Richer, J. F. Spinella, V. Saillour, R. Vidal, E.<br />
Bareke, S. Busche, B. Ge, T. Pastinen, D. Sinnett.<br />
1208F Comprehensive BRCA1 and BRCA2 mutational<br />
pr<strong>of</strong>ile in Lithuania. R. Janavicius, V. Rudaitis, L.<br />
Griskevicius.<br />
1209W A broad re-sequencing study <strong>of</strong> 409 genes<br />
in NCI-60 cell lines using the Ion Ampliseq<br />
Comprehensive Cancer Panel and Ion PGM<br />
semiconductor sequencing reveals previously<br />
unreported cell line-specific mutations. B. S. G. Kong,<br />
M. Shannon, I. Casuga, D. Joun, S. M. Chen, C.-Y. Li, D.<br />
Ruff, R. Bennett.<br />
1210T Germline sequencing for aggressive prostate<br />
carcinoma. D. Larson, D. Koboldt, E. Appelbaum, M.<br />
O’Laughlin, R. Fulton, J. Haslag-Min<strong>of</strong>f, I. Borecki, A.<br />
Kibel, R. Wilson, E. Mardis.<br />
1211F A next-generation sequencing diagnostic<br />
panel to test all cancer susceptibility genes. S. S.<br />
Mahamdallie, E. Ruark, K.-W. Lau, A. Renwick, S. Seal, E.<br />
Ramsay, S. Hanks, J. Douglas, N. Rahman.<br />
1212W New germline MET variants inhereditary<br />
papillary type 1 renal carcinomas within the French<br />
population. E. Rouleau, C. Lefol, S. Caputo, V. Verkarre,<br />
C. Guy, F. Copigny, C. Maugard, O. Caron, F. Eisinger, P.<br />
Berthet, Y.-J. Bignon, J. Chiesa, A. David, T. Frebourg,<br />
S. Giraud, S. Lejeune, J.-M. Limacher, H. Zattara, S.<br />
Deveaux, I. Bieche, S. Richard, R. Lidereau.<br />
1213T Rare mutations in XRCC2 confer increased risk<br />
<strong>of</strong> breast cancer. M. Southey, D. J. Park, F. Lesueur, T.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
160 POSTER SESSIONS<br />
Nguyen-Dumont, M. Pertesi, F. A. Odefrey, F. Hammet, S.<br />
L. Neuhausen, E. M. John, I. L. Andrulis, M. B. Terry, M.<br />
Daly, S. Buys, F. Le Calvez-Klem, A. Lonie, B. J. Pope, H.<br />
Tsimiklis, C. Voegele, F. M. Hilbers, N. Hoogerbrugge, A.<br />
Barroso, A. Osorio, G. G. Giles, P. Devilee, J. Benitez, J. L.<br />
Hopper, S. V. Tavtigian, D. E. Goldgar, kConFab, BCFR.<br />
1214F Identification <strong>of</strong> genetic susceptibility loci<br />
for familial prostate cancer through whole exome<br />
sequencing: The ICPCG study design. S. N. Thibodeau,<br />
M. DeRycke, S. McDonnell, S. Gunawardena, Y. W.<br />
Asmann, S. Middha, L. Cannon-Albright, J. L. Stanford,<br />
E. A. Ostrander, W. B. Isaacs, J. Xu, J. Schleutker, K. A.<br />
Cooney, E. M. Lange, J. D. Carpten, J. E. Bailey-Wilson,<br />
O. Cussenot, G. G. Giles, G. Severi, C. Maier, A. S.<br />
Whittemore, C. L. Hsieh, F. Wiklund, W. J. Catalona, W. D.<br />
Foulkes, D. Mandal, R. Eeles, D. Easton, D. Seminara, D.<br />
Schaid on behalf <strong>of</strong> International Consortium for Prostate<br />
Cancer <strong>Genetics</strong>.<br />
1215W Discovery <strong>of</strong> novel long noncoding RNAs<br />
and aberrant alternative splicing events by RNAsequencing<br />
in childhood acute lymphoblastic leukemia.<br />
R. Vidal, J. F. Spinella, V. Saillour, C. Richer, J. Healy, E.<br />
Bareke, S. Busche, B. Ge, T. Pastinen, A. Droit, D. Sinnett.<br />
1216T Association <strong>of</strong> polymorphisms in the FOXE1<br />
gene, but not NKX2-1, with familial papillary thyroid<br />
carcinoma. S. G. Wilson, C.-Y. Yan, L. Ward, S. Chew,<br />
V. Panicker, S. J. Brown, S. Chiripal, J. Goldblatt, T. D.<br />
Spector, J. Walsh.<br />
1217F XPC gene founder splicing site mutation<br />
is common in Brazilian xeroderma pigmentosum<br />
patients. M. I. W. Achatz, K. M. Santiago, F. P. Vairo, P.<br />
Ashton-Prolla, P. F. V. de Medeiros, R. M. Rocha, S. R.<br />
Rogatto.<br />
1218W Rare variants in genes from esophageal<br />
squamous cell carcinoma genome-wide association<br />
studies identified by exome/whole genome sequencing<br />
<strong>of</strong> high-risk upper gastrointestinal cancer families. A.<br />
M. Goldstein, N. Hu, K. J. Jacobs, L.-J. He, X.-Y. Han, M.<br />
Rotunno, M. Cullen, J. Boland, H. Su, L. Wang, C. Wang,<br />
L. Burdett, M. Malasky, A. Hutchinson, M. Yeager, T. Ding,<br />
C. Giffen, M. A. Tucker, S. J. Chanock, M. Lee, P. R. Taylor.<br />
1219T Identification <strong>of</strong> breast cancer susceptibility<br />
genes. L. Guidugli, J. N. Weitzel, X. Wang, S. Hart, F. J.<br />
Couch, C. Szabo.<br />
1220F Mutations in SDHA are a common cause <strong>of</strong><br />
paragangliomas and pheochromocytomas and give<br />
rise to a diverse tumor spectrum. A. R. Mensenkamp, J.<br />
U. Rao, K. L. I. van Gassen, B. Kusters, J. W. M. Lenders,<br />
H. P. M. Kunst, H. J. L. M. Timmers, M. J. L. Ligtenberg.<br />
1221W Identifying novel cancer susceptibility genes<br />
through exome sequencing and copy number analysis<br />
<strong>of</strong> individuals with Li Fraumeni-like cancer phenotypes.<br />
S. E. Plon, L. C. Strong, B. Powell, L. Jiang, H. Cheung, D.<br />
Ritter, D. M. Muzny, D. A. Wheeler, R. A. Gibbs.<br />
1222T Development and validation <strong>of</strong> NGS-based<br />
molecular diagnosis <strong>of</strong> inherited forms <strong>of</strong> colorectal<br />
cancer. J. Tinat, F. Charbonnier, S. Coutant, R. Marlin,<br />
G. Bougeard-Denoyelle, S. Baert-Desurmont, M. Tosi, T.<br />
Frebourg, I. Tournier.<br />
1223F Interpretation <strong>of</strong> variants <strong>of</strong> unknown<br />
significance with a large database <strong>of</strong> genotyped and<br />
phenotyped individuals. B. T. Naughton, A. Chowdry, J.<br />
M. Macpherson, G. M. Benton.<br />
1224W Exome sequencing identifies rare deleterious<br />
mutations in DNA repair genes FANCC and BLM as<br />
potential breast cancer susceptibility alleles. E. R.<br />
Thompson, M. A. Doyle, S. M. Rowley, D. Y. H. Choong,<br />
G. K. Philip, A. H. Trainer, P. A. James, G. Mitchell, I. G.<br />
Campbell, kConFab.<br />
1225T Cancer genetic testing panels: Preliminary<br />
experience within an adult genetics practice. C. G.<br />
Selkirk, S. M. Weiss, K. J. Vogel, A. C. Newlin, S. M.<br />
Weissman, P. J. Hulick.<br />
1226F Thirty percent <strong>of</strong> breast cancer families negative<br />
by commercial BRCA1/BRCA2 testing are resolved by<br />
mutations in 13 other breast cancer genes, by BRCA1/<br />
BRCA2 phenocopies, and by BRCA1/BRCA2 CNVs.<br />
T. Walsh, S. Casadei, A. M. Thornton, G. Bernier, C. H.<br />
Spurrell, S. M. Stray, J. Mandell, M. K. Lee, M.-C. King.<br />
1227W Comparison <strong>of</strong> next-generation sequencing<br />
with traditional sequencing and MLPA for BRCA1 and<br />
BRCA2 testing. K. Chun, A. Brown, K. Ng, R. Denroche, J.<br />
D. McPherson.<br />
1228T Genomic capture and massively parallel<br />
sequencing reveals inherited loss-<strong>of</strong>-function<br />
mutations in 8 genes in 19% <strong>of</strong> familial breast cancer<br />
patients from Greece. A. Stavropoulou, T. Walsh, F.<br />
Fostira, M. Tsitlaidou, S. Casadei, S. Glentis, G. Fountzilas,<br />
I. Konstantopoulou, M. C. King, D. Yannoukakos.<br />
1229F Elevated rate <strong>of</strong> somatic L1 retrotransposition in<br />
colorectal tumors. S. Solyom, A. D. Ewing, E. Rahrmann,<br />
T. Doucet, H. H. Nelson, D. F. Sigmon, A. Casella, B.<br />
Erlanger, S. Wheelan, G. Faulkner, D. Haussler, D.<br />
Largaespada, H. H. Kazazian.<br />
1230W Mutational analysis <strong>of</strong> splicing machinery genes<br />
SF3B1, U2AF1 and SRSF2 in myelodysplasia and other<br />
common tumors. S. Lee, E. Je, M. Kim, J. Oh, N. Yoo.<br />
1231T Calling allele or haplotype-specific copy<br />
number in tumor sequence data. N. Dewal, Y. Hu, M.<br />
L. Freedman, T. LaFramboise, I. Pe’er, R. A. Gibbs, D. A.<br />
Wheeler.<br />
1232F Somatic mutation detection <strong>of</strong> tumor and<br />
matched-normal samples for semiconductor-based<br />
sequencing. A. H. Joyner, S. Utiramerur, D. Brinza, H.<br />
Breu, B. Krishnaswami, A. Shukla, J. Zhai, Y. Lou, F.<br />
Hyland, D. Thomas, E. Beasley.<br />
1233W Acute lymphoblastic leukemia: Novel<br />
therapeutic approach based on an active patientindividualized<br />
multipeptide vaccination. C. Schroeder,<br />
M. Sturm, U. Pflückhahn, M. Feldhahn, O. Kohlbacher,<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
S. Stevanovic, H. G. Rammensee, P. Lang, O. Riess,<br />
P. Bauer.<br />
1234T No evidence for the role <strong>of</strong> somatic mutations<br />
and promoter hypermethylation <strong>of</strong> FH gene in the<br />
tumorigenesis <strong>of</strong> nonsyndromic uterine leiomyomas. S.<br />
Vaidya, K. P. Rao, Q. Hasan.<br />
1235F Somatic mutation spectrum <strong>of</strong> metastatic<br />
melanoma through exome sequencing <strong>of</strong> 48 tumornormal<br />
pairs. M. D. Willard, J. N. Calley, S.-S. Wong, R.<br />
H. Higgs, X. Ma, P. J. Ebert, S. M. Bray, I. H. Wulur, Y. Yue,<br />
Y. Lin, J. Wang, A. Aggarwal, S. Li, C. R. Reinhard, A. B.<br />
West, T. D. Barber.<br />
1236W RNA-seq identifies differentially expressed<br />
genes and mutations in oligodendrogliomas. E.<br />
Schrock, K. Szafranski, J. A. Campos Valenzuela, S.<br />
Schauer, D. Krex, A. Rump, K. Hackmann, G. Schackert,<br />
L. Kaderali, M. Platzer, B. Klink.<br />
1237T Identification and quantification <strong>of</strong> somatic<br />
mutations with the Ion AmpliSeq Cancer Panel. M.<br />
Andersen, S. Roman, K. Rhodes, C. VanLoy, A. Broomer,<br />
D. Topacio, G. Roma, R. Bennett, T. Neff, C. Beadling, C.<br />
Corless.<br />
1238F Whole-genome and targeted sequencing<br />
analysis <strong>of</strong> early stage high-grade serous ovarian<br />
cancer. M. Bibikova, S. Humphray, R. Grocock, J.<br />
Peden, F. Nielsen, Z. Kingsbury, J. Chien, E. L. Goode,<br />
V. Ho, C. April, S. Munchel, J. Cottrell, Y. Tarabishy, J. M.<br />
Cunningham, S. Kaufmann, L. C. Hartmann, K. R. Kalli, V.<br />
Shridhar, J.-B. Fan, G. Heath, D. Bentley.<br />
1239W Detection <strong>of</strong> somatic mutations in tumor<br />
genomes using de novo assembly with assembly to<br />
assembly mapping. A. R. Carson, W. Pfeiffer, T. Schwartz,<br />
G. Oliveira, T. Nicholas, G. Zhang, M. A. Miller, E. J. Topol,<br />
S. Levy.<br />
1240T Identification <strong>of</strong> therapeutic targetable<br />
mutations in cancer by whole transcriptome and<br />
genome sequencing. D. W. Craig, W. Liang, W. Tembe, A.<br />
Christ<strong>of</strong>orides, J. Aldrich, T. Izatt, J. M. Trent, J. D. Carpten.<br />
1241F Identification <strong>of</strong> somatic mutations in<br />
parathyroid tumors using whole exome sequencing. M.<br />
K. Cromer, L. F. Starker, M. Choi, R. Udelsman, C. Nelson-<br />
Williams, R. P. Lifton, T. Carling.<br />
1242W Exome sequencing <strong>of</strong> metastatic prostate<br />
tumors, GWAS and functional analysis <strong>of</strong> the<br />
methylation regulator TET2 in prostate cancer. M. Dean,<br />
M. Nickerson, K. M. Im, K. J. Misner, W. Tan, H. Lou, D.<br />
W. Wells, K. Frederickson, T. Harkins, T. Naab, B. Gold, T.<br />
Andersson, B. Zbar, W. M. Linehan, G. S. Bova, H. Li, S.<br />
Anderson, M. Yeager.<br />
1243T Identification <strong>of</strong> novel driver mutation in EGFR/<br />
KRAS/ALK: Negative lung adenocarcinoma <strong>of</strong> never<br />
smokers by whole exome sequencing. S. Han, J. Yoon,<br />
J. Ahn, H. Jang, M. Lee, H. Kim, B. Cho, J. Lee.<br />
1244F Detection <strong>of</strong> low frequency tumorigenesis<br />
POSTER SESSIONS 161<br />
variants by ultra deep sequencing (.1000x) across<br />
409 oncogenes. T. T. Harkins, C. C. Lee, M. Andersen,<br />
E. Levandowsky, M. Dindinger, J. Spangler, T. Ross, S.<br />
McLaughlin, V. Sheth.<br />
1245W Targeted sequencing <strong>of</strong> clinically relevant<br />
genes using TargetRich gene panels. K. Jansen<br />
Spayd, I. A. Vasenkova, T. Shvetsova, D. A. Kloske, R. C.<br />
Bachmeyer, D. T. Moore, K. E. Varley.<br />
1246T Rapid and economical re-sequencing <strong>of</strong><br />
hundreds <strong>of</strong> genes from sample-limited specimens<br />
using the Ion AmpliSeq Comprehensive Cancer<br />
Panel and Ion PGM semiconductor sequencing. D.<br />
Joun, S, M. Chen, B. Kong, I. Causga, C.-Y. Li, D. Ruff, R.<br />
Bennett, M. Shannon.<br />
1247F Bayes-MutSig: A novel approach to determine<br />
significantly mutated genes. N. B. Larson, H. Sicotte, J.<br />
Sinnwell, K. R. Kalari, E. Wieben, L. Wang, J. C. Boughey,<br />
M. Goetz, R. Weinshilboum, B. L. Fridley.<br />
1248W The transcriptional landscape and mutational<br />
pr<strong>of</strong>ile <strong>of</strong> lung adenocarcinoma. W. Lee, Y. Ju, J. Shin,<br />
J. Lee, B. Thomas, J. Lee, Y. Jung, J. Kim, J. Shin, S. Yoo,<br />
J. Kim, E. Lee, C. Kang, I. Park, H. Rhee, S. Lee, J. Kim, J.<br />
Kang, Y. Kim, J. Seo.<br />
1249T Genes with single nucleotide variations in earlyonset<br />
female breast cancer patients identified through<br />
exome sequencing. C. Lee, N. Leng, W. Kuo, H. Yang,<br />
K. Nobuta, C. Lin, C. Chang, Y. Lu, K. Lo, L. Hu, H. Chu,<br />
W. Chou, C. Chen, W. Yao, K. Chiu, A. Cheng, C. Shen, K.<br />
Chang, C. Haudenschild, C. Chen.<br />
1250F Pathway analysis <strong>of</strong> somatic mutations in<br />
the whole genome sequence <strong>of</strong> aggressive tumors<br />
in African <strong>American</strong> prostate cancer patients. K.<br />
Lindquist, R. Kazma, J. A. Mefford, T. J. H<strong>of</strong>fmann, N.<br />
Cardin, B. A. Rybicki, D. A. Chitale, A. Levin, J. S. Witte.<br />
1251W SeqWright’s next-gen sequencing <strong>of</strong> FFPE<br />
tumor tissue allows for analysis <strong>of</strong> multiple cancer<br />
markers with high sensitivity and excellent correlation<br />
to other validated clinical methods. A. C. Pond, X. X.<br />
Tan, L. T. Szkotnicki, V. Venegas, E. Zhou, Y. Mou, K. B.<br />
Thomas, P. Choppa, K. Guekunst, F. Lu.<br />
1252T Amplicon sequencing <strong>of</strong> tumors from xenograft,<br />
FFPE and fresh frozen samples. B. Riley-Gillis, C. Qiu, O.<br />
Puig, R. Benayed.<br />
1253F Loss <strong>of</strong> the canonical Notch mediator RBPJ is<br />
recurrent in oligoastrocytomas. P. Salo, E. I. Gaál, O.<br />
Tynninen, M. Niemelä, A. Laakso, A. Karppinen, A. Paetau,<br />
H. Mäenpää, J. Hernesniemi, M. Perola.<br />
1254W Characterization <strong>of</strong> a small cell prostate cancer<br />
using exome sequencing. A. F. Scott, D. W. Mohr, H.<br />
Ling, G. S. Liptak.<br />
1255T Pr<strong>of</strong>iling mutations in circulating tumor cells<br />
from breast cancer patients by targeted sequencing. Y.<br />
Shen, X. Xu, W. DeWitt, N. Xu, F. Z. Bisch<strong>of</strong>f, K. D. Crew,<br />
D. L. Hershman, M. A. Maurer, R. Parsons, K. Kalinsky.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
162 POSTER SESSIONS<br />
1256F Exome and whole genome mutational landscape<br />
in pancreatic ductal adenocarcinoma. L. Timms, A.<br />
Panchal, L. Mullen, J. Johns, R. Denroche, R. De Borja,<br />
F. Yousif, Z. Zha, M. Sam, A. M. K. Brown, T. Beck, J. D.<br />
McPherson.<br />
1257W De novo germline mosaic BRCA1 exon deletion<br />
associated with bilateral breast cancer. M. Tischkowitz,<br />
I. Delon, A. Taylor, A. Molenda, J. Drummond, K. Oakhill,<br />
A. Girling, H. Liu, J. Whittaker, R. Treacy.<br />
1258T Single-nucleotide variant calling from lowcoverage<br />
single-cell sequence data using tumor<br />
population structure. S. Vattathil, N. Navin, P. Scheet.<br />
1259F Initial genomic analysis <strong>of</strong> a pure erythroid<br />
leukemia developing in association with hydroxyurea<br />
treatment for sickle cell anemia. Z. Wang, D. Darbari, Z.<br />
McIver, I. Maric, L. Diaw, Y. Song, P. Johansson, J. B. He,<br />
J. Wei, A. J. Barrett, J. Khan, J. G. Taylor.<br />
1260W Novel L1 and Alu retrotransposon insertions<br />
in cancer-related gene loci in the NCI-60 cancer cell<br />
lines. J. Zampella, K. Burns.<br />
1261T Exome sequencing approach for identification<br />
<strong>of</strong> causative mutations in neur<strong>of</strong>ibromatosis type<br />
1-associated plexiform neur<strong>of</strong>ibromas. A. Pemov,<br />
H. Li, M. Wallace, D. R. Stewart, NISC Comparative<br />
Sequencing <strong>Program</strong>, NHGRI, NIH Intramural Sequencing<br />
Center.<br />
1262F DICER1 RNAseIIIb domain is mutated at two<br />
different sites in two different lesions in the same<br />
patient. M. Wu, N. Sabbaghian, N. Hamel, C. Choong, A.<br />
Charles, W. Foulkes.<br />
1263W Multiplex PCR-based targeted deep<br />
sequencing <strong>of</strong> the comprehensive human lung cancer<br />
gene panel for the detection <strong>of</strong> KRAS and EGFR<br />
mutations. Q. Peng, R. Gardner, N. Slepushkina, V.<br />
Devgan.<br />
1264T Highly sensitive detection <strong>of</strong> rare somatic<br />
mutations in tissue and plasma. A. Marziali.<br />
1265F Integrative investigation on breast cancer by<br />
ER, PR and HE2-defined subgroups using mRNA<br />
and microRNA expression pr<strong>of</strong>iling and cancer<br />
core pathway analysis. X. Dai, S. Khan, T. Heikkinen,<br />
P. Heikkilä, K. Aittomäki, C. Blomqvist, D. Greco, H.<br />
Nevanlinna.<br />
1266W Novel oligoheterocycles and potential ability as<br />
anti-cancer therapy. S. Al-Aqeel.<br />
1267T Relative telomere length differs according<br />
to DNA extraction method. L. Boardman, K.<br />
Litzelman, R. Johnson, M. Devine, R. Firl, A. Johnson,<br />
M. Vincent, J. Cunningham, C. Engelman, S. Seo,<br />
R. Gangnon, D. Rider, G. Petersen, S. Thibodeau, H.<br />
Skinner.<br />
1268F Hereditary breast/ovarian cancer in Algerian<br />
population: Molecular analysis <strong>of</strong> BRCA1 and BRCA2<br />
genes. F. Cherbal, R. Bakour, S. Adane, K. Boualga, N.<br />
Salhi, A. Chikh, P. Maillet.<br />
1269W GENECAPP: Sequence-specific in vivo analysis<br />
<strong>of</strong> protein-DNA interactions in human cancer cell<br />
lines. H. Guillen Ahlers, A. Ludwig-Kubinski, S. Tian,<br />
C. Anderson, A. M. Greene, J. Kennedy-Darling, M.<br />
Levenstein, R. Knoener, M. Chesnik, M. Scalf, Y. Yuan, R.<br />
Cole, M. Shortreed, L. Cirillo, R. Stewart, L. M. Smith, M.<br />
Olivier.<br />
1270T Examination <strong>of</strong> UVR-induced DNA damage and<br />
repair and its association with apoptosis in human<br />
keratinocytes and fibroblasts. M. Karbaschi, M. D.<br />
Evans, S. Macip, M. S. Cooke.<br />
1271F The IRS1 rs2943641 genetic variant and the<br />
protection against cancer. S. Romeo, C. Maglio, J.<br />
Andersson Assarsson, K. Sjöholm, L. Sjöström, L. M.<br />
Carlsson.<br />
1272W Lynch syndrome: Awareness among medical<br />
students at a United States medical school. J. S. Taylor,<br />
M. K. Frey, M. Biewald, M. Worley, Jr., S. Lin, K. Holcomb.<br />
1273T Characterization <strong>of</strong> active chromatin signatures<br />
in testicular germ cell tumor cell lines. S. J. White,<br />
Y. van de Zwan, C. M. de Boer, F. Rossello, L. H. J.<br />
Looijenga, A. J. Notini.<br />
1274F Single nucleotide polymorphisms and cancer<br />
risk in individuals with Costello syndrome. B. A.<br />
Thompson, G. Desachy, J. Quinn, A. E. Toland, L. A.<br />
Weiss, K. A. Rauen.<br />
1275W Assessment <strong>of</strong> Individuals with BRCA1 and<br />
BRCA2 large genomic rearrangements in high-risk<br />
breast cancer and ovarian cancer families. L. Zhang, A.<br />
Arnold, M. Harlan, M. Robson.<br />
1276T Genetic background <strong>of</strong> familial colorectal<br />
cancer type X. T. T. Nieminen, J.-P. Mecklin, H. J.<br />
Järvinen, P. Peltomäki.<br />
1277F Development <strong>of</strong> a robust method for<br />
establishing B cell lines using Epstein-Barr virus. I.<br />
Danjoh, R. Shirota, Y. Nakamura.<br />
1278W Association <strong>of</strong> single nucleotide<br />
polymorphisms in ERa, ERb, CYP17A1 and CYP19A1<br />
with breast cancer risk: A case control study from<br />
North India. S. Chattopadhyay, S. V. S. Deo, N. K.<br />
Shukla, S. A. Husain.<br />
1279T Efficacy <strong>of</strong> Sequenom Sample ID Plus®<br />
SNP genotyping in identification <strong>of</strong> FFPE tumor<br />
samples. J. K. Miller, N. Buchner, D. Pasternack, J. D.<br />
McPherson.<br />
Statistical <strong>Genetics</strong> and Genetic<br />
Epidemiology<br />
1280W Gene-specific accelerated transcriptional<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
aging in type 2 diabetes. J. Kent, M. Almeida, J. Peralta,<br />
H. H. H. Göring, J. Curran, M. Johnson, T. Dyer, S.<br />
Cole, J. Jowett, A. Comuzzie, M. Mahaney, L. Almasy,<br />
J. MacCluer, E. Moses, R. Duggirala, J. Blangero, S.<br />
Williams-Blangero.<br />
1281T Integrating metabolomic information in genomewide<br />
association studies. R. Rueedi, M. Ledda, T. Corre,<br />
R. Salek, V. Mooser, P. Vollenweider, G. Waeber, U. K.<br />
Genick, Z. Kutalik, S. Bergmann.<br />
1282F Application <strong>of</strong> principal components analysis<br />
to the investigation <strong>of</strong> expression pr<strong>of</strong>ile data. H. H. H.<br />
Göring, A. R. Sanders, E. I. Drigalenko, W. Moy, J. Duan,<br />
J. E. Curran, M. P. Johnson, E. K. Moses, J. Blangero, P.<br />
V. Gejman.<br />
1283W Prioritization <strong>of</strong> SNPs identified in microRNAs<br />
and their targeted genes by integrated analysis <strong>of</strong> high<br />
throughput datasets. X. Chen, H. Zhao.<br />
1284T Cis- and trans-eQTL analysis in 5,311 unrelated<br />
peripheral blood samples identifies novel disease<br />
pathways and helps to pinpoint causal variants.<br />
H. Westra, T. Esko, M. J. Peters, C. Schurmann, H.<br />
Yaghootkar, J. Kettunen, M. W. Christiansen, R. S. N.<br />
Fehrmann, G. J. te Meerman, A. H<strong>of</strong>man, F. Rivadeneira,<br />
E. Reinmaa, R. C. Jansen, J. Brody, S. A. Gharib, A.<br />
Suchy-Dicey, D. Enquobahrie, A. G. Uitterlinden, C.<br />
Wijmenga, B. M. Psaty, S. Ripatti, T. Frayling, A. Teumer, A.<br />
Metsepalu, J. B. J. van Meurs, L. Franke.<br />
1285F Ridge regression for genetic data: A semiautomatic<br />
method to guide the choice <strong>of</strong> ridge<br />
parameter. E. Cule, M. De Iorio.<br />
1286W Defining the functional significance <strong>of</strong> genes<br />
using natural human knockouts. J. D. H<strong>of</strong>fman, K. O.<br />
Polzin, A. E. Fish, P. Mayo, N. Schnetz-Boutaud, J. L.<br />
Haines.<br />
1287T Intronic single nucleotide polymorphism<br />
<strong>of</strong> CALM-1 gene is significantly associated with<br />
osteoarthritis knee. S. Raj, R. Srivastava, D. Sanghi, S.<br />
Awasthi, A. Mishra.<br />
1288F Genetic risk factor in development and<br />
progression <strong>of</strong> osteoarthritis knee. R. N. Srivastava, A.<br />
Mishra, S. Raj, D. Sanghi.<br />
1289W Functional variant within vitamin D metabolism<br />
gene ACADSB is associated with a more severe<br />
disease in multiple sclerosis. M. F. George, F. B. S.<br />
Briggs, P. P. Ramsay, H. Quach, A. Bernstein, B. Acuna, L.<br />
Shen, E. Mowry, C. Schaefer, L. F. Barcellos.<br />
1290T Homozygous c.14576G.A variant <strong>of</strong> RNF213<br />
predicts early-onset and severe form <strong>of</strong> Moyamoya<br />
disease. S. Miyatake, N. Miyake, H. Touho, H. Doi, H.<br />
Saitsu, K. Shimojima, T. Yamamoto, N. Okamoto, N.<br />
Kawahara, Y. Kuroiwa, M. Taguri, S. Morita, Y. Matsubara,<br />
S. Kure, N. Matsumoto.<br />
1291F C-reactive protein as a prognostic marker in<br />
melanoma progression. S. Fang, Y. Wang, D. Sui, H. Liu,<br />
POSTER SESSIONS 163<br />
C. Schacherer, J. Gardner, M. Ross, J. Gershenwald, J.<br />
Reveille, L. Wang, Q. Wei, C. Amos, J. Lee.<br />
1292W TGFBR1 variant associated with constitutively<br />
decreased TGF-b signaling and risk for colorectal<br />
cancer. M. J. Pennison, N. Bellam, J. Zimmerman, Q.<br />
Zeng, M. Wang, M. Sadim, V. Kaklamani, N. Yi, K. Zhang,<br />
J. Baron, D. O. Stram, B. Pasche, CCFR Investigators,<br />
Colon Cancer Family Registry, National Cancer Institute.<br />
1293T Limited survival <strong>of</strong> MEN1 patients with<br />
mutations in the JunD interacting domain and<br />
first elements for intrafamilial correlation in MEN1<br />
syndrome: A study from the GTE cohort. J. Thevenon,<br />
A. Bourredjem, L. Faivre, A. Costa, E. Gautier, C.<br />
Bonithon-Kopp, A. Calender, C. Binquet, P. Goudet,<br />
Members <strong>of</strong> Groupe d’…tude des Tumeurs Endocrines.<br />
1294F Association <strong>of</strong> vitamin D receptor gene<br />
polymorphism and vitamin D status in knee<br />
osteoarthritis. D. Sanghi, R. Srivastava, S. Raj.<br />
1295W Association between neural genes DRD2,<br />
AVPR1a, and ASPM and endophenotypes <strong>of</strong> speech<br />
sound disorder. C. M. Stein, F. Qiu, B. Truitt, R.<br />
Raghavendra, P. Joseph, A. A. Avrich, R. P. Igo, Jr., J. Tag,<br />
L. Freebairn, H. G. Taylor, B. A. Lewis, S. K. Iyengar.<br />
1296T Parent-<strong>of</strong>-origin effects and gender differences<br />
influence age-at-onset variation in FAP ATTRV30M<br />
kindreds. C. Lemos, T. Coelho, A. Martins-da-Silva, J.<br />
Sequeiros, A. Sousa.<br />
1297F Genome-wide analysis <strong>of</strong> germline copy number<br />
aberrations and association with breast cancer<br />
susceptibility. Y. Sapkota, B. S. Sehrawat, S. Ghosh, P. J.<br />
Robson, C. E. Cass, J. R. Mackey, S. Damaraju.<br />
1298W Whole-genome detection <strong>of</strong> disease-associated<br />
deletions or homozygosity in a case-control study <strong>of</strong><br />
rheumatoid arthritis. C. C. Wu, S. Shete, E. J. Jo, Y. E.<br />
Lu, Y. Xu, W. V. Chen, C. I. Amos.<br />
1299T T1D risk score modeling using dense genotypes<br />
in autoimmune associated genomic regions in 6,670<br />
cases and 9,416 controls and validation in 2,601<br />
affected sibpair families and 69 trio families. W.-M.<br />
Chen, S. Onengut-Gumuscu, P. Concannon, S. S. Rich,<br />
T1DGC.<br />
1300F Variants in/near DNER are reproducibly<br />
associated with type 2 diabetes in Pima Indians. Y. L.<br />
Muller, M. AbdusSamad, R. Hanson, W. C. Knowler, C.<br />
Bogardus, L. Baier.<br />
1301W Two multiple sclerosis risk variants from a<br />
large genome-wide association study are associated<br />
with disease progression in a population-based case<br />
cohort. H. Quach, M. F. George, F. B. S. Briggs, P. P.<br />
Ramsay, B. Acuna, L. Shen, E. Mowry, A. Bernstein, C.<br />
Schaefer, L. F. Barcellos.<br />
1302T Unraveling phenotype heterogeneity in prostate<br />
cancer susceptibility in Finland utilizing covariatebased<br />
analysis. C. D. Cropp, C. L. Simpson, T. Wahlfors,<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
164 POSTER SESSIONS<br />
A. George, M. P. S. Jones, U. Harper, D. Ponciano-<br />
Jackson, T. L. Tammela, J. Schleutker, J. E. Bailey-Wilson.<br />
1303F A search for genetic variants predisposing<br />
to radiation-induced meningioma. R. Bruchim, B.<br />
Oberman, R. Milgram, I. Novikov, S. Sadetzki.<br />
1304W Variants in one-carbon metabolism and<br />
blood folate, homocysteine and B12 deficiency in a<br />
population-based study. K. S. Crider, D. R. Maneval, N.<br />
F. Dowling, L. B. Bailey, G. Kaudwell, L. Hao, Z. Li, R. J.<br />
Berry.<br />
1305T Disease-associated genotype and allele sharing<br />
among human populations from throughout the world.<br />
M. M. DeAngelis, M. A. Morrison, D. J. Morgan, K. Mayne,<br />
R. Robinson, G. Silvestri, D. A. Schaumberg, E. E. Tsironi,<br />
I. K. Kim, J. Ramke, K. H. Park, L. A. Farrer.<br />
1306F Hidden heritability and risk prediction based<br />
on genome-wide association studies. N. Chatterjee, B.<br />
Wheeler, J. Sampson, P. Hartge, S. Chanock, J. Park.<br />
1307W Obesity susceptibility loci and associations<br />
across the pediatric body mass index distribution. S. F.<br />
A. Grant, H. Hakonarson, T. R. Rebbeck, J. A. Mitchell.<br />
1308T Large-scale genome-wide association metaanalysis<br />
using imputation from 2188-haplotype<br />
1000 Genomes reference panel identifies five novel<br />
susceptibility loci for BMI and additional novel sexspecific<br />
loci for BMI and WHR. M. Horikoshi, R. Mägi, I.<br />
Surakka, S. Wiltshire, A. Sarin, A. Mahajan, L. Marullo, T.<br />
Ferreira, S. Hägg, J. S. Ried, T. Winkler, G. Thorleifsson,<br />
N. Tsernikova, T. Esko, C. Willenborg, C. P. Nelson, M.<br />
Beekman, S. M. Willems, A. P. Morris, C. M. Lindgren, M. I.<br />
McCarthy, S. Ripatti, I. Prokopenko on behalf <strong>of</strong> ENGAGE<br />
Consortium.<br />
1309F A two-stage genome-wide association study to<br />
identify single nucleotide polymorphisms associated<br />
with development <strong>of</strong> erectile dysfunction following<br />
radiotherapy for prostate cancer. S. Kerns, R. Stock,<br />
N. Stone, M. Buckstein, Y. Shao, C. Campbell, L. Rath,<br />
R. Hixson, J. Cesaretti, M. Terk, H. Ostrer, B. Rosenstein,<br />
Collaboration developed under Radiogenomics<br />
Consortium.<br />
1310W Genetic variation and vitamin D sufficiency in<br />
the U.S. population (NHANES III). C. O. S. Neal, J. M.<br />
Jackson, K. S. Crider.<br />
1311T The genome-wide association study <strong>of</strong><br />
phenotypic robustness in human: A canalization study.<br />
R. Li, T. D. Spector, J. B. Richards.<br />
1312F A genome- and phenome-wide association<br />
study to identify genetic variants influencing platelet<br />
count and volume and their pleiotropic effects. K.<br />
Shameer, J. C. Denny, K. Ding, D. R. Crosslin, C. G. Chute,<br />
P. Peissig, J. Pacheco, R. Li, M. de Andrade, M. D. Ritchie,<br />
D. R. Masys, R. L. Chisholm, E. B. Larson, C. A. McCarty,<br />
D. M. Roden, G. P. Jarvik, I. J. Kullo.<br />
1313W Heterogeneity in polygenic contribution to<br />
ischemic stroke subtypes by age at onset. M. Traylor,<br />
H. S. Markus, S. Bevan, M. Dichgans, R. Malik, H. Segal,<br />
P. M. Rothwell, C. L. Sudlow, C. M. Lewis, Wellcome Trust<br />
Case Control Consortium (WTCCC2).<br />
1314T Strategies for developing prediction models with<br />
increased discriminatory accuracy from genome-wide<br />
association studies. J. Wu, R. M. Pfeiffer, M. H. Gail.<br />
1315F Concurrent modeling <strong>of</strong> multiple phenotypes<br />
and genotypes in family data: Implications for cleft<br />
gene discovery. M. Govil, N. Mukhopadhyay, R. M.<br />
Silva, A. R. Vieira, S. M. Weinberg, K. Neiswanger, M. L.<br />
Marazita.<br />
1316W A phenome-wide association study using<br />
multiple National Health and Nutrition Examination<br />
Surveys to identify pleiotropy. M. A. Hall, A. Verma, K.<br />
D. Brown-Gentry, R. Goodloe, J. Boston, S. Wilson, B.<br />
McClellan, C. Sutcliffe, H. H. Dilks, N. B. Gillani, H. Jin, P.<br />
Mayo, M. Allen, N. Schnetz-Boutaud, S. A. Pendergrass,<br />
D. C. Crawford, M. D. Ritchie.<br />
1317T Genetic variants in pigmentation genes, skin<br />
color, and risk <strong>of</strong> skin cancer in Japanese. T. Suzuki, Y.<br />
Abe, J. Yoshizawa, Y. Hozumi, T. Nakamura, G. Tamiya.<br />
1318F Validity <strong>of</strong> the Mendelian randomization<br />
approach: Do the principles really hold? M. Taylor, N. J.<br />
Timpson, J. P. Kemp, B. St. Pourcain, D. M. Evans, S. M.<br />
Ring, D. A. Lawlor, G. Davey Smith.<br />
1319W Polygenic modeling <strong>of</strong> healthy aging. N. E.<br />
Wineinger, G. Atzmon, N. Barzilai, N. J. Schork.<br />
1320T Extended haplotype association study in<br />
Crohn’s disease identifies a novel Ashkenazi Jewishspecific<br />
missense mutation in the NF- B pathway<br />
gene, HEATR3. K. Y. Hui, W. Zhang, A. Gusev, N. Warner,<br />
G. Nuñez, I. Pe’er, I. Peter, J. H. Cho.<br />
1321F Association analysis <strong>of</strong> CYP2A6 polymorphism<br />
in SIDS. Y. Inaoka, M. Nakatome, F. Satoh, I. Hasegawa,<br />
M. Q. Fujita, M. Osawa.<br />
1322W Do severity <strong>of</strong> early lung disease and meconium<br />
ileus in cystic fibrosis have common genetic<br />
contributors? W. Li, D. Su, T. Chiang, X. Li, M. R. Miller,<br />
K. Keenan, H. Corvol, F. A. Wright, S. Blackman, M. L.<br />
Drumm, G. R. Cutting, M. R. Knowles, P. R. Durie, J. M.<br />
Rommens, L. Sun, L. J. Strug.<br />
1323T Influence <strong>of</strong> host genetics and environment on<br />
nasal carriage <strong>of</strong> Staphylococcus aureus in Danish<br />
middle-aged and elderly twins. P. S. Andersen, J. K.<br />
Pedersen, P. Fode, R. L. Skov, V. G. Fowler, Jr., M. Stegger,<br />
K. Christensen.<br />
1324F Polygenes and estimated heritability <strong>of</strong> prostate<br />
cancer in an African <strong>American</strong> sample using GWAS<br />
data. J. He, G. Chen, B. Henderson, C. Haiman, D. Stram,<br />
Genome-Wide Association Studies <strong>of</strong> Prostate Cancer in<br />
African <strong>American</strong>s.<br />
1325W Using identity-by-descent information to detect<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
de novo and recent mutations in population-based<br />
exome-sequencing studies. N. Solovieff, M. Fromer, D.<br />
Ruderfer, J. Moran, K. Chambert, C. Hultman, P. Sullivan,<br />
H. Williams, E. Rees, P. Gormley, A. Palotie, G. Kirov, M.<br />
Owen, M. O’Donovan, P. Sklar, S. McCarroll, S. Purcell.<br />
1326T Mitochondrial DNA polymorphism 13704 (C/T)<br />
might induce hematologic malignancy predisposition<br />
in Turkish population. N. Duzkale, A. Tatar.<br />
1327F Significant association <strong>of</strong> LPL polymorphisms<br />
with HDL- cholesterol level in Tongan adults. I. Naka, R.<br />
Kimura, T. Inaoka, Y. Matsumura, J. Ohashi.<br />
1328W Personalized risk prediction for prostate cancer<br />
according to specific family history. L. Cannon-Albright,<br />
F. Albright, W. Lowrance, R. Stephenson.<br />
1329T Estimating disease risk from environmental<br />
and genetic factors to motivate behavioral changes.<br />
C. M. Lewis, J. M. Yarnall, G. H. M. Goddard, D. J. M.<br />
Crouch.<br />
1330F Improving celiac disease risk prediction by<br />
testing non-HLA variants additional to HLA variants.<br />
J. Romanos, A. Rosen, V. Kumar, G. Trynka, L. Franke,<br />
A. Szperl, J. Gutierrez-Achury, C. C. van Diemen,<br />
R. Kanninga, S. A. Jankipersadsing, A. K. Steck, G.<br />
Eisenbarth, D. A. van Heel, B. Cukrowska, V. Bruno, M. C.<br />
Mazzilli, C. Nunez, J. R. Bilbao, M. L. Mearin, D. Barisani,<br />
M. Rewers, J. Norris, A. Ivarsson, H. M. Boezen, E. Liu, C.<br />
Wijmenga, PreventCD Group.<br />
1331W Bayesian polygenic prediction <strong>of</strong> myocardial<br />
infarction risk and lipid levels. B. Vilhjalmsson, R. Do,<br />
E. A. Stahl, B. Pasaniuc, S. Pollack, N. Zaitlen, J. Yang,<br />
M. E. Goddard, P. M. Visscher, P. Kraft, N. Patterson, S.<br />
Kathiresan, A. L. Price.<br />
1332T Testing for the presence <strong>of</strong> liability models. C.<br />
Herold, T. Vaitsiakhovich, T. Becker.<br />
1333F Alcohol and aldehyde dehydrogenase<br />
polymorphisms and blood pressure elevation in<br />
Japanese over 20 years. M. Isomura, T. Wang, Y.<br />
Yoshida, T. Nabika.<br />
1334W The PPP6R3/LRP5 locus influences lean<br />
mass in children <strong>of</strong> different ethnic background<br />
and highlights pleiotropic effects on muscle-bone<br />
interactions. M. C. Medina Gomez, D. H. M. Heppe, K.<br />
Estrada, J. Van Meurs, A. H<strong>of</strong>man, Y.-H. Hsu, D. Karasik,<br />
V. W. V. Jaddoe, M. C. Zillikens, A. G. Uitterlinden, F.<br />
Rivadeneira, GEFOS Consortium.<br />
1335T Examining the interaction effect <strong>of</strong> SNPs<br />
associated with urinary bladder cancer. H. Schwender,<br />
S. Selinski, T. Stöcker, M. Blaszkewicz, R. Marchan, K.<br />
Ickstadt, K. Golka, J. Hengstler.<br />
1336F Multivariate modeling for a more powerful<br />
genetic association analysis. S. Eyheramendy, C. Meza.<br />
1337W Random-effects model for massive meta<br />
analysis in genome-wide association study with<br />
POSTER SESSIONS 165<br />
structured populations. E. Kang, N. Furlotte, B. Han, J.<br />
Joo, R. Davis, A. Lusis, E. Eskin.<br />
1338T Comparison <strong>of</strong> rare variant tests. J. Lihm, E. J.<br />
Yoon, H. Wu, T. Harris, C. Wong, J. Ceris, J. Weisburd, N.<br />
R. Mendell, W. Kim, K. Ahn, D. Gordon, S. J. Finch.<br />
1339F Artificial intelligence analysis <strong>of</strong> prostate cancer<br />
susceptibility using a pareto-optimized computational<br />
evolution system. J. H. Moore, D. P. Hill, A. Sulovari, L.<br />
Kidd.<br />
1340W A simple Bayesian method for modeling effect<br />
heterogenity across genetic studies. C. C. A. Spencer,<br />
P. J. Donnelly, M. Pirinen.<br />
1341T Effectively identifying and characterizing eQTLs<br />
from multiple tissues using a meta-analytic approach.<br />
J. Sul, B. Han, C. Ye, T. Choi, E. Eskin.<br />
1342F PEDF gene polymorphism (p.Met72Thr) analysis<br />
in diabetic retinopathy cases. S. Passan, V. Vanita.<br />
1343W Chromosome 10 gene may be associated to<br />
response to Leishmania antigens. L. Pereira, J. Pescarini,<br />
R. Ferreira, L. M. Camargo, H. Krieger, L. M. Garrido.<br />
1344T Genetic associations with essential amino acids<br />
in infants with patent ductus arteriosus. K. K. Ryckman,<br />
J. M. Dagle, O. A. Shchelochkov, S. L. Berberich, J. C.<br />
Murray.<br />
1345F Low frequency SNPs are associated with<br />
congenital and severe clinical phenotypes in an<br />
eectronic medical record. J. D. Mosley, D. M. Roden, J.<br />
D. Denny.<br />
1346W Rare variant testing for meta-analysis and<br />
survival analysis. H. Chen, T. Lumley, J. Dupuis, J. Brody,<br />
A. Morrison, B. Cornes, D. J. Lybarger, B. Davis, C. Sitlani,<br />
D. Siscovick, J. B. Meigs, L. A. Cupples.<br />
1347T Selection <strong>of</strong> sequence variants for quantitative<br />
traits using penalized regression: Using LASSO, LARS<br />
and elastic net in the tiled regression framework. Y.<br />
Kim, B. Suktitipat, A. J. M. Sorant, A. F. Wilson.<br />
1348F Identification <strong>of</strong> genome-wide SNPs that are<br />
informative for individual genetic heritage in the family<br />
investigation <strong>of</strong> nephropathy and diabetes. R. C.<br />
Williams, FIND Research Group.<br />
1349W Testing copy number variant/trait associations<br />
detected using Manhattan plots. G. A. Satten, D.<br />
Ramachandran, J. G. Mulle, A. S. Allen, L. J. H. Bean, C.<br />
Maslen, S. L. Sherman, R. H. Reeves, M. E. Zwick.<br />
1350T A novel collapsing method for rare copy number<br />
variants. J. P. Szatkiewicz, P. F. Sullivan, J. Y. Tzeng.<br />
1351F A pseudo-score-based meta-analysis in genetic<br />
association studies: Application to Mayo Genome<br />
Consortia data. E. Ryu, R. E. Gullerud, P. A. Decker, J.<br />
Pathak, P. J. Limburg, S. J. Bielinski.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
166 POSTER SESSIONS<br />
1352W Diacylglycerol kinase K variants impact<br />
hypospadias in a California study population. S. L.<br />
Carmichael, N. Mohammed, C. Ma, D. Iovannisci, S.<br />
Choudhry, L. S. Baskin, J. S. Witte, G. M. Shaw, E. J.<br />
Lammer.<br />
1353T GEEWAS: Family-based genome-wide<br />
association studies for non-normal responses. C.<br />
Ekstrom.<br />
1354F An multiple testing procedure for association<br />
studies appropriately incorporating admixture signals.<br />
G. Gao, W. Chen.<br />
1355W Correcting for population structure due to rare<br />
and common variants with an approximate Bayesian<br />
regression framework. G. E. H<strong>of</strong>fman, J. G. Mezey.<br />
1356T Unified association analysis <strong>of</strong> genes, regions<br />
or pathways containing multiple SNPs. L. C. Lazzeroni,<br />
A. Ray.<br />
1357F Genome-wide association study on the variation<br />
<strong>of</strong> quantitative trait as a tool to identify important<br />
genetic variants for related complex diseases: An<br />
example <strong>of</strong> CHD risk in T2D patients. Z. Liu, Q. Qi, F. Hu,<br />
L. Qi, L. Liang.<br />
1358W Power and sample size calculations for genetic<br />
association tests in the presence <strong>of</strong> pleiotropy. D.<br />
Londono, D. Gordon.<br />
1359T Using regression residuals to map association<br />
between genetic variants and environmentally<br />
influenced longitudinal phenotypes. A. Musolf, D.<br />
Londono, R. Wang, J. Brandon, J. A. Herring, C. A. Wise,<br />
H. Zou, M. Jin, L. Yu, S. J. Finch, T. C. Matise, D. Gordon.<br />
1360F Enabling mixed model association analysis<br />
for large case-control studies. A. Price, N. Zaitlen, B.<br />
Vilhjalmsson, T. Hayeck, S. Pollack, J. Yang, G. B. Chen,<br />
M. Goddard, P. Visscher, N. Patterson.<br />
1361W Accounting for parent-<strong>of</strong>-origin effects<br />
detects association between 4q35 genetic variants<br />
and combined asthma-plus-rhinitis phenotype. C.<br />
Sarnowski, G. Malerba, Q. Vincent, C. Laprise, K. Rohde,<br />
M. F. M<strong>of</strong>fatt, P. Margaritte-Jeannin, M.-H. Dizier, P. F.<br />
Pignatti, W. O. C. Cookson, M. Lathrop, F. Demenais, E.<br />
Bouzigon, EGEA Collaborative Group.<br />
1362T Evaluation <strong>of</strong> classical multivariate methods for<br />
gene-based tests <strong>of</strong> association with multiple related<br />
traits. Y. Shu, R. Watanabe, J. Lewinger.<br />
1363F A two-stage random forest approach to<br />
identify genetic variants using recombination hotspot<br />
information. S. Szymczak, Q. Li, Y. Kim, A. Dasgupta, J.<br />
D. Malley, J. E. Bailey-Wilson.<br />
1364W Effect size distribution for prioritizing results <strong>of</strong><br />
association studies. D. Zaykin, C.-L. Kuo.<br />
1365T Modeling multivariate and correlated data in<br />
genetic association analysis. J. H. Zhao, F. Xue, Q. Tan,<br />
S. Li, J. A. Luan.<br />
1366F A novel spatial mapping method identifies<br />
shared genetic effects across immune-mediated<br />
diseases. C. Cotsapas, J. Kasvin-Felton.<br />
1367W Adjust local ancestry to detect rare variants in<br />
next-generation sequencing data. X. Wang, X. Zhao.<br />
1368T Detecting association for low-frequency variants<br />
in case-control studies. C. Xing, C. Y. Lin.<br />
1369F The empirical assessment <strong>of</strong> statistical power <strong>of</strong><br />
rare variant association methods. K. Hao, H. Chen, H.<br />
Zhou, Z. Kan, H. Zheng, X. Liu, S. Li, T. Barber, Z. Gong,<br />
H. Gao, M. Willard, J. Xu, R. Hauptschein, P. Rejto, G.<br />
Wang, Q. Zhang, R. Cheng, K. Sung, Z. Peng, C. Zhang,<br />
Q. Zhang, R. Poon, S. Fan, J. Wang, J. Hardwick, C.<br />
Reinhard, Y. Li, J. Luk, M. Mao, H. Dai.<br />
1370W Rare variant burden tests and meta-analysis<br />
using summary level statistics. D. Liu, G. Abecasis.<br />
1371T A geometric framework for the evaluation <strong>of</strong><br />
rare variant tests <strong>of</strong> association. N. Tintle, K. Liu, S.<br />
Fast, M. Zawistowski.<br />
1372F Subset-based approach to combined genetic<br />
association analysis <strong>of</strong> heterogeneous phenotypes. S.<br />
Bhattacharjee, S. M. Boca, P. Rajaraman, K. B. Jacobs,<br />
W. A. Wheeler, B. S. Melin, P. Hartge, M. Yeager, C.<br />
C. Chung, S. J. Chanock, N. Chatterjee, GliomaScan<br />
Consortium.<br />
1373W Genome-wide significance thresholds for SNPs<br />
ascertained by sequencing. T. Blackwell, A. K. Manning,<br />
GoT2D Investigators.<br />
1374T On the analysis <strong>of</strong> imputed genotypes in familybased<br />
association studies. A. Cobat, A. Alcaïs, E. Schurr.<br />
1375F Sex-specific and X-chromosome association<br />
studies <strong>of</strong> venous thromboembolism. M. de Andrade, S.<br />
M. Armasu, L. L. Chan, J. A. Heit.<br />
1376W Correcting for the effect <strong>of</strong> cryptic relatedness<br />
and population structure among cohorts in metaanalysis<br />
<strong>of</strong> GWAS. T. Feng, N. Morris, X. Zhu.<br />
1377T Genome-wide association study-identified<br />
genetic variants for lipid traits are associated with<br />
gallstone disease in the diverse Third National Health<br />
and Nutrition Examination Survey. R. Goodloe, K.<br />
Brown-Gentry, N. Gillani, H. Jin, P. Mayo, M. Allen, B.<br />
McClellan, J. Boston, C. Sutcliffe, N. Schnetz-Boutaud, H.<br />
Dilks, D. Crawford.<br />
1378F A unified framework for testing for genetic<br />
associations integrating environmental exposures. S.<br />
S. Han, P. S. Rosenberg, N. Chatterjee.<br />
1379W Efficient association analysis for groups <strong>of</strong><br />
genetic markers that avoids confounding by genetic<br />
structure. D. Heckerman, C. Lippert, J. Listgarten.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1380T A non-threshold region-specific method for<br />
detecting rare variants in common diseases. A. R.<br />
Hsieh, C. C. Chang, C. S. J. Fann.<br />
1381F Joint admixture and association test on African<br />
<strong>American</strong> inflammatory bowel disease identifies<br />
novel significant loci. C. Huang, S. Kugathasan, D. P.<br />
McGovern, J. H. Cho, R. H. Duerr, J. D. Rioux, M. S.<br />
Silverberg, T. Dassopoulos, L. W. Datta, L. W. H. Kao, S.<br />
R. Brant.<br />
1382W Comparison <strong>of</strong> phylogenetic and haplotype<br />
methods for the study <strong>of</strong> genotype/phenotype<br />
association in genome-wide studies. M. G. Johnson, D.<br />
L. Sw<strong>of</strong>ford, M. W. Lutz, D. G. Crenshaw, A. D. Roses.<br />
1383T Benefits <strong>of</strong> using local whole exome reference<br />
panels for the imputation <strong>of</strong> rare variants in two<br />
European populations. P. Joshi, R. M. Fraser, V. Vitart, C.<br />
Hayward, R. McQuillan, O. Polasek, S. H. Wild, N. Hastie,<br />
A. F. Wright, H. Campbell, I. Rudan, C. Haley, P. Navarro,<br />
J. F. Wilson.<br />
1384F Combined linkage and association analyses<br />
identify a novel locus for obesity near PROX1 in Asians.<br />
H. Kim, Y. Yoo, Y. Ju, S. Lee, S. Cho, J. Sung, J. Kim, J.<br />
Seo.<br />
1385W A more powerful burden tests to detect rare<br />
genetic variants. J. Kim, J. Lee, S. Choi, M. S. Kwon,<br />
T. Park.<br />
1386T Efficiently identifying significant associations in<br />
genome-wide association studies. E. Kostem, E. Eskin.<br />
1387F A multi-SNP locus-association method reveals<br />
a substantial fraction <strong>of</strong> the missing heritability. Z.<br />
Kutalik, G. Ehret, D. Lamparter, C. Hoggart, J. Whittaker, J.<br />
S. Beckmann, GIANT Consortium.<br />
1388W Leveraging input and output structures for joint<br />
association mapping <strong>of</strong> epistatic and marginal eQTLs.<br />
S. Lee, E. Xing.<br />
1389T Evaluating the power <strong>of</strong> single variant<br />
association tests for low frequency variants in joint<br />
and meta-analysis. C. Ma, T. Blackwell, M. Boehnke, L. J.<br />
Scott, GoT2D Investigators.<br />
1390F One thousand genomes imputation in the NCI<br />
Breast and Prostate Cancer Cohort Consortium (BPC3)<br />
aggressive prostate cancer genome-wide association<br />
study. M. J. Machiela, C. Chen, L. Liang, W. R. Diver, V. L.<br />
Stevens, K. K. Tsilidis, S. J. Chanock, D. J. Hunter, P. Kraft,<br />
NCI Breast and Prostate Cancer Cohort Consortium.<br />
1391W SHAVE—Shrinkage estimator measured for<br />
multiple visits increases power in GWAS <strong>of</strong> quantitative<br />
traits. O. Meirelles, J. Ding, T. Tanaka, S. Sanna, H. Yang,<br />
D. B. Dudekula, F. Cucca, L. Ferrucci, G. Abecasis, D.<br />
Schlessinger.<br />
1392T To adjust or not to adjust, how and when to<br />
incorporate covariates into GWA studies. G. P. Page, N.<br />
Garge, E. O. Johnson.<br />
POSTER SESSIONS 167<br />
1393F Refining association mapping in a<br />
heterogeneous population: An example in a<br />
schizophrenia case-control study. A. Ray, L. C.<br />
Lazzeroni.<br />
1394W Improved heritability estimation from genomewide<br />
SNP data with application to epilepsy. D. Speed,<br />
G. Hemani, M. Johnson, D. Balding.<br />
1395T GLOMS: A mixed model-score test-based<br />
system for association studies <strong>of</strong> binary traits with<br />
risk covariates in populations <strong>of</strong> related individuals. S.<br />
Stanhope, M. Abney.<br />
1396F Tiled regression improves the false discovery<br />
rate in genome-wide association studies. B. Suktitipat,<br />
Y. Kim, A. J. M. Sorant, H. Sung, A. F. Wilson.<br />
1397W Gene-based association tests using dimension<br />
reduction methods and marker correlation structure.<br />
D. M. Swanson, C. Lange.<br />
1398T Impact <strong>of</strong> hidden sample structure on meta- and<br />
joint-analysis in genome-wide association studies. P. J.<br />
Walter, H. M. Kang.<br />
1399F Natural and orthogonal association framework<br />
to detect parent-<strong>of</strong>-origin effects. F. Xiao, J. Ma, C.<br />
Amos.<br />
1400W Efficient calculation for multi-SNP genetic risk<br />
scores. T. Johnson.<br />
1401T Gene-gene co-association and pathwaybased<br />
co-association studies for next-generation<br />
sequencing. L. Luo, M. Xiong.<br />
1402F May consanguinity between parents be a risk<br />
factor for insulin resistance in childhood obesity?<br />
Role <strong>of</strong> mitochondrial uncoupling protein 2 gene<br />
polymorphism. S. Oguzkan Balci, N. Col-Araz, M. Nacak,<br />
M. Araz, S. Halime, A. Balat, S. Pehlivan.<br />
1403W A gene-based association statistic for metaanalysis.<br />
P. Chanda, H. Huang, A. Alonso, J. S. Bader, D.<br />
E. Arking.<br />
1404T Joint testing <strong>of</strong> rare and common variants in<br />
admixed populations. H. Qin, J. Li, H.-W. Deng.<br />
1405F The role <strong>of</strong> KIR genes polymorphisms in<br />
Brazilian patients with rheumatoid arthritis and<br />
systemic lupus erythematosus. A. R. Marrero, T. D. J.<br />
Farias, C. C. Coêlho, L. D. Hausmann, D. G. Augusto, M.<br />
L. Petzl-Erler, I. A. Pereira, A. F. Zimmermann, S. C. M. S.<br />
Fialho, Y. C. N. Muniz, I. R. Souza.<br />
1406W Genome-wide linkage, association and gene<br />
expression analysis <strong>of</strong> antibody levels against 13<br />
common infections. R. Rubicz, R. Yolken, E. Drigalenko,<br />
M. A. Carless, T. D. Dyer, P. E. Melton, J. W. Kent, Jr.,<br />
R. Duggirala, J. E. Curran, M. P. Johnson, S. A. Cole,<br />
L. Almasy, E. K. Moses, N. V. Dhurandhar, E. Kraig, J.<br />
Blangero, C. T. Leach, H. H. H. Goring.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
168 POSTER SESSIONS<br />
1407T Combining affected families, independent<br />
cases, and controls to obtain a single, more powerful<br />
test <strong>of</strong> association. W. Stewart, J. Cerise.<br />
1408F Mixture modeling <strong>of</strong> rare variant association<br />
within exome sequencing data. B. A. Logsdon, J. Y.<br />
Dai, P. L. Auer, S. K. Ganesh, N. L. Smith, J. G. Wilson,<br />
T. A. Graubert, R. P. Tracy, L. A. Lange, H. Tang, S. Rich,<br />
G. Lettre, C. S. Carlson, R. Jackson, C. O’Donnell, M.<br />
M. Wurfel, D. A. Nickerson, C. Kooperberg, A. P. Reiner,<br />
NHLBI Exome Sequencing Project, Exome Sequencing<br />
Project Blood Counts Project Team.<br />
1409W Detecting association <strong>of</strong> rare variants by<br />
testing an optimally weighted combination <strong>of</strong><br />
variants in family-based designs. Q. Sha, S. Fang, S.<br />
Zhang.<br />
1410T Haplotype-based methods for detecting<br />
uncommon causal variants with common SNPs. N. Liu,<br />
W. Lin, N. Yi, D. Zhi, K. Zhang, G. Gao, H. Tiwari.<br />
1411F Multivariate adjusted sequence kernel<br />
association test for rare variants controlling for cryptic<br />
and family relatedness. K. Oualkacha, R. Li, B. Richards,<br />
A. Ciampi, C. Greenwood, UK10K Cohorts Goup.<br />
1412W Robust and powerful tests for rare variants<br />
using Fisher’s method to combine evidence <strong>of</strong><br />
association from two or more complementary tests. A.<br />
Derkach, J. F. Lawless, L. Sun.<br />
1413T Leveraging family history in genome-wide<br />
association studies. A. Ghosh, S. Wacholder, P. Hartge,<br />
M. Purdue, S. Chanock, N. Chatterjee.<br />
1414F Identifying environmental exposures for geneenvironment<br />
investigations using LASSO penalized<br />
regression methods. E. Mowry, X. Shao, F. B. S. Briggs,<br />
B. Acuna, L. Shen, A. Bernstein, C. Schaefer, L. F.<br />
Barcellos.<br />
1415W Application <strong>of</strong> targeted maximum likelihood<br />
estimation using genome-wide association data<br />
reveals new genetic predictors <strong>of</strong> disease severity in<br />
multiple sclerosis. X. Shao, M. van der Laan, F. Briggs,<br />
P. De Jager, L. Barcellos, International Multiple Sclerosis<br />
<strong>Genetics</strong> Consortium.<br />
1416T Case-sibling studies that acknowledge<br />
unstudied parents and enroll unmatched individuals.<br />
M. Shi, D. M. Umbach, C. R. Weinberg.<br />
1417F A variable-selection-based novel statistical<br />
approach to identify susceptible rare variants<br />
associated with complex diseases with deep<br />
sequencing data. H. Sun, S. Wang.<br />
1418W Causal-Seek: A strategy for finding causal<br />
variants via trans-ethnic fine-mapping. X. Wang, Y. Teo.<br />
1419T Novel insights into the genetics <strong>of</strong> Parkinson’s<br />
disease on chromosome 17. W. W. S. Lau.<br />
1420F Joint statistical modeling <strong>of</strong> multiple phenotypes<br />
in samples with related individuals. Z. Wang.<br />
1421W Association <strong>of</strong> three polymorphisms <strong>of</strong> IL-18<br />
genes (137G/C, 607C/A,133C/G) in patients with<br />
allergic rhinitis in the Iranian population. S. Ramazi,<br />
M. Motovalibashi, H. Khazraei, M. Hashemzadeh<br />
Chaleshtori.<br />
1422T Accounting for population stratification in DNA<br />
methylation studies. R. T. Barfield, L. M. Almli, V. Kilaru,<br />
A. K. Smith, K. B. Mercer, T. Klengel, D. Mehta, E. B.<br />
Binder, K. J. Ressler, K. N. Conneely.<br />
1423F Genetic case-control matching strategies for<br />
rare-variants analysis in genome-wide association<br />
studies. A. Lacour, T. Becker.<br />
1424W Ancestry informative principal components<br />
analysis in structured samples with known or cryptic<br />
relatedness. T. Thornton, M. Conomos.<br />
1425T Admixture and association mapping identifies<br />
marker in FAM19A2 associated with FEV 1 /FVC in<br />
African <strong>American</strong>s. M. M. Parker, M. G. Foreman, R. A.<br />
Mathias, T. H. Beaty, C. R. Gignoux, E. G. Burchard, J.<br />
B. Hetmanski, E. K. Silverman, J. D. Crapo, COPDGene<br />
Investigators.<br />
1426F The gamma method for gene set analysis <strong>of</strong><br />
RNA-seq data: Simulation results and application to a<br />
smallpox vaccine study. B. L. Fridley, G. D. Jenkins, D.<br />
E. Grill, J. M. Biernacka, R. B. Kennedy, G. A. Poland, A.<br />
L. Oberg.<br />
1427W Evaluation <strong>of</strong> SNP and indel imputation quality<br />
using reference haplotypes from the 1000 Genomes<br />
Project. Q. Duan, E. Y. Liu, K. L. Mohlke, D. C. Croteau-<br />
Chonka, Y. Li.<br />
1428T An efficient design to detect transplant donor<br />
and recipient genetic interactions. W. Guan, A. K. Israni.<br />
1429F Dissecting features <strong>of</strong> causal variants. S.<br />
Sengupta, X. Wen, G. Abecasis.<br />
1430W Genetic programming for detecting interactions<br />
<strong>of</strong> SNPs with fuzzy genotypes in association studies. T.<br />
Stöcker, H. Schwender.<br />
1431T Rare variant analysis for family-based design. W.<br />
Yip, G. De, I. Ionita-Lazza, N. Laird.<br />
1432F BMI trajectory from early childhood associates<br />
with leukocyte telomere length in Northern Finnish<br />
women. S. Das, J. L. Buxton, A. Rodriguez, A. Couto, M.<br />
Kaakinen, S. Sebert, P. O’Reilly, L. Coin, A. I. F. Blakemore,<br />
M.-R. Jarvelin.<br />
1433W A model for combining data on de novo<br />
mutations with case-control data to identify risk<br />
genes. X. He, S. Sanders, L. Liu, M. State, B. Devlin, K.<br />
Roeder.<br />
1434T Variable selection in high-dimensional meta-<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
analysis for genetic data. Q. He, H. Zhang, D. Y. Lin, C.<br />
L. Avery.<br />
1435F Integrative approaches for genetic association<br />
studies via Bayesian model uncertainty. M. A. Quintana,<br />
D. V. Conti.<br />
1436W Meta-analysis <strong>of</strong> co-regulated subnetworks<br />
in transciptomics data: Towards functional marker<br />
pr<strong>of</strong>iles <strong>of</strong> human aging. E. B. van den Akker, W. M.<br />
Passtoors, E. W. van Zwet, J. J. Goeman, M. Hulsman, V.<br />
Emilsson, M. Perola, B. T. Heijmans, A. B. Maier, J. N. Kok,<br />
P. E. Slagboom, M. J. T. Reinders, M. Beekman.<br />
1437T Integrative analysis <strong>of</strong> sequencing and GWAS<br />
data improves statistical power in detecting rare<br />
variants associated with complex diseases. Y. J. Hu, Y.<br />
Li, L. A. Lange, E. M. Lange, C. Bizon, P. L. Auer, G. Heiss,<br />
C. Kooperberg, N. Franceschini, U. Peters, A. P. Reiner, L.<br />
Hsu, S. Jiao, C. S. Carlson, K. E. North, D. Y. Lin, NHLBI<br />
GO Exome Sequencing Project.<br />
1438F Regionally-smoothed meta-analysis for GWAS<br />
studies. F. Begum, E. Feingold.<br />
1439W Phenotype mapping using Information Explorer.<br />
Y. Arens, J. L. Ambite, C. N. Hsu, L. Lange, S. Sharma, S.<br />
Voinea.<br />
1440T Data reduction techniques to construct new<br />
cellular and whole system biomarkers for aging.<br />
A. Brown, Z. Ding, L. Parts, D. Glass, D. Knowles, P.<br />
Deloukas, E. Dermitzakis, M. McCarthy, T. Spector, J.<br />
Winn, R. Durbin, MuTHER Consortium.<br />
1441F Prioritization <strong>of</strong> next-generation sequencing<br />
variants using data visualization. A. Bigelow, M. Meyer,<br />
N. J. Camp.<br />
1442W Integrating genome-wide gene expression<br />
and genotype data to predict HDL cholesterol levels<br />
in the Cholesterol and Pharmacogenetic Study. E.<br />
Holzinger, S. Dudek, A. Frase, M. Medina, R. Krauss, M.<br />
Ritchie.<br />
1443T ATOMIC : Assess genotype calling quality using<br />
R or Affymetrix’ genotyping console s<strong>of</strong>tware. A.<br />
Ziegler, A. Schillert.<br />
1444F Single center experience with peripheral blood<br />
gene expression pr<strong>of</strong>iling in a large cardiovascular<br />
cohort. E. Burns, S. Feng, C. Haynes, K. Abramson, M.<br />
Chryst-Ladd, E. R. Hauser, L. K. Newby, S. G. Gregory, W.<br />
E. Kraus, S. H. Shah.<br />
1445W Best practices and joint calling <strong>of</strong> the Illumina<br />
<strong>Human</strong>Exome BeadChip: The CHARGE consortium.<br />
M. L. Grove, B. J. Cochran, T. Haritunians, J. C. Bis,<br />
K. D. Taylor, M. Hansen, C. J. O’Donnell, J. I. Rotter,<br />
E. Boerwinkle, CHARGE Exome Chip Genotyping<br />
Committee.<br />
1446T A supervised approach for filtering and<br />
genotyping high quality short indels from nextgeneration<br />
sequencing data. A. Tan, H. M. Kang.<br />
POSTER SESSIONS 169<br />
1447F Merging genomic data for research in the<br />
Electronic MEdical Records and GEnomics Network:<br />
Lessons learned in eMERGE. M. D. Ritchie, S. Setia, G.<br />
Armstrong, L. Armstrong, Y. Bradford, D. C. Crawford, D.<br />
R. Crosslin, M. de Andrade, K. Doheny, M. G. Hayes, G.<br />
Jarvik, I. J. Kullo, R. Li, T. Manolio, M. Matsumoto, C. A.<br />
McCarty, D. Mirel, S. Nelson, L. Olson, E. Pugh, S. Purcell,<br />
G. Tromp, J. L. Haines.<br />
1448W Detecting sample contamination. M. Flickinger,<br />
G. Jun, K. F. Doheny, J. Romm, K. N. Hetrick, G. R.<br />
Abecasis, M. Boehnke, H. M. Kang.<br />
1449T Regression models to ‘explain’ departure from<br />
Hardy-Weinberg equilibrium. D. J. Schaid, J. P. Sinnwell,<br />
G. D. Jenkins.<br />
1450F SNP genotyping is a valuable tool for assessing<br />
the quality <strong>of</strong> next-generation sequencing data. J. Park,<br />
B. Vecchio-Pagán, H. Cuppens, G. Cutting.<br />
1451W Imputation quality thresholds for rare and<br />
common variants. G. Pistis, C. Sidore, A. Mulas, M.<br />
Zoledziewska, R. Berutti, F. Reinier, M. F. Urru, A. Maschio,<br />
M. Marcelli, A. Angius, C. Jones, G. Abecasis, S. Sanna,<br />
F. Cucca.<br />
1452T Error rates for very low MAF SNPs on the<br />
Illumina exome array. E. W. Pugh, H. Ling, J. M. Romm, I.<br />
A. McMullen, J. R. Huyghe, M. Boehnke, K. F. Doheny.<br />
1453F An algorithm for identifying high-order genegene<br />
interactions from pairwise statistical epistasis<br />
networks. T. Hu, A. S. Andrews, M. R. Karagas, J. H.<br />
Moore.<br />
1454W Fine-mapping in a covariate-based genomewide<br />
linkage scan <strong>of</strong> lung cancer susceptibility. C. L.<br />
Simpson, T. Green, B. Doan, C. I. Amos, S. M. Pinney, E.<br />
Y. Kupert, M. de Andrade, P. Yang, A. G. Schwartz, P. R.<br />
Fain, A. Gazdar, J. Minna, J. S. Wiest, H. Rothschild, D.<br />
Mandal, M. You, T. A. Coons, C. Gaba, M. W. Anderson, J.<br />
E. Bailey-Wilson.<br />
1455T Meta-analysis <strong>of</strong> 2,526 individuals demonstrates<br />
strong evidence for gene-environment interaction<br />
between NAT1 and tobacco smoke exposure in<br />
multiple sclerosis. F. B. S. Briggs, B. Acuna, L. Shen, P.<br />
Ramsay, H. Quach, A. Bernstein, I. Kockum, L. Alfredsson,<br />
T. Olsson, C. Schaefer, L. F. Barcellos.<br />
1456F Algebraic satistics and Markov bases in geneenvironment<br />
interactions. M. Rao, S. Venkatesan.<br />
1457W AprioriGWAS, a frequent itemset mining<br />
approach, detects angiogenesis gene interacting with<br />
CFH in age-related macular degeneration. Q. Zhang,<br />
Q. Long.<br />
1458T Genotype-by-environment interaction for<br />
multivariate environments using the Mahalanobis<br />
distance. V. P. Diego, H. H. H. Göring, J. Blangero.<br />
1459F Interactions between maternal genotypes<br />
and metabolites are associated with incidence <strong>of</strong><br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
170 POSTER SESSIONS<br />
congenital heart defects. S. Erickson, S. Chowdhury, S.<br />
L. MacLeod, M. A. Cleves, S. Melnyk, S. J. James, P. Hu,<br />
C. A. Hobbs.<br />
1460W A unified generalized multifactor reduction<br />
method for detecting gene-gene interactions in family<br />
and unrelated samples with application to nicotine<br />
dependence. X. Lou, G. Chen, N. Liu, Y. Klimentidis, X.<br />
Zhu, D. Zhi, X. Wang.<br />
1461T The 5p15 locus is associated with bronchial<br />
hyperresponsiveness in siblings unexposed to tobacco<br />
smoke in early life in French families ascertained<br />
through asthma. R. Nadif, P. Margaritte-Jeannin, E.<br />
Bouzigon, F. Kauffmann, M. Lathrop, F. Demenais, M.-H.<br />
Dizier.<br />
1462F Systematic identification <strong>of</strong> interaction effects<br />
between genome- and environment-wide associations<br />
in type 2 diabetes mellitus. C. J. Patel, R. Chen, K.<br />
Kodama, J. P. A. Ioannidis, A. J. Butte.<br />
1463W A new Bayesian framework for detecting geneenvironment<br />
interaction. X. Wen, M. Stephens, P. Zheng.<br />
1464T Overlapping G x G interactions associated with<br />
caries in permanent and primary dentition. K. Cuenco,<br />
M. K. Lee, Z. Zeng, J. R. Shaffer, X. Wang, E. Feingold,<br />
D. E. Weeks, S. M. Levy, R. J. Weyant, R. J. Crout, D. W.<br />
McNeil, M. L. Marazita.<br />
1465F Associations and interactions <strong>of</strong> genetic<br />
polymorphisms in innate immunity genes with early<br />
viral infections and susceptibility to asthma and<br />
asthma-related phenotypes. D. Daley, J. E. Park, J. He,<br />
J. Yan, L. Akhabir, D. Stefanowicz, A. B. Becker, M. Chan-<br />
Yeung, Y. Bossé, A. L. Kozyrskyj, A. L. James, A. W. Musk,<br />
C. Laprise, R. G. Hegele, P. D. Paré, A. J. Sandford.<br />
1466W Evidence for genetic interactions beyond<br />
variability explained by single SNPs in ulcerative<br />
colitis. M. H. Wang, X. Zhu, R. H. Duerr, C. Fiocchi, J. P.<br />
Achkar, Wellcome Trust Case Control Consortium.<br />
1467T Influence <strong>of</strong> SNPxSNP interaction on BMI in<br />
European <strong>American</strong> adolescents: Findings from the<br />
National Longitudinal Study <strong>of</strong> Adolescent Health. K.<br />
L. Young, M. Graff, K. E. North, A. S. Richardson, L. A.<br />
Lange, E. M. Lange, K. M. Harris, P. Gordon-Larsen.<br />
1468F Analyzing genome-wide SNP interactions using<br />
the Random Forest Fishing method. W. Yang, J. Chu,<br />
C. C. Gu.<br />
1469W Hunting for rare genetic variants in a complex<br />
disease? Do not forget about gene-environment<br />
interactions! R. Kazma, J. Witte.<br />
1470T Searching for an enrichment <strong>of</strong> genetic<br />
interaction signals in SNPs within known proteinprotein<br />
interactions. J. E. Mollon, B. Lehne, S. Sacks, T.<br />
Schlitt, M. E. Weale.<br />
1471F RAPID detection <strong>of</strong> gene-gene interactions<br />
underlying quantitative traits. N. Udpa, V. Bafna.<br />
1472W Evidence <strong>of</strong> gene-environment interaction for<br />
the chromosome 4 and environmental tobacco smoke<br />
in controlling the risk <strong>of</strong> cleft lip with/without cleft<br />
palate. T. Wu, I. Ruczinski, J. C. Murray, M. L. Marazita,<br />
R. G. Munger, J. B. Hetmanski, T. Murray, R. J. Redett, M.<br />
D. Fallin, K. Y. Liang, P. J. Patel, S. C. Jin, T. X. Zhang, H.<br />
Schwender, Y. H. Wu-Chou, P. K. Chen, S. S. Chong, F.<br />
Cheah, V. Yeow, X. Ye, H. Wang, S. Huang, E. W. Jabs, B.<br />
Shi, A. J. Wilcox, R. T. Lie, S. H. Jee, K. Christensen, A. F.<br />
Scott, T. H. Beaty.<br />
1473T Pathway-based analysis <strong>of</strong> gene-gene<br />
interactions for complex diseases. J. G. Zhang, J. Li, H.<br />
W. Deng.<br />
1474F Identification <strong>of</strong> host gene-gene interaction in<br />
saliva flow and Streptococcus mutans using MDR.<br />
M. Lee, K. T. Cuenco, Z. Zeng, X. Wang, J. R. Shaffer, E.<br />
Feingold, D. E. Weeks, R. J. Weyant, R. J. Crout, D. W.<br />
McNeil, M. L. Marazita.<br />
1475W Meta-analysis <strong>of</strong> gene by gene interaction. R. G.<br />
H<strong>of</strong>fmann, K. Yan, T. J. H<strong>of</strong>fmann, P. Simpson.<br />
1476T Identification <strong>of</strong> gene-gene interactions for<br />
Alzheimer disease using cooperative game theory.<br />
B. Vardarajan, G. Jun, R. Mayeux, J. L. Haines, M. A.<br />
Pericak-Vance, G. Schellenberg, K. L. Lunetta, L. A. Farrer,<br />
Alzheimer’s Disease <strong>Genetics</strong> Consortium.<br />
1477F Overestimation <strong>of</strong> relatedness in admixed and<br />
ancestrally heterogeneous populations using method<br />
<strong>of</strong> moments estimation. J. Morrison.<br />
1478W Genome-wide patterns <strong>of</strong> identity-by-descent<br />
sharing in the French Canadian founder population. H.<br />
Gauvin, C. Moreau, J.-F. Lefebvre, H. Vézina, D. Labuda,<br />
M.-H. Roy-Gagnon.<br />
1479T Identity-by-descent-based heritability analysis<br />
in the Northern Finland Birth Cohort. S. R. Browning, B.<br />
L. Browning.<br />
1480F Efficient and flexible IBD mapping in genomewide<br />
association studies based on graph representation<br />
<strong>of</strong> IBD information. B. Han, E. Y. Kang, V. Ramensky, N.<br />
Freimer, J. Scharf, C. Mathews, D. Yu, A. Ruiz-Linares, G.<br />
Rouleau, N. Cox, D. Pauls, E. Eskin, TSAICG.<br />
1481W Optimization <strong>of</strong> sequencing studies in<br />
population isolates using shared ancestral haplotypes.<br />
D. Glodzik, P. Navarro, V. Vitart, R. McQuillan, S. Wild, H.<br />
Campbell, A. Wright, J. Wilson, P. McKeigue.<br />
1482T Novel statistical model and computational<br />
methods for predicting HLA alleles from dense<br />
genotype data. Y. Guan, Y. Shen.<br />
1483F Haplotype clusters <strong>of</strong> rare variants in Korean<br />
genomes. S. Hochreiter, G. Klambauer, G. Povysil, D.-A.<br />
Clevert.<br />
1484W Evaluation <strong>of</strong> different phasing and imputation<br />
strategies in an isolated population with a mixture<br />
<strong>of</strong> unrelated individuals and extended pedigrees. J.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
O’Connell, O. Delaneau, N. Pirastu, S. Ulivi, P. Gasparini,<br />
J. Marchini.<br />
1485T Local ancestry inference using identity by<br />
descent. Z. Cai, B. L. Browning, S. R. Browning.<br />
1486F Detection <strong>of</strong> identity by descent based on rare<br />
variants. G. Povysil, G. Klambauer, S. Hochreiter.<br />
1487W Refined IBD: A new method for detecting<br />
identity by descent in population samples. B. L.<br />
Browning, S. R. Browning.<br />
1488T IBD estimation with whole-genome sequence<br />
data. L. Han, M. Abney.<br />
1489F Evaluating type 1 error and power for<br />
association and linkage in large complex pedigrees. A.<br />
C. Cummings, E. Torstenson, M. F. Davis, L. N. D’Aoust,<br />
W. K. Scott, M. A. Pericak-Vance, W. S. Bush, J. L. Haines.<br />
1490W Loss-<strong>of</strong>-co-homozygosity mapping: a novel<br />
non-parametric linkage analysis leveraging exome<br />
sequencing data. Y. Okada, N. Gupta, D. Mirel, S. Gabriel,<br />
T. Arayssi, F. Mouassess, W. A. L. Achkar, L. A. Kazkaz, R.<br />
M. Plenge.<br />
1491T Patterns <strong>of</strong> indel variation: Comparison <strong>of</strong><br />
calling methods and LD with SNPs. K. Huang, M. Ehm,<br />
N. Bing, Y. Liu, J. Xu, A. Slater, D. Fraser, J. Novembre, J.<br />
Li, M. Neison, Y. Li.<br />
1492F Estimating disease associations with common,<br />
low-risk alleles using pedigree data: Applications to<br />
breast cancer. D. R. Barnes, D. Barrowdale, J. Hopper, D.<br />
Goldgar, G. Chenevix-Trench, A. C. Antoniou, G. Mitchell,<br />
kConFab Investigators, AOCS Group.<br />
1493W Improving association tests by learning mode<br />
<strong>of</strong> inheritance from parental data. Z. Yu, D. Gillen, C. Li,<br />
M. Demetriou.<br />
1494T Enhanced maternal origin <strong>of</strong> the 22q11.2<br />
deletion in velo-cardio-facial/DiGeorge syndrome. M.<br />
Delio, T. Guo, D. McDonald-McGinn, E. Zackai, S. Herman,<br />
A. Higgins, K. Coleman, T. Wang, A. Auton, R. Shprintzen,<br />
B. Emanuael, B. Morrow.<br />
1495F Connection between heritability and polygenic<br />
risk score: Implications for the genetic architecture <strong>of</strong><br />
complex traits. V. V. Trubetskoy, E. R. Gamazon, M. E.<br />
Dolan, N. J. Cox, H. K. Im.<br />
1496W Genetic variants in DNA repair pathway genes<br />
and upper aerodigestive tract cancers: Combined<br />
analysis <strong>of</strong> data from genome-wide association<br />
studies. M.-C. Babron, R. Kazma, V. Gaborieau, J. D.<br />
McKay, P. Brennan, A. Sarasin, S. Benhamou, INHANCE<br />
Consortium.<br />
1497T Venous thromboembolism-susceptibility<br />
pathways by gene set analyses. J. Heit, S. M. Armasu, J.<br />
P. Sinnwell, D. J. Schaid, M. de Andrade.<br />
POSTER SESSIONS 171<br />
1498F Genetic pathways for ADHD show association to<br />
hyperactive/impulsive symptoms. A. Arias Vásquez, J.<br />
Bralten, B. Franke, I. Waldan, S. Faraone, J. Buitelaar.<br />
1499W Graphical models and intervention calculus for<br />
causal inference <strong>of</strong> genetic epidemiology studies. P.<br />
Wang, L. Jin, M. Xiong.<br />
1500T Multi-SNP analysis <strong>of</strong> GWAS reveals important<br />
gene-gene interactions and gene networks implicated<br />
in breast cancer. L. Briollais, A. Dobra, H. Massam, H.<br />
Ozcelik.<br />
1501F Connecting genome-wide association studies<br />
with a biological gene interaction network to<br />
uncover epistasis. D. S. Himmelstein, J. S. Witte, O. G.<br />
Troyanskaya, C. S. Greene.<br />
1502W Gene-based collapsing methods may not be<br />
powerful for pathway-based association analysis for<br />
exome sequencing data. G. Wu, D. Zhi.<br />
1503T Gene function prediction based on 80,000<br />
expression samples identifies downstream effects<br />
<strong>of</strong> many trait-associated SNPs in an eQTL dataset<br />
<strong>of</strong> 5,311 samples. J. Karjalainen, H. Westra, R. S. N.<br />
Fehrmann, T. Esko, M. J. Peters, E. M. Festen, G. J. te<br />
Meerman, S. B. Felix, H. Yaghootkar, J. Kettunen, M. W.<br />
Christiansen, A. H<strong>of</strong>man, F. Rivadeneira, E. Reinmaa, R.<br />
C. Jansen, J. Brody, S. A. Gharib, A. Suchy-Dicey, D.<br />
Enquobahrie, A. G. Uitterlinden, C. Wijmenga, B. M. Psaty,<br />
S. Ripatti, T. Frayling, A. Teumer, A. Metsepalu, J. B. J. van<br />
Meurs, L. Franke.<br />
1504F Constructing biological network using RNA-seq<br />
data. Y. Choi, M. Coram, H. Tang.<br />
1505W Network inference, integrative dynamic<br />
omics and personalized medicine. G. I. Mias, H. Im, E.<br />
Mitsunaga, R. Chen., J. Li-Pook-Than, L. Jiang, M. Snyder.<br />
1506T Stress-induced changes in gene interactions in<br />
human cells. R. Nayak, M. Kearns, V. G. Cheung.<br />
1507F An exploration <strong>of</strong> the use <strong>of</strong> low coverage whole<br />
genome sequencing datasets as additional controls<br />
for exome sequenced case series. D. Gurdasani, M. S.<br />
Sandhu, P. Kellam, P. J. Openshaw, J. K. Baillie, MOSAIC<br />
and GenISIS Investigators.<br />
1508W Genome pr<strong>of</strong>ile-based disease risk prediction.<br />
P. Hu, E. Boerwinkle, L. Jin, M. Xiong.<br />
1509T Whole genome sequencing-based imputation: A<br />
comparison between the 1000 Genomes data and the<br />
UK10K sequencing data. J. Huang.<br />
1510F EPACTS : A flexible and efficient sequencebased<br />
genetic analysis s<strong>of</strong>tware package. H. M. Kang,<br />
X. Zhan, X. Sim, C. Ma.<br />
1511W A Monte Carlo procedure for assessing cooccurring<br />
and anti-co-occurring gene mutations in<br />
cancer genome sequencing studies. P. Liu, X. Hua, H.<br />
Xu, Y. Lu.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
172 POSTER SESSIONS<br />
1512T Using whole exome sequencing to identify rare<br />
causal variants for oral clefts in multiplex families.<br />
T. H. Beaty, I. Ruczinski, M. M. Parker, J. B. Hetmanski,<br />
P. Duggal, M. A. Taub, S. Szymczak, Q. Li, C. Cropp, H.<br />
Ling, E. W. Pugh, Y. H. Wu-Chou, J. E. Bailey-Wilson, M.<br />
L. Marazita, J. C. Murray, E. Mangold, M. M. Noethen, K.<br />
Ludwig, A. F. Scott.<br />
1513F Analyzing deep whole genome sequence<br />
and genotype data <strong>of</strong> .1,000 individuals from large<br />
Mexican-<strong>American</strong> pedigrees in the T2D-GENES<br />
study. G. Jun, M. Almeida, P. Cingolani, A. Wood, C.<br />
Fuchsberger, T. M. Teslovich, T. Dyer, M. Rivas, K. Gaulton,<br />
J. Maller, J. Curran, J. Grunstad, T. Blackwell, D. Lehman,<br />
R. Grossman, S. Lincoln, J. Laramie, M. Boehnke, M.<br />
McCarthy, T. Frayling, R. Sladek, R. Duggirala, J. Blangero,<br />
G. Abecasis.<br />
1514W A flexible and effective Poisson mixed model<br />
framework for RNA sequencing and other count data.<br />
X. Zhou, J. Tung, Y. Gilad, S. Mukherjee, M. Stephens.<br />
1515T Sequence-based analysis identifies variants<br />
associated with serum lipids in African <strong>American</strong>s.<br />
A. Bentley, D. Shriner, A. Doumatey, J. Zhou, H. Huang,<br />
J. Mullikin, R. Blakesley, N. Hansen, G. Bouffard, P.<br />
Cherukuri, B. Maskeri, A. Young, A. Adeyemo, C. Rotimi.<br />
1516F Genetic factors associated with levels <strong>of</strong><br />
immune cell types. M. Steri, V. Orrù, E. Fiorillo, G. Sole,<br />
C. Sidore, F. Virdis, M. Dei, S. Lai, A. Mulas, M. G. Piras,<br />
M. Lobina, M. Marongiu, M. Zoledziewska, M. Congia, F.<br />
Busonero, A. Maschio, M. F. Urru, M. Marcelli, R. Atzeni, D.<br />
Firinu, M. Valentini, W. Mentzen, S. Naitza, M. B. Whalen,<br />
A. Angius, C. M. Jones, D. Schlessinger, G. Abecasis, S.<br />
Sanna, F. Cucca.<br />
1517W Characterization <strong>of</strong> rare variants in melanomaassociated<br />
genes in melanoma-prone families without<br />
CDKN2A/CDK4 mutations using exome sequencing<br />
data. R. Yang, K. Jacobs, M. Cullen, J. Boland, L. Burdett,<br />
M. Malasky, M. Rotunno, M. Yeager, S. Chanock, M.<br />
Tucker, A. Goldstein.<br />
1518T Comparison <strong>of</strong> variant calling strategies for<br />
large-scale exome sequencing projects. J. Floyd,<br />
A. Hendricks, L. Crooks, K. Walter, S. McCarthy, C.<br />
Anderson, UK10K Consortium.<br />
1519F A catalogue <strong>of</strong> structural variants identified in<br />
disease-based whole genome sequencing. A. Kumar,<br />
R. D. Pearson, R. E. Handsaker, K. J. Gaulton, S. A.<br />
McCarroll, M. I. McCarthy, GoT2D Consortium.<br />
1520W On the analysis <strong>of</strong> rare, exonic variation<br />
amongst subjects with autism spectrum disorders and<br />
population controls. L. Liu, E. Boerwinkle, J. Buxbaum,<br />
E. Cook, Jr., B. Devlin, G. Schellenberg, J. Sutcliffe, M.<br />
Daly, R. Gibbs, K. Roeder, ARRA Autism Sequencing<br />
Consortium.<br />
1521T Resolving dependence between overlapping<br />
reads in next-generation sequencing data. Y. Lo, G.<br />
Abecasis, S. Zöllner.<br />
1522F Single point and rare variant analysis by whole<br />
genome sequencing in 4,000 samples in the UK10K<br />
cohorts project. J. L. Min, UK10K Consortium Cohorts<br />
Group.<br />
1523W A statistical framework for the evaluation <strong>of</strong> de<br />
novo variation in psychiatric disease. K. E. Samocha,<br />
B. M. Neale, M. J. Daly, ARRA Autism Sequencing<br />
Consortium.<br />
1524T Efficient two-stage analysis approach for<br />
complex trait association with arbitrary depth<br />
sequencing data. S. Yan, Y. Li.<br />
1525F Improving the accuracy and efficiency <strong>of</strong><br />
sequencing experiments, by using previously<br />
sequenced genomes. X. Zhan, H. M. Kang, G. Abecasis.<br />
1526W Estimating and testing genetic effects for<br />
complex traits in sequence-based association studies<br />
and power comparisons. J. Zhou, N. Laird.<br />
1527T A unified statistical framework to correct for<br />
unknown population stratification, family structure and<br />
cryptic relatedness in the sequence-based association<br />
studies. Y. Zhu, J. Zhao, Y. Shugart, M. Xiong.<br />
1528F Genome-wide association study <strong>of</strong> primary<br />
tooth eruption identifies pleiotropic loci association<br />
with crani<strong>of</strong>acial distances. G. Fatemifar, C. Hoggart, L.<br />
Paternoster, J. P. Kemp, I. Prokopenko, M. Horikoshi, J. H.<br />
Tobias, S. Richmond, F. Geller, B. Feenstra, M. Melbye, T.<br />
Sørensen, A. Zhurov, A. M. Toma, S. Ring, B. S. Pourcain,<br />
N. J. Timpson, G. D. Smith, M. R. Jarvelin, D. M. Evans.<br />
1529W General framework for meta-analysis for<br />
sequencing association studies. S. Lee, X. Lin.<br />
1530T General class <strong>of</strong> family-based association tests<br />
for sequence data, and comparisons with populationbased<br />
association tests. I. Ionita-Laza, S. Lee, V.<br />
Makarov, J. D. Buxbaum, X. Lin.<br />
1531F A novel statistical approach to prioritize variants<br />
from deeply sequenced NGS samples using publicly<br />
available sequence controls. L. J. Strug, A. Derkach, T.<br />
Chiang, L. Addis, S. Dobbins, I. Tomlinson, R. Houlston,<br />
D. K. Pal.<br />
1532W Variable selection based weighting schemes for<br />
implicating rare variants in sequence data. A. E. Byrnes,<br />
M. Li, M. C. Wu, F. A. Wright, Y. Li.<br />
1533T Accurate local ancestry inference in exome<br />
sequence samples. Y. Hu, G. Abecasis, H. Kang.<br />
1534F Internal reference panel selection methods<br />
for genotype imputation: A novel sequencing study<br />
design strategy for genotyped samples. P. Zhang, N. A.<br />
Rosenberg, S. Zöllner.<br />
1535W Statistical methods for inference in population<br />
genetic studies with uncertain genotype data. E. Han.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1536T On association analysis <strong>of</strong> rare variants<br />
under population-substructure: An approach for<br />
the detection <strong>of</strong> subjects that can cause bias in the<br />
analysis. D. Qiao, M. Mattheisen, C. Lange.<br />
1537F Identity-by-descent analysis <strong>of</strong> sequence data.<br />
S. M. Smith, S. R. Browning, B. L. Browning.<br />
1538W Robust similarity regression for population<br />
substructure in rare variant aggregation analyses. J.<br />
Tzeng, C. Smith.<br />
1539T Detecting differential expression in splice<br />
variants in the absence <strong>of</strong> annotated is<strong>of</strong>orms using<br />
RNAseq. N. J. I. Lewin-Koh, T. Bhangale, M. Huntley, J.<br />
Kaminker, F. Cai, M. van der Brug.<br />
1540F Identification <strong>of</strong> new genetics variants for T2D in<br />
WTCCC data using genome-wide interaction analysis<br />
followed by core SNP and gene determination. Z.-X.<br />
Zhu, Z.-H. Zhu, X. Tong, M. Liang, W.-C. Cui, M. Yang, L.<br />
Zhou, M. D. Li, J. Zhu.<br />
1541W Imputing genotypes in large pedigrees: A<br />
comparison between GIGI and BEAGLE. C. Y. K.<br />
Cheung, E. Wijsman.<br />
1542T A hidden Markov model for coalescent-based<br />
mapping <strong>of</strong> complex trait loci from sequencing data in<br />
large-scale case-control studies. Z. Geng, P. Scheet, S.<br />
Zoellner.<br />
1543F Genetic Simulation Resources: A website for the<br />
registration and discovery <strong>of</strong> genetic data simulators.<br />
B. Peng, B. Racine, H. Chen, L. Mechanic, L. Clarke, E.<br />
Gillanders, E. Feuer.<br />
1544W Rare-variant tests in stratified populations. M.<br />
Schmidt, D. Kinnamon, E. Martin.<br />
1545T S<strong>of</strong>tware pipeline to detect SNPs and call their<br />
genotypes. M. Trost, H. M. Kang, G. Jun, G. R. Abecasis.<br />
1546F Bidimensional scale analysis: A novel approach<br />
to genographic analysis. Q. Huang, Y. Wu, Z. Li, X. Liu,<br />
W. Xie.<br />
1547W Genotype probability distributions on complex<br />
pedigrees, with applications to relationship testing. M.<br />
Vigeland, T. Egeland.<br />
1548T Trait specific genetic relatedness matrices for<br />
heritability estimates using linear mixed models. J.<br />
Mefford, J. Witte.<br />
1549F The confounding effect <strong>of</strong> cryptic relatedness<br />
on cohort studies for environmental risks. K. Shibata,<br />
G. Tamiya, M. Ueki, T. Nakamura, H. Narimatsu, I. Kubota,<br />
Y. Ueno, T. Kato, H. Yamashita, A. Fukao, T. Kayama,<br />
Yamagata University Genomic Cohort Consortium.<br />
1550W Genome wide mutation-rate map for the analysis<br />
<strong>of</strong> recurrent de novo mutations. P. Polak, S. R. Sunyaev.<br />
POSTER SESSIONS 173<br />
1551T JBASE: A Bayesian mixture model for joint<br />
analysis <strong>of</strong> sub-phenotypes and epistasis. R. Colak, T.<br />
Kim, H. Kazan, P. M. Kim, A. Goldenberg.<br />
1552F IMProve: An R package for parallelizing 1000<br />
Genomes based genotype imputation, statistical<br />
analyses, and extraction <strong>of</strong> independent hit loci. T. A.<br />
Johnson, Y. Nakamura, M. Kubo, T. Tsunoda.<br />
1553W An automatic toolbox for genome-wide<br />
association analyses. J. Luan, S. J. Sharp, N. J.<br />
Wareham, J. H. Zhao.<br />
1554T Variant association tool: A pipeline to perform<br />
quality control and association analysis <strong>of</strong> sequence<br />
and exome chip data. G. Wang, B. Peng, S. M. Leal.<br />
1555F MaCH-Admix: Genotype imputation for admixed<br />
populations. E. Y. Liu, M. Li, W. Wang, Y. Li.<br />
1556W Two roads both taken: Walking the phenotypic<br />
and genotypic paths to disease gene implication. A.<br />
Javed, P. Ng.<br />
1557T Inferring highly polymorphic gene alleles using<br />
sequence data and SNP genotypes in the Han Chinese<br />
population. S. Chang, C. Fann, A. Hsieh, C. Shiu.<br />
1558F The design <strong>of</strong> custom-made genotyping arrays<br />
to study asthma in populations <strong>of</strong> African descent.<br />
J. Gao, Y. Hu, J. S. Lee, N. Pearson, G. Abecasis, I.<br />
Ruczinski, T. H. Beaty, Z. Qin, R. A. Mathias, K. C. Barnes.<br />
1559W Detecting rare variants for both quantitative<br />
and qualitative traits using pedigree data. W. Guo, Y. Y.<br />
Shugart.<br />
1560T IsoDOT detects differential RNA-is<strong>of</strong>orm usage<br />
between two or more samples with high sensitivity and<br />
specificity. W. Sun.<br />
1561F Identification <strong>of</strong> loss <strong>of</strong> heterozygosity from<br />
unpaired tumor samples using next-generation<br />
sequencing. J. Lee, N. Pearson.<br />
1562W A robust and well-defined method for single<br />
nucleotide variant and indel detection. N. Tuzov.<br />
1563T DETECTANCE: Graphical s<strong>of</strong>tware for study<br />
design and planning, based on evaluation <strong>of</strong> the<br />
detectance distributions for probands conditional on<br />
the phenotypes <strong>of</strong> relatives. T. Hiekkalinna, P. Norrgrann,<br />
J. H. Lee, K. M. Weiss, M. Perola, J. D. Terwilliger.<br />
1564F Genetic instrumental variable studies <strong>of</strong> the<br />
effects <strong>of</strong> maternal risk factors on oral clefts. G. L.<br />
Wehby, L. M. Moreno, P. Romitti, K. Christensen, L.<br />
DeRoo, A. Wilcox, R. Munger, R. Lie, J. C. Murray.<br />
1565W The prevalence <strong>of</strong> X-linked hypohidrotic<br />
ectodermal dysplasia in Denmark. M. Nguyen-Nielsen,<br />
S. Skovbo, D. Svaneby, L. Pedersen, J. Fryzek.<br />
1566T The PhenX Toolkit: Standard measures facilitate<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
174 POSTER SESSIONS<br />
cross-study analyses. C. M. Hamilton, W. Huggins,<br />
H. Pan, D. B. Hancock, J. G. Pratt, J. A. Hammond, T.<br />
Hendershot, D. R. Maiese, K. A. Tryka, K. Sher, K. Conway,<br />
M. Scott, W. R. Harlan, J. Haines, L. C. Strader, H. A.<br />
Junkins, E. M. Ramos.<br />
1567F Comparison <strong>of</strong> genome-wide association<br />
studies for smoking behavior between self-reported<br />
and biomarker measures. A. I. Stiby, N. Timpson, M.<br />
Hickman, D. Evans, J. Kemp, G. Davey Smith, S. Ring, B.<br />
St. Pourcain, J. Henderson, J. Macleod.<br />
1568W Design <strong>of</strong> sequencing studies in family<br />
samples, with application to the study <strong>of</strong> substance<br />
use disorders. S. Feng, S. Vrieze, B. Tarrier, J. Bragg-<br />
Gresham, X. Zhan, C. Sidore, M. McGue, W. Iacono, G.<br />
Abecasis.<br />
1569T Family-based designs for sequencing studies.<br />
D. Thomas.<br />
1570F From a large-scale discovery study to a<br />
replication study. C. Kuo, D. Zaykin.<br />
1571W Optimal sample selection for large-scale<br />
next-generation sequencing experiments. G. W.<br />
Beecham, R. Rajbhandary, E. R. Martin, L. S. Wang, K.<br />
Lunetta, R. Mayeux, J. L. Haines, L. Farrer, M. Pericak-<br />
Vance, G. Schellenberg, Alzheimer’s Disease <strong>Genetics</strong><br />
Consortium.<br />
1572T Meta-analysis <strong>of</strong> ITGAM coding variant,<br />
rs1143679 (R77H) in systemic lupus erythematosus<br />
cases and controls. X. Kim-Howard, V. Pradhan, K. H.<br />
Chua, A. Maiti, K. Ghosh, S. Nath.<br />
1573F Understanding missing data in a large STR<br />
dataset <strong>of</strong> over 100,000 Brazilian individuals genotyped<br />
with PowerPlex 16 kit. V. R. C. Aguiar, R. V. Rohlfs, K. E.<br />
Lohmueller, A. M. Castro, F. S. V. Malta, A. C. S. Ferreira, I.<br />
D. Louro, R. Nielsen.<br />
1574W Population based study <strong>of</strong> permanent teeth<br />
agenesis in Japanese schoolchildren. J. Machida, T.<br />
Nishiyama, M. Kamamoto, S. Yamaguchi, M. Kimura,<br />
A. Shibata, K. Yamamoto, S. Makino, H. Miyachi, K.<br />
Shimozato, Y. Tokita.<br />
1575T Are heritability estimates <strong>of</strong> binary traits<br />
meaningful? P. H. Benchek, N. J. Morris.<br />
1576F Genetic ancestry and mammographic density<br />
among U.S. Caucasians. J. L. Caswell, K. Kerlikowske,<br />
J. Shepherd, S. R. Cummings, D. Hu, S. Huntsman,<br />
E. Ziv.<br />
1577W Robust partitioning <strong>of</strong> local heritability at<br />
associated GWAS loci. A. Gusev, G. Bhatia, B. Pasaniuc,<br />
N. Zaitlen, A. L. Price.<br />
1578T Multiple mediation analysis in case-control<br />
studies: Application to detecting joint mediating<br />
effects <strong>of</strong> smoking and chronic obstructive<br />
pulmonary disease on the association between<br />
CHRNA5-A3 genetic locus and lung cancer risk. J.<br />
Wang, S. Shete.<br />
1579F Bayesian-optimized linkage disequilibrium<br />
improves gene-based association tests. H. Huang, S.<br />
Zahid, P. Chanda, D. E. Arking, J. S. Bader.<br />
1580W Statistical models and inference methods<br />
for the in vivo DNA methylation process. A. Q. Fu, D.<br />
P. Genereux, R. Stoeger, A. F. Burden, C. D. Laird, M.<br />
Stephens.<br />
1581T A comparison <strong>of</strong> statistical methods for the<br />
analysis <strong>of</strong> methylome data. M. LeBlanc, B. Kulle.<br />
1582F Designing GWAS arrays for efficient imputationbased<br />
coverage. Y. Zhan, Y. Lu, T. Webster, J. Schmidt.<br />
1583W Does a higher BMI directly influence levels <strong>of</strong><br />
physical activity in children? Mendelian randomization<br />
using genotypic scores. R. C. Richmond, G. Davey<br />
Smith, D. M. Evans, B. St. Pourcain, J. P. Kemp, A. R.<br />
Ness, S. M. Ring, K. Tilling, N. J. Timpson.<br />
Cardiovascular <strong>Genetics</strong><br />
1584T Role <strong>of</strong> GATA5, FBN1 and TGFBR2 mutation in<br />
patients with bicuspid aortic valve. N. Abdulkareem, J.<br />
A. Aragon-Martin, G. Arno, V. Ramachandran, A. Child, M.<br />
Jahangiri.<br />
1585T Re-sequencing <strong>of</strong> 3699 individuals reveals novel<br />
low-frequency missense polymorphism in SCN10A<br />
associated with PR interval that alters channel<br />
activation. J. Brody, V. S. Macri, D. E. Arking, X. Yin, C.<br />
Liu, A. C. Morrison, A. Alonso, J. C. Bis, S. R. Heckbert,<br />
T. Lumley, C. Sitlani, L. A. Cupples, S. Pulit, C. Newton-<br />
Cheh, C. J. O’Donnell, E. J. Benjamin, D. Muzny, R. Gibbs,<br />
R. Jackson, J. W. Magnani, S. S. Rich, B. M. Psaty, E.<br />
Boerwinkle, P. T. Ellinor, N. Sotoodehnia, Cohorts for Heart<br />
and Aging Research in Genetic Epidemiology, NHLBI<br />
Exome Sequencing Project.<br />
1586T A functional SNP at APLN gene confers a risk<br />
to arterial stiffness in Chinese women. Y. C. Liao, S. W.<br />
Huang, Y. S. Wang, K. C. Chen, S. H. H. Juo.<br />
1587T Impact <strong>of</strong> inflammatory gene polymorphisms on<br />
left ventricular dysfunction in coronary artery disease<br />
patients. A. Mishra, A. Srivastava, T. Mittal, N. Garg, B.<br />
Mittal.<br />
1588T Identification <strong>of</strong> a new chromosomal locus for a<br />
mutation causing left ventricular non-compaction with<br />
ventricular tachycardia cardiopathology. E. Muhammad,<br />
A. Levitas, V. Sheffield, R. Parvari.<br />
1589T Sequencing candidate genes associated with<br />
conotruncal heart defects. K. Osoegawa, M. Ladner, K.<br />
Schultz, C. Parodi, N. Mohammed, D. Noonan, G. Shaw,<br />
E. Trachtenberg, E. Lammer.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1590T Significant association <strong>of</strong> two genetic variants in<br />
the ENPEP gene with lone atrial fibrillation in Koreans.<br />
D. Shin, H. Hwang, A. Park, N. Son, E. Shin, J. Lee, H.<br />
Pak, M. Lee, Y. Jang.<br />
1591T Molecular Investigation in sudden unexplained<br />
death syndromes in New York City. Y. Tang, D. Wang, L.<br />
Eng, K. Shah, S. Um, B. Zhou, M. Prinz, B. Sampson.<br />
1592T Associations <strong>of</strong> NINJ2 sequence variation with<br />
incident ischemic stroke: Analysis <strong>of</strong> common and rare<br />
variants in the Cohorts for Heart and Aging in Genomic<br />
Epidemiology Consortium. J. C. Bis, M. Fornage, A. L.<br />
DeStefano, J. Brody, M. A. Ikram, C. van Duijn, R. Gibbs,<br />
J. G. Reid, E. Boerwinkle, W. T. Longstreth, T. H. Mosley,<br />
S. Seshadri on behalf <strong>of</strong> CHARGE Neurology Working<br />
Group.<br />
1593T CCR5, TNF/LTA, CCL2, IL12B, IL10, MAL/TIRAP,<br />
ACTC1 genes are associated to the development <strong>of</strong><br />
chronic Chagas’ disease cardiomyopathy. C. Chevillard,<br />
A. F. Frade, P. Teixeira, B. Ianni, C. Wide Pissetti, A.<br />
Fragata, M. Hirata, M. Sampaio, B. Saba, F. Dias, E.<br />
Donadi, V. Rodrigues Jr., A. Pereira, J. Kalil, E. Cunha-<br />
Neto.<br />
1594T Analysis <strong>of</strong> candidate genes associated<br />
with intermediate traits identifies novel variants<br />
associated with coronary artery disease presence<br />
and severity. D. M. Craig, E. R. Hauser, E. Burns,<br />
M. Chryst-Ladd, C. Haynes, W. E. Kraus, I. C.<br />
Siegler, B. H. Brummett, R. C. Becker, R. B. Williams,<br />
S. H. Shah.<br />
1595T The shared allelic architecture <strong>of</strong> adiponectin<br />
levels and coronary artery disease. Z. Dastani, T.<br />
Johnson, F. Kronenberg, C. Nelson, T. L. Assimes,<br />
W. März, J. B. Richards, CARDIoGRAM Consortium,<br />
ADIPOGen Consortium.<br />
1596T Investigation <strong>of</strong> mutations in exons 19 and<br />
22 MYH7 gene in HCM patients in Chaharmahal<br />
va Bakhtiyari Province, Iran. S. Heydari Sodjani, R.<br />
Pourahmad, A. Khaledifar, M. Hashemzadeh, F. Azadegan,<br />
N. Bagheri, S. Badfar.<br />
1597T Polymorphisms in CHRNA3-CHRNA5-CHRNB4<br />
are associated with body mass index and systolic<br />
blood pressure in smokers in the Northern Finland<br />
Birth Cohort 1966. M. Kaakinen, F. Ducci, M. J. Sillanpää,<br />
E. Läärä, M.-R. Järvelin.<br />
1598T Genetic association studies <strong>of</strong> left ventricle<br />
dysfunction in coronary artery disease patients. B.<br />
Mittal, A. Mishra, A. Srivastava, T. Mittal, N. Garg.<br />
1599T Associations <strong>of</strong> sequenced regions SLC17A4<br />
and PIK3CG with common carotid intima-media<br />
thickness and plaque: A common and rare variant<br />
meta-analysis in the Cohorts for Heart and Aging in<br />
Genomic Epidemiology Consortium. C. J. O’Donnell, C.<br />
C. White, N. Franceschini, J. Brody, D. Muzny, R. Gibbs, E.<br />
Boerwinkle, B. Psaty, K. E. North, L. A. Cupples, J. C. Bis<br />
on behalf <strong>of</strong> CHARGE Subclinical Atherosclerosis Working<br />
Group.<br />
POSTER SESSIONS 175<br />
1600T CNVs contributing to the cause <strong>of</strong> congenital<br />
heart defects may include not only those containing<br />
candidate genes but regions more commonly<br />
associated with autism and other disorders.<br />
D. Warburton, M. Ronemus, J. Kline, M. Wigler, V.<br />
Jobanputra, D. Levy, K. Anyane-Yeboa, W. Chung, D.<br />
Awad.<br />
1601T Whole exome sequencing and hypertrophic<br />
cardiomyopathy. F. Dewey, S. Cordero, M. Wheeler, A.<br />
Pavlovic, K. Bommakanti, S. Pan, C. Caleshu, R. Chen, M.<br />
Snyder, E. Ashley.<br />
1602T Fine mapping the SCN10A gene region<br />
identifies novel associations with PR interval in<br />
African <strong>American</strong>s from an electronic medical record<br />
population. J. Jeff, M. Ritchie, J. Denny, H. Dilks, C.<br />
Sutcliffe, M. Basford, D. Roden, D. Crawford.<br />
1603T Association between 4q25 variants and<br />
cardioembolic stroke in the Vienna Stroke Registry.<br />
M. M. Luke, C. H. Tong, J. J. Catanese, J. J. Devlin, S.<br />
Greisenegger, C. Mannhalter.<br />
1604T Common genetic variants do not predict CAD<br />
in familial hypercholesterolemia. E. P. A. van Iperen,<br />
S. Sivapalaratnam, S. M. Boekholdt, G. K. Hovingh, S.<br />
Maiwald, M. W. Tanck, N. Soranzo, J. C. Stephens, J. G.<br />
Sambrook, M. Levi, W. H. Ouwehand, J. J. P. Kastelein, M.<br />
D. Trip, A. H. Zwinderman.<br />
1605T Genetic sources <strong>of</strong> variation in proprotein<br />
convertase subtilisin/kexin type 9, a protein that<br />
mediates degradation <strong>of</strong> LDL receptors and increases<br />
LDL levels. E. A. Rosenthal, R. Rajagopalan, J. Ranchalis,<br />
D. Szeto, K. Akinsanya, T. P. Roddy, J. M. Castro-Perez,<br />
G. Forrest, G. Wolfbauer, J. J. Albers, J. D. Brunzell, A. G.<br />
Motulsky, M. J. Rieder, D. A. Nickerson, E. M. Wijsman, G.<br />
P. Jarvik.<br />
1606T Twenty-three unreported genetic associations<br />
with lipid phenotypes: A dense gene-centric metaanalysis<br />
in 66,240 individuals across 32 studies. Y. Guo,<br />
F. W. Asselbergs, E. P. A. van Iperen, S. Sivapalaratnam,<br />
V. Tragante, C. Elbers, H. Hakonarson, B. J. Keating, F.<br />
Drenos, IBC-Lipids Consortium.<br />
1607T After LDLR, APOB and PCSK9, APOE is<br />
another major gene <strong>of</strong> autosomal dominant<br />
hypercholesterolemia. M. Varret, M. Marduel, K.<br />
Ouguerram, V. Serre, D. Bonnefont-Rousselot, K. E. Berge,<br />
M. Devillers, G. Luc, J.-M. Lecerf, L. Tosolini, M. Abifadel,<br />
T. P. Leren, J.-P. Rabès, C. Boileau.<br />
1608T Trans-ethnic fine-mapping <strong>of</strong> lipid loci in<br />
African <strong>American</strong>s, East Asians, and Europeans<br />
identifies population-specific signals and extensive<br />
allelic heterogeneity that increases the trait variance<br />
explained. Y. Wu, L. Waite, A. Jackson, S. Buyske, C.<br />
Carty, I. Cheng, D. Duggan, L. Dumitrescu, C. Haiman, L.<br />
Hindorff, C. Hsiung, S. Hunt, K. Hveem, J. Juang, E. Kim,<br />
M. Laakso, I. Njølstad, U. Peters, R. Rauramaa, W. Sheu,<br />
Y. Sung, J. Tuomilehto, T. Wang, Y. Chen, C. Kooperberg,<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
176 POSTER SESSIONS<br />
M. Boehnke, D. Crawford, T. Assimes, K. North, K. L.<br />
Mohlke.<br />
1609T Identification <strong>of</strong> a major genetic modifier in<br />
mouse models <strong>of</strong> TGFb vasculopathies. J. Calderon, H.<br />
Dietz.<br />
1610T Upregulation <strong>of</strong> Twist1 expression during acute<br />
myocardial infarction. J. B. Nevado.<br />
1611T Venous malformation-causing TIE2-mutations<br />
lead to AKT-mediated downregulation <strong>of</strong> PDGFB. M.<br />
Uebelhoer, M. Nätynki, J. Kangas, J. Soblet, A. Mendola,<br />
C. Godfraind, L. M. Boon, L. Eklund, N. Limaye, M.<br />
Vikkula.<br />
1612T Islet1 is a direct transcriptional target <strong>of</strong> the<br />
homeodomain transcription factor Shox2 in the<br />
sinoatrial node <strong>of</strong> the developing heart. G. A. Rappold,<br />
I. M. Berger, A. Glaser, C. Bacon, L. Li, K. U. Schneider, N.<br />
Gretz, H. Steinbeisser, W. Rottbauer, S. Just, S. H<strong>of</strong>fmann.<br />
1613T Analysis <strong>of</strong> sub-category for 141 cases <strong>of</strong><br />
congenital heat disease that have been surgically<br />
corrected during neonatal period. Q.-Y. Cao, J.-Z. Zhu,<br />
N. Zhong.<br />
1614T Analysis <strong>of</strong> cardiomyopathy using whole<br />
genome sequencing. E. M. McNally, J. R. Golbus,<br />
L. L. Pesce, D. Wolfgeher, L. Dellefave-Castillo, M. J.<br />
Puckelwartz.<br />
1615T The association between NOS3 gene variations<br />
and Brugada syndrome. S. Mehrtashfar, A. Ebrahimi, M.<br />
Moghadam, A. S. Khatir.<br />
1616T Targeted sequence capture and 454 sequencing<br />
<strong>of</strong> 23 cardiomyopathy genes: Implementation into<br />
diagnostics. O. Mook, M. Haagmans, R. Lekanne dit<br />
Deprez, F. Baas, M. Jakobs, N. H<strong>of</strong>man, I. Christiaans, M.<br />
Mannens.<br />
1617T Targeted next-generation sequencing <strong>of</strong><br />
thoracic aortic aneurysmal genes. L. Van Laer, D.<br />
Proost, G. Vandeweyer, J. Saenen, B. Paelinck, C. Vrints,<br />
B. Loeys.<br />
1618T The use <strong>of</strong> next-generation sequencing in<br />
clinical diagnostics <strong>of</strong> familial hypercholesterolaemia.<br />
J. Vandrovcova, E. Thomas, S. Atanur, P. Norsworthy,<br />
C. Neuwirth, Y. Tan, L. Game, A. Soutar, T. J. Aitman,<br />
Generation Scotland.<br />
1619T Targeted next-generation sequencing as a<br />
diagnostic test in patients with cardiomyopathies. Y. J.<br />
Vos, B. Sikkema-Raddatz, L. F. Johansson, E. N. de Boer,<br />
L. G. Boven, K. Y. van Spaendonck-Zwarts, M. P. van den<br />
Berg, J. P. van Tintelen, J. D. H. Jongbloed, R. J. Sinke.<br />
1620T Population sampling and in vitro modeling <strong>of</strong> a<br />
25bp deletion in MYBPC3 associated with hypertrophic<br />
cardiomyopathy. A. B. Chowdry, M. A. Mandegar, G. M.<br />
Benton, B. T. Naughton, B. R. Conklin.<br />
1621T Co-localization <strong>of</strong> lipid biomarker associations<br />
with gene expression across human tissues. C.<br />
Giambartolomei, H.-J. Westra, M. Kivimaki, M. Kumari, E.<br />
Schadt, L. Franke, A. Hingorani, V. Plagnol.<br />
1622T Silencing <strong>of</strong> Atp2b1 increases blood pressure<br />
through vasoconstriction. B. Oh, Y.-B. Shin, S.-M. Ji,<br />
S.-Y. Park, H.-J. Lee, K.-W. Hong, J.-E. Lim, M. Lim, Y.-H.<br />
Lee.<br />
1623T Metabolic imprints <strong>of</strong> genetically elevated body<br />
mass index in young adults. P. Würtz, A. J. Kangas, P.<br />
Soininen, O. Raitakari, T. Lehtimäki, M. R. Järvelin, M. Ala-<br />
Korpela, S. Ripatti.<br />
1624T Mendelian randomization studies do not support<br />
a causal effect <strong>of</strong> plasma lipids on insulin sensitivity. T.<br />
Fall, W. Xie, K. Hao, J. Ärnlöv, F. Abbasi, E. E. Schadt, G.<br />
Boran, T. Hansen, D. Greenawalt, J. J. Nolan, O. Pedersen,<br />
H. Häring, E. Ferrannini, A.-C. Syvänen, T. Quertermous,<br />
U. Smith, T. L. Assimes, M. Laakso, M. Walker, J. W.<br />
Knowles, M. N. Weedon, E. Ingelsson, T. M. Frayling on<br />
behalf <strong>of</strong> GENESIS Consortium.<br />
1625T Dissecting the genetic architecture <strong>of</strong> coronary<br />
artery disease by genome engineering. D. J. Segal, M.<br />
S. Bhakta, K. ThevaDas, C. Sun, N. M. Grace, J. A. Nolta,<br />
A. A. Knowlton, D. M. Rocke.<br />
1626T Application <strong>of</strong> Mendelian randomization on<br />
ascorbic acid and hypertension in .11,000 participants<br />
from 4 independent studies. K. H. Wade, N. J. Timpson,<br />
N. G. Forouhi, M.-J. Brion, R. M. Harbord, D. G. Cook, P.<br />
Johnson, A. McConnachie, R. W. Morris, S. Rodriguez,<br />
Z. Ye, S. Ebrahim, S. Padmanabhan, G. Watt, K. R.<br />
Bruckdorfer, N. J. Wareham, P. H. Whincup, S. Chanock,<br />
N. Sattar, D. A. Lawlor, G. Davey Smith.<br />
1627T Identification <strong>of</strong> a regulatory variant that binds<br />
C/EBPb at the GALNT2 human high-density lipoprotein<br />
cholesterol locus. T. S. Roman, M. P. Fogarty, S.<br />
Vadlamudi, A. F. Marvelle, K. J. Gaulton, A. J. Gonzalez, Y.<br />
Li, K. L. Mohlke.<br />
1628T Maternally transmitted coronary heart disease is<br />
associated with the mitochondrial tRNAThr 15927G.A<br />
mutation. M. X. Guan.<br />
1629T Mitochondrial haplogroups and genomic<br />
ancestry showed association with heart failure in<br />
Brazilians. C. Fridman, M. M. S. G. Cardena, A. K.<br />
Ribeiro-dos-Santos, S. E. Santos, J. E. Krieger, A. C.<br />
Pereira.<br />
1630T RNAi-based functional pr<strong>of</strong>iling <strong>of</strong> loci from<br />
blood lipid genome-wide association studies. H. Runz,<br />
P. Blattmann, C. Schuberth, R. Pepperkok.<br />
1631T A fine mapping <strong>of</strong> the genetic variation<br />
influencing the ratio <strong>of</strong> alternatively spliced CD40<br />
transcripts and conferring susceptibility to Kawasaki<br />
disease. Y. Onouchi, K. Ozaki, M. Terai, H. Hamada, H.<br />
Suzuki, T. Suenaga, Y. Suzuki, K. Yasukawa, R. Ebata,<br />
T. Saji, Y. Kemmotsu, K. Ouchi, F. Kishi, T. Yoshikawa, T.<br />
Nagai, K. Hamamoto, Y. Sato, K. Sasago, A. Takahashi, M.<br />
Kubo, T. Tsunoda, A. Hata, Y. Nakamura, T. Tanaka.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1632T The AA genotype <strong>of</strong> tumor necrosis factor<br />
induced protein 2 rs8126 polymorphism is associated<br />
with increased mortality in septic shock. S. A. Thair, J.<br />
H. Boyd, T. A. Nakada, J. A. Russell, K. R. Walley.<br />
1633T Significance <strong>of</strong> the NODAL p.H165R variant in<br />
complex cardiovascular malformations: A report <strong>of</strong> two<br />
lethal cases with an asymptomatic parent. Z. Ammous,<br />
A. Rajadhyaksha, P. Jayakar.<br />
1634T Parent <strong>of</strong> origin effect in HDL levels. J. S. Lilley,<br />
I. M. Predazzi, W. S. Bush, M. F. Linton, S. M. Williams, S.<br />
Fazio.<br />
1635T Loci on chromosomes 2q12, 6p21 and 13q14<br />
modulate the effect <strong>of</strong> smoking on carotid intimamedia<br />
thickness in whites, blacks and Hispanics. C.<br />
Dong, L. Wang, A. Beecham, D. Cabral, C. B. Wright, S. H.<br />
Blanton, T. Rundek, H. Zhao, R. L. Sacco.<br />
1636T A genome-wide gene-by-environment scan<br />
for mobile source air pollution in atherosclerosis and<br />
myocardial infarction identifies PIGR and HCN4. C. K.<br />
Ward-Caviness, L. Neas, C. Haynes, C. Blach, E. Burns, K.<br />
LaRocque-Abramson, E. Dowdy, W. Cascio, R. Devlin, D.<br />
Diaz-Sanchez, W. E. Kraus, S. H. Shah, S. G. Gregory, M.<br />
L. Miranda, E. R. Hauser.<br />
1637T Genome-wide association analysis <strong>of</strong> blood<br />
pressure incorporating gene-age interactions in the<br />
CHARGE, GBPgen, and ICBP Consortia. J. Simino,<br />
CHARGE, GBPgen, and ICBP Investigators.<br />
1638T A genome-wide association study <strong>of</strong> carotid<br />
intima-medial thickness, a preclinical marker <strong>of</strong><br />
atherosclerosis. S. H. Blanton, A. H. Beecham, L. Wang,<br />
C. Dong, D. Cabral, B. I. Hudson, M. Kiryiya, F. Jasmine,<br />
B. Pierce, R. Demmer, A. Habibul, M. Desvarieux, R.<br />
Sacco, T. Rundek.<br />
1639T Genome-wide association analyses <strong>of</strong> long-term<br />
blood pressure traits. S. K. Ganesh, G. B. Ehret, A.<br />
Chakravarti on behalf <strong>of</strong> CHARGE-BP and ICBP Consortia.<br />
1640T A genome-wide association study in a Lebanese<br />
population identifies three new loci for coronary artery<br />
disease. M. Ghassibe, J. Hager, J. B. Cazier, D. Platt, Y.<br />
Kamatani, M. Farrall, D. Gauguier, P. Zalloua.<br />
1641T An assessment <strong>of</strong> association <strong>of</strong> blood pressure<br />
with DNA variants in the Long Life Family Study and<br />
other studies. A. T. Kraja, J. H. Lee, R. Straka, I. B.<br />
Borecki, C. Kammerer, M. A. Province.<br />
1642T Novel tissue-specific transcriptomic signatures<br />
revealed by experimental endotoxemia in healthy<br />
human subjects. Y. Liu, J. Feguson, I. Silverman, B.<br />
Gregory, M. Li, M. Reilly.<br />
1643T Genome-wide association study for atrial<br />
fibrillation in the Japanese population. K. Ozaki, Y.<br />
Onouchi, N. Kamatani, T. Tsunoda, M. Kubo, Y. Nakamura,<br />
T. Tanaka.<br />
1644T Cardiovascular genetics. D. Seo, Z. Liu, N. Sikka,<br />
POSTER SESSIONS 177<br />
P. Goldschmidt-Clermont, M. A. Pericak-Vance, G. W.<br />
Beecham.<br />
1645T Functional relationship <strong>of</strong> the COL4A1/COL4A2<br />
locus on chromosome 13q34 to coronary artery disease.<br />
A. Turner, P. Lau, S. Soubeyrand, O. Jarinova, R. McPherson.<br />
1646T De novo copy number variants in non-syndromic<br />
left ventricular outflow tract obstruction. L. A. Umana,<br />
N. A. Hanchard, G. A. Zender, S. M. Fitzgerald-Butt, G.<br />
Zapata, P. Hernandez, M. S. Azamian, D. J. Penny, J. W.<br />
Belmont, K. L. McBride.<br />
1647T Genetic association <strong>of</strong> CVD-related loci with<br />
lipid traits in the Heart Strategies Concentrating on<br />
Risk Evaluation (Heart SCORE) Study. X. B. Wang,<br />
S. Reis, M. M. Barmada, I. Halder, F. Y. Demirci, M. I.<br />
Kamboh.<br />
1648T Genetic analysis <strong>of</strong> vascular disease in the<br />
Diabetes Heart Study. A. J. Cox, M. C. Y. Ng, J. Xu, C. D.<br />
Langefeld, J. J. Carr, B. I. Freedman, D. W. Bowden.<br />
1649T SNPs associated with plasma triglyceride levels<br />
influence response during intensive cardiovascular risk<br />
reduction. D. L. Ellsworth, A. Decewicz, M. Hicks, K. A.<br />
Mamula, A. Burke, M. J. Haberkorn, H. L. Patney, M. N.<br />
Vernalis.<br />
1650T Sex-specific association <strong>of</strong> cadherin with high<br />
density-lipoprotein cholesterol in the Long Life Family<br />
Study. M. F. Feitosa, A. T. Kraja, J. Lee, K. Christensen, J.<br />
Wang, C. Kammerer, M. A. Province, I. B. Borecki.<br />
1651T A genome-wide association study identifies<br />
KNG1 as a genetic determinant <strong>of</strong> plasma factor XI<br />
level and activated partial thromboplastin time. J.<br />
M. Soria, M. Sabater-Lleal, A. Martinez-Perez, A. Buil,<br />
L. Folkersen, J. C. Souto, M. Bruzelius, M. Borrell, J.<br />
Odeberg, S. Silveira, P. Eriksson, A. Almasy, A. Hamsten.<br />
1652T Gene variants are associated with s<strong>of</strong>t lipid-rich<br />
coronary plaque in African <strong>American</strong>s with replication<br />
in European <strong>American</strong>s. L. R. Yanek, B. G. Kral, D.<br />
Vaidya, T. F. Moy, L. C. Becker, D. M. Becker.<br />
1653T Genetic variation for leukocyte telomere<br />
length predicts incident coronary heart disease: The<br />
Framingham Heart Study. S. Hwang, A. Aviv, D. Levy,<br />
M. Mangino, S. Hunt, A. L. Fitzpatrick, J. C. Bis, E. S.<br />
Smith.<br />
1654T Genome-wide association analysis <strong>of</strong> plasma<br />
triglyceride in Korean population. B. Gombojav, D. H.<br />
Lee, M. K. Lee, Y. M. Song, K. Lee, J. Sung.<br />
1655T Genome-wide association study <strong>of</strong> calcific<br />
aortic valve disease. S. Guauque-Olarte, M. Lamontagne,<br />
N. Gaudreault, P. Mathieu, P. Pibarot, Y. Bossé, D.<br />
Messika-Zeitoun.<br />
1656T Genetic variants explaining sodium intake in<br />
a population with higher sodium intake level: The<br />
Healthy Twin Study, Korea. M. Kho, Y.-M. Song, K. Lee,<br />
J.-E. Lee, K. Kim, J. Sung.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
178 POSTER SESSIONS<br />
1657T Dietary intake <strong>of</strong> saturated fatty acids<br />
modulates the genetic effects on triglyceride<br />
concentrations in a Korean genome-wide study. H.<br />
Lee, H. Jang, M. Go, J. Park, J. Choi, J. Park, Y. Ahn, B.<br />
Han, J. Lee, J. Song.<br />
1658T A GWAS approach in search for modifiers<br />
<strong>of</strong> congenital heart disease in 22q11 microdeletion<br />
syndrome. G. M. Repetto, C. Vial, S. McGhee, N. K.<br />
Henderson-MacLennan, M. L. Guzman, M. Palomares, G.<br />
Lay-Son, K. Espinoza, T. Guo, B. Morrow.<br />
1659T Novel genes related to hypertension: A genecentric<br />
meta-analysis with over 127,000 individuals.<br />
V. Tragante do O., S. K. Ganesh, W. Guo, Y. Guo, E. N.<br />
Smith, M. B. Lanktree, T. Johnson, B. Almoguera Castillo,<br />
J. Barnard, J. Baumert, A. G. Uitterlinden, P. van der Harst,<br />
Y. T. van der Schouw, N. J. Samani, P. B. Munroe, P. I. W.<br />
de Bakker, X. Zhu, D. Levy, B. Keating, F. W. Asselbergs,<br />
IBC BP Consortium.<br />
1660T Additional variance <strong>of</strong> serum lipid levels<br />
explained by incorporating less significant genetic<br />
variants and allelic heterogeneity. R. Deka, G. Zhang,<br />
R. Karns, G. Sun, S. R. Indugula, H. Cheng, D. Havas-<br />
Augustin, N. Novokmet, Z. Durakovic, S. Missoni, R.<br />
Chakraborty, P. Rudan.<br />
1661T Admixture mapping <strong>of</strong> coronary artery calcified<br />
plaque in African <strong>American</strong>s with type 2 diabetes. J.<br />
Divers, N. D. Palmer, L. Lu, T. C. Register, J. J. Carr, P. J.<br />
Hicks, R. C. Hightower, S. C. Smith, J. Xu, A. J. Cox, K.<br />
A. Hruska, D. W. Bowden, C. E. Lewis, G. Heiss, M. A.<br />
Province, I. B. Borecki, K. F. Kerr, Y. D. Chen, W. Palmas,<br />
J. I. Rotter, C. L. Wassel, A. Bertoni, D. Herrington, L. E.<br />
Wagenknecht, C. D. Langefeld, B. I. Freedman.<br />
1662T Genome-wide association studies <strong>of</strong> NMR-based<br />
lipoprotein subclasses in African <strong>American</strong> populations<br />
elucidate subfractions affected by SNP variation. Y.<br />
Huang, WM. Chen, K. L. Keene, F. Chen, U. Nayak, X. Hou, I.<br />
J. Spruill, K. J. Hunt, J. K. Fernandes, K. H. Lok, J. Divers, J.<br />
C. Mychaleckyj, D. L. Kamen, W. Post, S. S. Rich, J. I. Rotter,<br />
G. S. Gilkeson, W. T. Garvey, M. Cushman, M. M. Sale.<br />
1663T Redefining fibromuscular dysplasia <strong>of</strong> the<br />
arteries as a TGF-b pathway disorder. R. Morissette, S.<br />
Ganesh, B. Griswold, L. Sloper, N. McDonnell.<br />
1664T Integrated microRNA and mRNA pr<strong>of</strong>iling <strong>of</strong><br />
the mouse ventricles during development <strong>of</strong> severe<br />
hypertrophic cardiomyopathy and heart failure. R. D.<br />
Bagnall, T. Tsoutsman, R. E. Shephard, W. Ritchie, C.<br />
Semsarian.<br />
1665T Novel transcripts and pathways identified in blood<br />
one week following implant <strong>of</strong> continuous-flow left<br />
ventricular assist device. J. L. Hall, W. Guan, A. Mitchell, R.<br />
Staggs, S. Grindle, N. Adhikari, S. Hozayen, P. Eckman.<br />
1666T Activation <strong>of</strong> TLR signaling in atherosclerosis<br />
and ischemic stroke. C.-C. Huang, R. Sieberg, G. Feng,<br />
S. Wang, M. Yu.<br />
1667T Genetic insights into nonalcoholic fatty liver<br />
disease from the proteomic analysis <strong>of</strong> HDL particles.<br />
K. Merath, M. Zickus, R. Komorowski, J. Wallace, M.<br />
Goldbladtt, S. Gawrieh, M. Olivier.<br />
1668T Do variations in genes encoding the argonaute<br />
proteins confer risk or protection from cardiovascular<br />
disease in Europeans? I. Predazzi, W. Bush, S. Williams.<br />
1669T Gene expression pr<strong>of</strong>iling in peripheral blood cells<br />
in patients with myocardial infarction at young age. T.<br />
Zeller, C. Müller, A. Schillert, M. O. Scheinhardt, S. Szymczak,<br />
F. Ojeda, C. R. Sinning, R. B. Schnabel, S. Wilde, P. S. Wild,<br />
K. J. Lackner, T. Munzel, A. Ziegler, S. Blankenberg.<br />
1670T A genetic study <strong>of</strong> familial intracranial<br />
aneurysm in French-Canadian and Inuits through<br />
exome sequencing. S. Zhou, L. Xiong, C. Bourassa, M.<br />
Bojanowski, N. Dupré, M. Dubé, A. Dionne-Laporte, D.<br />
Spiegelman, E. Henrion, O. Diallo, P. Dion, G. Rouleau.<br />
1671T Rare variant APOC3 R19X is associated with<br />
cardio-protective pr<strong>of</strong>iles in a diverse populationbased<br />
survey as part <strong>of</strong> the Population Architecture<br />
using Genomics and Epidemiology (PAGE) Study. D. C.<br />
Crawford, L. Dumitrescu, R. Goodloe, K. Brown-Gentry, C.<br />
Sutcliffe, R. Wiseman, P. Baker, H. H. Dilks, J. Boston, B.<br />
McClellan, Jr., P. Mayo, M. Allen, N. Schnetz-Boutaud, J.<br />
L. Haines, T. I. Pollin.<br />
1672T Resequencing <strong>of</strong> the cholesteryl ester transfer<br />
protein gene (CETP) in U.S. Whites and African Blacks<br />
with extreme HDL-C levels. D. Pirim, F. Y. Demirci, X.<br />
Wang, J. E. Hokanson, R. F. Hamman, C. H. Bunker, C. M.<br />
Kammerer, M. M. Barmada, M. I. Kamboh.<br />
1673T Comprehensive evaluation <strong>of</strong> the effects <strong>of</strong><br />
APOE genetic variation on plasma lipoprotein traits<br />
in U.S. Whites and African Blacks. Z. H. Radwan, F.<br />
Y. Demirci, X. Wang, F. Waqar, J. E. Hokanson, R. F.<br />
Hamman, C. H. Bunker, C. M. Kammerer, M. M. Barmada,<br />
M. I. Kamboh.<br />
1674T Filamin-C: A novel candidate for familial<br />
restrictive cardiomyopathy identified by whole-exome<br />
sequencing. M. Tariq, E. Miller, S. Ware.<br />
1675T Mutations in SMAD3 in a British cohort <strong>of</strong><br />
thoracic aortic aneurysm and dissection patients.<br />
G. Arno, J. A. Aragon-Martin, O. Song, N. P. Kamali, A.<br />
Saggar, M. Jahangiri, A. H. Child.<br />
1676T Distribution <strong>of</strong> sarcomere versus non-sarcomere<br />
gene mutations in over 2400 hypertrophic and dilated<br />
cardiomyopathy patients. S. Baxter, A. Daly, D. Macaya,<br />
N. Smaoui, G. Richard, W. Chung.<br />
1677T Burden <strong>of</strong> rare sarcomere gene variants in the<br />
Framingham and Jackson Heart Study cohorts. A.<br />
G. Bick, J. Flannick, K. Ito, S. Cheng, R. S. Vasan, M.<br />
G. Parfenov, D. S. Herman, S. R. DePalma, N. Gupta,<br />
S. B. Gabriel, B. H. Funke, H. L. Rehm, E. J. Benjamin,<br />
J. Aragam, H. A. Taylor, E. R. Fox, C. Newton-Cheh, S.<br />
Kathiresan, C. J. O’Donnell, J. G. Wilson, D. Altshuler, J. N.<br />
Hirschhorn, J. G. Seidman, C. Seidman.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1678T Whole-exome sequencing for identification<br />
<strong>of</strong> novel genes and variants underlying the risk <strong>of</strong><br />
long-QT syndrome. M. Chaix, P. Goyette, A. Alikashani,<br />
F. Latour, L. Robb, B. Mondesert, L. Rivard, S. Foisy, M.<br />
Ladouceur, R. M. Hamilton, M. Talajic, J. D. Rioux.<br />
1679T A rare genetic mutation (FBLN-4 mutation)<br />
found in a patient presenting with diffuse severe<br />
aortopathy. K. Coleman, P. Fernh<strong>of</strong>f, S. Shankar, C.<br />
Hebson, M. Clabby, B. Kogon, B. Loeys.<br />
1680T Rare variants in Notch pathway genes among<br />
individuals with congenital heart defects. K. McBride,<br />
G. Zender, S. Fitzgerald-Butt, J. Stemming, A. Hooper.<br />
1681T TTN mutations from exome sequences <strong>of</strong> 17<br />
DCM families: Clinical implications. A. Morales, N.<br />
Norton, D. Li, E. Rampersaud, E. Martin, S. Zuchner, S.<br />
Guo, M. Gonzalez, R. Hershberger.<br />
1682T A novel Ser33045Ala variant <strong>of</strong> TTN gene in<br />
a family with left ventricular non-compaction and<br />
syncope: Is there a linked etiopathogenesis? A.<br />
Psychogios, A. Marsidi.<br />
1683T Molecular autopsy for sudden death using<br />
whole genome sequencing. M. J. Puckelwartz, L.<br />
Dellefave-Castillo, D. Wolfgeher, V. Nelakuditi, M. T.<br />
Campbell, J. R. Golbus, E. M. McNally.<br />
1684T High incidence <strong>of</strong> GLA variants in a nonselected<br />
heart disease patient population suggests<br />
that the Fabry trait is a common cardiovascular<br />
genetic risk factor. R. Schiffmann, S. Forni, C. Swift,<br />
X. Wu, D. J. Lockhart, M. Chee, T. Kitaoka, E. Chudin,<br />
S. Pond, N. H. McNeill, K. Sims, E. R. Benjamin, L.<br />
Sweetman.<br />
1685T Exome sequencing identifies homozygous<br />
truncation mutations in MYOM2 in arrhythmogenic<br />
ventricular dysplasia/cardiomyopathy. J. Wang, C.<br />
Silverstein, H. Lee, E. Mokhonova, A. Seki, S. P. Taylor, M.<br />
Fishbein, M. Spencer, S. F. Nelson.<br />
1686T Replication <strong>of</strong> associations from large scale<br />
re-sequencing studies. D. Waterworth, L. Li, R. Scott,<br />
C. Gillson, J. Aponte, L. Warren, M. Nelson, M. Ehm, N.<br />
Wareham, S. Chissoe.<br />
1687T Rare copy number variants in congenital heart<br />
disease affecting gene structure. K. Dumas, Y. Bouhlal,<br />
M. McKeon, J. T. C. Shieh.<br />
1688T Rare variants in the APOA5 promoter are<br />
associated with a paradoxical HDL-C decrease in<br />
response to fen<strong>of</strong>ibric acid therapy. A. Brautbar, M.<br />
Barbalic, F. Chen, J. Belmont, S. Virani, S. Scherer, R.<br />
Hegele, C. Ballantyne.<br />
1689T COL4A1 and COL4A2 mutations cause<br />
genetically modifiable hemorrhagic stroke. M.<br />
Jeanne, J. Jorgensen, C. Labelle-Dumais, Y. Weng, W. B.<br />
Kauffman, M. de Leau, S. M. Greenberg, J. Rosand, J.<br />
Favor, D. B. Gould.<br />
POSTER SESSIONS 179<br />
1690T Association <strong>of</strong> 87 traits related to coronary<br />
heart disease and rare sequence variants in the<br />
ClinSeq Study. H. Sung, B. Suktitipat, K. Lewis, D. Ng,<br />
S. Gonsalves, J. K. Teer, N. F. Hansen, J. C. Mullikin, L. G.<br />
Biesecker, A. F. Wilson, NISC Comparative Sequencing<br />
<strong>Program</strong>.<br />
1691T Exome sequencing identifies a novel splice<br />
site mutation in LMNA and multigenic heterozygosity<br />
<strong>of</strong> potential modifiers in a multi-generation family<br />
with sick sinus syndrome, dilated cardiomyopathy<br />
and sudden cardiac death. M. V. Zaragoza, E. Jensen,<br />
F. Oh, C. K. Tran, V. Hoang, S. Hakim.<br />
1692T Whole-exome sequencing and quantitative<br />
analysis <strong>of</strong> genetic variants associated with blood<br />
pressure: The NHLBI Exome Sequencing Project. S. L.<br />
Pulit, ESP Blood Pressure Project Team, NHLBI Exome<br />
Sequencing Project.<br />
1693T Identification <strong>of</strong> novel genes and their mutations<br />
associated with hypertrophic cardiomyopathy. X. Liu,<br />
Q. Huang, X. Dai, W. Xie.<br />
1694T Linkage analysis and exome sequencing<br />
to identify causal variants for familial combined<br />
hyperlipidemia. A. Mak, C. R. Pullinger, M. J. Malloy, P. L.<br />
F. Tang, R. Deo, P. Y. Kwok.<br />
1695T Exome sequencing reveals a truncation<br />
mutation in the novex-3 is<strong>of</strong>orm <strong>of</strong> TTN that disrupts<br />
cardiomyocyte ultrastructure and segregates with<br />
familial dilated cardiomyopathy. J. L. Theis, V. V.<br />
Michels, S. Middha, S. Baheti, P. C. Abell Aleff, T. M.<br />
Olson.<br />
1696T Challenges in interpreting secondary variants<br />
from massively parallel sequencing, perspectives from<br />
the ClinSeq study. D. Ng, J. J. Johnston, K. L. Lewis,<br />
S. G. Gonsalves, L. N. Singh, L. C. Peller, J. K. Teer, J. C.<br />
Mullikin, L. G. Biesecker.<br />
1697T An intronic mutation affecting pre-mRNA<br />
splicing in the COL3A1 gene as novel mechanisms<br />
causing vascular Ehlres-Danlos syndrome. A.<br />
Watanabe, B. T. Naing, M. Sasaki, K. Akutsu, S. Kosaihira,<br />
A. Gemma, T. Shimada.<br />
1698T Impaired basement membrane function causes<br />
dilated cardiomyopathy in Marfan syndrome. J. R.<br />
Cook, L. Carta, L. Benard, E. R. Chemaly, E. Chiu, T.<br />
Hampton, N. Clayton, C. Nelson, B. Wentworth, R. J.<br />
Hajjar, F. Ramirez.<br />
1699T Oxidative stress as a modifier <strong>of</strong> cardiovascular<br />
disease in a mouse model <strong>of</strong> Williams Beuren<br />
syndrome. B. Kozel, L. Ye, R. Knutsen.<br />
1700T The National Registry <strong>of</strong> Genetically Triggered<br />
Thoracic Aortic Aneurysms (GenTAC): Registry<br />
progress and research successes. C. Maslen, GenTAC<br />
Consortium.<br />
1701T Association <strong>of</strong> CRP gene variation in Asian<br />
Indian Takayasu’s arteritis patients. K. Shah, D.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
180 POSTER SESSIONS<br />
Danda, R. Shah, S. Prasanna, P. Chandna, R. Chopra,<br />
S. Danda.<br />
1702T Cardiomyopathy as an emerging phenotype<br />
in hereditary inclusion body myopathy. S. Siebel, S.<br />
McGehee, A. Br<strong>of</strong>ferio, C. Ciccone, M. Huizing, L. Medne,<br />
R. Finkel, J. McKew, W. A. Gahl, N. Carrillo-Carrasco.<br />
1703T Role <strong>of</strong> the Pro12Ala, G972R, G1057D<br />
polymorphism <strong>of</strong> the PPAR- g 2, IRS1 and IRS2 genes<br />
in type 2 diabetes and coronary artery disease. S. Vats,<br />
K. Matharoo, V. Sambyal, A. J. S. Bhanwer.<br />
1704T Genetic causes <strong>of</strong> cardiomyopathy in pediatric<br />
transplant recipients. L. Zahavich, A. Al-Maawali, A.<br />
Dipchand, C. Manlhiot, S. Bowdin.<br />
1705T Is your mother or father’s family history more<br />
important when assessing your risk <strong>of</strong> having high<br />
blood pressure: Studies in humans and mice. C. L.<br />
Chiu, C. T. Morgan, S. J. Lupton, S. Lujic, J. M. Lind.<br />
1706T Analysis <strong>of</strong> variations from exome sequence<br />
data with subclinical cardiovascular disease in the<br />
diabetes heart study: Variations from exome sequence<br />
data with subclinical cardiovascular disease in the<br />
diabetes heart study. J. Adams, A. Cox, B. Freedman, J.<br />
Carr, D. Bowden.<br />
1707T Common familial effects on ischemic stroke and<br />
myocardial infarction: A Swedish national cohort study.<br />
K. Kasiman, C. Lundholm, S. Sandin, N. Malki, P. Sparén,<br />
E. Ingelsson.<br />
1708T Jervell and Lange-Nielson syndrome:<br />
Homozygous missense mutation in KCNQ1 in a Turkish<br />
family. S. Temel, O. Bostan, H. Cangul, E. Cil.<br />
1709T Genetic risk pr<strong>of</strong>iles for incident coronary<br />
heart disease using a 28 SNP marker panel in four<br />
prospective cohorts. E. Tikkanen, A. S. Havulinna, A.<br />
Palotie, V. Salomaa, S. Ripatti.<br />
1710T Vascular stiffness in a healthy high risk African<br />
<strong>American</strong> population is modified by the extent <strong>of</strong><br />
European admixture. D. Vaidya, R. A. Mathias, L. R.<br />
Yanek, L. C. Becker, D. M. Becker.<br />
1711T A Dutch founder mutation in the cardiac<br />
regulatory light chain (MYL2). I. P. C. Krapels, G. R. F.<br />
Claes, M. B. Hoos, Y. E. G. Barrois, J.-W. Sels, A. T. J.<br />
M. Helderman-van den Enden, P. G. A. Volders, H. J. M.<br />
Smeets, A. Van den Wijngaard.<br />
1712T Genome-wide DNA methylation pr<strong>of</strong>iling in<br />
myocardial infarction. A. Russo, G. Fiorito, S. Guarrera,<br />
C. Di Gaetano, F. Ricceri, F. Rosa, A. Allione, F. Voglino,<br />
L. Iacoviello, M. C. Giurdanella, R. Tumino, S. Grioni, V.<br />
Krogh, A. Mattiello, S. Panico, P. Vineis, C. Sacerdote, G.<br />
Matullo.<br />
1713T Common cardiovascular disease risk factors are<br />
associated with mitochondrial DNA levels. S. Mitchell,<br />
K. Brown-Gentry, M. Allen, L. Hunt, P. Mayo, N. Schnetz-<br />
Boutaud, D. C. Crawford, D. G. Murdock.<br />
1714T Assessing change in quality <strong>of</strong> life in patients<br />
participating in Additional KIF6 Risk Offers Better<br />
Adherence to Statins trial. H. R. Superko, S. L. Charland,<br />
B. C. Agatep, V. Herrera, M. Ryvkin, B. J. Schrader, J.<br />
Shabbeer, J. J. Devlin, E. J. Stanek.<br />
1715T Heritability <strong>of</strong> John Henryism, and correlation<br />
between John Henryism and hypertension in the<br />
Jackson Heart Study. S. G. Buxbaum, P. Goel, W. White,<br />
M. Gregoski, S. H. Dunn.<br />
Genetic Counseling and Clinical<br />
Testing<br />
1716W Assessment <strong>of</strong> health information technology<br />
tools use among cancer genetic counselors. M. Doerr,<br />
T. Vu, C. Eng.<br />
1717W Behavior and food-related concerns in<br />
children with Smith-Magenis syndrome are similar<br />
to Prader-Willi syndrome. L. V. Barton, T. P. York, S. H.<br />
Elsea.<br />
1718W Genetic counseling future in historicist Middle<br />
East culture. A. Haghighatfard, M. Mahdavi.<br />
1719W Pre-conception genetic counseling awareness<br />
in a post-secondary educational institute. A. Neogi, A.<br />
Mahesh, D. Jalaluddin Shariff.<br />
1720W Genetic counseling in India: Challenges in a<br />
developing country. R. Puri, U. Kotecha, R. Saxena, J.<br />
Verma, S. Movva, S. Kohli, I. C. Verma.<br />
1721W A novel GLI2 mutation and discordant<br />
holoprosencephaly phenotypes in monozygotic twins.<br />
C. Quindipan, M. Van Hirtum-Das, S. Saitta.<br />
1722W Furnishing appropriate information on<br />
mitochondrial diseases to patients and their families.<br />
Y. Sato, Y. Goto.<br />
1723W A special thalassemia case with probable<br />
uniparental disomy. Y. Zhang, J. Wu, M. Q. Mai, A. H. Yin,<br />
H. K. Ding, D. Q. Qin, Q. Y. Du, J. Q. Liang.<br />
1724W Understanding the needs <strong>of</strong> parents <strong>of</strong> children<br />
with a genetic diagnosis: Can it improve clinical<br />
practice? L. Bryson, J. Dunlop, A. Anderson, J. Berg.<br />
1725W A diagnostic assay for predicting medullary<br />
cystic kidney disease type 1. B. Blumenstiel, M.<br />
DeFelice, A. Kirby, A. Gnirke, A. Bleyer, S. Gabriel, M. Daly.<br />
1726W Studding the importance <strong>of</strong> common<br />
a-deletions among b-thalassemia minor individuals in<br />
an Iranian population based on their frequencies and<br />
CBC indexes. A. Moosavi, M. Karimipoor, S. Zeinali, B.<br />
Zarbakhsh.<br />
1727W Genomic data interpretation challenges:<br />
Healthy older relatives as super controls. M. S.<br />
Naslavsky, R. C. M. Pavanello, N. C. V. Lourenço, A.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
Cerqueira, M. Lazar, M. Vainz<strong>of</strong>, D. Schlesinger, M. Zatz.<br />
1728W Assessment <strong>of</strong> cascade testing in families <strong>of</strong><br />
carriers identified through newborn screening for<br />
cystic fibrosis in western Brittany, France. C. Ferec, I.<br />
Dugueperoux, M.-P. Audrezet, P. Parent, V. Scotet.<br />
1729W NextGen sequencing <strong>of</strong> HEXA: A more<br />
sensitive assay. J. H<strong>of</strong>fman, M. Umbarger, C. Kennedy,<br />
B. Bishop, P. Saunders, G. Porreca, E. Strovel, M.<br />
Blitzer, J. Douyard, J. Davies, S. Hallam, V. Greger, C.<br />
Towne.<br />
1730W No association between ATXN2 (SCA2)<br />
CAG repeat expansion and amyotrophic lateral<br />
sclerosis /parkinsonism-dementia complex <strong>of</strong> the<br />
Kii Peninsula, Japan. H. Tomiyama, C. Yamashita, R.<br />
Sasaki, Y. Li, M. Funayama, N. Hattori, S. Kuzuhara, Y.<br />
Kokubo.<br />
1731W Assigning disease liability <strong>of</strong> mutations in<br />
the CFTR gene improves detection rate <strong>of</strong> CF carrier<br />
screening. K. R. Siklosi, P. R. Sosnay, F. Van Goor, K.<br />
Kaniecki, M. Corey, A. S. Romalho, M. D. Amaral, R.<br />
Dorfman, R. Karchin, M. H. Lewis, H. Yu, J. Zielenski,<br />
J. M. Rommens, C. Castellani, C. M. Penland, G. R.<br />
Cutting.<br />
1732W Mutational screening <strong>of</strong> C9ORF72, SOD1,<br />
TARDBP and FUS genes in an ALS cohort from the<br />
Northeastern part <strong>of</strong> Italy. C. Bertolin, J. Agostini,<br />
C. D’Ascenzo, F. Boaretto, C. Salvoro, C. Angelini, E.<br />
Pegoraro, G. Sorarù, M. L. Mostacciuolo.<br />
1733W Cree leukoencephalopathy and Cree<br />
encephalitis carrier screening program: Live<br />
experiences <strong>of</strong> carrier and non-carrier couples. J. Le<br />
Clerc-Blain, H. Denoncourt, A. Richter, A. M. Laberge.<br />
1734W Diagnostic exome sequencing in movement<br />
disorders. E. J. Kamsteeg, C. F. H. A. Gilissen, K.<br />
Neveling, H. J. E. de Reuver, B. P. C. van de Warrenburg,<br />
M. A. A. P. Willemsen, S. Vermeer, H. G. Brunner, M. R.<br />
Nelen, H. Scheffer.<br />
1735W Whole exome sequencing as an approach to<br />
the diagnosis <strong>of</strong> the ataxic patients. Y. Yang, M. Vatta,<br />
Z. Niu, Y. Ding, H. Sun, M. Scheel, N. Saada, W. Liu, M.<br />
Wang, D. P. Sexton, A. C. Hawes, M. N. Bainbridge, P. A.<br />
Pham, J. G. Reid, D. M. Muzny, A. A. Braxton, P. A. Ward,<br />
T. M. Balmakund, W. K. Chung, A. Willis, S. E. Plon, J. R.<br />
Lupski, R. A. Gibbs, A. L. Beaudet, C. M. Eng.<br />
1736W A retrospective genetic analysis <strong>of</strong> cases<br />
reported using an XLMR/XLID next-generation<br />
sequencing panel. M. Parra, S. Mexal, R. Hoiness, K.<br />
Waller, I. Lu, C. Gau, J. A. Neidich, J. Wei.<br />
1737W Principles and informatic infrastructure<br />
for implementing diagnostic next-generation<br />
sequencing for genetically heterogeneous<br />
conditions. S. Topper, V. Nelakuditi, C. Tan, A. Reeder,<br />
D. del Gaudio, S. Das.<br />
1738W Clinical characterization <strong>of</strong> patients<br />
POSTER SESSIONS 181<br />
undergoing molecular testing for Ehlers Danlos<br />
syndrome at The Hospital for Sick Children in Toronto,<br />
Canada: Five year experience. L. Dupuis, M. A.<br />
Qoqandi, P. Kannu, L. Fishman, D. Chitayat, S. Bowdin,<br />
R. Mendoza-Londono.<br />
1739W Detection <strong>of</strong> oipA using PCR method can help<br />
to the diagnosis <strong>of</strong> Helicobacter pylori in the dyspeptic<br />
patients. L. Salimzadeh, N. Bagheri, F. Azadegan, G.<br />
Rahimian, A. Taghikhani, M. Hashemzadeh, H. Shirzad.<br />
1740W Connecting family branches through recurrent<br />
BRCA mutations. A. Toland, M. O’Connor, L. Senter.<br />
1741W Low prevalence <strong>of</strong> large genomic<br />
rearrangements in BRCA1/2 found in at-risk Southern<br />
California population. T. H<strong>of</strong>fman, M. Alvarado.<br />
1742W Clinical whole exome sequencing for the<br />
diagnosis <strong>of</strong> Mendelian disorders: <strong>Program</strong> design,<br />
implementation, and first year reporting experience.<br />
C. M. Eng, D. Muzny, J. Reid, M. Bainbridge, P. Pham, M.<br />
R. Bekheirnia, J. Beuten, M. Hardison, Z. Niu, R. Person,<br />
M. Vatta, F. Xia, A. Hawes, M. Wang, Y. Ding, H. Sun, M.<br />
Scheel, N. Saada, W. Liu, A. Braxton, P. Ward, A. Willis, J.<br />
Wiszniewska, S. E. Plon, J. R. Lupski, A. L. Beaudet, R. A.<br />
Gibbs, Y. Yang.<br />
1743W Diagnostic yield <strong>of</strong> single nucleotide<br />
polymorphism array-based genotyping is equivalent<br />
to metaphase cytogenetics for Turner syndrome. S. K.<br />
Prakash, D. C. Guo, C. L. Maslen, M. Silberbach, D. M.<br />
Milewicz, C. A. Bondy, GenTAC Investigators.<br />
1744W High resolution copy number pr<strong>of</strong>iling <strong>of</strong> the X<br />
chromosome in clinical diagnosis. S. A. Yatsenko, S.<br />
Madan-Khetarpal, U. Surti, A. Rajkovic.<br />
1745W MLPA-based strategy for discrete CNV<br />
genotyping: CNV-miRNAs as an example. M.<br />
Marcinkowska, P. Kozlowski.<br />
1746W Turkish medical students perceived genetic<br />
counseling style and the use <strong>of</strong> hypothetical genetic<br />
testing across 5 psychiatric and 3 non-psychiatric<br />
disorders. D. Kinney, E. A. Ergul, K. Munir, O. Kutuk, F.<br />
Topuz, A. Kanik.<br />
1747W Non-optical massive parallel DNA sequencing<br />
<strong>of</strong> BRCA1 and BRCA2 genes: Towards the diagnostic<br />
setting. J. L. Costa, S. Sousa, R. Fernandes, L. Cirnes, J.<br />
C. Machado.<br />
1748W Identifying the genetic cause <strong>of</strong> primary<br />
immunodeficiency diseases: Development <strong>of</strong> a<br />
next-generation sequencing approach for routine<br />
diagnostics. S. C. Drury, C. Bacchelli, S. Bibi, F. McKay,<br />
L. Jenkins, H. B. Gaspar, C. M. Cale, K. C. Gilmour, N. J.<br />
Lench.<br />
1749W Exome sequencing analysis for diagnostics.<br />
C. Gilissen, M. Nelen, K. Neveling, R. de Reuver, L. E. L.<br />
M. Vissers, N. Wieskamp, H. G. Yntema, J. de Ligt, M.<br />
Rosario, H. G. Brunner, H. Scheffer, J. A. Veltman.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
182 POSTER SESSIONS<br />
1750W Detection and mapping the breakpoints <strong>of</strong><br />
heteroplasmic mtDNA deletions by massively parallel<br />
sequencing. F.-Y. Li, H. Cui, D. Gonzalez, J. Wang, V.<br />
Zhang, L.-J. Wong.<br />
1751W Three novel AGL mutations in glycogen storage<br />
disease type III in Tunisian families. A. Mili, O. Mamaï, I.<br />
Ben Charfeddine, A. Amara, S. Pagliarani, S. Lucchiari, A.<br />
Saad, K. Limem, M. Gribaa.<br />
1752W Multiplex PCR assay for detection <strong>of</strong> the 2<br />
most common mutations in the pr<strong>of</strong>ilaggrin gene (FLG)<br />
involved in ichthyosis vulgaris. G. Pont-Kingdon, L.<br />
Hubley, E. E. Baldwin, E. Lyon.<br />
1753W GeneReviews as a source <strong>of</strong> medically<br />
actionable information for coincidentally diagnosed<br />
disorders. M. P. Adam, C. R. Dolan, A. R. Amemiya, M.<br />
Espeseth, T. D. Bird, K. Stephens, R. A. Pagon.<br />
1754W Comprehensive diagnostic hearing loss testing<br />
on a single platform: The OtoGenome test. S. S. Amr, T.<br />
J. Pugh, E. Duffy, L. Farwell, S. Gowrisankar, A. Lovelette-<br />
Hernandez, B. H. Funke, H. L. Rehm.<br />
1755W Allele drop out and MECP2 genetic testing. E.<br />
Bettella, R. Polli, E. Leonardi, A. Murgia.<br />
1756W Screening for and Identification <strong>of</strong> pathogenic<br />
mutations in patients with inherited retinal<br />
degenerations using targeted enrichment and<br />
next-generation sequencing. M. B. Consugar, Z. D.<br />
Fonseca-Kelly, E. M. Place, E. Au, S. M. Harper, X. Gai, E.<br />
L. Berson, E. A. Pierce.<br />
1757W Validation <strong>of</strong> whole exome sequencing assay<br />
for clinic service at Baylor College <strong>of</strong> Medicine. Y. Ding,<br />
D. M. Muzny, J. G. Reid, M. Wang, Y. Han, H. Dinh, D. P.<br />
Sexton, M. N. Bainbridge, A. C. Hawes, P. Pham, B. Yin,<br />
D. P. C. Ng, C. J. Buhay, J. Wiszniewska, M. Scheel, N.<br />
Saada, W. Liu, H. Sun, R. A. Gibbs, A. L. Beaudet, C. M.<br />
Eng, Y. Yang.<br />
1758W Advancing from targeted resequencing to whole<br />
exome sequencing for improving the molecular diagnosis<br />
<strong>of</strong> congenital disorders <strong>of</strong> glycosylation. M. A. Jones, B.<br />
G. Ng, P. He, M. E. Losfeld, S. Bhide, D. Rhodenizer, E. L. H.<br />
Chin, M. He, H. H. Freeze, M. R. Hegde.<br />
1759W A novel splice site variant (IVS44-3T.C) in<br />
COL3A1 results in small amounts <strong>of</strong> exon skipping<br />
and complicates genetic counseling in a family with<br />
features <strong>of</strong> hypermobility Ehlers-Danlos syndrome. D.<br />
F. Leistritz, U. Schwarze, D. Sarroza, P. D. Steele, C. Boni,<br />
B. A. Salbert, P. H. Byers.<br />
1760W A DNA-based method for detecting<br />
homologous blood doping. I. Manokhina, J. L. Rupert.<br />
1761W Identification <strong>of</strong> ARID1B mutations in<br />
intellectual disability/C<strong>of</strong>fin-Siris patients by clinical<br />
whole exome sequencing analysis. Z. Niu, M. Vatta, A.<br />
Willis, Y. Ding, H. Sun, M. Scheel, N. Saada, W. Liu, M.<br />
Wang, D. P. Sexton, A. C. Hawes, M. N. Brainbridge, P.<br />
Pham, J. G. Reid, D. M. Muzny, P. A. Ward, A. A. Braxton,<br />
A. Scheuerle, M. K. Koenig, S. E. Plon, J. R. Lupski, R. A.<br />
Gibbs, A. L. Beaudet, Y. Yang, C. M. Eng.<br />
1762W National Institutes <strong>of</strong> Health Genetic Testing<br />
Registry. W. S. Rubinstein, D. Maglott, B. L. Kattman,<br />
A. Malheiro, J. Lee, M. Ovetsky, V. Hem, G. Song, V.<br />
Gorelenkov, C. Fomous, J. Ostell.<br />
1763W EuroGentest Clinical Utility Gene Cards:<br />
Progress and perspectives. J. Schmidtke, A. Dierking.<br />
1764W Mutation screening <strong>of</strong> genes causing inherited<br />
immunodeficiency and bone marrow failure using nextgeneration<br />
sequencing. T. A. Sivakumaran, A. Husami, D.<br />
Kissell, K. Zhang.<br />
1765W Mutation analysis <strong>of</strong> the SOX2 and OTX2 genes<br />
in 235 patients with developmental eye disorders. N.<br />
Smaoui, B. Williams, S. Aradhya, S. Bale, S. Suchi, G.<br />
Richard.<br />
1766W Digitizing clinical genetic literature: A<br />
comprehensive, accurate and scalable approach. M.<br />
Sommargren, Locus Development, Inc.<br />
1767W Estimated variant rate for a next-generation<br />
sequencing panel <strong>of</strong> 13 genes associated with hereditary<br />
colon cancer. A. J. Stuenkel, S. L. Tandy, J. D. Siegfried.<br />
1768W Simple and accurate assays for targeting<br />
CFTR mutations <strong>of</strong> specific geographic/ethnic<br />
origins by PCR allelic discrimination: still a place for<br />
targeted tools. C. Vasseur, A. LeFloch, B. Costes, A. de<br />
Becdelièvre, T. Casals, C. Costa, M. Goossens, E.<br />
Girodon.<br />
1769W The CLARITY Challenge: Children’s leadership<br />
award for the reliable interpretation and appropriate<br />
transmission <strong>of</strong> your genomic information. C. A.<br />
Brownstein, E. T. DeChene, K. C. Flannery, S. W. Kong, M.<br />
C. Connolly, I. S. Kohane, A. H. Beggs, D. M. Margulies.<br />
1770W What is a clinical grade genome? F. De La Vega,<br />
A. Russell, M. A. Morales, C. D. Bustamante, M. G. Reese.<br />
1771W The mutation type and effect <strong>of</strong> variants<br />
underlying human genetic diseases. J. Westbrook, Y.<br />
Kobayashi, Locus Development, Inc.<br />
1772W Application <strong>of</strong> next-generation sequencing<br />
technology in the study <strong>of</strong> mitochondrial diseases. Y.<br />
Ma, Y. Cao, Z. Chen, H. Pan, Y. Qi.<br />
1773W A combined next-generation sequencing and<br />
exon-level aCGH diagnostic gene panel for severe<br />
developmental delay and epilepsy phenotypes. N.<br />
J. Lench, H. Moody, A. McTague, E. Meyer, S. Drury, S.<br />
Fielding, R. Palmer, M. A. Kurian, R. H. Scott.<br />
1774W High-throughput mutation screening in patients<br />
with inherited retinal dystrophies. X. Wang, A. Turner, M.<br />
Brooks, H. Rajasimha, K. Johnson, Y. Fann, A. Swaroop.<br />
1775W Predictive testing for neurodegenerative<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
conditions is <strong>of</strong>ten not predictive. C. L. Goldsmith, D. A.<br />
Dyment, K. M. Boycott.<br />
1776W Large scale population analysis challenges<br />
the current criteria for the molecular diagnosis <strong>of</strong><br />
fascioscapulohumeral muscular dystrophy. I. Scionti,<br />
F. Greco, G. Ricci, M. Govi, P. Arashiro, L. Vercelli, T.<br />
Mongini, A. Berardinelli, C. Angelini, G. Antonini, M. Cao,<br />
A. Di Muzio, M. Moggio, L. Morandi, E. Ricci, C. Rodolico,<br />
L. Ruggiero, L. Santoro, G. Siciliano, G. Tomelleri, C. P.<br />
Trevisan, G. Galluzzi, W. Wright, M. Zatz, R. Tupler.<br />
1777W Identification <strong>of</strong> a common pan-ethnic<br />
haplotype enriched on SMN1 duplication alleles<br />
improves the detection <strong>of</strong> silent (210) SMA carriers and<br />
significantly modifies residual risk estimates. M. Luo,<br />
L. Liu, I. Peter, J. Zhu, S. A. Scott, G. Zhao, C. Eversley, R.<br />
Kornreich, R. J. Desnick, L. Edelmann.<br />
1778W Multiplexing test for molecular diagnosis <strong>of</strong><br />
skeletal dysplasia (by CGC mutation panel). P. Tavares,<br />
A. Lopes, L. Lameiras, L. Dias, J. Sá, A. Palmeiro, P.<br />
Rendeiro.<br />
1779W A combination <strong>of</strong> panel and exome sequencing<br />
to identify novel human retinitis pigmentosa genes. F.<br />
Wang, H. Wang, J. Zaneveld, K. Zhang, R. Koenekoop,<br />
G. Silvestri, N. Solanki, J. Cheng, I. Lopez, H. Ren, D.<br />
Simpson, R. Chen.<br />
1780W Evaluation <strong>of</strong> BRCA1 mutations in patients with<br />
family history <strong>of</strong> breast cancer. S. Rummel, C. D. Shriver,<br />
R. E. Ellsworth.<br />
1781W Measuring clinician satisfaction with disclosure<br />
<strong>of</strong> genetic susceptibility test results: Findings from the<br />
REVEAL Study. S. L. Everhart, B. M. Wood, K. Valverde, L.<br />
Medne, J. S. Roberts, C. A. Chen, K. D. Christensen, R. C.<br />
Green, REVEAL Study Group.<br />
1782W Reactions to direct-to-consumer BRCA test<br />
results. U. Francke, C. Dijamco, A. K. Kiefer, N. Eriksson,<br />
J. Y. Tung, J. L. Mountain.<br />
1783W Targeted gene capture <strong>of</strong> BRCA1 using short,<br />
explicitly non-gene-specific, peptide nucleic acid baits.<br />
S. V. Tavtigian, K. Tao, R. Bell, J. Rosenthal, W. Kohlmann.<br />
1784W Predictive testing for idiopathic scoliosis: Are<br />
orthopedic surgeons and pediatricians ready and<br />
willing? A. M. Laberge, A. Moreau.<br />
1785W Myocilin genetic screening in severe<br />
glaucoma cases and cascade testing in the<br />
Australian and New Zealand Registry <strong>of</strong> Advanced<br />
Glaucoma. E. Souzeau, K. P. Burdon, B. Usher-Ridge,<br />
A. Dubowsky, J. E. Craig.<br />
1786W Parental awareness, attitudes, and experiences<br />
<strong>of</strong> genetic testing in autism spectrum disorders. A.<br />
Rupchock, M. Cuccaro, M. Alessandri, J. M. Lee.<br />
1787W Genetic testing in autism: Parental attitudes<br />
and expectations. M. Cuccaro, K. Czape, J. M. Lee, A.<br />
Rupchock, E. Bendik, M. Alessandri, S. Hahn.<br />
POSTER SESSIONS 183<br />
1788W Underestimated intimate issues after bilateral<br />
prophylactic mastectomy with breast reconstruction in<br />
healthy BRCA mutation carriers. A. Tibben, J. Gopie, C.<br />
Seynaeve, M. Ter Kuile, M. Menke-Pluymers, R. Timman,<br />
M. Mureau.<br />
1789W Risk <strong>of</strong> peripartum acute aortic dissection in<br />
women with ACTA2 mutations. E. Regalado, D. Guo, D.<br />
Milewicz.<br />
1790W Translational impact <strong>of</strong> VEGFA variants on the<br />
prediction and follow-up <strong>of</strong> ocular complications in<br />
pseudoxanthoma elasticum. E. De Vilder, M. J. Hosen,<br />
L. M. Martin, B. P. Leroy, J. M. Ebran, P. J. Coucke, A. De<br />
Paepe, O. M. Vanakker.<br />
1791W Familial occurrence and associated symptoms<br />
in a population <strong>of</strong> individuals with non-syndromic<br />
craniosynostosis. J. Greenwood, S. Boyadjiev, K. Osann,<br />
P. Flodman, V. Kimonis.<br />
1792W Personalized risk prediction in a populationbased<br />
biobank: The Estonian experience. K. Fischer, K.<br />
Läll, L. Leitsalu-Moynihan, P. C. Ng, T. Haller, T. Esko, A.<br />
Metspalu.<br />
1793W Acquired thrombophilias; The reproductive<br />
geneticist’s dilemma. T. Goldwaser, K. Bajaj, S. Klugman.<br />
1794W Family history and risk assessment in black<br />
South African women with breast cancer. T. Wainstein,<br />
C. van Wyk, A. Krause.<br />
1795W Support for patients with Young-Simpson<br />
syndrome, their families and other peoples concerned:<br />
Study <strong>of</strong> patients and family group meetings.<br />
Y. Yamanouchi, T. Nishikawa, K. Enomoto, N. Furuya,<br />
S. Mizuno, T. Kondo, M. Adachi, K. Muroya, M. Masuno,<br />
K. Kurosawa.<br />
1796W Duplications Xq28 are questionable for genetic<br />
counseling. C. Costa, A. Briand, C. Rothschild, E. Bieth,<br />
J. Melki, C. Metay, M. Goossens.<br />
Ethical, Legal, Social and Policy<br />
Issues in <strong>Genetics</strong><br />
1797W Surname leakage from personal genomes.<br />
Y. Erlich, M. Gymrek, D. Golan, E. Halprein, A. L. McGuire.<br />
1798F Optional enrollment into access controlled<br />
genomic databases: Decision making in hispanics<br />
versus non-Hispanics. S. Scollon, S. Gutierrez,<br />
A. L. McGuire, S. Hicks, S. E. Plon.<br />
1799W Development <strong>of</strong> institutional genomic research<br />
infrastructure in an academic pediatric hospital setting<br />
to enable large-scale enrollment, education and<br />
discovery. C. M. Clinton, S. K. Savage, C. A. Brownstein,<br />
I. A. Holm, D. M. Margulies, W. A. Wolf.<br />
1800F A proposal: A family driven social network<br />
model for clinical data sharing and research in<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
184 POSTER SESSIONS<br />
intellectual deficiencies and other neurodevelopmental<br />
disorders with specific genetic causes. J.-L. Mandel,<br />
J. S. Beckmann.<br />
1801W Turkish medical students attitude towards<br />
the ethics <strong>of</strong> genetic testing and genetic information<br />
disclosure in fragile X syndrome, breast cancer and<br />
Huntington disease. E. A. Ergul, I. Gun.<br />
1802F Hope and hype in sight: Multi-stakeholder<br />
perspectives on ocular gene therapy. S. Benjaminy,<br />
T. Bubela, M. Bieber, I. MacDonald.<br />
1803W Social and ethical implications <strong>of</strong> families’<br />
experiences <strong>of</strong> pediatric genetics: Key findings from a<br />
U.K. qualitative study exploring families’ expectations,<br />
their responses to diagnosis and their approach to<br />
managing the uncertainties <strong>of</strong> genetic investigations.<br />
J. McLaughlin, M. Wright, E. K. Clavering, E. Haimes.<br />
1804F Driving research forward, but in what direction?<br />
Scientist perspectives on goals and groups invested in<br />
autism genetic research. L. C. Milner, M. K. Cho.<br />
1805W Experiential process <strong>of</strong> securing free prior<br />
informed consent for genetics research from an<br />
indigenous population in the Philippines. C. D. Padilla,<br />
A. L. Sur, M. T. Guia-Padilla, M. Baluyot, E. M. Cutiongcode<br />
la Paz, S. Padilla.<br />
1806F The essential ethical considerations for using<br />
human genome sequencing as a diagnostic tool in<br />
clinical medicine. A. D. Zellers.<br />
1807W The evaluation <strong>of</strong> low template, degraded and<br />
mixed DNA pr<strong>of</strong>iles in forensic science. D. Balding.<br />
1808F Legal considerations regarding participant<br />
privacy in the genomic era <strong>of</strong> research on the African<br />
continent. G. E. B. Wright, P. Koornh<strong>of</strong>, N. Tiffin.<br />
1809W Insurance coverage <strong>of</strong> preventive services for<br />
individuals with genetic predispositions to cancer.<br />
A. Prince.<br />
1810F The implementation and impact <strong>of</strong> student<br />
athlete sickle cell trait screening: A survey <strong>of</strong> Division I<br />
California universities. L. Mar, N. Lovick, C. Hartshorne,<br />
M. Treadwell, J. Youngblom.<br />
1811W Direct to consumer genetic testing: What<br />
information for which consent? J. Atia, E. Rial-Sebbag,<br />
V. Anastosova, A. Cambon-Thomsen, F. Taboulet.<br />
1812F Genetic discrimination and the relevance <strong>of</strong> the<br />
United Nations Convention on the Rights <strong>of</strong> Persons<br />
with Disabilities. A. de Paor.<br />
1813W Representing the indigenous community:<br />
Researcher and physician voices spark debate over<br />
newborn screening <strong>of</strong> CPT1A in Alaska Native and First<br />
Nations populations. N. Garrison.<br />
1814F Next-generation sequencing <strong>of</strong> pluripotent stem<br />
cell lines: Ethical, social and policy considerations.<br />
R. Isasi.<br />
1815W Research policy <strong>of</strong> the “Genome Science”<br />
project in Japan. J. Minari, T. Shirai, G. Yoshizawa,<br />
K. Okada, N. Yamamoto, K. Kato.<br />
1816F Cultural influences on genetic testing in East<br />
Asia. H. Numabe.<br />
1817W The need for an ELSI watch <strong>of</strong> epigenetic<br />
information. E. Rial-Sebbag, A. Soulier, C. Delpierre.<br />
1818F Pervasive sequence patents cover the entire<br />
human genome. J. A. Rosenfeld, P. Zumbo, C. E. Mason.<br />
1819W The revised points <strong>of</strong> ethical guidelines for<br />
human genome research in Japan. Z. Yamagata,<br />
K. Muto.<br />
1820F Does evidence justify the use <strong>of</strong> multigene<br />
sequencing panels for rare genetic disorders?<br />
D. Allingham-Hawkins, A. Lea, L. Cushman-Spock,<br />
L. Wieselquist, S. Levine.<br />
1821W The student-athlete’s knowledge, behaviors,<br />
concerns and perceptions in regards to mandatory<br />
sickle cell trait testing. N. E. Thompson, B. W. Harrison,<br />
F. Ampy, R. F. Murray, Jr.<br />
1822F Primary care patients’ experience <strong>of</strong><br />
and reactions to direct-to-consumer genomic testing:<br />
A longitudinal qualitative study. K. Wasson, T. N.<br />
Sanders, N. S. Hogan, S. Cherny, K. J. Helzlsouer.<br />
1823W Whole genome sequencing: Will it destroy<br />
newborn screening? C. Allen, D. Avard, B. M. Knoppers.<br />
1824F Patient and provider perspectives on<br />
personalized genomic medicine: Qualitative substudy<br />
<strong>of</strong> a multicenter feasibility study <strong>of</strong> genomic<br />
sequencing in advanced cancer patients. J. P.<br />
Bytautas, F. A. Miller, R. Z. Hayeems, S. Ernst, H. Hirte,<br />
S. Hotte, A. Oza, A. Razak, S. Welch, E. Winquist, P. L.<br />
Bedard, J. Dancey, L. L. Siu.<br />
1825W Consumer genomics: Motivations and<br />
intentions. R. C. Green, J. Mountain, A. Kiefer, T. Moreno,<br />
E. MacBean, S. S. Kalia, J. S. Roberts, PGen Study Group.<br />
1826F The Ethical, Legal and Social Implications<br />
<strong>Program</strong>: Impact on federal policy. D. Mathews,<br />
B. Drehman.<br />
1827W Public perspectives regarding personalized<br />
medicine and genomic risk pr<strong>of</strong>iling within colorectal<br />
cancer screening. S. G. Nicholls, B. J. Wilson, S. Craigie,<br />
H. Etchegary, D. Castle, J. C. Carroll, B. K. Potter,<br />
L. Lemyre, J. Little on behalf <strong>of</strong> CIHR Emerging Team in<br />
Genomics in Screening.<br />
1828F Pursuing pharmacogenomic testing within<br />
a nonpr<strong>of</strong>it healthcare system: A comparison <strong>of</strong><br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
stakeholders’ perspectives. S. M. Fullerton,<br />
S. B. Trinidad, J. D. Ralston, J. T. Tufano, G. P. Jarvik,<br />
E. B. Larson.<br />
1829W Public preferences for the use <strong>of</strong> email and<br />
Internet communication in large-scale genetic and<br />
biobank research. J. Murphy Bollinger, R. Dvoskin,<br />
K. Kreger, D. Kaufman.<br />
1830F Public attitudes towards consumer genetics in<br />
Japan, South Korea and Taiwan. K. Muto, M. Sato, H.<br />
Hong, C. Chang.<br />
1831W Japanese networkers’ attitudes toward<br />
personal genome services. T. Kido, M. Kawashima.<br />
1832F Genetic risk predictions: Attitude <strong>of</strong> the Estonian<br />
public. L. Leitsalu-Moynihan, A. Allik, M. L. Tammesoo,<br />
A. Metspalu.<br />
1833W Attitude change for four years toward genetic<br />
testing <strong>of</strong> children for common disease risk in Japan.<br />
I. Ishiyama, K. Muto, A. Tamakoshi, T. Maeda, A. Nagai, Z.<br />
Yamagata.<br />
1834F African <strong>American</strong>s in South Florida’s<br />
perceptions about genetic research participation:<br />
Opportunities and barriers. J. M. Lee, M. Gavier, S. E.<br />
Hahn, L. Adams, D. A. Caldwell, K. G. Murphy, C. Jean,<br />
M. A. Pericak-Vance.<br />
1835W Unexpected results in biobank research:<br />
Experiences <strong>of</strong> information delivery and direction to<br />
health care after detection <strong>of</strong> mutations leading to long<br />
QT syndrome. H. Kaariainen, E. Kujala, P. Alha,<br />
V. Salomaa, S. Koskinen, H. Swan, A. Haukkala.<br />
1836F The Gene Partnership: A model for pediatric<br />
genetic repositories in the age <strong>of</strong> the incidentalome.<br />
I. A. Holm, C. M. Clinton, S. K. Savage, P. L. Taylor, K.<br />
D. Mandl, J. P. Bickel, D. J. Nigrin, I. S. Kohane, D. M.<br />
Margulies, L. M. Kunkel.<br />
1837W The Medical College <strong>of</strong> Wisconsin <strong>Program</strong> in<br />
Genomics and Ethics: An empirical bioethics venture.<br />
K. A. Strong, T. May, K. L. Zusevics, A. R. Derse.<br />
1838F Evaluation <strong>of</strong> a scalable method for returning<br />
results and genetic findings from genomic research to<br />
research participants. J. Y. Tung, S. Wu, B. T. Naughton,<br />
J. L. Mountain.<br />
1839W Perceptions <strong>of</strong> genetic counseling services<br />
in direct-to-consumer personal genomic testing. B.<br />
F. Darst, N. J. Schork, E. J. Topol, C. S. Bloss.<br />
1840F Shared decision-making: Seeking a change in<br />
the genetics consult. S. Adam, P. H. Birch, A. Townsend,<br />
F. Rousseau, J. M. Friedman.<br />
1841W Personal genomics: A study assessing the<br />
safety and health outcomes <strong>of</strong> receiving whole exome<br />
sequencing results. Y. Bombard, K. Schrader,<br />
E. Glogowski, R. Rau-Murthy, S. Patil, A. Eaton, E. Elkin,<br />
M. J. Massie, J. Hay, S. Shah, J. Vijai, N. Kauff, Z. Stadler,<br />
M. Robson, K. Offit.<br />
POSTER SESSIONS 185<br />
1842F Integrating exome/genome sequencing into<br />
clinical genetics practice. S. M. Jamal, H. K. Tabor,<br />
J. Conta, J. Yu, M. J. Bamshad.<br />
1843W A proposed approach to the integration <strong>of</strong><br />
sequence data at a pediatric academic institution.<br />
S. K. Savage, C. M. Clinton, I. A. Holm, I. S. Kohane,<br />
D. M. Margulies.<br />
1844F Assessing participant preferences for the return<br />
<strong>of</strong> genomic research results. L. Shahmirzadi, M. K. Cho,<br />
S. Soo-Jin Lee, K. E. Ormond.<br />
1845W The NHGRI/NIH Clinical Sequencing Exploratory<br />
Research <strong>Program</strong>. B. A. Ozenberger, L. A. Hindorff,<br />
S. D. Schully, J. Boyer, N. Lockhart, L. Lund, C. Mahomva,<br />
A. Felsenfeld, J. E. McEwen.<br />
1846W Genomic incidental findings: Perspectives <strong>of</strong><br />
geneticists and genetic counselors in the context <strong>of</strong><br />
clinical sequencing. Z. Lohn, S. Adam, P. H. Birch,<br />
A. Townsend, J. M. Friedman.<br />
1847W Accounting for racial disparities in mortality<br />
among children with Down syndrome. S. Santoro,<br />
A. Esbensen, L. Hendershot, F. Hickey, B. Patterson.<br />
1848W ELSI 2.0: A new initiative to create an international<br />
infrastructure for the ethical, legal and social implications<br />
<strong>of</strong> genomic research. K. Kato, J. Kaye, E. M. Meslin,<br />
B. M. Knoppers, E. T. Juengst, M. Deschenes, A. Cambon-<br />
Thomsen, D. Chalmers, J. De Vries, K. Edwards, N. Hoppe,<br />
A. Kent, C. Adebamowo, P. Marshall.<br />
1849W The challenges <strong>of</strong> defining a phenotype for<br />
addiction: In the words <strong>of</strong> addiction scientists.<br />
J. B. McCormick, J. E. Ostergren, R. R. Hammer, H. S.<br />
Harvey, M. Dingel, B. A. Koenig.<br />
1850W Discriminating faces: Visual cues <strong>of</strong> ancestry.<br />
J. Wagner, P. Claes, M. Shriver.<br />
<strong>Genetics</strong> Education<br />
1851F Integrating medical genetics into primary health<br />
care: Report <strong>of</strong> a pilot program in Brazil. T. Vieira,<br />
C. Giugliani, L. Silva, L. Faccini, J. Leite, O. Artigalás,<br />
M. Lenz, M. Rojas, R. Giugliani.<br />
1852F The Gene Messenger impact project: A<br />
genetics e-learning program for family physicians.<br />
J. C. Carroll, R. Grad, P. Pluye, J. Allanson, J. Permaul,<br />
N. Pimlott, B. J. Wilson.<br />
1853F Examining the research training <strong>of</strong> recent<br />
genetic counseling graduates. S. Hahn, A. Rupchock,<br />
E. Bendik, E. Burkett, E. Heise.<br />
1854F Increasing the number <strong>of</strong> URMs in genomic<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
186 POSTER SESSIONS<br />
science. D. Murray, D. Whittington, R. Gibbs.<br />
1855F Pharmacotherapy <strong>of</strong> Inherited Metabolic<br />
Diseases PharmD Fellowship Training <strong>Program</strong>. J. Utz,<br />
W. Whitley.<br />
1856F Promoting student engagement and critical<br />
thinking in genetics: An evaluation <strong>of</strong> “Luck <strong>of</strong> the<br />
Draw” game. M. Godfrey, A. Bower, K. L. Tracy, R.<br />
Anderson, A. Jameton, B. Arobba, C. Ryan.<br />
1857F Genetic numeracy in college students:<br />
A quantitative analysis. M. Bergman, H. Honore Goltz.<br />
1858F The Growing Stronger Organization and the<br />
Acondroplasia - Achondroplasia Blog: A parents’<br />
initiative to share knowledge and foster alliances<br />
towards potential therapeutic approaches for<br />
achondroplasia. M. Kaisermann.<br />
1859F <strong>Genetics</strong> Home Reference, ten years in: Where<br />
we are now. S. M. Morrison, M. L. Cheh, S. Calvo, H.<br />
Collins, J. Fun, K. Greenberg, L. Forman-Neall.<br />
1860F Investigating a conceptual change strategy<br />
to improve student understanding <strong>of</strong> basic genetics<br />
concepts in undergraduate non-science major and<br />
nursing student populations. B. Bowling, M. Glassford,<br />
S. Barnes, S. Borgman, E. Reilly, T. Beery, C. Huether.<br />
1861F Alignment and assessment problems in the<br />
undergraduate genetics curriculum. M. Dougherty,<br />
T. McElhinny, B. Bowling, J. Libarkin.<br />
1862F YouTube as an educational resource for visual<br />
and kinesthetic learners: A study <strong>of</strong> DNA replication<br />
animations. J. M. Lind.<br />
1863F Genetic counseling in India: Current certification<br />
courses and a need for the development <strong>of</strong> a master’s<br />
training program. K. Shah.<br />
Health Services Research<br />
1864F A strategy <strong>of</strong> applying comprehensive<br />
therapeutic approaches for training children with<br />
autism. H. Xu, N. Zhong.<br />
1865F <strong>Genetics</strong> and public health: The experience<br />
<strong>of</strong> a referral center for diagnosis <strong>of</strong> 22q11.2 deletion<br />
in Brazil and suggestions for implementing genetic<br />
testing. T. Vieira, I. Sgardioli, V. Gil-da-Silva-Lopes.<br />
1866F Outreach, genetic counseling and testing <strong>of</strong><br />
patients at risk for hereditary breast and ovarian<br />
cancer ascertained through the use <strong>of</strong> the electronic<br />
medical record. H. Kershberg, E. Parkhurst, M. Alvarado,<br />
H. Zhou, J. Natoli, G. Tiller.<br />
1867F Prevalence <strong>of</strong> Down syndrome in the United<br />
States. A. P. Presson, G. Partyka, K. M. Jensen, S. A.<br />
Rasmussen, O. J. Devine, L. McCabe, E. R. B. McCabe.<br />
1868F Rare disease initiatives in Europe: Centers<br />
<strong>of</strong> expertise in Germany. C. Huebner, M. Stuhrmann-<br />
Spangenberg, C. Zeidler, J. Schmidtke.<br />
1869F Implementation <strong>of</strong> universal Lynch syndrome<br />
screening in an integrated health-care delivery system.<br />
K. A. B. Goddard, T. Kauffman, M. Morse, J. Davis, C.<br />
Young, E. Esterberg, C. McGinley, J. Reiss.<br />
1870F Beyond NGS technology: Overcoming key<br />
challenges for nation-wide implementation <strong>of</strong> nextgeneration<br />
sequencing into routine diagnostics.<br />
T. Vrijenhoek on behalf <strong>of</strong> Centre for Genome Diagnostics.<br />
1871F Inherited Neuropathies Consortium: A<br />
collaborative approach to genetic research in<br />
Charcot-Marie-Tooth disease. F. Speziani, S. M. E.<br />
Feely, C. Siskind, S. H. Blanton, G. Beecham, J. M. Vance,<br />
M. Shy, S. Zuchner, Inherited Neuropathies Consortium.<br />
1872F Genomic technologies: Effective integration<br />
into pediatric clinical care. R. Hayeems, N. Hoang, S.<br />
Chenier, J. Stavropoulos, S. Pu, S. Wodak, R. Babul-Hirji,<br />
J. Davies, L. Velsher, J. Aw, R. Weksberg, C. Shuman.<br />
1873F Genomic technologies: Effective integration<br />
into adult preventive medicine. N. Hoang, R. Hayeems,<br />
J. Davies, L. Velsher, J. Aw, S. Chenier, J. Stavropoulos,<br />
S. Pu, S. Wodak, R. Babul-Hirji, R. Weksberg, C. Shuman.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1874F Evaluating laboratories’ interpretation <strong>of</strong> genetic<br />
test results through a EuroGentest Pr<strong>of</strong>iciency Testing<br />
survey. E. Girodon, S. Berwouts, M. Rodriguez de Alba<br />
Freiria, AF. Roux, D. Barton, L. Hoefsloot, S. Gardner,<br />
O. Kamarainen, B. Fowler, M. A. Morris, E. Dequeker,<br />
R. Hastings.<br />
1875F Interstate compatibility and emergency<br />
preparedness <strong>of</strong> newborn screening laboratories at<br />
the interface <strong>of</strong> clinical medicine and public health.<br />
J. Mulvihill, P. Hopkins, S. Berberich.<br />
1876F Evaluation <strong>of</strong> the Bogotá Congenital<br />
Malformations Surveillance <strong>Program</strong>. I. Zarante,<br />
C. Mallarino, G. Gracia.<br />
1877F Drivers, barriers and opportunities for genetic<br />
testing services in emerging economies: The Genetic<br />
Testing in Emerging Economies project. I. Nippert,<br />
A. Christianson, D. D. G. Horovitz, R. Raouf, C. D. Padilla,<br />
V. Penchaszadeh, A. Rajab, I. C. Verma, N. Zhong,<br />
L. Gribaldo, U. Krist<strong>of</strong>fersson, J. Schmidtke.<br />
Complex Traits and Polygenic<br />
Disorders<br />
1878W Genetic variation in susceptibility to<br />
hypothyroidism induced hearing impairment. Q. Fang,<br />
T. J. Jones, T.-W. Gong, A. H. Mortensen, M. T. Fleming,<br />
D. F. Dolan, M. I. Lomax, K. R. Johnson, M. Mustapha,<br />
S. A. Camper.<br />
1879T Transethnic mapping <strong>of</strong> putative diabetic<br />
nephropathy loci in African <strong>American</strong>s. N. D. Palmer,<br />
M. C. Y. Ng, J. N. Cooke, M. Petrulis, B. I. Freedman,<br />
D. W. Bowden.<br />
1880F The exon 3 deleted/full-lenght polymorphism<br />
<strong>of</strong> the growth hormone receptor in the Brazilian<br />
population: Association with idiopathic short<br />
stature and body composition measurements in<br />
osteoporosis. F. A. Marques, T. C. L. Lins, C. T. Neves,<br />
M. T. O. Cardoso, R. M. Lima, R. J. Oliveira, R. W.<br />
Pereira, R. Pogue.<br />
1881W Variants in PTPN22 and SMOC2 genes and the<br />
risk <strong>of</strong> thyroid disease in the Jordanian population.<br />
A. Alkhateeb, N. Marzouka, R. Tashtosh.<br />
1882T Genetic associations with neonatal thyroid<br />
stimulating hormone levels. F. Alul, O. Shchelochkov,<br />
S. Berberich, J. Murray, K. Ryckman.<br />
1883F TNF-b Nco1 polymorphism in relation to<br />
postoperative sepsis outcome in joint care surgery.<br />
K. Baghel, R. Srivastava, S. Raj, D. Sanghi.<br />
1884W Preeclampsia is associated with variation in<br />
endoglin pathway genes. M. J. Bell, J. M. Roberts, S. A.<br />
Founds, A. Jeyabalan, L. Terhorst, Y. P. Conley.<br />
POSTER SESSIONS 187<br />
1885T Genetic polymorphisms in ESR1 and ESR2<br />
genes and risk <strong>of</strong> hypospadias in a multi-ethnic<br />
study population. S. Choudhry, E. J. Lammer, J. S.<br />
Witte, S. Dasgupta, C. Ma, G. M. Shaw, L. S. Baskin,<br />
S. L. Carmichael.<br />
1886F A missense mutation in exon 2 <strong>of</strong> adiponectin<br />
receptor 2 is associated with serum insulin in<br />
overweight and obese African-<strong>American</strong> subjects.<br />
A. Doumatey, G. Chen, J. Zhou, H. Huang, A. Adeyemo,<br />
C. Rotimi.<br />
1887W Common variants associated with normal<br />
tension glaucoma and optic nerve degeneration<br />
are also associated with glaucoma in exfoliation<br />
syndrome. B. Fan, S. Loomis, J. H. Kang, D. Y. Wang,<br />
B. Yaspan, M. A. Hauser, L. R. Pasquale, J. L. Haines,<br />
J. L. Wiggs.<br />
1888T Genetic variants in selenoprotein P plasma<br />
1 gene (SEPP1) are associated with fasting insulin<br />
and first phase insulin response in Hispanics. J. N.<br />
Hellwege, N. D. Palmer, J. T. Ziegler, C. D. Langefeld,<br />
C. Lorenzo, J. M. Norris, T. Takamura, D. W. Bowden.<br />
1889F Replication <strong>of</strong> GWAS meta-analysis associations<br />
in a large Amish pedigree support VWF, ABO, STXBP5,<br />
STAB2, and SCARA5 as modifiers <strong>of</strong> VWF and FVIII<br />
levels. J. Hinckley, K. Wang, T. Burns, L. Law, A. Shapiro,<br />
J. Di Paola.<br />
1890W Mutation analysis in zinc finger protein<br />
is<strong>of</strong>orm 1 (ZNF644) in cases with moderate and high<br />
myopia. N. Kaur, S. Saini, V. Vanita.<br />
1891T To study the association <strong>of</strong> peroxisome<br />
proliferator-activated receptor gamma (PPARG) gene<br />
polymorphism (p.Pro12Ala) with diabetic retinopathy.<br />
R. Kaur, S. Goyal, V. Vanita.<br />
1892F Association <strong>of</strong> the IL17 gene polymorphisms<br />
with lumbar disc disease. A. Kelempisioti, I. Daavittila,<br />
N. Noponen, S. Barral, J. Ott, J. Niinimaki, T. Koskelainen,<br />
L. Ala-Koko, J. Karppinen, M. Männikkö.<br />
1893W Association and interaction <strong>of</strong> polymorphisms<br />
in angiogenic genes with endometriosis. M. M. Latha,<br />
Q. Hasan, V. L. Kodati.<br />
1894T The HLA-DPB1 and DRB1 genes are<br />
synergistically associated with Graves disease in<br />
Han Chinese children. Y. Lee, C. Huang, W. Ting, F. Lo,<br />
T. Chang, C. Chu, Y. Wu, S. Chang, W. Lin, M. Lin.<br />
1895F Fine-mapping within regions <strong>of</strong> admixture<br />
linkage to sarcoidosis risk in African <strong>American</strong>s.<br />
A. M. Levin, P. McKeigue, I. Datta, C. G. Montgomery,<br />
I. Adrianto, M. Colombo, M. C. Iannuzzi, B. A. Rybicki.<br />
1896W Fine-mapping <strong>of</strong> central adiposity loci using<br />
association results from multi-ethnic populations.<br />
C. Liu, CHARGE, GIANT, CARe, and African <strong>American</strong><br />
Central Adiposity Consortia.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
188 POSTER SESSIONS<br />
1897T Investigation <strong>of</strong> genetic variation in scavenger<br />
receptor class B, member 1 (SCARB1) and association<br />
with serum carotenoids. G. J. McKay, E. Loane, J. M.<br />
Nolan, S. Beatty, G. Silvestri.<br />
1898F Genetic analysis <strong>of</strong> FUS/TLS gene in essential<br />
tremor. K. Mirzozoda, N. Parmalee, S. Kisselev, N. Merner,<br />
P. Dion, G. Rouleau, E. D. Louis, L. Clark.<br />
1899W Genetic and functional data implicates BCHE<br />
as a novel vitiligo candidate gene. L. Nascimento,<br />
C. Castro, V. Fava, R. Werneck, M. Mira.<br />
1900T Targeted deep-resequencing <strong>of</strong> the CLDN1<br />
gene in African <strong>American</strong>s for asthma. N. M. Rafaels,<br />
L. Huang, C. Vergara, R. Lewis, L. Gao, I. Ruczinski,<br />
T. H. Beaty, A. De Benedetto, L. A. Beck, R. A. Mathias,<br />
K. C. Barnes.<br />
1901F Targeted resequencing <strong>of</strong> SLE susceptible loci.<br />
E. Rai, B. Wakeland, C. Liang, P. Raj, K. Viswanathan,<br />
D. Karp, N. Olsen, I. Dozmorov, L. Davis, P. Doshi, Q. Z. Li,<br />
G. Wiley, K. Kaufman, J. A. Kelly, J. Harley, P. Gaffney, E.<br />
K. Wakeland.<br />
1902W Study <strong>of</strong> BMP4 gene in a Brazilian sample with<br />
congenital anomalies <strong>of</strong> kidney and urinary tract.<br />
G. S. Reis, A. C. S. Silva, T. R. Heilbuth, I. S. Freitas, L. A.<br />
de Marco, D. M. Miranda.<br />
1903T Detection <strong>of</strong> 4 new mutations related to oral<br />
clefts by direct sequencing. M. Simioni, T. K. de Araujo,<br />
R. G. Faria, C. V. Maurer-Morelli, V. L. Gil-da-Silva-Lopes.<br />
1904F Meta-analysis demonstrates that an<br />
interleukin-6 polymorphism is protective against<br />
preterm birth in women <strong>of</strong> European descent. W. Wu,<br />
E. Clark, G. Stoddard, S. Esplin, T. Manuck, J. Xing,<br />
M. Varner, L. Jorde.<br />
1905W Gender-specific association <strong>of</strong> the interleukin<br />
18 gene with gallstone disease. H. Yang, S. Shih,<br />
T. Chang, H. Wang, K. Hu, C. Chang, C. Chang, C. Hung,<br />
H. Chan, M. Lin, Y. Lee.<br />
1906T Search for new modifiers <strong>of</strong> disease severity<br />
in Jamaican sickle cell disease patients using wholeexome<br />
DNA sequencing. G. Lettre, G. Galarneau,<br />
M. Beaudoin, K. S. Lo, M. Reid, G. Serjeant, I. R.<br />
Hambleton, J. N. Hirschhorn, C. A. McKenzie.<br />
1907F Complex trait alleles are enriched for cellspecific<br />
chromatin marks. S. Raychaudhuri, G. Trynka,<br />
H. Xu, B. E. Stranger, X. S. Liu.<br />
1908W A regulatory variant in FZD6 gene contributes<br />
to nonsyndromic cleft lip and palate. J. Hecht, N.<br />
Cvjetkovic, L. Maili, A. M. Letra, M. Raia, E. C. Swindell,<br />
J. F. Teichgraeber.<br />
1909T Next-generation sequencing <strong>of</strong> unresolved<br />
Meckel syndrome pedigrees reveals a complex genetic<br />
makeup. K. Hopp, C. M. Heyer, J. L. Sundsbak, S. J.<br />
Koon, V. J. Kubly, V. E. Torres, P. C. Harris.<br />
1910F Role <strong>of</strong> the PRICKLE genes in neural tube<br />
defects in humans. R. Allache, V. Capra, M. Q. Wang,<br />
C. M. Bosoi, P. Drapeau, A. G. Bassuk, Z. Kibar.<br />
1911W Investigation <strong>of</strong> complex copy number<br />
polymorphisms and age-related macular degeneration.<br />
S. Cantsilieris, S. White, R. Guymer, P. Baird.<br />
1912T Identification <strong>of</strong> a pleiotropic effect locus<br />
associated with a composite CVD risk trait in the<br />
genetic isolate <strong>of</strong> Norfolk Island. L. R. Griffiths, M.<br />
Benton, H. Cox, C. Bellis, M. Carless, M. Hanna, D.<br />
Eccles, J. Blangero, R. A. Lea.<br />
1913F Association <strong>of</strong> BMI and waist-related genetic<br />
variants with visceral adipose tissue volume in the<br />
Family Heart Study. A. Justice, M. Graff, N. Franceschini,<br />
A. P. Reiner, M. F. Feitosa, J. J. Carr, J. G. Terry, P. Gordon-<br />
Larsen, M. K. Wojczynski, I. B. Borecki, K. E. North.<br />
1914W Follow up analyses <strong>of</strong> the APOL1/MYH9 locus<br />
and non-diabetic end stage renal disease (non-DM<br />
ESRD) in African <strong>American</strong>s: The FIND Consortium.<br />
M. Li, FIND Consortium.<br />
1915T HLA typing <strong>of</strong> a large type 1 diabetes cohort<br />
using SNP genotyping <strong>of</strong> the extended MHC.<br />
J. Bradfield, D. S. Monos, H. Q. Qu, C. Kim, M. Rossman,<br />
K. D. Rosenman, S. F. A. Grant, C. Polychronakos, H.<br />
Hakonarson.<br />
1916F Systematic evaluation <strong>of</strong> validated type 2<br />
diabetes and glycemic trait loci for association with<br />
insulin clearance. M. O. Goodarzi, X. Guo, J. Cui, M. R.<br />
Jones, T. Haritunians, A. H. Xiang, Y. I. Chen, K. D. Taylor,<br />
T. A. Buchanan, W. A. Hsueh, L. J. Raffel, J. I. Rotter.<br />
1917W Whole genome sequencing to identify<br />
functional variants that contribute to type 2 diabetes<br />
and obesity in Pima Indians. K. Huang, C. Bogardus,<br />
L. Baier.<br />
1918T Tracking elusive modifier loci using identity-bydescent<br />
and influential alleles. E. Marchani, E. Wisjman.<br />
1919F Genetic dissection <strong>of</strong> Chiari type I malformation<br />
using stratified whole genome linkage approaches.<br />
C. Markunas, K. Soldano, K. Dunlap, H. Cope, E. Asiimwe,<br />
J. Stajich, D. Enterline, G. Grant, H. Fuchs, S. Gregory, A.<br />
Ashley-Koch.<br />
1920W Heritability and linkage analysis <strong>of</strong> the scale<br />
<strong>of</strong> aging vigor in epidemiology in the Long Life Family<br />
Study. J. L. Sanders, J. Singh, R. L. Minster, C. M.<br />
Kammerer, M. M. Barmada, E. W. Daw, M. Feitosa,<br />
R. Costa, N. Schupf, J. Walston, A. B. Newman.<br />
1921T Genome-wide linkage analyses <strong>of</strong> hematological<br />
phenotypes in Long Life Family Study. J. Singh, R. L.<br />
Minster, M. M. Barmada, E. W. Daw, B. Thyagarajan,<br />
K. Christensen, A. B. Newman, C. M. Kammerer.<br />
1922F Effect <strong>of</strong> DNA polymorphisms <strong>of</strong> apolipoprotein<br />
B gene on lipid homeostasis in obese Egyptians. G. El-<br />
Kannishy, R. Elbaz, A. Wafa, H. AbdElHafez, A. Settin.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1923W Identification <strong>of</strong> genes influencing serum levels<br />
<strong>of</strong> brain-derived neurotrophic factor in large Mexican<br />
<strong>American</strong> pedigrees. M. A. Almeida, J. M. Peralta, J. W.<br />
Kent, J. E. Curran, T. D. Dyer, G. Juan, T. M. Teslovich,<br />
C. Fuchsberger, A. R. Wood, T. M. Frayling, P. Cingolani,<br />
T. W. Blackwell, R. Sladek, G. Atzmon, J. Laramie, S. Lincoln,<br />
D. M. Lehman, G. Abecasis, L. A. Almasy, R. Duggirala,<br />
D. C. Glahn, J. Blangero.<br />
1924T First genome-wide analysis in pediatric multiple<br />
sclerosis (MS) confirms a role for adult MS risk<br />
variants and reveals new candidates. L. F. Barcellos, J.<br />
R. Oksenberg, E. Elboudwarej, H. Quach, F. Briggs,<br />
A. Belman, A. Chokkalingam, P. A. Buffler, L. Krupp,<br />
E. Waubant.<br />
1925F Metabochip analysis in over 12,000 African<br />
<strong>American</strong>s identifies several variants associated with<br />
metabolic syndrome: Results from the Population<br />
Architecture using Genomics and Epidemiology (PAGE)<br />
Study. C. L. Carty, J. Haessler, I. Cheng, V. Aroda,<br />
T. Thornton-Wells, C. N. Hsu, S. Liu, R. Jackson, C.<br />
Carlson, L. A. Hindorff, L. LeMarchand, J. S. Pankow,<br />
U. Peters, K. E. North, C. Kooperberg.<br />
1926W Power <strong>of</strong> population diversity and positive<br />
selection in probing the biology <strong>of</strong> asthma disparities.<br />
G. Dunston, T. Mason, L. Ricks-Santi.<br />
1927T Conditional analysis identifies three novel<br />
major histocompatibility complex loci associated with<br />
psoriasis. J. Knight, S. L. Spain, F. Capon, J. N. Barker,<br />
M. E. Weale, R. C. Trembath, WTCCC2, Genetic Analysis<br />
<strong>of</strong> Psoriasis Consortium, I-chip for Psoriasis Consortium.<br />
1928F Prevalence <strong>of</strong> MYH9 common variants<br />
associated with non-diabetic end-stage renal disease<br />
and chronic kidney disease in the diverse National<br />
Health and Nutrition Examination Surveys as part <strong>of</strong><br />
the Epidemiologic Architecture for Genes Linked to<br />
Environment (EAGLE). S. Wilson, K. Brown-Gentry, N.<br />
Gillani, H. Jin, B. McClellan, J. Boston, C. Sutcliffe, H.<br />
Dilks, D. Crawford.<br />
1929W Both classical and non-classical human<br />
leukocyte antigen (HLA) loci in the HLA region<br />
contribute to Graves disease susceptibility. P. Chen,<br />
W. Yang, T. Chang.<br />
1930T Fine mapping on chromosome 10q24.2 implicates<br />
ADD3 in biliary atresia. M.-M. Garcia-Barceló, G. Cheng,<br />
C. S. M. Tang, X. L. Liu, R.Z. Zhang, M. T. So, E. H. M.<br />
Wong, P. H. Y. Chung, I. H. Y. Chan, J. Liu, W. Zhong, H. Xia,<br />
J. Yu, K. K. Y. Wong, S. S. Cherny, P. C. Sham, P. K. H. Tam.<br />
1931F Whole exome sequencing and subsequent<br />
association studies reveals novel candidate variants<br />
associated with severe types <strong>of</strong> alopecia areata.<br />
S. Lee, C. Park, O.-S. Kwon, J.-I. Kim, J. S. Seo.<br />
1932W Next-generation sequencing <strong>of</strong> 11 targeted<br />
genes show serum urate levels and gout age <strong>of</strong> onset<br />
are influenced by both rare and common variants. A.<br />
Tin, L. C. Shimmin, A. Kottgen, E. Boerwinkle, J. Coresh,<br />
J. E. Hixson, W. H. Kao.<br />
POSTER SESSIONS 189<br />
1933T Genetic variation in vitamin D pathway genes<br />
impacts serum vitamin D deficiency and cardiometabolic<br />
traits in individuals with and without type<br />
2 diabetes. T. R. Braun, L. F. Been, P. R. Blackett, D. K.<br />
Sanghera.<br />
1934F Coding variants at a single multiallelic amino<br />
acid position <strong>of</strong> a HLA class II gene influence follicular<br />
lymphoma risk in Europeans and Asians. J. N. Foo,<br />
K. E. Smedby, P. I. W. de Bakker, I. D. Irwan, H. Darabi,<br />
X. Jia, L. Padyukov, D. E. K. Tan, H. Hjalgrim, A. Seow,<br />
K. Humphreys, J. J. Liu.<br />
1935W Common polymorphisms <strong>of</strong> dopamine<br />
D2 receptor (DRD2) gene are not associated with<br />
adolescent obesity, but with hyperinsulinemia. N. Col<br />
Araz, M. Nacak, S. Oguzkan Balci, N. Benlier, S. Pehlivan,<br />
A. Balat, M. Araz.<br />
1936T Association analysis <strong>of</strong> chromosome 3q markers<br />
in nonsyndromic cleft lip/palate. A. Letra, M. Cooper,<br />
T. McHenry, E. Czeizel, F. W. B. Deleyiannis, L. Ma, E. E.<br />
Castilla, F. Poletta, L. L. Field, A. R. Vieira, R. M. Silva,<br />
M. L. Marazita.<br />
1937F Genotype-phenotype correlations <strong>of</strong> facial<br />
shape and asymmetry in unaffected relatives <strong>of</strong><br />
children with non-syndromic cleft lip/palate and<br />
controls. S. Miller, N. Nidey, S. Weinberg, M. L. Marazita,<br />
J. C. Murray, G. L. Wehby, L. M. Moreno.<br />
1938W Cannabinoid receptor-1 (CNR-1) gene 1359G/A<br />
polymorphism is related with childhood obesity, but<br />
not with insulin resistance. M. Nacak, N. Col Araz,<br />
S. Oguzkan Balci, N. Benlier, S. Pehlivan, A. Balat,<br />
M. Araz.<br />
1939T Altered expression but no genetic association <strong>of</strong><br />
the epidermal transglutaminases in atopic dermatitis.<br />
M. C. G. Winge, A. Lieden, A. Sääf, I. Kockum, E. Ekelund,<br />
E. Rodriguez, T. Hoppe, R. Fölster-Holst, A. Franke, M.<br />
Tengvall-Linder, H. Baurecht, S. Weidinger, C. F. Wahlgren,<br />
M. Nordenskjöld, M. Bradley.<br />
1940F Genetic variation and epigenetic modification <strong>of</strong><br />
TACR1 gene are associated with postoperative nausea<br />
and vomiting in surgical patients. T. Hayase, S. Sugino,<br />
M. Yamakage.<br />
1941W Identification <strong>of</strong> a novel 1p31 locus<br />
associated with the combined asthma plus allergic<br />
rhinitis phenotype through positional cloning<br />
in asthma-ascertained families. M.-H. Dizier, P.<br />
Margaritte-Jeannin, A.-M. Madore, I. Annesi-Maesano,<br />
J. Just, F. Kauffmann, C. Laprise, M. Lathrop, E.<br />
Bouzigon, F. Demenais.<br />
1942T Dense genotyping <strong>of</strong> six atopic dermatitis and<br />
180 autoimmune risk loci in 2,425 atopic dermatitis<br />
patients. D. Ellinghaus, E. Rodríguez, H. Baurecht,<br />
J. Esparza Gordillo, Y.-A. Lee, S. Cichon, C. Gieger,<br />
H.-E. Wichmann, R. Duerr, C. Büning, S. Brand,<br />
S. Schreiber, S. Weidinger, A. Franke.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
190 POSTER SESSIONS<br />
1943F Identification <strong>of</strong> functional variants in<br />
FOXO3A, a confirmed candidate gene influencing<br />
human longevity: Genetic investigation requires<br />
special attention to sequence homology with<br />
FOXO3B. F. Flachsbart, L. Gentschew, C. Däumer,<br />
N. Badarinarayan, A. Caliebe, M. Krawczak, S. Schreiber,<br />
A. Nebel.<br />
1944W PDGFRa mutations in humans with isolated cleft<br />
palate. V. Shotelersuk, S. Rattanasopha, S. Tongkobpetch,<br />
C. Srichomthong, P. Siriwan, K. Suphapeetiporn.<br />
1945T Copy-number variation in chromosome 5q31-<br />
33 is associated with Graves’ disease susceptibility.<br />
X. Chu, M. Shen, Y. Bai, F. Xie, W. Huang.<br />
1946F Genetic analysis <strong>of</strong> HLA-G gene: Association<br />
study in a Brazilian cohort relating the 14bp indel<br />
frequencies in a psoriasis case/control study.<br />
G. Debortoli, B. S. Almeida, A. Firmino, D. H. Nunes,<br />
M. M. Sens, V. P. M. da Silva, A. R. Marrero, Y. C. N.<br />
Muniz, I. R. Souza.<br />
1947W Lung eQTL in the major histocompatibility<br />
complex. M. Lamontagne, C. Couture, M. Laviolette,<br />
Y. Bossé, Merck-Laval-UBC-Groningen Lung eQTL<br />
Consortium.<br />
1948T Rare TLR pathways gene variants and<br />
susceptibility to invasive pneumococcal disease:<br />
A population-based study. K. S. Elliott, M. K. Ellis,<br />
A. Rautanen, M. A. Rivas, D. W. Crook, A. V. S. Hill,<br />
S. J. Chapman.<br />
1949F Association <strong>of</strong> VPS26 variants with<br />
susceptibility to infection by Leishmania in Brazil,<br />
Iran and Sudan. A. Romano, H. Dessein, A. Muller,<br />
F. Santoro, A. Salhi, S. Rafati, S. El Saafi, J. P. Gorvel,<br />
L. Argiro, A. Dessein.<br />
1950W MTHFR 677 C.T polymorphism does not<br />
influence the risk <strong>of</strong> polycystic ovarian syndrome.<br />
S. Rajender, J. Carlus, K. Singh, K. Thangaraj.<br />
1951T Mapping <strong>of</strong> a novel locus modifying glaucoma<br />
severity within the GLC1K region at 20p12. P. Belleau,<br />
S. Dubois, K. Lebel, R. Arseneault, E. Shink, J. L. Anctil,<br />
G. Côté, M. A. Walter, M. Amyot, V. Raymond.<br />
1952F Fine-mapping <strong>of</strong> eight psoriasis susceptibility<br />
loci. S. Das, P. E. Stuart, J. Ding, T. Tejasvi, Y. Li, L. C.<br />
Tsoi, V. Chandran, J. Fischer, C. Helms, K. C. Duffin,<br />
J. J. Voorhees, A. M. Bowcock, G. G. Krueger, G. M.<br />
Lathrop, R. P. Nair, P. Rahman, G. R. Abecasis,<br />
D. Gladman, J. T. Elder.<br />
1953W Association <strong>of</strong> markers in DOCK6 with total<br />
cholesterol concentration in <strong>American</strong> Indians.<br />
J. K. DiStefano, M. Khosroheidari, E. Eddy, S. Kobes,<br />
W. C. Knowler, R. L. Hanson.<br />
1954T Fine-scale genetic mapping reveals multiple<br />
signals <strong>of</strong> association in waist-hip ratio loci and shows<br />
evidence <strong>of</strong> sexually dimorphic genetic effects.<br />
T. Ferreira, D. Shungin, D. C. Croteau-Chonka,<br />
T. W. Winkler, A. E. Locke, R. Mägi, R. J. Strawbridge,<br />
T. Workalemahu, K. Fischer, J. Wu, A. U. Jackson, F. Day,<br />
M. C. Zillikens, A. E. Justice, H. Völzke, I. Barrsos,<br />
C. S. Fox, E. Ingelsson, M. I. McCarthy, E. K. Speliotes,<br />
P. W. Franks, L. Qi, J. N. Hirschhorn, R. J. F. Loos, K. E.<br />
North, I. M. Heid, L. A. Cupples, A. P. Morris, K. L. Mohlke,<br />
C. M. Lindgren on behalf <strong>of</strong> Genetic Investigation <strong>of</strong><br />
ANthropometric Traits (GIANT) Consortium.<br />
1955F The FTO gene polymorphisms are associated<br />
with obesity in the Chinese population: The SAPPHIRe<br />
follow-up study. C.-M. Hwu, M.-W. Lin, P.-T. Tsai,<br />
C.-A. Hsiung, L.-M. Chuang, W. H.-H. Sheu, Y.-R. Hung,<br />
L.-T. Ho.<br />
1956W Consanguinity in Pakistani families reveals new<br />
loci in a complex genetic trait: Stuttering. M. H. Raza,<br />
R. Amjad, S. Riazuddin, D. Drayna.<br />
1957T Genome-wide linkage scan <strong>of</strong> male sexual<br />
orientation. A. R. Sanders, K. Dawood, G. Rieger, J. A.<br />
Badner, E. S. Gershon, R. S. Krishnappa, A. B. Kolundzija,<br />
S. Guo, G. W. Beecham, E. R. Martin, J. M. Bailey.<br />
1958F Linkage studies in a large stuttering family<br />
indicate multiple novel loci and possible assortative<br />
mating. A. A. Schaffer, M. H. Raza, E. M. Gertz,<br />
J. Mundorff, J. Lukong, J. Kuster, D. Drayna.<br />
1959W Fine mapping <strong>of</strong> 6q27 for association with<br />
blood pressure. B. Tayo, B. Salako, A. Luke, X. Zhu,<br />
A. Adeyemo, C. Rotimi, A. Ogunniyi, R. Cooper.<br />
1960T Efficient pooled sequencing <strong>of</strong> 1,077 candidate<br />
genes in individuals with short stature. S. R. Wang,<br />
D. B. Mirel, A. Dauber, J. N. Hirschhorn.<br />
1961F Molecular analysis <strong>of</strong> common tag<br />
polymorphisms in hemochromatosis (HFE) genes in<br />
Iranian patients affected with PCOS. S. Matoo, A. Yasari<br />
Mazandarani, N. Hatamnejadian, B. Sedaghati Khayat,<br />
M. Moghaddam, A. Ebrahimi.<br />
1962W Molecular analysis <strong>of</strong> hepcidin common<br />
polymorphisms in Iranian patients affected with PCOS.<br />
A. Yasari Mazandarani, S. Matoo, N. Hatamnejadian,<br />
B. Sedaghati Khayat, M. Moghaddam, A. Ebrahimi.<br />
1963T Mitochondrial haplogroups and age-related<br />
maculopathy. Y. P. Conley, Y. Jiang, M. C. Kenney,<br />
N. Udar, R. E. Ferrell, D. E. Weeks, M. B. Gorin.<br />
1964F Candidate genes as a modifier <strong>of</strong> age at<br />
Huntington disease motor onset. E. M. Ramos,<br />
J. Latourelle, J.-H. Lee, T. Gillis, J. S. Mysore, J. F. Gusella,<br />
J.-M. Lee, I. Alonso, J. Sequeiros, R. H. Myers, M. E.<br />
MacDonald.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1965W Variations in potassium channel genes are<br />
associated with persistent breast pain after breast<br />
cancer surgery. D. J. Langford, B. McCann, T. Koetters,<br />
C. Baggott, C. West, J. D. Levine, C. Elboim, G. Abrams,<br />
D. Hamolsky, L. Dunn, H. Rugo, M. Dodd, S. M. Paul,<br />
J. Neuhaus, B. A. Cooper, B. Schmidt, J. Cataldo,<br />
A. Dhruva, B. E. Aouizerat.<br />
1966T HLA haplotypes influence hearing in old age.<br />
T. Solomon, D. L. Newman.<br />
1967F A Y chromosome association study in<br />
inflammatory bowel disease. L. Jostins, C. A. Anderson,<br />
J. C. Barrett, International IBD <strong>Genetics</strong> Consortium.<br />
1968W Prevalence <strong>of</strong> alpha-1 antitrypsin deficiency<br />
and hereditary hemochromatosis gene mutations in<br />
Algarve, Portugal. V. Gaio, A. Fernandes, F. Mendonça,<br />
F. Orta Correia, A. Beleza, A. Gil, M. Bourbon, A. M.<br />
Vicente, C. M. Dias, M. Barreto da Silva.<br />
1969T Menarche timing-related variants identified by<br />
recent GWAS are associated with growth outcomes in<br />
male and female children. C. He, E. Wagner, G. Eckert,<br />
Z. Yu, H. Pratt, W. Tu.<br />
1970F Haplotypes <strong>of</strong> the inducible nitric oxide synthase<br />
gene are strongly associated with levels <strong>of</strong> exhaled<br />
nitric oxide in adults: A population-based study.<br />
S. Dahgam, L. Modig, A. T. Naluai, A. C. Olin, F. Nyberg.<br />
1971W Identification <strong>of</strong> genetic factors for<br />
chronic otitis media with effusion using a targeted<br />
resequencing approach. E. Allen, J. Mychaleckyj, X. Hou,<br />
W. Chen, A. Quinlan, K. Keene, S. Rich, K. Daly, M. Sale.<br />
1972T Genetic polymorphisms <strong>of</strong> long pentraxin-3 are<br />
associated with polypoidal choroidal vasculopathy and<br />
exudative age-related macular degeneration.<br />
J. H. Chen, Y. Yang, Y. Zheng, C. Xu, W. Chen, M. Zhang,<br />
H. Chen, C. P. Pang.<br />
1973F Contribution <strong>of</strong> the reading disability risk locus<br />
DYX2 and dopamine signaling factors ANKK1/DRD2 to<br />
language impairment and brain imaging phenotypes. J.<br />
D. Eicher, N. R. Powers, L. L. Miller, K. L. Mueller,<br />
J. B. Tomblin, S. M. Ring, J. R. Gruen, Pediatric Imaging<br />
Neurocognition <strong>Genetics</strong> Study.<br />
1974W The maternal folate hydrolase gene<br />
polymorphism is associated with neural tube defects<br />
in a high-risk Chinese population. J. Guo, J. H. Wang, H.<br />
Xie, H. Z. Zhao, F. Wang, C. Liu, L. Wang, X. L. Lu,<br />
Y. H. Bao, J. Z. Zou, G. L. Wang, B. Niu, T. Zhang.<br />
1975T Association study <strong>of</strong> NPR3 polymorphisms with<br />
aspirin exacerbated respiratory disease. J. H. Kim,<br />
B. L. Park, C. S. Park, H. D. Shin.<br />
1976F Identification <strong>of</strong> DNA variants in 11 candidate<br />
genes for developmental dyslexia by next-generation<br />
sequencing. H. Matsson, E. Tiraboschi, M. Huss,<br />
J. Noppola-Hemmi, H. Lyytinen, P. H. T. Leppanen,<br />
N. Neuh<strong>of</strong>f, A. Warnke, G. Schulte-Körne, M. M. Nöthen,<br />
J. Schumacher, M. Peyrard-Janvid, J. Kere.<br />
POSTER SESSIONS 191<br />
1977W Sequencing <strong>of</strong> IL10 in Behçet’s disease<br />
patients. I. Sousa, J. M. Xavier, N. Rei, F. Barcelos,<br />
P. Abrantes, J. Vedes, G. Jesus, M. Salgado, F. Fontes,<br />
J. V. Patto, J. Crespo, S. A. Oliveira.<br />
1978T Variants <strong>of</strong> XBP1 are associated with vitiligo<br />
in the presence <strong>of</strong> autoimmunity. R. G. Tarlé, L. M.<br />
Nascimento, C. C. S. De Castro, R. I. Werneck, V. M. Fava,<br />
M. T. Mira.<br />
1979F Genetic association <strong>of</strong> SLE with CD247 (CD3z).<br />
M. Martins, A. H. Williams, M. E. Alarcón-Riquelme,<br />
J. M. Anaya, S. C. Bae, S. A. Boackle, L. A. Criswell,<br />
G. S. Gilkeson, D. L. Kamen, C. O. Jacob, J. A. James,<br />
J. A. Kelly, K. L. Moser, R. H. Sc<strong>of</strong>ield, R. P. Kimberly,<br />
J. C. Edberg, L. M. Vila, M. Petri, R. Ramsey-Goldman,<br />
M. E. Comeau, J. Ziegler, M. C. Marion, J. T. Merrill,<br />
T. B. Niewold, B. P. Tsao, B. I. Freedman, S. B. Glenn,<br />
J. B. Harley, C. D. Langefeld, C. Fesel.<br />
1980W Estrogen receptor beta genetic variants are<br />
associated with intraocular pressure elevation in<br />
women. F. Mabuchi, Y. Sakurada, K. Kashiwagi,<br />
Z. Yamagata, H. Iijima, S. Tsukahara.<br />
1981T Expression <strong>of</strong> alternatively spliced transcripts <strong>of</strong><br />
MAP2K4 gene in rheumatoid arthritis. K. Shchetynsky,<br />
M. Ronninger, L. Padyukov.<br />
1982F RNA-seq survey <strong>of</strong> human lymphoid and myeloid<br />
cells: A resource for identifying causal genes in<br />
validated immune-mediated disease loci. S. Foisy,<br />
C. Beauchamp, A. Alikashani, F. Latour, M. Ladouceur,<br />
S. Lessage, J. D. Rioux.<br />
1983W Preliminary data suggest an upstream<br />
IRX1 sequence variant identified in a family with<br />
kyphoscoliosis disrupts the wild-type expression<br />
pattern in zebrafish. C. M. Justice, K. Bishop,<br />
B. Carrington, P. Cruz, K. Swindle, R. Sood, N. H. Miller,<br />
A. F. Wilson, NISC Comparative Sequencing <strong>Program</strong>.<br />
1984T Phenotypic analysis <strong>of</strong> peptidylarginine<br />
deiminase type 4 knockout mice. A. Suzuki, Y. Kochi,<br />
H. Shoda, K. Fujio, E. Kanno, T. Sawada, R. Yamada,<br />
K. Yamamoto.<br />
1985F Rs34424835 PGRN gene variation a possible<br />
modifier in frontotemporal lobar degeneration. E. Vitale,<br />
A. Iuliano, A. Polverino, V. Agosti, C. Vitale, A. Postiglione,<br />
P. Sorrentino, S. Pappatà, G. Milan, G. Sorrentino.<br />
1986W Proteomic analysis <strong>of</strong> Shank3 overexpression<br />
in mouse neuroblastoma cultures showed<br />
differentially expressed proteins involved in glycolysis,<br />
cytoskeleton,biosynthetic and cell cycle processes, and<br />
ubiquitin-proteasome. N. Zhong, W. Ju, W. Yan, X.-L. Zhao,<br />
E. C. Jenkins, W. T. Brown, Y. Wang, J. H. Zhou.<br />
1987T Transcription factor pr<strong>of</strong>ile <strong>of</strong> a single nucleotide<br />
polymorphism located -224 A/G in neuropeptide<br />
receptor Y2 (NPY2R) gene in predisposition to<br />
hypertension. E. Albino, K. Sugimoto, T. Katsuya,<br />
A. Deng, J. Dutil.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
192 POSTER SESSIONS<br />
1988F Functional assessment <strong>of</strong> CRY2 type II diabetes<br />
variants using a targeted circadian luciferase assay.<br />
J. Lane, A. Tare, C. Cowan, R. Saxena.<br />
1989W Modification <strong>of</strong> endothelial progenitor<br />
cell recruitment by tyrosinase in oxygen-induced<br />
retinopathy. B. E. O’Bryhim, R. S. White, R. C. A. Symons.<br />
1990T Understanding the impact <strong>of</strong> body mass index<br />
and associated SNPs on serum metabolites. J. Kumar,<br />
R. Karlsson, J. Prince, M. Hong, C. Broeckling, J. Prenni,<br />
E. Ingelsson, F. Wiklund.<br />
1991F Biological processes <strong>of</strong> human development and<br />
genome-wide linkage disequilibrium. I. Culminskaya,<br />
A. Kulminski, A. Yashin.<br />
1992W The type 1 diabetes gene CLEC16A functions<br />
in NK cells to restrain secretory functions including<br />
cytokine release and cytotoxicity. M. Bakay, R. Pandey,<br />
A. Mohamed-Hadley, P. Banerjee, H. H. Hakonarson.<br />
1993T Influence <strong>of</strong> ethnicity with type 2 diabetes in<br />
association <strong>of</strong> UCP2 -866G/A, PGC1a (Gly 482 Ser) and<br />
SIRT1 -1400T/C polymorphisms in North Indian Punjabi<br />
population groups. A. Bhanwer, N. Kaul, R. N. K. Bamezai.<br />
1994F Allelic variation in the protein stability <strong>of</strong><br />
HLA shapes genetic association <strong>of</strong> HLA with type 1<br />
diabetes. H. Miyadera, J. Ohashi, K. Tokunaga.<br />
1995W Functional characterization <strong>of</strong> gene regulatory<br />
elements associated with epilepsy. R. Y. Birnbaum,<br />
Y. Zhang, C. Wei, N. Ahituv.<br />
1996T Differential behavior <strong>of</strong> splice is<strong>of</strong>orms <strong>of</strong> the<br />
asthma susceptibility gene DENND1B. M. E. March,<br />
P. M. A. Sleiman, C. Hou, J. Bradfield, C. E. Kim,<br />
E. Frackelton, J. T. Glessner, H. Hakonarson.<br />
1997F Targeted resequencing identifies secretiondefective<br />
variants <strong>of</strong> decoy receptor 3 in pediatric-onset<br />
inflammatory bowel disease. C. J. Cardinale,<br />
S. Panossian, F. Wang, E. Frackelton, C. E. Kim,<br />
F. D. Mentch, R. M. Chiavacci, K. E. Kachelries, R. Pandey,<br />
S. F. A. Grant, R. N. Baldassano, H. Hakonarson.<br />
1998W A population-based immunologic phenotype<br />
study for the identification <strong>of</strong> high risk individuals to<br />
childhood infectious diseases in Vietnam. R. Miyahara,<br />
L. M. Yoshida, H. Nakamura, K. Takahashi, X. M. Trinh,<br />
D. A. Dang, N. H. Tran, K. Ariyoshi, M. Yasunami.<br />
1999T A birth-cohort study for the identification <strong>of</strong><br />
genetic risk for childhood infectious diseases in<br />
Vietnam. M. Yasunami, L. M. Yoshida, R. Miyahara,<br />
H. Nakamura, K. Takahashi, H. Moriuchi, D. A. Dang,<br />
N. H. Tran, K. Ariyoshi.<br />
2000F Variant genotypes <strong>of</strong> PKR1 and PKR2 in patients<br />
<strong>of</strong> recurrent pregnancy loss. M. Su, L. Wu, P. Kuo.<br />
2001W Post GWAS analysis <strong>of</strong> the BCL11A intronic<br />
region to define its role in regulating HbF levels.<br />
F. Anedda, S. Sanna, I. Asunis, G. Usala, F. Danjou,<br />
L. Perseu, A. Cabriolu, C. A. Caria, L. Porcu, M. G. Marini,<br />
M. Marongiu, C. Sidore, R. Berutti, M. Pala, A. Angius,<br />
F. Busonero, A. Maschio, S. Satta, F. Demartis, L. Maccioni,<br />
A. Meloni, R. Nagaraja, G. Abecasis, D. Schlessinger,<br />
M. S. Ristaldi, R. Galanello, P. Moi, F. Cucca, S. Sanna,<br />
M. Uda.<br />
2002T Additional patients and an association study<br />
support a role <strong>of</strong> SOX9 in CD-ACD-PRS phenotypic<br />
continuum and in CPO. M. Quentric, L. Desmyter,<br />
M. Ghassibe, W. Courtens, S. Kivirikko, H. Antoine-Poirel,<br />
G. Ameye, B. Bayet, G. Francois, R. Vanwijck, O. Boute,<br />
P. Pellerin, M. Rubini, M. Vikkula.<br />
2003F The impact <strong>of</strong> amino acid polymorphisms<br />
in four genes <strong>of</strong> the tumor necrosis factor (TNF)<br />
and interferon-gamma pathways on BCG-triggered<br />
production <strong>of</strong> TNF. T. Yu, L. de Léséleuc, A. Cobat,<br />
L. Simkin, G. F. Black, K. Stanley, P. van Helden, L. Abel,<br />
A. AlcaÔs, E. G. Hoal, E. Schurr.<br />
2004W Functional variants <strong>of</strong> NFKBIE and RTKN2 genes<br />
are associated with rheumatoid arthritis susceptibility<br />
in Japanese. K. Myouzen, Y. Kochi,<br />
Y. Okada, C. Terao, A. Suzuki, K. Ikari, T. Tsunoda,<br />
A. Takahashi, M. Kubo, A. Taniguchi, F. Matsuda,<br />
K. Ohmura, S. Momohara, T. Mimori, H. Yamanaka,<br />
N. Kamatani, R. Yamada, Y. Nakamura, K. Yamamoto.<br />
2005T Resequencing ITGAM reveals two functionally<br />
deleterious rare variants in systemic lupus<br />
erythematosus cases. A. L. Roberts, E. R. A. Thomas,<br />
S. Bhosle, L. Game, O. Obraztsova, T. J. Aitman,<br />
T. J. Vyse, B. Rhodes.<br />
2006F DcR3 mutations in systemic lupus<br />
erythematosus patients lead to enhanced lymphocyte<br />
proliferation. K. Suphapeetiporn, C. Chokdeemeeboon,<br />
P. Ammarinthnukrowh, S. Tongkobpetch, C. Srichomthong,<br />
T. Deekajorndech, P. Rianthavorn, P. Kingwattanakul,<br />
Y. Avihingsanon, V. Hoven, S. Edwards, N. Hirankarn,<br />
V. Shotelersuk.<br />
2007W A CD14 promoter polymorphism is implicated<br />
in tuberculosis susceptibility in a South African<br />
population. M. Möller, C. Wagman, M. Daya,<br />
C. Kok, L. van der Merwe, P. D. van Helden, E. G. Hoal.<br />
2008T Effects <strong>of</strong> IL9 and IL9 receptor gene<br />
polymorphisms on allergic rhinitis in Iranian females.<br />
F. Fatahi, H. Khazraee, K. Ghatreh, M. Hashemzadeh.<br />
2009F TRIB1 is involved in the susceptibility <strong>of</strong> nonalcoholic<br />
fatty liver disease. S. Iwamoto, Y. Ishizuka, Y.<br />
Kitamura, S. Makishima, S. Boonvisut, K. Nakayama.<br />
2010W Alleles <strong>of</strong> a rapidly-evolving ETV6 binding<br />
site in DCDC2 confer risk <strong>of</strong> reading and language<br />
impairment. N. R. Powers, J. D. Eicher, F. Butter,<br />
L. L. Miller, S. M. Ring, M. Mann, J. R. Gruen.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2011T Polymorphisms in phosphatidylethanolamine<br />
N-methyltransferase (PEMT) gene associates with<br />
obesity and gene expression. S. K. Das, K. A. Langberg,<br />
A. K. Mondal, N. K. Sharma.<br />
<strong>2012</strong>F Identification <strong>of</strong> a cis regulatory variant that<br />
binds a transcriptional repressor complex including<br />
PDX1 at the JAZF1 type 2 diabetes locus. M. P. Fogarty,<br />
T. M. Panhuis, S. Vadlamudi, M. L. Buchkovich,<br />
K. L. Mohlke.<br />
2013W Investigation <strong>of</strong> mtDNA mutations in nonsyndromic<br />
hearing loss patients in Fars Province, Iran,<br />
using PCR- RFLP procedure. S. Heydari Sodejani,<br />
M. Montazer Zohori, E. Farokhi, A. Shirmardi, G. Banitalebi,<br />
S. Reisi, M. Abolhasani, M. Akbari, M. Hashemzadeh.<br />
2014T Genetic and environmental predictors <strong>of</strong> serum<br />
vitamin D3 levels in African <strong>American</strong>s. R. A. Kittles,<br />
K. Batai, E. Shah, M. Ruden, J. Newsome, S. Agate,<br />
A. Murphy, H. Y. Chen.<br />
2015F Vitamin D receptor ChIP-seq in human CD 41<br />
T-cells and association with multiple sclerosis.<br />
A. Handel, G. Disanto, G. Giovannoni, G. Ebers,<br />
S. Ramagopalan.<br />
2016W Gene-gene interaction in disease association<br />
for systemic lupus erythematosus in Asian<br />
populations. J. Yang, Y. Zhang, X. Zhang, Y. Lau, W. Yang.<br />
2017T Prevalence <strong>of</strong> diabetes-associated gene<br />
variants and its association with blood glucose levels<br />
in the Algarve population, Portugal. M. Barreto da Silva,<br />
V. Gaio, A. Fernandes, F. Mendonça, F. Orta Gomes,<br />
A. Beleza, A. Gil, M. Bourbon, A. M. Vicente, C. M. Dias.<br />
2018F Genome-wide methylation analysis <strong>of</strong> DNA<br />
from <strong>of</strong>fspring exposed to a diabetic intrauterine<br />
environment. M. del Rosario, R. L. Hanson, V. Ossowsky,<br />
W. C. Knowler, C. Bogardus, L. J. Baier.<br />
2019W HNF1a and ABCA1 genes polymorphisms in<br />
gestational diabetes mellitus. E. Zamarron-Licona,<br />
M. C. Martinez-Lopez, R. Diaz-Martinez.<br />
2020T External sources <strong>of</strong> vitamin D modify the effects<br />
<strong>of</strong> the GC and CYP2R1 genes on 25-hydroxyvitamin<br />
D concentrations: CAREDS. C. D. Engelman, K. J. Meyers,<br />
S. K. Iyengar, Z. Liu, C. Karki, R. P. Igo, Jr., B. Truitt, J.<br />
Robinson, G. E. Sarto, R. Wallace, L. Tinker,<br />
E. LeBlanc, Y. Song, J. A. Mares, A. E. Millen.<br />
2021F Mapping variation in the response to vitamin D<br />
in peripheral blood. C. Jeong, J. C. Maranville, S. Baxter,<br />
A. Di Rienzo.<br />
2022W The interaction between adolescent parental<br />
knowledge and genetic risk for alcohol dependence<br />
predicts adult alcohol dependence. J. L. Meyers, J. E.<br />
Salvatore, R. J. Rose, J. Kaprio, D. M. Dick.<br />
POSTER SESSIONS 193<br />
2023T Association study <strong>of</strong> FUT2 (rs601338) with celiac<br />
disease and inflammatory bowel disease in the Finnish<br />
population. A. S. Parmar, N. Alakulppi, P. Paavola-<br />
Sakki, K. Kurppa, L. Halme, M. Färkkilä, U. Turunen, M.<br />
Lappalainen, K. Kontula, K. Kaukinen, M. Mäki,<br />
K. Lindfors, J. Partanen, P. Sistonen, J. Mättö, P. Wacklin,<br />
P. Saavalainen, E. Einarsdottir.<br />
2024F Identifying novel gene-environment interactions<br />
for HDL-cholesterol. L. Parnell, K. Richardson, C. Q. Lai,<br />
J. M. Ordovas.<br />
2025W Genetically-determined differences in arsenic<br />
metabolism efficiency influence risk for arsenic-induced<br />
skin lesions: A Mendelian randomization study. B. Pierce,<br />
L. Tong, M. Argos, F. Jasmine, M. Kibriya, H. Ahsan.<br />
2026T The ubiquitin proteasome system: Geneenvironment<br />
interactions in Parkinson’s disease.<br />
S. Rhodes, B. Ritz.<br />
2027F Genetic trade-<strong>of</strong>fs may explain some paradoxes<br />
<strong>of</strong> genetics <strong>of</strong> human longevity. S. Ukraintseva, K.<br />
Arbeev, A. Kulminski, I. Akushevich, D. Wu, A. Yashin.<br />
2028W Interaction analysis <strong>of</strong> exogenous estrogen in<br />
age-related macular degeneration: New gene-based<br />
2-degree-<strong>of</strong>-freedom joint test finds joint effects<br />
within the VEGF signaling pathway. M. D. Courtenay,<br />
W. H. Cade, P. L. Whitehead, S. G. Schwartz, J. L. Kovach,<br />
G. Wang, A. Agarwal, J. L. Haines, M. A. Pericak-Vance,<br />
W. K. Scott.<br />
2029T Heritability and host SNP associations <strong>of</strong><br />
microbial species in the human gut. J. K. Goodrich,<br />
R. Blekhman, J. T. Bell, T. D. Spector, A. G. Clark,<br />
R. E. Ley.<br />
2030F SNPs for BMI demonstrate consistent results<br />
through the lifecourse. N. Heard-Costa, L. D. Atwood,<br />
C. Jaquish, C. T. Liu, L. A. Cupples, C. S. Fox.<br />
2031W Examining the roles <strong>of</strong> diet, age, and sex on the<br />
composition <strong>of</strong> the human fecal microbiome.<br />
E. R. Davenport, O. Mizrahi-Man, L. B. Barreiro, C. Ober,<br />
Y. Gilad.<br />
2032T Gene-to-gene interaction in the development <strong>of</strong><br />
gout. A. Taniguchi, W. Urano, N. Ichikawa, H. Yamanaka.<br />
2033F The genetic basis <strong>of</strong> preeclampsia in<br />
populations adapted to high altitude. P. Ortiz-Tello,<br />
K. Sandoval Mendoza, V. Villanueva Dávalos, A. Moreno<br />
Estrada, J. Manzaneda, F. Manzaneda, A. McKenney,<br />
L. Enriquez Lencinas, C. Bustamante, J. Baker.<br />
2034W The effect <strong>of</strong> race, sex, age, socioeconomic,<br />
behavioral factors, and genetics on dental caries in<br />
different tooth surfaces. D. Lewis, E. Feingold, Z. Zeng,<br />
J. Shaffer, X. Wang, R. Weyant, D. W. McNeil, M. Marazita.<br />
2035T Telomere length in human blood cells and the<br />
prediction <strong>of</strong> survival. J. Deelen, M. Beekman, V. Codd,<br />
H. E. D. Suchiman, A. J. M. de Craen, N. J. Samani,<br />
J. J. Houwing-Duistermaat, P. E. Slagboom.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
194 POSTER SESSIONS<br />
2036F Early life infection associated with shorter adult<br />
blood telomere lengths in Cebu, the Philippines. D. T. A.<br />
Eisenberg, J. Borja, M. G. Hayes, C. W. Kuzawa.<br />
2037W Characterization and generalization <strong>of</strong> HFE<br />
rs1800562 genotype-phenotype relationships in the<br />
diverse National Health and Nutrition Examination<br />
Surveys as part <strong>of</strong> the Epidemiologic Architecture for<br />
Genes Linked to Environment. K. Brown-Gentry,<br />
B. Niloufar, J. Hailing, B. McClellan, J. Boston, C. Sutcliffe,<br />
H. Dilks, D. Crawford.<br />
2038T Analysis <strong>of</strong> established type 2 diabetes<br />
associated variants in <strong>American</strong> Indians. R. Hanson,<br />
S. Kobes, W. Knower, C. Bogardus, L. Baier.<br />
2039F Describing the contribution <strong>of</strong> multiple sclerosis<br />
genetic risk factors in Sardinian multiple sclerosis<br />
cases. A. Hadjixen<strong>of</strong>ontos, L. Foco, V. Bakthavachalam,<br />
P.-A. Gourraud, A. Ticca, P. Bitti, R. Pastorino,<br />
L. Bernardinelli, J. L. McCauley.<br />
2040W Heritability and linkage analysis <strong>of</strong> the Health<br />
Aging Index in the Long Life Family Study. M. M. Barmada,<br />
J. L. Sanders, A. M. Matteini, K. Christensen, R. Mayeux,<br />
T. Perls, I. Borecki, Q. Zhang, A. B. Newman, Long Life<br />
Family Study.<br />
2041T Genetic determinants <strong>of</strong> age-related macular<br />
degeneration in diverse populations: The Population<br />
Architecture using Genomics and Epidemiology Study.<br />
N. Restrepo, K. Spencer, R. Goodloe, T. Garrett, G. Heiss,<br />
P. Buzkova, N. Jørgensen, R. Jensen, T. Matise, B. Klein,<br />
R. Klein, W. Tien Yin, B. Cornes, E. Shyong Tai, M. Ritchie,<br />
J. Haines, D. Crawford.<br />
2042F Genetic variation and age at natural menarche<br />
and menopause in African <strong>American</strong> women from<br />
the Population Architecture using Genomics and<br />
Epidemiology (PAGE) Study. J. Malinowski, K. L. Spencer,<br />
C. L. Carty, N. Franceschini, L. Fernández-Rhodes,<br />
A. Young, I. Cheng, M. D. Ritchie, C. A. Haiman, L. Wilkens,<br />
C. Wu, T. C. Matise, C. S. Carlson, K. Brennan, A. Park,<br />
A. Rajkovic, L. A. Hindorff, S. Buyske, D. C. Crawford.<br />
2043W African ancestry is a risk factor for asthma and<br />
high total IgE levels in African admixed populations.<br />
C. I. Vergara, T. Murray, N. Rafaels, R. Lewis, M. Campbell,<br />
C. Foster, L. Gao, M. Faruque, R. Riccio Oliveira, E. Carvalho,<br />
M. I. Araujo, A. A. Cruz, H. Watson, D. Mercado, J. Knight-<br />
Madden, I. Ruczinski, G. Dunston, J. Ford, L. Caraballo,<br />
T. Beaty, R. A. Mathias, K. C. Barnes.<br />
2044T Validation <strong>of</strong> the HELIC population isolate<br />
collections as cohorts for complex trait association<br />
mapping. E. Zeggini, I. Tachmazidou, A. Farmaki,<br />
L. Southam, N. W. Rayner, K. Daoutidou, A. Kolb-<br />
Kokocinski, K. Panoutsopoulou, E. Tsafantakis,<br />
M. Karaleftheri, G. Dedoussis.<br />
2045F Evidence <strong>of</strong> natural selection at Crohn’s GWAS loci<br />
based on population genetic variation. B. M. P. M. Bowen,<br />
J. H. Cho.<br />
2046W Genetic associations with serologic autoimmunity<br />
in a large multi-ancestral systemic lupus erythematosus<br />
cohort. S. N. Kariuki, B. S. Franek, A. A. Kumar, M. Kumabe,<br />
K. M. Kaufman, J. M. Anaya, M. E. Alarcón-Riquelme,<br />
S. C. Bae, E. E. Brown, B. I. Freedman, G. S. Gilkeson,<br />
C. O. Jacob, J. A. James, R. P. Kimberly, J. Martin,<br />
J. T. Merrill, B. Pons-Estel, B. P. Tsao, T. J. Vyse,<br />
C. D. Langefeld, J. B. Harley, K. L. Moser, P. M. Gaffney,<br />
A. D. Skol, T. B. Niewold.<br />
2047T HLA DRB1 amino acid position 11 is highly<br />
associated with rheumatoid arthritis in African<br />
<strong>American</strong>s. R. J. Reynolds, S. Raychaudhuri, P. I. W. de<br />
Bakker, X. Jia, M. I. Danila, A. F. Ahmed, L. W. Moreland,<br />
R. Brasington, L. F. Callahan, E. A. Smith, R. M. Plenge,<br />
S. L. Bridges, Jr., CLEAR Investigators.<br />
2048F GCKR polymorphism and insulin resistance in<br />
<strong>American</strong>s <strong>of</strong> Mexican origin. Y. Lu, H. Q. Qu, Q. Li,<br />
S. P. Fisher-Hoch, J. B. McCormick.<br />
2049W Characterization <strong>of</strong> clinical characteristics and<br />
genetic burden <strong>of</strong> multiple sclerosis in Hispanics.<br />
I. Konidari, A. Hadjixen<strong>of</strong>ontos, C. P. Manrique,<br />
A. H. Beecham, P. L. Whitehead, V. Bakthavachalam,<br />
P.-A. Gourraud, M. A. Pericak-Vance, L. Tornes, M. Ortega,<br />
K. W. Rammohan, S. Delgado, J. L. McCauley.<br />
2050T Investigating a role for functional variation in HIV-1<br />
control through exome sequencing. P. J. McLaren,<br />
P. Shea, I. Bartha, K. V. Shianna, D. B. Goldstein, J. Fellay.<br />
2051F The effect <strong>of</strong> genetic and interaction factors for<br />
risk prediction in type 2 diabetes. D. Shigemizu, T. Abe,<br />
T. Morizono, T. A. Johnson, K. A. Boroevich, M. Kubo, Y.<br />
Nakamura, S. Maeda, T. Tsunoda.<br />
2052W Genome-wide association study <strong>of</strong> structural<br />
foot disorders (lesser-toe deformity, hallux valgus<br />
and plantar s<strong>of</strong>t-tissue atrophy) in older Caucasian<br />
populations. Y.-H. Hsu, C.-H. Cheng, Y. Liu, L. A. Cupples,<br />
J. Jordan, M. Hannan.<br />
2053T Multi-stage genome-wide association metaanalyses<br />
identified two new loci for bone mineral<br />
density. L. Zhang, J. Li, Y. F. Pei, Y. Lin, H. Shen, K. Estrada,<br />
F. Rivadeneira, A. G. Uitterlinden, C. S. Shin, H. J. Choi,<br />
E. L. Duncan, P. J. Leo, M. A. Brown, Y. Z. Liu, Y. J. Liu,<br />
J. G. Zhang, Q. Tian, Y. P. Wang, X. Z. Zhu, S. Y. Wu,<br />
C. J. Papasian, H. W. Deng.<br />
2054F <strong>Genetics</strong> <strong>of</strong> left- and right-hemisphere<br />
subcortical structures in the human brain. M. E. Renteria,<br />
A. Wallace, L. Strike, K. Johnson, D. P. Hibar, J. L. Stein, G.<br />
De Zubicaray, K. L. McMahon, G. W. Montgomery,<br />
P. M. Thompson, N. G. Martin, S. E. Medland, M. J. Wright.<br />
2055W Variant in the HLA-DPB1 region inversely<br />
associated with follicular lymphoma risk in metaanalysis<br />
<strong>of</strong> two genome-wide association studies.<br />
L. Conde, K. E. Smedby, J. N. Foo, J. Riby, K. Humphreys,<br />
F. C. M. Sillé, H. Darabi, S. Sanchez, H. Hjalgrim, J. Liu,<br />
P. M. Bracci, C. F. Skibola.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2056T Genome-wide linkage and association analyses<br />
in uterine leiomyomata reveal FASN as a risk gene.<br />
S. L. Eggert, K. L. Huyck, P. Somasundaram, R. Kavalla,<br />
E. A. Stewart, A. T. Lu, J. N. Painter, G. W. Montgomery,<br />
S. E. Medland, S. A. Treloar, K. T. Zondervan, D. R. Nyholt,<br />
A. C. Heath, P. A. F. Madden, L. Rose, P. M. Ridker,<br />
D. I. Chasman, N. G. Martin, R. M. Cantor, C. C. Morton.<br />
2057F X chromosome markers associated with COPD:<br />
A meta-analysis in 3 cohorts. M. Hardin, M. McDonald,<br />
M. Matthiessen, M. Cho, E. Wan, P. Castaldi, D. Lomas,<br />
P. Bakke, A. Gulsvik, J. Crapo, T. Beaty, C. Lange,<br />
E. K. Silverman, D. DeMeo, COPDGene and ECLIPSE<br />
Investigators.<br />
2058W Periodontitis shares IL2RA as a genetic risk<br />
factor with rheumatoid arthritis, multiple sclerosis,<br />
type 1 diabetes, and Crohn’s disease. A. S. Schaefer,<br />
M. Nothnagel, C. Graetz, Y. Jockel, I. Harks, I. Staufenbiel,<br />
J. Eberhardt, E. Guzeldemir, N. Cine, E. Yilmaz, R.<br />
Nohutcu, B. Ehmke, P. Eickholz, M. Folwaczny, J. Meyle,<br />
U. Schlagenhauf, M. Laine, H. Dommisch, C. Bruckmann,<br />
B. Noack, B. Groessner-Schreiber, C. Doerfer, A. Franke,<br />
S. Jepsen, B. G. Loos, S. Schreiber.<br />
2059T Genetic factors underlying birth weight and<br />
cardiovascular disease: A study <strong>of</strong> 17,048 Finns.<br />
K. Auro, E. Widen, J. Eriksson, A. Palotie, T. Lehtimäki,<br />
O. Raitakari, M. Perola.<br />
2060F Genome-wide association study <strong>of</strong> orthostatic<br />
hypotension and supine-standing blood pressure<br />
changes in two Korean populations. K. Hong, Y. Kim.<br />
2061W Genetic association <strong>of</strong> erythrocyte and platelet<br />
phenotypes in Mexican <strong>American</strong>s. P. E. Melton,<br />
J. E. Curran, M. Carless, M. P. Johnson, T. D. Dyer,<br />
J. W. MacCluer, E. K. Moses, H. H. H. Goring,<br />
R. Duggirala, D. Glahn, J. Blangero, L. Almasy.<br />
2062T GWAS in an isolated Sardinian population<br />
contribute to elucidate the genetic control <strong>of</strong> serum<br />
angiotensin converting enzyme level. I. Persico,<br />
M. P. Concas, G. B. Maestrale, L. Portas, F. Murgia,<br />
M. Cosso, D. Serra, M. Pirastu.<br />
2063F Flipping sign test <strong>of</strong> GWAS summary statistics<br />
on multiple correlated traits. Z. Zhang, N. Franceschini,<br />
T. Edwards, B. Keating, B. Tayo, E. Fox, A. Johnson,<br />
Y. Sun, Y. Sung, M. Nalls, J. Hunter, A. Dresbach,<br />
S. Musani, G. Papanicolaou, G. Lettre, A. Adebowale,<br />
R. Cooper, A. P. Reiner, D. Rao, D. Levy, X. Zhu.<br />
2064W Association study on the X chromosome<br />
identifies novel genes associated with systemic lupus<br />
erythematosus in Asian populations. W. Yang, Y. Zhang,<br />
N. Hirankarn, X. Zhang, Y. Lau.<br />
2065T Genetic modifiers <strong>of</strong> the palatal phenotype in<br />
22q11 microdeletion syndrome: Preliminary results <strong>of</strong> a<br />
genome-wide association study. C. Vial, G. M. Repetto,<br />
M. Palomares, S. McGhee, N. K. Henderson-MacLennan,<br />
M. L. Guzman, K. Espinoza, G. Lay-Son.<br />
POSTER SESSIONS 195<br />
2066F Genome-wide copy number variation in anorectal<br />
malformations. S. S. Cherny, E. H. M. Wong, L. Cui,<br />
C. L. Ng, C. S. M. Tang, M. T. So, B. H. K. Yip, G. Cheng,<br />
V. C. H. Liu, P. C. Sham, P. K. H. Tam, M.-M. Garcia-Barceló.<br />
2067W A genome-wide meta-analysis <strong>of</strong> copy number<br />
variation identifies novel childhood obesity loci.<br />
D. Hadley, J. Bradfield, H. Hakonarson, S. Grant on behalf<br />
<strong>of</strong> Early Growth <strong>Genetics</strong> Consortium.<br />
2068T Copy number variation analysis implicates locus<br />
5q21.2 with raised intra-ocular pressure. A. Nag,<br />
P. G. Hysi, C. Venturini, S. MacGregor, A. W. Hewitt,<br />
T. L. Young, P. Mitchell, A. C. Viswanathan, D. A. Mackey,<br />
C. J. Hammond, WTCCC2.<br />
2069F Genome- wide analysis <strong>of</strong> copy number variants<br />
in Down syndrome-associated congenital heart<br />
defects. D. Ramachandran, J. Mulle, A. E. Locke,<br />
P. Bose, L. J. Bean, S. Le, T. Rosser, K. Dooley,<br />
D. J. Cutler, E. Feingold, S. Y. Cheong, C. L. Cua,<br />
C. L. Maslen, R. H. Reeves, S. L. Sherman, M. E. Zwick.<br />
2070W Rare genetic variation in relation to circulating<br />
adiponectin. S. Gustafsson, L. Lind, A. Mahajan,<br />
S. Söderberg, A. Flyvbjerg, C. M. Lindgren, A. P. Morris, I.<br />
Ingelsson.<br />
2071T Comprehensive evaluation <strong>of</strong> type 2 diabetes<br />
susceptibility loci in East Asians by using 1000<br />
Genomes Project data. K. Hara, H. Fujita, T. A. Johnson,<br />
S. Maeda, T. Tsunoda, M. Kubo, T. Kadowaki.<br />
2072F Genome-wide association study <strong>of</strong> age-related<br />
macular degeneration identifies associated variants in<br />
the TNXB-FKBPL-NOTCH4 region <strong>of</strong> chromosome 6p21.3.<br />
V. Cipriani, H.-T. Leung, V. Plagnol, C. Bunce,<br />
J. C. Khan, H. Shahid, A. T. Moore, S. P. Harding,<br />
P. N. Bishop, C. Hayward, S. Campbell, A. M. Armbrecht,<br />
B. Dhillon, I. J. Deary, H. Campbell, M. Dunlop, A. F.<br />
Dominiczak, S. S. Mann, S. A. Jenkins, A. R. Webster, A. C.<br />
Bird, M. Lathrop, D. Zelenika, A. J. Cree, J. Gibson, S. Ennis,<br />
A. J. Lotery, A. F. Wright, D. G. Clayton, J. R. W. Yates.<br />
2073W Evidence for association and biologic support<br />
<strong>of</strong> a novel locus for serum albumin. N. Franceschini,<br />
F. J. A. van Rooij, B. P. Prins, M. F. Feitosa, M. Karakas,<br />
Q. Wu, C. A. Winkler, J. Kopp, J. F. Felix, K. E. North,<br />
B. Z. Alizadeh, L. A. Cupples, J. R. B. Perry, A. P. Morris on<br />
behalf <strong>of</strong> CHARGE Consortium Protein Working Group.<br />
2074T Gene-based meta-analysis <strong>of</strong> genome-wide<br />
association studies implicates new susceptibility loci<br />
for obesity. S. Hägg, Y. Pawitan, E. Ingelsson on behalf <strong>of</strong><br />
GIANT Consortium.<br />
2075F Homozygosity mapping in a Sindh Pakistan<br />
family identifies new candidate regions for primary<br />
autosomal recessive microcephaly. P. Lemay, M. Sindhi,<br />
N. Sehar, S. Kashif, Q. Brohi, J. Michaud, Z. Kibar.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
196 POSTER SESSIONS<br />
2076W Large-scale rare-variant analyses <strong>of</strong> eight<br />
quantitative traits reveal novel loci for triglycerides and<br />
fasting insulin in genome-wide studies imputed from<br />
2188-haplotype 1000 Genomes reference panel. R. Mägi,<br />
M. Horikoshi, I. Surakka, S. Wiltshire, A.-P. Sarin, T. Esko, A.<br />
Mahajan, T. Ferreira, M. Beekman, S. Gustafsson,<br />
S. Hägg, C. Ladenvall, L. Marullo, C. P. Nelson, J. S. Ried,<br />
G. Thorleifsson, N. Tsernikova, S. M. Willems, C. Willenborg,<br />
T. Winkler, C. M. Lindgren, M. I. McCarthy, S. Ripatti,<br />
I. Prokopenko, A. P. Morris for ENGAGE Consortium.<br />
2077T Common genetic variants underlie<br />
endometriosis and fat distribution but not overall<br />
adiposity. N. Rahmioglu, S. Macgregor, H. R. Harris,<br />
A. Morris, S. A. Missmer, G. W. Montgomery, C. M.<br />
Lindgren, K. T. Zondervan, International EndoGene<br />
Consortium, GIANT Consortium.<br />
2078F Genome-wide association <strong>of</strong> single nucleotide<br />
polymorphisms with weight loss outcomes following<br />
Roux-en-Y gastric bypass surgery. E. Rinella, C. Still,<br />
Y. Shao, G. C. Wood, X. Chu, B. Salerno, G. S. Gerhard,<br />
H. Ostrer.<br />
2079W Identification <strong>of</strong> common and specific genetic<br />
determinants to skin prick test reactivity using<br />
genome-wide association study and gene-based test<br />
approaches. P.-E. Sugier, A. Vaysse, C. Loucoubar,<br />
C. Sarnowski, P. Margaritte-Jeannin, M.-H. Dizier,<br />
M. Lathrop, F. Demenais, E. Bouzigon, EGEA Collaborative<br />
Group.<br />
2080T A genome-wide meta-analysis <strong>of</strong> circulating<br />
levels <strong>of</strong> IGF-I and IGFBP-3. A. Teumer, R. S. Vasan, M.<br />
Bidlingmaier, T. Tanaka, N. L. Glazer, M. Nethander,<br />
T. Harris, M. Beekman, R. Westendorp, E. Slagboom, J<br />
. I. Rotter, P. P. Pramstaller, Q. Sun, C. Zhang, C. S. P. Lam,<br />
M. O. Goodarzi, K. Rice, B. M. Psaty, G. Li, J. B. Meigs,<br />
L. Kuller, M. N. Pollak, C. van Duijn, A. Tönjes, S. Berndt,<br />
E. Ziv, X. Xue, C. Ohlsson, H. Wallasch<strong>of</strong>ski, R. C. Kaplan<br />
on behalf <strong>of</strong> CHARGE Insulin-Like Growth Factor Working<br />
Group.<br />
2081F Phenotypic refinement and genome-wide<br />
association analysis identifies a functional variant in<br />
ADCY3 associated with BMI. N. J. Timpson, R. Gaillard,<br />
E. Stergiakouli, H. R. Taal, D. M. Evans, F. Rivadeneira,<br />
B. St. Pourcain, A. G. Uitterlinden, J. Kemp, A. H<strong>of</strong>man,<br />
S. Ring, V. W. V. Jaddoe, G. Davey Smith.<br />
2082W A genome-wide association study <strong>of</strong> kidney<br />
transplant survival: Donors recipients and interactions.<br />
C. Franklin, M. Hernandez Fuentes, J. Mollon, I. Rebollo<br />
Mesa, E. Perucha, P. Conlon, N. Anyanwu, S. H. Sacks,<br />
M. E. Weale, N. Soranzo, G. Lord, United Kingdom and<br />
Ireland Renal Transplant Consortium, the Wellcome Trust<br />
Case-Control Consortium 3.<br />
2083T Admixture mapping <strong>of</strong> vitamin D in African<br />
<strong>American</strong>s. I. Halder, L. Pearson, .S. Mulukutla,<br />
M. Shriver, V. Causer, G. Huggins, S. Reis.<br />
2084F A genome-wide association study establishes<br />
multiple susceptibility loci for Sjögren’s syndrome.<br />
C. J. Lessard, H. Li, I. Adrianto, J. A. Ice, R. Jonsson,<br />
G. G. Illei, M. Rischmueller, G. Nordmark, X. Mariette,<br />
C. Miceli-Richard, M. Wahren-Herlenius, T. Witte, M.<br />
Brennan, R. Omdal, P. M. Gaffney, J. A. Lessard, W.-F. Ng,<br />
N. Rhodus, B. Segal, R. H. Sc<strong>of</strong>ield, J. A. James, J.-M.<br />
Anaya, J. B. Harley, C. G. Montgomery, K. Moser Sivils.<br />
2085W Pooling-based genome-wide association study<br />
for intracranial aneurysms in the Portuguese population.<br />
P.C. S. Abrantes, I. Sousa, M. M. Santos, V. Francisco,<br />
T. Krug, J. M. Xavier, A. Jacinto, D. Coiteiro, S. A. Oliveira.<br />
2086T Genetic variants at the IGHC locus are associated<br />
with IgG levels in multiple sclerosis patients. E. Albrecht,<br />
D. Buck, M. Aslam, A. Goris, N. Hauenstein, A. Jochim,<br />
S. Cepok, V. Grummel, B. Dubois, A. Berthele, P. Lichtner,<br />
C. Gieger, J. Winkelmann, B. Hemmer.<br />
2087F A web-based initiative to accelerate research on<br />
genetics and disease in African <strong>American</strong>s. K. E. Barnholt,<br />
A. K. Kiefer, H. L. Gates, Jr., M. Nelson, M. Mullins, E. Baker,<br />
J. Frank, C. D. Bustamante, T. W. Love, R. A. Kittles,<br />
N. Eriksson, J. L. Mountain.<br />
2088W First systematic association study <strong>of</strong> achalasia<br />
points to a strong involvement <strong>of</strong> the HLA region in the<br />
disease process. J. Becker, M. Knapp, M. M. Wouters,<br />
G. Trynka, V. Kumar, L. Franke, H.-J. Westra, C. Wijmenga,<br />
G. E. Boeckxstaens, M. M. Nöthen, I. Gockel, J. Schumacher.<br />
2089T Genetic variants associated with breast size also<br />
influence breast cancer risk. G. Benton, N. Eriksson,<br />
C. B. Do, A. K. Kiefer, J. L. Mountain, D. A. Hinds,<br />
U. Francke, J. Y. Tung.<br />
2090F Meta-analysis <strong>of</strong> genetic associations in up<br />
to 339,224 individuals identify 67 new loci for BMI,<br />
confirming a neuronal contribution to body weight<br />
regulation and implicating several novel pathways.<br />
S. I. Berndt, S. Vedantam, F. Day, S. Gustafsson,<br />
A. E. Locke, C. Powell, B. Kahali, D. C. Croteau-Chonka, T.<br />
W. Winkler, A. Scherag, I. Barroso, J. S. Beckmann,<br />
A. Justice, C. M. Lindgren, T. Pers, P. Visscher, J. Yang,<br />
M. Boehnke, G. Abecasis, C. J. Willer, K. L. Mohlke,<br />
K. E. North, J. N. Hirschhorn, E. Ingelsson, R. J. F. Loos,<br />
E. K. Speliotes for GIANT Consortium.<br />
2091W Selective immunoglobulin A deficiency is<br />
associated with IFIH1, TNFAIP3, PVT1, FAS, CDH23 and<br />
TM7SF3 in a genome-wide association study and metaanalysis.<br />
P. G. Bronson, A. P. Manoharan, T. R. Bhangale,<br />
W. Ortmann, R. C. Ferreira, Q. Pan-Hammarström,<br />
L. Hammarström, R. R. Graham, T. W. Behrens.<br />
2092T Three new susceptibility loci for hyperuricemia<br />
identified through a genome-wide association analysis<br />
in Han Chinese. C.-H. Chen, Y.-T. Chen, Y.-T. Chen,<br />
J.-Y. Wu.<br />
2093F Candidate genetic loci for telomere length:<br />
A family based association study <strong>of</strong> Long Life Family<br />
Study. R. Cheng, J. H. Lee, M. S. Kang, M. A. Province,<br />
R. Mayeux, L. S. Honig.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2094W Common variations at chromosome 21q22<br />
influences the risk <strong>of</strong> age-related nuclear cataract: The<br />
Singapore Malay Eye Study. C. Y. Cheng, J. Liao, X. Li,<br />
C. C. Khor, W. T. Tay, A. G. Tan, J. J. Wang, P. Mitchell,<br />
Y. Y. Teo, E. S. Tai, S. M. Saw, T. Aung, T. Y. Wong.<br />
2095T A genome-wide association study on<br />
progressive and bout-onset multiple sclerosis patients.<br />
F. Clarelli, P. Brambilla, F. Esposito, G. Giacalone,<br />
M. Rodegher, M. Sorosina, C. Guaschino, N. Barizzone,<br />
P. Cavalla, E. Patti, D. Galimberti, E. Scarpini, S. Lupoli,<br />
R. Capra, G. Tedeschi, G. Mancardi, G. Coniglio,<br />
L. Grimaldi, A. Ghezzi, D. Cusi, V. Martinelli, M. Leone,<br />
S. D’Alfonso, G. C. Comi, F. Martinelli Boneschi.<br />
2096F Novel loci for caffeinated c<strong>of</strong>fee consumption<br />
revealed by a genome-wide meta-analysis <strong>of</strong> 91,000<br />
individuals. M. Cornelis on behalf <strong>of</strong> C<strong>of</strong>fee & Caffeine<br />
<strong>Genetics</strong> Consortium.<br />
2097W Genome-wide association study <strong>of</strong> Tanner<br />
puberty staging in males and females. D. Cousminer,<br />
N. Timpson, D. Berry, W. Ang, I. Ntalla, M. Groen-Blokhuis,<br />
M. Guxens, M. Kähönen, J. Viikari, T. Lehtimäki, K.<br />
Panoutsopoulou, D. Boomsma, E. Zeggini, G. Dedoussis,<br />
C. Pennell, O. Raitakari, E. Hyppönen, G. Davey Smith, M.<br />
McCarthy, E. Widén, Early Growth <strong>Genetics</strong> Consortium.<br />
2098T Genetic variation associated with circulating<br />
monocyte count in the eMERGE Network. D. Crosslin,<br />
A. McDavid, N. Weston, X. Zheng, E. Hart, M. de Andrade,<br />
I. Kullo, C. McCarty, K. Doheny, E. Pugh, A. Kho,<br />
M. Hayes, M. Ritchie, A. Saip, D. Crawford, P. Crane,<br />
K. Newton, R. Li, D. Mirel, A. Crenshaw, E. Larson,<br />
C. Carlson, G. Jarvik.<br />
2099F A genome-wide association study <strong>of</strong> systemic<br />
lupus erythematosus in North <strong>American</strong>s <strong>of</strong> European<br />
ancestry. F. Y. Demirci, X. Wang, A. H. Kao, A. Clarke, R.<br />
Ramsey-Goldman, S. Manzi, M. M. Barmada,<br />
M. I. Kamboh.<br />
2100W Genome-wide association study <strong>of</strong> sexual<br />
orientation in a large, web-based cohort. E. M. Drabant,<br />
A. K. Kiefer, N. Eriksson, J. L. Mountain, U. Francke,<br />
J. Y. Tung, D. A. Hinds, C. B. Do.<br />
2101T Identification <strong>of</strong> multiple novel susceptibility<br />
regions for primary sclerosing cholangitis through dense<br />
genotyping <strong>of</strong> autoimmunity risk loci. E. Ellinghaus,<br />
J. Z. Liu, T. Folseraas, A. Franke, C. A. Anderson, T. H.<br />
Karlsen on behalf <strong>of</strong> International Primary Sclerosing<br />
Cholangitis Study Group and Immunochip Consortium.<br />
2102F Screening <strong>of</strong> inflammation-related SNPs<br />
identifies a functional IL6 receptor variant as a risk<br />
factor for atopic dermatitis. J. Esparza Gordillo,<br />
H. Schaarschmidt, L. Liang, W. O. C. M. Cookson,<br />
M. L. Lee-Kirsch, J. Henderson, L. Paternoster, J. I.<br />
Harper, E. Mangold, M. M. Nothen, F. Rüschendorf,<br />
T. Kerscher, I. Marenholz, A. Matanovic, S. Lau, T. Keil,<br />
C. P. Bauer, M. Kurek, A. Ciechanowicz, M. Macek, A.<br />
Franke, M. Kabesch, N. Hubner, G. Abecasis,<br />
S. Weidinger, M. F. M<strong>of</strong>fatt, Y. A. Lee.<br />
POSTER SESSIONS 197<br />
2103W A novel sarcoidosis risk locus for Europeans on<br />
chromosome 11q13.1. A. Fischer, B. Schmid,<br />
D. Ellinghaus, M. Nothnagel, K. I. Gaede, M. Schürmann,<br />
S. Lipinski, P. Rosenstiel, G. Zissel, K. Höhne, M. Petrek,<br />
V. Kolek, S. Pabst, C. Grohé, J. Grunewald, M. Ronninger,<br />
A. Ecklund, L. Padyukov, C. Gieger, H.-E. Wichmann,<br />
A. Nebel, A. Franke, J. Müller-Quernheim, S. H<strong>of</strong>mann,<br />
S. Schreiber.<br />
2104T A GWAS on age-related hearing impairment in a<br />
European population. E. Fransen, S. Bonneux,<br />
I. Schrauwen, F. Di Berardini, I. Dhooge, J. J. Corneveaux,<br />
J. D. Ohmen, P. H. Van de Heyning, R. Friedman,<br />
M. J. Huentelman, G. Van Camp.<br />
2105F An extensive literature-based multilocus genetic<br />
score is associated with all-cause-mortality and major<br />
diseases: The Rotterdam and TwinGene studies.<br />
A. Ganna, A. C. Janssens, A. H<strong>of</strong>man, F. Rivadeneira,<br />
A. G. Uitterlinden, P. K. E. Magnusson, N. L. Pedersen,<br />
E. Ingelsson, H. Tiemeier.<br />
2106W Large-scale meta-analysis in up to 40,429<br />
Europeans identifies genetic loci associated with<br />
non-fasting plasma glucose and reveals links to<br />
glucose uptake in muscle. K. S. Gutierrez, V. Lagou,<br />
A. Isaacs, J. B. Meigs, Y. S. Aulchenko, I. Prokopenko for<br />
MAGIC (Meta-Analyses <strong>of</strong> Glucose and Insulin-Related<br />
Traits Consortium) Investigators.<br />
2107T Genome-wide association study detects multiple<br />
novel loci associated with nuclear magnetic resonance<br />
spectroscopy detected metabolites in human serum.<br />
P. Henneman, A. Verhoeven, H. Dharuri, J. van Klinken,<br />
A. Meissner, S. Göraler, A. Deelder, R. Frants, L. Karssen,<br />
B. Oostra, K. Willems van Dijk, C. van Duijn.<br />
2108F Ontology, visual, and informatics enhancements<br />
to the NHGRI genome-wide association study catalog.<br />
L. A. Hindorff, J. A. L. MacArthur, D. Welter, T. Burdett,<br />
P. Hall, H. A. Junkins, H. Parkinson.<br />
2109W Genome-wide association study <strong>of</strong> time-to<br />
diabetic retinopathy . S. M. Hosseini, A. P. Boright, L.<br />
Sun, K. Howard, A. J. Canty, S. B. Bull, B. E. Klein, R.<br />
Klein, A. D. Paterson, DCCT/EDIC Research Group.<br />
2110T Genome-wide screen for telomere length loci<br />
identifies a cancer risk associated gene in Finnish<br />
cohorts. I. Hovatta, I. Surakka, I. Sirén, J. Kettunen, J. G.<br />
Eriksson, P. Knekt, V. Salomaa, J. Kaprio, S. Ripatti.<br />
2111F GWAS identifies 13 polymorphisms associated<br />
with motion sickness. B. S. Hromatka, E. R. Chang, J. Y.<br />
Tung, J. L. Mountain, U. Francke, C. B. Do, N. Eriksson.<br />
2112W Identification <strong>of</strong> leprosy host genetic<br />
susceptibility loci. A. Irwanto, L. Hong, F. Zhang, J. Liu.<br />
2113T Genetic risk score in multiple sclerosis: Back<br />
to the individual in the post-GWAS era. N. Isobe, P.<br />
KhanKhanian, B. Vinod, S. Cailler, H. Harbo, A. Santaniello,<br />
S. Hauser, J. Oksenberg, P. Gourraud.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
198 POSTER SESSIONS<br />
2114F A genome-wide association study <strong>of</strong> HIV-1<br />
infection in African <strong>American</strong> and European <strong>American</strong><br />
injection drug users. E. Johnson, D. Hancock, J. Levy,<br />
G. Page, S. Novak, C. Glasheen, N. Gaddis, N. Saccone,<br />
J. Rice, Q. Wang, M. Moreau, K. Doheny, J. Romm, A.<br />
Brook, L. Bierut, A. Kral.<br />
2115W <strong>Genetics</strong> <strong>of</strong> myopia in a participant driven, webbased<br />
cohort. A. K. Kiefer, J. Y. Tung, C. B. Do,<br />
D. A. Hinds, J. L. Mountain, U. Francke, N. Eriksson.<br />
2116T A meta-analysis <strong>of</strong> 52,439 individuals identifies<br />
four loci associated with leptin levels independent <strong>of</strong><br />
adiposity. T. O. Kilpeläinen, Q. Sun, Z. Kutalik,<br />
K. Kristiansson, M. Mangino, M. Su, P. P. Framstaller,<br />
D. Pasko, T. Tanaka, Y. J. Sung, P. Henneman, A. Mahajan,<br />
M. Beekman, M. E. Kleber, T. I. A. Sørensen, L. J.<br />
Rasmussen-Torvik, O. T. Raitakari, L. Perusse, C. Ohlsson,<br />
M. Walker, S. M. Willems, R. H. Myers, J. Eriksson,<br />
V. Salomaa, H. Grallert, T. B. Harris, O. Pedersen, R. J.<br />
Loos for LEPGen Consortium.<br />
2117F Pathway-based analysis <strong>of</strong> genome-wide<br />
association studies for the personality traits. H. Kim,<br />
S. Roh, C. Hong, E. Lee, Y. Sung, H. Lee, H. Chung,<br />
J. Lee, H. Kim.<br />
2118W A genome-wide association study identifies<br />
a novel susceptible locus for refractive error at<br />
19q13.12 in Korea. W. R. Kim, T. Y. Chung, Y. M. Song,<br />
K. Lee, J. Sung.<br />
2119T A genome-wide association study on hallux<br />
valgus angle identifies candidate loci: The Healthy Twin<br />
Study Korea. S.-J. Lee, D. Lee, J.-H. Hwang, Y.-M. Song,<br />
K. Lee, J. Sung.<br />
2120F Sciatica in young adult population: A genomewide<br />
association study in the young Finns. S. Lemmelä,<br />
S. Solovieva, R. Shiri, T. Lehtimäki, I. Seppälä,<br />
M. Kähönen, M. Juonala, J. Viikari, O. Raitakari, E. Viikari-<br />
Juntura, K. Husgafvel-Pursiainen.<br />
2121W GWAS <strong>of</strong> blood cell traits identifies novel<br />
associated loci and epistatic interactions in Caucasian<br />
and African <strong>American</strong> children. J. Li, J. T. Glessner, H.<br />
Zhang, C. Hou, Z. Wei, J. Bradfield, F. D. Mentch, Y. Guo,<br />
C. Kim, Q. Xia, R. M. Chiavacci, K. A. Thomas, H. Qiu, S.<br />
Grant, S. L. Furth, H. Hakonarson, P. M. A. Sleiman.<br />
2122T A genome-wide analysis <strong>of</strong> longitudinal forced<br />
expiratory volume in one second in the Framingham<br />
Heart Study. S.-Y. Liao, X. Lin, D. C. Christiani.<br />
2123F Hundreds <strong>of</strong> loci contribute to body fat<br />
distribution and central adiposity. A. E. Locke, D.<br />
Shungin, T. Ferreira, T. W. Winkler, D. C. Croteau-Chonka,<br />
R. Magi, T. Workalemahu, K. Fischer, J. Wu, R. J.<br />
Strawbridge, A. Justice, F. Day, N. Heard-Costa, C. S. Fox,<br />
M. C. Zillikens, E. K. Speliotes, H. Völzke, L. Qi, I. Barroso,<br />
I. M. Heid, K. E. North, P. W. Franks, M. I. McCarthy, J.<br />
N. Hirschhorn, L. A. Cupples, E. Ingelsson, A. P. Morris,<br />
R. J. F. Loos, C. M. Lindgren, K. L. Mohlke, Genetic<br />
Investigation <strong>of</strong> ANthropometric Traits Consortium.<br />
2124W Significant evidence for association in genomewide<br />
analyses <strong>of</strong> lipid levels in Pima Indians. A.<br />
Malhotra, S. Kobes, W. C. Knowler, L. J. Baier,<br />
R. L. Hanson.<br />
2125T Investigation <strong>of</strong> lipid pathway genes in late<br />
onset Alzheimer’s disease. L. L. McClain, X. Wang,<br />
M. M. Barmada, F. Y. Demirci, O. L. Lopez, M. I. Kamboh.<br />
2126F Genome-wide association study identifies<br />
genetic loci associated with iron overload in HFE<br />
hemochromatosis. J. Mosser, R. Bouvet, J. Morcet,<br />
M. Perrin, A. M. Jouanolle, M. P. Roth, E. Génin, Y.<br />
Deugnier, M. de Tayrac.<br />
2127W Not a stretch: Variant near the dermal gene<br />
elastin is associated with stretch marks. M. E. Mullins,<br />
N. Eriksson, A. K. Kiefer, J. Y. Tung.<br />
2128T Identification <strong>of</strong> three new genes associated to<br />
serum butyrylcholinesterase activity by GWAS in two<br />
genetically distant isolated populations. F. Murgia,<br />
L. Portas, S. Ulivi, N. Pirastu, S. Vaccargiu, D. Parracciani,<br />
P. Gasparini, M. Pirastu.<br />
2129F Common genetic variants <strong>of</strong> primary open-angle<br />
glaucoma in Japanese population. M. Nakano, Y. Ikeda,<br />
Y. Tokuda, M. Fuwa, R. Sato, N. Omi, H. Adachi, M. Ueno,<br />
K. Mori, S. Kinoshita, K. Tashiro.<br />
2130W The associations <strong>of</strong> HLA-DP locus with chronic<br />
hepatitis B and viral clearance are widely replicated in<br />
East-Asian populations. N. Nishida, Y. Tanaka, H. Sawai,<br />
Y. Mawatari, M. Yamaoka, A. Koike, K. Matsuura, M.<br />
Sugiyama, K. Murata, M. Korenaga, N. Masaki, K.-H. Han,<br />
K. Tokunaga, M. Mizokami.<br />
2131T Three novel loci identified with BMI in a<br />
genome-wide association study <strong>of</strong> 47,098 men and<br />
women <strong>of</strong> African ancestry. K. E. North, K. L. Monda,<br />
G. K. Chen, K. T. Taylor, L. A. Lange, C. Palmer, R. J. Loos,<br />
A. P. Reiner, D. R. Velez Edwards, M. C. Ng, T. L. Edwards,<br />
C. Kooperbeerg, B. E. Henderson, G. J. Papanicolaou,<br />
J. N. Hirschhorn, C. Haiman, African <strong>American</strong> BMI<br />
Consortium.<br />
2132F Genetic determinants <strong>of</strong> IL-1 receptor<br />
antagonist in the circulation. M.-L. Nuotio, K.<br />
Kristiansson, M. Perola, V. Salomaa.<br />
2133W Multi-ethnic GWA meta-analysis identifies new<br />
endometriosis risk loci. D. R. Nyholt, S.-K. Low, C. A.<br />
Anderson, J. P. Painter, S. Uno, A. P. Morris, S. MacGregor,<br />
S. D. Gordon, A. K. Henders, N. G. Martin, J. Attia, E. G.<br />
Holliday, M. McEvoy, R. J. Scott, S. H. Kennedy, S. A.<br />
Treloar, S. A. Missmer, S. Adachi, K. Tanaka, Y. Nakamura,<br />
K. T. Zondervan, H. Zembutsu, G. W. Montgomery.<br />
2134T Genome-wide association study reveals new<br />
candidate loci for hand osteoarthritis. A. Näkki, J.<br />
Eriksson, E. Widen, A. Palotie, U. M. Kujala, J. Saarela.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2135F Genome-wide association study and metaanalysis<br />
<strong>of</strong> intraocular pressure in primary open-angle<br />
glaucoma cases and controls in the NEIGHBOR,<br />
GLAUGEN and AMD-MMAP MI Consortia. A. B. Ozel,<br />
S. Moroi, D. Reed, E. Trager, K. Scott, J. Gilbert, S. Garnai,<br />
S. Akbari, M. Nika, C. Schmidt, B. Yaspan, K. Branham,<br />
W. Chen, J. Heckenlively, A. Swaroop, G. Abecasis,<br />
A. Ashley-Koch, M. Ulmer, M. Hauser, J. Haines, L. R.<br />
Pasquale, J. Wiggs, J. Richards, J. Z. Li, NEIGHBOR<br />
Consortium.<br />
2136W Haplotype association mapping in 33 inbred<br />
mouse strains identifies genetic regions contributing<br />
to chronic hypoxia-induced pulmonary hypertension.<br />
M. W. Pauciulo, D. Koller, P. Hale, T. D. Le Cras, P. Pastura,<br />
B. Aronow, C. Tolentino, D. Li, T. Foroud, W. C. Nichols.<br />
2137T Large-scale genome-wide association metaanalysis<br />
<strong>of</strong> fasting glycemic traits using imputation<br />
from 2188-haplotype 1000 Genomes reference panel<br />
within ENGAGE consortium. I. Prokopenko, R. Mägi,<br />
M. Horikoshi, I. Surakka, S. Wiltshire, A.-P. Sarin,<br />
A. Mahajan, L. Marullo, T. Ferreira, S. Hägg, J. S. Ried,<br />
G. Thorleifsson, T. Esko, S. M. Willems, A. P. Morris, M. I.<br />
McCarthy, S. Ripatti, European Network for Genetic and<br />
Genomic Epidemiology Consortium.<br />
2138F BRC allergene study: A TwinsUK GWAS <strong>of</strong> a<br />
metabolite associated with allergic response to nickel.<br />
L. Quaye, L. Bevan, T. Tsakok, C. Menni, A. Moayyeri,<br />
I. Erte, T. D. Spector, C. J. Hammond, F. O. Nestle.<br />
2139W Experience with Illumina Infinium FFPE DNA<br />
restoration solution. J. Romm, S. Pottinger, L. Aker,<br />
C. Hilton, C. Ongaco, K. Doheny.<br />
2140T The Kaiser Permanente/UCSF Genetic<br />
Epidemiology Research Study on Adult Health and<br />
Aging: A genome-wide association analysis <strong>of</strong> type<br />
2 diabetes. L. C. Sakoda, L. Shen, S. Sciortino, D. K.<br />
Ranatunga, R. W. Grant, T. J. H<strong>of</strong>fmann, M. N. Kvale,<br />
S. Hesselson, Y. Banda, P. Kwok, N. Risch, C. Schaefer,<br />
A. Ferrara.<br />
2141F A genome-wide association study <strong>of</strong> Helicobacter<br />
pylori infection susceptibility. C. Schurmann, J. Mayerle,<br />
L. Stolk, M. J. Peters, G. Homuth, A. G. Uitterlinden, M. M.<br />
Lerch, E. Kuipers.<br />
2142W GWAS needs a good phenotype: Clustering<br />
tooth surfaces into biologically-informative dental<br />
caries outcomes. J. R. Shaffer, E. Feingold, X. Wang,<br />
M. Lee, K. T. Cuenco, D. E. Weeks, R. J. Weyant, R. Crout,<br />
D. W. McNeil, M. L. Marazita.<br />
2143T X chromosome SNPs not strongly associated<br />
with juvenile idiopathic arthritis. M. Sudman, M. Marion,<br />
T. Howard, J. Haas, S. Prahalad, J. Bohnsack, C. Wise,<br />
M. Punaro, C. Rose, M. Ryan, M. Wagner, C. D. Langefeld,<br />
D. Glass, S. Thompson.<br />
2144F In quest <strong>of</strong> aging- and longevity-associated<br />
genetic markers. R. Tamm, M. Alver, K. Fischer, R. Magi,<br />
A. Metspalu.<br />
POSTER SESSIONS 199<br />
2145W Genome-wide association scan <strong>of</strong> osteoporotic<br />
fracture: A meta-analysis <strong>of</strong> 10,012 African <strong>American</strong><br />
women. K. C. Taylor, D. Edwards, T. Edwards, D. S.<br />
Evans, G. Li, K. E. North, N. Franceschini, R. Jackson,<br />
M. Donneyong, A. Z. LaCroix, J. A. Robbins, B. Lewis,<br />
M. L. Stefanick, Y. Liu, M. Garcia, T. B. Harris, J. A. Cauley.<br />
2146T Genome-wide association analysis <strong>of</strong> percent<br />
body fat in adults from the Fels Longitudinal Study.<br />
B. Towne, J. Blangero, A. C. Choh, J. E. Curran, C. Bellis,<br />
T. D. Dyer, E. W. Demerath, M. Lee, R. M. Siervogel,<br />
S. A. Czerwinski.<br />
2147F Genome-wide association meta-analyses in<br />
over 210,000 individuals identify 20 sexually dimorphic<br />
genetic variants for body fat distribution. T. W. Winkler,<br />
D. C. Croteau-Chonka, T. Ferreira, K. Fischer, A. E. Locke,<br />
R. Mägi, D. Shungin, T. Workalemahu, J. Wu, F. Day,<br />
A. U. Jackson, A. Justice, R. Strawbridge, H. Völzke,<br />
L. Qi, M. C. Zillikens, C. S. Fox, E. K. Speliotes, I. Barroso,<br />
E. Ingelsson, J. N. Hirschhorn, M. I. McCarthy, P. W.<br />
Franks, A. P. Morris, L. A. Cupples, K. E. North, K. L.<br />
Mohlke, R. J. F. Loos, I. M. Heid, C. M. Lindgren, GIANT<br />
Consortium.<br />
2148W 1000 Genomes imputation identifies low<br />
frequency-large effect circulating biomarker associations<br />
undetected by HapMap-based imputation. A. R. Wood,<br />
J. Tyrrell, D. G. Hernandez, M. A. Nalls, H. Yaghootkar, J. R.<br />
Gibbs, L. W. Harries, S. Chong, M. Moore, J. M. Guralnik,<br />
S. Bandinelli, A. Murray, L. Ferrucci, A. B. Singleton,<br />
D. Melzer, M. N. Weedon, T. M. Frayling.<br />
2149T So fresh or so clean? A genetic variant near<br />
olfactory receptor genes associates with cilantro taste<br />
preference. S. Wu, J. Y. Tung, A. B. Chowdry, A. K. Kiefer,<br />
J. L. Mountain, N. Eriksson.<br />
2150F Genome-wide association study for<br />
Behçet’s disease in an Iranian dataset<br />
using a DNA pooling approach. J. Xavier, M. Martins,<br />
J. Sobral, F. Shahram, F. Davatchi, B. S. Abdollahi,<br />
A. Nadji, N. M. Shafiee, F. Ghaderibarim, S. A. Oliveira.<br />
2151W A genome-wide association study identifies<br />
susceptibility loci for non-syndromic sagittal<br />
craniosynostosis on chromosomes 20 and 7. G. Yagnik,<br />
C. M. Justice, Y. Kim, I. Peter, E. W. Jabs, X. Ye, L. Shi,<br />
M. L. Cunningham, V. Kimonis, T. Roscioli, S. A. Wall,<br />
A. O. M. Wilkie, J. Stoler, J. T. Richtsmeier, Y. Heuzé, P. A.<br />
Sanchez-Lara, M. F. Buckley, C. M. Druschel, J. L. Mills,<br />
M. Caggana, P. A. Romitti, D. M. Kay, C. Senders, P. J.<br />
Taub, O. D. Klein, J. Boggan, C. Naydenov, J. Kim, A. F.<br />
Wilson, S. A. Boyadjiev.<br />
2152T Finding genome-transcriptome-phenome<br />
association with structured association mapping and<br />
visualization in GenAMap. J. Yin, R. E. Curtis, E. P. Xing.<br />
2153F A genome-wide association study <strong>of</strong> central<br />
corneal thickness in Latinos. X. Gao, W. J. Gauderman,<br />
P. Marjoram, M. Torres, T. Haritunians, J. Z. Kuo, Y. I.<br />
Chen, K. D. Taylor, J. I. Rotter, R. Varma.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
200 POSTER SESSIONS<br />
2154W CDKN2BAS genotype: Primary open angle<br />
glaucoma feature correlations in the GLAUGEN study<br />
and the NEIGHBOR consortium. L. R. Pasquale, S. J.<br />
Loomis, J. H. Kang, B. L. Yaspan, D. L. Budenz, D. S.<br />
Friedman, D. Gaasterland, T. Gaasterland, R. K. Lee,<br />
P. R. Lichter, Y. Liu, C. A. McCarty, S. Moroi, L. M. Olson,<br />
T. Realini, J. S. Schuman, K. Singh, D. Vollrath,<br />
G. Wollstein, D. J. Zack, W. Abdrabou, M. A. Hauser, E.<br />
Delbono, R. R. Allingham, M. A. Pericak-Vance,<br />
R. N. Weinreb, K. Zhang, J. E. Richards, J. L. Haines,<br />
J. L. Wiggs.<br />
2155T Ethnicity and ancestry information from<br />
genome-wide association studies: The NHGRI GWAS<br />
catalog. H. A. Junkins, J. A. L. MacArthur, P. Hall,<br />
K. A. Harvey, T. A. Manolio, L. A. Hindorff.<br />
2156F OFCD syndrome gene BCOR is associated with<br />
dental caries. X. Wang, Z. Zeng, J. R. Shaffer, E. Feingold,<br />
D. E. Weeks, M. Lee, K. T. Cuenco, R. J. Weyant, R. Crout,<br />
D. W. McNeil, M. L. Marazita.<br />
2157W Sickle-cell locus is a major modifier <strong>of</strong> human<br />
susceptibility to invasive bacterial infection: A genomewide<br />
association study <strong>of</strong> bacteremia susceptibility.<br />
A. Rautanen, M. Pirinen, C. Spencer, T. Mills, S. Chapman,<br />
K. Rockett, J. A. Scott, T. N. Williams, P. Donnelly, A. V. Hill.<br />
2158T Using genomics to decipher causation in severe<br />
edematous childhood malnutrition: A pilot GWAS. N. A.<br />
Hanchard, S. Howell, K. Marshall, T. Forrester, M. Reid,<br />
X. Wang, L. M. Franco, J. W. Belmont, C. A. McKenzie.<br />
2159F Genome-wide association study <strong>of</strong> body mass<br />
index in Samoans. R. L. Minster, G. Sun, S. R. Indugula,<br />
H. Cheng, N. L. Hawley, S. Viali, R. Deka, D. E. Weeks,<br />
S. T. McGarvey.<br />
2160W Variants in RUNX3 contribute to susceptibility<br />
to psoriatic arthritis exhibiting further common ground<br />
with ankylosing spondylitis. A. Reis, M. Apel, S. Uebe,<br />
J. Bowes, E. Giardina, E. Korendowych, K. Juneblad, F.<br />
Pasutto, A. B. Ekici, R. McManus, P. Ho, I. N. Bruce, A.<br />
W. Ryan, F. Behrens, B. Böhm, H. Traupe, J. Lohmann, C.<br />
Gieger, H. E. Wichmann, L. Padyukov, O. FitzGerald, G. M.<br />
Alenius, N. McHugh, G. Novelli, H. Burkhardt, A. Barton,<br />
U. Hüffmeier.<br />
2161T Association analysis between X-chromosome<br />
variants and asthma in 50,000 individuals. C. S. Tang,<br />
D. Hinds, M. A. R. Ferreira.<br />
2162F Early adiposity phenotypes associate with<br />
common variants at LEPR, FTO, TFAP2B and<br />
GNPDA2. M.-R. Jarvelin, S. Das, H. R. Taal, U. Sovio,<br />
D. Mook-Kanamori, N. M. Warrington, N. J. Timpson,<br />
D. L. Cousminer, E. Thiering, I. Y. Millwood, J. L. Buxton,<br />
S. Sebert, M. Kaakinen, A. I. F. Blakemore, J. Eriksson,<br />
P. Froguel, M. McCarthy, L. Coin, P. O’Reilly, V. W. V.<br />
Jaddoe, Early Growth <strong>Genetics</strong> Consortium.<br />
2163W Multiple human genetic variants associated<br />
with Epstein-Barr virus load in the 1000 Genomes and<br />
HapMap lymphoblastoid cell lines. C. Houldcr<strong>of</strong>t, A. Gall,<br />
J. Z. Liu, A. L. Palser, S. J. Watson, C. A. Anderson, P. Kellam.<br />
2164T Genome-wide association study on expressive<br />
language development in children from the general<br />
population links early word production to common<br />
variation at 3p12.3. B. St Pourcain, R. Cents, W. Ang,<br />
P. F. O’Reilly, F. Velders, N. Warrington, C. M. A. Haworth,<br />
O. S. P. Davis, A. Whitehouse, N. Timpson, J. Kemp, D. M.<br />
Evans, M. Marinelli, Y. Wren, S. Roulstone, R. Plomin,<br />
V. Jaddoe, M.-R. Jarvelin, C. Pennell, H. Tiemeier,<br />
G. Davey Smith, EAGLE.<br />
2165F A genome-wide association study <strong>of</strong> early<br />
menopause and the predictive impact <strong>of</strong> identified<br />
variants on risk. J. R. B. Perry, T. Corre, T. Esko,<br />
S. Chanock, D. Chasman, E. Demerath, M. Garcia,<br />
S. Hankinson, F. Hu, D. Hunter, K. Lunetta, A. Metspalu,<br />
G. Montgomery, J. Murabito, A. Newman, K. Ong,<br />
T. Spector, K. Stefansson, A. Swerdlow, U. Thorsteinsdottir,<br />
R. Van Dam, A. G. Uitterlinden, J. Visser, P. Vollenweider,<br />
D. Toniolo, A. Murray on behalf <strong>of</strong> Reprogen Consortium.<br />
2166W Genome-wide association study <strong>of</strong> nocturnal<br />
awakening in asthma. D. Chhabra, A. Dahlin, Q. Duan,<br />
B. Himes, S. T. Weiss, K. G. Tantisira.<br />
2167T Preliminary meta-analysis <strong>of</strong> genome-wide<br />
association studies <strong>of</strong> lung function in children.<br />
M. Kowgier, M. Bustamante, J. Sunyer, J. Heinrich,<br />
C. Flexeder, G. Koppelman, M. Kerkh<strong>of</strong>, E. S. Schultz,<br />
E. Melen, S. Birch, R. Granell, E. Kreiner-Møller,<br />
H. Bisgaard, J. Henderson, L. J. Palmer.<br />
2168F A genome-wide meta-analysis identifies<br />
common variants in LOC<strong>2012</strong>29 and NOS2A associated<br />
with fractional exhaled nitric oxide in childhood. R. J. P.<br />
van der Valk, L. Duijts, M. T. Salam,<br />
J. Sunyer, E. Melen, G. Koppelman, A. Custovic,<br />
J. Heinrich, H. Bisgaard, A. J. Henderson, V. W. V. Jaddoe,<br />
J. C. de Jongste on behalf <strong>of</strong> GABRIEL and EArly <strong>Genetics</strong><br />
and Lifecourse Epidemiology Consortia.<br />
2169W Phenotypic dissection <strong>of</strong> bone mineral<br />
density facilitates the identification <strong>of</strong> skeletal site<br />
specificity on the genetic regulation <strong>of</strong> bone. J. P.<br />
Kemp, C. Medina-Gomez, K. Estrada, D. H. M. Heppe,<br />
M. C. Zillikens, N. J. Timpson, B. St. Pourcain, S. M.<br />
Ring, A. H<strong>of</strong>man, V. W. V. Jaddoe, G. Davey Smith, A. G.<br />
Uitterlinden, J. H. Tobias, F. Rivadeneira, D. M. Evans.<br />
2170T A multiethnic genome-wide association study<br />
<strong>of</strong> HIV-1 viral load among injection drug users. D. B.<br />
Hancock, J. L. Levy, G. P. Page, S. P. Novak, C. Glasheen,<br />
N. C. Gaddis, N. L. Saccone, J. P. Rice, Q. Wang,<br />
M. Moreau, K. Doheny, J. Romm, A. I. Brooks, L. J. Bierut,<br />
A. H. Kral, E. O. Johnson.<br />
2171F Genetic variants near the NTRK2 gene are<br />
associated with weight at birth in twins. S. J. Metrustry,<br />
T. Spector, A. M. Valdes.<br />
2172W A systematic meta-analysis <strong>of</strong> associations <strong>of</strong><br />
genetic variants influencing protein phosphorylation<br />
with bone mineral density phenotypes. T. Niu, L. Zhang,<br />
F.-Y. Deng, J. Li, Y.-F. Pei, Y. Liu, H. Shen, Y.-Z. Liu,<br />
H.-W. Deng.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2173T Chromosome X revisited: Variants in Xq21.1<br />
associate with adult stature in a meta-analysis <strong>of</strong> 14,700<br />
Finns. T. Tukiainen, J. Kettunen, A.-P. Sarin, J. G. Eriksson,<br />
A. Jula, V. Salomaa, O. T. Raitakari,<br />
M.-R. Järvelin, S. Ripatti.<br />
2174F A genome-wide association study identifies two<br />
susceptibility loci for Crohn’s disease in a Japanese<br />
population. K. Yamazaki, J. Umeno, A. Takahashi,<br />
A. Hirano, T. Johnson, N. Kumasaka, T. Morizono,<br />
N. Hosono, T. Kawaguchi, M. Takazoe, T. Yamada,<br />
Y. Suzuki, H. Tanaka, S. Motoya, M. Hosokawa, Y. Arimura,<br />
Y. Shinomura, T. Matsui, T. Matsumoto, M. Iida, T. Tsunoda,<br />
Y. Nakamura, N. Kamatani, M. Kubo.<br />
2175W Large scale GWAS-meta analysis identifies<br />
novel variants associated with mean leukocyte<br />
telomere length. V. Codd, C. P. Nelson, E. Albrecht,<br />
P. van der Harst, M. Mangino, J. Deelen, J. L. Buxton, J. J.<br />
Hottenga, K. Fischer, I. Surakka, L. Broer, D. R. Nyholt, P.<br />
Salo, S. Hagg, P. J. Talmud, N. L. Pedersen, M. Perola, J.<br />
Kaprio, N. G. Martin, C. M. van Duijn, I. Hovatta, C. Gieger,<br />
A. Metspalu, D. I. Boomsma, M. R. Jarvelin, W. H. van<br />
Gilst, P. E. Slagboom, T. D. Spector, N. J. Samani,<br />
ENGAGE Consortium.<br />
2176T Suggestive loci for osteoporosis: A variance<br />
components linkage analysis <strong>of</strong> extended pedigrees.<br />
S. C. Nguyen, N. D. Nguyen, J. C. Center, J. A. Eisman,<br />
T. V. Nguyen.<br />
2177F Linkage analysis for identification <strong>of</strong> rare, highpenetrance<br />
celiac disease risk variants in the Finnish<br />
and Hungarian populations. E. Einarsdottir, K. Kurppa,<br />
K. Kaukinen, I. Korponay-Szabo, K. Mustalahti, M. Balogh,<br />
M. Mäki, P. Saavalainen.<br />
2178W Whole genome linkage analysis to identify<br />
genes for childhood dental caries. N. Mukhopadhyay,<br />
M. Govil, Z. Zheng, E. Feingold, D. E. Weeks, J. R. Shaffer,<br />
X. Wang, R. J. Weyant, R. Crout, D. W. McNeil, M. L.<br />
Marazita.<br />
2179T simQTL: S<strong>of</strong>tware for simulation <strong>of</strong> a complex<br />
etiological model under a set <strong>of</strong> epidemiological<br />
model parameters. J. D. Terwilliger, K. M. Weiss, J. H.<br />
Lee, B. Lambert.<br />
2180F A hybrid likelihood model for sequence-based<br />
disease association studies. Y. Chen, H. Carter, J. Parla,<br />
M. Kramer, F. S. Goes, M. Pirooznia, P. P. Zandi, W. R.<br />
McCombie, J. B. Potash, R. Karchin.<br />
2181W Novel methods for combined linkage and<br />
association analyses <strong>of</strong> complex quantitative traits in<br />
very large families sheds light on genetics <strong>of</strong> musical<br />
aptitude. Y. Huang, J. Oikkonen, L. Ukkola-Vuoti, P.<br />
Raijas, K. Karma, P. Onkamo, A. Thomas, I. Jarvela,<br />
V. J. Vieland.<br />
2182T Linkage and genome-wide association studies<br />
reveal distinct facets <strong>of</strong> the genetic architecture <strong>of</strong><br />
alopecia areata. L. Petukhova, A. M. Christiano.<br />
POSTER SESSIONS 201<br />
2183F Rare and common variants in extracellular<br />
matrix gene, FBN2, are associated with Mendelian and<br />
multifactorial macular degenerative disease. R. R. Priya,<br />
X. Zhan, R. N. Fariss, C. F. Chakarova, K. E. Branham,<br />
M. M. Campos, J. S. Friedman, B. Brooks, H. K. Rajasimha,<br />
M. A. Morrison, S. G. Jacobson, M. L. Klein, E. Y. Chew,<br />
D. Stambolian, M. M. DeAngelis, S. S. Bhattacharya, J. R.<br />
Heckenlively, G. R. Abecasis, A. Swaroop.<br />
2184W Genetic evidence for an ethnic diversity in the<br />
susceptibility to Ménière’s disease. J. Ohmen, C. White,<br />
J. Wang, L. Fisher, H. Zhang, M. Derebery, R. Friedman.<br />
2185T Genomics <strong>of</strong> response to healing following a<br />
meniscectomy. D. D. Vance, L. Wang, E. Rampersaud,<br />
T. Guettouche, W. H. Cade, R. L. Belton, B. P. Lesniak,<br />
J. M. Vance, M. A. Pericak-Vance, L. D. Kaplan.<br />
2186F GWAS <strong>of</strong> host-pathogen interactions implicates<br />
methionine salvage and microtubules in regulation <strong>of</strong><br />
inflammatory cell death. D. C. Ko, K. P. Shukla, S. I. Miller.<br />
2187W An integrative approach to mapping complex,<br />
glycemic traits in skeletal muscle tissue. S. Keildson,<br />
J. Fadista, C. Ladenvall, A. K. Hedman, H.-F. Zheng,<br />
L. Groop, P. Franks, O. Hansson, C. M. Lindgren, MuTHER<br />
Consortium.<br />
2188T -eQTL analysis <strong>of</strong> dysregulated interferonpathway<br />
genes identifies OAS1 as a novel candidate for<br />
susceptibility to Sjögren’s syndrome. H. Li, J. A. Ice,<br />
J. A. Kelly, I. Adrianto, S. B. Glenn, K. S. Hefner, E. S.<br />
Vista, D. U. Stone, R. Gopalakrishnan, G. D. Houston,<br />
D. M. Lewis, M. D. Rohrer, P. Hughes, J. B. Harley, C. G.<br />
Montgomery, J. Chodosh, J. A. Lessard, J.-M. Anaya, B. M.<br />
Segal, N. L. Rhodus, L. Radfar, M. B. Frank, R. H. Sc<strong>of</strong>ield,<br />
C. J. Lessard, K. Moser Sivils.<br />
2189F Integrative genomic analysis identifies multiple<br />
loci influencing the human immune response to<br />
influenza vaccination. L. M. Franco, K. L. Bucasas,<br />
J. M. Wells, D. Nino, X. Wang, G. E. Zapata, N. Arden,<br />
J. M. Quarles, M. S. Bray, R. B. Couch, J. W. Belmont,<br />
C. A. Shaw.<br />
2190W Barrett’s esophagus and esophageal<br />
adenocarcinoma show substantial polygenetic variance,<br />
with genetic overlap between the diseases. W. E. Ek,<br />
D. Whiteman, D. M. Levine, T. L. Vaughan, S. MacGregor on<br />
behalf <strong>of</strong> BEAGESS Study Investigators.<br />
2191T Rare germline copy number variants in Hodgkin<br />
lymphoma families. M. Rotunno, M. L. McMaster,<br />
L. R. Goldin.<br />
2192F The proportion <strong>of</strong> heritability <strong>of</strong> type 2 diabetes<br />
estimated through GWAS that is attributable to<br />
functional genetic variation. J. M. Torres, E. R. Gamazon,<br />
S. K. Das, H. M. Highland, G. I. Bell, C. L. Hanis, N. J. Cox.<br />
2193W Proportion <strong>of</strong> heritability and implications <strong>of</strong><br />
pleiotropy attributable to GWAS hits for ECG phenotypes<br />
in the Erasmus Rucphen Family Study. A. Isaacs, C. Silva,<br />
J. A. Kors, B. A. Oostra, C. M. van Duijn.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
202 POSTER SESSIONS<br />
2194T The role <strong>of</strong> genes and life-course-related<br />
processes in onset <strong>of</strong> common diseases in late life.<br />
A. Kulminski, I. Culminskaya, K. Arbeev, S. Ukraintseva,<br />
L. Arbeeva, A. Yashin.<br />
2195F Ancestry-directed sequence analysis for rare<br />
variants in admixed populations. E. Ziv, D. Hu.<br />
2196W The convergence <strong>of</strong> functional genomics,<br />
heritability estimation and polygenic modeling:<br />
Emerging spectrum <strong>of</strong> allelic variation in bipolar<br />
disorder. E. R. Gamazon, H. K. Im, C. Liu, D. L. Nicolae,<br />
N. J. Cox.<br />
2197T Contributions <strong>of</strong> cis and trans eQTLs to the<br />
heritability <strong>of</strong> schizophrenia. C. Jumper, E. R. Gamazon,<br />
A. Konkashbaev, C. Liu, D. L. Nicolae, N. J. Cox.<br />
2198F The contribution <strong>of</strong> sequencing-based GWAS in<br />
explaining the missing heritability <strong>of</strong> quantitative traits.<br />
E. Porcu, C. Sidore, M. Steri, F. Busonero, A. Mulas,<br />
M. Dei, S. Lai, M. G. Piras, S. Naitza, D. Schlessinger,<br />
G. Abecasis, S. Sanna, F. Cucca.<br />
2199W Polygenic analysis shows that low frequency<br />
SNPs confer early onset myocardial infarction risk.<br />
E. Stahl, R. Do, B. Vilhjalmsson, N. Stitziel, S. Sunyaev, A.<br />
Price, R. M. Plenge, S. Kathiresan, S. Raychaudhuri.<br />
2200T Ubiquitous polygenicity <strong>of</strong> human complex<br />
traits: Genome-wide analysis <strong>of</strong> 49 traits in Koreans.<br />
J. Yang, T. Lee, J. Kim, S. Cho, P. Visscher, H. Kim.<br />
2201F Prediction <strong>of</strong> human height with large panels <strong>of</strong><br />
SNPs: Insights into genetic architecture. Y. C. Klimentidis,<br />
A. I. Vazquez, G. de los Campos.<br />
2202W Heritability estimation <strong>of</strong> height from common<br />
genetic variants in a large sample <strong>of</strong> African <strong>American</strong>s.<br />
F. Chen, G. K. Chen, R. C. Millikan, E. M. John, C. B.<br />
Ambrosone, L. Berstein, W. Zheng, J. J. Hu, R. G. Ziegler,<br />
S. L. Deming, E. V. Bandera, W. J. Blot, S. S. Strom, S. I.<br />
Berndt, R. A. Kittles, B. A. Rybicki, W. Issacs, S. A. Ingles,<br />
J. L. Stanford, W. R. Diver, J. S. Witte, L. B. Signorello, S. J.<br />
Chanock, L. Le Marchand, L. N. Kolonel, B. E. Henderson,<br />
C. A. Haiman, D. O. Stram.<br />
2203T Optimizing risk stratification to discover novel<br />
neuroblastoma genes. A. Goldenberg, B. Wang, S. Diskin,<br />
J. M. Maris, M. Irwin.<br />
2204F Correlations between associated SNPs cause<br />
upward bias in whole genome-based heritability<br />
estimation. C. Li, C. Yang, J. Ferguson, J. Cho, H. Zhao.<br />
2205W Enrichment <strong>of</strong> rare non-synonymous variants<br />
in 196 lipid-associated genes in subjects with extreme<br />
levels <strong>of</strong> HDL-C: Evidence for rare allele model in<br />
etiology <strong>of</strong> dyslipidemia. M. M. Motazacker, J. Peter, M.<br />
Treskes, J. A. Kuivenhoven, G. K. Hovingh.<br />
2206T Missing heritability and the use <strong>of</strong> genome-wide<br />
expression data as an indicator <strong>of</strong> genetic variation in<br />
genome scans. P. Schliekelman, G. Sun, S. Zhang.<br />
2207F Estimating the proportion <strong>of</strong> variation in<br />
susceptibility to PTSD captured by common SNPs.<br />
C. Yang, J. Gelernter, C. Li, H. Kranzler, L. Farrer, H. Zhao.<br />
2208W Simulation-based study investigating “missing<br />
heritability”: A euphemism for the abject failure <strong>of</strong><br />
modern genomics to elucidate the etiology <strong>of</strong> complex<br />
traits. J. H. Lee, R. Cheng, K. M. Weiss, T. Hiekkalinna,<br />
J. D. Terwilliger.<br />
2209T A quantitative population genetic framework to<br />
constrain the range <strong>of</strong> genetic architectures underlying<br />
complex human traits. V. Agarwala, J. Flannick, S. Sunyaev,<br />
D. Altshuler.<br />
2210F Multi-ethnic polygenic prediction in CARe and<br />
other cohorts contrasts the genetic architectures <strong>of</strong><br />
height and body mass index. E. K. Speliotes, J. O’Connell,<br />
R. Do, B. Vilhjalmsson, S. Pollack, Y. Gong, N. Patterson, M.<br />
Akylbekova, A. Cupples, M. Fornage, J. Hirschhorn, W. H. L.<br />
Kao, L. Lange, G. Lettre, M. Li, J. Mychaleckyj, S. Musani,<br />
G. Papanicolaou, J. I. Rotter, D. Siscovick, X. Zhu, J. G.<br />
Wilson, . GIANT Consortium, J. Johnson, P. I. W. de Bakker,<br />
S. Raychaudhuri, R. M. Plenge, A. Price, E. A. Stahl.<br />
2211W Can ‘asthma genes’ predict asthma?<br />
J. A. Curtin, D. Belgrave, J. Hankinson, A. Custovic,<br />
A. Simpson.<br />
2212T What is the total SNP-associated heritability<br />
for alcohol dependence? N. G. Martin, G. Zhu, P. A.<br />
Lind, A. C. Heath, P. A. F. Madden, M. L. Pergadia, G. W.<br />
Montgomery, J. B. Whitfield.<br />
2213F A knockout mouse model for canine juvenile<br />
epilepsy. E. M. Nevalainen, E. Seppala, H. Lohi.<br />
2214W ER stress response genes and their natural<br />
variation, discovered using the Drosophila model<br />
system. C. Y. Chow, M. F. Wolfner, A. G. Clark.<br />
2215T Physical and genetic interactions between BBS<br />
genes and CEP290. Y. Zhang, K. Bugge, C. C. Searby,<br />
R. F. Mullins, S. Seo, V. C. Sheffield.<br />
2216F Vacuolated lens-associated neural tube defects<br />
are regulated on a multigenic basis by Cdx and retinoic<br />
acid signaling pathway. B. Li, P. Matteson, M. Ababon,<br />
A. Q. Nato, T. Matise, V. Nanda, J. Millonig.<br />
2217W HLA class-I supertypes are associated with<br />
specific M. tuberculosis strain infections. M. Salie, L. van<br />
der Merwe, M. Moller, M. Martin, X. Gao, R. Warren, M.<br />
Carrington, E. Hoal.<br />
2218T Peripheral blood cell counts are heritable in a<br />
large, unselected rhesus macaque pedigree. A. Vinson,<br />
A. D. Mitchell, D. T<strong>of</strong>fey.<br />
2219F A copy number variant at the KIT ligand locus<br />
confers risk for canine squamous cell carcinoma <strong>of</strong> the<br />
digit. E. A. Ostrander, B. Decker, E. Carlins, B. VonHoldt,<br />
G. Carpintero-Ramirez, H. G. Parker, R. K. Wayne, D. M.<br />
Karyadi.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2220W Large-scale transcriptional and epigenetic<br />
changes bridge maternal nutritional imbalance and<br />
metabolic syndrome. X. Yang, L. Peterson, T. Fare,<br />
J. Zhu, R. Kleinhanz, C. Suver, A. M. Cumiskey, R. L. Rosa,<br />
A. Vosatka, M. Skinner, E. E. Schadt, P. Y. Lum.<br />
2221T Gene expression pr<strong>of</strong>iling in mild traumatic brain<br />
injury, post-traumatic stress disorder, sleep disorders<br />
and depression among redeployed military personnel.<br />
H. Lee, D. Wang, R. Pierce, T. Baxter, R. Dionne, H. Kim,<br />
V. Mysliwiec, T. Barr.<br />
2222F <strong>Genetics</strong> <strong>of</strong> obesity across development in a<br />
model system. C. A. Schmitt, S. Service, R. M. Cantor,<br />
A. J. Jasinska, M. J. Jorgensen, J. R. Kaplan, N. B. Freimer.<br />
2223W Modeling 3D facial shape in relation to sex and<br />
genomic ancestry estimated from DNA. M. D. Shriver,<br />
P. Claes, D. K. Liberton, K. M. Rosana, E. E. Quillen,<br />
L. N. Pearson, B. McEvoy, M. Bauchet, H. Tang, G. Barsh,<br />
D. M. Absher, D. A. Puts, J. Rocha, S. Beleza, R. W. Pereira,<br />
J. K. Wagner, J. Boster.<br />
2224T Endogenous DUX4 induces myotube-specific<br />
apoptosis in FSHD muscular dystrophy and is<br />
regulated by Wnt/b-catenin signaling. G. J. Block,<br />
D. Narayanan, A. M. Amell, L. M. Petek, D. G. Miller.<br />
2225F Development <strong>of</strong> a novel Col3a1 transgenic<br />
mouse model for vascular Ehlers-Danlos syndrome.<br />
F. Malfait, Y. Kang, S. Symoens, P. Coucke, M. Renard, B.<br />
Guillemyn, J. De Backer, F. Branco-Madeira, W. Toussaint,<br />
L. Vanhoutte, S. Janssens, B. Descamps, C. Vanhove, P.<br />
Segers, B. Lambrecht, A. De Paepe.<br />
2226W An integrative genetic and metabolomic analysis<br />
suggests altered phosphatidylcholine metabolism in<br />
asthma. J. S. Ried, H. Baurecht, F. Stückler, J. Krumsiek,<br />
J. Adamski, C. Gieger, J. Heinrich, M. Kabesch, A. Peters,<br />
E. Rodriguez, K. Suhre, R. Wang-Sattler, K. Strauch, H.-E.<br />
Wichmann, F. J. Theis, T. Illig, S. Weidinger.<br />
2227T Genomic data integration reveals molecular<br />
modularity <strong>of</strong> Parkinson disease. A. Dumitriu, Y. Xia,<br />
R. H. Myers.<br />
2228F Pathway analysis <strong>of</strong> the GENEVA Alcohol<br />
Consumption GWAS meta-analysis. O. Harari, A. Goate,<br />
GENEVA Alcohol Consumption Working Group.<br />
2229W Pathway-based meta analysis <strong>of</strong> ulcerative<br />
colitis genome-wide association studies. C. Kao,<br />
Z. Wei, J. Li, W. Wang, J. Glessner, C. Cardinale,<br />
J. Bradfield, E. Frackelton, C. Kim, F. Mentch, H. Qui,<br />
S. Grant, R. Baldassano, H. Hakonarson, International IBD<br />
<strong>Genetics</strong> Consortium.<br />
2230T Shared genetic variants between traits and<br />
diseases reveal novel disease risk factors. L. Li, D.<br />
Ruau, C. Patel, R. Chen, A. Butte.<br />
2231F Comparison <strong>of</strong> pathways implicated in anticitrillunated<br />
peptide antibody positive and negative<br />
rheumatoid arthritis patients. P. Martin, S. Viatte, A. Brass,<br />
S. Eyre, Rheumatoid Arthritis Consortium for Immunochip.<br />
POSTER SESSIONS 203<br />
2232W Patterns <strong>of</strong> genetic expression in mental<br />
retardation associated or not with microcephaly.<br />
T. F. Almeida, D. V. Bernardo, C. R. D. C. Quaio, G. L.<br />
Yamamoto, E. D. F. Carvalho, C. A. Kim, D. R. Bertola.<br />
2233T Molecular analysis <strong>of</strong> GABRA1 and EFHC1 genes<br />
in patients with juvenile myoclonic epilepsy and other<br />
idiopathic generalized epilepsies. C. V. Soler, M. C.<br />
Gonsales, F. A. Oliveira, L. E. Betting, F. Cendes, I. Lopes-<br />
Cendes.<br />
2234F Genome-wide expression analysis <strong>of</strong> idiopathic<br />
scoliosis endophenotypes. K. Gorman, S. Bouhnik,<br />
Q. Yuan, C. Julien, A. Franco, K. Choquet, L. Suvarnan,<br />
M.-Y. Akoume, A. Moreau.<br />
2235W Molecular pr<strong>of</strong>iling <strong>of</strong> osteogenic disregulation<br />
in non-syndromic craniosynostosis: New insights<br />
from microarray and morphological studies. M. Barba,<br />
W. Lattanzi, G. Tamburrini, M. C. Geloso, L. Massimi,<br />
M. A. Puglisi, M. Caldarelli, C. Di Rocco, F. Michetti,<br />
C. Bernardini.<br />
2236T Network-based genomic mapping highlights<br />
the influence <strong>of</strong> central-nervous system pathways on<br />
obesity. M. Nikpay, P. Lau, R. Dent, R. McPherson.<br />
2237F A comprehensive knowledgebase <strong>of</strong> autism<br />
genetic evidence. Y. Huang, L. Xu, J. Li, M. Zhao,<br />
X. Tang, L. Wei.<br />
2238W Mathematical modeling <strong>of</strong> the insulin signal<br />
transduction pathway for prediction <strong>of</strong> insulin<br />
sensitivity from expression data. C. K. Ho, J. C. Liao,<br />
G. Sriram, K. M. Dipple.<br />
2239T Examining genetic risk factors <strong>of</strong> obesity:<br />
Pathway analysis <strong>of</strong> GWAS data. M. A. Simonson,<br />
M. C. Keller, M. B. McQueen.<br />
2240F Hypothesis independent pathway analysis<br />
identifies biologic pathways implicated in POAG<br />
etiology. B. L. Yaspan, J. L. Wiggs, L. R. Pasquale,<br />
S. J. Loomis, J. H. Kang, D. L. Budenz, D. S. Friedman,<br />
D. Gaasterland, T. Gaasterland, R. K. Lee, P. R. Lichter,<br />
Y. Liu, C. A. McCarty, S. E. Moroi, L. M. Olson, J. E.<br />
Richards, T. Realini, J. S. Schuman, K. Singh, D. Vollrath,<br />
G. Wollstein, D. J. Zack, R. R. Allingham, M. A. Pericak-<br />
Vance, R. N. Weinreb, K. Zhang, M. A. Hauser, J. L. Haines.<br />
2241W Selecting likely causal genes from genome-wide<br />
association studies <strong>of</strong> BMI and height by integrative<br />
network-based analysis. T. H. Pers, S. Vedantam, T. Esko,<br />
F. Day, S. Berndt, S. Gustafsson, A. E. Locke, A. R. Wood,<br />
B. Kahali, D. C. Croteau-Chonka, C. Powell, P. Dworzynski,<br />
C. E. Thomas, A. G. Pedersen, S. Brunak, A. Justice,<br />
K. L. Mohlke, E. Ingelsson, R. J. F. Loos, E. K. Speliotes,<br />
T. M. Frayling, J. N. Hirschhorn, Genetic Investigation <strong>of</strong><br />
ANthropometric Traits Consortium.<br />
2242T A systems biology approach to ionotropic<br />
GABAergic networks in epilepsy, a model <strong>of</strong> complex<br />
neurogenetic disease. M. Jaworski.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
204 POSTER SESSIONS<br />
2243F P2RX7 SNPs and external apical root resoprtion<br />
during orthodontia. J. Hartsfield, G. Falcao-Alencar,<br />
J. Dempsey, E. Jacobson, G. Kluemper, D. Fardo, J. Macri,<br />
L. Morford.<br />
2244W Pathway analysis <strong>of</strong> variation in DNA repair<br />
genes indicates involvement <strong>of</strong> repair <strong>of</strong> oxidative DNA<br />
lesions in human longevity. M. Soerensen, B. Debrabant,<br />
J. Mengel-From, T. Stevnsner, V. A. Bohr, K. Christensen,<br />
Q. Tan, L. Christiansen.<br />
2245T Constructing endophenotypes <strong>of</strong> complex<br />
disease using nonnegative matrix factorization and<br />
adjusted Rand index. H. M. Wang, C. L. Hsiao,<br />
A. R. Hsieh, Y. C. Lin, S. J. Fann.<br />
2246F Candidate genes <strong>of</strong> several complex diseases<br />
via an integrated analysis <strong>of</strong> GWAS and eQTL. C. Fuller,<br />
X. He, Y. Song, H. Li.<br />
2247W Association study-based gene-set enrichment<br />
analysis identified biological pathways associated with<br />
fetal hemoglobin levels in sickle cell disease patients.<br />
G. Galarneau, S. Coady, M. Puggal, N. Jeffries, D. Paltoo,<br />
A. Kutlar, G. J. Papanicolaou, G. Lettre.<br />
2248T Performances <strong>of</strong> single-SNP and pathway-based<br />
analyses <strong>of</strong> genome-wide data to detect genetic factors<br />
shared by eosinophil and basophil counts in asthmaascertained<br />
families. C. Loucoubar, M. Brossard, P.-E.<br />
Sugier, A. Vaysse, P. Jeannin, M.-H. Dizier, M. Lathrop, E.<br />
Bouzigon, F. Demenais, EGEA Collaborative Group.<br />
2249F Association <strong>of</strong> common genetic variants with<br />
hypoxemia among non-Hispanic White and African<br />
<strong>American</strong> COPD cases highlights hematological<br />
disease genes. M. N. McDonald, M. H. Cho, E. Wan,<br />
P. Castaldi, D. A. Lomas, H. O. Coxson, L. D. Edwards,<br />
W. MacNee, J. Vestbo, J. C. Yates, A. Agusti, P. M. A.<br />
Calverley, B. Celli, C. Crim, S. Rennard, E. Wouters, P.<br />
Bakke, X. Kong, R. Tal-Singer, B. Miller, A. Gulsvik, E.<br />
A. Regan, B. J. Makke, C. Lange, J. E. Hokanson, J. D.<br />
Crapo, T. H. Beaty, E. K. Silverman, C. P. Hersh on behalf<br />
<strong>of</strong> ECLIPSE and COPDGene Coauthors.<br />
2250W ICAM3 expression level integrates the<br />
effects <strong>of</strong> six MS susceptibility alleles: Dissecting<br />
a molecular cascade relevant to MS susceptibility.<br />
T. Raj, M. Kuchroo, L. B. Chibnik, L. Ottoboni, X. Hu, B. T.<br />
Keenan, S. Raychaudhuri, B. E. Stranger, P. L. De Jager.<br />
2251T Random enrichment <strong>of</strong> minor alleles <strong>of</strong> common<br />
SNPs affects complex traits and diseases in model<br />
organisms and humans. S. Huang, X. Tan, J. Liang,<br />
C. Zeng, J. Zhang, J. Chen, L. Ma, A. Dogan,<br />
G. Brockmann, O. Goldmann, E. Medina, M. Xian, K. Yi,<br />
Y. Li, Q. Lu, Y. Huang, D. Wang, J. Yu, H. Guo, K. Xia,<br />
Z. Zhu, D. Yuan.<br />
2252F Functional characterization <strong>of</strong> DcR3 and NF-kB in<br />
EBV transformed cell lines from IBD patients <strong>of</strong> different<br />
allelic background and role in disease pathogenesis.<br />
R. Pandey, C. J. Cardinale, S. Panossian, F. Wang, E.<br />
Frackelton, C. Kim, F. Mentch, R. Chiavacci, K. Kachelries,<br />
S. Grant, R. Baldassano, H. Hakonarson.<br />
2253W Integrative analysis <strong>of</strong> whole-gene coexpression<br />
network and exome sequence data to<br />
characterize pathways relevant to rheumatoid arthritis.<br />
H. Nakaoka, S. Mitsunaga, H. Inoko, I. Inoue.<br />
2254T Integrating genetic linkage analysis and<br />
computational prioritization in identifying host genetic<br />
factors response to influenza A virus infection. S. Bao,<br />
X. Zhou, X. Zhang, P. Tang, J. Zhou, Y. Li, K. To, Y. Song.<br />
2255F Molecular markers <strong>of</strong> severe cerebral malaria:<br />
Expression <strong>of</strong> complement and Toll-like receptor pathway<br />
genes associates with the malaria severity in Mali.<br />
R. Sobota, J. Manning, A. Dara, A. Niangaly, A. Djimde,<br />
O. Doumbo, A. Kone, M. Thera, G. Vernet, P. Leissner,<br />
C. Plowe.<br />
2256W Cross-ethnic gene co-expression network<br />
analysis in human adipose reveals novel triglyceride<br />
genes. D. Weissglas, B. E. Haas, S. Horvath, K. H.<br />
Pietiläinen, R. M. Cantor, E. Nikkola, A. Rissanen, M.<br />
Civelek, I. Cruz-Bautista, L. Riba, J. Kuusisto, J. Kaprio, T.<br />
Tusie-Luna, M. Laakso, C. A. Aguilar-Salinas, P. Pajukanta.<br />
2257T Discovery and replication <strong>of</strong> nuclear genes<br />
influenced by mitochondrial genetic variation. J. Hall,<br />
W. Bush.<br />
2258F Polygenic inheritance <strong>of</strong> paclitaxel-induced<br />
peripheral neuropathy driven by axon outgrowth gene<br />
sets. A. Chhibber, J. Mefford, S. A. Pendergrass, R. M.<br />
Plenge, M. D. Ritchie, E. A. Stahl, J. S. Witte, D. L. Kroetz.<br />
2259W Association <strong>of</strong> adrenomedullin gene<br />
polymorphisms and lipid levels in Chinese population.<br />
S. Chen, X. Lu, L. Wang, H. Li, J. Huang, D. Gu.<br />
2260T A high-throughput molecular assay for detection <strong>of</strong><br />
renal graft acute cellular rejection using peripheral blood.<br />
M. Mikula, O. Zhukov, F. M. Hantash, N. Park, K. Zhang, J. R.<br />
Rion, P. Putheti, C. Snopkowski, A. Buller-Burckle, J. Popov,<br />
W. Sun, B. Crossley, M. P. Hernandez-Fuentes, S. Sacks, M.<br />
Suthanthiran, T. B. Strom, C. M. Strom, S. J. Naides.<br />
2261F Protein interaction networks reveal novel autism<br />
risk genes within GWAS statistical noise. C. Correia,<br />
Y. Diekmann, G. Oliveira, J. B. Pereira- Leal, A. M. Vicente,<br />
Autism Genome Project.<br />
2262W Systems biology in a non-human primate model:<br />
Transcriptomes <strong>of</strong> normal development in the vervet<br />
monkey. A. J. Jasinska, N. Tran, C. Blum, J. DeYoung,<br />
O.-W. Choi, Y. Huang, P. Thomas, E. Eskin, K. Dewar,<br />
J. Wasserscheid, G. M. Weinstock, W. Warren, M. Jorgensen,<br />
R. Cantor, R. Woods, G. Coppola, N. Freimer.<br />
2263T Estrogen pathway polymorphisms in relation<br />
to primary open angle glaucoma in the GLAUGEN<br />
study and the NEIGHBOR consortium. S. Loomis,<br />
L. R. Pasquale, B. L. Yaspan, J. H. Kang, D. Gaasterland,<br />
T. Gaasterland, R. K. Lee, P. R. Lichter, Y. Liu, C. A.<br />
McCarty, S. E. Moroi, L. Olson, J. S. Schuman, K. Singh,<br />
D. Vollrath, G. Wollstein, D. J. Zack, R. R. Allingham, M. A.<br />
Pericak-Vance, R. N. Weinreb, K. Zhang, M. A. Hauser, J. E.<br />
Richards, J. L. Haines, J. L. Wiggs, NEIGHBOR Consortium.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2264F Possible roles <strong>of</strong> miRNA to regulate effective<br />
signaling network in controlling cell fate. M. Nomura,<br />
S. Kondo, T. Nagashima, Y. Suzuki, M. Okada-<br />
Hatakeyama.<br />
2265W Unraveling the molecular mechanisms<br />
underlying the teratogenicity <strong>of</strong> Topamax (topiramate).<br />
S. K. Rafi, A. J. Olm-Shipman, I. Saadi.<br />
2266T The CARTaGENE Genomics Project: Systems<br />
genetics <strong>of</strong> cardiometabolic phenotypes. Y. Idaghdour,<br />
J.-P. Goulet, J. Hussin, A. Hodgkinson, E. Gbeha, J.-C.<br />
Grenier, T. de Malliard, V. Bruat, E. Hip-Ki, C. Boileau, Y.<br />
Payette, P. Awadalla.<br />
2267F Association <strong>of</strong> insulin-like growth factor-1<br />
gene polymorphism in Kuwaiti Arab patients with<br />
rheumatoid arthritis. M. Haider, G. S. Dhaunsi,<br />
S. S. Uppal.<br />
2268W Variations within ARID5B, CEBPE, and<br />
IKZF1 and risk <strong>of</strong> childhood leukemia. L. Hsu,<br />
A. Chokkalingam, C. Metayer, J. Wiemels, P. Buffler.<br />
2269T Contribution <strong>of</strong> common PCSK1 genetic variants<br />
to obesity in a sample <strong>of</strong> 8,359 subjects from two<br />
multi-ethnic <strong>American</strong> populations. H. Choquet,<br />
J. Kasberger, A. Hamidovic, M. Fornage, E. Jorgenson.<br />
2270F Association between IRF6 gene and nonsyndromic<br />
cleft lip and/or palate in Brazil. T. Felix,<br />
L. T. Souza, T. W. Kowalski, I. L. Monlleó, E. M. Ribeiro, J.<br />
Souza, G. F. Leal, A. C. Fett-Conte, V. Gil-da-Silva-Lopes.<br />
2271W Validation <strong>of</strong> the PPP1R12B as a candidate gene<br />
for childhood asthma susceptibility. M. B. Freidin, A. V.<br />
Polonikov.<br />
2272T Association <strong>of</strong> the SNP rs 9939609 <strong>of</strong> the fat<br />
mass and obesity associated gene (FTO) with the risk<br />
for obesity in children from Yucatan, Mexico.<br />
L. Gonzalez-Herrera, N. Mendez-Dominguez, F. Herrera-<br />
Sanchez, G. Uicab-Pool, V. Hernandez-Escalante, L. Ruiz-<br />
Ortiz, G. Storey-Montalvo, J. Zavala-Castro.<br />
2273F Shared genetic loci between leprosy and<br />
inflammatory bowel disease in Korean patients.<br />
Y. Jung, M. Hong, J. Baek, S. Yang, K. Song.<br />
2274W Fatness related allelic variant near insulin<br />
receptor substrate 1 gene is associated with low<br />
low-density lipoprotein cholesterol in childhood and<br />
a better cardiometabolic pr<strong>of</strong>ile in their adulthood:<br />
The Bogalusa Heart Study. S. Li, W. Chen, E. N. Smith,<br />
S. S. Murray, C. Fernandez, J. Xu, S. R. Srinivasan, N. J.<br />
Schork, G. S. Berenson.<br />
2275T Genetic variants associate with nonalcoholic<br />
fatty liver disease in African and Hispanic <strong>American</strong>s.<br />
S. K. Musani, N. D. Palmer, M. F. Feitosa, M. A. Jhun, L. M.<br />
Yerges-Armstrong, R. Hernaez, J. Liu, B. Kahali, J. J. Carr,<br />
T. B. Harris, A. V. Smith, L. E. Wagenknecht, I. B. Borecki,<br />
E. K. Speliotes, L. F. Bielak for <strong>Genetics</strong> <strong>of</strong> Obesity-Related<br />
Liver Disease Consortium.<br />
POSTER SESSIONS 205<br />
2276F Genetic association to ERAP1 in psoriasis<br />
is confined to disease onset after puberty and not<br />
dependent on HLA-C*06. P. Nikamo, J. Lysell,<br />
L. Padyukov, I. Kockum, M. Ståhle.<br />
2277W On the association <strong>of</strong> common polygenic variation<br />
with body mass index across adolescent development:<br />
A longitudinal twin study. R. E. Peterson, B. T. Webb, E. C.<br />
Prom-Wormley, J. L. Silberg, L. J. Eaves, H. H. Maes.<br />
2278T Absence <strong>of</strong> the chromosome 16p11.2<br />
duplication in metabolically normal, constitutionally<br />
thin individuals with extremely low BMI. J. Hager,<br />
N. Germain, E. Meugnier, B. Galusca, H. Vidal, B. Estour.<br />
2279F Lack <strong>of</strong> association <strong>of</strong> genetic variants in<br />
PROX1, ADCY5, SLC2A2, DGKB-TMEM195, ADRA2A,<br />
CRY2, FADS1, IGF1 and C2CD4B with glucose- and<br />
insulin-related traits in Chinese adolescents. R. C. W.<br />
Ma, C. Tam, G. Jiang, J. Ho, V. Lam, Y. Wang, H. M. Lee,<br />
A. Kong, W. Y. So, J. Chan.<br />
2280W Combined effects <strong>of</strong> genetic variants identified<br />
from genome-wide association studies increased risk<br />
<strong>of</strong> type 2 diabetes in Chinese. C. Tam, J. Ho, Y. Wang,<br />
V. Lam, M. Ng, R. Ma, W. So, J. Chan.<br />
2281T AGRP SNPs and gender effects on obesity in<br />
African <strong>American</strong>s. E. Shah, A. Patterson, U. Al-Alem,<br />
R. A. Kittles.<br />
2282F Pleiotropic effects <strong>of</strong> obesity-susceptibility loci<br />
on metabolic traits: A meta-analysis <strong>of</strong> up to 37,874<br />
individuals. J. van Vliet-Ostaptchouk, M. den Hoed, J.<br />
Luan, J.-H. Zhao, K. K. Ong, P. J. van der Most, A. Wong, R.<br />
Hardy, D. Kuh, M. M. van der Klauw, M. Bruinenberg, B. H. R.<br />
Wolffenbuttel, N. J. Wareham, H. Snieder, R. J. F. Loos.<br />
2283W Investigation <strong>of</strong> celiac disease susceptibility<br />
variants in the Irish population using the immunochip.<br />
C. Coleman, E. Quinn, A. W. Ryan, J. Conroy, S. Ennis,<br />
V. Trimble, R. McManus.<br />
2284T Risk alleles associated with ANA production in<br />
healthy population or transition to autoimmunity. E.<br />
Wakeland, P. Raj, E. Rai, Q. Z. Li, D. Karp, P. Doshi,<br />
N. Olsen, K. M. Sivils, J. James, J. Kelly, B. Lauwerys.<br />
2285F Interleukin-18 genetic polymorphism and<br />
Kawasaki disease in Han Chinese children. H. Chi,<br />
M.-R. Chen, N.-C. Chiu, F.-Y. Huang, H.-W. Chan, S.-C.<br />
Chang, C.-L. Lin, Y.-J. Lee.<br />
2286W Association between IL1A, IL1B and TNFA<br />
polymorphisms and glaucoma in a Brazilian population.<br />
M. B. Oliveira, J. P. C. Vasconcellos, V. P. Costa, M. B. Melo.<br />
2287T Evaluation <strong>of</strong> new classification criteria for<br />
HLA-DRB1 alleles based on three amino acid positions<br />
(11, 71 and 74) in Japanese RA patients: Disease<br />
susceptibility and severity. S. Yoshida, K. Ikari, K. Yano,<br />
Y. Toyama, A. Taniguchi, H. Yamanaka, S. Momohara.<br />
2288F Genetic susceptibility to leptospirosis in the<br />
Azorean island <strong>of</strong> São Miguel population. L. M. Esteves,<br />
S. M. Bulhıes, M. J. Brilhante, C. C. Branco, F. M. Mota, C.<br />
Paiva, M. L. Vieira, L. Mota-Vieira.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
206 POSTER SESSIONS<br />
2289W A replication study supports NOD2 and CCDC122<br />
as leprosy susceptibility genes. H. Salomão, W. L. Silva,<br />
P. Medeiros, V. M. Fava, I. M. F. Dias-Baptista, M. L. C.<br />
Virmond, M. O. Moraes, M. T. Mira, A. C. Pereira-Latini.<br />
2290T Positive association <strong>of</strong> apolipoprotein E4<br />
polymorphism with recurrent pregnancy loss in Iranian<br />
patients. M. T. Akbari, N. Asgari.<br />
2291F Investigation <strong>of</strong> rs4236601 and rs4977756 SNPs<br />
in a primary open-angle glaucoma Brazilian population.<br />
H. F. Nunes, M. B. Oliveira, J. P. C. Vasconcellos, V. P.<br />
Costa, M. B. de Melo.<br />
2292W Role <strong>of</strong> genetic variation at the FTO gene<br />
in genetic susceptibility to osteoarthritis. K.<br />
Panoutsopoulou, S. Metrustry, S. Doherty, L. L. Laslett, R.<br />
A. Maciewicz, D. J. Hart, W. Zhang, K. R. Muir, M. Wheeler,<br />
arcOGEN Consortium, C. Cooper, T. Spector, F. M. Cicuttini,<br />
G. Jones, N. K. Arden, M. Doherty, E. Zeggini, A. Valdes.<br />
2293T Association <strong>of</strong> COX-2, IL-1b and IL-1 RN<br />
gene polymorphisms with susceptibility to chronic<br />
periodontitis in North India population. G. Prakash,<br />
S. Ajay, K. K. Gupta, J. Dixit, D. Bali, B. Mittal.<br />
2294F A variant <strong>of</strong> filaggrin are associated with<br />
susceptibility to food allergy in the Japanese<br />
population. T. Hirota, M. Ebisawa, T. Imai, Y. Suzuk,<br />
N. Shimojo, Y. Kohno, M. Kubo, M. Tamari.<br />
2295W AKT1 fails to replicate as a longevity-associated<br />
gene in Danish and German nonagenarians and<br />
centenarians. M. Nygaard, M. Soerensen,<br />
F. Flachsbart, J. Mengel-From, Q. Tan, S. Schreiber,<br />
A. Nebel, K. Christensen, L. Christiansen.<br />
2296T Association <strong>of</strong> HLA-DRB1 and HLA-DQB1 genes<br />
with asthma in the Spanish population. M. Pino-Yanes,<br />
A. Corrales, M. Acosta-Herrera, J. Cumplido, F. Sánchez-<br />
García, R. González, J. Figueroa, I. Sánchez-Machín,<br />
O. Acosta, A. Sánchez-Palacios, J. C. García-Robaina,<br />
J. Villar, E. G. Burchard, T. Carrillo, C. Flores.<br />
2297F Turning the GWAS upside down: A PheWAS<br />
approach in studying human disease. S. Hebbring,<br />
S. Schrodi, Z. Ye, Z. Zhou, D. Page, M. Brilliant.<br />
2298W Assessment <strong>of</strong> bias in an EMR-derived cohort.<br />
W. S. Bush, L. C. Dumitrescu, D. C. Crawford.<br />
2299T Defining the use <strong>of</strong> electronic medical records<br />
in genetic studies <strong>of</strong> multiple sclerosis. M. F. Davis, J. L.<br />
McCauley, J. C. Denny, J. R. Oksenberg, S. L. Hauser, M.<br />
A. Pericak-Vance, J. L. Haines.<br />
2300F The NINDS Repository: A public resource <strong>of</strong><br />
biomaterials for genetic, mechanistic and biomarker<br />
discovery for neurological disorders. A. Scutti, M. Self,<br />
K. Reeves, J. Santana, S. Heil, C. Pérez, A. Nasuti, R.<br />
Corriveau, C. Tarn.<br />
2301W Mutation <strong>of</strong> SLC45A3 in familial and sporadic<br />
Ménière’s disease. C. A. Campbell, B. J. Boese, C. C.<br />
Della Santina, C. Li, N. C. Meyer, L. T. TeGrootenhuis,<br />
J. Webster, D. A. Stephan, H. Najmabadi, A. Danashi, A. P.<br />
May, K. Fredrickson, B. J. Gantz, J. P. Carey, L. B. Minor,<br />
M. R. Hansen, T. T. Harkins, R. J. H. Smith.<br />
2302T Next-generation sequencing identifies genes<br />
dysregulated in otosclerotic stapes bone and provides<br />
a candidate gene set for filtering <strong>of</strong> whole exome<br />
sequence data in familial cases. J. L. Ziff, J. Lavy, H.<br />
Powell, S. Khalil, K. P. Steel, S. R. Saeed, S. J. Dawson.<br />
2303F Dissection <strong>of</strong> healthy aging by whole genome<br />
and exome sequencing <strong>of</strong> supercentenarian genomes.<br />
X. Estivill, N. Badarinarayan, P. Rosenstiel, M. Bayés, S.<br />
Ossowski, C. Tornador, H. Blanche, G. Escaramís, M. Gut,<br />
S. Heath, F. Flachsbart, A. Nebel, M. Lathrop, A. Franke,<br />
M. Gratacòs, S. Schreiber, I. Gut, D. Trujillano.<br />
2304W Whole exome sequencing cases: Fnding and<br />
testing with external controls. A. Hendricks on behalf <strong>of</strong><br />
UK10K Statistics Group.<br />
2305T Whole-exome sequencing study <strong>of</strong> four families<br />
with bipolar disorder. E. Elhaik, M. Pirooznia, F. S. Goes,<br />
J. Parla, R. Karchin, A. Chakravarti, P. P. Zandi, W. R.<br />
McCombie, J. B. Potash.<br />
2306F Whole exome sequencing <strong>of</strong> five<br />
consanguineous families with juvenile myoclonic<br />
epilepsy. B. Ouled Amar Bencheikh, J. Gauthier, F.<br />
Lahjouji, l. Jouan, P. La Chance Touchette, K. Khaldi, H.<br />
Lamghari, C. Bourassa, D. Spiegelman, A. Dionne laporte,<br />
H. Daoud, F. Hamdan, H. Belaidi, O. Ouazzani, P. Dion, P.<br />
Cossette, G. Rouleau.<br />
2307W GEnetics <strong>of</strong> Nephropathy–an International<br />
Effort (GENIE): CNV analysis. Y. Meng, R. M. Salem, A.<br />
J. McKnight, E. P. Brennan, N. Sandholm, C. Forsblom,<br />
J. Florez, C. Godson, P.-H. Groop, A. P. Maxwell, J. N.<br />
Hirschhorn for GENIE Consortium.<br />
2308T Whole genome sequencing identifies coding<br />
variants influencing canonical lipid species in Mexican<br />
<strong>American</strong> families. C. Bellis, P. J. Meikle, J. M. Weir, J.<br />
B. Jowett, T. M. Teslovich, G. Jun, S. Kumar, M. Almeida,<br />
J. M. Peralta, E. E. Quillen, C. Fuchsberger, A. R. Wood,<br />
T. M. Frayling, P. Cingolani, T. W. Blackwell, R. Sladek,<br />
G. Atzmon, J. Laramie, S. Lincoln, D. M. Lehman, G.<br />
Abecasis, M. C. Mahaney, T. D. Dyer, L. Almasy, R.<br />
Duggirala, J. Blangero, J. E. Curran.<br />
2309F Identifying non-synonymous variants exhibiting<br />
pleiotropic effects on preeclampsia and CVD risk<br />
traits. M. P. Johnson, S. P. Brennecke, J. M. Peralta, T.<br />
D. Dyer, M. A. Almeida, J. M. Pr<strong>of</strong>fitt, C. E. East, A. G.<br />
Comuzzie, M. C. Mahaney, L. Almasy, J. E. Curran, J.<br />
Blangero, E. K. Moses.<br />
2310W Analysis <strong>of</strong> coding variants identified from<br />
exome sequencing in diabetic and non-diabetic<br />
nephropathy genes in African <strong>American</strong>s. J. N. Cooke,<br />
N. D. Palmer, M. C. Y. Ng, P. J. Hicks, J. A. Bonomo, J. M.<br />
Hester, C. D. Langefeld, B. I. Freedman, D. W. Bowden.<br />
2311T Assessing the role <strong>of</strong> low-frequency variants in<br />
type 2 diabetes risk using exome sequencing <strong>of</strong> 2,000<br />
Danish individuals. K. E. Lohmueller, T. Sparso, Q. B. Li,<br />
E. Andersson, N. Grarup, A. Albrechtsen, T. Korneliussen,<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
K. Kristiansen, T. Hansen, G. Sanchez, I. Hallgrímsdóttir,<br />
J. Wang, R. Nielsen, O. Pedersen.<br />
2312F Whole exome sequencing identifies a novel<br />
mutation within the FOXP3 gene in 2-generational<br />
family with inflammatory bowel disease. D. T. Okou,<br />
K. Mondal, L. J. Kobrynski, J. G. Mulle, D. Ramachandran,<br />
V. C. Patel, P. Bose, J. P. Waters, P. Sampath, D. J. Cutler,<br />
M. E. Zwick, S. Kugathasan.<br />
2313W Identification <strong>of</strong> rare genetic variants that<br />
contribute to diabetic nephropathy in type 2 diabetes<br />
through family-based targeted exome sequencing.<br />
M. G. Pezzolesi, J. Jeong, A. M. Smiles, J. Skupien, J. C.<br />
Mychaleckyj, S. S. Rich, J. H. Warram, A. S. Krolewski.<br />
2314T Exome sequencing and functional data identify<br />
PRDM1 and NPD52 as susceptibility factors in<br />
Crohn’s disease. A. Franke, D. Ellinghaus,<br />
H. Zhang, S. Schreiber, M. Parkes.<br />
2315F Exome sequencing for Crohn’s disease<br />
pedigrees. B.-S. Petersen, Y. Zeissig, M. Kohl, S.<br />
Schreiber, S. Zeissig, A. Franke.<br />
2316W Whole-exome sequencing <strong>of</strong> patients with<br />
isolated biliary atresia. E. A.-L. Tsai, S. Sukhadia,<br />
C. Grochowski, C.-F. Lin, O. Valladares, L.-S. Wang,<br />
L. Leonard, G. D. Schellenberg, K. M. Loomes, B. A.<br />
Haber, M. Devoto, N. B. Spinner.<br />
2317T Identification <strong>of</strong> low-frequency and common<br />
variants associated with circulating levels <strong>of</strong> vitamin<br />
B 12 and folate. N. Grarup, C. H. Sandholt, P. Sulem,<br />
T. S. Ahluwalia, T. Sparsø, A. Albrechtsen, L. Husemoen,<br />
D. R. Witte, Y. Li, A. Linneberg, R. Nielsen, T. Jørgensen, J.<br />
Wang, T. Hansen, U. Thorsteinsdottir, K. Stefansson,<br />
O. Pedersen.<br />
2318F Whole-exome sequencing in age-related<br />
macular degeneration (AMD) using a highly-discordant<br />
phenotype and genotype design: Evidence for novel<br />
loci underlying bilateral late AMD. W. K. Scott, W. H.<br />
Cade, M. D. Courtenay, P. L. Whitehead, I. Konidari,<br />
W. F. Hulme, S. G. Schwartz, J. L. Kovach, G. Wang,<br />
A. Agarwal, J. L. Haines, M. A. Pericak-Vance.<br />
2319W Deep resequencing <strong>of</strong> GWAS loci identifies a<br />
novel rare variant in RNF186 associated with ulcerative<br />
colitis. P. Goyette, M. Beaudoin, G. Boucher, C. Stevens,<br />
K. S. Sin Lo, A. Alikashani, M. Ladouceur, M. A. Rivas,<br />
S. R. Brant, R. H. Duerr, D. P. McGovern, M. S. Silverberg,<br />
M. D’Amato, A. Franke, S. Vermeire, G. Lettre, J. H.<br />
Cho, R. J. Xavier, M. J. Daly, J. D. Rioux, NIDDK and<br />
International IBD <strong>Genetics</strong> Consortia.<br />
2320T Traits <strong>of</strong> human disease significance segregating in<br />
the non-human primate vervet. W. Warren, A. J. Jasinska,<br />
N. Tran, Y. Huang, K. Dewar, J. Kaplan, P. Minx, L. Hillier, R. K.<br />
Wilson, M. Nordborg, G. M. Weinstock, N. B. Freimer.<br />
2321F Association and replication <strong>of</strong> rare allele<br />
windows within cis-regulatory regions to nearby gene<br />
expression. A. Fish, L. Wiley, W. Bush.<br />
Than, K. Nadeau, M. Snyder.<br />
POSTER SESSIONS 207<br />
2323T Whole-genome deep-coverage sequencing<br />
<strong>of</strong> asthma genomes. M. A. R. Ferreira, C. S. Tang, G.<br />
Chenevix-Trench.<br />
2324F Rare non-coding variant prioritization and<br />
burden testing in whole genome sequencing <strong>of</strong><br />
complex traits. K. J. Gaulton, M. A. Rivas, M. van de<br />
Bunt, C. M. Lindgren, M. I. McCarthy, GoT2D Consortium.<br />
2325W Deep sequencing <strong>of</strong> genomic regions<br />
associated with cleft lip susceptibility. C. Harris,<br />
E. Leslie, R. Fulton, T. Miner, E. Appelbaum, C. Fronick,<br />
M. Mead, D. Larson, M. Adela Mansilla, A. Lidral,<br />
L. Moreno, J. Hecht, M. Marazita, A. Scott, T. Beaty,<br />
J. Murray, R. Wilson, G. Weinstock.<br />
2326T Exome sequencing identifies rare variants<br />
associated with the common pain disorder<br />
fibromyalgia. H. Hor, E. Docampo, R. Rabionet, M. Gut,<br />
M. Bayés, I. Gut, A. Collado, S. Ossowski, X. Estivill.<br />
2327F Application <strong>of</strong> whole genome sequencing<br />
to identify susceptibility loci for polycystic ovary<br />
syndrome. G. Kosova, R. S. Legro, A. Dunaif, M. Urbanek.<br />
2328W CYP1B1, MYOC and LTBP2 mutations in primary<br />
congenital glaucoma patients in the United States. S.<br />
Lim, K. Tran-Viet, T. Yanovitch, S. Freedman,<br />
T. Klemm, W. Call, C. Powell, A. Ravichandran, R.<br />
Metlapally, E. Nading, S. Rozen, T. Young.<br />
2329T Enhancing sequencing lab workflows in the<br />
SardiNIA project. A. Maschio, F. Busonero, C. Sidore,<br />
E. A. Ketterer, E. B. Pedersen, A. M. Chidester, A. M.<br />
Gurkan, M. R. Coon, M. Dei, S. Lai, A. Mulas, M. G. Piras,<br />
M. Lobina, B. Tarrier, S. Sanna, C. A. Brennan, G. R.<br />
Abecasis, F. Cucca, R. H. Lyons.<br />
2330F Whole-exome sequencing identifies novel risk<br />
variants for thrombotic storm. P. Whitehead, N. D.<br />
Dueker, G. Beecham, D. Hedges, A. Beecham, S. Hahn,<br />
N. H<strong>of</strong>mann, J. W. Lawson, D. Erkan, L. R. Brandao, A. H.<br />
James, M. J. Manco-Johnson, R. Kulkarni, C. S. Kitchens,<br />
T. L. Ortel, J. M. Vance, M. A. Pericak-Vance.<br />
2331W Identification <strong>of</strong> genetic modifiers associated<br />
with risk <strong>of</strong> stroke in children with sickle cell anemia.<br />
J. M. Flanagan, H. Linder, V. Sheehan, T. A. Howard, B.<br />
Aygun, J. S. Hankins, M. Wang, G. A. Neale, R. E. Ware.<br />
2332T Implication <strong>of</strong> rare variants from European-derived<br />
adiposity loci in African <strong>American</strong>s. J. Hester, P. Mudgal, J.<br />
Li, J. Xu, P. Hicks, B. Freedman, D. Bowden, M. Ng.<br />
2333F Assessing the effect <strong>of</strong> rare variants on cancer<br />
drug-induced cytotoxicity phenotypes using whole<br />
genome sequence data. A. Tikhomirov, A. Pluzhnikov, C.<br />
R. King, A. Konkashbaev, E. Gamazon, M. E. Dolan, D. L.<br />
Nicolae, N. J. Cox.<br />
2334W Detecting rare variant effects using extreme<br />
phenotype sampling in sequencing association<br />
studies. I. Barnett, S. Lee, X. Lin.<br />
2335T Whole genome sequencing to identify rare genetic<br />
2322W Asthma: An omics view through discordant<br />
monozygotic twins. R. Chen, S. Runyon, J. Li-Pook-<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
208 POSTER SESSIONS<br />
variation responsible for resistance to HIV infection. P. R.<br />
Shea, K. Pelak, K. V. Shianna, D. Ge, D. B. Goldstein, NIAID<br />
Center for HIV/AIDS Vaccine Immunology (CHAVI).<br />
2336F Rare variants are strongly associated with<br />
age <strong>of</strong> menarche: First results from NHLBI-Exome<br />
Sequencing Project. K. L. Bucasas, G. T. Wang, P. L.<br />
Auer, M. Kan, J. M. Murabito, N. Franceschini, E. W.<br />
Demerath, K. L. Lunetta, A. Rodriguez, L. A. Lange, R. D.<br />
Jackson, S. M. Leal, NHLBI Exome Sequencing Project.<br />
2337W Detecting rare variant associations with<br />
waist-to-hip ratio in NHLBI-ESP female cohorts. M.<br />
Kan, K. L. Bucasas, P. L. Auer, G. Wang, A. Rodriguez,<br />
J. Ellis, L. A. Cupples, Y. D. I. Chen, J. Dupuis, C. Fox,<br />
M. D. Gross, N. Heard-Costa, J. B. Meigs, J. S. Pankow,<br />
J. I. Rotter, D. Siscovick, J. G. Wilson, J. Shendure, R.<br />
Jackson, U. Peters, E. Whitsel, J. Zhong, D. Lin, L. Hsu,<br />
N. Franceschini, C. Carlson, K. E. North, L. A. Lange, A. P.<br />
Reiner, S. M. Leal, NHLBI Exome Sequencing Project.<br />
2338T Identification <strong>of</strong> rare susceptibility variants for<br />
bipolar disorder by exome sequencing. C. Cruceanu, A.<br />
Ambalavanan, J. P. Lopez, J. Gauthier, D. Spiegelman, R. G.<br />
Lafrenière, P. Gr<strong>of</strong>, M. Alda, G. Turecki, G. Rouleau.<br />
2339F Deep sequencing in extended pedigrees reveals<br />
both common and rare non-synonymous variants<br />
influencing free triiodothyronine levels. J. E. Curran, S.<br />
Kumar, M. Almeida, J. M. Peralta, T. D. Dyer, T. M. Teslovich,<br />
G. Jun, C. Fuchsberger, A. R. Wood, T. M. Frayling, P.<br />
Cingolani, T. W. Blackwell, R. Sladek, G. Atzmon, S. P.<br />
Fowler, V. S. Farook, S. Puppala, J. Laramie, S. Lincoln, D.<br />
M. Lehman, G. R. Abecasis, R. Duggirala, J. Blangero.<br />
2340W Exome sequencing to identify causal variants in<br />
a multiplex anencephaly family. D. Krupp, K. LaRocque-<br />
Abramson, K. Soldano, M. E. Garrett, A. E. Ashley-Koch,<br />
S. G. Gregory.<br />
2341T Statistical power and effect size overestimation for<br />
combined single point and sequence kernel association<br />
tests in case-control studies. A. M. Valdes, F. Lari.<br />
2342F Exome sequencing <strong>of</strong> cluster headache patients<br />
with Sardinian ancestry. L. Jouan, H. Daoud, B. Ouled<br />
Amar Bencheikh, A. Dionne-Laporte, D. Spiegelman,<br />
O. Diallo, E. Henrion, A. Szuto, J. Gauthier, P. A. Dion,<br />
M. Manchia, M. Alda, M. Del Zompo, G. A. Rouleau.<br />
2343W Whole-genome sequencing analysis <strong>of</strong> more<br />
than 700 members <strong>of</strong> an extended pedigree. Y. Huang,<br />
A. Jasinska, V. Ramensky, N. Juretic, S. Service, N. Tran,<br />
R. Wilson, W. Warren, G. Weinstock, K. Dewar, N. Freimer.<br />
2344T Sequencing Initiative Suomi: Identification <strong>of</strong> loss<br />
<strong>of</strong> function variants enriched in the Finnish population. K.<br />
Rehnström, E. T. Lim, A. Palotie on behalf <strong>of</strong> SISu Consortium.<br />
2345F Diabetes related DNA mutations in <strong>American</strong>s<br />
<strong>of</strong> Mexican origin with health disparities disclosed by<br />
next-gen sequencing. H. Q. Qu, Q. Li, Y. Lu, S. P. Fisher-<br />
Hoch, J. B. McCormick.<br />
2346W Exome sequencing in severe COPD cases<br />
and resistant smoking controls from COPDGene. M.<br />
H. Cho, M. Emond, R. A. Mathias, J. E. Hokanson, T. H.<br />
Beaty, N. Laird, C. Lange, K. C. Barnes, M. Bamshad, J. D.<br />
Crapo, E. K. Silverman, COPDGene Investigators, NHLBI<br />
Exome Sequencing Project.<br />
2347T Meta-analyses <strong>of</strong> 6391 Danish individuals<br />
identify novel genetic loci associated with circulating<br />
levels <strong>of</strong> interleukin 18, insulin-like growth factorbinding<br />
protein 1, and heat shock 70kda protein 1b.<br />
T. S. Ahluwalia, N. Grarup, A. Albrechtsen, T. Sparsø,<br />
C. H. Sandholt, T. Lauritzen, D. R. Witte, T. Jørgensen,<br />
S. Hamren, M. Rowe, J. A. Kolberg, Y. Li, R. Nielsen,<br />
J. Wang, T. Hansen, O. Pedersen.<br />
2348F Further analysis <strong>of</strong> a visual migraine aura locus<br />
on chromosome 9q21-q22 using exome sequencing.<br />
M. E. Hiekkala, M. A. Kaunisto, B. S. Winsvold, E.<br />
Hämäläinen, V. Artto, S. Vepsäläinen, M. Färkkilä, M.<br />
Kallela, A. Palotie, M. Wessman.<br />
2349W Extensions <strong>of</strong> <strong>Human</strong> Variation Database in<br />
Japanese Integrated Database Project. A. Koike, N.<br />
Nishida, M. Yoshida, M. Kawashima, I. Inoue, S. Tsuji,<br />
K. Tokunaga.<br />
2350T Genetic burden analysis <strong>of</strong> common associated<br />
variants in an isolate population <strong>of</strong> Southern<br />
Ostrobothnia and in extended multiplex families.<br />
V. Leppä, E. Jakkula, S. Ripatti, P.-A. Gourraud, K.<br />
Koivisto, P. Tienari, J. Kaprio, J. Eriksson, T. Lehtimäki, S.<br />
Koskinen, A. Palotie, J. Saarela.<br />
2351F Assessing association between known PTPN22<br />
and SUMO4 variants and type 1 diabetes in an Indian<br />
population. S. R. Manyam, U. Ratnamala, K. R. S. S. Rao,<br />
S. K. Nath, U. Radhakrishna.<br />
2352W Duffy interaction with chromosome 4 determine<br />
the number <strong>of</strong> malaria episodes <strong>of</strong> individuals from<br />
Western Brazilian Amazon. J. Pescarini, L. M. Garrido, L.<br />
C. Pereira, R. G. M. Ferreira, L. M. A. Camargo, H. Krieger.<br />
2353T Role <strong>of</strong> genetic variants <strong>of</strong> inflammatory genes<br />
with inflammation, malnutrition and susceptibility to<br />
end-stage renal disease in North Indian population.<br />
R. Sharma, R. K. Sharma, A. Saxena, S. Agrawal.<br />
2354F Genetic predisposition to hypertension associates<br />
with increased risk <strong>of</strong> type 2 diabetes. Q. Qi, J. Forman,<br />
F. Hu, L. Qi.<br />
2355W A systemic monitoring <strong>of</strong> cleft lip/palate in Hebei<br />
Province <strong>of</strong> China through a birth defect surveillance: A<br />
15-year (1996-2010) report. J.-Z. Zhu, N. Zhong.<br />
2356T De novo and inherited copy number variants<br />
are a common cause <strong>of</strong> short stature. C. T. Thiel, D.<br />
Zahnleiter, U. Trautmann, A. B. Ekici, D. Wieczorek, E.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
Psychiatric <strong>Genetics</strong>, Neurogenetics<br />
and Neurodegeneration<br />
2370W Genetic association analysis between glycine<br />
cleavage system and schizophrenia. A. Yoshikawa,<br />
F. Nishimura, H. Hibino, K. Kohda, M. Tochigi, Y. Kawamura,<br />
T. Umekage, T. Sasaki, K. Kasai, C. Kakiuchi.<br />
2371T A gene search for a new spinocerebellar ataxia.<br />
K. Ishikawa, N. Sato, Y. Hashimoto, M. Obayashi,<br />
H. Matsuo, H. Mizusawa.<br />
2372F Combining genotype and gene expression data to<br />
unravel the genetics <strong>of</strong> major depressive disorder.<br />
S. Mostafavi, A. Battle, X. Zhu, S. Montgomery, J. B. Potash,<br />
M. M. Weissman, C. Haudenschild, C. McCormick, K. B.<br />
Beckman, R. Mei, A. Urban, D. Koller, D. F. Levinson.<br />
2373W Transcript pr<strong>of</strong>ile analysis <strong>of</strong> interleukin-1<br />
beta gene in immature and adult zebrafish brain after<br />
seizure. P. G. Barbalho, F. R. Pinto, R. Mangolin, C. V.<br />
Maurer-Morelli.<br />
2374T An integrative analysis pinpoints the pathogenesis<br />
<strong>of</strong> autism in the cerebellar vermis. D.-A. Clevert,<br />
S. Hochreiter.<br />
2375F Common genetic variants in the GNB3, ARNTL,<br />
and NPAS2 loci are associated with objectively<br />
measured sleep traits in the elderly. D. S. Evans,<br />
N. Parimi, C. M. Nievergelt, K. L. Stone, T. Blackwell, S.<br />
Redline, S. Ancoli-Israel, E. S. Orwoll, S. R. Cummings,<br />
G. J. Tranah, Study <strong>of</strong> Osteoporotic Fractures and<br />
Osteoporotic Fractures in Men Study Groups.<br />
2376W GWAS <strong>of</strong> alcohol abuse and dependence in the<br />
CATIE schizophrenia sample. V. F. Gonçalves, C. Zai, A.<br />
Paterson, L. Sun, J. L. Kennedy, J. Knight.<br />
2377T Familial study <strong>of</strong> essential tremor at Columbia<br />
University. N. Hernandez, D. Tirri, L. Clark, E. Louis.<br />
2378F Significant linkage <strong>of</strong> familial essential tremor to<br />
a novel locus on chromosome 5. J. E. Hicks, I. Konidari,<br />
J. R. Gilbert, W. K. Scott.<br />
2379W Autism and obesity: Is there any mechanistic<br />
connection? Z. Talebizadeh, M. Miralles.<br />
2380T Haplotypes in the expression quantitative<br />
trait locus <strong>of</strong> interleukin-1� gene are associated with<br />
schizophrenia. M. Yoshida, K. Shiroiwa, K. Mouri, T.<br />
Sasada, H. Ishiguro, T. Inada, T. Arinami, O. Shirakawa, A.<br />
Hishimoto.<br />
2381F Selection <strong>of</strong> candidate genes from linkage<br />
regions identified by the individual behavioral domains<br />
<strong>of</strong> autism spectrum disorders. A. Hare, J. Flax, Z.<br />
Fermano, M. Azaro, A. Seto, S. Y. Cheong, S. Buyske, B.<br />
Zimmerman-Bier, C. W. Bartlett, L. M. Brzustowicz.<br />
POSTER SESSIONS 209<br />
2382W Association <strong>of</strong> Neuregulin 1 polymorphisms<br />
with a North Indian schizophrenia cohort. P. Kukshal,<br />
T. Bhatia, A. M. Bhagwat, R. E. Gur, R. C. Gur, S. N.<br />
Despande, V. L. Nimgaonkar, B. K. Thelma.<br />
2383T Single nucleotide polymorphism fine mapping <strong>of</strong><br />
the AVPR1A and OXTR loci reveals an OXTR association<br />
with a social memory endophenotype in probands<br />
with autism and their family members. A. Lori, I. Lee,<br />
J. F. Cubells, E. B. Binder, T. Lehtimäki, K. Puura, K. N.<br />
Conneely, L. J. Young, D. Skuse.<br />
2384F The effects <strong>of</strong> ABCB1 polymorphisms and<br />
expression in perinatal depression. S. E. Parets, A. Lori,<br />
M. N. To, D. J. Newport, Z. N. Stowe, J. F. Cubells, A. K.<br />
Smith.<br />
2385W HMNC1 and COMT gene polymorphism<br />
associated with postpartum depression.<br />
M. Romano-Silva, D. M. Miranda, P. Figueira,<br />
H. Correa, A. Alvim-Soares.<br />
2386T Disrupted in schizophrenia 1 gene in autist<br />
patients. P. Sarda, J. Puechberty, M. Girard, A. Schneider,<br />
S. Taviaux, G. Lefort, D. Genevieve, A. Baghdadli.<br />
2387F Phenotypic description <strong>of</strong> a child with a<br />
10q23.1 deletion involving only NRG3. N. Sobreira, D.<br />
Avramopoulos, A. Pulver, B. Menten, B. Loeys, D. Valle.<br />
2388W Determination <strong>of</strong> a rare variant and common<br />
variants in COMT for their involvement in the etiology<br />
<strong>of</strong> smoking dependence using Mid-South Tobacco<br />
Case-Control study samples. J. Yang, S. Wang, J. Z. Ma,<br />
T. J. Payne, M. D. Li.<br />
2389T Copy number variations and agenesis <strong>of</strong><br />
the corpus callosum, narrowing the recurrent 8p<br />
duplication interval. S. Esmaeeli Nieh, L. Fernandez, S.<br />
Sajan, E. Rider, P. Bukshpun, M. Wakahiro, J. T. Glessner,<br />
H. Hakonarson, S. L. Christian, W. B. Dobyns, E. H. Sherr.<br />
2390F Serotonin transporter and receptor genes<br />
significantly impact nicotine dependence through<br />
genetic interactions in both European <strong>American</strong> and<br />
African <strong>American</strong> smokers. Z. Yang, C. Seneviratne, S.<br />
Wang, J. Z. Ma, T. J. Payne, J. Wang, M. D. Li.<br />
2391W Genetic association <strong>of</strong> FKBP5 and CRHR1<br />
with cortisol response to acute psychosocial stress in<br />
healthy adults. P. B. Mahon, P. P. Zandi, J. B. Potash,<br />
G. Nestadt, G. S. Wand.<br />
2392T Associations <strong>of</strong> genetic polymorphisms in<br />
GRIN2B and GABRG2 with epilepsy susceptibility. C.<br />
Chen, C. Hung, Y. Kao, H. Liou.<br />
2393F Interpreting the impact <strong>of</strong> mutations in SCN1A<br />
in the context <strong>of</strong> the most severe phenotypes amongst<br />
the generalized epilepsies with febrile seizures plus.<br />
M. Gonsales, P. Preto, M. A. Montenegro, M. M. Guerreiro,<br />
I. Lopes-Cendes.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
210 POSTER SESSIONS<br />
2394W Next-generation sequencing and mutation<br />
screening in patients with familial mesial temporal<br />
lobe epilepsy: Investigating the chromosome 18p11.31<br />
candidate locus. R. O. Santos, M. G. Borges, W. T. S.<br />
T. Ide, C. S. Rocha, R. Secolin, F. M. Artiguenave, C. L.<br />
Yasuda, A. C. Coan, M. E. Morita, F. Cendes, C. V. Maurer-<br />
Morelli, I. Lopes-Cendes.<br />
2395T Characterization <strong>of</strong> a GEFS� locus on<br />
6q16.3q22.31. P. Szafranski, G. Von Allmen, B. Graham,<br />
S. Fogarty, A. A. Wilfong, S.-H. L. Kang, J. A. Fereira,<br />
W. Bi, J. A. Rosenfeld, L. G. Shaffer, S. W. Cheung,<br />
P. Stankiewicz, S. R. Lalani.<br />
2396F Identifying disease genes in a large highly inbred<br />
consanguineous kindred from Turkey with idiopathic<br />
generalized epilepsy. F. N. Tuncer, S. A. Ugur Iseri, M.<br />
Calik, A. Iscan, G. Altiokka Uzun, U. Ozbek.<br />
2397W Haplotype sharing and linkage analyses <strong>of</strong><br />
multigenerational families with multiple sclerosis<br />
identified two chromosomal regions at 12p12.3-q12<br />
and 16q21-q22.3. N. Matsunami, J. Stevens, L. Baird, B.<br />
Otterud, T. Varvil, T. Leppert, J. W. Rose, M. F. Leppert.<br />
2398T Homozygosity mapping and exome sequencing<br />
identifies a gene on 11q24.2 for non-syndromic<br />
autosomal recessive intellectual disability in a<br />
Pakistani family. M. A. Rafiq, I. A. Balouch, K. Mittal, A.<br />
Mikhailov, M. Ayub, P. John, J. B. Vincent.<br />
2399F Investigation <strong>of</strong> inherited copy number<br />
variations in extended Asperger syndrome families.<br />
M. Rossi, K. Rehnström, O. Pietiläinen, V. Leppä, T.<br />
Hiekkalinna, T. Nieminen-von Wendt, J. Barrett, I. Hovatta,<br />
S. Ripatti, A. Palotie.<br />
2400W Gene analysis <strong>of</strong> familial and sporadic<br />
amyotrophic lateral sclerosis in Kyushu island <strong>of</strong><br />
Japan. H. Furuya, A. Watanabe, H. Arahata, Y. Kawano, N.<br />
Fujii, H. Kikuchi, T. Fujiwara, T. Hokonohara, A. Iwaki, H.<br />
Shibata, Y. Fukumaki.<br />
2401T Replication and generalization <strong>of</strong> genetic risk<br />
factors for depression, anxiety and panic attack in a<br />
population-based cohort with African, European and<br />
Mexican ancestries. J. N. Vega, K. Brown-Gentry, D. C.<br />
Crawford, T. A. Thornton-Wells.<br />
2402F Genome-wide genetic studies <strong>of</strong> two<br />
consanguineous Pakistani multiplex pedigrees with<br />
schizophrenia and bipolar disorder. L. Xiong, S. Zhou,<br />
M. Christian, S. Provost, G. Asselin, Q. Brohi, M. Denton,<br />
R. Joober, L. E. DeLisi, G. A. Rouleau.<br />
2403W A comprehensive genotype-phenotype study<br />
for CHRNA7 and CHRFAM7A in autism and intellectual<br />
disability. J. Ge, C. P. Schaaf, B. Zhang, A. L. Hall,<br />
M. Ali, S. Tinschert, U. Moog, A. Patel, P. Stankiewicz,<br />
A. L. Beaudet.<br />
2404T Genetic variant <strong>of</strong> AKT1 and AKTIP associated<br />
with risk for late-onset depression in a Brazilian<br />
population. P. Pereira, M. Romano-Silva, M. Bicalho, E.<br />
Moraes, L. Malloy-Diniz, R. Nicolato, G. Pimenta, M. Mello,<br />
I. Bozzi, D. Miranda.<br />
2405F Whole genome gene expression analysis <strong>of</strong><br />
patients with 22q11 deletion syndrome and controls.<br />
K. K. Mantripragada, S. Chawner, M. B. van den Bree,<br />
R. G. Thomas, L. Bates, M. J. Owen, N. M. Wiliams.<br />
2406W Fine-mapping <strong>of</strong> a region <strong>of</strong> interest in an<br />
extended family with multiple cases <strong>of</strong> autism. N. H.<br />
Chapman, K. Ankeman, R. Bernier, A. Estes, J. Munson,<br />
Z. Brkanac, W. Raskind, H. Coon, E. M. Wijsman.<br />
2407T Investigation <strong>of</strong> GWAS findings in schizophrenia<br />
in a case control and a family sample from Indonesia.<br />
D. B. Wildenauer, W. Qin, M. D. B. Wildenauer, A. A. A. A.<br />
Kusumawhardani, B. Benyamin, S. G. Schwab, Indonesia<br />
Schizophrenia <strong>Genetics</strong> Consortium.<br />
2408F Association analysis <strong>of</strong> mitochondrial DNA<br />
with suicidal behavior in schizophrenia. V. De Luca, A.<br />
Hassan, N. Hettige, C. Borlido, G. Polsinelli.<br />
2409W Application <strong>of</strong> whole genome resequencing to<br />
identify the causative gene for an autosomal recessive<br />
oculopharyngodistal myopathy. M. Taira, H. Ishiura, Y.<br />
Ichikawa, B. Ahsan, Y. Fukuda, J. Mitsui, Y. Takahashi, K.<br />
Higasa, J. Yoshimura, I. Nishino, J. Shimizu, S. Murayama,<br />
E. Uyama, S. Morishita, J. Goto, S. Tsuji.<br />
2410T Glucocerebrosidase mutations and dementia<br />
with Lewy bodies. L. Clark, K. Mirzozoda, J. H. Lee, R.<br />
Mayeux, L. S. Honig.<br />
2411F Both ISRE and GAS interferon regulatory<br />
sequences found in chromosome 21 genes that<br />
are important in brain development and function.<br />
A. Jagadeesh, J. Nagappa, K. Sampson, H. North, L.<br />
Gutman, P. Lenferna de la Motte, M. Sellers, I. Dhanoya,<br />
D. Elyaman, J. Husni, L. E. Maroun.<br />
2412W Genome-wide SNP analysis in a large<br />
consanguineous Turkish family reveals diagnosis as<br />
Unverricht-Lundborg disease. U. Ozbek, S. A. Ugur Iseri,<br />
F. N. Tuncer, I. Karacan, O. Ozdemir, G. Altiokka Uzun, M.<br />
Calik, A. Iscan.<br />
2413T CRHR2 differentially modulates anxious<br />
temperament and plasma cortisol in a rhesus<br />
macaque model <strong>of</strong> childhood anxiety. G. L. Fawcett,<br />
M. Raveendran, J. A. Oler, A. S. Fox, S. E. Shelton, N.<br />
H. Kalin, J. M. Cheverud, D. M. Muzny, R. A. Gibbs, J.<br />
Rogers.<br />
2414F Deregulation <strong>of</strong> neuronal cytoskeleton dynamics<br />
and androgen receptor gene pathways converge<br />
to aberrant synapse modulation in autism. K. Griesi<br />
Oliveira, D. Y. Sunaga, L. A. Cruz, E. Vadasz, M. R.<br />
Passos-Bueno.<br />
2415W Calcium channel genes are associated with<br />
autism spectrum disorders. A. Lu, X. Dai, R. M. Cantor.<br />
2416T X-chromosomal dystonia parkinsonism<br />
syndrome: Disease-specific sequence change DSC3<br />
<strong>of</strong> TAF1/DYT3 multiple transcript system affects<br />
dopamine metabolism, vesicular transport, and<br />
synapse function. U. Mueller, D. Nolte, A. H<strong>of</strong>mann, J.<br />
Schultze, T. Herzfeld.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2417F Identification <strong>of</strong> microduplications <strong>of</strong> the ATRX<br />
gene in autism spectrum disorders. B. A. Oliveira, I. C.<br />
Conceição, C. Correia, P. Jorge, R. Santos, C. Café, J.<br />
Almeida, S. Mouga, F. Duque, G. Oliveira, A. M. Vicente.<br />
2418W Alanyl-tRNA synthetase mutation in dominant<br />
distal hereditary motor neuropathy and Charcot-Marie-<br />
Tooth disease. H. Takashima, A. Hashiguchi, J. Hu, Z.<br />
Zhao, Y. Higuchi, Y. Sakiyama, S. Tokunaga, Y. Okamoto,<br />
A. Yoshimura.<br />
2419T Association <strong>of</strong> interleukin 6 gene polymorphisms<br />
with genetic susceptibilities to spastic tetraplegia in<br />
males: A case-control study. Q. Xing, M. Chen, T. Li, S.<br />
Lin, D. Bi, D. Zhu, Q. Shang, C. Ma, Q. Li, L. He, C. Zhu.<br />
2420F ADCYAP1R1 genotype associates with posttraumatic<br />
stress symptoms in highly-traumatized<br />
African <strong>American</strong> females. L. M. Almli, K. B. Mercer, H.<br />
Feng, K. N. Conneely, B. Bradley, K. J. Ressler.<br />
2421W EFHC2 shows female-specific association with<br />
autism. K. M. Tsang, Y. Cheng, J. F. Quinn, L. A. Weiss.<br />
2422T Ataxia with oculomotor apraxia type 2 in the<br />
Canadian aboriginal population: Expanding the disease<br />
distribution. E. R. Dola, J. N. Hartley, F. A. Booth, A. A.<br />
Mhanni.<br />
2423F Lamin B1 is a novel regulator <strong>of</strong> myelin and<br />
mediates cell-autonomous neuropathology in a murine<br />
model <strong>of</strong> autosomal dominant leukodystrophy. M. Y.<br />
Heng, L. J. Ptacek, Y. H. Fu.<br />
2424W Weight loss and low serum glucose levels in<br />
Machado-Joseph disease/spinocerebellar ataxia type<br />
3. L. B. Jardim, G. N. Souza, A. D. Russo, T. L. Monte, R.<br />
M. Castilhos, A. F. S. Schuh, K. C. Donis, R. D’Ávila, T. C.<br />
Gheno, G. V. Furtado, D. O. G. Souza, M. L. Saraiva-Pereira,<br />
L. V. C. Portela, C. R. M. Rieder, J. Dubois, J. A. M. Saute.<br />
2425T Spinocerebellar ataxias with hypogonadism:<br />
Unraveling a rare group <strong>of</strong> neuroendocrinologic<br />
syndromes. C. Lourenco, C. Sobreira, V. Cintra, R.<br />
Giugliani, W. Marques, Jr.<br />
2426F A neuronal cellular model <strong>of</strong> 22q11.2 DS exhibits<br />
disruptions to the miRNA regulatory pathway and may<br />
increase the rate <strong>of</strong> schizophrenia in individuals with<br />
22q11.2 DS. W. Manley, M. R. Ababon, P. G. Matteson,<br />
J. H. Millonig, L. M. Brzustowicz.<br />
2427W Analysis <strong>of</strong> aging phenotypes from long-term<br />
expression <strong>of</strong> the progeria mutation in the brain. J.<br />
Baek, E. Schmidt, S. Rodriguez, C. Strandgren, B. Rozell,<br />
E. Mugnaini, M. Eriksson.<br />
2428T Neurodegeneration and associated phenotypes<br />
in adults with 22q11.2 deletion syndrome. N. J. Butcher,<br />
T.-R. Kiehl, E. Chow, E. Rogaeva, A. E. Lang, A. S. Bassett.<br />
2429F CXCR4 (chemokine receptor) expression analysis<br />
in chronic cuprizone mouse model <strong>of</strong> multiple sclerosis.<br />
G. Celikyapi, T. Avsar, G. Terzioglu, S. Uyar Bozkurt, G.<br />
Yanikkaya Demirel, A. Siva, T. Altug, E. Tahir Turanli.<br />
POSTER SESSIONS 211<br />
2430W Increased error-related brain activity in youth<br />
with obsessive-compulsive disorder and unaffected<br />
siblings. G. Hanna, M. Carrasco, S. Harbin, J. Nienhuis,<br />
K. Fitzgerald, W. Gehring.<br />
2431T Bipolarity in children with dyslexia. C. C. Mignot,<br />
F. X. Coude.<br />
2432F Sequential processing deficit as a cognitive<br />
endophenotype in a multigenerational family with a<br />
severe speech sound disorder. B. Peter, K. Chapman,<br />
W. Raskind.<br />
2433W Investigation <strong>of</strong> the role <strong>of</strong> serotonin and<br />
histamine pathways in the etiology <strong>of</strong> Tourette’s<br />
syndrome. N. Sun, G. A. Heiman, L. Deng, M. Sheldon,<br />
J. C. Moore, A. J. Toro-Ramos, R. P. Hart, Z. Pang, J. A.<br />
Tischfield.<br />
2434T Is DS22q11.2 distal a frequent etiology <strong>of</strong><br />
mathematical learning disability? M. R. S. Carvalho, G.<br />
S. Vianna, L. F. S. Oliveira, B. C. Moreira, R. Sturzeneker,<br />
M. J. B. Aguiar, L. Leão, G. Paskulin, P. Zen, V. G. Haase.<br />
2435F DNA methylation alterations in first-episode<br />
schizophrenia patients: Comprehensive analysis using<br />
peripheral blood cells. M. Nishioka, M. Bundo, S. Koike,<br />
C. Kakiuchi, T. Araki, K. Kasai, K. Iwamoto.<br />
2436W Clinical and molecular genetic analysis in<br />
Ullrich congenital muscular dystrophy with dominant<br />
and recessive inheritance. B. Bozorgmehr, A.<br />
Kariminejad, S. Nafisi, U. Andoni, C. Gartioux, C. Ledevil,<br />
V. Allamand, P. Richard, M. Kariminejad.<br />
2437T Epigenomes landscaped by histone H3K9me3<br />
contribute to the pathology <strong>of</strong> Huntington’s disease. J.<br />
Shin, J. Lee, Y. Hwang, W. Lee, J. Wie, K. Kim, M. Lee, D.<br />
Hwang, R. Ratan, N. Kowall, I. So, J. Kim, H. Ryu.<br />
2438F Novel PRRT2 mutation in an African-<strong>American</strong><br />
family with paroxysmal kinesigenic dyskinesia. M. S.<br />
LeDoux, J. Xiao, P. Hedera, A. Puschmann, D. Momč ilović ,<br />
S. W. Wu.<br />
2439W Incomplete penetrance versus variable<br />
expressivity in del 16p11.2: analysis <strong>of</strong> cognitive<br />
performance and social functioning as quantitative<br />
rather than dichotomous traits. A. Moreno-De-Luca, S.<br />
M. Myers, T. D. Challman, D. W. Evans, R. P. Goin-Kochel,<br />
E. Hanson, R. Bernier, L. Green Snyder, J. E. Spiro, W. K.<br />
Chung, J. N. Constantino, D. H. Ledbetter.<br />
2440T How to best phenotype the broader autism<br />
phenotype in adults. T. Nishiyama, H. Kishino, K. Okada,<br />
S. Sakai, Y. Kamio, M. Suzuki, K. Adachi, S. Sumi, M.<br />
Kojima, S. Suzuki.<br />
2441F Executive dysfunction and bipolarity disorder in<br />
school-age children with academic impairment. F. X.<br />
Coude, C. C. Mignot.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
212 POSTER SESSIONS<br />
2442W Identification <strong>of</strong> a dosage-sensitive brain<br />
development gene within the critical region <strong>of</strong> 1q<br />
deletion syndrome. E. A. Erickson, W. A. Gahl, C.<br />
Boerkoel.<br />
2443T Results <strong>of</strong> genome-wide analyses on<br />
neurodevelopmental phenotypes at four-year follow-up<br />
following cardiac surgery in infancy. D. S. K. Kim, I. B.<br />
S. Stanaway, R. R. Rajagopalan, G. W. Wernovsky, J. B.<br />
Bernbaum, C. B. S. Solot, N. B. Burnham, E. Z. Zackai,<br />
R. R. C. Clancy, S. C. N. Nicolson, M. G. Gerdes, D. A.<br />
Nickerson, H. H. Hakonarson, J. W. G. Gaynor, G. P. Jarvik.<br />
2444F BrainSpan Atlas <strong>of</strong> the developing human brain.<br />
S. Sunkin, A. Bernard, T. Chen, C. Dang, S. Ding, A.<br />
Ebbert, O. Evgrafov, B. Fischl, M. Gerstein, D. Geschwind,<br />
A. Harmanci, J. Hohmann, S. Horvath, T. Hyde, A. Jones,<br />
Y. Kawasawa, R. Kitchen, J. Kleinman, P. Levitt, M. Li,<br />
S. Mane, N. Parikshak, A. Sboner, E. Shen, K. Smith, D.<br />
Weinberger, M. Hawrylycz, J. Knowles, N. Sestan, E. Lein.<br />
2445W Knockdown <strong>of</strong> putative human autism genes,<br />
SHANK3 and SYNGAP1, produces common behavioral<br />
phenotypes in zebrafish. J. E. Dallman, R. Kozol, Q. Yan,<br />
H. N. Cukier, V. Mayo, A. J. Griswold, P. L. Whitehead, J.<br />
L. Haines, J. R. Gilbert, M. L. Cuccaro, E. R. Martin, M. A.<br />
Pericak-Vance.<br />
2446T Short tandem repeat: A versatile marker in<br />
diagnosis <strong>of</strong> genetic disorders. S. Muthuswamy, A.<br />
Kumar, S. Agarwal.<br />
2447F Genomic rearrangements in idiopathic cerebral<br />
palsy. R. Segel, H. Ben-Pazi, S. Zeligson, A. Fattal-<br />
Valevski, A. Aran, V. Gross, N. Shneebaum, D. Shmueli, D.<br />
Lev, L. Blumkin, S. Perlberg, E. Levy-Lahad.<br />
2448W Gain <strong>of</strong> function Na v 1.7 mutations in patients<br />
with small fiber neuropathy. M. M. Gerrits, C. G. Faber,<br />
J. G. J. Hoeijmakers, D. M. L. Merckx, H. J. M. Smeets, S.<br />
D. Dib-Haij, S. G. Waxman, I. S. J. Merkies.<br />
2449T A new screening test for Fragile X syndrome:<br />
Quantitative measurement <strong>of</strong> FMRP in dried blood<br />
spots. W. T. Brown, T. Adayev, R. Kascsak, R. Kascsak, C.<br />
Dobkin, S. Nolin, G. LaFauci.<br />
2450F Disease specific pathway analysis in multiple<br />
sclerosis. T. Avsar, M. Durasi, S. Saip, O. U. Sezerman,<br />
A. Siva, E. Tahir Turanli.<br />
2451W Diagnosing complex neurological disease<br />
by next-generation sequencing. K. Haugarvoll, S.<br />
Johansson, C. Tzoulis, B. I. Haukanes, C. Bredrup, H.<br />
Boman, P. M. Knappskog, L. A. Bind<strong>of</strong>f.<br />
2452T Elevations <strong>of</strong> pro-inflammatory cytokines/<br />
chemokines in patients with Aicardi-Goutières<br />
syndrome. J. L. Schmidt, A. Takanohashi, M. Prust, K. F.<br />
Gold, J. Wang, H. Gordish-Dressman, G. Rice, H. Gornall,<br />
M. Bloom, Y. J. Crow, P. Lebon, K. Nagaraju, A. Vanderver.<br />
2453F Strategy for genotyping triplet repeats unstable<br />
sequences. S. Lindo_Samanamud, O. Ortega, M.<br />
Cornejo-Olivas, V. Marca, P. Mazzetti.<br />
2454W Cleavage and polyadenylation specificity factor<br />
1 regulates alternative splicing <strong>of</strong> interleukin 7 receptor<br />
exon 6. S. G. Gregory, I. Evsyukova, S. Bradrick, M. A.<br />
Garcia-Blanco.<br />
2455T Functional analysis <strong>of</strong> ASNS variant identified in<br />
progressive microcephaly and brain atrophy patients.<br />
Y. Hitomi, E. K. Ruzzo, D. L. Silver, Y. Anikster, D. B.<br />
Goldstein.<br />
2456F Impaired PPAR� function underlies<br />
mitochondrial demise and neurodegeneration<br />
in Huntington’s disease: Mechanistic basis and<br />
therapeutic implications. A. S. Dickey, V. V. Pineda, A.<br />
Buttgereit, M. M. Torres, T. Tsunemi, A. R. La Spada.<br />
2457W NHEJ1 deficiency causes abnormal<br />
development <strong>of</strong> the cerebral cortex. B. El Waly, E.<br />
Buhler, M. R. Haddad, F. Watrin, L. Villard.<br />
2458T KCTD13 is a major driver <strong>of</strong> mirrored<br />
neuroanatomical phenotypes associated with the<br />
16p11.2 copy number variant. C. Golzio, J. Willer, M.<br />
E. Talkowski, E. C. Oh, Y. Taniguchi, S. Jacquemont, A.<br />
Reymond, M. Sun, A. Sawa, J. S. Gusella, A. Kamiya, J. S.<br />
Beckmann, N. Katsanis.<br />
2459F miR-137 expression in schizophrenia and bipolar<br />
disorder brains. I. Guella, A. Sequeira, B. Rollins, F. Torri,<br />
M. P. Vawter, F. Macciardi.<br />
2460W Common gene co-expression network analysis<br />
in schizophrenia and bipolar disorder. S. Hong, X. Chen,<br />
L. Jin, M. Xiong.<br />
2461T Delusion-associated SNPs in NRG3 show<br />
regulatory potential, dysregulate NRG3 splicing and<br />
differentially bind to nuclear proteins. M. Zeledón,<br />
M. Taub, N. Eckart, R. Wang, M. Szymanski, P. Chen,<br />
A. Pulver, J. A. McGrath, P. Wolyniec, D. Avramopoulos,<br />
A. Sawa, D. Valle.<br />
2462F USF1 regulates sleep and circadian traits in<br />
humans. H. M. Ollila, K. M. Rytkönen, K. Silander,<br />
M. Perola, V. Salomaa, M. Härmä, S. Puttonen,<br />
T. Porkka-Heiskanen, T. Paunio.<br />
2463W Sodium channel mutations and epilepsy.<br />
J. E. O’Brien, M. H. Meisler.<br />
2464T Phosphorylation and regulation <strong>of</strong> FMRP.<br />
M. Santoro, S. Warren.<br />
2465F The cis-regulatory effect <strong>of</strong> an Alzheimer’s<br />
disease-associated polymorphic poly-T locus on<br />
expression <strong>of</strong> TOMM40 and APOE genes. O. Chiba-<br />
Falek, C. Linnertz, W. Gottschalk, D. Crenshaw, M. Lutz,<br />
J. Allen, S. Saith, M. Mihovilovic, L. Anderson, K. Welsh-<br />
Bohmer, A. Roses.<br />
2466W Apolipoprotein E �4 as a factor in the evaluation<br />
<strong>of</strong> the genetic risk <strong>of</strong> Alzheimer’s dementia in Filipinos.<br />
M. Daroy, C. Casingal, C. Mapua, D. Florendo, R. Matias,<br />
J. Dominguez, St. Luke’s Dementia Study Group.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2467T Functional testing <strong>of</strong> schizophrenia associated<br />
variants in NOS1AP. C. T. Ramirez, N. Wratten, Y. Huang,<br />
A. Dulencin, J. Millonig, V. J. Vieland, A. S. Bassett, L. M.<br />
Brzustowicz.<br />
2468F MIR137, a candidate gene for schizophrenia:<br />
identification <strong>of</strong> targets and downstream effects.<br />
A. L. Collins, R. J. Bloom, Y. Kim, P. F. Sullivan.<br />
2469W Schizophrenia mir137 risk genotype is<br />
associated with DLPFC hyperactivation. T. G. M. van<br />
Erp, I. Guella, M. P. Vawter, F. Torri, J. Fallon, F. Macciardi,<br />
S. G. Potkin.<br />
2470T A loss-<strong>of</strong>-function variant in the human histidyltRNA<br />
synthetase (HARS) gene is neurotoxic in vivo. A.<br />
Antonellis, A. Vester, G. Velez-Ruiz, H. M. McLaughlin, J.<br />
R. Lupski, K. Talbot, J. M. Vance, S. Zuchner, R. H. Roda,<br />
K. H. Fischbeck, L. G. Biesecker, G. Nicholson, A. A. Beg,<br />
NISC Comparative Sequencing <strong>Program</strong>, NIH.<br />
2471F Neuronal expression <strong>of</strong> FIG4 and<br />
neurodegeneration. G. M. Lenk, C. J. Ferguson,<br />
M. H. Meisler.<br />
2472W Global mapping <strong>of</strong> FUS-binding sites and global<br />
pr<strong>of</strong>iling <strong>of</strong> FUS-mediated RNA metabolisms in the<br />
mouse brain. K. Ohno, A. Masuda, S. Ishigaki, Y. Fujioka,<br />
Y. Iguchi, M. Katsuno, A. Shibata, F. Urano, G. Sobue.<br />
2473T Sortilin-related receptor 1 is associated with<br />
cognitive impairment in Filipinos. C. R. Casingal, M. L.<br />
G. Daroy, C. A. Mapua, D. J. A. Florendo, J. C. Dominguez,<br />
St. Luke’s Dementia Study Group.<br />
2474F Identifying neuropsychological and cognitive<br />
endophenotypes <strong>of</strong> schizophrenia-associated<br />
exonic variants <strong>of</strong> NPAS3 and COMT. L. M. Luoma,<br />
G. Macintyre, F. B. Berry, D. LaFreniere, S. Purser, A.<br />
Beierbach, P. Tibbo, D. W. Cox, S. Purdon.<br />
2475W Production <strong>of</strong> IL-6 is altered in primary human<br />
macrophages carrying 255Adel PARK2 gene variation. R.<br />
H. M. Sindeaux, A. C. Senegaglia, R. P. Munhoz, H. A. Teive,<br />
S. Raskin, M. M. A. Stefani, M. T. Mira, V. S. Sotomaior.<br />
2476T Broadening the role <strong>of</strong> FMRP targets across<br />
autism spectrum disorders. J. Steinberg, C. Webber.<br />
2477F Expanded hexanucleotide GGGGCC repeat<br />
RNA associated with ALS/FTD is sufficient to cause<br />
neurodegeneration. Z. Xu, M. Poidevin, H. Li, T. Wingo,<br />
P. Jin.<br />
2478W An integrated and systematic approach to<br />
autism pathway analysis. Z. Lin, S. J. Sanders, J. K.<br />
Lowe, D. H. Geschwind, M. State, H. Zhao.<br />
2479T RNA sequencing in iPSC-derived neurons<br />
identifies gene expression changes associated with<br />
22q11.2 microdeletion syndrome. Y. Tian, S. Pasca, J.<br />
Ou, A. Krawisz, J. BernsteinJon, J. Rapoport, J. Hallmayer,<br />
S. Horvath, M. Pellegrini, R. Dolmetsch, D. Geschwind,<br />
ACE <strong>Genetics</strong> Consortium.<br />
POSTER SESSIONS 213<br />
2480F The effects <strong>of</strong> inherited deletions on<br />
neurocognition in Canadian children with 22q11.2<br />
deletion syndrome. E. Chow, A. Ho, D. Young, S.<br />
Langlois, C. Cytrabaum, A. Rideout, S. Dyack.<br />
2481W Brain-derived neurotrophic factor (BDNF)<br />
Val66Met and adulthood chronic stress interact to<br />
affect depressive symptoms. R. Jiang, B. H. Brummett,<br />
M. A. Babyak, I. C. Siegler, R. B. Williams.<br />
2482T miRNA expression in the prefrontal cortex <strong>of</strong><br />
suicide completers. J. P. Lopez, R. Lim, B. Labonte, C.<br />
Cruceanu, J. P. Yang, V. Yerko, C. Ernst, N. Mechawar, P.<br />
Pavlidis, G. Turecki.<br />
2483F Distinct gene expression and DNA methylation<br />
perturbations in PTSD with severe child abuse versus<br />
no PTSD with no child abuse. D. Mehta, T. Klengel, K.<br />
N. Conneely, A. K. Smith, A. Altmann, M. Rex-Haffner, A.<br />
Loeschner, M. Gonik, K. B. Mercer, B. Bradley, B. Müller-<br />
Myshok, K. J. Ressler, E. B. Binder.<br />
2484W Frequency <strong>of</strong> polymorphisms <strong>of</strong> the alcohol<br />
dehydrogenase enzyme (ADH1B and ADH1C) and<br />
aldehyde dehydrogenase enzyme (ALDH) in the<br />
Brazilian population. G. P. M. Antonialli, B. Coprerski, R.<br />
M. Minillo, M. P. Migliavacca, D. Brunoni, A. B. A. Perez.<br />
2485T Serotonin transporter (SLC6A4) and receptor<br />
(5-HT2A) gene polymorphisms in healthy Brazilian<br />
individuals with diverse ethnic backgrounds. B.<br />
Coprerski, M. P. Micliavacca, A. B. A. Perez, A. P. P. Costa,<br />
D. Brunoni.<br />
2486F Regulatory effects <strong>of</strong> genes associated with<br />
schizophrenia. N. Eckart, R. Wang, J. McGrath, P.<br />
Wolyniec, M. Zeledòn, M. Szymanski, A. Pulver, D. Valle,<br />
D. Avramopoulos.<br />
2487W Genome-wide association study <strong>of</strong> 32,143<br />
individuals reveals several novel associations in<br />
schizophrenia. C. O’Dushlaine, S. Ripke, J. Moran, K.<br />
Chambert, P. Sklar, S. Purcell, C. Hultman, S. McCarroll,<br />
P. Sullivan, Swedish Schizophrenia Consortium.<br />
2488T Genome-wide association study reveals genes<br />
influencing the rate <strong>of</strong> cognitive decline among<br />
persons with Alzheimer’s disease are distinct from<br />
those associated with disease risk. R. Sherva, Y.<br />
Tripodis, D. Bennett, L. A. Chibnik, P. K. Crane, P. De<br />
Jager, L. B. Farrer, J. Shulman, R. C. Green.<br />
2489F Genome-wide scan for copy number variation<br />
association with age at onset <strong>of</strong> Alzheimer’s disease.<br />
K. Szigeti, D. Lal, Y. Li, R. Doody, K. Wilhelmsen, L.<br />
Yan, S. Liu, C. Ma, Texas Alzheimer Research and Care<br />
Consortium.<br />
2490W Utilizing eQTL networks to identify genes<br />
relevant to autism in the 16p11.2 region. Y. Cheng,<br />
W. Lauren.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
214 POSTER SESSIONS<br />
2491T A genomic instability model <strong>of</strong> autism: Global<br />
copy number burden associated with autism. N. Katiyar,<br />
S. Girirajan, A. Srikanth, K. H. Yeoh, S. J. Khoo,<br />
F. Tassone, R. Hansen, I. Hertz-Picciotto, E. E. Eichler,<br />
I. N. Pessah, S. B. Selleck, M. D. Ritchie.<br />
2492F The impact <strong>of</strong> glutamate and gammaaminobutyric<br />
acid receptor signaling in non-syndromic<br />
autism. A. Mohamed-Hadley, D. Hadley, Z. Wu, C. Kao,<br />
A. Kini, J. Glessner, R. Pellegrino, C. Kim, K. Thomas, H.<br />
Hakonarson, AGP Consortium.<br />
2493W Chromosome 15q11.2 is associated with<br />
schizophrenia risk in a set <strong>of</strong> patients. D. Rudd, M.<br />
Axelsen, S. Casey, S. Mugge, N. Andreasen, T. Wassink.<br />
2494T Genome-wide copy number analysis on<br />
schizophrenia in Han Chinese. E. Wong, A. W. Butler,<br />
Q. Wang, S. S. Cherny, T. Li, P. C. Sham.<br />
2495F Rare copy number variants in schizophrenia<br />
and bipolar disorder in a Latino population. C. Xu, A. N.<br />
Blackburn, S. Gonzalez, E. C. Villa, M. Ramirez, J. Zavala,<br />
M. Rodriguez, C. Camarillo, J. Ordonez, R. Armas, S. A.<br />
Contreras, R. J. Leach, D. Flores, D. Jerez, A. Ontiveros,<br />
H. Nicolini, D. Lehman, M. Escamilla.<br />
2496W Genome-wide copy number variation analysis<br />
<strong>of</strong> narcolepsy in the Japanese population. M. Yamasaki,<br />
T. Miyagawa, H. Toyoda, K. Seik Soon, A. Koike, T. Sasaki,<br />
Y. Honda, M. Honda, K. Tokunaga.<br />
2497T Integrating GWAS and protein-protein<br />
interaction network identifies a subnetwork implicated<br />
in alcohol dependence. S. Han, B. Z. Yang, H. Kranzler,<br />
F. Lindsay, H. Zhao, J. Gelernter.<br />
2498F APP associated with late-onset Alzheimer<br />
disease in autopsy-confirmed dataset. T. Montine, G. W.<br />
Beecham, R. Rajbhandary, K. L. Hamilton, A. C. Naj, E. R.<br />
Martin, R. Mayeux, J. L. Haines, L. Farrer, G. Schellenberg,<br />
M. A. Pericak-Vance, Alzheimer’s Disease <strong>Genetics</strong><br />
Consortium.<br />
2499W An association study comparing children with<br />
extreme high and extreme low obsessive-compulsive<br />
traits in the general population. P. D. Arnold, V. Sinopoli,<br />
J. Crosbie, L. Park, A. Dupuis, A. Paterson, R. J. Schachar.<br />
2500T Irish high-density schizophrenia families are<br />
enriched for common polygenic effects. T. B. Bigdeli,<br />
S. A. Bacanu, B. T. Webb, B. S. Maher, D. L. Thiselton, B.<br />
Wormley, F. A. O’Neill, D. Walsh, A. H. Fanous, B. P. Riley,<br />
K. S. Kendler.<br />
2501F Genome-wide association study for maternal<br />
effects in autism. S. Buyske, E. S. Stenroos, W. G.<br />
Johnson.<br />
2502W Analysis <strong>of</strong> putative pathogenic CNVs in autistic<br />
patients <strong>of</strong> Portuguese origin. I. C. Conceição, B. A.<br />
Oliveira, C. Correia, J. Coelho, C. Café, J. Almeida, S.<br />
Mouga, F. Duque, G. Oliveira, A. M. Vicente.<br />
2503T GWAS identifies biologically relevant SNP<br />
associations with sexual partnering behavior. J.<br />
Gelernter, H. R. Kranzler, R. Sherva, R. Koesterer, L.<br />
Almasy, H. Zhao, L. A. Farrer.<br />
2504F A genome-wide association study <strong>of</strong> alcohol<br />
dependence using a hybrid design. L. M. Hack, A.<br />
E. Adkins, B. T. Webb, B. S. Maher, D. G. Patterson, D.<br />
Walsh, C. A. Prescott, D. M. Dick, K. S. Kendler, B. P. Riley.<br />
2505W Genetic analysis <strong>of</strong> tobacco use in the Swedish<br />
Twin Registry: Genome-wide association studies <strong>of</strong><br />
cigarette and snus consumption. P. A. Lind, D. Cesarini,<br />
D. J. Benjamin, P. D. Koellinger, P. K. E. Magnusson, M.<br />
Johannesson, S. E. Medland.<br />
2506T Genome-wide association study for intracranial<br />
aneurysm in the Japanese population. S. Low, A.<br />
Takahashi, M. Kubo, Y. Nakamura.<br />
2507F Genome-wide association study identified<br />
susceptibility loci associated with nicotine dependence<br />
in a Japanese population. D. Nishizawa, K. Shinya, J.<br />
Hasegawa, N. Sato, F. Tanioka, H. Sugimura, K. Ikeda.<br />
2508W Genome-wide meta-analysis <strong>of</strong> autism<br />
spectrum disorders (ASD) supports A2BP1 as an ASD<br />
candidate gene. Y. S. Park, J. Jaworski, I. Konidari, P.<br />
Whitehead, M. L. Cuccaro, E. R. Martin, J. L. Haines, M. A.<br />
Pericak-Vance.<br />
2509T A polygenic analysis <strong>of</strong> autism, depression<br />
and schizophrenia risk alleles’ effect on reproductive<br />
fitness in the general population. R. A. Power, R. Uher,<br />
S. Ripke, C. M. Lewis, P. McGuffin, P. Lichtenstein, H.<br />
Wallum.<br />
2510F Maternal genetic effects on autism risk: Results<br />
from the Early Markers for Autism study. J. F. Quinn,<br />
L. C. Croen, L. W. Weiss.<br />
2511W Genome-wide pathway analysis in multiple<br />
cohorts implicates histone genes and inflammation<br />
in hippocampal atrophy. V. K. Ramanan, L. Shen, J. D.<br />
West, S. Kim, S. L. Risacher, K. Nho, Y. Wang, J. Wan, T.<br />
M. Foroud, L. A. Farrer, A. J. Saykin, Alzheimer’s Disease<br />
Neuroimaging Initiative.<br />
2512T Dissection <strong>of</strong> genetic architecture <strong>of</strong> bipolar<br />
disorder and schizophrenia: Results from a combined<br />
dataset <strong>of</strong> nearly 40,000 individuals. S. Ripke, D. M.<br />
Ruderfer, Psychiatric Genomics Consortium.<br />
2513F The Kaiser Permanente/UCSF Genetic<br />
Epidemiology Research Study on Adult Health and<br />
Aging: Genome-wide association study <strong>of</strong> anxiety<br />
disorders. L. Shen, T. H<strong>of</strong>fmann, M. Kvale, L. Sakoda, D.<br />
Ranatunga, L. Walter, S. Sciortino, D. Ludwig, Y. Banda, S.<br />
Hesselson, P. Kwok, R. Risch, C. Schaefer.<br />
2514W Genome-wide association <strong>of</strong> structural<br />
MRI data in a large, normally developing, pediatric<br />
population. P. M. A. Sleiman, T. Satterthwaite, K. Ruparel,<br />
C. Kim, R. Chiavacci, M. E. Calkins, R. C. Gur, R. E. Gur,<br />
H. Hakonarson.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2515T Gene-based analyses <strong>of</strong> attention deficit<br />
hyperactivity disorder GWAS data. I. D. Waldman, S.<br />
V. Faraone, Psychiatric Genomics Consortium: ADHD<br />
Subgroup.<br />
2516F Genome-wide association study <strong>of</strong> bipolar<br />
disorder with a history <strong>of</strong> binge eating. S. J. Winham,<br />
S. McElroy, S. Crow, M. Frye, C. Colby, D. Walker, D.-S.<br />
Choi, M. Chauhan, J. M. Biernacka.<br />
2517W Variation in genes related to cochlear biology<br />
is strongly associated with adult-onset deafness in<br />
Border Collies. J. S. Yokoyama, E. T. Lam, A. L. Ruhe, C.<br />
A. Erdman, K. R. Robertson, A. A. Webb, D. C. Williams,<br />
M. L. Chang, M. K. Hytonen, H. Lohi, S. P. Hamilton, M.<br />
W. Neff.<br />
2518T Genome-wide association study <strong>of</strong> Korean<br />
patients with autism spectrum disorder. H. Yoo, S. Kim,<br />
M. Park, I. Cho, S. Cho, B. Kim, J. Kim, S. Park, D. H.<br />
Geschwind, Y. Kwak, J. K. Lowe, Korean Autism Genetic<br />
Study Consortium.<br />
2519F Combined genome-wide association study <strong>of</strong><br />
Tourette syndrome and obsessive-compulsive disorder.<br />
D. Yu, TSAICG, IOCFGC, TS GWAS Consortium.<br />
2520W Genome-wide significant evidence <strong>of</strong><br />
association <strong>of</strong> a NUP153 missense variant with familial<br />
late-onset Alzheimer’s disease. A. R. Parrado, B. Hooli,<br />
K. Mullin, L. Gotta, M. Mattheisen, C. Lange, L. Bertram,<br />
R. E. Tanzi.<br />
2521T Beta-amyloid toxicity modifier genes and the<br />
risk <strong>of</strong> Alzheimer’s disease. S. L. Rosenthal, X. Wang,<br />
M. M. Barmada, F. Y. Demirci, O. L. Lopez, M. I. Kamboh.<br />
2522F WTCCC3 and GCAN: A genome-wide<br />
association scan <strong>of</strong> anorexia nervosa. V. Boraska, C.<br />
M. Bulik, D. A. Collier, P. F. Sullivan, E. Zeggini, Genetic<br />
Consortium for Anorexia Nervosa, Wellcome Trust Case<br />
Control Consortium 3.<br />
2523W Novel approach to genome wide association<br />
meta-analysis for bipolar disorder reveals network <strong>of</strong><br />
calcium channel and calcium signaling genes including<br />
epistatic effects. V. J. Vieland, K. A. Walters, K. Tobin, M.<br />
A. Azaro, A. Hare, Y. Huang, S.-C. Seok, T. Lehner, L. M.<br />
Brzustowicz.<br />
2524T Constructing a prediction model for bipolar<br />
disorder using genome-wide association dataset.<br />
L. Chuang, C. Kao, P. Kuo.<br />
2525F Involvement <strong>of</strong> the PTCHD1 gene in autism and<br />
intellectual disability. K. Mittal, K. Sritharan, J. Ross,<br />
A. Vaags, S. Scherer, A. Noor, J. Ellis, J. Vincent.<br />
2526W Genetic schizophrenia risk variants jointly<br />
modulate total brain and white matter volume. A. F.<br />
Terwisscha van Scheltinga, S. C. Bakker, N. E. M. van<br />
Haren, E. M. Derks, J. E. Buizer-Voskamp, H. B. M. Boos,<br />
W. Cahn, H. E. Hulsh<strong>of</strong>f Pol, S. Ripke, R. A. Oph<strong>of</strong>f, R. S.<br />
Kahn, Psychiatric GWAS Consortium.<br />
POSTER SESSIONS 215<br />
2527T PET scans with [ 11 C]Flumazenil demonstrate<br />
a downregulation <strong>of</strong> the GABA A receptor availability<br />
in fragile X syndrome patients. F. Kooy, I. Heulens, C.<br />
D’Hulst, N. Van der Aa, K. Van Laere.<br />
2528F �-Catenin is genetically and biologically<br />
associated with cortical cataract and future Alzheimerrelated<br />
structural and functional brain changes. G. Jun,<br />
J. A. Moncaster, C. Koutras, S. Seshadri, J. Buros, A. C.<br />
McKee, G. Levesque, P. A. Wolf, P. St. George-Hyslop, L.<br />
E. Goldstein, L. A. Farrer.<br />
2529W Genes, brain and cognition in Down syndrome.<br />
J. R. Korenberg, L. Dai, S. Gouttard, J. Edgin, L. Nadel,<br />
E. K. Jeong, J. Anderson, G. Gerig.<br />
2530T The non-invasive quantification <strong>of</strong> muscle<br />
degeneration in facioscapulohumeral muscular<br />
dystrophy with fast bound-pool fraction imaging:<br />
A 3.0T MRI study. H. R. Underhill, S. D. Friedman,<br />
V. L. Yarnykh, D. W. W. Shaw.<br />
2531F Neural cell adhesion gene variation and brain<br />
morphometry in Alzheimer’s disease. K. N. Holohan,<br />
S. L. Risacher, S. Swaminathan, J. D. West, M. Inlow, S.<br />
K. Conroy, V. Ramanan, T. Foroud, L. Shen, A. J. Saykin,<br />
Alzheimer’s Disease Neuroimaging Initiative.<br />
2532W Genetic interactions in focal adhesion and<br />
extracellular matrix pathways are associated with<br />
increase in ventricle size over time in the Alzheimer’s<br />
Disease Neuroimaging Initiative cohort. M. Koran, S.<br />
Meda, M. Sivley, T. Thornton-Wells.<br />
2533T Gene expression <strong>of</strong> GABA receptors and<br />
regulators in peripheral blood <strong>of</strong> a drug naïve firstepisode<br />
psychosis sample. V. K. Ota, C. S. Noto, A.<br />
Gadelha, M. L. Santoro, J. J. Mari, M. I. Melaragno, M. A.<br />
C. Smith, Q. Cordeiro, R. A. Bressan, S. I. Belangero.<br />
2534F Effect <strong>of</strong> DRD1 rs4532 polymorphism on<br />
treatment-resistant schizophrenia. L. .M. N. Spindola, V.<br />
K. Ota, A. Gadelha, A. F. Santos Filho, M. L. Santoro, D. M.<br />
Christ<strong>of</strong>olini, F. T. S. Bellucco, J. J. Mari, M. I. Melaragno,<br />
M. A. C. Smith, R. A. Bressan, S. I. Belangero.<br />
2535W Genetic risk factors (CHRNA5-CHRNA3-CHRNB4)<br />
and smoking cessation among hospitalized patients<br />
with acute myocardial infarction. L.-S. Chen, P. A. Lenzini,<br />
R. G. Bach, J. A. Spertus, L. J. Bierut, S. Cresci.<br />
2536T STXBP1 and KCNQ2 are mutated in the majority<br />
<strong>of</strong> patients having Ohtahara syndrome that does not<br />
evolve into West syndrome. M. Milh, C. Lacoste, J.<br />
Sutera-Sardo, S. Auvin, M.-A. Barthez, A. Kaminska, A.<br />
Roubertie, D. Ville, C. Badens, B. Chabrol, L. Villard.<br />
2537F Identification <strong>of</strong> LRRK2 p.G2019S disease<br />
modifiers. J. Trinh, D. Evans, C. Thompson, A. Donald, B.<br />
Shah, C. Szu Tu, F. Pishotta, C. Vilarino-Guell, R. Amouri,<br />
F. Hentati, R. Gibson, M. Farrer.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
216 POSTER SESSIONS<br />
2538W APOE and SNCA predict cognitive performance<br />
in Parkinson’s disease. I. Mata, J. Leverenz, J.<br />
Trojanowski, A. Siderowf, B. Ritz, S. Rhodes, S. Factor, C.<br />
Wood-Siverio, J. Quinn, K. Chung, A. Espay, F. Revilla, K.<br />
Edwards, T. Montine, C. Zabetian.<br />
2539T Abnormal responses to visual cortex activation in<br />
early stage Huntington disease patients using 31P-NMR<br />
spectroscopy. F. Mochel, T. M. Nguyen, D. Deelchand, D.<br />
Rinaldi, R. Valabregue, C. Wary, A. Durr, P. G. Henry.<br />
2540F Sympathovagal balance in major depressive<br />
disorder: Influence <strong>of</strong> the BDNF and 5-HTTLPR<br />
(serotonin transporter) polymorphisms. A. Perez,<br />
A. R. Brunoni, B. Coprerski, D. Brunoni.<br />
2541W Complex genetic scores can predict smoking<br />
cessation success and uptake <strong>of</strong> addictive substance<br />
use. G. Uhl, D. Sisto, D. Walther, W. Eaton, N. Ialongo, J.<br />
Rose.<br />
2542T Integrated copy number and gene expression<br />
analysis detects a CREB1 association with Alzheimer’s<br />
disease. N. Sule, Y. Li, I. Sheffer, C. Shaw, S. Powell,<br />
B. Dawson, S. Zaidi, K. Bucasas, J. Lupski, K. Wilhelmsen,<br />
R. Doody, K. Szigeti.<br />
2543F Genetic modifiers <strong>of</strong> EEG brain activity during<br />
sleep in humans. S. Warby, H. E. Moore IV, O. Carrillo,<br />
J. Faraco, L. Lin, P. E. Peppard, T. Young, E. Mignot.<br />
2544W The eQTLs in language-related genes reveal a<br />
gene x gene interaction between BDNF and PCDH17<br />
in the human brain. N. Li, S. Y. Cheong, M. Goode, S. A.<br />
Petrill, A. S. Bassett, L. M. Brzustowicz, C. W. Bartlett.<br />
2545T The KIAA0319 gene is associated with language<br />
progression more than its level. S. Tezenas du Montcel,<br />
B. Feng, C. Barr, B. Falissard, M. Boivin, G. Dionne.<br />
2546F Genome-wide association <strong>of</strong> executive function<br />
in a normally developing pediatric cohort. J. J.<br />
Connolly, P. M. A. Sleiman, R. C. Gur, M. E. Calkins, D. J.<br />
Abrams, R. M. Chiavacci, H. Qiu, F. D. Mentch, R. E. Gur,<br />
H. Hakonarson.<br />
2547W Lipidomic pr<strong>of</strong>iling in Lewy body disease brain<br />
autopsies carrying lysosomal storage disorder gene<br />
variants. N. Parmalee, R. B. Chan, N. Park, E. P. Cortes,<br />
J. P. Vonsattel, K. Marder, L. Honig, J. H. Lee, G. Di Paolo,<br />
L. Clark.<br />
2548T Study <strong>of</strong> plasma metabolites levels in discordant<br />
sibling pairs with autism. G. Malerba, R. Wang-Sattler,<br />
E. Trabetti, J. Adamski, P. Prandini, L. Xumerle, C. Zusi, A.<br />
Pasquali, R. Galavotti, P. F. Pignatti, T. Illig, Italian Autism<br />
Network.<br />
2549F Genome scan for cognitive trait loci <strong>of</strong> dyslexia:<br />
Rapid naming and rapid switching <strong>of</strong> colors, letters<br />
and numbers. W. H. Raskind, K. Rubenstein, M.<br />
Matsushita, V. W. Berninger, E. M. Wijsman.<br />
2550W Identification <strong>of</strong> genes and pathways regulated<br />
by epigenetic mechanisms in determining general<br />
intelligence (g) <strong>of</strong> inbred mice. P. Cha, K. Kobayashi, Y.<br />
Ando, C. Yu, S. Yamagata, K. Okada, J. Sese, K. Takao, T.<br />
Miyakawa, T. Toda.<br />
2551T Quantitative linkage analysis with the<br />
endophenotype <strong>of</strong> social responsiveness identifies<br />
genome-wide significant linkage to a narrow region at<br />
8p21.3. J. K. Lowe, D. M. Werling, J. N. Constantino, R. M.<br />
Cantor, D. H. Geschwind.<br />
2552F Nonpathogenic traits: A study <strong>of</strong> susceptibility<br />
to sympathetic yawning. E. T. Cirulli, A. J. Bartholomew,<br />
D. B. Goldstein.<br />
2553W Combined genetic analysis <strong>of</strong> DNA methylation<br />
and gene expression in schizophrenia identifies<br />
disease susceptibility loci. K. R. van Eijk, M. P. M. Boks,<br />
S. de Jong, E. Strengman, R. S. Kahn, S. Horvath, R. A.<br />
Oph<strong>of</strong>f.<br />
2554T Infantile-onset dystonia and juvenile<br />
parkinsonism associated with spastic paraplegia<br />
caused by mutations in SPG11. G. Yoon, B. Baskin, M.<br />
Tarnopolsky, P. Rebeiro, B. Banwell, P. N. Ray.<br />
2555F CNV detection from affymetrix axiom SNP chips<br />
in the early markers for autism study. G. Desachy, L. A.<br />
Croen, L. A. Weiss.<br />
2556W Prioritization <strong>of</strong> whole exome sequencing in<br />
Parkinson disease. J. Farlow, H. Lin, K. Hetrick, H. Ling,<br />
E. Pugh, K. Bowling, P. Jain, Y. Liu, K. Doheny, R. M.<br />
Myers, T. Foroud.<br />
2557T High yield <strong>of</strong> massively parallel sequencing<br />
in autosomal recessive intellectual disability in 23<br />
families: Identification <strong>of</strong> the causative mutation in<br />
12 families. R. Abou Jamra, R. Buchert, S. Uebe, H.<br />
Tawamie, S. H. Eck, E. Graf, K. Eberlein, J. Bauer, E. M.<br />
Dill, C. Blumentritt, F. F. Brockschmidt, M. M. Nöthen, J.<br />
Schumacher, A. Ekici, T. Strom, A. Reis.<br />
2558F Identification <strong>of</strong> rare variants in childhood<br />
onset schizophrenia using exome sequencing. A.<br />
Ambalavanan, S. L. Girard, J. Gauthier, L. Xiong, A.<br />
Dionne-Laporte, D. Spiegelman, E. Henrion, O. Diallo, A.<br />
Levert, P. A. Dion, J. Rapoport, R. Joober, G. A. Rouleau.<br />
2559W The Asp620Asn mutation <strong>of</strong> VPS35 in Japanese<br />
patients with typical Parkinson disease. M. Ando, M.<br />
Funayama, Y. Li, K. Kashihara, Y. Murakami, N. Ishizu, C.<br />
Toyoda, K. Noguchi, T. Hashimoto, N. Nakano, R. Sasaki,<br />
Y. Kokubo, S. Kuzuhara, K. Ogaki, C. Yamashita, H.<br />
Yoshino, H. Tomiyama, N. Hattori.<br />
2560T The Autism Sequencing Consortium: Autism<br />
gene discovery in .20,000 exomes. J. D. Buxbaum, M.<br />
J. Daly, B. Devlin, T. Lehner, K. Roeder, M. W. State for<br />
Autism Sequencing Consortium.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2561F Host genetic contribution to development<br />
<strong>of</strong> progressive multifocal leukoencephalopathy in<br />
the presence <strong>of</strong> immune suppression or immunemodulating<br />
drugs. J. P. Carulli, C. Sun, S. Szak, C. Organ,<br />
A. G. Day-Williams, C. Liu, H. H. Ackerman, T. Olsson,<br />
F. Piehl, P. Cinque, C. S. Tan, I. J. Koralnik, R. P. Viscidi,<br />
L. Gorelik, K. Simon, P. Duda, T. Harris, S. Bushnell,<br />
T. Compton.<br />
2562W Disruption <strong>of</strong> a large intergenic non-coding<br />
RNA in subjects with neurodevelopmental disabilities.<br />
C. Ernst, M. Talkowski, J. Gusella, C. Morton.<br />
2563T A rare haplotype containing two AKAP9<br />
missense mutations identified by whole-exome<br />
sequencing is associated with risk <strong>of</strong> Alzheimer<br />
disease in African <strong>American</strong>s. M. W. Logue, M. Schu,<br />
B. N. Vardarajan, J. Farrell, C. T. Baldwin, M. D. Fallin, L.<br />
A. Farrer.<br />
2564F Transposable elements in schizophrenia:<br />
evolutionary analysis and hypothesis for a functional<br />
role. F. Macciardi, M. Vawter, T. VanErp, F. Torri, B. Lerer,<br />
E. Osimo, J. A. Knowles, S. G. Potkin, C. Pato, M. Pato,<br />
S. Gaudi.<br />
2565W Whole-genome sequencing <strong>of</strong> 50 LRRK2 G2019S<br />
carriers discordant for Parkinson’s disease. C. Y.<br />
McLean, E. Drabant, E. Harrington, C. B. Do, N. Eriksson.<br />
2566T Cumulative mutation load in PDZ domains 4,<br />
5, and 6 <strong>of</strong> glutamate receptor interacting protein 2 in<br />
autism. T. Niranjan, A. Adamczyk, M. Han, R. Mejias, R.<br />
Rose, H. Bravo, M. Taub, C. Schwartz, D. Valle, R. Huganir,<br />
T. Wang.<br />
2567F Candidate genes for sleepwalking from exome<br />
sequencing in an autosomal-dominant family. B.<br />
Schormair, H. Slawik, B. Frauscher, T. Mitterling, E. Graf, T.<br />
Wieland, B. Högl, T. M. Strom, M. Wiegand, T. Meitinger, J.<br />
Winkelmann.<br />
2568W Rare variants in GWAS loci <strong>of</strong> restless legs<br />
syndrome. E. C. Schulte, F. Knauf, B. Schormair, P.<br />
Lichtner, C. Trenkwalder, B. Högl, B. Frauscher, K. Berger,<br />
I. Fietze, N. Gross, K. Stiasny-Kolster, M. Hornyak, W.<br />
Oertel, C. G. Bachmann, W. Paulus, A. Zimprich, A. Peters,<br />
C. Gieger, B. Müller-Myshok, T. Meitinger, J. Winkelmann.<br />
2569T Exome analysis for early-onset amyotrophic<br />
lateral sclerosis with autosomal recessive mode <strong>of</strong><br />
inheritance. Y. Takahashi, K. Higasa, S. Takagi, T. Kurita,<br />
H. Ishiura, J. Mitsui, Y. Fukuda, J. Yoshimura, T. L. Saito,<br />
S. Morishita, J. Goto, S. Tsuji.<br />
2570F Identification <strong>of</strong> candidate genes through<br />
analysis <strong>of</strong> copy number variation in autism families<br />
from Austria. J. B. Vincent, G. Egger, A. Lionel,<br />
H. Mahmood, A. Mikhailov, K. Roetzer, C. Windpassinger,<br />
W. Kaschnitz, S. W. Scherer, E. Petek.<br />
2571W Genetic and functional study <strong>of</strong> the disks largeassociated<br />
protein 2 (DLGAP2) gene as a candidate<br />
gene <strong>of</strong> schizophrenia. M. Cheng, J. Li, S. Luu, S. Hsu,<br />
T. Hu, H. Tsai, C. Chen.<br />
POSTER SESSIONS 217<br />
2572T Targeted sequencing reveals association <strong>of</strong> sets<br />
<strong>of</strong> rare variants in novel candidate genes as well as cell<br />
adhesion and GTPase regulatory pathways with autism<br />
spectrum disorder. A. J. Griswold, J. M. Jaworski, S. H.<br />
Slifer, D. J. Hedges, R. H. Chung, W. F. Hulme, I. Konidari,<br />
P. L. Whitehead, J. A. Rantus, A. R. Diaz, Y. M. Pasco, R.<br />
M. Tursi, S. M. Williams, R. Menon, M. L. Cuccaro, E. R.<br />
Martin, J. L. Haines, J. R. Gilbert, J. P. Hussman, M. A.<br />
Pericak-Vance.<br />
2573F Multiple hits in the neuregulin signaling pathway<br />
in schizophrenia. A. Hatzimanolis, J. McGrath, P.<br />
Wolyniec, V. K. Lasseter, G. Nestadt, R. Wang, T. Li, P.<br />
Wong, D. Valle, A. E. Pulver, D. Avramopoulos.<br />
2574W Discovery <strong>of</strong> rare variants <strong>of</strong> candidate<br />
genes related to nicotine dependence through deep<br />
sequencing. S. Wang, W.-Y. Cui, Z. Yang, J. Yang, J. Z.<br />
Ma, T. J. Payne, C. A. Hodgkinson, D. Goldman, M. D. Li.<br />
2575T Rare deletions at the gephyrin (GPHN) locus<br />
in autism spectrum disorder and schizophrenia. A.<br />
C. Lionel, A. K. Vaags, D. Sato, M. J. Gazzellone, H. Y.<br />
Chen, G. Costain, G. Egger, S. Walker, A. Prasad, C. R.<br />
Marshall, E. B. Mitchell, C. Windpassinger, J. B. Vincent,<br />
B. A. Fernandez, S. Kirmani, J. C. Hodge, A. S. Bassett, S.<br />
W. Scherer.<br />
2576F Reciprocal duplication <strong>of</strong> the Williams-Beuren<br />
syndrome deletion on chromosome 7q11.23 is<br />
associated with schizophrenia. J. G. Mulle, A. E. Pulver,<br />
J. M. McGrath, P. Wolyniec, A. F. Dodd, D. J. Cutler, J.<br />
Sebat, D. Malhotra, G. Nestadt, D. F. Conrad, C. P. Barnes,<br />
M. Hurles, M. Ikeda, N. Iwata, D. Levinson, P. V. Gejman,<br />
A. R. Sanders, J. Duan, A. A. Mitchell, I. Peter, P. Sklar, C.<br />
T. O’Dushlaine, D. Grozeva, M. C. O’Donovan, M. J. Owen,<br />
C. M. Hultman, A. K. Kähler, P. F. Sullivan, G. Kirov, S. T.<br />
Warren, Molecular <strong>Genetics</strong> <strong>of</strong> Schizophrenia Consortium.<br />
2577W Assessing the impact <strong>of</strong> different types <strong>of</strong> de<br />
novo rare variation in whole-exome sequenced autism<br />
spectrum disorders trio families. D. Pinto, M. Fromer,<br />
A. Goldberg, S. M. Purcell, P. Sklar, E. Boerwinkle, M. J.<br />
Daly, B. Devlin, E. H. Cook, K. Roeder, R. A. Gibbs, G. D.<br />
Schellenberg, J. S. Sutcliffe, M. W. State, J. D. Buxbaum<br />
on behalf <strong>of</strong> ARRA Autism Sequencing Consortium and<br />
Autism Sequencing Consortium.<br />
2578T Etiologic rare variants in autism multiplex<br />
families: Exome and CNVs analyses. C. Toma, A. Tristán,<br />
A. Hervás, B. Torrico, R. Valdés-Mas, N. Balmaña, M.<br />
Maristany, X. S. Puente, M. Bayés, B. Cormand.<br />
2579F Utility <strong>of</strong> a comprehensive multi-gene testing<br />
panel for epilepsy and evaluation <strong>of</strong> the expectations<br />
for whole exome sequencing in these disorders.<br />
G. Richard, E. Butler, D. McKnight, K. Retterer, A.<br />
Shanmugham, R. Rubenstein, K. Hruska, E. Haverfield, S.<br />
Aradhya.<br />
2580W Rare variants within PAX6 enhancer elements<br />
are enriched in rolandic epilepsy. L. Addis, T. Chiang,<br />
A. Derkach, S. Newhouse, S. Dobbins, I. Tomlinson, R.<br />
Houlston, L. J. Strug, D. K. Pal.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
218 POSTER SESSIONS<br />
2581T Mutations in the novel protein PRRT2 cause<br />
paroxysmal kinesigenic dyskinesia with infantile<br />
convulsions. H.-Y. Lee, Y. Huang, N. Bruneau, M.<br />
Hermann, E. Quinn, J. Maas, R. Edwards, K. Bhatia, M. K.<br />
Bruno, H. Houlden, J. Jankovic, W. Lee, U. Müller, B.-W.<br />
Soong, K. J. Swoboda, N. Wood, M. Hanna, A. Bowcock,<br />
P. Szepetowski, Y.-H. Fu, L. J. Ptacek.<br />
2582F Identification <strong>of</strong> rare variants under an<br />
alcoholism susceptibility linkage peak in a COGA<br />
family using whole exome sequencing. M. Kapoor, J.<br />
Wang, A. Hinrichs, S. Bertelsen, J. Budde, A. Agrawal, J.<br />
Tischfield, L. Almasy, M. Schuckit, L. Bierut, A. Goate.<br />
2583W Deep resequencing <strong>of</strong> 9 confirmed late-onset<br />
Alzheimer disease loci identifies multiple genomic<br />
regions with potentially functional variants. J. R.<br />
Gilbert, A. C. Naj, L. Wang, M. A. Kohli, K. L. Hamilton, R.<br />
Rajbhandary, P. L. Whitehead, R. M. Carney, B. Levin, E.<br />
A. Crocco, C. B. Wright, G. W. Beecham, E. R. Martin, S.<br />
Zuchner, J. L. Haines, M. A. Pericak-Vance.<br />
2584T Whole exome sequencing in childhood-onset<br />
schizophrenia. K. Ahn, H. Sung, T. Anderson, Y. Yao, J.<br />
Rapoport.<br />
2585F Complete genome sequence based genetic<br />
analysis <strong>of</strong> monozygotic twins discordant for<br />
schizophrenia. C. Castellani, R. O’Reilly, S. Singh.<br />
2586W Exome sequencing <strong>of</strong> extended pedigrees<br />
with late-onset Alzheimer disease identifies TTC3 as<br />
a candidate gene for AD. K. Hamilton, M. A. Kohli, A.<br />
C. Naj, R. Rajbhandary, T. Plitnik, K. John-Williams, P. L.<br />
Whitehead, J. R. Gilbert, E. R. Martin, G. W. Beecham, J.<br />
L. Haines, S. Zuchner, M. A. Pericak-Vance.<br />
2587T Exome sequencing reveals de novo gene<br />
disruptions in children on the autistic spectrum. I.<br />
Iossifov, M. Ronemus, D. Levy, Z. Wang, I. Hakker, J.<br />
Rosenbaum, B. Yamrom, Y. Lee, G. Narzisi, A. Leotta, J.<br />
Kendall, E. Grabowska, B. Ma, L. Rodgers, J. Troge, P.<br />
Andrews, E. Ghiban, J. Parla, R. Demeter, L. L. Fulton, R.<br />
S. Fulton, V. J. Magrini, K. Ye, J. C. Darnell, R. B. Darnell,<br />
E. R. Mardis, R. K. Wilson, M. C. Schatz, W. R. McCombie,<br />
M. Wigler.<br />
2588F Secretin receptor and the associated molecular<br />
processes relevant to autism spectrum disorder. K.<br />
Kojima, T. Yamagata, A. Matsumoto, M. Saito, E. F. Jimbo,<br />
M. Y. Momoi.<br />
2589W Exome sequencing <strong>of</strong> multiplex, schizophrenic<br />
families implicate variants from chromosome 5q in<br />
neurocognitive performance. M. Z. Kos, M. A. Carless,<br />
J. Peralta, E. E. Quillen, R. C. Gur, M. F. Pogue-Geile,<br />
K. Prasad, J. Blangero, V. L. Nimgaonkar, R. E. Gur, L.<br />
Almasy.<br />
2590T Mining for rare genetic variation underlying<br />
psychiatric disorders using family-based sequencing.<br />
S. McCarthy, J. Badner, D. Morris, M. Ayub, M. Kramer, D.<br />
Blackwood, A. Corvin, W. Byerley, W. R. McCombie.<br />
2591F Identification <strong>of</strong> the causative gene for SPG27<br />
by exome capture. A. Noreau, I. A. Meijer, S. L. Girard, D.<br />
Spiegelman, A. Szuto, P. Cossette, P. A. Dion, G. A. Rouleau.<br />
2592W DEC2 gene mutations associated with distinct<br />
sleep phenotypes and sleep length. R. Pellegrino, I.<br />
H. Kavakli, N. Goel, C. Cardinale, D. Dinges, S. Tufik, J.<br />
Hogenesh, A. Pack, H. Hakonarson.<br />
2593T Common and rare variants in obsessivecompulsive<br />
disorder identified by exome and targeted<br />
resequencing. D. Trujillano, S. Ossowski, P. Alonso, C.<br />
Tornador, J. M. Menchón, M. Gratacòs.<br />
2594F Deep whole genome sequencing in 18 Irish<br />
individuals with schizophrenia. B. T. Webb, E. Loken,<br />
T. B. Bigdeli, B. Wormley, F. A. O’Neill, D. Walsh, K. S.<br />
Kendler, B. P. Riley.<br />
2595W The genetic architecture <strong>of</strong> severe nonsyndromic<br />
sporadic intellectual disability. T. Wieland, D.<br />
Wieczorek, E. Graf, S. Endele, T. Schwarzmayr, J. Beygo,<br />
N. Di Donato, A. Dufke, M. Hempel, D. Horn, P. Joset, A.<br />
Röpke, U. Moog, E. Wohlleber, C. Zweier, A. B. Ekici, A.<br />
M. Zink, A. Rump, C. Meisinger, H. Grallert, H. Sticht, A.<br />
Schenck, H. Engels, G. Rappold, P. Wieacker, O. Riess, T.<br />
Meitinger, A. Reis, T. M. Strom, A. Rauch.<br />
2596T A spectrum <strong>of</strong> mutations in 12 PLP1-related<br />
disorders in patients from SARAH network <strong>of</strong><br />
rehabilitation hospitals in Brazil. S. C. L. Santos, D. R.<br />
Carvalho, R. I. Takata, C. E. Speck-Martins.<br />
2597F Association between the NMDA receptor<br />
subunit 2B gene (GRIN2B) gene and Alzheimer’s<br />
disease. F. Trecroci, R. Cittadella, M. Liguori, F. Condino,<br />
P. Spadafora, E. V. De Marco, G. Di Palma, V. Andreoli.<br />
2598W Rare missense variants in CHRNA5 and<br />
CHRNB3 are associated with increased risk <strong>of</strong> alcohol<br />
and cocaine dependence. G. Haller, J. Budde, M.<br />
Kapoor, A. Agrawal, H. Edenberg, J. Kramer, L. Bierut, A.<br />
Goate.<br />
2599T Excess <strong>of</strong> rare variants from targeted<br />
resequencing <strong>of</strong> the NKAPL gene in schizophrenia.<br />
E. K. Loken, D. Brohawn, D. Walsh, F. A. O’Neill, K. S.<br />
Kendler, B. P. Riley.<br />
2600F Exome sequencing <strong>of</strong> singleton trios and quads<br />
to reveal de novo mutations in schizophrenia. A. C.<br />
Watts, T. Walsh, M. K. Lee, S. Gulsuner, A. M. Thornton, J.<br />
McClellan, M. C. King, Genes in Schizophrenia (GENESIS)<br />
Consortium.<br />
2601W Novel missense mutations and partial<br />
deficiency <strong>of</strong> collagen VI in Ullrich congenital muscular<br />
dystrophy. J. Yuan, I. Higuchi, Y. Sakiyama, Y. Inamori,<br />
E. Matsuura, Y. Higuchi, A. Yoshimura, A. Hashiguchi, K.<br />
Higashi, Y. Koreeda, K. Arimura, H. Takashima.<br />
2602T Searching for the genes <strong>of</strong> Tourette’s: The<br />
Tourette International Collaborative <strong>Genetics</strong> Study. G.<br />
A. Heiman, T. V. Fernandez, P. J. Hoekstra, A. Dietrich, R.<br />
A. King, M. W. State, J. A. Tischfield, TIC <strong>Genetics</strong> Team.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2603F Evidence for involvement <strong>of</strong> EIF4G1, not VPS35<br />
variations in Parkinson disease. J. Vance, K. Nuytemans,<br />
G. Bademci, V. Inchausti, S. Zuchner, A. Dressen, C.<br />
Jauregio, D. D. Kinnamon, A. Mehta, Y. Pasco, A. Aviram, A.<br />
Diaz, L. Wang, F. Nahab, C. Singer, W. Hulme, I. Konidari, Y.<br />
Edwards, G. Beecham, E. R. Martin, W. K. Scott.<br />
2604W Revealing the complex nature <strong>of</strong> a monogenic<br />
disease: Exome sequencing <strong>of</strong> Rett syndrome. F. Ariani,<br />
M. A. Mencarelli, E. Grillo, L. Bianciardi, I. Meloni, C. Di<br />
Marco, C. Lo Rizzo, F. Mari, A. Renieri.<br />
2605T De novo indels in autism spectrum disorders. S.<br />
Dong, S. Sanders, A. J. Willsey, M. Murtha, N. DiLullo, L.<br />
Wei, M. State.<br />
2606F Resequencing and promoter methylation<br />
analysis <strong>of</strong> the dopamine D2 receptor gene in<br />
schizophrenia. Y. Chuang, M. Cheng, C. Lu, M. Tsai, Y.<br />
Shen, S. Hsu, C. Chen.<br />
2607W A comprehensive genetic analysis <strong>of</strong> 421<br />
Japanese patients with Charcot-Marie-Tooth<br />
disease using DNA microarray chips. A. Hashiguchi,<br />
A. Yoshimura, Y. Higuchi, T. Nakamura, S. Tokunaga, Y.<br />
Okamoto, H. Takashima.<br />
2608T A new frameshif mutation in the dopamine<br />
receptor D4 exon III VNTR 7-repeat allele. D. S. S. Lobo,<br />
M. Tampakeras, N. Freeman, J. L. Kennedy.<br />
2609F SPG4 mutations in Brazilian patients with<br />
hereditary spastic paraplegia. I. Lopes-Cendes, D. B.<br />
Dogini, C. Cartaxo, S. Raskin, H. A. G. Teive, J. Saute, L.<br />
B. Jardim, M. C. França, Jr.<br />
2610W Changes in the human transcriptome caused by<br />
LMNB1 duplication in a case <strong>of</strong> autosomal dominant<br />
leukodystrophy: An RNA-seq study. P. Cherukuri, D.<br />
Simeonov, K. Fuentes-Fajardo, P. Zumbo, C. Mason, S.<br />
Lin, Y. H. Fu, C. Boerkoel, T. Markello, W. Gahl, C. Toro.<br />
2611T Exome sequencing <strong>of</strong> young onset sporadic<br />
amyotrophic lateral sclerosis trios. A. E. Renton, J. R.<br />
Gibbs, J. O. Johnson, M. A. Nalls, C. Sassi, Y. Abramzon,<br />
C. Edsall, G. Restagno, M. Sabatelli, A. Chiò, B. J. Traynor.<br />
2612F PRRT2 gene missense mutations account for<br />
both paroxysmal kinesigenic dyskinesia and infantile<br />
convulsions in a Chinese pedigree. C. Cai, W. D. Li.<br />
2613W Whole-exome sequencing and homozygosity<br />
analysis to dissect autism, a complex genetic disorder.<br />
M. H. Chahrour, T. W. Yu, E. T. Lim, B. Ataman, M. E.<br />
Coulter, R. S. Hill, C. R. Stevens, C. R. Schubert, ARRA<br />
Autism Sequencing Collaboration, M. E. Greenberg, S. B.<br />
Gabriel, C. A. Walsh.<br />
2614T Gene-based rare variant analyses reveal loci<br />
associated with autism spectrum disorder. N. Dueker,<br />
E. R. Martin, A. J. Griswold, H. N. Cukier, S. Slifer, J.<br />
Jaworski, I. Konidari, P. L. Whitehead, M. Schmidt, D.<br />
J. Hedges, D. Martinez, S. Clarke, M. L. Cuccaro, J. R.<br />
Gilbert, J. L. Haines, M. A. Pericak-Vance.<br />
POSTER SESSIONS 219<br />
2615F Data sharing in the genomic age: Genome<br />
Variant Database for Neuromuscular Diseases. M.<br />
Gonzalez, R. F. Acosta Lebrigio, S. Zuchner.<br />
2616W X-linked Charcot-Marie-Tooth disease type 1<br />
in Japan: Genetic, clinical, and electrophysiological<br />
study <strong>of</strong> 33 cases. Y. Higuchi, A. Yoshimura, T.<br />
Nakamura, S. Tokunaga, A. Hashiguchi, Y. Okamoto, H.<br />
Takashima.<br />
2617T De novo mutations in autism spectrum disorders<br />
revealed by whole genome sequencing. Y. Jiang, X. Jin,<br />
J. Yu, R. K. Yuen, D. Cao, M. Wang, S. Walker, L. Lau, D.<br />
Merico, Y. Shi, Q. Xu, B. Zhou, Z. Hu, B. Cheng, N. Chen,<br />
J. Mei, K. Xia, X. Xu, Y. Wang, Y. Wu, J. Wang, J. Wang,<br />
C. Lajonchere, G. Dawson, H. Yang, A. Shih, B. Devlin, Z.<br />
Sun, S. W. Scherer, Y. Li.<br />
2618F Analysis <strong>of</strong> low-frequency, protein altering<br />
variation in 13,000 individuals from a Swedish<br />
schizophrenia cohort on the exome array. B. M. Neale,<br />
J. Goldstein, C. O’Dushlaine, M. Fromer, G. Genovese, J.<br />
L. Moran, K. Chambert, C. M. Hultman, P. Sklar, S. Purcell,<br />
M. J. Daly, P. F. Sullivan, S. McCarroll.<br />
2619W Search for rare-variant risks <strong>of</strong> Parkinson’s<br />
disease by sequencing <strong>of</strong> candidate genes and exome<br />
sequencing. W. Satake, Y. Suzuki, Y. Ando, T. Nishioka, K.<br />
Syoji, H. Tomiyama, M. Yamamoto, M. Murata, N. Hattori,<br />
S. Sugano, T. Toda.<br />
2620T Rare combination <strong>of</strong> inherited mutations<br />
in a large multigenerational pedigree with autism<br />
spectrum disorder and co-morbid neurodevelopmental<br />
disorders. P. Szatmari, O. Migita, I. O’Connor, A. Prasad,<br />
D. Sato, S. Walker, A. Thompson, S. W. Scherer, D. Pinto.<br />
2621F Resequencing <strong>of</strong> 17 genes in the N-methyl-Daspartate<br />
glutamate system to identify rare variants<br />
affecting risk <strong>of</strong> substance dependence. P. Xie, H. R.<br />
Kranzler, J. H. Krystal, L. A. Farrer, H. Zhao, J. Gelernter.<br />
2622W Widespread novel RNA editing in human brain<br />
tissue, identified by RNA-seq. L. Hou, N. Akula, J.<br />
Wendland, D. T. Chen, X. Jiang, K. Choi, B. K. Lipska, J. E.<br />
Kleinman, F. J. McMahon.<br />
2623T Association <strong>of</strong> the polymorphisms <strong>of</strong> ITPK1 gene<br />
in inositol metabolic pathways with NTDs. Z. Guan, J.-<br />
H. Wang, J. Guo, F. Wang, X.-W. Wang, G.-N. Li, Q. Xie, X.<br />
Han, B. Niu, T. Zhang.<br />
2624F High apolipoprotein E4 allele frequency in FXTAS<br />
patients. M. Mila, F. Silva, I. Madrigal, M.-I. Alvarez-Mora,<br />
R. Oliva, L. Rodriguez-Revenga.<br />
2625W Generation and characterization <strong>of</strong> induced<br />
pluripotent stem cells from patients with the<br />
autosomal dominant disorder spinocerebellar ataxia<br />
type 1. N. Mollema, A. Shanmugam, E. Leathley, D.<br />
Kaufman, H. T. Orr.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
220 POSTER SESSIONS<br />
2626T Quality <strong>of</strong> life in Machado-Joseph disease/<br />
spinocerebellar ataxia type 3 is related to depressive<br />
and extracerebellar disease features. J. A. Saute, R.<br />
D’Ávila, R. M. Castilhos, T. L. Monte, A. F. S. Schuh, K.<br />
C. Donis, G. N. Souza, A. D. Russo, T. C. Gheno, G. V.<br />
Furtado, M. L. Saraiva-Pereira, C. R. M. Rieder, L. B.<br />
Jardim.<br />
2627F A health non penetrant pedigree derives from a<br />
late onset Parkinsonism founder index case with SCA2<br />
and SCA8 expansions. V. Volpini, H. San Nicolas, J.<br />
Corral, L. De Jorge, B. Campos.<br />
2628W Impaired TFEB signaling accounts<br />
for autophagy pathway dysfunction in the<br />
neurodegenerative proteinopathy X-linked spinal and<br />
bulbar muscular atrophy. C. Cortes, Y. Batlevi, J. E.<br />
Young, H. Frankowski, B. L. Sopher, G. A. Garden, A. R.<br />
La Spada.<br />
2629T The histone demethylase KDM5C gene is a<br />
direct target <strong>of</strong> the ARX homeobox transcription<br />
factor. L. Poeta, F. Fusco, D. Drongitis, C. Shoubridge,<br />
G. Manganelli, A. Padula, S. Filosa, M. Courtney, P.<br />
Collombat, M. B. Lioi, J. Gecz, M. V. Ursini, M. G. Miano.<br />
2630F 15q11.2 Microdeletion and FMR1 premutation<br />
in a family with intellectual disabilities and autism. L.<br />
Rodriguez-Revenga, I. Madrigal, M. Mila.<br />
2631W FRAXE molecular diagnosis in individuals<br />
referred for FRAXA screening. A. Javed, G. Ali, L.<br />
Caicedo, I. Marques, R. Santos, P. Jorge.<br />
2632T An isogenic, epi-isoautosomal fibroblast<br />
model to investigate FMR1 premutation-associated<br />
cellular dysfunction. K. A. Koscielska, S. Roenspie, P. J.<br />
Hagerman.<br />
2633F Formation <strong>of</strong> an R-loop at the FMR1 5’UTR:<br />
Unraveling the extra thread <strong>of</strong> FMR1 expression. E. W.<br />
Loomis, F. L. Chédin, P. J. Hagerman.<br />
2634W The role <strong>of</strong> AGG interruptions, alternative<br />
splicing and bidirectional transcription in the stability<br />
and function <strong>of</strong> the FMR1 gene. C. M. Yrigollen, H. Tang,<br />
E. Loomis, G. Filippova, P. J. Hagerman, F. Tassone.<br />
2635T MutL� is required to repair short slipped-DNAs<br />
<strong>of</strong> trinucleotide repeats. G. Panigrahi, M. Slean, J.<br />
Simard, C. Pearson.<br />
2636F Regional alterations <strong>of</strong> transcriptome-wide<br />
AGO:miRNA binding pr<strong>of</strong>iles in Huntington’s disease<br />
patient brains. R. L. Boudreau, P. Jiang, B. L. Gilmore, Y.<br />
Xing, B. L. Davidson.<br />
2637W Large repeat expansions in the C9ORF72<br />
gene contribute to a spectrum <strong>of</strong> neurodegenerative<br />
disorders including Alzheimer disease. M. A. Kohli,<br />
K. John-Williams, R. Rajbhandary, A. Naj, P. Whitehead,<br />
K. Hamilton, R. M. Carney, C. Wright, E. Crocco, H. E.<br />
Gwirtzman, R. Lang, G. Beecham, E. R. Martin, J. Gilbert,<br />
M. Benatar, G. W. Small, D. Mash, G. Byrd, J. L. Haines,<br />
M. A. Pericak-Vance, S. Züchner.<br />
2638T C9ORF72 repeat expansions are a genetic cause<br />
<strong>of</strong> parkinsonism. S. Lesage, I. Le Ber, C. Condroyer,<br />
E. Broussolle, A. Gabelle, S. Thobois, A. Durr, A. Brice,<br />
Parkinson’s Disease <strong>Genetics</strong> Study Group.<br />
2639F Autosomal dominant family history is a highly<br />
sensitive but not exclusive indicator <strong>of</strong> pathogenic<br />
C9ORF72 expansions in frontotemporal dementia and<br />
amyotrophic lateral sclerosis. J. C. Fong, S. J. Sha, L.<br />
Takada, K. J. Rankin, J. S. Yokoyama, N. J. Rutherford,<br />
A. M. Karydas, B. K. Khan, M. C. Baker, M. DeJesus-<br />
Hernandez, M. Pribadi, G. Coppola, D. H. Geschwind, R.<br />
Rademakers, A. L. Boxer, B. L. Miller.<br />
2640W Walking down the molecular pathogenic road <strong>of</strong><br />
ARX polyalanine tract expansions: Where do they part?<br />
C. Shoubridge, K. P. Y. Lee, T. Mattiske, J. Gécz.<br />
2641T Copy number variation <strong>of</strong> the neuronal glucose<br />
transporter 3 and age <strong>of</strong> onset in Huntington’s disease.<br />
A. Vittori, C. Breda, M. Repici, T. F. Outeiro, F. Giorgini, E.<br />
J. Hollox, REGISTRY Investigators <strong>of</strong> EHDN.<br />
2642F Spinocerebellar ataxias in Brazil: Frequencies<br />
and potential modifiers <strong>of</strong> phenotype. R. M. Castilhos,<br />
P. Schaeffer, T. C. Gheno, G. V. Furtado, K. C. Donis, O.<br />
Barsottini, J. L. Pedroso, D. Z. Salarini, F. R. Vargas, M.<br />
A. F. D. Lima, C. Godeiro, L. C. S. Silva, M. B. P. Toralles,<br />
H. Y. Wanderley, P. F. V. Medeiros, S. Santos, H. van den<br />
Linden, E. M. Ribeiro, E. T. Pereira, M. L. Saraiva-Pereira,<br />
L. B. Jardim, Rede Neurogenética.<br />
2643W Comprehensive haplotype analysis <strong>of</strong> the<br />
Huntington’s disease gene. J. Lee, H. Li, J. C. Roach, N.<br />
Goodman, L. Hood, J. A. Kaye, H. Zayed, I. H. Kratter, A.<br />
C. Daub, S. Finkbeiner, R. H. Myers, M. E. MacDonald, J.<br />
F. Gusella.<br />
2644T Brain-specific junctophilins: Function and role<br />
in neurodegeneration. X. Sun, M. Bhat, C. Zhang, W.<br />
Zheng, R. L. Margolis, D. D. Rudnicki.<br />
2645F Repeat associated non-AUG translation in repeat<br />
expansion disorders. T. Zu, B. Gibbens, L. P. W. Ranum.<br />
2646W microRNA expression in Alzheimer’s disease:<br />
An exploratory investigation. L. M. Bekris, F. Lutz, T. J.<br />
Montine, C. E. Yu, E. R. Peskind, J. B. Leverenz.<br />
2647T Behavioral abnormalities <strong>of</strong> knockout mice<br />
<strong>of</strong> Grm3, a candidate gene for schizophrenia<br />
susceptibility. Y. Fukumaki, R. Fujioka, T. Nii, A. Iwaki, A.<br />
Shibata, I. Ito, K. Kitaichi, M. Nomura, S. Hattori, K. Takao,<br />
T. Miyakawa.<br />
2648F Repeat expansion in C9ORF72 in Alzheimer’s<br />
disease. E. Majounie, Y. Abramzon, A. E. Renton, R. Perry,<br />
S. S. Bassett, O. Pletnikova, J. C. Troncoso, J. Hardy, A. B.<br />
Singleton, B. J. Traynor.<br />
2649W Oxr1 is essential for protection against<br />
oxidative stress-induced neurodegeneration. P. L.<br />
Oliver, M. J. Finelli, K. Liu, B. Edwards, E. Bitoun, E. B.<br />
Becker, K. E. Davies.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2650T Joint SNP analysis identifies multiple signals<br />
underlying association between CHRNB3-CHRNA6 and<br />
nicotine dependence. B. Sadler, E. Johnson, N. Saccone,<br />
L. Bierut, A. Goate.<br />
2651F Variation in gene expression related<br />
to schizophrenia-associated neurocognitive<br />
endophenotypes. E. E. Quillen, M. A. Carless, J. Neary, M.<br />
Z. Kos, R. C. Gur, M. F. Pogue-Geile, K. Prasad, J. Blangero,<br />
H. H. H. Göring, V. L. Nimgaonkar, R. E. Gur, L. Almasy.<br />
2652W A genome-wide epigenetic analysis in<br />
monozygotic twins discordant for schizophrenia. F.<br />
Nishimura, A. Yoshikawa, S. Nanko, A. Imamura, Y. Okazaki,<br />
K. Iwamoto, T. Kato, T. Sasaki, K. Kasai, C. Kakiuchi.<br />
2653T microRNA-9 and -206 expression pr<strong>of</strong>ile in<br />
human amyotrophic lateral sclerosis. D. Dogini, A.<br />
Nucci, I. Lopes-Cendes, M. C. França, Jr.<br />
2654F Altered cell growth and mTOR signaling in<br />
idiopathic autism spectrum disorders. A. M. Suzuki, C.<br />
O. F. Machado, K. G. Oliveira, E. Vadasz, M. R. Passos-<br />
Bueno, A. L. Sertie.<br />
2655W Investigating the genetic susceptibility to<br />
epilepsy in animal models using gene expression<br />
studies. A. H. B. Matos, V. D. B. Pascoal, D. R.<br />
Nascimento, M. Martins, C. S. Rocha, J. F. Vasconcellos,<br />
M. T. Chamma, C. V. Maurer-Morelli, A. S. Martins, A. C.<br />
Valle, A. L. B. Godard, I. Lopes-Cendes.<br />
2656T Effects <strong>of</strong> oral L-carnitine administration in<br />
narcolepsy patients. T. Miyagawa, H. Kawamura, M. Obuchi,<br />
A. Ikesaki, A. Ozaki, K. Tokunaga, Y. Inoue, M. Honda.<br />
2657F Discovery <strong>of</strong> genetic syndromes in patients<br />
manifesting with primary neuropsychiatric disorders. J.<br />
So, J. L. Kennedy.<br />
2658W Genomic and bioinformatic analyses <strong>of</strong> sex<br />
differences in autism spectrum disorder. D. M. Werling,<br />
J. K. Lowe, V. Chandran, R. M. Cantor, D. H. Geschwind,<br />
ACE <strong>Genetics</strong> Consortium.<br />
2659T Analysis <strong>of</strong> RBFOX1 gene expression in<br />
lymphoblastoid cell lines <strong>of</strong> discordant ASD sib pairs.<br />
C. Zusi, P. Prandini, G. Malerba, A. Marostica, E. Trabetti,<br />
P. F. Pignatti, Italian Autism Network.<br />
2660F Protein-protein interaction network for autism<br />
spectrum disorders. R. Corominas, X. Yang, G. N. Lin, S.<br />
Kang, Y. Shen, L. Ghamsari, S. A. Wanamaker, S. Tam, M.<br />
Rodriguez, M. Broly, V. Romero, I. Lemmens, M. Tasan, J.<br />
Tavernier, F. P. Roth, M. Calderwood, J. Sebat, K. Salehi-<br />
Ashtiani, D. E. Hill, M. Vidal, T. Hao, L. M. Iakoucheva.<br />
2661W Transcriptome analysis <strong>of</strong> brain-related<br />
diseases in whole blood by RNA sequencing. S.<br />
de Jong, T. Wang, A. P. S. Ori, M. Wiedau-Pazos, E.<br />
Strengman, N. Tran, J. DeYoung, R. S. Kahn, M. P. M.<br />
Boks, S. Horvath, R. A. Oph<strong>of</strong>f.<br />
POSTER SESSIONS 221<br />
Molecular Basis <strong>of</strong> Mendelian<br />
Disorders<br />
2662W The role <strong>of</strong> GTF2IRD1 in the auditory pathology<br />
<strong>of</strong> Williams-Beuren syndrome. C. P. Canales, A. C. Y.<br />
Wong, G. D. Housley, P. W. Gunning, E. C. Hardeman, S.<br />
J. Palmer.<br />
2663T Tricellulin is required to maintain the barrier<br />
function <strong>of</strong> the reticular lamina and protect the<br />
cochlear hair cells from potassium toxicity. G. Nayak, I.<br />
A. Belyantseva, R. Yousaf, S. Edelmann, S. Lee, G. Sinha,<br />
M. Rafeeq, S. M. Jones, C. M. Van Itallie, J. M. Anderson,<br />
A. Forge, G. I. Frolenkov, S. Riazuddin.<br />
2664F Generation and characterization <strong>of</strong> Plp1dup, a<br />
new mouse model <strong>of</strong> Pelizaeus-Merzbacher disease<br />
with tandem genomic duplication. G. Hobson, K. Clark,<br />
L. Sakowski, K. Sperle, L. Banser, D. Bessert, R. Sk<strong>of</strong>f.<br />
2665W Gtf2i copy number affects the growth <strong>of</strong> neural<br />
progenitors in the developing mouse cortex. H. Oh, L.<br />
R. Osborne.<br />
2666T GPM6A is duplicated in a patient with learning<br />
disability and behavioral anomalies and influences<br />
stress response and long-term memory in Drosophila<br />
melanogaster. C. Zweier, A. Gregor, J. Kramer, I.<br />
Schanze, A. B. Ekici, A. Schenck, A. Reis.<br />
2667F FASPS associated Per3 mutation affects<br />
mesenchymal stem cell differentiation. K. Kaasik, C. R.<br />
Jones, Y. H. Xu, S. Nishino, L. J. Ptacek, Y. H. Fu.<br />
2668W Characterization <strong>of</strong> a novel mit<strong>of</strong>usin 2 knockin<br />
mouse model. A. Rebelo, A. Strickland, F. Zhang, J. Price,<br />
J. Silva, R. Wen, B. Bolon, J. Vance, S. Zuchner.<br />
2669T Triply mouse model <strong>of</strong> Tay-Sachs disease shows<br />
altered brain ganglioside pattern. V. Seyrantepe, Z.<br />
Timur.<br />
2670F Deficiency <strong>of</strong> SPECC1L downregulates PI3K-<br />
AKT signaling in the pathogenesis <strong>of</strong> oblique facial<br />
clefts. N. R. Wilson, A. J. Olm-Shipman, L. Pitstick, B. C.<br />
Bjork, I. Saadi.<br />
2671W Transgenic rescue <strong>of</strong> BBS phenotypes in Bbs4<br />
null mice. X. Chamling, S. Seo, K. Bugge, C. C. Searby, A.<br />
V. Drack, K. Rahmouni, V. C. Sheffield.<br />
2672T Overexpression <strong>of</strong> Rai1 in mouse forebrain<br />
neurons is enough to cause most PTLS-like<br />
phenotypes. L. Cao, J. Molina, P. Carmona-Mora, A.<br />
Oyarzo, J. Young, K. Walz.<br />
2673F A zebrafish model for Richieri-Costa-Pereira<br />
syndrome: Knockdown <strong>of</strong> eif4a3 gene results in<br />
crani<strong>of</strong>acial development disorder. L. Alvizi, A. Weiner,<br />
F. Favaro, R. Zechi-Ceide, A. Richieri-Costa, M. Guion-<br />
Almeida, N. Calcaterra, M. R. Passos-Bueno.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
222 POSTER SESSIONS<br />
2674W A glial origin for periventricular nodular<br />
heterotopia caused by impaired expression <strong>of</strong><br />
Filamin-A. A. Carabalona, S. Beguin, E. Pallesi-<br />
Pocachard, E. Buhler, C. Pellegrino, K. Arnaud, P. Hubert,<br />
M. Ouahla, J.-P. Siffroi, S. Khantane, I. Coupry, C. Goizet,<br />
A. Bernabe-Gelot, A. Represa, C. Cardoso.<br />
2675T Mining phenotype and disease models from the<br />
mouse genome informatics resource. J. T. Eppig, S. M.<br />
Bello, H. Dene, A. Anagnostopoulos, H. Onda, R. Babiuk,<br />
M. N. Knowlton, M. Tomczuk, C. L. Smith.<br />
2676F Molecular genetics and modeling <strong>of</strong> a novel<br />
BBS5 mutation. M. H. Al-Hamed, C. V. Lennep, F. Al-<br />
Fadhly, R. J. Simms, B. F. Meyer, J. A. Sayer.<br />
2677W Limb differences in muscle dystrophy and gene<br />
expression in a murine model <strong>of</strong> MDC1A suggest possible<br />
targets for therapy. J. S. Benjamin, R. Marx, R. D. Cohn.<br />
2678T FREM1 deficiency causes a syndromic form <strong>of</strong><br />
congenital diaphragmatic hernia in humans and mice.<br />
T. F. Beck, O. Shchelochkov, Z. Yu, B. Kim, H. Zaveri, B.<br />
Lee, D. W. Stockton, M. Justice, D. A. Scott.<br />
2679F Characterization <strong>of</strong> visual impairment in a Wfs1<br />
mouse model <strong>of</strong> Wolfram syndrome. C. Delettre, D.<br />
Bonnet-Wersinger, Y. Tanizawa, G. Lenaers, C. Hamel.<br />
2680W Gene therapy for X-linked retinitis pigmentosa in<br />
a knockout mouse model <strong>of</strong> RP2. S. Mookherjee, L. Li, A.<br />
K. Ghosh, N. Khan, P. Colosi, H. Khanna, A. Swaroop.<br />
2681T Altered splicing <strong>of</strong> BIN1 muscle-specific<br />
exon in human and Great Danes with progressive<br />
centronuclear myopathies. J. Bohm, N. Vasli, M. Maurer,<br />
B. S. Cowling, W. Kress, G. D. Shelton, U. Schara, J.<br />
Anderson, R. Herrmann, J. Weis, L. Tiret, J. Laporte.<br />
2682F Upregulation <strong>of</strong> androgen-binding protein is<br />
associated with testicular phenotype in Smarcal1 del/del<br />
mice. A. Baradaran-Heravi, C. F. Boerkoel.<br />
2683W A mouse model <strong>of</strong> mut � methylmalonic acidemia.<br />
J. S. Sénac, V. H. Aswani, J. R. Sysol, I. Manoli, C. P. Venditti.<br />
2684T Allelic heterogeneity contributes to variable<br />
ocular dysgenesis caused by Col4a1 and Col4a2<br />
mutations in mice. M. Mao, D. S. Kuo, C. Labelle-<br />
Dumais, M. Jeanne, J. Favor, D. B. Gould.<br />
2685F Tmprss3 loss <strong>of</strong> function impairs cochlear inner<br />
hair cell BK channel properties. B. Delprat, L. Molina, L.<br />
Fasquelle, R. Nouvian, N. Salvetat, H. Scott, M. Guipponi,<br />
F. Molina, J. L. Puel.<br />
2686W Interaction with p97/VCP alters the intracellular<br />
itinerary <strong>of</strong> the copper-transporting ATPase, ATP7A. L.<br />
Yi, S. G. Kaler.<br />
2687T JNK phosphorylation is responsible for the<br />
greater osteogenic potential <strong>of</strong> periosteum derived<br />
fibroblasts harboring the FGFR2 S252W mutation<br />
(Apert syndrome). R. Atique, E. Yeh, H. Matsushita, N.<br />
Alonso, M. R. Passos-Bueno.<br />
2688F Novel p.Leu795Pro INSR mutation with<br />
decreased autophosphorylation in a patient with<br />
Donohue syndrome. T. Hovnik, K. Trebusˇ ak Podkrajsˇ ek,<br />
J. Kovač , N. Bratanič , T. Battelino.<br />
2689W Post-transcriptional regulation <strong>of</strong> DMD by its<br />
3’UTR. A. Larsen, M. Howard.<br />
2690T NPHP10 (SDCCAG8) interacts with components<br />
<strong>of</strong> the multi-aminoacyl-tRNA synthetase complex. K.<br />
Weihbrecht, M. Humbert, V. Sheffield, S. Seo.<br />
2691F Effect <strong>of</strong> the mutations Gly250Val and Leu451Val<br />
on the expression <strong>of</strong> the gene HEXA: Disease causing<br />
or pseudo-mutations. L. Peleg, R. Svirski, Y. Lerental, M.<br />
Karpati, A. J. Simon.<br />
2692W Identification and biochemical characterization<br />
<strong>of</strong> a novel mutation in DDX11 causing Warsaw<br />
breakage syndrome. J.-M. Capo-Chichi, S. Bhati, J.<br />
A. Sommers, T. Yammine, E. Chouery, L. Patry, G. A.<br />
Rouleau, M.-E. Samuels, F. F. Hamdan, J. L. Michaud, R.<br />
M. Brosh, Jr., A. Megarbane, Z. Kibar.<br />
2693T Development <strong>of</strong> a cell-based reporter assay for<br />
the analysis <strong>of</strong> regulatory interactions between FGF23/<br />
KLOTHO/FGFR1, small inhibitors, and downstream<br />
targets. S. Diener, B. Lorenz-Depiereux, T. M. Strom.<br />
2694F The most activating calcium-sensing receptor<br />
mutation is located in the sixth transmembrane domain<br />
and can be corrected with chemical treatments. A.-S.<br />
Lia-Baldini, A. Nizou, C. Magdelaine, F. Sturtz, B. Funalot,<br />
A. Liendhard.<br />
2695W Dysregulated pathways in Cornelia de Lange<br />
syndrome cells mutated in core cohesin genes.<br />
A. Musio, L. Mannini, A. Gimigliano, l. Bianchi, M. A.<br />
Deardorff, F. Cucco, I. D. Krantz, L. Bini.<br />
2696T Conformations <strong>of</strong> slipped-DNA junctions<br />
determine correct or mutagenic repair <strong>of</strong> CAG/<br />
CTG repeats. M. M. Slean, K. Reddy, B. Wu, K. Nichol<br />
Edamura, M. Kekis, F. Nelissen, R. Aspers, M. Tessari, O.<br />
D. Scharer, S. S. Wijmenga, C. E. Pearson.<br />
2697F High incidence <strong>of</strong> SMAD3 mutations in thoracic<br />
aortic aneurysm and/or dissection patients. H.<br />
Morisaki, I. Yamanaka, A. Yoshida, R. Sultana, H. Tanaka,<br />
Y. Iba, H. Sasaki, H. Matsuda, K. Minatoya, T. Kosho, N.<br />
Okamoto, A. Kawame, T. Morisaki.<br />
2698W Clinical exome sequencing leads to the<br />
diagnosis <strong>of</strong> Timothy syndrome in a patient with<br />
prolonged QT, dysmorphic features, seizures, and<br />
intellectual disability. W. Zeng, K. D. Gonzalez, X. Li, H.<br />
M. Lu, H. Lu, E. M. Miller, S. Ware, J. J. Wei.<br />
2699T Mutations in calmodulin cause ventricular<br />
tachycardia and sudden cardiac death. M. Nyegaard,<br />
M. T. Overgaard, M. T. Søndergaard, M. Vranas, E. R. Behr,<br />
L. L. Hildebrandt, J. Lund, P. L. Hedley, A. J. Camm, G.<br />
Wettrell, I. Fosdal, M. Christiansen, A. D. Børglum.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2700F Role <strong>of</strong> SP1-binding site polymorphism <strong>of</strong><br />
COLIAI gene and a sequence variation 713-8 del C <strong>of</strong><br />
TGF�1 polymorphism in osteoporosis in thalassemia<br />
major patients. S. Agarwal, K. Singh, R. Kumar.<br />
2701W Loss-<strong>of</strong>-function mutations in IGSF1 cause<br />
a novel X-linked syndrome <strong>of</strong> TSH deficiency and<br />
macroorchidism. M. Breuning, Y. Sun, B. Bak, N.<br />
Schoenmaker, A. S. P. van Trotsenburg, P. Voshol, E.<br />
Cambridge, J. White, P. le Tisser, S. Mousavy Gharavy, J.<br />
Martinez-Barbera, W. Oostdijk, L. Persani, P. Beck-Peccoz,<br />
T. Davis, A. Hokken-Koelega, C. Ruivenkamp, J. F.J. Laros,<br />
M. Kriek, S. Kant, J. T. den Dunnen, R. Hennekam, K.<br />
Chatterjee, M. Dattani, J. Wit, D. Bernard.<br />
2702T Hyperphagia, leptin, and brain-derived<br />
neurotrophic factor in subjects with Alström syndrome<br />
and BMI-Z matched controls. M. D. Hicks, J. D.<br />
Marshall, P. Maffei, A. E. Hanish, L. A. Hunter, S. M. Brady,<br />
N. M. Sedaka, R. Sherafat Kazemzadeh, J. W. Tsao, G.<br />
Milan, J. Naggert, J. A. Yanovski, J. C. Han.<br />
2703F The Euro-WABB Registry: Differences in molecular<br />
genetic confirmation between monogenic Wolfram,<br />
Alström, and Bardet-Biedl syndromes. A. Farmer, S. Ayme,<br />
P. Maffei, S. Mccafferty, R. Sinnott, W. Mlynarski, V. Nunes, V.<br />
Paquis, K. Parkinson, V. Tillman, T. Barrett.<br />
2704W Biallelic RFX6 inactivation can cause intestinal<br />
atresia with childhood rather than neonatal onset<br />
diabetes. F. H. Sansbury, R. Caswell, H. Lango Allen, S. E.<br />
Flanagan, B. Kirel, S. Ellard, A. T. Hattersley.<br />
2705T Identification <strong>of</strong> a de novo mutation in the<br />
thyroid hormone receptor � gene in a Colombian family<br />
with RTH. M. C. Lozano, L. Mejia, P. Duran, C. Lattig.<br />
2706F Use <strong>of</strong> lineage markers to predict founder effect<br />
<strong>of</strong> E180Splice mutation in GHR gene causing Laron<br />
syndrome: A witness <strong>of</strong> Jewish exodus. F. T. Goncalves,<br />
C. Fridman, E. M. Pinto, Z. Laron, J. Guevara-Aguirre, F.<br />
G. Carsola, D. Damiani, T. S. Lins, O. Shevah, V. Hwa, A.<br />
L. Rosembloom, R. G. Rosenfeld, U. P. Arnhold, A. A. L.<br />
Jorge.<br />
2707W <strong>Genetics</strong> <strong>of</strong> congenital hypogonadotropic<br />
hypogonadism in Denmark. J. Tommiska, P.<br />
Christiansen, N. Jørgensen, J. Lawaetz, A. Juul, T. Raivio.<br />
2708T A rare gain-<strong>of</strong>-function mutation in an<br />
inhibitory upstream open reading frame in CDKN1B 5’<br />
untranslated region causes MEN4 phenotype. G. Occhi,<br />
D. Regazzo, G. Trivellin, F. Boaretto, D. Ciato, S. Ferasin, F.<br />
Cetani, E. Pardi, M. Korbonits, N. Pellegata, G. Opocher, F.<br />
Mantero, C. Scaroni.<br />
2709F Next-generation sequencing to identify cryptic<br />
ABCC8 and HADH splice site mutations in patients<br />
with congenital hyperinsulinaemic hypoglycaemia. S.<br />
Ellard, R. Caswell, M. Weedon, K. Hussain, S. E. Flanagan.<br />
2710W ABCC8 and KCNJ11 gene mutational analysis<br />
in Slovenian patients with neonatal diabetes and<br />
congenital hyperinsulinism. K. Trebusˇ ak Podkrajsˇ ek, M.<br />
Avbelj, T. Hovnik, N. Bratina, N. Bratanič , T. Battelino.<br />
POSTER SESSIONS 223<br />
2711T Severe familial growth hormone deficiency due<br />
to defective U12-dependent processing <strong>of</strong> pituitary<br />
developmental genes. L. A. Perez-Jurado, R. Flores, G.<br />
A. Martos-Moreno, I. Cuscó, J. Argente.<br />
2712F Impaired energy homeostasis and arrested<br />
maturation underlie neutrophil dysfunction in glycogen<br />
storage disease type Ib. H. S. Jun, D. A. Weinstein, Y. M.<br />
Lee, B. C. Mansfield, J. Y. Chou.<br />
2713W A novel mutation in PSTPIP1 is responsible<br />
for PAPA syndrome in a Jordanian child. H. El-Shanti,<br />
F. Al-Amri, B. Fathalla, S. Al-Dosari, M. Al-Mutawa, M.<br />
Kambouris.<br />
2714T Prevalence <strong>of</strong> ��� anti3.7 triplication in betathalassemia<br />
carriers in south <strong>of</strong> Iran. G. Shariati,<br />
M. Hamid, A. H. Saberi, B. Sharififard, B. Keikhaei, M.<br />
Pedram.<br />
2715F Mutational analysis <strong>of</strong> Korean patients with<br />
Diamond-Blackfan anemia. H. Chae, J. Park, M. Kim, A.<br />
Kwon, S. Lee, Y. Kim, J. W. Lee, N. G. Chung, B. Cho, D.<br />
C. Jeong.<br />
2716W Apoptosis is responsible for neutropenia in<br />
Cohen syndrome. L. Duplomb, L. Faivre, A. Hammann,<br />
G. Jego, N. Droin, E. Lopez, B. Aral, N. Gigot, S. El<br />
Chehadeh, F. Huet, P. Callier, J. Thevenon, V. Carmignac,<br />
C. Capron, M.-A. Gougerot-Pocidalo, F. Girodon, J.-N.<br />
Bastie, L. Delva, C. Thauvin-Robinet.<br />
2717T A novel pig model <strong>of</strong> SCID; A tool for cancer and<br />
immune research. N. M. Ellinwood, E. H. Waide, D. M.<br />
Thekkoot, N. Boddicker, R. R. R. Rowland, E. M. Snella, J.<br />
K. Jens, C. R. Wyatt, J. W. Ross, D. Troyer, C. K. Tuggle, J.<br />
C. M. Dekkers.<br />
2718F Polymorphism in the HMOX-1 gene is associated<br />
with high levels <strong>of</strong> HbF in Brazilian patients with sickle<br />
cell anemia. M. B. Melo, G. P. Gil, G. Ananina, M. B.<br />
Oliveira, M. J. Silva, M. N. N. Santos, M. A. C. Bezerra, B.<br />
L. D. Hatzlh<strong>of</strong>er, A. S. Araujo, F. F. Costa.<br />
2719W Beta-thalassemia in the Aegan Region <strong>of</strong><br />
Turkey: Identification <strong>of</strong> a novel deletion mutation. F.<br />
Ozkinay, H. Onay, E. Karaca, E. Arslan, A. Ece, B. Erturk,<br />
M. Tekin, O. Cogulu, Y. Aydinok, C. Vergin.<br />
2720T Development <strong>of</strong> a diagnostic panel for<br />
genetic immunodeficiencies using next-generation<br />
sequencing. E. M. Coonrod, J. Durtschi, A. Kumanovics,<br />
R. L. Margraf, H. R. Hill, K. V. Voelkerding.<br />
2721F Spectrum <strong>of</strong> gene mutations in Chinese patients<br />
with refractory human herpes viruses associated<br />
disease. H. Liu, F. Wang, Y. Zhang, Y. Wang, W. Teng, L.<br />
Guo, C. Tong, T. Wu, Y. Zhao, J. Gu, D. Lu.<br />
2722W Exome sequencing identifies missense IRF2BP2<br />
mutation in a family with autosomal dominant common<br />
variable immunodeficiency. L. Tian, D. Li, M. Keller, K.<br />
Cecilia, E. Frackelton, F. Otieno, H. Hakonarson, J. S.<br />
Orange.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
224 POSTER SESSIONS<br />
2723T C-terminal frameshift truncation and extension<br />
mutation in POU3F4. W. Park, B. Choi, D. Kim, A. Kim.<br />
2724F Dominant allele <strong>of</strong> DFNM1 suppresses DFNB26<br />
associated recessive hearing loss. R. Yousaf, Z. M.<br />
Ahmed, G. Nayak, R. J. Morell, S. Sumanas, E. R. Wilcox,<br />
S. Riazuddin, T. B. Friedman, S. Riazuddin.<br />
2725W Phenome-wide, cross-species comparisons<br />
identify novel disease genes with high accuracy. D. P.<br />
Smedley, C. J. Mungall, S. C. Doelken, S. Köehler, B. J.<br />
Ruef, M. Westerfield, P. N. Robinson, S. E. Lewis, W. C.<br />
Skarnes, Members <strong>of</strong> Mouse <strong>Genetics</strong> Project.<br />
2726T Mutation screening in CYP1B1 in glaucoma<br />
cases from North India. A. Bhardwaj, V. Vanita.<br />
2727F Screening <strong>of</strong> SOX10 and MITF regulatory regions<br />
in Waardenburg syndrome type 2. N. Bondurand, V.<br />
Baral, A. Chaoui, Y. Watanabe, M. Goossens, T. Attie-<br />
Bitach, S. Marlin, V. Pingault.<br />
2728W Utilization <strong>of</strong> gene mapping and candidate gene<br />
mutation screening for diagnosing clinically equivocal<br />
conditions. V. Chini, D. Stambouli, F. M. Nedelea, G. A.<br />
Filipescu, D. Mina, H. El-Shanti, M. Kambouris.<br />
2729T Search for a new gene responsible for nonsyndromic<br />
craniosynostosis. S. El Chehadeh-Djebbar, F.<br />
Di Rocco, C. Collet, M. Le Merrer, J. Puechberty, G. Lefort,<br />
B. Aral, S. Lambert, N. Gigot, M. Payet, C. Ragon, N.<br />
Marle, A.-L. Mosca-Boidron, J.-R. Teyssier, F. Mugneret, C.<br />
Thauvin-Robinet, P. Sarda, L. Faivre, P. Callier.<br />
2730F Mutation screening in CNGA1 in an autosomal<br />
recessive retinitis pigmentosa family. S. Goyal, V. Vanita.<br />
2731W A novel mutation <strong>of</strong> the nicastrin (NCSTN)<br />
gene in a large Indian family with autosomal dominant<br />
hidradenitis suppurativa (or acne inversa). D. Jhala, U.<br />
Ratnamala, T. Y. Mehta, F. M. S. Al-Ali, M. Raveendrababu,<br />
S. S. Chettiar, M. V. Rao, S. Nair, J. J. Sheth, M. R.<br />
Kuracha, S. K. Nath, U. Radhakrishna.<br />
2732T A systematic approach to identifying disease<br />
genes in Mullerian aplasia. H.-G. Kim, H. K. Nishimoto,<br />
R. Ullmann, J. A. Phillips III, Y. Shen, R. H. Reindollar, H. H.<br />
Ropers, V. M. Kalscheuer, L. C. Layman.<br />
2733F Linkage analysis in an autosomal recessive<br />
retinitis pigmentosa family. V. Kumar, S. Saini.<br />
2734W Homozygosity mapping and mutation pr<strong>of</strong>ile<br />
<strong>of</strong> the MYO7A gene in Saudi patients with Usher<br />
syndrome. K. Ramzan, M. Al-Owain, K. Taibah, G. Bin-<br />
Khamis, R. Allam, A. Al-Mostafa, S. Al-Hazza, F. Imtiaz.<br />
2735T Mutation analysis in an autosomal recessive<br />
retinitis pigmentosa family. S. Saini, J. R. Singh, V.<br />
Vanita.<br />
2736F The role <strong>of</strong> APCS and RBP4 genes as modifiers<br />
<strong>of</strong> age-at-onset in familial amyloid polyneuropathy<br />
(FAP ATTRV30M). D. Santos, T. Coelho, J. L. Neto, J. P.<br />
Basto, J. Sequeiros, I. Alonso, C. Lemos, A. Sousa.<br />
2737W Linkage analysis in families with autosomal<br />
dominant corneal dystrophies. D. Singh, V. Vanita.<br />
2738T A novel chromosomal locus in a family with<br />
primary ciliary dyskinesia. R. Parvari, M. Mazor, S.<br />
Alkrinawi, V. C. Sheffield, M. Aviram.<br />
2739F Polymorphism <strong>of</strong> VEGF+674 gene as potential<br />
risk factor for age related macular degeneration in<br />
Indian patients. D. Gupta, V. Gupta, S. Chawla, S. R.<br />
Phadke.<br />
2740W Whole genome analysis identifies mutations<br />
in inositol polyphosphate phosphatase-like 1 as the<br />
cause <strong>of</strong> opsismodysplasia. J. E. Below, D. Earl, K. M.<br />
B<strong>of</strong>ferding, M. J. McMillin, J. Smith, E. Turner, M. Stephan,<br />
L. Al-Gazali, J. Hertecant, D. H. Cohn, D. A. Krakow, D. A.<br />
Nickerson, M. J. Bamshad.<br />
2741T Novel loci for autosomal dominant nocturnal<br />
frontal lobe epilepsy. S. E. Heron, M. Bahlo, K. R. Smith,<br />
P. Hickey, C. Bromhead, C. P. Derry, J. S. Duncan, S.<br />
Howell, S. F. Berkovic, I. E. Scheffer, L. M. Dibbens.<br />
2742F Identification <strong>of</strong> a new gene for X-linked<br />
Charcot-Marie-Tooth neuropathy using linkage and<br />
exome analysis. M. Kennerson, E. Yiu, D. Chuang,<br />
S.-C. Tso, C. Ly, A. Kidambi, G. Perez Siles, M. Ryan, G.<br />
Nicholson.<br />
2743W A novel splice site mutation in Erlin2 gene<br />
causes complicated form <strong>of</strong> hereditary spastic<br />
paraplegia in a Saudi family. S. Majid, S. Bohlega, S.<br />
Hagos, H. Dossari, K. Ramzan, Z. Hassnan.<br />
2744T Clinical and genetic study <strong>of</strong> a new form <strong>of</strong><br />
familial multiple keratoakanthoma in a Tunisian family:<br />
The palmoplantar familial multiple keratoacanthoma.<br />
O. Mamaô, L. Bouss<strong>of</strong>ara, L. Adala, I. Ben Charfeddine, S.<br />
Bouraoui, A. Amara, R. Nouira, M. Denguezli, B. Sriha, M.<br />
Gribaa, A. Saad.<br />
2745F FBLN5 mutation as the cause <strong>of</strong> HMSN I in<br />
a Czech family: Usefulness <strong>of</strong> combination <strong>of</strong> SNP<br />
linkage and exome sequencing analysis. D. Brozˇ ková, P.<br />
Lasˇ sˇ uthová, J. Lisoň ová, M. Kru˚ tová, P. Seeman.<br />
2746W Expansion <strong>of</strong> a repeat motif in the<br />
5’untranslated region <strong>of</strong> EIF4A3 causes crani<strong>of</strong>acial<br />
and limb defects (Richieri-Costa-Pereira syndrome). F.<br />
Favaro, R. M. Zechi-Ceide, L. Alvizi, J. Souza, T. M. Felix,<br />
S. R. F. Twigg, S. J. McGowan, A. O. M. Wilkie, A. Richieri-<br />
Costa, M. L. Guion-Almeida, M. R. Passos-Bueno.<br />
2747T A recurrent mutation <strong>of</strong> keratin 4 gene causing<br />
white sponge nevus in a Japanese family. M. Kimura,<br />
T. Nagao, J. Machida, S. Yamaguchi, A. Shibata, G.<br />
Takeuchi, H. Miyachi, K. Shimozato, Y. Tokita.<br />
2748F Molecular analysis <strong>of</strong> benign familial neonatalinfantile<br />
convulsion in a Japanese family. Y. Yamada, K.<br />
Yamada, D. Fukushi, K. Miura, N. Nomura, A. Yamano, T.<br />
Kumagai, N. Wakamatsu.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2749W A newly identified locus for benign adult familial<br />
myoclonic epilepsy on chromosome 3q26.32-3q28.<br />
P. Yeetong, S. Ausavarat, R. Bhidayasiri, K. Piravej, N.<br />
Pasutharnchat, T. Desudchit, C. Chunharas, J. Loplumlert,<br />
C. Limotai, K. Suphapeetiporn, V. Shotelersuk.<br />
2750T Calpain-5 causes autoimmune uveitis, retinal<br />
neovascularization and photoreceptor degeneration. V.<br />
B. Mahajan, J. M. Skeie, A. G. Bassuk, J. H. Fingert, T. A.<br />
Braun, H. T. Daggett, J. C. Folk, V. C. Sheffield, E. M. Stone.<br />
2751F Soluble ICAM-1 levels are associated to a<br />
protective prognosis in sickle cell retinopathy. P. R. S.<br />
Cruz, T. R. Zaccarioto, F. N. Mitsuuchi, S. A. C. Pereira<br />
Filho, R. P. C. Lira, I. Meyer, M. A. C. Bezerra, K. Y. Fertrin,<br />
F. F. Costa, M. B. Melo.<br />
2752W X-linked CHARGE-like Abruzzo-Erickson<br />
syndrome and classic cleft palate with ankyloglossia<br />
result from, i>TBX22 splicing mutations. P. Stanier, E.<br />
Pauws, E. Peskett, C. Boissin, K. Mengrelis, E. Carta, M.<br />
A. Abruzzo, M. Lees, G. E. Moore, R. P. Erickson.<br />
2753T Enlarged vestibular aqueduct syndrome:<br />
Characterization <strong>of</strong> three new mutations. E. Prera, S.<br />
Arndt, A. Aschendorff, R. Birkenhäger.<br />
2754F A novel molecular basis for Carpenter<br />
syndrome. S. Movva, U. Kotecha, R. Puri, I. C. Verma.<br />
2755W De novo activating mutations in<br />
phosphatidylserine synthase 1 cause a rare mental<br />
retardation-multiple congenital anomalies syndrome.<br />
S. B. Sousa, D. Jenkins, E. Chanudet, A. Barnicoat,<br />
K. Chrzanowska, J. Sá, J. Saraiva, R. Scott, D.<br />
Wattanasirichaigoon, G. Anderson, G. Tasseva, J. Vance,<br />
P. Beales, G. E. Moore.<br />
2756T Exome sequencing <strong>of</strong> a consanguineous<br />
Palestinian kindred with syndromic cleft palate. H.<br />
Shahin, U. Sharaha, M. Lee, S. Saed, J. van Aalst, M. C.<br />
King, T. Walsh.<br />
2757F Mutations in the DOCK6 gene in Adams-Oliver<br />
syndrome. W. Wuyts, A. Laureys, E. Van Hul, M. De<br />
Smedt, K. Storm, N. Van der Aa.<br />
2758W Novel mutations <strong>of</strong> the FGD1 gene in 16<br />
patients with Aarskog-Scott syndrome. T. Kaname,<br />
K. Yanagi, N. Okamoto, K. Kurosawa, Y. Izumikawa,<br />
Y. Fukushima, Y. Makita, M. Tsukahara, A. Altincik, S.<br />
Mizuno, K. Naritomi.<br />
2759T Exome sequencing identifies an IFIH1 mutation<br />
causing Singleton-Merten syndrome by dysregulation<br />
<strong>of</strong> the innate immune response. F. Rutsch, M.<br />
MacDougall, C. Lu, Y. Nitschke, I. Buers, O. Mamaeva, D.<br />
K. Crossman, J. Dong, C. Müller, H. G. Kehl, J. Kleinheinz,<br />
P. Barth, K. Barczyk, D. Bazin, J. Altmüller, H. Thiele, P.<br />
Nürnberg, W. Höhne, A. S. Feigenbaum, R. Hennekam.<br />
2760F Mutations in PVRL1 and PVRL4 genes define<br />
nectinopathies as developmental field disorders <strong>of</strong><br />
ectodermal derivatives and cutaneous syndactyly with<br />
or without cleft lip/palate. E. Agolini, P. Fortugno, L.<br />
B. Ousager, A. Bygum, L. Graul-Neumann, K. Stieler, A.<br />
Kuechler, G. Zambruno, F. Brancati.<br />
POSTER SESSIONS 225<br />
2761W ELN mutations in autosomal dominant cutis<br />
laxa. E. Lawrence, M. McGowan, C. Su, M. Mac Neal, K.<br />
Levine, A. Zaenglein, M. Bodzioch, A. Kiss, Z. Urban.<br />
2762T RIPK4 mutations explain a portion <strong>of</strong> IRF6negative<br />
popliteal pterygium cases. E. J. Leslie, S.<br />
Goudy, M. Cunningham, J. C. Murray.<br />
2763F Sacsin-related ataxia caused by the novel<br />
missense mutation Arg272His in a patient from<br />
Southern Italy. F. Cavalcanti, A. Nicoletti, G. Annesi, P.<br />
Tarantino, M. Gagliardi, G. Mostile, V. Dibilio, A. Quattrone,<br />
A. Gambardella, M. Zappia.<br />
2764W SCA36 molecular analysis in patients with<br />
spinocerebellar ataxia. D. Di Bella, E. Sarto, C. Mariotti,<br />
C. Gellera, S. Magri, F. Taroni.<br />
2765T Germline CAG repeat instability causes<br />
extreme CAG repeat expansion with infantile onset<br />
<strong>of</strong> spinocerebellar ataxia type 2 in <strong>of</strong>fspring. J. Ek, T.<br />
Vinther-Jensen, M. Dunoe, F. Skovby, L. E. Hjermind, J. E.<br />
Nielsen, T. T. Nielsen.<br />
2766F Genetic aspects <strong>of</strong> Dravet syndrome in southern<br />
Italy. M. Gagliardi, P. Tarantino, F. Cavalcanti, M. Sesta, P.<br />
Conti, D. Galeone, G. Tortorella, A. Labate, M. Caracciolo, T.<br />
Mirante, A. Bagal‡, A. Quattrone, A. Gambardella, G. Annesi.<br />
2767W Vacuolar-type H � -ATPase V1A subunit is a<br />
molecular partner <strong>of</strong> Wolfram syndrome 1 protein,<br />
which regulates its stability and expression. S.<br />
Gharanei, M. Zatyka, D. Astuti, J. Fenton, E. Rabai, A. Sik,<br />
Z. Nagy, T. Barrett.<br />
2768T Altered expression <strong>of</strong> carbonic anhydraserelated<br />
protein XI in neuronal cells expressing mutant<br />
ataxin-3. M. Hsieh, W. H. Chang, C. F. Hsu, C. L. Kuo, I.<br />
Nishimori, T. Minakuchi, N. Nukina.<br />
2769F Alterations in RNA splicing underlie<br />
development <strong>of</strong> ataxia in SCA1 mice. M. A. C. Ingram, P.<br />
Bergmann, H. Kang, H. Y. Zoghbi, H. T. Orr.<br />
2770W Clinical spectrum <strong>of</strong> intragenic CAMTA1<br />
rearrangements: From non-progressive congenital<br />
ataxia to intellectual disability. E. Lopez, J. Thevenon,<br />
B. Keren, D. Heron, C. Mignot, C. Altuzara, M. Béri-<br />
Dexheimer, C. Bonnet, L. Burglen, D. Minot, J. Vigneron,<br />
P. Charles, A. Brice, L. Gallagher, J. Amiel, C. Mach, C.<br />
Depienne, D. Doummar, L. Duplomb, V. Carmignac, P.<br />
Callier, A.-L. Mosca-Boidron, V. Roze, B. Aral, F. Razavi, P.<br />
Jonveaux, L. Faivre, C. Thauvin-Robinet.<br />
2771T Analysis <strong>of</strong> human mitochondrial aminoacyl-tRNA<br />
synthetase complexes in patients with MARS2 mutations.<br />
I. Thiffault, F. Sasarman, T. Nishimura, E. A. Shoubridge.<br />
2772F Mutations in GPSM2 cause the brain<br />
malformations and hearing loss <strong>of</strong> Chudley-<br />
McCullough syndrome. D. Doherty, A. E. Chudley, G.<br />
Coghlan, G. E. Ishak, A. M. Innes, E. G. Lemire, R. C.<br />
Rogers, A. A. Mhanni, I. G. Phelps, S. J. M. Jones, S. H.<br />
Zhan, A. P. Fejes, H. Shahin, M. Kanaan, H. Akay, M. Tekin,<br />
B. Triggs-Raine, T. Zelinski, FORGE Canada Consortium.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
226 POSTER SESSIONS<br />
2773W Thrombospondin genes are required for<br />
development <strong>of</strong> normal cochlear function and<br />
maintenance. M. Mustapha, D. Mendus, V. Sundaresan.<br />
2774T Lack <strong>of</strong> the VPS35 Asp620Asn mutation in<br />
southern Italian patients with familial Parkinson’s<br />
disease. G. Annesi, M. Gagliardi, P. Tarantino, F.<br />
Cavalcanti, T. Mirante, M. Caracciolo, A. Bagal‡, A.<br />
Gambardella, A. Quattrone.<br />
2775F Ubiquilin 2 mutations in Italian patients with<br />
amyotrophic lateral sclerosis and frontotemporal<br />
dementia. C. Gellera, C. Tiloca, R. Del Bo, L. Corrado, V.<br />
Pensato, J. Agostini, C. Cereda, A. Ratti, B. Castellotti,<br />
S. Corti, A. Bagarotti, A. Cagnin, P. Milani, C. Gabelli, G.<br />
Riboldi, L. Mazzini, G. Sorarù, S. D’Alfonso, F. Taroni, G. P.<br />
Comi, N. Ticozzi, V. Silani.<br />
2776W <strong>Genetics</strong> <strong>of</strong> primary microcephaly in Indian<br />
families. A. Kumar, V. Bhat, G. Mohan, S. C. Girimaji.<br />
2777T ZIC1 and ZIC4 deletion at 3q24 is not constantly<br />
associated to Dandy-Walker malformation. S. Loddo, V.<br />
Parisi, L. Bernardini, A. Ferraris, A. Capalbo, L. Travaglini,<br />
G. Zanni, M. L. Di Sabato, S. Tumini, A. Novelli, V. Sabolic,<br />
E. Bertini, B. Dallapiccola, E. M. Valente.<br />
2778F A frameshift mutation in the gene encoding<br />
folliculin-interacting protein 2 associated with<br />
hypomyelination and tremors in the Weimaraner. P.<br />
Patel, T. Pemberton, S. Choi, J. Mayer, F.-Y. Li, N. Safra, D.<br />
Bannasch, K. Sullivan, B. Breuhaus, I. Duncan.<br />
2779W Familial cortical myoclonus with a mutation<br />
in NOL3. J. F. Russell, J. L. Steckley, G. Coppola, A. F.<br />
G. Hahn, M. A. Howard, Z. Kornberg, A. Huang, S. M.<br />
Mirsattari, B. Merriman, E. Klein, M. Choi, H.-Y. Lee, A.<br />
Kirk, C. Nelson-Williams, G. Gibson, S. C. Baraban, R. P.<br />
Lifton, D. H. Geschwind, Y.-H. Fu, L. J. Ptacek.<br />
2780T Mutations in PRRT2 result in familial infantile<br />
convulsions with marked variability in clinical<br />
expression and SUDEP. P. Tarantino, G. Palamara,<br />
A. Labate, M. Gagliardi, L. Mumoli, E. Ferlazzo, F.<br />
Cavalcanti, U. Aguglia, G. Incorpora, A. Gambardella, G.<br />
Annesi.<br />
2781F Molecular analysis <strong>of</strong> NIPA1 gene mutations<br />
in patients with spastic paraplegia. F. Taroni, S.<br />
Caldarazzo, E. Sarto, M. Plumari, V. Martinelli, D.<br />
Pareyson, S. Baratta, D. Di Bella.<br />
2782W Incomplete nonsense-mediated decay<br />
facilitates detection <strong>of</strong> a multi-exonic deletion<br />
mutation in SCGE. J. Xiao, K. Marshall, M. LeDoux.<br />
2783T Is<strong>of</strong>orm-selective MeCP2-e1 deficient mice<br />
recapitulate the neurologic defecits <strong>of</strong> Rett syndrome.<br />
D. H. Yasui, K. W. Dunaway, M. S. Golub, N. C. Schanen,<br />
J. M. LaSalle.<br />
2784F ARHGEF26/SGEF controls arteriosclerosis,<br />
retinal fovea, immunity and neurodevelopment. P.<br />
Bitoun, E. Pipiras, B. Benzacken, A. Delahaye.<br />
2785W Homozygosity mapping and exome sequencing<br />
in a Saudi-Arabian family with unspecified juvenile<br />
neurodegeneration. E. Frackelton, P. M. A. Sleiman, L.<br />
Tien, S. Panossian, K. Xu, B. Tweddale, N. Abdel-Magid,<br />
C. Kim, Y. Housawi, H. Hakonarson.<br />
2786T Neuropathology in POL III related disorders:<br />
Myelin loss in 4H syndrome. A. Vanderver, J. Schmidt,<br />
G. Carosso, D. Tonduti, G. Bernard, J. Lai, C. Rossi, M.<br />
Quezado, K. Wong, R. Schiffman.<br />
2787F Identification <strong>of</strong> homozygous WFS1 mutations<br />
(p.Asp211Asn, p.Gln486*) causing severe Wolfram<br />
syndrome and first report <strong>of</strong> male fertility. A. Haghighi,<br />
A. Haghighi, A. Setoodeh, N. Saleh-Gohari, D. Astuti, T.<br />
G. Barrett.<br />
2788W Whole exome sequencing in children<br />
with unclassified, sporadic, early-onset epileptic<br />
encephalopathies. K. R. Veeramah, L. Johnstone, D.<br />
Wolf, R. Sprissler, T. M. Karafet, D. Talwar, R. P. Erickson,<br />
M. F. Hammer.<br />
2789T Determining the genetic architecture <strong>of</strong> Joubert<br />
syndrome. D. O’Day, B. J. O’Roak, I. G. Phelps, J. C.<br />
Dempsey, I. Glass, H. C. Mefford, J. Shendure, D. Doherty.<br />
2790F <strong>Genetics</strong> <strong>of</strong> Joubert syndrome in the French<br />
Candian population. M. Srour, J. Schwartzentruber, F. F.<br />
Hamdan, L. H. Ospina, L. Patry, D. Labuda, C. Massicotte,<br />
S. Dobrzeniecka, J.-M. Capo-Chichi, S. Papillon-<br />
Cavanagh, M. E. Samuels, K. M. Boycott, M. I. Shevell,<br />
R. Laframboise, V. Désilets, D. Amron, E. Andermann,<br />
G. Sebire, B. Maranda, G. A. Rouleau, J. Majewski, J. L.<br />
Michaud, FORGE Canada Consortium.<br />
2791W Mechanisms underlying non-recurrent<br />
microdeletions causing neur<strong>of</strong>ibromatosis type-1. J.<br />
Vogt, K. Bengesser, K. Claes, K. Wimmer, L. Messiaen, L.<br />
Kluwe, V.-F. Mautner, H. Kehrer-Sawatzki.<br />
2792T The DYRK1A gene is a rare cause <strong>of</strong> Angelmanlike<br />
syndrome with severe microcephaly and epilepsy.<br />
J.-B. Courcet, E. Lopez, J. Thevenon, N. Gigot, L. Jego,<br />
C. Ragon, A. Masurel-Paulet, P. Callier, N. Marle, A.-L.<br />
Mosca-Boidron, F. Huet, C. Philippe, L. Lambert, P.<br />
Malzac, L. Faivre, A. Moncla, C. Thauvin-Robinet.<br />
2793F Exome sequencing reveals cause <strong>of</strong><br />
hypomyelinating leukodystrophy. D. L. Dinwiddie, N. A.<br />
Miller, C. J. Saunders, S. E. Soden, G. M. Hobson, S. F.<br />
Kingsmore.<br />
2794W Intractable epilepsy and tau protein pathology<br />
in a child with a defect in the synaptic vesicle recycling<br />
pathway. D. A. Dyment, A. Smith, P. Humphreys, J.<br />
Woulfe, FORGE Canada Consortium, D. E. Bulman, J.<br />
Schwartzentruber, J. Majewski, J. Michaud, K. M. Boycott.<br />
2795T Novel CDKL5 splicing variant in a boy with earlyonset<br />
seizures. R. Polli, G. Ho, E. Leonardi, E. Bettella, E.<br />
Fontana, B. Dalla Bernardina, J. Christodoulou, A. Murgia.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2796F The molecular role <strong>of</strong> GTF2IRD1, a protein<br />
implicated in the neurodevelopmental features <strong>of</strong><br />
Williams-Beuren syndrome. P. Carmona-Mora, J.<br />
Widagdo, K. M. Taylor, R. Tsz-Wai Pang, P. W. Gunning, E.<br />
C. Hardeman, S. J. Palmer.<br />
2797W Contribution <strong>of</strong> POLR3A and POLR3B recessive<br />
mutations to hypomyelinating leucodystrophy. H.<br />
Daoud, M. Tétreault, K. Choquet, W. Gibson, M. Syn<strong>of</strong>zik,<br />
B. Brais, A. Vanderver, G. Bernard.<br />
2798T Identification <strong>of</strong> disease causing mutations in<br />
the serine/threonine kinase VRK1 gene in two siblings<br />
with primary microcephaly, neuropathy and spinal<br />
muscular atrophy. C. Gonzaga-Jauregui, W. Wiszniewski,<br />
J. Reid, D. Muzny, R. A. Gibbs, J. R. Lupski, Baylor-<br />
Hopkins Center for Mendelian Genomics.<br />
2799F Molecular screening <strong>of</strong> patients with CMT2<br />
disease. G. Bergamin, C. Briani, E. Pegoraro, A.<br />
Martinuzzi, E. Battiston, F. Boaretto, M. L. Mostacciuolo.<br />
2800W Novel autosomal recessive syndrome<br />
characterized by manganese deficiency, cerebellar<br />
atrophy, skeletal dysplasia, and cognitive impairment<br />
caused by mutation in SLC39A8. C. L. Beaulieu, M.<br />
Galvez-Peralta, D. Redl, L. Huang, E. G. Puffenberger,<br />
S. C. Hampson, A. E. Chudley, J. N. Scott, R. A. Hegele,<br />
D. R. McLeod, A. E. MacKenzie, D. E. Bulman, J. S.<br />
Parboosingh, D. W. Nebert, A. .M. Innes, K. M. Boycott,<br />
FORGE Canada Consortium.<br />
2801T GNAL is a new causative gene for primary<br />
dystonia. T. Fuchs, R. Saunders-Pullman, I. Masuho, M. San<br />
Luciano, D. Raymond, S. White, E. Ainehsazan, N. Sharma,<br />
M. E. Ehrlich, K. Martemyanov, S. B. Bressman, L. J. Ozelius.<br />
2802F Analysis <strong>of</strong> Aicardi syndrome genome using<br />
array CGH and exome sequencing. W. Liu, M.<br />
Bainbridge, A. Balasa, X. Wang, D. Murdock, R. Gibbs, I.<br />
B. Van den Veyver.<br />
2803W Molecular analysis for Gaucher, Tay-Sach’s and<br />
Sandh<strong>of</strong>f disease in Indian patients. J. J. Sheth, M. A.<br />
Mistri, C. M. Ankleshwaria, P. Tamhankar, A. Bavdekar, CA.<br />
Datar, M. Kamate, S. Gupta, F. J. Sheth.<br />
2804T Progress and challenges in elucidating the<br />
molecular genetic basis <strong>of</strong> cluster headache. L.<br />
Southgate, S. Scollen, W. He, A. Moss, M. A. Simpson,<br />
B. Zhang, L. Xi, T. Schlitt, M. Weale, C. L. Hyde, J. C.<br />
Stephens, C. Sjöstrand, M. B. Russell, M. Leone, S. L.<br />
John, R. C. Trembath.<br />
2805F Japanese Chin dogs with GM2 gangliosidosis are<br />
homozygous for a HEXA missense mutation and are a<br />
potential large animal model for Tay-Sachs disease. D.<br />
Gilliam, A. C. Freeman, D. N. Sanders, R. Zeng, D. A. Wenger,<br />
G. S. Johnson, M. L. Katz, M. Vandenberg, S. Holmes, M.<br />
Kent, R. Rech, E. Howerth, S. R. Platt, D. P. O’Brien.<br />
2806W Identification <strong>of</strong> novel X-linked intellectual<br />
disability genes by human X chromosome exome<br />
sequencing. T. Wang, T. Niranjan, C. Skinner, M. May, L.<br />
Holloway, C. Schwartz.<br />
POSTER SESSIONS 227<br />
2807T Genetic studies to gain insight into the function<br />
<strong>of</strong> the MeCP2 domains in vivo. L. Heckman, H. Zoghbi.<br />
2808F Combination <strong>of</strong> linkage analysis and exome<br />
sequencing identifies a novel form <strong>of</strong> autosomal<br />
recessive syndromic intellectual deficiency linked to DNA<br />
damage response defect. M. Langouet, A. Saadi, C. Bole-<br />
Feysot, P. Nitschke, A. Munnich, M. Chaouch, L. Colleaux.<br />
2809W Neuronal cells generated through differentiation<br />
<strong>of</strong> stem cells isolated from patient’s skin recapitulate<br />
the main features <strong>of</strong> Niemann Pick C disease. A.<br />
Dardis, N. Bergamin, D. Cesselli, S. Zampieri, B. Bembi, A.<br />
Beltrami, C. A. Beltrami.<br />
2810T Severely impaired respiratory chain causes<br />
multisystem apoptosis-driven developmental defects, a<br />
new mitochondrial phenotype in vertebrates. A. Indrieri,<br />
V. van Rahden, V. Tiranti, I. Conte, J. Quartararo, M. Morleo,<br />
D. Iaconis, R. Tammaro, G. Chesi, M. Cermola, R. Tatè, I.<br />
Maystadt, S. Demuth, A. Zvulunov, I. D’Amato, P. G<strong>of</strong>frini, I.<br />
Ferrero, P. Bovolenta, K. Kutsche, M. Zeviani, B. Franco.<br />
2811F Whole exome sequencing reveals novel and<br />
known genes mutations in a cohort <strong>of</strong> centronuclear<br />
myopathy patients. P. Agrawal, O. Ceyhan, K. Schmitz, E.<br />
Dechene, M. Viola, K. Markianos, A. Beggs.<br />
2812W Mutations in the human isoprenoid synthase<br />
domain containing gene are a common cause <strong>of</strong><br />
congenital and limb girdle muscular dystrophies. S.<br />
Cirak, A. R. Foley, R. Herrmann, T. Willer, M. Yau, S. Torelli,<br />
P. Vondracek, R. Helen, C. Longman, R. Korinthenberg, G.<br />
Marruso, P. Nürnberg, UK10K Consortium, V. Plagnol, M.<br />
Hurles, C. Sewry, K. P. Campbell, T. Voit, F. Muntoni.<br />
2813T Prevalence <strong>of</strong> MECP2 mutations among girls<br />
presenting significant clinical overlap between Rett<br />
and Angelman syndromes. T. M. R. de Assis, G. A.<br />
Molfetta, C. A. Ferreira, C. H. P. Grangeiro, W. A. Silva, Jr.<br />
2814F Identification <strong>of</strong> six novel NF1 mutations in<br />
neur<strong>of</strong>ibromatosis type 1 patients from the Azorean<br />
island <strong>of</strong> São Miguel (Portugal). L. Mota-Vieira, B. Campos,<br />
R. Cabral, A. L. Rodrigues, A. Raposo, A. Carvalho.<br />
2815W A pan-European study <strong>of</strong> the pathological<br />
C9orf72 hexanucleotide (G4C2) expansion<br />
associated with frontotemporal lobar degeneration<br />
and amyotrophic lateral sclerosis. J. van der Zee, I.<br />
Gijselinck, L. Dillen, T. Van Langenhove, M. Cruts, C.<br />
Van Broeckhoven, Belgian Neurology Consortium and<br />
European Early-Onset Dementia Consortium.<br />
2816T Identification <strong>of</strong> novel ALS genes using linkage<br />
analysis and next-gen sequencing. K. L. Williams, J.<br />
A. Solski, J. C. Durnall, A. D. Thoeng, S. Warraich, G.<br />
Rouleau, G. A. Nicholson, I. P. Blair.<br />
2817F The distributions <strong>of</strong> two SOD1 missense<br />
mutations in the pet dog population and their<br />
association with canine degenerative myelopathy, a<br />
model for amyotrophic lateral sclerosis. R. Zeng, J. R.<br />
Coates, L. Hansen, G. C. Johnson, F. A. Wininger, M. L.<br />
Katz, G. S. Johnson.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
228 POSTER SESSIONS<br />
2818W Explore the impact <strong>of</strong> parkin mutations in ERassociated<br />
protein degradation: Cellular models for<br />
juvenile PD. M. Alves-Ferreira, S. Morais, J. Sequeiros, I.<br />
Alonso.<br />
2819T A nonsense mutation in DHTKD1 causes<br />
Charcot-Marie-Tooth disease type 2 in a large Chinese<br />
pedigree. M. Gu, W. Xu, L. Sun, W. Guo, J. Ma, S. Chen,<br />
W. Huang, Z. Wang.<br />
2820F Identification <strong>of</strong> the SPG46 gene by nextgeneration<br />
sequencing in four families with autosomal<br />
recessive complicated spastic paraplegia. G. Stevanin,<br />
R. Schüle, K. Smets, E. Martin, S. Zuchner, L. J. Loureiro,<br />
A. Boukhris, A. Rastetter, T. de Coninck, M. Gonzalez, E.<br />
Mundwiller, F. Lamari, G. Gyapay, P. Coutinho, C. Mhiri, P.<br />
de Jongue, E. Kabashi, A. Brice.<br />
2821W A balanced (1q32;14q31) translocation<br />
associated with epilepsy, learning disability and<br />
leukemia has breakpoints in developmental genes as<br />
detected by whole-genome sequencing. M. I. Rees, S.<br />
Ali, R. H. Thomas, J. G. Mullins, M. Kerr, S. K. Chung.<br />
2822T A DYNC1H1 mutation causes a quadricepsdominant<br />
neurogenic muscular atrophy. S. Saitoh, Y.<br />
Tsurusaki, K. Tomizawa, A. Sudo, N. Asahina, H. Shiraishi, J.<br />
Ito, H. Tanaka, H. Doi, H. Saitsu, N. Miyake, N. Matsumoto.<br />
2823F Late-onset Charcot-Marie-Tooth disease 4F<br />
caused by periaxin gene mutation. S. Tokunaga, A.<br />
Hashiguchi, A. Yoshimura, K. Maeda, T. Suzuki, H. Haruki,<br />
T. Nakamura, H. Takashima.<br />
2824W Detection <strong>of</strong> slipped-DNAs at the trinucleotide<br />
repeats <strong>of</strong> the myotonic dystrophy type I disease locus<br />
in patient tissues. M. M. Axford, Y.-H. Wang, M. Nakamori,<br />
M. Zannis-Hadjopoulos, C. Thornton, C. E. Pearson.<br />
2825T A lyonization study in heterozygous females<br />
for X-linked adrenoleukodystrophy. F. S. Pereira, C.<br />
Habekost, U. Matte, L. B. Jardim.<br />
2826F Mutations in CUL4B, a member <strong>of</strong> the Cullin-<br />
RING ubiquitin ligase complex, cause syndromic<br />
X-linked intellectual disability associated with short<br />
stature. A. K. Srivastava, M. Cook, K. Corrier, L. Lee, S. S.<br />
Cathey, F. Bartel, K. R. Holden, C. Skinner, A. D. Chaubey,<br />
B. R. DuPont, N. VerBerkmoes, R. J. Schroer.<br />
2827W Identification <strong>of</strong> novel exon splice enhancers<br />
in the growth hormone gene (GH1) mutated in isolated<br />
GH deficiency. D. Babu, I. Fusco, S. Mellone, M. Godi, A.<br />
Petri, F. Prodam, S. Bellone, P. Momigliano-Richiardi, G.<br />
Bona, M. Giordano.<br />
2828T Functional analysis <strong>of</strong> R75Q dominant mutation<br />
and in cis recessive mutation V37I <strong>of</strong> GJB2 gene<br />
causing hearing loss in a Korean family. J. Kim, J. Jung,<br />
Y. Kim, J. Choi, K. Lee.<br />
2829F Progressive hearing impairment with<br />
homozygous deletion in GJB2 gene (Connexin-26) and<br />
normal newborn hearing screening. N. Lublingh<strong>of</strong>f, E.<br />
Löhle, R. Birkenhäger.<br />
2830W Bestrophin mutation within Ca 2� binding domain<br />
alters Cl � conductance. S. Brar, B. Pattnaik, P. Halbach,<br />
S. Tokarz, D. Pillers.<br />
2831T Functional characterization <strong>of</strong> SLC2A9 allelic<br />
variants in Czech population. B. Stiburkova, O. Hurba, V.<br />
Krylov, A. Mencikova.<br />
2832F Identification <strong>of</strong> a missense mutation outside<br />
the forkhead domain <strong>of</strong> FOXL2 causing a severe form<br />
<strong>of</strong> BPES type II. H. Haghighi-Kakhki, A. Haghighi, H.<br />
Verdin, N. Piri, N. Saleh-Gohari, E. De Baere.<br />
2833W The UBIAD1 prenyltransferase links<br />
menaquione-4 synthesis to cholesterol metabolic<br />
enzymes. M. Nickerson, A. Bosley, J. Weiss, B. Kostiha,<br />
W. Brandt, T. Andresson, T. Okano, M. Dean.<br />
2834T Intergenic or 5’UTR deletion <strong>of</strong> transcription factor<br />
4 (TCF4) gene in Pitt-Hopkins syndrome. J. Lee, S.-U.<br />
Moon, E. Shin, S. Hassed, J. Chanloner, X. Wang, S. Li.<br />
2835F No evidence <strong>of</strong> genetic difference for clinical<br />
severity between monozygotic twins with Rett<br />
syndrome. T. Kubota, K. Miyake, T. Hirasawa, Y.<br />
Minakuchi, A. Toyoada.<br />
2836W Two-nucleotide deletion <strong>of</strong> the ATP7A gene,<br />
leading not to premature termination, but to translation<br />
reinitiation, produces mild phenotype in a male<br />
Menkes disease patient. T. Wada, T. Murakami, H.<br />
Shimbo, H. Osaka, H. Kodama.<br />
2837T Retinoic acid induced 1, RAI1: Molecular and<br />
functional studies to understand its relationship to<br />
neurobehavioral alterations. K. Walz, I. C. Perez, P.<br />
Carmona-Mora, C. Abad, C. P. Canales, L. Cao, A. K.<br />
Srivastava, J. I. Young.<br />
2838F RAB11FIP1 interacts with the BLOC-1 complex<br />
to retrieve melanogenic proteins from the recycling<br />
pathway and a dominant negative mutation in<br />
RAB11FIP1 causes Hermanksy-Pudlak syndrome type<br />
10. A. R. Cullinane, J. Pan, M. A. Merideth, J. A. Curry, J.<br />
G. White, M. Huizing, W. A. Gahl.<br />
2839W Two novel RRM2B gene mutations in a patient<br />
with autosomal recessive progressive external<br />
ophthalmoplegia, encephalopathy and cytochrome c<br />
oxidase deficiency. N. S. Hauser, R. Bai.<br />
2840T Isogenic D4Z4 contracted and non-contracted<br />
immortal muscle cell clones as a model for FSHD. S.<br />
van der Maarel, Y. Krom, J. Dumonceaux, K. Mamchoui,<br />
B. den Hamer, V. Mariot, E. Negroni, L. Geng, R. Tawil, S.<br />
Tapscott, B. van Engelen, V. Mouly, G. Butler-Browne.<br />
2841F MEFV second exon variation analysis in familial<br />
Mediterranean fever. A. K. Kirectepe, G. Celikyapi Erdem,<br />
O. Kasapcopur, E. Tahir Turanli.<br />
2842W Role <strong>of</strong> NLRP7 in recurrent hydatidiform moles<br />
and reproductive wastage. R. Slim, C. Messaed, E.<br />
Akoury, W. Chebaro, W. Buckett, J. Arseneau, P. Sauthier.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2843T A novel GUCY2D mutation, V933A, causes<br />
central areolar choroidal dystrophy. A. E. Hughes, W.<br />
Meng, A. J. Lotery, D. T. Bradley.<br />
2844F Novel splice site mutations in NPHS1 gene in<br />
Indian congenital nephrotic syndrome patients. S.<br />
Sharma, A. Bagga, M. Kabra.<br />
2845W Genetic basis <strong>of</strong> prune belly syndrome:<br />
Screening the candidate genes. L. Baker, S. Harrison, C.<br />
Granberg, C. Villanueva.<br />
2846T DNA copy-number variations in persistent<br />
cloaca patients. S. Harrison, L. Baker.<br />
2847F Whole genome sequencing reveals a deletion<br />
<strong>of</strong> the last exon <strong>of</strong> FAN1 in Basenji dogs with adultonset<br />
Fanconi syndrome. G. S. Johnson, F. H. Farias,<br />
T. Mhlanga-Mutangadura, J. F. Taylor, D. P. O’Brien, R. D.<br />
Schnabel.<br />
2848W Formation <strong>of</strong> a novel N-glycosylation motif in<br />
integrin �3 due to a rare ITGA3 gene polymorphism<br />
causes congenital nephrotic syndrome and interstitial<br />
lung disease. K. Y. Renkema, N. Nicolaou, C. Margadant,<br />
S. H. Kevelam, M. R. Lilien, M. J. S. Oosterveld, M. Kreft,<br />
A. M. van Eerde, R. Pfundt, P. A. Terhal, B. van der Zwaag,<br />
N. Sachs, R. Goldschmeding, N. V. A. M. Knoers, A.<br />
Sonnenberg.<br />
2849T Defining the phenotypic specificity <strong>of</strong> Schimke<br />
immuno-osseous dysplasia. M. Morimoto, C. Myung,<br />
K. Beirnes, D. Leung, H. K. Fam, K. Choi, Y. Huang, C. F.<br />
Boerkoel.<br />
2850F High-throughput mutation analysis in patients<br />
with a nephronophthisis-associated ciliopathy applying<br />
multiplexed barcoded array-based PCR amplification<br />
and next-generation sequencing. E. A. Otto, J. Halbritter,<br />
K. Diaz, B. Tarrier, M. Chaki, C. Fu, J. L. Innis, S. J. Allen,<br />
R. H. Lyons, C. J. Stefanidis, H. Omran, N. A. Soliman.<br />
2851W Founder mutation in RPSPH4A identified in<br />
patients <strong>of</strong> Hispanic descent with primary ciliary<br />
dyskinesia. M. A. Zariwala, M. W. Leigh, S. D. Davis, M.<br />
C. Armstrong, M. L. Daniels, J. L. Carson, M. Hazucha, S.<br />
S. Dell, M. R. Knowles, Genetic Disorders <strong>of</strong> Mucociliary<br />
Clearance Consortium.<br />
2852T Leri’s pleonosteosis results from defective<br />
SMAD signaling. S. Banka, S. Cain, J. Urquhart, S. Carim,<br />
S. Daly, G. Erdem, M. Bottomley, D. Donnai, B. Kerr, H.<br />
Kingston, C. Kielty, W. G. Newman.<br />
2853F Abnormal type I collagen folding and matrix<br />
deposition in a cyclophilin B KO mouse model <strong>of</strong><br />
recessive osteogenesis imperfecta. W. A. Cabral, E.<br />
Makareeva, M. Weis, S. Leikin, D. R. Eyre, J. C. Marini.<br />
2854W Differential contributions <strong>of</strong> P3H1 to collagen<br />
processing in the pathogenesis <strong>of</strong> osteogenesis<br />
imperfecta. E. P. Homan, C. Lietman, I. Grafe, J.<br />
Lennington, R. Morello, W. R. Hogue, D. Napierala, M.<br />
M. Jiang, B. Dawson, T. K. Bertin, Y. Chen, R. Lua, O.<br />
Lichtarge, J. Hicks, M. A. Weis, D. R. Eyre, B. Lee.<br />
POSTER SESSIONS 229<br />
2855T Characterization <strong>of</strong> transient receptor potential<br />
vanilloid channel 4 in metatropic dysplasia primary cell<br />
lines. L. M. Hurd, S. M. Kirwin, K. M. Vinette, M. B. Bober,<br />
W. G. Mackenzie, R. L. Duncan, V. L. Funanage.<br />
2856F Exome sequencing identifies a de novo<br />
missense mutation in TGF-b1 in a sporadic patient<br />
with craniotubular bone dysplasia. D. Li, A. Haghighi,<br />
F. Salehzade, L. Tian, H. Haghighi-Kakhki, C. Kim, E.<br />
Frackelton, F. Otieno, H.-D. Nah, H. Hakonarson.<br />
2857W An intracellular role for FGFR2 in bent<br />
bone dysplasia syndrome. C. L. Neben, B. Idoni, A.<br />
Sarukhanov, D. Krakow, A. E. Merrill.<br />
2858T ZDHHC13 is a key regulator in postnatal<br />
epiphyseal development. I. W. Song, W. R. Li, J. Y. Wu,<br />
M. T. Lee, Y. T. Chen.<br />
2859F Identification <strong>of</strong> novel genes downstream <strong>of</strong><br />
FGFR2 contributing to coronal suture synostosis in<br />
a murine model for Crouzon syndrome. S. Kumar, E.<br />
Peskett, J. A. Britto, E. Pauws.<br />
2860W Identification <strong>of</strong> copy number variants in<br />
413 isolated talipes equinovarus patients: role <strong>of</strong><br />
transcriptional regulators <strong>of</strong> limb development. D. M.<br />
Alvarado, J. G. Buchan, S. L. Frick, J. E. Herzenberg, M.<br />
B. Dobbs, C. A. Gurnett.<br />
2861T Mutation <strong>of</strong> B3GAT3 causes skeletal dysplasia<br />
in a consanguineous clan from Nias. B. S. Budde, S.<br />
Mizumoto, R. Kogawa, C. Becker, J. Altmüller, H. Thiele,<br />
P. Frommolt, M. R. Toliat, J. M. Hämmerle, W. Höhne, K.<br />
Sugahar, P. Nürnberg, I. Kennerknecht.<br />
2862F Mutation analysis <strong>of</strong> the BIN1 gene performed<br />
to evaluate the cause <strong>of</strong> centronuclear myopathy in<br />
two fetuses <strong>of</strong> consanguineous parents from Sudan. N.<br />
Dohrn, A. Petersen, P. Skovbo, I. S. Pedersen, A. Ernst, H.<br />
Krarup, M. B. Petersen.<br />
2863W Novel ROR2 mutations in patients with autosomal<br />
recessive Robinow syndrome. J. Mazzeu, H. Kayserilli,<br />
C. A. Kim, D. Brunoni, P. C. Pieri, A. Richieri-Costa, H. van<br />
Bokhoven, H. G. Brunner, A. M. Vianna-Morgante.<br />
2864T Whole exome sequencing identifies mutations<br />
in the nucleoside transporter gene SLC29A3 in<br />
dysosteosclerosis, a form <strong>of</strong> osteopetrosis. P. Campeau,<br />
J. T. Lu, G. Sule, M.-M. Jiang, Y. Bae, S. Madan, W. Högler,<br />
N. J. Shaw, S. Mumm, R. A. Gibbs, M. P. Whyte, B. H. Lee.<br />
2865F Polymorphisms in osteoporosis and their<br />
associations with bone metabolism. R. Richterová, P.<br />
Cibulková, A. Bóday, D. Stejskal, P. Novosad, P. Fojtík, P.<br />
Hrdý.<br />
2866W Combination <strong>of</strong> whole-genone cytogenetics<br />
array, high-throughput SNP genotyping, homozygosity<br />
mapping and Sanger sequencing identify FXN gene<br />
expansion leading to axonal peripheral neuropathy and<br />
ataxia phenotype in two consanguineous families from<br />
North West Africa. H. Azzedine, B. Hubert, W. Amer, F.<br />
Ferrat, M. Chaouch, F. Lagace, R. Fetni, C. Paisan-Ruiz.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
230 POSTER SESSIONS<br />
2867T Exome sequencing in small families segregating<br />
autosomal dominant non-syndromic hearing loss. H.<br />
Azaiez, E. Shearer, K. Booth, M. Hildebrand, N. Meyer, R.<br />
J. H. Smith.<br />
2868F Application <strong>of</strong> massive parallel sequencing for<br />
mutation discovery and genetic diagnosis <strong>of</strong> hereditary<br />
hearing loss in Chinese DFNA families. H. Yuan, J.<br />
Cheng, Y. Lu, X. Zhou, X. Zhang, R. Choy.<br />
2869W A new gene for autosomal recessive<br />
congenital ichthyosis identified by exome sequencing<br />
demonstrates impact <strong>of</strong> ceramide synthesis and acyl<br />
chain length for keratinocyte terminal differentiation. K.<br />
Eckl, R. Tidhar, M. L. Preil, H. Thiele, I. Hausser, V. Oji, A.<br />
Önal-Akan, S. Brodesser, F. Stock, R. Casper, J. Altmüller,<br />
P. Nürnberg, H. Traupe, A. H. Futerman, H. C. Hennies.<br />
2870T The NIH Undiagnosed Diseases <strong>Program</strong>:<br />
Defining pathogenicity for personalized medicine. C.<br />
F. Boerkoel III, M. C. Malicdan, D. Adams, C. Toro, C. Tifft,<br />
W. A. Gahl, T. Markello.<br />
2871F Efficient search for allelically heterogeneous<br />
disease genes in whole genome or exome datasets. K.<br />
D’Aco, M. A. Aquino, N. M. Pearson.<br />
2872W From large-scale clinical recruitment to<br />
identification <strong>of</strong> a novel mutation in ADAMTSL2 in a<br />
family with Ehler-Danlos syndrome. A. S. Desai, D.<br />
Hadley, L. Tian, C. Kim, E. Frackelton, R. Chiavacci, F. G.<br />
Otieno, F. Mentch, H. Hakonarson, K. Wang, S. Pannosian.<br />
2873T Exome sequencing for the knowledgedriven<br />
and unbiased disease-mutation search <strong>of</strong><br />
mitochondrial respiratory chain disorder. M. Kohda, Y.<br />
Tokuzawa, Y. Moriyama, H. Kato, N. Uehara, Y. Nakachi,<br />
N. Matoba, S. Tamaru, Y. Kishita, T. Yamazaki, M. Mori, K.<br />
Murayama, Y. Mizuno, A. Ohtake, Y. Okazaki.<br />
2874F Exome sequencing for disease gene discovery<br />
in Jeune’s asphyxiating thoracic dystrophy. P. Taylor, S.<br />
Wu, S. F. Nelson, D. H. Cohn, D. Krakow.<br />
2875W Seeking causative genes for human congenital<br />
general anosmia in multiply-affected Israeli families.<br />
A. Alkelai, T. Olender, D. Oz-Levi, I. Keydar, R. Milgrom, E.<br />
Feldmesser, E. Ben-Asher, E. K. Ruzzo, D. B. Goldstein, E.<br />
Pras, D. Lancet.<br />
2876T Studying a locus for bilateral congenital<br />
perisylvian polymicrogyria: Linkage analysis,<br />
cytoscan HD array and target enrichment/sequencing<br />
approaches. F. R. Torres, S. S. Tsuneda, E. H. Yamamoto,<br />
R. Secolin, M. G. Borges, W. T. S. T. Ide, C. S. Rocha, F. M.<br />
Artiguenave, F. Cendes, M. Guerreiro, I. Lopes-Cendes.<br />
2877F Targeted exome sequencing for molecular<br />
diagnostics <strong>of</strong> heterogeneous genetic disorders:<br />
Primary ciliary dyskinesia. J.-L. Blouin, J. Bevillard,<br />
M. Guipponi, C. Gehrig, A. Vannier, F. Santoni, S. E.<br />
Antonarakis, F. Fellmann, S. Fokstuen, R. Lazor.<br />
2878W Mutations affecting components <strong>of</strong> the<br />
SWI/SNF complex cause C<strong>of</strong>fin-Siris syndrome. N.<br />
Matsumoto, Y. Tsurusaki, N. Miyake.<br />
2879T Identifying mutations causing atypical progeria<br />
by exome sequencing and CNV analysis. K. M.<br />
McSweeney, L. B. Gordon, J. Xu, W. Ping, M. F. Arlt, J. Li,<br />
T. Glover.<br />
2880F Diagnostic sequencing applications using the Ion<br />
Torrent. D. Muzny, X. Wang, C. Buhay, M. Wang, H. Dinh, J.<br />
Reid, D. Wheeler, L. Lotta, E. Boerwinkle, R. Gibbs.<br />
2881W Next-generation sequencing reveals an allelic<br />
variant <strong>of</strong> GLI2 in a Turkish pedigree with a unique<br />
clinical phenotype. D. Pehlivan, A. Yesilyurt, C. G.<br />
Gonzaga-Jauregui, E. Karaca, Y. Pehlivan, S. Guran, R. A.<br />
Gibbs, J. R. Lupski.<br />
2882T Rapid and efficient mutation detection in<br />
the hundreds <strong>of</strong> target genes by bench-top next<br />
generation sequencer with custom target capture<br />
method. A. Shimizu, C. Torii, N. Suzuki, H. Mutai, J.<br />
Kudoh, R. Kosaki, T. Matsunaga, K. Kosaki.<br />
2883F Identification <strong>of</strong> candidate genes associated<br />
with autosomal dominant pulmonary fibrosis by wholeexome<br />
sequencing. W. Wiszniewski, C. G. Gonzaga-<br />
Jauregui, T. J. Vece, D. M. Muzny, M. N. Bainbridge, J. G.<br />
Reid, R. A. Gibbs, J. R. Lupski, Baylor-Hopkins Center for<br />
Mendelian Genomics.<br />
2884W Family matters: Exome sequencing can identify<br />
causal variants in isolated probands through familybased<br />
studies. H. Yu, C. R. Coughlin, E. A. Geiger, M.<br />
Friederich, L. Medne, J. E. Ming, E. H. Zackai, J. L. Van<br />
Hove, X. Gai, G. H. Scharer, T. H. Shaikh.<br />
2885T Whole exomic triangulation and systems biology<br />
identify novel pathogenic substrates for autosomal<br />
dominant long QT syndrome. N. J. Boczek, D. J. Tester,<br />
J. R. Giudicessi, T. J. Kamp, M. J. Ackerman.<br />
2886F X-exome sequencing identifies the<br />
causal variant in a large pedigree with X-linked<br />
intellectual disability, truncal obesity, gynecomastia,<br />
hypogonadism and unusual face. J. K. P. van Amstel, M.<br />
Harakalova, M. J. van den Boogaard, R. J. Sinke, S. van<br />
Lieshout, M. van Tuil, K. Duran, I. Renkens, P. A. Terhal,<br />
C. G. F. de Kovel, I. J. Nijman, M. M. van Haelst, N. V. A.<br />
M. Knoers, G. van Haaften, W. P. Kloosterman, R. C. M.<br />
Hennekam, E. Cuppen.<br />
2887W Completing the BBS jigsaw by exome<br />
sequencing and phenotype-genotype correlations:<br />
LZTFL1, a BBSome-related gene associated with<br />
developmental features is BBS17. H. Dollfus, F. Stutzman,<br />
M. Gerard, A. Verioes, E. Schaefer, C. Stoetzel, V. Marion.<br />
2888T Simultaneous identification <strong>of</strong> single nucleotide<br />
mutations and DNA copy number aberrations in<br />
neurodevelopmental disorders by exome sequencing.<br />
A.-M. Sulonen, H. Almusa, H. Edgren, P. Ellonen, L.<br />
Forsstrom, T. Linnankivi, S. Knuutila, J. Saarela.<br />
2889F USP9X mutation in a child with developmental<br />
delay and multiple congenital anomalies. M. S. Brett, A.<br />
H. M. Lai, E. C. P. Lim, J. R. McPherson, B. W. M. Cham,<br />
Z. J. Zang, P. Tan, S. Rozen, E. C. Tan.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2890W Congenital cataracts, hypomyelination,<br />
progressive microcephaly, digital anomalies: A new<br />
recessive syndrome due to mutations in a nucleoporin<br />
gene? E. Geraghty, G. Carvill, I. Glass, R. Kapur, D.<br />
Doherty, H. Mefford.<br />
2891T Trio-exome sequencing identifies mutations<br />
<strong>of</strong> the gene encoding the histone acetyltransferase<br />
KAT6B/MYST4 in individuals with the Young-Simpson<br />
syndrome. K. Kurosawa, K. Enomoto, T. Kondoh,<br />
S. Mizuno, M. Adachi, K. Muroya, Y. Yamanouchi, T.<br />
Nishikawa, N. Furuya, M. Tominaga, T. Naruto, K. Ida, Y.<br />
Kuroda, T. Sengstag, R. Manabe, M. Masuno.<br />
2892F Exome sequencing identifies a missense<br />
mutation <strong>of</strong> ANKRD26 in autosomal dominant<br />
thrombocytopenia. C. Kim, P. M. A. Sleiman, L. Tien,<br />
S. Panossian, K. Xu, B. Tweddale, N. Abdel-Magid, E.<br />
Frackelton, Y. Housawi, H. Hakonarson.<br />
2893W Holoprosencephaly: Identification <strong>of</strong> new<br />
candidate genes by high throughput sequencing <strong>of</strong><br />
family trios. V. David, C. Dubourg, M. de Tayrac, V. Dupé,<br />
M. Aubry, L. Ratié, S. Mercier, J. Mosser, S. Odent.<br />
2894T Exome sequencing reveals a novel de novo<br />
GNAS gene mutation in a boy with usual presentation<br />
<strong>of</strong> pseudohypoparathroidism. M. J. Dasouki, S. E.<br />
Soden, E. G. Farrow, C. J. Saunders, D. L. Dinwiddie, N. A.<br />
Miller, S. F. Kingsmore.<br />
2895F Clinical diagnostic exome identifies novel<br />
mutations in the C20orf7 gene, a mitochondrial<br />
complex I assembly factor, in a Taiwanese infant with<br />
Leigh’s disease. J. J. Wei, K. D. Gonzalez, X. Li, H. M. Lu,<br />
H. Lu, R. Chang, R. Wang, J. Abdenur, W. Zeng.<br />
2896W De novo mutations in MLL cause Wiedemann-<br />
Steiner syndrome. W. D. Jones, D. Dafou, M. McEntagart,<br />
W. J. Woollard, F. V. Elmslie, M. Holder-Espinasse, M.<br />
Irving, M. Lees, A. K. Saggar, S. Smithson, R. C. Trembath,<br />
C. Deshpande, M. A. Simpson.<br />
2897T Targeted resequencing <strong>of</strong> known and candidate<br />
epilepsy genes in 500 patients with epileptic<br />
encephalopathies. G. Carvill, B. J. O’Roak, S. C. Yendle,<br />
J. Cook, N. Krumm, S. F. Berkovic, J. Shendure, I. E.<br />
Scheffer, H. C. Mefford.<br />
2898F Deciphering the genetic basis <strong>of</strong> progressive<br />
myoclonus epilepsies by exome sequencing. M.<br />
Muona, S. F. Berkovic, L. Dibbens, K. L. Oliver, T. Joensuu,<br />
E. Hämäläinen, A. Palotie, A.-E. Lehesjoki.<br />
2899W Mutations in a zinc finger protein cause a novel<br />
autosomal recessive mental retardation syndrome<br />
identified through homozygosity mapping and whole<br />
exome sequencing <strong>of</strong> a single affected individual.<br />
M. Kambouris, T. Ben-Omran, Y. Al-Sarraj, R. Ali, M.<br />
Almureikhi, K. Erraffi, H. El-Shanti.<br />
2900T Exome sequencing <strong>of</strong> seven cases affected<br />
by a congenital muscular dystrophy with hyperlaxity<br />
belonging to five French-Canadian families. M.<br />
Tétreault, G. D’Anjou, J. Mathieu, M. Vanasse, B. Brais.<br />
POSTER SESSIONS 231<br />
2901F Diagnosis <strong>of</strong> syndromic autism using a 62-gene<br />
next-generation sequencing panel: Experience from<br />
a clinical diagnostic laboratory. J. R. Jones, M. J.<br />
Basehore, S. McGee, K. J. Champion, M. J. Friez.<br />
2902W Empowering a clinical genetic setting through<br />
the introduction <strong>of</strong> whole exome sequencing in<br />
prenatal and postnatal investigations. C. Pangalos, B.<br />
Hagnefelt, Z. Agioutantis, C. Konialis.<br />
2903T Use <strong>of</strong> whole exome sequencing to determine<br />
the genetic etiology <strong>of</strong> inherited congenital cataracts.<br />
L. M. Reis, R. C. Tyler, E. V. Semina.<br />
2904F A next-generation sequencing assay for the<br />
diagnosis <strong>of</strong> the Noonan spectrum <strong>of</strong> disorders. A. B.<br />
Santani, T. Tischler, A. Sasson, J. Perin, M. Sarmady, E.<br />
Frackelton, B. Tweddale, N. Abdel-Magid, S. Panossian,<br />
P. Warren, H. Feret, M. Deardorff, A. Wilkens, M. Italia,<br />
B. Ruth, J. Miller, E. Zackai, D. Monos, E. Rappaport, H.<br />
Hakonarson, P. White, C. Stolle.<br />
2905W French Canadian founder mutation in the SBDS<br />
gene causing Shwachman-Diamond Syndrome. L.<br />
Steele, M. Eliou, J. M. Rommens, P. N. Ray, T. L. Stockley.<br />
2906T Confirmation <strong>of</strong> cause and manner <strong>of</strong> death<br />
via a comprehensive cardiac autopsy including whole<br />
exome next-generation sequencing. D. J. Tester, J. J.<br />
Maleszewski, T. M. Kruisselbrink, M. J. Ackerman.<br />
2907F Diagnostic exome sequencing uncovers<br />
Mendelian inheritance in neurological disease. E. C.<br />
Chao, X. Li, K. Gonzalez, A. Fatemi, J. Cohen, W. Zeng.<br />
2908W Whole exome sequencing identifies potential<br />
homozygous mutations in a family with two sisters<br />
with brain malformation. E. Karaca, D. Pehlivan, C. G.<br />
Gonzaga-Jauregui, M. Ozen, A. Yuksel, W. Wiszniewski,<br />
A. Stray-Pedersen, D. Munzy, R. A. Gibbs, J. R. Lupski,<br />
Baylor-Hopkins Center for Mendelian <strong>Genetics</strong>.<br />
2909T Recessive mutations in MYL2 cause infantile<br />
fiber type disproportion and cardiomyopathy. M. A.<br />
J. Weterman, P. B. Barth, K. Y. van Spaendonck-Zwarts,<br />
E. Aronica, B. T. Poll-The, O. Brouwer, J. P. van Tintelen,<br />
Z. Qahar, E. J. Bradley, M. B. de Wissel, L. Salviati, C.<br />
Angelini, L. van den Heuvel, Y. E. M. Thomasse, A. P.<br />
Backx, G. Nuernberg, P. Nuernberg, F. Baas.<br />
2910F Molecular diagnosis in Stargardt’s disease<br />
through a tiered sequencing approach. J. Zaneveld,<br />
H. Wang, F. Wang, L. Mao, K. Zhang, Y. Duan, J. Zhu, J.<br />
Chiang, R. Chen.<br />
2911W Identification <strong>of</strong> mutations in the prostaglandin<br />
transporter gene SLCO2A1 in Japanese patients with<br />
pachydermoperiostosis. J. Kudoh, T. Sasaki, A. Shimizu,<br />
A. Shiohama, A. Hirakiyama, T. Okuyama, A. Seki, K.<br />
Kabashima, A. Otsuka, A. Ishiko, K. Tanese, S. Miyakawa,<br />
J. Sakabe, M. Kuwahara, M. Amagai, H. Okano, M.<br />
Suematsu, H. Niizeki.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
232 POSTER SESSIONS<br />
2912T CIAS1 mutations associate with familial<br />
Mediterranean fever in Turkish patients and a novel<br />
V734G mutation in MEFV. E. Yosunkaya, N. Buyru.<br />
2913F Exome sequencing <strong>of</strong> a dog trio affected with a<br />
canine progressive retinal degeneration. S. J. Ahonen,<br />
H. Lohi.<br />
2914W Mutations in NESP4, a KASH domain protein<br />
linking the nucleus to the cytoskeleton, lead to hearing<br />
impairment in humans and mice. K. B. Avraham, Z.<br />
Brownstein, H. F. Horn, D. R. Lenz, S. Shivatzki, A. Dror, K.<br />
J. Roux, S. Kozlov, B. Burke, C. L. Stewart.<br />
2915T Genetic characterization <strong>of</strong> a large keratinization<br />
disorder cohort, utilizing whole exome sequencing to<br />
discover mutations in known and novel genes. L. M.<br />
Boyden, C. Tian, C. Saraceni, E. Loring, L. Milstone, R. P.<br />
Lifton, H. Vernon, D. Zand, A. S. Paller, K. A. Choate.<br />
2916F X-linked familial focal segmental<br />
glomerulosclerosis with first-degree heart block<br />
caused by a mutation in the NXF5 gene. T. Esposito, R.<br />
A. Lea, B. H. Maher, D. Moses, H. C. Cox, S. Magliocca,<br />
V. D’Alessio, A. Angius, T. Titus, T. Kay, A. Parnham, F.<br />
Gianfrancesco, L. R. Griffiths.<br />
2917W Mutations in SLC52A2 impair rib<strong>of</strong>lavin<br />
transport and cause Brown-Vialetto-Van Laere<br />
syndrome. T. B. Haack, C. Makowski, Y. Yao, E. Graf,<br />
M. Hempel, T. Wieland, U. Tauer, U. Athing, J. A. Mayr, P.<br />
Freisinger, H. Yoshimatsu, K. Inui, T. M. Strom, T. Meitinger,<br />
A. Yonezawa, H. Prokisch.<br />
2918T Identification <strong>of</strong> a causative variant underlying<br />
nonsyndromic autosomal-dominant intellectual<br />
disability in an extended family. N. Jinawath, B. Pupacdi,<br />
E. Wohler, V. Charoensawan, D. Wattanasirichaigoon.<br />
2919F Targeted exome capture and paired-end<br />
massively parallel sequencing reveals new mutations<br />
for human hereditary deafness in the Middle East.<br />
M. Kanaan, Z. Brownstein, A. Abu Rayyan, D. Karfunkel,<br />
D. Dweik, Y. Bhonker, A. Yeheskel, L. Friedman, N. Kol,<br />
O. Yaron, V. Oron-Karni, M. Frydman, N. Shomron, K. B.<br />
Avraham.<br />
2920W Defective ion transport in sweat glands cause<br />
generalized isolated anhidrosis. J. Klar, M. Sobol, K.<br />
Mäbert, M. Tariq, M. Rasool, M. Jameel, T. Naeem, N. A.<br />
Malik, A. Johansson, L. Feuk, S. M. Baig, N. Dahl.<br />
2921T Exome sequencing identifies a novel mutation<br />
in GJA1 as the cause <strong>of</strong> alopecia, leukonychia, skin<br />
hyperkeratosis and crani<strong>of</strong>acial anomalies. Z. Lin, H.<br />
Wang, J. Zhang, Q. Chen, M. Lee, X. Wang, R. Li, Y. Yang.<br />
2922F Mutation discovery in ENU-derived mouse<br />
models for metabolic bone disease by whole<br />
chromosome and whole exome sequencing. B. Lorenz-<br />
Depiereux, S. Sabrautzki, S. Diener, E. Graf, T. Wieland,<br />
A. Benet-Pagès, S. Eck, B. Rathkolb, M. Klaften, J. A.<br />
Aguilar-Pimentel, J. Calzada-Wack, E. Janas, E. Wolf, M.<br />
Ollert, F. Neff, M. Hrabé de Angelis, T. M. Strom.<br />
2923W Exome sequencing identified a novel mutation<br />
in CACNA1S in a Japanese family with malignant<br />
hyperthermia. N. Matoba, H. Iwasa, M. Kohda, Y.<br />
Yatsuka-Kanesaki, Y. Ichihara, H. Kikuchi, Y. Suzuki, S.<br />
Sugano, Y. K. Hayashi, I. Nishino, Y. Okazaki.<br />
2924T Identification <strong>of</strong> a novel missense mutation<br />
in RAD51 in a large family with congenital mirror<br />
movements. O. E. Onat, S. Gulsuner, R. Bilgen, G. M. Dal,<br />
K. Bilguvar, H. Boyaci, K. Doerschner, H. Uysal, M. Gunel,<br />
T. Ozcelik.<br />
2925F De novo mutations <strong>of</strong> the gene encoding the<br />
histone acetyltransferase KAT6B cause genitopatellar<br />
syndrome. M. A. Simpson, C. Deshpande, D. Dafou, L. E.<br />
L. M. Vissers, W. J. Woollard, S. E. Holder, G. Gillessen-<br />
Kaesbach, R. Derks, S. M. White, P. Cohen-Snuijf, S. G.<br />
Kant, L. H. Hoefsloot, W. Reardon, H. G. Brunner, E. M. F.<br />
H. Bongers, R. C. Trembath.<br />
2926W Focal facial dermal dysplasia, type IV is<br />
associated with mutations in CYP26C1. A. Slavotinek, P.<br />
Mehrotra, B. Li, I. Nazarenko, P. Ling-Fung, R. Z. Lao, C.<br />
Chu, M. Yahyavi, C. Chou, A. L. Marqueling, K. Cordoro, I.<br />
Frieden, M.-A. Morren, K. Devriendt, T. Prescott, T. Glaser,<br />
P.-Y. Kwok, M. Petkovich, R. Desnick.<br />
2927T Identity-by-descent mapping reveals a new<br />
locus for primary congenital glaucoma, GLC3E, on<br />
chromosome 19p13.2. H. Verdin, B. P. Leroy, B. D’haene,<br />
F. Coppieters, S. Lefever, P. G. Kestelyn, E. De Baere.<br />
2928F Mutations in HOXB1 cause autosomal<br />
recessive congenital facial palsy with sensorineural<br />
hearing loss and strabismus. B. D. Webb, S. Shaaban,<br />
H. Gaspar, L. F. Cunha, C. R. Schubert, K. Hao, C.<br />
D. Robson, W. Chan, C. Andrews, S. MacKinnon,<br />
D. T. Oystreck, D. G. Hunter, A. J. Iacovelli, X. Ye, A.<br />
Camminady, E. C. Engle, E. W. Jabs.<br />
2929W Genetic heterogeneity underlying female<br />
infertility and sensorineural hearing loss and<br />
identification <strong>of</strong> LARS2 as a third gene for Perrault<br />
syndrome. S. B. Pierce, T. Walsh, R. Michaelson-Cohen,<br />
R. E. Klevit, M.-C. King, K. Gersak, E. Levy-Lahad.<br />
2930T Exome sequencing in apparently recessive<br />
and apparently X-linked HSP families identifies an<br />
ATL1 mutation hotspot which is associated with low<br />
penetrance dominant inheritance. C. Beetz, R. E.<br />
Varga, H. Fadel, R. Schüle, I. Valenzuela, F. Speziani,<br />
G. Rudenskaja, G. Nürnberg, H. Thiele, J. Altmüller, V.<br />
Alvarez, J. Gamez, P. Nürnberg, S. Zuchner.<br />
2931F Autosomal recessive lethal congenital<br />
contractural syndrome type 4 caused by a mutation in<br />
MYBPC1. O. S. Birk, B. Markus, G. Narkis, R. Z. Birk, I.<br />
Cohen, D. Landau.<br />
2932W Exome sequencing <strong>of</strong> a pedigree with caudal<br />
regression syndrome. G. Cheng, E. H. M. Wong, P.<br />
C. Sham, S. S. Cherny, S. Maas, S. W. Scherer, C. R.<br />
Marshall, S. L. Pereira, P. K. H. Tam, M.-M. Garcia-Barceló.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2933T Loss <strong>of</strong> function mutations in OMIM genes<br />
reveal a burden <strong>of</strong> disease susceptibility in a<br />
consanguineous population. K. A. Fakhro, J. L.<br />
Rodriguez-Flores, N. R. Hackett, J. Salit, J. Fuller, J. A.<br />
Malek, L. Chouchane, R. Badii, A. Al-Marri, J. G. Mezey,<br />
R. G. Crystal.<br />
2934F Causal gene discovery in Mendelian disorders<br />
using whole exome sequencing. S. Jhangiani,<br />
M. Bainbridge, J. Lu, M. Wang, H. Dinh, Y. Han, J.<br />
Santibanez, M. Caramins, P. Campeau, B. Lee, J. Reid, J.<br />
Lupski, E. Boerwinkle, D. Muzny, R. Gibbs.<br />
2935W Whole genome sequencing and copy number<br />
analysis <strong>of</strong> exome sequencing in two families with splithand/split-foot<br />
malformation identifies chromosomal<br />
rearrangements affecting putative exonic enhancers. H.<br />
Lango Allen, R. Caswell, P. Turnpenny, C. Turner, C. Wragg,<br />
W. Xie, M. Weedon, X. Xu, S. Ellard.<br />
2936T Searching novel genes for hereditary hearing<br />
loss in multiplex families using next generation<br />
sequencing. Y. H. Lin, C. C. Wu, Y. C. Lu, C. J. Hsu, P. L.<br />
Chen.<br />
2937F Combination <strong>of</strong> genomic technologies and<br />
consanguinity in order to identify pathogenic variants<br />
in recessive disorders. P. Makrythanasis, M. Nelis, F.<br />
Santoni, M. Guipponi, F. Béna, A. Vannier, G. Duriaux-<br />
Sail, S. Gimelli, E. Stathaki, E. Falconnet, S. Temtamy, A.<br />
Megarbane, M. Aglan, M. S. Zaki, S. Fokstuen, A. Bottani,<br />
A. Masri, S. Psoni, S. Kitsiou, H. Fryssira, N. All-Allawi,<br />
A. Sefiani, S. Al-Hait, S. Elalaoui, N. Jalkh, L. Al-Gazali,<br />
F. Al-Jasmi, H. Chaabouni Bouhamed, H. Hamamy, S. E.<br />
Antonarakis.<br />
2938W A single exome variant is the only expected<br />
variant by likelihood ratio for a rare heritable de novo<br />
dominant disorder in a three generation family with<br />
two affected. S. M. Marchegiani, T. C. Markello, L. A.<br />
Wolfe, K. Fuentes-Fajardo, D. R. Adams, W. A. Gahl, J. C.<br />
Mullikin, T. Davis, J. P. Accardi, C. J. Tifft, C. F. Boerkoel,<br />
NISC Comparative Sequencing <strong>Program</strong>.<br />
2939T Whole-genome sequencing identifies mutations<br />
in known and novel genes for early infantile epileptic<br />
encephalopathy. H. C. Martin, A. T. Pagnamenta, K.<br />
Hudspith, A. Rimmer, R. Copley, E. Sadighi Akha, J.<br />
Broxholme, A. Kanapin, J.-B. Cazier, D. Shears, H.<br />
Stewart, D. Bentley, J. Taylor, E. Blair, P. Donnelly.<br />
2940F Novel intellectual disability genes identified by<br />
exome sequencing. R. Rabionet, O. Drechsel, A. Puig, J.<br />
Gonzalez, I. Madrigal, M. I. Alvarez, N. Baena, M. Viñas, S.<br />
Ossowski, M. Guitart, M. Mila, X. Estivill.<br />
2941W Targeted deep resequencing identifies a<br />
mutation in MID2, as causal for X-linked intellectual<br />
disability with varied disease severity. B. K. Thelma, S.<br />
G. Thenral, A. Michealraj, M. Kabra, G. Kaur, R. C. Juyal.<br />
2942T Exome sequencing and functional biology<br />
reveal novel genes causing infantile mitochondrial<br />
encephalopathy. P. Bonnen, A. Besse, T. Donti, S. Lalani,<br />
F. Scaglia, W. Craigen, B. Graham.<br />
POSTER SESSIONS 233<br />
2943F TIMM44 mutations identified by family-based<br />
WES cause severe mitochondrial respiratory chain<br />
disease due to defective mitochondrial protein import.<br />
M. J. Falk, S. Srinivasan, S. Dingley, J. Ostrovsky, M.<br />
Tsukikawa, E. Polyak, E. Place, M. Consugar, J. C. Perin,<br />
N. Avadhani, E. A. Pierce, X. Gai.<br />
2944W A novel form <strong>of</strong> limb girdle muscular dystrophy<br />
caused by impairment <strong>of</strong> an ER-to-Golgi trafficking<br />
component. N. Bögershausen, Y. Li, J. C. von Kleist-<br />
Retzow, R. Wirth, G. Nürnberg, H. Thiele, J. Altmüller, B.<br />
Schoser, P. Nürnberg, R. Heller, B. Wollnik.<br />
2945T Tackling giants with next-generation<br />
sequencing: homozygous or compound heterozygous<br />
truncating mutations <strong>of</strong> TTN from exome analysis<br />
define novel forms <strong>of</strong> cardiomyopathy with skeletal<br />
myopathy. C. Chauveau, C. Julien, H. Marks, R. Foley, A.<br />
L. Kho, B. Talim, M.-C. Arne-Bes, E. Uro-Coste, P. Maury,<br />
A. Vihola, B. Udd, H. Topaloglu, S. Moore, M. Gautel, C.<br />
Bonnemann, M.-E. Samuels, A. Ferreiro.<br />
2946F Exome sequencing for the molecular diagnosis<br />
<strong>of</strong> muscle disorders: Successes and challenges<br />
encountered. K. K. McDonald, J. Stajich, C. P. Blach, A.<br />
E. Ashley-Koch, M. A. Hauser.<br />
2947W Usher-exome: An efficient diagnostic approach<br />
when used in combination with LSDB USHBases,<br />
Variant Manager USHVAM and USMA. A. F. Roux, T.<br />
Besnard, G. Garcia Garcia, D. Baux, C. Vaché, L. Larrieu,<br />
V. Faugère, J. Millan, M. Claustres.<br />
2948T Loss <strong>of</strong> function mutations in HINT1 are a major<br />
cause <strong>of</strong> autosomal recessive axonal neuropathy with<br />
neuromyotonia. M. Zimon, J. Baets, L. Almeida-Souza, J.<br />
Nikodinovic, Y. Parman, E. Battaloglu, V. Guergueltcheva, I.<br />
Tournev, M. Auer-Grumbach, P. De Rijk, T. Müller, E. Fransen,<br />
P. Van Damme, W. Löscher, N. Barisˇ i ć , Z. Mitrovic, S. Previtali,<br />
H. Topaloglu, G. Bernert, A. Beleza-Meireles, B. Ishpekova,<br />
K. Peeters, A. Hahn, S. Züchner, V. Timmerman, P. Van Dijck,<br />
V. Milic Rasic, A. Janecke, P. De Jonghe, A. Jordanova.<br />
2949F Identification <strong>of</strong> novel genes in human primary<br />
immunodeficiency diseases using exome sequencing.<br />
S. Khan, B. Wakeland, C. Liang, M. De la Morena, N. Van<br />
Oers, E. Wakeland.<br />
2950W The ADAMTS18 gene is responsible for autosomal<br />
recessive syndromic retinal dystrophy. S. Banfi, I. Peluso,<br />
F. Testa, M. Pizzo, R. Collin, N. Meola, M. Mutarelli, G.<br />
Dharmalingam, M. Melone, I. Conte, F. Simonelli.<br />
2951T Novel PLP1 gene mutation discovered by whole<br />
genome sequencing in brothers with infantile onset<br />
dopa-responsive dystonia and delayed central nervous<br />
system demyelination. R. L. Margraf, J. Durtschi, K.<br />
Mallempati, J. Bonkowsky, R. Lutz, K. V. Voelkerding, K. J.<br />
Swoboda.<br />
2952F Digenic inheritance in autosomal recessive<br />
non-syndromic hearing loss cases carrying GJB2<br />
heterozygote mutations: Assessment <strong>of</strong> GJB4 and<br />
GJA1. D. Kooshavar, M. R. Noori Daloii, M. Hashemzadeh<br />
Chaleshtori.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
234 POSTER SESSIONS<br />
2953W Exocrine and endocrine pancreatic damage in<br />
cystic fibrosis are associated with SLC26A9. D. Soave,<br />
T. Chiang, M. Miller, D. Su, K. Keenan, W. Li, W. Ip, F.<br />
Wright, S. Blackman, H. Corvol, M. Knowles, G. Cutting,<br />
M. Drumm, L. Sun, J. Rommens, P. Durie, L. Strug.<br />
2954T Clinical findings <strong>of</strong> a three-generation family<br />
with GLA nonsense mutation (W162X). E. Severin, A.<br />
Stan, C. Dragomir, G. J. Sarca.<br />
2955F Targeted array-CGH analysis to identify copynumber<br />
changes underlying ciliopathies. A. Lindstrand,<br />
C. Carvalho, D. Pehlivan, R. D. Clark, C. A. Johnson, H.<br />
Omran, B. Franco, H. Kremer, P. L. Beales, P. J. Scambler,<br />
E. R. Maher, J. R. Lupski, N. Katsanis.<br />
2956W Is the R202Q mutation clinically relevant in<br />
familial Mediterranean fever, though? S. Duzenli, A. O.<br />
Arslan.<br />
2957T Molecular basis <strong>of</strong> microphthalmia/<br />
anophthalmia. N. Chassaing, A. Causse, A. Delahaye, A.<br />
Vigouroux, P. Calvas.<br />
2958F Identification and functional investigation <strong>of</strong><br />
non-coding NIPBL regulatory elements. D. Braunholz,<br />
J. Wilde, L. D. Michelis, K. S. Wendt, E. Watrin, J. Eckhold,<br />
I. D. Krantz, G. Gillessen-Kaesbach, M. A. Deardorff, F. J.<br />
Kaiser.<br />
2959W Molecular genetic studies <strong>of</strong> nonsyndromic<br />
oculocutaneous albinism in the Pakistani population.<br />
T. Jaworek, T. Kausar, N. Tariq, S. Sadia, M. I. Maqsood,<br />
A. Sohail, M. A. Bhatti, M. Ali, S. Riazuddin, R. S. Shaikh,<br />
Z. M. Ahmed.<br />
2960T A case <strong>of</strong> lymphedema with microcephaly and<br />
chorioretinopathy with a mutation in the KIF11 gene. D.<br />
Finegold, E. Lawrence, K. Levine, R. Ferrell.<br />
2961F miRNA-411 negatively regulates YAF2 and<br />
myogenic factors. Y. Chen, N. Harafuji, P. Schneiderat,<br />
M. C. Walter.<br />
2962W Transcriptional pr<strong>of</strong>iling in facioscapulohumeral<br />
muscular dystrophy to identify candidate biomarkers.<br />
F. Rahimov, O. D. King, D. G. Leung, G. M. Bibat, C. P.<br />
Emerson, Jr., K. R. Wagner, L. M. Kunkel.<br />
2963T The second most prevalent mutation <strong>of</strong> fukutin in<br />
Japanese Fukuyama muscular dystrophy. K. Kobayashi,<br />
R. Kato, E. Kondo, M. Osawa, K. Saito, T. Toda.<br />
2964F Molecular study <strong>of</strong> KRT14 mutations for making<br />
a screening panel test for Iranian patient affected with<br />
epidermolysis bullosa. M. Mahdavi, M. Moghaddam, A.<br />
Kakavand, N. Hatamnejadian, B. Sedaghati Khayat, H.<br />
Dehghanpour, A. Ebrahimi.<br />
2965W Mutations in ANO5 in the Norwegian limb<br />
girdle muscle dystrophy population. M. Van Ghelue,<br />
M. Ingebrigtsen, A. Skogstad, B. Hestholm, C. Wahl, S.<br />
I. Mellgren, F. Rasmussen, M. Rasmussen, B. Karimé, C.<br />
Jonsrud.<br />
2966T Mutation <strong>of</strong> the EYS gene implicated in<br />
autosomal recessive retinitis pigmentosa leads to<br />
abnornmal cellular aggregates and cell death. W.<br />
Mustill, P. Kruczek, A. C. Zelh<strong>of</strong>, S. S. Bhattacharya.<br />
Prenatal, Perinatal and<br />
Reproductive <strong>Genetics</strong><br />
2967T Mitochondrial DNA variations in human ova<br />
and blastocyst and its clinical implications and IVF<br />
outcome. M. Shamsi, G. Periyasamy, L. Chawla, N.<br />
Malhotra, N. Singh, S. Mittal, P. Talwar, K. Thangaraj, R.<br />
Dada.<br />
2968T Cumulus cell microRNA pr<strong>of</strong>iles are associated<br />
with oocyte aneuploidy. B. R. McCallie, J. C. Parks, N.<br />
Treff, R. T. Scott, W. B. Schoolcraft, M. G. Katz-Jaffe.<br />
2969T Prenatal diagnosis <strong>of</strong> sirenomelia by combining<br />
two-dimensional ultrasound, new fetal skeletal<br />
rendering, three-dimensional helical computer<br />
tomography and magnetic resonance imaging. X.-L.<br />
Chen, R. Liu, X.-H. Yang, N. Zhong.<br />
2970T Comparative study on quantitative parameters<br />
<strong>of</strong> blood perfusion and microvessel density in placenta<br />
<strong>of</strong> rat model <strong>of</strong> preeclampsia evaluated with contrastenhanced<br />
ultrasound. Y.-Q. Xu, X.-L. Chen, X.-J. Lu,<br />
X.-H. Yang, P.-W. Chen, J.-H. Huang, C. Huang, Z.-L. Lu,<br />
N. Zhong.<br />
2971T Prenatal ultrasound and autopsy findings in<br />
Simpson-Golabi-Behmel syndrome. K. Chong, J.<br />
Jessen, M. Injeyan, K. Fong, S. Salem, S. Keating, P.<br />
Shannon.<br />
2972T Testing the most frequent genetic diseases<br />
optimizes abnormal gene identity and test accuracy<br />
worldwide. R. Lebo.<br />
2973T Single nucleotide polymorphism based method<br />
for fetal fraction quantification in maternal plasma<br />
using massively parallel sequencing. G. Hogg, J. Tynan,<br />
M. Tang, S. Sovath, A. Maer, D. van den Boom, P. Oeth.<br />
2974T The Pregnancy and Health Pr<strong>of</strong>ile Pilot Project:<br />
Evaluating the impact <strong>of</strong> integrating a novel family<br />
history and genetic screening tool on patients,<br />
providers, and clinical practice. E. Edelman, B. Lin, T.<br />
Doksum, B. Drohan, K. Hughes, S. Dolan, V. Edelson, J.<br />
O’Leary, L. Vasquez, S. Copeland, J. Scott.<br />
2975T Chromosomal structural abnormalities among<br />
Filipino couples with recurrent pregnancy losses. E. C.<br />
Cutiongco-de la Paz, A. D. Berboso, E. G. Salonga, C. M.<br />
David-Padilla.<br />
2976T Factor II G20210A and factor V G1691A<br />
mutations and methylenetetrahydr<strong>of</strong>olate reductase<br />
C677T polymorphism in 155 women with repeated<br />
pregnancy loss. S. Seyedhassani, M. Houshmand, M.<br />
Neshan, F. Saeb.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2977T Functional consequences <strong>of</strong> miscarriage copy<br />
number variations. J. Wen, C. W. Hanna, S. Martell, P. C.<br />
K. Leung, W. P. Robinson, M. Stephenson, E. Rajcan-<br />
Separovic.<br />
2978T The fetal fraction <strong>of</strong> cell-free DNA in maternal<br />
plasma is not affected by a priori risk <strong>of</strong> fetal trisomy.<br />
T. Musci, H. Brar, E. Wang, B. Brar, A. Y. Batey, A.<br />
Oliphant, M. E. Norton.<br />
2979T Role <strong>of</strong> E2F1 in testicular descent and fertility. C.<br />
Jorgez, J. Addai, J. Newberg, V. Vangapandu, A. Sahin, J.<br />
Rosenfeld, L. Lipshultz, D. Lamb.<br />
2980T Study <strong>of</strong> four SNPs in SLC6A14, INSR, TAS2R38<br />
and OR2W3 genes for association with Iranian<br />
idiopathic infertile men. E. Siasi, A. Aleyasin.<br />
2981T NLRP7 subcellular localization in human oocytes<br />
and early cleavage stages. E. Akoury, L. Zhang, M.<br />
Seoud, A. Ao, R. Slim.<br />
2982T <strong>Human</strong> spermatogenic failure purges<br />
deleterious mutation load from the autosomes and<br />
both sex chromosomes, including the gene DMRT1.<br />
D. F. Conrad, A. Lopes, K. I. Aston, F. Carvalho, J.<br />
Goncalves, R. Mathiesen, N. Huang, A. Ramu, J. Downie,<br />
S. Fernandes, A. Amorim, A. Barros, M. Hurles, S.<br />
Moskovtsev, C. Ober, J. Schiffman, P. N. Schlegel, M. De<br />
Sousa, D. T. Carrell.<br />
2983T A homozygous deletion <strong>of</strong> DPY19L2 gene is a<br />
cause <strong>of</strong> globozoospermia in men from the Republic<br />
<strong>of</strong> Macedonia. D. Plaseska-Karanfilska, P. Noveski, S.<br />
Madjunkova, I. Maleva, V. Sotiroska, Z. Petanovski.<br />
2984T Decreased puberty and fertility development<br />
in NELF KO mice due to impaired GnRH neuron<br />
migration. S. Quaynor, L. Chorich, R. Cameron, L.<br />
Layman.<br />
2985T Deficiency <strong>of</strong> PRSS37, a putative trypsin-like<br />
serine protease, causes male infertility from mouse to<br />
human. Z. G. Wang, C. L. Shen, J. B. Liu, J. S. Feng, Y.<br />
Kuang, H. X. Zhang, W. T. Wu, J. Chi, L. Y. Tang, J. Fei.<br />
2986T Changes in placental DNA methylation may be<br />
associated with karyotypically normal miscarriage. C.<br />
W. Hanna, D. E. McFadden, W. P. Robinson.<br />
2987T Co-culture <strong>of</strong> mouse embryonic stem cells with<br />
Sertoli cells promote in vitro generation <strong>of</strong> germ cells.<br />
M. Miryounesi, K. Nayernia, M. Dianatpour, S. Savad, M.<br />
H. Modarressi.<br />
2988T Androgen receptor CAG repeat length may<br />
influence the risk <strong>of</strong> polycystic ovarian syndrome. J. C.<br />
Silas, R. Singh, S. Nirmala Sadasivam, M. N. Sadasivam,<br />
L. Singh, K. Thangaraj.<br />
2989T An analysis <strong>of</strong> the initial experience <strong>of</strong>fering cellfree<br />
fetal DNA testing to pregnant women. J. Taylor, A.<br />
Ables, L. Hudgins.<br />
POSTER SESSIONS 235<br />
2990T Identification <strong>of</strong> messenger RNA <strong>of</strong> fetoplacental<br />
source in maternal plasma <strong>of</strong> women with normal<br />
pregnancies and pregnancies with intrauterin growth<br />
restriction. P. Ayala Ramírez, R. García Robles, J. D.<br />
Rojas, M. Bermúdez, J. Bernal Villegas.<br />
2991T Instant familial haplotyping in conjunction with<br />
embryo analysis in preimplantation genetic diagnosis<br />
using DNA microarrays. G. Altarescu, D. A. Zeevi, S.<br />
Zeligson, S. Perlberg, T. Eldar-Geva, E. J. Margalioth, E.<br />
Levy Lahad, P. Renbaum.<br />
2992T Role <strong>of</strong> cytokines in recurrent miscarriages. F.<br />
Parveen, S. Agrawal.<br />
2993T Developmental neuropsychological assessment<br />
<strong>of</strong> 4-5-year-old children born after preimplantation<br />
genetic diagnosis: A pilot study. G. Sacks, J. Guedalia,<br />
T. Eldar-Geva, T. Gilboa, E. J. Margalioth, E. Levy-Lahad,<br />
G. Altarescu.<br />
2994T Terminological clarification in PGD: Could it<br />
reframe the debate? S. Côté, P. Hamet.<br />
2995T A novel, generic, preimplantation genetic<br />
diagnosis protocol applied to cystic fibrosis involving<br />
mutation detection through high resolution melting<br />
analysis and simultaneous haplotype analysis through<br />
QF-PCR. A. Destouni, M. Poulou, G. Kakourou, C. Vrettou,<br />
J. Traeger-Synodinos, I. Fylaktou, E. Kanavakis, M. Tzetis.<br />
2996T PGD and heteroplasmic mitochondrial DNA<br />
point mutations: A systematic review estimating the<br />
chance <strong>of</strong> healthy <strong>of</strong>fspring. D. M. E. I. Hellebrekers, R.<br />
Wolfe, A. T. M. Hendrickx, I. F. M. de Coo, C. E. de Die, J.<br />
P. M. Geraedts, P. F. Chinnery, H. J. M. Smeets.<br />
2997T Successful pre-implantation genetic diagnosis<br />
in isolated sulfite oxidase deficiency: A happy end to<br />
the saga <strong>of</strong> a devastating neurogenetic disorder. A.<br />
Kondkar, K. Abu-Amero, M. Salih, T. Bosley.<br />
2998T Outcomes <strong>of</strong> 687 in vitro fertilization cycles and<br />
5871 embryos evaluated using 23-chromosome single<br />
nucleotide polymorphism microarray preimplantation<br />
genetic screening for recurrent pregnancy loss. K. J.<br />
Tobler, P. R. Brezina, A. T. Benner, L. Du, B. Boyd, W. G.<br />
Kearns.<br />
2999T Cleavage-stage blastomere biopsy significantly<br />
impairs human embryonic reproductive potential<br />
while blastocyst-stage trophectoderm biopsy does<br />
not: A paired randomized controlled trial utilizing SNP<br />
microarray-based DNA fingerprinting. N. R. Treff, K. M.<br />
Ferry, T. Zhao, J. Su, E. J. Forman, R. T. Scott, Jr.<br />
3000T Comparison <strong>of</strong> two whole genome amplification<br />
methods for preimplantation genetic diagnosis with<br />
HLA typing on beta-thalassaemia. Q. Wang, J. F. C.<br />
Chow, W. S. B. Yeung, E. H. Y. Ng, P. C. Ho.<br />
3001T Preimplantation genetic diagnosis for a carrier<br />
<strong>of</strong> complex chromosome rearrangement resulting in a<br />
healthy <strong>of</strong>fspring. K. Writzl, A. Veble, B. Peterlin.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
236 POSTER SESSIONS<br />
3002T Preimplantation genetic diagnosis in genomic<br />
regions with duplications and pseudogenes: Long<br />
range PCR in the single cell assay. D. A. Zeevi, R.<br />
Ron El, P. Renbaum, E. Kasterstein, D. Strassburger,<br />
D. Komarovsky, B. Maslanski, I. Ben-Ami, O. Bern, A.<br />
Komski, E. Levy Lahad, G. Altarescu.<br />
3003T TAR syndrome diagnosis confirmed by aCGH<br />
analysis. S. Ceylaner, Y. K. Terzi, S. Kalyoncu, F. I. Sahin.<br />
3004T Prenatal detection <strong>of</strong> anophthalmia in three<br />
cases with significantly different neonatal outcomes. T.<br />
Bardakjian, D. Dorsainville, A. Schneider.<br />
3005T Antenatal detection <strong>of</strong> a fetus with bilateral<br />
anophthalmia and pulmonary hypoplasia: A rare case<br />
report. C. C. Albu, D. F. Albu, M. Dumitrescu, E. Severin.<br />
3006T Outcomes following antenatal diagnosis <strong>of</strong><br />
ultrasonographically isolated cleft lip with or without<br />
cleft palate. A. Lehman, L. Burnell, C. Verchere, D.<br />
Pugash, S. Robertson, A. Loo.<br />
3007T cfDNA is not compromised by temperature<br />
stress <strong>of</strong> maternal blood collected in Streck cell-free<br />
DNA BCT. A. Huang, A. Srinivasan, V. Nguyen, J. Cheng,<br />
J. Sprowl, R. Van Luchene, A. Aziz, D. Comstock.<br />
3008T Effective epigenetic biomarker in first-trimester<br />
maternal plasma for non-invasive fetal trisomy 21<br />
detection. J. Lim, D. Lee, S. Kim, M. Kim, S. Park, Y. Han,<br />
M. Kim, M. Kim, K. Choi, H. Ryu.<br />
3009T Prenatal diagnosis <strong>of</strong> a fetus with mosaic<br />
trisomy 18, omphalocele and severe intrauterine<br />
growth restriction: Case report. D. F. Albu, C. C. Albu, A.<br />
Oncescu, E. Severin, M. Dumitrescu.<br />
3010T Chromosomal abnormalities in prenatal diagnosis:<br />
An Indian perspective. B. B. Ganguly, N. N. Kadam.<br />
3011T A powerful ‘smart tip’ method for nucleic acid<br />
extraction and enrichment <strong>of</strong> cell-free fetal DNA<br />
from maternal plasma. A. Gindlesperger, T. Stokes, P.<br />
Belgrader, R. Holmberg.<br />
3012T Prenatal detection <strong>of</strong> a supernumerary dicentric<br />
chromosome 15 through cytogenetics and array CGH<br />
after fetal ultrasound findings <strong>of</strong> micrognathia and<br />
small stomach bubble. J. L. Giordano, L. Cohen, V.<br />
Pulijaal, S. Gelber.<br />
3013T Prenatal diagnosis and fetal autopsy findings in<br />
Aicardi syndrome. M. C. Injeyan, I. Miron, P. Shannon, A.<br />
Malinowski, S. Blaser, D. Chitayat.<br />
3014T High-throughput massively parallel sequencing<br />
for fetal aneuploidy detection from maternal plasma. T.<br />
J. Jensen, T. Zwiefelh<strong>of</strong>er, R. C. Tim, Z. Dzakula, S. K. Kim,<br />
A. R. Mazloom, G. McLennan, C. Deciu, D. van den Boom,<br />
M. Ehrich.<br />
3015T Isolation <strong>of</strong> selected, single chromosomes from<br />
the isolated circulating fetal cells for clonal expansion,<br />
molecular pr<strong>of</strong>iling, and next-generation sequencing.<br />
M. Malecki, R. Malecki.<br />
3016T Noninvasive prenatal sex determination using<br />
massively parallel sequencing in samples from a large<br />
clinical validation study. P. Oeth, A. Mazloom, T. Wang,<br />
G. E. Palomaki, J. A. Canick, A. Bombard, D. van den<br />
Boom, M. Ehrich, C. Deciu.<br />
3017T MeDIP real time qPCR <strong>of</strong> maternal peripheral<br />
blood reliably identifies trisomy 21. P. Patsalis, E.<br />
Tsaliki, C. Spyrou, G. Koumbaris, E. Kypri, S. Kyriakou,<br />
C. Sotiriou, E. Touvana, A. Keravnou, A. Karagrigoriou,<br />
K. Lamnissou, V. Velissariou, C. Sismani, E. A.<br />
Papageorgiou.<br />
3018T Highly accurate non-invasive detection <strong>of</strong> fetal<br />
aneuploidy <strong>of</strong> chromosomes 13, 18, 21, X and Y by<br />
targeted sequencing. M. Rabinowitz, G. Gemelos, M. Hill,<br />
B. Levy, S. McAdoo, M. Savage, Z. Demko.<br />
3019T Accuracy <strong>of</strong> prenatal diagnosis in elective<br />
termination <strong>of</strong> pregnancy. J. Saraiva, F. Ramos, S. Maia,<br />
M. Branco, J. Raposo, J. Sá, S. Sousa, M. Venâncio, R.<br />
Pina, E. Galhano, L. Ramos.<br />
3020T Non-Invasive Chromosomal Evaluation Study:<br />
Results <strong>of</strong> a multicenter, prospective, cohort study for<br />
detection <strong>of</strong> fetal trisomy 21 and trisomy 18. K. Song,<br />
H. Brar, J. Weiss, A. Karimi, L. C. Laurent, A. B. Caughey,<br />
M. H. Rodriguez, J. Williams, III, M. E. Mitchell, C. D. Adair,<br />
H. Lee, B. Jacobsson, M. W. Tomlinson, D. Oepkes, D.<br />
Hollemon, A. B. Sparks, A. Oliphant, M. E. Norton, NICE<br />
Study Group.<br />
3021T Detection <strong>of</strong> fetal sub-chromosomal alterations<br />
in maternal plasma cell-free DNA using massively<br />
parallel sequencing. A. Srinivasan, X. Li, J. Sprowl, A.<br />
Huang, A. Sehnert, R. Rava.<br />
3022T Approach to prenatally diagnosed esophageal<br />
atresia/tracheoesophageal fistula. B. Suskin, S.<br />
Klugman, T. Goldwaser, A. Roe, K. Bajaj.<br />
3023T Quantification <strong>of</strong> fetal DNA in maternal plasma<br />
by massively parallel sequencing using fetal-specific<br />
methylation markers. M. Tang, J. Tynan, S. Sovath, A.<br />
Maer, G. Hogg, D. van den Boom, P. Oeth.<br />
3024T Curated gene set outperforms GWAS data on<br />
pathway-based genetic analysis. J. Padbury, A. Uzun, A.<br />
Dewan, S. Istrail.<br />
3025T Analysis <strong>of</strong> etiology and complications among<br />
1,128, including 493 iatrogenic and 635 spontaneous,<br />
Chinese preterm births. M. Xiao, W. Ren, N. Zhong.<br />
3026T Admixture mapping identifies susceptibility loci<br />
associated with preterm birth in African <strong>American</strong>s.<br />
H. Tsai, X. Liu, X. Hong, G. Wang, T. Chang, Q. Chen, C.<br />
Pearson, D. Caruso, L. Heffner, B. Zuckerman, X. Wang.<br />
3027T Single nucleotide polymorphism in Toll-like<br />
receptor 6 is associated with risk for Ureaplasma<br />
respiratory tract colonization and bronchopulmonary<br />
dysplasia in preterm infants. A. H. Winters, T. D. LeVan,<br />
S. N. Vogel, K. L. Chesko, T. I. Pollin, R. M. Viscardi.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3028T Genome-wide association study <strong>of</strong> preterm<br />
delivery in mothers. F. Geller, B. Feenstra, M. Melbye, R.<br />
Myhre, S. Myking, Early Growth <strong>Genetics</strong> Consortium, T.<br />
I. A. Sørensen, P. Magnus, M. L. Marazita, J. C. Murray, B.<br />
Jacobsson.<br />
3029T Evidence <strong>of</strong> SNP variation in the folic acid<br />
metabolic pathway associates with preterm birth. Y.<br />
Chen, B.-J. Wang, M.-J. Liu, Y. Wang, J. Mao, S.-N. Wang,<br />
J.-R. Dai, H. Li, N. Zhong.<br />
3030T Investigation <strong>of</strong> genetic risk factors for chronic<br />
adult diseases in preterm birth. N. Falah, J. McElroy, V.<br />
Snegovskikh, C. Lockwood, E. Kuczynski, E. Norwitz, J.<br />
Murray, R. Menon, K. Teramo, L. Muglia, T. Morgan.<br />
3031T Maternal SNPs in the p53 pathway: Risk factors<br />
for aneuploidy 21? A. P. C. Brandalize, J. A. Boquett, L.<br />
R. Fraga, L. Schuller-Faccini.<br />
3032T Disomy 21 mosaicism in sperm. E. Iwarsson, U.<br />
Kvist, M. A. Hultén.<br />
3033T DiGeorge sequence due to uncontrolled<br />
maternal gestational diabetes. A. Ludtke, T. Mucci, M.<br />
Aquino, E. Graber, L. Mehta.<br />
3034T Investigation <strong>of</strong> telomere length in newborns<br />
and correlation with gestation age and birth weight.<br />
E. C. Tan, S. N. Lim, Z. Yahya, D. Zeegers, T. Moe, E. E. P.<br />
Kyaw, G. S. H. Yeo, M. P. Hande.<br />
Clinical <strong>Genetics</strong> and Dysmorphology<br />
3035W A case <strong>of</strong> arthrogryposis and mosaic Turner<br />
syndrome. L. Mora, A. Lopez, I. Zarante.<br />
3036F Paternal uniparental disomy 6 and 2q13 deletion<br />
detected prenatally in a patient with cardiac defects,<br />
transient neonatal diabetes mellitus, hydrocephalus<br />
and dysmorphic features. D. Niyazov, C. Tillis, D.<br />
Feliperamirez, A. Robichaux.<br />
3037W Congenital acquired mosaicism for monosomy<br />
7. J. Hiemenga, S. Klemm, J. Foley, H. Toriello.<br />
3038F Overgrowth as a presenting symptom <strong>of</strong> the<br />
22q11.2 duplication syndrome: A novel association. D.<br />
McDonald-McGinn, E. Bratton, K. Dickinson, A. Kohut,<br />
A. Bailey, A. Wilkens, I. Krantz, B. Emanuel, S. Saitta, M.<br />
Deardorff, E. H. Zackai.<br />
3039W Down syndrome patients nutritional evaluation<br />
at the Hospital para el Nino Poblano outpatients. M.<br />
Cortes, J. M. Aparicio, R. J. M. Perez, F. E. P. Romero.<br />
3040F Follow-up <strong>of</strong> patient with non-supernumerary<br />
ring chromosome 7: Clinical manifestations,<br />
cytogenetic and molecular analysis. C. Salas, P. Perez-<br />
Vera, D. Cervantes, R. Cruz-Alcivar, R. Daber, L. Conlin,<br />
L. Leonard, N. B. Spinner, C. Durán-McKinster, V. Del<br />
Castillo-Ruiz.<br />
POSTER SESSIONS 237<br />
3041W Mowat-Wilson syndrome: Case report. J. Acosta<br />
Guio, A. Zarante.<br />
3042F The association <strong>of</strong> low socioeconomic status and<br />
the risk <strong>of</strong> having children with Down syndrome: A report<br />
from the National Down Syndrome Project. J. E. Hunter, E.<br />
G. Allen, L. J. H. Bean, S. B. Freeman, S. L. Sherman.<br />
3043W Surgical intervention for esophageal atresia in<br />
patients with trisomy 18. E. Nishi, T. Nakamura, K. Iio, S.<br />
Mizuno, H. Kawame, Y. Fukushima, T. kosho.<br />
3044F Mosaic supernumerary ring chromosome<br />
3: Does copy number gain <strong>of</strong> FOXP1 contribute<br />
to expressive speech impairment and intellectual<br />
disability? I. Filges, A. Datta, E. Boehringer, L. Suda, B.<br />
Roethlisberger, P. Miny.<br />
3045W Cat eye syndrome: Wide clinical variability in<br />
three patients from the same family. M. I. Melaragno,<br />
S. I. Belangero, A. N. Pacanaro, F. T. Belucco, D. M.<br />
Christ<strong>of</strong>olini, L. D. Kulikowski, R. S. Guilherme, A. Bortolai,<br />
A. R. Dutra, F. B. Piazzon, M. C. Cernach.<br />
3046F Maternally inherited Xq26.2 duplication in a male<br />
<strong>of</strong>fspring with severe prenatal and postnatal growth<br />
deficiency, dysmorphic facial features, hydrocephalus<br />
and developmental delay resembling Russell-Silver<br />
syndrome. L. Tuzovic, J. Wynn, L. Rohena, K. Anyane-<br />
Yeboa, A. Iglesias.<br />
3047W De novo translocation disrupting mediator<br />
complex subunit in a patient with Pierre-Robin<br />
sequence and developmental delay. K. H. Utami, A.<br />
M. Hillmer, E. G. Y. Chew, C. L. Winata, V. Korzh, S.<br />
Mathavan, P. Sarda, S. Davila, V. Cacheux.<br />
3048F 614kb Duplication at chromosome 9q22.32<br />
encompassing PTCH1 gene in a family with reciprocal<br />
translocation (9;20)(q22;q13) and intrafamilial<br />
phenotypic variability. C. Vinkler, D. Lev, A. Singer, A.<br />
Frumkin, M. Davidovich, M. Michelson, Y. Michaeli-Yossef.<br />
3049W Case report: A boy with 49, XXXXY syndrome,<br />
diagnosed by karyotype and a characteristic<br />
phenotype. A. Zarante, J. C. Prieto, O. Moreno.<br />
3050F 6p25 Interstitial deletion in two dizygotic twins<br />
with gyral pattern anomaly and speech and language<br />
disorder. M. Bozza, L. Bernardini, A. Novelli, P. Brovedani,<br />
E. Moretti, R. Canapicchi, V. Doccini, T. Filippi, A. Battaglia.<br />
3051W Microdeletion <strong>of</strong> 19p13.3 in a girl with Peutz-<br />
Jeghers syndrome, intellectual disability, hypotonia,<br />
and dysmorphic features. Y. Kuroda, T. Saito, J. Nagai,<br />
K. Ida, T. Naruto, M. Masuno, K. Kurosawa.<br />
3052F Maternal mosaicism for deletion <strong>of</strong> 22q13.3<br />
resulting in siblings with Phelan-McDermid syndrome.<br />
K. Phelan, B. R. DuPont, R. C. Rogers.<br />
3053W De novo interstitial deletion <strong>of</strong> 3q22.1-q22.3 in<br />
two patients: A new microdeletion syndrome. Y. Wilnai,<br />
W. Wilson, C. Jett, M. Manning.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
238 POSTER SESSIONS<br />
3054F Chromosomal microarray analysis <strong>of</strong> individuals<br />
with autism or learning deficits presenting for genetic<br />
services. J. Roberts, J. Hayes, N. Dzidic, K. Hovanes, M.<br />
Dasouki, M. G. Butler.<br />
3055W A Wolf Hirschhorn-like phenotype in a patient with<br />
a de novo 6q26-q27 deletion and 20p13-p12.1 duplication.<br />
F. Faucz, H. Salomão, R. B. de Alexandre, A. Bonalumi, J.<br />
Souza, J. A. Rosenfeld, S. Raskin, V. S. Sotomaior.<br />
3056F Submicroscopic chromosomal rearrangements<br />
in patients with an Angelman syndrome-like<br />
phenotype. K. Hosoki, T. Ohta, N. Niikawa, S. Saitoh.<br />
3057W Twenty-two year follow-up <strong>of</strong> identical<br />
twins with discordant phenotype due to a ring 13<br />
chromosomal mosaicism in one <strong>of</strong> them. Y. Lacassie.<br />
3058F 12p microRNA expression in fibroblast cell lines<br />
from probands with Pallister-Killian syndrome. K. Izumi,<br />
Z. Zhang, M. Kaur, I. Krantz.<br />
3059W <strong>Genetics</strong> <strong>of</strong> precocious puberty: A proband with<br />
Klinefelter syndrome, maternal uniparental disomy 14<br />
and precocious puberty. K. Reddy, H. Bass, J. Keni.<br />
3060F Molecular genetic testing <strong>of</strong> recurrent<br />
anencephaly in a family without partial trisomy 2p22pter.<br />
C. Sergi, J. Gekas, D. Kamnasaran.<br />
3061W Urethrocystoscopy, diagnostic laparoscopy,<br />
versus testicular descent gonadectomy in a patient<br />
with ambiguous genitalia: A case report. F. Cuellar-<br />
López, J. M. Aparicio, l. de la Torre.<br />
3062F Congenital association VACTERL at the Hospital<br />
para el Nino Poblano, Mexico: Fourteen case reports.<br />
A. Garcia-Guzman, J. M. Aparicio-Rodriguez.<br />
3063W Orthodontic correction in malformated<br />
unilateral teeth structure in a patient with<br />
pseudoachondroplasia: A case report. S. Ochoa, J. M.<br />
Aparicio, D. D. A. Camarillo, S. S. Cabrera.<br />
3064F Hearing loss frequency in a pediatric patient<br />
group at a third level hospital. A. Romero, J. M. Aparicio,<br />
L. P. C. Gallegos.<br />
3065W Diagnostic exome sequencing reveals a de<br />
novo mutation in the DYNC1H1 gene in a sporadic case<br />
<strong>of</strong> developmental delay, seizures, and polymicrogyria.<br />
K. D. Gonzalez, J. Wei, X. Li, H. M. Lu, H. Lu, J. S. Cohen,<br />
R. McClellan, S. Naidu, W. Zeng.<br />
3066F Congenital poikiloderma, fatty infiltration <strong>of</strong><br />
muscles and pulmonary fibrosis: A new syndrome.<br />
S. Mercier, S. Kury, J. M. Mussini, A. Magot, B. Isidor, S.<br />
Barbarot, A. David, S. Bezieau.<br />
3067W Prenatal diagnosis <strong>of</strong> a fetus with a<br />
rare association <strong>of</strong> a multiple heart and renal<br />
malformations: Case report. M. Dumitrescu, D. F. Albu,<br />
C. C. Albu, A. Oncescu, E. Severin.<br />
3068F Complex chromosomal translocation leading to<br />
a dual diagnosis <strong>of</strong> Prader-Willi syndrome and Cri-duchat<br />
in a 14- year-old boy illustrating the importance <strong>of</strong><br />
re-evaluation in an individual with atypical Prader-Willi<br />
phenotype. J. A. Gold, S. Ramanathan.<br />
3069W Molecular characterization <strong>of</strong> SHOX gene and<br />
regulatory regions in patients with idiopathic short<br />
stature from three medical centers in <strong>of</strong> Bogota,<br />
Colombia. T. Vinasco, G. Jaimes, M. Coll, C. Cespedes,<br />
H. Velasco.<br />
3070F Clinical and molecular characterization <strong>of</strong><br />
non-syndromic craniosynostosis: An international<br />
consortium approach. M. L. Cunningham, P. A.<br />
Romitti, C. M. Justice, A. F. Wilson, T. Roscioli, E.<br />
Oláh, B. Bessenyei, M. R. Passos-Bueno, B. Wollnik,<br />
A. O. M. Wilkie, S. A. Boyadjiev Boyd, International<br />
Craniosynostosis Consortium.<br />
3071W Molecular prenatal diagnosis <strong>of</strong> a sporadic<br />
alobar holoprosencephalic fetus: Genotype-phenotype<br />
correlations. J. Gekas, C. Sergi, D. Kamnasaran.<br />
3072F Sonic Hedgehog regulatory region deletion in<br />
a patient with holoprosencephaly. L. Ribeiro-Bicudo,<br />
R. Quiezi, M. Ansari, K. Williamson, A. Richieri-Costa, D.<br />
FitzPatrick.<br />
3073W Associated malformations among infants with<br />
radial ray deficiency. C. Stoll, B. Dott, Y. Alembik, M. P.<br />
Roth.<br />
3074F Or<strong>of</strong>aciodigital syndrome in a group <strong>of</strong> patients<br />
who attended Operation Smile Foundation in Colombia,<br />
between 2005 and <strong>2012</strong>. J. Martinez, I. Briceno, A.<br />
Venegas, S. Bohorquez, M. Montiel, A. Patiño, L. Arias.<br />
3075W A new type <strong>of</strong> acr<strong>of</strong>acial dysplasia: Prenatal<br />
diagnosis and autopsy findings. K. Millar, A. Toi, S.<br />
Keating, P. Shannon, S. Unger, D. Chitayat.<br />
3076F Development <strong>of</strong> a visit assessment tool to address<br />
birth defects and dysmorphology. O. A. Abdul-Rahman, L.<br />
Hayes, B. Loyola, D. A. Stevenson, S. Astley, C. Chambers,<br />
K. L. Jones, H. E. Hoyme, F. Waffern, J. C. Carey.<br />
3077W A new case <strong>of</strong> crani<strong>of</strong>acial microsomia autosomal<br />
dominant associated with complete right side testicular<br />
and scrotal ectopia. J. Rojas Martínez, J. C. Prieto Rivera.<br />
3078F A replication study <strong>of</strong> genome-wide significant<br />
rheumatoid arthritis susceptibility loci in the Pakistani<br />
population. S. F. Jalil, A. Bhatti, F. Y. Demirci, X. Wang, I.<br />
Ahmed, M. Ahmed, M. M. Barmada, J. M. Malik, P. John,<br />
M. I. Kamboh.<br />
3079W A novel missense mutation in PARD3 is<br />
associated with class III malocclusion. T. Nikopensius,<br />
M. Kals, T. Annilo, T. Jagomägi, M. Saag, A. Metspalu.<br />
3080F Genotype/phenotype correlation in Smith-<br />
Magenis syndrome with abnormal 17p deletions.<br />
T. Vilboux, A. C. M. Smith, S. Chandrasekharappa, C.<br />
Ciccone, J. Blancato, W. J. Introne, W. A. Gahl, M. Huizing.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3081W MiR-133a and MiR-422a in human circulating<br />
monocytes are potential microRNA biomarkers<br />
underlying postmenopausal osteoporosis. Y. Wang, L.<br />
Li, B. T. Moore, X. H. Peng, X. Fang, J. M. Lappe, R. R.<br />
Recker, P. Xiao.<br />
3082F Genome-wide mosaic paternal uniparental<br />
isodisomy. J. Kalish, A. Wilkens, S. Mulchandani, E.<br />
Zackai, N. Spinner, M. Bartolomei, L. Conlin, M. Deardorff.<br />
3083W The catalase: Influence <strong>of</strong> C-262 T<br />
polymorphism on keratoconus. S. Torabi Dalivandan,<br />
Z. Salehi, S. Saboohi, M. J. Mohammadi Fatideh, H.<br />
Yourdkhani.<br />
3084F Metabolic abnormalities in Williams-Beuren<br />
syndrome patients and candidate genes. M. G.<br />
Palacios, R. Flores, V. Campuzano, M. del Campo, M.<br />
Segura-Puimedón, L. A. Perez-Jurado.<br />
3085W Bilateral radioulnar synostosis and vertebral<br />
anomalies in a child with a 16p13.3 interstitial deletion.<br />
T. Slavin, A. Tam, K. Lee, S. Lee, W. Burkhalter.<br />
3086F ASTN2 deletions in autism spectrum disorder<br />
and related neuropsychiatric phenotypes. M. T. Carter,<br />
A. C. Lionel, A. K. Vaags, B. A. Fernandez, W. Roberts, P.<br />
Szatmari, C. R. Marshall, S. W. Scherer.<br />
3087W Atypical deletions <strong>of</strong> the Williams-Beuren<br />
syndrome region implicate genes involved in mild<br />
facial phenotype, epilepsy and autistic traits. G. Merla,<br />
L. Micale, C. Fusco, B. Augello, P. Alfieri, M. C. Digilio, D.<br />
Menghini, S. Vicari.<br />
3088F Morphogenesis <strong>of</strong> the face in Wolf-Hirschhorn<br />
syndrome: Three elucidative patients. J. Carey, A.<br />
Calhoun, P. Hammond, A. Lortz, S. South.<br />
3089W Growth hormone receptor gene polymorphism<br />
and Prader-Willi syndrome. M. G. Butler, J. Roberts, J.<br />
Hayes, X. Tan, A. Manzardo.<br />
3090F Molecular characterization and genotype/<br />
phenotype correlation <strong>of</strong> ten patients with structural<br />
rearrangements in the NIPBL gene. Y.-W. Cheng, C. Tan,<br />
K. Arndt, S. Das, D. del Gaudio.<br />
3091W TSC2-PKD1 contiguous deletion syndrome<br />
with aortic stenosis and severe myopia. K. Enomoto, Y.<br />
Sugawara, M. Hotate, Y. Motoyoshi, Y. Hatai, S. Mizutani,<br />
K. Kurosawa.<br />
3092F Jacobsen syndrome: Cognitive-behavioral<br />
pr<strong>of</strong>iles, developmental trajectories, and IQ related to<br />
deletion size. G. Fisch.<br />
3093W Concurrent deletion <strong>of</strong> BMP4 and OTX2<br />
genes: Clinical evidence <strong>of</strong> synergistic effect <strong>of</strong> the<br />
two master genes in ophthalmogenesis. R. Kosaki, T.<br />
Takenouchi, C. Torii, S. Nishina, K. Kosaki.<br />
3094F Interstitial deletion <strong>of</strong> 3.8 Mb in chromosome<br />
6q25.2-6q25.3 in a patient with C<strong>of</strong>fin-Siris syndrome. S.<br />
Mizuno, E. Nishi, Y. Muramatsu, M. Tominaga, K. Kurosawa.<br />
POSTER SESSIONS 239<br />
3095W Detailed neurodevelopmental phenotype <strong>of</strong><br />
a child with a 22q11.2 distal deletion. S. Mosca, L. M.<br />
Langevin, A. C. Lionel, C. R. Marshall, B. Argiropoulos, A.<br />
M. Innes, S. W. Scherer, D. Dewey, J. S. Parboosingh, F.<br />
P. Bernier.<br />
3096F A de novo 163 kb interstitial 1q44 microdeletion in<br />
a boy with thin corpus callosum, psychomotor delay and<br />
seizures. K. Selmer, E. Bryne, O. Rødningen, M. Fannemel.<br />
3097W Genotype phenotype correlation study <strong>of</strong><br />
2q23.1 microdeletion syndrome and characterization <strong>of</strong><br />
three new patients. L. Zhang, H. T. Bjornsson, D. Batista,<br />
G. Wiesner, T. Wang, A. Parikh.<br />
3098F Polycystic kidney disease and a 2.5Mb<br />
duplication on chromosome 3p22.1. K. Dahan, M.<br />
Madhoun, M. Gilliaux, V. Benoit, B. Grisart.<br />
3099W Subtelomeric deletion including the WHSC1<br />
gene located in the critical region <strong>of</strong> the Wolf-<br />
Hirschhorn syndrome. A. L. S. Ludmila Serafim, J. M.<br />
Pina Neto, l. F. Mazzucatto.<br />
3100F Atypical form <strong>of</strong> osteopathia striata with<br />
cranial sclerosis and increased mineral density in<br />
an adolescent female with mosaic chromosome 2<br />
rearrangement. R. Mendoza-Londono, A. Howard, E.<br />
Sochett, L. Dupius, D. J. Stavropoulos, R. C. C. Wong, S.<br />
Robertson, A. M. Joseph-George.<br />
3101W Further evidence <strong>of</strong> the role <strong>of</strong> HOXA genes in<br />
anatomical development. P. A. Mowery-Rushton, R. A.<br />
Schultz, J. B. Ravnan, J. E. Burton, J. Kussmann, J. A.<br />
Rosenfeld, B. C. Ballif, L. G. Shaffer.<br />
3102F 4p16.3 Deletion limited to WHSCR2. N. Okamoto,<br />
K. Shimojima, T. Yamamoto.<br />
3103W Array CGH in 190 Korean patients with<br />
developmental delay and/or intellectual disability: A<br />
single tertiary care university center study. Y. Sohn, C.<br />
Lee, S. Park, J. Yun, E. Jung, H. Kim, S. Yim.<br />
3104F Diagnostic investigation in Rwandan patients<br />
with MR/MCA. A. Uwineza, J. Hitayezu, L. Mutesa.<br />
3105W Clinical features and genomic characterization<br />
<strong>of</strong> two subjects with a pure duplication <strong>of</strong> 9q34. H.<br />
Yoshihashi, M. Ikegami, C. Torii, K. Kosaki.<br />
3106F Osteopathia striata with cranial sclerosis and<br />
developmental delay in a male with a mosaic deletion<br />
in chromosome region Xq11.2. S. Chenier, A. Noor, L.<br />
Dupuis, D. J. Stavropoulos, R. Mendoza-Londono.<br />
3107W Keratoconus associated with Williams-Beuren<br />
syndrome: New case report. M. C. Frasson, M. M. Viana,<br />
L. L. Leao, M. St<strong>of</strong>anko, H. Goncalves-Dornelas, P. S.<br />
Cunha, M. J. B. Aguiar.<br />
3108F Minimal interstitial deletion in a patient with de<br />
novo 15q24 microdeletion syndrome presenting with<br />
severe scoliosis. X. Gao, C. Johnston, S. Sparagana, C.<br />
A. Wise.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
240 POSTER SESSIONS<br />
3109W Microdeletions in 9q33.3-q34.1 may constitute<br />
a contiguous gene deletion syndrome characterized<br />
by developmental delay, microcephaly, mild<br />
dysmorphisms, strabismus, and seizures <strong>of</strong> incomplete<br />
penetrance. J. A. Lee, J. K. Ehret, E. Wohlleber, S. Vogt,<br />
A. M. Zink, E. Rossier, M. Bonin, U. Grassh<strong>of</strong>f, A. Bevot, M.<br />
Mathieu-Dramard, G. Plessis, A. de Broca, S. Kanafani, B.<br />
Röthlisberger, M. Holder-Espinasse, I. Simonic, L. Willatt, P.<br />
Miny, I. Filges, J. Andrieux, H. V. Firth, A. Dufke, H. Engels.<br />
3110F Identification and diagnosis <strong>of</strong> Williams-Beuren<br />
syndrome in a public genetic center in Brazil. M. M.<br />
Viana, M. St<strong>of</strong>anko, P. S. Cunha, H. Goncalves-Dornelas,<br />
M. J. B. Aguiar, S. D. J. Pena.<br />
3111W Implementation <strong>of</strong> molecular karyotyping<br />
in routine diagnostics provides new insights into<br />
the pathophysiology <strong>of</strong> Silver-Russell syndrome. S.<br />
Spengler, M. Begemann, N. Ortiz Brüchle, P. M. Kroisel, B.<br />
Oehl-Jaschkowitz, G. Raabe-Meyer, C. Spaich, P. Blümel,<br />
U. Moog, K. Zerres, T. Eggermann.<br />
3112F Clinical, molecular cytogenetic evaluation and<br />
genotype-phenotype correlation <strong>of</strong> a patient with<br />
partial Jacobsen syndrome without thrombocytopenia<br />
caused by an 13 Mb deletion <strong>of</strong> del(11)(q24.1). J. Moon,<br />
J. Kim, J. Kim, M. Nam, S. Yoon.<br />
3113W Triplication <strong>of</strong> 7q11.23 distal to the critical<br />
region for the Williams-Beuren syndrome. J. G. Pappas,<br />
R. D. Nass, E. Ward, I. K. Gadi.<br />
3114F A de novo 9.0 Mb deletion at chromosome<br />
region 10q21.3-q22.3 associated with severe<br />
psychomotor delay and mild Noonan phenotype:<br />
A case report. S. Baffini, G. Scarselli, L. Castiglia, M.<br />
Vinci, S. Amata, M. Fichera, J. D. Barp, E. Gambineri, E.<br />
Chiappini, M. L. Giovannucci Uzielli.<br />
3115W A first reported case <strong>of</strong> a microdeletion in<br />
8q22.22q23 in Colombia: Phenotypic and genotypic<br />
correlation. P. Paez, S. Perdomo, X. Rojas.<br />
3116F A microdeletion <strong>of</strong> about 831 kb in a young<br />
woman causes a loss <strong>of</strong> more than 30 genes on the<br />
long arm <strong>of</strong> chromosome 17 including a copy <strong>of</strong> the<br />
BRCA1 gene: Implications for genetic counseling and<br />
clinical management. P. M. Kroisel, J. B. Geigl, M. Mach,<br />
C. Pischler, E. Vallant, M. R. Speicher, K. Wagner.<br />
3117W A familial atypical Williams-Beuren deletion<br />
encopassing ELN and part <strong>of</strong> LIMK1 gene. B. Demeer,<br />
F. M. Caron, S. Chenichene, G. Morin, A. Receveur,<br />
H. Copin, A. de Broca, O. Godefroy, D. Sanlaville, M.<br />
Mathieu, P. Saugier-Veber.<br />
3118F 12q21 Deletion syndrome with intellectual<br />
disability and facial dysmorphism. A. Matsumoto, T.<br />
Yamagata, Y. Nozaki, E. F. Jimbo, M. Y. Momoi.<br />
3119W Autism, mild facial dysmorphism, abnormal<br />
EEG, sleep problems and language impairment in<br />
interstitial duplication 15q11-q13 syndrome. N. Urraca,<br />
C. Cleary, E. Pivnick, K. McVicar, V. Brewer, R. Thibert, N.<br />
C. Schanen, M. C. Esmer, D. Lamport, L. T. Reiter.<br />
3120F Mucolipidosis III gamma, tuberous sclerosis,<br />
and polycystic kidney disease caused by a contiguous<br />
gene deletion on chromosome 16p13.3. J. Barea, L.<br />
Bird.<br />
3121W GH deficiency and epilepsy in a patient with a<br />
19q13.3 duplication encompassing the PTH2, KCNC3<br />
and KCNA7genes. M. Vincent, C. Jeandel, J. Puechberty,<br />
C. Coubes, F. Dallavale, F. Rivier, A. Schneider, M. Girard,<br />
N. Ruiz, M. Tournaire, I. Touitou, G. Lefort, P. Sarda, D.<br />
Genevieve.<br />
3122F A large deletion confined to COL4A5 causes<br />
Alport syndrome and diffuse leiomyomatosis. M.J.<br />
N. Sá, R. Sousa, F. T. Costa, F. Carvalho, S. Alves, F.<br />
Carvalho, J. P. Oliveira.<br />
3123W Genetic study <strong>of</strong> a family segregating<br />
Waardenburg-Shah syndrome. L. Cui, H. M. Wong, J.<br />
Zhu, F. de Almeida M., P. H. Tam, M.-M. Garcia-Barceló.<br />
3124F Founder effect <strong>of</strong> spinocerebellar ataxia<br />
type 7 in a Mexican population. Y. Tapia-Guerrero,<br />
O. Hernández-Hernández, M. Maldonado-Rodríguez,<br />
C. Cerecedo-Zapata, N. Leyva, L. Velázquez-Pérez, B.<br />
Cisneros, J. J. Magaña.<br />
3125W Study <strong>of</strong> GJB2, GJB6 and MT-RNR1 m.1555A.G<br />
in Mexican hearing loss patients. M. Arenas-Sordo,<br />
I. Menendez, E. Hernández-Zamora, A. Simarci, D.<br />
Gutierrez, P. Murphy, X. Leyva, F. Huesca, J. Dominguez-<br />
Aburto, M. Tekin.<br />
3126F A family with an OPA1 mutation and associated<br />
hearing loss. C. Williams, H. Stalker, S. Schimpf-<br />
Linzenbold, B. Wissinger.<br />
3127W Cerebrocostomandibular syndrome: Clinical<br />
features <strong>of</strong> three new cases and preliminary analysis<br />
<strong>of</strong> exome sequencing data. D. C. Lynch, E. Lemire, B.<br />
Chodirker, A. M. Innes, J. S. Parboosingh, F. P. Bernier,<br />
FORGE Canada Consortium.<br />
3128F Dandy Walker malformation in a boy with Ellis-van<br />
Creveld dysplasia. J. Davis, E. Carter, P. Brill, C. Raggio.<br />
3129W NEK1 and DYNC2H1 are both involved in short<br />
rib polydactyly Majewski type but not in Beemer<br />
Langer cases. J. El Hokayem, C. Huber, A. Couve, J.<br />
Aziza, G. Baujat, R. Bouvier, D. P. Cavalcanti, F. A. Collins,<br />
M. P. Cordier, A. L. Delezoide, M. Gonzales, D. Johnson,<br />
M. Le Merrer, A. Levy-Mozziconacci, P. Loget, D. Martin-<br />
Coignard, J. Martinovic, G. R. Mortier, M. J. Perez, J.<br />
Roume, G. Scarano, A. Munnich, V. Cormier-Daire.<br />
3130F Refsum disease: Genotype-phenotype<br />
correlation <strong>of</strong> a novel PHYH mutation in a Brazilian<br />
patient. L. A. R. Gabriel, J. Chiang, R. C. C. Filho, L. G.<br />
Freitas, M. P. Avila.<br />
3131W Description <strong>of</strong> sclerocornea in a patient with<br />
van den Ende Gupta syndrome and homozygous<br />
mutation in SCARF2. M. Migliavacca, N. Sobreira, G.<br />
Antonialli, M. Moysés, M. Melaragno, D. Valle, D. Brunoni,<br />
A. Perez.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3132F Two brothers with autosomal-recessive primary<br />
hypertrophic osteoarthropathy caused by homozygous<br />
deletion in HPGD gene: Neonatal findings and longterm<br />
follow-up. B. Tüysüz, S. Yilmaz, K. Bilguvar, O.<br />
Kasapçopur, E. Gül, M. Günel.<br />
3133W Germline mosaicism for a 12q24 deletion<br />
identifies haploinsufficiency <strong>of</strong> MED13L as a cause <strong>of</strong><br />
hypotonia and moderate developmental delay. R. C.<br />
Gallagher, S. Scrivner, K. Brown, A. Collins, M. Saenz.<br />
3134F Genetic analysis <strong>of</strong> the GBA gene in Japanese<br />
familial Parkinson’s disease. Y. Li, M. Funayama, T.<br />
Sekine, L. Li, H. Yoshino, K. Nishioka, H. Tomiyama, N.<br />
Hattori.<br />
3135W Manganese-related T1 hyperintensities <strong>of</strong> the<br />
basal ganglia in hereditary hemorrhagic telangiectasia<br />
with iron-deficiency anemia. M. McKinnon, S. Appel-<br />
Cresswell, B. Jung, S. Langlois.<br />
3136F CASK aberrations in males with Ohtahara<br />
syndrome and cerebellar hypoplasia. H. Saitsu, M.<br />
Kato, H. Osaka, N. Moriyama, H. Horita, K. Nishiyama, T.<br />
Yoshinori, H. Doi, N. Miyake, K. Hayasaka, N. Matsumoto.<br />
3137W Unusual presentation <strong>of</strong> combined saggitalmetopic<br />
synostosis is caused by mutations in the<br />
MSX2 gene: Expanding the phenotype <strong>of</strong> the Bostontype<br />
craniosynostosis syndrome. O. M. Vanakker, A.<br />
Janssen, M. J. Hosen, P. Jeannin, P. J. Coucke, A. De<br />
Paepe.<br />
3138F Automated preparation <strong>of</strong> samples for benchtop<br />
sequencing applications. I. Meek.<br />
3139W Neur<strong>of</strong>ibromatosis type 1 and infantile<br />
my<strong>of</strong>ibromatosis: A shared genetic basis or<br />
independently co-existent entities? S. Krishnamurthi, V.<br />
Cox, H. Guo, K. Rauen.<br />
3140F Homozygosity mapping and candidate gene<br />
cloning identified CLDN10 variation to be possibly<br />
responsible for congenital ichthyosis: Renal<br />
hypokalemia in an Algerian family. S. Hadj-Rabia, Y. Al-<br />
Sarraj, M. Kambouris, C. Bodemer, H. El-Shanti.<br />
3141W Homozygous mutation <strong>of</strong> SIX1 associated with<br />
a severe branchio-oto-renal syndrome phenotype. S. L.<br />
Sawyer, M. A. Thomas, R. Lamont, L. Dimnik, P. Gordon,<br />
X. C. Wei, F. P. Bernier, J. S. Parboosingh, A. M. Innes.<br />
3142F Cardiac malformations associated with germline<br />
WT1 mutations in children presenting with Wilms’<br />
tumor. S. Bowdin, C. Owens, D. Malkin, N. Parkinson, M.<br />
Friedburg, R. Grant.<br />
3143W False positive diagnosis <strong>of</strong> Marfan syndrome in<br />
adult patient with homocystinuria who fulfilled Ghent<br />
criteria. S. Dyack, H. MacDonald, K. Schindeler, A. Rideout.<br />
3144F VCP disease is associated with cytokine<br />
imbalances in patient plasma. E. Dec, F. Zaldivar, M.<br />
Wencel, M. Khare, J. Vesa, V. E. Kimonis.<br />
POSTER SESSIONS 241<br />
3145W Further expansion <strong>of</strong> the Chediak-<br />
Higashi phenotype: Three adult siblings with<br />
neurodegenerative disease and homozygous for a<br />
novel LYST deletion. L. Mehta, C. Cho, F. R. Dembitzer, A.<br />
Szporn, M. C. Chicka, J. D. Wesfeld-Adams.<br />
3146F Familial acanthosis nigricans: Phenotypic<br />
features <strong>of</strong> aberrant area cutanea and hyperpigmented<br />
dots identified by dermoscopy. N. Oiso, M. Miyake, K.<br />
Fukai, A. Kawada.<br />
3147W Clinical clues to differentiate among severe<br />
forms <strong>of</strong> osteogenesis imperfecta. P. Prasun, A. Jay, D.<br />
Stockton.<br />
3148F Description <strong>of</strong> a fetal syndrome associated<br />
with HNF1B mutation and a wide intrafamilial disease<br />
variability. M. Rasmussen, I. Vogel, O. B. Petersen, M.<br />
Ramsing, L. Sunde.<br />
3149W Novel molecular changes and their associated<br />
clinical characteristics in Saudi patients with familial<br />
hemophagocytic lymphohistiocytosis. A. Al-Ahmari, O.<br />
Alsmadi, L. Elbaik, T. Elamin, B. Al-Saud, S. Al-Shambri,<br />
M. Al-Awwami, I. Al-Fawaz, M. Ayas, K. Siddiqui, M.<br />
Viqaruddin, A. Hawwari.<br />
3150F Hip pathology in Majewski osteodysplastic<br />
primordial dwarfism type II. M. B. Bober, A. F. Karatas, A.<br />
L. Duker, K. Rogers, C. Ditro, W. G. Mackenzie.<br />
3151W Boyadjiev-Jabs syndrome: Clinical and<br />
molecular characterization <strong>of</strong> three new patients. S. A.<br />
Boyadjiev Boyd, S. Kim, L. Bivina, E. Zackai, P. L. Crotwell,<br />
K. Õunap, J. Kim.<br />
3152F Schinzel-Gideon syndrome in two Brazilian<br />
patients: Report <strong>of</strong> a novel mutation in SETBP1. E. D. F.<br />
Carvalho, M. Lazar, T. F. Almeida, C. R. D. C. Quaio, G. L.<br />
Yamamoto, K. M. Rocha, C. A. Kim, M. R. Passos-Bueno,<br />
D. R. Bertola.<br />
3153W HOXA10 and HOXA13 sequence variations<br />
in human female genital malformations including<br />
congenital absence <strong>of</strong> the uterus and vagina. A. Ekici,<br />
C. Büttner, P. Strissel, P. Oppelt, S. Renner, S. Brucker, M.<br />
Beckmann, R. Strick.<br />
3154F Establishing a paternal age effect for Crouzon<br />
syndrome with acanthosis nigricans. T. Greer, C.<br />
LaDana, P. Barros-Nunez, F. Di Rocco, C. Collet, E. W.<br />
Jabs, R. L. Glaser.<br />
3155W Characterization <strong>of</strong> hyper-IgM syndrome due to<br />
CD40 deficiency in 11 patients. A. Hawwari, H. Alassiri,<br />
Z. Al-Sum, A. Al-Ghonaium, S. Al-Muhsen, H. Al-Dhekri,<br />
R. Arnaout, O. Alsmadi, E. Borrero, A. Abu-staiteh, H. Al-<br />
Mousa, B. K. Al-Saud.<br />
3156F New insights into the renal aspects <strong>of</strong><br />
hypotrichosis-lymphedema-telangiectasia syndrome<br />
caused by a mutation in the SOX18 gene. S. Moalem, M.<br />
Vikkula, E. Harvey, D. Chitayat.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
242 POSTER SESSIONS<br />
3157W Missense and synonymous TCF4 mutations<br />
are responsible for splicing defects in Pitt-Hopkins<br />
syndrome. M. Nasser, L. Drévillon, A. Briand-Suleau,<br />
J. Ghoumid, T. Gaillon, V. Bodereau, L. Pasquier, M.<br />
Goossens, J. Amiel, D. Héron, I. Giurgea.<br />
3158F Clinical genetics in silico: Use <strong>of</strong> an electronic<br />
medical record in an integrated healthcare system<br />
to identify individuals with undiagnosed Noonan<br />
syndrome. M. E. Nunes, R. E. Barber, S. K. Kwok, R. R.<br />
Wilson, D. J. Levy.<br />
3159W Detailed clinical and or<strong>of</strong>acial phenotype <strong>of</strong><br />
three families with compound heterozygous WNT10A<br />
mutations using three-dimensional imaging methods.<br />
C. W. Ockeloen, C. Vink, S. ten Kate, C. van Heumen, T.<br />
Kleefstra, C. Carels.<br />
3160F Tegumentary manifestations in RASopathies<br />
are common and deserve special attention. C. R. D. C.<br />
Quaio, A. S. Brasil, A. C. Pereira, C. A. Kim, D. R. Bertola.<br />
3161W Molecular analysis and expression studies in<br />
a novel candidate gene for syndromic coloboma. N.<br />
K. Ragge, A. Wyatt, D. Robinson, D. Bunyan, D. Wong, I.<br />
Ragoussis.<br />
3162F Variable expressivity <strong>of</strong> FREM1-related<br />
anomalies in a family with novel mutation. A. Singer, A.<br />
Slavotinek, H. Leiba, S. Josefsberg, C. Vinkler.<br />
3163W Identification <strong>of</strong> a KRIT1 p.Gln201Glu mutation<br />
in a Persian family with multiple cerebral, spinal and<br />
skin cavernous malformations. S. M. Sperber, D. Fathi,<br />
M. Shahbazi, M. M. Motahari, B. Friedman, A. Haghighi.<br />
3164F Novel 3q26 EVI1/MECOM deletion syndrome in a<br />
newborn with multiple severe congenital abnormalities<br />
and bone marrow failure. L. T. van der Veken, M. B.<br />
Bierings, M. C. Maiburg, F. Groenendaal, A. C. Bloem, N.<br />
V. Knoers, A. Buijs.<br />
3165W KIAA 2022-related X-linked intellectual deficiency:<br />
Confirmation <strong>of</strong> a discrete entity in five patients. L. Van<br />
Maldergem, V. M. Kalscheuer, M. Doco-Fenzy, A. Medeira, A.<br />
de Brouwer, E. Landais, L. Villard, J. Dupont.<br />
3166F Extending the phenotype spectrum <strong>of</strong> IQSEC2<br />
mutations: Report <strong>of</strong> a patient with IQSEC2 intragenic<br />
duplication and atypical variant <strong>of</strong> Rett syndrome. M.<br />
Willems, F. Tran Mau-Them, J. Puechberty, G. Lefort, A.<br />
Schneider, I. Touitou, M. Girard, M. Tournaire, N. Ruiz-<br />
Pallares, F. Rivier, S. Drunat, P. Sarda, D. Genevieve.<br />
3167W Mutations in TGF-beta binding domains in<br />
the FBN1 gene result in diverse connective tissue<br />
dysplasia syndromes with short stature. K. H. C. Wu, A.<br />
Baxter, J. R. Pinner, D. Mowat, T. Dudding, B. Bennetts, K.<br />
Holman, E. Ormshaw, T. Gayagay, L. C. Adès, C. L. G<strong>of</strong>f, V.<br />
Cormier-Daire, D. O. Sillence.<br />
3168F Clinical and genetic analysis in Chinese patients<br />
with megalencephalic leukoencephalotathy with<br />
subcortical cysts. M. Guo, Y. Jiang, H. Xie, Y. Wu, J.<br />
Shang, Q. Gu, X. Wu, J. Wang.<br />
3169W Skeletal clinical characteristics <strong>of</strong> osteogenesis<br />
imperfecta caused by haploinsufficiency mutations in<br />
COL1A1. I. M. Benamor, P. Roughley, F. H. Glorieux, F. Rauch.<br />
3170F A new dominant frontonasal dysplasia with<br />
major posterior cranial defect. S. Odent, S. Mercier,<br />
M. de Tayrac, J. Mosser, P. Loget, C. Rozel, S. Jaillard,<br />
J. Milon, L. Riffaud, G. Le Bouar, P. Poulain, E. Martin, C.<br />
Dubourg, V. David.<br />
3171W Cerebrovascular changes in a patient with<br />
Noonan syndrome and a RAF1 mutation. Y. Zarate, A.<br />
Lichty, G. Matheus, K. Champion, K. Clarkson, K. Holden.<br />
3172F EFTUD2 haploinsufficiency leads to syndromic<br />
esophageal atresia. J. Amiel, C. Gordon, M. Oufadem, C.<br />
Decaestecker, A.-S. Jourdain, J. Andrieux, V. Malan, J.-L.<br />
Alessandri, C. Baumann, O. Boute-Benejean, B. Delobel,<br />
D. Lacombe, S. Mehta, I. Simonic, F. Escande, N. Porchet,<br />
S. Manouvrier-Hanu, F. Petit, A. Munnich, M. Vekemans, S.<br />
Lyonnet, L. de Pontual, M. Holder-Espinasse.<br />
3173W Al-Awadi/Raas-Rothshild/Schinzel-Fuhrman<br />
spectrum phenotypes in patients with no mutations<br />
in WNT7A. O. Caluseriu, E. Sherridan, K. M. Girisha, J.<br />
Parboosingh, A. M. Innes, F. P. Bernier.<br />
3174F A long polyphenilalanine repeats expansion<br />
in the RUNX2 gene in a patient with cleidocranial<br />
dysplasia. M. Michelson-Kerman, E. Leshinsky-Silver, D.<br />
Lev, A. Singer, C. Vinkler.<br />
3175W Novel mutation in the ADAMTSL4 gene in a child<br />
with bilateral ectopia lentis and aortic root dilatation:<br />
Expandingthe phenotype? R. L. Sanchez, Z. Ammous,<br />
P. Jayakar.<br />
3176F Mutations in DMD gene identified during clinical<br />
evaluation <strong>of</strong> patients with autism and/or global<br />
developmental delay. J. Moeschler, S. Upton, J. Ozmore.<br />
3177W Copy number variants in monozygotic twins<br />
with neur<strong>of</strong>ibromatosis 1. E. Schorry, E. Sites, D.<br />
Viskochil, D. Stevenson, N. Ullrich, T. Smolarek, L. Martin.<br />
3178F A novel synonymous mutation causing aberrant<br />
splicing on the SLC26A4 gene in a Korean patient with<br />
a hearing loss. Y. Kim, J. Kim, J. Y. Choi, K.-A. Lee.<br />
3179W Overlapping anophthalmia syndromes: SOX2,<br />
the new kid on the block. A. Schneider, T. Bardakjian.<br />
3180F Distinct clinical and neurological features in a<br />
Korean boy with Schinzel - Giedion syndrome caused<br />
by a de novo SETBP1 mutation. J. M. Ko, B. C. Lim, K. J.<br />
Kim, Y. S. Hwang, C. H. Chae.<br />
3181W Crisponi syndrome in a Turkish newborn: A<br />
possible founder mutation in the CRLF1 gene? V.<br />
Benoit, P. Hilbert, M. Deprez, A. Charon, I. Maystadt, S.<br />
Moortgat.<br />
3182F Interference with IS-PCR assays for Inv22<br />
testing <strong>of</strong> hemophilia A. T. Lewis, G. Pont-Kingdon, Y.<br />
Louie, J. Swenson.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3183W Complex ear abnormalities, choanal atresia,<br />
coloboma and renal hypoplasia in a patient with<br />
mutations in CHD7 and EYA1 and microdeletion <strong>of</strong><br />
2q23.1. R. Badilla-Porras, L. Dupuis, T. Stockley, D. J.<br />
Stavropoulos, R. Mendoza-Londono.<br />
3184F Severe CHST3 mutations in two Brazilian<br />
families with spondyloepiphyseal dysplasia with<br />
congenital joint dislocations. W. A. R. Baratela, T. F.<br />
Almeida, G. L. Yamamoto, J. H. Marques, O. Letaif, A. C.<br />
Pereira, C. A. Kim, D. R. Bertola.<br />
3185W Computer-aided facial recognition <strong>of</strong><br />
individuals with FG (Opitz-Kaveggia) syndrome caused<br />
by p.Arg961Trp mutation in MED12. L. Basel-Vanagaite,<br />
L. Karlinsky, L. Wolf, M. Shohat, C. Skinner, C. Rogers, R.<br />
Stevenson, C. M. Schwartz, J. M. Graham, Jr.<br />
3186F Hand abnormalities in Loeys-Dietz syndrome:<br />
Expanding the clinical spectrum. B. Chung, A. Hinek, T.<br />
Bradley, L. Grossse-Wortmann, S. Blaser, D. Chitayat.<br />
3187W Gorlin syndrome: Three unrelated female Mexican<br />
cases. N. O. Dávalos, S. A. Alonso Barragan, I. M. Salazar-<br />
Dávalos, M. A. Aceves-Aceves, S. A. Ramirez-Garcia, L. R.<br />
Topete -Gonzalez, D. A. Fierro-Rodriguez, D. M. Prado, A. R.<br />
Rincon-Sanchez, I. P. Dávalos, D. García-Cruz.<br />
3188F Diamond-Blackfan anemia: A case report and<br />
seven-year follow up. M. G. González-Mercado, L.<br />
Bobadilla-Morales, N. O. Dávalos, D. García-Cruz, A. Corona-<br />
Rivera, C. E. Monterrubio-Ledezma, I. M. Salazar-Dávalos, A.<br />
González-Mercado, M. A. Aceves-Aceves, I. P. Dávalos.<br />
3189W Familial Beare-Stevenson cutis gyrata<br />
syndrome in the absence <strong>of</strong> craniosynostosis. E. Leon,<br />
J. Jung, M. Ririe, D. Stevenson.<br />
3190F Report <strong>of</strong> a novel mutation in the SLC26A2 gene<br />
found in a Colombian adult patient with diastrophic<br />
dysplasia. T. Pineda, A. Rossi, L. Bonafè, A. Superti-<br />
Furga, H. Velasco.<br />
3191W Intragenic NSD1 duplication <strong>of</strong> exons 14-17 in a<br />
patient with Sotos syndrome. S. Ramanathan, R. D. Clark.<br />
3192F Craniosynostosis as a bone anomaly <strong>of</strong> Kabuki<br />
syndrome. A. Shimada, I. Tamada, H. Yoshihashi.<br />
3193W The variable spectrum <strong>of</strong> SMAD4 mutations. J.<br />
van den Ende, N. Van der Aa, T. Boiy.<br />
3194F A new frontonasal dysplasia syndrome<br />
associated with SIX2 deletion. S. L. Zimmerman, H. M.<br />
Saal, Z. M. Ahmed, R. B. Hufnagel.<br />
3195W Importance <strong>of</strong> or<strong>of</strong>acial features and the role<br />
<strong>of</strong> dentistry in the early diagnosis <strong>of</strong> developmental<br />
disorders. Z. ÷ncel Torun, D. Torun, K. Karaer, R. O. Rosti.<br />
3196F Renin receptor/ATP6AP2 gene mutation: An<br />
X-linked cause <strong>of</strong> mental retardation, postnatal<br />
microcephaly and intractable seizures. D. Chitayat, K.<br />
Sirewanda, R. Mendoza, S. Blaser, J. Raiman, J. Jessen,<br />
E. Donner, C. Schwartz.<br />
POSTER SESSIONS 243<br />
3197W SCN1B sequence variations in Iranian patients<br />
with epilepsy, causality or susceptibility? A. Ebrahimi,<br />
M. Moghaddasi, M. Houshmand, S. Zeinali, S. H.<br />
Tonekaboni, M. S. Fallah, M. Mamarabadi.<br />
3198F A novel KCNQ2 mutation in a Mexican-<strong>American</strong><br />
family with benign familial neonatal convulsions. A.<br />
Sznewajs, E. Rider, E. Sherr.<br />
3199W Coronal craniosynostosis and radial ray<br />
hypoplasia: A third report <strong>of</strong> TWIST mutation in a<br />
33-week fetus with diaphragmatic hernia. J. Piard, C.<br />
Collet, F. Arbez-Gindre, L. Van Maldergem.<br />
3200F Identification <strong>of</strong> a novel gene causing fetal<br />
akinesia deformation sequence. M. M. Weiss, G. Tan, M.<br />
Smit, J. I. de Vries, J. P. vd Voorn, I. Kluijt, E. Sistermans,<br />
H. Meijers-Heijboer, S. Gr<strong>of</strong>fen, Q. Waisfisz.<br />
3201W Identification <strong>of</strong> a new syndrome with severe type<br />
<strong>of</strong> cutaneous photosensitivity, mild mental retardation<br />
and short stature caused by KIAA1530 (UVSSA) gene. R.<br />
Sharifi, A. Ahmadi, E. Ozkan, R. Maro<strong>of</strong>ian.<br />
3202F Infantile cerebral and cerebellar atrophy<br />
population screening using PCR-RFLP method. V. Adir,<br />
E. Shahak, E. Golinker, N. Ekhilevitch, Z. U. Borochowitz.<br />
3203W Genotype-phenotype correlation <strong>of</strong> enlarged<br />
vestibular aqueduct syndrome. R. Birkenhager, S. Arndt,<br />
W. Maier, A. Aschendorff, E. Löhle, R. Laszig.<br />
3204F Molecular diagnosis <strong>of</strong> congenital muscular<br />
dystrophies with defective glycosylation <strong>of</strong> alpha<br />
dystroglycan using next-generation sequencing<br />
technology. J. Chae, B. Lim, J. Ko, J. Choi, M. Wo, W.<br />
Park, B. Min.<br />
3205W Various clinical manifestations in 40 cases with<br />
type 1 neur<strong>of</strong>ibromatosis. C. K. Cheon.<br />
3206F Mutation analysis results <strong>of</strong> 5� reductase type<br />
2 enzyme deficiency patients. H. Onay, D. Goksen, A.<br />
Aykut, F. Hazan, S. Darcan, F. Ozkinay.<br />
3207W Griscelli syndrome with RAB 27A mutation and<br />
prenatal diagnosis. I. Panigrahi, R. Suther, B. Behera, A.<br />
Rawat, R. Marwaha.<br />
3208F Molecular diagnosis <strong>of</strong> rare Mendelian diseases<br />
using whole exome sequencing. B. Rodríguez-Santiago,<br />
S. Boronat, J. Argente, I. Valenzuela, M. del Campo, L. A.<br />
Perez-Jurado, L. Armengol.<br />
3209W Next-generation sequencing for low and<br />
high-bone density disorders. G. Sule, P. Campeau, S.<br />
Nagamani, B. Dawson, M. Grover, C. Bacino, J. Lu, E.<br />
Lemire, R. Gibbs, D. Cohn, V. Zhang, L. Wong, B. Lee.<br />
3210F Molecular diagnosis <strong>of</strong> autosomal dominant<br />
polycystic kidney disease using massively parallel<br />
sequencing. Y. Tan, A. Michaeel, G. Liu, J. Blumenfield, S.<br />
Donahue, T. Parker, D. Levine, H. Rennert.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
244 POSTER SESSIONS<br />
3211W Genotype-phenotype correlation in Bardet-<br />
Biedl syndrome. E. Forsythe, K. Sparks, M. S. B. Huda,<br />
J. Hazlehurst, S. Mujahid, P. Carroll, B. McGowan, J. W.<br />
Tomlinson, S. Mohammed, P. L. Beales.<br />
3212F Photoreceptor loss in LCR-deletion associated<br />
blue cone monochromacy: Implications for gene<br />
therapy. R. B. Hufnagel, A. Dubra, R. A. Sisk, J. C.<br />
Gardner, S. Riazuddin, A. J. Hardcastle, A. T. Moore, J.<br />
Neitz, M. Michaelides, M. Neitz, J. Carroll, Z. M. Ahmed.<br />
3213W VCP-associated inclusion body myopathy<br />
with Paget disease <strong>of</strong> bone and/or frontotemporal<br />
dementia: Expanding natural history and genotypephenotype<br />
characterization. M. Khare, S. G. Mehta, R.<br />
Ramani, G. J. Watts, B. Martin, M. Simon, K. E. Osann, S.<br />
Donkervoort, E. Dec, A. Nalbandian, A. Wang, T. Mozaffar,<br />
C. D. Smith, V. E. Kimonis.<br />
3214F A novel short stature syndrome caused by<br />
defects in glycosaminoglycan synthesis due to altered<br />
xylosyltransferase 1 activity. J. Schreml, B. Durmaz,<br />
O. Çog˘ ulu, K. Keupp, F. Beleggia, E. Pohl, E. Milz, G.<br />
Nürnberg, P. Nürnberg, J. Kuhn, M. Coker, S. Kalkan Ucar,<br />
F. Özkinay, B. Wollnik.<br />
3215W Case studies for the clinical diagnosis <strong>of</strong> rare,<br />
congenital, pediatric disorders by whole genome<br />
sequencing. S. Szelinger, V. Narayanan, H. Boman, A. F.<br />
Hahn, J. J. Corneveaux, A. L. Siniard, A. A. Kurdoglu, M. J.<br />
Huentelman, D. W. Craig.<br />
3216F Variable phenotypic spectrum in a cohort<br />
<strong>of</strong> patients with ARID1B mutations. S. Boulanger, L.<br />
Mariage, D. Lederer, S. Moortgat, A. Destree, P. Hilbert, I.<br />
Maystadt.<br />
3217W Whole exome sequencing in patients with<br />
intellectual disabilities. I. Madrigal, U. Liljedahl, M. I.<br />
Alvarez, O. Karlberg, L. Rodriguez-Revenga, A. Mur, A.-C.<br />
Syvänen, M. Mila.<br />
3218F Identification <strong>of</strong> the p.A140V mutation in MECP2<br />
gene in a family with non specific X-linked mental<br />
retardation. I. Maystadt, S. Boulanger, P. Vrielynck, S.<br />
Moortgat, A. Destree, D. Lederer.<br />
3219W Whole exome sequencing identifies titin (TTN)<br />
mutations as a cause <strong>of</strong> centronuclear myopathy.<br />
O. Ceyhan, P. B. Agrawal, K. Schmitz, E. DeChene, K.<br />
Markianos, A. H. Beggs.<br />
3220F Unexpected EGFR3 variants confounding<br />
achondroplasia mutation detection. A. Millson, A. F.<br />
Rope, E. Lyon.<br />
3221W Analysis <strong>of</strong> C9orf72 repeat expansion in<br />
Japanese patients with ALS. K. Ogaki, Y. Li, N. Atsuta,<br />
H. Tomiyama, M. Funayama, H. Watanabe, R. Nakamura,<br />
H. Yoshino, S. Yato, A. Tamura, Y. Naito, A. Taniguchi, K.<br />
Fujita, Y. Izumi, R. Kaji, N. Hattori, G. Sobue, Japanese<br />
Consortium for Amyotrophic Lateral Sclerosis Research<br />
(JaCALS).<br />
3222F Three pycnodysostosis cases with a novel<br />
mutation in cathepsin K gene. T. Ozdemir, T. Atik, E.<br />
Karaca, H. Onay, F. Ozkinay, O. Cogulu.<br />
3223W Application <strong>of</strong> next-generation sequencing for<br />
mutation detection in autosomal dominant polycystic<br />
kidney disease. H. C. Park, A. Kang, J. Y. Jang, Y. Hwang,<br />
H. Kim, M. Han, D. K. Kim, K. Oh, W. Park, H. I. Cheong,<br />
C. Ahn.<br />
3224F Whole exome sequencing identifies a missense<br />
mutation in SEPT2 as a probable cause <strong>of</strong> a new<br />
autosomal dominant syndrome with distinctive face,<br />
ear anomalies, and learning disability. A. Rump,<br />
K. Hackmann, A. Dahl, A. Fischer, M. Schweiger, M.<br />
Schilhabel, A. ElSharawy, A. Franke, E. Schrock, N. Di<br />
Donato.<br />
3225W Oculocutaneous albinism (OCA1A/B): Founder<br />
mutations in the tyrosinase gene in Colombia. O.<br />
Urtatiz, D. Sanabria, M. C. Lattig.<br />
3226F Ophthalmologic findings in Mexican patients with<br />
myotonic dystrophy type I. P. Barojas, J. J. Magaña,<br />
G. Ortega, N. Leyva, B. Cisneros, O. Hernández-Hernández,<br />
E. Barojas.<br />
3227W Molecular diagnosis <strong>of</strong> myotonic dystrophy<br />
type I by PCR Southern method. G.-H. Kim, J.-J. Lee,<br />
S.-H. Choi, J.-Y. Lee, J.-M. Kim, Y.-M. Kim, B. H. Lee,<br />
H.-W. Yoo.<br />
3228F Mutations in FOXP2 cause childhood apraxia<br />
<strong>of</strong> speech: Report <strong>of</strong> a novel intragenic deletion in<br />
an Australian patient. M. S. Hildebrand, S. Turner, J.<br />
Damiano, R. J. H. Smith, M. Bahlo, I. E. Scheffer, A. T.<br />
Morgan.<br />
3229W Exome sequencing identifies a novel MRE11<br />
mutation in a patient with generalized myoclonic<br />
tremor. R. Miyamoto, H. Morino, H. Maruyama, Y. Izumi,<br />
R. Kaji, H. Kawakami.<br />
3230F Pathophysiological features <strong>of</strong> dermatan<br />
4-O-sulfotransferase 1-deficient Ehlers-Danlos<br />
syndrome. T. Kosho, S. Mizumoto, M. Kobayashi, Y.<br />
Fujita, J. Nakayama, N. Miyake, Y. Nomura, A. Hatamochi,<br />
Y. Fukushima, K. Sugahara, N. Matsumoto.<br />
3231W Rupture <strong>of</strong> chordae tendineae as an initial<br />
presentation <strong>of</strong> an haploinsufficiency mutation in<br />
COL3A1. Z. Xu, B. F. Griswold, L. J. Sloper, A. S. Shah, N.<br />
B. McDonnell.<br />
3232F Prenatal diagnosis and identification <strong>of</strong><br />
heterozygous frameshift mutation in PRRX1 in an infant<br />
with agnathia-otocephaly. M. Donnelly, E. Todd, M.<br />
Wheeler, V. D. Winn, D. Kamnasaran.<br />
3233W Identification <strong>of</strong> the disease causing gene in<br />
a familial autosomal recessive form <strong>of</strong> congenital<br />
nystagmus by exome sequencing. B. Isidor, J.<br />
Albuisson, S. Bezieau.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3234F Identification <strong>of</strong> X-linked RPGR ORF15<br />
mutations in females diagnosed with autosomal<br />
dominant retinitis pigmentosa. J. D. Churchill, S. J.<br />
Bowne, L. S. Sullivan, R. A. Lewis, D. K. Wheaton, D. G.<br />
Birch, K. E. Branham, J. R. Heckenlively, S. P. Daiger.<br />
3235W A recurrent 143 kb duplication in TSPAN7 as<br />
a possible cause <strong>of</strong> intellectual disability. J. Hoyer, M.<br />
Krumbiegel, C. Kraus, A. Reis.<br />
3236F Alpha thalassemia /mental retardation X linked:<br />
An uncommon presentation. U. H. Kotecha, R. Puri, C.<br />
Badens, I. C. Verma.<br />
3237W Proteolipid protein 1 gene mutation in 44<br />
Chinese patients with Pelizaeus-Merzbacher disease<br />
and prenatal diagnosis <strong>of</strong> five fetuses in three Chinese<br />
families with PMD probands. J. Wang, D. Li, Y. Wu, H.<br />
Zhao, J. Shang, J. Qin, F. Fang, X. Wu, Y. Jiang.<br />
3238F Four years <strong>of</strong> data from the California Cystic<br />
Fibrosis Newborn Screening <strong>Program</strong> and experiences<br />
<strong>of</strong> the Sutter CF Center. M. Tsang, B. Chipps, M.<br />
Kharrazi, K. Pearson, S. O’Bra.<br />
3239W Polymicrogyria awareness is a critical first<br />
step in facilitating early diagnosis and intervention for<br />
those affected by this rare congenital brain anomaly. C.<br />
Byrge, A. Perszyk, PMG Awareness Organization, Inc.<br />
3240F Novel KIF7 mutations extend the phenotypic<br />
spectrum <strong>of</strong> acrocallosal syndrome. A. Putoux, S.<br />
Nampoothiri, V. Cormier-Daire, N. Laurent, P. Beales, A.<br />
Schnizel, D. Bartholdi, C. Alby, S. Thomas, N. Elkhartoufi, J.<br />
Litzler, F. Encha-Razavi, R. Kannan, A. Munnich, L. Faivre,<br />
N. Boddaert, A. Rauch, M. Vekemans, T. Attie-Bitach.<br />
3241W Goldberg-Shprintzen syndrome: KBP, the<br />
KIAA1279 encoding protein, is located to cytoskeleton,<br />
but not to mitochondria. L. Drévillon, A. Megarbane, B.<br />
Demeer, C. Matar, P. Benit, A. Briand-Suleau, J. Ghoumid,<br />
M. Nasser, V. Bodereau, M. Doco-Fenzy, P. Rustin, D.<br />
Gaillard, M. Goossens, I. Giurgea.<br />
3242F Crani<strong>of</strong>acial and dental development in cardi<strong>of</strong>acio-cutaneous<br />
syndrome: The importance <strong>of</strong> Ras<br />
signaling homeostasis. A. Goodwin, S. Oberoi, M.<br />
Landan, C. Charles, J. Groth, A. Martinez, C. Fairley, W. E.<br />
Tidyman, L. A. Weiss, O. D. Klein, K. A. Rauen.<br />
3243W Sotos syndrome diagnosis confirmed by aCGH.<br />
F. I. Sahin, Y. K. Terzi, M. Derbent.<br />
3244F Expanding (or narrowing) the phenotype <strong>of</strong><br />
Beckwith-Wiedemann syndrome. E. Todd, G. Bellus.<br />
3245W Genetic studies in VACTERL association.<br />
J. Winberg, P. Gustavsson, E. Sahlin, G. Annerén,<br />
E. Iwarsson, P.-J. Svensson, F. Bradley, E. Nordenskjöld,<br />
N. Papadogiannakis, A. Nordgren, A. Nordenskjöld.<br />
3246F A homozygous AHI1 mutation in a Moroccan<br />
consanguineous Joubert syndrome family. L. Baala, S.<br />
Chafai Elalaoui, M. Chalon, N. Elkhartoufi, M. Mansouri, Y.<br />
Kriouele, O. Perche, S. Briault, T. Attie, A. Sefiani.<br />
POSTER SESSIONS 245<br />
3247W Twin discordance and congenital<br />
hydrocephalus. C. Lee, J. T. C. Shieh.<br />
3248F Hallermann-Streiff Syndrome: Case report from<br />
Mongolia. P. Erkhembulgan, M. Purevdorj, T. Altansukh, I.<br />
Purevdorj.<br />
3249W Global gene pr<strong>of</strong>iling identifies a novel<br />
cytoskeleton pathway involved in VCP-associated<br />
myopathy. A. Nalbandian, S. Ghimbovschi, S. Radom-<br />
Aizik, E. H<strong>of</strong>fman, V. Kimonis.<br />
3250F External validation <strong>of</strong> the Bartholdi clinical<br />
scoring system for Silver-Russell syndrome: A report<br />
<strong>of</strong> a Brazilian cohort. G. L. Yamamoto, A. Bonaldi, A. M.<br />
Vianna-Morgante, I. Gomy, C. A. Kim, D. R. Bertola.<br />
Evolutionary and Population <strong>Genetics</strong><br />
3251W Copy number differences <strong>of</strong> putative regulatory<br />
elements shape primate expression pr<strong>of</strong>iles. R. Iskow,<br />
O. Gokcumen, A. Abyzov, J. Malukiewicz, Q. Zhu, A.<br />
T. Sukumar, A. A. Pai, R. E. Mills, L. Habegger, D. A.<br />
Cusanovich, M. A. Rubel, G. H. Perry, M. Gerstein, A. C.<br />
Stone, Y. Gilad, C. Lee.<br />
3252T Linkage disequilibrium, population structuring<br />
and genome-wide association studies reveal<br />
metabolism and crani<strong>of</strong>acial dysmorphology mutations<br />
in the domestic cat. L. A. Lyons, H. Alhaddad, B.<br />
Gandolfi, R. A. Grahn.<br />
3253F Genome-wide scan for identifying selection<br />
footprints in immune related pathways. J. Molineros,<br />
S. Nath.<br />
3254W Signatures <strong>of</strong> selection surrounding large<br />
insertions and deletions in coding regions identified<br />
between modern and Denisovan humans, as well<br />
as four other species <strong>of</strong> primates genome-wide. W.<br />
Guiblet, K. Zhao, D. Ferrer-Torres, C. T. Ruiz-Rodriguez, A.<br />
Roca, S. Massey, J. C. Martínez-Cruzado, T. Oleksyk.<br />
3255T An optimized panel for ancestry informative<br />
markers derived from the Mexican Genome Diversity<br />
Project. J. C. Fernandez-Lopez, A. V. Contreras, M. J.<br />
Gómez-Vázquez, C. Rangel-Escareño, I. Silva-Zollezzi.<br />
3256F A fish-specific transposable element shapes the<br />
repertoire <strong>of</strong> p53 target genes in zebrafish. M. N. Loviglio,<br />
L. Micale, M. Manzoni, C. Fusco, B. Augello, E. Migliavacca,<br />
G. Cotugno, E. Monti, G. Borsani, A. Reymond, G. Merla.<br />
3257W Meiotic recombination hotspots in humans:<br />
Dynamics and controlling factors. L. Odenthal-Hesse,<br />
A. J. Jeffreys.<br />
3258T The MHC linkage haplotype in the Finnish<br />
population. A. Wennerström, M. L. Lokki, MHC Disease<br />
Research Group.<br />
3259F Fine-scale mapping <strong>of</strong> meiotic recombination in<br />
Mongolians and Koreans. T. Bleazard, Y. S. Ju, J. Sung,<br />
J. S. Seo.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
246 POSTER SESSIONS<br />
3260W Heterogeneity in recombination among African<br />
populations. M. Capredon, J. Hussin, J. Quinlan, Y.<br />
Idaghdour, L. Barreiro, T. de Malliard, J. C. Grenier, E.<br />
Gbeha, P. Awadalla.<br />
3261T Linkage disequilibrium patterns in a Brazilian<br />
population: A comparison <strong>of</strong> X chromosome STR<br />
markers with autosomal and Y chromosome STR<br />
markers. S. Oliveira, C. Mendes-Júnior, A. Trindade-Filho.<br />
3262F Association <strong>of</strong> (CCTTT)n polymorphism in the<br />
NOS2A gene with tuberculosis in two population<br />
groups <strong>of</strong> India. M. Jena, P. Das, R. Bamezai.<br />
3263W Purifying selection in mitochondrial proteincoding<br />
genes is highly effective in mammals and<br />
congruent with evolution <strong>of</strong> nuclear genes. S. I.<br />
Nikolaev, K. Popadin, T. Junier, M. Baranova, S. E.<br />
Antonarakis.<br />
3264T Molecular phylogeny <strong>of</strong> an autosomal region<br />
under natural selection. V. A. Canfield, A. Berg, S.<br />
Peckins, S. Oppenheimer, K. C. Cheng.<br />
3265F MtDNA analysis <strong>of</strong> global populations supports<br />
that major population expansions began before<br />
Neolithic time. H. Zheng, S. Yan, Z. Qin, L. Jin.<br />
3266W Different DNA methylation <strong>of</strong> FOXP2 target<br />
genes in adult cortices <strong>of</strong> humans and chimpanzees.<br />
U. Zechner, D. Seifert, E. Schneider, N. El Hajj, B. Navarro,<br />
I. Kondova, R. E. Bontrop, O. Bartsch, T. Haaf.<br />
3267T Skin color variation in the Orang Asli Tribes <strong>of</strong><br />
Peninsular Malaysia. K. C. Ang, M. S. Ngu, K. P. Reid,<br />
M. S. Teh, A. S. Zamzuraida, D. X. R. Koh, A. Berg, S.<br />
Oppenheimer, S. Hood, M. M. Clyde, B. M. Md-Zain, V. A.<br />
Canfield, K. C. Cheng.<br />
3268F Exome and RNA sequencing <strong>of</strong> French-<br />
Canadians reveals an excess <strong>of</strong> rare variants that are<br />
enriched at functionally important sites. A. Hodgkinson,<br />
F. Casals, Y. Idaghdour, J. Hussin, V. Bruat, T. de Malliard,<br />
J.-C. Grenier, J.-P. Goulet, E. Gbeha, E. Hip-Ki, S. Girard,<br />
J.-F. Spinella, V. Saillour, D. Sinnett, G. Rouleau, P.<br />
Awadalla.<br />
3269W Evidence for selection at the BDNF Val66Met<br />
polymorphism in 1000 Genomes Project populations.<br />
C. V. Van Hout, A. G. Clark.<br />
3270T Mobile element evolution <strong>of</strong> the Callithrix<br />
jacchus (common marmoset). M. K. Konkel, J. A.<br />
Walker, B. Ullmer, R. Hubley, A. F. A. Smit, M. A. Batzer for<br />
Marmoset Genome Sequencing and Analysis Consortium.<br />
3271F Association <strong>of</strong> GSTT1, MI and M3 gene<br />
polymorphism with age and quantity <strong>of</strong> smoke in<br />
Northern Indian COPD patients. R. K. Shukla, S. Kant, S.<br />
Bhattacharya, B. Mittal.<br />
3272W Polymorphic miRNA genomic sequences<br />
embedded in CNV sites: A prospective screening in<br />
Brazilian admixed population sample. T. C. L. Lins, D. E.<br />
Jimenez, A. P. M. Barbosa, R. W. Pereira.<br />
3273T Ascertainment bias in microsatellites: Impact on<br />
estimates <strong>of</strong> mutation rates. B. Li, M. Kimmel.<br />
3274F Characterizing recent evolutionary changes on<br />
the human lineage using the high-coverage Denisovan<br />
genome. F. Racimo, M. Kircher, J. Kelso, S. Pääbo,<br />
Archaic Genome Analysis Consortium.<br />
3275W Recurrent tissue-specific mtDNA mutations are<br />
common in humans. S. M. Williams, D. C. Samuels, B. Li,<br />
Z. Song, E. Torstenson, A. Rokas, T. A. Thornton-Wells, J.<br />
H. Moore, T. M. Hughes, R. D. H<strong>of</strong>fman, J. L. Haines, D. P.<br />
Mortlock, C. Li.<br />
3276T Associations <strong>of</strong> human leukocyte antigen G with<br />
resistance and susceptibility to HIV-1 infection in the<br />
Pumwani Sex Worker Cohort. M. Luo, W. Turk, J. Kimani,<br />
C. Wachihi, T. Bielawny, T. Ball, F. Plummer.<br />
3277F Alleles at the rs3212368 SNP at the 3’UTR <strong>of</strong> the<br />
MC1R gene are associated with human pigmentation<br />
by possible microRNA influence. L. A. Marano, A. L.<br />
Simões, E. A. Donadi, C. T. Mendes-Junior.<br />
3278W Targeted re-sequencing <strong>of</strong> 328 inherited<br />
disease-associated genes in a family trio and HapMap<br />
populations using the Ion AmpliSeq Inherited<br />
Disease Panel and Ion PGM semiconductor<br />
sequencing. I. Casuga, B. Kong, D. Joun, S.-M. Chen,<br />
C.-Y. Li, D. Ruff, R. Bennet, M. Shannon.<br />
3279T Sequencing <strong>of</strong> an extended pedigree in Western<br />
chimpanzees. O. Venn, I. Turner, Z. Iqbal, I. Mathieson, N.<br />
de Groot, G. McVean.<br />
3280F Allelic and genotypic associations <strong>of</strong> SNPs <strong>of</strong><br />
the OCA2 and HERC2 genes with eye, hair and skin<br />
pigmentation and the presence <strong>of</strong> freckles in Brazil. E.<br />
S. Andrade, N. C. A. Fracasso, P. S. Strazza Júnior, A. L.<br />
Simões, C. T. Mendes-Junior.<br />
3281W AKT3, ANGPTL4, eNOS3, and VEGFA<br />
associations with high altitude sickness in Han and<br />
Tibetan Chinese at the Qinghai-Tibetan Plateau. N.<br />
Buroker, X.-H. Ning, Z.-N. Zhou, K. Li, W.-J. Cen, X.-F. Wu,<br />
W.-Z. Zhu, C. R. Scott, S.-H. Chen.<br />
3282T A population genetic measure <strong>of</strong> the de novo<br />
mutation rate using identity-by-descent estimates. C. W.<br />
K. Chiang, J. Li, M. G. Ehm, M. R. Nelson, J. Novembre.<br />
3283F Determination <strong>of</strong> PON1 and P2RY12<br />
polymorphisms distribution in Hungary living<br />
population samples. B. Melegh, I. Janicsek, Cs. Sipeky,<br />
B. Duga, B. I. Melegh, L. Jaromi, L. Magyari, J. Bene.<br />
3284W Mapping the genetic diversity <strong>of</strong> HLA haplotype<br />
in Asia populations. W. Y. Saw, R. T. H. Ong, C. C. Khor,<br />
N. Kato, Y. Y. Teo.<br />
3285T Long runs <strong>of</strong> homozygosity contain a higher<br />
fraction <strong>of</strong> all genome-wide deleterious homozygotes<br />
relative to the fraction <strong>of</strong> all genome-wide nondamaging<br />
homozygotes. Z. A. Szpiech, J. Xu, T. J.<br />
Pemberton, W. Peng, S. Zöllner, N. A. Rosenberg, J. Z. Li.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3286F The genetic structure <strong>of</strong> Western Balkan<br />
populations based on autosomal and haploid markers.<br />
K. Tambets, L. Kovacevic, D. Primorac, G. Lauc, A.<br />
Leskovac, Z. Jakovski, K. Drobnic, S. Kovacevic, T. Bego,<br />
E. Metspalu, D. Marjanovic, R. Villems.<br />
3287W Analysis <strong>of</strong> TLR4 SNPs 299 and 399 in a<br />
population <strong>of</strong> full-term Wisconsin infants. D. Pillers, J.<br />
DeValk, M. Baker, S. Schrodi, S. Tokarz.<br />
3288T Using Time to Most Recent Common Ancestor<br />
to detect selection in population samples <strong>of</strong> wholegenome<br />
sequences. H. Hunter-Zinck, A. G. Clark.<br />
3289F Estimating inbreeding coefficients from NGS<br />
data: Impact on genotype calling and allele frequency<br />
estimation. F. G. Vieira, M. Fumagalli, A. Albrechtsen, R.<br />
Nielsen.<br />
3290W Maternal genetic variation near PRKAA1<br />
and EDNRA is associated with birth weight among<br />
residents <strong>of</strong> high altitude. A. W. Bigham, M. J. Wilson,<br />
V. A. Browne, C. G. Julian, E. Vargas, C. Rodriquez, M. D.<br />
Shriver, L. G. Moore.<br />
3291T Selective turnover in human regulatory regions:<br />
Out with the old, in with the new. L. D. Ward, M. Kellis,<br />
ENCODE Project Consortium.<br />
3292F Signs <strong>of</strong> high populational differentiation on the<br />
major histocompatibility complex region on Native<br />
South <strong>American</strong> populations. K. Nunes, E. J. M. Santos,<br />
J. F. Guerreiro, D. Meyer.<br />
3293W High diversity <strong>of</strong> ADH1B gene among the<br />
Tibetans. L. Kang, L. Yan, K. Hu, F. Chen, H. Li.<br />
3294T Natural selection increases mutational<br />
robustness in complex diseases: Mendelian evidence<br />
from early versus late onset common diseases. B. E.<br />
Baysal.<br />
3295F Evolutionary role <strong>of</strong> the human skull: comparing<br />
neutral and selective markers. D. V. Bernardo, T. F.<br />
Almeida.<br />
3296W Characterization <strong>of</strong> human-specific duplicated<br />
neural genes suggests a model <strong>of</strong> functional<br />
antagonism. M. Y. Dennis, F. Antonacci, C. Golzio, J.<br />
Huddleston, T. A. Graves, P. H. Sudmant, D. W. Raible, N.<br />
Katsanis, R. K. Wilson, E. E. Eichler.<br />
3297T A genetic mechanism for Tibetan high-altitude<br />
adaptation. C. D. Huff, F. R. Lorenzo, M. Myllymäki, S.<br />
Swierczek, M. E. Salama, G. L. Semenza, V. Gordeuk, J.<br />
Xing, T. S. Simonson, L. B. Jorde, P. Koivunen, J. T. Prchal.<br />
3298F Selection and migration in spatially structured<br />
populations. I. Mathieson, G. McVean.<br />
3299W Evidence <strong>of</strong> recent positive selection in<br />
Africans at known and novel BMI loci. T. Edwards, G.<br />
J. Papanicolaou, K. North, D. R. Velez Edwards, African<br />
<strong>American</strong> BMI Consortium.<br />
POSTER SESSIONS 247<br />
3300T Characterizing the adaptation to high altitude in<br />
Tibetans. E. Huerta-Sanchez, X. Jin, B. Peter, Y. Liang, M. He,<br />
X. Yi, A. Asan, Y. Shan, P. Ni, J. Wang, R. Nielsen, J. Wang.<br />
3301F Recent positive selection <strong>of</strong> HLA-DPB1*04:01<br />
in Japanese population. M. Kawashima, J. Ohashi, N.<br />
Nishida, K. Tokunaga.<br />
3302W Haplotype signatures <strong>of</strong> negative selection. D.<br />
Ortega Del Vecchyo, J. Novembre.<br />
3303T Genome-wide signatures <strong>of</strong> natural selection in<br />
diverse African populations. L. B. Scheinfeldt, S. Soi, C.<br />
Lambert, D. Hu, A. Coulibaly, H. Hutton, C. Elbers, W. Ko,<br />
W. Beggs, A. Ranciaro, S. Thompson, J. Hirbo, J. Bodo, O.<br />
Doumbo, M. Ibrahim, A. Froment, G. Lema, T. Nyambo, S.<br />
Omar, C. Wambebe, D. Meskel, G. Belay, S. A. Tishk<strong>of</strong>f.<br />
3304F Contrasting selective forces shaping the type-II<br />
C-type lectin receptor family. H. Quach, S. Fornarino, G.<br />
Laval, L. Quintana-Murci.<br />
3305W Balancing selection in the human genome. M.<br />
DeGiorgio, K. E. Lohmueller, R. Nielsen.<br />
3306T Reproduction and immunity-driven natural<br />
selection in the hominid WFDC locus. Z. Ferreira,<br />
S. Seixas, A. Andres, W. Kretzschmar, J. Mullikin, W.<br />
Swanson, M. K. Gonder, S. Tishk<strong>of</strong>f, A. Stone, A. G. Clark,<br />
E. Green, B. Hurle, NIH Intramural Sequencing Center.<br />
3307F Identification <strong>of</strong> hypoxia-tolerance regions in<br />
high-altitude populations. R. Ronen, N. Udpa, D. Zhou,<br />
T. Stobdan, O. Appenzeller, K. Frazer, J. Liang, Y. Li, V.<br />
Bafna, G. Haddad.<br />
3308W Positive selection on base excision repair<br />
pathway in Yoruba and British populations. M. Wang, R.<br />
Li, Y. He, L. Jin.<br />
3309T Expression quantitative trait loci are adaptive to<br />
multiple environmental factors. K. Ye, Z. Gu.<br />
3310F Balancing selection on a non-coding region with<br />
regulatory function. Q. Zhu, O. Gokcumen, L. Mulder, R.<br />
Iskow, C. Austermann, M. Steward, C. Scharer, T. Raj, J.<br />
Boss, S. Sunyaev, A. Price, B. Stranger, V. Simon, C. Lee.<br />
3311W Characterizing selection signatures associated<br />
with high-altitude adaptation in Tibetans. A. Ferrer<br />
Admetlla, Y. Wang, B. Peter, N. Vinckenbosch, E. Sanchez-<br />
Huerta, X. Jin, A. Asan, J. Wang, J. Wang, R. Nielsen.<br />
3312T Detecting population structure and genetic<br />
differentiation from high-throughput re-sequencing<br />
data. M. Fumagalli, T. Korneliussen, T. Linderoth, F. Vieira,<br />
A. Albrechtsen, R. Nielsen.<br />
3313F Different haplotypes in East Asia and Europe<br />
both show positive selection in 1q24. C. Heffelfinger, A.<br />
J. Pakstis, W. C. Speed, M. P. Snyder, K. K. Kidd.<br />
3314W Early origins <strong>of</strong> Southeast Asian ovalocytosis<br />
during the Austronesian expansion. J. A. Wilder, A. M.<br />
Paquette, M. K. Thompson.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
248 POSTER SESSIONS<br />
3315T Local genome diversity studies in Puerto Rico:<br />
Uncovering distribution <strong>of</strong> ancestry proportions<br />
and disease allele frequencies across the island. Y.<br />
M. Afanador, I. Rivera, E. P. Tascón-Peñaranda, J. L.<br />
Rodriguez-Florez, C. A. Winkler, A. V. Washington, E.<br />
Suárez, J. C. Martinez-Cruzado, T. K. Oleksyk, Local<br />
Genome Diversity Studies Consortium.<br />
3316F Indian genome architecture reveals high diversity<br />
and suggests ancient African ancestry. S. Kumar, R.<br />
Singh, N. Banerjee, H. Gowda, M. Kramer, S. Kamalakaran,<br />
V. Varadan, A. Janevski, B. Muthusamy, B. Chakrabarti,<br />
S. M. Srikanth, S. Keerthikumar, T. S. Keshava Prasad, S.<br />
Vivekandandan, V. Makkapati, A. Panigrahi, P. Kumar, P.<br />
van Ho<strong>of</strong>t, E. Ghiban, L. Gelley, S. Muller, G. Atwal, W. R.<br />
McCombie, A. Pandey, A. Chakravarti, N. Dimitrova.<br />
3317W Genetic evidence <strong>of</strong> paleolithic colonization<br />
and neolithic expansion <strong>of</strong> modern humans on the<br />
Tibetan Plateau. B. Su, X. Qi, C. Cui, Y. Peng, X. Zhang,<br />
Z. Yang, H. Zhong, H. Zhang, K. Xiang, X. Cao, Y. Wang,<br />
O. Ouzhuluobu, B. Basang, C. Ciwangsangbu, B. Bianba,<br />
G. Gonggalanzi, T. Wu, H. Chen, H. Shi.<br />
3318T Genomic ancestry and structure <strong>of</strong> the African-<br />
European admixed population <strong>of</strong> the Cape Verde<br />
Islands. S. Beleza, N. A. Johnson, S. I. Candille, D. M.<br />
Absher, I. I. Araújo, A. Correia e. Silva, M. D. Shriver, J.<br />
Rocha, G. S. Barsh, H. Tang.<br />
3319F Mitochondrial DNA in Myanmar: Complete<br />
mitochondrial genome sequencing revealed several<br />
new lineages within macro-haplogroup M. J.<br />
Horst, M. Summerer, G. Erhart, D. Horst, B. Horst, S.<br />
Sanguansermsri, A. Manhart, F. Kronenberg, A. Kloss-<br />
Brandstätter.<br />
3320W Asian expansion <strong>of</strong> modern human out <strong>of</strong><br />
Africa. H. Li.<br />
3321T Using Y-chromosome haplotypes to improve<br />
inferred ancestral origins in European populations.<br />
N. Myres, P. Underhill, R. King, J. Byrnes, K. Noto, S.<br />
Woodward, N. Angerh<strong>of</strong>er, C. Ball, K. Chahine.<br />
3322F Ethiopian genome project. L. Pagani, T. Kivisild, A.<br />
Tarekegn, R. Ekong, C. Plaster, I. Gallego Romero, T. Oljira, E.<br />
Mekonnen, Q. Ayub, S. Q. Mehdi, M. G. Thomas, D. Luiselli,<br />
E. Bekele, N. Bradman, D. J. Balding, C. Tyler-Smith.<br />
3323W Analysis <strong>of</strong> whole mitochondrial genomes from<br />
Iñupiat populations <strong>of</strong> the Alaskan North Slope. J. Raff,<br />
M. Rzhetskaya, J. Tackney, M. G. Hayes.<br />
3324T Genetic ancestrality estimative for Brasilia<br />
population using CODIS autosomal markers. A. E.<br />
Svidzinski, G. C. Dalton, R. C. Toledo, A. C. Arcanjo, S. F.<br />
Oliveira.<br />
3325F The population genetics <strong>of</strong> native Peruvian<br />
populations: Evolutionary inferences and biomedical<br />
implications. E. Tarazona-Santos, L. Pereira, M. Scliar,<br />
R. Zamudio, G. B. Soares-Souza, L. W. Zuccherato, M.<br />
Gouveia, F. Soares, F. Kehdy, W. C. S. Magalhaes, M. R.<br />
Rodrigues, E. Hollox, S. J. Chanock, R. H. Gilman.<br />
3326W Coalescent inference <strong>of</strong> evolutionary<br />
parameters using serially sampled genomic sequence<br />
data: Theory and applications in human population<br />
genetics. D. A. Vasco, M. Kato, Z. Ye, D. Lee, T. Carter, S.<br />
J. Hebbring, A. Rodrgio, S. Schrodi, S. Lin.<br />
3327T Ancestry perception bias in Latin <strong>American</strong><br />
admixed populations. K. Adhikari, A. Ruiz-Linares, G.<br />
Bedoya, C. Bortolini, S. Canizales, C. Gallo, S. Gibbon, R.<br />
Gonzalez, F. Rothhammer, CANDELA Consortium.<br />
3328F OriginMiner : Show me your genes and I’ll tell<br />
you where you come from. M. de Tayrac, M. C. Babron,<br />
E. Génin.<br />
3329W Genetic ancestry and admixture analysis in<br />
a Bermudian population reveals evidence <strong>of</strong> Native<br />
<strong>American</strong> origins consistent with oral histories and<br />
genealogies. J. B. Gaieski, E. Elhaik, A. C. Owings, M. G.<br />
Vilar, A. T. Walia, D. F. Gaieski, R. S. Wells, T. G. Schurr,<br />
The Genographic Consortium.<br />
3330T The MHC and HLA alleleic diversity <strong>of</strong> the<br />
1000 Genome samples. P. Gourraud, N. Cereb, P.<br />
KhanKhanian, M. Maiers, S. Yang, R. Dunivin, M. Feolo, J.<br />
Rioux, S. Hauser, J. Oksenberg.<br />
3331F Identification <strong>of</strong> sickle cell disease alleles in<br />
the Eastern Caribbean population. C. Logronio, M.<br />
Graham, K. Wiitala, P. Gibbons, E. Bashover, C. Headland,<br />
I. McIntosh.<br />
3332W Khoesan genomic signatures in contemporary<br />
populations from Southern Africa. D. C. Petersen,<br />
O. Libiger, R. Hardie, L. I. Hannick, R. Wilkinson, R. H.<br />
Glash<strong>of</strong>f, M. Mukerji, P. Fernandez, N. J. Schork, V. M.<br />
Hayes, Indian Genome Variation Consortium.<br />
3333T Complete mitochondrial DNA genome<br />
sequences from the first New Zealanders: Ancient DNA<br />
and the settlement <strong>of</strong> East Polynesia. E. A. Matisoo-<br />
Smith, M. Knapp, S. Prost, K. A. Horsburgh, J. Stanton,<br />
H. Buckley.<br />
3334F A panel <strong>of</strong> ancestry informative markers<br />
for estimating and correcting potential effects <strong>of</strong><br />
population stratification in Han Chinese. P. Qin, W. Jin,<br />
D. Lu, H. Lou, J. Wang, H. Xu, L. Jin, S. Xu.<br />
3335W Genomic demographics <strong>of</strong> the genetically<br />
isolated Amish populations <strong>of</strong> Ohio and Indiana. L. N.<br />
D’Aoust, A. C. Cummings, L. Jiang, R. Laux, D. Fuzzell, L.<br />
Caywood, L. Reinhart-Mercer, M. Courtenay, W. K. Scott,<br />
M. A. Pericak-Vance, J. L. Haines.<br />
3336T Jethro’s descendants: A journey <strong>of</strong> 1000 years.<br />
E. Friedman, J. Zidan, D. Ben Avraham, T. Maray, G.<br />
Atzmon.<br />
3337F Overview <strong>of</strong> the genetic variations in the Y<br />
chromosome in the Japanese population. Y. Sato, T.<br />
Shinka, A. Yamauchi, Y. Nakahori.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3338W Genome-wide SNP variation in sub-Saharan<br />
Africa is influenced by cultural and ethno-linguistic<br />
affiliation. S. Soi, L. Scheinfeldt, C. Lambert, J. Hirbo, A.<br />
Ranciaro, S. Thompson, J.-M. Bodo, M. Ibrahim, G.<br />
Lema, T. Nyambo, S. Omar, C. Wambebe, D. Meskel, G.<br />
Belay, A. Froment, S. A. Tishk<strong>of</strong>f.<br />
3339T Positive natural selection and recent<br />
evolutionary history in Malays. X. Liu, R. T. H. Ong, L. P.<br />
Wong, W. T. Poh, N. E. Pillai, C. C. Khor, Y. Y. Teo.<br />
3340F Genetic evidence <strong>of</strong> multiple non-Asian<br />
migrations into the New World. N. Angerh<strong>of</strong>er, S.<br />
Woodward, N. Myres, T. Steele, A. Nelson, U. A. Perego,<br />
K. Chahine.<br />
3341W The CARTaGENE Genomics Project : Population<br />
genetics analysis <strong>of</strong> the founding population <strong>of</strong><br />
Quebec. P. Awadalla, J. Hussin, Y. Idaghdour, A.<br />
Hodgkinson, J.-P. Goulet, J.-C. Grenier, T. de Malliard, V.<br />
Bruat, E. Gbeha, M. Capredon, E. Hip-Ki, Y. Payette, C.<br />
Boileau.<br />
3342T The Kaiser Permanente/UCSF Genetic<br />
Epidemiology Research Study on Adult Health<br />
and Aging: Characterizing ancestry <strong>of</strong> the GERA<br />
cohort using genome-wide data. Y. Banda, M. Kvale,<br />
T. H<strong>of</strong>fmann, S. Hesselson, H. Tang, C. Sabatti, D.<br />
Ranatunga, C. Schaefer, P. Kwok, N. Risch.<br />
3343F Population diversity and history <strong>of</strong> the Indian<br />
subcontinent: Uncovering the deeper mosaic <strong>of</strong> substructuring<br />
and the intricate network <strong>of</strong> dispersals. A.<br />
Basu, N. Sarkar Roy, P. P. Majumder.<br />
3344W Mitochondrial origins <strong>of</strong> the Cape Coloureds <strong>of</strong><br />
South Africa. K. G. Beaty, D. L. Phillips, M. Henneberg, M.<br />
H. Crawford.<br />
3345T North African Jewish and non-Jewish<br />
populations form distinctive, orthogonal clusters. C.<br />
Campbell, P. F. Palamara, M. Dubrovsky, L. R. Botigué, M.<br />
Fellous, G. Atzmon, C. Oddoux, A. Pearlman, L. Hao, B.<br />
Henn, E. Burns, C. Bustamante, D. Comas, E. Friedman, I.<br />
Pe’er, H. Ostrer.<br />
3346F Hyper-sharing individuals in founder<br />
populations: Theory and implications to imputation<br />
strategies. S. Carmi, P. Palamara, V. Vacic, T. Lencz, A.<br />
Darvasi, I. Pe’er.<br />
3347W Analytical inference <strong>of</strong> human demographic<br />
history using multiple individual genome sequences. H.<br />
Chen, D. Reich.<br />
3348T Predicting the geographic origin <strong>of</strong> individuals<br />
using genome-wide SNP data. D. J. M. Crouch, M. E.<br />
Weale.<br />
3349F Y chromosome J haplogroups trace post glacial<br />
period expansion from Turkey and Caucasus into the<br />
Middle East. B. Douaihy, D. Platt, M. Haber, A. Salloum, F.<br />
Mouzaya, M. Bou Dagher-Kharrat, G. Khazen, E. Matisoo-<br />
Smith, R. S. Wells, C. T. Smith, P. Zalloua, Genographic<br />
Consortium.<br />
POSTER SESSIONS 249<br />
3350W Genotyping at the DAT1 locus: Determination<br />
<strong>of</strong> VNTR allele frequencies in descendents <strong>of</strong> the<br />
founding families <strong>of</strong> Southwest Louisiana. J. Drost, A.<br />
Figueroa, J. Angle.<br />
3351T A two-sex model for the admixture history<br />
<strong>of</strong> a hybrid population. A. Goldberg, P. Verdu, N. A.<br />
Rosenberg.<br />
3352F Admixed human genomes reveal complex<br />
migration patterns from the early spread <strong>of</strong> modern<br />
humans to the 21st century. S. Gravel, J. M. Kidd, J. K.<br />
Byrnes, A. Moreno-Estrada, F. Zakharia, S. Mushar<strong>of</strong>f, F.<br />
M. De La Vega, C. D. Bustamante.<br />
3353W Quantitative characterization <strong>of</strong> the ancestry <strong>of</strong><br />
the Estonian population. T. Haller, L. Leitsalu-Moynihan,<br />
P. C. Ng, K. Fischer, T. Esko, K. Läll, A. Metspalu.<br />
3354T Demographic inference and whole genome scan<br />
for natural selection in Biaka pygmies from Central<br />
Africa. P. H. Hsieh, K. R. Veeramah, J. D. Wall, R. N.<br />
Gutenkunst, M. F. Hammer.<br />
3355F Analysis <strong>of</strong> contributions <strong>of</strong> archaic genome and<br />
their functions in modern non-Africans. Y. Hu, Q. Ding,<br />
Y. Wang, H. Zheng, L. Jin.<br />
3356W Anisotropic isolation by distance: The main<br />
orientations <strong>of</strong> human genetic differentiation. F. Jay, P.<br />
Sjödin, M. Jakobsson, M. G. B. Blum.<br />
3357T On the use <strong>of</strong> deterministic functions for<br />
deriving approximate coalescent distributions. E.<br />
Jewett, N. Rosenberg.<br />
3358F Exploring population admixture dynamics using<br />
empirical and simulated genome-wide distribution <strong>of</strong><br />
ancestral chromosomal segments. W. Jin, S. Wang, L.<br />
Jin, S. Xu.<br />
3359W Population history and Y-chromsome diversity<br />
<strong>of</strong> the Poqomchi’ Maya <strong>of</strong> Eastern Guatemala. S.<br />
Johnson, A. Justice, M. Crawford.<br />
3360T Local ancestry inference in the Thousand<br />
Genomes Project admixed populations. E. E. Kenny,<br />
B. Maples, C. Churchhouse, A. Gupta Hinch, A. Williams,<br />
Y. Baran, S. Gravel, A. Moreno Estrada, C. Gignoux, F.<br />
Zakharia, A. W. Bigham, M. D. Shriver, A. Ruiz-Linares, G.<br />
Bedoya, T. K. Oleksyk, J. Dutil, J. C. Martinez-Cruzado, E.<br />
Gonzalez Burchard, S. Myers, E. Halperin, J. Marchini, C.<br />
D. Bustamante, 1000 Genomes Consortium.<br />
3361F A likelihood ratio test for sex-bias and its<br />
application to whole-genome sequencing data <strong>of</strong> a<br />
set <strong>of</strong> globally-distributed populations. S. Mushar<strong>of</strong>f, J.<br />
M. Kidd, B. M. Henn, S. Gravel, B. Maples, K. Eilertson,<br />
M. C. Yee, H. M. Cann, G. Euskirchen, M. Snyder, C. D.<br />
Bustamante, S. Ramachandran.<br />
3362W Population structure and genetic diversity in<br />
Argentinean populations. M. Muzzio, J. M. B. Motti, E.<br />
Kenny, L. S. Jurado-Medina, M. C. Yee, J. Beltramo, R.<br />
Santos, T. Cooke, V. Ramallo, M. Schawb, O. Cornejo, G.<br />
Bailliet, C. M. Bravi, C. D. Bustamante.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
250 POSTER SESSIONS<br />
3363T Rediscovering the people who greeted<br />
Columbus through mtDNA sequence analysis. M. A.<br />
Nieves-Colon, E. P. Tascón-Peñaranda, M. Diaz-Matallana,<br />
I. Carrero-Gonzalez, F. Curbelo-Canabal, J. Galanther,<br />
M. L. Perez-Quiñones, H. J. Diaz-Zabala, C. Eng, O. R.<br />
Wever, F. Mercedes de la Cruz, A. Alvarez-Serrano, E. G.<br />
Burchard, J. C. Martínez-Cruzado.<br />
3364F Continent-wide decoupling <strong>of</strong> Y-chromosomal<br />
genetic variation from language and geography in<br />
native South <strong>American</strong>s. M. Nothnagel, L. Roewer, L.<br />
Gusmao, V. Gomes, M. Gonzalez, D. Corach, A. Sala, E.<br />
Alechine, T. Palha, N. Santos, A. Ribeiro-dos-Santos, M.<br />
Geppert, S. Willuweit, M. Nagy, S. Zweynert, M. Baeta,<br />
C. Nunez, B. Martinez-Jarreta, F. Gonzalez-Andrade, E.<br />
Fagundes de Carvalho, D. Aparecida da Silva, J. J. Builes,<br />
D. Turbon, A. M. Lopez Parra, E. Eduardo Arroyo-Pardo, U.<br />
Toscanini, L. Borjas, C. Barletta, S. Santos, M. Krawczak.<br />
3365W Using haplotypes to infer ancestral origins for<br />
recently admixed individuals. K. Noto, J. K. Byrnes,<br />
N. Myres, N. Angerh<strong>of</strong>er, S. R. Woodward, C. A. Ball, K.<br />
Chahine.<br />
3366T Haplotype sharing distributions for fine-scale<br />
demographic reconstruction. P. Palamara, T. Lencz, A.<br />
Darvasi, I. Pe’er.<br />
3367F Inference <strong>of</strong> population splits and mixtures from<br />
genome-wide allele frequency data. J. K. Pickrell, J. K.<br />
Pritchard.<br />
3368W Inferring Y chromosome phylogeny by<br />
sequencing diverse populations. G. D. Poznik, P. A.<br />
Underhill, B. M. Henn, M. C. Yee, E. Sliwerska, G. M.<br />
Euskirchen, L. Quintana-Murci, E. Patin, M. Snyder, J. M.<br />
Kidd, C. D. Bustamante.<br />
3369T Towards understanding the population<br />
substructure and ancestry in Kuwaiti population. R.<br />
Rajagopalan, O. Alsmadi, F. Alkayal, G. Thareja, S. John, P.<br />
Hebbar, A. Thangavel.<br />
3370F The evolutionary history <strong>of</strong> mutations associated<br />
with leukemia. S. Ramachandran, M. Kantesaria, A.<br />
Walia, J. Yang.<br />
3371W Identification <strong>of</strong> regions under selection in the<br />
Gullah African <strong>American</strong> population. P. S. Ramos, S.<br />
Sajuthi, Y. Huang, J. Divers, K. M. Kaufman, J. B. Harley,<br />
R. P. Kimberly, D. L. Kamen, C. D. Langefeld, M. M. Sale,<br />
W. T. Garvey, G. S. Gilkeson.<br />
3372T A genome-wide map <strong>of</strong> Neandertal ancestry<br />
in modern humans. S. Sankararaman, N. Patterson, S.<br />
Mallick, S. Pääbo, D. Reich.<br />
3373F Genetic diversity and migration history <strong>of</strong><br />
indigenous populations from the Central Valley <strong>of</strong><br />
Mexico. T. Schurr, M. Vilar, R. Gomez, H. Zillges, A. Sanders,<br />
A. Owings, J. Gaieski, The Genographic Consortium.<br />
3374W Unexpected relationships and inbreeding in<br />
HapMap phase III populations. E. Stevens, J. Baugher,<br />
M. Shirley, L. Frelin, J. Pevsner.<br />
3375T Class I MHC region genetic markers have<br />
different dinamics than neutral genomic regions in<br />
Brazilian populations. R. C. P. Toledo, A. C. Arcanjo, C.<br />
T. Mendes-Júnior, E. C. Castelli, J. A. Peña, R. V. Andrade,<br />
M. N. Klautau-Guimarães, S. F. Oliveira.<br />
3376F Coalescence-based estimation <strong>of</strong> population<br />
history in the presence <strong>of</strong> admixture from genetic<br />
variation data. M. Tsai, G. Blelloch, R. Ravi, R. Schwartz.<br />
3377W The GenoChip: A new tool for genetic<br />
anthropology. S. Wells, E. Greenspan, S. Staats, T. Krahn,<br />
C. Tyler-Smith, Y. Xue, S. T<strong>of</strong>anelli, P. Francalacci, F.<br />
Cucca, L. Pagani, L. Jin, H. Li, T. G. Schurr, J. B. Gaieski,<br />
C. Melendez, M. G. Vilar, A. C. Owings, R. Gomez, R.<br />
Fujita, F. Santos, D. Comas, O. Balanovsky, E. Balanovska,<br />
P. Zalloua, H. Soodyall, R. Pitchappan, G. Arun Kumar, M.<br />
F. Hammer, B. Greenspan, E. Elhaik.<br />
3378T Genetic, genomic and penotypic<br />
characterization <strong>of</strong> Qinghai Mongolians. J. Xing, U.<br />
Tanna, T. S. Simonson, W. S. Watkins, D. J. Witherspoon,<br />
W. Wu, G. Qing, C. D. Huff, L. B. Jorde, R. L. Ge.<br />
3379F Paleolithic human migrations in East Eurasia by<br />
sequencing Y chromosomes. S. Yan, C. C. Wang, L. Jin.<br />
3380W Reconstructing the history <strong>of</strong> Indigenous<br />
<strong>American</strong> populations from the Thousand Genomes<br />
Project admixed populations <strong>of</strong> the Americas. F.<br />
Zakharia, M. Muzzio, K. Sandoval, A. Moreno-Estrada, S.<br />
Gravel, J. Byrnes, C. R. Guignoux, J. L. Rodriguez-Flores,<br />
B. Maples, W. Guiblet, J. Dutil, E. E. Kenny, A. W. Bigham,<br />
M. D. Shriver, 1000 Genomes Consortium, A. Ruiz-Linares,<br />
T. K. Oleksyk, J. C. Martinez-Cruzado, E. Gonzalez<br />
Burchard, C. D. Bustamante.<br />
3381T The genetic aspect <strong>of</strong> the Slavic settlement<br />
in the East Alps region. A. Zupan, K. Vrabec, T. Dovč ;<br />
drnovšek, D. Glavač .<br />
3382F Principal component analysis produces an<br />
inaccurate representation <strong>of</strong> population structure<br />
under certain conditions. J. Bentham, D. L. Morris, D. S.<br />
Cunninghame Graham, C. L. Pinder, V. Anand, J. E. Wither,<br />
J. D. Rioux, M. E. Alarcón-Riquelme, T. J. Vyse.<br />
3383W The Kaiser Permanente/UCSF Genetic<br />
Epidemiology Research Study on Adult Health and<br />
Aging: Local ancestry estimations in the admixed<br />
individuals <strong>of</strong> the Genetic Epidemiology Research on<br />
Aging cohort. S. I. Candille, N. A. Johnson, Y. Banda, T.<br />
H<strong>of</strong>fman, M. Kvale, C. Sabatti, S. Hesselson, P. Y. Kwok,<br />
C. Schaefer, N. Risch, H. Tang.<br />
3384T Multi-way admixture deconvolution using<br />
phased or unphased ancestral panels. C. Churchhouse,<br />
J. Marchini.<br />
3385F A panel <strong>of</strong> ancestry informative markers for the<br />
South African Coloured population. M. Daya, L. Van der<br />
Merwe, M. Möller, E. Hoal, C. R. Gignoux, J. M. Galanter,<br />
B. M. Henn.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3386W A scalable pipeline for local ancestry inference<br />
using thousands <strong>of</strong> reference individuals. C. B. Do, E.<br />
Durand, J. M. Macpherson, B. Naughton, J. L. Mountain.<br />
3387T Global genome-wide variations comparisons<br />
show a generally homogeneous Levant that has been<br />
recently structured by culture. M. Haber, D. Comas, P.<br />
A. Zalloua.<br />
3388F <strong>Human</strong> and Helicobacter pylori ancestries<br />
in Colombian populations with contrasting risks <strong>of</strong><br />
gastric cancer. N. Kodaman, A. Pazos, M. B. Piazuelo, B.<br />
G. Schneider, C. L. Shaffer, J. Romero-Gallo, T. de Sablet,<br />
L. E. Bravo, K. Wilson, T. Cover, P. Correa, S. Williams.<br />
3389W Deep ancestry within a Neandertal-like region<br />
on human chromosome 12. F. L. Mendez, J. C. Watkins,<br />
M. F. Hammer.<br />
3390T Sub-continental ancestry <strong>of</strong> admixed Caribbean<br />
populations and implications for medical genomics<br />
in the Americas. A. Moreno Estrada, S. Gravel, M. L.<br />
Cuccaro, F. Zakharia, P. Ortiz-Tello, R. J. Martinez, J. L.<br />
McCauley, E. E. Kenny, D. J. Hedges, R. W. Morris, J. K.<br />
Byrnes, S. Acevedo, P. J. Norman, Z. Layrisse, P. Parham,<br />
C. D. Bustamante, E. R. Martin.<br />
3391W Population structure and ancestry inference<br />
under sample selection bias. S. S. Shringarpure, E. P. Xing.<br />
3392T Genome-wide effects <strong>of</strong> sex-specific<br />
incompatibility on neutral introgression. M. Uyenoyama.<br />
3393W Admixture analysis <strong>of</strong> spontaneous hepatitis<br />
C virus clearance among individuals <strong>of</strong> African<br />
descent. G. L. Wojcik, P. Duggal on behalf <strong>of</strong> International<br />
Consortium <strong>of</strong> HCV Spontaneous Resolution.<br />
3394T A genome-wide perspective <strong>of</strong> population<br />
structure and individual admixture in Xinjiang:<br />
Implications for demographic history and complex trait<br />
gene mapping. S. Xu, S. Li, D. Lu, P. Qin, H. Lou, W. Jin,<br />
X. Pan, L. Jin.<br />
3395W Genomics variants in the endogamous Mashadi<br />
Jewish population identified by pooled whole exome<br />
sequencing. H. Ostrer, W. J. Huh, G. Akler, L. U., M.<br />
Popovic, D. Kural, J. Sheffield, E. Burns, G. Atzmon, C.<br />
Oddoux.<br />
3396T An evaluation <strong>of</strong> genetic characteristics <strong>of</strong> two<br />
population isolates from Greece: The HELIC-Pomak<br />
and MANOLIS studies. G. Dedoussis, I. Tachmazidou,<br />
A. E. Farmaki, L. Southam, K. Palin, A. Kolb-Kokocinski,<br />
W. Rayner, E. Daoutidou, I. Ntalla, K. Panoutsopoulou, E.<br />
Tsafantakis, M. Karaleftheri, E. Zeggini.<br />
3397W Genomic variants in the Dominican population<br />
identified by whole exome genotyping using Affymetrix<br />
Axiom Arrays. C. Oddoux, C. Cambell, L. U., H. Ostrer.<br />
3398T A population-based study and subsequent<br />
disclosure <strong>of</strong> autosomal recessive disease-causing<br />
mutations in a founder population. J. X. Chong, R. L.<br />
Anderson, R. Ouwenga, D. J. Waggoner, C. Ober.<br />
POSTER SESSIONS 251<br />
3399W Deep-coverage whole genome sequencing <strong>of</strong><br />
100 Qatari reveals elevated prevalence <strong>of</strong> populationspecific<br />
variants linked to disease. J. L. Rodriguez-<br />
Flores, K. A. Fakhro, N. R. Hackett, J. Salit, J. Fuller, J. A.<br />
Malek, R. Badii, A. Al-Marri, L. Chouchane, R. G. Crystal,<br />
J. G. Mezey.<br />
3400T Single gene disorders in Western India: Cohort<br />
<strong>of</strong> high risk group. C. Ankleshwaria, J. Sheth, H. Patel, J.<br />
Lekshami, F. Sheth.<br />
3401W Study on the distribution <strong>of</strong> rare genetic<br />
variations in the French Canadian population. S. Girard,<br />
L.-P. Lemieux Perreault, I. Mongrain, G. Lettre, J. Rioux,<br />
M. Phillips, S. de Denus, G. A. Rouleau, J.-C. Tardif, M.-P.<br />
Dube.<br />
3402T Identification <strong>of</strong> a novel Native <strong>American</strong> Y<br />
chromosome founding lineage in northwest South<br />
America. L. Roewer, M. Nothnagel, L. Gusmão, V. Gomes,<br />
M. Gonzaléz, D. Corach, A. Sala, E. Alechine, T. Palha, N.<br />
Santos, A. Ribeiro-dos-Santos, M. Geppert, S. Willuweit,<br />
M. Nagy, S. Zweynert, M. Baeta, C. Núñez, B. Martínez-<br />
Jarreta, F. González-Andrade, E. Fagundes de Carvalho,<br />
D. Aparecida da Silva, J. J. Builes, D. Turbón, A. M. Lopez<br />
Parra, E. Arroyo-Pardo, U. Toscanini, L. Borjas, C. Barletta,<br />
S. Santos, M. Krawczak.<br />
3403W Single nucleotide variation analysis <strong>of</strong> protein<br />
domain signatures <strong>of</strong> human genes. J. Freudenberg.<br />
3404T Investigating the evolution <strong>of</strong> deleterious<br />
mutations in the major histocompatibility complex<br />
as a potential explanation for frequently observed<br />
HLA-disease associations. T. L. Lenz, D. M. Jordan, S.<br />
R. Sunyaev.<br />
3405W Quantifying the degree <strong>of</strong> purifying selection<br />
in genes associated with nephrotic syndrome. M. G.<br />
Sampson, M. Kretzler, H. M. Kang.<br />
3406T An assessment <strong>of</strong> population stratification<br />
in rare variant association tests using an analytic<br />
model <strong>of</strong> joint site frequency spectra. M. Reppell, M.<br />
Zawistowski, D. Wegmann, R. Weyant, P. L. St. Jean, M.<br />
G. Ehm, M. R. Nelson, J. Novembre, S. Zöllner.<br />
3407W Estimating and interpreting F ST : The impact <strong>of</strong><br />
rare variants. G. Bhatia, N. Patterson, S. Sankararaman,<br />
A. L. Price.<br />
3408T Are rare and common variant stratification<br />
patterns the same? E. Génin, M.-C. Babron, M. de<br />
Tayrac, D. N. Rutledge, E. Zeggini.<br />
3409W Variant frequency and the scale <strong>of</strong> population<br />
structure. P. Raska, O. De la Cruz Cabrera.<br />
3410T Male-specific common CNVs and complex<br />
gender differences in CNV detected among 808<br />
olfactory receptor loci, in 150 phenotypically normal<br />
individuals from the 1000 Genome Project. F.<br />
Shadravan.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
252 POSTER SESSIONS<br />
3411W Transcriptome sequencing across seven<br />
diverse populations characterizing novel transcript<br />
is<strong>of</strong>orms and allele-specific expression. H. A. Costa, A.<br />
R. Martin, J. M. Kidd, B. M. Henn, M. C. Yee, F. Grubert,<br />
S. B. Montgomery, H. M. Cann, M. P. Snyder, C. D.<br />
Bustamante.<br />
3412T African genome variation project. I. Tachmazidou,<br />
F. Ayele, C. Pomilla, J. Asimit, D. Gurdasani, R. Nsubuga,<br />
D. Shriner on behalf <strong>of</strong> APCDR Investigators.<br />
3413W Inference <strong>of</strong> genetic ancestry using genotype<br />
data from a single individual. C. Chen, S. Lee, S. Pollack,<br />
D. Hunter, P. Kraft, J. Hirschhorn, A. Price.<br />
3414W A unified model <strong>of</strong> meiosis combining<br />
recombination, non-disjunction, interference and<br />
infertility. H. R. Johnston IV, D. J. Cutler.<br />
Epigenetics<br />
3415T Landscape <strong>of</strong> DNA methylation in meningiomas.<br />
F. Gao, L. Shi, J. Russin, L. Zeng, X. Chang, T. Chen, S.<br />
Giannotta, D. Weisenberger, G. Zada, W. Mack, K. Wang.<br />
3416T A panel <strong>of</strong> epigenetic biomarkers <strong>of</strong> NSCLC<br />
identified from a comprehensive microarray-based<br />
DNA methylation analysis. S. C. Guo, X. T. Wang, J. B.<br />
Xu, F. L. Jin, J. C. Wang.<br />
3417T Methylome correlation structure in human aging<br />
brain. G. P. Srivastava, M. L. Eaton, B. T. Keenan, L. B.<br />
Chibnik, J. A. Schneider, M. Kellis, D. A. Bennett, P. L. De<br />
Jager.<br />
3418T Quantifying and normalizing methylation levels<br />
in illumina arrays. H. Xu, D. Ryu, S. Su, X. Wang, R.<br />
Podolsky, V. George.<br />
3419T Bone health at age 49-51 years is associated<br />
with IGF2 DNA methylation levels in the Newcastle<br />
Thousand Families Study cohort. C. Potter, J. C.<br />
McConnell, L. Barrett, R. M. Francis, M. S. Pearce, C. L.<br />
Relton.<br />
3420T NSD1 mutations in Sotos syndrome alter<br />
the DNA methylation landscape <strong>of</strong> genes involved<br />
in somatic growth and neuronal transmission. R.<br />
Weksberg, H. Jin, Y. Chen, D. Grafodatskaya, M. Inbar-<br />
Feigenberg, B. H. Y. Chung, C. Cytrynbaum, S. Choufani.<br />
3421T Aberrant expression <strong>of</strong> DNA methylation,<br />
cellular proliferation and DNA repair genes in<br />
gastric carcinogenesis? D. Q. Calcagno, F. Wisnieski,<br />
T. B. Brilhante, C. O. Gigek, E. S. Chen, M. F. Leal, S.<br />
Demachki, P. P. Assumpção, R. Artigiani, L. G. Lorenco, R.<br />
R. Burbano, M. A. C. Smith.<br />
3422T Novel microRNAs and epigenetic biomarkers for<br />
gastrointestinal stromal tumors. D. Glavač , M. Ravnik-<br />
Glavač .<br />
3423T The epigenetic alteration <strong>of</strong> PPP1R3C in the<br />
colorectal cancer. S. K. Lee, J. W. Moon, J. Kim, H. S.<br />
Kim, S. H. Park.<br />
3424T EGCG applications on HT-29 and MCF-7<br />
cell lines and evaluation <strong>of</strong> tumor suppressor gene<br />
methylation. O. Ozer, Y. K. Terzi, O. Darcansoy Iseri, Z.<br />
Yilmaz Celik, F. I. Sahin.<br />
3425T Methylation, mutational and expression analysis<br />
<strong>of</strong> IL6, IL8 and IL1B on the different tumor tissues.<br />
M. Poulin, A. Meyer, G. Gonzalez, J. Xu, L. Yan. 3426T<br />
Methylation pr<strong>of</strong>iling <strong>of</strong> tumor suppressor genes in invasive<br />
ductal breast carcinoma. Y. K. Terzi, F. I. Sahin, O. Ozer, Z.<br />
Yilmaz Celik, B. Demirhan, M. C. Yagmurdur.<br />
3427T Whole genome bisulfite sequencing <strong>of</strong> acute<br />
lymphoblastic leukemia cells. P. Wahlberg, J. Nordlund,<br />
O. Karlberg, C. Bäcklin, U. Liljedahl, E. Forestier, M.<br />
Gustafsson, G. Lönnerholm, A.-C. Syvänen.<br />
3428T Integrative genomic and epigenomic pr<strong>of</strong>iling<br />
<strong>of</strong> bladder cancer. A. Woloszynska-Read, D. Wang, L.<br />
Yan, Q. Hu, J. Wang, W. Bshara, J. Conroy, K. Guru, C.<br />
Morrison, S. Liu, D. L. Trump, C. S. Johnson.<br />
3429T Differential and sex-specific DNA methylation<br />
<strong>of</strong> the placental LEP promoter in early onset<br />
preeclampsia. K. Hogg, J. D. Blair, M. S. Peñaherrera, K.<br />
Louie, P. von Dadelszen, W. P. Robinson.<br />
3430T A genome-wide DNA methylation association<br />
study <strong>of</strong> young-onset hypertension in Han Chinese<br />
population <strong>of</strong> Taiwan. K. M. Chiang, H. C. Yang, J. W.<br />
Chen, W. H. Pan.<br />
3431T Genome-wide DNA methylation pr<strong>of</strong>iling<br />
<strong>of</strong> monozygotic twins discordant for trisomy 21.<br />
A. Letourneau, M. R. Sailani, F. Santoni, D. Robyr, P.<br />
Makrythanasis, A. Sharp, S. E. Antonarakis.<br />
3432T Genome-wide quantitative DNA methylation<br />
analysis <strong>of</strong> imprinted DMRs in patients with Beckwith-<br />
Wiedemann syndrome by MALDI-TOF MS technology.<br />
T. Maeda, K. Jozaki, H. YAtsuki, K. Higashimoto, H.<br />
Soezima.<br />
3433T Epigenomic features and transcription factor<br />
binding sites associate with hotspots <strong>of</strong> genomic<br />
instability in human germline and in cancer. C. Coarfa,<br />
C. S. Pichot, A. R. Jackson, A. Tandon, S. Raghuraman, S.<br />
Paithankar, A. V. Lee, S. E. McGuire, A. Milosavljevic.<br />
3434T DNA methylation influences lipid and adipokine<br />
pr<strong>of</strong>iles. M. A. Carless, H. Kulkarni, D. L. Rainwater, A. G.<br />
Comuzzie, M. C. Mahaney, J. Blangero.<br />
3435T Identification <strong>of</strong> epigenetic markers underlying<br />
increased risk <strong>of</strong> type 2 diabetes in South Asians: The<br />
EpiMigrant Pilot Study. A. Drong, C. Blancher, M. R.<br />
Jarvelin, C. M. Lindgren, P. Elliott, M. I. McCarthy, J. S.<br />
Kooner, J. C. Chambers.<br />
3436T Epigenome-wide association analysis identified<br />
aging alteration <strong>of</strong> DNA methylation level in the<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
genes related to metabolic pathways. H. Kitajima, K.<br />
Yamamoto.<br />
3437T Alterations in methylation status <strong>of</strong> immune<br />
response genes promoters in cell-free DNA during<br />
a hemodialysis procedure in patients with diabetic<br />
nephropathy and in non-diabetic subjects. M.<br />
Korabecna, E. Pazourkova, A. Horinek, M. Mokrejsova, V.<br />
Tesar.<br />
3438T Genome-wide DNA methylation study <strong>of</strong> obesity<br />
and type 2 diabetes. D. Zhou, D. Zhang, Z. Zhang.<br />
3439T Density <strong>of</strong> inter-individual epigenome variation<br />
uncovered by integrative epigenome mapping at single<br />
base resolution. J. J. Lambourne, S. Busche, V. Adoue, T.<br />
Kwan, M. Caron, G. Bourque, M. Lathrop, T. Pastinen.<br />
3440T Allelic-dropout during PCR in the promoter <strong>of</strong><br />
an imprinted gene potentially caused by interaction<br />
between G-quadruplex structures and DNA<br />
methylation. M. A. Kennedy, A. J. Stevens, S. Stuffrein-<br />
Roberts, A. Gibb, K. Doudney, A. Bagshaw, A. Aitchison,<br />
M. R. Eccles, V. V. Filichev, P. R. Joyce.<br />
3441T <strong>Genetics</strong> <strong>of</strong> global DNA methylation patterns<br />
in adipose tissue from twins and its effect on gene<br />
expression and disease: The MuTHER Study. E.<br />
Grundberg, E. Meduri, J. K. Sandling, A. K. Hedman, S.<br />
Keildson, J. Nisbet, M. Sekowska, A. Wilk, A. Barett, K.<br />
S. Small, J. T. Bell, E. T. Dermitzakis, M. I. McCarthy, T. D.<br />
Spector, P. Deloukas.<br />
3442T A methylome-wide MBD-seq study followed by<br />
replication in a total <strong>of</strong> 3,000 schizophrenia casecontrol<br />
samples identifies new disease biomarkers. K.<br />
A. Aberg, J. L. McClay, S. Nerella, S. L. Clark, G. Kumar,<br />
W. Chen, A. N. Khachane, G. Gao, L. Y. Xie, A. Hudson, J.<br />
Bukszar, C. M. Hultman, P. F. Sullivan, P. K. E. Magnusson,<br />
E. J. C. G. van den Oord, Swedish Schizophrenia<br />
Consortium.<br />
3443T Genome-wide estimation <strong>of</strong> DNA methylation<br />
heritability in CD4 � T-cells from 80 families. D. Absher, L.<br />
Waite, H. Tiwari, D. Arnett.<br />
3444T Epigenetic second hit on gene body <strong>of</strong> PKD1<br />
leads to cystic kidney in ADPKD. J. Bae, Y. Woo, J. Lee,<br />
J. Park, Y. Kim.<br />
3445T Altered DNA methylation in preeclamptic<br />
placentas. J. D. Blair, R. K. C. Yuen, P. von Dadelszen, W.<br />
P. Robinson.<br />
3446T Highly abnormal methylation <strong>of</strong> the placental<br />
genome in the CBAXDBA model <strong>of</strong> pregnancy failure.<br />
S. Brown, E. Bonney, L. Brown.<br />
3447T DNA methylation pr<strong>of</strong>iles <strong>of</strong> paediatric obsessive<br />
compulsive disorder. D. T. Butcher, G. L. Hanna, D. R.<br />
Rosenberg, R. Weksberg, P. D. Arnold.<br />
3448T Complete or partial loss <strong>of</strong> methylation at<br />
the GNAS locus identified in patients referred for<br />
POSTER SESSIONS 253<br />
molecular diagnosis <strong>of</strong> pseudohypoparathyroidism<br />
type 1a. G. S. Charames, S. J. Steinberg, B. A. Karczeski,<br />
M. A. Levine, G. R. Cutting.<br />
3449T DNA methylation <strong>of</strong> ADCYAP1R1 is associated<br />
with childhood asthma in Puerto Ricans. W. Chen, N.<br />
Boutaoui, Y. Y. Han, J. Brehm, C. Schmitz, E. Acosta-<br />
Perez, M. Cloutier, D. Calvert, S. Thornton-Thompson, D.<br />
B. Wakefield, M. Alvarez, A. Colón-Semidey, G. Canino, J.<br />
C. Celedón.<br />
3450T The role <strong>of</strong> DNA methylation in cognitive decline<br />
and Alzheimer’s disease. L. B. Chibnik, B. T. Keenan, G.<br />
Srivastava, M. L. Eaton, A. Meissner, J. A. Schneider, M.<br />
Kellis, D. Bennett, P. L. De Jager.<br />
3451T Distinct DNA methylation signature in ovarian<br />
cancer histological subtypes. M. S. Cicek, D. C.<br />
Koestler, B. L. Fridley, S. M. Armasu, K. R. Kalli, M. C.<br />
Larson, R. A. Vierkant, B. J. Winterh<strong>of</strong>f, J. Chien, J. B.<br />
Fan, M. Bibikova, B. Klotzle, G. Konecny, V. Shridhar, J. M.<br />
Cunningham, E. L. Goode.<br />
3452T Identifying new biomarkers for alcohol use<br />
behaviors in a methylome-wide MBD-seq study. S.<br />
L. Clark, K. A. Aberg, S. Nerella, G. Kumar, J. L. McClay,<br />
W. Chen, L. Y. Xie, A. Hudson, G. Gao, J. Bukszar, C. M.<br />
Hultman, P. K. E. Magnusson, P. F. Sullivan, E. J. C. G. van<br />
den Oord, Swedish Schizophrenia Consortium.<br />
3453T Smoking reduces DNA methylation levels at<br />
multiple genomic loci. P. Deloukas, L. Tsaprouni, T.-P.<br />
Yang, J. Bell, K. J. Dick, S. Kanoni, C. Nelson, E. Meduri, F.<br />
Cambien, C. Hengstenberg, J. Erdmann, H. Schunkert, A.<br />
H. Goodall, W. H. Ouwehand, T. Spector, N. J. Samani.<br />
3454T DNA hypomethylation <strong>of</strong> INS-IGF2 and BACH2<br />
in affected individuals within discordant monozygotic<br />
twins supports a role for epigenetic influences in type<br />
1 diabetes susceptibility. E. Elboudwarej, H. Quach, P.<br />
Ramsay, J. Lane, E. Sinclair, L. Criswell, P. Fain, J. Jeffrey,<br />
G. Eisenbarth, L. Barcellos, J. Noble.<br />
3455T Migration and DNA methylation: A comparison<br />
<strong>of</strong> methylation patterns in type 2 diabetes<br />
susceptibility genes between Indians and Europeans.<br />
H. R. Elliott, G. K. Walia, A. Duggirala, A. Groom, S. U.<br />
Reddy, G. R. Chandak, V. Gupta, M. Laakso, J. M. Dekker,<br />
M. Walker, S. Ebrahim, G. Davey Smith, C. L. Relton, RISC<br />
Consortium.<br />
3456T DNA methylation alterations associated<br />
with autism spectrum disorders. D. Grafodatskaya,<br />
R. Rajendram, Y. Lou, D. T. Butcher, L. Senman, C.<br />
Windpassinger, W. Roberts, S. W. Scherer, R. Weksberg.<br />
3457T A population-based method for identification <strong>of</strong><br />
differential methylation regions among samples. C. L.<br />
Hsiao, C. S. J. Fann, C. J. Chang.<br />
3458T <strong>Genetics</strong> and epigenetics <strong>of</strong> PON1 in Mexican-<br />
<strong>American</strong> children. K. Huen, K. Harley, P. Yousefi, A.<br />
Bradman, L. Barcellos, B. Eskenazi, N. Holland.<br />
3459T Comprehensive DNA methylation pr<strong>of</strong>iling<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
254 POSTER SESSIONS<br />
<strong>of</strong> 3.7 million CpGs with the SureSelect target<br />
enrichment system. K. Jeong, M. Corioni, F. Useche, A.<br />
Shafer, E. Haugen, B. Novak, S. Happe, D. Roberts, J.<br />
Stamatoyannopoulos, E. LeProust.<br />
3460T The development <strong>of</strong> a method for in-solution<br />
hybrid capture <strong>of</strong> bisulfite-converted DNA for targeted<br />
bisulfite sequencing <strong>of</strong> 175 ADME genes. M. Kals, M.<br />
Ivanov, M. Kacevska, A. Metspalu, M. Ingelman-Sundberg,<br />
L. Milani.<br />
3461T Association <strong>of</strong> fetal-derived hypermethylated<br />
RASSF1A concentrations in placenta-mediated<br />
pregnancy complications. S. Kim, M. Kim, S. Park, D.<br />
Lee, J. Lim, J. Han, H. Ahn, J. Chung, M. Ryu.<br />
3462T Epigenome-wide association study <strong>of</strong><br />
rheumatoid arthritis. I. Koh, J. Kim, J. Yoon, B. Kim, I.<br />
Park, K. Kim, Y. Kim, R. Huh, B. Han, S. Bae, J. Bae, J.<br />
Lee.<br />
3463T DNA methylation analysis <strong>of</strong> iPS cells using<br />
whole-genome bisulphite sequencing. D. S. Lee, J. Y.<br />
Shin, Y. S. Ju, J. I. Kim, P. Tonge, M. Puri, A. Nagy, J. S.<br />
Seo.<br />
3464T Advanced genome-wide methylome pr<strong>of</strong>iling<br />
and analysis <strong>of</strong> leukemia reveals novel epigenetic<br />
dynamics. S. Li, A. Akalin, F. Garrett-Bakelman, A.<br />
Melnick, C. Mason.<br />
3465T Differential methylation <strong>of</strong> colorectal adenomas<br />
<strong>of</strong> the right side. J. Li, D. Koestler, J. Baron, A. Dietrich,<br />
G. Tsongalis, L. Butterly, M. Goodrich, C. Marsit, J. Moore,<br />
A. Andrew, A. Srivastava.<br />
3466T Methylation quantitative trait loci and epigenetic<br />
networks underlying asthma-related traits. L. Liang,<br />
S. A. G. Willis-Owen, K. C. C. Wong, A. Binia, G. Davies,<br />
J. M. Hopkin, I. Yang, T. Pastinen, D. A. Schwartz, G.<br />
Abecasis, G. M. Lathrop, M. F. M<strong>of</strong>fatt, W. O. C. M.<br />
Cookson.<br />
3467T Activation <strong>of</strong> silenced tumor suppressor genes<br />
in prostate cancer cells by a novel energy restrictionmimetic<br />
agent. H. Lin, Y. Kuo, Y. Weng, I. Lai, T. Huang, S.<br />
Lin, D. Niu, C. Chen.<br />
3468T Patterns <strong>of</strong> SNP-based genome-wide heritability<br />
<strong>of</strong> methylation in four brain regions. J. Listgarten, G.<br />
Quon, C. Lippert, D. Heckerman.<br />
3469T Statistical models to predict DNA methylation<br />
level across different tissues in human. B. Ma, E.<br />
Wilker, S. A. G. Willis-Owen, K. C. C. Wong, A. Baccarelli,<br />
J. Schwartz, W. O. C. M. Cookson, K. Khabbaz, M. A.<br />
Mittleman, M. F. M<strong>of</strong>fatt, L. Liang.<br />
3470T Comparative DNA methylation in TrkB gene<br />
across brain regions <strong>of</strong> suicide completers. G.<br />
Maussion, B. Labonté, C. Ernst, A. Diallo, J. Yang, N.<br />
Mechawar, G. Turecki.<br />
3471T Methylomic variation In Alzheimer’s disease.<br />
J. Mill, K. Lunnon, M. Volta, R. Smith, J. Powell, Y. Patel,<br />
N. Buckley, J. Cooper, C. Troakes, V. Haroutunian, S.<br />
Lovestone, L. Schalkwyk.<br />
3472T Cytosine modifications and cellular sensitivity to<br />
chemotherapeutics. E. L. Moen, X. Zhang, S. M. Delaney,<br />
L. A. Godley, M. E. Dolan, W. Zhang.<br />
3473T Aberrant promoter hypermethylation <strong>of</strong> MMP16<br />
gene in the colorectal cancer. J. Moon, S. Lee, J. Kim,<br />
G. You, J. Lee, J. Kim, H. Kim, S. Park.<br />
3474T Deep sequencing reveals allelic and<br />
parental inheritance patterns <strong>of</strong> genome-wide DNA<br />
methylation in large number <strong>of</strong> nuclear pedigrees with<br />
schizophrenia. R. A. Oph<strong>of</strong>f, N. Plongthongkum, T. Wang,<br />
Y. Zhang, K. R. Van Eijk, R. S. Kahn, M. P. M. Boks, S.<br />
Horvath, K. Zhang.<br />
3475T Methylation pattern <strong>of</strong> twin groups with Behcet’s<br />
syndrome. M. Ozkilic, B. Shamloo, G. Celikyapi Erdem, E.<br />
Seyahi, H. Yazici, E. Tahir Turanli.<br />
3476T Integrated analysis <strong>of</strong> genome-wide DNA<br />
methylation and gene expression in post-mortem<br />
schizophrenia brain samples. R. Pidsley, J. Viana, C.<br />
Troakes, S. Al-Sarraj, L. Schalkwyk, J. Mill.<br />
3477T Determination <strong>of</strong> methylation pr<strong>of</strong>ile in<br />
patients with schizophrenia. B. Rukova, R. Staneva, S.<br />
Hadjidekova, D. Nikolova, V. Milanova, D. Toncheva.<br />
3478T Association <strong>of</strong> CpG island shore methylation in<br />
peripheral blood with disease state and SNP variants<br />
in the MLH1 region in colorectal cancer patients. A.<br />
Savio, M. Lemire, M. Mrkonjic, S. Gallinger, B. Zanke, T.<br />
Hudson, B. Bapat.<br />
3479T The DNA methylation landscape <strong>of</strong> human<br />
placenta. D. Schroeder, H. Yu, P. Lott, D. Hong, C. Walker,<br />
I. Korf, J. M. LaSalle.<br />
3480T Methylation quantitative trait loci are consistently<br />
detected across ancestry, age and tissue type. A. K.<br />
Smith, V. Kilaru, M. Kocak, L. M. Almli, K. B. Mercer, E. B.<br />
Binder, K. J. Ressler, F. A. Tylavsky, K. N. Conneely.<br />
3481T Whole-genome methylation analysis: New<br />
insights in BEN molecular ethiology. R. Staneva, B.<br />
Rukova, I. Dimova, S. Hadzhidekova, O. Boyanova, M.<br />
Polenakovic, V. Stefanovic, R. Cukuranovic, V. Djonov, A.<br />
Galabov, D. Toncheva.<br />
3482T Genome-wide differences in DNA methylation<br />
identified in children with Williams-Beuren syndrome.<br />
E. Strong, D. Butcher, C. B. Mervis, C. A. Morris, R.<br />
Weksberg, L. R. Osborne.<br />
3483T Genome-wide pr<strong>of</strong>iling <strong>of</strong> 5-formylcytosine in<br />
embryonic stem cells. K. E. Szulwach, C. X. Song, Q.<br />
Dai, Y. Fu, P. Liu, L. Li, Y. Li, G. L. Xu, C. He, P. Jin.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3484T Extremely preterm infants are epigenetically<br />
different from term infants at birth and an epigenetic<br />
legacy <strong>of</strong> preterm birth may remain at 18 years <strong>of</strong> age.<br />
C. Theda, M. Cruickshank, A. Oshlack, P. Sheehan, R.<br />
Saffery, P. Davis, LW. Doyle, J. Craig.<br />
3485T Genome-wide detection and analysis <strong>of</strong> CpG<br />
dinucleotide methylation in cancer fatigue studies. D.<br />
Wang, H. Lee, W. Xiao, C. Hsiao, H. Kim, R. Dionne, L.<br />
Saligan.<br />
3486T Prediction <strong>of</strong> total serum IgE using genomewide<br />
methylation pr<strong>of</strong>ile. X. Wang, S. A. G. Willis-Owen,<br />
K. C. C. Wong, A. Binia, G. Davies, J. M. Hopkin, G. M.<br />
Lathrop, M. F. M<strong>of</strong>fatt, W. O. C. M. Cookson, L. Liang.<br />
3487T Epigenomic pr<strong>of</strong>iling <strong>of</strong> autism spectrum<br />
disorder. C. C. Y. Wong, L. C. Schalkwyk, E. L. Meaburn,<br />
A. Ronald, T. S. Price, R. Plomin, D. H. Geschwind, J. Mill.<br />
3488T Microarray-based genome-wide analyses <strong>of</strong><br />
DNA methylation in hematological malignancies. Y.<br />
Yang, H. Mei, L. Edelmann, A. J. Sharp, I. Peter, V. Najfeld,<br />
C. R. Geyer, J. F. DeCoteau, S. A. Scott.<br />
3489T Discovery <strong>of</strong> cross-reactive probes in the<br />
Illumina Infinium <strong>Human</strong>Methylation450 microarray:<br />
A cautionary tale. Y. Chen, M. Lemire, S. Choufani, D. T.<br />
Butcher, D. Grafodatskaya, B. W. Zanke, R. Weksberg.<br />
3490T Epigenetic changes in response to common<br />
environmental compounds. V. Labrie, I. Rezaian, S.<br />
Konigorski, N. Miller, Y. Li, C. Austin, R. Tice, M. Xia, A.<br />
Ngom, L. Rueda, R. Kustra, A. Petronis.<br />
3491T Regulatory network <strong>of</strong> microRNA action: miR-<br />
199a in health and diseases. S. Gu, Y. K. Suen, W. Y.<br />
Chan.<br />
3492T Gold nanoparticles cause variation in the level <strong>of</strong><br />
methylation in H3K4 and H3K9. A. Polverino, A. Iuliano,<br />
L. Cristino, R. Imperatore, A. Longo, G. Carotenuto, S. De<br />
Nicola, M. Piscopo, L. Fucci, E. Vitale.<br />
3493T Gene methylation and allelic expression imbalance<br />
<strong>of</strong> the CYP1A2 and CYP3A4 genes in human livers. J. Shi,<br />
W. Shou, Z. Niu, Y. Wang, K. Zhang, W. Huang.<br />
3494T 6q24 Transient neonatal diabetes mellitus: 16<br />
years <strong>of</strong> data collection. I. K. Temple, S. Kabwama,<br />
L. Doherty, S. Ennis, E. Cook, L. Harrison, S. Ellard, S.<br />
Flanagan, A. T. Hattersley, J. P. H. Shield, D. J. G. Mackay.<br />
3495T Genome-wide pr<strong>of</strong>iling <strong>of</strong> human uniparental<br />
tissues to search for novel imprinted genes. S. Wen,<br />
W. Wan, A. Balasa, S. Mahadevan, Z. Liu, I. B. Van den<br />
Veyver.<br />
3496T Next generation bisulfite analysis around<br />
a 2.2 kb ICR1 deletion in 11p15.5 reveals variable<br />
hypermethylation explaining reduced penetrance in<br />
BWS families. J. Beygo, V. Citro, D. Prawitt, M. Heitmann,<br />
K. Rademacher, B. Horsthemke, A. Riccio, K. Buiting.<br />
POSTER SESSIONS 255<br />
3497T A noncoding imprinted RNA, MESTIT1 is<br />
essential for the repression in cis <strong>of</strong> KLF14. S. Horike,<br />
M. Meguro-Horike.<br />
3498T MeCP2 is required for chromatin higher-order<br />
structure and dynamics at the imprinted 15q11-q13<br />
locus. M. Meguro-Horike, D. H. Yasui, W. Powell, J. M.<br />
LaSalle, S. Horike.<br />
3499T DNA methylation analysis <strong>of</strong> reciprocal genomewide<br />
UPDs to define imprinted differentially methylated<br />
regions in the human genome. K. Nakabayashi, A. M.<br />
Trujillo, C. Tayama, V. Romanelli, P. Lapunzina, M. Kagami,<br />
H. Soejima, H. Ogata, F. Court, D. Monk, K. Hata.<br />
3500T The imprinted C15orf2 gene in the Prader-Willi<br />
syndrome region encodes a nuclear pore complex<br />
associated protein. L. C. Neumann, Y. Markaki, E.<br />
Mladenov, D. H<strong>of</strong>fmann, K. Buiting, B. Horsthemke.<br />
3501T The ‘language gene’ FOXP2 is not imprinted.<br />
A. C. Thomas, J. M. Frost, F. Khadem, P. Stanier, G. E.<br />
Moore.<br />
3502T Evaluation <strong>of</strong> gene expression pr<strong>of</strong>ile <strong>of</strong><br />
chromatin modification enzymes in ACP02 and ACP03<br />
gastric cell lines. J. C. Santos, R. R. Burbano, M. L.<br />
Ribeiro.<br />
3503T Expression patterns <strong>of</strong> histone acetylation<br />
modifier genes in gastric cancer. F. Wisnieski, D. Q.<br />
Calcagno, M. F. Leal, T. B. Pontes, C. O. Gigek, E. S.<br />
Chen, S. Demachki, L. G. Lourenço, P. P. Assumpção, R.<br />
Artigiani, R. R. Burbano, M. A. C. Smith.<br />
3504T The enzyme holocarboxylase synthetase<br />
mediates biotin-independent gene-silencing through<br />
the recruitment <strong>of</strong> histone deacetilases in the nucleus<br />
<strong>of</strong> human cells. I. Trujillo, T. Barrios-García, S. Reyes-<br />
Carmona, I. Meneses-Morales, A. Leon-Del-Rio.<br />
3505T Epigenetic variation among humans. M.<br />
Kasowski, F. Grubert, S. Kyriazopoulou-Panagiotopoulou,<br />
A. Kundaje, J. Li, D. Spacek, M. Snyder.<br />
3506T Expression <strong>of</strong> mouse Lin28 gene is<br />
epigenetically regulated by histone modification. A.<br />
Pang, A. Title, O. M. Rennert.<br />
3507T Transcriptional and epigenetic variation in<br />
human induced pluripotent stem cells. N. Kumasaka, F.<br />
Rouhani, L. Vallier, A. Bradley, D. Gaffney.<br />
3508T The ratio <strong>of</strong> IGF2/IGF2R in chorionic villus<br />
samples as a biomarker for birth weight. C. Demetriou,<br />
A. Thomas, M. Ishida, S. Abu-Amero, R. Aggarwal, D.<br />
Peebles, A. Syngelaki, K. Nicolaides, L. Regan, G. E. Moore.<br />
3509T Genome-wide studies <strong>of</strong> methylation in<br />
the mouse frontal cortex reveals novel imprinted<br />
differential methylated regions and non-CG<br />
methylation. C. Barr, W. Xie, Y. Feng, K. Wigg, E.<br />
Dempster, L. Gomez, J. Eubanks, B. Ren.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
256 POSTER SESSIONS<br />
3510T An integrated analysis <strong>of</strong> DNA methylation,<br />
histone modifications and gene expression in<br />
monozygotic twins discordant for psoriasis identifies<br />
disease-associated genes. R. Lyle, K. Gervin, G. D.<br />
Gilfillan, M. Hammerø, H. S. Hjorthaug, A. O. Olsen, T.<br />
Hughes, J. R. Harris, D. E. Undlien.<br />
3511T Monozygotic male twins with loss <strong>of</strong><br />
methylation at DMR2 but discordant for clinical<br />
features <strong>of</strong> Beckwith Wiedemann syndrome. J. Lazier,<br />
M. A. Thomas.<br />
3512T Acquired epigenetic and chromosomal<br />
instability alterations are present in adults who<br />
experienced childhood sexual abuse: A discordant<br />
monozygotic twin study. T. York, J. Brumelle, J. Juusola,<br />
K. Kendler, E. Eaves, A. Amstadter, S. Aggen, K. Jones, S.<br />
Latendresse, A. Ferreira-Gonzalez, C. Jackson-Cook.<br />
3513T Genome-wide DNA methylation and gene<br />
expression analyses <strong>of</strong> monozygotic twins discordant<br />
for intelligence levels. C. C. Yu, M. Furukawa, K.<br />
Kobayashi, C. Shikishima, P. C. Cha, J. Sese, H.<br />
Sugawara, K. Iwamoto, T. Kato, J. Ando, T. Toda.<br />
3514T Analysis <strong>of</strong> expressed SNPs identifies new<br />
genes escaping X-chromosome inactivation and<br />
variable extents <strong>of</strong> expression from the inactive X. A.<br />
Cotton, B. Ge, T. Pastinen, C. Brown.<br />
3515T Investigating the role <strong>of</strong> the WICH chromatin<br />
remodeling complex in maintaining facultative<br />
heterochromatin at the human inactive X chromosome<br />
through targeted deletion <strong>of</strong> the BAZ1B gene using<br />
zinc finger nuclease technology. A. E. Culver-Cochran,<br />
B. P. Chadwick.<br />
3516T DNA methylation pr<strong>of</strong>iling in X;autosome<br />
translocations supports a role for repeat elements in<br />
the spread <strong>of</strong> X chromosome inactivation. A. Sharp, N.<br />
Bala, M. Brahmachary, P. Garg, C. Borel.<br />
3517T Tools for epigenetic research. L. Apone, P. Liu, G.<br />
Lohman, E. Cantor, B. Langhorst, D. Munafo, C. Sumner,<br />
E. Yigit, L. Merrill, F. Stewart, T. Evans, E. Dimalanta, T.<br />
Davis.<br />
3518T Sex-influenced epigenetic effects in<br />
chromosomal rearrangements. J. Kapalanga, D. Wong,<br />
N. Nwebube, A. Gandy.<br />
3519T The relationship between paternal uniparental<br />
disomy and clinical features in patients with Beckwith-<br />
Wiedemann syndrome. O. Yasufumi, K. Jozaki, T. Maeda,<br />
H. Yatsuki, K. Higashimoto, H. Soejima.<br />
3520T Streamlined chromosome conformation capture<br />
workflow for the studies <strong>of</strong> human �-globin gene<br />
control by locus control region. C. Woo, C. Liu, S. Dong.<br />
3521T microRNAs in the sclera: Role in ocular growth<br />
regulation and implications for myopia. R. Metlapally, P.<br />
Gonzalez, F. A. Hawthorne, K. Tran-Viet, C. F. Wildsoet, T.<br />
L. Young.<br />
3522T DNA combing assay for detection <strong>of</strong><br />
contraction-dependent facioscapulohumeral muscular<br />
dystrophy (FSHD1). F. Z. Boyar, P. Chan, V. Sulcova, D.<br />
Tsao, R. Owen, P. Walrafen, C. D. Braastad, M. Jocson, W.<br />
Sun, A. Anguiano, C. M. Strom.<br />
3523T RNA editing <strong>of</strong> the SDHB transcripts (C to U) in<br />
peripheral blood monocytes. R. T. Taggart, J. D. Tario, K.<br />
H. De Jong, P. K. Wallace, B. E. Baysal.<br />
3524T FTO levels affect RNA modification and the<br />
transcriptome. T. Berulava, M. Ziehe, L. Klein-Hitpass, E.<br />
Mladenov, J. Thomale, U. Rüther, B. Horsthemke.<br />
3525T Prioritizing candidate functional SNPs at GWAS<br />
loci using epigenomic datasets from ENCODE. K. S. Lo,<br />
C. D. Palmer, J. N. Hirschhorn, G. Lettre.<br />
Bioinformatics and Genomic<br />
Technology<br />
3526W Bioinformatic parallel processing tools<br />
development for mutation identification from whole<br />
exome data following homozygosity mapping<br />
for autosomal recessive disorders. Y. Al-Sarraj, A.<br />
Abouzehry, H. ElShanti, M. Kambouris.<br />
3527F Kailos Blue: A complete cloud-based<br />
bioinformatics solution for management and analysis<br />
<strong>of</strong> targeted sequencing across next-generation<br />
sequencing platforms. R. C. Bachmeyer, D. A. Kloske, B.<br />
Stone, K. E. Varley, D. T. Moore.<br />
3528W Streamlined, accurate low level detection <strong>of</strong><br />
variants in deep, next-generation sequencing data<br />
from amplicons. C. Boysen, M. Matvienko, N. Thomson,<br />
B. Turner, J. Bendtsen, H. Sandmann, J. Jakobsen, P.<br />
Nielsen, A. Joecker, A. Joecker.<br />
3529F De novo assembly by positional sequencing. B.<br />
Bready, P. Goldstein, W. H. Heaton, P. Ianakiev, H.-Y. Li, J.<br />
S. Oliver, J. Thompson.<br />
3530W Translational research in newborn screening:<br />
development <strong>of</strong> informatics tools to support<br />
longitudinal research and accelerate transformations<br />
in clinical practice. A. Brower, B. Bowdish, M. Porter, J.<br />
Pennington, S. Wrazien, J. Loutrel, P. White, M. Watson.<br />
3531F Web-based tool for target sequence capture<br />
assay design. J. Cai, B. Morrow.<br />
3532W wANNOVAR: Annotating genetic variants for<br />
personal genomes via the Web. X. Chang, K. Wang.<br />
3533F Simultaneous analysis <strong>of</strong> common and rare<br />
variants in complex traits. G. Chen, A. Yuan, A. Bentley,<br />
D. Shriner, A. Adeyemo, C. Rotimi.<br />
3534W On combining reference data to improve<br />
imputation accuracy. J. Chen, J. G. Zhang, J. Li, Y. F. Pei,<br />
H. W. Deng.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3535F Improved filtering and annotation <strong>of</strong> nextgeneration<br />
sequencing variants in clinical gene panels.<br />
H. K. Chong, S. Mexal, A. M. Elliott, H. M. Lu, H. Lu, X. Li.<br />
3536W Discovery <strong>of</strong> a cis-regulatory SNP at the<br />
PPARG diabetes risk locus. M. Claussnitzer, H. Grallert,<br />
S. N. Dankel, B. Klocke, H. Lee, S. Hauck, V. Glunk, C.<br />
H<strong>of</strong>fmann, M. Seifert, G. Mellgren, T. Illig, H. Hauner, H.<br />
Laumen.<br />
3537F dbGENO: A web-based complex disease<br />
curation pipeline. D. Cook, J. Dagle, K. Ryckman, J.<br />
Murray.<br />
3538W EVA: Exome Variation Analyzer, a tool for<br />
filtering strategies in medical genomics. S. Coutant,<br />
C. Cabot, A. Lefebvre, M. Léonard, E. Prieur-Gaston, D.<br />
Campion, T. Lecroq, T. Frebourg, H. Dauchel.<br />
3539F Random design tool for additional MIDs for<br />
Roche sequencing platforms. S. H. Eck, B. Grumbt, I.<br />
Nieberle, C. Marschall, K. Hirv, H.-G. Klein.<br />
3540W A functional gene-based test for association<br />
in Tourette’s syndrome and obsessive-compulsive<br />
disorder. P. Evans, TSA Consortium for <strong>Genetics</strong>, The<br />
International OCD Foundation <strong>Genetics</strong> Collaborative.<br />
3541F Statistical considerations for decisions on<br />
applying globin RNA reduction in blood samples for<br />
gene expression experiments. S. Feng, J. Dungan, S.<br />
Gregory, C. Haynes, W. Kraus.<br />
3542W Bi<strong>of</strong>ilter 2.0 for advanced predictive model<br />
development, testing, and hypothesis generation<br />
using expert domain knowledge resources. A. Frase,<br />
J. Wallace, C. Moore, N. Katiyar, S. A. Pendergrass, M. D.<br />
Ritchie.<br />
3543F Iterated correction <strong>of</strong> a diploid parental<br />
reference sequence and its use during exome<br />
alignments for disease gene discovery. T. R. Gall, D. R.<br />
Adams, C. F. Boerkoel, K. Fuentes-Fajardo, W. A. Gahl, P.<br />
Cherukuri, M. Sincan, C. Toro, C. J. Tifft, T. C. Markello.<br />
3544W Kinship index variations among populations<br />
and thresholds for familial searching. J. Ge, B. Budowle.<br />
3545F Transparent, accessible, and robust functional<br />
analysis <strong>of</strong> SNPs. B. Giardine, R. Burhans, C. Riemer, A.<br />
Ratan, R. Harris, G. Von Kuster, R. C. Hardison, Y. Zhang,<br />
W. Miller, Galaxy Development Team.<br />
3546W ParseCNV integrative CNV association s<strong>of</strong>tware<br />
with quality tracking. J. Glessner, H. Hakonarson.<br />
3547F Web-based interactive visual analysis <strong>of</strong> NGS<br />
data using Galaxy. J. Goecks, A. Nekrutenko, J. Taylor,<br />
Galaxy Team.<br />
3548W Computational and informational challenges<br />
in providing clinically-relevant genome interpretation<br />
from high-throughput sequencing data. R. K. Hart,<br />
Locus Development, Inc.<br />
POSTER SESSIONS 257<br />
3549F Capture-recapture models for evaluation <strong>of</strong><br />
algorithms estimating functionality <strong>of</strong> missense<br />
mutations. S. Hicks, S. E. Plon, M. Kimmel.<br />
3550W The Unified Sample Identifier: A universal<br />
sample coding system to manage large numbers<br />
<strong>of</strong> biological samples. P. H<strong>of</strong>fmann, J. E. Bolz, A.<br />
Reinscheidt, T. F. Wienker, S. Cichon, S. Herms.<br />
3551F Systematic evaluations <strong>of</strong> sequencing errors<br />
in next-generation sequencing data. Y. Hu, Y. Liu, J.<br />
Ferguson, I. Silverman, B. Gregory, M. Reilly, M. Li.<br />
3552W EGpr<strong>of</strong>ile: A tool for rapid pr<strong>of</strong>iling analysis <strong>of</strong><br />
epigenetic marks with ChIP-seq data. W. Huang, L. Li.<br />
3553F SOAPfuse detects gene fusions from paired-end<br />
RNA-seq data with single base resolution. W. Jia, K.<br />
Qiu, M. He, P. Song, Q. Zhou, F. Zhou, X. Hu, Y. Li, G. Guo.<br />
3554W Personalized genomics: Personalized pathway<br />
mapping. P. Jia, Z. Zhao.<br />
3555F Correcting for expression heterogeneity while<br />
identifying regulatory hotspots. J. Joo, J. Sul, B. Han,<br />
E. Eskin.<br />
3556W GeneTalk: An expert exchange platform for<br />
assessing rare sequence variants. T. Kamphans, P. M.<br />
Krawitz.<br />
3557F UCSC Genome Browser <strong>2012</strong>: Distributed data,<br />
enhanced interactivity, variant annotation integrator. W.<br />
J. Kent, A. Hinrichs, D. Karolchick, A. Zweig, B. Raney, H.<br />
Clawson, M. Cline, L. Guruvadoo, K. Learned, R. Kuhn, B.<br />
Rhead, T. Dreszer, L. Meyers, C. Li, M. Diekhans, G. Roe,<br />
P. Fujita, D. Haussler.<br />
3558W Curating genomic epidemiology data in the<br />
PAGE study. G. Kumaraguruparan, G. Mehta, A. Q. Nato,<br />
J. L. Ambite, S. Buyske, R. Mayani, C. Cai, J. S. Vockler, E.<br />
Deelman, T. C. Matise.<br />
3559F Predicting causal variants in exome sequencing<br />
<strong>of</strong> Mendelian disorders. J. Kwan, M. X. Li, P. C. Sham.<br />
3560W Analysis <strong>of</strong> Ewing sarcoma NGS transcriptome<br />
data highlights mechanisms <strong>of</strong> cancer progression. M.<br />
Laurance, J. Billaud, C. Bullitt.<br />
3561F Low concordance <strong>of</strong> variant calling algorithms<br />
in exome sequencing. G. Lyon, T. Jiang, G. Sun, W.<br />
Wang, J. Hu, P. Bodily, L. Tian, B. Moore, H. Hakonarson,<br />
J. Wang, M. Yandell, E. Johnson, Z. Wei, K. Wang.<br />
3562W DIVERGENOMEnrich: Expanding information on<br />
a genetic variation database through automatic online<br />
data retrieval. W. Magalhaes, G. Souza, G. Kingman, E.<br />
Tarazona, M. Rodrigues, Epigen-Brazil.<br />
3563F Fast and accurate local ancestry inference on<br />
whole genome-scale data using conditional random<br />
fields. B. Maples, F. Zakharia, S. Gravel, E. Kenny, C.<br />
Bustamante.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
258 POSTER SESSIONS<br />
3564W Exome sequencing <strong>of</strong> Mayo Clinic Biobank<br />
samples for evaluation <strong>of</strong> quality and quantity <strong>of</strong> data.<br />
S. Middha, S. K. McDonnell, Z. C. Fogarty, M. S. DeRycke,<br />
K. J. Johnson, N. M. Lindor, D. J. Schaid, J. E. Olson, J. R.<br />
Cerhan, S. N. Thibodeau.<br />
3565F Genome-wide association study on the world<br />
fastest supercomputer, k computer. K. Misawa, A.<br />
Hasegawa, T. Tsunoda.<br />
3566W A bioinformatics approach for the identification<br />
<strong>of</strong> developmental QTL candidate genes. A. Q. Nato, B.<br />
Li, F. Chen, J. H. Millonig, T. C. Matise.<br />
3567F Multivariate pr<strong>of</strong>iling approach to inference on<br />
differential expression in RNA-seq data with small<br />
sample size. S. Oh, M. Kim, S. Song.<br />
3568W Challenges and approaches to computational<br />
candidate gene prioritization using gene networks. P.<br />
Pavlidis, E. Mercier, J. Gillis.<br />
3569F BlueSNP: An R package for high-scalability<br />
genome-wide association studies on compute<br />
clusters. R. J. Prill, H. Huang, S. Tata.<br />
3570W Fast and accurate identification <strong>of</strong> novel<br />
sequences in de novo human genome assemblies using<br />
NSIT. B. Pupacdi, A. Javed, M. J. Zaki, M. Ruchirawat.<br />
3571F NGS for the masses: Empowering biologists to<br />
improve bioinformatic productivity. K. Qaadri.<br />
3572W Evaluation and visualization <strong>of</strong> functional<br />
perturbations <strong>of</strong> pathways based on whole genome<br />
variations. H. Qin, Y. Y. Shugart.<br />
3573F Use <strong>of</strong> an ad hoc information system to support<br />
data search at a genomics center. H. Qiu, F. Mentch, E.<br />
Frackelton, C. Kim, L. Hermannsson, H. Hakonarson.<br />
3574W Using biosignatures to stratify clinical<br />
response: Evaluation <strong>of</strong> classification methods using<br />
simulated gene expression signatures and real patient<br />
cohorts. P. Ravindran, C. Ooi, L. Kai, H. Zhong, A.<br />
Belousov, H. Bitter.<br />
3575F Mitre: A tool for bulk updates <strong>of</strong> SNP identifiers.<br />
N. W. Rayner, N. Robertson, M. I. McCarthy.<br />
3576W Genomic analysis from sequencer to bedside:<br />
An integrated analysis pipeline for research and<br />
clinical sequencing. J. G. Reid, M. N. Bainbridge, F.<br />
Yu, M. Dahdouli, D. Challis, P. Pham, D. P. Sexton, E.<br />
Boerwinkle, R. A. Gibbs.<br />
3577F <strong>Human</strong> genome pattern mining framework for<br />
complex diseases. M. Riemenschneider, M. Stoll.<br />
3578W A tool for selecting endogenous control for<br />
qRT-PCR using high throughput expression data. C.<br />
S. Rocha, C. V. Maurer-Morelli, I. Lopes-Cendes, F. M.<br />
Artiguenave.<br />
3579F Golden Helix GenomeBrowse: Cloud-enabled<br />
visual analytics <strong>of</strong> DNA and RNA-seq NGS data. G.<br />
Rudy, S. Gardner, M. Thiesen.<br />
3580W Informatics challenges on utilizing nextgeneration<br />
sequencing to advance disease<br />
understanding. S. Saisanit, J. Hakenberg, Y. Li.<br />
3581F Integrated genome-phenome analysis. M. M.<br />
Segal, M. S. Williams, J. G. Gleeson.<br />
3582W Variation data services at NCBI: Archives, tools,<br />
and curation for research and medicine. S. Sherry,<br />
K. Addess, V. Ananiev, C. Chen, D. Church, M. Feolo, J.<br />
Garner, T. Heffron, D. H<strong>of</strong>fman, M. Kholodov, A. Kitts, J.<br />
Lee, J. Lopez, D. Maglott, R. Maiti, L. Phan, G. Riley, W.<br />
Rubinstein, D. Rudnev, Y. Shao, E. Shekhtman, K. Sirotkin,<br />
D. Slotta, R. Tully, R. Villamarin-Salomon, Q. Wang, M. H.<br />
Ward, H. Zhang.<br />
3583F snpActs: A versatile web interface for<br />
annotating and prioritizing SNV data sets. B. Stade, D.<br />
Ellinghaus, B. Petersen, M. Forster, A. Franke.<br />
3584W Games for gene annotation and phenotype<br />
classification. A. I. Su, S. Loguercio, C. Wu, B. M. Good.<br />
3585F HMM-Fisher: A hidden Markov model-based<br />
method for identifying differential methylation. S. Sun,<br />
X. Yu.<br />
3586W Automated HGVS-recommended sequence<br />
variant description. P. Taschner, J. F. J. Laros, M.<br />
Vermaat, J. T. den Dunnen.<br />
3587F RNAseq analysis using the pipeline graphical<br />
workflow environment in neuropsychiatric disorders.<br />
F. Torri, I. D. Dinov, A. Zamanyan, S. Hobel, P. Petrosyan,<br />
Z. Liu, P. Eggert, I. Guella, J. Pierce, A. P. Clark, J. A.<br />
Knowles, J. Ames, C. Kesselman, A. W. Toga, S. Potkin,<br />
M. P. Vawter, F. Macciardi.<br />
3588W ENViz: A Cytoscape plugin for integrative<br />
statistical analysis and visualization <strong>of</strong> multiple sample<br />
matched data sets. A. Tsalenko, A. Kuchinsky, R. Navon,<br />
M. L. Creech, I. Steinfeld, Z. Yakhini.<br />
3589F Determining probability <strong>of</strong> rare variants: Design<br />
implications for family-based sequencing studies. W.<br />
Wang, G. Peng.<br />
3590W Harvest: A web-based biomedical data<br />
discovery and reporting application development<br />
platform. P. S. White, B. Ruth, M. J. Italia, J. Miller, J. W.<br />
Pennington.<br />
3591F Pinpoint: A new algorithm to detect gene-gene<br />
interactions in large-scale genome-wide association<br />
studies. D. Wong, S. Szymczak, J. E. Bailey-Wilson.<br />
3592W A unified analysis framework for detecting<br />
genetic variations from next-generation sequencing<br />
data. C. Xiao, S. Sherry.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3593F HMM-DM: Identifying differential methylation<br />
patterns using a hidden Markov model. X. Yu, S. Sun.<br />
3594W Genotype calling for next-generation<br />
sequencing data from multiple populations. K. Zhang,<br />
D. Zhi.<br />
3595F Detecting structural variants in cancer from<br />
whole genome and exome sequencing. J. Zhang, Y. Shi,<br />
W. Foulkes, J. Majewski.<br />
3596W Causal inference <strong>of</strong> gene regulation based on<br />
sub-network assembly. W. Hsieh, C. Peng, A. Dai, S.<br />
Peng, T. Yen.<br />
3597F Identification <strong>of</strong> candidate variants in population<br />
based whole exome sequencing data through<br />
integration <strong>of</strong> functional prediction with bayesian<br />
penalized regression. J. Lu, A. Sabo, J. Reid, D. Muzny,<br />
E. Boerwinkle, R. Gibbs, ARRA Autism Sequencing<br />
Consortium.<br />
3598W Joint association <strong>of</strong> multiple correlated<br />
phenotypes using matrix-variate linear mixed-models.<br />
N. Furlotte, E. Eskin.<br />
3599F The human gene connectome: A map <strong>of</strong> short<br />
cuts for morbid allele discovery. Y. Itan, S. Y. Zhang,<br />
G. Vogt, A. Abhyankar, L. Quintana-Murci, L. Abel, J. L.<br />
Casanova.<br />
3600W Transcriptome sequencing <strong>of</strong> nPOD type<br />
1 diabetes pancreatic samples for viral sequence<br />
identification. S. Morfopoulou, G. Zhao, R. Ferreira, A.<br />
Pugliese, J. Petrosino, L. Thackray, V. Plagnol, nPOD-Virus<br />
Group.<br />
3601F VARITAS: Variant analysis with rapid<br />
incorporation <strong>of</strong> annotation sources. B. Powell.<br />
3602W Clinical diagnostic tools for family genome and<br />
exome data. A. Russell, F. De La Vega, J. Rule, M. Reese.<br />
3603F ASAP: An easy-to-use pipeline for sequencing<br />
data processing. E. Torstenson, C. Li.<br />
3604W Identifying biological pathways and human<br />
diseases in high-throughput human genetic studies. C.<br />
Xie, X. Mao, J. Huang, Y. Ding, J. Wu, S. Dong, L. Kong, G.<br />
Gao, C. Li, L. Wei.<br />
3605F GenAMap: A visual analytics s<strong>of</strong>tware platform<br />
for eQTL and GWAS analysis. E. Xing, R. Curtis, S. Lee,<br />
S. Shringarpure, J. Yin.<br />
3606W PHV: A high accuracy SNP and indel variant<br />
caller based on the pr<strong>of</strong>ile hidden Markov model. M.<br />
Zhao, W. Lee, G. Marth.<br />
3607F Developing copy number variation based casecontrol<br />
association analysis tool and its application for<br />
disease analysis. Y. Chung, J. H. Kim, H. J. Hu, S. H. Yim,<br />
J. S. Bae, S. Y. Kim.<br />
POSTER SESSIONS 259<br />
3608W DWAC-seq: Dynamic Window Approach for<br />
CNV detection using next-generation targeted and full<br />
genome sequencing tag density. V. Koval, J. van Rooij,<br />
K. Estrada, P. Arp, M. Jhamai, R. Kraaij, A. Uitterlinden, E.<br />
Cuppen, V. Guryev.<br />
3609F Fast detection <strong>of</strong> de novo copy number variants<br />
from case-parent SNP arrays identifies a deletion on<br />
chromosome 7p14.1 associated with non-syndromic<br />
isolated cleft lip/palate. I. Ruczinski, R. B. Scharpf, S.<br />
Younkin, H. Schwender, M. Marazita, A. F. Scott, T. H.<br />
Beaty.<br />
3610W VarioML framework for comprehensive<br />
variation data representation and exchange. M. Byrne,<br />
I. A. C. Fokkema, O. Lancaster, T. Adamusiak, A. Ahonen-<br />
Bishopp, D. Atlan, C. Beroud, M. Cornell, R. Dalgeish, A.<br />
Devereau, G. P. Patrinos, M. A. Swertz, P. E. M. Taschner,<br />
G. A. Thorisson, M. Vihinen, A. J. Brookes, J. Muilu.<br />
3611F Gene-centered viewing, storing and sharing <strong>of</strong><br />
exome/genome variant and phenotype data. J. T. den<br />
Dunnen, I. F. Fokkema, I. C. Lugtenburg, J. Hoogenboom,<br />
Z. Tatum, G. C. P. Schaafsma, M. Vermaat, J. F. J. Laros, P.<br />
E. M. Taschner.<br />
3612W Leveraging metadata for experimental<br />
discovery at the ENCODE portal. E. L. Hong, C. Sloan, V.<br />
Malladi, K. Rosenbloom, G. Barber, G. Binkley, E. T. Chan,<br />
R. Fang, B. C. Hitz, D. Karolchik, V. Kirkup, K. Learned,<br />
J. Long, M. Maddren, M. Wong, A. Zweig, D. Haussler, J.<br />
Kent, J. M. Cherry.<br />
3613F A Bayesian hierarchical generalized linear model<br />
for identifying multiple interacting genes in familybased<br />
case-control studies. J. Li, N. Yi.<br />
3614W A national platform for clinical genetic analysis<br />
<strong>of</strong> high-throughput sequencing data in Norway. M.<br />
C. Eike, H. LÊrum, T. Hughes, S. Bremer, S. Bergan, G.<br />
Thomassen, M. Aanestad, T. Grünfeld, D. E. Undlien.<br />
3615F Haplotyping human genomes using wholegenome<br />
sequence data. V. Bansal.<br />
3616W Comparing protein prediction methods using<br />
disease-causing missense variants. P. Duggal, Y. Kim,<br />
M. K. Tilley, M. M. Parker, A. Maroo, A. P. Klein.<br />
3617F Considerations for the processing and direct-toconsumer<br />
return <strong>of</strong> exome sequences. E. D. Harrington,<br />
C. McLean, A. Shmygelska, A. Chowdry, B. Naughton.<br />
3618W Topological mapping and exploration <strong>of</strong><br />
genotyping data using Iris. J. Paquette, G. Singh, G.<br />
Carlsson, P. Y. Lum.<br />
3619F Development <strong>of</strong> 1920 barcodes for large-scale<br />
targeted sequencing using the Access Array system.<br />
X. Wang, F. Kaper, P. Chen, C. Friedlnader, G. Sun, A. May.<br />
3620W NGS Catalog: A database <strong>of</strong> next-generation<br />
genome sequencing studies in humans. J. Xia, Q.<br />
Wang, P. Jia, B. Wang, W. Pao, Z. Zhao.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
260 POSTER SESSIONS<br />
3621F Genotype imputation via matrix completion. E.<br />
C. Chi, H. Zhou, G. K. Chen, D. Ortega Del Vecchyo, K.<br />
Lange.<br />
3622W Phenome-wide association study <strong>of</strong> common<br />
PXDN variants demonstrates association with aortic<br />
aneurysms. J. Denny, L. Bastarache, G. Bhave, S. McCall,<br />
M. Sample, R. Carroll, P. Peissig, A. Kho, C. McCarty, M.<br />
Brilliant, J. Cowan, R. Chisholm, E. Larson, G. Jarvik, C.<br />
Chute, I. Kullo, D. Roden, B. Hudson.<br />
3623F Rare variant association testing under lowcoverage<br />
and pooling. E. Halperin, J. H. Sul, O. Navon,<br />
B. Han, L. Conde, P. Bracci, J. Riby, C. Skibola, E. Eskin.<br />
3624W BioBin: A bioinformatics tool for biologically<br />
inspired collapsing <strong>of</strong> rare variants. C. B. Moore, J. R.<br />
Wallace, A. T. Frase, S. A. Pendergrass, M. D. Ritchie.<br />
3625F NCBI’s ClinVar: Data archive and tools for<br />
human variation <strong>of</strong> medical interest. D. Maglott, S.<br />
Chitipiralla, D. Church, M. Feolo, J. Garner, W. Jang, J.<br />
Lee, R. Maiti, J. Ostell, L. Phan, G. Riley, W. S. Rubinstein,<br />
D. Shao, S. Sherry, K. Sirotkin, R. Tully, R. Villamarin, M.<br />
Ward.<br />
3626W Estimation <strong>of</strong> haplotype frequencies from<br />
pooled sequence data. D. E. Kessner, J. Novembre.<br />
3627F Leveraging the haplotype information in long<br />
reads for variant calling. A. P. Singh, Y. Shen.<br />
3628W A model <strong>of</strong> binding on DNA microarrays:<br />
Understanding the combined effect <strong>of</strong> probe synthesis<br />
failure, cross-hybridization, DNA fragmentation and<br />
other experimental details <strong>of</strong> affymetrix arrays. Y. A.<br />
Jakubek, D. J. Cutler.<br />
3629F A recursively partitioned mixture model for<br />
clustering time-course gene expression data. D. C.<br />
Koestler, C. J. Marsit, B. C. Christensen, K. T. Kelsey, E. A.<br />
Houseman.<br />
3630W Probing altered gene expression pr<strong>of</strong>iles and<br />
pathways that affect mitochondrial metabolism in<br />
cancer cells and neurodegenerative diseases through<br />
network biology approach. A. D. Yadavalli, N. B. Sepuri.<br />
3631F Drug repositioning through data integration<br />
and advanced classification tools. D. Greco, Y. Zhao, F.<br />
Napolitano, R. Tagliaferri, M. D’Amato, J. Kere.<br />
3632W Gemini: A flexible, scalable analysis framework<br />
for medical and population genomics. U. D. Paila, A. R.<br />
Quinlan.<br />
3633F NOCALLER: A tool to account for missing<br />
genotypes. Z. Kronenberg, C. D. Huff, M. Yandell.<br />
3634W A novel model to predict splicing consequences<br />
<strong>of</strong> intronic nucleotide substitutions in the human<br />
genome. A. Shibata.<br />
3635F Prioritizing disease-linked variants, genes, and<br />
pathways with an interactive whole genome analysis<br />
pipeline for the MedSeq project. S. Kong, K. Lee, K. B.<br />
Hwang, J. M. Bohn, R. C. Green, I. S. Kohane.<br />
3636W The 1000 Genomes Project, data availability<br />
and accessibilty. L. Clarke, H. Zheng Bradley, R. Smith, I.<br />
Streeter, E. Kulesha, I. Toneva, B. Vaughan, P. Flicek, 1000<br />
Genomes Project Consortium.<br />
3637F Bioinformatics optimization for the detection <strong>of</strong><br />
low-level heteroplasmy in the mitochondrial genome in<br />
myelodysplastic syndrome. S. Dames, E. Duncavage, J.<br />
Thompson, P. Shami, K. Eilbeck, M. Salama, R. Mao.<br />
3638W Rare variant discovery in Illumina nextgeneration<br />
sequencing data: Prediction method to<br />
differentiate true variants from false positives. J.<br />
Durtschi, R. L. Margraf, K. V. Voelkerding.<br />
3639F Memory efficient assembly <strong>of</strong> mammalian size<br />
genome. F. Hormozdiari, E. Eskin.<br />
3640W Target capture-assisted sequence assembly for<br />
accurate genotyping <strong>of</strong> insertions and deletions. C. J.<br />
Kennedy, N. Chennagiri, M. A. Umbarger, G. J. Porreca, P.<br />
C. Saunders, V. Greger.<br />
3641F CLC bio’s integrated framework for<br />
identification and comparison <strong>of</strong> genomic variants<br />
in Mendelian diseases. M. Matvienko, A. Joecker, C.<br />
Boysen, U. Appelt, A. Fejes, L. Kahns, S. Mønsted, J.<br />
Grydholt, B. Knudsen, M. Bundgaard, J. Buur Sinding, H.<br />
Handberg, A.-M. Hein, M. Nygaard Ravn, A. Joecker, M.<br />
VÊrum, R. Forsberg.<br />
3642W Sensitivity and resolution <strong>of</strong> whole chromosome<br />
mapping for detection and characterization <strong>of</strong><br />
structural variations in human genomes. R. Moore.<br />
3643F Comparison <strong>of</strong> next-generation sequencing<br />
alignment programs using 215 whole genomes from<br />
the Cache County Study on Memory Health and Aging.<br />
P. G. Ridge, Jr., J. D. Durtschi, C. D. Corcoran, R. G.<br />
Munger, Q. O. Snell, M. J. Clement, K. V. Voelkerding, J.<br />
S. K. Kauwe.<br />
3644W Continuously evolving informatics at a mediumscale<br />
genomics center. L. Watkins, M. Barnhart, J.<br />
Goldstein, S. Griffith, E. Hsu, K. Roberts, D. Snyder, B. Craig,<br />
K. Hetrick, K. Doheny, Center for Inherited Disease Research.<br />
3645F Genotype concordance between low-coverage<br />
whole genome and high-coverage exome sequencing:<br />
Results from the UK10K Study. H. Zheng on behalf <strong>of</strong><br />
UK10K Consortium Cohorts Group.<br />
3646W Genotype calling and haplotype inference<br />
for next-generation sequencing data incorporating<br />
haplotype information in sequencing reads. D. Zhi, K.<br />
Zhang.<br />
3647F Exploring why whole genome sequencing<br />
methods result in different variant calls by comparing<br />
and integrating multiple datasets. J. M. Zook, D.<br />
Samarov, M. Salit.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3648W Next-generation biomarker screening: Using<br />
Roche’s 454 sequencing platform to identify somatic<br />
biomarkers. C. Lasyone, X. Tan, A. Pond, L. Szkotnicki, V.<br />
Venegas, K. B. Thomas, M. Berry, F. Lu.<br />
3649F De novo assembly <strong>of</strong> extremely long singlemolecule<br />
genome maps imaged in Irys nanochannel<br />
arrays. M. Requa, M. Austin, H. Dai, P. Deshpande, O.<br />
Hampton, H. Sadowski, M. Saghbini, M. Xiao, H. Cao.<br />
3650W Defining best practice guidelines for the use <strong>of</strong><br />
NGS applications in genome diagnostics: A national<br />
collaborative study <strong>of</strong> Dutch genome diagnostic<br />
laboratories (LOD). N. van der Stoep, M. M. Weiss, Q.<br />
Waisfisz, C. Ruivenkamp, M. Nelen, J. D. H. Jongbloed, H.<br />
Brüggenwirth, M. van Slegtenhorst, R. Lekanne dit Deprez,<br />
O. Mook, A. Van den Wijngaard, M. Vogel, B. Van der<br />
Zwaag, M. M. A. M. Mannens, Dutch National Board for<br />
DNA-Diagnostics (LOD).<br />
3651F Genome phantasmagoria: Naming genes in<br />
alternative loci. E. Bruford, R. Seal, M. Wright.<br />
3652W Rapid preparation <strong>of</strong> targeted resequencing<br />
libraries from DNA samples using the Access Array<br />
system. C. Friedlander, X. Wang, R. Ramakrishnan.<br />
3653F MitoExome: A custom whole exome kit for<br />
mitochondrial disease research and diagnosis that<br />
captures all MitoCarta genes and the mitochondrial<br />
genome. X. Gai, E. A. Pierce, M. Consugar, M. Lvova, D.<br />
C. Wallace, E. LeProust, M. J. Falk.<br />
3654W High-throughput solution for illumina fragment<br />
library sample preparations. A. Jackson, S. Verrow, M. Blair.<br />
3655F Comparison <strong>of</strong> two next-generation sequencing<br />
technologies on the genomes <strong>of</strong> a trio family. E.<br />
Jorgenson, R. Kazma.<br />
3656W Single-molecule, electronic, solid-state<br />
sequencing <strong>of</strong> M13 DNA. J. S. Oliver, B. Bready, D.<br />
Dederich, J. Freitas, H. Geiser, Y. He, D. Hevroni, M.<br />
Jouzi, H.-Y. Lee, P. Mukhatira, M. Nadel, J. Sariadaridis, J.<br />
Thompson.<br />
3657F Efficient genotyping <strong>of</strong> individuals using<br />
overlapping pool sequencing and imputation. Z. Wang,<br />
F. Hormozdiari, W. Yang, E. Eskin.<br />
3658W Whole-genome sequencing analysis <strong>of</strong> SNPs<br />
and structural variants in DNA from blood versus EBVtransformed<br />
lymphoblasts from the same subject. X.<br />
Zhu, C. Laurent, M. Haney, A. E. Urban, D. F. Levinson.<br />
3659F Genomic capture combined with long read and<br />
short read high-throughput sequencing for assembly<br />
<strong>of</strong> the MHC region. R. J. Bloom, A. L. Collins, A. E.<br />
Byrnes, Q. Langdon, S. Happe, J. Barboza, O. Hardy, G.<br />
Yuan, S. Ranade, P. Mieczkowski, P. F. Sullivan.<br />
3660W Automated pipeline for whole exome/genome<br />
sequencing analysis on Mendelian diseases. Y. Guo,<br />
K. Wang.<br />
POSTER SESSIONS 261<br />
3661F Computational analysis <strong>of</strong> Exome-seq for<br />
disease gene identification with eDIVA. S. Ossowski, R.<br />
Rahman, O. Drechsel.<br />
3662W The biologist’s tool for finding a needle in a<br />
haystack: CLC bio’s platform to identify interesting de<br />
novo and accumulative variants in the whole genome<br />
sequence <strong>of</strong> family trios. N. Thomson, A. Joecker, C.<br />
Boysen, M. Matvienko, U. Appelt, A. Fejes, L. Kahns, S.<br />
Mønsted, J. Grydholt, B. Knudsen, M. Bungaard, J. Buur<br />
Sinding, H. Handberg, A. Hiene, M. Nygaard Ravn, A.<br />
Joecker, M. VÊrum, R. Forsberg.<br />
3663F Ultra-fast clinical sequencing and annotation <strong>of</strong><br />
human genomes on the Illumina HiSeq 2500 platform.<br />
S. Humphray, J. Weir, Z. Kingsbury, T. James, R. Grocock,<br />
P. Saffrey, E. Margulies, K. Hall, D. Bentley, G. Smith, J.<br />
Betley, C. Raczy.<br />
3664W Managing computing resources in large<br />
sequencing studies: Strategies and lessons from<br />
sequencing 2,120 Sardinian genomes. A. Kwong,<br />
C. Sidore, S. Sanna, H. M. Kang, G. Jun, M. Trost,<br />
P. Anderson, T. Gliedt, R. Cusano, M. Pitzalis, M.<br />
Zoledziewska, A. Maschio, F. Busonero, M. Lobina, M.<br />
Balloi, B. Tarrier, C. Brennan, C. Jones, F. Cucca, G.<br />
Abecasis, SardiNIA Project.<br />
3665F Clinical implementation <strong>of</strong> targeted nextgeneration<br />
sequencing in a mid-sized diagnostic<br />
laboratory. H. Racher, L. Dimnik, P. Gordon, M. I. Innes, F.<br />
Bernier, J. S. Parboosingh.<br />
3666W High-fidelity sequencing for detection <strong>of</strong> lowfrequency<br />
single nucleotide variants. K. M. Squire, Z.<br />
Chen, S. F. Nelson.<br />
3667F Species identification by polymorphisms <strong>of</strong><br />
mitochondrial 12S rRNA and 16S rRNA genes. R. Li, L.<br />
Yang.<br />
3668W Rapid and efficient methods for preparing<br />
globin- and rRNA-depleted directional RNA-seq<br />
libraries. C. Kinross, J. Hitchen, N. Caruccio, R.<br />
Sooknanan.<br />
3669F Sequencing performance <strong>of</strong> FFPE DNA in the<br />
SureSelect XT2 Target Enrichment System. J. Barboza,<br />
M. Ramirez, A. Giuffre, J. Ong, H. Ravi, M. Guadalupe, S.<br />
Joshi, M. Visitacion, C. Pabón-Peña, S. Hunt, B. Novak, D.<br />
Roberts, S. Happe, E. LeProust.<br />
3670W Torrent Variant Caller: Enabling next level <strong>of</strong><br />
genomic analysis. D. Brinza, Z. Zhang, E. Tsung, A.<br />
Joyner, C. Scafe, G. Del Mistro, F. Hyland, E. Beasley, S.<br />
Utiramerur.<br />
3671F A next-gen sequencing s<strong>of</strong>tware workflow for<br />
cancer genomics on a desktop computer. M. Keyser, K.<br />
Maxfield, T. Schwei, T. Durfee, A. Pollack-Berti, D. Nash, J.<br />
Stieren, S. Baldwin, R. Nelson, K. Dullea, J. Schroeder, P.<br />
Pinnkas, G. Plunkett III, F. Blattner.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
262 POSTER SESSIONS<br />
3672W Strategy for identification, prediction, and<br />
prioritization <strong>of</strong> non-coding variants <strong>of</strong> uncertain<br />
significance in heritable breast cancer. P. K. Rogan, E.<br />
J. Mucaki, A. Stuart, N. Bryans, E. Dovigi, B. Shirley, J. H.<br />
Knoll, P. J, Ainsworth.<br />
3673F Genomic approach for environmental stress<br />
assessment in coral, Scleronephthya gracillimum. S.<br />
Woo, S. J. Hwang, S. Yum, J. I. Song.<br />
3674W RNA-seq uncovers the influence <strong>of</strong> structural<br />
variants on transcriptome diversity. E. Ait Yahya<br />
Graison, A. Reymond.<br />
3675F Detection <strong>of</strong> local signals in genomics. D.<br />
Siegmund, B. Yakir, N. Zhang.<br />
3676W Gene expression pr<strong>of</strong>iling <strong>of</strong> prokaryotic<br />
samples using LIQA WT kit. N. Guha.<br />
3677F In silico identification <strong>of</strong> microRNA-mRNA target<br />
pairs as potential biomarkers in prostate cancer. J.<br />
Billaud, C. Tavano, D. Toburen.<br />
3678W Active learning for phenotype mapping. C. Hsu,<br />
J. L. Ambite, Y. Arens, L. Lange, S. Sharma, S. Voinea.<br />
3679F Filtering and annotation <strong>of</strong> variants that are<br />
rare: Methods to facilitate the analysis <strong>of</strong> rare germline<br />
genetic variants from massively parallel sequencing<br />
datasets. D. J. Park, T. Nguyen-Dumont, F. Odefrey, A.<br />
Lonie, M. C. Southey, B. J. Pope.<br />
3680W Accurate, efficient next-generation DNA<br />
sequencing for clinical carrier screening. G. J. Porreca,<br />
M. Umbarger, C. Kennedy, P. Saunders, B. Breton, N.<br />
Chennagiri, J. Emh<strong>of</strong>f, V. Greger, D. Maganzini, C. Micale,<br />
M. Nizzari, C. Towne.<br />
3681F High-throughput CFTR full-gene analysis using<br />
Illumina’s MiSeq TruSeq custom amplicon technology.<br />
J. Radecki, S. Lee, H. Lu, S. Mexal, A. Elliott.<br />
3682W Sensitive detection <strong>of</strong> minor variants and viral<br />
haplotypes using Single-Molecule, Real-Time (SMRT ® )<br />
sequencing. A. Sethuraman, Y. Guo, M. Brown, J. Toma,<br />
A. Newton, W. Huang, M. Sugiyama, C. Petropoulos, M.<br />
Mizokami, E. Paxinos.<br />
3683F High-throughput amplicon sequencing using the<br />
personal genome machine. J. Boland, D. Roberson, M.<br />
Cullen, M. Yeager, K. Jacobs, S. Chanock, V. Lonsberry.<br />
3684W A simple method for improving the limit<br />
<strong>of</strong> detection for capillary electrophoresis DNA<br />
sequencing: A comparison <strong>of</strong> methodologies<br />
for KRAS variant detection. C. Davidson, E.<br />
Zeringer, K. J. Champion, M.-P. Gauthier, F. Wang, J.<br />
Boonyaratanakornkit, J. R. Jones, E. Schreiber.<br />
3685F HaloPlex target enrichment from FFPE tissues.<br />
F. Roos, H. Johansson, M. Isaksson, P. Eriksson, L.<br />
Forsmark, F. Dahl.<br />
3686W Optimized sample and library preparation <strong>of</strong><br />
FFPE tumor samples for targeted next-generation<br />
sequencing. N. Udar, R. Haigis, E. B. Jaeger.<br />
3687F TargetRich: Targeted sub-exome sequencing.<br />
I. A. Vasenkova, K. Jansen Spayd, T. Shvetsova, D. A.<br />
Kloske, R. C. Bachmeyer, D. T. Moore, K. E. Varley.<br />
3688W A functional approach to sequence capture<br />
analysis <strong>of</strong> disease pathways. M. Wijdicks, D. Burgess,<br />
M. D’Ascenzo, M. Brockman, J. Wendt, C. Skalitzky, D.<br />
Green, T. Richmond, L. Brown, R. Slezer.<br />
3689F Comparison <strong>of</strong> two NGS preparation methods<br />
for preimplantation and prenatal screening and<br />
diagnostics. J. P. Langmore, E. Kamberov, M.<br />
Mastronardi, T. Tesmer.<br />
3690W Droplet digital PCR enables reliable<br />
discrimination <strong>of</strong> copy number variation. J. R. Berman,<br />
N. Heredia, J. Regan, L. Montesclaros, S. Hodges, C.<br />
Troup, G. Karlin-Neumann.<br />
3691F Integrating high-quality DNA sequence capture<br />
with MiSeq for clinical sequencing. P. Shen, W. Wang, A.<br />
Chi, R. Davis, C. Scharfe.<br />
3692W Improved performance <strong>of</strong> solution based target<br />
enrichment by spike-in <strong>of</strong> individually synthesized<br />
capture probes. G. R. Mehta, Locus Development, Inc.<br />
3693F Accurate multiplexing for clinical next-generation<br />
DNA sequencing. M. A. Umbarger, G. P. Porreca.<br />
3694W Enhanced performance <strong>of</strong> the Illumina MiSeq ®<br />
next-generation sequencing ecosystem. K. Hall, C.<br />
Tregidgo, I. Rasolonjatovo, A. Breton, J. Bwanali, A.<br />
Jackson, E. Vermaas, D. Bond, M. Siu, C. Bruce, A.<br />
Powell, P. Tran, D. McBride, M. Ross.<br />
3695F Single-day, highly multiplexed amplicon<br />
sequencing with MiSeq ® . A. Iyer, A. Tian, K. Chang,<br />
E. Guzman, E. Upsall, I. Lewis, M. Won, W. Chang,<br />
D. Pokholok, R. Haigis, S. Norberg, M. Ronaghi, K.<br />
Gunderson, R. Shen, C. Lin.<br />
3696W WildFire: A simple monoclonal colony<br />
generation technology without emulsion PCR. Z. Ma, K.<br />
Lao, R. Lee, S. Goyal.<br />
3697F Nextera ® Enrichment: A new Nextera library<br />
prep protocol for targeted enrichment supporting 12plex<br />
pre-enrichment sample pooling. P. McInerney, S.<br />
Melnyk, M. Chen, M. Tsan, S. Cooper, H. Grunenwald, M.<br />
Lewis, R. Shen, J. Whitacre.<br />
3698W Development <strong>of</strong> Ion Torrent’s 400-base<br />
sequencing technology. X. Peng, G. Luo, T. Lincecum, E.<br />
Tozer, D. Mazur, K. Aguinaldo, G. Lowman, M. Landes, B.<br />
Strohecker, T. Nikiforov, P. Vander Horn.<br />
3699F From tumor to genome sequence with<br />
nanogram quantities <strong>of</strong> DNA: Ultralow target capture<br />
and DNA-Seq from FFPE samples. M. Phelan, L. Pham,<br />
G. Miyada, S. Kain, T. Cormier.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
3700W GnuBIO desktop sequencer: Fully integrated<br />
DNA preparation sequencing and analysis. T. Raz, A.<br />
Aslam, J. Boyce, N. Nerkizian, J. Emh<strong>of</strong>f, A. Esmall, J.<br />
Fanning, H. Ghandour, K. Moulton, P. Stokes, T. Hung, S.<br />
Kiani, P. Mary, J. Healy.<br />
3701F Utilizing next-generation sequencing for exome<br />
analysis. K. Stangier, F. Ernst, Y. Kumar, T. Paprotka.<br />
3702W Novel enrichment reagent for the study <strong>of</strong> the<br />
human microbiome. F. J. Stewart, G. R. Feehery, E. Yigit,<br />
E. T. Dimalanta, B. W. Langhorst, L. M. Apone, P. Liu, D.<br />
B. Munafo, C. J. Sumner, J. Bybee, L. M. Mazzola, T. B.<br />
Davis, S. Pradhan.<br />
3703F Structural variations identified using solid-state<br />
nanodetectors. J. Thompson, B. Bready, D. Dederich, D.<br />
Hevroni, M. Jouzi, H.-Y. Lee, D. Lloyd, P. Mukhatira, M.<br />
Nadel, J. Oliver, J. Saraidaridis.<br />
3704W Automaton <strong>of</strong> whole exome and targeted<br />
sequencing workflows in a high-throughput lab. M.<br />
Zilka, B. Marosy, A. Robinson, J. Gearhart, B. Craig, J.<br />
Romm, K. Doheny.<br />
3705F Automated genomic DNA QC ensures high<br />
quality data from downstream workflows. M.<br />
Gassmann, D. Rabiller, A. Padmanaban, D. McDade-<br />
Walker.<br />
3706W Optimization <strong>of</strong> a miRNA expression pr<strong>of</strong>iling<br />
workflow for ion semiconductor sequencing. T.<br />
Guettouche, J. Clarke, A. Andersen, L. Navarro, Y.<br />
Cardentey, W. Hulme, G. Bademci, D. Van Booven, D.<br />
Hedges, M. Pericak-Vance, J. Gilbert.<br />
3707F Functionalized nanoparticles for effective DNA<br />
purification. A. Lai, A. Fu.<br />
3708W POP-ONE: A new sieving matrix for<br />
capillary electrophoresis that supports a wide range<br />
<strong>of</strong> applications with a single instrument set-up. J.<br />
A. Romero, B. F. Johnson, F. Mercer, J. A. Fisher, D.<br />
Rodriguez, S. Hung, M. Wenz, W. Liao, J. Lee.<br />
3709F Automation <strong>of</strong> the Agilent target enrichment<br />
portfolio. M. R. Visitacion, J. Karbowski, F. Roos, B. Arezi,<br />
B. Novak, M. Isaksson, A. Giuffre, S. Happe, D. Roberts,<br />
E. Leproust, F. Dahl.<br />
3710W Sequencing <strong>of</strong> complete HLA haplotypes:<br />
Resequencing and population studies. M. S. Won, S.<br />
Norberg, T. Royce, T. Dunn, T. Mann, N. Nemat-Gorgani, L.<br />
A. Guethlein, L. Abi-Rached, L. Tian, K. L. Gunderson, P. J.<br />
Norman, M. Ronaghi, P. Parham.<br />
3711F DNA Sudoku: Hunting rare genetic variations<br />
using combinatorial pooling. D. Esposito, D. Golan, B.<br />
Blumenstiel, Y. Erlich.<br />
3712W From sample collection to bacterial<br />
identification in a single day: 16s rRNA sequencing<br />
using novel primers on the Ion Torrent Personal<br />
Genome Machine. G. S. Watts, M. M. Oshiro, B. W.<br />
Futscher, D. G. Armstrong.<br />
POSTER SESSIONS 263<br />
3713F Very high resolution HLA genotyping with the<br />
454 Life Sciences GS FLX system: Simplification<br />
<strong>of</strong> workflow using fusion primers or a four primer<br />
system. B. N. Hoglund, C. L. Holcomb, T. C. Williams, D.<br />
Goodridge, H. A. Erlich.<br />
3714W Highly multiplexed amplicon preparation<br />
for targeted re-sequencing <strong>of</strong> sample limited<br />
specimens using the Ion AmpliSeq technology and<br />
semiconductor sequencing. C. Li, B. Kong, D. Joun, I.<br />
Casuga, M. Shannon, S. Chen, M. Andersen, D. Ruff, R.<br />
Bennett.<br />
3715F A fast solution to NGS library preparation with<br />
low nanogram DNA input. P. Liu, G. Lohman, E. Cantor,<br />
B. W. Langhorst, E. Yigit, L. M. Apone, D. B. Munafo, C.<br />
Sumner, F. J. Stewart, T. C. Evans, E. T. Dimalanta, T. B.<br />
Davis.<br />
3716W Pre-capture pooling for targeted enrichment <strong>of</strong><br />
libraries for next-generation sequencing. B. Marosy, B.<br />
Craig, A. Robinson, M. Zilka, K. Hetrick, S. Griffith, H. Ling,<br />
J. Romm, K. F. Doheny.<br />
3717F Rapid and accurate semiconductor-based<br />
sequencing <strong>of</strong> human exomes: Workflow and<br />
performance on a familial trio. G. Meredith, G. Bee, L.<br />
Pickle, M. Dudas, G. Del Mistro, C. Scafe, M. Schorn, J.<br />
Miller, M. Minto, B. Reed, G. Fry, J. Gioia, J. Hildebrandt,<br />
P. Leong, M. Reddy, K. Atehortua-Khalsa, M. Sedova, S.<br />
McLaughlin, V. Sheth, M. Shah, D. Thomas, H. Breu, M.<br />
Rhodes, C. Adams, F. Hyland, R. Bennett.<br />
3718W TotalScript: A versatile and robust tool for<br />
RNAseq applications. F. Syed, S. Kuersten, A. Radek, R.<br />
Vaidyanathan.<br />
3719F Automating high-throughput creation<br />
<strong>of</strong> sequencing libraries. J. Bishop, W. Zhang, D.<br />
Mandelman, M. Allen, A. Harris, R. Bennett.<br />
3720W Highest sample quality for molecular analysis<br />
through ambient stabilization technologies: Improved<br />
genome, transcriptome and proteome analysis from<br />
saliva, blood and tissue samples. R. Muller, V. Liberal, S.<br />
Wilkinson, A. Stassinopoulos, J. Muller-Cohn.<br />
3721F Increased sensitivity in whole-genome bisulfite<br />
sequencing: A novel ‘post-bisulfite conversion’ library<br />
construction method for sub-nanogram inputs. R.<br />
Sooknanan, A. Adey, J. Hitchen, J. Shendure, N. Caruccio.<br />
3722W Highly efficient miRNA isolation method using<br />
solid phase reverse immobilization technology and<br />
Biomek automation. B.-N. Lee.<br />
3723F miRNA extraction from human plasma using<br />
high capacity miRNA anti-probe magnetic beads. A.<br />
Zampetaki, T. Xu, A. V. Vlassov, N. Bernard, M. Mayr.<br />
3724W Single Molecule Real-Time (SMRT ® ) sequencing<br />
<strong>of</strong> genes implicated in autosomal recessive diseases.<br />
Y. Guo, A. Bashir, E. Gould, R. Kornreich, L. Edelmann,<br />
T. Brandt, Y. Kasai, J. Chin, E. Paxinos, A. Kasarskis, E.<br />
Schadt.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present<br />
POSTER SESSIONS
264 POSTER SESSIONS<br />
3725F Detection <strong>of</strong> rare somatic mutations using a<br />
simplified, specific digital PCR workflow with zero<br />
dead volume. M. C. Pallas, D. Keys, J. Wilde, J. C. Nurse.<br />
3726W Rapidly pr<strong>of</strong>iling thousands <strong>of</strong> large non-coding<br />
RNAs and mRNAs from nanogram amounts <strong>of</strong> total<br />
RNA using a single microarray design. A. Bergstrom<br />
Lucas, K. Swaminathan, V. Kulkarni, E. LeProust, S.<br />
Fulmer-Smentek.<br />
3727F Development <strong>of</strong> a system based on SMART<br />
technology for robust transcriptome library<br />
preparation from small quantities <strong>of</strong> degraded sample.<br />
M. Bostick, C. Chang, A. Farmer.<br />
3728W Selective sequencing <strong>of</strong> mature transcripts in<br />
the human brain by cytoplasmic RNA-seq. A. Zaghlool,<br />
A. Ameur, J. Halvardson, L. Cavelier, L. Feuk.<br />
3729F Targeted library preparation for Ion Torrent<br />
sequencing using HaloPlex PCR. H. Johansson,<br />
E. Agne, K. Zettermann, M. Isaksson, P. Eriksson, B.<br />
Skarpås, F. Roos, F. Dahl.<br />
3730W SNP genotyping using the Affymetrix ® Axiom ®<br />
2.0 platform. M. Shapero, M. Purdy, H. Dong, S. Hsiung,<br />
R. Kurapati, J. Law, H. Lee, H. Loi, D. Nguyen, P. H. Wang,<br />
A. Yan, C. S. Yu, M. Shirazi.<br />
3731F Information tracking through the use and<br />
customization <strong>of</strong> the Exemplar LIMS in a medium<br />
scale sequencing laboratory. B. Craig, D. Newcomer, S.<br />
Griffith, B. Marosy, A. Robinson, M. Zilka, K. F. Doheny.<br />
3732W Locus reference genomic sequences:<br />
Reference sequences for the reporting <strong>of</strong> clinically<br />
relevant sequence variants. J. A. L. MacArthur, A.<br />
Astashyn, E. Birney, R. Dalgleish, P. Flicek, L. Gil, P.<br />
Larsson, D. Maglott, W. M. McLaren, R. E. Tully, F.<br />
Cunningham.<br />
3733F QC measures for whole exome and targeted<br />
sequencing library prep and enrichment in a highthroughput<br />
lab. A. Robinson, M. Zilka, B. Marosy, B.<br />
Craig, J. Romm, K. Doheny.<br />
3734W Additional annotation enhances biologically<br />
relevant sub classification <strong>of</strong> the Illumina<br />
<strong>Human</strong>Methylation450 BeadChip array. E. Price, A.<br />
Cotton, L. Lam, E. Emberly, C. Brown, W. Robinson, M.<br />
Kobor.<br />
3735F Computer-aided detection <strong>of</strong> defects<br />
in Affymetrix CEL data files. D. C. Edwards, A.<br />
Konkashbaev, A. Pluzhnikov, N. J. Cox, J. B. Tomblin, K.<br />
L. Mueller.<br />
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
EXHIBITORS<br />
The purpose <strong>of</strong> the exhibit program is to further the education <strong>of</strong> registrants by providing an<br />
opportunity for exhibitors to present information on products or services relevant to registrants’<br />
pr<strong>of</strong>essional interests. In keeping with that purpose, sale and order-taking (entering into<br />
a contract <strong>of</strong> sale) are discouraged on the exhibit floor and other related convention areas.<br />
Registrants are encouraged to view the exhibits in the Exhibit Hall <strong>of</strong> the Moscone Center<br />
during the following hours:<br />
Wednesday, November 7: 10:00 am – 4:30 pm<br />
Thursday, November 8: 10:00 am – 4:30 pm<br />
Friday, November 9: 10:00 am – 4:30 pm<br />
To assist in locating specific products and services <strong>of</strong> interest, a product and service index<br />
appears immediately after the exhibitor listings. This index is organized alphabetically by<br />
products/services, followed by names <strong>of</strong> exhibiting companies <strong>of</strong>fering the product/services<br />
and their respective booth numbers. Booth numbers also follow the names <strong>of</strong> the exhibiting<br />
companies below.<br />
<strong>ASHG</strong> Central – Exhibit Hall Booth 913, Lower Level South<br />
Visit <strong>ASHG</strong> Central to address membership questions, view sample publications, apply for<br />
membership, and to find out more about <strong>ASHG</strong>. Also available in <strong>ASHG</strong> Central will be editors<br />
<strong>of</strong> The <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> (AJHG). The AJHG provides a record <strong>of</strong> research<br />
and review relating to heredity in humans, the application <strong>of</strong> genetic principles in medicine<br />
and public policy, and related areas <strong>of</strong> molecular and cell biology, behavioral, molecular,<br />
biochemical, population and clinical genetics. You can also find more information on the city <strong>of</strong><br />
Boston, Massachusetts, the site <strong>of</strong> <strong>ASHG</strong>’s 2013 Annual Meeting and register to win a gift from<br />
the Boston Convention and Visitor’s Bureau!<br />
<strong>ASHG</strong> Central is located in booth #913, in the very center <strong>of</strong> the Exhibit Hall! It is open during<br />
exhibit hours and will have comfortable seating, charging stations, Wi-Fi access, and much<br />
more! We hope you stop by to see us while visiting the exhibits and posters. You can also<br />
meet <strong>ASHG</strong> <strong>2012</strong> Board and <strong>Program</strong> Committee members during poster session hours. Make<br />
<strong>ASHG</strong> Central your destination for networking, plugging in, and for all the <strong>ASHG</strong> information<br />
you need!<br />
Social Media Zone – Exhibit Hall Booth 1525<br />
The Social Media Zone in the Exhibit Hall is for those who want to explore the world <strong>of</strong> <strong>ASHG</strong><br />
and Social Media. Get better acquainted with Twitter and meet your expert users, or get tips so<br />
you can become a Twitter user! Catch up on the #<strong>ASHG</strong><strong>2012</strong> Twitter stream live, recharge your<br />
devices, use Wi-Fi, and have insightful face-to-face conversations with your fellow attendees.<br />
Stop by to ask questions <strong>of</strong> and meet three top genomics “Tweeps.” Three power Twitter users<br />
will be in the booth daily from 1:00 pm – 1:30 pm:<br />
Wednesday, November 7 Chris Gunter – @girlscientist<br />
Thursday, November 8 William Bush – @vubush<br />
Friday, November 9 Daniel MacArthur – @dgmacarthur<br />
EXHIBITORS
The Heart <strong>of</strong> the Exhibit Hall<br />
Get Answers at the <strong>ASHG</strong> Membership booth<br />
Meet your Editors at the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> booth<br />
Learn about Boston, the destination for <strong>ASHG</strong> 2013<br />
Meet <strong>Society</strong> Leadership<br />
Sit down in our seating area<br />
Recharge your electronics<br />
Network Net with colleagues<br />
Central
We enable people<br />
with life-altering conditions<br />
to lead better lives.<br />
Come visit us at <strong>ASHG</strong> Booth 600.<br />
US/COR-00695<br />
To be as brave as the people we help.
We enable people<br />
with life-altering conditions<br />
to lead better lives.<br />
Come visit us at <strong>ASHG</strong> Booth 600.<br />
US/COR-00695<br />
To be as brave as the people we help.
NOTES
NOTES
VISIT THE EXHIBITS AND POSTERS<br />
Wednesday: 10:00 am – 4:30 pm<br />
Thursday: 10:00 am – 4:30 pm<br />
Friday: 10:00 am – 4:30 pm
FACILITY<br />
STORAGE<br />
1268<br />
1269<br />
1267<br />
1266<br />
1188<br />
1189<br />
1187<br />
1186<br />
980<br />
981<br />
979<br />
978<br />
900<br />
901<br />
899<br />
898<br />
692<br />
693<br />
691<br />
690<br />
612<br />
613<br />
611<br />
610<br />
484<br />
485<br />
483<br />
482<br />
436<br />
437<br />
435<br />
434<br />
FACILITY<br />
STORAGE<br />
EXITS<br />
1398<br />
1399<br />
1397<br />
1396<br />
1338<br />
1339<br />
1337<br />
1336<br />
Statistical <strong>Genetics</strong>/<br />
Genetic Epidemiology<br />
1116<br />
1117<br />
1115<br />
1114<br />
1052<br />
1053<br />
1051<br />
1050<br />
765<br />
763<br />
762<br />
Pharmacogenetics<br />
540<br />
541<br />
539<br />
538<br />
Cancer<br />
<strong>Genetics</strong><br />
Cancer<br />
<strong>Genetics</strong><br />
Cytogenetics<br />
Development<br />
828<br />
829<br />
827<br />
826 Therapy/<br />
764 Genetic Disorders<br />
Metabolic<br />
Disorders<br />
Genome Structure,<br />
Variation/Function<br />
PERS<br />
1410<br />
1411<br />
1385<br />
1384<br />
1350<br />
1351<br />
1325<br />
1324<br />
1290<br />
1291<br />
1245<br />
1244<br />
1210<br />
1211<br />
1165<br />
1164<br />
1130<br />
1131<br />
1101<br />
1100<br />
1066<br />
1067<br />
1037<br />
1036<br />
1002<br />
1003<br />
957<br />
956<br />
922<br />
923<br />
877<br />
876<br />
842<br />
843<br />
813<br />
812<br />
778<br />
779<br />
749<br />
748<br />
714<br />
715<br />
669<br />
668<br />
634<br />
635<br />
589<br />
588<br />
554<br />
555<br />
525<br />
524<br />
506<br />
507<br />
461<br />
460<br />
458<br />
459<br />
413<br />
412<br />
Exit #1<br />
Exit #4<br />
1412<br />
1413<br />
1383<br />
1382<br />
1352<br />
1353<br />
1323<br />
1322<br />
1292<br />
1293<br />
1243<br />
1242<br />
1212<br />
1213<br />
1163<br />
1162<br />
1132<br />
1133<br />
1099<br />
1098<br />
1068<br />
1069<br />
1035<br />
1034<br />
1004<br />
1005<br />
955<br />
954<br />
924<br />
925<br />
875<br />
874<br />
844<br />
845<br />
811<br />
810<br />
780<br />
781<br />
747<br />
746<br />
716<br />
717<br />
667<br />
666<br />
636<br />
637<br />
587<br />
586<br />
556<br />
557<br />
523<br />
522<br />
PERS<br />
100<br />
1426<br />
1427<br />
1369<br />
1368<br />
1366<br />
1377<br />
1309<br />
1308<br />
1306<br />
1307<br />
1229<br />
1228<br />
1226<br />
1227<br />
1149<br />
1148<br />
1146<br />
1147<br />
1085<br />
1084<br />
1082<br />
1083<br />
1021<br />
1020<br />
1018<br />
1019<br />
941<br />
940<br />
938<br />
939<br />
861<br />
860<br />
858<br />
859<br />
797<br />
796<br />
794<br />
795<br />
733<br />
732<br />
730<br />
731<br />
653<br />
652<br />
650<br />
651<br />
573<br />
572<br />
570<br />
571<br />
509<br />
508<br />
40'<br />
Exit #3<br />
10'<br />
PERS<br />
Exit #5 Exit #7 Exit #9 Exit #11 Exit #13 Exit #15<br />
Exit #6<br />
PERS<br />
WOMEN<br />
MEN<br />
RESTROOMS<br />
WF<br />
Phones<br />
POSTER<br />
P OSTER<br />
STORAGE ATTENDANT<br />
PERS<br />
127<br />
N<br />
226 227<br />
O<br />
326<br />
N<br />
327<br />
O<br />
426 427<br />
20'<br />
125 224<br />
N<br />
225<br />
N<br />
324 325 424 425 524<br />
P<br />
P<br />
R<br />
R<br />
O<br />
O<br />
121 220<br />
F<br />
221<br />
I<br />
320<br />
F<br />
321<br />
I<br />
20'<br />
421<br />
20'<br />
T<br />
T<br />
119 218 219 318 319 418 419 518<br />
113<br />
20'<br />
109<br />
210<br />
211<br />
208 209<br />
205<br />
203<br />
312<br />
20'<br />
310 311<br />
308<br />
304 305<br />
302<br />
307<br />
301<br />
20'<br />
20'<br />
406<br />
404 405 504<br />
402<br />
20'<br />
413<br />
30'<br />
411<br />
409<br />
20'<br />
508<br />
20'<br />
400 401 500<br />
SEATING<br />
AREA<br />
527<br />
20'<br />
525<br />
521<br />
519<br />
511<br />
507 606<br />
505 604<br />
503<br />
20'<br />
501<br />
20' 20'<br />
624<br />
620<br />
618 619<br />
610<br />
600<br />
627<br />
625<br />
30'<br />
30'<br />
20' 20'<br />
20'<br />
20'<br />
726<br />
724<br />
718<br />
609<br />
601<br />
PERS<br />
WF<br />
PHONES<br />
PERS<br />
ENTRANCE<br />
PERS<br />
ENTRANCE<br />
Exit #8<br />
Exit #10<br />
TO UPPER<br />
SOUTH LOBBY<br />
725<br />
719<br />
826 827<br />
20'<br />
20'<br />
711<br />
701<br />
20'<br />
20'<br />
824 825<br />
818 819<br />
20'<br />
40'<br />
813<br />
20'<br />
811<br />
807<br />
20'<br />
805<br />
803<br />
20'<br />
801<br />
924<br />
721 820 821<br />
20'<br />
918<br />
910<br />
904<br />
900<br />
WOMEN MEN<br />
WOMEN MEN<br />
RESTROOMS RESTROOMS<br />
1428<br />
1429 1467<br />
1466 1468<br />
1469 1507<br />
1506 1508<br />
1509 1547<br />
1546 1548<br />
1549 1587<br />
1586 1588<br />
1589 1627<br />
1626 1628<br />
1629 1667<br />
1666 1668<br />
1669 1707<br />
1706 1708<br />
1709 1747<br />
1746 1748<br />
1749 1787<br />
1786 1788<br />
1789 1827<br />
1826 1828<br />
1829 1867<br />
1866 1868<br />
1869 1907<br />
1906 1908<br />
1909 1947<br />
1946 1948<br />
1949 1987<br />
1986 1988<br />
1989 2027<br />
2026 2028<br />
2029 2067<br />
2066 2068<br />
2069 2107<br />
2106 2108<br />
2109 2147<br />
2146 2148<br />
2149 2187<br />
2186 2188<br />
2189 2227<br />
2226 2228<br />
2229 2267<br />
2266 2268<br />
2269 2307<br />
2306 2308<br />
2309 2347<br />
2346 2348<br />
2349 2387<br />
2386 2388<br />
2389 2427<br />
2426 2428<br />
2429 2467<br />
2466 2468<br />
2469 2507<br />
2506 2508<br />
2509 2547<br />
2546 2548<br />
2549 2587<br />
2586 2588<br />
2589 2627<br />
2626 2628<br />
2629 2667<br />
2666 2668<br />
2669 2707<br />
2706 2708<br />
2709 2747<br />
2746 2748<br />
2749 2787<br />
2786<br />
Statistical <strong>Genetics</strong>/<br />
Genetic Epidemiology<br />
1446<br />
1447 1449<br />
1448 1486<br />
1487 1489<br />
1488 1526<br />
1527 1529<br />
1528 1566<br />
1567 1569<br />
1568 1606<br />
1607 1609<br />
1608 1646<br />
1647 1649<br />
1648 1686<br />
1687 1689<br />
1688 1726<br />
1727 1729<br />
1728 1766<br />
1767 1769<br />
1768 1806<br />
1807 1809<br />
1808 1846<br />
1847 1849<br />
1848 1886<br />
1887 1889<br />
1888 1926<br />
1927 1929<br />
1928 1966<br />
1967 1969<br />
1968 2006<br />
2007 2009<br />
2008 2046<br />
2047 2049<br />
2048 2086<br />
2087 2089<br />
2088 2126<br />
2127 2129<br />
2128 2166<br />
2167 2169<br />
2168 2206<br />
2207 2209<br />
2208 2246<br />
2247 2249<br />
2248 2286<br />
2287 2289<br />
2288 2326<br />
2327 2329<br />
2328 2366<br />
2367 2369<br />
2368 2406<br />
2407 2409<br />
2408 2446<br />
2447 2449<br />
2448 2486<br />
2487 2489<br />
2488 2526<br />
2527 2529<br />
2528 2566<br />
2567 2569<br />
2568 2606<br />
2607 2609<br />
2608 2646<br />
2647 2649<br />
2648 2686<br />
2687 2689<br />
2688 2726<br />
2727 2729<br />
2728 2766<br />
2767 2769<br />
2768<br />
111<br />
Cardiovascular <strong>Genetics</strong><br />
Genetci Counseling/<br />
Clinical Testing<br />
FLOOR PLAN OF EXHIBIT AND POSTER AREA<br />
<strong>ASHG</strong> 62ND ANNUAL MEETING<br />
MOSCONE CENTER-SOUTH HALLS ABC<br />
ELSI<br />
<strong>Genetics</strong> Education<br />
Health Services<br />
925<br />
20'<br />
923<br />
1022<br />
TO UPPER<br />
SOUTH LOBBY<br />
LOBBY<br />
PERS<br />
1026 1027<br />
20'<br />
20'<br />
1025 1124<br />
1023 1122<br />
Exit #12<br />
1127 1226 1227<br />
20'<br />
1125 1224 1225 1324<br />
PERS<br />
TO UPPER<br />
SOUTH LOBBY<br />
PERS<br />
Exit #14<br />
1427 1526<br />
1425 1524<br />
PERS<br />
WF<br />
PHONES<br />
Complex Traits/Polygenic Disorders Psychiatric <strong>Genetics</strong>, Neurogentics/Neurdegeneration<br />
50'<br />
1220<br />
20'<br />
1320<br />
20'<br />
1321 1420<br />
1520<br />
20'<br />
1521<br />
20'<br />
20'<br />
<strong>ASHG</strong> Central<br />
Membership<br />
1119 1218 1219 1318 1319 1418 1419 1518 1519 1618 1619<br />
AJHG<br />
Charging Station<br />
40'<br />
913<br />
WiFi Zone<br />
1212 P 1312<br />
20'<br />
30' U<br />
1210 B 1211 1310<br />
20' 20'<br />
1311 1410<br />
1413 1512<br />
1411 1510<br />
20'<br />
20'<br />
1511<br />
1613 1712<br />
1611 1710<br />
20'<br />
20'<br />
L<br />
20'<br />
20'<br />
1109 1208 I 1209 1308<br />
C<br />
1609 1708<br />
907 1007<br />
A<br />
T<br />
1307 1406<br />
1506<br />
20'<br />
1606<br />
20'<br />
20'<br />
20'<br />
1102<br />
20'<br />
1105 1204 I 1304<br />
20'<br />
O<br />
1103 N 1203<br />
20'<br />
20'<br />
S<br />
20' 20'<br />
1303 1402<br />
1405 1504<br />
1403 1502<br />
1505 1604<br />
1503 1602<br />
FASEB/<br />
1605 Career<br />
Resources<br />
30'<br />
1603<br />
901<br />
1001 1100 1101 1200 1201 1300 1301 1400 1401 1500 1501 1600 1601 1700<br />
20'<br />
1325<br />
20'<br />
BUSINESS<br />
CENTER<br />
SEATING<br />
AREA<br />
25'<br />
Social<br />
Media 20'<br />
Zone<br />
1525<br />
PERS<br />
Molecular Basis <strong>of</strong><br />
Mendelian Disorders<br />
20'<br />
POSTER<br />
P OSTER ATTENDANT<br />
STORAGE<br />
Exit #16<br />
3094<br />
3093<br />
3095<br />
3096<br />
3170<br />
3169<br />
3171<br />
3172<br />
3246<br />
3245<br />
3247<br />
3248<br />
3322<br />
3321<br />
3323<br />
3324<br />
3402<br />
3401<br />
3403<br />
3404<br />
3486<br />
3485<br />
3487<br />
3488<br />
3570<br />
3569<br />
3571<br />
3572<br />
3652<br />
3651<br />
3653<br />
3654<br />
PERS<br />
Employment<br />
Boards<br />
TC<br />
Electrical for F&B & Water Cooler<br />
F&B<br />
WC<br />
2788<br />
2789<br />
2847<br />
2846<br />
2848<br />
2849<br />
2907<br />
2906<br />
2908<br />
2909<br />
2966<br />
2967<br />
2968<br />
3026<br />
3025<br />
3027<br />
3028<br />
Exit #17<br />
E nt rance Exhibitor Lounge<br />
9m x 14m<br />
(43' x 30')<br />
3716<br />
3715<br />
3717<br />
3718<br />
EMERGENCY<br />
PEDESTRIAN RAMP<br />
PERS<br />
Molecular Basis <strong>of</strong><br />
Mendelian Disorders<br />
Prenatal, Perinatal/<br />
Reproductive <strong>Genetics</strong><br />
Clinical <strong>Genetics</strong>/<br />
Dysmorphology<br />
Evolutionary/<br />
Population <strong>Genetics</strong><br />
Epigentics<br />
Bioinformatics/<br />
Technology<br />
Exit #19<br />
2802<br />
2803<br />
2833<br />
2832<br />
2862<br />
2863<br />
2893<br />
2892<br />
2922<br />
2923<br />
2953<br />
2952<br />
2981<br />
2982<br />
3012<br />
3011<br />
3041<br />
3042<br />
3072<br />
3071<br />
3117<br />
3118<br />
3148<br />
3147<br />
3193<br />
3194<br />
3224<br />
3223<br />
3269<br />
3270<br />
3300<br />
3299<br />
3345<br />
3346<br />
3380<br />
3379<br />
3425<br />
3426<br />
3464<br />
3463<br />
3509<br />
3510<br />
3548<br />
3547<br />
3593<br />
3594<br />
3630<br />
3629<br />
3675<br />
3676<br />
3708<br />
3707<br />
3725<br />
3726<br />
Exit #18<br />
2804<br />
2805<br />
2831<br />
2830<br />
2864<br />
2865<br />
2891<br />
2890<br />
2924<br />
2925<br />
2951<br />
2950<br />
2983<br />
2984<br />
3010<br />
3009<br />
3043<br />
3044<br />
3070<br />
3069<br />
3119<br />
3120<br />
3146<br />
3145<br />
3195<br />
3196<br />
3222<br />
3221<br />
3271<br />
3272<br />
3298<br />
3297<br />
3347<br />
3348<br />
3378<br />
3377<br />
3427<br />
3428<br />
3462<br />
3461<br />
3511<br />
3512<br />
3546<br />
3545<br />
3595<br />
3596<br />
3628<br />
3627<br />
3677<br />
3678<br />
3706<br />
3705<br />
3727<br />
3728<br />
PERS<br />
3735<br />
2816<br />
2817<br />
2819<br />
2818<br />
2876<br />
2877<br />
2879<br />
2878<br />
2936<br />
2937<br />
2939<br />
2938<br />
2995<br />
2996<br />
2998<br />
2997<br />
3055<br />
3056<br />
3058<br />
3057<br />
3131<br />
3132<br />
3134<br />
3133<br />
3207<br />
3208<br />
3210<br />
3209<br />
3283<br />
3284<br />
3286<br />
3285<br />
3359<br />
3360<br />
3694<br />
3693<br />
3362<br />
3361<br />
3443<br />
3444<br />
3446<br />
3445<br />
3527<br />
3528<br />
3530<br />
3529<br />
3611<br />
3612<br />
3614<br />
3613<br />
3691<br />
3692<br />
Moscone<br />
Freeman<br />
Service Desk<br />
Lead<br />
Retrieval<br />
Lead<br />
Retrieval<br />
271<br />
Sales Office<br />
3m x 5m<br />
ES Break<br />
Room<br />
3m x 3m<br />
Crate S torage<br />
6 ' T ABLE<br />
Lead Retrieval<br />
Room<br />
4m x 4m<br />
ES4<br />
ES3<br />
3m x 6m 3m x 6m<br />
ES2<br />
3m x 6m<br />
ES1<br />
3m x 6m
Exhibitors<br />
■ 23andMe, Inc ............................................. 826<br />
Tel: 650-963-8937<br />
Email: mdelsol@23andme.com<br />
URL: http://www.23andme.com<br />
23andMe, Inc. is a leading personal genetics<br />
company dedicated to helping individuals understand<br />
their own genetic information through DNA analysis<br />
technologies and web-based interactive tools. The<br />
vision for 23andMe is to personalize healthcare<br />
by making and supporting meaningful discoveries<br />
through genetic research. More information is<br />
available at www.23andme.com.<br />
■ Abbott Molecular ...................................... 625<br />
Tel: 224-361-7000/800-553-7042<br />
Email: customerservice@abbottmolecular.com<br />
URL: http://www.abbottmolecular.com<br />
Abbott Molecular is a leader in molecular<br />
diagnostics for the analysis <strong>of</strong> DNA, RNA, and<br />
proteins. Our instruments and reagents detect<br />
pathogens and subtle changes in patients’ genes<br />
and chromosomes, permitting earlier diagnosis, the<br />
selection <strong>of</strong> appropriate therapies and improved<br />
monitoring <strong>of</strong> disease progression.<br />
■ Accelrys, Inc. ............................................. 421<br />
Tel: 858-799-5000<br />
Email: byron.konold@accelrys.com<br />
URL: http://www.accelrys.com<br />
Accelrys (NASDAQ:ACCL), a leading scientific<br />
enterprise R&D s<strong>of</strong>tware and services company, <strong>of</strong>fers<br />
industry-leading capabilities in modeling and simulation,<br />
enterprise lab management, workflow and automation<br />
and data management and informatics supporting<br />
improved scientific innovation lifecycle management.<br />
Accelrys electronic lab notebooks include the flexible<br />
Contur ELN, Symyx Notebook by Accelrys and<br />
VelQuest SmartLab. Visit www.accelrys.com.<br />
■ Actelion Pharmaceuticals US, Inc. .......... 401<br />
Tel: 41 61 565 83 65<br />
Email: stephane.dazet@actelion.com<br />
URL: http://www.actelion.com<br />
Actelion US is a biopharmaceutical company focusing<br />
on the discovery, development and commercialization<br />
<strong>of</strong> innovative treatments to serve high unmet<br />
medical needs. Zavesca ® (miglustat) is indicated<br />
for the treatment <strong>of</strong> adult patients with mild to<br />
moderate type 1 Gaucher disease for whom enzyme<br />
replacement therapy is not a therapeutic option.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 273<br />
■ Active Motif, Inc ........................................ 427<br />
Tel: 760-431-1263<br />
Email: rubin@activemotif.com<br />
URL: http://www.activemotif.com<br />
Active Motif: Enabling Epigenetic Research.<br />
Active Motif is dedicated to developing and delivering<br />
innovative cell biology-based research tools and<br />
biocomputing resources that help researchers<br />
worldwide in their quest to elucidate the function,<br />
regulation and interactions <strong>of</strong> the genes and their<br />
encoded proteins.<br />
■ Advanced Analytical ............................... 1304<br />
Tel: 515-296-6600<br />
Email: rschmidt@aati-us.com<br />
URL: http://www.aati-us.com<br />
Advanced Analytical Technologies, Inc.<br />
Our newest instrument, the Fragment Analyzer<br />
Automated CE System, uses capillary electrophoresis<br />
for rapid and accurate analysis <strong>of</strong> Next Gen<br />
Sequencing (NGS) fragment libraries by automating<br />
the separation <strong>of</strong> fragments. Additionally, it can<br />
be used on RNA and genomic DNA. The system<br />
improves workflow and eliminates bottlenecks.<br />
■ Affymetrix, Inc. .......................................... 918<br />
Tel: 408-731-5000/800-223-5281<br />
Email: sales@affymetrix.com<br />
URL: http://www.affymetrix.com<br />
Affymetrix powers the Genome Generation to<br />
advance our understanding <strong>of</strong> human biology and<br />
disease by providing solutions supporting a wide<br />
range <strong>of</strong> applications for genetic origin discovery,<br />
functional characterization, and translational research.<br />
Whether you perform genome-wide association<br />
studies, targeted genotyping, cancer or constitutional<br />
cytogenetics and copy number analysis, wholetranscript<br />
pr<strong>of</strong>iling, microRNA analysis, resequencing,<br />
or in situ hybridization, visit us for proven and tailored<br />
solutions to your research needs.<br />
■ Agilent Technologies ................................ 609<br />
Tel: 800-227-9770<br />
Email: agilent_inquiries@agilent.com<br />
URL: http://www.genomics.agilent.com<br />
Agilent’s portfolio includes the leading SureSelect<br />
and HaloPlex Target Enrichment Next-Generation<br />
Sequencing Platforms, Gene Expression and<br />
Cytogenetic Microarrays, GeneSpring and<br />
Cytogenomics S<strong>of</strong>tware, qPCR, PCR, Mutagenesis,<br />
Cloning, and SureFISH probes. Agilent <strong>of</strong>fers the<br />
Bioanalyzer & TapeStation instruments for sample QC,<br />
and Automation for optimized workflow productivity.<br />
EXHIBITORS
274 EXHIBITORS<br />
■ AGRE-Autism Genetic Resource<br />
Exchange ...................................................... 319<br />
Tel: 323-297-4716<br />
Email: rbutler@agre.org<br />
URL: http://www.agre.org<br />
The Autism Genetic Resource Exchange (AGRE) is<br />
a program <strong>of</strong> Autism Speaks to advance genetic<br />
research in Autism Spectrum Disorders (ASDs).<br />
Genetic biomaterials and clinical data are obtained<br />
from families that have more than one family member<br />
diagnosed with an ASD. The biological samples,<br />
along with the accompanying clinical data, are made<br />
available to AGRE-approved researchers.<br />
■ Alexion Pharmaceuticals ....................... 1410<br />
Tel: 203-272-2596<br />
Email: millerg@alxn.com<br />
URL: http://www.alxn.com<br />
Alexion Pharmaceuticals is a biopharmaceutical<br />
company focused on serving patients with severe<br />
and ultra-rare disorders through the innovation,<br />
development and commercialization <strong>of</strong> lifetransforming<br />
products. Alexion developed and<br />
markets Soliris ® (eculizumab) as a treatment for<br />
patients with PNH and aHUS. Alexion is evaluating<br />
other potential indications for Soliris and is<br />
developing four other innovative product candidates<br />
■ Ambry <strong>Genetics</strong>......................................... 311<br />
Tel: 949-900-5560/866-262-7943<br />
Email: bneal@ambrygen.com<br />
URL: http://www.ambrygen.com<br />
Ambry <strong>Genetics</strong> redefines diagnostic and genomic<br />
services through innovation and ingenuity. Extensive<br />
testing menus include: Diagnostic Exome, Oncology,<br />
Cardiology, Neurology and Pulmonology panels.<br />
Our genomic services focus on next-generation<br />
sequencing, exome sequencing, microarrays, targeted<br />
enrichment, genotyping and bioinformatics to <strong>of</strong>fer<br />
cost effective and research specific solutions. For<br />
more information please visit: www.ambrygen.com<br />
■ <strong>American</strong> Board <strong>of</strong> Medical <strong>Genetics</strong> ..... 225<br />
Tel: 301-634-7315<br />
Email: abmg@abmg.org<br />
URL: http://www.abmg.org<br />
The <strong>American</strong> Board <strong>of</strong> Medical <strong>Genetics</strong> (ABMG),<br />
member board <strong>of</strong> the ABMS, serves the public and<br />
the medical pr<strong>of</strong>ession by promoting and assuring<br />
standards <strong>of</strong> excellence in medical genetics. ABMG<br />
accredits training programs, credentials and certifies<br />
practitioners <strong>of</strong> medical genetics, and fosters life-long<br />
learning through maintenance <strong>of</strong> certification.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ <strong>American</strong> College <strong>of</strong> Medical <strong>Genetics</strong><br />
and Genomics (ACMG) ................................ 318<br />
Tel: 301-718-9603<br />
Email: acmg@acmg.net<br />
URL: http://www.acmg.net<br />
To improve health through medical genetics, the<br />
<strong>American</strong> College <strong>of</strong> Medical <strong>Genetics</strong> and Genomics<br />
will define and promote excellence in medical genetics<br />
practice and the integration <strong>of</strong> translational research<br />
into practice; promote and provide medical genetics<br />
education; and increase access to medical genetics<br />
services and integrate genetics into patient care.<br />
■ <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> .... 913<br />
Tel: 866-314-2355<br />
Email: ajhg@ajhg.net<br />
URL: http://www.ajhg.org<br />
The <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> (AJHG)<br />
provides a record <strong>of</strong> research and review relating to<br />
heredity in humans, and the application <strong>of</strong> genetic<br />
principles in medicine and public policy, and related<br />
areas <strong>of</strong> molecular and cell biology, behavioral,<br />
molecular, biochemical, population and clinical<br />
genetics.<br />
■ <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> .... 913<br />
Tel: 301-634-7300/(866) HUMGENE<br />
Email: society@ashg.org<br />
URL: http://www.ashg.org<br />
<strong>ASHG</strong> Central is located in booth #913, the very<br />
center <strong>of</strong> the Exhibit Hall! It is open during exhibit<br />
hours and will have comfortable seating, charging<br />
stations, Wi-Fi access, and much more! We hope<br />
you stop by to see us while visiting the exhibits<br />
and posters. You can also meet <strong>ASHG</strong> <strong>2012</strong> Board<br />
and <strong>Program</strong> Committee members during poster<br />
session hours. Make <strong>ASHG</strong> Central your destination<br />
for networking, plugging in, and for all the <strong>ASHG</strong><br />
information you need!<br />
■ Amicus Therapeutics, Inc. ....................... 511<br />
Tel: 609-662-2000<br />
Email: info@amicustherapeutics.com<br />
URL: http://www.amicustherapeutics.com<br />
Amicus Therapeutics is a biopharmaceutical company<br />
at the forefront <strong>of</strong> developing therapies for rare<br />
and orphan diseases. The company is developing<br />
orally administered, small molecule drugs called<br />
pharmacological chaperones, a novel, first-in-class<br />
approach to treating a broad range <strong>of</strong> diseases<br />
including lysosomal storage disorders and diseases <strong>of</strong><br />
neurodegeneration.
■ AnaSpec Inc, Eurogentec Group ........... 1100<br />
Tel: 510-791-9560/800-452-5530<br />
Email: theresa@anaspec.com<br />
URL: http://www.anaspec.com<br />
AnaSpec, EGT Group, a leading provider <strong>of</strong> integrated<br />
proteomic and genomic solutions, <strong>of</strong>fers expertise<br />
in peptides, antibodies, assay kits, fluorescent dyes,<br />
unusual amino acids and qPCR. We have qPCR<br />
mastermixes plates and tubes for every Real Time<br />
PCR platform plus excellent technical support, as<br />
well as housekeeping genes’ primers/probes/assays.<br />
■ Applied Spectral Imaging, Inc................ 1220<br />
Tel: 760-929-2840/800-611-3466<br />
Email: sales@spectral-imaging.com<br />
URL: http://www.spectral-imaging.com<br />
Applied Spectral Imaging makes patient care better<br />
through advanced biomedical imaging. ASI <strong>of</strong>fers<br />
cytogeneticists and pathologists accurate analysis by<br />
providing state- <strong>of</strong>-the-art diagnostic aids. ASI has<br />
over 2,500 systems deployed worldwide, <strong>of</strong>fices in<br />
the U.S., Europe and Asia as well as a global network<br />
<strong>of</strong> over 50 distributors.<br />
■ Applied StemCell, Inc. .............................. 527<br />
Tel: 1-408-773-8007/1-866-497-4180<br />
Email: info@appliedstemcell.com<br />
URL: http://www.appliedstemcell.com<br />
TARGATT Gene Targeting in Cell Lines: Applied<br />
StemCell Inc. (ASC) is a fast growing biotechnology<br />
company with its headquarter based in Menlo Park,<br />
California. With solid expertise and extensive experience<br />
in stem cell and transgene technologies, ASC focuses<br />
on the application <strong>of</strong> new technologies for stem cell<br />
and transgenic communities. Based on Proprietary<br />
Technologies, we <strong>of</strong>fer a customized Fast & Site-<br />
Specific gene targeting service for any cell line for your<br />
projects, e.g.Gene Editing, Gene Modification, Cell-<br />
Based Assays and Drug Screening (HTP Screening).<br />
■ Ariosa Diagnostics .................................. 1609<br />
Tel: 855-927-4672/1-855-9-ARIOSA<br />
Email: ClientServices@ariosadx.com<br />
URL: http://www.ariosadx.com<br />
Ariosa Diagnostics, Inc., is a molecular diagnostics<br />
company committed to providing safe, highly accurate<br />
and affordable prenatal tests for maternal and fetal<br />
health. Led by an experienced team, Ariosa is using its<br />
proprietary technology to perform a directed analysis<br />
<strong>of</strong> cell-free DNA in blood. Ariosas simple blood<br />
test equips pregnant women and their healthcare<br />
providers with reliable information to make decisions<br />
regarding their health, without creating unnecessary<br />
stress or anxiety.The company began operations in<br />
2010 and is headquartered in San Jose, Calif.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 275<br />
■ ARUP Laboratories ................................. 1518<br />
Tel: 801-583-2787/800-242-2787<br />
Email: christina.m.sellers@aruplab.com<br />
URL: http://www.aruplab.com/genetics<br />
ARUP Laboratories is a leading national reference<br />
laboratory <strong>of</strong>fering more than 3,000 tests and test<br />
combinations, ranging from routine screening<br />
tests to esoteric molecular and genetic assays.<br />
ARUP Laboratories <strong>Genetics</strong> Division <strong>of</strong>fers testing<br />
in all areas <strong>of</strong> genetics, including biochemical,<br />
cytogenetics, microarray, and next-generation<br />
sequencing. www.aruplab.com/genetics<br />
■ <strong>ASHG</strong>/FASEB Career Resources ........... 1702<br />
Tel: 860-437-5700<br />
Email: clientserv@jobtarget.com<br />
URL: http://careers.faseb.org<br />
FASEB’s Career Resources are designed to provide<br />
career information and facilitate employment<br />
connections in the life sciences community. These<br />
resources embody new concepts, technologies,<br />
and services, as well as the best <strong>of</strong> our “FASEB<br />
Placement Service.” Our main focus is to help<br />
develop biomedical careers, so whether an<br />
undergraduate, postgraduate, postdoctoral,<br />
seasoned scientist, or an employer seeking to hire<br />
top-notch scientists and pr<strong>of</strong>essionals, the resources<br />
and tools found here are designed to help.<br />
■ Asper Biotech Ltd. .................................. 1418<br />
Tel: 372-7307-295<br />
Email: info@asperbio.com<br />
URL: http://www.asperbio.com<br />
Asper Biotech is a genetic testing company<br />
specialized in retinal disorders, reproductive medicine<br />
and oncology. Asper Ophthalmics testing portfolio<br />
includes a comprehensive panel <strong>of</strong> tests targeting<br />
hereditary eye disorders. Asper Oncogenetics <strong>of</strong>fers<br />
tests to determine predisposition to various cancers.<br />
Asper Reprogenetics provides tests for reproductive<br />
problems and prenatal diagnostics.<br />
■ Asuragen, Inc. ........................................... 503<br />
Tel: 512-681-5200/877-777-1874<br />
Email: jbourland@asuragen.com<br />
URL: http://www.asuragen.com<br />
Asuragen is a fully integrated molecular diagnostic<br />
company using the genome to drive patient<br />
management. We <strong>of</strong>fer diagnostics products and<br />
clinical laboratory services focused on innovative<br />
PCR-based approaches for Fragile X testing (FMR1<br />
gene), AmplideX and Xpansion Interpreter for detection<br />
<strong>of</strong> methylation status and determination <strong>of</strong> AGG<br />
sequence detection (number and location). To learn<br />
more, visit www.asuargen.com.<br />
EXHIBITORS
276 EXHIBITORS<br />
■ Athena Diagnostics ................................ 1308<br />
Tel: 508-756-2886/800-394-4493<br />
Email: melissa.s.hodgson@athenadiagnostics.com<br />
URL: http://www.athenadiagnostics.com<br />
Athena Diagnostics is a leader in diagnostic testing<br />
for neurological diseases. Athena, a division <strong>of</strong> Quest<br />
Diagnostics, is dedicated to providing neurologists<br />
and other physicians and specialists with insights that<br />
can improve patient health. Athena provides the most<br />
comprehensive test menu and intellectual property<br />
portfolio for neurological, endocrine, and renal<br />
conditions through more than 350 diagnostic tests.<br />
■ AutoGen, Inc. ............................................. 807<br />
Tel: 508-429-5965/800-292-5678<br />
Email: info@autogen.com<br />
URL: http://www.autogen.com<br />
The AutoGen FLEX STAR is the finest automated<br />
system available for extracting DNA from large<br />
volumes <strong>of</strong> whole blood, cells and saliva. The FLEX<br />
STAR features positive sample tracking and all the<br />
sample processing capacity you will need for real<br />
productivity. In addition, its outstanding reliability<br />
makes it a system you can count on day in and<br />
day out. Backed by AutoGen’s best in the industry<br />
customer support, the FLEX STAR provides you with<br />
tools you need to PREP WITH CONFIDENCE.<br />
■ Axeq Technologies .................................... 820<br />
Tel: 240-314-0570/1-855-864-2937<br />
Email: jbae@axeq.com<br />
URL: http://www.axeq.com<br />
Axeq Technologies is dedicated to providing a<br />
premier level <strong>of</strong> Next-Generation Sequencing<br />
services to researchers and scientists worldwide.<br />
Axeq represents a high level <strong>of</strong> dedication to quality<br />
<strong>of</strong> work, customer services and scientific integrity.<br />
Axeq also embraces the highest standard U.S. and<br />
European business practices and ethical standards.<br />
■ Baylor College <strong>of</strong> Medicine, Medical<br />
<strong>Genetics</strong> Laboratories................................. 711<br />
Tel: 713-798-6555/800-411-4363<br />
Email: medgen@bcm.tmc.edu<br />
URL: http://www.bcmgeneticlabs.org<br />
Baylor College <strong>of</strong> Medicine’s, Medical <strong>Genetics</strong><br />
Laboratories <strong>of</strong>fer a broad range <strong>of</strong> diagnostic<br />
genetics tests including DNA diagnostics,<br />
sequencing, cytogenetics, FISH diagnostics, cancer<br />
cytogenetics, chromosomal microarray analysis,<br />
whole exome sequencing, biochemical genetics, and<br />
mitochondrial DNA analysis. Please visit our booth for<br />
more information.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ BC Platforms Ltd ...................................... 819<br />
Tel: 358 9 2517 7340<br />
Email: info@bcplatforms.com<br />
URL: http://www.bcplatforms.com<br />
BC Platforms provides advanced data management<br />
solutions for GWAS, SNP and next-generation<br />
sequencing projects. Combine genotypes and<br />
phenotypes to create efficient workflows for highperformance,<br />
distributed data analysis using over<br />
30 academic s<strong>of</strong>tware programs. A web-interface<br />
provides multiple users parallel access to the<br />
database for secure data analysis and results sharing.<br />
■ Beckman Coulter, Inc. ............................ 1601<br />
Tel: 800-742-2345<br />
URL: http://www.beckmancoulter.com<br />
■ BGI ............................................................ 1419<br />
Tel: 617-500-2741<br />
Email: info@bgiamericas.com<br />
URL: http://www.bgiamericas.com<br />
BGI, the worlds largest genomics organization, provides<br />
comprehensive sequencing and bioinformatics services<br />
for medical, agricultural and environmental applications.<br />
With cutting-edge technologies and an experienced<br />
team that has generated over 250 publications in top<br />
tier journals, BGI delivers rapid, cost-effective, and<br />
high quality results that enable researchers to achieve<br />
scientific breakthroughs.<br />
■ Biobase Corporation .............................. 1319<br />
Tel: 978-922-1643/800-305-0670<br />
Email: info@biobase-international.com<br />
URL: http://www.biobase-international.com<br />
BIOBASE is a leading provider <strong>of</strong> manually-curated<br />
databases for molecular diagnostics. The <strong>Human</strong> Gene<br />
Mutation Database (HGMD ® ) and Genome Trax<br />
<strong>of</strong>fers well-structured data, assembled by qualified<br />
experts, organized in an easily searchable manner that<br />
enables researchers to make clinical interpretations <strong>of</strong><br />
data arising from next-generation sequencing efforts.<br />
■ BioChain Institute Inc ............................. 1611<br />
Tel: 510-783-8588/888-762-2568<br />
Email: info@biochain.com<br />
URL: http://www.biochain.com<br />
BioChain provides high quality processed bio-sample<br />
products and analysis services for translational<br />
medicine, clinical product research and development.<br />
BioChains’ products and services are available for<br />
DNA and RNA sequencing, PCR and RT-qPCR, gene<br />
expression, DNA/RNA purification, protein extraction/<br />
purification, and expression analysis.
■ BioDiscovery, Inc. ..................................... 813<br />
Tel: 310-414-8100<br />
Email: customerservice@biodiscovery.com<br />
URL: http://www.biodiscovery.com<br />
BioDiscovery develops, markets and sells advanced<br />
s<strong>of</strong>tware solutions for the analysis <strong>of</strong> data from<br />
high-throughput microarray and next-generation<br />
sequencing technologies. BioDiscovery provides a<br />
full line <strong>of</strong> modular s<strong>of</strong>tware packages built for power,<br />
versatility, and efficiency spanning image analysis,<br />
microarray data processing, and advanced analysis <strong>of</strong><br />
CNV, expression, and methylation data.<br />
■ BioDot, Inc. ................................................ 308<br />
Tel: 949-440-3685<br />
Email: biodot@biodot.com<br />
URL: http://www.biodot.com<br />
■ BioFire Diagnostics .................................. 719<br />
Tel: 801-736-6354/800-735-6544<br />
Email: cameron.gunary@bi<strong>of</strong>iredx.com<br />
URL: http://www.filmarray.com<br />
Idaho Technologies is now BioFire Diagnostics.<br />
BioFire Diagnostics has a 22 year history <strong>of</strong> PCR<br />
innovation. Our LightScanner ® Hi-Res Melting ®<br />
systems and LCGreen Plus ® reagents will take<br />
your hypotheses to publications more efficiently.<br />
LightScanner systems provide the best quality, most<br />
easily accessed Hi-Res Melting data on the market.<br />
Stop by booth #719 and see why!<br />
■ Bioline USA Inc. ...................................... 1324<br />
Tel: 508-880-8990/888-257-5155<br />
Email: info.us@bioline.com<br />
URL: http://www.bioline.com<br />
Bioline is ISO 9001:2008 certified and one <strong>of</strong> the<br />
worlds few manufacturers <strong>of</strong> dNTPs. Bioline is able to<br />
<strong>of</strong>fer bulk, custom and OEM dNTP services. We have<br />
developed and manufacture more than 300 reagents<br />
and kits for molecular biology, cell analysis and<br />
nucleic acid and protein separation and purification.<br />
■ BioMarin Pharmaceutical Inc. ............... 1619<br />
Tel: 415-506-6700<br />
Email: kward@bmrn.com<br />
URL: http://www.bmrn.com<br />
BioMarin develops and commercializes innovative<br />
biopharmaceuticals for serious diseases and medical<br />
conditions. Approved products include the first and<br />
only enzyme replacement therapies for MPS I and MPS<br />
VI and the first and only FDA-approved medication for<br />
PKU. Visit www.BMRN.com to learn more.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 277<br />
■ BioMarin Scientific Exchange ................ 1524<br />
Tel: 415-506-6781<br />
Email: kward@bmrn.com<br />
URL: http://www.bmrn.com<br />
BioMarin develops and commercializes innovative<br />
biopharmaceuticals for serious diseases and medical<br />
conditions. Approved products include the first<br />
and only enzyme replacement therapies for MPS I<br />
and MPS VI and the first and only FDA-approved<br />
medication for PKU. Visit www.BMRN.com to<br />
learn more.<br />
■ BioNano Genomics, Inc. ........................... 924<br />
Tel: 858-888-7600<br />
Email: info@bionanogenomics.com<br />
URL: http://www.bionanogenomics.com<br />
BioNano Genomics platform provides<br />
unprecedented understanding <strong>of</strong> whole-genome<br />
biology. The technology enables highly parallel<br />
visualization <strong>of</strong> extremely long DNA molecules<br />
at single-molecule scale, capturing biologically<br />
meaningful positional information. By retaining<br />
architectural context, the data facilitates more<br />
complete genome assembly and broad detection <strong>of</strong><br />
structural variants.<br />
■ Bio-Rad ...................................................... 524<br />
Tel: 510-741-1000/800-4-BIORAD<br />
Email: lsg.orders.us@bio-rad.com<br />
URL: http://www.discover.bio-rad.com<br />
Providing instrumentation and reagents to support<br />
life science research. Depend on Bio-Rad for tools,<br />
technologies and expertise to enable genomic<br />
and proteomic analysis. Products for droplet<br />
digital PCR, conventional and real-time PCR, SPR,<br />
transfection, RNAi, biomarker expression pr<strong>of</strong>iling,<br />
xMAP technology, cancer biomarkers, expression<br />
proteomics, electrophoresis, blotting-systems,<br />
chromatography, imaging.<br />
■ BioReliance ............................................... 604<br />
Tel: 301-738-1000/800-553-5372<br />
Email: genomicservices@bioreliance.com<br />
URL: http://www.bioreliance.com<br />
BioReliance Genomics: the premier service provider<br />
supporting clinical trials from Phase I to post market<br />
monitoring. We apply over 60 years <strong>of</strong> regulatory<br />
and validation expertise to novel highly-multiplexed<br />
detection technologies and bioinformatics for RNA<br />
expression analysis and targeted human genotyping,<br />
including NGS and the Illumina VeraCode ADME<br />
core panel.<br />
EXHIBITORS
278 EXHIBITORS<br />
■ BioTeam Inc. .............................................. 109<br />
Tel: 978-304-1222<br />
Email: stan@bioteam.net<br />
URL: http://www.bioteam.net<br />
BioTeam is a unique consulting practice dedicated<br />
to delivering objective, diagnostic solutions to our<br />
clients using technology to solve complex genetic<br />
problems. BioTeam has compiled our best practices<br />
for managing sequencing data into a simple and<br />
cost-effective solution called MiniLIMS. MiniLIMS the<br />
next-generation LIMS you can afford.<br />
■ BioTechniques......................................... 1604<br />
Tel: 212-520-2714<br />
Email: christine.briglia@informausa.com<br />
URL: http://www.biotechniques.com<br />
BioTechniques, the international journal <strong>of</strong> life science<br />
methods, provides open access to first-quality,<br />
peer-reviewed papers on laboratory techniques and<br />
protocols. Now in its 53rd volume, BioTechniques has<br />
over 80,000 print subscribers worldwide. The journal<br />
augments its peer-reviewed content with feature<br />
articles and topic-specific supplements. Visit<br />
www.biotechniques.com for more details.<br />
■ BlueGnome Limited .................................. 209<br />
Tel: 44 1223 885990/800-418-9656<br />
Email: info@cambridgebluegnome.com<br />
URL: http://www.cambridgebluegnome.com<br />
BlueGnome (www.cambridgebluegnome.com)<br />
works with clinical and scientific communities to<br />
design, manufacture and supply microarray-based<br />
products for the investigation <strong>of</strong> genetic disorders.<br />
Products are supplied to hospitals, genetics<br />
centers and IVF clinics worldwide where they are<br />
used to investigate developmental delay, specific<br />
cancers and an associated list <strong>of</strong> known genetic<br />
syndromes.<br />
■ Boreal Genomics ...................................... 724<br />
Tel: 604-822-8268/800-681-5644<br />
Email: info@borealgenomics.com<br />
URL: http://www.borealgenomics.com<br />
Boreal provides systems and laboratory services for<br />
high sensitivity pr<strong>of</strong>iling <strong>of</strong> cancer mutations from<br />
plasma and low tumor content samples.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ Cartagenia ............................................... 1022<br />
Tel: 617-475-5105<br />
Email: info@cartagenia.com<br />
URL: http://www.cartagenia.com<br />
Cartagenia provides reliable s<strong>of</strong>tware allowing genetic<br />
labs and clinicians to perform clinically relevant<br />
analyses efficiently. With BENCH lab CNV for<br />
cytogenetics and BENCH lab NGS for sequencing,<br />
your lab technicians, directors, counselors and<br />
scientists have the right tools and knowledge at their<br />
fingertips supporting variant triage and automating<br />
lab reporting.<br />
■ Cell Press ................................................. 1212<br />
Tel: 617-661-7057/888-437-4636<br />
Email: usinfo-f@elsevier.com<br />
URL: http://www.cell.com<br />
Cell Press publishes the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong><br />
<strong>Genetics</strong>, the premier journal <strong>of</strong> the <strong>American</strong> <strong>Society</strong><br />
<strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>. Visit booth #1212 to learn more<br />
about this exciting partnership and <strong>ASHG</strong> member<br />
discounts on journals, including Cell, Molecular Cell,<br />
and Cell Stem Cell. New for <strong>2012</strong>, Cell Reports an<br />
open access journal spanning the entire life sciences<br />
spectrum. www.cell.com<br />
■ Center for Inherited Disease Research<br />
(CIDR) ........................................................... 119<br />
Tel: 410-550-7116<br />
Email: kimkutchins@jhmi.edu<br />
URL: http://www.cidr.jhmi.edu<br />
The Johns Hopkins University Center for Inherited<br />
Disease Research (CIDR) provides high quality<br />
next-generation sequencing and genotyping services<br />
to investigators working to discover genes that<br />
contribute to common disease. CIDR <strong>of</strong>fers custom<br />
targeted and whole exome sequencing services<br />
as well as GWAS, custom, epigenetic and linkage<br />
genotyping. www.cidr.jhmi.edu<br />
■ Centogene AG ......................................... 1026<br />
Tel: 49 3812036520<br />
Email: <strong>of</strong>fice@centogene.com<br />
URL: http://www.centogene.com<br />
CENTOGENE, The Rare Disease Company, is a global<br />
leader in the field <strong>of</strong> molecular diagnostics. Extremely<br />
short turn-around-times, analysis and interpretation<br />
by medical experts is guaranteed. CENTOGENE<br />
provides prenatal analysis, newborn screening, and<br />
the analysis <strong>of</strong> biomarkers for metabolic diseases.<br />
CENTOGENE works with international partners<br />
developing new orphan drugs.
■ chemagen from PerkinElmer ................. 1426<br />
Tel: 203-925-4602/800-762-4000<br />
Email: CustomerCareUS@perkinelmer.com<br />
URL: http://www.PerkinElmer.com<br />
chemagen is a leading supplier <strong>of</strong> automation and<br />
reagents for fast and reliable magnetic bead based<br />
DNA and RNA extraction for sample volumes from<br />
10 ul to 10 ml for blood, tissues, saliva, bacteria,<br />
food, PCR products, etc. The one instrument<br />
performs all functions with fast processing,<br />
unmatched sample volume range and robust<br />
chemistry.<br />
■ Children’s Hospital <strong>of</strong> Philadelphia ......... 327<br />
Tel: 215-590-6528<br />
Email: RobertsJ1@email.chop.edu<br />
URL: http://www.chop.edu/labs<br />
Founded in 1855, The Children’s Hospital <strong>of</strong><br />
Philadelphia is the birthplace <strong>of</strong> pediatric medicine<br />
in America. A passionate spirit <strong>of</strong> innovation has<br />
driven this renowned institution to pursue scientific<br />
discovery, establish the highest standards <strong>of</strong> care,<br />
and deliver diagnostic services that help children<br />
around the world lead happier, healthier lives.<br />
■ CIHR Institute <strong>of</strong> <strong>Genetics</strong> ..................... 1321<br />
Tel: 613-957-6126<br />
URL: http://www.cihr.gc.ca/e/13147.html<br />
The CIHR Institute <strong>of</strong> <strong>Genetics</strong> supports research<br />
on the human and model genomes and on all<br />
aspects <strong>of</strong> genetics, basic biochemistry and cell<br />
biology related to health and disease, including<br />
the translation <strong>of</strong> knowledge into health policy and<br />
practice, and the societal implications <strong>of</strong> genetic<br />
discoveries.<br />
■ Cincinnati Children’s Hospital Medical<br />
Center ......................................................... 1505<br />
Tel: 513-636-7355<br />
Email: askthelab@cchmc.org<br />
URL: http://www.cincinnatichildrens.org/<br />
clinicallab<br />
The clinical laboratories at Cincinnati Children’s<br />
Hospital Medical Center <strong>of</strong>fer quick, convenient<br />
diagnostic laboratory services designed and<br />
interpreted by world renowned clinical experts.<br />
We have over 400 specialty tests, and have<br />
specialty programs and expertise in molecular<br />
diagnostics, cardiology, immunodeficiencies, and<br />
cytogenetics.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 279<br />
■ City <strong>of</strong> Hope Clinical Molecular Diagnostic<br />
Laboratory .................................................... 321<br />
Tel: 626-256-4673 x 64401/888-826-4362<br />
Email: mdl@coh.org<br />
URL: http://mdl.city<strong>of</strong>hope.org<br />
The City <strong>of</strong> Hope Molecular Diagnostic Laboratory<br />
(MDL) specializes in clinical genetic testing<br />
services for cancer predisposition, coagulopathies,<br />
connective tissue disorders, muscular dystrophies,<br />
neuropsychiatric disorders and pharmacogenetics.<br />
For more up-to-date information about our tests,<br />
please visit our website at http://mdl.city<strong>of</strong>hope.org<br />
■ CLC bio ...................................................... 501<br />
Tel: 617-444-8765<br />
Email: alykkebak@clcbio.com<br />
URL: http://www.clcbio.com<br />
CLC bio is the world’s leading bioinformatics<br />
solution provider and the only one that provides both<br />
desktop and server s<strong>of</strong>tware seamlessly integrated<br />
and optimized for best performance. By developing<br />
their own proprietary algorithms, CLC bio scientists<br />
have successfully parallelized the data calculations<br />
to achieve remarkable improvements in speed over<br />
comparable solutions.<br />
■ Clontech Laboratories, A Takara<br />
Bio company .............................................. 1708<br />
Tel: 608-310-3516<br />
Email: leslie_miller@clontech.com<br />
URL: http://www.clontech.com/takara<br />
Reliable and innovative research reagents from<br />
Takara Bio and Clontech. Our products are trusted<br />
by scientists worldwide for applications from gene<br />
expression analysis using qPCR to high-fidelity PCR,<br />
protein expression, and epigenetics. Move your<br />
research forward with PrimeSTAR ® GXL and Max<br />
polymerases, TaKaRa Ex Taq ® and LA Taq ® , and<br />
PrimeScript RTase.<br />
■ Cold Spring Harbor Laboratory Press ......1209<br />
Tel: 516-422-4005<br />
Email: mazzullo@cshl.edu<br />
URL: http://www.cshlpress.org<br />
Cold Spring Harbor Laboratory continues to shape<br />
contemporary biomedical research and education<br />
with programs in cancer, neuroscience, plant biology,<br />
and quantitative biology. Its Meetings & Courses<br />
program hosts more than 8,000 international<br />
scientists each year and its Press publishes books,<br />
journals, and electronic media for scientists, students,<br />
and the general public.<br />
EXHIBITORS
280 EXHIBITORS<br />
■ Complete Genomics, Inc. ......................... 907<br />
Tel: 650-943-2800<br />
Email: events@completegenomics.com<br />
URL: http://www.completegenomics.com<br />
Through its pioneering sequencing-as-a-service<br />
model, Complete Genomics provides researchers and<br />
clinicians the most accurate whole human genomes.<br />
The ease <strong>of</strong> use and power <strong>of</strong> Complete’s advanced<br />
informatics and analysis provide genomic information<br />
needed to understand, prevent, diagnose and treat<br />
diseases.<br />
■ Connective Tissue Gene Tests ................ 718<br />
Tel: 484-244-2900<br />
Email: inquiries@ctgt.net<br />
URL: http://www.ctgt.net<br />
CTGT is committed to providing the broadest<br />
range <strong>of</strong> molecular diagnostic tests for inherited<br />
connective tissue disorders — about 200 tests<br />
and still growing. CTGT has high test sensitivity,<br />
fast turnaround time, expert advice and superior<br />
customer service.<br />
■ Coriell Institute for Medical Research ........312<br />
Tel: 856-966-7377/800-752-3805<br />
Email: ccr@coriell.org<br />
URL: http://ccr.coriell.org<br />
Coriell Institute for Medical Research is an<br />
independent, non-pr<strong>of</strong>it biomedical research center.<br />
Founded in 1953, Coriell is one <strong>of</strong> the world’s<br />
leading biobanks, distributing biospecimens and<br />
<strong>of</strong>fering custom research and biobanking services<br />
to scientists. Coriell examines the utility <strong>of</strong> genetic<br />
information in personalized medicine through its<br />
CPMC research study.<br />
■ Covaris Inc. .............................................. 1008<br />
Tel: 781-932-3959<br />
Email: info@covarisinc.com<br />
URL: http://www.covarisinc.com<br />
Covaris provides advanced sample preparation<br />
systems for life and analytical science. Covaris<br />
sample prep technologies support a wide variety <strong>of</strong><br />
applications including NGS, ChIP, and proteomics.<br />
Our patented Adaptive Focused Acoustic (AFA)<br />
technology is the industry standard for DNA shearing<br />
and is used by major genome centers and academic<br />
institutions worldwide.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ Cytocell Ltd/Rainbow Scientific, Inc. ..........404<br />
Tel: 860-298-8382/888-831-4247<br />
Email: info@rainbowscientific.com<br />
URL: http://www.rainbowscientific.com<br />
Cytocell celebrates its 20th year as a leading provider<br />
<strong>of</strong> innovative DNA screening solutions for the accurate<br />
detection <strong>of</strong> human genetic diseases. Cytocell<br />
manufactures complete ranges <strong>of</strong> DNA FISH probes for<br />
use in clinical cytogenetics. Please review our updated<br />
list <strong>of</strong> FISH probes for hematological malignancies<br />
including our new full line <strong>of</strong> OncoSight Solid Tumor<br />
FISH probes. Check out www.myprobes.com regarding<br />
their custom FISH probe-making services.<br />
■ Cytonet LLC............................................. 1301<br />
Tel: 919-354-1930<br />
Email: joel.hare@cytonetllc.com<br />
URL: http://www.cytonetllc.com<br />
Cytonet is a biotechnology company with sites in<br />
Germany and Durham, NC USA. Cytonet develops cellbased<br />
products for liver diseases. Liver cells from nontransplantable<br />
livers are recovered and subsequently<br />
transplanted into children with genetic disorders in<br />
approved Phase-II clinical studies. Donated livers are<br />
provided by 50+; US-OPO and Tissue Banks.<br />
■ Data Unlimited International, Inc........... 1503<br />
Tel: 240-631-7933<br />
Email: contact@duii.com<br />
URL: http://www.duii.com<br />
Starfruit Technologies is Laboratory Information<br />
Management System (LIMS) & QA s<strong>of</strong>tware/<br />
database/computer/barcode for genetic and<br />
immunology labs enables sample, patient,<br />
biorepository, billing databases; mutation, variant,<br />
disease, genotype databases, SNP databank;<br />
instrument interface, barcode, QA/QC; worksheet,<br />
workflow, inventory, protocol, image; epidemiological<br />
frequency, trend, geographical distribution, disease/<br />
disorder susceptibility, reporting; 21CFR11, CAP,<br />
CLIA, HIPPA, PHI.<br />
■ Diagenode Inc ........................................... 406<br />
Tel: 862-209-4680<br />
Email: custsupport.na@diagenode.com<br />
URL: http://www.diagenode.com<br />
Diagenode is an international life science company<br />
that develops and commercializes innovative<br />
instruments, reagents and systems for life science<br />
research. Our goal is to develop cutting-edge<br />
products that advance research in the rapidly<br />
evolving field <strong>of</strong> epigenetics. We specialize in <strong>of</strong>fering<br />
a broad range <strong>of</strong> chromatin immunoprecipitation and<br />
DNA methylation products.
■ DNA Genotek ............................................. 900<br />
Tel: 613-723-5757/1-866-813-6354<br />
Email: info@dnagenotek.com<br />
URL: http://www.dnagenotek.com<br />
DNA Genotek is focused on providing high-quality<br />
biological sample collection, stabilization and<br />
preparation products for genetic-based applications<br />
including molecular diagnostics and research <strong>of</strong> both<br />
host and microbial DNA or RNA in oral samples.<br />
The company’s Oragene product line provides<br />
reliability and ease-<strong>of</strong>-use which has resulted in rapid<br />
worldwide adoption by top tier health institutions.<br />
■ DNAnexus, Inc. .......................................... 507<br />
Tel: 650-209-0362<br />
Email: info@dnanexus.com<br />
URL: http://dnanexus.com<br />
DNAnexus is a pioneering, collaborative tool for<br />
the analysis, visualization, and management <strong>of</strong><br />
genomic data. DNAnexus’ foundation is a scalable,<br />
cloud-based platform that is fostering an expanding<br />
ecosystem <strong>of</strong> application developers and researchers<br />
that enables faster data delivery and accelerates the<br />
interpretation <strong>of</strong> genomic data in research and clinical<br />
applications.<br />
■ DNASTAR, Inc............................................ 801<br />
Tel: 608-258-7420/866-511-5090<br />
Email: info@dnastar.com<br />
URL: http://www.dnastar.com<br />
DNASTAR has pioneered development <strong>of</strong> desktop<br />
computer sequence assembly and analysis s<strong>of</strong>tware<br />
to increase life scientists’ productivity for over<br />
25 years. DNASTAR’s products include Lasergene<br />
s<strong>of</strong>tware for traditional sequence analysis and several<br />
other integrated tools for next-generation DNA and<br />
RNA sequence assembly and analysis and protein<br />
sequence and structure visualization.<br />
■ EdgeBio ................................................... 1506<br />
Tel: 301-990-2685/800-326-2685<br />
Email: info@edgebio.com<br />
URL: http://www.edgebio.com<br />
EdgeBio <strong>of</strong>fers next-generation sequencing services.<br />
From experimental design to bioinformatics, EdgeBio<br />
is the perfect solution for all your sequencing needs.<br />
EdgeBio also sells kits for sequencing reaction<br />
cleanup, PCR purification, and plasmid purification,<br />
as well as competent cells.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 281<br />
■ Elsevier .................................................... 1210<br />
Tel: 212-989-5800/888-437-4636<br />
Email: usinfo-f@elsevier.com<br />
URL: http://www.elsevier.com<br />
Explore Elsevier’s high impact genetics journals<br />
and books. Learn the latest in research news<br />
from journals such as The <strong>American</strong> Journal <strong>of</strong><br />
<strong>Human</strong> <strong>Genetics</strong>. Our exciting books on display<br />
include Our Genes, Our Choices, Genomic and<br />
Personalized Medicine and many more. Discover<br />
our electronic research and solution tools via<br />
SciVerse ScienceDirect.<br />
■ Embi Tec .................................................. 1406<br />
Tel: 858-684-3190/800-255-1777<br />
Email: inquiry@embitec.com<br />
URL: http://www.embitec.com<br />
Embi Tec manufactures and distributes innovative,<br />
cost and space effective lab equipment such as the<br />
RunOne Electrophoresis System, MultiCaster<br />
Systems, ViewOne LabLite (miniature white light<br />
box), LightOne Illuminators for setting up and<br />
cherry-picking 96- or 384-well plates, PrepOne<br />
Sapphire (non-UV, blue light box), PrepOne<br />
ImageCatcher and AnyBlood Direct PCR buffers.<br />
■ EMC Isilon ............................................... 1320<br />
Tel: 206-315-7500<br />
Email: info@isilon.com<br />
URL: http://www.emc.com/isilon<br />
EMC© Isilon is the global leader in scale-out<br />
storage. We deliver powerful yet simple solutions<br />
for enterprises that want to manage their data, not<br />
their storage. Isilon’s products are simple to install,<br />
manage and scale, at any size.<br />
■ Emory <strong>Genetics</strong> Laboratory ..................... 211<br />
Tel: 404-778-8499/855-831-7447<br />
Email: dkauke@emory.edu<br />
URL: http://www.geneticslab.emory.edu<br />
Emory <strong>Genetics</strong> Laboratory (EGL) is a worldwide<br />
leader in rare disease clinical genetic testing.<br />
Associated with Emory University’s prestigious<br />
Department <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> in its School <strong>of</strong><br />
Medicine, EGL’s biochemical, cytogenetic, and<br />
molecular laboratories perform integrated and<br />
comprehensive testing including whole exome<br />
sequencing, prenatal microarrays and inherited<br />
metabolic disorder testing.<br />
EXHIBITORS
282 EXHIBITORS<br />
■ Enlis Genomics ......................................... 203<br />
Tel: 510-413-8305<br />
Email: contact@enlis.com<br />
URL: http://www.enlis.com<br />
Overall Winner <strong>of</strong> the 2011 Illumina Data<br />
Excellence Award! Genome analysis made simple.<br />
Our Genome Research s<strong>of</strong>tware is the easiest way to<br />
analyze tens or even hundreds <strong>of</strong> human genomes -<br />
all on a standard desktop or laptop computer. Sign<br />
up for a free trial today.<br />
■ Epicentre (an Illumina company) ........... 1218<br />
Tel: 608-258-3080/800-284-8474<br />
Email: techhelp@epicentre.com<br />
URL: http://www.epicentre.com<br />
Epicentre (an Illumina company) <strong>of</strong>fers innovative,<br />
time-saving kits for gene expression studies.<br />
Featured are the ScriptSeq and TotalScript kits<br />
for rRNA-free RNA-Seq library sample prep in 1<br />
day from any RNA sample. Kits for genomic DNA<br />
purification and microarray target labeling will also be<br />
highlighted.<br />
■ EpigenDx ................................................... 721<br />
Tel: 508-497-9400/800-941-6884<br />
Email: info@epigendx.com<br />
URL: http://epigendx.com<br />
EpigenDx is a genomic and epigenomic research<br />
company that specializes in disease biomarker<br />
discovery and molecular diagnosis. The company<br />
provides the products and services for DNA<br />
methylation analysis and quantitative mutation<br />
analysis. EpigenDx also provides products and<br />
laboratory services for scientific researchers from<br />
academic, government and industrial communities.<br />
■ Epigentek Group Inc ............................... 1127<br />
Tel: 877-374-4368<br />
Email: info@epigentek.com<br />
URL: http://www.epigentek.com<br />
Epigentek is the leading provider <strong>of</strong> epigenetic assay<br />
kits, antibodies, reagents, and services through a<br />
complete and systematic approach. It is the first<br />
and only company to specialize exclusively in<br />
epigenetics and has pioneered the commercialization<br />
<strong>of</strong> many technologies commonly used today in DNA<br />
methylation, histone modification, and chromatin<br />
studies.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ European <strong>Human</strong> <strong>Genetics</strong><br />
Conference 2013 .......................................... 219<br />
Tel: 31 703838901<br />
Email: fvanlaer@rose-international.com<br />
URL: http://www.eshg.org/eshg2013<br />
The European <strong>Human</strong> <strong>Genetics</strong> Conference 2013<br />
will be held in Paris, France, from 8-11 June 2013.<br />
Please visit our booth for more information and ESHG<br />
membership application. To view the conference<br />
program, details on abstract submission and for<br />
online registration for the conference: www.eshg.org/<br />
eshg2013<br />
■ Exiqon ...................................................... 1712<br />
Tel: 781-376-4150/888-647-2879<br />
Email: lac@exiqon.com<br />
URL: http://www.exiqon.com<br />
Exiqon is a leading supplier <strong>of</strong> microRNA research<br />
tools based on our proprietary LNA technology.<br />
Researchers around the world are using our<br />
products to make groundbreaking discoveries<br />
about the correlation between gene activity and the<br />
development <strong>of</strong> cancer and other diseases. Exiqon<br />
Services <strong>of</strong>fers expertise in microRNA pr<strong>of</strong>iling and<br />
biomarker discovery from clinical samples.<br />
■ Expression Analysis .................................. 508<br />
Tel: 919-405-2248/866-293-6094<br />
Email: kmichailo@expressionanalysis.com<br />
URL: http://www.expressionanalysis.com<br />
EA provides cutting-edge genomic sequencing, gene<br />
expression, genotyping, and bioinformatics services<br />
to global pharmaceutical companies, diagnostic test<br />
developers, government agencies, and academic<br />
labs. EA conducts every project under clinicalgrade<br />
quality control and <strong>of</strong>fers the bioinformatics<br />
expertise and computational infrastructure to process<br />
enormous volumes <strong>of</strong> genomic data with consistency<br />
and speed.<br />
■ FASEB ...................................................... 1700<br />
Tel: 301-634-7288<br />
Email: khicks@faseb.org<br />
URL: http://www.faseb.org<br />
Celebrating its Centennial, 100 Years <strong>of</strong> Advancing<br />
the Life Sciences, FASEB is recognized as the<br />
policy voice <strong>of</strong> biomedical researchers, representing<br />
26 scientific societies (over 100,000 members); the<br />
nations largest coalition <strong>of</strong> biomedical researchers.<br />
Products/services include: The FASEB Journal,<br />
Science Research Conferences, MARC travel awards,<br />
and <strong>Society</strong> Management Services.
■ Fluidigm Corporation ............................... 725<br />
Tel: 650-266-6000/866-358-4354<br />
Email: Marketing@fluidigm.com<br />
URL: http://www.fluidigm.com<br />
Fluidigm develops and manufactures innovative<br />
micr<strong>of</strong>luidics solutions for life science systems. These<br />
solutions consist <strong>of</strong> its integrated fluidic circuit (IFC)<br />
technology, with instruments that simplify workflow<br />
and improve accuracy for genomics research<br />
applications, including single-cell gene expression,<br />
high-throughput SNP genotyping and next-generation<br />
sequencing.<br />
■ Geisinger Health System .......................... 821<br />
Tel: 570-214-9725/800-845-7112<br />
Email: jheid1@geisinger.edu<br />
URL: http://Join-Geisinger.org<br />
Geisinger Health System serves nearly 3 million<br />
people in Pennsylvania through a network <strong>of</strong><br />
4 hospitals, 38 community practice sites and over 900<br />
Geisinger physicians. Geisinger has an institutional<br />
commitment to research and a focus on personalized<br />
medicine, and has been nationally recognized for<br />
research, innovative practices and quality care.<br />
■ Gene Codes Corporation ...................... 1310<br />
Tel: 734-769-7249/800-497-4939<br />
Email: info@genecodes.com<br />
URL: http://www.genecodes.com<br />
Gene Codes Corporation develops Sequencher,<br />
DNA sequence analysis s<strong>of</strong>tware for traditional<br />
and next-generation DNA data sets. Geneticists<br />
around the world rely on Sequencher’s intuitive user<br />
interface, speedy alignment algorithms, and powerful<br />
SNP discovery tools to guide them towards results.<br />
Stop by to see our latest release <strong>of</strong> Sequencher.<br />
■ GeneDx .................................................... 1119<br />
Tel: 301-519-2100/800-229-5227<br />
Email: genedx@genedx.com<br />
URL: http://www.genedx.com<br />
GeneDx tests for more than 350 rare Mendelian<br />
disorders using DNA sequencing and deletion/<br />
duplication analysis <strong>of</strong> the associated gene(s), and<br />
<strong>of</strong>fers oligonucleotide microarray-based testing<br />
and next-generation sequencing-based panels for<br />
inherited cardiac disorders, mitochondrial disorders,<br />
and neurodevelopmental disorders. GeneDx <strong>of</strong>fers<br />
MFM and Ob-Gyn diagnostics including prenatal/<br />
maternal risk assessment, and carrier testing.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 283<br />
■ GeneInsight ............................................. 1224<br />
Tel: 617-954-9738<br />
Email: mband@partners.org<br />
URL: http://www.geneinsight.com<br />
GeneInsight Suite is an IT platform, developed at<br />
Partners HealthCare, to streamline the analysis,<br />
interpretation and reporting <strong>of</strong> genetic test results<br />
and facilitate delivery <strong>of</strong> test results to treating<br />
clinicians. The application consists <strong>of</strong> a laboratory<br />
knowledge management application, a clinician<br />
access application and a network infrastructure that<br />
enhances communication.<br />
■ Gene Link, Inc ........................................... 627<br />
Tel: 914-769-1192/800-436-3546<br />
Email: support@genelink.com<br />
URL: http://www.genelink.com<br />
Gene Link is a leading supplier <strong>of</strong> premium custom<br />
complex modified oligonucleotides, siRNA, RNA,<br />
fluorescent probes and other molecular biology<br />
products. Gene Detection System product lines for<br />
triple repeat disorders e.g. Fragile X, Huntington s<br />
disease, Myotonic Dystrophy, FRDA and FRAXE. Gene<br />
Link services include custom probe and siRNA design.<br />
■ GeneTests ................................................ 1413<br />
Tel: 206-221-4674<br />
Email: newgr@u.washington.edu<br />
URL: http://www.genetests.org<br />
GeneTests (www.genetests.org) provides medical<br />
genetics information for physicians, clinicians and<br />
researchers pertaining to diagnosis, management,<br />
and genetic counseling for heritable disorders<br />
through the expert-authored, peer-reviewed<br />
publication GeneReviews, an international genetic<br />
testing Laboratory Directory and Clinic Directory, and<br />
educational materials. Funded by contract from NIH,<br />
sponsored by University <strong>of</strong> Washington, Seattle.<br />
■ Genetic Engineering & Biotechnology<br />
News ........................................................... 1500<br />
Tel: 914-740-2200<br />
Email: smccarthy@bioconferences.com<br />
URL: http://www.genengnews.com<br />
Genetic Engineering & Biotechnology News (GEN) is<br />
the longest-running, most widely read, and largest<br />
circulated global biotechnology news publication.<br />
Published 21 times a year and recently redesigned<br />
to focus on Biobusiness, OMICS, Drug Discovery,<br />
Bioprocessing, and Translational Medicine, GEN<br />
reports on key news developments and technology<br />
trends in the bioindustry.<br />
EXHIBITORS
284 EXHIBITORS<br />
■ <strong>Genetics</strong> <strong>Society</strong> <strong>of</strong> America/G3 - Genes,<br />
Genomes, <strong>Genetics</strong> ..................................... 227<br />
Tel: 301-634-7300/866-486-GENE<br />
Email: society@genetics-gsa.org<br />
URL: http://www.genetics-gsa.org | http://www.<br />
g3journal.org<br />
The <strong>Genetics</strong> <strong>Society</strong> <strong>of</strong> America is a scientific<br />
membership society <strong>of</strong> 5,000 researchers and<br />
educators. GSA established the open-access peerreviewed<br />
journal G3: GENES|GENOMES|GENETICS as<br />
a forum for the publication <strong>of</strong> high-quality foundational<br />
research, including articles on useful genetic and<br />
genomic information and datasets in human genetics.<br />
■ Gene Tools, LLC ...................................... 1401<br />
Tel: 541-929-7840<br />
Email: custsupport@gene-tools.com<br />
URL: http://www.gene-tools.com<br />
Gene Tools manufactures Morpholino oligos for<br />
blocking translation, modifying splicing or inhibiting<br />
miRNA activity. Morpholinos are used in cell cultures,<br />
embryos or, as Vivo-Morpholinos, in adult animals.<br />
Morpholinos are effective, specific, stable and nontoxic.<br />
Backed by PhD-level customer support, Gene<br />
Tools designs and synthesizes Morpholinos and<br />
<strong>of</strong>fers cytosolic delivery options.<br />
■ Genformatic ............................................. 1420<br />
Tel: 512-565-4693<br />
Email: info@genformatic.com<br />
URL: http://www.genformatic.com<br />
Genformatic provides comprehensive genome<br />
sequence analysis services, including optimized<br />
sequence alignment and variant identification, variant<br />
annotation and interpretation <strong>of</strong> phenotypic implications,<br />
and production <strong>of</strong> a prioritized list <strong>of</strong> probable variant<br />
impacts upon health. Genformatic can process one<br />
genome or hundreds <strong>of</strong> genomes in parallel for research<br />
investigations or clinical applications.<br />
■ Genial Genetic Solutions/Rainbow<br />
Scientific, Inc. .............................................. 402<br />
Tel: 860-298-8382/888-831-4247<br />
Email: info@rainbowscientific.com<br />
URL: http://www.rainbowscientific.com<br />
Genial Genetic Solutions <strong>of</strong>fers the robotic MultiPrep<br />
Genie and Cell Sprint Harvesting systems for both<br />
surface culture and suspension culture harvesting.<br />
Our ProCell cytogenetic reagents yield high quality<br />
cytogenetic preparations. Our suite <strong>of</strong> genetic<br />
database s<strong>of</strong>tware products including Shire, iGene<br />
and iPassport QMS, <strong>of</strong>fer integrated multi-discipline<br />
genetic patient management with excellent auditing<br />
and document/process control capabilities.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ GenoLogics ............................................. 1105<br />
Tel: 250-483-7011/866-457-5467<br />
Email: info@genologics.com<br />
URL: http://www.genologics.com<br />
GenoLogics is a leading provider <strong>of</strong> LIMS s<strong>of</strong>tware<br />
specifically designed for next-generation omics<br />
labs. The GenoLogics LIMS delivers end-to-end<br />
management <strong>of</strong> genomics laboratory samples, tests<br />
and results. GenoLogics is uniquely qualified to<br />
meet information management needs <strong>of</strong> the nextgeneration<br />
laboratory by delivering a LIMS that is<br />
scalable, adaptable and useable.<br />
■ Genomatix S<strong>of</strong>tware ................................. 425<br />
Tel: 734-205-5990/877-436-6628<br />
Email: grant@genomatix.com<br />
URL: http://www.genomatix.com<br />
Genomatix is a computational biology company<br />
known for its excellence in science. We have<br />
accumulated extensive data content and developed<br />
multiple s<strong>of</strong>tware applications for understanding<br />
gene regulation for 15+ years. Leveraging this<br />
history <strong>of</strong> excellence in systems biology, Genomatix<br />
now provides a comprehensive, integrated analysis<br />
solution for all NGS applications.<br />
■ Genzyme, a San<strong>of</strong>i Company ................... 901<br />
Tel: 617-768-6512<br />
Email: lena.ortins@genzyme.com<br />
URL: http://www.genzyme.com<br />
Genzyme has pioneered the development and<br />
delivery <strong>of</strong> transformative therapies for patients<br />
affected by rare and debilitating diseases for over<br />
30 years. With a focus on rare diseases and multiple<br />
sclerosis, we are dedicated to making a positive<br />
impact on the lives <strong>of</strong> the patients and families we<br />
serve. Visit www.genzyme.com.<br />
■ GnuBIO, Inc. .............................................. 521<br />
Tel: 617-446-6744<br />
Email: info@gnubio.com<br />
URL: http://www.gnubio.com<br />
GnuBIO is a pioneer in the field <strong>of</strong> scalable DNA<br />
sequencing technology. The GnuBIO technology is<br />
an emulsion-based micr<strong>of</strong>luidic technology. GnuBIO’s<br />
platform seamlessly incorporates all DNA sequencing<br />
functions into one single system (including DNA<br />
enrichment, amplification and sequencing), with<br />
a single user interface producing results in hours<br />
versus days.
■ Golden Helix, Inc. ...................................... 818<br />
Tel: 406-585-8137<br />
Email: info@goldenhelix.com<br />
URL: http://www.goldenhelix.com<br />
Golden Helix helps genetic research groups working<br />
with large-scale DNA-sequencing or microarray<br />
data overcome the frustration and challenges <strong>of</strong><br />
bioinformatic roadblocks. By empowering researchers<br />
with highly effective s<strong>of</strong>tware tools, world-class<br />
support, and complementary analytic services, we<br />
refute the notion that analysis has to be difficult or<br />
time consuming.<br />
■ Greenwood Genetic Center ................... 1027<br />
Tel: 864-941-8110/800-473-9411<br />
URL: http://www.ggc.org<br />
The Greenwood Genetic Center is a nonpr<strong>of</strong>it institute<br />
organized to provide clinical genetic services,<br />
diagnostic laboratory testing, educational resources,<br />
and research in the field <strong>of</strong> medical genetics.<br />
Our laboratory <strong>of</strong>fers biochemical, cytogenetic,<br />
and molecular diagnostic testing. We strive to<br />
Give Greater Care by combining state-<strong>of</strong>-the-art<br />
diagnostics with exceptional service.<br />
■ Hamilton Company ................................. 1613<br />
Tel: 775-858-3000/800-648-5950<br />
Email: kcavallaro@hamiltoncompany.com<br />
URL: http://www.hamiltonrobotics.com<br />
Hamilton Robotics is dedicated to the design<br />
and manufacture <strong>of</strong> automated liquid handling<br />
workstations. Key to our products is our air<br />
displacement pipetting and monitoring technology<br />
and s<strong>of</strong>tware controlling our systems. Our<br />
workstations and s<strong>of</strong>tware serve as a common high<br />
precision and flexible base upon which to provide<br />
automated solutions.<br />
■ Hitachi Solutions America Ltd. .............. 1502<br />
Tel: 650-615-7600<br />
Email: rlynde@miraibio.com<br />
Hitachi Solutions and Hitachi High<br />
Technologies have partnered to leverage<br />
breakthrough technologies to create the secure<br />
infrastructure needed to allow validated genomic<br />
data and related phenotypic data to be combined.<br />
This new platform will give users the ability to<br />
mine and view data in novel ways to make new<br />
discoveries.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 285<br />
■ <strong>Human</strong> Variome Project Intl. Ltd ............. 221<br />
Tel: 61 3 8344-1831<br />
Email: rania@variome.org<br />
URL: http://www.humanvariomeproject.org<br />
The <strong>Human</strong> Variome Project is an international<br />
consortium <strong>of</strong> individuals who are working towards<br />
reducing the burden <strong>of</strong> genetic disease. The aim<br />
<strong>of</strong> the <strong>Human</strong> Variome Project is to ensure that all<br />
information on genetic variation can be collected,<br />
curated, interpreted and shared freely and openly<br />
with the world.<br />
■ Illumina, Inc. ............................................ 1109<br />
Tel: 858-202-4500/800-809-4566<br />
Email: info@illumina.com<br />
URL: http://www.illumina.com<br />
Illumina ® provides innovative sequencing and<br />
array-based solutions for genotyping, copy number<br />
variation analysis, methylation studies, gene<br />
expression pr<strong>of</strong>iling, and low-multiplex analysis <strong>of</strong><br />
DNA, RNA, and protein. We also provide tools and<br />
services that are fueling advances in consumer<br />
genomics and diagnostics, paving the way for<br />
molecular medicine and ultimately transforming<br />
healthcare.<br />
■ Incom, Inc. ............................................... 1300<br />
Tel: 508-909-2200<br />
Email: dar@incomusa.com<br />
URL: http://www.incomusa.com<br />
Incom is a manufacturer <strong>of</strong> glass and polymer fused<br />
fiber optic faceplates and tapers, as well as polymer<br />
and glass micro structures. We have participated<br />
in the development <strong>of</strong> microwell arrays for genome<br />
sequencing, large-area faceplates and tapers for<br />
X-ray applications, and microcapillary arrays for TOF<br />
and neutron detection.<br />
■ Ingenuity Systems, Inc. .......................... 1101<br />
Tel: 650-381-5100<br />
Email: hbullock@ingenuity.com<br />
URL: http://www.ingenuity.com<br />
Ingenuity Systems enables researchers to model,<br />
analyze and understand complex biological systems<br />
foundational to human health and disease. Products<br />
leverage the Ingenuity Knowledge Base and include<br />
IPA, Ingenuity iReport, Ingenuity Variant Analysis,<br />
Ingenuity Analysis Services, and content and custom<br />
services for pharmaceutical, biotech and academic<br />
organizations. Learn more at www.ingenuity.com.<br />
EXHIBITORS
286 EXHIBITORS<br />
■ Innopsys .................................................... 805<br />
Tel: 312-925-8210<br />
Email: contact@innopsys.com<br />
URL: http://www.innopsys.com<br />
Offering the InnoScan 900 and InnoScan 900<br />
fluorescence microarray scanners with optional<br />
autoloaders, Innopsys empowers users with the<br />
fastest reading times and highest resolution on<br />
the market. Innoscan scanners use Mapix, Innopsys<br />
proprietary image acquisition and analysis s<strong>of</strong>tware,<br />
giving customers a user-friendly interface and the<br />
fastest spot-finding on the market.<br />
■ IntegenX Inc. ........................................... 1311<br />
Tel: 925-701-3400<br />
Email: information@integenX.com<br />
URL: http://www.integenX.com<br />
IntegenX Inc. produces automated sample processing<br />
systems and reagent kits for the life sciences and<br />
applied sciences markets. Our Apollo 324 System<br />
automates next-generation library preparation for all<br />
major NGS platforms. GenTegra reagents enable<br />
ambient temperature storage <strong>of</strong> RNA and DNA.<br />
Our products dramatically reduce process time and<br />
expense. www.integenx.com<br />
■ Integrated DNA Technologies, Inc. ......... 301<br />
Tel: 319-626-8400/800-328-2661<br />
Email: custcare@idtdna.com<br />
URL: http://www.idtdna.com<br />
Integrated DNA Technologies (IDT) is a leader in<br />
custom biology for the research and diagnostic<br />
life science market and serves academic research,<br />
biotechnology, and pharmaceutical development.<br />
Products include DNA oligos, qPCR assays, and<br />
custom gene synthesis to support many applications<br />
such as DNA sequencing, SNP detection, and<br />
functional genomics.<br />
■ Integrated <strong>Genetics</strong>/LabCorp .................. 606<br />
Tel: 336-222-7566/800-222-7566<br />
Email: Anders@labcorp.com<br />
URL: http://www.labcorp.com<br />
Integrated <strong>Genetics</strong> is a leading provider <strong>of</strong><br />
reproductive genetic testing services driven by its<br />
commitment to physicians and their patients. With an<br />
expansive menu <strong>of</strong> complex tests and technologies,<br />
Integrated <strong>Genetics</strong> spans the continuum <strong>of</strong> care<br />
from prenatal diagnostics to the largest commercial<br />
genetic counseling network in the laboratory industry.<br />
www.integratedgenetics.com.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ Interactive Bios<strong>of</strong>tware ............................ 413<br />
Tel: 33278770405<br />
Email: contact@interactive-bios<strong>of</strong>tware.com<br />
URL: http://www.interactive-bios<strong>of</strong>tware.com<br />
Interactive Bios<strong>of</strong>tware is the creator <strong>of</strong> Alamut,<br />
the original mutation interpretation s<strong>of</strong>tware used<br />
by leading genetic scientists around the world.<br />
Interactive Bios<strong>of</strong>tware is changing genetic<br />
diagnostics and research by simplifying the mutation<br />
interpretation process, while saving scientists<br />
time, improving outcome quality and enhancing<br />
productivity.<br />
■ Ion Torrent ................................................. 100<br />
Tel: 650-243-6000<br />
Email: sales@iontorrent.com<br />
URL: http://www.iontorrent.com<br />
Life Technologies Corporation (NASDAQ: LIFE)<br />
is a global biotechnology company dedicated to<br />
moving science forward to improve life in meaningful<br />
ways for everyone. Our premier brands are the most<br />
cited, most trusted in the life sciences industry:<br />
Invitrogen, Applied Biosystems ® , Gibco ® , Molecular<br />
Probes ® , Novex ® , TaqMan ® , Ambion ® , and Ion<br />
Torrent.<br />
■ Irvine Scientific.......................................... 620<br />
Tel: 949-261-7800/800-437-5706<br />
Email: amcgrath@irvinesci.com<br />
URL: http://www.irvinesci.com<br />
Irvine Scientific is a leader in the design,<br />
manufacture and distribution <strong>of</strong> cell culture media<br />
and medical devices. Our goal is to develop<br />
and provide unsurpassed products and services<br />
for customers in biopharmaceutical, human<br />
reproductive, regenerative medicine, cytogenetics<br />
and research settings. We support a diverse cross<br />
section <strong>of</strong> the medical industry, from large scale<br />
industrial bioprocessing to IVF clinics and research<br />
in medically oriented areas.<br />
■ JAMA Network ........................................ 1201<br />
Tel: 312-464-5000<br />
Email: millette.jackson-bates@ama-assn.org<br />
URL: http://www.amapublications.org<br />
The JAMA Network is a consortium <strong>of</strong> peer-reviewed<br />
print and online medical publications, published by<br />
the AMA Publishing Group, that includes JAMA and 9<br />
specialty Archives Journals.
■ JMG (BMJ Group) ................................... 1103<br />
Tel: 44 (0)20 7387 4410<br />
Email: reponse.jmg@bmjgroup.com<br />
URL: http://jmg.bmj.com<br />
Journal <strong>of</strong> Medical <strong>Genetics</strong> (JMG) is a leading<br />
international peer reviewed journal covering original<br />
research in human genetics, including reviews <strong>of</strong> and<br />
opinion on the latest developments. Published monthly,<br />
each edition includes original articles, short reports,<br />
review articles, hypothesis articles, book reviews, online<br />
mutation reports and e-letters. Visit jmg.bmj.com to<br />
find out more.<br />
■ JSI medical systems GmbH ................... 1023<br />
Tel: 0049-7825-863620-0<br />
Email: mail@JSI-medisys.com<br />
URL: http://www.JSI-medisys.com<br />
JSI medical systems with U.S. <strong>of</strong>fice in CA is<br />
located in the Black Forest area at southwest<br />
Germany. Our s<strong>of</strong>tware Sequence Pilot is the<br />
leading premium product for analysis <strong>of</strong> next-<br />
generation sequencing, conventional sequencing,<br />
HLA SBT, HLA 454, MLPA and Affymetrix chip<br />
resequencing data. For detailed information see<br />
www.jsi-medisys.com<br />
■ Kailos <strong>Genetics</strong>, Inc. ................................. 310<br />
Tel: 256-327-9800/866-833-6865<br />
Email: mike@kailosgenetics.com<br />
URL: http://www.kailosgenetics.com<br />
TargetRich sets new expectations in targeted<br />
enrichment. A single-tube workflow - from start to<br />
finish - provides a fast, easy and scalable enrichment.<br />
Whether a custom solution, or fixed panel, our<br />
proprietary technology <strong>of</strong>fers the specificity, high<br />
alignment and uniformity for efficient next-generation<br />
sequencing with just 10ng <strong>of</strong> starting material.<br />
■ Kapa Biosystems Inc .............................. 1512<br />
Tel: 781-497-2933/855-527-2246<br />
Email: fritz.tiedt@kapabiosystems.com URL:<br />
http://www.kapabiosystems.com<br />
Kapa Biosystems <strong>of</strong>fers a portfolio <strong>of</strong> best-in-class<br />
PCR reagents engineered using our high-throughput<br />
molecular evolution platform. The novel DNA<br />
polymerases contained within our kits confer<br />
dramatic improvements to performance that enable<br />
results and applications not possible with wild-type<br />
enzymes. Next-generation PCR is defined as the shift<br />
from generalist wild-type enzymes toward designer<br />
specialist enzymes.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 287<br />
■ Karger Publishers ................................... 1208<br />
Tel: 860-675-7834/800-828-5479<br />
Email: karger.susan@snet.net<br />
URL: http://www.karger.com<br />
Karger is pleased to announce the publication <strong>of</strong><br />
An International System for <strong>Human</strong> Cytogenetic<br />
Nomenclature (2013). Other titles include the book<br />
series Genome Dynamics and Monographs in<br />
<strong>Human</strong> <strong>Genetics</strong>; and the journals Cytogenetic and<br />
Genome Research, Journal <strong>of</strong> Nutrigenetics and<br />
Nutrigenomics, Molecular Syndromology, Public<br />
Health Genomics, and Sexual Development.<br />
■ Knome, Inc. ............................................. 1007<br />
Tel: 617-715-1000<br />
Email: aryan@knome.com<br />
URL: http://www.knome.com<br />
Knome is a leading provider <strong>of</strong> human genome<br />
interpretation s<strong>of</strong>tware and services. Medical and<br />
research institutions use our innovative solutions<br />
to identify the genetic basis <strong>of</strong> disease, tumor<br />
growth, and drug response. Designed to accelerate<br />
the discovery process, Knome’s technologies are<br />
helping to pave the transition to molecular-based,<br />
personalized medicine.<br />
■ Kreatech Inc. ............................................. 811<br />
Tel: 919-407-8347/866-572-1432<br />
Email: na-customerservice@kreatech.com<br />
URL: http://www.kreatech.com<br />
Kreatech, Inc. <strong>of</strong>fers POSEIDON FISH probes<br />
with REPEAT-FREE technology. Kreatech has an<br />
extensive portfolio <strong>of</strong> FISH probes and custom design<br />
capability. Kreatech’s labeling technology, ULS - the<br />
Universal Linkage System, allows non-enzymatic,<br />
accurate and fast labeling <strong>of</strong> DNA, RNA and proteins;<br />
one universal labeling system compatible with all<br />
biological samples.<br />
■ Labcyte Inc. ............................................. 1402<br />
Tel: 408-747-2000/1-877-742-6548<br />
Email: info@labcyte.com<br />
URL: http://www.labcyte.com<br />
Labcyte is revolutionizing life science with the<br />
Echo ® liquid handler which uses acoustic energy to<br />
transfer liquids. This touchless technology provides<br />
dramatically better results by eliminating pipette tips<br />
and their associated problems, while saving hundreds<br />
<strong>of</strong> thousands <strong>of</strong> dollars annually in decreased<br />
consumables. Labcyte technologies have broad<br />
application in many fields.<br />
EXHIBITORS
288 EXHIBITORS<br />
■ Laboratory for Molecular Medicine,<br />
PCPGM ....................................................... 1225<br />
Tel: 617-768-8500<br />
Email: lmm@partners.org<br />
URL: http://pcpgm.partners.org/LMM/<br />
The Harvard-affiliated Laboratory for Molecular<br />
Medicine, a CLIA-certified molecular diagnostic<br />
laboratory within the Partners Healthcare Center<br />
for Personalized Genetic Medicine, bridges the gap<br />
between research and medicine by translating genetic<br />
discoveries into clinical testing, including expanding<br />
current disease areas and developing new content for<br />
clinical use on next-generation technologies.<br />
■ Leica Microsystems Corp ........................ 824<br />
Tel: 800-248-0123/800-248-0123<br />
Email: info@leica-microsystems.com<br />
URL: http://www.leica-microsystems.com<br />
■ LGC Genomics/Kbioscience .................. 1125<br />
Tel: 978-232-9430<br />
Email: bonnie.alvarado@lgcgenomics.com<br />
URL: http://www.kbioscience.co.uk/<br />
|http://www.lgc.co.uk/divisions/lgc_genomi<br />
LGC Genomics, now incorporating KBioscience,<br />
<strong>of</strong>fers a powerful array <strong>of</strong> products and services for<br />
nucleic acid extraction, genotyping, and sequencing.<br />
Our novel PCR-based KASP genotyping chemistry<br />
<strong>of</strong>fers superb data quality, maximum flexibility,<br />
and tremendous cost savings versus competing<br />
technologies. Please visit our booth to learn more!<br />
■ Life Technologies ...................................... 601<br />
Tel: 760-603-7200<br />
URL: http://www.lifetechnologies.com<br />
Life Technologies Corporation (NASDAQ: LIFE) is a<br />
global biotechnology company dedicated to moving<br />
science forward to improve life in meaningful ways<br />
for everyone. Our premier brands are the most cited,<br />
most trusted in the life sciences industry: Invitrogen,<br />
Applied Biosystems, Gibco, Molecular Probes,<br />
Novex, TaqMan, Ambion, and Ion Torrent.<br />
■ McGraw-Hill............................................. 1521<br />
Tel: 877-840-2297<br />
Email: digitalsales@mhedu.com<br />
URL: http://www.ommbid.com<br />
As one <strong>of</strong> the world’s premier medical publishers,<br />
McGraw Hill provides geneticists, researchers,<br />
educators, and students with access to OMMBID,<br />
the unparalleled online resource for genetic<br />
contribution to health and disease, as well as<br />
information for the broader medical world.<br />
Visit: www.ommbid.com, www.accessmedicine.com,<br />
and www.accesspediatrics.com to learn more.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ MetaSystems .......................................... 1303<br />
Tel: 617-924-9950/888-489-9959<br />
Email: hwhitney@metasystems.org<br />
URL: http://www.metasystems.org<br />
MetaSystems provides fast, easy-to-use genetic<br />
imaging and high-throughput slide scanning systems:<br />
ikaros for automatic karyotyping, isis for FISH<br />
imaging, CGH, mFISH, high resolution color and<br />
banding analysis, metafer for fully automatic slide<br />
analysis, spot counting, rare cell detection, metaphase<br />
search, array analysis, XCyte DNA probes. Please<br />
visit our website www.metasystems.org<br />
■ Microsonic Systems Inc. .......................... 618<br />
Tel: 408-844-4980<br />
Email: sales@microsonics.com<br />
URL: http://www.microsonics.com<br />
Microsonic Systems Inc. develops acoustics-based<br />
instruments for a broad base <strong>of</strong> life science sample<br />
prep applications. The high-throughput Microsonics<br />
ST300 system with patented ultrasonic technology<br />
provides high quality fragments for NGS; parallel<br />
sample processing and automation maximizes walkaway<br />
time with upgrade path to meet growing needs.<br />
Learn more at www.microsonics.com.<br />
■ MRC-Holland ........................................... 1122<br />
Tel: 31 20 489 1248<br />
Email: info@mlpa.com<br />
URL: http://www.mlpa.com<br />
MRC-Holland is the company that produces and<br />
develops SALSA MLPA probemixes that can be<br />
used for the analysis <strong>of</strong> copy number changes and<br />
methylation status <strong>of</strong> genomic sequences in a wide<br />
variety <strong>of</strong> inherited diseases as well as in tumors.<br />
■ Myriad Genetic Laboratories ................. 1501<br />
Tel: 801-505-5192/800-469-7423<br />
Email: sphillip@myriad.com<br />
URL: http://www.myriadpro.com<br />
Myriad <strong>Genetics</strong> is a leading molecular diagnostic<br />
company dedicated to making a difference in patients<br />
lives through the discovery and commercialization<br />
<strong>of</strong> transformative tests to assess a persons risk <strong>of</strong><br />
developing disease, guide treatment decisions and<br />
assess risk <strong>of</strong> disease progression and recurrence.<br />
■ NanoString Technologies, Inc. ................. 210<br />
Tel: 206-378-6266/888-358-6266<br />
Email: info@nanostring.com<br />
URL: http://www.nanostring.com<br />
NanoString Technologies is a privately held life<br />
sciences company marketing a complete solution for<br />
detecting and counting large sets <strong>of</strong> target molecules<br />
in biological samples.
■ Natera ........................................................ 504<br />
Tel: 650-249-9090 ext 357<br />
Email: ksong@natera.com<br />
URL: http://www.natera.com<br />
Natera provides reproductive genetic tests using<br />
bioinformatics in combination with sequencing<br />
technologies. Tests include preimplantation genetic<br />
diagnosis (PGD) for IVF, rapid turnaround molecular<br />
karyotyping <strong>of</strong> products <strong>of</strong> conception, non-invasive<br />
prenatal paternity testing, and non-invasive prenatal<br />
testing.<br />
■ National Center for Biotechnology<br />
Information ................................................... 224<br />
Tel: 301-496-2475<br />
Email: info@ncbi.nlm.nih.gov<br />
URL: http://www.ncbi.nlm.nih.gov<br />
NCBI provides integrated access to DNA and protein<br />
sequence data, associated mapping data, protein<br />
structures, and MEDLINE. Demonstrations <strong>of</strong> the<br />
GenBank database, the Entrez retrieval system,<br />
PubMed for MEDLINE searching, BLAST and VAST<br />
similarity searches for sequence and structures, and<br />
the BankIt and Sequin sequence submission s<strong>of</strong>tware<br />
will be provided.<br />
■ National <strong>Human</strong> Genome Research<br />
Institute ........................................................ 825<br />
Tel: 301-402-0911<br />
Email: mccrimmono@mail.nih.gov<br />
URL: http://www.genome.gov<br />
The National <strong>Human</strong> Genome Research Institute<br />
(NHGRI) led the National Institutes <strong>of</strong> Health’s (NIH)<br />
contribution to the International <strong>Human</strong> Genome<br />
Project. The human genomed was succesfully<br />
sequenced in 2003. Now, the NHGRI’s mission has<br />
expanded to encompass a broad range <strong>of</strong> studies<br />
aimed at understanding the structure and function <strong>of</strong><br />
the human genome and its role in health and disease.<br />
■ Nature Publishing Group .......................... 500<br />
Tel: 212-726-9200<br />
Email: institutions@us.nature.com<br />
URL: http://www.nature.com<br />
The NPG portfolio combines the excellence <strong>of</strong><br />
Nature its associated research and review journals,<br />
and leading academic and society journals in the<br />
life, physical and clinical sciences. Open access<br />
options are <strong>of</strong>fered through the academic and society<br />
journals, Nature Communications and through<br />
a new fully open access publication: Scientific<br />
Reports<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 289<br />
■ New England Biolabs, Inc. ....................... 904<br />
Tel: 978-380-7388<br />
Email: shnider@neb.com<br />
URL: http://www.neb.com<br />
NEB leads the industry in the discovery and<br />
production <strong>of</strong> enzymes for molecular biology<br />
applications including sample preparation for nextgeneration<br />
sequencing. NEB’s global reputation<br />
for manufacturing products <strong>of</strong> the highest quality<br />
coupled with best in class technical support makes<br />
NEB a first choice for customers demanding<br />
optimized reagents for advanced technologies.<br />
■ NextGxDx ................................................... 411<br />
Tel: 615-236-4569<br />
Email: kmcknight@nextgxdx.com<br />
URL: http://www.nextgxdx.com<br />
NextGxDx is a web-based genetic diagnostics<br />
platform, allowing hospitals and physicians to identify<br />
appropriate genetic tests and cross-reference<br />
multiple laboratories. Enabling physicians to research<br />
tests by patient symptoms, instantly compare<br />
tests across laboratories, and determine existing<br />
relationships, NextGxDx provides physicians with<br />
a single destination for discovering, comparing and<br />
ordering tests.<br />
■ Norgen Biotek Corp. ................................. 208<br />
Tel: 905-227-8848/1-866-667-4362<br />
Email: info@norgenbiotek.com<br />
URL: http://www.norgenbiotek.com<br />
Norgen is an innovative biotechnology company<br />
specializing in sample collection, preservation and<br />
preparation kits. We provide RNA, microRNA, DNA<br />
and protein isolation and clean-up kits based on a<br />
proprietary technology. Norgen also supplies the<br />
most extensive range <strong>of</strong> saliva and urine collection,<br />
concentration and isolation products available to<br />
meet a wide range <strong>of</strong> applications.<br />
■ NVIGEN .................................................... 1403<br />
Tel: 408-830-9988<br />
Email: info@nvigen.com<br />
URL: http://www.nvgien.com<br />
NVIGEN <strong>of</strong>fers customizable nanoparticle services<br />
and prepackaged nanoparticle reagents for research<br />
and industry needs. Our bioentity-conjugated<br />
nanoparticles, with magnetic and optical properties,<br />
provide efficient performance for genomic purification<br />
& extraction, co-immunoprecipitation, molecular and<br />
cell separation, targeted delivery and imaging. Our IP<br />
holds tremendous potential for high-sensitivity,<br />
high-throughput platforms and partnerships alike.<br />
EXHIBITORS
290 EXHIBITORS<br />
■ NXT-Dx ..................................................... 1025<br />
Tel: 32 92650252<br />
Email: maarten.braspenning@nxt-dx.com<br />
URL: http://www.nxt-dx.com<br />
NXT-Dx is a privately owned epigenetics company,<br />
providing methylation and small RNA analysis<br />
services to epigenetics researchers worldwide.<br />
Our services include MBD-based genome-wide<br />
DNA methylation sequencing, bisulfite sequencing,<br />
miRNA and/or lncRNA expression pr<strong>of</strong>iling and RNA<br />
sequencing. We <strong>of</strong>fer full-scope service from sample<br />
shipment, pre-processing, sequencing/RT-QPCR,<br />
bio-informatics to results visualization.<br />
■ Office <strong>of</strong> Rare Diseases Research (NIH) ..... 326<br />
Tel: 301-402-4336/888-205-2311<br />
Email: ordr@mail.nih.gov<br />
URL: http://rarediseases.info.nih.gov<br />
The Office <strong>of</strong> Rare Diseases Research (ORDR)<br />
supports and coordinates rare disease research,<br />
responds to research opportunities and provides<br />
information on rare diseases. ORDR serves the needs<br />
<strong>of</strong> patients who have any one <strong>of</strong> the thousands <strong>of</strong> rare<br />
diseases known today. ORDR coordinates and fosters<br />
relationships with patient advocacy groups to academic<br />
institutions as well as other NIH Institutes and Centers.<br />
■ Omixon Biocomputing .................................205<br />
Tel: 36 705748001<br />
Email: attila.berces@omixon.com,<br />
boglarka.fekete@omixon.com<br />
URL: http://www.omixon.com<br />
Omixon provides s<strong>of</strong>tware for next-generation<br />
sequencing data analysis with its flagship product<br />
Omixon Target. Omixon Target was designed with<br />
the vision <strong>of</strong> assisting diagnostics laboratories to<br />
adapt NGS technologies. The underlying mapping,<br />
alignment and variant calling algorithms are intended<br />
to meet the high precision and analysis quality control<br />
requirements <strong>of</strong> diagnostics labs.<br />
■ OpGen, Inc ............................................... 1124<br />
Tel: 301-869-9683<br />
Email: jmacemon@opgen.com<br />
URL: http://www.opgen.com<br />
OpGen, Inc. provides whole genome analysis<br />
systems and services for sequence assembly, strain<br />
typing and comparative genomics applications.<br />
Genomics research and public health labs use<br />
OpGen’s technology to produce high-resolution,<br />
ordered, restriction maps from single DNA molecules<br />
that provide a comprehensive view <strong>of</strong> genomic<br />
architecture. Learn more at www.OpGen.com<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ Otogenetics Corporation ......................... 827<br />
Tel: 855-686-4363/855-686-4363<br />
Email: sales@otogenetics.com<br />
Otogenetics Corporation based in suburb <strong>of</strong><br />
Atlanta, GA specializes in <strong>of</strong>fering high coverage<br />
sequencing for panels <strong>of</strong> disease genes or<br />
pathway-focused genes (e.g., whole exome <strong>of</strong><br />
various species, deafness genes, cancer genes,<br />
cardiomyopathy genes, etc.) and apply NGS for<br />
RNA-Seq and pr<strong>of</strong>iling <strong>of</strong> epigenetic modifications<br />
<strong>of</strong> genomic DNA.<br />
■ Oxford Gene Technology .......................... 302<br />
Tel: 44 (0)1865 856800<br />
Email: contact@ogt.co.uk<br />
URL: http://www.ogt.co.uk<br />
OGTs CytoSure range <strong>of</strong> aCGH products provides<br />
the complete array solution for constitutional<br />
and cancer cytogenetics: from high resolution<br />
oligonucleotide arrays, including the ISCA designs<br />
and the new cancer +SNP combination array using<br />
OGTs proprietary SNP chemistry, to optimized<br />
labeling kits and cytogenetically focused analysis and<br />
interpretation s<strong>of</strong>tware.<br />
■ Oxford Nanopore Technologies Ltd ........ 418<br />
Tel: 44 845 034 7900<br />
Email: info@nanoporetech.com<br />
URL: http://www.nanoporetech.com<br />
Oxford Nanopore Technologies is developing the<br />
electronic devices GridION and MinION for the direct<br />
analysis <strong>of</strong> single molecules including DNA, RNA/<br />
miRNA and proteins. Please visit exhibition booth to<br />
find out more. www.nanoporetech.com<br />
■ Oxford University Press.......................... 1200<br />
Tel: 800-451-7556<br />
Email: custserv.us@oup.com<br />
URL: http://www.oup.com/us<br />
Oxford University Press publishes some <strong>of</strong> the most<br />
respected genetics books and journals in the world,<br />
including <strong>Human</strong> Molecular <strong>Genetics</strong>. Our booth will<br />
feature Common Malformations, by Lewis Holmes<br />
and Achieving Justice in Genomic Translation, edited<br />
by Burke, et al., and the rest <strong>of</strong> Oxford’s leading<br />
books in genetics.
■ Pacific Biosciences .................................. 610<br />
Tel: 650-521-8003<br />
Email: info@pacificbiosciences.com<br />
URL: http://www.pacificbiosciences.com/<br />
The PacBio RS, a high resolution genetic analyzer,<br />
helps scientists solve genetically complex problems.<br />
Based on single-molecule, real-time (SMRT)<br />
technology, it enables: targeted sequencing to<br />
comprehensively characterize genetic variations;<br />
de novo genome assembly to identify, annotate<br />
and decipher genomic structures; and DNA base<br />
modification identification to help characterize<br />
epigenetic regulation.<br />
■ Palmyra S<strong>of</strong>tware.................................... 1519<br />
Tel: 510-423-3144<br />
Email: info@palmyras<strong>of</strong>tware.com<br />
URL: http://www.palmyras<strong>of</strong>tware.com<br />
Palmyra S<strong>of</strong>tware develops visual s<strong>of</strong>tware to<br />
automate computational analysis <strong>of</strong> high-throughput<br />
data, focusing on NGS sequencing data. The<br />
s<strong>of</strong>tware enables biologists and bioinformaticians<br />
alike to easily organize multiple analysis runs,<br />
from execution to results files. The s<strong>of</strong>tware also<br />
encourages efficiency <strong>of</strong> computational resources,<br />
re-using workflows and tracing history <strong>of</strong> results.<br />
■ Partek Incorporated ............................... 1307<br />
Tel: 314-878-2329<br />
Email: tsilber@partek.com<br />
URL: http://www.partek.com<br />
Partek provides s<strong>of</strong>tware for next-generation<br />
sequencing, microarray, and qPCR data analysis<br />
and visualization that empowers biologists to find<br />
biological meaning within their data. With an intuitive<br />
interface designed for researchers, Partek’s complete<br />
solution takes raw data to statistical and pathway<br />
analysis that allows true multi omics integration.<br />
■ PerkinElmer, Inc. Life Sciences &<br />
Technology ................................................. 1325<br />
Tel: 203-925-4602/800-762-4000<br />
Email: CustomerCareUS@perkinelmer.com<br />
URL: http://www.PerkinElmer.com<br />
PerkinElmer’s Life Sciences & Technology division<br />
<strong>of</strong>fers a wide range <strong>of</strong> automation and detection<br />
solutions for genomics and cellular imaging,<br />
including state-<strong>of</strong>-the art micr<strong>of</strong>luidics, lab<br />
automation and liquid handling systems for NGS<br />
supported by the Geospiza informatics platform.<br />
Visit us at booth 1325.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 291<br />
■ Pfizer ........................................................ 1511<br />
Tel: 212-733-2323<br />
Email: sandra.kusek@pfizer.com<br />
URL: http://www.pfizer.com<br />
At Pfizer, we apply science and our global<br />
resources to improve health and well-being at<br />
every stage <strong>of</strong> life. Every day, Pfizer colleagues<br />
work across developed and emerging markets<br />
to advance wellness, prevention, treatments and<br />
cures that challenge the most feared diseases <strong>of</strong><br />
our time.<br />
■ Phalanx Biotech Group ............................ 307<br />
Tel: 650-320-8669<br />
Email: info@onearray.com<br />
Phalanx Biotech Group provides genomic<br />
products and services worldwide to academic,<br />
pharmaceutical, biotech, and clinical research<br />
communities. Our expertise in expression pr<strong>of</strong>iling<br />
and genetic analysis stems from our excellence<br />
as an ODM <strong>of</strong> OneArray ® gene expression<br />
microarrays, CytoOneArray ® targeted chromosomal<br />
microarrays, and comprehensive knowledge<br />
developed as an application-focused service<br />
provider.<br />
■ PhenX Toolkit ............................................ 125<br />
Tel: 919-541-6954<br />
Email: hmp@rti.org<br />
URL: http://www.phenxtoolkit.org<br />
The PhenX Toolkit is a web-based catalog that<br />
<strong>of</strong>fers high-priority measures for consideration<br />
and inclusion in genome-wide association studies<br />
(GWAS) and large-scale genomic research efforts.<br />
With the Toolkit, investigators can identify highquality,<br />
standard measures to add to a new or<br />
ongoing study, and will simplify comparisons<br />
across studies.<br />
■ The PMD Foundation, Inc......................... 324<br />
Tel: 302-383-7748<br />
Email: PMDChair@pmdfoundation.org<br />
URL: http://www.pmdfoundation.org<br />
The PMD Foundation is a 501(c)3 non-pr<strong>of</strong>it<br />
organization formed to make a world where there<br />
is no Pelizaeus Merzbacher Disease. We do this by<br />
raising awareness and serving: PMD Children and<br />
their Families, the General Public, the Researchers<br />
and the Clinicians.<br />
EXHIBITORS
292 EXHIBITORS<br />
■ POSSUM - Murdoch Childrens Research<br />
Institute ........................................................ 218<br />
Tel: 61 3 83416277<br />
Email: possum@mcri.edu.au<br />
URL: http://www.possum.net.au.<br />
POSSUMweb is a dysmorphology database. NEW<br />
RELEASE fully web-based version, with free-text<br />
search, greater inter-activity, even use on your<br />
ipad. Assists clinicians in diagnosing syndromes in<br />
patients, using traits and images. Useful teaching<br />
tool, around 4000 syndromes including multiple<br />
malformations, chromosomal abnormalities,<br />
skeletal dysplasias, metabolic disorders, extensive<br />
trait atlas.<br />
■ Prevention<strong>Genetics</strong> LLC ........................ 1318<br />
Tel: 715-387-0484<br />
Email: s.samuels@preventiongenetics.com<br />
URL: http://www.preventiongenetics.com<br />
Prevention<strong>Genetics</strong> <strong>of</strong>fers Next-Gen, Clinical<br />
DNA Testing and DNA Banking services. We <strong>of</strong>fer<br />
clinical sequencing tests for over 500 genes.<br />
Our experienced team <strong>of</strong> geneticists provide fast<br />
turnaround times, outstanding personalized service,<br />
and the most reasonable prices in the industry. Our<br />
lab is fully CLIA accredited. To learn more visit www.<br />
preventiongenetics.com.<br />
■ Progeny S<strong>of</strong>tware, LLC ............................ 518<br />
Tel: 561-859-0773/800-776-4369<br />
Email: info@progenygenetics.com<br />
URL: http://www.progenygenetics.com<br />
Since 1996, Progeny has been the pedigree data<br />
management s<strong>of</strong>tware <strong>of</strong> choice for over 1900 sites<br />
in over 78 countries. Now available, an online Family<br />
History Questionnaire that integrates into your EMR,<br />
or any system. Sample tracking and genotype data<br />
management s<strong>of</strong>tware also available. See a demo at<br />
Booth 518.<br />
■ Prognosys Biosciences, Inc. .................... 304<br />
Tel: 858-459-2428<br />
Email: info@prognosysbio.com<br />
URL: http://www.prognosysbio.com<br />
Sequensys, a division <strong>of</strong> Prognosys Biosciences,<br />
<strong>of</strong>fers next-generation sequencing services. These<br />
now include MiSeq services, Voila! study-level RNA-<br />
Seq analysis, and Rivia target enrichment kits.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ Promega Corporation ............................. 1405<br />
Tel: 608-274-4330<br />
Email: mary.oconnell@promega.com<br />
URL: http://www.promega.com<br />
Promega Corporation is a world leader in applying<br />
molecular biology and biochemistry to the<br />
development <strong>of</strong> innovative, high value products for<br />
the life sciences. Stop by our booth to learn about<br />
our latest solutions for nucleic acid purification from<br />
blood and other sample types as well as products for<br />
qPCR and RT-qPCR.<br />
■ Pubget, Inc. ............................................. 1520<br />
Tel: 800-584-1899<br />
Email: marketing@pubget.com<br />
URL: http://www.pubget.com<br />
Pubget develops cloud-based content access tools<br />
for researchers. The core product, Pubget.com,<br />
is a site for legally finding and directly retrieving<br />
research papers. Pubget.com provides access to<br />
content for over 500 libraries worldwide. Pubget’s<br />
corporate services include marketing solutions,<br />
such as display advertising, API and textmining<br />
solutions.<br />
■ Public Library <strong>of</strong> Science ....................... 1606<br />
Tel: 415-568-3172<br />
Email: cassadi@plos.org<br />
URL: http://www.plos.org<br />
Public Library <strong>of</strong> Science (PLOS) is a nonpr<strong>of</strong>it<br />
open access publisher, membership, and advocacy<br />
organization with a mission to accelerate progress in<br />
science and medicine by leading a transformation in<br />
research communication.<br />
■ QIAGEN Inc. ............................................. 1001<br />
Tel: 800-426-8157/800-426-8157<br />
Email: customercare-us@qiagen.com<br />
URL: http://www.qiagen.com<br />
QIAGEN is the leading global provider <strong>of</strong> sample<br />
and assay technologies that are used to transform<br />
biological materials into valuable molecular<br />
information. QIAGEN markets more than 500<br />
products around the world, selling both consumable<br />
kits and automation systems to four customer<br />
classes: Academia, Applied Testing, Pharma , and<br />
Molecular Diagnostics.
■ RainDance Technologies, Inc. ................. 910<br />
Tel: 781-861-6300<br />
Email: marketing@raindancetech.com<br />
URL: http://www.RainDanceTech.com<br />
RainDance Technologies, the Digital Biology<br />
Company, is pioneering the use <strong>of</strong> high-throughput<br />
picodroplet-based analysis in human health and life<br />
science research. The complete RainDance solution<br />
includes automated instrumentation, customizable<br />
bioinformatics and high-value consumables and<br />
reagents for next-generation DNA sequencing and<br />
digital PCR applications.<br />
■ Rare Disease Therapeutics, Inc. ............. 419<br />
Tel: 615-399-0700<br />
Email: tpodgorski@raretx.com<br />
URL: http://www.raretx.com<br />
Rare Disease Therapeutics, Inc. is Americas first<br />
exclusively orphan drug company committed to<br />
developing and marketing drugs for rare disorders.<br />
RDT is dedicated to patients with unmet medical<br />
needs that have been overlooked by other<br />
pharmaceutical companies and distributes Orfadin ®<br />
(nitisinone) for hereditary tyrosinemia type I and<br />
Cystadane ® (betaine anhydrous for oral solution) for<br />
homocystinuria.<br />
■ Recombine LLC ........................................ 525<br />
Tel: 646-470-7422<br />
Email: alex@recombine.com<br />
URL: http://www.recombine.com<br />
Recombine is a clinical genetic testing company. We<br />
provide an integrated service covering everything<br />
from sample collection to patient counseling. We<br />
leverage new and powerful genotyping technologies<br />
to provide state-<strong>of</strong>-the-art, comprehensive and cost<br />
effective diagnostics. We simplify the genetic testing<br />
process so you can focus on caring for your patients.<br />
■ Roche Applied Science ............................ 701<br />
Tel: 317-521-4468<br />
Email: heather.easterling@roche.com<br />
URL: http://www.roche-applied-science.com<br />
Roche Applied Science supplies an extensive<br />
portfolio <strong>of</strong> instruments and kits to support<br />
translational research. Our enabling technologies<br />
include the LightCycler 480 Instrument, MagNA<br />
Pure 96 Instrument, and custom qPCR assays.<br />
We also provide solutions for targeted sequencing,<br />
including the GS Junior and GS FLX Systems, and<br />
NimbleGen sequence capture.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 293<br />
■ Rubicon Genomics, Inc. ........................... 803<br />
Tel: 734-368-1705<br />
Email: langmore@rubicongenomics.com<br />
URL: http://www.rubicongenomics.com<br />
Rubicon provides proprietary ThruPLEX, OmniPLEX,<br />
and PicoPLEX kits for the most rapid, sensitive<br />
and reproducible preparation <strong>of</strong> clinical samples<br />
(including single cells, plasma, FFPE-tissue<br />
and immunoprecipitates). Kits for research and<br />
diagnostics are available from Rubicon, distributors,<br />
and OEM partners for genetic, epigenetic, and<br />
expression analysis using NGS, arrays and PCR.<br />
■ RUCDR ..................................................... 1102<br />
Tel: 732-445-1027 x40058<br />
Email: jmckiml@dls.rutgers.edu<br />
URL: http://www.rucdr.org<br />
By utilizing a technologically advanced infrastructure<br />
and the highest quality biomaterials, RUCDR has<br />
become a world leader in support <strong>of</strong> genetics<br />
research. RUCDR scientists work to convert<br />
precious biosamples into renewable resources<br />
thereby extending research capabilities. We <strong>of</strong>fer<br />
comprehensive biobanking, sequencing, nucleic acid<br />
and functional analytics and stem cell services.<br />
■ Sage Science Inc. ................................... 1510<br />
Tel: 888-744-2244<br />
Email: alex@sagescience.com<br />
URL: http://www.sagescience.com<br />
Sage Science manufactures the Pippin Prep and<br />
BluePippin DNA size selection systems for NGS<br />
library construction. An automated alternative manual<br />
gel purification, the platform uses pre-cast agarose<br />
gel cassettes collects sized DNA fragments in buffer.<br />
In addition to savings in time and effort, Pippin-sized<br />
libraries provide superior sequencing results.<br />
■ Sanford Research ..................................... 325<br />
Tel: 605-312-6413<br />
Email: liz.donohue@sanfordhealth.org<br />
URL: http://www.sanfordresearch.org/cords<br />
Here at Sanford Research, we are committed to<br />
finding cures and advancing therapies into rare<br />
diseases. To further this mission, we established the<br />
Coordination <strong>of</strong> Rare Diseases at Sanford (CoRDS) —<br />
a national rare disease registry designed to accelerate<br />
research into these rare conditions. CoRDS collects<br />
and stores basic contact and clinical information on<br />
individuals <strong>of</strong> any age who have been diagnosed<br />
with a rare disease (undiagnosed individuals are also<br />
eligible for enrollment).<br />
EXHIBITORS
294 EXHIBITORS<br />
■ SCC S<strong>of</strong>t Computer ................................ 1618<br />
Tel: 727-789-0100<br />
Email: sales@s<strong>of</strong>tcomputer.com<br />
URL: http://www.s<strong>of</strong>tcomputer.com<br />
SCC S<strong>of</strong>t Computer’s comprehensive genetics<br />
information management suite <strong>of</strong>fers a full range <strong>of</strong><br />
genetics tools to automate workflow in the laboratory.<br />
This suite <strong>of</strong>fers a selection <strong>of</strong> Cytogenetics,<br />
Molecular, Flow Cytometry, HLA (immunogenetics),<br />
Diagnostic Pathology, and Biochemistry systems that<br />
are highly configurable and allow for unique, userdefined<br />
protocols.<br />
■ Science/AAAS ......................................... 1312<br />
Tel: 202-326-6417/800-731-4939<br />
Email: membership@aaas.org<br />
URL: http://www.aaas.org<br />
Since 1848, AAAS and its members have worked<br />
together to advance science and serve society. As<br />
part <strong>of</strong> these efforts, AAAS publishes Science, a<br />
multidisciplinary peer-reviewed journal, and <strong>of</strong>fers<br />
programs focused on science policy, international<br />
cooperation, science education, diversity, and career<br />
development for scientists.<br />
■ SciGene ...................................................... 619<br />
Tel: 408-733-7337/800-342-2119<br />
Email: custserv@scigene.com<br />
URL: http://www.scigene.com/<br />
SciGene equipment automates the complex, tedious<br />
benchwork required to process DNA microarrays<br />
for CMA testing. Starting with patient DNA,<br />
specialized instruments perform labeling through<br />
post-hybridization processing; producing consistently<br />
high quality arrays ready for scanning. SciGene<br />
automation boosts productivity, lowering costs,<br />
reducing re-test rates and standardizing tests for<br />
more reliable results.<br />
■ Sequenom, Inc. ......................................... 519<br />
Tel: 858-202-9000<br />
Email: aloria@sequenom.com<br />
URL: http://www.sequenom.com<br />
Sequenom <strong>of</strong>fers instrumentation and reagents for<br />
highly sensitive, robust nucleic acid detection. Cited<br />
in >1,500 publications, the MassARRAY System<br />
has proven its utility for genetic analysis and GWAS<br />
validation. The system <strong>of</strong>fers high-throughput, costeffective<br />
validation <strong>of</strong> somatic mutations and other<br />
biomarkers downstream <strong>of</strong> sequencing. Sequenom<br />
also <strong>of</strong>fers custom research services.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ SeqWright, Inc. .......................................... 726<br />
Tel: 713-528-4363/800-720-4363<br />
Email: admin@seqwright.com<br />
URL: http://www.seqwright.com<br />
SeqWright, Inc. is a full-service CLIA certified and<br />
GLP compliant nucleic acid technology CRO focused<br />
on traditional and next-generation sequencing. The<br />
companys mission is to drive scientific and medical<br />
innovation by helping to facilitate and accelerate the<br />
research, development and regulatory submission<br />
efforts <strong>of</strong> its customers.<br />
■ Seven Bridges Genomics ....................... 1204<br />
Tel: 617-714-4921<br />
Email: team@sbgenomics.com<br />
URL: http://www.sbgenomics.com<br />
The IGOR platform by Seven Bridges Genomics<br />
is a cloud computing system that enables clinical/<br />
translational researchers to manage and scale<br />
their own analysis <strong>of</strong> next-generation sequencing<br />
data. We enable whole-exome and whole-genome<br />
analysis with the leading peer-reviewed tools;<br />
scientists can apply and cite cutting-edge methods<br />
with no hardware or programming experience<br />
required.<br />
■ Shire ........................................................... 600<br />
Tel: 617-349-0200<br />
URL: http://www.shire.com<br />
Shire HGT, a business within the Shire group<br />
<strong>of</strong> companies, is committed to developing,<br />
manufacturing, and commercializing therapies for rare<br />
genetic diseases. The company achieves this through<br />
collaboration with academic researchers, physicians<br />
and patient associations, with the goal <strong>of</strong> providing<br />
therapies for patients worldwide.<br />
■ Signature Genomics from<br />
PerkinElmer ................................................ 1327<br />
Tel: 203-925-4602/800-762-4000<br />
Email: CustomerCareUS@perkinelmer.com<br />
URL: http://www.PerkinElmer.com<br />
Signature Genomics from PerkinElmer <strong>of</strong>fers<br />
whole genome microarray assessment with<br />
combined results <strong>of</strong> CNE and TA from more than<br />
1,800 oncogenes, all from one sample, using one<br />
technology. The analysis and report are provided<br />
by Signature Genomics’ OncoGlyphix ® s<strong>of</strong>tware.<br />
Signature’s Hematology Diagnosis <strong>of</strong>fering is fully<br />
validated while our Solid Tumor <strong>of</strong>fering is well into<br />
development.
■ SimulConsult, Inc. ................................... 1266<br />
Tel: 617-879-1670<br />
Email: genome@simulconsult.com<br />
URL: http://www.simulconsult.com<br />
SimulConsult provides diagnostic decision<br />
support tools for medical pr<strong>of</strong>essionals that save<br />
time. The Genome-Phenome Analyzer provides<br />
clinical correlations among patient findings, labs<br />
and annotated variant tables with SimulConsult’s<br />
manually curated, computational database <strong>of</strong><br />
diseases and their findings, and can be used<br />
for panels and WES/WGS in CLIA and research<br />
laboratories.<br />
■ S<strong>of</strong>t<strong>Genetics</strong>, LLC. .................................. 1219<br />
Tel: 814-237-9340/888-791-1270<br />
Email: info@s<strong>of</strong>tgenetics.com<br />
URL: http://www.s<strong>of</strong>tgenetics.com<br />
Featuring NextGENe s<strong>of</strong>tware for analysis <strong>of</strong> all NGS<br />
data; enhanced capabilities and functionalities added<br />
to GeneMarker and New GeneMarkerMTP, multiple<br />
template Processor. New ChimerMarker, Chimerism<br />
Analysis and long term monitoring s<strong>of</strong>tware and<br />
Mutation Surveyor s<strong>of</strong>tware for the analysis <strong>of</strong><br />
Sanger Sequences. S<strong>of</strong>t<strong>Genetics</strong> is providing<br />
demonstrations and 30-day trials.<br />
■ Sony DADC .............................................. 1411<br />
Tel: 43 (0) 6246 880-0<br />
Email: biosciences@sonydadc.com<br />
URL: http://biosciences.sonydadc.com<br />
Sony DADC, centered in Salzburg, Austria helps<br />
companies globally respond to the challenges <strong>of</strong><br />
the rapidly growing Life Sciences and IVD market<br />
by <strong>of</strong>fering OEM development as well as ISO 13485<br />
certified mass manufacturing and supply <strong>of</strong> polymerbased<br />
smart consumables (including content filling,<br />
packaging and global logistics).<br />
■ Spiral <strong>Genetics</strong> .......................................... 113<br />
Tel: 206-634-2918<br />
Email: dreesbl@spiralgenetics.com<br />
Spiral <strong>Genetics</strong> <strong>of</strong>fers three advantages for DNA<br />
sequence data analysis: speed, accuracy and scale.<br />
The company’s cloud-based bioinformatics platform<br />
is easy to access and analyze, from reads to variants,<br />
for a whole human genomes’ worth <strong>of</strong> data in<br />
3 hours.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 295<br />
■ Springer ................................................... 1211<br />
Tel: 212-460-1500/800-777-4643<br />
Email: exhibits-ny@springer.com<br />
URL: http://www.springer.com<br />
Get hands-on experience with Springer’s multiformat<br />
publishing model: print — eBook — MyCopy<br />
(printed eBooks for US$ 24.95). Our mission is to<br />
support your research. Come browse our books in<br />
your preferred format: print, online, or iPad. Ensure<br />
optimized print and electronic dissemination <strong>of</strong> your<br />
work! Get Read. Publish With Springer. http://www.<br />
springer.com<br />
■ STARLIMS ................................................ 1400<br />
Tel: 954-964-8663<br />
Email: sales@starlims.com<br />
URL: http://www.starlims.com<br />
STARLIMS has nearly 25 years <strong>of</strong> experience working<br />
with hundreds <strong>of</strong> laboratories in the clinical and<br />
diagnostic sectors. STARLIMS solutions are based<br />
on the same award-winning platform that has helped<br />
laboratories around the world achieve their analytical,<br />
regulatory and business objectives. Its unified webbased<br />
platform includes LIMS, ELN and SDMS.<br />
■ Streck ....................................................... 1600<br />
Tel: 800-843-0912<br />
Email: custserv@streck.com<br />
URL: http://www.streck.com<br />
Streck develops and manufactures products for<br />
clinical and research laboratories. Streck’s core<br />
technology is cell stabilization, and the pioneering<br />
research has led to the development <strong>of</strong> a number<br />
<strong>of</strong> patented products for use in hematology,<br />
immunology and flow cytometry. Streck’s<br />
innovative products include blood collection tubes<br />
and molecular diagnostic products.<br />
■ SurModics ............................................... 1006<br />
Tel: 952-500-7000<br />
Email: bsmith@surmodics.com<br />
URL: http://www.surmodicsivd.com<br />
SurModics IVD <strong>of</strong>fers protein stabilizers for<br />
immunoassays, conjugates, and microarrays (all<br />
with BSA-free versions), blocking reagents, BioFX<br />
colorimetric and chemiluminescent substrates,<br />
secondary antibodies, and several accessory<br />
reagents, autoimmune and infectious disease<br />
antigens from Diarect AG, activated microarray slides,<br />
and custom in vitro diagnostic surface chemistries.<br />
EXHIBITORS
296 EXHIBITORS<br />
■ SwitchGear Genomics .............................. 305<br />
Tel: 650-323-6763<br />
Email: rinis@switchgeargenomics.com<br />
SwitchGear Genomics <strong>of</strong>fers a full, simplified<br />
luciferase-based reporter assay solution with<br />
18,000 human promoter reporters, 12,000 3’UTR<br />
reporters, validated inducible promoters, synthetic<br />
response elements, and optimized reagents to study<br />
gene regulation as it occurs in living cells. Utilizing a<br />
novel synthetic luciferase gene with industry-leading<br />
brightness, the LightSwitch System measures the<br />
impact <strong>of</strong> transcript regulation and translational<br />
efficiency in cell-based systems.<br />
■ Tecan .......................................................... 405<br />
Tel: 919-361-5200/800-352-5128<br />
Email: claire.rhodes@tecan.com<br />
URL: http://www.tecan.com<br />
Tecan is a leading global provider <strong>of</strong> laboratory<br />
instruments and solutions. The company specializes<br />
in the development, production and distribution<br />
<strong>of</strong> instruments and automated workflow solutions<br />
for laboratories in the life sciences sector. Its<br />
clients include pharmaceutical and biotechnology<br />
companies, university research departments, forensic<br />
and diagnostic laboratories.<br />
■ Therapeutics for Rare and Neglected<br />
Diseases .......................................................220<br />
Tel: 301-827-2533<br />
Email: trnd@mail.nih.gov<br />
URL: http://trnd.nih.gov<br />
The Therapeutics for Rare and Neglected<br />
Diseases (TRND) program is an effort to encourage<br />
and speed the development <strong>of</strong> new drugs for rare and<br />
neglected diseases. TRND provides an opportunity<br />
to gain access to rare and neglected disease drug<br />
development capabilities, expertise, and clinical/<br />
regulatory resources in a collaborative environment.<br />
■ Thermo Scientific ...................................... 624<br />
Tel: 800-678-5599<br />
Email: info@nanodrop.com<br />
URL: http://www.thermoscientific.com<br />
Demand Thermo Scientific products to accelerate<br />
discovery and move science forward. The Thermo<br />
Scientific portfolio includes a broad array <strong>of</strong><br />
high-quality instruments, reagents, laboratory<br />
consumables, equipment, and services designed to<br />
help you run your laboratory at peak performance,<br />
from start to finish. See the entire Thermo Scientific<br />
lineup at www.thermoscientific.com<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
■ Time Logic ................................................. 426<br />
Tel: 760-431-1263/877-222-9543<br />
Email: tlsales@activemotif.com<br />
URL: http://www.timelogic.com/<br />
About TimeLogic For the past 15 years, TimeLogic<br />
has been providing high-throughput computing<br />
solutions for the bioinformatics community. Our<br />
FPGA-based DeCypher systems deliver industryleading<br />
price to performance and provide faster<br />
results and lower operational costs than alternative<br />
solutions. Find out more and schedule your own<br />
benchmark tests at www.timelogic.com<br />
■ Transgenomic, Inc. ................................... 505<br />
Tel: 402-452-5400/888-813-7253<br />
Email: info@transgenomic.com<br />
URL: http://www.transgenomic.com<br />
Transgenomic, Inc. advances personalized<br />
medicine in cancer and inherited diseases through<br />
proprietary technologies and clinical and research<br />
services. Transgenomic has three divisions:<br />
Diagnostic Tools produces equipment, reagents, and<br />
consumables for molecular testing and cytogenetics.<br />
Pharmacogenomic Services supports oncology<br />
preclinical and clinical trials. Clinical Laboratories<br />
provides molecular diagnostics.<br />
■ trinean ...................................................... 1605<br />
Tel: 00 3292727535<br />
Email: tony.montoye@trinean.com<br />
URL: http://www.trinean.com<br />
Trinean <strong>of</strong>fers the DropSense96 platform for<br />
high throughput and label-free DNA-RNAprotein<br />
quantification. This micr<strong>of</strong>luidic-based<br />
reader performs UV/VIS scans on 96 droplets (2l)<br />
within 5 minutes. In-depth spectral analysis by<br />
the innovative cDrop s<strong>of</strong>tware allows specific<br />
quantification by defining the spectral contribution <strong>of</strong><br />
the target molecule and co-purified substances within<br />
samples.<br />
■ UAB Medical Genomics Laboratory ........ 320<br />
Tel: 205-934-5562<br />
Email: medgenomics@uab.edu<br />
URL: http://www.genetics.uab.edu/medgenomics<br />
The Medical Genomics Laboratory (MGL) is a<br />
CAP-certified, non-pr<strong>of</strong>it clinical laboratory at the<br />
University <strong>of</strong> Alabama at Birmingham, <strong>of</strong>fering<br />
comprehensive testing for common and rare genetic<br />
disorders. The MGL specializes in testing for all forms<br />
<strong>of</strong> the neur<strong>of</strong>ibromatoses, including NF1, Legius<br />
syndrome, NF2, segmental NF, spinal NF, NF-Noonan<br />
and schwannomatosis.
■ UCLA Clinical Genomics Center ............. 923<br />
Tel: 310-775-5884<br />
Email: scwebb@mednet.ucla.edu<br />
URL: http://www.pathology.ucla.edu/genomics<br />
The comprehensive services <strong>of</strong> the UCLA Clinical<br />
Genomics Center, performed within CLIA-certified<br />
and CAP-accredited laboratories, include an<br />
extensive menu <strong>of</strong> genetic and genomic testing<br />
for hereditary disorders (including whole exome<br />
sequencing), cancer diagnosis and management,<br />
and genetic counseling. Other areas <strong>of</strong> expertise<br />
include Sanger sequencing, FISH diagnostics, and<br />
chromosomal microarray.<br />
■ The University <strong>of</strong> Chicago Genetic<br />
Services ........................................................409<br />
Tel: 773-834-0555/888-824-3637<br />
Email: ucgslabs@genetics.uchicago.edu<br />
URL: http://dnatesting.uchicago.edu<br />
Our laboratory is committed to high quality genetic<br />
diagnostics and translational research toward the<br />
development <strong>of</strong> tests for orphan diseases. Our<br />
focus is neurodevelopmental disorders. Some<br />
<strong>of</strong> our services include genetic testing for brain<br />
malformation syndromes, microcephaly, epileptic<br />
encephalopathy and Cornelia de Lange syndrome.<br />
■ University <strong>of</strong> Southern California,<br />
Information Sciences Institute ...................226<br />
Tel: 310-822-1511<br />
Email: arens@isi.edu<br />
The University <strong>of</strong> Southern California’s Information<br />
Sciences Institute and the University <strong>of</strong> North<br />
Carolina, Chappel Hill, funded by NHLBI’s Phenotype<br />
Finder IN Data Resources (PFINDR) program, are<br />
developing advanced informatics approaches to<br />
categorize and correlate phenotypic measures across<br />
multiple datasets to improve data reuse and facilitate<br />
novel discoveries.<br />
■ USB products from Affymetrix ................. 925<br />
Tel: 216-765-5000/800-321-9322<br />
Email: usbcustomerservice<br />
@affymetrix.com<br />
URL: http://usb.affymetrix.com<br />
Affymetrix ® , Inc. <strong>of</strong>fers a broad line <strong>of</strong> USB ®<br />
molecular biology products and biochemicals for all<br />
<strong>of</strong> your research needs. Choose from ExoSAP-IT ®<br />
reagent for PCR cleanup, VeriQuest qPCR Master<br />
Mixes, DNA polymerases, PrepEase ® purification<br />
products for DNA, RNA, and protein purification,<br />
modifying enzymes, cloning kits, nucleotides, and<br />
more. Visit usb.affymetrix.com.<br />
= First time exhibitor<br />
Shaded = Meeting Supporter<br />
EXHIBITORS 297<br />
■ V&P Scientific, Inc. .................................. 1425<br />
Tel: 858-455-0643/800-455-0644<br />
Email: sales@vp-scientific.com<br />
URL: http://www.vp-scientific.com<br />
V&Ps 96, 384 and 1536 pin tools transfer nanoliter<br />
through microliter volumes to microplates, agar,<br />
membranes, glass slides. Unique stirring systems<br />
for mixing in microplates and reservoirs keep cells,<br />
particulates and magnetic beads in suspension for<br />
pipetting. Hand-Held Magnetc Bead Separation<br />
Blocks for rapid manual separation and washing in<br />
microplates.<br />
■ Wiley - Blackwell ..................................... 1203<br />
Tel: 201-748-6000<br />
Email: info@wiley.com<br />
URL: http://www.wiley.com<br />
Wiley-Blackwell is the international scientific,<br />
technical, medical and scholarly publishing business<br />
<strong>of</strong> John Wiley & Sons, with strengths in every major<br />
academic and pr<strong>of</strong>essional field and partnerships<br />
with many <strong>of</strong> the world’s leading societies. For more<br />
information, please visit www.wileyblackwell.com or<br />
http://onlinelibrary.wiley.com/<br />
■ Zymo Research Corporation ................... 400<br />
Tel: 949-679-1190/888-882-9682<br />
Email: ssanchez@zymoresearch.com<br />
URL: http://www.zymoresearch.com<br />
Since 1994, Zymo Research has been <strong>of</strong>fering<br />
innovative, quality, and easy-to-use tools for<br />
Epigenetics research and DNA/RNA purification. As<br />
“The Epigenetics Company” Zymo Research is an<br />
industry leader in epigenetic product and service<br />
development. Our products are well known for their<br />
quality, affordability, efficiency, and unparalleled<br />
technical and customer support.<br />
EXHIBITORS
The Heart <strong>of</strong> the Exhibit Hall<br />
Get Answers at the <strong>ASHG</strong> Membership booth<br />
Meet your Editors at the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> booth<br />
Learn about Boston, the destination for <strong>ASHG</strong> 2013<br />
Meet <strong>Society</strong> Leadership<br />
Sit down in our seating area<br />
Recharge your electronics<br />
Network Net with colleagues<br />
Central
96- AND 384-WELL TRACKING DEVICE/<br />
PIPETTING AID<br />
Embi Tec .............................................................. 1406<br />
ACCOUNTING & FINANCIAL SERVICES<br />
FASEB ................................................................. 1700<br />
AFFINITY-PURIFIED SECONDARY ANTIBODIES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Epigentek Group Inc. ........................................... 1127<br />
SurModics ........................................................... 1006<br />
AFFYMETRIX CHIP RESEQUENCING ANALYSIS<br />
JSI medical systems GmbH ................................ 1023<br />
AGAROSE<br />
Affymetrix, Inc. ...................................................... 918<br />
USB products from Affymetrix .............................. 925<br />
AGG MAPPING<br />
ASURAGEN, INC. .................................................. 503<br />
ALLELE SPECIFIC EXPRESSION ANALYSIS<br />
EpigenDx ............................................................... 721<br />
ALPHA FETO-PROTEIN TESTING (AFP)<br />
ARUP Laboratories .............................................. 1518<br />
ALZHEIMER TESTING SERVICES<br />
Athena Diagnostics ............................................. 1308<br />
ANALYTICAL SERVICES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Expression Analysis ............................................... 508<br />
Genformatic ......................................................... 1420<br />
Golden Helix, Inc. .................................................. 818<br />
Knome, Inc. ......................................................... 1007<br />
RUCDR ................................................................ 1102<br />
Seven Bridges Genomics .................................... 1204<br />
ARM PROBES<br />
MetaSystems ....................................................... 1303<br />
ASSOCIATION<br />
BC Platforms Ltd ................................................... 819<br />
FASEB ................................................................. 1700<br />
Golden Helix, Inc. .................................................. 818<br />
<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />
ASSOCIATION MANAGEMENT SERVICES<br />
FASEB ................................................................. 1700<br />
AUTOIMMUNE ANTIGENS<br />
SurModics ........................................................... 1006<br />
AUTOMATED GENETIC ANALYSIS<br />
INSTRUMENTATION<br />
Advanced Analytical ............................................ 1304<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
PRODUCT AND SERVICE INDEX<br />
299<br />
Beckman Coulter, Inc. ......................................... 1601<br />
BioNano Genomics, Inc. ....................................... 924<br />
Diagenode Inc ....................................................... 406<br />
Genformatic ......................................................... 1420<br />
Innopsys ................................................................ 805<br />
Labcyte Inc. ......................................................... 1402<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
NanoString Technologies, Inc................................ 210<br />
Pacific Biosciences ............................................... 610<br />
RainDance Technologies, Inc. ............................... 910<br />
RUCDR ................................................................ 1102<br />
Sequenom, Inc. ..................................................... 519<br />
AUTOMATED KARYOTYPING<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
AUTOMATED LIQUID HANDLING WORKSTATIONS<br />
Agilent Technologies ............................................. 609<br />
Beckman Coulter, Inc. ......................................... 1601<br />
Diagenode Inc ....................................................... 406<br />
Labcyte Inc. ......................................................... 1402<br />
Tecan ..................................................................... 405<br />
trinean .................................................................. 1605<br />
AUTOMATED NUCLEIC ACID PURIFICATION<br />
INSTRUMENTATION<br />
AutoGen, Inc. ........................................................ 807<br />
Beckman Coulter, Inc. ......................................... 1601<br />
chemagen from PerkinElmer ............................... 1426<br />
IntegenX Inc. ....................................................... 1311<br />
RUCDR ................................................................ 1102<br />
Tecan ..................................................................... 405<br />
trinean .................................................................. 1605<br />
BAC DNA ISOLATION<br />
AutoGen, Inc. ........................................................ 807<br />
chemagen from PerkinElmer ............................... 1426<br />
EdgeBio ............................................................... 1506<br />
Epicentre (an Illumina company) ......................... 1218<br />
SeqWright, Inc. ...................................................... 726<br />
Zymo Research Corporation ................................. 400<br />
BACTERIAL ELECTROPORATION SYSTEMS<br />
Bio-Rad ................................................................. 524<br />
BAR CODE<br />
Data Unlimited International, Inc. ........................ 1503<br />
BIOCHEMICAL ANALYSES<br />
ARUP Laboratories .............................................. 1518<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Greenwood Genetic Center ................................. 1027<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Tecan ..................................................................... 405<br />
PRODUCT INDEX
300 PRODUCT AND SERVICE INDEX<br />
BIOCHEMICAL REAGENTS<br />
Affymetrix, Inc. ...................................................... 918<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Epicentre (an Illumina company) ......................... 1218<br />
Epigentek Group Inc. ........................................... 1127<br />
Gene Tools, LLC .................................................. 1401<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Roche Applied Science ......................................... 701<br />
USB products from Affymetrix .............................. 925<br />
BIOCHEMICALS<br />
Affymetrix, Inc. ...................................................... 918<br />
Gene Tools, LLC .................................................. 1401<br />
SurModics ........................................................... 1006<br />
USB products from Affymetrix .............................. 925<br />
BIOINFORMATICS<br />
Gene Codes Corporation .................................... 1310<br />
BIOLOGICALS<br />
Alexion Pharmaceuticals ..................................... 1410<br />
SurModics ........................................................... 1006<br />
Therapeutics for Rare and Neglected Diseases .... 220<br />
BIOMARKERS<br />
Exiqon ................................................................. 1712<br />
BIOMATERIALS<br />
AGRE-Autism Genetic Resource Exchange .......... 319<br />
Diagenode Inc ....................................................... 406<br />
RUCDR ................................................................ 1102<br />
BIOTINYLATED ANTIBODIES<br />
Epigentek Group Inc. ........................................... 1127<br />
SurModics ........................................................... 1006<br />
BISULFITE SEQUENCING<br />
NXT-Dx ................................................................ 1025<br />
BLOOD DNA PURIFICATION<br />
AutoGen, Inc. ........................................................ 807<br />
BioReliance ........................................................... 604<br />
chemagen from PerkinElmer ............................... 1426<br />
Embi Tec .............................................................. 1406<br />
Gene Link, Inc ....................................................... 627<br />
RUCDR ................................................................ 1102<br />
Zymo Research Corporation ................................. 400<br />
BLOTTING EQUIPMENT<br />
Bio-Rad ................................................................. 524<br />
BLOTTING MEMBRANES<br />
Bio-Rad ................................................................. 524<br />
BOOKS, JOURNALS, AND ELECTRONIC<br />
PUBLICATIONS<br />
Cold Spring Harbor Laboratory Press ................. 1209<br />
BOOKS, JOURNALS, ENCYCLOPEDIAS,<br />
PUBLICATIONS<br />
<strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> ................... 913<br />
Cold Spring Harbor Laboratory Press ................. 1209<br />
Elsevier ................................................................ 1210<br />
FASEB ................................................................. 1700<br />
Greenwood Genetic Center ................................. 1027<br />
<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />
Karger Publishers ................................................ 1208<br />
Oxford University Press ....................................... 1200<br />
Springer ............................................................... 1211<br />
BUCCAL DNA PURIFICATION<br />
AutoGen, Inc. ........................................................ 807<br />
BioReliance ........................................................... 604<br />
chemagen from PerkinElmer ............................... 1426<br />
RUCDR ................................................................ 1102<br />
Tecan ..................................................................... 405<br />
Zymo Research Corporation ................................. 400<br />
CANCER GENE PANELS<br />
SeqWright, Inc. ...................................................... 726<br />
cDNA<br />
Bioline USA Inc. ................................................... 1324<br />
chemagen from PerkinElmer ............................... 1426<br />
Epicentre (an Illumina company) ......................... 1218<br />
Gene Link, Inc ....................................................... 627<br />
IntegenX Inc. ....................................................... 1311<br />
QIAGEN Inc. ........................................................ 1001<br />
SeqWright, Inc. ...................................................... 726<br />
Thermo Scientific................................................... 624<br />
cDNA LIBRARIES<br />
Agilent Technologies ............................................. 609<br />
BioReliance ........................................................... 604<br />
IntegenX Inc. ....................................................... 1311<br />
SeqWright, Inc. ...................................................... 726<br />
Thermo Scientific................................................... 624<br />
CELL BANKING<br />
BioReliance ........................................................... 604<br />
RUCDR ................................................................ 1102<br />
CELL CULTURE MEDIA<br />
Applied StemCell, Inc. ........................................... 527<br />
Irvine Scientific ...................................................... 620<br />
Life Technologies ................................................... 601<br />
CELL CULTURES<br />
Applied StemCell, Inc. ........................................... 527<br />
BioReliance ........................................................... 604<br />
Coriell Institute for Medical Research ................... 312<br />
RUCDR ................................................................ 1102<br />
CELL DISRUPTORS<br />
Diagenode Inc ....................................................... 406
CELL SEPARATION EQUIPMENT<br />
Diagenode Inc ....................................................... 406<br />
CELLULAR IMAGING<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
CELLULAR ISOLATION PRODUCTS<br />
NVIGEN ............................................................... 1403<br />
CHARACTERIZATION<br />
SeqWright, Inc. ...................................................... 726<br />
CHEMICALS<br />
USB products from Affymetrix .............................. 925<br />
CHEMILUMINESCENCE SYSTEMS<br />
Gene Link, Inc ....................................................... 627<br />
SurModics ........................................................... 1006<br />
CHIP PRODUCTS<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Covaris Inc. ......................................................... 1008<br />
Diagenode Inc ....................................................... 406<br />
Innopsys ................................................................ 805<br />
IntegenX Inc. ....................................................... 1311<br />
Oxford Gene Technology ....................................... 302<br />
Recombine LLC ..................................................... 525<br />
RUCDR ................................................................ 1102<br />
Sony DADC ......................................................... 1411<br />
trinean .................................................................. 1605<br />
CHIP-SEQ<br />
Axeq Technologies ................................................ 820<br />
CHROMATIN IMMUNOPRECIPITATION<br />
PRODUCTS<br />
Diagenode Inc ....................................................... 406<br />
CHROMATOGRAPHY WORKSTATIONS<br />
Transgenomic, Inc. ................................................ 505<br />
CHROMOSOMAL ABERRATIONS<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
BioDiscovery, Inc. .................................................. 813<br />
Cartagenia ........................................................... 1022<br />
GeneDx ................................................................ 1119<br />
MetaSystems ....................................................... 1303<br />
MRC-Holland ....................................................... 1122<br />
Oxford Gene Technology ....................................... 302<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
RUCDR ................................................................ 1102<br />
Seven Bridges Genomics .................................... 1204<br />
Signature Genomics from PerkinElmer ............... 1327<br />
CHROMOSOMAL ANEUPLOIDY SCREENING<br />
Ariosa Diagnostics ............................................... 1609<br />
CHROMOSOMAL MICROARRAY<br />
UCLA Clinical Genomics Center ........................... 923<br />
PRODUCT AND SERVICE INDEX 301<br />
CHROMOSOME ANALYSES<br />
Affymetrix, Inc. ...................................................... 918<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Ariosa Diagnostics ............................................... 1609<br />
ARUP Laboratories .............................................. 1518<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
BlueGnome Limited ............................................... 209<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
Golden Helix, Inc. .................................................. 818<br />
Greenwood Genetic Center ................................. 1027<br />
Knome, Inc. ......................................................... 1007<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
NanoString Technologies, Inc................................ 210<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Phalanx Biotech Group ......................................... 307<br />
RUCDR ................................................................ 1102<br />
Seven Bridges Genomics .................................... 1204<br />
Signature Genomics from PerkinElmer ............... 1327<br />
Transgenomic, Inc. ................................................ 505<br />
CHROMOSOME ENUMERATOR PROBES<br />
Abbott Molecular ................................................... 625<br />
Cytocell Ltd/Rainbow Scientific, Inc. .................... 404<br />
CHROMOSOME IN SITU SYSTEMS<br />
MetaSystems ....................................................... 1303<br />
CHROMOSOME PAINTING SYSTEMS<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
CLINICAL TRIAL SUPPORT<br />
SeqWright, Inc. ...................................................... 726<br />
CLONING PRODUCTS<br />
Agilent Technologies ............................................. 609<br />
Bioline USA Inc. ................................................... 1324<br />
EdgeBio ............................................................... 1506<br />
Embi Tec .............................................................. 1406<br />
Epicentre (an Illumina company) ......................... 1218<br />
New England Biolabs, Inc. .................................... 904<br />
USB products from Affymetrix .............................. 925<br />
CMA AUTOMATION EQUIPMENT<br />
SciGene ................................................................. 619<br />
COLUMNS<br />
Transgenomic, Inc. ................................................ 505<br />
COMPETITIVE GENOMIC HYBRIDIZATION<br />
INSTRUMENT<br />
Affymetrix, Inc. ...................................................... 918<br />
MetaSystems ....................................................... 1303<br />
Tecan ..................................................................... 405<br />
COMPUTER SOFTWARE<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
BC Platforms Ltd ................................................... 819<br />
Biobase Corporation ........................................... 1319<br />
PRODUCT INDEX
302 PRODUCT AND SERVICE INDEX<br />
BioDiscovery, Inc. .................................................. 813<br />
Cartagenia ........................................................... 1022<br />
CLC bio ................................................................. 501<br />
Data Unlimited International, Inc. ........................ 1503<br />
Enlis Genomics ...................................................... 203<br />
Gene Codes Corporation .................................... 1310<br />
GeneInsight ......................................................... 1224<br />
Genformatic ......................................................... 1420<br />
Golden Helix, Inc. .................................................. 818<br />
Hitachi Solutions America Ltd. ............................ 1502<br />
Innopsys ................................................................ 805<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
JSI medical systems GmbH ................................ 1023<br />
Knome, Inc. ......................................................... 1007<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
Omixon Biocomputing .......................................... 205<br />
Oxford Gene Technology ....................................... 302<br />
Palmyra S<strong>of</strong>tware ................................................ 1519<br />
Partek Incorporated............................................. 1307<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
SCC S<strong>of</strong>t Computer ............................................ 1618<br />
University <strong>of</strong> Southern California, Information<br />
Sciences Institute ............................................... 226<br />
CONFOCAL SCANNER<br />
Innopsys ................................................................ 805<br />
CONTRACT RESEARCH SYNTHESIS<br />
Knome, Inc. ......................................................... 1007<br />
Therapeutics for Rare and Neglected Diseases .... 220<br />
COURSES & CONFERENCES<br />
European <strong>Human</strong> <strong>Genetics</strong> Conference 2013 ....... 219<br />
Science/AAAS ..................................................... 1312<br />
CULTURED CELLS<br />
AGRE-Autism Genetic Resource Exchange .......... 319<br />
CUSTOM ANTIBODIES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
SurModics ........................................................... 1006<br />
CUSTOM CDNA LIBRARIES<br />
BioReliance ........................................................... 604<br />
SeqWright, Inc. ...................................................... 726<br />
CUSTOM CLONING SERVICE<br />
SeqWright, Inc. ...................................................... 726<br />
CUSTOM DNA PROBES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Cytocell Ltd/Rainbow Scientific, Inc. .................... 404<br />
Gene Link, Inc ....................................................... 627<br />
MetaSystems ....................................................... 1303<br />
CUSTOMIZED OLIGOS<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Gene Link, Inc ....................................................... 627<br />
Gene Tools, LLC .................................................. 1401<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
CUSTOM LABORATORY WORKFLOW SYSTEMS<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
GeneInsight ......................................................... 1224<br />
CUSTOM MEDIA SERVICES<br />
Irvine Scientific ...................................................... 620<br />
CUSTOM MONOCLONAL ANTIBODY SERVICE<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
CUSTOM MUTATION ANALYSIS<br />
UCLA Clinical Genomics Center ........................... 923<br />
CUSTOM SHOTGUN LIBRARIES<br />
SeqWright, Inc. ...................................................... 726<br />
CUSTOM TARGETED SEQUENCING<br />
Center for Inherited Disease Research (CIDR) ...... 119<br />
CUVETTES - ELECTROPORATION<br />
Bio-Rad ................................................................. 524<br />
CYTOGENETIC ANALYZER<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
BioNano Genomics, Inc. ....................................... 924<br />
Illumina, Inc. ........................................................ 1109<br />
Leica Microsystems Corp ...................................... 824<br />
Oxford Gene Technology ....................................... 302<br />
Tecan ..................................................................... 405<br />
Transgenomic, Inc. ................................................ 505<br />
CYTOGENETIC TESTING<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
GeneDx ................................................................ 1119<br />
Greenwood Genetic Center ................................. 1027<br />
Innopsys ................................................................ 805<br />
Leica Microsystems Corp ...................................... 824<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Phalanx Biotech Group ......................................... 307<br />
SciGene ................................................................. 619<br />
Signature Genomics from PerkinElmer ............... 1327<br />
Transgenomic, Inc. ................................................ 505<br />
UCLA Clinical Genomics Center ........................... 923<br />
DATABASE MANAGEMENT - CLINICAL GENETICS<br />
BC Platforms Ltd ................................................... 819<br />
Cartagenia ........................................................... 1022<br />
Data Unlimited International, Inc. ........................ 1503<br />
GeneInsight ......................................................... 1224<br />
Genformatic ...............................................................1420<br />
Genial Genetic Solutions/Rainbow<br />
Scientific, Inc. ...................................................... 402<br />
GenoLogics ......................................................... 1105<br />
Interactive Bios<strong>of</strong>tware .......................................... 413
MetaSystems ....................................................... 1303<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
RUCDR ................................................................ 1102<br />
SCC S<strong>of</strong>t Computer ............................................ 1618<br />
University <strong>of</strong> Southern California, Information<br />
Sciences Institute ............................................... 226<br />
DATABASE MANAGEMENT - CYTOGENETICS<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
BC Platforms Ltd ................................................... 819<br />
Cartagenia ........................................................... 1022<br />
Data Unlimited International, Inc. ........................ 1503<br />
Genial Genetic Solutions/Rainbow Scientific, Inc. .....402<br />
MetaSystems ....................................................... 1303<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
SCC S<strong>of</strong>t Computer ............................................ 1618<br />
Signature Genomics from PerkinElmer ............... 1327<br />
DATABASE MANAGEMENT - MOLECULAR<br />
GENETICS<br />
BC Platforms Ltd ................................................... 819<br />
Cartagenia ........................................................... 1022<br />
Data Unlimited International, Inc. ........................ 1503<br />
Genformatic ......................................................... 1420<br />
Genial Genetic Solutions/Rainbow Scientific, Inc. .....402<br />
GenoLogics ......................................................... 1105<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
Laboratory for Molecular Medicine, PCPGM ...... 1225<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
SCC S<strong>of</strong>t Computer ............................................ 1618<br />
University <strong>of</strong> Southern California, Information<br />
Sciences Institute ............................................... 226<br />
DATABASE OF BIOTECHNOLOGY JOBS<br />
Science/AAAS ..................................................... 1312<br />
DATABASE PROTEOMICS<br />
Biobase Corporation ........................................... 1319<br />
DATABASES - GENE MAPPING<br />
BC Platforms Ltd ................................................... 819<br />
Biobase Corporation ........................................... 1319<br />
Hitachi Solutions America Ltd. ............................ 1502<br />
Knome, Inc. ......................................................... 1007<br />
RUCDR ................................................................ 1102<br />
DATABASES - GENETIC COUNSELING<br />
Natera .................................................................... 504<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
DATABASES - GENETIC ORGANIZATIONS<br />
Natera .................................................................... 504<br />
NextGxDx .............................................................. 411<br />
Sanford Research .................................................. 325<br />
DATABASES - GENETIC TESTING<br />
Biobase Corporation ........................................... 1319<br />
Data Unlimited International, Inc. ........................ 1503<br />
GeneInsight ......................................................... 1224<br />
GeneTests ............................................................ 1413<br />
PRODUCT AND SERVICE INDEX 303<br />
Genformatic ......................................................... 1420<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
MetaSystems ....................................................... 1303<br />
Natera .................................................................... 504<br />
DATABASES - LABORATORIES<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Cartagenia ........................................................... 1022<br />
Data Unlimited International, Inc. ........................ 1503<br />
GeneTests ............................................................ 1413<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
MetaSystems ....................................................... 1303<br />
Natera .................................................................... 504<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
DATABASES - PHENOTYPE/DISEASE<br />
DESCRIPTIONS<br />
BC Platforms Ltd ................................................... 819<br />
Enlis Genomics ...................................................... 203<br />
GeneInsight ......................................................... 1224<br />
GeneTests ............................................................ 1413<br />
Hitachi Solutions America Ltd. ............................ 1502<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
Knome, Inc. ......................................................... 1007<br />
POSSUM - Murdoch Childrens Research Institute .....218<br />
Sanford Research .................................................. 325<br />
University <strong>of</strong> Southern California, Information<br />
Sciences Institute ............................................... 226<br />
DATA COORDINATING CENTER (DCC)<br />
AGRE-Autism Genetic Resource Exchange .......... 319<br />
DENSITOMETERS<br />
Bio-Rad ................................................................. 524<br />
DIAGNOSTIC AIDS<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
MRC-Holland ....................................................... 1122<br />
POSSUM - Murdoch Childrens Research Institute ...218<br />
Rubicon Genomics, Inc. .......................................... 803<br />
SurModics ........................................................... 1006<br />
DIAGNOSTIC SYSTEMS<br />
Abbott Molecular ................................................... 625<br />
Exiqon ................................................................. 1712<br />
Gene Link, Inc ....................................................... 627<br />
Innopsys ................................................................ 805<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
QIAGEN Inc. ........................................................ 1001<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Signature Genomics from PerkinElmer ............... 1327<br />
DIRECT LABELED PROBES<br />
BlueGnome Limited ............................................... 209<br />
MetaSystems ....................................................... 1303<br />
DISPENSERS<br />
Labcyte Inc. ......................................................... 1402<br />
Tecan ..................................................................... 405<br />
PRODUCT INDEX
304 PRODUCT AND SERVICE INDEX<br />
DNA AMPLIFICATION EQUIPMENT<br />
Agilent Technologies ............................................. 609<br />
Bio-Rad ................................................................. 524<br />
BlueGnome Limited ............................................... 209<br />
Natera .................................................................... 504<br />
QIAGEN Inc. ........................................................ 1001<br />
RainDance Technologies, Inc. ............................... 910<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Streck .................................................................. 1600<br />
DNA ANALYSES<br />
Agilent Technologies ............................................. 609<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Athena Diagnostics ............................................. 1308<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
BioDiscovery, Inc. .................................................. 813<br />
BioFire Diagnostics ............................................... 719<br />
Bioline USA Inc. ................................................... 1324<br />
BioNano Genomics, Inc. ....................................... 924<br />
Bio-Rad ................................................................. 524<br />
BioReliance ........................................................... 604<br />
BlueGnome Limited ............................................... 209<br />
Cartagenia ........................................................... 1022<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
CLC bio ................................................................. 501<br />
Connective Tissue Gene Tests .............................. 718<br />
DNAnexus, Inc. ...................................................... 507<br />
EdgeBio ............................................................... 1506<br />
Enlis Genomics ...................................................... 203<br />
Expression Analysis ............................................... 508<br />
Gene Codes Corporation .................................... 1310<br />
Golden Helix, Inc. .................................................. 818<br />
Greenwood Genetic Center ................................. 1027<br />
IntegenX Inc. ....................................................... 1311<br />
JSI medical systems GmbH ................................ 1023<br />
Knome, Inc. ......................................................... 1007<br />
MetaSystems ....................................................... 1303<br />
MRC-Holland ....................................................... 1122<br />
Myriad Genetic Laboratories ............................... 1501<br />
NanoString Technologies, Inc................................ 210<br />
Natera .................................................................... 504<br />
Omixon Biocomputing .......................................... 205<br />
Pacific Biosciences ............................................... 610<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Phalanx Biotech Group ......................................... 307<br />
Prognosys Biosciences, Inc. ................................. 304<br />
QIAGEN Inc. ........................................................ 1001<br />
RainDance Technologies, Inc. ............................... 910<br />
Recombine LLC ..................................................... 525<br />
RUCDR ................................................................ 1102<br />
Sequenom, Inc. ..................................................... 519<br />
SeqWright, Inc. ...................................................... 726<br />
Seven Bridges Genomics .................................... 1204<br />
Signature Genomics from PerkinElmer ............... 1327<br />
Transgenomic, Inc. ................................................ 505<br />
trinean .................................................................. 1605<br />
UCLA Clinical Genomics Center ........................... 923<br />
DNA CUSTOM SYNTHESIS<br />
Gene Link, Inc ....................................................... 627<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
SeqWright, Inc. ...................................................... 726<br />
DNA DAMAGE DETECTION PRODUCTS<br />
MetaSystems ....................................................... 1303<br />
DNA FINGERPRINTING<br />
BioReliance ........................................................... 604<br />
IntegenX Inc. ....................................................... 1311<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
UCLA Clinical Genomics Center ........................... 923<br />
DNA ISOLATION KITS<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
AutoGen, Inc. ........................................................ 807<br />
Bioline USA Inc. ................................................... 1324<br />
chemagen from PerkinElmer ............................... 1426<br />
Diagenode Inc ....................................................... 406<br />
DNA Genotek ........................................................ 900<br />
Epicentre (an Illumina company) ......................... 1218<br />
Epigentek Group Inc. ........................................... 1127<br />
Gene Link, Inc ....................................................... 627<br />
Life Technologies ................................................... 601<br />
NVIGEN ............................................................... 1403<br />
Roche Applied Science ......................................... 701<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Zymo Research Corporation ................................. 400<br />
DNA LABELING PRODUCTS<br />
BioNano Genomics, Inc. ....................................... 924<br />
BlueGnome Limited ............................................... 209<br />
Gene Link, Inc ....................................................... 627<br />
MetaSystems ....................................................... 1303<br />
Oxford Gene Technology ....................................... 302<br />
SciGene ................................................................. 619<br />
DNA MARKERS<br />
Bioline USA Inc. ................................................... 1324<br />
BioReliance ........................................................... 604<br />
Embi Tec .............................................................. 1406<br />
Natera .................................................................... 504<br />
New England Biolabs, Inc. .................................... 904<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
QIAGEN Inc. ........................................................ 1001<br />
Transgenomic, Inc. ................................................ 505<br />
DNA MARKERS & STAIN<br />
Affymetrix, Inc. ...................................................... 918<br />
New England Biolabs, Inc. .................................... 904<br />
DNA METHYLATION ANAYLSIS<br />
Diagenode Inc ....................................................... 406<br />
DNA METHYLATION ASSAY DESIGN AND<br />
VALIDATION<br />
EpigenDx ............................................................... 721
DNA METHYLATION CONTROLS<br />
(HUMAN, RAT, MOUSE)<br />
EpigenDx ............................................................... 721<br />
DNA MUTATION DETECTION PRODUCTS<br />
Advanced Analytical ............................................ 1304<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ASURAGEN, INC. .................................................. 503<br />
Bio-Rad ................................................................. 524<br />
Boreal Genomics ................................................... 724<br />
JSI medical systems GmbH ................................ 1023<br />
MRC-Holland ....................................................... 1122<br />
Omixon Biocomputing .......................................... 205<br />
Pacific Biosciences ............................................... 610<br />
RainDance Technologies, Inc. ............................... 910<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Seven Bridges Genomics .................................... 1204<br />
Transgenomic, Inc. ................................................ 505<br />
DNA PREPARATION<br />
BioReliance ........................................................... 604<br />
chemagen from PerkinElmer ............................... 1426<br />
Coriell Institute for Medical Research ................... 312<br />
Covaris Inc. ......................................................... 1008<br />
Diagenode Inc ....................................................... 406<br />
DNA Genotek ........................................................ 900<br />
EdgeBio ............................................................... 1506<br />
Epigentek Group Inc. ........................................... 1127<br />
Expression Analysis ............................................... 508<br />
IntegenX Inc. ....................................................... 1311<br />
Microsonic Systems Inc. ....................................... 618<br />
New England Biolabs, Inc. .................................... 904<br />
Prognosys Biosciences, Inc. ................................. 304<br />
RainDance Technologies, Inc. ............................... 910<br />
RUCDR ................................................................ 1102<br />
Sage Science Inc. ................................................ 1510<br />
SciGene ................................................................. 619<br />
SeqWright, Inc. ...................................................... 726<br />
trinean .................................................................. 1605<br />
Zymo Research Corporation ................................. 400<br />
DNA PROBES<br />
Abbott Molecular ................................................... 625<br />
Cytocell Ltd/Rainbow Scientific, Inc. .................... 404<br />
Gene Link, Inc ....................................................... 627<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
MRC-Holland ....................................................... 1122<br />
Oxford Gene Technology ....................................... 302<br />
Prognosys Biosciences, Inc. ................................. 304<br />
QIAGEN Inc. ........................................................ 1001<br />
DNA PURIFICATION<br />
Affymetrix, Inc. ...................................................... 918<br />
AutoGen, Inc. ........................................................ 807<br />
BioReliance ........................................................... 604<br />
chemagen from PerkinElmer ............................... 1426<br />
Diagenode Inc ....................................................... 406<br />
DNA Genotek ........................................................ 900<br />
EdgeBio ............................................................... 1506<br />
Epicentre (an Illumina company) ......................... 1218<br />
PRODUCT AND SERVICE INDEX 305<br />
Expression Analysis ............................................... 508<br />
IntegenX Inc. ....................................................... 1311<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
Life Technologies ................................................... 601<br />
NVIGEN ............................................................... 1403<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Sage Science Inc. ................................................ 1510<br />
SciGene ................................................................. 619<br />
SeqWright, Inc. ...................................................... 726<br />
Tecan ..................................................................... 405<br />
USB products from Affymetrix .............................. 925<br />
Zymo Research Corporation ................................. 400<br />
DNA RECOVERY DEVICES<br />
Embi Tec .............................................................. 1406<br />
Sage Science Inc. ................................................ 1510<br />
DNA SAMPLES<br />
BC Platforms Ltd ................................................... 819<br />
BioReliance ........................................................... 604<br />
Coriell Institute for Medical Research ................... 312<br />
Diagenode Inc ....................................................... 406<br />
DNA Genotek ........................................................ 900<br />
IntegenX Inc. ....................................................... 1311<br />
QIAGEN Inc. ........................................................ 1001<br />
Rubicon Genomics, Inc. ........................................ 803<br />
RUCDR ................................................................ 1102<br />
trinean .................................................................. 1605<br />
DNA SEQUENCE ANALYSIS SOFTWARE<br />
Agilent Technologies ............................................. 609<br />
BC Platforms Ltd ................................................... 819<br />
BGI ...................................................................... 1419<br />
Cartagenia ........................................................... 1022<br />
DNASTAR, Inc. ...................................................... 801<br />
Enlis Genomics ...................................................... 203<br />
Gene Codes Corporation .................................... 1310<br />
Genformatic ......................................................... 1420<br />
Hitachi Solutions America Ltd. ............................ 1502<br />
Illumina, Inc. ........................................................ 1109<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
JSI medical systems GmbH ................................ 1023<br />
Knome, Inc. ......................................................... 1007<br />
Life Technologies ................................................... 601<br />
Natera .................................................................... 504<br />
Omixon Biocomputing .......................................... 205<br />
Pacific Biosciences ............................................... 610<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Prognosys Biosciences, Inc. ................................. 304<br />
RainDance Technologies, Inc. ............................... 910<br />
Seven Bridges Genomics .................................... 1204<br />
Transgenomic, Inc. ................................................ 505<br />
DNA SEQUENCERS<br />
Diagenode Inc ....................................................... 406<br />
Illumina, Inc. ........................................................ 1109<br />
Ion Torrent ............................................................. 100<br />
Life Technologies ................................................... 601<br />
Natera .................................................................... 504<br />
PRODUCT INDEX
306 PRODUCT AND SERVICE INDEX<br />
Pacific Biosciences ............................................... 610<br />
RainDance Technologies, Inc. ............................... 910<br />
Roche Applied Science ......................................... 701<br />
DNA SEQUENCING ACCESSORIES<br />
BioNano Genomics, Inc. ....................................... 924<br />
Covaris Inc. ......................................................... 1008<br />
Diagenode Inc ....................................................... 406<br />
EdgeBio ............................................................... 1506<br />
Epicentre (an Illumina company) ......................... 1218<br />
Illumina, Inc. ........................................................ 1109<br />
IntegenX Inc. ....................................................... 1311<br />
Microsonic Systems Inc. ....................................... 618<br />
New England Biolabs, Inc. .................................... 904<br />
RainDance Technologies, Inc. ............................... 910<br />
Rubicon Genomics, Inc. ........................................ 803<br />
DNA SEQUENCING KITS<br />
Agilent Technologies ............................................. 609<br />
Diagenode Inc ....................................................... 406<br />
EdgeBio ............................................................... 1506<br />
Epicentre (an Illumina company) ......................... 1218<br />
Epigentek Group Inc. ........................................... 1127<br />
Kailos <strong>Genetics</strong>, Inc. .............................................. 310<br />
Natera .................................................................... 504<br />
Pacific Biosciences ............................................... 610<br />
Rubicon Genomics, Inc. ........................................ 803<br />
USB products from Affymetrix .............................. 925<br />
Zymo Research Corporation ................................. 400<br />
DNA SEQUENCING SERVICES<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Athena Diagnostics ............................................. 1308<br />
Axeq Technologies ................................................ 820<br />
BGI ...................................................................... 1419<br />
BioReliance ........................................................... 604<br />
Center for Inherited Disease Research (CIDR) ...... 119<br />
Complete Genomics, Inc. ...................................... 907<br />
Connective Tissue Gene Tests .............................. 718<br />
EdgeBio ............................................................... 1506<br />
Expression Analysis ............................................... 508<br />
GeneDx ................................................................ 1119<br />
Illumina, Inc. ........................................................ 1109<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
Knome, Inc. ......................................................... 1007<br />
Phalanx Biotech Group ......................................... 307<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Roche Applied Science ......................................... 701<br />
SeqWright, Inc. ...................................................... 726<br />
The University <strong>of</strong> Chicago Genetic Services ......... 409<br />
DNA SEQUENCING SOLUTIONS<br />
BGI ...................................................................... 1419<br />
BioNano Genomics, Inc. ....................................... 924<br />
BioReliance ........................................................... 604<br />
CLC bio ................................................................. 501<br />
Diagenode Inc ....................................................... 406<br />
DNASTAR, Inc. ...................................................... 801<br />
EdgeBio ............................................................... 1506<br />
Epicentre (an Illumina company) ......................... 1218<br />
Expression Analysis ............................................... 508<br />
Genformatic ......................................................... 1420<br />
Hitachi Solutions America Ltd. ............................ 1502<br />
Illumina, Inc. ........................................................ 1109<br />
IntegenX Inc. ....................................................... 1311<br />
Ion Torrent ............................................................. 100<br />
Natera .................................................................... 504<br />
Pacific Biosciences ............................................... 610<br />
Prognosys Biosciences, Inc. ................................. 304<br />
RainDance Technologies, Inc. ............................... 910<br />
SeqWright, Inc. ...................................................... 726<br />
Spiral <strong>Genetics</strong> ...................................................... 113<br />
DNA SHEARING<br />
Diagenode Inc ....................................................... 406<br />
DNA SIGNING & STR ANALYSIS<br />
Genformatic ......................................................... 1420<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
SeqWright, Inc. ...................................................... 726<br />
DNA SYNTHESIS PRODUCTS<br />
Gene Link, Inc ....................................................... 627<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
QIAGEN Inc. ........................................................ 1001<br />
Rubicon Genomics, Inc. ........................................ 803<br />
DNA WORKSTATION<br />
IntegenX Inc. ....................................................... 1311<br />
Microsonic Systems Inc. ....................................... 618<br />
QIAGEN Inc. ........................................................ 1001<br />
SciGene ................................................................. 619<br />
Tecan ..................................................................... 405<br />
trinean .................................................................. 1605<br />
DRI BLOCK HEATER<br />
SciGene ................................................................. 619<br />
DRUG TARGET/BIOMARKER DISCOVERY AND<br />
VALIDATION<br />
SeqWright, Inc. ...................................................... 726<br />
DYES & LABELING REAGENTS<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
EBV IMMORTALIZATION<br />
RUCDR ................................................................ 1102<br />
EDUCATIONAL RESOURCES<br />
AGRE-Autism Genetic Resource Exchange .......... 319<br />
Greenwood Genetic Center ................................. 1027<br />
National Center for Biotechnology Information ..... 224<br />
Office <strong>of</strong> Rare Diseases Research (NIH) ................ 326<br />
POSSUM - Murdoch Childrens Research Institute .... 218<br />
Pubget, Inc. .......................................................... 1520<br />
Science/AAAS ..................................................... 1312<br />
ELECTRONIC IMAGING SYSTEMS<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Leica Microsystems Corp ...................................... 824
ELECTROPHORESIS ACCESSORIES<br />
Embi Tec .............................................................. 1406<br />
Sony DADC ......................................................... 1411<br />
ELECTROPHORESIS BUFFERS<br />
Embi Tec .............................................................. 1406<br />
SurModics ........................................................... 1006<br />
USB products from Affymetrix .............................. 925<br />
ELECTROPHORESIS EQUIPMENT<br />
Advanced Analytical ............................................ 1304<br />
Agilent Technologies ............................................. 609<br />
Bio-Rad ................................................................. 524<br />
Embi Tec .............................................................. 1406<br />
QIAGEN Inc. ........................................................ 1001<br />
Sage Science Inc. ................................................ 1510<br />
ELECTROPHORESIS PRECAST GELS<br />
Embi Tec .............................................................. 1406<br />
Sage Science Inc. ................................................ 1510<br />
EMPLOYMENT OPPORTUNITIES-CAREER<br />
RESOURCES<br />
Science/AAAS ..................................................... 1312<br />
ENZYME-CONJUGATED ANTIBODIES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Epigentek Group Inc. ........................................... 1127<br />
SurModics ........................................................... 1006<br />
ENZYME REPLACEMENT THERAPY<br />
BioMarin Pharmaceutical Inc. ............................. 1619<br />
Shire ...................................................................... 600<br />
ENZYMES<br />
Bioline USA Inc. ................................................... 1324<br />
Epicentre (an Illumina company) ......................... 1218<br />
Epigentek Group Inc. ........................................... 1127<br />
New England Biolabs, Inc. .................................... 904<br />
QIAGEN Inc. ........................................................ 1001<br />
Roche Applied Science ......................................... 701<br />
USB products from Affymetrix .............................. 925<br />
Zymo Research Corporation ................................. 400<br />
EPIGENETIC PRODUCTS<br />
Diagenode Inc ....................................................... 406<br />
EPIGENETIC SERVICES<br />
Center for Inherited Disease Research (CIDR) ...... 119<br />
EXOME SEQUENCING, TARGETED SEQUENCING<br />
Axeq Technologies ................................................ 820<br />
EXPRESSION ANALYSIS SOFTWARE<br />
BC Platforms Ltd ................................................... 819<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Sequenom, Inc. ..................................................... 519<br />
PRODUCT AND SERVICE INDEX 307<br />
FACTOR V MUTATION<br />
ARUP Laboratories .............................................. 1518<br />
FACTOR V MUTATION TESTING<br />
ARUP Laboratories .............................................. 1518<br />
Athena Diagnostics ............................................. 1308<br />
Greenwood Genetic Center ................................. 1027<br />
UCLA Clinical Genomics Center ........................... 923<br />
FAMILIAL MEDITERRANEAN FEVER<br />
UCLA Clinical Genomics Center ........................... 923<br />
FILMARRAY MULTIPLEX PCR MOLECULAR<br />
INFECTIOUS DISEASE TESTING PLATFORM<br />
BioFire Diagnostics ............................................... 719<br />
FILTERS, CUSTOM<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
FILTERS, FILTER SETS<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
FILTERS, MULTICOLOR SETS<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
FISH SLIDE AUTOMATION EQUIPMENT<br />
SciGene ................................................................. 619<br />
FISH SYSTEMS<br />
Abbott Molecular ................................................... 625<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
Natera .................................................................... 504<br />
SciGene ................................................................. 619<br />
Tecan ..................................................................... 405<br />
FISH TESTING<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
ARUP Laboratories .............................................. 1518<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
BlueGnome Limited ............................................... 209<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
Greenwood Genetic Center ................................. 1027<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
SciGene ................................................................. 619<br />
Signature Genomics from PerkinElmer ............... 1327<br />
UCLA Clinical Genomics Center ........................... 923<br />
FLUORESCENCE IMAGE ANALYSIS EQUIPMENT<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
BioNano Genomics, Inc. ....................................... 924<br />
Innopsys ................................................................ 805<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
FLUORESCENCE REPORTER DYES<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
PRODUCT INDEX
308 PRODUCT AND SERVICE INDEX<br />
FLUORESCENT ANTIBODIES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
SurModics ........................................................... 1006<br />
FLUORESCENT FILTERS<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
Tecan ..................................................................... 405<br />
FLUORESCENT IMAGING<br />
Bio-Rad ................................................................. 524<br />
Incom, Inc. ........................................................... 1300<br />
Innopsys ................................................................ 805<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
New England Biolabs, Inc. .................................... 904<br />
NVIGEN ............................................................... 1403<br />
FLUORESCENT SUBSTRATES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
FLUOROGENIC PROBES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
MetaSystems ....................................................... 1303<br />
FLUOROMETER<br />
Tecan ..................................................................... 405<br />
trinean .................................................................. 1605<br />
FRAGILE X TESTING<br />
ARUP Laboratories .............................................. 1518<br />
ASURAGEN, INC. .................................................. 503<br />
Athena Diagnostics ............................................. 1308<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Greenwood Genetic Center ................................. 1027<br />
Natera .................................................................... 504<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
RUCDR ................................................................ 1102<br />
Signature Genomics from PerkinElmer ............... 1327<br />
Transgenomic, Inc. ................................................ 505<br />
UCLA Clinical Genomics Center ........................... 923<br />
FREE BETA/PAPP-A SCREENING WITH NUCHAL<br />
TRANSLUCENCY (NT)<br />
ARUP Laboratories .............................................. 1518<br />
FREE BETA PRENATAL SCREENING<br />
ARUP Laboratories .............................................. 1518<br />
FREIDRICH’S ATAXIA<br />
UCLA Clinical Genomics Center ........................... 923<br />
FRET PROBES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Gene Link, Inc ....................................................... 627<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
GEL ELECTROPHORESIS EQUIPMENT<br />
Bio-Rad ................................................................. 524<br />
Diagenode Inc ....................................................... 406<br />
Embi Tec .............................................................. 1406<br />
QIAGEN Inc. ........................................................ 1001<br />
GEL READING APPARATUS<br />
Embi Tec .............................................................. 1406<br />
GENE AMPLIFICATION PROBES<br />
Gene Link, Inc ....................................................... 627<br />
Leica Microsystems Corp ...................................... 824<br />
Natera .................................................................... 504<br />
QIAGEN Inc. ........................................................ 1001<br />
Rubicon Genomics, Inc. ........................................ 803<br />
GENE EXPRESSION MICROARRAYS<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
BioDiscovery, Inc. .................................................. 813<br />
Expression Analysis ............................................... 508<br />
Illumina, Inc. ........................................................ 1109<br />
Innopsys ................................................................ 805<br />
Life Technologies ................................................... 601<br />
Natera .................................................................... 504<br />
Oxford Gene Technology ....................................... 302<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Phalanx Biotech Group ......................................... 307<br />
QIAGEN Inc. ........................................................ 1001<br />
RUCDR ................................................................ 1102<br />
SeqWright, Inc. ...................................................... 726<br />
Tecan ..................................................................... 405<br />
GENE EXPRESSION PRODUCTS<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
Beckman Coulter, Inc. ......................................... 1601<br />
BGI ...................................................................... 1419<br />
BioDiscovery, Inc. .................................................. 813<br />
Bio-Rad ................................................................. 524<br />
Diagenode Inc ....................................................... 406<br />
Epicentre (an Illumina company) ......................... 1218<br />
Illumina, Inc. ........................................................ 1109<br />
Ingenuity Systems, Inc. ....................................... 1101<br />
Life Technologies ................................................... 601<br />
NanoString Technologies, Inc................................ 210<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Phalanx Biotech Group ......................................... 307<br />
QIAGEN Inc. ........................................................ 1001<br />
Roche Applied Science ......................................... 701<br />
Rubicon Genomics, Inc. ........................................ 803<br />
SciGene ................................................................. 619<br />
Sequenom, Inc. ..................................................... 519<br />
SwitchGear Genomics........................................... 305<br />
Thermo Scientific................................................... 624
GENE FUNCTION DATABASES<br />
Biobase Corporation ........................................... 1319<br />
Hitachi Solutions America Ltd. ............................ 1502<br />
Ingenuity Systems, Inc. ....................................... 1101<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
Knome, Inc. ......................................................... 1007<br />
Prognosys Biosciences, Inc. ................................. 304<br />
GENE MAPPING DATABASE<br />
BC Platforms Ltd ................................................... 819<br />
Biobase Corporation ........................................... 1319<br />
Hitachi Solutions America Ltd. ............................ 1502<br />
Illumina, Inc. ........................................................ 1109<br />
Natera .................................................................... 504<br />
GENE MAPPING PRODUCTS<br />
Illumina, Inc. ........................................................ 1109<br />
Natera .................................................................... 504<br />
Pacific Biosciences ............................................... 610<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
RUCDR ................................................................ 1102<br />
GENE SYNTHESIS<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
QIAGEN Inc. ........................................................ 1001<br />
Rubicon Genomics, Inc. ........................................ 803<br />
GENE TARGETING<br />
Applied StemCell, Inc. ........................................... 527<br />
Expression Analysis ............................................... 508<br />
Natera .................................................................... 504<br />
Omixon Biocomputing .......................................... 205<br />
QIAGEN Inc. ........................................................ 1001<br />
SeqWright, Inc. ...................................................... 726<br />
Thermo Scientific................................................... 624<br />
GENE TARGETING REAGENTS & VECTORS<br />
Applied StemCell, Inc. ........................................... 527<br />
Gene Tools, LLC .................................................. 1401<br />
Natera .................................................................... 504<br />
SwitchGear Genomics........................................... 305<br />
Thermo Scientific................................................... 624<br />
GENE THERAPY PRODUCTS<br />
Applied StemCell, Inc. ........................................... 527<br />
QIAGEN Inc. ........................................................ 1001<br />
Therapeutics for Rare and Neglected Diseases .... 220<br />
GENETICALLY ENGINEERED MICE<br />
Amicus Therapeutics, Inc. ..................................... 511<br />
GENETIC COUNSELING & SERVICES<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Greenwood Genetic Center ................................. 1027<br />
Myriad Genetic Laboratories ............................... 1501<br />
UCLA Clinical Genomics Center ........................... 923<br />
PRODUCT AND SERVICE INDEX 309<br />
GENETIC RESOURCE<br />
AGRE-Autism Genetic Resource Exchange .......... 319<br />
<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />
Natera .................................................................... 504<br />
NextGxDx .............................................................. 411<br />
POSSUM - Murdoch Childrens Research<br />
Institute ............................................................... 218<br />
GENETIC TESTING - 1A+ MYOTONIC DYSTROPHY<br />
Athena Diagnostics ............................................. 1308<br />
GENETIC TESTING - A-1 ANTITRYPSIN<br />
DEFICIENCY<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
Recombine LLC ..................................................... 525<br />
GENETIC TESTING - ANGELMAN SYNDROME<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Greenwood Genetic Center ................................. 1027<br />
MRC-Holland ....................................................... 1122<br />
GENETIC TESTING - APOE GENOTYPING FOR<br />
HYPERLIPIDEMIA<br />
ARUP Laboratories .............................................. 1518<br />
GENETIC TESTING - BREAST & OVARIAN<br />
Expression Analysis ............................................... 508<br />
MRC-Holland ....................................................... 1122<br />
Myriad Genetic Laboratories ............................... 1501<br />
Omixon Biocomputing .......................................... 205<br />
GENETIC TESTING - CANAVAN DISEASE<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
MRC-Holland ....................................................... 1122<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
Recombine LLC ..................................................... 525<br />
GENETIC TESTING - CHARCOT-MARIE-TOOTH<br />
Athena Diagnostics ............................................. 1308<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Connective Tissue Gene Tests .............................. 718<br />
MRC-Holland ....................................................... 1122<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
GENETIC TESTING - CYSTIC FIBROSIS<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
Athena Diagnostics ............................................. 1308<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
PRODUCT INDEX
310 PRODUCT AND SERVICE INDEX<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Greenwood Genetic Center ................................. 1027<br />
MRC-Holland ....................................................... 1122<br />
Natera .................................................................... 504<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
Recombine LLC ..................................................... 525<br />
UCLA Clinical Genomics Center ........................... 923<br />
GENETIC TESTING - DUCHENNE MUSCULAR<br />
DYSTROPHY<br />
Athena Diagnostics ............................................. 1308<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Greenwood Genetic Center ................................. 1027<br />
MRC-Holland ....................................................... 1122<br />
GENETIC TESTING - FACTOR V MUTATION<br />
ARUP Laboratories .............................................. 1518<br />
Athena Diagnostics ............................................. 1308<br />
Greenwood Genetic Center ................................. 1027<br />
Recombine LLC ..................................................... 525<br />
UCLA Clinical Genomics Center ........................... 923<br />
GENETIC TESTING - FAP, DIRECT<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Myriad Genetic Laboratories ............................... 1501<br />
GENETIC TESTING - FRAGILE X<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
ASURAGEN, INC. .................................................. 503<br />
Athena Diagnostics ............................................. 1308<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Greenwood Genetic Center ................................. 1027<br />
Natera .................................................................... 504<br />
Recombine LLC ..................................................... 525<br />
UCLA Clinical Genomics Center ........................... 923<br />
GENETIC TESTING - GAUCHER DISEASE<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Recombine LLC ..................................................... 525<br />
GENETIC TESTING - GENERAL<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
Connective Tissue Gene Tests .............................. 718<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Expression Analysis ............................................... 508<br />
GeneDx ................................................................ 1119<br />
Genzyme, a San<strong>of</strong>i Company ................................ 901<br />
Greenwood Genetic Center ................................. 1027<br />
Laboratory for Molecular Medicine, PCPGM ...... 1225<br />
MRC-Holland ....................................................... 1122<br />
NextGxDx .............................................................. 411<br />
Recombine LLC ..................................................... 525<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Transgenomic, Inc. ................................................ 505<br />
UCLA Clinical Genomics Center ........................... 923<br />
The University <strong>of</strong> Chicago Genetic Services ......... 409<br />
GENETIC TESTING, GENERAL, INFORMATION<br />
RESOURCE<br />
GeneTests ............................................................ 1413<br />
GENETIC TESTING - GILBERT SYNDROME<br />
Recombine LLC ..................................................... 525<br />
GENETIC TESTING - HEMOCHROMATOSIS<br />
ARUP Laboratories .............................................. 1518<br />
Greenwood Genetic Center ................................. 1027<br />
MRC-Holland ....................................................... 1122<br />
Recombine LLC ..................................................... 525<br />
UCLA Clinical Genomics Center ........................... 923<br />
GENETIC TESTING - HEMOPHILIAS<br />
ARUP Laboratories .............................................. 1518<br />
MRC-Holland ....................................................... 1122<br />
Recombine LLC ..................................................... 525<br />
GENETIC TESTING - HNPCC, DIRECT<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
MRC-Holland ....................................................... 1122<br />
Myriad Genetic Laboratories ............................... 1501<br />
GENETIC TESTING - HNPCC-MS.I<br />
ARUP Laboratories .............................................. 1518<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
GENETIC TESTING INSTRUMENTATION -<br />
ATM GENE<br />
Illumina, Inc. ........................................................ 1109<br />
GENETIC TESTING INSTRUMENTATION -<br />
BREAST CANCER<br />
Illumina, Inc. ........................................................ 1109<br />
SciGene ................................................................. 619<br />
GENETIC TESTING INSTRUMENTATION -<br />
CYSTIC FIBROSIS<br />
Illumina, Inc. ........................................................ 1109<br />
SciGene ................................................................. 619<br />
GENETIC TESTING INSTRUMENTATION -<br />
GAUCHER DISEASE<br />
Genzyme, a San<strong>of</strong>i Company ................................ 901<br />
Illumina, Inc. ........................................................ 1109
GENETIC TESTING INSTRUMENTATION -<br />
LOSS OF HETEROZYGOSITY<br />
Illumina, Inc. ........................................................ 1109<br />
GENETIC TESTING INSTRUMENTATION -<br />
MUSCULAR DYSTROPHY<br />
Illumina, Inc. ........................................................ 1109<br />
GENETIC TESTING - LISSENCEPHALY<br />
SYNDROME<br />
MRC-Holland ....................................................... 1122<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
GENETIC TESTING - NEUROFIBROMATOSIS 1,<br />
DIRECT<br />
ARUP Laboratories .............................................. 1518<br />
Athena Diagnostics ............................................. 1308<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
MRC-Holland ....................................................... 1122<br />
UAB Medical Genomics Laboratory ...................... 320<br />
GENETIC TESTING - PRADER WILLIE<br />
SYNDROME<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Greenwood Genetic Center ................................. 1027<br />
MRC-Holland ....................................................... 1122<br />
GENETIC TESTING - PROTHROMBIN (FACTOR II)<br />
MUTATION<br />
ARUP Laboratories .............................................. 1518<br />
Greenwood Genetic Center ................................. 1027<br />
Recombine LLC ..................................................... 525<br />
GENETIC TESTING RESOURCE<br />
NextGxDx .............................................................. 411<br />
GENETIC TESTING - RETT SYNDROME<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
Athena Diagnostics ............................................. 1308<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
GeneDx ................................................................ 1119<br />
Greenwood Genetic Center ................................. 1027<br />
MRC-Holland ....................................................... 1122<br />
GENETIC TESTING - SPINOCEREBELLAR<br />
ATAXIA 1<br />
Athena Diagnostics ............................................. 1308<br />
MRC-Holland ....................................................... 1122<br />
GENETIC TESTING - TAY SACHS<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ARUP Laboratories .............................................. 1518<br />
PRODUCT AND SERVICE INDEX 311<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
MRC-Holland ....................................................... 1122<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
Recombine LLC ..................................................... 525<br />
GENETIC TESTING - TELOMERE DELETIONS &<br />
REARRANGEMENTS<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
GeneDx ................................................................ 1119<br />
MRC-Holland ....................................................... 1122<br />
GENETIC VARIATION SCREENING SERVICES<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Ariosa Diagnostics ............................................... 1609<br />
Connective Tissue Gene Tests .............................. 718<br />
Genformatic ......................................................... 1420<br />
Innopsys ................................................................ 805<br />
Prognosys Biosciences, Inc. ................................. 304<br />
RUCDR ................................................................ 1102<br />
GENE TRANSFER DEVICE<br />
Bio-Rad ................................................................. 524<br />
GENE TRANSFER EQUIPMENT<br />
Bio-Rad ................................................................. 524<br />
GENOMATIX SOFTWARE INC.<br />
Genomatix S<strong>of</strong>tware .............................................. 425<br />
GENOME VIEWER<br />
Hitachi Solutions America Ltd. ............................ 1502<br />
GENOMIC ANALYSIS REAGENTS<br />
BioNano Genomics, Inc. ....................................... 924<br />
BlueGnome Limited ............................................... 209<br />
Illumina, Inc. ........................................................ 1109<br />
New England Biolabs, Inc. .................................... 904<br />
Pacific Biosciences ............................................... 610<br />
Roche Applied Science ......................................... 701<br />
Rubicon Genomics, Inc. ........................................ 803<br />
SciGene ................................................................. 619<br />
Sequenom, Inc. ..................................................... 519<br />
Thermo Scientific................................................... 624<br />
GENOMIC DNAS<br />
Advanced Analytical ............................................ 1304<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ASURAGEN, INC. .................................................. 503<br />
Bioline USA Inc. ................................................... 1324<br />
Gene Link, Inc ....................................................... 627<br />
IntegenX Inc. ....................................................... 1311<br />
New England Biolabs, Inc. .................................... 904<br />
QIAGEN Inc. ........................................................ 1001<br />
Rubicon Genomics, Inc. ........................................ 803<br />
SeqWright, Inc. ...................................................... 726<br />
GENOMIC PURIFICATION<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
PRODUCT INDEX
312 PRODUCT AND SERVICE INDEX<br />
BioReliance ........................................................... 604<br />
chemagen from PerkinElmer ............................... 1426<br />
Gene Link, Inc ....................................................... 627<br />
IntegenX Inc. ....................................................... 1311<br />
Life Technologies ................................................... 601<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
SeqWright, Inc. ...................................................... 726<br />
GENOMIC PURIFICATION (DNA)<br />
Affymetrix, Inc. ...................................................... 918<br />
AutoGen, Inc. ........................................................ 807<br />
BioReliance ........................................................... 604<br />
chemagen from PerkinElmer ............................... 1426<br />
Diagenode Inc ....................................................... 406<br />
DNA Genotek ........................................................ 900<br />
Epicentre (an Illumina company) ......................... 1218<br />
Epigentek Group Inc. ........................................... 1127<br />
Expression Analysis ............................................... 508<br />
Gene Link, Inc ....................................................... 627<br />
IntegenX Inc. ....................................................... 1311<br />
QIAGEN Inc. ........................................................ 1001<br />
Rubicon Genomics, Inc. ........................................ 803<br />
SciGene ................................................................. 619<br />
SeqWright, Inc. ...................................................... 726<br />
Tecan ..................................................................... 405<br />
trinean .................................................................. 1605<br />
Zymo Research Corporation ................................. 400<br />
GENOTYPING PRODUCTS<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Bioline USA Inc. ................................................... 1324<br />
DNA Genotek ........................................................ 900<br />
Fluidigm Corporation ............................................. 725<br />
Gene Codes Corporation .................................... 1310<br />
Illumina, Inc. ........................................................ 1109<br />
Ingenuity Systems, Inc. ....................................... 1101<br />
Innopsys ................................................................ 805<br />
IntegenX Inc. ....................................................... 1311<br />
Life Technologies ................................................... 601<br />
New England Biolabs, Inc. .................................... 904<br />
Pacific Biosciences ............................................... 610<br />
QIAGEN Inc. ........................................................ 1001<br />
Roche Applied Science ......................................... 701<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Sequenom, Inc. ..................................................... 519<br />
GENOTYPING SERVICES<br />
Affymetrix, Inc. ...................................................... 918<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
BGI ...................................................................... 1419<br />
BioReliance ........................................................... 604<br />
Center for Inherited Disease Research (CIDR) ...... 119<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Expression Analysis ............................................... 508<br />
Illumina, Inc. ........................................................ 1109<br />
Ingenuity Systems, Inc. ....................................... 1101<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
Prognosys Biosciences, Inc. ................................. 304<br />
QIAGEN Inc. ........................................................ 1001<br />
Recombine LLC ..................................................... 525<br />
RUCDR ................................................................ 1102<br />
SeqWright, Inc. ...................................................... 726<br />
UCLA Clinical Genomics Center ........................... 923<br />
GENOTYPING SERVICES ‘FREE GENOTYPING’<br />
Center for Inherited Disease Research (CIDR) ...... 119<br />
GWAS AND COPY NUMBER/LOH ANALYSIS<br />
EpigenDx ............................................................... 721<br />
GWAS GENOTYPING<br />
Center for Inherited Disease Research (CIDR) ...... 119<br />
HARVESTER SYSTEMS<br />
Genial Genetic Solutions/Rainbow<br />
Scientific, Inc. ..................................................... 402<br />
HEATBLOCKS<br />
SciGene ................................................................. 619<br />
HEMOCHROMATOSIS<br />
ARUP Laboratories .............................................. 1518<br />
HIGH RESOLUTION MELTING ANALYSIS<br />
SYSTEMS<br />
BioFire Diagnostics ............................................... 719<br />
HIGH RESOLUTION MELTING REAGENTS,<br />
MASTER MIXES<br />
BioFire Diagnostics ............................................... 719<br />
HIGH RESOLUTION MELTING SOFTWARE<br />
BioFire Diagnostics ............................................... 719<br />
HIGH-THROUGHPUT PRODUCTION<br />
Embi Tec .............................................................. 1406<br />
Expression Analysis ............................................... 508<br />
Illumina, Inc. ........................................................ 1109<br />
IntegenX Inc. ....................................................... 1311<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
Labcyte Inc. ......................................................... 1402<br />
Microsonic Systems Inc. ....................................... 618<br />
QIAGEN Inc. ........................................................ 1001<br />
RUCDR ................................................................ 1102<br />
SciGene ................................................................. 619<br />
trinean .................................................................. 1605<br />
HLA NEXT-GENERATION SEQUENCING<br />
ANALYSIS<br />
JSI medical systems GmbH ................................ 1023<br />
HYBRIDIZATION INCUBATORS<br />
SciGene ................................................................. 619<br />
HYBRIDIZATION REAGENTS<br />
Phalanx Biotech Group ......................................... 307
IDENTIFICATION<br />
Data Unlimited International, Inc. ........................ 1503<br />
DNA Genotek ........................................................ 900<br />
IntegenX Inc. ....................................................... 1311<br />
IHC INSTRUMENTATION<br />
Leica Microsystems Corp ...................................... 824<br />
IMAGE ANALYZER<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
BioDiscovery, Inc. .................................................. 813<br />
Leica Microsystems Corp ...................................... 824<br />
IMAGING PRODUCTS<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
BioDiscovery, Inc. .................................................. 813<br />
Embi Tec .............................................................. 1406<br />
Incom, Inc. ........................................................... 1300<br />
Innopsys ................................................................ 805<br />
Leica Microsystems Corp ...................................... 824<br />
Roche Applied Science ......................................... 701<br />
IMMUNOASSAYS<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Diagenode Inc ....................................................... 406<br />
Leica Microsystems Corp ...................................... 824<br />
QIAGEN Inc. ........................................................ 1001<br />
IMMUNOCHEMICALS<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
SurModics ........................................................... 1006<br />
IMMUNOHISTOCHEMISTRY<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
MetaSystems ....................................................... 1303<br />
SurModics ........................................................... 1006<br />
IMMUNOMAGNETIC BEADS<br />
Diagenode Inc ....................................................... 406<br />
INBORN ERRORS OF METABOLISM<br />
Amicus Therapeutics, Inc. ..................................... 511<br />
BioMarin Pharmaceutical Inc. ............................. 1619<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
Greenwood Genetic Center ................................. 1027<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
INCUBATORS<br />
SciGene ................................................................. 619<br />
IND ADVICE AND PRODUCT DEVELOPMENT<br />
PLANNING<br />
Therapeutics for Rare and Neglected Diseases .... 220<br />
INFECTIOUS DISEASE ANTIGENS<br />
SurModics ........................................................... 1006<br />
PRODUCT AND SERVICE INDEX 313<br />
INFERTILITY - DELETION Y DNA ANALYSIS<br />
ARUP Laboratories .............................................. 1518<br />
Innopsys ................................................................ 805<br />
Natera .................................................................... 504<br />
INFERTILITY TREATMENT<br />
Natera .................................................................... 504<br />
INFORMATION ABOUT RESEARCH FUNDING<br />
OPPORTUNITIES<br />
CIHR Institute <strong>of</strong> <strong>Genetics</strong> ................................... 1321<br />
INFORMATION RESOURCE<br />
GeneTests ............................................................ 1413<br />
NextGxDx .............................................................. 411<br />
Office <strong>of</strong> Rare Diseases Research (NIH) ................ 326<br />
POSSUM - Murdoch Childrens Research<br />
Institute ............................................................... 218<br />
Seven Bridges Genomics .................................... 1204<br />
University <strong>of</strong> Southern California, Information<br />
Sciences Institute ............................................... 226<br />
INHIBIN<br />
ARUP Laboratories .............................................. 1518<br />
IN SITU HYBRIDIZATION ANALYSES<br />
BioReliance ........................................................... 604<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
IN SITU INSTRUMENTATION<br />
IntegenX Inc. ....................................................... 1311<br />
Leica Microsystems Corp ...................................... 824<br />
SciGene ................................................................. 619<br />
Tecan ..................................................................... 405<br />
INSTITUTIONAL & NOT-FOR-PROFIT EXHIBITORS<br />
Greenwood Genetic Center ................................. 1027<br />
Science/AAAS ..................................................... 1312<br />
Therapeutics for Rare and Neglected Diseases .... 220<br />
INTERNET-BASED INFORMATION RESOURCE<br />
Biobase Corporation ........................................... 1319<br />
GeneTests ............................................................ 1413<br />
<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />
NextGxDx .............................................................. 411<br />
Office <strong>of</strong> Rare Diseases Research (NIH) ................ 326<br />
Pubget, Inc. ......................................................... 1520<br />
Seven Bridges Genomics .................................... 1204<br />
University <strong>of</strong> Southern California, Information<br />
Sciences Institute ............................................... 226<br />
INTERPRETATION OF MEDICAL AND HEALTH<br />
IMPLICATIONS OF SNPS, INDELS, CNVS AND<br />
OTHER VARIANTS<br />
Genformatic ......................................................... 1420<br />
IN VIVO - ELECTROPORATION<br />
Applied StemCell, Inc. ........................................... 527<br />
PRODUCT INDEX
314 PRODUCT AND SERVICE INDEX<br />
ISOLATION KITS<br />
Bioline USA Inc. ................................................... 1324<br />
Epigentek Group Inc. ........................................... 1127<br />
Exiqon ................................................................. 1712<br />
New England Biolabs, Inc. .................................... 904<br />
Phalanx Biotech Group ......................................... 307<br />
QIAGEN Inc. ........................................................ 1001<br />
Zymo Research Corporation ................................. 400<br />
LAB AUTOMATION AND LIQUID HANDLING<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
LABELED STREPTAVIDIN<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
LABELS<br />
Data Unlimited International, Inc. ........................ 1503<br />
LABORATORY ANALYSIS SERVICES<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
BlueGnome Limited ............................................... 209<br />
Expression Analysis ............................................... 508<br />
Leica Microsystems Corp ...................................... 824<br />
Rubicon Genomics, Inc. ........................................ 803<br />
RUCDR ................................................................ 1102<br />
STARLIMS ........................................................... 1400<br />
LABORATORY ANIMALS<br />
Applied StemCell, Inc. ........................................... 527<br />
LABORATORY DISPOSABLES<br />
Diagenode Inc ....................................................... 406<br />
LABORATORY - GENETIC TESTING & SERVICES<br />
Applied StemCell, Inc. ........................................... 527<br />
Ariosa Diagnostics ............................................... 1609<br />
ASURAGEN, INC. .................................................. 503<br />
Athena Diagnostics ............................................. 1308<br />
BlueGnome Limited ............................................... 209<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
Connective Tissue Gene Tests .............................. 718<br />
Diagenode Inc ....................................................... 406<br />
DNA Genotek ........................................................ 900<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Expression Analysis ............................................... 508<br />
Gene Link, Inc ....................................................... 627<br />
Genformatic ......................................................... 1420<br />
Greenwood Genetic Center ................................. 1027<br />
JSI medical systems GmbH ................................ 1023<br />
Laboratory for Molecular Medicine, PCPGM ...... 1225<br />
Leica Microsystems Corp ...................................... 824<br />
Myriad Genetic Laboratories ............................... 1501<br />
Natera .................................................................... 504<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
Rubicon Genomics, Inc. ........................................ 803<br />
RUCDR ................................................................ 1102<br />
SeqWright, Inc. ...................................................... 726<br />
Signature Genomics from PerkinElmer ............... 1327<br />
STARLIMS ........................................................... 1400<br />
Transgenomic, Inc. ................................................ 505<br />
UAB Medical Genomics Laboratory ...................... 320<br />
UCLA Clinical Genomics Center ........................... 923<br />
LABORATORY INFORMATION MANAGEMENT<br />
SYSTEM<br />
Data Unlimited International, Inc. ........................ 1503<br />
LASER CAPTURE MICRODISSECTION<br />
Life Technologies ................................................... 601<br />
Rubicon Genomics, Inc. ........................................ 803<br />
LIBRARY SCREENING SERVICES<br />
Applied StemCell, Inc. ........................................... 527<br />
Thermo Scientific................................................... 624<br />
LIQUID CULTURE MEDIA<br />
Irvine Scientific ...................................................... 620<br />
LIQUID HANDLING EQUIPMENT<br />
Embi Tec .............................................................. 1406<br />
Hamilton Company .............................................. 1613<br />
Labcyte Inc. ......................................................... 1402<br />
SciGene ................................................................. 619<br />
Tecan ..................................................................... 405<br />
LNA<br />
Exiqon ................................................................. 1712<br />
LONG NON-CODING RNA EXPRESSION<br />
PROFILING<br />
NXT-Dx ................................................................ 1025<br />
LUCIFERASE-BASED REPORTER PLASMIDS<br />
SwitchGear Genomics........................................... 305<br />
LUMINOMETER<br />
Tecan ..................................................................... 405<br />
LYSOSOMAL STORAGE DISEASES<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Amicus Therapeutics, Inc. ..................................... 511<br />
BioMarin Pharmaceutical Inc. ............................. 1619<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
Genzyme, a San<strong>of</strong>i Company ................................ 901<br />
Greenwood Genetic Center ................................. 1027<br />
MACHINE LEARNING<br />
University <strong>of</strong> Southern California, Information<br />
Sciences Institute ............................................... 226<br />
MAGNETIC PARTICLES<br />
chemagen from PerkinElmer ............................... 1426<br />
MAGNETIC SEPARATORS<br />
chemagen from PerkinElmer ............................... 1426<br />
Diagenode Inc ....................................................... 406<br />
New England Biolabs, Inc. .................................... 904
MAGVIGEN | MAGNETIC NANOPARTICLES FOR<br />
GENOMIC PURIFICATION<br />
NVIGEN ............................................................... 1403<br />
MAPPING TOOLS<br />
BC Platforms Ltd ................................................... 819<br />
BGI ...................................................................... 1419<br />
Biobase Corporation ........................................... 1319<br />
BioNano Genomics, Inc. ....................................... 924<br />
Knome, Inc. ......................................................... 1007<br />
MASS SPECS<br />
Agilent Technologies ............................................. 609<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
QIAGEN Inc. ........................................................ 1001<br />
Sequenom, Inc. ..................................................... 519<br />
MBD-BASED GENOME-WIDE METHYLATION<br />
SEQUENCING<br />
NXT-Dx ................................................................ 1025<br />
MEDIA<br />
Applied StemCell, Inc. ........................................... 527<br />
Pubget, Inc. ......................................................... 1520<br />
MEDICAL JOURNALS<br />
JMG (BMJ Group) ............................................... 1103<br />
MEETING MANAGEMENT SERVICES<br />
FASEB ................................................................. 1700<br />
MEETINGS AND COURSES<br />
Cold Spring Harbor Laboratory Press ................. 1209<br />
METABOLIC STUDIES<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Greenwood Genetic Center ................................. 1027<br />
METHYLATION PCR<br />
ASURAGEN, INC. .................................................. 503<br />
METHYLOME SEQUENCING<br />
Axeq Technologies ................................................ 820<br />
M-FISH<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
MICROARRAY ANALYSIS SOFTWARE<br />
Partek Incorporated............................................. 1307<br />
MICROARRAY BIOCHIP ANALYSIS<br />
Agilent Technologies ............................................. 609<br />
Athena Diagnostics ............................................. 1308<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
Biobase Corporation ........................................... 1319<br />
BioDiscovery, Inc. .................................................. 813<br />
Coriell Institute for Medical Research ................... 312<br />
PRODUCT AND SERVICE INDEX 315<br />
Ingenuity Systems, Inc. ....................................... 1101<br />
Innopsys ................................................................ 805<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Phalanx Biotech Group ......................................... 307<br />
Signature Genomics from PerkinElmer ............... 1327<br />
MICROARRAY CHAMBERS AND CASSETTES<br />
SciGene ................................................................. 619<br />
MICROARRAY DATA MANAGEMENT SYSTEMS -<br />
DATABASE<br />
BC Platforms Ltd ................................................... 819<br />
Biobase Corporation ........................................... 1319<br />
BioDiscovery, Inc. .................................................. 813<br />
BlueGnome Limited ............................................... 209<br />
Cartagenia ........................................................... 1022<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Signature Genomics from PerkinElmer ............... 1327<br />
MICROARRAYERS<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
MICROARRAY REAGENTS<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
BlueGnome Limited ............................................... 209<br />
Epicentre (an Illumina company) ......................... 1218<br />
Illumina, Inc. ........................................................ 1109<br />
Oxford Gene Technology ....................................... 302<br />
Phalanx Biotech Group ......................................... 307<br />
QIAGEN Inc. ........................................................ 1001<br />
Roche Applied Science ......................................... 701<br />
Rubicon Genomics, Inc. ........................................ 803<br />
SurModics ........................................................... 1006<br />
MICROARRAY SCANNERS<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
Illumina, Inc. ........................................................ 1109<br />
Innopsys ................................................................ 805<br />
Roche Applied Science ......................................... 701<br />
Tecan ..................................................................... 405<br />
MICROARRAY SLIDES<br />
Agilent Technologies ............................................. 609<br />
BlueGnome Limited ............................................... 209<br />
Incom, Inc. ........................................................... 1300<br />
Oxford Gene Technology ....................................... 302<br />
Phalanx Biotech Group ......................................... 307<br />
Roche Applied Science ......................................... 701<br />
Sony DADC ......................................................... 1411<br />
SurModics ........................................................... 1006<br />
MICRODELETION SYNDROME PROBES<br />
Greenwood Genetic Center ................................. 1027<br />
MRC-Holland ....................................................... 1122<br />
MICRODISSECTION<br />
Rubicon Genomics, Inc. ........................................ 803<br />
PRODUCT INDEX
316 PRODUCT AND SERVICE INDEX<br />
MICROFLUIDICS<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
MICROPLATE FLUORESCENCE POLARIZATION<br />
READER<br />
Tecan ..................................................................... 405<br />
MICROPLATE READERS & WASHERS<br />
Tecan ..................................................................... 405<br />
trinean .................................................................. 1605<br />
MICROPLATES<br />
Incom, Inc. ........................................................... 1300<br />
Sony DADC ......................................................... 1411<br />
trinean .................................................................. 1605<br />
MICROPLATE WASHERS<br />
Tecan ..................................................................... 405<br />
MICRORNA<br />
Exiqon ................................................................. 1712<br />
MICRORNA ANALYSIS<br />
Phalanx Biotech Group ......................................... 307<br />
MICRORNA MICROARRAYS<br />
Phalanx Biotech Group ......................................... 307<br />
MICRORNA SERVICE<br />
Phalanx Biotech Group ......................................... 307<br />
MICROSCOPES<br />
Leica Microsystems Corp ...................................... 824<br />
MetaSystems ....................................................... 1303<br />
MINI-PREPS - 96 WELL<br />
QIAGEN Inc. ........................................................ 1001<br />
MIRNA EXPRESSION PROFILING<br />
NXT-Dx ................................................................ 1025<br />
MITOCHONDRIAL DNA MUTATION TESTING<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
BioReliance ........................................................... 604<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
GeneDx ................................................................ 1119<br />
JSI medical systems GmbH ................................ 1023<br />
MRC-Holland ....................................................... 1122<br />
Transgenomic, Inc. ................................................ 505<br />
MLPA ANALYSIS<br />
JSI medical systems GmbH ................................ 1023<br />
MOLECULAR BEACONS<br />
Gene Link, Inc ....................................................... 627<br />
MOLECULAR BEACON SYNTHESIS<br />
Gene Link, Inc ....................................................... 627<br />
MOLECULAR BIOLOGY REAGENTS<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
ASURAGEN, INC. .................................................. 503<br />
BioFire Diagnostics ............................................... 719<br />
Bioline USA Inc. ................................................... 1324<br />
EdgeBio ............................................................... 1506<br />
Epicentre (an Illumina company) ......................... 1218<br />
Gene Link, Inc ....................................................... 627<br />
Gene Tools, LLC .................................................. 1401<br />
Life Technologies ................................................... 601<br />
New England Biolabs, Inc. .................................... 904<br />
Roche Applied Science ......................................... 701<br />
Rubicon Genomics, Inc. ........................................ 803<br />
USB products from Affymetrix .............................. 925<br />
Zymo Research Corporation ................................. 400<br />
MOLECULAR DIAGNOSTICS<br />
Transgenomic, Inc. ................................................ 505<br />
MOLECULAR INFECTIONS DISEASE TESTING<br />
BioFire Diagnostics ............................................... 719<br />
MOLECULAR MODELING SOFTWARE<br />
Ingenuity Systems, Inc. ....................................... 1101<br />
MOUSE MODELS<br />
Applied StemCell, Inc. ........................................... 527<br />
mRNA ISOLATION<br />
Bio-Rad ................................................................. 524<br />
BioReliance ........................................................... 604<br />
chemagen from PerkinElmer ............................... 1426<br />
Exiqon ................................................................. 1712<br />
New England Biolabs, Inc. .................................... 904<br />
Prognosys Biosciences, Inc. ................................. 304<br />
QIAGEN Inc. ........................................................ 1001<br />
Roche Applied Science ......................................... 701<br />
SeqWright, Inc. ...................................................... 726<br />
Zymo Research Corporation ................................. 400<br />
mRNA PURIFICATION KIT<br />
Affymetrix, Inc. ...................................................... 918<br />
Bio-Rad ................................................................. 524<br />
chemagen from PerkinElmer ............................... 1426<br />
Epicentre (an Illumina company) ......................... 1218<br />
Gene Link, Inc ....................................................... 627<br />
Tecan ..................................................................... 405<br />
Zymo Research Corporation ................................. 400<br />
MUTATION DETECTION<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
ASURAGEN, INC. .................................................. 503<br />
Bio-Rad ................................................................. 524<br />
Boreal Genomics ................................................... 724<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />
Illumina, Inc. ........................................................ 1109
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
JSI medical systems GmbH ................................ 1023<br />
MRC-Holland ....................................................... 1122<br />
Myriad Genetic Laboratories ............................... 1501<br />
Omixon Biocomputing .......................................... 205<br />
Pacific Biosciences ............................................... 610<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Seven Bridges Genomics .................................... 1204<br />
Transgenomic, Inc. ................................................ 505<br />
UCLA Clinical Genomics Center ........................... 923<br />
MUTATION INTERPRETATION<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
MYCOPLASMA DETECTION SYSTEMS<br />
RUCDR ................................................................ 1102<br />
NDAR FEDERATION<br />
AGRE-Autism Genetic Resource Exchange .......... 319<br />
NEUROGENETIC TESTING SERVICES<br />
Athena Diagnostics ............................................. 1308<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
GeneDx ................................................................ 1119<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
NEUROLOGICAL TESTING SERVICES<br />
Athena Diagnostics ............................................. 1308<br />
NEW TECHNOLOGY REVIEWS<br />
Science/AAAS ..................................................... 1312<br />
NEXT-GENERATION SEQUENCING<br />
SeqWright, Inc. ...................................................... 726<br />
NEXT-GENERATION SEQUENCING ANALYSIS<br />
JSI medical systems GmbH ................................ 1023<br />
NEXT GENERATION SEQUENCING ANALYSIS<br />
Seven Bridges Genomics .................................... 1204<br />
NEXT-GENERATION SEQUENCING ANALYSIS<br />
SOFTWARE<br />
Partek Incorporated............................................. 1307<br />
NEXT-GENERATION SEQUENCING LIBRARY<br />
PREPARATION<br />
Advanced Analytical ............................................ 1304<br />
NEXTGEN SEQUENCING SAMPLE PREP<br />
Epicentre (an Illumina company) ......................... 1218<br />
NGS DATA ANALYSIS<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
PRODUCT AND SERVICE INDEX 317<br />
NGS SOFTWARE<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
NONCODING RNA<br />
Exiqon ................................................................. 1712<br />
NONINVASIVE PRENATAL TESTING<br />
Ariosa Diagnostics ............................................... 1609<br />
NONISOTOPIC REAGENTS<br />
Gene Link, Inc ....................................................... 627<br />
NONRADIOACTIVE LABELING PRODUCTS<br />
Gene Link, Inc ....................................................... 627<br />
NON-UV LIGHT BOX<br />
Embi Tec .............................................................. 1406<br />
NUCLEIC ACID ISOLATIONS<br />
Bioline USA Inc. ................................................... 1324<br />
chemagen from PerkinElmer ............................... 1426<br />
EdgeBio ............................................................... 1506<br />
Expression Analysis ............................................... 508<br />
Gene Link, Inc ....................................................... 627<br />
Phalanx Biotech Group ......................................... 307<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Roche Applied Science ......................................... 701<br />
Rubicon Genomics, Inc. ........................................ 803<br />
RUCDR ................................................................ 1102<br />
SeqWright, Inc. ...................................................... 726<br />
Zymo Research Corporation ................................. 400<br />
NUCLEIC ACID KITS<br />
chemagen from PerkinElmer ............................... 1426<br />
EdgeBio ............................................................... 1506<br />
Gene Link, Inc ....................................................... 627<br />
IntegenX Inc. ....................................................... 1311<br />
New England Biolabs, Inc. .................................... 904<br />
Phalanx Biotech Group ......................................... 307<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Zymo Research Corporation ................................. 400<br />
NUCLEIC ACID PURIFICATION<br />
Affymetrix, Inc. ...................................................... 918<br />
AutoGen, Inc. ........................................................ 807<br />
chemagen from PerkinElmer ............................... 1426<br />
DNA Genotek ........................................................ 900<br />
EdgeBio ............................................................... 1506<br />
Epigentek Group Inc. ........................................... 1127<br />
Gene Link, Inc ....................................................... 627<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
Life Technologies ................................................... 601<br />
QIAGEN Inc. ........................................................ 1001<br />
SeqWright, Inc. ...................................................... 726<br />
Tecan ..................................................................... 405<br />
trinean .................................................................. 1605<br />
Zymo Research Corporation ................................. 400<br />
PRODUCT INDEX
318 PRODUCT AND SERVICE INDEX<br />
NUCLEIC ACID QUANTITATION KITS<br />
Agilent Technologies ............................................. 609<br />
ASURAGEN, INC. .................................................. 503<br />
BioNano Genomics, Inc. ....................................... 924<br />
Zymo Research Corporation ................................. 400<br />
NUCLEIC ACID STABILIZATION REAGENTS<br />
DNA Genotek ........................................................ 900<br />
IntegenX Inc. ....................................................... 1311<br />
Zymo Research Corporation ................................. 400<br />
OEM MANUFACTURING<br />
ASURAGEN, INC. .................................................. 503<br />
BioFire Diagnostics ............................................... 719<br />
chemagen from PerkinElmer ............................... 1426<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
New England Biolabs, Inc. .................................... 904<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Zymo Research Corporation ................................. 400<br />
OLIGO ANNEALING<br />
Gene Link, Inc ....................................................... 627<br />
SeqWright, Inc. ...................................................... 726<br />
OLIGONUCLEOTIDE PURIFICATION<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Gene Link, Inc ....................................................... 627<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
trinean .................................................................. 1605<br />
Zymo Research Corporation ................................. 400<br />
OLIGONUCLEOTIDES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Bio-Rad ................................................................. 524<br />
Exiqon ................................................................. 1712<br />
Gene Link, Inc ....................................................... 627<br />
Gene Tools, LLC .................................................. 1401<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
Oxford Gene Technology ....................................... 302<br />
Therapeutics for Rare and Neglected Diseases .... 220<br />
ONCOLOGY CLINICAL TRIALS<br />
Transgenomic, Inc. ................................................ 505<br />
ONCOLOGY DIAGNOSTIC TOOLS<br />
Transgenomic, Inc. ................................................ 505<br />
ONCOLOGY PRECLINICAL TRIALS<br />
Transgenomic, Inc. ................................................ 505<br />
OVENS<br />
SciGene ................................................................. 619<br />
PCR ENZYMES<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
Bioline USA Inc. ................................................... 1324<br />
Epicentre (an Illumina company) ......................... 1218<br />
Kapa Biosystems Inc ........................................... 1512<br />
New England Biolabs, Inc. .................................... 904<br />
Roche Applied Science ......................................... 701<br />
USB products from Affymetrix .............................. 925<br />
PCR PLASTICS<br />
EdgeBio ............................................................... 1506<br />
Thermo Scientific................................................... 624<br />
PCR/PRIMER DESIGN SOFTWARE<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
PCR PURIFICATION - 96 WELL<br />
chemagen from PerkinElmer ............................... 1426<br />
EdgeBio ............................................................... 1506<br />
Life Technologies ................................................... 601<br />
RUCDR ................................................................ 1102<br />
SeqWright, Inc. ...................................................... 726<br />
Tecan ..................................................................... 405<br />
USB products from Affymetrix .............................. 925<br />
Zymo Research Corporation ................................. 400<br />
PCR-RELATED PRODUCTS<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
ASURAGEN, INC. .................................................. 503<br />
BC Platforms Ltd ................................................... 819<br />
BioFire Diagnostics ............................................... 719<br />
Bioline USA Inc. ................................................... 1324<br />
Diagenode Inc ....................................................... 406<br />
EdgeBio ............................................................... 1506<br />
Embi Tec .............................................................. 1406<br />
Exiqon ................................................................. 1712<br />
Fluidigm Corporation ............................................. 725<br />
Illumina, Inc. ........................................................ 1109<br />
Incom, Inc. ........................................................... 1300<br />
IntegenX Inc. ....................................................... 1311<br />
Labcyte Inc. ......................................................... 1402<br />
New England Biolabs, Inc. .................................... 904<br />
RainDance Technologies, Inc. ............................... 910<br />
Streck .................................................................. 1600<br />
Thermo Scientific................................................... 624<br />
USB products from Affymetrix .............................. 925<br />
PEDIGREE DRAWING SOFTWARE<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
PEPTIDE ANTIBODIES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Diagenode Inc ....................................................... 406<br />
Epigentek Group Inc. ........................................... 1127<br />
NVIGEN ............................................................... 1403<br />
PEPTIDES (CUSTOM)<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Therapeutics for Rare and Neglected Diseases .... 220<br />
PEPTIDE SYNTHESIS REAGENTS<br />
AnaSpec Inc, Eurogentec Group ......................... 1100
PHARMACEUTICALS<br />
Amicus Therapeutics, Inc. ..................................... 511<br />
BioMarin Pharmaceutical Inc. ............................. 1619<br />
Rare Disease Therapeutics, Inc. ............................ 419<br />
Therapeutics for Rare and Neglected Diseases .... 220<br />
PHARMACOGENETIC TESTING SERVICES<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
BioReliance ........................................................... 604<br />
Boreal Genomics ................................................... 724<br />
Expression Analysis ............................................... 508<br />
Genformatic ......................................................... 1420<br />
PHARMACOGENOMIC SERVICES<br />
SeqWright, Inc. ...................................................... 726<br />
PHENOTYPE MAPPING<br />
University <strong>of</strong> Southern California, Information<br />
Sciences Institute ............................................... 226<br />
PHOTOGRAPHIC EQUIPMENT<br />
Embi Tec .............................................................. 1406<br />
PIPETTES<br />
Hamilton Company .............................................. 1613<br />
PK/ADME<br />
Therapeutics for Rare and Neglected Diseases .... 220<br />
PLASMID PURIFICATION<br />
Affymetrix, Inc. ...................................................... 918<br />
AutoGen, Inc. ........................................................ 807<br />
EdgeBio ............................................................... 1506<br />
SeqWright, Inc. ...................................................... 726<br />
trinean .................................................................. 1605<br />
USB products from Affymetrix .............................. 925<br />
Zymo Research Corporation ................................. 400<br />
PLASTIC LABORATORY WARE<br />
SciGene ................................................................. 619<br />
POLYMORPHIC GENETIC MARKERS<br />
BC Platforms Ltd ................................................... 819<br />
PRECAST ACRYLAMIDE GELS<br />
Embi Tec .............................................................. 1406<br />
PRECAST AGAROSE GELS<br />
Embi Tec .............................................................. 1406<br />
Sage Science Inc. ................................................ 1510<br />
PRENATAL INTERPRETIVE SOFTWARE<br />
Genformatic ......................................................... 1420<br />
PRIMERS<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
ASURAGEN, INC. .................................................. 503<br />
Exiqon ................................................................. 1712<br />
PRODUCT AND SERVICE INDEX 319<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
Thermo Scientific................................................... 624<br />
PROBES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Exiqon ................................................................. 1712<br />
Gene Link, Inc ....................................................... 627<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
MetaSystems ....................................................... 1303<br />
MRC-Holland ....................................................... 1122<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Thermo Scientific................................................... 624<br />
PROBES - CANCER<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Exiqon ................................................................. 1712<br />
MRC-Holland ....................................................... 1122<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Signature Genomics from PerkinElmer ............... 1327<br />
PROTEIN DETECTION<br />
Innopsys ................................................................ 805<br />
NVIGEN ............................................................... 1403<br />
PROTEIN EXPRESSION KIT<br />
New England Biolabs, Inc. .................................... 904<br />
PROTEIN PURIFICATION<br />
New England Biolabs, Inc. .................................... 904<br />
NVIGEN ............................................................... 1403<br />
Tecan ..................................................................... 405<br />
trinean .................................................................. 1605<br />
USB products from Affymetrix .............................. 925<br />
PROTEIN SEQUENCE ANALYSIS SOFTWARE<br />
Knome, Inc. ......................................................... 1007<br />
PROTEOMIC SERVICES<br />
BGI ...................................................................... 1419<br />
PUBLICATIONS<br />
JMG (BMJ Group) ............................................... 1103<br />
PUBLISHER<br />
Science/AAAS ..................................................... 1312<br />
PUBLISHING<br />
JMG (BMJ Group) ............................................... 1103<br />
PURIFICATION SYSTEMS<br />
SciGene ................................................................. 619<br />
qPCR ANALYSIS SOFTWARE<br />
Partek Incorporated............................................. 1307<br />
qPCR PROBES<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Bioline USA Inc. ................................................... 1324<br />
PRODUCT INDEX
320 PRODUCT AND SERVICE INDEX<br />
Exiqon ................................................................. 1712<br />
Illumina, Inc. ........................................................ 1109<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
Roche Applied Science ......................................... 701<br />
Thermo Scientific................................................... 624<br />
QUALITY CONTROL SOFTWARE<br />
BC Platforms Ltd ................................................... 819<br />
Data Unlimited International, Inc. ........................ 1503<br />
GeneInsight ......................................................... 1224<br />
Genial Genetic Solutions/Rainbow<br />
Scientific, Inc. ..................................................... 402<br />
QUANTITATIVE EXPRESSION ANALYSIS<br />
Affymetrix, Inc. ...................................................... 918<br />
Biobase Corporation ........................................... 1319<br />
BioReliance ........................................................... 604<br />
Exiqon ................................................................. 1712<br />
Fluidigm Corporation ............................................. 725<br />
NanoString Technologies, Inc................................ 210<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Sequenom, Inc. ..................................................... 519<br />
SeqWright, Inc. ...................................................... 726<br />
Thermo Scientific................................................... 624<br />
QUANTITATIVE PCR ANALYSIS SYSTEM<br />
Agilent Technologies ............................................. 609<br />
ASURAGEN, INC. .................................................. 503<br />
Exiqon ................................................................. 1712<br />
Fluidigm Corporation ............................................. 725<br />
Life Technologies ................................................... 601<br />
NanoString Technologies, Inc................................ 210<br />
Roche Applied Science ......................................... 701<br />
Thermo Scientific................................................... 624<br />
QUENCHER<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
REAGENTS<br />
Agilent Technologies ............................................. 609<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
ASURAGEN, INC. .................................................. 503<br />
Beckman Coulter, Inc. ......................................... 1601<br />
BioFire Diagnostics ............................................... 719<br />
Bioline USA Inc. ................................................... 1324<br />
Diagenode Inc ....................................................... 406<br />
Exiqon ................................................................. 1712<br />
Gene Tools, LLC .................................................. 1401<br />
Genial Genetic Solutions/Rainbow<br />
Scientific, Inc. ..................................................... 402<br />
IntegenX Inc. ....................................................... 1311<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
NanoString Technologies, Inc................................ 210<br />
New England Biolabs, Inc. .................................... 904<br />
NVIGEN ............................................................... 1403<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Thermo Scientific................................................... 624<br />
USB products from Affymetrix .............................. 925<br />
REFERENCE LABORATORY TESTING<br />
Athena Diagnostics ............................................. 1308<br />
Cincinnati Children’s Hospital Medical Center .... 1505<br />
Laboratory for Molecular Medicine, PCPGM ...... 1225<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
Transgenomic, Inc. ................................................ 505<br />
UCLA Clinical Genomics Center ........................... 923<br />
REPORTER ASSAYS<br />
SwitchGear Genomics........................................... 305<br />
RESEARCH DATABASE<br />
AGRE-Autism Genetic Resource Exchange .......... 319<br />
BC Platforms Ltd ................................................... 819<br />
Biobase Corporation ........................................... 1319<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
Pubget, Inc. ......................................................... 1520<br />
Sanford Research .................................................. 325<br />
University <strong>of</strong> Southern California, Information<br />
Sciences Institute ............................................... 226<br />
RESEARCH GRANTS & FELLOWSHIPS<br />
AGRE-Autism Genetic Resource Exchange .......... 319<br />
CIHR Institute <strong>of</strong> <strong>Genetics</strong> ................................... 1321<br />
RETROVIRAL EXPRESSION SYSTEM<br />
Thermo Scientific................................................... 624<br />
RISK ASSESSMENT<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
RNA<br />
Advanced Analytical ............................................ 1304<br />
BioReliance ........................................................... 604<br />
Coriell Institute for Medical Research ................... 312<br />
DNA Genotek ........................................................ 900<br />
Exiqon ................................................................. 1712<br />
Expression Analysis ............................................... 508<br />
Illumina, Inc. ........................................................ 1109<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
NanoString Technologies, Inc................................ 210<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Seven Bridges Genomics .................................... 1204<br />
Thermo Scientific................................................... 624<br />
RNA/DNA/PROTEIN PURIFICATION FROM THE<br />
SAME SAMPLE<br />
Norgen Biotek Corp............................................... 208<br />
RNA ISOLATION<br />
Bio-Rad ................................................................. 524<br />
BioReliance ........................................................... 604<br />
chemagen from PerkinElmer ............................... 1426<br />
Epicentre (an Illumina company) ......................... 1218<br />
Exiqon ................................................................. 1712<br />
Expression Analysis ............................................... 508<br />
Life Technologies ................................................... 601<br />
New England Biolabs, Inc. .................................... 904<br />
NVIGEN ............................................................... 1403
Phalanx Biotech Group ......................................... 307<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Roche Applied Science ......................................... 701<br />
RNA ISOLATION KITS<br />
AutoGen, Inc. ........................................................ 807<br />
Bioline USA Inc. ................................................... 1324<br />
Bio-Rad ................................................................. 524<br />
chemagen from PerkinElmer ............................... 1426<br />
Diagenode Inc ....................................................... 406<br />
Exiqon ................................................................. 1712<br />
New England Biolabs, Inc. .................................... 904<br />
Phalanx Biotech Group ......................................... 307<br />
Zymo Research Corporation ................................. 400<br />
RNA MARKERS<br />
Affymetrix, Inc. ...................................................... 918<br />
New England Biolabs, Inc. .................................... 904<br />
RNA/MICRORNA PURIFICATION KITS<br />
Norgen Biotek Corp............................................... 208<br />
RNA PURIFICATION<br />
Affymetrix, Inc. ...................................................... 918<br />
BioReliance ........................................................... 604<br />
Expression Analysis ............................................... 508<br />
Life Technologies ................................................... 601<br />
NVIGEN ............................................................... 1403<br />
trinean .................................................................. 1605<br />
USB products from Affymetrix .............................. 925<br />
RNA PURIFICATION KITS<br />
Affymetrix, Inc. ...................................................... 918<br />
Agilent Technologies ............................................. 609<br />
AutoGen, Inc. ........................................................ 807<br />
NVIGEN ............................................................... 1403<br />
USB products from Affymetrix .............................. 925<br />
Zymo Research Corporation ................................. 400<br />
RNA-SEQ SAMPLE PREP KITS<br />
Epicentre (an Illumina company) ......................... 1218<br />
RNA SEQUENCING<br />
NXT-Dx ................................................................ 1025<br />
RNA SYNTHESIS PRODUCTS<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
Exiqon ................................................................. 1712<br />
IntegenX Inc. ....................................................... 1311<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
ROBOTIC ARRAYING SYSTEMS<br />
Labcyte Inc. ......................................................... 1402<br />
ROBOTIC COLONY PICKERS<br />
Hamilton Company .............................................. 1613<br />
ROBOTIC SAMPLE PROCESSORS<br />
Agilent Technologies ............................................. 609<br />
Diagenode Inc ....................................................... 406<br />
PRODUCT AND SERVICE INDEX 321<br />
Hamilton Company .............................................. 1613<br />
IntegenX Inc. ....................................................... 1311<br />
Microsonic Systems Inc. ....................................... 618<br />
SciGene ................................................................. 619<br />
Tecan ..................................................................... 405<br />
ROBOTIC SUPPLIES<br />
Tecan ..................................................................... 405<br />
ROBOTIC WORKSTATIONS<br />
Agilent Technologies ............................................. 609<br />
Beckman Coulter, Inc. ......................................... 1601<br />
chemagen from PerkinElmer ............................... 1426<br />
Diagenode Inc ....................................................... 406<br />
Hamilton Company .............................................. 1613<br />
Microsonic Systems Inc. ....................................... 618<br />
SciGene ................................................................. 619<br />
Tecan ..................................................................... 405<br />
trinean .................................................................. 1605<br />
RT-PCR KITS<br />
AnaSpec Inc, Eurogentec Group ......................... 1100<br />
ASURAGEN, INC. .................................................. 503<br />
BioFire Diagnostics ............................................... 719<br />
Bioline USA Inc. ................................................... 1324<br />
Epicentre (an Illumina company) ......................... 1218<br />
Exiqon ................................................................. 1712<br />
Illumina, Inc. ........................................................ 1109<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
Life Technologies ................................................... 601<br />
New England Biolabs, Inc. .................................... 904<br />
Roche Applied Science ......................................... 701<br />
Thermo Scientific................................................... 624<br />
USB products from Affymetrix .............................. 925<br />
SALIVA DNA COLLECTION KITS<br />
Norgen Biotek Corp............................................... 208<br />
SALIVA DNA PURIFICATION KITS<br />
Norgen Biotek Corp............................................... 208<br />
SAMPLE ARCHIVING<br />
DNA Genotek ........................................................ 900<br />
Epicentre (an Illumina company) ......................... 1218<br />
IntegenX Inc. ....................................................... 1311<br />
SAMPLE INVENTORY MANAGEMENT<br />
SOLUTIONS<br />
Data Unlimited International, Inc. ........................ 1503<br />
IntegenX Inc. ....................................................... 1311<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
SAMPLE PREPARATION<br />
BC Platforms Ltd ................................................... 819<br />
Beckman Coulter, Inc. ......................................... 1601<br />
Covaris Inc. ......................................................... 1008<br />
Diagenode Inc ....................................................... 406<br />
DNA Genotek ........................................................ 900<br />
Epigentek Group Inc. ........................................... 1127<br />
Expression Analysis ............................................... 508<br />
PRODUCT INDEX
322 PRODUCT AND SERVICE INDEX<br />
IntegenX Inc. ....................................................... 1311<br />
Life Technologies ................................................... 601<br />
Microsonic Systems Inc. ....................................... 618<br />
New England Biolabs, Inc. .................................... 904<br />
Prognosys Biosciences, Inc. ................................. 304<br />
RainDance Technologies, Inc. ............................... 910<br />
Rubicon Genomics, Inc. ........................................ 803<br />
Sage Science Inc. ................................................ 1510<br />
SciGene ................................................................. 619<br />
Tecan ..................................................................... 405<br />
trinean .................................................................. 1605<br />
Zymo Research Corporation ................................. 400<br />
SCIENTIFIC ASSOCIATION<br />
Science/AAAS ..................................................... 1312<br />
SCREENING TESTS<br />
Applied StemCell, Inc. ........................................... 527<br />
BioReliance ........................................................... 604<br />
Greenwood Genetic Center ................................. 1027<br />
MRC-Holland ....................................................... 1122<br />
Thermo Scientific................................................... 624<br />
SEQUENCE ALIGNMENT AND VARIANT<br />
CALLING<br />
Genformatic ......................................................... 1420<br />
SEQUENCE ANALYSIS SOFTWARE<br />
BC Platforms Ltd ................................................... 819<br />
Cartagenia ........................................................... 1022<br />
CLC bio ................................................................. 501<br />
DNASTAR, Inc. ...................................................... 801<br />
EdgeBio ............................................................... 1506<br />
Enlis Genomics ...................................................... 203<br />
Genformatic ......................................................... 1420<br />
Hitachi Solutions America Ltd. ............................ 1502<br />
Illumina, Inc. ........................................................ 1109<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
JSI medical systems GmbH ................................ 1023<br />
Knome, Inc. ......................................................... 1007<br />
Life Technologies ................................................... 601<br />
Omixon Biocomputing .......................................... 205<br />
Palmyra S<strong>of</strong>tware ................................................ 1519<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Prognosys Biosciences, Inc. ................................. 304<br />
Seven Bridges Genomics .................................... 1204<br />
Spiral <strong>Genetics</strong> ...................................................... 113<br />
SEQUENCING ACCESSORIES<br />
Diagenode Inc ....................................................... 406<br />
EdgeBio ............................................................... 1506<br />
Epicentre (an Illumina company) ......................... 1218<br />
Illumina, Inc. ........................................................ 1109<br />
IntegenX Inc. ....................................................... 1311<br />
Microsonic Systems Inc. ....................................... 618<br />
New England Biolabs, Inc. .................................... 904<br />
SEQUENCING BUFFERS<br />
EdgeBio ............................................................... 1506<br />
Life Technologies ................................................... 601<br />
USB products from Affymetrix .............................. 925<br />
SEQUENCING QC FOR PRIMERS<br />
Prognosys Biosciences, Inc. ................................. 304<br />
SEQUENCING SERVICES<br />
Axeq Technologies ................................................ 820<br />
Baylor College <strong>of</strong> Medicine, Medical <strong>Genetics</strong><br />
Laboratories........................................................ 711<br />
BGI ...................................................................... 1419<br />
BioReliance ........................................................... 604<br />
Center for Inherited Disease Research (CIDR) ...... 119<br />
Complete Genomics, Inc. ...................................... 907<br />
EdgeBio ............................................................... 1506<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Expression Analysis ............................................... 508<br />
GeneDx ................................................................ 1119<br />
Genformatic ......................................................... 1420<br />
Illumina, Inc. ........................................................ 1109<br />
Knome, Inc. ......................................................... 1007<br />
Myriad Genetic Laboratories ............................... 1501<br />
Prevention<strong>Genetics</strong> LLC ...................................... 1318<br />
Prognosys Biosciences, Inc. ................................. 304<br />
RUCDR ................................................................ 1102<br />
SeqWright, Inc. ...................................................... 726<br />
UCLA Clinical Genomics Center ........................... 923<br />
Zymo Research Corporation ................................. 400<br />
SERUM<br />
Exiqon ................................................................. 1712<br />
SIGNAL AMPLIFICATION<br />
Natera .................................................................... 504<br />
SNP ANALYTICAL SERVICES<br />
Axeq Technologies ................................................ 820<br />
BioReliance ........................................................... 604<br />
EdgeBio ............................................................... 1506<br />
Expression Analysis ............................................... 508<br />
Genformatic ......................................................... 1420<br />
Golden Helix, Inc. .................................................. 818<br />
Knome, Inc. ......................................................... 1007<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Prognosys Biosciences, Inc. ................................. 304<br />
RUCDR ................................................................ 1102<br />
SeqWright, Inc. ...................................................... 726<br />
Seven Bridges Genomics .................................... 1204<br />
Signature Genomics from PerkinElmer ............... 1327<br />
UCLA Clinical Genomics Center ........................... 923<br />
SNP DETECTION PROBES<br />
Integrated DNA Technologies, Inc. ........................ 301<br />
Natera .................................................................... 504
SNP GENOTYPING ANALYSIS<br />
EpigenDx ............................................................... 721<br />
SNP SCORING<br />
BioReliance ........................................................... 604<br />
Enlis Genomics ...................................................... 203<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
SNP SCREENING<br />
Ambry <strong>Genetics</strong> ..................................................... 311<br />
BioFire Diagnostics ............................................... 719<br />
Enlis Genomics ...................................................... 203<br />
Fluidigm Corporation ............................................. 725<br />
Genformatic ......................................................... 1420<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
Life Technologies ................................................... 601<br />
Pacific Biosciences ............................................... 610<br />
Seven Bridges Genomics .................................... 1204<br />
SOCIETY<br />
European <strong>Human</strong> <strong>Genetics</strong> Conference 2013 ....... 219<br />
SOFTWARE<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
BC Platforms Ltd ................................................... 819<br />
CLC bio ................................................................. 501<br />
Data Unlimited International, Inc. ........................ 1503<br />
DNAnexus, Inc. ...................................................... 507<br />
DNASTAR, Inc. ...................................................... 801<br />
Enlis Genomics ...................................................... 203<br />
GeneInsight ......................................................... 1224<br />
Genformatic ......................................................... 1420<br />
Genial Genetic Solutions/Rainbow<br />
Scientific, Inc. ..................................................... 402<br />
GenoLogics ......................................................... 1105<br />
Golden Helix, Inc. .................................................. 818<br />
Ingenuity Systems, Inc. ....................................... 1101<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
JSI medical systems GmbH ................................ 1023<br />
Knome, Inc. ......................................................... 1007<br />
Leica Microsystems Corp ...................................... 824<br />
National Center for Biotechnology Information ..... 224<br />
NextGxDx .............................................................. 411<br />
Omixon Biocomputing .......................................... 205<br />
Oxford Gene Technology ....................................... 302<br />
Palmyra S<strong>of</strong>tware ................................................ 1519<br />
Partek Incorporated............................................. 1307<br />
POSSUM - Murdoch Childrens Research<br />
Institute ............................................................... 218<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
SCC S<strong>of</strong>t Computer ............................................ 1618<br />
Seven Bridges Genomics .................................... 1204<br />
Spiral <strong>Genetics</strong> ...................................................... 113<br />
STARLIMS ........................................................... 1400<br />
SOFTWARE AND DATABASE TOOLS FOR<br />
VARIANT TRIAGE AND LAB REPORTING<br />
AUTOMATION<br />
Cartagenia ........................................................... 1022<br />
PRODUCT AND SERVICE INDEX 323<br />
SOFTWARE - ARRAY ANALYSIS<br />
Agilent Technologies ............................................. 609<br />
BC Platforms Ltd ................................................... 819<br />
Biobase Corporation ........................................... 1319<br />
BioDiscovery, Inc. .................................................. 813<br />
BlueGnome Limited ............................................... 209<br />
Cartagenia ........................................................... 1022<br />
DNASTAR, Inc. ...................................................... 801<br />
Golden Helix, Inc. .................................................. 818<br />
Ingenuity Systems, Inc. ....................................... 1101<br />
Oxford Gene Technology ....................................... 302<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Phalanx Biotech Group ......................................... 307<br />
Signature Genomics from PerkinElmer ............... 1327<br />
SOFTWARE - DATA MANAGING<br />
AGRE-Autism Genetic Resource Exchange .......... 319<br />
BC Platforms Ltd ................................................... 819<br />
BioDiscovery, Inc. .................................................. 813<br />
BlueGnome Limited ............................................... 209<br />
Cartagenia ........................................................... 1022<br />
CLC bio ................................................................. 501<br />
Data Unlimited International, Inc. ........................ 1503<br />
GeneInsight ......................................................... 1224<br />
Genformatic ......................................................... 1420<br />
GenoLogics ......................................................... 1105<br />
Hitachi Solutions America Ltd. ............................ 1502<br />
Interactive Bios<strong>of</strong>tware .......................................... 413<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
SCC S<strong>of</strong>t Computer ............................................ 1618<br />
STARLIMS ........................................................... 1400<br />
SOFTWARE - PEDIGREE DRAWING<br />
BC Platforms Ltd ................................................... 819<br />
Progeny S<strong>of</strong>tware, LLC ......................................... 518<br />
SOLID PHASE EXTRACTION<br />
Hamilton Company .............................................. 1613<br />
SONICATORS & ACCESSORIES<br />
Diagenode Inc ....................................................... 406<br />
SPECTROPHOTOMETER<br />
trinean .................................................................. 1605<br />
SPIN COLUMNS<br />
Zymo Research Corporation ................................. 400<br />
STATISTICAL GENETICS CONSULTATION<br />
Center for Inherited Disease Research (CIDR) ...... 119<br />
STORAGE PRODUCTS<br />
DNA Genotek ........................................................ 900<br />
EMC Isilon ........................................................... 1320<br />
SYRINGES<br />
Hamilton Company .............................................. 1613<br />
PRODUCT INDEX
324 PRODUCT AND SERVICE INDEX<br />
TARGET ENRICHMENT KITS<br />
Prognosys Biosciences, Inc. ................................. 304<br />
TELOMERE SPECIFIC PROBES<br />
Cytocell Ltd/Rainbow Scientific, Inc. .................... 404<br />
MRC-Holland ....................................................... 1122<br />
TEMPLATE PREPARATION KITS<br />
Pacific Biosciences ............................................... 610<br />
TEST KITS<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
Myriad Genetic Laboratories ............................... 1501<br />
Transgenomic, Inc. ................................................ 505<br />
THERMAL CYCLERS<br />
Agilent Technologies ............................................. 609<br />
Bio-Rad ................................................................. 524<br />
Life Technologies ................................................... 601<br />
SciGene ................................................................. 619<br />
Streck .................................................................. 1600<br />
THERMAL PLATE SEALER<br />
Bio-Rad ................................................................. 524<br />
THERMAL PROFILING SYSTEMS<br />
SciGene ................................................................. 619<br />
THERMOSTABLE DNA POLYMERASE<br />
Affymetrix, Inc. ...................................................... 918<br />
New England Biolabs, Inc. .................................... 904<br />
USB products from Affymetrix .............................. 925<br />
TISSUE CULTURE MEDIA<br />
Life Technologies ................................................... 601<br />
TISSUE CULTURES<br />
BioReliance ........................................................... 604<br />
TISSUE MICROSCOPY<br />
PerkinElmer, Inc. Life Sciences & Technology ..... 1325<br />
TOXICITY TESTS<br />
Myriad Genetic Laboratories ............................... 1501<br />
Therapeutics for Rare and Neglected Diseases .... 220<br />
TRAINING<br />
Emory <strong>Genetics</strong> Laboratory................................... 211<br />
Laboratory for Molecular Medicine, PCPGM ...... 1225<br />
TRAINING COURSES<br />
BlueGnome Limited ............................................... 209<br />
<strong>Human</strong> Variome Project Int. Ltd ............................ 221<br />
TRANSCRIPTION REAGENTS<br />
New England Biolabs, Inc. .................................... 904<br />
TRANSCRIPTOME<br />
Axeq Technologies ................................................ 820<br />
TRANSFECTION REAGENTS<br />
New England Biolabs, Inc. .................................... 904<br />
Thermo Scientific................................................... 624<br />
USB products from Affymetrix .............................. 925<br />
TRAVEL AWARDS<br />
FASEB ................................................................. 1700<br />
TRISOMY DETECTION<br />
Ariosa Diagnostics ............................................... 1609<br />
TWIN ZYGOSITY TESTING<br />
UCLA Clinical Genomics Center ........................... 923<br />
ULTRAVIOLET PRODUCTS -<br />
TRANSILLUMINATORS<br />
Embi Tec .............................................................. 1406<br />
UPD TESTING<br />
Greenwood Genetic Center ................................. 1027<br />
UV/VIS SPECTROPHOTOMETERS<br />
trinean .................................................................. 1605<br />
VARIANT ANNOTATION AND PREDICTION<br />
OF PROBABLE PHENOTYPIC EFFECT OF<br />
VARIANTS<br />
Genformatic ......................................................... 1420<br />
VIDEO CAMERAS (COLOR) FOR MICROSCOPY<br />
Applied Spectral Imaging, Inc. ............................ 1220<br />
WATER BATHS<br />
SciGene ................................................................. 619<br />
WESTERN BLOTTING EQUIPMENT<br />
Bio-Rad ................................................................. 524<br />
Tecan ..................................................................... 405<br />
WESTERN BLOTTING KITS<br />
Bio-Rad ................................................................. 524<br />
WHOLE EXOME SEQUENCING<br />
Center for Inherited Disease Research (CIDR) ...... 119<br />
UCLA Clinical Genomics Center ........................... 923<br />
WHOLE GENOME AND EXOME ANALYSIS<br />
Genformatic ......................................................... 1420<br />
WHOLE GENOME SEQUENCING<br />
Axeq Technologies ................................................ 820<br />
YEAST TWO-HYBRID SYSTEMS<br />
Thermo Scientific................................................... 624
CMEs and CEUs<br />
Poster Sessions are not eligible for CME or CEU credits<br />
For questions, contact ashgmeetings@ashg.org.<br />
CMEs and CEUs 325<br />
Continuing Medical Education Credits (CMEs)<br />
The <strong>ASHG</strong> <strong>2012</strong> Annual Meeting has been planned and implemented in accordance<br />
with the Essential Areas and policies <strong>of</strong> the Accreditation Council for Continuing<br />
Medical Education (ACCME) through the joint sponsorship <strong>of</strong> the <strong>American</strong> College<br />
<strong>of</strong> Medical <strong>Genetics</strong> and Genomics (ACMG) and <strong>ASHG</strong>. ACMG is accredited by<br />
the ACCME to provide continuing medical education for physicians. All educational<br />
programming is developed and must be presented in compliance with all<br />
ACCME accreditation requirements and therefore, ACMG designates this educational<br />
activity for a maximum <strong>of</strong> 25.75 AMA PRA Category 1 Credit(s) TM . Physicians<br />
should only claim credit commensurate with the extent <strong>of</strong> their participation in the<br />
activity.<br />
Procedures: There is a non-refundable $45 fee payable during the registration<br />
process. You can apply for credits through the online application available<br />
November 10, <strong>2012</strong>. The deadline to submit your request is December 28, <strong>2012</strong>.<br />
Attendees may pick up self-reporting tracking forms in either the <strong>ASHG</strong> Office, Room<br />
111 or at the Information Counter located in the Registration Area, North Lobby <strong>of</strong><br />
the Moscone Center. Please see section below for the learning objectives, target<br />
audience, disclosure policy and a list <strong>of</strong> authors with disclosures <strong>of</strong> potential conflicts<br />
<strong>of</strong> interest.<br />
MDs and PhDs should apply for CMEs. The <strong>American</strong> Board <strong>of</strong> Medical <strong>Genetics</strong><br />
(ABMG) will accept CMEs for MDs or PhDs participating in the Maintenance <strong>of</strong><br />
Certification (MOC) program in any ABMG specialty.<br />
Continuing Education Unit Credits (CEUs) for California-Licensed Clinical and<br />
Molecular Laboratory Directors<br />
<strong>ASHG</strong> has been approved for Continuing Education Units for up to 24.5 units through<br />
the Pr<strong>of</strong>essional Acknowledgment for Continuing Education (P.A.C.E. ® ) program for<br />
California-Licensed Clinical and Molecular Laboratory Directors.<br />
Procedures: There is a non-refundable $35 fee payable during the registration<br />
process. Those who registered in advance received an e-mail with instructions and<br />
a copy <strong>of</strong> the self-reporting tracking. You may also pick up your CEU packet in the<br />
<strong>ASHG</strong> Meeting Office, Room 111. The deadline to submit your request for PACE<br />
credits is Monday, December 3, <strong>2012</strong>. No requests will be taken after this date.<br />
Clinical Laboratory Scientists should apply for PACE CEUs. ABMG will accept PACE<br />
CEUs for diplomats participating in the MOC program in the following categories: Clinical<br />
Biochemical Geneticist, Clinical Cytogeneticist, and Clinical Molecular Geneticist.<br />
CMEs and CEUs
326 CMEs and CEUs<br />
Continuing Education Unit Credits (CEUs) for Genetic Counselors<br />
<strong>ASHG</strong> has been approved for up to 25.75 Category 1 CEU credits (25 contact hours)<br />
for genetic counselors through the National <strong>Society</strong> <strong>of</strong> Genetic Counselors (NSGC).<br />
NSGC is approved as an authorized provider <strong>of</strong> continuing education and training by<br />
the International Association for Continuing Education and Training (IACET).<br />
Procedures: There is a non-refundable $40 fee payable during the registration<br />
process. Registrants MUST apply for credits via the online submission system<br />
after the meeting. The submission site will open on Saturday, November 10, <strong>2012</strong>.<br />
The deadline to request credits is Monday, December 3, <strong>2012</strong>. No submissions will<br />
be taken after this deadline. You will need your registration ID in order to successfully<br />
complete the CEU application. Those who registered in advance received an e-mail<br />
with instructions and a copy <strong>of</strong> the tracking form. For your convenience, tracking forms<br />
will also be available in the <strong>ASHG</strong> Meeting Office, Room 111 or at the Information<br />
Center located in the Registration Area, North Lobby.<br />
Genetic Counselors and Nurses should apply for CEUs. The <strong>American</strong> Board <strong>of</strong><br />
Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes<br />
<strong>of</strong> certification and recertification.<br />
<strong>ASHG</strong> <strong>2012</strong> Learning Objectives<br />
All attendees obtaining CME credits will be able to apply the newly acquired knowledge<br />
and methods in the evaluation, diagnosis, intervention, treatment and follow-up <strong>of</strong> patients<br />
with a variety <strong>of</strong> disorders. At the completion <strong>of</strong> the meeting, participants will be able to: (1)<br />
recognize gaps in knowledge <strong>of</strong> facts and new methods in genetics; (2) demonstrate ways<br />
that the new information and its context may be applied in their own practices; (3) better<br />
interpret results <strong>of</strong> complex genetic tests and recognize instances <strong>of</strong> most appropriate<br />
use; and (4) understand in detail the benefits and potential harms <strong>of</strong> utilizing the newest<br />
genetic technologies. The <strong>2012</strong> <strong>ASHG</strong> Annual Meeting will help attendees to:<br />
• Identify and fill gaps in knowledge in human genetics in areas <strong>of</strong> statistical<br />
analysis, full genome sequencing, next-generation sequencing, genetic<br />
neurodegenerative and other disorders, and epigenetics.<br />
• Explain the value and use <strong>of</strong> newest technological methods in full genome<br />
sequencing in diagnosis <strong>of</strong> disorders and family studies.<br />
• Provide context from discussions on the benefits and harms <strong>of</strong> returning<br />
results <strong>of</strong> full genome sequencing to patients.<br />
• Set principles for the provision <strong>of</strong> results and their interpretation in full genome<br />
sequencing and the diagnosis <strong>of</strong> genetic risks and explain how genome<br />
sequencing may be useful in an undiagnosed patient.<br />
• Accrue guidelines for the successful counseling <strong>of</strong> patients receiving complex<br />
genetic results.<br />
• Present the newest results <strong>of</strong> gene therapy trials so clinicians may enroll<br />
patients or apply therapies to appropriate patents.<br />
• Identify and explain the newest non-invasive pre-natal diagnostic methods.<br />
• Integrate results <strong>of</strong> genomic testing into electronic health records and other<br />
methods to store information.
CMEs and CEUs 327<br />
• Recognize methods to utilize centralized databases in the diagnosis and<br />
treatment <strong>of</strong> patients.<br />
<strong>ASHG</strong> <strong>2012</strong> Target Audience<br />
This meeting is targeted to research scientists, clinical and laboratory practitioners<br />
and others interested in the field <strong>of</strong> human genetics and genomics. There is some<br />
special focus on workshops intended for trainees. The program is varied so that<br />
participants may select from several concurrent sessions that fit their specialized<br />
research interests and clinical practice applications.<br />
<strong>Program</strong> Format<br />
Invited Sessions<br />
The <strong>2012</strong> program is highlighted by 24 invited scientific sessions that have been<br />
scheduled over three concurrent time periods. The <strong>Program</strong> Committee reviewed<br />
95 proposals for invited sessions. The review process took into consideration the<br />
merit and timeliness <strong>of</strong> each proposal as well as the need to balance topics in the<br />
overall scientific program. The sessions highlight a wide range <strong>of</strong> topics <strong>of</strong> interest to<br />
genetics practitioners, researchers and counselors. Any conflicts were managed in<br />
the process described above.<br />
Plenary Session Presentations and Platform Sessions (abstract-driven)<br />
The Plenary Session includes a diverse set <strong>of</strong> six presentations, selected from the<br />
top-rated abstracts submitted for this year’s annual meeting as determined by the<br />
<strong>2012</strong> <strong>Program</strong> Committee. Forty-five abstract-driven platform sessions totaling<br />
405 oral presentations have been programmed. There are five sets <strong>of</strong> nine concurrent<br />
platform sessions.<br />
The <strong>Program</strong> Committee had the difficult task <strong>of</strong> determining which abstracts would<br />
be accepted, and in what presentation format. Below is a brief description <strong>of</strong> how this<br />
task was performed:<br />
1. Based on the author’s topic preference and keyword selection, an abstract<br />
was initially reviewed by the <strong>Program</strong> Committee member responsible for<br />
that topic. If it was determined that the abstract would be more appropriately<br />
categorized under another topic, it was transferred to that topic. Sub-topic<br />
designations were helpful in assigning abstracts to the most appropriate topic.<br />
2. Each abstract was then electronically sent to three reviewers (including a<br />
<strong>Program</strong> Committee member) who are experts in the field. Each reviewer<br />
scored the abstracts independently and without knowledge <strong>of</strong> the score given<br />
by the other reviewers. Abstracts were then assigned a score from 1 (highest<br />
priority) to 8 (reject). The best cumulative score that an abstract could obtain<br />
from all three reviewers was a 3 (1+1+1). Any conflicts were managed in the<br />
process described above.<br />
3. In general, abstracts receiving scores within the top 8% for each topic were<br />
selected for platform (oral) presentations. The number <strong>of</strong> available oral<br />
CMEs and CEUs
328 CMEs and CEUs<br />
presentations for a given topic was in rough proportion to the number <strong>of</strong><br />
abstracts submitted for that topic, with some discretion given to the <strong>Program</strong><br />
Committee to adjust for the quality <strong>of</strong> abstracts in each topic in a given year.<br />
This created a total number <strong>of</strong> 411 oral presentations.<br />
4. The top scoring abstracts from each topic were then considered by the<br />
<strong>Program</strong> Committee for possible inclusion in the plenary session. Selection <strong>of</strong><br />
plenary session presentations was based not only on the cumulative scores,<br />
but also on the impact <strong>of</strong> the science being presented and the balance <strong>of</strong><br />
topics in the session. Six abstracts were finally chosen to constitute the<br />
plenary session in recognition <strong>of</strong> the speed at which new, high-impact scientific<br />
discoveries are now being made in human genetics.<br />
5. The concurrent platform sessions were then assembled from the remaining<br />
405 abstracts chosen for oral presentations (step 3 above, minus the 6 plenary<br />
abstracts). Within the constraints that each concurrent session has exactly<br />
nine abstracts, these platform sessions typically contain abstracts grouped<br />
by topic/approach. Some <strong>of</strong> the platform sessions are “multidisciplinary”<br />
sessions centered around a topic and are designed to bring together<br />
investigators interested in that topic from diverse areas <strong>of</strong> genetics.<br />
RECORDED PRESENTATIONS AVAILABLE AFTER THE MEETING<br />
Invited Sessions, Award Presentations, and the Plenary Sessions will be<br />
recorded and posted on the Web site after the meeting.<br />
These recordings are free to meeting registrants.<br />
Visit the <strong>ASHG</strong> Web site in early December to view these presentations.
SPEAKER AND AUTHOR DISCLOSURES<br />
In accordance with the Accreditation Council for Continuing Medical Education<br />
through the joint sponsorship <strong>of</strong> the <strong>American</strong> College <strong>of</strong> Medical <strong>Genetics</strong> and<br />
Genomics (ACMG) and <strong>ASHG</strong>, all faculty, speakers and moderators must disclose<br />
the existence <strong>of</strong> any financial interest and/or other relationship(s) they might have with<br />
the manufacturer(s) or provider(s) <strong>of</strong> any commercial product(s) or service(s) to be<br />
discussed during their presentation: receiving a salary, royalty, intellectual property<br />
rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or<br />
other ownership interest, excluding diversified mutual funds), or other financial benefit.<br />
Financial benefits are usually associated with roles such as employment, management<br />
position, independent contractor (including contracted research), consulting,<br />
speaking and teaching, membership on advisory committees or review panels, board<br />
membership, and other activities for which remuneration is received or expected.<br />
If members <strong>of</strong> the <strong>ASHG</strong> <strong>2012</strong> <strong>Program</strong> Committee indicated a relationship which<br />
could be perceived by some as a real or apparent conflict <strong>of</strong> interest in planning the<br />
program, the committee member refrained from discussion. The following presenters<br />
have indicated a relationship that within the context <strong>of</strong> their presentation could be<br />
perceived by some as a real or apparent conflict <strong>of</strong> interest but do not consider that<br />
it will influence their presentation. The disclosures have been reviewed and conflict <strong>of</strong><br />
interest resolved or managed. The number following each company name represents<br />
the specific relationship from the list below.<br />
1. Stock options or bond holdings in a for-pr<strong>of</strong>it corporation or self-directed pension plan<br />
2. Research grants, other grants, scholarships, or fellowships<br />
3. Employment (full or part-time)<br />
4. Ownership or partnership<br />
5. Consulting fees or other remuneration<br />
6. Non-remunerative positions <strong>of</strong> influence such as <strong>of</strong>ficer, board member, trustee,<br />
or public spokesperson<br />
7. Receipt <strong>of</strong> royalties<br />
8. Speakers' bureau<br />
9. Receive substantial in-kind or donated goods or services<br />
10. Inventor/patent owner<br />
11. Advisor<br />
12. Collaboration<br />
13. Company owner<br />
14. Receipt <strong>of</strong> travel grants/honoraria<br />
15. Other<br />
• If a presentation is in a platform session, the abstract number is added in<br />
parentheses.<br />
• If a presenter or organizer is not listed, then that person had no relationship to<br />
disclose.<br />
• Disclosures will also be included in presentation slides.<br />
329<br />
SPEAKER/AUTHOR DISCLOSURES
330 SPEAKER AND AUTHOR DISCLOSURES<br />
Abecasis, G., University <strong>of</strong> Michigan/ArticDx - 7;<br />
GlaxoSmithKline - 2 (Session 7)<br />
Ahmed, A., Genzyme Corporation - 2 (715)<br />
Andersen, M., Life Technologies - 3;<br />
Life Technologies - 1 (1237)<br />
Aradhya, S., GeneDx - 3 (332)<br />
Bachmeyer, R. C., Kailos <strong>Genetics</strong> Inc. - 1, 3, 4, 6 (3527)<br />
Bai, R., GeneDx - 3 (330)<br />
Ballif, B. C., Signature Genomic Laboratories,<br />
PerkinElmer, Inc., Spokane, - 3 (884)<br />
Basel-Vanagaite, L., FDNA Ltd., Herzlyia, Israel - 5 (3185)<br />
Bauer, P., Actelion Pharmaceuticals Ltd - 5 (684)<br />
Baxter, S., GeneDx - 3 (1676)<br />
Bergstrom Lucas, A., Agilent Technologies - 3 (3726)<br />
Berman, J. R., Bio-Rad Laboratories - 3 (3690)<br />
Bianchi, D., Verinata Health, Inc. - 1, 2, 5, 11, 12;<br />
McGraw-Hill - 7; Wiley-Blackwell - 3 (Session 79)<br />
Bibikova, M., Illumina, Inc. - 1, 3 (1238)<br />
Biesecker, L. G., Wiley Blackwell - 5; Illumina Corp - 6<br />
(Session 73)<br />
Billaud, J., Ingenuity Systems - 3 (3677)<br />
Bishop, J., Life Technologies - 3 (3719)<br />
Blangero, J., Eli Lilly and Co - 2 (Session 8)<br />
Bloom, R. J., Agilent Technologies - 9, 12; Pacific<br />
Biosciences - 9, 12 (3659)<br />
Bombard, A. T., Sequenom, Inc. - 1, 3; UCSD - 3, 12<br />
(Session 79)<br />
Bostick, M., Clontech Laboratories, Inc - 3 (3727)<br />
Boyar, F. Z., Quest Diagnostics - 3, 10;<br />
Genomic Vision - 10, 12 (3522)<br />
Boysen, C., CLC bio - 3 (3528)<br />
Bready, B., Nabsys - 1, 3, 4, 10, 13 (3529)<br />
Brown, M. P. S., Pacific Biosciences <strong>of</strong> California -<br />
1, 3 (36)<br />
Brownstein, C. A., Boston Children’s Hospital - 3 (1769)<br />
Busche, S., WaferGen - 12 (256)<br />
Carulli, J. P., Biogen Idec - 1, 2, 3, 12 (2561)<br />
Casanova, J.-L., San<strong>of</strong>i-Aventis - 5, 11; Merck - 5<br />
(Session 80)<br />
Casuga, I., Ion Torrent/Life Technologies - 3 (3278)<br />
Chao, E. C., Ambry <strong>Genetics</strong> - 3 (2907)<br />
Cheng, S., Genzyme, a San<strong>of</strong>i Company - 1, 3, 10<br />
(793)<br />
Chiabai, M. A., CNPq - 2; FAP-DF - 2 (1202)<br />
Cho, J. H., Pfizer - 5 (Session 80)<br />
Chowdry, A. B., 23andMe Inc. - 1, 3 (1620)<br />
Cipriani, V., Cambridge Enterprise on behalf <strong>of</strong><br />
Cambridge University - 10; UCL business on behalf<br />
<strong>of</strong> University College London - 10 (2072)<br />
Conklin, B., iPierian Inc - 1 (Session 78)<br />
Conley, Y. P., University <strong>of</strong> Pittsburgh - 10 (1963)<br />
Costa, P., Agilent Technologies - 3 (922)<br />
Dai, X., Academy <strong>of</strong> Finland - 2; University <strong>of</strong><br />
Helsinki - 3; Chancellor’s Travel Grant - 14 (1265)<br />
DaRe, J., Transgenomic, Inc. - 1, 3 (688)<br />
Darnell, R. B., MSKCC (cloning Ri antigen) -<br />
7 (Session 24)<br />
Davidson, C., Life Technologies - 3 (3684)<br />
De La Vega, F., Omicia, Inc. - 1, 3, 5 (1770)<br />
Delio, M., NIH Grant Support - 2 (1494)<br />
de Paor, A., Irish Research Council for the <strong>Human</strong>ities<br />
& Social Sciences - 2 (1812)<br />
Dermitzakis, E. T., DNAnexus - 11 (561)<br />
Dewey, F., Personalis - 5 (1601)<br />
Dickson, P., BioMarin - 2; Genzyme - 2 (785)<br />
Durand, E. Y., 23andMe, Inc. - 3 (179)<br />
Eberle, M. A., Illumina - 1, 3 (942)<br />
Ehm, M. G., GlaxoSmithKline - 1, 2 (649)<br />
Eicher, J. D., J.S. <strong>Genetics</strong> - 1, 4, 7, 10, 11 (1973)<br />
Elboudwarej, E., Novartis - 5; Genentech - 5;<br />
San<strong>of</strong>i-Aventis - 5; GlaxoSmithKilne - 5 (3454)<br />
Erez, A., Neogenis - 12 (165)<br />
Eriksson, N., 23andMe - 1, 3 (114); Boehringer<br />
Ingelheim - 12 (619)<br />
Fagerholm, R., On-Q-ity Inc. - 12 (1171)<br />
Falk, M. J., United Mitochondrial Disease<br />
Foundation - 6 (2943)<br />
Feinerman, B., StemCellRegenMed - 3 (792)<br />
Francke, U., 23andMe, Inc. - 3 (1782)<br />
Friedlander, C., Fluidigm Incorp. - 1, 3 (3652)<br />
Gai, X., Agilent - 12 (3653)<br />
Gajecka, M., PerkinElmer, Inc., Spokane - 3 (934)<br />
Ganesh, S. K., Affymetrix - 11; BioGen Idec - 11 (1639)<br />
Geiss, G., Nanostring Technologies - 1, 3, 10 (1039)<br />
Germain, D. P., Amicus Therapeutics - 14 (772)<br />
Gilbert, D., VitaPath <strong>Genetics</strong>, Inc. - 1, 3 (75)<br />
Goizet, C., Genzyme - 2, 14; Shire - 14; Actelion -<br />
14 (716)<br />
Goker-Alpan, O., Shire HGT - 3, 14, (768)<br />
Gonzalez, K. D., Ambry <strong>Genetics</strong> - 3 (3065)<br />
Green, R. C., 23andMe, Inc. - 9, 12; Pathway<br />
Genomics Corporation - 12 (1825)<br />
Guettouche, T., Caliper - 12; Ion Torrent/Life<br />
Technologies - 14 (3706)<br />
Gunter, C., Kailos <strong>Genetics</strong> - 5 (Session 81)<br />
Hageman, G. S., Sequenom Inc - 5, 11;<br />
Optherion Inc - 10, 15; shareholder (Session 7)<br />
Hagerman, P., US Patent Office - 10; Pacific<br />
Biosciences - 5, 13 (477)<br />
Hagerman, R., Novartis - 2; Roche - 2; Seaside<br />
Therapeutics - 2 (770)<br />
Hart, R. K., Locus Development, Inc. - 1, 3, 4, 10, 13<br />
(3548)<br />
Hartshorne, T., Life Technologies - 3 (1146)<br />
Heckerman, D., Micros<strong>of</strong>t - 1, 3 (1379)<br />
Hegde, M., RainDance - 11; GenomeQuest - 11<br />
(Session 3)<br />
High, K., BioMarin Pharmaceuticals - 5; Bluebird Bio,<br />
Inc. - 1, 5; Bristol-Myers Squibb - 5; Elsevier - 7;<br />
Genzyme, Inc. - 11; INSERM - 15 tool; Jackson<br />
Laboratories - 15; McGraw Hill - 7; Nordic Biotech - 5;<br />
Novo Nordisk - 14, ); PTC Therapeutics - 12;<br />
Sangamo Biosciences|Life Sci (Session 23)<br />
Hirschhorn, J. N., Pfizer - 2 (Session 2, Session 81)<br />
H<strong>of</strong>fman, J., Good Start <strong>Genetics</strong> - 2; Genzyme<br />
Therapeutics - 2 (1729)<br />
Hogg, G., Sequenom Center for Molecular Medicine -<br />
3; Sequenom, Inc. - 3 (2973)<br />
Hoglund, B. N., Roche Molecular Systems - 3 (3713)<br />
Hollox, E. J., Pfizer - 2 (Session 22)<br />
Holstege, H., Life Technologies - 12 (494)<br />
Huang, A., Verinata Health, Inc. - 3 (3007)<br />
Ibrahim, J., Shire HGT - 3, 14 (769)<br />
Jacob, H., Primary <strong>Genetics</strong> - 4 (Session 3)<br />
Jansen Spayd, K., Kailos <strong>Genetics</strong> Inc. - 3 (1245)<br />
Javed, A., Gene Link, Inc - 3 (2631)
Jensen, T. J., Sequenom, Inc. - 1, 3 (3014)<br />
Jeong, K., Agilent Technologies - 3 (3459)<br />
Jiang, R., Williams LifeSkills, Inc. - 1, 4 (2481)<br />
Johnson, F. K., Amicus Therapeutics - 1, 3 (732)<br />
Joun, D., Life Technologies - 3 (1246)<br />
Kaper, F., Illumina, Inc. - 3 (596)<br />
Karczewski, K. J., Personalis - 10 (562)<br />
Kennedy, C. J., Good Start <strong>Genetics</strong> - 1, 3, 10 (3640)<br />
Kitzman, J. O., Univ <strong>of</strong> Washington - 10 (74)<br />
Kong, A., deCode <strong>Genetics</strong> - 3 (Session 75)<br />
Kormanik, K., Hyperion Therapeutics - 2; NIH - 2 (662)<br />
Kutalik, Z., GlaxoSmithKline - 12 (1387)<br />
Laberge, A. M., Fourth Dimension Spine LLC (NYC,<br />
USA) - 2 (1784)<br />
Langmore, J. P., Rubicon Genomics, Inc. - 1, 3, (3689)<br />
Laurance, M., Ingenuity - 3 (3560)<br />
Lebo, R., USPTO-application - 10 (2972)<br />
Le Clerc-Blain, J., Cree Board <strong>of</strong> Health and Social<br />
Services <strong>of</strong> James Bay - 14 (1733)<br />
Ledbetter, D. H., Roche Nimblegen - 5; Celula - 5<br />
(Session 77)<br />
Letra, A., NIH - 2 (1936)<br />
Levy, B., Natera - 1, 5, 11 (73)<br />
Li, C., Life Technologies - 3 (3714)<br />
Li, H., The National Natural Science Foundation <strong>of</strong><br />
China 30770106 - 2 (798)<br />
Li, M., Life Technologies - 14 (399)<br />
Lih, C.-J., Life Technologies - 12 (1068)<br />
Lins, T. C. L., CNPq - 2; CAPES - 2; FAP-DF - 14 (3272)<br />
Liu, P., New England Biolabs - 3 (3715)<br />
Loomis, E. W., Pacific Biosciences <strong>of</strong> California, Inc -<br />
9, 12 (2633)<br />
Lorget, F., BioMarin - 3, 10; INSERM U781 - 12 (763)<br />
Luke, M. M., Celera - 3, 4 (1603)<br />
Luo, M., Mount Sinai School <strong>of</strong> Medicine - 10 (1777)<br />
Lyon, E., Novartis - 5; Complete Genomics - 1, 5;<br />
Oregon Health Sciences - 14; National <strong>Society</strong> <strong>of</strong><br />
Genetic Counselors - 14; University <strong>of</strong> Utah/ARUP<br />
Laboratories- 3; NICHD/NIH- 2; NHGRI/NIH- 2<br />
(Session 3)<br />
Madhusoodanan, J., NextBio - 3 (1183)<br />
Mancini-DiNardo, D., Myriad Genetic Laboratories,<br />
Inc. - 1, 3 (1021)<br />
Manokhina, I., Partnership for Clean Competition - 2<br />
(1760)<br />
Marques, F. A., CNPq - 2; CAPES - 2; FAP-DF - 14 (1880)<br />
Martin, C. L., Emory <strong>Genetics</strong> Laboratory - 3; NIH - 2;<br />
Simons Foundation - 2 (Session 17, Session 77)<br />
Martis, S., MRC Holland - 3 (652)<br />
Marziali, A., Boreal Genomics - 3, 4, 6, 10 (1264)<br />
Matsunami, N., Lineagen Inc. - 1, 2 (2397)<br />
McDonald, M. N., NIH - 2; GlaxoSmithKline funded<br />
ECLIPSE study - 2 (2249)<br />
McInerney, P., Illumina, Inc. - 1, 3; Epicentre, Inc.<br />
(an Illumina company) - 3 (3697)<br />
McKay, G. J., Nutrasight Consultancy Limited - 5 (1897)<br />
Mehta, G. R., Locus Development - 1, 3, 4, 10, 13 (3692)<br />
Menashe, I., MindSpec - 3 (446)<br />
Meredith, G., Life Technologies Corp - 1, 3 (3717)<br />
Mikula, M., Dept Molecular <strong>Genetics</strong>, Quest<br />
Diagnostics Nichols Inst, San - 1, 3 (2260)<br />
Miyagawa, T., Clinical Trial Operations Division, Site<br />
Support Institute C - 3 (2656)<br />
SPEAKER AND AUTHOR DISCLOSURES 331<br />
Morales, A., Informed Medical Decisions, Inc. -<br />
5 (1681)<br />
Moreno, T., Pathway Genomics - 1, 3, 12 (Session 9)<br />
Morford, L., <strong>American</strong> Association <strong>of</strong> Women Dentists -<br />
2; Southern Association <strong>of</strong> Orthodontists - 2 (1147)<br />
Morgan, T., Biomarin - 15; Clinical trial support for all<br />
but the first author (730)<br />
Mountain, J., 23andMe, Inc. - 1, 3 (Session 9)<br />
Mowery-Rushton, P. A., Signature Genomic<br />
Laboratories, PerkinElmer, Inc., Spokane, - 3 (3101)<br />
Moya, P. R., F. H<strong>of</strong>fmann-La Roche AG - 3 (261)<br />
Muller, R., Biomatrica - 3 (3720)<br />
Mullins, M. E., 23andMe, Inc. - 3 (2127)<br />
Munafo, D., New England Biolabs, Inc - 3 (512)<br />
Musci, T., Ariosa Diagnostics - 1, 3 (2978)<br />
Myres, N., AncestryDNA - 3 (3321)<br />
Neale, B. M., Illumina - 14 (2618)<br />
Nestrasil, I., Shire HGT - 2, 5 (714)<br />
Nguyen-Nielsen, M., Edimer Pharmaceuticals<br />
(MA, USA) - 2 (1565)<br />
Nicholls, K., GSK - 1, 3, 14; Amicus - 1, 3, 11, 14 (745)<br />
Niemi, A.-K., United Mitochondrial Disease<br />
Foundation - 2 (744)<br />
Nishida, A., JCR Pharmaceuticals - 3 (781)<br />
Normanno, N., Life Tecnologies - 12 (1060)<br />
Noto, K., Ancestry.com - 1, 3; AncestryDNA - 1 (3365)<br />
Nurmi, E. L., BioMarin - 5; Novartis - 5; Seaside<br />
Therapeutics - 2; Roche - 2 (639)<br />
Nussbaum, R. L., Complete Genomics -<br />
1, 5 (Session 77)<br />
Oeth, P., Sequenom, Inc. - 1; Sequenom Center for<br />
Molecular Medicine - 3 (3016)<br />
Oliver, J. S., Nabsys - 1, 3, 4, 10, 13 (3656)<br />
Ong, F. S., National Institutes <strong>of</strong> Health - 2; Cedars-<br />
Sinai Medical Center - 2; Complete Genomics,<br />
Inc. - 15; Illumina, Inc. - 15; Stock Ownership<br />
(not stock options as in 1) (130)<br />
O’Roak, B. J., Yale University - 10 (10)<br />
Ota, V. K., FAPESP - 2 (2533)<br />
Pallone, N. L., BioMarin - 2; Nutricia - 2; Vitaflo - 2;<br />
Mead Johnson - 2 (742)<br />
Pare, G., Boehringer Ingelheim Pharma Inc. - 2, 5, 8,<br />
12 (617)<br />
Patsalis, P., NIPD <strong>Genetics</strong> Ltd. - 10 (3017)<br />
Peltekova, V., OICR - 2; CIHR - 2; Ontario Research<br />
Funds - 2 (1093)<br />
Peng, Q., QIAGEN - 3 (1263)<br />
Peng, X., Life Technologies - 3 (3698)<br />
Perez-Jurado, L. A., qGenomics - 6, 11 (2711)<br />
Pericak-Vance, M. A., Artic Dx, Inc - 10 (Session 7)<br />
Peterschmitt, M. J., Genzyme - 3 (773)<br />
Phelan, M., NuGEN Technologies, Inc. - 1, 3 (3699)<br />
Porreca, G. J., Good Start <strong>Genetics</strong> - 1, 3, 10 (3680)<br />
Potocki, L., Baylor College <strong>of</strong> Medicine - 3 (Session 28)<br />
Pour-Jafari, H., Hamadan Univ Med Sci - 3 (860)<br />
Powers, N. R., JS <strong>Genetics</strong>, Inc - 4, 7, 10, 11, 13 (2010)<br />
Rabinowitz, M., Natera, Inc. - 3, 1, 10 (3018)<br />
Rath, M., Life Technologies Inc. - 3, 10 (532)<br />
Ray, F. A., KromaTiD Inc. - 1, 3, 4, 10 (948)<br />
Raz, T., GnuBio - 3 (3700)<br />
Rehm, H. L., Partners Healthcare - 3; Complete<br />
Genomics - 11; GenomeQuest - 11; Illumina - 12<br />
(Session 77)<br />
SPEAKER/AUTHOR DISCLOSURES
332 SPEAKER AND AUTHOR DISCLOSURES<br />
Requa, M., BioNano Genomics, Inc - 3 (3649)<br />
Richard, G., GeneDx - 3 (2579)<br />
Richards, S., Life Technologies - 15; Receive<br />
discounted reagents and share data (Session 3)<br />
Rieder, M. J., Adaptive Biotechnologies - 1, 3 (530)<br />
Riley-Gillis, B., H<strong>of</strong>fmann-La Roche - 3 (1252)<br />
Roberts, J. S., 23andMe - 12; Pathway Genomics - 12<br />
(Session 9)<br />
Rodríguez-Santiago, B., Quantitative Medicine<br />
Laboratories - 3 (3208)<br />
Rogan, P. K., Cytognomix - 10 (3672)<br />
Romano-Silva, M., FAPEMIG: CBB-APQ-00075-09 - 2;<br />
CNPq 573646/2008-2 - 2 (2385)<br />
Romero, J. A., Life Technologies - 3 (3708)<br />
Roos, F., Agilent Technologies - 3 (3685)<br />
Rosenfeld, J. A., Signature Genomic Laboratories,<br />
PerkinElmer, Inc. - 3 (274)<br />
Russell, A., Omicia, Inc. - 1, 3, 4 (3602)<br />
Ruvolo, M., Agilent Technologies - 3 (975)<br />
Sá, M. J. N., Harvard Medical School Portugal<br />
<strong>Program</strong> - Junior Award - 2; Fundação para a<br />
Ciência e Tecnologia - 2 (3122)<br />
Saisanit, S., Roche Pharmaceuticals - 3 (3580)<br />
Schiffmann, R., Amicus Therapeutics - 2, 3, 5;<br />
Progrnosys, Biosciences, Inc - 3; Shire <strong>Human</strong><br />
Genetic Therapies - 2, 5 (1684)<br />
Schmidt, J. L., NIHDS/NIH - 2; <strong>American</strong> Academy <strong>of</strong><br />
Neurology - 2; BDF Newlife and National Institutes for<br />
Health Research - 2; USPTO - 3; patent pending (2452)<br />
Schwartz, S., Laboratory Corporation <strong>of</strong> America - 3 (949)<br />
Scott, C. R., Genzyme Corporation - 5 (727)<br />
Segal, M. M., SimulConsult - 3, 4, 10, 13 (3581)<br />
Sidow, A., DNAnexus - 1, 5 (397)<br />
Sikela, J. M., GATC Science LLC - 4, 7, 10, 13<br />
(Session 22)<br />
Siklosi, K. R., Cystic Fibrosis Foundation - 2 (1731)<br />
Smaoui, N., GeneDx - 3 (1765)<br />
Snyder, M. W., Ariosa Diagnostics - 11; Stratos<br />
Genomics - 11; Good Start <strong>Genetics</strong> - 11; Adaptive<br />
TCR - 11 (94)<br />
Soler, C. V., CINAPCE <strong>Program</strong>, Campinas, Brazil -<br />
12 (2233)<br />
Song, K., Ariosa Diagnostics - 1, 3 (3020)<br />
Spritz, R. A., Pfizer - 15; Spouse full-time employee<br />
<strong>of</strong> Pfizer, Inc. (Session 80)<br />
Srinivasan, A., Verinata Health, Inc. - 3 (3021)<br />
Stuenkel, A. J., Ambry <strong>Genetics</strong> - 1, 3 (1767)<br />
Superko, H. R., Celera Corporation, Alameda, CA., - 3;<br />
Medco Research Institute, LLC/an Express Scripts<br />
Company, Bethesda, MD - 1, 3; Ariosa Diagnostics<br />
Inc. - 3 (1714)<br />
Swaroop, A., University <strong>of</strong> Michigan - 7, 10 (Session 7)<br />
Syed, F., Illumina - 3 (3718)<br />
Talkowski, M. E., Signature Genomic Laboratories,<br />
PerkinElmer, Inc - 3 (68)<br />
Tang, M., Sequenom CMM - 3; Sequenom Inc - 1 (3023)<br />
Tanzi, R. E., Prana Biotechnology - 1, 5 (Session 10)<br />
Tavares, P., CGC <strong>Genetics</strong> - 13 (1778)<br />
Tavtigian, S. V., Myriad <strong>Genetics</strong>, Inc. - 7, 10 (1783)<br />
Taylor, J., Ariosa Diagnostics - 5 (2989)<br />
Taylor, J. C., LifeTechnologies - 12; Johnson &<br />
Johnson - 12; AstraZeneca - 12 (133)<br />
Thompson, J., Nabsys - 1, 3, 4, 10, 13 (3703)<br />
Thomson, N., CLC bio - 1, 3 (3662)<br />
Torchia, B., Signature Genomic Laboratories,<br />
PerkinElmer, Inc., Spokane,WA - 3 (902)<br />
Uhl, G., Duke University - 10 (2541)<br />
Umbarger, M. A., Good Start <strong>Genetics</strong> - 1, 3, 10 (3693)<br />
Utz, J., Genzyme - 2; Actelion, Shire - 5; Actelion,<br />
Shire, BioMarin, Genzyme - 8 (1855)<br />
Vaidya, D., Excet Inc - 5 (1710)<br />
Vaidyanathan, R., Epicentre (an illumina Company) - 3;<br />
Illumina - 3 (585)<br />
van der Valk, R. J. P., GlaxoSmithKline - 2 (2168)<br />
Vasenkova, I. A., Kailos <strong>Genetics</strong> Inc. - 3 (3687)<br />
Velasco, H., National University - 3 (703)<br />
Visitacion, M. R., Agilent Technologies, Inc - 3 (3709)<br />
Voorhoeve, E., Signature Genomics Laboratories - 3<br />
(98)<br />
Wang, L.-S., Johnson & Johnson Pharm Res & Dev -<br />
2 (342)<br />
Wang, X., Fluidigm Corp. - 1, 3 (3619)<br />
Watts, G. S., Ion Torrent - 9 (3712)<br />
Wernig, M., Fate Therapeutics - 7, 10; Stem Cells Inc. -<br />
11 (Session 78)<br />
Westbrook, J., Locus Development, Inc. - 1, 3 (1771)<br />
White, M., Hypogen - 1, 4, 11, 13 (245)<br />
Whitley, C. B., Shire <strong>Human</strong> Genetic Therapies - 2, 5,<br />
11, 12, 14 (801)<br />
Wisotzkey, R., NextBio - 3 (1190)<br />
Woo, C., Life Technologies - 3 (3520)<br />
Woo, S., Korean Coral Resources Bank, Ministry <strong>of</strong><br />
Land Transport Mari - 2; Korea Ocean Research and<br />
Development Institute - 2 (3673)<br />
Wu, S., 23andMe, Inc. - 1 (2149)<br />
Xie, P., Merck - 2; Eli Lilly and Co - 5; GlaxoSmithKline<br />
- 5; Alkermes - 5 (2621)<br />
Xue, Z., GlaxoSmithKline - 1, 2, 3 (651)<br />
Yamasaki, M., Central Research Laboratory, Hitachi<br />
Ltd, Tokyo, Japan - 12 (2496)<br />
Yim, P. W., Life Technologies - 3 (486)<br />
Zeng, W., Ambry <strong>Genetics</strong> - 3 (2698)<br />
Zhan, Y., Affymetrix - 1, 3 (1582)<br />
Zhang, Z., UMDF - 6 (534)<br />
Zhao, Z., MolecularMD - 5; GlaxoSmithKline - 11;<br />
Millennium Pharmaceuticals - 11; Illumina - 5 (136)<br />
Zhong, J., Roche - 3 (242)<br />
Ziegler, A., Affymetrix - 12 (1443)<br />
Zimran, A., Protalix Biotherapeutics - 1, 5, 11, 14;<br />
Shire <strong>Human</strong> Genetic Therapies - 8, 14 (788)
1<br />
1000 Genomes Consortium,<br />
331, 3360T, 3380W<br />
1000 Genomes Project, 41<br />
1000 Genomes Project<br />
Consortium, 3636W<br />
16p11.2 European Consortium<br />
Collaborators, 62<br />
A<br />
Aaltonen, L., 997T<br />
Aanestad, M., 3614W<br />
Aartsma-Rus, A., 574W<br />
Ababon, M., 2216F<br />
Ababon, M. R., 2426F<br />
Abad, C., 2837T<br />
Abbasi, F., 1624T<br />
Abbott, D. E., 195<br />
Abd El-Fattah<br />
El- Hashash, O., 214<br />
AbdElHafez, H., 1922F<br />
Abdelhak, S., 105<br />
Abdellaoui, A., 459F<br />
Abdel-Magid, N., 2785W,<br />
2892F, 2904F<br />
Abdelmalek, M., 531F<br />
Abdelmoula Bouayed, N.,<br />
539F<br />
Abdel-Rahman, M. H.,<br />
1197W<br />
Abdenur, J., 2895F<br />
Abdollahi, B. S., 2150F<br />
Abdrabou, W., 2154W<br />
Abd Ruboh, A., 930T<br />
Abdulkareem, N., 1584T*<br />
Abdul-Rahman, O. A., 124,<br />
3076F*<br />
Abdul Razack, A. H., 1083W<br />
AbdusSamad, M., 1300F<br />
Abe, T., 396, 2051F<br />
Abe, Y., 1317T<br />
Abecasis, G., Session 7,<br />
88, 108, 113, 176, 177,<br />
186, 476W, 547F, 641T,<br />
1370W, 1391W, 1429F,<br />
1451W, 1513F, 1516F,<br />
1521T, 1525F, 1533T,<br />
1558F, 1568W, 1923W,<br />
2001W, 2090F, 2102F,<br />
2135F, 2198F, 2308T,<br />
3466T, 3664W<br />
Abecasis, G. R., 46, 117,<br />
154, 157, 170, 276,<br />
1448W, 1545T, 1952F,<br />
2183F, 2329T, 2339F<br />
*Presenting Author<br />
SPEAKER AND AUTHOR INDEX<br />
This index includes an alphabetical listing <strong>of</strong> all speakers, presenting authors, co-authors<br />
and study groups/consortia for the <strong>2012</strong> <strong>ASHG</strong> meeting. Session numbers follow invited<br />
speaker names; abstract numbers follow poster/platform author names. Presenting<br />
author names are noted with an asterisk.<br />
Abel, L., 365, 2003F, 3599F<br />
Abell Aleff, P. C., 1695T<br />
Aberg, K. A., 3442T*, 3452T<br />
Abhyankar, A., 127, 202,<br />
3599F<br />
Abifadel, M., 1607T<br />
Abi-Rached, L., 3710W<br />
Ables, A., 2989T<br />
Abnet, C. C., 1010F, 1076F<br />
Abney, M., Session 75, 278,<br />
1395T, 1488T<br />
Abolhasani, M., 2013W<br />
Abou Jamra, R., 2557T*<br />
Abouzehry, A., 3526W<br />
Abraham, A., 931W<br />
Abramowicz, M., 105<br />
Abrams, A., 794W<br />
Abrams, D. J., 2546F<br />
Abrams, G., 1965W<br />
Abramson, K., 1444F<br />
Abramzon, Y., 2611T, 2648F<br />
Abrantes, P., 1977W<br />
Abrantes, P. C. S., 2085W*<br />
Abruzzo, M. A., 2752W<br />
Absher, D., 434W, 3443T*<br />
Absher, D. M., 2223W,<br />
3318T<br />
Abu-Amero, K., 2997T<br />
Abu-Amero, S., 303, 3508T<br />
Abu Rayyan, A., 2919F<br />
Abu-staiteh, A., 3155W<br />
Abyzov, A., 334, 3251W<br />
Accardi, J. P., 2938W<br />
ACE <strong>Genetics</strong> Consortium,<br />
2479T, 2658W<br />
ACE Network Consortium,<br />
553F<br />
Acevedo, S., 3390T<br />
Aceves-Aceves, M. A.,<br />
3187W, 3188F<br />
Achatz, M. I. W., 1102T,<br />
1217F*<br />
Achermann, J. C., 361<br />
Achkar, J. P., 1466W<br />
Achkar, W. A. L., 1490W<br />
Ackerman, H. H., 2561F<br />
Ackerman, M. J., 2885T,<br />
2906T<br />
Ackerman, S. L., Session 24<br />
Acosta, O., 2296T<br />
Acosta Guio, J., 3041W*<br />
Acosta-Herrera, M., 2296T<br />
Acosta Lebrigio, R. F.,<br />
2615F<br />
Acosta-Perez, E., 3449T<br />
Acquaye, T. K., 626T<br />
Acuna, B., 1289W, 1301W,<br />
1414F, 1455T<br />
Adachi, H., 2129F<br />
Adachi, K., 2440T<br />
Adachi, M., 1795W, 2891T<br />
Adachi, S., 2133W<br />
Adair, C. D., 3020T<br />
Adala, L., 2744T<br />
Adam, M. P., 1753W*<br />
Adam, S., 1840F*, 1846W<br />
Adamczyk, A., 2566T<br />
Adami, H.-O., 991T<br />
Adams, C., 953W, 3717F<br />
Adams, D., 359*, 2870T<br />
Adams, D. J., 105<br />
Adams, D. R., 2938W,<br />
3543F<br />
Adams, E., 784W<br />
Adams, J., 1706T*<br />
Adams, L., 1834F<br />
Adams, M. C., 231*<br />
Adams, S. A., 832F*<br />
Adamski, J., 2226W, 2548T<br />
Adamusiak, T., 3610W<br />
Adane, S., 1268F<br />
Adayev, T., 2449T<br />
Addai, J., 2979T<br />
Addess, K., 3582W<br />
Addis, L., 1531F, 2580W*<br />
Addison, S. M. F., 378<br />
Adebamowo, C., 1003T,<br />
1848W<br />
Adebowale, A., 2063F<br />
Adela Mansilla, M., 2325W<br />
Adès, L. C., 3167W<br />
Adey, A., 3721F<br />
Adey, A. C., 1014W*<br />
Adeyemo, A., 241, 1515T,<br />
1886F, 1959W, 3533F<br />
ADGC, ADNI, GERAD, 340<br />
ADGC Consortium, 343<br />
Adhikari, K., 3327T*<br />
Adhikari, N., 1665T<br />
Adir, V., 3202F*<br />
Adkins, A. E., 2504F<br />
Admiraal, R. J. C., 58<br />
Adoue, V., 569F, 3439T<br />
Adrianto, I., 529F, 1895F,<br />
2084F, 2188T<br />
Afanador, Y. M., 3315T*<br />
Afanasjev, V., 1140W<br />
Afenjar, A., 127, 131<br />
Afi Rawlings-Goss, R., 518W*<br />
African <strong>American</strong> BMI<br />
Consortium, 2131T,<br />
3299W<br />
Afzal, V., 4, 407<br />
Agarwal, A., 2028W, 2318F<br />
Agarwal, P., 649T<br />
Agarwal, S., 2446T, 2700F*<br />
333<br />
Agarwala, V., 2209T*<br />
Agate, S., 2014T<br />
Agatep, B. C., 1714T<br />
AGEN-T2D, DIAGRAM,<br />
MA-T2D and SA-T2D<br />
Consortia, 49<br />
Aggarwal, A., 1235F<br />
Aggarwal, R., 3508T<br />
Aggarwal, S., 555F<br />
Aggarwal, V., 73, 957W,<br />
977W*<br />
Aggen, S., 3512T<br />
Agioutantis, Z., 2902W<br />
Aglan, M., 2937F<br />
Agne, E., 3729F<br />
Agolini, E., 2760F*<br />
Agosti, V., 1985F<br />
Agostini, J., 1732W, 2775F<br />
AGP Consortium, 2492F<br />
Agrap, B., 1172F<br />
Agrawal, A., 2582F, 2598W<br />
Agrawal, P., 2811F*<br />
Agrawal, P. B., 3219W<br />
Agrawal, S., 2353T, 2992T<br />
Aguena, M., 814F, 852F<br />
Aguglia, U., 2780T<br />
Aguiar, M. J. B., 2434T,<br />
3107W, 3110F<br />
Aguiar, V. R. C., 182, 1573F*<br />
Aguiar-Garcia, P., 650T<br />
Aguilar-Chávez, E. A., 2363F<br />
Aguilar-Pimentel, J. A.,<br />
2922F<br />
Aguilar-Salinas, C. A.,<br />
2256W<br />
Aguilera, M., 728T<br />
Aguilera, P., 1053W<br />
Aguinaldo, K., 3698W<br />
Aguirre Hernandez, J.,<br />
1105T*<br />
Agusti, A., 2249F<br />
Aguzzi, R., 773W<br />
Ahaghotu, C., 1009T<br />
Ahearn, J., 458W<br />
Ahituv, N., 246, 1995W<br />
Ahluwalia, T. S., 2317T,<br />
2347T*<br />
Ahmadi, A., 3201W<br />
Ahmadi, K., 44, 583F<br />
Ahmadzadeh, A., 1118F<br />
Ahmed, A., 714T, 715F*<br />
Ahmed, A. F., 2047T<br />
Ahmed, I., 3078F<br />
Ahmed, M., 3078F<br />
Ahmed, R., 931W<br />
Ahmed, S., 209<br />
Ahmed, Z. M., 2724F,<br />
2959W, 3194F, 3212F<br />
SPEAKER AND AUTHOR INDEX
334 SPEAKER AND AUTHOR INDEX<br />
Ahmudavalli, S. M., 300<br />
Ahn, C., 3223W<br />
Ahn, H., 3461T<br />
Ahn, J., 1243T<br />
Ahn, J. W., 906T*<br />
Ahn, K., 1338T, 2584T*<br />
Ahn, Y., 1657T<br />
Aho, H., 1139F<br />
Ahonen, S. J., 2913F*<br />
Ahonen-Bishopp, A.,<br />
3610W<br />
Ahsan, B., 52, 2409W<br />
Ahsan, H., 2025W<br />
Ahting, U., 699F, 782W<br />
Aiello, A., 435F<br />
Ainehsazan, E., 2801T<br />
Ainsworth, P. J., 1138T*,<br />
3672W<br />
Airaud, F., 1204T<br />
Aird, D., 322<br />
Aissat, A., 572W<br />
Aitchison, A., 3440T<br />
Aitman, T. J., 1618T, 2005T<br />
Aittomäki, K., 897W, 1006T,<br />
1117T, 1171T, 1265F<br />
Ait Yahya Graison, E.,<br />
3674W*<br />
Aiyar, L., 320*<br />
Ajay, S., 2293T<br />
Ajbro, K. D., 805F*<br />
Ajit Bolar, N., 80<br />
Akalin, A., 3464T<br />
Akarsu, N., 219<br />
Akay, H., 2772F<br />
Akbari, M., 2013W<br />
Akbari, M. T., 2290T*<br />
Akbari, S., 2135F<br />
Aken, B. L., 506W<br />
Aker, L., 2139W<br />
Akerlund, M., 190<br />
Akerstedt, A. M., 168<br />
Akey, J., 283<br />
Akey, J. M., 10<br />
Akhabir, L., 1465F<br />
Akin, H., 965W, 1106F*<br />
Akinrinade, O., 992F<br />
Akinsanya, K., 1605T<br />
Akiyama, J., 407<br />
Akiyama, J. A., 254<br />
Akler, G., 3395W<br />
Akmen, H. O., 232<br />
Akoume, M.-Y., 2234F<br />
Akoury, E., 2842W, 2981T*<br />
Aksakal, O., 594W<br />
Aktas, S., 1025F<br />
Akula, N., 260*, 2622W<br />
Akushevich, I., 2027F<br />
Akutsu, K., 1697T<br />
Akylbekova, E., 350<br />
Akylbekova, M., 2210F<br />
Akyol, M., 1136F<br />
Al Ageeli, E., 1205F<br />
Al-Ahmari, A., 3149W*<br />
Alaimo, J. T., 640T*<br />
Ala-Koko, L., 1892F<br />
Ala-Korpela, M., 656T, 1623T<br />
Alakulppi, N., 2023T<br />
Alakus, H., 395<br />
Al-Alem, U., 2281T<br />
Al-Ali, F. M. S., 2731W<br />
*Presenting Author<br />
Ala-Mello, S., 252<br />
Al-Amri, F., 2713W<br />
Al-Aqeel, A., 723F*<br />
Al-Aqeel, S., 1266W*<br />
Alarcón-Riquelme, M. E.,<br />
1979F, 2046W, 3382F<br />
Alassiri, H., 3155W<br />
Alasti, F., 419F*<br />
Alavi-Naini, SM., 843F<br />
Al-Awwami, M., 3149W<br />
Al-azzam, S., 856T<br />
Albanes, D., 1012T, 1091F,<br />
1154F<br />
Albers, C. A., 383*<br />
Albers, J. J., 1605T<br />
Albertyn, Z., 242<br />
Albino, E., 1987T*<br />
Albracht, D., 465F<br />
Albrecht, E., 2086T*, 2175W<br />
Albrechtsen, A., 2311T,<br />
2317T, 2347T, 3289F,<br />
3312T<br />
Albright, F., 1328W<br />
Albu, C. C., 3005T*, 3009T,<br />
3067W<br />
Albu, D. F., 3005T, 3009T*,<br />
3067W<br />
Albuisson, J., 3233W<br />
Alby, C., 77, 403, 3240F<br />
Alcaïs, A., 1374T, 2003F<br />
Alcalay, R., 746T<br />
Al-Chalabi, A., 348<br />
Alcivar, 872T<br />
Alda, M., 2338T, 2342F<br />
Al-Dhekri, H., 3155W<br />
Al-Dosari, S., 2713W<br />
Aldrich, J., 1240T<br />
Alechine, E., 3364F, 3402T<br />
Aleman, G., 526W<br />
Alembik, Y., 3073W<br />
Alenius, G. M., 2160W<br />
Alessandri, J.-L., 3172F<br />
Alessandri, M., 1786W,<br />
1787W<br />
Alexander, G. J., 153<br />
Alexander, I. E., 166<br />
Aleyasin, A., 2980T<br />
Al-Fadhly, F., 2676F<br />
Al-Fawaz, I., 3149W<br />
Alfieri, P., 3087W<br />
Alfredsson, L., 1455T<br />
Al-Gazali, L., 8, 160, 2740W,<br />
2937F<br />
Al-Ghonaium, A., 3155W<br />
Alha, P., 1835W<br />
Alhaddad, H., 3252T<br />
Al-Hafid, N., 166<br />
Al-Hait, S., 2937F<br />
Al-Hamed, M. H., 2676F*<br />
Al-Hazza, S., 2734W<br />
Al-Hertani, W., 675F*, 720T<br />
Ali, B. R., 160<br />
Ali, G., 2631W<br />
Ali, M., 2403W, 2959W<br />
Ali, R., 2899W<br />
Ali, S., 2821W<br />
Aliefendioglu, D., 702T<br />
Alikashani, A., 1678T,<br />
1982F, 2319W<br />
Alizadeh, B. Z., 111, 2073W<br />
Alizadeh, S. A., 1096T<br />
Al-Jasmi, F., 2937F<br />
Alkan, C., 14<br />
Al-Kateb, H., 912T, 1028F*<br />
Alkayal, F., 3369T<br />
Alkelai, A., 53, 2875W*<br />
Alkhateeb, A., 1881W*<br />
Alkrinawi, S., 2738T<br />
Allache, R., 1910F*<br />
All-Allawi, N., 2937F<br />
Allam, R., 2734W<br />
Allamand, V., 2436W<br />
Allanson, J., 124, 150, 1852F<br />
Allayee, H., 110<br />
Allegra, M., 218<br />
Allegri, L., 845F<br />
Allen, A. S., 1349W<br />
Allen, C., 1823W*<br />
Allen, E., 1971W*<br />
Allen, E. G., 253, 3042F<br />
Allen, J., 2465F<br />
Allen, M., 1316W, 1377T,<br />
1671T, 1713T, 3719F<br />
Allen, S., 36<br />
Allen, S. J., 406, 2850F<br />
Allik, A., 1832F<br />
Allingham, R. R., 386,<br />
2154W, 2240F, 2263T<br />
Allingham-Hawkins, D.,<br />
1820F*<br />
Allione, A., 1712T<br />
Allon-Shalev, S., 1165T<br />
Al-Maawali, A., 1704T<br />
Almada, B. V. P., 814F, 852F<br />
Al-Mahdawi, S., 761W<br />
Al-Marri, A., 2933T, 3399W<br />
Almarri, M. A., 153<br />
Almasy, A., 1651T<br />
Almasy, L., 1280W, 1406W,<br />
2061W, 2308T, 2309F,<br />
2503T, 2582F, 2589W,<br />
2651F<br />
Almasy, L. A., 1923W<br />
Almeida, B. S., 994T, 1946F<br />
Almeida, J., 2417F, 2502W<br />
Almeida, M., 176, 1280W,<br />
1513F, 2308T, 2339F<br />
Almeida, M. A., 1923W*,<br />
2309F<br />
Almeida, R., 523F<br />
Almeida, T. F., 2232W*,<br />
3152F, 3184F, 3295F<br />
Almeida-King, J., 497F<br />
Almeida-Souza, L., 201,<br />
2948T<br />
Almli, L. M., 1422T, 2420F*,<br />
3480T<br />
Almoguera Castillo, B.,<br />
1659T<br />
Al-Mostafa, A., 2734W<br />
Al-Mousa, H., 3155W<br />
Al-Muhsen, S., 3155W<br />
Almureikhi, M., 2899W<br />
Almusa, H., 327, 2888T<br />
Al-Mutawa, M., 2713W<br />
Al-Olama, A., 1011W<br />
Alonso, A., 1403W, 1585T<br />
Alonso, I., 1964F, 2736F,<br />
2818W<br />
Alonso, N., 2687T<br />
Alonso, P., 2593T<br />
Alonso Barragan, S. A.,<br />
3187W<br />
Al-Owain, M., 2734W<br />
Al-Saad, S., 8<br />
Al-Saffar, M., 8<br />
Al-Sannaa, N., 219<br />
Al-Sarraj, S., 3476T<br />
Al-Sarraj, Y., 2899W, 3140F,<br />
3526W*<br />
Al-Saud, B., 3149W<br />
Al-Saud, B. K., 3155W<br />
Al-Shambri, S., 3149W<br />
Alsmadi, O., 3149W,<br />
3155W, 3369T<br />
Al-Sum, Z., 3155W<br />
Altaescu, G., 788W<br />
Altamirano, M., 1022F<br />
Altamuro, D., 966T<br />
Altansukh, T., 3248F<br />
Altarescu, G., 746T, 2991T*,<br />
2993T, 3002T<br />
Altemose, N., 284<br />
Altenmüller, E., 200<br />
Alter, B. P., 1196F<br />
Altincik, A., 2758W<br />
Altinors, N., 1013F<br />
Altiokka Uzun, G., 2396F,<br />
2412W<br />
Altman, R. B., 633T, 635T,<br />
646T<br />
Altmann, A., 2483F<br />
Altmüller, J., 2759T, 2861T,<br />
2869W, 2930T, 2944W<br />
Altshuler, D., 176, 208, 249,<br />
280, 1677T, 2209T<br />
Altug, T., 2429F<br />
Al-Turki, S., 101, 216, 364<br />
Altuzara, C., 2770W<br />
Altuzarra, C., 329<br />
Alul, F., 1882T*<br />
Alvarado, C., 398<br />
Alvarado, D. A., 220<br />
Alvarado, D. M., 2860W*<br />
Alvarado, M., 1741W, 1866F<br />
Alvarez, M., 3449T<br />
Alvarez, M. C., 1187F<br />
Alvarez, M. I., 2940F, 3217W<br />
Alvarez, V., 2930T<br />
Alvarez-Mora, M.-I., 2624F<br />
Alvarez-Serrano, A., 3363T<br />
Alver, M., 2144F<br />
Alves, S., 3122F<br />
Alves-Ferreira, M., 2818W*<br />
Alvim-Soares, A., 2385W<br />
Alvizi, L., 2673F*, 2746W<br />
Al-Yahyaee, S. A., 160<br />
Alzheimer’s Disease <strong>Genetics</strong><br />
Consortium, 342, 344,<br />
1476T, 1571W, 2498F<br />
Alzheimer’s Disease<br />
Neuroimaging Initiative,<br />
2511W, 2531F<br />
Alzoubi, K., 855W, 856T*<br />
Amagai, M., 2911W<br />
Amara, A., 1751W, 2744T<br />
Amaral, M. D., 1731W<br />
Amarillo, I. E., 950T<br />
Amata, S., 3114F<br />
Amato, R. S., 432W
Ambalavanan, A., 2338T,<br />
2558F*<br />
Ambannavar, R., 1198T<br />
Ambite, J. L., 1439W,<br />
3558W, 3678W<br />
Ambrosone, C. B., 2202W<br />
Ambs, S., 1003T, 1097F<br />
Ambulos, N., 602T<br />
Amelio, A. L., 1162T*<br />
Amell, A. M., 55, 2224T<br />
Amemiya, A. R., 1753W<br />
Amer, W., 2866W<br />
Ames, J., 3587F<br />
Ameur, A., 3728W<br />
Ameye, G., 2002T<br />
Amiel, J., 126, 843F, 915W,<br />
2770W, 3157W, 3172F*<br />
Amin, N., 109, 459F<br />
Amin Al Olama, A., 205,<br />
1148F*<br />
Amini, P., 1083W<br />
Amiran, R., 858T<br />
Amiri, H., 689F<br />
Amirisetty, S., 578W<br />
Amjad, R., 1956W<br />
Ammarinthnukrowh, P.,<br />
2006F<br />
Ammous, Z., 1633T*,<br />
3175W<br />
Amor, D. J., 217<br />
Amorim, A., 2982T<br />
Amos, C., 1291F, 1399F<br />
Amos, C. I., 593F, 1298W,<br />
1454W<br />
Amouri, R., 2537F<br />
Ampy, F., 1821W<br />
Amr, S. S., 1754W*<br />
Amron, D., 2790F<br />
Amstadter, A., 3512T<br />
Amundadottir, L., 1088F,<br />
1199F<br />
Amyere, M., 1015T*<br />
Amyot, M., 1951T<br />
Anagnostopoulos, A., 2675T<br />
Anand, V., 3382F<br />
Ananiev, V., 3582W<br />
Ananina, G., 426W*, 2718F<br />
Anastosova, V., 1811W<br />
Anaya, J. M., 307, 1979F,<br />
2046W<br />
Anaya, J.-M., 529F, 2084F,<br />
2188T<br />
Anayane-Yeboa, K., 977W<br />
Anchan, R., 78, 82<br />
Ancoli-Israel, S., 2375F<br />
Anctil, J. L., 1951T<br />
Andelfinger, G., 31<br />
Anderlid, B. M., 80<br />
Andermann, E., 2790F<br />
Andersen, A., 3706W<br />
Andersen, C. L., 401<br />
Andersen, E. F., 886T*<br />
Andersen, H. S., 737F<br />
Andersen, M., 1237T*,<br />
1244F, 3714W<br />
Andersen, P. S., 1323T*<br />
Andersen, T. A., 805F<br />
Anderson, A., 1724W<br />
Anderson, C., 1269W,<br />
1518T<br />
*Presenting Author<br />
Anderson, C. A., 153, 354,<br />
1967F, 2101T, 2133W,<br />
2163W<br />
Anderson, G., 2755W<br />
Anderson, J., 2529W, 2681T<br />
Anderson, J. M., 2663T<br />
Anderson, L., 2465F<br />
Anderson, M., 7<br />
Anderson, M. W., 1454W<br />
Anderson, N., 433F, 835F<br />
Anderson, P., 3664W<br />
Anderson, R., 1052F, 1856F<br />
Anderson, R. L., 3398T<br />
Anderson, S., 912T, 1242W<br />
Anderson, T., 2584T<br />
Andersson, A., 31<br />
Andersson, E., 2311T<br />
Andersson, H. C., 666T*,<br />
907W<br />
Andersson, T., 1242W<br />
Andersson Assarsson, J.,<br />
1271F<br />
Andersson-Assarsson, J.<br />
C., 427F*<br />
Ando, J., 3513T<br />
Ando, M., 2559W*<br />
Ando, Y., 2550W, 2619W<br />
Andoni, U., 2436W<br />
Andrade, E. S., 3280F*<br />
Andrade, J. G., 478W<br />
Andrade, R. V., 3375T<br />
Andrade-Lima, L. C., 814F<br />
Andreasen, D., 1194W<br />
Andreasen, N., 2493W<br />
Andreasen, N. C., 422W<br />
Andreassen, K. E., 991T<br />
Andreoli, V., 2597F<br />
Andres, A., 3306T<br />
Andresen, B. S., 737F*<br />
Andresson, T., 1088F,<br />
2833W<br />
Andrew, A., 3465T<br />
Andrew-Faucett, W., 299<br />
Andrews, A. M., 261<br />
Andrews, A. S., 1453F<br />
Andrews, C., 2928F<br />
Andrews, H., 442W<br />
Andrews, L., Session 20<br />
Andrews, P., 2587T<br />
Andrieu-Abadie, N., 54<br />
Andrieux, J., 299, 889W,<br />
911W, 925W, 3109W,<br />
3172F<br />
Andrulis, I. L., 1213T<br />
Anedda, F., 2001W*<br />
Ang, K., 309<br />
Ang, K. C., 3267T*<br />
Ang, W., 2097W, 2164T<br />
Angeles, M., 928T<br />
Angelini, C., 1732W, 1776W,<br />
2909T<br />
Angerh<strong>of</strong>er, N., 3321T,<br />
3340F*, 3365W<br />
Angius, A., 113, 157, 177,<br />
186, 547F, 823F, 1451W,<br />
1516F, 2001W, 2916F<br />
Angle, B., 66<br />
Angle, J., 3350W<br />
Angot, E., 32<br />
Angrist, M., 3<br />
SPEAKER AND AUTHOR INDEX 335<br />
Angstadt, A. Y., 1107W*<br />
Anguiano, A., 876T, 3522T<br />
Anikster, Y., 53, 199, 660T,<br />
731F, 2455T<br />
Ankeleshwaria, C., 700T<br />
Ankeman, K., 2406W<br />
Ankener, W., 544W<br />
Ankleshwaria, C., 3400T*<br />
Ankleshwaria, C. M., 2803W<br />
Annagür, A., 219<br />
Annerén, G., 3245W<br />
Annesi, G., 2763F, 2766F,<br />
2774T*, 2780T<br />
Annesi-Maesano, I., 1941W<br />
Annilo, T., 1163F*, 3079W<br />
Annunziata, F., 735F<br />
Ansari, M., 3072F<br />
Antalfy, B., 234<br />
Antao, N. N., 614T<br />
Anthony, D., 216, 809F<br />
Anthony, S. P., 1186T<br />
Antignac, C., 322, 324<br />
Antoine-Poirel, H., 2002T<br />
Antonacci, F., 3296W<br />
Antonarakis, S. E., 67, 84,<br />
85, 550W, 556W, 561F,<br />
567F, 582W, 807F, 2877F,<br />
2937F, 3263W, 3431T<br />
Antonellis, A., 2470T*<br />
Antonialli, G., 3131W<br />
Antonialli, G. P. M., 2484W*<br />
Antonini, G., 1776W<br />
Antonini, S., 874T<br />
Antoniou, A., 208, 1109F<br />
Antoniou, A. C., 207*, 210,<br />
1492F<br />
Anvar, S. Y., 542W<br />
Anyane-Yeboa, K., 1600T,<br />
3046F<br />
Anyanwu, N., 2082W<br />
Ao, A., 2981T<br />
Aoki, K., 724T<br />
Aoki, M., 396<br />
Aouizerat, B. E., 1965W<br />
Aparecida da Silva, D.,<br />
3364F, 3402T<br />
Aparicio, J. M., 926T*,<br />
1018T, 3039W, 3061W,<br />
3063W, 3064F<br />
Aparicio-Rodriguez, J. M.,<br />
3062F<br />
APCDR Investigators,<br />
3412T<br />
Apel, M., 2160W<br />
Apolo, A. B., 1092W<br />
Apone, L., 512W, 3517T*<br />
Apone, L. M., 3702W,<br />
3715F<br />
Aponte, J., 1686T<br />
Appel, I. M., 980T<br />
Appelbaum, E., 1210T,<br />
2325W<br />
Appel-Cresswell, S., 346,<br />
3135W<br />
Appelt, U., 3641F, 3662W<br />
Appenzeller, O., 3307F<br />
April, C., 1193F, 1238F<br />
Aquino, M., 3033T<br />
Aquino, M. A., 2871F<br />
Aquino-Michaels, K., 646T<br />
Arabzadeh, M., 1056W<br />
Aradhya, S., 103, 332*,<br />
1765W, 2579F<br />
Aragam, J., 1677T<br />
Aragon-Martin, J. A., 1584T,<br />
1675T<br />
Arahata, H., 2400W<br />
Arai, Y., 396<br />
Araki, T., 2435F<br />
Aral, B., 2716W, 2729T,<br />
2770W<br />
Aran, A., 2447F<br />
Aranha, I., 927W*<br />
Arashiro, P., 1776W<br />
Arasimavičius, J., 653T<br />
Araujo, A. S., 426W, 2718F<br />
Araújo, B. P. B., 479F<br />
Araújo, I. I., 3318T<br />
Araujo, M. I., 2043W<br />
Arayssi, T., 1490W<br />
Araz, M., 1402F, 1935W,<br />
1938W<br />
Arbeev, K., 2027F, 2194T<br />
Arbeeva, L., 2194T<br />
Arbez-Gindre, F., 3199W<br />
Arboleda, V., 361*<br />
Arcanjo, A. C., 3324T,<br />
3375T<br />
Archaic Genome Analysis<br />
Consortium, 3274F<br />
Archana, G., 878T<br />
Archibald, A. D., 143<br />
Arciniegas, N., 659F*<br />
arcOGEN Consortium,<br />
2292W<br />
Arden, N., 2189F<br />
Arden, N. K., 2292W<br />
Ardissone, F., 1153T<br />
Ardlie, K., 368*<br />
Ardon, O., 660T*, 689F<br />
Arenas-Aranda, D. J., 1168T<br />
Arenas-Sordo, M., 3125W*<br />
Arends, M. J., 105<br />
Arens, Y., 1439W*, 3678W<br />
Arepalli, S., 564W<br />
Aretz, S., 1005W*<br />
Arezi, B., 3709F<br />
Argente, J., 2711T, 3208F<br />
Argiro, L., 1949F<br />
Argiropoulos, B., 910T,<br />
3095W<br />
Argos, M., 2025W<br />
Ariani, F., 2604W*<br />
Arias, L., 3074F<br />
Arias Vásquez, A., 1498F*<br />
Arimura, K., 2601W<br />
Arimura, Y., 2174F<br />
Arinami, T., 2380T<br />
Ariyoshi, K., 1998W, 1999T<br />
Arjona, D., 330<br />
Arking, D. E., 1403W, 1579F,<br />
1585T<br />
Arlt, M. F., 339*, 2879T<br />
Armas, R., 2495F<br />
Armasu, S. M., 1375F,<br />
1497T, 3451T<br />
Armbrecht, A. M., 2072F<br />
Armengol, L., 3208F<br />
Armory, P., 1082F<br />
Armour, C., 719F<br />
SPEAKER AND AUTHOR INDEX
336 SPEAKER AND AUTHOR INDEX<br />
Armstrong, D. G., 3712W<br />
Armstrong, G., 1447F<br />
Armstrong, L., 1447F<br />
Armstrong, M. C., 2851W<br />
Arnaout, R., 3155W<br />
Arnaud, K., 2674W<br />
Arndt, K., 3090F<br />
Arndt, S., 2753T, 3203W<br />
Arne-Bes, M.-C., 2945T<br />
Arnell, C., 1021T<br />
Arnett, D., 3443T<br />
Arnhold, U. P., 2706F<br />
Arning, M., 630T<br />
Ärnlöv, J., 1624T<br />
Arno, G., 1584T, 1675T*<br />
Arnold, A., 1275W<br />
Arnold, P. D., 2499W*,<br />
3447T<br />
Arobba, B., 1856F<br />
Aroda, V., 1925F<br />
Aronica, E., 2909T<br />
Aronow, B., 2136W<br />
Arp, P., 3608W<br />
ARRA Autism Sequencing<br />
Collaboration, 2613W<br />
ARRA Autism Sequencing<br />
Consortium, 11, 268,<br />
1520W, 1523W, 3597F<br />
ARRA Autism Sequencing<br />
Consortium and Autism<br />
Sequencing Consortium,<br />
2577W<br />
Arroyo-Pardo, E., 3402T<br />
Arseneau, J., 2842W<br />
Arseneault, R., 1951T<br />
Arslan, A. O., 2956W<br />
Arslan, E., 2719W<br />
Artigalás, O., 1851F<br />
Artigiani, R., 3421T, 3503T<br />
Artiguenave, F. M., 2394W,<br />
2876T, 3578W<br />
Artinger, K. B., 819F<br />
Arts, H., 324<br />
Arts, H. H., 216<br />
Artto, V., 2348F<br />
Arun Kumar, G., 3377W<br />
Arveiler, B., 473F*, 841F<br />
Asabere, A., 551F<br />
Asahina, N., 2822T<br />
Asan, A., 3300T, 3311W<br />
Aschard, H., 318*<br />
Aschendorff, A., 2753T,<br />
3203W<br />
Aschim, E. L., 991T<br />
Asgari, N., 2290T<br />
Ash, C., 1093T<br />
Ashe, T. D., 565F<br />
Ashfield, A., 1082F<br />
Ashford, L., 730T<br />
Ashkenazi Genome<br />
Consortium, 17<br />
Ashley, E., 1601T<br />
Ashley-Koch, A., 3, 386,<br />
531F, 1919F, 2135F<br />
Ashley-Koch, A. E., 2340W,<br />
2946F<br />
Ashton-Prolla, P., 1217F<br />
Ashutosh, A., 971W<br />
Asico, L., 245<br />
Asiimwe, E., 1919F<br />
*Presenting Author<br />
Asimit, J., 3412T<br />
Aslam, A., 3700W<br />
Aslam, M., 2086T<br />
Asmal, L., 644T<br />
Asmann, Y. W., 986F,<br />
1214F<br />
Aspers, R., 2696T<br />
Aspesi, A., 1153T<br />
Asselbergs, F. W., 609T,<br />
1606T, 1659T<br />
Asselin, G., 2402F<br />
Assimes, T., 1608T<br />
Assimes, T. L., 115, 434W,<br />
1595T, 1624T<br />
Assumpção, P. P., 1008W,<br />
1132T, 3421T, 3503T<br />
Astashyn, A., 3732W<br />
Astbury, C., 456W, 912T<br />
Astley, S., 3076F<br />
Aston, K. I., 2982T<br />
Astuti, D., 2767W, 2787F<br />
Asunis, I., 2001W<br />
Aswani, V. H., 2683W<br />
Ataman, B., 2613W<br />
Atanur, S., 1618T<br />
Atefi, M., 136<br />
Atehortua-Khalsa, K., 3717F<br />
Ather, S., 667F<br />
Athing, U., 2917W<br />
Atia, J., 1811W*<br />
Atik, T., 965W, 3222F<br />
Atique, R., 2687T*<br />
Atkin, J., 456W<br />
Atkin, J. F., 124<br />
Atkinson, A. L., 143<br />
Atkinson, E., 2362T<br />
Atlan, D., 3610W<br />
Atsuta, N., 3221W<br />
Attanasio, C., 4*<br />
Attarian, S., 328<br />
Attia, J., 2133W<br />
Attie, T., 3246F<br />
Attie-Bitach, T., 2727F,<br />
3240F<br />
Attié-Bitach, T., 77, 403<br />
Attri, S., 802W<br />
Attwood, A. H., 978T<br />
Atwal, G., 3316F<br />
Atwood, L. D., 2030F<br />
Atzeni, R., 157, 177, 1516F<br />
Atzmon, G., 17, 169, 269,<br />
1319W, 1923W, 2308T,<br />
2339F, 3336T, 3345T,<br />
3395W<br />
Au, E., 1756W<br />
Au, P.-Y. B., 1052F*<br />
Aubart, M., 56*<br />
Aubry, M., 2893W<br />
Audi Delaney, L., 131<br />
Audrezet, M.-P., 1728W<br />
Auer, M., 1115F<br />
Auer, P. L., 301, 1408F,<br />
1437T, 2336F, 2337W<br />
Auerbach, A. D., 1069T*<br />
Auer-Grumbach, M., 201,<br />
2948T<br />
Augello, B., 775W, 3087W,<br />
3256F<br />
Augustin, J., 345<br />
Augustine, N. H., 495F<br />
Augusto, D. G., 1405F<br />
Aulchenko, Y. S., 2106W<br />
Aung, T., 2094W<br />
Auro, K., 2059T*<br />
Ausavarat, S., 2749W<br />
Austermann, C., 3310F<br />
Austin, C., 3490T<br />
Austin, H., 611T<br />
Austin, M., 3649F<br />
Autism Genome Project,<br />
2261F<br />
Autism Sequencing<br />
Consortium, 2560T<br />
Auton, A., 285, 1494T<br />
Auvin, S., 2536T<br />
Au-Young, J., 1195T*<br />
Avadhani, N., 2943F<br />
Avallone, B., 808F<br />
Avansini, S. H., 514W*<br />
Avard, D., 1823W<br />
Avbelj, M., 2710W<br />
Avdjieva-Tzavella, D. M.,<br />
923W<br />
Avery, C. L., 1434T<br />
Avihingsanon, Y., 2006F<br />
Avila, M. P., 3130F<br />
Avila, S., 976T<br />
Avila Arreguin, E., 773W<br />
Aviram, A., 270, 2603F<br />
Aviram, M., 2738T<br />
Aviv, A., 1653T<br />
Avraham, K. B., 2914W*,<br />
2919F<br />
Avramopoulos, D., 504W,<br />
2387F, 2461T, 2486F,<br />
2573F<br />
Avrich, A. A., 1295W<br />
Avril, M. F., 1158W<br />
Avsar, T., 2429F, 2450F*<br />
Aw, J., 1872F, 1873F<br />
Awad, D., 1600T<br />
Awadalla, P., 31, 2266T,<br />
3260W, 3268F,<br />
3341W*<br />
Awano, H., 729F, 781W<br />
Awasthi, S., 1287T<br />
Axelsen, M., 2493W<br />
Axelsson, T., 617T, 619T<br />
Axford, M. M., 2824W*<br />
Aya-Bonilla, C. A., 1042T*<br />
Ayala Ramírez, P., 2990T*<br />
Ayas, M., 3149W<br />
Aydinok, Y., 2719W<br />
Ayele, F., 3412T<br />
Aygun, B., 2331W<br />
Aykut, A., 3206F<br />
Ayme, S., 2703F<br />
Aypar, U., 887W*<br />
Ayres, C., 1038W<br />
Ayub, M., 2398T, 2590T<br />
Ayub, Q., 3322F<br />
Ayyub, H., 418W<br />
Azad, A. K., 1108T*<br />
Azadegan, F., 1143W,<br />
1596T, 1739W<br />
Azaiez, H., 2867T*<br />
Azamian, M. S., 1646T<br />
Azaro, M., 2381F<br />
Azaro, M. A., 2523W<br />
Azen, C., 237<br />
Aziz, A., 3007T<br />
Aziz, N., Session 3<br />
Aziza, J., 3129W<br />
Azzedine, H., 2866W*<br />
B<br />
Baaj, S., 865W*<br />
Baala, L., 3246F*<br />
Baas, A. F., 87<br />
Baas, F., 197, 200, 1616T,<br />
2909T<br />
Babatz, T. D., 504W*<br />
Babin, P., 841F<br />
Babiuk, R., 2675T<br />
Babovic-Vuksanovic, D.,<br />
887W<br />
Babron, M.-C., 1496W*,<br />
3408T<br />
Babron, M. C., 3328F<br />
Babrzadeh, F., 398<br />
Babu, D., 2827W*<br />
Babul-Hirji, R., 1872F,<br />
1873F<br />
Babyak, M. A., 2481W<br />
Bacanu, S. A., 2500T<br />
Baccarelli, A., 3469T<br />
Bacchelli, C., 1748W<br />
Bach, R. G., 2535W<br />
Bachmann, C. G., 2568W<br />
Bachmeyer, R. C., 1245W,<br />
3527F*, 3687F<br />
Bacino, C., 432W, 898T,<br />
952T, 3209W<br />
Backes, C., 515F<br />
Bäcklin, C., 3427T<br />
Backus, K., 1116W<br />
Backx, A. P., 2909T<br />
Bacon, C., 1612T<br />
Badarinarayan, N., 1943F,<br />
2303F<br />
Bademci, G., 347, 2603F,<br />
3706W<br />
Badenas, C., 1053W*<br />
Badens, C., 2536T, 3236F<br />
Bader, J. S., 1403W, 1579F<br />
Bader, S., 242<br />
Badfar, S., 1596T<br />
Badii, R., 2933T, 3399W<br />
Badilla-Porras, R., 3183W*<br />
Badner, J., 2590T<br />
Badner, J. A., 1957T<br />
Bae, J., 3444T*, 3462T<br />
Bae, J. S., 3607F<br />
Bae, S., 3462T<br />
Bae, S. C., 1979F, 2046W<br />
Bae, Y., 411, 2864T<br />
Baek, J., 2273F, 2427W*<br />
Baena, N., 2940F<br />
Baere, E., 298<br />
Baert, A., 539F<br />
Baert-Desurmont, S., 1222T<br />
Baeta, M., 3364F, 3402T<br />
Baets, J., 201*, 2948T<br />
Baez-Cabrera, L., 1130F<br />
Baffini, S., 3114F*<br />
Bafna, V., 1043F, 1471F,<br />
3307F<br />
Bagalà, A., 2766F, 2774T
Bagarotti, A., 2775F<br />
Bagdonaite, l., 920T<br />
Bagga, A., 2844F<br />
Baggott, C., 1965W<br />
Baghdadli, A., 2386T<br />
Baghel, K., 764W, 1883F*<br />
Bagheri, N., 1143W*, 1596T,<br />
1739W<br />
Bagnall, R. D., 1664T*<br />
Bagot, M., 29, 1062W<br />
Bagshaw, A., 3440T<br />
Bahce, M., 1136F<br />
Baheti, S., 1695T<br />
Bahi-Buisson, N., 104<br />
Bahlo, M., 2741T, 3228F<br />
Bai, R., 330*, 2839W<br />
Bai, Y., 1945T<br />
Bai, Y.-M., 610T<br />
Baier, H., 810F<br />
Baier, L., 1300F, 1917W,<br />
2038T<br />
Baier, L. J., 2018F, 2124W<br />
Baig, S. M., 2920W<br />
Bailes, A., 456W<br />
Bailes, A. K., 912T<br />
Bailey, A., 3038F<br />
Bailey, J. M., 1957T<br />
Bailey, L., 789W<br />
Bailey, L. B., 1304W<br />
Bailey, M., 340<br />
Bailey, M. H., 1149W*<br />
Bailey, S. M., 948T<br />
Bailey-Wilson, J. E., 1001F,<br />
1081T, 1214F, 1302T,<br />
1363F, 1454W, 1512T,<br />
3591F<br />
Baillie, J. K., 1507F<br />
Bailliet, G., 3362W<br />
Bain, S. M., 978T*<br />
Bainbridge, M., 314, 1742W,<br />
2802F, 2934F<br />
Bainbridge, M. N., 1735W,<br />
1757W, 2883F, 3576W<br />
Baird, L., 2397W<br />
Baird, P., 1072T, 1911W<br />
Bajaj, K., 1793W, 3022T<br />
Bajanowski, T., 86<br />
Bak, B., 2701W<br />
Bak, M., 805F<br />
Bakay, M., 1992W*<br />
Baker, A., 1194W<br />
Baker, C., 12, 14<br />
Baker, E., 2087F<br />
Baker, J., 1198T, 2033F<br />
Baker, L., 2845W*, 2846T<br />
Baker, M., 3287W<br />
Baker, M. C., 2639F<br />
Baker, P., 1671T<br />
Baker, T., 642T<br />
Bakke, P., 2057F, 2249F<br />
Bakker, B., 55<br />
Bakker, S. C., 2526W<br />
Bakour, R., 1268F<br />
Bakthavachalam, V., 2039F,<br />
2049W<br />
Bala, N., 3516T<br />
Balanovska, E., 3377W<br />
Balanovsky, O., 3377W<br />
Balasa, A., 2802F, 3495T<br />
Balasenthil, S., 1095W<br />
*Presenting Author<br />
Balasubramanian, S., 41,<br />
280<br />
Balat, A., 1402F, 1935W,<br />
1938W<br />
Balci, T., 1164W*, 1178F<br />
Baldassano, R., 319,<br />
2229W, 2252F<br />
Baldassano, R. N., 1997F<br />
Baldi, M., 71<br />
Balding, D., 1394W, 1807W*<br />
Balding, D. J., 684T, 3322F<br />
Baldo, G., 691F*<br />
Baldwin, C. T., 343, 2563T<br />
Baldwin, E. E., 886T, 1752W<br />
Baldwin, S., 3671F<br />
Bale, S., 330, 766W, 1765W<br />
Bale, S. J., 222<br />
Bali, D., 2293T<br />
Balkhy, S., 8<br />
Ball, C., 3321T<br />
Ball, C. A., 3365W<br />
Ball, T., 3276T<br />
Ballabio, A., 735F<br />
Ballantyne, C., 1688T<br />
Ballantyne, C. M., 272<br />
Ballard, D. H., 306<br />
Ballew, B., 1196F<br />
Ballif, B. C., 66, 884T*,<br />
3101W<br />
Ballinger, T., 466W<br />
Balloi, M., 3664W<br />
Balmakund, T. M., 1735W<br />
Balmaña, N., 2578T<br />
Balog, J., 55<br />
Balogh, M., 2177F<br />
Balouch, I. A., 2398T<br />
Baluyot, M., 1805W<br />
Balzotti, M., 1021T<br />
Bamezai, R., 3262F<br />
Bamezai, R. N. K., 1993T<br />
Bamshad, M., 2346W<br />
Bamshad, M. J., 55, 74, 94,<br />
148, 171, 301, 1842F,<br />
2740W<br />
Bancr<strong>of</strong>t, E. K., 1109F*<br />
Banda, Y., 112, 118, 421F,<br />
2140T, 2513F, 3342T*,<br />
3383W<br />
Bandera, E. V., 2202W<br />
Bandiera, S., 522W<br />
Bandinelli, S., 2148W<br />
Banerjee, A., 361<br />
Banerjee, N., 3316F<br />
Banerjee, P., 1992W<br />
Banerjee-Basu, S., 446W<br />
Banfi, S., 2950W*<br />
Banikazemi, M., 693F<br />
Banitalebi, G., 2013W<br />
Banka, S., 2852T*<br />
Banks, E., 288<br />
Bannasch, D., 2778F<br />
Banning, M., 979W<br />
Banning, M. J. G., 955W<br />
Bansal, V., 3615F*<br />
Banser, L., 2664F<br />
Banwell, B., 2554T<br />
Bao, S., 557F, 2254T*<br />
Bao, Y., 1146W<br />
Bao, Y. H., 1974W<br />
Bapat, B., 3478T<br />
SPEAKER AND AUTHOR INDEX 337<br />
Baraban, S. C., 2779W<br />
Baradaran-Heravi, A.,<br />
2682F*<br />
Baraitser, M., 124<br />
Baral, V., 842F, 2727F<br />
Baran, Y., 3360T<br />
Barann, M., 567F, 582W<br />
Baranova, M., 3263W<br />
Baratela, W. A. R., 3184F*<br />
Baratta, S., 2781F<br />
Barb, J., 260<br />
Barba, M., 2235W*<br />
Barbalho, P. G., 2373W*<br />
Barbalic, M., 1688T<br />
Barbany, G., 1024T, 1035W,<br />
1126T<br />
Barbarot, S., 3066F<br />
Barbaroux, C., 1205F<br />
Barber, G., 3612W<br />
Barber, R. E., 3158F<br />
Barber, T., 1369F<br />
Barber, T. D., 1235F<br />
Barbosa, A. P. M., 3272W<br />
Barboza, J., 3659F, 3669F*<br />
Barcellos, L., 1415W, 3454T,<br />
3458T<br />
Barcellos, L. F., 1289W,<br />
1301W, 1414F, 1455T,<br />
1924T*<br />
Barcellos, N., 879W<br />
Barcelos, F., 1977W<br />
Barcia, G., 202*<br />
Barczyk, K., 2759T<br />
Bardakjian, T., 810F, 3004T*,<br />
3179W<br />
Bardoni, B., 513F, 817F*<br />
Barea, J., 3120F*<br />
Bareke, E., 394, 1207T,<br />
1215W<br />
Barešová, V., 322<br />
Barett, A., 3441T<br />
Barfield, R. T., 66, 1422T*<br />
Barg, C. J., 142*<br />
Barić, I., 672T<br />
Barillot, M., 841F<br />
Baris, D., 1091F, 1092W<br />
Barisani, D., 1330F<br />
Barisic, N., 201<br />
Barišić, N., 2948T<br />
Barizzone, N., 2095T<br />
Bar-Joseph, I., 53<br />
Barker, A., 78<br />
Barker, J. N., 1927T<br />
Barker, J. N. W. N., 154<br />
Barkovich, A. J., 266<br />
Barletta, C., 3364F, 3402T<br />
Barmada, M. M., 1647T,<br />
1672T, 1673T, 1920W,<br />
1921T, 2040W*, 2099F,<br />
2125T, 2521T, 3078F<br />
Barnard, J., 1659T<br />
Barnes, A. M., 222*<br />
Barnes, C. P., 2576F<br />
Barnes, D. R., 1492F*<br />
Barnes, K., 536W<br />
Barnes, K. C., 158, 171,<br />
1558F, 1900T, 2043W,<br />
2346W<br />
Barnes, L. L., 343<br />
Barnes, S., 690T, 1860F<br />
Barnett, I., 2334W*<br />
Barnhart, M., 3644W<br />
Barnholt, K. E., 626T,<br />
1017W, 2087F*<br />
Barnicoat, A., 2755W<br />
Barnwell, J., 348<br />
Barojas, E., 3226F<br />
Barojas, P., 3226F*<br />
Baron, J., 1292W, 3465T<br />
Barp, J. D., 3114F<br />
Barr, C., 2545T, 3509T*<br />
Barr, T., 2221T<br />
Barragán-Hernandez, M.,<br />
1121F<br />
Barral, S., 1892F<br />
Barreiro, L., 3260W<br />
Barreiro, L. B., 2031W<br />
Barreto da Silva, M.,<br />
1968W, 2017T*<br />
Barrett, A., 44, 583F<br />
Barrett, A. J., 1259F<br />
Barrett, B., 1066T<br />
Barrett, C., 395<br />
Barrett, C. L., 1051T*<br />
Barrett, J., 101, 156*, 291,<br />
364, 453F, 2399F<br />
Barrett, J. C., 35, 37, 153,<br />
354, 1967F<br />
Barrett, J. H., 211*<br />
Barrett, L., 3419T<br />
Barrett, M. T., 1186T<br />
Barrett, T., 2703F, 2767W<br />
Barrett, T. G., 2787F<br />
Barrientos, M. P., 926T<br />
Barrionuevo, B. A., 9<br />
Barrios-García, T., 3504T<br />
Barrois, Y. E. G., 1711T<br />
Barros, A., 2982T<br />
Barros-Nunez, P., 3154F<br />
Barroso, A., 1213T<br />
Barroso, I., 33, 43, 45,<br />
2090F, 2123F, 2147F<br />
Barrowdale, D., 208, 1492F<br />
Barrsos, I., 1954T<br />
Barry, B. J., 266<br />
Barry, W., 147<br />
Barsh, G., 2223W<br />
Barsh, G. S., 3318T<br />
Bar-Shira, A., 704T<br />
Barsottini, O., 2642F<br />
Bartek, J., 1171T<br />
Bartel, F., 2826F<br />
Barth, P., 2759T<br />
Barth, P. B., 2909T<br />
Barth, P. G., 197<br />
Bartha, I., 2050T<br />
Barthez, M.-A., 403, 2536T<br />
Bartholdi, D., 3240F<br />
Bartholomew, A. J., 2552F<br />
Bartkova, J., 1171T<br />
Bartlett, C. W., 2381F,<br />
2544W<br />
Bartlett, J., 245<br />
Bartman, T., 196<br />
Bartoli, M., 328<br />
Bartolomei, M., 3082F<br />
Barton, A., 2160W<br />
Barton, D., 1874F<br />
Barton, L. V., 1717W*<br />
Barts, J., 493F<br />
SPEAKER AND AUTHOR INDEX
338 SPEAKER AND AUTHOR INDEX<br />
Bartsch, O., 849F*, 3266W<br />
Barzilai, N., 1319W<br />
Basang, B., 3317W<br />
Basehore, M. J., 2901F<br />
Basel-Vanagaite, L., 105,<br />
126, 3185W*<br />
Basford, M., 1602T<br />
Bashir, A., 3724W<br />
Bashover, E., 3331F<br />
Baskin, B., 2554T<br />
Baskin, L. S., 1352W, 1885T<br />
Bass, F., 348<br />
Bass, H., 3059W<br />
Bassell, G., 540W<br />
Basset-Seguin, N., 29,<br />
1062W<br />
Bassett, A. S., 2428T,<br />
2467T, 2544W, 2575T<br />
Bassett, S. S., 2648F<br />
Basso, M., 896T, 899W<br />
Bassuk, A., 419F<br />
Bassuk, A. G., 1910F,<br />
2750T<br />
Bastarache, L., 3622W<br />
Bastie, J.-N., 2716W<br />
Bastin, J., 737F<br />
Basto, J. P., 2736F<br />
Basu, A., 3343F*<br />
Batai, K., 1009T*, 2014T<br />
Bates, L., 2405F<br />
Batey, A. Y., 2978T<br />
Bathgate, A., 153<br />
Batish, S. D., 63<br />
Batista, D., 300, 889W,<br />
3097W<br />
Batista, D. A. S., 935W<br />
Batlevi, Y., 2628W<br />
Battaglia, A., 881W*, 3050F<br />
Battaloglu, E., 201, 2948T<br />
Battelino, T., 2688F, 2710W<br />
Battersby, B., 327<br />
Battiston, E., 2799F<br />
Battle, A., 369*, 2372F<br />
Batzer, M. A., 600F, 3270T<br />
Batzoglou, S., 397<br />
Bauchet, M., 2223W<br />
Baudouin, V., 324<br />
Bauduer, F., 716T<br />
Bauer, A., 132<br />
Bauer, C. P., 2102F<br />
Bauer, J., 2557T<br />
Bauer, J. W., 297<br />
Bauer, M., 1176W<br />
Bauer, P., 684T*, 1200W,<br />
1233W<br />
Bauer, T., 236<br />
Bauernh<strong>of</strong>er, T., 1115F<br />
Baugher, J., 3374W<br />
Baujat, G., 915W, 3129W<br />
Baumann, C., 3172F<br />
Baumert, J., 1659T<br />
Baur, J., 534W<br />
Baurecht, H., 1939T, 1942T,<br />
2226W<br />
Bauwens, M., 539F<br />
Baux, D., 2947W<br />
Bauzon, F., 615T<br />
Bavdekar, A., 700T, 2803W<br />
Bawcom, A., 730T<br />
Baxter, A., 3167W<br />
*Presenting Author<br />
Baxter, S., 248, 1676T*,<br />
2021F<br />
Baxter, T., 2221T<br />
Bayés, M., 54, 2303F,<br />
2326T, 2578T<br />
Bayet, B., 2002T<br />
Bayetti, K., 794W<br />
Baylor-Hopkins Center for<br />
Mendelian <strong>Genetics</strong>,<br />
2908W<br />
Baylor-Hopkins Center for<br />
Mendelian Genomics,<br />
360, 2798T, 2883F<br />
Bayoumi, R., 160<br />
Bayrak-Toydemir, P., 225<br />
Baysal, B. E., 3294T*, 3523T<br />
Bazett-Jones, D., 1050W<br />
Bazin, A., 77<br />
Bazin, D., 2759T<br />
BCAC, 209<br />
Bchetnia, M., 778W<br />
Beadling, C., 1237T<br />
BEAGESS Study Investigators,<br />
2190W<br />
Beales, P., 324, 2755W,<br />
3240F<br />
Beales, P. L., 216, 219,<br />
2955F, 3211W<br />
Bean, L. J., 2069F<br />
Bean, L. J. H., 253, 1349W,<br />
3042F<br />
Beasley, E., 133, 1232F,<br />
3670W<br />
Beatty, S., 1897T<br />
Beaty, K. G., 3344W*<br />
Beaty, T., 1076F, 2043W,<br />
2057F, 2325W<br />
Beaty, T. H., 1425T, 1472W,<br />
1512T*, 1558F, 1900T,<br />
2249F, 2346W, 3609F<br />
Beauchamp, C., 1982F<br />
Beaudet, A. L., 314, 430W,<br />
432W, 759W, 898T,<br />
1735W, 1742W, 1757W,<br />
1761W, 2403W<br />
Beaudoin, M., 1906T, 2319W<br />
Beaulieu, C. L., 701F,<br />
2800W*<br />
Beck, C. R., 428W*<br />
Beck, L. A., 1900T<br />
Beck, T., 1093T, 1256F<br />
Beck, T. F., 834F, 839F,<br />
2678T*<br />
Becker, A. B., 1465F<br />
Becker, C., 2861T<br />
Becker, D. M., 1652T, 1710T<br />
Becker, E. B., 2649W<br />
Becker, F., 857W<br />
Becker, J., 806F, 2088W*<br />
Becker, L. C., 1652T, 1710T<br />
Becker, R. C., 1594T<br />
Becker, T., 106, 1332T,<br />
1423F<br />
Beckhaus, T., 782W<br />
Beckman, K. B., 2372F<br />
Beckman, L., 753T<br />
Beckmann, J. S., 62, 110,<br />
299, 1387F, 1800F,<br />
2090F, 2458T<br />
Beckmann, M., 3153W<br />
Beckmann, N. D., 62, 299<br />
Beck-Peccoz, P., 2701W<br />
Bedard, P. L., 135, 1824F<br />
Bedford, J. S., 948T<br />
Bedja, D., 240<br />
Bedoya, G., 3327T, 3360T<br />
Bee, G., 3717F<br />
Beecham, A., 1635T, 2330F<br />
Beecham, A. H., 270*,<br />
1638T, 2049W<br />
Beecham, G., 347, 1871F,<br />
2330F, 2603F, 2637W<br />
Beecham, G. W., 344,<br />
1571W*, 1644T, 1957T,<br />
2498F, 2583W, 2586W<br />
Beekman, M., 119, 1308T,<br />
1436W, 2035T, 2076W,<br />
2080T, 2116T<br />
Been, L., 474W*<br />
Been, L. F., 1933T<br />
Beer, M. A., 258, 545F<br />
Beery, T., 1860F<br />
Beesley, J., 210<br />
Beetz, C., 2930T*<br />
Beg, A. A., 2470T<br />
Beg, M. B., 871W<br />
Begay, T., 988T<br />
Begemann, M., 3111W<br />
Beggs, A., 2811F<br />
Beggs, A. H., 1769W,<br />
3219W<br />
Beggs, W., 3303T<br />
Bego, T., 3286F<br />
Beguin, S., 2674W<br />
Begum, F., 253, 1438F*<br />
Behera, B., 3207W<br />
Behr, E. R., 86, 2699T<br />
Behrendtz, M., 1023W<br />
Behrens, F., 2160W<br />
Behrens, T., 342<br />
Behrens, T. W., 306, 2091W<br />
Beier, D. R., 825F<br />
Beierbach, A., 2474F<br />
Beinat, M., 325<br />
Beiraghi, S., 821F*<br />
Beirnes, K., 2849T<br />
Beiser, A., 123<br />
Beiswanger, C., 966T<br />
Bejerano, G., Session 5, 286*<br />
Bekele, E., 3322F<br />
Bekheirnia, M. R., 314,<br />
1742W<br />
Bekris, L. M., 2646W*<br />
Belaidi, H., 2306F<br />
Belangero, S. I., 2533T,<br />
2534F, 3045W<br />
Belay, G., 3303T, 3338W<br />
Beldjord, C., 890T<br />
Beleggia, F., 3214F<br />
Beleza, A., 1968W, 2017T<br />
Beleza, S., 2223W, 3318T*<br />
Beleza-Meireles, A., 201,<br />
2948T<br />
Belgian Neurology<br />
Consortium and<br />
European Early-Onset<br />
Dementia Consortium,<br />
2815W<br />
Belgrader, P., 3011T<br />
Belgrave, D., 2211W<br />
Belitsky, G., 1180T<br />
Bell, D. A., 257<br />
Bell, G. I., 2192F<br />
Bell, J., 583F, 3453T<br />
Bell, J. T., 44, 2029T, 3441T<br />
Bell, M. J., 1884W*<br />
Bell, R., 293, 1783W<br />
Bellam, N., 1292W<br />
Belleau, P., 1951T*<br />
Bellis, C., 533F, 1912T,<br />
2146T, 2308T*<br />
Bellivier, F., 259<br />
Bello, S. M., 2675T<br />
Bellon, L., 493F<br />
Bellone, M., 1036T<br />
Bellone, S., 2827W<br />
Bellos, E., 429F*<br />
Bellucco, F. T. S., 2534F<br />
Bellus, G., 3244F<br />
Belman, A., 1924T<br />
Belmont, J., 1688T<br />
Belmont, J. W., 337, 1646T,<br />
2158T, 2189F<br />
Belousov, A., 242, 3574W<br />
Below, J., 223<br />
Below, J. E., 49, 2740W*<br />
Belton, J., 255<br />
Belton, R. L., 2185T<br />
Beltrami, A., 2809W<br />
Beltrami, C. A., 2809W<br />
Beltramo, J., 3362W<br />
Belucco, F. T., 3045W<br />
Belyantseva, I. A., 2663T<br />
Bembi, B., 692T*, 2809W<br />
Béna, F., 67, 2937F<br />
Ben-Abdallah-Bouhjar, I.,<br />
944T*<br />
Benachi, A., 72, 894T<br />
Ben-Ami, I., 3002T<br />
Benamor, I. M., 3169W*<br />
Benard, L., 1698T<br />
Ben-Asher, E., 53, 2875W<br />
Benatar, M., 347, 2637W<br />
Ben Avraham, D., 3336T<br />
Benayed, R., 1252T<br />
Bencaz, A., 1081T<br />
Ben Charfeddine, I., 1751W,<br />
2744T<br />
Benchek, P. H., 1575T*<br />
Ben-Chetrit, E., 746T<br />
Bender, F., 685F<br />
Bender, H. A., 168<br />
Bendik, E., 1787W, 1853F<br />
Bendjilali, N., 589F*<br />
Bendsen, E., 805F<br />
Bendtsen, J., 3528W<br />
Bene, J., 3283F<br />
Beneken, C., 1115F<br />
Benet-Pagès, A., 2922F<br />
Bengesser, K., 939W,<br />
2791W<br />
Benhamed, S., 330<br />
Benhamou, S., 1496W<br />
Benistan, K., 772W, 890T<br />
Benit, P., 3241W<br />
Benitez, J., 27, 206, 1150T,<br />
1213T<br />
Benjamin, D. J., 2505W<br />
Benjamin, E. J., 1585T,<br />
1677T
Benjamin, E. R., 1684T<br />
Benjamin, J. S., 2677W*<br />
Benjaminy, S., 1802F*<br />
Ben-Khelifa, H., 944T<br />
Benko, E., 522W<br />
Benlier, N., 1935W, 1938W<br />
Benlloch, S., 205, 1148F,<br />
1011W<br />
Benner, A. T., 2998T<br />
Bennet, R., 3278W<br />
Bennett, C., 214<br />
Bennett, D., 2488T, 3450T<br />
Bennett, D. A., 343, 380,<br />
3417T<br />
Bennett, J., Session 23,<br />
806F*<br />
Bennett, R., 1209W, 1237T,<br />
1246T, 3714W, 3717F,<br />
3719F<br />
Bennetts, B., 3167W<br />
Benoist, C. O., 528W<br />
Benoist-Lasselin, C., 763W<br />
Benoit, V., 3098F, 3181W*<br />
Ben-Omran, T., 8, 2899W<br />
Benowitz, N. L., 642T<br />
Ben-Pazi, H., 2447F<br />
Ben-Salem, S., 160<br />
Ben-Shachar, S., 704T*<br />
Bensussan, A., 29, 1062W<br />
Bentham, J., 3382F*<br />
Bentley, A., 1515T*, 3533F<br />
Bentley, D., 1238F, 2939T,<br />
3663F<br />
Benton, G., 2089T*<br />
Benton, G. M., 1223F, 1620T<br />
Benton, M., 1042T, 1912T<br />
Benyahia, B., 889W<br />
Benyamin, B., 2407T<br />
Benzacken, B., 901W,<br />
973W, 2784F<br />
Ben-Zeev, B., 53, 660T,<br />
731F<br />
Berardinelli, A., 1776W<br />
Berberich, S., 1875F, 1882T<br />
Berberich, S. L., 1344T<br />
Berboso, A. D., 2975T<br />
Berchuk, A., 210<br />
Bercovich, D., 1165T*<br />
Berenson, G. S., 2274W<br />
Berezney, R., 82<br />
Berg, A., 309, 3264T, 3267T<br />
Berg, A. S., 1016F, 1107W<br />
Berg, C., 1012T<br />
Berg, D., 1119W<br />
Berg, J., 645T, 1082F, 1724W<br />
Berg, J. P., 576W<br />
Berg, J. S., 231<br />
Bergadá, I., 361<br />
Bergamin, G., 2799F*<br />
Bergamin, N., 2809W<br />
Bergan, S., 3614W<br />
Bergantino, F., 1060T<br />
Bergbaum, A., 906T<br />
Berge, K. E., 1607T<br />
Bergen, A. W., 642T*<br />
Berger, I. M., 1612T<br />
Berger, K., 2568W<br />
Berglund, L., 619T<br />
Bergman, M., 1857F*<br />
Bergmann, P., 2769F<br />
*Presenting Author<br />
Bergmann, S., 62, 1281T<br />
Bergstrom, D., 983F<br />
Bergstrom Lucas, A., 975W,<br />
3726W*<br />
Berhane, Y. B., 1108T<br />
Béri-Dexheimer, M., 2770W<br />
Berk<strong>of</strong>sky-Fessler, W., 242<br />
Berkovic, S. F., 203, 2741T,<br />
2897T, 2898F<br />
Berletch, J. B., 379<br />
Berlin, D., 966T<br />
Berman, J. R., 3690W*<br />
Bermúdez, M., 2990T<br />
Bern, O., 3002T<br />
Bernabe-Gelot, A., 2674W<br />
Bernal, W., 535F*<br />
Bernaldez, R., 1131W,<br />
1141T<br />
Bernal Villegas, J., 2990T<br />
Bernard, A., 2444F<br />
Bernard, D., 2701W<br />
Bernard, G., 2786T, 2797W<br />
Bernard, N., 3723F<br />
Bernard, O., 325<br />
Bernardinelli, L., 2039F<br />
Bernardini, C., 2235W<br />
Bernardini, L., 881W, 943W,<br />
2777T, 3050F<br />
Bernardo, D. V., 2232W,<br />
3295F*<br />
Bernbaum, J. B., 2443T<br />
Berndt, S., 205, 2080T,<br />
2241W<br />
Berndt, S. I., 108, 1148F,<br />
2090F*, 2202W<br />
Bernert, G., 201, 2948T<br />
Bernier, D., 954T<br />
Bernier, F., 1052F, 3665F<br />
Bernier, F. P., 3095W,<br />
3127W, 3141W, 3173W<br />
Bernier, G., 1226F<br />
Bernier, R., 10, 14, 299,<br />
2406W, 2439W<br />
Berninger, V. W., 2549F<br />
Bernstein, A., 1289W,<br />
1301W, 1414F, 1455T<br />
Bernstein, B., 380<br />
Bernstein, K. E., 130<br />
BernsteinJon, J., 2479T<br />
Beroud, C., 3610W<br />
Beroukhim, R., 266<br />
Berry, D., 2097W<br />
Berry, D. J., 271<br />
Berry, F. B., 2474F<br />
Berry, G. T., 326<br />
Berry, M., 3648W<br />
Berry, R. J., 1304W<br />
Berry, S., 725F*<br />
Berry, S. A., 774W<br />
Berson, E. L., 1756W<br />
Berstein, L., 2202W<br />
Bertelsen, S., 340, 2582F<br />
Berthele, A., 2086T<br />
Berthet, P., 1212W<br />
Bertin, T., 411<br />
Bertin, T. K., 2854W<br />
Bertini, E., 54, 943W, 2777T<br />
Bertola, D. R., 439F, 895W,<br />
2232W, 3152F, 3160F,<br />
3184F, 3250F<br />
SPEAKER AND AUTHOR INDEX 339<br />
Bertolin, C., 1732W*<br />
Bertoni, A., 1661T<br />
Bertram, L., 2520W<br />
Berulava, T., 3524T*<br />
Berutti, R., 113, 157, 177,<br />
547F, 1451W, 2001W<br />
Berwouts, S., 1874F<br />
Besnard, T., 2947W<br />
Besse, A., 2942T<br />
Bessee, A., 676T<br />
Bessenyei, B., 3070F<br />
Bessert, D., 2664F<br />
Bessières, B., 77, 403<br />
Bessling, S. L., 79, 818F<br />
Betancourt, M., 1022F<br />
Betancur, C., 901W<br />
Betley, J., 366, 1176W,<br />
3663F<br />
Betta, P. G., 1153T<br />
Bettella, E., 1755W*, 2795T<br />
Betti, M., 1153T<br />
Betting, L. E., 2233T<br />
Bettinger, J. C., 640T<br />
Betz, R. C., 106<br />
Beunders, G., 98<br />
Beuten, J., 314, 1742W<br />
Bevan, L., 2138F<br />
Bevan, S., 1313W<br />
Bevans, M., 711F<br />
Beverloo, H. B., 980T<br />
Bevillard, J., 2877F<br />
Bevins, C. L., 449F<br />
Bevot, A., 3109W<br />
Beyan, C., 1136F<br />
Beygo, J., 2595W, 3496T*<br />
Bezerra, M. A., 426W<br />
Bezerra, M. A. C., 2718F,<br />
2751F<br />
Bezieau, S., 3066F, 3233W<br />
Bézieau, S., 1204T<br />
Bhagat, G., 1031F<br />
Bhagwat, A. M., 2382W<br />
Bhakta, M. S., 1625T<br />
Bhamani, F. I., 871W*<br />
Bhandari, A., 480W<br />
Bhangale, T., 1539T<br />
Bhangale, T. R., 2091W<br />
Bhanwer, A., 1993T*<br />
Bhanwer, A. J. S., 1703T<br />
Bhardwaj, A., 2726T*<br />
Bhaskar, A., 182<br />
Bhat, M., 2644T<br />
Bhat, V., 2776W<br />
Bhati, S., 2692W<br />
Bhatia, G., 89, 350, 1577W,<br />
3407W*<br />
Bhatia, K., 2581T<br />
Bhatia, T., 2382W<br />
Bhatnagar, S., 984W<br />
Bhatt, D. L., 317<br />
Bhattacharjee, S., 1372F*<br />
Bhattacharya, S., 3271F<br />
Bhattacharya, S. S., 2183F,<br />
2966T<br />
Bhatti, A., 3078F<br />
Bhatti, M. A., 2959W<br />
Bhatti, S., 630T<br />
Bhave, G., 3622W<br />
Bhidayasiri, R., 2749W<br />
Bhide, S., 1758W<br />
Bhonker, Y., 2919F<br />
Bhosle, S., 2005T<br />
Bi, D., 2419T<br />
Bi, W., 432W, 893W, 898T,<br />
952T*, 2395T<br />
Bian, H., 242<br />
Bianba, B., 3317W<br />
Bianchi, D., Session 79,<br />
765W<br />
Bianchi, l., 2695W<br />
Bianciardi, L., 2604W<br />
Bibat, G. M., 2962W<br />
Bibi, S., 1748W<br />
Bibikova, M., 596W, 1238F*,<br />
3451T<br />
Bicalho, M., 2404T<br />
Bick, A. G., 1677T*<br />
Bickel, J. P., 1836F<br />
Bickley, V., 967W<br />
Bidichandani, S. I., 381<br />
Bidlingmaier, M., 2080T<br />
Bieber, M., 1802F<br />
Bieche, I., 1212W<br />
Bielak, L. F., 2275T<br />
Bielawny, T., 3276T<br />
Bielecki, R., 1093T<br />
Bielinski, S. J., 618T, 1351F<br />
Bierings, M. B., 3164F<br />
Biernacka, J. M., 605T*,<br />
1426F, 2516F<br />
Bierut, L., 2114F, 2582F,<br />
2598W, 2650T<br />
Bierut, L. J., 2170T, 2535W<br />
Biesecker, B. B., 316*<br />
Biesecker, L. G., Session<br />
73, 33, 316, 358, 674T,<br />
1690T, 1696T, 2470T<br />
Bieth, E., 572W, 1796W<br />
Biewald, M., 1272W<br />
Bigdeli, T. B., 2500T*, 2594F<br />
Bigelow, A., 1441F*<br />
Bigham, A. W., 3290W*,<br />
3360T, 3380W<br />
Bignon, Y.-J., 1212W<br />
Bilan, F., 77<br />
Bilbao, J. R., 1330F<br />
Bilder, R. M., 639T<br />
Bilgen, R., 2924T<br />
Bilguvar, K., 2924T, 3132F<br />
Billaud, J., 3560W, 3677F*<br />
Billings, L., 249*<br />
Biloglav, A., 1023W<br />
Binder, E. B., 1422T, 2383T,<br />
2483F, 3480T<br />
Bind<strong>of</strong>f, L. A., 2451W<br />
Bing, N., 1491T<br />
Bini, L., 2695W<br />
Binia, A., 3466T, 3486T<br />
Bin-Khamis, G., 2734W<br />
Binkley, G., 3612W<br />
Binquet, C., 1293T<br />
Bint, S., 906T<br />
Birayavci, C., 1164W, 1178F<br />
Biray Avci, C., 1166F*,<br />
1172F<br />
Birch, D. G., 3234F<br />
Birch, P. H., 1840F, 1846W<br />
Birch, S., 2167T<br />
Bird, A. C., 2072F<br />
Bird, L., 3120F<br />
SPEAKER AND AUTHOR INDEX
340 SPEAKER AND AUTHOR INDEX<br />
Bird, T. D., 1753W<br />
Birk, O. S., 2931F*<br />
Birk, R. Z., 2931F<br />
Birkeland, S. R., 339<br />
Birkenhager, R., 3203W*<br />
Birkenhäger, R., 2753T, 2829F<br />
Birmingham, D., 458W<br />
Birnbaum, R. Y., 1995W*<br />
Birney, E., 35, 3732W<br />
Birzele, F., 242<br />
Bis, J. C., 1445W, 1585T,<br />
1592T*, 1599T, 1653T<br />
Bisch<strong>of</strong>f, F. Z., 1255T<br />
Bisgaard, H., 2167T, 2168F<br />
Bisgaard Pedersen, A.-M.,<br />
889W<br />
Bishay, D. L., 968T<br />
Bishop, B., 1729W<br />
Bishop, D. T., 211, 213<br />
Bishop, J., 3719F*<br />
Bishop, K., 664T, 1983W<br />
Bishop, P. N., 2072F<br />
Bishopric, N. H., 86<br />
Bissig, K., 165<br />
Bitner, M., 126<br />
Bitoun, E., 2649W<br />
Bitoun, P., 2784F*<br />
Bitter, H., 3574W<br />
Bitti, P., 2039F<br />
Bivina, L., 3151W<br />
Bizet, A., 324<br />
Bizon, C., 170, 231, 1437T<br />
Bjeda, D., 80<br />
Bjork, B. C., 825F*, 2670F<br />
Bjornsson, H. T., 3097W<br />
Blach, C., 1636T<br />
Blach, C. P., 2946F<br />
Black, G. F., 2003F<br />
Black, P. M., 266<br />
Blackburn, A. N., 2495F<br />
Blackburn, E., 96, 112<br />
Blackett, P. R., 1933T<br />
Blackman, S., 1322W,<br />
2953W<br />
Blackwell, T., 1373W*,<br />
1389T, 1513F, 2375F<br />
Blackwell, T. W., 176,<br />
1923W, 2308T, 2339F<br />
Blackwood, D., 2590T<br />
Black-Ziegelbein, E. A., 60<br />
Blair, E., 2939T<br />
Blair, I. P., 2816T<br />
Blair, J. D., 3429T, 3445T*<br />
Blair, M., 3654W<br />
Blake, T. L., 664T<br />
Blakemore, A. I. F., 1432F,<br />
2162F<br />
Blakesley, R., 1515T<br />
Blancato, J., 3080F<br />
Blanchard, C., 716T, 841F<br />
Blanche, H., 2303F<br />
Blancher, C., 3435T<br />
Blanco, A., 1059W<br />
Blangero, J., Session 8,<br />
176, 533F, 1280W,<br />
1282F, 1406W, 1458T,<br />
1513F, 1912T, 1923W,<br />
2061W, 2146T, 2308T,<br />
2309F, 2339F, 2589W,<br />
2651F, 3434T<br />
*Presenting Author<br />
Blank, R. D., 710T*<br />
Blankenberg, S., 275, 1669T<br />
Blanton, S., 57<br />
Blanton, S. H., 1635T,<br />
1638T*, 1871F<br />
Blasco, M., 546W<br />
Blaser, S., 675F, 3013T,<br />
3186F, 3196F<br />
Blaszkewicz, M., 1335T<br />
Blattmann, P., 1630T<br />
Blattner, F., 3671F<br />
Blauw, H. M., 431F<br />
Blazer, K., 321*<br />
Bleazard, T., 3259F*<br />
Blekhman, R., 537F*, 2029T<br />
Blelloch, G., 3376F<br />
Bleyer, A., 322, 1725W<br />
Blitzer, M., 1729W<br />
Block, G. J., 55, 2224T*<br />
Bloem, A. C., 3164F<br />
Blomenkamp, K., 735F<br />
Blomqvist, C., 1006T,<br />
1117T, 1171T, 1265F<br />
Blondal, T., 1194W<br />
Bloom, M., 2452T<br />
Bloom, R. J., 2468F, 3659F*<br />
Bloss, C. S., Session 9,<br />
146*, 1839W<br />
Blot, W. J., 2202W<br />
Blouin, J.-L., 2877F*<br />
Blow, M. J., 4, 407<br />
Blum, C., 2262W<br />
Blum, M. G. B., 3356W<br />
Blümel, P., 3111W<br />
Blumenfield, J., 3210F<br />
Blumenstiel, B., 322,<br />
1725W*, 3711F<br />
Blumenthal, I., 68, 70,<br />
554W*<br />
Blumentritt, C., 2557T<br />
Blumkin, L., 2447F<br />
Boackle, S. A., 1979F<br />
Boardman, L., 1267T*<br />
Boaretto, F., 1732W, 2708T,<br />
2799F<br />
Bobadilla-Morales, L.,<br />
3188F<br />
Bober, M. B., 2855T, 3150F*<br />
Boca, S. M., 1372F<br />
Bochukova, E., 43<br />
Bock, H.-G., 898T<br />
Boczek, N. J., 2885T*<br />
Bodamer, O. A., 297<br />
Bóday, A., 2865F<br />
Boddaert, N., 202, 329,<br />
522W, 3240F<br />
Boddicker, N., 2717T<br />
Bode, A., 262<br />
Bodemer, C., 128*, 3140F<br />
Bodenh<strong>of</strong>er, U., 95*<br />
Bodereau, V., 3157W,<br />
3241W<br />
Bodily, P., 3561F<br />
Bodmer, W., 181<br />
Bodo, J., 283, 3303T,<br />
3338W<br />
Bodria, M., 845F<br />
Bodzioch, M., 2761W<br />
Boeckxstaens, G. E.,<br />
2088W<br />
Boehm, C., 227<br />
Boehnke, M., 46, 88, 117,<br />
176, 280, 1389T, 1448W,<br />
1452T, 1513F, 1608T,<br />
2090F<br />
Boehringer, E., 3044F<br />
Boeke, J. D., 504W<br />
Boekholdt, S. M., 1604T<br />
Boengers, E. M. H. F., 216<br />
Boerkoel, C., 359, 2442W,<br />
2610W<br />
Boerkoel, C. F., 755W,<br />
2682F, 2849T, 2938W,<br />
3543F<br />
Boerkoel III, C. F., 2870T*<br />
Boerwinkle, E., 121, 170,<br />
174, 183, 187, 192,<br />
272, 349, 648T, 1445W,<br />
1508W, 1520W, 1585T,<br />
1592T, 1599T, 1932W,<br />
2577W, 2880F, 2934F,<br />
3576W, 3597F<br />
Boese, B. J., 2301W<br />
Boesten, I., 708T<br />
Boettger, L. M., 437F<br />
Boezen, H. M., 1330F<br />
B<strong>of</strong>ferding, K. M., 2740W<br />
Bogardus, C., 1300F,<br />
1917W, 2018F, 2038T<br />
Bogdanovic, R., 216<br />
Bögershausen, N., 2944W*<br />
Boggan, J., 2151W<br />
Boggs, B., 330<br />
Bohlega, S., 2743W<br />
Böhm, B., 2160W<br />
Bohm, J., 328, 2681T*<br />
Bohn, J. M., 3635F<br />
Bohnsack, J., 2143T<br />
Bohorquez, S., 951W,<br />
3074F<br />
Bohossian, N., 624T<br />
Bohr, V. A., 2244W<br />
Boileau, C., 56, 1607T,<br />
2266T, 3341W<br />
Boissin, C., 2752W<br />
Boivin, M., 2545T<br />
Boiy, T., 3193W<br />
Bojanowski, M., 1670T<br />
Bojesen, S. E., 206, 210<br />
Bokhoven, H., 672T<br />
Boks, M. P. M., 431F,<br />
2553W, 2661W, 3474T<br />
Boland, J., 30, 1218W,<br />
1517W, 3683F*<br />
Bole-Feysot, C., 104, 324,<br />
403, 2808F<br />
Boles, J. W., 970T<br />
Bolon, B., 2668W<br />
Bolz, J. E., 3550W<br />
Bolze, A., 365*<br />
Boman, H., 2451W, 3215W<br />
Bombard, A., 3016T<br />
Bombard, A. T., Session 79<br />
Bombard, Y., 142, 1841W*<br />
Bommakanti, K., 1601T<br />
Bona, G., 2827W<br />
Bonafè, L., 164, 3190F<br />
Bonaldi, A., 874T, 882T*,<br />
3250F<br />
Bonalumi, A., 870T, 3055W<br />
Bonassi, S., 1153T<br />
Bond, D., 3694W<br />
Bondon-Broders, F., 842F<br />
Bondurand, N., 842F, 843F,<br />
2727F*<br />
Bondy, C. A., 1743W<br />
Bonet, C., 987W<br />
Bonetti, M., 215<br />
Bongers, E. M., 100<br />
Bongers, E. M. F. H., 2925F<br />
Bongers, E. M. H. F., 80<br />
Boni, C., 1759W<br />
Bonilla, E., 1022F<br />
Bonin, M., 1200W*, 3109W<br />
Bonithon-Kopp, C., 1293T<br />
Bonkowsky, J., 2951T<br />
Bonnefont, J.-P., 72<br />
Bonnefont-Rousselot, D.,<br />
1607T<br />
Bonnemann, C., 711F,<br />
2945T<br />
Bonnen, P., 676T, 2942T*<br />
Bonner, J., 463F<br />
Bonnet, C., 2770W<br />
Bonnet-Wersinger, D.,<br />
2679F<br />
Bonneux, S., 2104T<br />
Bonney, E., 3446T<br />
Bonnière, M., 77, 403<br />
Bono, S., 71<br />
Bonomo, J. A., 2310W<br />
Bontrop, R., 285<br />
Bontrop, R. E., 3266W<br />
Bonyadi, M., 57<br />
Booker, J., 688T<br />
Boomsma, D., 434W,<br />
2097W<br />
Boomsma, D. I., 2175W<br />
Boon, L. M., 83, 1015T,<br />
1611T<br />
Boone, P. M., 430W*<br />
Boonvisut, S., 2009F<br />
Boonyaratanakornkit, J.,<br />
3684W<br />
Boos, H. B. M., 2526W<br />
Booth, F., 954T<br />
Booth, F. A., 2422T<br />
Booth, K., 2867T<br />
Boquett, J. A., 3031T<br />
Boran, G., 1624T<br />
Boraska, V., 2522F*<br />
Borck, G., 105*<br />
Borecki, I., 18, 1210T,<br />
2040W<br />
Borecki, I. B., 1641T, 1650T,<br />
1661T, 1913F, 2275T<br />
Borel, C., 3516T<br />
Borenstein, E., 10<br />
Borgan, C., 893W<br />
Borges, M. G., 2394W,<br />
2876T<br />
Børglum, A., 2369F<br />
Børglum, A. D., 2699T<br />
Borgman, S., 1860F<br />
Boright, A. P., 2109W<br />
Borja, J., 2036F<br />
Borjas, L., 3364F, 3402T<br />
Borlido, C., 2408F<br />
Bornman, M. S. R., 1085F<br />
Bornstein, E., 957W
Borochowitz, Z. U., 3202F<br />
Boroevich, K. A., 396,<br />
2051F<br />
Boronat, S., 3208F<br />
Borowsky, M., 326<br />
Borrel, C., 561F<br />
Borrell, M., 1651T<br />
Borrero, E., 3155W<br />
Borsani, G., 3256F<br />
Borsuk, LA., 1165T<br />
Bortolai, A., 3045W<br />
Bortolini, C., 3327T<br />
Bose, P., 2069F, 2312F<br />
Bosl, G., 998F<br />
Bosley, A., 1088F, 2833W<br />
Bosley, T., 2997T<br />
Bosman, A., 807F*<br />
Bosoi, C. M., 1910F<br />
Boss, J., 3310F<br />
Bossé, Y., 1465F, 1655T,<br />
1947W<br />
Bostan, O., 1708T<br />
Boster, J., 2223W<br />
Bostick, M., 3727F*<br />
Boston, J., 1316W, 1377T,<br />
1671T, 1928F, 2037W<br />
Botigué, L. R., 3345T<br />
Bottani, A., 2937F<br />
Bottiglieri, T., 168<br />
Bottomley, M., 2852T<br />
Bottomley, W., 45<br />
Boualga, K., 1268F<br />
Boucher, G., 2319W<br />
Bou Dagher-Kharrat, M.,<br />
3349F<br />
Boudes, P., 732T, 745F<br />
Boudes, P. F., 772W<br />
Boudreau, R. L., 2636F*<br />
Bouffard, G., 1515T<br />
Bougeard-Denoyelle, G.,<br />
1090T, 1222T<br />
Boughey, J. C., 1247F<br />
Bouhlal, Y., 501F*, 1687T<br />
Bouhnik, S., 2234F<br />
Boukhris, A., 2820F<br />
Boulanger, S., 3216F*,<br />
3218F<br />
Bouligand, J., 894T<br />
Boulling, A., 854F*<br />
Bouquillon, S., 299<br />
Bouraoui, S., 2744T<br />
Bourassa, C., 1670T, 2306F<br />
Bourbon, M., 1968W, 2017T<br />
Bourgeois, B. F. D., 266<br />
Bourgeron, T., 259<br />
Bourque, G., 3439T<br />
Bourrat, E., 128<br />
Bourredjem, A., 1293T<br />
Bouss<strong>of</strong>ara, L., 2744T<br />
Boutaoui, N., 3449T<br />
Boute, O., 2002T<br />
Boute-Benejean, O., 3172F<br />
Bouvet, R., 2126F<br />
Bouvier, R., 3129W<br />
Bouzigon, E., 1361W,<br />
1461T, 1941W, 2079W,<br />
2248T<br />
Bova, G. S., 1242W<br />
Boven, L. G., 1619T<br />
Bovolenta, P., 2810T<br />
*Presenting Author<br />
Bowcock, A., 2581T<br />
Bowcock, A. M., 154, 1952F<br />
Bowden, D., 1706T, 2332T<br />
Bowden, D. W., 178, 1648T,<br />
1661T, 1879T, 1888T,<br />
2310W<br />
Bowden, S., 458W<br />
Bowdin, S., 1704T, 1738W,<br />
3142F*<br />
Bowdish, B., 3530W<br />
Bowen, B. M. P. M., 2045F*<br />
Bowen, M., 17<br />
Bower, A., 1856F<br />
Bowes, J., 2160W<br />
Bowling, B., 1860F*, 1861F<br />
Bowling, K., 2556W<br />
Bowne, S. J., 3234F<br />
Bowton, E., 247, 647T<br />
Boxer, A. L., 2639F<br />
Boyaci, H., 2924T<br />
Boyadjiev, S., 1791W<br />
Boyadjiev, S. A., 2151W<br />
Boyadjiev Boyd, S. A.,<br />
3070F, 3151W*<br />
Boyanova, O., 3481T<br />
Boyar, F., 876T<br />
Boyar, F. Z., 3522T*<br />
Boyce, J., 3700W<br />
Boycott, K., Session 74,<br />
198<br />
Boycott, K. M., 131, 701F,<br />
1775W, 2790F, 2794W,<br />
2800W<br />
Boyd, B., 3, 2998T<br />
Boyd, J. H., 1632T<br />
Boyd, K., 1108T<br />
Boyden, L. M., 2915T*<br />
Boyer, J., 1845W<br />
Boyer, T. G., 125<br />
Boysen, C., 3528W*, 3641F,<br />
3662W<br />
Bozon, V., 136<br />
Bozorgmehr, B., 2436W*<br />
Bozza, M., 3050F*<br />
Bozzao, C., 760W<br />
Bozzi, I., 2404T<br />
BPC3, TNBCC, and BCAC,<br />
1150T<br />
Braastad, C. D., 3522T<br />
Bracci, P., 1152W, 3623F<br />
Bracci, P. M., 2055W<br />
Brackett, D., 474W<br />
Bradfield, J., 319, 1915T*,<br />
1996T, 2067W, 2121W,<br />
2229W<br />
Bradford, Y., 247, 1447F<br />
Bradley, A., 3507T<br />
Bradley, B., 2420F, 2483F<br />
Bradley, D. T., 2843T<br />
Bradley, E. J., 197, 2909T<br />
Bradley, F., 3245W<br />
Bradley, M., 1939T<br />
Bradley, T., 1133F, 3186F<br />
Bradman, A., 3458T<br />
Bradman, N., 3322F<br />
Bradrick, S., 2454W<br />
Bradshaw, P., 1047W*<br />
Bradshaw, P. S., 1046F<br />
Brady, S. M., 2702T<br />
Bragat, A. C., 745F<br />
SPEAKER AND AUTHOR INDEX 341<br />
Brage, S., 2359T<br />
Bragg-Gresham, J., 113*,<br />
1568W<br />
Bragin, E., 291<br />
Brahmachary, M., 3516T<br />
Brainbridge, M. N., 1761W<br />
Brais, B., 2797W, 2900T<br />
Bralten, J., 1498F<br />
Brambilla, P., 624T, 2095T<br />
Brancati, F., 131, 2760F<br />
Branch, S., 136<br />
Branco, C. C., 2288F<br />
Branco, M., 3019T<br />
Branco-Madeira, F., 2225F<br />
Brand, S., 1942T<br />
Brandalize, A. P. C., 3031T*<br />
Brandao, L. R., 2330F<br />
Brandl, E., 612T<br />
Brandon, J., 1359T<br />
Brandt, T., 3724W<br />
Brandt, W., 2833W<br />
Branham, K., 2135F<br />
Branham, K. E., 2183F,<br />
3234F<br />
Branson, H., 675F<br />
Brant, S. R., 1381F, 2319W<br />
Brar, B., 2978T<br />
Brar, H., 2978T, 3020T<br />
Brar, S., 2830W*<br />
Brasil, A. S., 3160F<br />
Brasington, R., 2047T<br />
Braslavsky, D., 361<br />
Brass, A., 2231F<br />
Brassat, D., 624T<br />
Bratanič, N., 2688F, 2710W<br />
Bratina, N., 2710W<br />
Bratton, E., 3038F<br />
Braun, T. A., 2750T<br />
Braun, T. R., 1933T*<br />
Braunholz, D., 204, 2958F*<br />
Brautbar, A., 187, 1688T*<br />
Braverman, A. C., 80<br />
Braverman, N., 722T*<br />
Braverman, N. E., 8<br />
Braverman, R., 238<br />
Bravi, C. M., 3362W<br />
Bravo, H., 2566T<br />
Bravo, H. C., 260<br />
Bravo, L. E., 3388F<br />
Braxton, A., 1742W<br />
Braxton, A. A., 1735W,<br />
1761W<br />
Bray, M. S., 2189F<br />
Bray, S. M., 1235F<br />
Brazilian Network Members,<br />
879W<br />
Brazma, A., 567F, 582W<br />
Bready, B., 3529F*, 3656W,<br />
3703F<br />
Breast Cancer Association<br />
Consortium, 206<br />
Brebner, A., 673F, 705F*,<br />
706T, 719F<br />
Breda, C., 2641T<br />
Breden, F., 375<br />
Bredrup, C., 2451W<br />
Brefort, T., 515F<br />
Brehm, J., 3449T<br />
Breit, H., 830F<br />
Brem, R. B., 571F<br />
Breman, A. M., 432W<br />
Bremer, R., 1064F<br />
Bremer, S., 3614W<br />
Bremnes, R. M., 991T<br />
Brémont, F., 572W<br />
Brennan, C., 177, 3664W<br />
Brennan, C. A., 2329T<br />
Brennan, E. P., 2307W<br />
Brennan, K., 2042F<br />
Brennan, M., 2084F<br />
Brennan, P., 1012T, 1496W<br />
Brennand, K. J., 436W<br />
Brennecke, S. P., 2309F<br />
Brenner, S., 499F*<br />
Brenner, S. E., Session 4,<br />
362<br />
Bressac-de Paillerets, B.,<br />
1158W<br />
Bressan, R. A., 2533T,<br />
2534F<br />
Bressman, S. B., 2801T<br />
Bresson, J. L., 129<br />
Breton, A., 3694W<br />
Breton, B., 3680W<br />
Brett, M. S., 2889F*<br />
Breu, H., 1232F, 3717F<br />
Breuhaus, B., 2778F<br />
Breuning, M., 2701W*<br />
Brewer, F., 884T<br />
Brewer, V., 3119W<br />
Brezina, P., 78*<br />
Brezina, P. R., 2998T<br />
Briand, A., 1796W<br />
Briand-Suleau, A., 843F,<br />
894T*, 3157W, 3241W<br />
Briani, C., 2799F<br />
Briault, S., 3246F<br />
Brice, A., 29, 2638T, 2770W,<br />
2820F<br />
Briceno, I., 951W*, 3074F<br />
Brick, K., 417F*, 592W<br />
Brick, L., 103<br />
Bridges, S. L., Jr., 2047T<br />
Briggs, F., 1415W, 1924T<br />
Briggs, F. B. S., 1289W,<br />
1301W, 1414F, 1455T*<br />
Briley, D., 630T<br />
Briley, L., 630T<br />
Brilhante, M. J., 2288F<br />
Brilhante, T. B., 3421T<br />
Brilhante, V., 327<br />
Brill, P., 3128F<br />
Brilliant, M., 2297F, 3622W<br />
Brinkerh<strong>of</strong>f, C. D., 1071W<br />
Brinza, D., 1232F, 3670W*<br />
Briollais, L., 1500T*<br />
Brion, M.-J., 1626T<br />
Brisset, S., 894T<br />
Brisuda, A., 1012T<br />
Britel, L. K., 398<br />
Britto, J. A., 2859F<br />
Brkanac, Z., 2406W<br />
Brockman, M., 3688W<br />
Brockmann, G., 2251T<br />
Brockschmidt, F. F., 106,<br />
2557T<br />
Brodesser, S., 2869W<br />
Brody, J., 584W, 1284T,<br />
1346W, 1503T, 1585T*,<br />
1592T, 1599T<br />
SPEAKER AND AUTHOR INDEX
342 SPEAKER AND AUTHOR INDEX<br />
Broeckelmann, E. M., 837F*<br />
Broeckling, C., 1189T,<br />
1990T<br />
Broer, L., 2175W<br />
Br<strong>of</strong>ferio, A., 1702T<br />
Brohawn, D., 2599T<br />
Brohi, Q., 2075F, 2402F<br />
Broly, M., 2660F<br />
Bromhead, C., 2741T<br />
Bronson, P. G., 2091W*<br />
Brook, A., 2114F<br />
Brook, M., 1150T<br />
Brookes, A. J., 3610W<br />
Brooks, A., 127<br />
Brooks, A. I., 2170T<br />
Brooks, B., 2183F<br />
Brooks, B. P., 664T<br />
Brooks, J., 1167W<br />
Brooks, M., 822F, 1774W<br />
Brooks, M. J., 827F*<br />
Brooks, S., 316<br />
Broomer, A., 1237T<br />
Brophy, P., 419F<br />
Brosch, M., 580W<br />
Brosh, R. M., Jr., 2692W<br />
Brossard, M., 211, 1158W*,<br />
2248T<br />
Brothers, K. B., 247, 631T*<br />
Broussolle, E., 2638T<br />
Brouwer, O., 2909T<br />
Brovedani, P., 3050F<br />
Brower, A., 725F, 3530W*<br />
Brown, A., 546W, 1227W,<br />
1440T*<br />
Brown, A. M. K., 135*,<br />
1256F<br />
Brown, C., 372, 3514T,<br />
3734W<br />
Brown, C. D., 614T<br />
Brown, D., 493F, 738T*<br />
Brown, E. E., 2046W<br />
Brown, J., 686T, 1159T<br />
Brown, K., 3133W<br />
Brown, K. M., 212<br />
Brown, L., 3446T, 3688W<br />
Brown, M., 3682W<br />
Brown, M. A., 152, 209,<br />
2053T<br />
Brown, M. P. S., 36*<br />
Brown, M. R., 202<br />
Brown, N. J., 606T<br />
Brown, S., 3446T*<br />
Brown, S. G., 978T<br />
Brown, S. J., 1216T<br />
Brown, W. T., 1986W, 2449T*<br />
Browne, V. A., 3290W<br />
Brown-Ford, S., 587F*<br />
Brown-Gentry, K., 1377T,<br />
1671T, 1713T, 1928F,<br />
2037W*, 2401T<br />
Brown-Gentry, K. D., 1316W<br />
Browning, B. L., Session 75,<br />
1479T, 1485T, 1487W*,<br />
1537F<br />
Browning, S. R., 1479T*,<br />
1485T, 1487W, 1537F<br />
Brownstein, C. A., 1769W*,<br />
1799W<br />
Brownstein, Z., 2914W,<br />
2919F<br />
*Presenting Author<br />
Broxholme, J., 2939T<br />
Brožková, D., 2745F*<br />
Bruat, V., 31, 2266T, 3268F,<br />
3341W<br />
Bruce, C., 3694W<br />
Bruce, I. N., 2160W<br />
Bruchim, R., 1303F*<br />
Bruckdorfer, K. R., 1626T<br />
Brucker, S., 3153W<br />
Bruckmann, C., 2058W<br />
Brueton, L., 300<br />
Bruford, E., 3651F*<br />
Brüggemann, N., 200<br />
Brüggenwirth, H., 3650W<br />
Bruinenberg, M., 2282F<br />
Brumelle, J., 3512T<br />
Brummett, B. H., 1594T,<br />
2481W<br />
Brunak, S., 2241W<br />
Bruneau, N., 2581T<br />
Brunetti-Pierri, N., 127, 164,<br />
433F, 735F<br />
Brunner, H. G., Session 74,<br />
Session 81, 80, 97, 100,<br />
102, 124, 125, 214,<br />
1734W, 1749W, 2863W,<br />
2925F<br />
Bruno, M. K., 2581T<br />
Bruno, V., 1330F<br />
Brunoni, A. R., 2540F<br />
Brunoni, D., 2484W, 2485T,<br />
2540F, 2863W, 3131W<br />
Bruns, G. A. P., 82<br />
Brunzell, J. D., 1605T<br />
Brusco, A., 550W, 790W<br />
Brusius-Facchin, A. C., 747F<br />
Brussino, A., 550W<br />
Brüstle, O., 236<br />
Bruzel, A., 370<br />
Bruzelius, M., 1651T<br />
Bryan, N., 165<br />
Bryans, N., 3672W<br />
Bryc, K., 178*<br />
Bryne, E., 3096F<br />
Bryois, J., 560W*<br />
Bryson, L., 1724W*<br />
Brzoska, P., 1068W<br />
Brzustowicz, L. M., 2381F,<br />
2426F, 2467T, 2523W,<br />
2544W<br />
Bshara, W., 3428T<br />
Bubela, T., 1802F<br />
Bucasas, K., 2542T<br />
Bucasas, K. L., 2189F,<br />
2336F*, 2337W<br />
Buchan, J. G., 220*, 2860W<br />
Buchanan, D. D., 141,<br />
1067F, 1206W<br />
Buchanan, T. A., 1916F<br />
Buchert, R., 2557T<br />
Buchholz, S., 330<br />
Buchkovich, M., 292*<br />
Buchkovich, M. L., 46,<br />
<strong>2012</strong>F<br />
Buchner, N., 1279T<br />
Buck, D., 2086T<br />
Buckett, W., 2842W<br />
Buckley, H., 3333T<br />
Buckley, K., 1138T<br />
Buckley, M. F., 214, 2151W<br />
Buckley, N., 3471T<br />
Buckstein, M., 1309F<br />
Bucourt, M., 77<br />
Budak, B., 594W<br />
Budde, B. S., 2861T*<br />
Budde, J., 2582F, 2598W<br />
Budenz, D. L., 2154W,<br />
2240F<br />
Budman, D., 1133F<br />
Budowle, B., 3544W<br />
Budunova, I., 1181F<br />
Bueno, D. F., 813F, 814F,<br />
852F<br />
Buermans, H., 813F<br />
Buers, I., 2759T<br />
Buffa, F., 509F<br />
Buffler, P., 2268W<br />
Buffler, P. A., 1924T<br />
Bugge, K., 404, 2215T,<br />
2671W<br />
Bugge, K. E., 387<br />
Buhay, C., 2880F<br />
Buhay, C. J., 1757W<br />
Buhler, E., 2457W, 2674W<br />
Bui, P., 873W<br />
Bui, P. H., 1029W*<br />
Buijs, A., 3164F<br />
Buil, A., 44, 546W*, 560W,<br />
561F, 583F, 1651T<br />
Builes, J. J., 3364F, 3402T<br />
Buitelaar, J., 1498F<br />
Buiting, K., 392, 872T,<br />
3496T, 3500T<br />
Buizer-Voskamp, J., 431F*<br />
Buizer-Voskamp, J. E.,<br />
2526W<br />
Bukowski, R., 537F<br />
Bukshpun, P., 2389T<br />
Bukszar, J., 3442T, 3452T<br />
Bulhões, S. M., 2288F<br />
Bulik, C. M., 2522F<br />
Bull, S. B., 2109W<br />
Bullens, S., 763W<br />
Buller-Burckle, A., 2260T<br />
Bullitt, C., 3560W<br />
Bulman, D., 198<br />
Bulman, D. E., 131, 701F,<br />
2794W, 2800W<br />
Bulstrode, N. W., 303<br />
Bunce, C., 2072F<br />
Bundgaard, M., 3641F<br />
Bundo, M., 2435F<br />
Bungaard, M., 3662W<br />
Büning, C., 1942T<br />
Bunker, C. H., 1672T, 1673T<br />
Bunting, S., 763W<br />
Bunyan, D., 3161W<br />
Burbano, R. R., 1008W,<br />
1132T, 3421T, 3502T,<br />
3503T<br />
Burbidge, L. A., 1021T<br />
Burch, L. H., 606T<br />
Burchard, E. G., 158, 1425T,<br />
2296T, 3363T<br />
Burden, A. F., 1580W<br />
Burdett, L., 1010F, 1012T,<br />
1218W, 1517W<br />
Burdett, T., 2108F<br />
Burdette, L., 30<br />
Burdon, K. P., 1785W<br />
Burgess, D., 3688W<br />
Burgess, K. E., 845F<br />
Burglen, L., 2770W<br />
Burhans, R., 3545F<br />
Burin, M., 685F<br />
Burke, A., 1649T<br />
Burke, B., 2914W<br />
Burke, L., Session 28<br />
Burkett, E., 1853F<br />
Burkhalter, W., 3085W<br />
Burkhardt, H., 2160W<br />
Burkley, B., 646T<br />
Burlet, P., 72<br />
Burnell, L., 3006T<br />
Burnham, N. B., 2443T<br />
Burns, D. K., 637T<br />
Burns, E., 1444F*, 1594T,<br />
1636T, 3345T, 3395W<br />
Burns, K., 1260W<br />
Burns, K. H., 504W<br />
Burns, T., 1889F<br />
Burnside, R. D., 949W<br />
Buroker, N., 727F, 3281W*<br />
Buros, J., 343, 2528F<br />
Burren, O., 453F<br />
Burroughs, A., 153<br />
Burton, C., 1021T<br />
Burton, J., 1014W<br />
Burton, J. E., 3101W<br />
Burtt, N., 169<br />
Burtt, N. P., 172<br />
Burzynski, G. M., 545F<br />
Busche, S., 31, 256*, 394,<br />
1207T, 1215W, 3439T<br />
Busch-Netwich, E., 37<br />
Bush, W., 312, 1668T,<br />
2257T, 2321F<br />
Bush, W. S., 1489F, 1634T,<br />
2298W*<br />
Bushnell, S., 2561F<br />
Buslon, V., 981W<br />
Busonero, F., 113, 157,<br />
177, 276, 1516F, 2001W,<br />
2198F, 2329T, 3664W<br />
Busse, T., 65<br />
Bustamante, C., 285, 2033F,<br />
3345T, 3563F<br />
Bustamante, C. D., 186,<br />
293, 371, 1112F, 1770W,<br />
2087F, 3352F, 3360T,<br />
3361F, 3362W, 3368W,<br />
3380W, 3390T, 3411W<br />
Bustamante, M., 2167T<br />
Butcher, D., 3482T<br />
Butcher, D. T., 3447T*,<br />
3456T, 3489T<br />
Butcher, N. J., 2428T*<br />
Butler, A. W., 2494T<br />
Butler, E., 2579F<br />
Butler, M. G., 3054F,<br />
3089W*<br />
Butler-Browne, G., 2840T<br />
Butt, M., 784W<br />
Butte, A., 2230T<br />
Butte, A. J., 562W, 1462F<br />
Butter, F., 2010W<br />
Butterly, L., 3465T<br />
Buttgereit, A., 2456F<br />
Büttner, C., 3153W<br />
Bützow, R., 1026W
Buur Sinding, J., 3641F,<br />
3662W<br />
Buxbaum, J., 1520W<br />
Buxbaum, J. D., 268, 343,<br />
1530T, 2560T*, 2577W<br />
Buxbaum, S. G., 1715T*<br />
Buxton, J. L., 1432F, 2162F,<br />
2175W<br />
Buyru, N., 2912T<br />
Buys, S., 1213T<br />
Buyske, S., 1608T, 2042F,<br />
2381F, 2501F*, 3558W<br />
Buysse, K., 214<br />
Buzkova, P., 2041T<br />
Bwanali, J., 3694W<br />
Bybee, J., 3702W<br />
Byerley, W., 2590T<br />
Byers, P. H., 80, 1759W<br />
Bygum, A., 2760F<br />
Byrd, G., 2637W<br />
Byrd, G. S., 343<br />
Byrge, C., 3239W*<br />
Byrne, M., 3610W*<br />
Byrnes, A. E., 1532W*,<br />
3659F<br />
Byrnes, J., 3321T, 3380W<br />
Byrnes, J. K., 3352F,<br />
3365W, 3390T<br />
Byrois, J., 561F<br />
Bytautas, J. P., 1824F*<br />
C<br />
Caberg, J.-H., 925W<br />
Cabezas, R., 76<br />
Cabot, C., 3538W<br />
Cabral, D., 1635T, 1638T<br />
Cabral, R., 2814F<br />
Cabral, W. A., 222, 2853F*<br />
Cabrera, L., 1119W<br />
Cabrera, S. S., 3063W<br />
Cabrera-Luque, J., 670T<br />
Cabrera-Rios, M., 659F<br />
Cabriolu, A., 2001W<br />
Cacheux, V., 3047W<br />
Cadby, G., 1153T<br />
Cade, W. H., 2028W, 2185T,<br />
2318F<br />
Cadenne, M., 716T<br />
Café, C., 2417F, 2502W<br />
Caggana, M., 2151W<br />
CAGI Participants, 499F<br />
Cagnin, A., 2775F<br />
Cahayag, R., 784W<br />
Cahill, M., 263<br />
Cahn, W., 2526W<br />
Cai, C., 553F, 844F, 2612F*,<br />
3558W<br />
Cai, F., 1539T<br />
Cai, G., 268<br />
Cai, J., 242, 3531F*<br />
Cai, X., 266<br />
Cai, Z., 1485T*<br />
Caiazzo, C., 71<br />
Caicedo, L., 2631W<br />
Cailler, S., 2113T<br />
Cailley, D., 473F<br />
Cain, C., 2<br />
Cain, S., 2852T<br />
*Presenting Author<br />
Cairney, A. E. L., 1138T<br />
Calcagno, D. Q., 1008W,<br />
1132T, 3421T*, 3503T<br />
Calcaterra, N., 2673F<br />
Caldarazzo, S., 2781F<br />
Caldarelli, M., 2235W<br />
Calderon, J., 1609T*<br />
Calderwood, M., 2660F<br />
Caldwell, D. A., 1834F<br />
Cale, C. M., 1748W<br />
Calender, A., 1293T<br />
Caleshu, C., 1601T<br />
Calhoun, A., 3088F<br />
Calibi, M., 322<br />
Caliebe, A., 1943F<br />
Calik, M., 2396F, 2412W<br />
Calkins, M. E., 2514W,<br />
2546F<br />
Call, W., 2328W<br />
Callahan, L. F., 2047T<br />
Callan, C., 597F<br />
Callens, T., 1139F<br />
Callewaert, B., 128, 129*<br />
Calley, J. N., 1235F<br />
Callier, P., 2716W, 2729T,<br />
2770W, 2792T<br />
Callier, S., 241<br />
Caluseriu, O., 3173W*<br />
Calvas, P., 390, 2957T<br />
Calverley, P. M. A., 2249F<br />
Calvert, D., 3449T<br />
Calvo, S., 1859F<br />
Calvo, S. E., 326<br />
Calzada-Wack, J., 2922F<br />
Camarena, V., 794W<br />
Camargo, L. M., 1343W<br />
Camargo, L. M. A., 2352W<br />
Camarillo, C., 2495F<br />
Camarillo, D. D. A., 3063W<br />
Cambell, C., 3397W<br />
Cambien, F., 3453T<br />
Cambon-Thomsen, A.,<br />
1811W, 1848W<br />
Cambridge, E., 2701W<br />
Camerini-Otero, R. D., 417F,<br />
592W<br />
Cameron, R., 2984T<br />
Camilleri, E., 1042T<br />
Camm, A. J., 2699T<br />
Camminady, A., 2928F<br />
Camp, N., 1001F<br />
Camp, N. J., 1441F<br />
Campbell, C., 1185W,<br />
1309F, 3345T*<br />
Campbell, C. A., 2301W*<br />
Campbell, C. D., 14, 278*<br />
Campbell, F., 630T<br />
Campbell, H., 1383T,<br />
1481W, 2072F, 2366F<br />
Campbell, I. G., 27, 1224W<br />
Campbell, I. M., 229*, 430W<br />
Campbell, K. P., 2812W<br />
Campbell, M., 2043W<br />
Campbell, M. R., 257<br />
Campbell, M. T., 1683T<br />
Campbell, N. G., 268<br />
Campbell, S., 2072F<br />
Campeau, P., 127, 165,<br />
2864T*, 2934F, 3209W<br />
Camper, S. A., 1878W<br />
SPEAKER AND AUTHOR INDEX 343<br />
Campion, D., 345, 3538W<br />
Campos, B., 2627F, 2814F<br />
Campos, M. M., 2183F<br />
Campos Valenzuela, J. A.,<br />
1236W<br />
Camps, C., 509F<br />
Campuzano, V., 3084F<br />
Canales, C. P., 410,<br />
2662W*, 2837T<br />
Canapicchi, R., 3050F<br />
Cancel-Tassin, G., 28, 1001F<br />
CANDELA Consortium,<br />
3327T<br />
Candille, S. I., 581F, 3318T,<br />
3383W*<br />
Canfield, T., 255<br />
Canfield, V., 309<br />
Canfield, V. A., 3264T*,<br />
3267T<br />
Cangul, H., 1708T<br />
Canham, N., 80<br />
Canick, J. A., 3016T<br />
Canino, G., 3449T<br />
Canizales, S., 3327T<br />
Cann, G., 1167W*<br />
Cann, H. M., 371, 3361F,<br />
3411W<br />
Cannon-Albright, L., 28,<br />
1001F, 1149W, 1214F,<br />
1328W*<br />
Canson, D. M., 707F<br />
Cantor, E., 3517T, 3715F<br />
Cantor, R., 2262W<br />
Cantor, R. M., 2056T, 2222F,<br />
2256W, 2415W, 2551T,<br />
2658W<br />
Cantsilieris, S., 1911W*<br />
Cantú, C., 872T<br />
Cantwell, L. B., 342, 343<br />
Canty, A. J., 2109W<br />
Cao, A., 113<br />
Cao, D., 159, 2617T<br />
Cao, H., 3649F<br />
Cao, L., 2672T*, 2837T<br />
Cao, M., 92*, 1776W<br />
Cao, Q.-Y., 1613T*<br />
Cao, X., 3317W<br />
Cao, Y., 1772W<br />
Capalbo, A., 2777T<br />
Capelo, L. P., 852F<br />
Capo-Chichi, J.-M.,<br />
2692W*, 2790F<br />
Capon, F., 154, 1927T<br />
Caporaso, N. E., 30, 1154F<br />
Capra, R., 2095T<br />
Capra, V., 1910F<br />
Capredon, M., 3260W*,<br />
3341W<br />
Capron, C., 2716W<br />
Caputo, S., 1062W, 1212W<br />
Caraballo, L., 2043W<br />
Carabalona, A., 889W,<br />
2674W*<br />
Caracciolo, M., 2766F,<br />
2774T<br />
Caramins, M., 2934F<br />
Carbajo, R., 682T<br />
Cardena, M. M. S. G.,<br />
1629T<br />
Cardenas, R., 1141T<br />
Cárdenas-Cardos, R.,<br />
1131W<br />
Cardentey, Y., 3706W<br />
Cardin, N., 1250F<br />
Cardinale, C., 2229W,<br />
2592W<br />
Cardinale, C. J., 1997F*,<br />
2252F<br />
CARDIoGRAM Consortium,<br />
ADIPOGen Consortium.,<br />
1595T<br />
CARDIoGRAMplusC4D<br />
Consortium, 115<br />
Cardon, L. R., 641T, 649T<br />
Cardoso, C., 889W, 2674W<br />
Cardoso, M. T. O., 1880F<br />
Cardozo, G. P., 776W<br />
CARe Analysis Core, 350<br />
Carels, C., 3159W<br />
Carey, A., 689F<br />
Carey, J., 290, 3088F*<br />
Carey, J. C., 3076F<br />
Carey, J. P., 2301W<br />
Carey, V., 536W<br />
Caria, C. A., 2001W<br />
Carim, S., 2852T<br />
Carless, M., 1912T, 2061W<br />
Carless, M. A., 1406W,<br />
2589W, 2651F, 3434T*<br />
Carling, T., 1241F<br />
Carlins, E., 2219F<br />
Carlo, S., 659F<br />
Carlson, C., 530W, 1925F,<br />
2098T, 2337W<br />
Carlson, C. S., 1408F,<br />
1437T, 2042F<br />
Carlson, E., 603T<br />
Carlsson, G., 3618W<br />
Carlsson, J., 582W<br />
Carlsson, L. M., 1271F<br />
Carlsson, L. M. S., 427F<br />
Carlus, J., 1950W<br />
Carmack, C., 399<br />
Carmi, S., 17, 3346F*<br />
Carmichael, S. L., 1352W*,<br />
1885T<br />
Carmignac, V., 2716W,<br />
2770W<br />
Carmona-Mora, P., 410,<br />
2672T, 2796F*, 2837T<br />
Carneiro, M., 288<br />
Carnevale, A., 956T, 1141T<br />
Carney, R. M., 2583W,<br />
2637W<br />
Caron, F. M., 3117W<br />
Caron, M., 3439T<br />
Caron, O., 1212W<br />
Carosso, G., 2786T<br />
Carotenuto, G., 3492T<br />
Carpenter, C., 651T<br />
Carpenter, K., 166<br />
Carpenter, M., 186<br />
Carpentier, S., 54<br />
Carpintero-Ramirez, G.,<br />
2219F<br />
Carpten, J., 28, 1001F<br />
Carpten, J. D., 1214F,<br />
1240T<br />
Carr, A., 132<br />
Carr, J., 1706T<br />
SPEAKER AND AUTHOR INDEX
344 SPEAKER AND AUTHOR INDEX<br />
Carr, J. J., 1648T, 1661T,<br />
1913F, 2275T<br />
Carraro, D., 1151F<br />
Carrasco, M., 2430W<br />
Carrato, A., 1091F<br />
Carrell, D. T., 2982T<br />
Carrera, C., 1053W<br />
Carrero-Gonzalez, I., 3363T<br />
Carrillo, O., 2543F<br />
Carrillo, T., 2296T<br />
Carrillo-Carrasco, N., 711F,<br />
1702T<br />
Carrington, B., 1983W<br />
Carrington, M., 2217W<br />
Carroll, C. J., 327*<br />
Carroll, J., 3212F<br />
Carroll, J. C., 142, 149, 150,<br />
1827W, 1852F*<br />
Carroll, P., 3211W<br />
Carroll, R., 3622W<br />
Carsola, F. G., 2706F<br />
Carson, A. R., 1239W*<br />
Carson, D. A., 1051T<br />
Carson, J. L., 2851W<br />
Carta, E., 2752W<br />
Carta, L., 81, 767W*, 1698T<br />
Cartault, F., 522W, 915W<br />
Cartaxo, C., 2609F<br />
Carter, C. S., 404*<br />
Carter, E., 826F*, 864T, 3128F<br />
Carter, H., 2180F<br />
Carter, M., 198<br />
Carter, M. T., 3086F*<br />
Carter, N., 101, 291, 364<br />
Carter, T., 3326W<br />
Cartier, N., Session 23<br />
Carty, C., 1608T<br />
Carty, C. L., 1925F*, 2042F<br />
Caruccio, N., 3668W, 3721F<br />
Carulli, J. P., 2561F*<br />
Caruso, D., 3026T<br />
Carvajal-Carmona, L.,<br />
1072T*<br />
Carvalho, A., 2814F<br />
Carvalho, C., 2955F<br />
Carvalho, C. M. B., 61,<br />
337*, 428W, 485F<br />
Carvalho, D. R., 2596T<br />
Carvalho, E., 2043W<br />
Carvalho, E. D. F., 2232W,<br />
3152F*<br />
Carvalho, E. F., 883W<br />
Carvalho, F., 2982T, 3122F<br />
Carvalho, K. M., 883W<br />
Carvalho, M. F., 883W*<br />
Carvalho, M. R. S., 2434T*<br />
Carvil, G. L., 10<br />
Carvill, G., 2890W, 2897T*<br />
Casadei, S., 26, 1089W*,<br />
1226F, 1228T<br />
Casadio, C., 1153T<br />
Casalone, E., 1153T<br />
Casals, F., 31, 3268F<br />
Casals, T., 1768W<br />
Casanova, J.-L., Session<br />
80, 365<br />
Casanova, J. L., 127, 202,<br />
3599F<br />
Casavant, T. L., 60<br />
Cascio, W., 1636T<br />
*Presenting Author<br />
Casella, A., 1229F<br />
Casenave, P., 716T<br />
Casey, G., 1072T<br />
Casey, S., 2493W<br />
Casingal, C., 2466W<br />
Casingal, C. R., 2473T*<br />
Casper, R., 2869W<br />
Cass, C. E., 1297F<br />
Cassidy, A., 645T*<br />
Castaldi, P., 2057F, 2249F<br />
Castañon, M., 1048T<br />
Castelazo-Rodriguez, G.,<br />
1168T<br />
Castellani, C., 1731W,<br />
2585F*<br />
Castelli, E. C., 3375T<br />
Castellotti, B., 2775F<br />
Castéra, L., 1205F<br />
Castiglia, L., 3114F<br />
Castilhos, R. M., 2424W,<br />
2626T, 2642F*<br />
Castilla, E. E., 1936T<br />
Castillo-Fernandez, J. E.,<br />
1129T<br />
Castle, A., 794W<br />
Castle, D., 149, 150, 1827W<br />
Castor, A., 1023W<br />
Castrillo, J. L., 976T<br />
Castro, A. M., 182, 381,<br />
1573F<br />
Castro, C., 1899W<br />
Castro, E. C., 1109F<br />
Castro, J. M., 1111T, 1127F,<br />
1128W<br />
Castro, O., 928T<br />
Castro-Giner, F., 54<br />
Castro-Perez, J. M., 1605T<br />
Casuga, I., 1209W, 3278W*,<br />
3714W<br />
Caswell, J. L., 1576F*<br />
Caswell, R., 2704W, 2709F,<br />
2935W<br />
Catalano, L. M., 66<br />
Cataldo, J., 1965W<br />
Catalona, W., 28, 1001F<br />
Catalona, W. J., 1214F<br />
Catanese, J. J., 1603T<br />
Catania, M. V., 513F<br />
Cathey, S. S., 2826F<br />
Cauchin, E., 1204T<br />
Caughey, A. B., 3020T<br />
Cauley, J. A., 2145W<br />
Caulfield, M. J., 79<br />
Caumes, R., 915W<br />
Causer, V., 2083T<br />
Causga, I., 1246T<br />
Causse, A., 2957T<br />
Caux-Moncoutier, V., 1205F<br />
Cavadino, A., 271<br />
Cavalcanti, D. P., 3129W<br />
Cavalcanti, F., 2763F*,<br />
2766F, 2774T, 2780T<br />
Cavalieri, S., 790W*<br />
Cavalla, P., 2095T<br />
Cavallari, L. H., 646T<br />
Cavalli, R., 790W<br />
Cavelier, L., 3728W<br />
Caywood, L., 3335W<br />
Cazier, J.-B., 2939T<br />
Cazier, J. B., 1640T<br />
CCFR Investigators, Colon<br />
Cancer Family Registry,<br />
National Cancer Institute,<br />
1292W<br />
CCT Consortium, 388<br />
Cebulla, C. M., 1197W<br />
Cecilia, K., 2722W<br />
Cederbaum, S., 165<br />
Cederbaum, S. D., 680T<br />
Cedro-Tanda, A., 1168T*<br />
Cejas, D., 666T<br />
Celedón, J. C., 3449T<br />
Celikyapi, G., 2429F*<br />
Celikyapi Erdem, G., 2841F,<br />
3475T<br />
Celis, A., 2363F<br />
Celli, B., 2249F<br />
Cen, W.-J., 3281W<br />
Cendes, F., 514W, 2233T,<br />
2394W, 2876T<br />
Cengiz, F. B., 57<br />
Center, J. C., 2176T<br />
Center for Inherited Disease<br />
Research, 3644W<br />
Centre for Genome<br />
Diagnostics, 1870F<br />
Cents, R., 2164T<br />
Cepok, S., 2086T<br />
Cereb, N., 3330T<br />
Cerecedo-Zapata, C.,<br />
3124F<br />
Cereda, C., 2775F<br />
Cerhan, J. R., 3564W<br />
Ceris, J., 1338T<br />
Cerise, J., 1407T<br />
Cermola, M., 2810T<br />
Cernach, M. C., 3045W<br />
Cerqueira, A., 1727W<br />
Cerroni, L., 1063T<br />
Cervantes, D., 3040F<br />
Cesaretti, J., 1309F<br />
Cesarini, D., 2505W<br />
Cespedes, C., 3069W<br />
Cesselli, D., 2809W<br />
Cetani, F., 2708T<br />
Ceyhan, O., 2811F, 3219W*<br />
Ceylaner, S., 3003T*<br />
Cha, D., 900T<br />
Cha, P., 2550W*<br />
Cha, P. C., 3513T<br />
Chaabouni Bouhamed, H.,<br />
2937F<br />
Chabchoub, E., 925W<br />
Chabrol, B., 2536T<br />
Chadha-Boreham, H., 684T<br />
Chadwick, B. P., 3515T<br />
Chae, C. H., 3180F<br />
Chae, H., 2715F*<br />
Chae, J., 877W, 3204F*<br />
Chae, Y. M., 846F<br />
Chafai Elalaoui, S., 3246F<br />
Chahine, K., 3321T, 3340F,<br />
3365W<br />
Chahrour, M. H., 8, 2613W*<br />
Chaix, M., 1678T*<br />
Chakarova, C. F., 2183F<br />
Chaki, M., 406*, 2850F<br />
Chakrabarti, B., 3316F<br />
Chakraborty, P., 142, 150<br />
Chakraborty, R., 1660T<br />
Chakravarti, A., 13, 121,<br />
305, 308, 1639T, 2305T,<br />
3316F<br />
Chaleshtori, M. A., 59<br />
Challis, D., 3576W<br />
Challman, T. D., 2439W<br />
Chalmers, D., 1848W<br />
Chalon, M., 3246F<br />
Chalouhi, G., 72<br />
Cham, B. W. M., 2889F<br />
Chamarthi, B., 50*<br />
Chambers, C., 3076F<br />
Chambers, J. C., 110*, 383,<br />
3435T<br />
Chambers, S. K., 1087T<br />
Chambert, K., 284, 290,<br />
1325W, 2487W,<br />
2618F<br />
Chambliss, J., 1081T<br />
Chamling, X., 2671W*<br />
Chamma, M. T., 2655W<br />
Chammas, R., 1008W<br />
Champion, K., 3171W<br />
Champion, K. J., 2901F,<br />
3684W<br />
Chan, A. T., 191<br />
Chan, D., 638T<br />
Chan, E., 865W<br />
Chan, E. T., 3612W<br />
Chan, H., 1905W<br />
Chan, H.-W., 2285F<br />
Chan, I. H. Y., 1930T<br />
Chan, J., 2279F, 2280W<br />
Chan, L. L., 1375F<br />
Chan, P., 3522T<br />
Chan, R. B., 2547W<br />
Chan, W., 2928F<br />
Chan, W. Y., 3491T<br />
Chan, Y., 2364W*<br />
Chanda, P., 1403W*, 1579F<br />
Chandak, G. R., 3455T<br />
Chandirasekar, R., 1044W*<br />
Chandler, R. J., 664T, 669F*<br />
Chandna, P., 1701T<br />
Chandra, A., 1177T<br />
Chandran, V., 1952F, 2658W<br />
Chandrasekharappa, S.,<br />
3080F<br />
Chang, C., 893W, 1249T,<br />
1830F, 1905W, 3727F<br />
Chang, C. C., 1380T<br />
Chang, C. J., 3457T<br />
Chang, D., 183<br />
Chang, E. R., 498W*, 2111F<br />
Chang, G., 989F<br />
Chang, I., 629T<br />
Chang, J., 1027T<br />
Chang, K., 1249T, 3695F<br />
Chang, M. L., 2517W<br />
Chang, R., 2895F<br />
Chang, S., 985T, 1557T*,<br />
1894T<br />
Chang, S.-C., 2285F<br />
Chang, T., 985T*, 1894T,<br />
1905W, 1929W, 3026T<br />
Chang, W., 3695F<br />
Chang, W. H., 2768T<br />
Chang, X., 3415T, 3532W*<br />
Chang, Y.-T., 610T<br />
Chang-Claude, J., 206
Chanloner, J., 2834T<br />
Chanock, S., 191, 205,<br />
1012T, 1097F, 1119W,<br />
1148F, 1154F, 1306F,<br />
1413T, 1517W, 1626T,<br />
2165F, 3683F<br />
Chanock, S. J., 30, 213,<br />
1010F, 1150T, 1160F,<br />
1218W, 1372F, 1390F,<br />
2202W, 3325F<br />
Chan-Seng-Yue, M., 1093T<br />
Chantot-Bastaraud, S.,<br />
973W<br />
Chanudet, E., 303, 2755W<br />
Chan-Yeung, M., 1465F<br />
Chao, E. C., 2907F*<br />
Chaouch, M., 2808F, 2866W<br />
Chaoui, A., 2727F<br />
Chapman, B., 356<br />
Chapman, B. A., 326<br />
Chapman, K., 670T*, 2432F<br />
Chapman, N. H., 2406W*<br />
Chapman, S., 2157W<br />
Chapman, S. J., 1948T<br />
Charames, G. S., 3448T*<br />
Charbonnier, F., 32, 1222T<br />
CHARGE, GBPgen, and<br />
ICBP Investigators, 1637T<br />
CHARGE, GIANT, CARe,<br />
and African <strong>American</strong><br />
Central Adiposity<br />
Consortia, 1896W<br />
CHARGE-BP and ICBP<br />
Consortia, 1639T<br />
CHARGE Consortium<br />
Protein Working Group,<br />
111, 2073W<br />
CHARGE Exome Chip<br />
Genotyping Committee,<br />
1445W<br />
CHARGE Gene Expression<br />
Working Group, 584W<br />
CHARGE Insulin-Like<br />
Growth Factor Working<br />
Group, 2080T<br />
CHARGE Neurology<br />
Working Group, 1592T<br />
CHARGE Nutrition Working<br />
Group, 51<br />
CHARGE Subclinical<br />
Atherosclerosis Working<br />
Group, 1599T<br />
Charland, S. L., 1714T<br />
Charles, A., 1262F<br />
Charles, C., 3242F<br />
Charles, P., 2770W<br />
Charoensawan, V., 2918T<br />
Charon, A., 3181W<br />
Chartterjee, N., 1012T<br />
Chase, J., 728T<br />
Chasman, D., 109, 2165F<br />
Chasman, D. I., 51, 609T,<br />
2056T<br />
Chassaing, N., 124, 2957T*<br />
Chatelain, S. M., 926T,<br />
1018T<br />
Chatterjee, K., 2701W<br />
Chatterjee, N., 1091F,<br />
1306F*, 1372F, 1378F,<br />
1413T<br />
*Presenting Author<br />
Chattopadhyay, K., 1073F*<br />
Chattopadhyay, S., 1278W*<br />
Chatzisevastou-Loukidou,<br />
C., 84<br />
Chaubey, A. D., 2826F<br />
Chaudru, V., 1158W<br />
Chauhan, M., 605T, 2516F<br />
Chauveau, C., 2945T*<br />
Chavez, H. O., 926T<br />
Chávez, M., 2365T*<br />
Chawla, L., 2967T<br />
Chawla, S., 865W, 2739F<br />
Chawner, S., 2405F<br />
Chayama, K., 396<br />
Cheah, F., 1472W<br />
Chebaro, W., 2842W<br />
Chechi, T., 770W<br />
Chedin, F., 552W<br />
Chédin, F. L., 2633F<br />
Chee, M., 1684T<br />
Cheguri, S., 998F, 999W,<br />
1159T<br />
Cheh, M. L., 1859F<br />
Chelin, C., 77<br />
Chemaly, E. R., 1698T<br />
Chen, B., 242<br />
Chen, C., 356, 989F, 1249T,<br />
1390F, 2392T*, 2571W,<br />
2606F, 3413W*, 3467T,<br />
3582W<br />
Chen, C. A., 1781W<br />
Chen, C.-H., 2092T*<br />
Chen, C.-P., 797W<br />
Chen, D., 382<br />
Chen, D. C., 1034F<br />
Chen, D. T., 260, 2622W<br />
Chen, E. S., 1132T, 3421T,<br />
3503T<br />
Chen, F., 123, 1662T, 1688T,<br />
2202W*, 3293W, 3566W<br />
Chen, G., 241, 242, 356,<br />
1324F, 1460W, 1886F,<br />
3533F*<br />
Chen, G. B., 1360F<br />
Chen, G. K., 2131T, 2202W,<br />
3621F<br />
Chen, H., 169, 202,<br />
1346W*, 1369F, 1543F,<br />
1972T, 3317W, 3347W*<br />
Chen, H. Y., 2014T, 2575T<br />
Chen, J., 333, 2251T,<br />
3534W*<br />
Chen, J. H., 1972T*<br />
Chen, J. L., 1054T*<br />
Chen, J. W., 3430T<br />
Chen, K., 511F, 989F<br />
Chen, K. C., 1586T<br />
Chen, L., 50, 1059W<br />
Chen, L.-S., 2535W*<br />
Chen, M., 189, 1201T*,<br />
2419T, 3697F<br />
Chen, M.-R., 2285F<br />
Chen, N., 1095W, 2617T<br />
Chen, P., 399, 1929W*,<br />
2461T, 3619F<br />
Chen, P. K., 1472W<br />
Chen, P. L., 2936T<br />
Chen, P.-W., 2970T<br />
Chen, Q., 2921T, 3026T<br />
Chen., R., 1505W<br />
SPEAKER AND AUTHOR INDEX 345<br />
Chen, R., 385, 562W, 1462F,<br />
1601T, 1779W, 2230T,<br />
2322W*, 2910F<br />
Chen, S., 69, 116, 245,<br />
411*, 785W, 1021T,<br />
2259W*, 2819T, 3714W<br />
Chen, S, M., 1246T<br />
Chen, S.-H., 256, 3281W<br />
Chen, S.-M., 3278W<br />
Chen, S. M., 1209W<br />
Chen, T., 985T, 2444F,<br />
3415T<br />
Chen, T.-J., 907W*<br />
Chen, W., 22, 178, 766W,<br />
1110W, 1354F, 1971W,<br />
1972T, 2135F, 2274W,<br />
3442T, 3449T*, 3452T<br />
Chen, WM., 1662T<br />
Chen, W.-M., 1299T*<br />
Chen, W. M., 123<br />
Chen, W. V., 1298W<br />
Chen, X., 1283W*, 2460W<br />
Chen, X.-L., 2969T*, 2970T<br />
Chen, Y., 80, 411, 722T,<br />
795W, 834F, 989F, 1608T,<br />
2180F*, 2854W, 2961F*,<br />
3029T*, 3420T, 3489T*<br />
Chen, Y. D., 1661T<br />
Chen, Y. D. I., 2337W<br />
Chen, Y. I., 1916F, 2153F<br />
Chen, Y.-T., 2092T<br />
Chen, Y. T., 2858T<br />
Chen, Z., 140*, 1086W,<br />
1108T, 1772W, 3666W<br />
Chenevix-Trench, G., 206,<br />
207, 208, 209, 210*,<br />
1150T, 1492F, 2323T<br />
Cheng, A., 1249T<br />
Cheng, B., 2617T<br />
Cheng, C., 442W<br />
Cheng, C.-H., 2052W<br />
Cheng, C. Y., 429F, 2094W*<br />
Cheng, D., 830F, 1108T<br />
Cheng, E., 940T<br />
Cheng, G., 1930T, 2066F,<br />
2932W*<br />
Cheng, H., 511F, 1660T,<br />
2159F<br />
Cheng, I., 1608T, 1925F,<br />
2042F<br />
Cheng, J., 1779W, 2868F,<br />
3007T<br />
Cheng, K., 309, 1133F<br />
Cheng, K. C., 3264T, 3267T<br />
Cheng, M., 2571W*, 2606F<br />
Cheng, R., 1369F, 2093F*,<br />
2208W<br />
Cheng, S., 793W*, 1677T<br />
Cheng, Y., 2421W, 2490W*<br />
Cheng, Y.-W., 3090F*<br />
Cheng, Z., 14<br />
Chenichene, S., 3117W<br />
Chenier, S., 1872F, 1873F,<br />
3106F*<br />
Chennagiri, N., 3640W,<br />
3680W<br />
Cheon, C. K., 964T, 3205W*<br />
Cheong, H. I., 3223W<br />
Cheong, S. Y., 2069F,<br />
2381F, 2544W<br />
Cherbal, F., 1268F*<br />
Chernos, J., 910T<br />
Cherny, S., 1822F<br />
Cherny, S. S., 1930T,<br />
2066F*, 2494T, 2932W<br />
Cherry, J. M., 3612W<br />
Cherukuri, P., 359, 1515T,<br />
2610W*, 3543F<br />
Chesi, G., 2810T<br />
Chesko, K. L., 3027T<br />
Chesnik, M., 1269W<br />
Chessa, L., 760W*<br />
Chettiar, S. S., 2731W<br />
Chettrit, J., 1204T<br />
Cheung, C. Y. K., 1541W*<br />
Cheung, G., 429F<br />
Cheung, H., 1221W<br />
Cheung, L., 336<br />
Cheung, S., 893W<br />
Cheung, S. W., 13, 229,<br />
430W, 432W, 433F, 898T,<br />
952T, 2395T<br />
Cheung, V., 253, 535F,<br />
544W<br />
Cheung, V. G., 257, 370*,<br />
500W, 1506T<br />
Cheverud, J. M., 272, 2413T<br />
Chevessier, F., 328<br />
Chevillard, C., 1593T*<br />
Chew, E. G. Y., 3047W<br />
Chew, E. Y., 2183F<br />
Chew, S., 1216T<br />
Chhabra, D., 2166W*<br />
Chhibber, A., 2258F*<br />
Chi, A., 3691F<br />
Chi, E. C., 3621F*<br />
Chi, H., 2285F*<br />
Chi, J., 2985T<br />
Chiabai, M. A., 1202F*<br />
Chiaie, B., 298<br />
Chiang, C. W. K., 3282T*<br />
Chiang, J., 2910F, 3130F<br />
Chiang, K. M., 3430T*<br />
Chiang, T., 1322W, 1531F,<br />
2580W, 2953W<br />
Chiano, M., 630T*<br />
Chiappini, E., 3114F<br />
Chiavacci, R., 2252F,<br />
2514W, 2872W<br />
Chiavacci, R. M., 812F,<br />
1997F, 2121W, 2546F<br />
Chiba-Falek, O., 2465F*<br />
Chibnik, L. A., 2488T<br />
Chibnik, L. B., 2250W,<br />
3417T, 3450T*<br />
Chibnik, L. E., 380<br />
Chicka, M. C., 3145W<br />
Chidester, A. M., 2329T<br />
Chien, J., 1238F, 3451T<br />
Chien, L., 629T*<br />
Chien, Y. H., 683F, 706T<br />
Chiesa, J., 1212W<br />
Chikh, A., 1268F<br />
Child, A., 1584T<br />
Child, A. H., 1675T<br />
Chiliza, B., 644T<br />
Chin, E. L. H., 1758W<br />
Chin, J., 3724W<br />
China Atherosclerosis<br />
<strong>Genetics</strong> Consortium, 116<br />
SPEAKER AND AUTHOR INDEX
346 SPEAKER AND AUTHOR INDEX<br />
Chinault, C., 330<br />
Chines, P. S., 46<br />
Ching, B., 1146W, 1195T<br />
Chini, V., 2728W*<br />
Chinnery, P. F., 751F, 2996T<br />
Chiò, A., 2611T<br />
Chiou, M., 655T<br />
Chipendo, P. I., 528W<br />
Chipps, B., 3238F<br />
Chiripal, S., 1216T<br />
Chisholm, R., 3622W<br />
Chisholm, R. L., 618T, 1312F<br />
Chissoe, S., 1686T<br />
Chissoe, S. L., 641T, 649T<br />
Chitale, D. A., 1250F<br />
Chitayat, D., 214, 320, 720T,<br />
1738W, 3013T, 3075W,<br />
3156F, 3186F, 3196F*<br />
Chitipiralla, S., 3625F<br />
Chiu, C. L., 1705T*<br />
Chiu, E., 767W, 1190F,<br />
1698T<br />
Chiu, K., 1249T<br />
Chiu, N.-C., 2285F<br />
Chiyo, T., 799W<br />
Cho, B., 1243T, 2715F<br />
Cho, C., 3145W<br />
Cho, H.-J., 964T*<br />
Cho, I., 2518T<br />
Cho, J., 17, 189, 2204F<br />
Cho, J. H., Session 80,<br />
1320T, 1381F, 2045F,<br />
2319W<br />
Cho, M., 2057F<br />
Cho, M. H., 2249F, 2346W*<br />
Cho, M. K., Session 79,<br />
1804F, 1844F<br />
Cho, S., 1384F, 2200T,<br />
2518T<br />
Cho, T., 933W<br />
Cho, Y. H., 739F*<br />
Choate, K. A., 2915T<br />
Chodirker, B., 3127W<br />
Chodosh, J., 529F, 2188T<br />
Choh, A. C., 2146T<br />
Choi, B., 2723T<br />
Choi, D.-S., 2516F<br />
Choi, H. J., 2053T<br />
Choi, J., 877W, 1657T,<br />
2828T, 3204F<br />
Choi, J. R., 863W<br />
Choi, J. Y., 3178F<br />
Choi, K., 260, 2622W,<br />
2849T, 3008T<br />
Choi, M., 1241F, 2779W<br />
Choi, O.-W., 2262W<br />
Choi, S., 269, 1385W,<br />
2778F<br />
Choi, S.-H., 3227W<br />
Choi, T., 1341T<br />
Choi, Y., 581F, 1504F*<br />
Chokdeemeeboon, C.,<br />
2006F<br />
Chokkalingam, A., 1924T,<br />
2268W<br />
Chong, H. K., 3535F*<br />
Chong, J. X., 278, 3398T*<br />
Chong, K., 2971T*<br />
Chong, S., 2148W<br />
Chong, S. S., 1472W<br />
*Presenting Author<br />
Chong, T., 1093T<br />
Choong, C., 1262F<br />
Choong, D. Y. H., 1224W<br />
Choppa, P., 1251W<br />
Chopra, R., 1701T<br />
Choquet, H., 2269T*<br />
Choquet, K., 2234F, 2797W<br />
Chorich, L., 2984T<br />
Chou, C., 516W, 2926W<br />
Chou, J. Y., 2712F<br />
Chou, W., 1249T<br />
Chouchane, L., 2933T,<br />
3399W<br />
Choudhri, H., 509F*<br />
Choudhry, S., 1352W,<br />
1885T*<br />
Chouery, E., 2692W<br />
Choufani, S., 3420T, 3489T<br />
Chow, C. Y., 2214W*<br />
Chow, E., 2428T, 2480F*<br />
Chow, J. F. C., 3000T<br />
Chow, W. H., 1012T<br />
Chowdhury, M. R., 918T<br />
Chowdhury, R., 253<br />
Chowdhury, S., 1459F<br />
Chowdry, A., 483F, 1223F,<br />
3617F<br />
Chowdry, A. B., 1620T*,<br />
2149T<br />
Choy, R., 2868F<br />
Chrast, J., 506W<br />
Chretien, F., 329<br />
Christacos, N. C., 945W*,<br />
953W<br />
Christensen, B. C., 3629F<br />
Christensen, E., 702T, 737F<br />
Christensen, K., 317*,<br />
1323T, 1472W, 1564F,<br />
1650T, 1921T, 2040W,<br />
2244W, 2295W<br />
Christensen, K. D., 1781W<br />
Christiaans, I., 1616T<br />
Christian, M., 2402F<br />
Christian, S. L., 2389T<br />
Christiani, D. C., 2122T<br />
Christiano, A. M., 2182T<br />
Christiansen, L., 2244W,<br />
2295W<br />
Christiansen, M., 2699T<br />
Christiansen, M. W., 584W,<br />
1284T, 1503T<br />
Christiansen, P., 2707W<br />
Christianson, A., 1877F<br />
Christman, M. F., 632T<br />
Christodoulou, J., 166*,<br />
2795T<br />
Christ<strong>of</strong>olini, D., 899W<br />
Christ<strong>of</strong>olini, D. M., 2534F,<br />
3045W<br />
Christ<strong>of</strong>orides, A., 1240T<br />
Chryst-Ladd, M., 1444F,<br />
1594T<br />
Chrzanowska, K., 2755W<br />
Chu, A. Y., 51*<br />
Chu, C., 1894T, 2926W<br />
Chu, H., 1249T<br />
Chu, J., 536W*, 1468F<br />
Chu, S., 553F<br />
Chu, X., 1945T*, 2078F<br />
Chua, K. H., 1572T<br />
Chuang, D., 2742F<br />
Chuang, L., 2524T*<br />
Chuang, L.-M., 1955F<br />
Chuang, W., 516W<br />
Chuang, Y., 2606F*<br />
Chudin, E., 1684T<br />
Chudley, A. E., 2772F,<br />
2800W<br />
Chun, K., 1227W*<br />
Chung, B., 3186F*<br />
Chung, B. H. Y., 3420T<br />
Chung, C., 1097F<br />
Chung, C. C., 213*, 1372F<br />
Chung, E. M. K., 809F<br />
Chung, H., 2117F<br />
Chung, J., 1008W, 3461T<br />
Chung, K., 2538W<br />
Chung, M., 530W<br />
Chung, N. G., 2715F<br />
Chung, P. H. Y., 1930T<br />
Chung, R. H., 2572T<br />
Chung, S. A., 306<br />
Chung, S. H., 614T<br />
Chung, S. K., 262*, 2821W<br />
Chung, T. Y., 2118W<br />
Chung, W., 299, 330, 1600T,<br />
1676T<br />
Chung, W. K., 1735W,<br />
2439W<br />
Chung, Y., 3607F*<br />
Chunharas, C., 2749W<br />
Church, D., Session 77,<br />
464W*, 3582W, 3625F<br />
Church, J., 362, 728T<br />
Churchhouse, C., 3360T,<br />
3384T*<br />
Churchill, J. D., 3234F*<br />
Chutake, Y. K., 381*<br />
Chute, C., 3622W<br />
Chute, C. G., 618T, 1312F<br />
Ciampi, A., 1411F<br />
Ciana, G., 692T<br />
Ciato, D., 2708T<br />
Cibulková, P., 2865F<br />
Ciccone, C., 711F, 1702T,<br />
3080F<br />
Cicek, M. S., 3451T*<br />
Cichon, S., 259, 420W,<br />
1942T, 3550W<br />
Cicuttini, F. M., 2292W<br />
Ciechanowicz, A., 2102F<br />
Cieck, M., 139<br />
Cieslak-Janzen, J., 251<br />
CIHR Emerging Team in<br />
Genomics in Screening,<br />
150, 1827W<br />
Cil, E., 1708T<br />
Cilio, R., 202<br />
CIMBA, OCAC and BCAC,<br />
210<br />
Cine, N., 2058W<br />
Cingolani, P., 169, 176,<br />
1513F, 1923W, 2308T,<br />
2339F<br />
Cinque, P., 2561F<br />
Cintra, V., 2425T<br />
Cipriani, V., 2072F*<br />
Cirak, S., 2812W*<br />
Cirillo, L., 1269W<br />
Cirkel, G., 400<br />
Cirnes, L., 1747W<br />
Cirulli, E. T., 2552F*<br />
Cisneros, B., 3124F, 3226F<br />
Citro, V., 3496T<br />
Cittadella, R., 2597F<br />
Civallero, G., 685F<br />
Civelek, M., 2256W<br />
Ciwangsangbu, C., 3317W<br />
Clabby, M., 1679T<br />
Claes, C., 59<br />
Claes, G. R. F., 1711T<br />
Claes, K., 423F, 2791W<br />
Claes, P., 1850W, 2223W<br />
Clague, J., 1071W<br />
Clancy, R. R. C., 2443T<br />
Clare, S., 1098W<br />
Clarelli, F., 2095T*<br />
Clark, A., 183<br />
Clark, A. G., 187, 357, 537F,<br />
2029T, 2214W, 3269W,<br />
3288T, 3306T<br />
Clark, A. P., 3587F<br />
Clark, E., 1904F<br />
Clark, K., 2664F<br />
Clark, L., 17, 442W, 1898F,<br />
2377T, 2410T*, 2547W<br />
Clark, L. N., 845F<br />
Clark, R., 869W<br />
Clark, R. D., 2955F, 3191W<br />
Clark, S. L., 3442T, 3452T*<br />
Clark, T., 647T<br />
Clarke, A., 865W, 2099F<br />
Clarke, C., 534W<br />
Clarke, J., 419F, 3706W<br />
Clarke, L., 1543F, 3636W*<br />
Clarke, N. F., 295<br />
Clarke, S., 2614T<br />
Clarkson, K., 3171W<br />
Claussnitzer, M., 3536W*<br />
Claustres, M., 2947W<br />
Clavering, E. K., 1803W<br />
Clawson, H., 3557F<br />
Clayton, A. C., 1145F<br />
Clayton, D. G., 2072F<br />
Clayton, E. W., 631T<br />
Clayton, N., 767W, 1698T<br />
Clayton, P. T., 167<br />
Clayton, S., 101, 291, 364<br />
CLEAR Investigators, 2047T<br />
Cleary, C., 3119W<br />
Cleary, S. P., 141<br />
Clement, M. J., 3643F<br />
Clemmer, G., 623T<br />
Clendenning, M., 1067F<br />
Clerget-Darpoux, F.,<br />
Session 8<br />
Cleveland, J. L., 1162T<br />
Clevert, D.-A., 1483F,<br />
2374T*<br />
Cleves, M. A., 1459F<br />
Cline, M., 3557F<br />
Clinton, C. M., 1799W*,<br />
1836F, 1843W<br />
Cloutier, M., 3449T<br />
Clyde, M. M., 3267T<br />
Clynes, D., 418W<br />
Coa, D., 503F<br />
Coady, S., 2247W<br />
Coakley, D., 774W<br />
Coan, A. C., 514W, 2394W
Coarfa, C., 3433T*<br />
Coates, J., 784W<br />
Coates, J. R., 2817F<br />
Cobat, A., 1374T*, 2003F<br />
Cobb, B., 419F<br />
Cocco, E., 157<br />
Cochran, B. J., 1445W<br />
Codd, V., 2035T, 2175W*<br />
Coe, B. P., 10, 14, 274<br />
Coêlho, C. C., 1405F<br />
Coelho, J., 2502W<br />
Coelho, T., 1296T, 2736F<br />
Coeli-Lacchini, F. B., 479F<br />
Coenen, M. J. H., 243*, 306,<br />
621T<br />
C<strong>of</strong>fee & Caffeine <strong>Genetics</strong><br />
Consortium, 2096F<br />
C<strong>of</strong>fman, K., 904T<br />
Coghill, D., 645T<br />
Coghlan, G., 2772F<br />
Cogulu, O., 965W, 2719W,<br />
3222F<br />
Çogˇulu, O., 3214F<br />
Cohen, I., 2931F<br />
Cohen, J., 2907F<br />
Cohen, J. S., 3065W<br />
Cohen, L., 3012T<br />
Cohen, M., 86<br />
Cohen, N., 958T<br />
Cohen-Snuijf, P., 2925F<br />
Cohn, D., 3209W<br />
Cohn, D. H., 2740W, 2874F<br />
Cohn, G. M., 768W, 769W<br />
Cohn, R. D., 2677W<br />
Cohorts for Heart and Aging<br />
Research in Genetic<br />
Epidemiology, NHLBI<br />
Exome Sequencing<br />
Project, 1585T<br />
Coin, L., 159, 429F, 1432F,<br />
2162F<br />
Coiteiro, D., 2085W<br />
Cok, J., 1119W<br />
Coker, M., 3214F<br />
Colak, R., 1551T*<br />
Col Araz, N., 1402F, 1935W*,<br />
1938W<br />
Colas, C., 1170W<br />
Colby, C., 2516F<br />
Cole, R., 1269W<br />
Cole, S., 1280W<br />
Cole, S. A., 1406W<br />
Coleman, C., 2283W*<br />
Coleman, K., 1494T, 1679T*<br />
Colins, C., 491F<br />
Coll, M., 3069W<br />
Collaboration developed<br />
under Radiogenomics<br />
Consortium, 1309F<br />
Collado, A., 2326T<br />
Colleaux, L., 104, 202, 2808F<br />
Collee, J. M., 27<br />
Collet, C., 2729T, 3154F,<br />
3199W<br />
Collet, J. P., 756W<br />
Colley, A., 66<br />
Collier, D. A., 2522F<br />
Collin, R., 2950W<br />
Collins, A., 3133W<br />
Collins, A. L., 2468F*, 3659F<br />
*Presenting Author<br />
Collins, F., 324<br />
Collins, F. A., 3129W<br />
Collins, F. S., Session 69,<br />
46, 304<br />
Collins, H., 1859F<br />
Collins, I., 1088F, 1199F<br />
Collins, J. A., 265<br />
Collins, J. E., 37<br />
Collins, R., 115, 970T<br />
Collombat, P., 2629T<br />
Colombo, M., 1895F<br />
Colon Cancer Family<br />
Registry, 141, 1067F,<br />
1206W<br />
Colon Cancer Family<br />
Registry, COGENT<br />
Consortium, 1072T<br />
Colón-Semidey, A., 3449T<br />
Colosi, P., 2680W<br />
Colvin, C., 1021T<br />
Comas, D., 3345T, 3377W,<br />
3387T<br />
Combe, J., 1119W<br />
Comeau, M. E., 1979F<br />
Comi, G., 624T<br />
Comi, G. C., 2095T<br />
Comi, G. P., 2775F<br />
Compton, J., 330<br />
Compton, T., 2561F<br />
Comstock, D., 3007T<br />
Comuzzie, A., 1280W<br />
Comuzzie, A. G., 2309F,<br />
3434T<br />
Concannon, P., 1299T<br />
Concas, M. P., 2062T<br />
Conceição, I. C., 2417F,<br />
2502W*<br />
Conde, L., 1104W, 2055W*,<br />
3623F<br />
Condino, F., 2597F<br />
Condreay, L., 630T<br />
Condroyer, C., 2638T<br />
Congia, M., 1516F<br />
Congiu, C., 86<br />
Coniglio, G., 2095T<br />
Conklin, B., Session 78<br />
Conklin, B. R., 1620T<br />
Conkright, M. D., 1162T<br />
Conley, B., 1068W<br />
Conley, Y. P., 1884W, 1963T*<br />
Conlin, L., 3040F, 3082F<br />
Conlon, P., 2082W<br />
Conneely, K. N., 66, 1422T,<br />
2383T, 2420F, 2483F,<br />
3480T<br />
Connolly, J. J., 2546F*<br />
Connolly, M., 131, 750T<br />
Connolly, M. C., 1769W<br />
Connolly, S., 70, 617T, 619T<br />
Conomos, M., 1424W<br />
Conrad, D. F., 560W, 2576F,<br />
2982T*<br />
Conrad, P., 1059W<br />
Conroy, J., 2283W, 3428T<br />
Conroy, S. K., 2531F<br />
Consortium <strong>of</strong> Investigators<br />
<strong>of</strong> Modifiers <strong>of</strong> BRCA1/2<br />
(CIMBA) Collaborators,<br />
207, 208<br />
Constantine, S., 1151F<br />
SPEAKER AND AUTHOR INDEX 347<br />
Constantino, J. N., 2439W,<br />
2551T<br />
Constantino-Casas, F.,<br />
1105T<br />
Consugar, M., 2943F, 3653F<br />
Consugar, M. B., 1756W*<br />
Conta, J., 1842F<br />
Conte, I., 2810T, 2950W<br />
Conte, M. I., 505F*<br />
Conti, D. V., 642T, 1435F<br />
Conti, P., 2766F<br />
Contreras, A. V., 526W*,<br />
3255T<br />
Contreras, S. A., 2495F<br />
CONVERGE Consortium,<br />
355<br />
Conway, K., 1566T<br />
Cook, D., 3537F*<br />
Cook, D. G., 1626T<br />
Cook, E., 13, 3494T<br />
Cook, E., Jr., 1520W<br />
Cook, E. H., 2577W<br />
Cook, J., 2897T<br />
Cook, J. R., 81, 767W, 815F,<br />
1698T*<br />
Cook, M., 2826F<br />
Cook, M. B., 213<br />
Cooke, J. N., 1879T,<br />
2310W*<br />
Cooke, M. S., 1270T<br />
Cooke, T., 3362W<br />
Cooke, T. F., 293*<br />
Cooksley, R., 715F, 801W<br />
Cookson, M. R., 564W<br />
Cookson, W. O. C., 1361W<br />
Cookson, W. O. C. M.,<br />
2102F, 3466T, 3469T,<br />
3486T<br />
Coon, H., 195, 2406W<br />
Coon, M. R., 2329T<br />
Cooney, K., 28*, 1001F<br />
Cooney, K. A., 1080W,<br />
1214F<br />
Coonrod, E. M., 2720T*<br />
Coons, T. A., 1454W<br />
Coop, G., 282<br />
Cooper, B. A., 1965W<br />
Cooper, C., 2292W<br />
Cooper, C. D. O., 219<br />
Cooper, D. N., 939W<br />
Cooper, J., 453F, 3471T<br />
Cooper, M., 1936T<br />
Cooper, R., 1959W, 2063F<br />
Cooper, S., 1167W, 3697F<br />
COPDGene and ECLIPSE<br />
Investigators, 2057F<br />
COPDGene Investigators,<br />
1425T<br />
COPDGene Investigators,<br />
NHLBI Exome<br />
Sequencing Project,<br />
2346W<br />
Cope, H., 3, 1919F<br />
Copeland, S., 2974T<br />
Copigny, F., 1212W<br />
Copin, H., 3117W<br />
Copley, R., 2939T<br />
Coppieters, F., 539F*, 2927T<br />
Coppieters, W., 708T<br />
Coppola, D., 1061F<br />
Coppola, G., 2262W, 2639F,<br />
2779W<br />
Coprerski, B., 2484W,<br />
2485T*, 2540F<br />
Corach, D., 3364F, 3402T<br />
Coram, M., 1504F<br />
Corbin, I., 99*<br />
Corcoran, C. D., 3643F<br />
Corcoran, D., 586W<br />
Corda, E., 1158W<br />
Cordeiro, I., 131<br />
Cordeiro, Q., 2533T<br />
Cordell, H. J., 153<br />
Cordero, S., 1601T<br />
Cordier, M. P., 3129W<br />
Cordisco, M., 83<br />
Cordoro, K., 2926W<br />
Córdova-Fletes, C., 1030T*<br />
Cordova-Solis, I. A., 1168T<br />
Core, L. J., 415F<br />
Coresh, J., 1932W<br />
Corey, M., 1731W<br />
Corioni, M., 3459T<br />
Corless, C., 1237T<br />
Cormand, B., 2578T<br />
Cormier, T., 3699F<br />
Cormier-Daire, V., 127,<br />
324, 403, 915W, 3129W,<br />
3167W, 3240F<br />
Cornejo, O., 3362W<br />
Cornejo, O. E., 293<br />
Cornejo-Olivas, M., 2453F<br />
Cornelis, M., 2096F*<br />
Cornelissen, S., 1117T<br />
Cornell, M., 3610W<br />
Cornes, B., 1346W, 2041T<br />
Cornes, B. K., 269<br />
Corneveaux, J. J., 2104T,<br />
3215W<br />
Cornforth, M. N., 948T<br />
Corominas, R., 480W,<br />
2660F*<br />
Corona-Rivera, A., 3188F<br />
Corrado, L., 2775F<br />
Corral, J., 2627F<br />
Corrales, A., 2296T<br />
Corre, T., 1281T, 2165F,<br />
2366F<br />
Correa, H., 2385W<br />
Correa, P., 3388F<br />
Correia, C., 2261F*, 2417F,<br />
2502W<br />
Correia e. Silva, A., 3318T<br />
Corrier, K., 2826F<br />
Corriveau, R., 853F, 2300F<br />
Cortes, A., 152*<br />
Cortes, C., 2628W*<br />
Cortes, E., 1049F, 1077W<br />
Cortes, E. P., 2547W<br />
Cortes, M., 467F*, 3039W*<br />
Cortese, R., 377*<br />
Cortessis, V., 213<br />
Corti, S., 2775F<br />
Corvin, A., 2590T<br />
Corvol, H., 1322W, 2953W<br />
Corydon, T. J., 737F<br />
Cossette, P., 2306F, 2591F<br />
Cosso, M., 2062T<br />
Cost, G. J., 255<br />
Costa, A., 1293T<br />
SPEAKER AND AUTHOR INDEX
348 SPEAKER AND AUTHOR INDEX<br />
Costa, A. F., 514W<br />
Costa, A. L. F., 514W<br />
Costa, A. P. P., 2485T<br />
Costa, C., 572W, 1768W,<br />
1796W*<br />
Costa, F. F., 426W, 2718F,<br />
2751F<br />
Costa, F. T., 3122F<br />
Costa, H. A., 371, 3411W*<br />
Costa, J. L., 1747W*<br />
Costa, P., 922T*<br />
Costa, R., 1920W<br />
Costa, V. P., 2286W, 2291F<br />
Costain, G., 2575T<br />
Costantini, S., 1060T<br />
Costes, B., 1768W<br />
Côté, G., 1951T<br />
Cote, L., 442W<br />
Côté, S., 2994T*<br />
Cotsapas, C., 1366F*<br />
Cotten, C. M., 3<br />
Cotton, A., 3514T*, 3734W<br />
Cottrell, C. E., 912T*<br />
Cottrell, J., 596W, 942T,<br />
1238F<br />
Cotugno, G., 3256F<br />
Coubes, C., 936T, 3121W<br />
Couch, F., 208<br />
Couch, F. J., 27, 207,<br />
1150T*, 1219T<br />
Couch, R. B., 2189F<br />
Coucke, P., 59, 2225F<br />
Coucke, P. J., 128, 129,<br />
833F, 1790W, 3137W<br />
Coude, F. X., 2431T, 2441F*<br />
Coughlin, C., 451F<br />
Coughlin, C. R., 2884W<br />
Coulet, F., 1170W<br />
Coulibaly, A., 3303T<br />
Coulson, R., 64<br />
Coulter, M. E., 8, 2613W<br />
Coupry, I., 716T, 2674W<br />
Courcet, J.-B., 2792T*<br />
Court, F., 3499T<br />
Courtenay, M., 3335W<br />
Courtenay, M. D., 2028W*,<br />
2318F<br />
Courtens, W., 2002T<br />
Courtney, M., 2629T<br />
Cousminer, D., 2097W*<br />
Cousminer, D. L., 2162F<br />
Coutant, S., 32, 345, 1222T,<br />
3538W*<br />
Coutinho, P., 2820F<br />
Couto, A., 1432F<br />
Couture, C., 1947W<br />
Couve, A., 3129W<br />
Couvelard, A., 29<br />
Covas, D. T., 1045T<br />
Coventry, A., 183<br />
Cover, T., 3388F<br />
Cowan, C., 520W, 1988F<br />
Cowan, J., 3622W<br />
Cowling, B. S., 2681T<br />
Cox, A., 1706T<br />
Cox, A. J., 1648T*, 1661T<br />
Cox, C., 294<br />
Cox, D. W., 2474F<br />
Cox, H., 1912T<br />
Cox, H. C., 2916F<br />
*Presenting Author<br />
Cox, N., 368, 613T, 1480F<br />
Cox, N. J., 40, 424W, 623T,<br />
1003T, 1495F, 2192F,<br />
2196W, 2197T, 2333F,<br />
3735F<br />
Cox, V., 869W, 3139W<br />
Coxson, H. O., 2249F<br />
Coyle, M., 893W<br />
Cozad, R. A., 66<br />
Craft, J., 1021T<br />
Craig, B., 3644W, 3704W,<br />
3716W, 3731F*, 3733F<br />
Craig, D. M., 1594T*<br />
Craig, D. W., 1240T*,<br />
3215W<br />
Craig, J., 3484T<br />
Craig, J. E., 1785W<br />
Craigen, W., 163, 676T,<br />
2942T<br />
Craigen, W. J., 667F*, 683F<br />
Craigie, S., 1827W<br />
Craigie, S. M., 149, 150<br />
Crain, B., 1051T<br />
Crandall, B., 873W<br />
Crane, P., 2098T<br />
Crane, P. K., 342, 2488T<br />
Crapo, J., 2057F<br />
Crapo, J. D., 1425T, 2249F,<br />
2346W<br />
Crary, F., 64<br />
Crawford, B., 686T<br />
Crawford, D., 1377T, 1602T,<br />
1608T, 1928F, 2037W,<br />
2041T, 2098T<br />
Crawford, D. C., 226, 247,<br />
618T, 647T, 1316W,<br />
1447F, 1671T*, 1713T,<br />
2042F, 2298W, 2401T<br />
Crawford, M., 3359W<br />
Crawford, M. H., 3344W<br />
Creadon-Swindell, G., 451F<br />
Cree, A. J., 2072F<br />
Creech, C. B., 247<br />
Creech, M. L., 3588W<br />
Crenshaw, A., 290, 2098T<br />
Crenshaw, D., 2465F<br />
Crenshaw, D. G., 637T,<br />
1382W<br />
Cresci, S., 2535W<br />
Crespo, J., 1977W<br />
Crew, K. D., 1255T<br />
Crider, K. S., 1304W*,<br />
1310W<br />
Crim, C., 2249F<br />
Crisponi, L., 823F, 847F<br />
Cristino, L., 3492T<br />
Criswell, L., 3454T<br />
Criswell, L. A., 306, 1979F<br />
Crobu, F., 547F<br />
Crocco, E., 2637W<br />
Crocco, E. A., 2583W<br />
Croen, L., 463F<br />
Croen, L. A., 7, 2555F<br />
Croen, L. C., 2510F<br />
Cromer, M. K., 1241F*<br />
Crook, D. W., 1948T<br />
Crooks, L., 1518T<br />
Cropp, C., 1512T<br />
Cropp, C. D., 1302T*<br />
Crosbie, J., 2499W<br />
Crosby, J. R., 648T<br />
Crossley, B., 2260T<br />
Crosslin, D., 2098T*<br />
Crosslin, D. R., 1312F,<br />
1447F<br />
Crossman, D. K., 2759T<br />
Croteau-Chonka, D. C.,<br />
108, 1427W, 1954T,<br />
2090F, 2123F, 2147F,<br />
2241W<br />
Crotti, L., 86<br />
Crotwell, P. L., 3151W<br />
Crouch, D. J. M., 1329T,<br />
3348T*<br />
Crouch, J., 148<br />
Crout, R., 2142W, 2156F,<br />
2178W<br />
Crout, R. J., 1464T, 1474F<br />
Crow, S., 605T, 2516F<br />
Crow, Y. J., 2452T<br />
Crowe, C., 456W<br />
Cruceanu, C., 2338T*,<br />
2482T<br />
Cruchaga, C., 340, 342<br />
Cruickshank, M., 3484T<br />
Cruts, M., 2815W<br />
Cruz, A. A., 2043W<br />
Cruz, L. A., 814F, 2414F<br />
Cruz, P., 1983W<br />
Cruz, P. R. S., 426W, 2751F*<br />
Cruz-Alcivar, R., 872T*,<br />
3040F<br />
Cruz-Bautista, I., 2256W<br />
Crystal, R. G., 2933T,<br />
3399W<br />
Cua, C. L., 2069F<br />
Cubells, J. F., 2383T, 2384F<br />
Cubillo, M. A., 926T<br />
Cubillo, M. A. L., 1018T<br />
Cucca, F., 113, 157, 177,<br />
186, 276, 547F, 823F,<br />
1391W, 1451W, 1516F,<br />
2001W, 2198F, 2329T,<br />
3377W, 3664W<br />
Cuccaro, M., 1786W,<br />
1787W*<br />
Cuccaro, M. L., 9, 588W,<br />
2445W, 2508W, 2572T,<br />
2614T, 3390T<br />
Cucco, F., 2695W<br />
Cuccuru, G., 157<br />
Cuckle, H., 274<br />
Cuebas, D., 662T<br />
Cuellar, F. L., 926T, 1018T<br />
Cuellar-López, F., 3061W*<br />
Cuenca-Roldán, T., 1131W<br />
Cuenco, K., 1464T*<br />
Cuenco, K. T., 1474F,<br />
2142W, 2156F<br />
Cuevas, O., 2365T<br />
Cuffe, S., 1108T<br />
Cui, C., 3317W<br />
Cui, H., 683F, 1087T, 1750W<br />
Cui, J., 1916F<br />
Cui, L., 2066F, 3123W*<br />
Cui, W., 722T<br />
Cui, W.-C., 1540F<br />
Cui, W.-Y., 2574W<br />
Cukier, H. N., 9*, 2445W,<br />
2614T<br />
Cukrowska, B., 1330F<br />
Cukuranovic, R., 3481T<br />
Cule, E., 1285F*<br />
Cullen, M., 30, 1218W,<br />
1517W, 3683F<br />
Cullinane, A. R., 709F,<br />
2838F*<br />
Culminskaya, I., 1991F*,<br />
2194T<br />
Culver, J. O., 1071W*<br />
Culver-Cochran, A. E.,<br />
3515T*<br />
Cumiskey, A. M., 2220W<br />
Cummings, A. C., 1489F*,<br />
3335W<br />
Cummings, S. A., 109<br />
Cummings, S. R., 1576F,<br />
2375F<br />
Cumplido, J., 2296T<br />
Cunha, L. F., 2928F<br />
Cunha, P. S., 3107W, 3110F<br />
Cunha-Neto, E., 1593T<br />
Cunliffe, H. E., 1186T<br />
Cunningham, S., 166<br />
Cunningham, F., 3732W<br />
Cunningham, G., 670T<br />
Cunningham, J., 139, 1267T<br />
Cunningham, J. M., 1238F,<br />
3451T<br />
Cunningham, M., 126,<br />
2762T<br />
Cunningham, M. L., 33,<br />
813F, 2151W, 3070F*<br />
Cunninghame Graham, D.<br />
S., 306, 3382F<br />
Cuppen, E., 217, 400*,<br />
423F, 2886F, 3608W<br />
Cuppens, H., 1450F<br />
Cupples, A., 350, 2210F<br />
Cupples, L. A., 111, 117,<br />
170, 174, 317, 349,<br />
1346W, 1585T, 1599T,<br />
1954T, 2030F, 2052W,<br />
2073W, 2123F, 2147F,<br />
2337W<br />
Curbelo-Canabal, F., 3363T<br />
Cureklibatir, I., 1106F<br />
Curhan, G. C., 51<br />
Currall, B. B., 862T*<br />
Curran, J., 176, 1280W,<br />
1513F<br />
Curran, J. E., 533F, 1282F,<br />
1406W, 1923W, 2061W,<br />
2146T, 2308T, 2309F,<br />
2339F*<br />
Curry, B., 971W<br />
Curry, C., 869W<br />
Curry, C. J., 79, 1070F<br />
Curry, J. A., 2838F<br />
Curtin, J. A., 2211W*<br />
Curtis, R., 3605F<br />
Curtis, R. E., 2152T<br />
Cusano, R., 113, 177, 547F,<br />
823F, 3664W<br />
Cusanovich, D. A., 3251W<br />
Cuscó, I., 2711T<br />
Cushion, T. D., 262<br />
Cushman, M., 1662T<br />
Cushman-Spock, L., 1820F<br />
Cusi, D., 845F, 2095T
Cusin, V., 56<br />
Cussenot, O., 1001F, 1214F<br />
Cust, A. E., 212<br />
Custovic, A., 2168F, 2211W<br />
Cutiongco-de la Paz, E. C.,<br />
2975T*<br />
Cutiongco-de la Paz, E. M.,<br />
1805W<br />
Cutler, D. J., 2069F, 2312F,<br />
2576F, 3414W, 3628W<br />
Cutrer, F. M., 2362T<br />
Cutting, G., 1450F, 2953W<br />
Cutting, G. R., 78, 1322W,<br />
1731W, 3448T<br />
Cutts, A., 133<br />
Cvjetkovic, N., 1908W<br />
Cytrabaum, C., 2480F<br />
Cytrynbaum, C., 3420T<br />
Czape, K., 1787W<br />
Czeizel, E., 1936T<br />
Czerwinski, S. A., 2146T<br />
D<br />
Daavittila, I., 1892F<br />
Dabelea, D., 249<br />
Daber, R., 3040F<br />
D’Aco, K., 2871F*<br />
Dada, R., 2967T<br />
Dadaev, T., 205, 1011W,<br />
1109F<br />
d’Adamo, P., 2366F<br />
Dafou, D., 780W, 2896W,<br />
2925F<br />
Daggett, H. T., 2750T<br />
Dagle, J., 3537F<br />
Dagle, J. M., 1344T<br />
D’Agnano, D., 760W<br />
Dahan, K., 3098F*<br />
Dahdouli, M., 3576W<br />
Dahgam, S., 1970F*<br />
Dahl, A., 3224F<br />
Dahl, F., 3685F, 3709F, 3729F<br />
Dahl, M., 702T<br />
Dahl, N., 2920W<br />
Dahl, O., 991T<br />
Dahlin, A., 2166W<br />
Dahlman, K. B., 136<br />
Dahoun, S., 67<br />
Dai, A., 3596W<br />
Dai, C., 516W<br />
Dai, H., 1369F, 3649F<br />
Dai, J.-R., 3029T<br />
Dai, J. Y., 1408F<br />
Dai, L., 538W, 2529W<br />
Dai, Q., 3483T<br />
Dai, X., 1265F*, 1693T,<br />
2415W<br />
Dai, Z., 953W*<br />
Daiger, S. P., 3234F<br />
Dal, G. M., 2924T<br />
D’Alessio, V., 2916F<br />
Daley, D., 1465F*<br />
D’Alfonso, S., 2095T, 2775F<br />
Dalgeish, R., 3610W<br />
Dalgleish, R., 3732W<br />
Dalla Bernardina, B., 2795T<br />
Dallapiccola, B., 105, 943W,<br />
2777T<br />
*Presenting Author<br />
Dallavale, F., 3121W<br />
Dallman, J. E., 297, 2445W*<br />
Dalton, G. C., 3324T<br />
Daly, A., 33, 45, 1676T<br />
Daly, K., 1971W<br />
Daly, M., 252, 322, 333, 352,<br />
1213T, 1520W, 1725W<br />
Daly, M. J., 11, 280, 290,<br />
295, 1523W, 2319W,<br />
2560T, 2577W, 2618F<br />
Daly, S., 2852T<br />
Damaraju, S., 1297F<br />
D’Amato, I., 2810T<br />
D’Amato, M., 2319W, 3631F<br />
Dames, S., 3637F*<br />
Damiani, D., 2706F<br />
Damiani, M., 994T<br />
Damiano, J., 3228F<br />
Danashi, A., 2301W<br />
Dancey, J., 135, 1824F<br />
Danchin, N., 609T<br />
Danda, D., 1701T<br />
Danda, S., 1701T<br />
Dandara, C., 1073F<br />
Danesh, J., 115<br />
Daneshjou, R., 646T*<br />
Dang, C., 2444F<br />
Dang, D., 759W<br />
Dang, D. A., 1998W, 1999T<br />
D’Angelo, A., 808F<br />
D’Angelo, C., 895W*<br />
Danhauser, K., 699F<br />
Daniels, M. L., 2851W<br />
Danila, M. I., 2047T<br />
Danjoh, I., 1277F*<br />
Danjou, F., 2001W<br />
D’Anjou, G., 2900T<br />
Dankel, S. N., 3536W<br />
Dantas, V. G. L., 891W<br />
D’Antoni, S., 513F<br />
Daoud, H., 2306F, 2342F,<br />
2797W*<br />
D’Aoust, L. N., 1489F,<br />
3335W*<br />
Daoutidou, E., 3396T<br />
Daoutidou, K., 2044T<br />
Dara, A., 2255F<br />
Darabi, H., 1934F, 2055W<br />
Darabos, C., 188*<br />
Darbari, D., 1259F<br />
Darbro, B., 419F<br />
Darcan, S., 3206F<br />
Darcansoy Iseri, O., 3424T<br />
Dardis, A., 692T, 2809W*<br />
DaRe, J., 688T*<br />
Darling, T. N., 33<br />
Darnell, J. C., 2587T<br />
Darnell, R. B., Session 24,<br />
2587T<br />
Daroy, M., 2466W*<br />
Daroy, M. L. G., 2473T<br />
Darst, B. F., 1839W*<br />
Darvasi, A., 17, 264, 3346F,<br />
3366T<br />
Darvish, D., 682T<br />
Das, K., 130, 315<br />
Das, P., 3262F<br />
Das, S., 958T, 1432F*,<br />
1737W, 1952F*, 2162F,<br />
3090F<br />
SPEAKER AND AUTHOR INDEX 349<br />
Das, S. K., 2011T*, 2192F<br />
D’Ascenzo, C., 1732W<br />
D’Ascenzo, M., 3688W<br />
Dasgupta, A., 1363F<br />
Dasgupta, N., 161, 690T*<br />
Dasgupta, S., 1885T<br />
da Silva, V. P. M., 1946F<br />
Dasouki, M., 3054F<br />
Dasouki, M. J., 2894T*<br />
Dassopoulos, T., 1381F<br />
Dastani, Z., 1595T*<br />
Dastgir, J., 711F<br />
Datar, C., 700T<br />
Datar, CA., 2803W<br />
Date, H., 52<br />
Datta, A., 3044F<br />
Datta, I., 1895F<br />
Datta, L. W., 1381F<br />
Dattani, M., 2701W<br />
Daub, A. C., 2643W<br />
Dauber, A., 131, 1960T<br />
Dauchel, H., 3538W<br />
Däumer, C., 1943F<br />
Dávalos, I. P., 3187W, 3188F<br />
Dávalos, N. O., 3187W*,<br />
3188F<br />
Davatchi, F., 2150F<br />
Dave, B. J., 968T<br />
Davenport, E. R., 2031W*<br />
Davey Smith, G., 583F,<br />
1318F, 1567F, 1583W,<br />
1626T, 2081F, 2097W,<br />
2164T, 2169W, 3455T<br />
David, A., 403, 1212W,<br />
3066F<br />
David, D. M., 152<br />
David, J., 950T<br />
David, V., 2893W*, 3170F<br />
Davidovic, L., 513F, 817F<br />
Davidovich, M., 3048F<br />
David-Padilla, C. M., 2975T<br />
Davidson, B., Session 23<br />
Davidson, B. L., 2636F<br />
Davidson, C., 3684W*<br />
Davies, A. G., 640T<br />
Davies, C., 142, 493F<br />
Davies, G., 2366F, 3466T,<br />
3486T<br />
Davies, J., 320, 1729W,<br />
1872F, 1873F<br />
Davies, K. E., 2649W<br />
Davies, M., 153, 546W<br />
D’Ávila, R., 2424W, 2626T<br />
Davila, S., 429F, 3047W<br />
Davis, B., 648T, 1346W<br />
Davis, E. C., 129<br />
Davis, E. E., 3*<br />
Davis, J., 433F, 1869F,<br />
3128F*<br />
Davis, L., 1901F<br />
Davis, L. K., 424W*<br />
Davis, M. F., 1489F, 2299T*<br />
Davis, O. S. P., 2164T<br />
Davis, P., 3484T<br />
Davis, R., 1337W, 3691F<br />
Davis, R. J., 393<br />
Davis, R. W., 1112F<br />
Davis, S. D., 2851W<br />
Davis, T., 512W, 2701W,<br />
2938W, 3517T<br />
Davis, T. B., 3702W, 3715F<br />
Davy, G., 1205F<br />
Daw, E. W., 1920W, 1921T<br />
Dawood, K., 1957T<br />
Dawsey, S. M., 1010F,<br />
1076F<br />
Dawson, A. J., 954T*<br />
Dawson, B., 2542T, 2854W,<br />
3209W<br />
Dawson, B. C., 795W<br />
Dawson, G., 2617T<br />
Dawson, L., 1066T<br />
Dawson, L. M., 1084T<br />
Dawson, S. J., 2302T<br />
Day, D., 153<br />
Day, F., 108, 1954T, 2090F,<br />
2123F, 2147F, 2241W<br />
Daya, M., 2007W, 3385F*<br />
Day-Williams, A. G., 169,<br />
2561F<br />
Daza, R., 322<br />
D-CarDia Collaboration, 271<br />
DCCT/EDIC Research<br />
Group, 2109W<br />
DDD and UK10K Projects,<br />
455F<br />
DDD Project, 101, 364<br />
De, G., 1431T<br />
de Alexandre, R., 1151F*<br />
de Alexandre, R. B., 3055W<br />
De Almeida, S., 129<br />
de Almeida M., F., 3123W<br />
Dean, E., 1152W*<br />
Dean, M., 1242W*, 2833W<br />
de Andrade, M., 618T,<br />
1312F, 1375F*, 1447F,<br />
1454W, 1497T, 2098T<br />
de Angelis, A., 808F*<br />
deAngelis, M., 385<br />
DeAngelis, M. M., 1305T*,<br />
2183F<br />
Deans, T. A., 611T<br />
de Araujo, T. K., 1903T<br />
Deardorff, M., 2904F, 3038F,<br />
3082F<br />
Deardorff, M. A., 2695W,<br />
2958F<br />
Deary, I. J., 2072F, 2366F<br />
de Assis, T. M. R., 2813T*<br />
De Backer, J., 128, 2225F<br />
De Baere, E., 539F, 2832F,<br />
2927T<br />
de Bakker, P. I. W., 87, 155,<br />
609T, 1659T, 1934F,<br />
2047T, 2210F<br />
de Becdelièvre, A., 572W,<br />
1768W<br />
De Benedetto, A., 1900T<br />
de Blois, M.-C., 915W<br />
de Boer, A., 609T<br />
de Boer, C. M., 1122W,<br />
1273T<br />
de Boer, E. N., 1619T<br />
DeBoever, C., 395<br />
De Borja, R., 1093T, 1256F<br />
Debortoli, G., 1946F*<br />
de Bot, S. T., 160<br />
Debrabant, B., 2244W<br />
de Broca, A., 3109W,<br />
3117W<br />
SPEAKER AND AUTHOR INDEX
350 SPEAKER AND AUTHOR INDEX<br />
de Brouwer, A., 3165W<br />
de Brouwer, A. P. M., 100,<br />
102, 125, 160*, 672T<br />
Dec, E., 3144F*, 3213W<br />
Decaestecker, C., 3172F<br />
Decanini-Arcaute, H., 1030T<br />
de Carvalho, T., 691F<br />
de Castro, C., 895W<br />
De Castro, C. C. S., 1978T<br />
Decewicz, A., 1649T<br />
de Chadarévian1, J., 924T<br />
DeChene, E., 3219W<br />
Dechene, E., 2811F<br />
DeChene, E. T., 1769W<br />
Deciu, C., 3014T, 3016T<br />
Decker, B., 2219F<br />
Decker, P. A., 1351F<br />
de Coninck, T., 2820F<br />
de Coo, I., 708T<br />
de Coo, I. F. M., 2996T<br />
De Coo, R., 796W*<br />
DeCoteau, J. F., 3488T<br />
de Craen, A. J. M., 2035T<br />
de Denus, S., 3401W<br />
Dederich, D., 3656W, 3703F<br />
de Die, C. E., 2996T<br />
De Dios, J. K., 711F*<br />
Dedoussis, G., 106, 2044T,<br />
2097W, 3396T*<br />
Dedoussis, G. V., 110<br />
Deekajorndech, T., 2006F<br />
Deelchand, D., 2539T<br />
Deelder, A., 2107T<br />
Deelen, J., 2035T*, 2175W<br />
Deelman, E., 3558W<br />
Defebvre, L., 345<br />
DeFelice, M., 322, 1725W<br />
Defoort-Delhemmes, S., 390<br />
Degenhardt, F., 420W<br />
DeGiorgio, M., 3305W*<br />
Degner, J., 2<br />
de Groot, N., 3279T<br />
Deguchi, K., 234<br />
Dehghanpour, H., 2964F<br />
Dehner, L. P., 132<br />
Dei, M., 177, 1516F, 2198F,<br />
2329T<br />
Deidda, F., 157<br />
Deignan, J., 315<br />
Deignan, J. L., 130<br />
Deininger, P., 524W<br />
De Iorio, M., 1285F<br />
Dei Rossi, A., 1198T<br />
De Jaegere, S., 539F<br />
De Jager, P., 624T, 1415W,<br />
2488T<br />
De Jager, P. L., 380*, 528W,<br />
2250W, 3417T, 3450T<br />
DeJesus-Hernandez, M.,<br />
2639F<br />
de Jong, D. J., 243<br />
De Jong, K. H., 3523T<br />
de Jong, S., 2553W,<br />
2661W*<br />
de Jong, V., 348<br />
De Jonghe, P., 201, 2948T<br />
de Jongste, J. C., 2168F<br />
de Jongue, P., 2820F<br />
De Jorge, L., 2627F<br />
Deka, R., 1660T*, 2159F<br />
*Presenting Author<br />
Dekker, J., 255<br />
Dekker, J. M., 3455T<br />
Dekkers, J. C. M., 2717T<br />
de Klein, A., 834F<br />
de Klerk, E., 542W*<br />
de Koning, B., 708T<br />
de Koning-Tijssen, M. A.<br />
J., 200<br />
de Kovel, C. G. F., 2886F<br />
Delabar, J., 84<br />
De la Cruz Cabrera, O.,<br />
3409W<br />
De La Forest, A., 587F<br />
Delahaye, A., 973W, 2784F,<br />
2957T<br />
De la Morena, M., 2949F<br />
Delaneau, O., 90*, 1484W<br />
Delaney, J., 1190F<br />
Delaney, J. T., 247<br />
Delaney, K., 714T, 801W<br />
Delaney, S. M., 614T, 3472T<br />
del Angel, G., 288*<br />
De la Rosa-Alvarado, R.,<br />
1030T<br />
de la Torre, l., 3061W<br />
Delattre, V., 894T<br />
De La Vega, F., 1770W*,<br />
3602W<br />
De La Vega, F. M., 3352F<br />
Del Bo, R., 2775F<br />
Delbono, E., 2154W<br />
del Campo, M., 3084F, 3208F<br />
del Castillo, I., 1<br />
del Castillo, V., 875W, 956T,<br />
976T*<br />
Del Castillo-Ruiz, V., 872T,<br />
3040F<br />
de Leau, M., 1689T<br />
de Leeuw, N., 102, 955W*,<br />
979W<br />
de Léséleuc, L., 2003F<br />
Delettre, C., 2679F*<br />
Deleyiannis, F. W. B., 1936T<br />
Delezoide, A.-L., 77<br />
Delezoide, A. L., 3129W<br />
Delgado, P. A., 873W*<br />
Delgado, R., 694T<br />
Delgado, S., 2049W<br />
del Gaudio, D., 958T,<br />
1737W, 3090F<br />
Del Giudice, E., 943W<br />
Deliard, S., 812F<br />
Deligniere, A., 202<br />
de Ligt, J., 97*, 100, 102,<br />
215, 459F, 1749W<br />
Delio, M., 1494T*<br />
DeLisi, L. E., 2402F<br />
Dell, S. S., 2851W<br />
Dell’Angelica, E. C., 361<br />
Della Santina, C. C., 2301W<br />
Dellefave-Castillo, L.,<br />
1614T, 1683T<br />
Dellinger, A., 531F<br />
Del Mistro, G., 3670W,<br />
3717F<br />
Delobel, B., 299, 3172F<br />
Delon, I., 1257W<br />
De Lonlay, P., 329<br />
de los Campos, G., 2201F<br />
Delot, E., 361<br />
Deloukas, P., 44, 110, 115,<br />
117, 383, 560W, 583F,<br />
1440T, 3441T, 3453T*<br />
Delozier, C. D., 1070F*<br />
Delphin, N., 324, 390<br />
Delpierre, C., 1817W<br />
Delprat, B., 2685F*<br />
del Rosario, M., 955W,<br />
2018F*<br />
Del Solar, M., 81, 767W,<br />
815F<br />
DeLuca, A. P., 60<br />
DeLuca, D., 368<br />
De Luca, V., 2408F*<br />
de Luca, V., 628T<br />
Deluce, J., 612T<br />
Delva, L., 2716W<br />
Del Zompo, M., 2342F<br />
Demachki, S., 1008W,<br />
1132T, 3421T, 3503T<br />
de Malliard, T., 31, 2266T,<br />
3260W, 3268F, 3341W<br />
De Marco, E. V., 2597F<br />
de Marco, L. A., 1902W<br />
De Mari, J., 685F<br />
Demartis, F., 2001W<br />
De Mazancourt, P., 890T<br />
Dembitzer, F. R., 3145W<br />
Dembour, G., 84<br />
de Medeiros, P. F. V., 1217F<br />
Demeer, B., 3117W*, 3241W<br />
de Mello, M. P., 478W, 479F<br />
de Melo, M. B., 2291F<br />
Demenais, F., 211, 1158W,<br />
1361W, 1461T, 1941W,<br />
2079W, 2248T<br />
DeMeo, D., 2057F<br />
Demerath, E., 2165F<br />
Demerath, E. W., 2146T,<br />
2336F<br />
Demeter, R., 2587T<br />
Demetriou, C., 3508T*<br />
Demetriou, M., 1493W<br />
Demichelis, F., 1100F<br />
Deming, S. L., 2202W<br />
Demirci, F. Y., 1647T, 1672T,<br />
1673T, 2099F*, 2125T,<br />
2521T, 3078F Demirhan,<br />
B., 3426T<br />
Demko, Z., 3018T<br />
Demko, Z. P., 73<br />
Demmer, L., Session 28<br />
Demmer, L. A., 66<br />
Demmer, R., 1638T<br />
Demontis, D., 2369F<br />
Demos, M., 750T<br />
Dempsey, J., 2243F<br />
Dempsey, J. C., 2789T<br />
Dempsey Nunez, L., 673F*<br />
Dempster, E., 3509T<br />
de Munnik, S. A., 955W<br />
Demuth, S., 2810T<br />
den Dunnen, J. T., 542W,<br />
574W, 2701W, 3586W,<br />
3611F*<br />
Dene, H., 2675T<br />
Deng, A., 1987T<br />
Deng, F.-Y., 2172W<br />
Deng, H. W., 1473T, 2053T,<br />
3534W<br />
Deng, H.-W., 1404T, 2172W<br />
Deng, L., 2433W<br />
Deng, T., 577F<br />
Deng, X., 379<br />
Deng, Z., 798W<br />
Denguezli, M., 2744T<br />
den Hamer, B., 2840T<br />
den Hertog, J., 215<br />
den Hoed, M., 2282F,<br />
2359T*<br />
De Nicola, S., 3492T<br />
Dennis, J., 205, 206<br />
Dennis, M., 12<br />
Dennis, M. Y., 14, 3296W*<br />
Denny, J., 1602T, 3622W*<br />
Denny, J. C., 247, 618T,<br />
631T, 1312F, 2299T<br />
Denny, J. D., 1345F<br />
Denoncourt, H., 1733W<br />
Denroche, R., 1227W,<br />
1256F<br />
Dent, R., 2236T<br />
Dentici, M. L., 105<br />
Denton, M., 2402F<br />
Deo, R., 1694T<br />
Deo, S. V. S., 1278W<br />
de Oliveira, P., 691F<br />
De Paepe, A., 128, 129,<br />
423F, 833F, 1790W,<br />
2225F, 3137W<br />
de Pagter, M., 400<br />
DePalma, S. R., 1677T<br />
de Paor, A., 1812F*<br />
Depienne, C., 2770W<br />
Deplancke, B., 415F<br />
de Pontual, L., 3172F<br />
Depping, R., 204<br />
De Preux Charles, A. S.,<br />
810F<br />
Deprez, M., 3181W<br />
DePristo, M. A., 41, 280,<br />
288, 295<br />
Dequeker, E., 1874F<br />
de Ravel, T., 539F<br />
Derbent, M., 3243W<br />
Derebery, M., 2184W<br />
de Reuver, H. J. E., 1734W<br />
de Reuver, R., 1749W<br />
De Rijk, P., 2948T<br />
Derijks, L. J. J., 243<br />
Derkach, A., 1412W*,<br />
1531F, 2580W<br />
Derks, E. M., 2526W<br />
Derks, R., 2925F<br />
Dermadi Bebek, D., 982T<br />
Dermitzakis, E., 368, 583F,<br />
1440T<br />
Dermitzakis, E. T., 44, 401,<br />
415F, 546W, 556W,<br />
560W, 561F*, 567F,<br />
582W, 3441T<br />
Deroma, L., 692T<br />
DeRoo, L., 1564F<br />
DeRosa, B. A., 588W*<br />
Derouet, C., 1062W<br />
Derrick, A., 262<br />
Derrien, T., 506W<br />
Derry, C. P., 2741T<br />
Derse, A. R., 1837W<br />
DeRycke, M., 1214F
DeRycke, M. S., 986F*,<br />
1206W, 3564W<br />
de Sablet, T., 3388F<br />
Desachy, G., 99, 1274F,<br />
2555F*<br />
Desai, A. S., 2872W*<br />
Desai, K., 188<br />
Desai, M., 911W<br />
Desai, S., 911W, 1146W<br />
Descamps, B., 2225F<br />
Descamps, V., 29, 1062W<br />
Descartes, M., 884T, 898T<br />
Deschamps, L., 29<br />
Deschenes, M., 1848W<br />
DeScipio, C., 935W<br />
Desguerre, I., 202, 522W<br />
Deshommes, J., 259<br />
Deshpande, C., 2896W,<br />
2925F<br />
Deshpande, P., 3649F<br />
Désilets, V., 2790F<br />
Desir, J., 105<br />
Desmaris, C., 530W<br />
De Smedt, M., 2757F<br />
Desmyter, L., 2002T<br />
Desnick, R., 678T, 2926W<br />
Desnick, R. J., 652T, 1777W<br />
De Sousa, M., 2982T<br />
Despande, S. N., 2382W<br />
Dessein, A., 1949F<br />
Dessein, H., 1949F<br />
DeStefano, A. L., 1592T<br />
Destouni, A., 2995T*<br />
Destree, A., 3216F, 3218F<br />
Destrée, A., 127, 131<br />
Desudchit, T., 2749W<br />
Desvarieux, M., 1638T<br />
Detains, D., 56<br />
de Tayrac, M., 2126F,<br />
2893W, 3170F, 3328F*,<br />
3408T<br />
Deugnier, Y., 2126F<br />
Deuschl, G., 200<br />
Deutsch, S., 84<br />
DeValk, J., 3287W<br />
Deveaux, S., 1212W<br />
Devereau, A., 3610W<br />
Devgan, V., 1263W<br />
De Vilder, E., 1790W*<br />
Devilee, P., 27, 1213T<br />
Devillers, M., 1607T<br />
Devine, M., 1267T<br />
Devine, O. J., 1867F<br />
Devlin, B., 553F, 1433W,<br />
1520W, 2560T, 2577W,<br />
2617T<br />
Devlin, J., 544W<br />
Devlin, J. J., 1603T, 1714T<br />
Devlin, R., 1636T<br />
Devoto, M., 2316W<br />
Devriendt, K., 124, 2926W<br />
De Vries, B., 100*<br />
de Vries, B. B. A., 97, 103,<br />
125, 160, 955W<br />
de Vries, F. A. T., 980T*<br />
De Vries, J., 1848W<br />
de Vries, J. I., 3200F<br />
de Vries, P., 97<br />
Dewal, N., 1231T*<br />
Dewan, A., 76, 3024T<br />
*Presenting Author<br />
Dewar, K., 2262W, 2320T,<br />
2343W<br />
Dewey, D., 3095W<br />
Dewey, F., 1601T*<br />
de Wind, N., Session 4<br />
de Wissel, M. B., 2909T<br />
DeWitt, W., 1255T<br />
De Witte, A., 922T, 975W<br />
DeYoung, J., 2262W,<br />
2661W<br />
De Zubicaray, G., 2054F<br />
D’haene, B., 2927T<br />
Dhanoya, I., 2411F<br />
Dharamrup, S., 66<br />
Dharmalingam, G., 2950W<br />
Dharuri, H., 228*, 2107T<br />
Dhaunsi, G. S., 2267F<br />
Dheedene, A., 59<br />
Dhillon, B., 2072F<br />
Dhillon, K. K., 137*<br />
Dhole, T. N., 1177T<br />
Dhooge, I., 2104T<br />
Dhruva, A., 1965W<br />
D’Hulst, C., 2527T<br />
Dhurandhar, N. V., 1406W<br />
Diallo, A., 3470T<br />
Diallo, O., 1670T, 2342F,<br />
2558F<br />
Diamond, B., 306<br />
Dianatpour, M., 1169F*,<br />
2987T<br />
Dianzani, I., 1153T*<br />
Dias, A., 896T, 899W<br />
Dias, C. M., 1968W, 2017T<br />
Dias, F., 1593T<br />
Dias, L., 1778W<br />
Dias-Baptista, I. M. F.,<br />
2289W<br />
Diaw, L., 1259F<br />
Diaz, A., 2603F<br />
Diaz, A. R., 2572T<br />
Diaz, G., 774W<br />
Diaz, G. A., 168<br />
Diaz, K., 406, 2850F<br />
Diaz-Horta, O., 57<br />
Diaz-Martinez, R., 2019W<br />
Diaz-Matallana, M., 3363T<br />
Diaz-Sanchez, D., 1636T<br />
Diaz-Zabala, H. J., 1074W*,<br />
3363T<br />
Dibbens, L., 2898F<br />
Dibbens, L. M., 2741T<br />
Di Bella, D., 2764W*, 2781F<br />
Di Berardini, F., 2104T<br />
Dib-Haij, S. D., 2448W<br />
Dibilio, V., 2763F<br />
Dichgans, M., 1313W<br />
Dick, D. M., 2022W, 2504F<br />
Dick, J., 1193F<br />
Dick, J. E., 1093T<br />
Dick, K. J., 3453T<br />
Dickel, D. E., 254*<br />
Dickens, C. M., 433F, 465F<br />
Dickerson, C., 250<br />
Dickey, A. S., 2456F*<br />
Dickinson, K., 3038F<br />
Dickinson, K. A., 774W<br />
Dickinson, M., 834F, 839F<br />
Dicks, E., 139, 1084T<br />
Dickson, D. W., 346<br />
SPEAKER AND AUTHOR INDEX 351<br />
Dickson, P., 785W*<br />
Dickson, P. I., 695F, 697F<br />
Dicskon, P., 734T<br />
Didelot, G., 62<br />
Di Donato, N., 2595W, 3224F<br />
Diego, V. P., 1458T*<br />
Diehl, A., 531F<br />
Diehl, E. J., 378<br />
Diekhans, M., 3557F<br />
Diekmann, Y., 2261F<br />
Diekstra, A., 160<br />
Diener, S., 2693T*, 2922F<br />
Dierdorff, J., 419F<br />
Dierking, A., 1763W<br />
DietGen Consortium, 51<br />
Dietrich, A., 2602T, 3465T<br />
Dietz, H., Session 81, 80,<br />
81, 1609T<br />
Dietz, H. C., 79, 240<br />
Di Fiore, P. P., 1<br />
Di Gaetano, C., 1153T,<br />
1712T<br />
Digilio, M. C., 943W, 3087W<br />
Di Gregorio, E., 550W<br />
Dijamco, C., 1782W<br />
Dilks, H., 1377T, 1602T,<br />
1928F, 2037W<br />
Dilks, H. H., 1316W, 1671T<br />
Dill, E. M., 2557T<br />
Dillen, L., 2815W<br />
Dillman, A., 564W<br />
DiLullo, N., 2605T<br />
Dimalanta, E., 512W, 3517T<br />
Dimalanta, E. T., 3702W,<br />
3715F<br />
Di Marco, C., 2604W<br />
DiMauro, S., 232<br />
Dimitrova, N., 3316F<br />
Dimnik, L., 3141W, 3665F<br />
Dimos, J., 236<br />
Dimova, I., 3481T<br />
Di Muzio, A., 1776W<br />
Dindinger, M., 1068W,<br />
1244F<br />
Ding, B., 609T<br />
Ding, H. K., 1723W<br />
Ding, J., 154, 276*, 1391W,<br />
1952F<br />
Ding, K., 1312F<br />
Ding, L., 1203W*<br />
Ding, Q., 3355F<br />
Ding, S., Session 78, 2444F<br />
Ding, T., 1010F, 1076F,<br />
1218W<br />
Ding, Y., 314, 1735W,<br />
1742W, 1757W*, 1761W,<br />
3604W<br />
Ding, Z., 1440T<br />
Dingel, M., 1849W<br />
Dinges, D., 2592W<br />
Dingley, S., 2943F<br />
Dinh, H., 1757W, 2880F,<br />
2934F<br />
Di Nicola, M., 936T<br />
Dinov, I. D., 3587F<br />
Dinur, T., 746T<br />
Dinwiddie, D. L., 366,<br />
2793F*, 2894T<br />
Dion, P., 1670T, 1898F,<br />
2306F<br />
Dion, P. A., 2342F, 2558F,<br />
2591F<br />
Dionne, G., 2545T<br />
Dionne, R., 2221T, 3485T<br />
Dionne-Laporte, A., 1670T,<br />
2342F, 2558F<br />
Dionne laporte, A., 2306F<br />
Di Palma, G., 2597F<br />
Di Paola, J., 1889F<br />
Di Paolo, G., 2547W<br />
Dipchand, A., 1704T<br />
Dipple, K. M., 2238W<br />
Di Rienzo, A., Session 6,<br />
248, 2021F<br />
Di Rocco, C., 2235W<br />
Di Rocco, F., 763W, 2729T,<br />
3154F<br />
di Rocco, M., 127<br />
Di Sabato, M. L., 943W,<br />
2777T<br />
Disanto, G., 2015F<br />
Diskin, S., 2203T<br />
Disteche, C. M., 379*<br />
DiStefano, J. K., 1953W*<br />
Ditro, C., 3150F<br />
Dittwald, P., 432W*, 485F<br />
Diver, W., 1012T<br />
Diver, W. R., 1091F, 1390F,<br />
2202W<br />
Divers, J., 178, 1661T*,<br />
1662T, 3371W<br />
Divon, M., 432W<br />
Dixit, J., 2293T<br />
Dixon, A. K., 33<br />
Dixon, T., 239<br />
Dizier, M.-H., 1361W, 1461T,<br />
1941W*, 2079W, 2248T<br />
Djakovic, S., 508W<br />
Djimde, A., 2255F<br />
Djonov, V., 3481T<br />
Djouadi, F., 737F<br />
Do, C. B., 114, 179, 498W,<br />
1017W, 2089T, 2100W,<br />
2111F, 2115W, 2565W,<br />
3386W*<br />
Do, R., 120*, 350, 1331W,<br />
2199W, 2210F<br />
Doan, B., 1454W<br />
Dobbins, S., 1531F, 2580W<br />
Dobbs, M. B., 220, 2860W<br />
Dobkin, C., 2449T<br />
Dobra, A., 1500T<br />
Dobrovolny, R., 678T<br />
Dobrzeniecka, S., 2790F<br />
Dobson, J. M., 1105T<br />
Dobyns, W., 124<br />
Dobyns, W. B., 2389T<br />
Docampo, E., 2326T<br />
Doccini, V., 881W, 3050F<br />
Doco-Fenzy, M., 3165W,<br />
3241W<br />
Docquier, I., 1015T<br />
Dodd, A. F., 2576F<br />
Dodd, M., 1965W<br />
Dodge, M., 905W<br />
Dodurga, Y., 1025F, 1166F<br />
Doedens, M., 1193F<br />
Doelken, S. C., 2725W<br />
Doerfer, C., 2058W<br />
Doering, J., 591F, 865W<br />
SPEAKER AND AUTHOR INDEX
352 SPEAKER AND AUTHOR INDEX<br />
Doerr, H.-G., 2356T<br />
Doerr, M., 1716W*<br />
Doerschner, K., 2924T<br />
Doevendans, P. A. F. M.,<br />
609T<br />
Dogan, A., 2251T<br />
Dogan Sigva, Z. O., 1164W,<br />
1178F<br />
Dogini, D., 2653T*<br />
Dogini, D. B., 514W, 2609F<br />
Doheny, D., 678T*<br />
Doheny, K., 1447F, 2098T,<br />
2114F, 2139W, 2170T,<br />
2556W, 3644W, 3704W,<br />
3733F<br />
Doheny, K. F., 46, 123,<br />
1448W, 1452T, 3716W,<br />
3731F<br />
Doherty, D., 10, 2772F*,<br />
2789T, 2890W<br />
Doherty, L., 3494T<br />
Doherty, M., 2292W<br />
Doherty, S., 2292W<br />
Dohrn, N., 2862F*<br />
Doi, H., 1290T, 2822T, 3136F<br />
Doksum, T., 2974T<br />
Doktor, T. K., 737F<br />
Dola, E. R., 2422T*<br />
Dolan, C. R., 1753W<br />
Dolan, D. F., 1878W<br />
Dolan, M. E., 614T, 1495F,<br />
2333F, 3472T<br />
Dolan, S., 2974T<br />
Dolgado Bohorquez, E. E.,<br />
432W<br />
Dolgalev, I., 998F<br />
Dollfus, H., 390, 2887W*<br />
Dolmetsch, R., 2479T<br />
Domchek, S. M., 1003T<br />
Domingo, E., 133<br />
Dominguez, J., 2466W<br />
Domínguez, J., 960T<br />
Dominguez, J. C., 2473T<br />
Dominguez-Aburto, J.,<br />
3125W<br />
Domínguez Ortiz, J., 956T*<br />
Dominiczak, A. F., 845F,<br />
2072F<br />
Dommisch, H., 2058W<br />
Dompmartin, A., 83<br />
Dompmartin, J. B., 1015T<br />
Donadi, E., 1593T<br />
Donadi, E. A., 3277F<br />
Donahue, L., 983F<br />
Donahue, S., 3210F<br />
Donald, A., 2537F<br />
Donaldson, P. T., 153<br />
Doneda, D., 696T<br />
Dong, C., 1635T*, 1638T<br />
Dong, H., 3730W<br />
Dong, J., 2759T<br />
Dong, L., 824F, 830F<br />
Dong, S., 412W, 486W,<br />
2605T*, 3520T, 3604W<br />
Dong, Z., 1182W<br />
Donis, K. C., 2424W, 2626T,<br />
2642F<br />
Donkervoort, S., 3213W<br />
Donnai, D., Session 81, 127,<br />
2852T<br />
*Presenting Author<br />
Donnelly, L., 609T<br />
Donnelly, M., 3232F*<br />
Donnelly, P., 181, 285,<br />
2157W, 2939T<br />
Donnelly, P. J., 1340W<br />
Donnelly, R., 1155W<br />
Donner, E., 3196F<br />
Donner, M., 86<br />
Donneyong, M., 2145W<br />
Donovan, J., 1011W<br />
Donovan, J. L., 1148F<br />
Donsante, A., 235, 791W<br />
Donti, T., 661F*, 667F, 676T,<br />
2942T<br />
Doody, R., 2489F, 2542T<br />
Dooley, C. M., 363<br />
Dooley, K., 2069F<br />
Dorfman, R., 1731W<br />
Dörk, T., 1117T<br />
Dornelles, A. D., 696T<br />
Dornelles-Wawruk, H., 903W<br />
Doros, L., 132<br />
Dörr, M., 275<br />
Dorrani, N., 315<br />
Dorsainville, D., 3004T<br />
Dorssers, L. C. J., 1122W<br />
Dorward, H., 709F<br />
Doshi, P., 1901F, 2284T<br />
Dos Santos, L., 1133F<br />
Dossari, H., 2743W<br />
Dott, B., 3073W<br />
Doty, A., 1061F<br />
Doty, C., 265<br />
Doty, S., 826F<br />
Douaihy, B., 3349F*<br />
Doucet, T., 1229F<br />
Doudney, K., 967W*, 3440T<br />
Dougherty, B., 133, 503F<br />
Dougherty, M., 1861F*<br />
Douglas, G., 399<br />
Douglas, J., 1211F<br />
Douglas, S., 198<br />
Doulatov, S., 1193F<br />
Doumatey, A., 241, 1515T,<br />
1886F*<br />
Doumbo, O., 2255F, 3303T<br />
Doummar, D., 2770W<br />
Dousset, V., 716T<br />
Douyard, J., 1729W<br />
Dovč drnovšek, T., 3381T<br />
Dovigi, E., 3672W<br />
Dowdy, E., 1636T<br />
Dowling, N. F., 1304W<br />
Downie, J., 2982T<br />
Downing, J. R., 31<br />
Dowty, J. G., 141<br />
Doxiadis, G., 449F<br />
Doyle, A. J., 79*<br />
Doyle, J., 80<br />
Doyle, J. J., 79, 240<br />
Doyle, LW., 3484T<br />
Doyle, M. A., 1224W<br />
Dozmorov, I., 1901F<br />
Dozmorov, M., 549F<br />
Draaken, M., 1005W<br />
Drabant, E., 2565W<br />
Drabant, E. M., 2100W*<br />
Drack, A. V., 2671W<br />
Dragomir, C., 2954T<br />
Dragosky, M., 773W<br />
Drake, W. M., 780W<br />
Drapeau, P., 1910F<br />
Draper, D., 711F<br />
Drayna, D., 1956W, 1958F<br />
Drechsel, O., 2940F, 3661F<br />
Drehman, B., 1826F<br />
Drenos, F., 122, 1606T<br />
Dresbach, A., 2063F<br />
Dressen, A., 347, 492W,<br />
2603F<br />
Dreszer, T., 3557F<br />
Drévillon, L., 843F, 3157W,<br />
3241W*<br />
Drew, C., 262<br />
Drichel, D., 106<br />
Drigalenko, E., 1406W<br />
Drigalenko, E. I., 1282F<br />
Driman, D. K., 1138T<br />
Driscoll, D., 65<br />
Drnasin, K., 845F<br />
Drobnic, K., 3286F<br />
Drogemoller, B., 644T*<br />
Drohan, B., 2974T<br />
Droin, N., 2716W<br />
Droit, A., 1215W<br />
Drong, A., 3435T*<br />
Drongitis, D., 2629T<br />
Dror, A., 2914W<br />
Drory, V., 63<br />
Drost, J., 3350W*<br />
Drouin, V., 124<br />
Druker, H., 1055F*<br />
Drumm, M., 2953W<br />
Drumm, M. L., 1322W<br />
Drummond, J., 1257W<br />
Drunat, S., 3166F<br />
Drury, S., 1773W<br />
Drury, S. C., 1748W*<br />
Druschel, C. M., 2151W<br />
D’Souza, D., 1093T<br />
Du, L., 2998T<br />
Du, Q. Y., 1723W<br />
Duan, J., 1282F, 2576F<br />
Duan, Q., 622T*, 1427W*,<br />
2166W<br />
Duan, Y., 2910F<br />
Dubé, M., 1670T<br />
Dube, M.-P., 3401W<br />
Dubey, G. K., 588W<br />
Dubinsky, A. N., 508W*<br />
Dubois, B., 2086T<br />
Dubois, J., 2424W<br />
Dubois, S., 1951T<br />
Dubois d’Enghien, C., 1205F<br />
Dubourg, C., 2893W, 3170F<br />
Dubowsky, A., 1785W<br />
Dubra, A., 3212F<br />
Dubrovsky, M., 3345T<br />
Ducci, F., 1597T<br />
Ducker, S., 153<br />
Duclos, J., 1170W*<br />
Duda, P., 2561F<br />
Dudas, M., 3717F<br />
Dudding, T., 198, 3167W<br />
Dudek, S., 226, 1442W<br />
Dudekula, D. B., 1391W<br />
Dudley, J. T., 562W<br />
Dueker, N., 2614T*<br />
Dueker, N. D., 9, 2330F<br />
Duerr, R., 1942T<br />
Duerr, R. H., 1381F, 1466W,<br />
2319W<br />
Duffin, K. C., 1952F<br />
Duffy, E., 1754W<br />
Dufke, A., 2595W, 3109W<br />
Dufour, S., 842F<br />
Duga, B., 3283F<br />
Dugan-Rocha, S., 3<br />
Duggal, P., 1512T, 3393W,<br />
3616W*<br />
Duggan, D., 1608T<br />
Duggirala, A., 3455T<br />
Duggirala, R., 176, 1280W,<br />
1406W, 1513F, 1923W,<br />
2061W, 2308T, 2339F<br />
Dugueperoux, I., 1728W<br />
Duijkers, L., 216<br />
Duijts, L., 2168F<br />
Duker, A. L., 3150F<br />
Dulac, O., 202<br />
Dulencin, A., 2467T<br />
Dullea, K., 3671F<br />
Dumaine, A., 259<br />
Duman, D., 57<br />
Dumanski, J. P., 434W<br />
Dumas, K., 501F, 1687T*<br />
Dumas, L., 433F*<br />
Dumaz, N., 29<br />
Dumitrescu, L., 618T*,<br />
1608T, 1671T<br />
Dumitrescu, L. C., 2298W<br />
Dumitrescu, M., 3005T,<br />
3009T, 3067W*<br />
Dumitriu, A., 2227T*<br />
Dumonceaux, J., 2840T<br />
Dumont, B. L., 278<br />
Dunaif, A., 2327F<br />
Dunaway, K. W., 2783T<br />
Duncan, E. L., 2053T<br />
Duncan, G., 222<br />
Duncan, I., 2778F<br />
Duncan, J. S., 2741T<br />
Duncan, R. L., 2855T<br />
Duncan, S., 587F<br />
Duncavage, E., 3637F<br />
Duncombe, A., 390<br />
Dungan, J., 3541F<br />
Dunham, I., 35<br />
Dunivin, R., 3330T<br />
Dunlap, K., 1919F<br />
Dunlop, J., 1724W<br />
Dunlop, M., 1072T, 2072F,<br />
2366F<br />
Dunn, L., 1965W<br />
Dunn, S. H., 1715T<br />
Dunn, T., 3710W<br />
Dunning, A., 208, 1011W,<br />
1150T<br />
Dunning, A. M., 206, 209,<br />
210<br />
Duno, M., 702T<br />
Dunoe, M., 2765T<br />
Dunston, G., 1926W*,<br />
2043W<br />
Dupé, V., 2893W<br />
Dupérée, A., 778W<br />
Dupius, L., 3100F<br />
Duplomb, L., 2716W*,<br />
2770W<br />
DuPont, B. R., 2826F, 3052F
Dupont, J., 3165W<br />
Dupré, N., 1670T<br />
Dupuis, A., 2499W<br />
Dupuis, J., 269, 279,<br />
1346W, 2337W<br />
Dupuis, L., 103, 1738W*,<br />
3106F, 3183W<br />
Dupuis, S., 556W<br />
Duque, F., 2417F, 2502W<br />
Durakovic, Z., 1660T<br />
Durambure, C., 1090T<br />
Duran, K., 217, 400, 2886F<br />
Duran, P., 2705T<br />
Duran, R., 753T<br />
Durand, C., 841F<br />
Durand, E., 3386W<br />
Durand, E. Y., 179*<br />
Durán-González, J., 2363F<br />
Durán-McKinster, C., 872T,<br />
3040F<br />
Durasi, M., 2450F<br />
Durbin, R., 44, 252, 546W,<br />
1440T<br />
Durfee, T., 3671F<br />
Duriaux-Sail, G., 2937F<br />
Durie, P., 142, 2953W<br />
Durie, P. R., 1322W<br />
Durmaz, A., 965W<br />
Durmaz, B., 965W*, 3214F<br />
Durnall, J. C., 2816T<br />
Durr, A., 2539T, 2638T<br />
Dursun, A., 702T<br />
Durtschi, J., 2720T, 2951T,<br />
3638W*<br />
Durtschi, J. D., 3643F<br />
Duru, N., 984W<br />
Dutch National Board for<br />
DNA-Diagnostics (LOD),<br />
3650W<br />
Dutil, J., 996W, 1074W,<br />
1987T, 3360T, 3380W<br />
Dutra, A. R., 3045W<br />
Dutra, R., 896T, 899W<br />
Dutra-Clarke, A., 1159T<br />
Duttgupta, R., 1142F*<br />
Duzenli, S., 2956W*<br />
Duzkale, N., 1326T*<br />
Dvorakova, L., 570W<br />
Dvoskin, R., 1829W<br />
Dweik, D., 2919F<br />
Dworzynski, P., 2241W<br />
Dyack, S., 167, 2480F,<br />
3143W*<br />
Dyer, T., 1280W, 1513F<br />
Dyer, T. D., 176, 533F, 1406W,<br />
1923W, 2061W, 2146T,<br />
2308T, 2309F, 2339F<br />
Dykxhoorn, D., 489F<br />
Dykxhoorn, D. M., 588W<br />
Dyment, D. A., 1775W,<br />
2794W*<br />
Dzakula, Z., 3014T<br />
Dzenkeviciute, V., 920T<br />
Dzidic, N., 3054F<br />
E<br />
EAGLE, 2164T<br />
Eapen, V., 8<br />
*Presenting Author<br />
Earl, D., 466W, 2740W<br />
Earl, J., 1091F<br />
Early Growth <strong>Genetics</strong><br />
Consortium, 2067W,<br />
2097W, 2162F, 3028T<br />
East, C. E., 2309F<br />
Easton, D., 28, 205, 208,<br />
1001F, 1011W, 1214F<br />
Easton, D. F., 206, 207, 209,<br />
210, 1148F, 1150T<br />
Eaton, A., 1841W<br />
Eaton, M. L., 380, 3417T,<br />
3450T<br />
Eaton, W., 2541W<br />
Eaves, E., 3512T<br />
Eaves, L. J., 2277W<br />
Ebata, R., 1631T<br />
Ebbert, A., 2444F<br />
Ebel, C., 328<br />
Eberhardt, J., 2058W<br />
Eberle, M. A., 596W, 942T*<br />
Eberlein, K., 2557T<br />
Ebers, G., 2015F<br />
Ebert, P. J., 1235F<br />
Ebisawa, M., 2294F<br />
Ebrahim, S., 885W*, 1626T,<br />
3455T<br />
Ebrahimi, A., 1175F, 1615T,<br />
1961F, 1962W, 2964F,<br />
3197W*<br />
Ebran, J. M., 1790W<br />
Eccles, D., 1912T<br />
Eccles, M. R., 3440T<br />
Ece, A., 2719W<br />
Eck, S., 2922F<br />
Eck, S. H., 2557T, 3539F*<br />
Eckart, N., 2461T, 2486F*<br />
Eckert, G., 1969T<br />
Eckhold, J., 204, 2958F<br />
Eckl, K., 2869W*<br />
Ecklund, A., 2103W<br />
Eckman, P., 1665T<br />
ECLIPSE and COPDGene<br />
Coauthors, 2249F<br />
Edberg, J. C., 1979F<br />
Eddy, E., 1953W<br />
Edelman, E., 2974T*<br />
Edelmann, L., 652T, 958T,<br />
1777W, 3488T, 3724W<br />
Edelmann, S., 2663T<br />
Edelson, C., 390<br />
Edelson, V., 2974T<br />
Edenberg, H., 2598W<br />
Edgin, J., 2529W<br />
Edgren, H., 2888T<br />
Edie, S., 310*<br />
Edsall, C., 2611T<br />
Eduardo Arroyo-Pardo, E.,<br />
3364F<br />
Edwards, A., 105<br />
Edwards, B., 2649W<br />
Edwards, D., 2145W<br />
Edwards, D. C., 3735F*<br />
Edwards, K., 1848W,<br />
2538W<br />
Edwards, L. D., 2249F<br />
Edwards, R., 2581T<br />
Edwards, R. P., 993W<br />
Edwards, S., 209, 2006F<br />
Edwards, S. L., 210<br />
SPEAKER AND AUTHOR INDEX 353<br />
Edwards, T., 2063F, 2145W,<br />
3299W*<br />
Edwards, T. L., 2131T<br />
Edwards, Y., 2603F<br />
Eeles, R., 28, 205*, 1001F,<br />
1011W, 1109F, 1214F<br />
Eeles, R. A., 1148F<br />
EGEA Collaborative Group,<br />
1361W, 2079W, 2248T<br />
Egeland, T., 1547W<br />
Egertson, J., 10<br />
Eggens, V. R. C., 197*<br />
Egger, G., 2570F, 2575T<br />
Eggermann, T., 3111W<br />
Eggert, P., 3587F<br />
Eggert, S. L., 2056T*<br />
Ehm, M., 294, 1491T, 1686T<br />
Ehm, M. G., 476W, 641T,<br />
649T*, 3282T, 3406T<br />
Ehmke, B., 2058W<br />
Ehret, G., 1387F<br />
Ehret, G. B., 1639T<br />
Ehret, J. K., 3109W<br />
Ehrich, M., 3014T, 3016T<br />
Ehrlich, M. E., 2801T<br />
Ehrmann, D., 249<br />
Eicher, J. D., 1973F*, 2010W<br />
Eichler, E., 93, 98<br />
Eichler, E. E., 10, 12, 14, 74,<br />
94, 274, 278, 375, 2491T,<br />
3296W<br />
Eickholz, P., 2058W<br />
Eid, J., 477F<br />
Eidem, H., 316<br />
Eike, M. C., 3614W*<br />
Eikelboom, J., 617T<br />
Eiklid, K., 921W<br />
Eilbeck, K., 3637F<br />
Eilertson, K., 3361F<br />
Einarsdottir, E., 2023T,<br />
2177F*<br />
Eini, R., 1122W<br />
Eisenbarth, G., 1330F,<br />
3454T<br />
Eisenberg, D. T. A., 2036F*<br />
Eisinger, F., 1212W<br />
Eisman, J. A., 2176T<br />
Eisner, F., 1115F<br />
Eisner, G., 245<br />
Ek, J., 2765T*<br />
Ek, W. E., 2190W*<br />
Ekelund, E., 1939T<br />
Ekelund, U., 2359T<br />
Ekhilevitch, N., 3202F<br />
Ekici, A., 2557T, 3153W*<br />
Ekici, A. B., 2160W, 2356T,<br />
2595W, 2666T<br />
Eklund, L., 1611T<br />
Eklund, N., 2366F<br />
Ekong, R., 3322F<br />
Ekstrom, C., 1353T*<br />
El Agwany, A., 930T<br />
Elalaoui, S., 2937F<br />
Elamin, T., 3149W<br />
Elangovan, R., 771W<br />
Elazar, Z., 53<br />
Elbaik, L., 3149W<br />
Elbaz, R., 1922F<br />
Elbers, C., 283, 1606T,<br />
3303T<br />
Elboim, C., 1965W<br />
Elboudwarej, E., 1924T,<br />
3454T*<br />
El Chehadeh, S., 2716W<br />
El Chehadeh-Djebbar, S.,<br />
2729T*<br />
Elcioglu, N., 219<br />
Eldar-Geva, T., 2991T,<br />
2993T<br />
Elder, J. T., 154, 1952F<br />
Eldin, K., 661F<br />
Elemento, O., 376<br />
Elghezal, H., 944T<br />
Elhaik, E., 2305T*, 3329W,<br />
3377W<br />
El Hajj, N., 3266W<br />
El-Hattab, A., 163<br />
El Hokayem, J., 3129W*<br />
Elhosary, P. C., 266<br />
Elias, A. F., 658T*<br />
Elias, E., 238*<br />
Eliasson, S. C., 805F<br />
Elie, C., 72<br />
Eliou, M., 2905W<br />
El-Kannishy, G., 1922F*<br />
Elkhartoufi, N., 3240F,<br />
3246F<br />
Elkin, E., 1841W<br />
Ellard, S., 2704W, 2709F*,<br />
2935W, 3494T<br />
Elling, U., 110<br />
Ellinghaus, D., 1942T*,<br />
2103W, 2314T, 3583F<br />
Ellinghaus, E., 154, 2101T*<br />
Ellingson, M. S., 1058F<br />
Ellingwood, S., 886T<br />
Ellinor, P. T., 1585T<br />
Ellinwood, N. M., 695F,<br />
785W, 2717T*<br />
Elliott, A., 3681F<br />
Elliott, A. M., 3535F<br />
Elliott, H. R., 3455T*<br />
Elliott, K. S., 1948T*<br />
Elliott, P., 3435T<br />
Elliott, S., 727F<br />
Ellis, J., 2337W, 2525F<br />
Ellis, M. K., 1948T<br />
Ellison, J., 66<br />
Ellonen, P., 327, 897W, 2888T<br />
Ellsworth, D. L., 1649T*<br />
Ellsworth, R. E., 1002W,<br />
1780W<br />
Elmslie, F. V., 2896W<br />
El Saafi, S., 1949F<br />
Elsea, S. H., 103, 1717W<br />
El-Shanti, H., 2713W*,<br />
2728W, 2899W, 3140F<br />
ElShanti, H., 3526W<br />
ElSharawy, A., 515F*,<br />
2368T, 3224F<br />
Elshimali, Y., 1034F<br />
Elsner, G. L., 871W<br />
Elstein, D., 746T*, 788W<br />
Elston, R. C., Session 8<br />
Elton, L., 432W<br />
El Waly, B., 2457W*<br />
Elyaman, D., 2411F<br />
Emanuael, B., 1494T<br />
Emanuel, B., 65, 3038F<br />
Emberly, E., 3734W<br />
SPEAKER AND AUTHOR INDEX
354 SPEAKER AND AUTHOR INDEX<br />
eMERGE Network, 618T<br />
Emerging Team in Genomics<br />
in Screening, 149<br />
Emerson, C. P., Jr., 2962W<br />
Emerson, J., 171<br />
Emerson, R., 530W<br />
Emery, A. E., Session 68<br />
Emes, R., 809F<br />
Emh<strong>of</strong>f, J., 3680W, 3700W<br />
Emilsson, V., 1436W<br />
Emiroglu, M., 1<br />
Emond, M., 2346W<br />
Emond, M. J., 171*<br />
Emrick, L., 163*<br />
Emsley, R., 644T<br />
Encarnacion, M., 346<br />
Encha-Razavi, F., 77, 403,<br />
3240F<br />
ENCODE Project<br />
Consortium, 3291T<br />
Endele, S., 2595W<br />
Eng, C., 158, 898T, 1075T,<br />
1144T, 1716W, 3363T<br />
Eng, C. M., 314, 1735W,<br />
1742W*, 1757W, 1761W<br />
Eng, L., 1591T<br />
ENGAGE Consortium, 119,<br />
1308T, 2076W, 2175W<br />
ENGAGE (European<br />
Network for Genetic and<br />
Genomic Epidemiology)<br />
Consortium, 190<br />
Engelhardt, B., 372*<br />
Engelman, C., 1267T<br />
Engelman, C. D., 2020T*<br />
Engels, H., 2595W, 3109W<br />
Engle, E. C., 2928F<br />
Engle, J. L., 1016F*<br />
English, M. A., 824F<br />
Enjolras, O., 83<br />
Enjorlas, A., 1015T<br />
Enneman, A., 109<br />
Ennis, S., 2072F, 2283W,<br />
3494T<br />
Enns, G. M., 744T<br />
Enomoto, K., 1795W,<br />
2891T, 3091W*<br />
Enquobahrie, D., 584W,<br />
1284T, 1503T<br />
Enriquez Lencinas, L., 2033F<br />
Entelis, N., 329<br />
Enterline, D., 1919F<br />
EPIC Gastric Cancer<br />
Working Group, 987W<br />
Epigen-Brazil, 3562W<br />
Eppig, J. T., 2675T*<br />
Epping, E., 422W<br />
Eppsteiner, R. W., 60<br />
Erasmus, C. E., 160<br />
Erdem, G., 2852T<br />
Erdman, C. A., 2517W<br />
Erdman, L., 456W, 912T<br />
Erdmann, J., 115, 3453T<br />
Erez, A., 165*, 433F, 795W<br />
Ergul, E. A., 1746W, 1801W*<br />
Erhart, G., 3319F<br />
Erickson, E. A., 2442W*<br />
Erickson, R. L., 213<br />
Erickson, R. P., 2752W,<br />
2788W<br />
*Presenting Author<br />
Erickson, S., 1459F*<br />
Eriksson, F., 434W<br />
Eriksson, J., 109, 252, 656T,<br />
2059T, 2116T, 2134T,<br />
2162F, 2350T<br />
Eriksson, J. G., 2110T,<br />
2173T, 2366F<br />
Eriksson, M., 2427W<br />
Eriksson, N., 106, 114*,<br />
498W, 617T, 619T*, 626T,<br />
1017W, 1782W, 2087F,<br />
2089T, 2100W, 2111F,<br />
2115W, 2127W, 2149T,<br />
2565W<br />
Eriksson, P., 1651T, 3685F,<br />
3729F<br />
Erkan, D., 2330F<br />
Erkhembulgan, P., 3248F*<br />
Erlanger, B., 1229F<br />
Erlich, H. A., 3713F<br />
Erlich, Y., 333, 1797W*,<br />
3711F<br />
Erm, T., 1140W<br />
Ernst, A., 2862F<br />
Ernst, C., 554W, 2482T,<br />
2562W*, 3470T<br />
Ernst, F., 3701F<br />
Ernst, S., 1824F<br />
Ernster, M., 963W<br />
Erogullari, A., 204*<br />
Erraffi, K., 2899W<br />
Erte, I., 2138F<br />
Ertekin-Taner, N., 343<br />
Erturk, B., 2719W<br />
Esbensen, A., 1847W<br />
Escamilla, M., 2495F<br />
Escande, F., 3172F<br />
Escano, C., 245<br />
Escaramís, G., 2303F<br />
Eskenazi, B., 3458T<br />
Eskin, E., 39*, 180, 1337W,<br />
1341T, 1386T, 1480F,<br />
2262W, 3555F, 3598W,<br />
3623F, 3639F, 3657F<br />
Esko, T., 108*, 119, 154,<br />
584W, 1284T, 1308T,<br />
1503T, 1792W, 2076W,<br />
2137T, 2165F, 2241W,<br />
2366F, 3353W<br />
Eslamizadeh, S., 1056W<br />
Esmaeeli Nieh, S., 2389T*<br />
Esmall, A., 3700W<br />
Esmer, M. C., 3119W<br />
Esparza Gordillo, J., 1942T,<br />
2102F*<br />
Espay, A., 2538W<br />
ESP Blood Pressure Project<br />
Team, 1692T<br />
Espeseth, M., 1753W<br />
Espinosa, I., 1054T<br />
Espinosa-Parrilla, Y., 987W*<br />
Espinoza, K., 1658T, 2065T<br />
Esplin, E. D., 869W*<br />
Esplin, S., 1904F<br />
Esposito, C., 1060T<br />
Esposito, D., 3711F*<br />
Esposito, E., 505F<br />
Esposito, F., 624T, 2095T<br />
Esposito, T., 2916F*<br />
Essand, M., 434W<br />
Essioux, L., 242<br />
Ester, A., 952T<br />
Esterberg, E., 1869F<br />
Estes, A., 2406W<br />
Esteves, L. M., 2288F*<br />
Estivill, X., 84, 567F, 582W,<br />
2303F*, 2326T, 2940F<br />
Estour, B., 2278T<br />
Estrada, K., 109, 1334W,<br />
2053T, 2169W, 3608W<br />
Estrada, S. C., 707F<br />
Etain, B., 259<br />
Etchegary, H., 149, 150*,<br />
1827W<br />
Etemadi, A., 1076F<br />
Eubanks, J., 3509T<br />
Eun, B., 908T<br />
Euro, L., 327<br />
EUROBATS Consortium,<br />
546W<br />
European Network for<br />
Genetic and Genomic<br />
Epidemiology<br />
Consortium, 2137T<br />
Euskirchen, G., 3361F<br />
Euskirchen, G. M., 3368W<br />
Evangelou, E., 109<br />
Evans, D., 343, 1567F,<br />
2537F<br />
Evans, D. M., 351, 560W,<br />
1318F, 1528F, 1583W,<br />
2081F, 2164T, 2169W<br />
Evans, D. S., 2145W,<br />
2375F*<br />
Evans, D. W., 2439W<br />
Evans, J. P., 231<br />
Evans, M. D., 1270T<br />
Evans, P., 3540W*<br />
Evans, T., 3517T<br />
Evans, T. C., 3715F<br />
Evenson, M., 912T, 1028F<br />
Everhart, S. L., 1781W*<br />
Eversley, C., 1777W<br />
Evgrafov, O., 2444F<br />
Evrony, G. D., 266<br />
Evsyukova, I., 2454W<br />
Ewing, A. D., 466W*, 1229F<br />
Eyheramendy, S., 1336F*<br />
Eymard, B., 328<br />
Eyre, D. R., 222, 2853F,<br />
2854W<br />
Eyre, S., 2231F<br />
Eyries, M., 1170W<br />
Ezekowitz, M., 619T<br />
Ezekowitz, M. D., 617T<br />
Ezgu, F., 745F<br />
Ezzatizadeh, V., 761W<br />
F<br />
Faas, B. H. W., 955W<br />
Fabbri, H. C., 478W*<br />
Faber, C. G., 2448W<br />
Fabian, J., 969W<br />
Faccini, L., 1851F<br />
Facio, F. M., 316<br />
Factor, S., 2538W<br />
Fadel, H., 2930T<br />
Fadista, J., 47*, 2187W<br />
Fagerholm, R., 1171T*<br />
Fagundes de Carvalho, E.,<br />
3364F, 3402T<br />
Fahiminiya, S., 706T<br />
Fähling, M., 522W<br />
Fahn, S., 442W<br />
Failla, P., 100<br />
Fain, P., 3454T<br />
Fain, P. R., 1454W<br />
Fairfax, B. P., 373*, 563F<br />
Fairley, C., 3242F<br />
Faivre, L., 1293T, 2716W,<br />
2729T, 2770W, 2792T,<br />
3240F<br />
Fakhro, K. A., 2933T*,<br />
3399W<br />
Falah, N., 3030T*<br />
Falcão, R. P., 1045T<br />
Falcao-Alencar, G., 1147T,<br />
2243F<br />
Falconnet, E., 561F, 2937F<br />
Falik-Zaccai, T., 199*<br />
Falissard, B., 2545T<br />
Falk, M., 534W<br />
Falk, M. J., 330, 2943F*,<br />
3653F<br />
Falk, R., 300<br />
Fall, T., 108, 1624T*, 2358W<br />
Fallah, M. S., 3197W<br />
Fallahi-Sichani, M., 1162T<br />
Fallet-Bianco, C., 77<br />
Fallin, M. D., 343, 463F,<br />
1472W, 2563T<br />
Fallon, J., 2469W<br />
Fam, H. K., 2849T<br />
Fan, B., 1887W*<br />
Fan, J. B., 596W, 1193F,<br />
3451T<br />
Fan, J.-B., 942T, 1238F<br />
Fan, J.-H., 1010F<br />
Fan, J. H., 1076F<br />
Fan, S., 1369F<br />
Fan, W., 888T, 1110W*<br />
Fancher, K., 983F<br />
Fanen, P., 572W<br />
Fang, E., 399<br />
Fang, F., 3237W<br />
Fang, J., 1097F<br />
Fang, P., 337<br />
Fang, Q., 1878W*<br />
Fang, R., 3612W<br />
Fang, S., 1291F*, 1409W<br />
Fang, X., 3081W<br />
Fanganiello, R., 852F*<br />
Fann, C., 1557T<br />
Fann, C. S. J., 1380T, 3457T<br />
Fann, S. J., 2245T<br />
Fann, Y., 1774W<br />
Fannemel, M., 3096F<br />
Fanning, J., 3700W<br />
Fanous, A. H., 2500T<br />
Faraco, J., 2543F<br />
Faraone, S., 1498F<br />
Faraone, S. V., 2515T<br />
Faravashi, N., 975W<br />
Fardeau, M., 328<br />
Fardo, D., 1147T, 2243F<br />
Fare, T., 2220W<br />
Fares-Taie, L., 390<br />
Farez, T., 778W
Faria, R. G., 1903T<br />
Farias, F. H., 2847F<br />
Farias, T. D. J., 1405F<br />
Farina, G., 157<br />
Fariss, R. N., 824F, 2183F<br />
Färkkilä, M., 2023T, 2348F<br />
Farley, J., 1186T<br />
Farlow, J., 2556W*<br />
Farmaki, A., 2044T<br />
Farmaki, A. E., 3396T<br />
Farmer, A., 2703F*, 3727F<br />
Farnham, J. M., 1149W<br />
Farokhi, E., 2013W<br />
Farook, V. S., 2339F<br />
Farooqi, I. S., 43<br />
Farrall, M., 115, 1640T<br />
Farrell, J., 385, 2563T<br />
Farrer, L., 385*, 1571W,<br />
2207F, 2498F<br />
Farrer, L. A., 343, 344, 1305T,<br />
1476T, 2503T, 2511W,<br />
2528F, 2563T, 2621F<br />
Farrer, L. B., 2488T<br />
Farrer, M., 2537F<br />
Farrer, M. J., 346<br />
Farrow, E., 366<br />
Farrow, E. G., 2894T<br />
Faruque, M., 2043W<br />
Farwell, L., 1754W<br />
Fasquelle, L., 2685F<br />
Fast, S., 1371T<br />
Fatahi, F., 2008T*<br />
Fatemi, A., 2907F<br />
Fatemifar, G., 1528F*<br />
Fathalla, B., 2713W<br />
Fathi, D., 3163W<br />
Fattal-Valevski, A., 2447F<br />
Faucz, F., 1151F, 3055W*<br />
Faucz, F. R., 870T<br />
Faugère, V., 2947W<br />
Faulkner, G., 1229F<br />
Faury, D., 1182W<br />
Fava, V., 1899W<br />
Fava, V. M., 1978T, 2289W<br />
Favarin, M. C., 1045T<br />
Favaro, F., 2673F, 2746W*<br />
Favor, J., 1689T, 2684T<br />
Fawcett, G. L., 595F, 2413T*<br />
Fazio, S., 1634T<br />
Fazli, H., 860T<br />
Fecenko-Tacka, K., 853F<br />
Feehery, G. R., 3702W<br />
Feely, S. M. E., 1871F<br />
Feenstra, B., 1528F, 3028T<br />
Feenstra, I., 58<br />
Feger, C., 328<br />
Feguson, J., 1642T<br />
Fehrmann, R. S. N., 1284T,<br />
1503T<br />
Fei, J., 2985T<br />
Feigenbaum, A. S., 2759T<br />
Feinerman, B., 792W*<br />
Feingold, E., 22, 253, 1438F,<br />
1464T, 1474F, 2034W,<br />
2069F, 2142W, 2156F,<br />
2178W<br />
Feingold, M., 131<br />
Feitosa, M., 1920W<br />
Feitosa, M. F., 111, 1650T*,<br />
1913F, 2073W, 2275T<br />
*Presenting Author<br />
Fejerman, L., 1075T*<br />
Fejes, A., 3641F, 3662W<br />
Fejes, A. P., 2772F<br />
Feki, A., 67<br />
Feld, R., 1108T<br />
Felder, R., 245<br />
Feldhahn, M., 1200W,<br />
1233W<br />
Feldman, D., 998F<br />
Feldman, M. W., 1112F<br />
Feldmesser, E., 2875W<br />
Feliciani, C., 745F<br />
Feliperamirez, D., 3036F<br />
Felix, J., 111<br />
Felix, J. F., 2073W<br />
Felix, S. B., 1503T<br />
Felix, T., 2270F*<br />
Felix, T. M., 2746W<br />
Fellay, J., 2050T<br />
Fellmann, F., 2877F<br />
Fellous, M., 3345T<br />
Felsenfeld, A., 1845W<br />
Feng, B., 2545T<br />
Feng, F., 1004F<br />
Feng, G., 1666T<br />
Feng, H., 2420F<br />
Feng, J. S., 2985T<br />
Feng, Q., 647T<br />
Feng, S., 521F, 1444F,<br />
1568W*, 3541F*<br />
Feng, T., 1376W*<br />
Feng, Y., 3509T<br />
Fenizia, F., 1060T<br />
Fenton, J., 2767W<br />
Fenwick, A. L., 218<br />
Feolo, M., 3330T, 3582W,<br />
3625F<br />
Ferasin, S., 2708T<br />
Ferec, C., 1728W*<br />
Fereira, J. A., 2395T<br />
Feret, H., 2904F<br />
Ferguson, B., 595F<br />
Ferguson, C. J., 2471F<br />
Ferguson, J., 2204F, 3551F<br />
Ferguson, N., 1065W<br />
Ferlazzo, E., 2780T<br />
Fermano, Z., 2381F<br />
Fernandes, A., 1968W,<br />
2017T<br />
Fernandes, B., 994T<br />
Fernandes, G. R., 776W,<br />
1202F<br />
Fernandes, J. K., 1662T<br />
Fernandes, R., 1747W<br />
Fernandes, S., 2982T<br />
Fernandez, B., 175<br />
Fernandez, B. A., 2575T,<br />
3086F<br />
Fernandez, C., 2274W<br />
Fernandez, L., 196*, 2389T<br />
Fernandez, P., 3332W<br />
Fernandez, T. V., 2602T<br />
Fernandez-Lopez, J. C.,<br />
3255T*<br />
Fernández-Rhodes, L.,<br />
2042F<br />
Fernh<strong>of</strong>f, P., 1679T<br />
Ferrandino, A., 334<br />
Ferrannini, E., 1624T<br />
Ferrante, D., 1153T<br />
SPEAKER AND AUTHOR INDEX 355<br />
Ferrara, A., 2140T<br />
Ferrari, C., 299<br />
Ferrari, I., 903W, 961W<br />
Ferraris, A., 943W, 2777T<br />
Ferrat, F., 2866W<br />
Ferraz-de-Souza, B., 361<br />
Ferreira, A. C. S., 182, 1573F<br />
Ferreira, C. A., 2813T<br />
Ferreira, M. A. R., 2161T,<br />
2323T*<br />
Ferreira, R., 1343W, 3600W<br />
Ferreira, R. C., 2091W<br />
Ferreira, R. G. M., 2352W<br />
Ferreira, S. G., 814F<br />
Ferreira, T., 108, 119, 1308T,<br />
1954T*, 2076W, 2123F,<br />
2137T, 2147F<br />
Ferreira, Z., 3306T*<br />
Ferreira-Gonzalez, A.,<br />
3512T<br />
Ferreiro, A., 2945T<br />
Ferrell, R., 2960T<br />
Ferrell, R. E., 1963T<br />
Ferrer, X., 716T<br />
Ferrer Admetlla, A., 3311W*<br />
Ferrero, I., 2810T<br />
Ferrer-Torres, D., 3254W<br />
Ferretti, V., 135<br />
Ferriero, R., 164*<br />
Ferrucci, L., 1391W, 2148W<br />
Ferry, K. M., 2999T<br />
Fert-Bober, J., 80<br />
Fertrin, K. Y., 2751F<br />
Ferwerda, B., 283<br />
Fesel, C., 1979F<br />
Festen, E. M., 1503T<br />
Fetni, R., 2866W<br />
Fett-Conte, A. C., 2270F<br />
Feuer, E., 1543F<br />
Feuk, L., 2920W, 3728W<br />
Fialho, S. C. M. S., 1405F<br />
Fichera, M., 100, 3114F<br />
Ficicioglu, C., 705F<br />
Field, L. L., 1936T<br />
Fielding, S., 1773W<br />
Fields, S., 311<br />
Fierro-Rodriguez, D. A.,<br />
3187W<br />
Fietze, I., 2568W<br />
Figarella-Branger, D., 328<br />
Figlin, R. A., 651T<br />
Figueira, P., 2385W<br />
Figuera, L. E., 650T, 1111T,<br />
1128W<br />
Figueroa, A., 3350W<br />
Figueroa, J., 1117T, 2296T<br />
Figueroa, J. D., 1091F<br />
Filges, I., 3044F*, 3109W<br />
Filho, R. C. C., 3130F<br />
Filhol, E., 324<br />
Filichev, V. V., 3440T<br />
Filipescu, G. A., 2728W<br />
Filippi, T., 881W, 3050F<br />
Filippova, G., 2634W<br />
Filippova, G. N., 55<br />
Filosa, S., 2629T<br />
Finch, S. J., 1338T, 1359T<br />
FIND Consortium, 1914W<br />
FIND Research Group,<br />
1348F<br />
Finegold, D., 2960T*<br />
Finelli, M. J., 2649W<br />
Fingerlin, T., 433F<br />
Fingert, J. H., 2750T<br />
Finkbeiner, S., 2643W<br />
Finkel, R., 1702T<br />
Finnerup, N. B., 2369F<br />
Fiocchi, C., 1466W<br />
Fiorentino, F., 71*<br />
Fiorillo, E., 1516F<br />
Fiorito, G., 1153T, 1712T<br />
Firinu, D., 1516F<br />
Firl, R., 1267T<br />
Firmino, A., 1946F<br />
Firth, H., 101, 291, 364<br />
Firth, H. V., 3109W<br />
Fisch, A. S., 602T*<br />
Fisch, G., 3092F*<br />
Fischbeck, K. H., 2470T<br />
Fischer, A., 2103W*, 3224F<br />
Fischer, J., 1952F<br />
Fischer, K., 190, 1792W*,<br />
1954T, 2123F, 2144F,<br />
2147F, 2175W, 3353W<br />
Fischl, B., 2444F<br />
Fish, A., 2321F*<br />
Fish, A. E., 1286W<br />
Fishbein, M., 1685T<br />
Fisher, D., 144<br />
Fisher, J. A., 3708W<br />
Fisher, L., 2184W<br />
Fisher, S. A., 968T<br />
Fisher, T., 316<br />
Fisher-Hoch, S. P., 2048F,<br />
2345F<br />
Fishman, E., 80<br />
Fishman, L., 1738W<br />
Fishman, S. J., 83<br />
Fitzgerald, K., 2430W<br />
FitzGerald, O., 2160W<br />
Fitzgerald, T., 101, 364,<br />
455F<br />
Fitzgerald, T. W., 291*<br />
Fitzgerald-Butt, S., 1680T<br />
Fitzgerald-Butt, S. M.,<br />
1646T<br />
Fitzpatrick, A. L., 1653T<br />
FitzPatrick, D., 4, 101, 291,<br />
364, 3072F<br />
Flachsbart, F., 515F, 1943F*,<br />
2295W, 2303F<br />
Flaman, J.-M., 1090T*<br />
Flanagan, J., 732T<br />
Flanagan, J. M., 2331W*<br />
Flanagan, S., 3494T<br />
Flanagan, S. E., 2704W,<br />
2709F<br />
Flannagan, J. M., 648T<br />
Flannery, K. C., 1769W<br />
Flannick, J., 169, 172*,<br />
1677T, 2209T<br />
Flax, J., 2381F<br />
Fleming, A., 361<br />
Fleming, F., 422W<br />
Fleming, M. R., 202<br />
Fleming, M. T., 1878W<br />
Fletez-Brant, C., 545F<br />
Flexeder, C., 2167T<br />
Flicek, P., 464W, 497F,<br />
3636W, 3732W<br />
SPEAKER AND AUTHOR INDEX
356 SPEAKER AND AUTHOR INDEX<br />
Flickinger, M., 1448W*<br />
Flierl, A., 803W<br />
Flint, J., 105, 355<br />
Flodman, P., 1791W<br />
Flogelova, H., 845F<br />
Florendo, D., 2466W<br />
Florendo, D. J. A., 2473T<br />
Florentin-Arar, L., 539F<br />
Florer, J. B., 736T*<br />
Flores, C., 2296T<br />
Flores, D., 2495F<br />
Flores, R., 2711T, 3084F<br />
Florez, J., 249, 2307W<br />
Florez, J. C., 50, 269<br />
Florian, I. S., 849F<br />
Florin, A. T., 1145F<br />
Floyd, J., 1518T*<br />
Fluiter, K., 197<br />
Flutre, T., 273*<br />
Flyvbjerg, A., 2070W, 2358W<br />
Foco, L., 2039F<br />
Fode, P., 1323T<br />
Fogarty, M. P., 46, 1627T,<br />
<strong>2012</strong>F*<br />
Fogarty, S., 2395T<br />
Fogarty, Z. C., 3564W<br />
Foisy, S., 1678T, 1982F*<br />
Fojtík, P., 2865F<br />
Fok, A. S. L., 821F<br />
Fokkema, I. A. C., 3610W<br />
Fokkema, I. F., 3611F<br />
Fokstuen, S., 2877F, 2937F<br />
Foley, A. R., 2812W<br />
Foley, J., 3037W<br />
Foley, R., 2945T<br />
Folk, J. C., 2750T<br />
Folkersen, L., 1651T<br />
Folseraas, T., 2101T<br />
Fölster-Holst, R., 1939T<br />
Folwaczny, M., 2058W<br />
Fombonne, E., 175<br />
Fomous, C., 1762W<br />
Fong, J. C., 2639F*<br />
Fong, J. H., 300<br />
Fong, K., 2971T<br />
Fonseca, A. C. S., 874T*,<br />
882T<br />
Fonseca, S. A. S., 882T<br />
Fonseca-Kelly, Z. D., 1756W<br />
Fonseka, C. Y., 444W<br />
Fontana, E., 2795T<br />
Fontanillas, P., 169, 176,<br />
269<br />
Fontes, A. M., 1045T<br />
Fontes, F., 1977W<br />
Foo, J. N., 1934F*, 2055W<br />
Footz, T., 575F*<br />
Forabosco, A., 847F<br />
Ford, B., 442W<br />
Ford, J., 2043W<br />
Foreman, M. G., 1425T<br />
Forestier, E., 1023W, 1024T,<br />
1035W, 3427T<br />
Forge, A., 2663T<br />
FORGE Canada Consortium,<br />
131, 2772F, 2790F, 2794W,<br />
2800W, 3127W<br />
FORGE Consortium, 701F<br />
Forman, E. J., 2999T<br />
Forman, J., 2354F<br />
*Presenting Author<br />
Forman-Neall, L., 1859F<br />
Fornage, M., 350, 1592T,<br />
2210F, 2269T<br />
Fornarino, S., 3304F<br />
Forni, S., 1684T<br />
Foroud, T., 2136W, 2531F,<br />
2556W<br />
Foroud, T. M., 343, 2511W<br />
Forouhi, N. G., 1626T<br />
Forrest, G., 1605T<br />
Forrester, T., 2158T<br />
Forsberg, L. A., 434W*<br />
Forsberg, R., 3641F, 3662W<br />
Forsblom, C., 2307W<br />
Forsmark, L., 3685F<br />
Forsstrom, L., 2888T<br />
Forster, M., 3583F<br />
Forsythe, E., 3211W*<br />
Fortes, F., 1102T<br />
Fortner, M., 474W<br />
Fortugno, P., 2760F<br />
Fortuna, A., 913W*<br />
Forzano, F., 131<br />
Fosdal, I., 2699T<br />
Foskett, T. J., 824F<br />
Fosså, S. D., 991T<br />
Foster, B., 368<br />
Foster, C., 2043W<br />
Foster, J. G., 103<br />
Foster II, J., 57<br />
Fostira, F., 1191W*, 1228T<br />
Fotia, G., 823F<br />
Foulkes, W., 28, 1001F,<br />
1262F, 3595F<br />
Foulkes, W. D., 1065W,<br />
1214F<br />
Founds, S. A., 1884W<br />
Fountzilas, G., 1228T<br />
Fowler, B., 1874F<br />
Fowler, S. P., 2339F<br />
Fowler, V. G., Jr., 1323T<br />
Fox, A. S., 2413T<br />
Fox, C., 2337W<br />
Fox, C. S., 1954T, 2030F,<br />
2123F, 2147F<br />
Fox, E., 2063F<br />
Fox, E. R., 1677T<br />
Fox, J. E., 884T<br />
Fracasso, N. C. A., 3280F<br />
Frackelton, E., 319, 1996T,<br />
1997F, 2229W, 2252F,<br />
2722W, 2785W*, 2856F,<br />
2872W, 2892F, 2904F,<br />
3573F<br />
Frade, A. F., 1593T<br />
Fraga, L. R., 3031T<br />
Fragata, A., 1593T<br />
Framstaller, P. P., 2116T<br />
França, M. C., Jr., 2609F,<br />
2653T<br />
Francalacci, P., 3377W<br />
Francannet, C., 894T<br />
Francelle, L., 259<br />
Franceschini, N., 111,<br />
1437T, 1599T, 1913F,<br />
2042F, 2063F, 2073W*,<br />
2145W, 2336F, 2337W<br />
Francioli, L., 459F<br />
Francis, R. M., 3419T<br />
Francisco, V., 2085W<br />
Francis-West, P., 814F<br />
Francke, U., Session 57,<br />
114, 1017W, 1782W*,<br />
2089T, 2100W, 2111F,<br />
2115W<br />
Franco, A., 2234F<br />
Franco, B., 808F, 2810T,<br />
2955F<br />
Franco, L. M., 337, 2158T,<br />
2189F*<br />
Francois, G., 2002T<br />
François, S., 716T<br />
Franek, B. S., 2046W<br />
Frank, J., 2087F<br />
Frank, M. B., 529F, 2188T<br />
Franke, A., 154, 515F,<br />
1939T, 1942T, 2058W,<br />
2101T, 2102F, 2103W,<br />
2303F, 2314T*, 2315F,<br />
2319W, 2368T, 3224F,<br />
3583F<br />
Franke, B., 243, 306, 621T,<br />
1498F<br />
Franke, L., 108, 461F, 523F,<br />
1284T, 1330F, 1503T,<br />
1621T, 2088W<br />
Frankel, W. L., 1173W<br />
Frankish, A., 367, 506W<br />
Franklin, C., 2082W*<br />
Franklin, N., 743F*<br />
Frankowski, H., 2628W<br />
Franks, P., 249, 2187W<br />
Franks, P. W., 117, 1954T,<br />
2123F, 2147F<br />
Fransen, E., 59, 2104T*,<br />
2948T<br />
Fransen, K., 461F<br />
Frants, R., 2107T<br />
Franzil, A. M., 692T<br />
Frase, A., 1442W, 3542W*<br />
Frase, A. T., 3624W<br />
Fraser, D., 630T, 1491T<br />
Fraser, R. M., 1383T<br />
Frasson, M. C., 3107W*<br />
Fraumeni, J., 1012T<br />
Frauscher, B., 2567F,<br />
2568W<br />
Frayling, T., 269, 584W,<br />
1284T, 1503T, 1513F<br />
Frayling, T. M., 108, 176,<br />
1624T, 1923W, 2148W,<br />
2241W, 2308T, 2339F<br />
Frazer, K., 3307F<br />
Frazer, K. A., 395, 1051T<br />
Frebourg, T., 32, 345,<br />
1090T, 1212W, 1222T,<br />
3538W<br />
Frederickson, K., 1242W<br />
Fredrich, M., 740T*<br />
Fredrickson, K., 2301W<br />
Freebairn, L., 1295W<br />
Freedland, S., 1185W<br />
Freedman, B., 1706T, 2332T<br />
Freedman, B. I., 1648T,<br />
1661T, 1879T, 1979F,<br />
2046W, 2310W<br />
Freedman, M. L., 1231T<br />
Freedman, N. D., 1010F,<br />
1076F<br />
Freedman, S., 2328W<br />
Freeman, A. C., 2805F<br />
Freeman, C., 1031F<br />
Freeman, N., 2608T<br />
Freeman, S. B., 3042F<br />
Freese, D. K., 718T<br />
Freeze, H. H., 1758W<br />
Freidin, M. B., 2271W*<br />
Freimer, N., 252, 1480F,<br />
2262W, 2343W<br />
Freimer, N. B., 2222F, 2320T<br />
Freisinger, P., 699F, 782W,<br />
2917W<br />
Freitas, E. L., 439F, 891W*,<br />
961W<br />
Freitas, I. S., 1902W<br />
Freitas, J., 3656W<br />
Freitas, L. G., 3130F<br />
Frelin, L., 3374W<br />
French, J., 210<br />
French, J. D., 209<br />
French, S., 981W<br />
French LFS Working Group,<br />
1090T<br />
Freppon, D., 893W<br />
Freudenberg, J., 306,<br />
3403W*<br />
Frey, M. K., 1272W<br />
Frias, S., 875W*, 928T,<br />
956T, 960T, 1048T,<br />
1049F<br />
Frías, S., 976T<br />
Frick, S. L., 2860W<br />
Fridley, B., 139, 603T<br />
Fridley, B. L., 1247F,<br />
1426F*, 3451T<br />
Fridman, C., 1629T*, 2706F<br />
Friedburg, M., 3142F<br />
Frieden, I., 2926W<br />
Friederich, M., 2884W<br />
Friedlander, C., 3652W*<br />
Friedländer, M., 567F<br />
Friedlnader, C., 3619F<br />
Friedman, B., 3163W<br />
Friedman, D. S., 2154W,<br />
2240F<br />
Friedman, E., 3336T*,<br />
3345T<br />
Friedman, J. M., 1840F,<br />
1846W<br />
Friedman, J. S., 2183F<br />
Friedman, L., 2919F<br />
Friedman, R., 2104T,<br />
2184W<br />
Friedman, S. D., 2530T<br />
Friedman, T. B., 2724F<br />
Friend, K., 198<br />
Friez, M. J., 2901F<br />
Frints, S. G. M., 215<br />
Frisch, E., 699F<br />
Fritsch, C., 580W<br />
Froguel, P., 2162F<br />
Frolenkov, G. I., 2663T<br />
Froment, A., 283, 3303T,<br />
3338W<br />
Fromer, M., 290, 1325W,<br />
2577W, 2618F<br />
Frommolt, P., 2861T<br />
Fronick, C., 2325W<br />
Frost, J. M., 3501T<br />
Frucht, S., 442W
Frumkin, A., 3048F<br />
Fry, A., 124<br />
Fry, G., 3717F<br />
Frydman, M., 2919F<br />
Frydman, N., 72<br />
Frydman, R., 72<br />
Frye, M., 605T, 2516F<br />
Fryns, J. P., 124<br />
Fryssira, H., 84, 2937F<br />
Fryzek, J., 1565W<br />
Fu, A., 3707F<br />
Fu, A. Q., 1580W*<br />
Fu, B., 438W<br />
Fu, C., 2850F<br />
Fu, J., 523F<br />
Fu, R., 443F<br />
Fu, W., 10, 283<br />
Fu, Y., 3483T<br />
Fu, Y.-H., 2581T, 2779W<br />
Fu, Y. H., 2423F, 2610W,<br />
2667F<br />
Fu, Y. P., 1092W<br />
Fu, Y.-P., 1091F*<br />
Fucci, L., 3492T<br />
Fuchs, H., 1919F<br />
Fuchs, T., 2801T*<br />
Fuchsberger, C., 46, 88*,<br />
172, 176, 1513F, 1923W,<br />
2308T, 2339F<br />
Fuentes-Fajardo, K., 359,<br />
2610W, 2938W, 3543F<br />
Fuji, N., 726T<br />
Fujii, N., 2400W<br />
Fujimoto, A., 396*<br />
Fujio, K., 1984T<br />
Fujioka, R., 2647T<br />
Fujioka, Y., 2472W<br />
Fujita, H., 2071T<br />
Fujita, K., 52, 3221W<br />
Fujita, M. Q., 1321F<br />
Fujita, P., 3557F<br />
Fujita, R., 3377W<br />
Fujita, Y., 3230F<br />
Fujiwara, T., 2400W<br />
Fukai, K., 3146F<br />
Fukao, A., 1549F<br />
Fukuda, S., 559F<br />
Fukuda, Y., 2409W, 2569T<br />
Fukumaki, Y., 2400W,<br />
2647T*<br />
Fukushi, D., 2748F<br />
Fukushima, Y., 2758W,<br />
3043W, 3230F<br />
Fuller, A., 332<br />
Fuller, C., 2246F*<br />
Fuller, J., 2933T, 3399W<br />
Fullerton, S. M., 1828F*<br />
Fulmer-Smentek, S., 922T,<br />
975W, 3726W<br />
Fulp, J., 1061F<br />
Fulton, L. L., 2587T<br />
Fulton, R., 484W*, 1210T,<br />
2325W<br />
Fulton, R. S., 244, 2587T<br />
Fumagalli, M., 3289F,<br />
3312T*<br />
Fun, J., 1859F<br />
Funalot, B., 2694F<br />
Funanage, V. L., 2855T<br />
Funato, F., 755W<br />
*Presenting Author<br />
Funayama, M., 1730W,<br />
2559W, 3134F, 3221W<br />
Funke, B. H., 1677T, 1754W<br />
Furey, T. S., 292<br />
Furge, K. A., 1186T<br />
Furlan, L., 825F<br />
Furlotte, N., 1337W, 3598W*<br />
Furtado, G. V., 2424W,<br />
2626T, 2642F<br />
Furth, S. L., 2121W<br />
Furukawa, M., 3513T<br />
Furuya, H., 2400W*<br />
Furuya, N., 1795W, 2891T<br />
Fusco, C., 775W, 3087W,<br />
3256F<br />
Fusco, F., 505F, 2629T<br />
Fusco, I., 2827W<br />
Futerman, A. H., 2869W<br />
Futscher, B. W., 3712W<br />
Fuwa, M., 2129F<br />
Fuzzell, D., 3335W<br />
Fylaktou, I., 2995T<br />
G<br />
Gaál, E. I., 1253F<br />
Gaasterland, D., 2154W,<br />
2240F, 2263T<br />
Gaasterland, T., 2154W,<br />
2240F, 2263T<br />
Gaba, C., 1454W<br />
Gabelle, A., 2638T<br />
Gabelli, C., 2775F<br />
Gabis, G., 660T<br />
Gaborieau, V., 1012T,<br />
1496W<br />
Gabriel, L. A. R., 3130F*<br />
Gabriel, S., 8, 280, 322,<br />
1490W, 1725W<br />
Gabriel, S. B., 1677T,<br />
2613W<br />
GABRIEL and EArly<br />
<strong>Genetics</strong> and Lifecourse<br />
Epidemiology Consortia,<br />
2168F<br />
Gaddis, N., 2114F<br />
Gaddis, N. C., 2170T<br />
Gadelha, A., 2533T, 2534F<br />
Gadi, I., 949W<br />
Gadi, I. K., 3113W<br />
Gaede, K. I., 2103W<br />
Gaedigk, R., 811F<br />
Gaffney, D., 3507T<br />
Gaffney, D. J., 153<br />
Gaffney, P., 1901F<br />
Gaffney, P. M., 306, 549F,<br />
566W, 2046W, 2084F<br />
Gage, F. H., 436W<br />
Gagliardi, M., 2763F,<br />
2766F*, 2774T, 2780T<br />
Gahl, W., 359, 755W,<br />
2610W<br />
Gahl, W. A., 709F, 711F,<br />
1702T, 2442W, 2838F,<br />
2870T, 2938W, 3080F,<br />
3543F<br />
Gai, X., 1756W, 2884W,<br />
2943F, 3653F*<br />
Gaieski, D. F., 3329W<br />
SPEAKER AND AUTHOR INDEX 357<br />
Gaieski, J., 3373F<br />
Gaieski, J. B., 3329W*,<br />
3377W<br />
Gail, M. H., 1314T<br />
Gaillard, D., 403, 3241W<br />
Gaillard, R., 2081F<br />
Gaillon, T., 3157W<br />
Gaio, V., 1968W*, 2017T<br />
Gajecka, M., 934T*<br />
Galabov, A., 3481T<br />
Galanello, R., 2001W<br />
Galanter, J. M., 158, 3385F<br />
Galanther, J., 3363T<br />
Galarneau, G., 1906T,<br />
2247W*<br />
Galas, D. J., 195<br />
Galasko, D., 340<br />
Galavotti, R., 2548T<br />
Galaxy Development Team,<br />
3545F<br />
Galaxy Team, 3547F<br />
Galea, S., 435F<br />
Galeone, D., 2766F<br />
Galesi, O., 100<br />
Galhano, E., 3019T<br />
Galimberti, D., 2095T<br />
Galindo, P., 694T<br />
Gall, A., 2163W<br />
Gall, T. R., 3543F*<br />
Gallagher, C. J., 1016F,<br />
1107W<br />
Gallagher, L., 2770W<br />
Gallagher, R. C., 3133W*<br />
Gallant, N. M., 712T*<br />
Gallardo, M., 546W<br />
Gallego Romero, I., 3322F<br />
Gallegos, L. P. C., 3064F<br />
Gallegos, M., Jr., 1111T*<br />
Gallegos, M. P., 1077W,<br />
1127F, 1128W<br />
Gallentine, W. B., 3<br />
Gallinger, S., 141, 1067F,<br />
1079F, 1093T, 1206W,<br />
3478T<br />
Gallo, C., 3327T<br />
Gallo, E., 80<br />
Galluzzi, G., 1776W<br />
Galusca, B., 2278T<br />
Galvez-Peralta, M., 2800W<br />
Gamazon, E., 613T, 2333F<br />
Gamazon, E. R., 269, 424W,<br />
623T, 1003T, 1495F,<br />
2192F, 2196W*, 2197T<br />
Gambardella, A., 2763F,<br />
2766F, 2774T, 2780T<br />
Gambin, A., 432W, 485F<br />
Gambin, T., 432W, 485F*,<br />
898T<br />
Gambineri, E., 3114F<br />
Game, L., 1618T, 2005T<br />
Gameiro, C., 572W<br />
Gamez, J., 2930T<br />
Gámez-Nava, J. I., 2363F<br />
Gammill, H. S., 74, 94<br />
Gammon, A. D., 1058F<br />
Gan, X., 355*<br />
Gandhi, M. K., 1042T<br />
Gandolfi, B., 3252T<br />
Gandy, A., 3518T<br />
Gandy, S., 940T<br />
Ganesh, S., 1663T<br />
Ganesh, S. K., 1408F,<br />
1639T*, 1659T<br />
Gangnon, R., 1267T<br />
Ganguly, A., 140, 391*<br />
Ganguly, B. B., 3010T*<br />
Ganguly, T., 140, 391<br />
Ganna, A., 2105F*<br />
Gantz, B. J., 2301W<br />
Gao, C., 824F<br />
Gao, F., 125, 3415T*<br />
Gao, G., 1354F*, 1410T,<br />
3442T, 3452T, 3604W<br />
Gao, H., 1112F*, 1369F,<br />
2358W*<br />
Gao, J., 1558F*<br />
Gao, L., 1900T, 2043W<br />
Gao, X., 221, 1004F,<br />
2153F*, 2217W, 3108F*<br />
Gao, Y., 36<br />
Gao, Z., 285<br />
Gapstur, S., 205<br />
Gapstur, S. M., 1091F<br />
Garbanati, J., 753T<br />
Garbarini, J., 65<br />
Garbes, L., 236<br />
Garcia, L., 2360F<br />
Garcia, M., 834F, 839F,<br />
2145W, 2165F<br />
García, N., 987W<br />
Garcia, R., 946T*<br />
Garcia, V., 54<br />
Garcia-Barceló, M.-M., 408,<br />
1930T*, 2066F, 2932W,<br />
3123W<br />
Garcia-Blanco, M. A.,<br />
2454W<br />
Garcia-Closas, M., 206,<br />
1091F, 1117T, 1150T<br />
García-Closas, R., 1091F<br />
García-Cruz, D., 3187W,<br />
3188F<br />
Garcia-Figueroa, J., 682T<br />
Garcia Garcia, G., 2947W<br />
Garcia-Guzman, A., 3062F*<br />
Garcia-Hernandez, N.,<br />
1168T<br />
García-Miñaúr, S., 126, 217<br />
García-Ortiz, H., 48<br />
García-Robaina, J. C.,<br />
2296T<br />
García Robles, R., 2990T<br />
Gardeitchik, T., 672T<br />
Garden, G. A., 2628W<br />
Gardner, J., 1291F<br />
Gardner, J. C., 3212F<br />
Gardner, R., 1263W<br />
Gardner, S., 1874F, 3579F<br />
Garg, N., 1587T, 1598T<br />
Garg, P., 3516T<br />
Garg, V., 195<br />
Garge, N., 1392T<br />
Garnai, S., 2135F<br />
Garner, J., 3582W, 3625F<br />
Garraway, L. A., 402<br />
Garrec, C., 1204T*<br />
Garrett, M., 531F*<br />
Garrett, M. E., 2340W<br />
Garrett, T., 2041T<br />
Garrett-Bakelman, F., 3464T<br />
SPEAKER AND AUTHOR INDEX
358 SPEAKER AND AUTHOR INDEX<br />
Garrido, L. M., 1343W,<br />
2352W<br />
Garrido, M. A. H., 1018T<br />
Garrison, E., 41*<br />
Garrison, N., 1813W*<br />
Gartioux, C., 2436W<br />
Garvey, W. T., 1662T, 3371W<br />
Garwood, M., 821F<br />
Gary, D. S., 545F<br />
Gasanova, V., 1181F<br />
Gascon, G. G., 8<br />
Gaspar, H., 2928F<br />
Gaspar, H. B., 1748W<br />
Gaspard, H., 129<br />
Gasparini, P., 1484W,<br />
2128T, 2366F<br />
Gasperini, M., 263<br />
Gass, M., 2360F<br />
Gassmann, M., 3705F*<br />
Gastier-Foster, J., 456W<br />
Gastier-Foster, J. M., 912T<br />
Gates, H. L., Jr., 2087F<br />
Gatinois, V., 936T*<br />
Gatti, R. A., 790W<br />
Gat-Viks, I., 322<br />
Gau, C., 1736W<br />
Gauderman, W. J., 2153F<br />
Gaudet, M., 208<br />
Gaudi, S., 2564F<br />
Gaudreault, N., 1655T<br />
Gauguier, D., 1640T<br />
Gaulton, K., 176, 1513F<br />
Gaulton, K. J., 172, 1519F,<br />
1627T, 2324F*<br />
Gautel, M., 2945T<br />
Gauthier, J., 2306F, 2338T,<br />
2342F, 2558F<br />
Gauthier, M.-P., 532W, 3684W<br />
Gautier, E., 1293T<br />
Gauvin, H., 1478W*<br />
Gavier, M., 1834F<br />
Gawrieh, S., 441F, 1667T<br />
Gayagay, T., 3167W<br />
Gaynor, J. W. G., 2443T<br />
Gayther, S., 139, 210<br />
Gayther, S. A., 1156T<br />
Gazave, E., 183<br />
Gazdar, A., 1454W<br />
Gazula, V., 202<br />
Gazzellone, M. J., 2575T<br />
Gbeha, E., 2266T, 3260W,<br />
3268F, 3341W<br />
Ge, B., 256, 394, 569F,<br />
1207T, 1215W, 3514T<br />
Ge, D., 53, 2335T<br />
Ge, J., 2403W*, 3544W*<br />
Ge, M., 661F<br />
Ge, R. L., 3378T<br />
Gearhart, J., 3704W<br />
Gecz, J., 2629T<br />
Gécz, J., 2640W<br />
Gee, H. Y., 406<br />
Geer, J., 33<br />
GEFOS Consortium, 109,<br />
1334W<br />
Gehrig, C., 561F, 2877F<br />
Gehring, W., 2430W<br />
Geiger, E. A., 819F, 2884W<br />
Geigl, J. B., 1063T*, 1115F,<br />
3116F<br />
*Presenting Author<br />
Geiser, H., 3656W<br />
Geiss, G., 1039T*<br />
Gejman, P. V., 1282F, 2576F<br />
Gekas, J., 3060F, 3071W*<br />
GELAC Study Group, 989F<br />
Gelb, B. D., 82<br />
Gelb, M. H., 727F<br />
Gelber, S., 3012T<br />
Gelernter, J., 2207F, 2497T,<br />
2503T*, 2621F<br />
Geller, F., 1528F, 3028T*<br />
Gellera, C., 2764W, 2775F*<br />
Gelley, L., 3316F<br />
Gelman, A., 53<br />
Geloso, M. C., 2235W<br />
Gelowani, V., 61, 63*<br />
Gemelos, G., 3018T<br />
Gemma, A., 1697T<br />
GENCODE Consortium, 367<br />
Generation Scotland, 1618T<br />
Genereux, D. P., 1580W<br />
Genes in Schizophrenia<br />
(GENESIS) Consortium,<br />
2600F<br />
GENESIS Consortium, 1624T<br />
Genetic Analysis <strong>of</strong> Psoriasis<br />
Consortium, Wellcome<br />
Trust Case Control<br />
Consortium 2, 154<br />
Genetic Consortium for<br />
Anorexia Nervosa,<br />
Wellcome Trust Case<br />
Control Consortium 3,<br />
2522F<br />
Genetic Disorders <strong>of</strong><br />
Mucociliary Clearance<br />
Consortium, 2851W<br />
Genetic Investigation <strong>of</strong><br />
ANthropometric Traits<br />
Consortium, 2123F,<br />
2241W<br />
Genetic Investigation <strong>of</strong><br />
ANthropometric Traits<br />
(GIANT) Consortium,<br />
1954T<br />
<strong>Genetics</strong> <strong>of</strong> Obesity-Related<br />
Liver Disease<br />
Consortium, 2275T<br />
<strong>Genetics</strong> <strong>of</strong> Type-2 Diabetes<br />
Consortium, 88<br />
GENEVA Alcohol<br />
Consumption Working<br />
Group, 2228F<br />
Genevieve, D., 2386T,<br />
3121W, 3166F<br />
Geng, L., 2840T<br />
Geng, Z., 1542T*<br />
Genick, U. K., 1281T<br />
GENIE Consortium, 2307W<br />
Génin, E., 2126F, 3328F,<br />
3408T*<br />
Genographic Consortium,<br />
3329W, 3349F, 3373F<br />
GenoMEL Consortium, 211<br />
Genome <strong>of</strong> the Netherlands<br />
Consortium, 459F<br />
Genome Reference<br />
Consortium, 464W<br />
Genome-Wide Association<br />
Studies <strong>of</strong> Prostate<br />
Cancer in African<br />
<strong>American</strong>s, 1324F<br />
Genomics and Randomized<br />
Trials Network ( GARNET),<br />
123<br />
Genovese, G., 284*, 2618F<br />
GenTAC Consortium, 1700T<br />
GenTAC Investigators,<br />
1743W<br />
Gentry, R. C., 9<br />
Gentschew, L., 1943F<br />
Genuardi, M., 1130F<br />
George, A., 1302T<br />
George, B., 931W<br />
George, E., 1019F<br />
George, M. F., 1289W*,<br />
1301W<br />
George, P., 967W<br />
George, V., 3418T<br />
Georges, M., 256<br />
Geppert, M., 3364F, 3402T<br />
Geraedts, J. P. M., 2996T<br />
Gerafi, S., 858T<br />
Geraghty, E., 2890W*<br />
Geraghty, M. T., 160, 701F*,<br />
719F<br />
Gerard, M., 2887W<br />
Gerards, M., 708T<br />
Gerber, S., 324, 390<br />
Gerdes, M. G., 2443T<br />
Gerety, S., 101, 364<br />
Gerfen, J., 338*<br />
Gerges, N., 1182W<br />
Gerhard, G. S., 2078F<br />
Gerhart, D., 140<br />
Gerig, G., 2529W<br />
Gerkes, E., 126<br />
Germain, D. P., 772W*, 890T<br />
Germain, N., 2278T<br />
Gerrits, M. M., 2448W*<br />
Gerry, N., 966T<br />
Gerry, N. P., 632T<br />
Gersak, K., 2929W<br />
Gershenwald, J., 1291F<br />
Gershon, E. S., 1957T<br />
Gerstein, M., 334, 551F,<br />
2444F, 3251W<br />
Gerstein, M. B., 41, 280<br />
Gertz, E. M., 1958F<br />
Gervin, K., 3510T<br />
Geschwind, D., 553F, 2444F,<br />
2479T<br />
Geschwind, D. H., 2478W,<br />
2518T, 2551T, 2639F,<br />
2658W, 2779W, 3487T<br />
Geske, J., 605T<br />
Gesualdo, L., 845F<br />
Getts, B. C., 1142F<br />
Getz, G., 25, 368, 402<br />
Geuvadis Consortium, 567F,<br />
582W<br />
Gevers, D., 537F<br />
Geyer, C. R., 3488T<br />
Ghaderibarim, F., 2150F<br />
Ghaffarpour, M., 1056W*,<br />
1124F<br />
Ghamsari, L., 2660F<br />
Ghandour, H., 3700W<br />
Gharanei, S., 2767W*<br />
Gharani, N., 632T*<br />
Gharavi, A. G., 845F<br />
Gharib, S., 584W<br />
Gharib, S. A., 1284T, 1503T<br />
Gharizadeh, B., 398<br />
Ghassibe, M., 1640T*, 2002T<br />
Ghatreh, K., 2008T<br />
Gheno, T. C., 2424W,<br />
2626T, 2642F<br />
Ghezzi, A., 2095T<br />
Ghezzi, D., 699F<br />
Ghia, E., 395<br />
Ghiban, E., 2587T, 3316F<br />
Ghiggeri, G. M., 845F<br />
Ghimbovschi, S., 3249W<br />
Ghorab, K., 328<br />
Ghosh, A., 1413T*<br />
Ghosh, A. K., 2680W<br />
Ghosh, J., 971W<br />
Ghosh, K., 1572T<br />
Ghosh, M., 918T<br />
Ghosh, S., 1297F<br />
Ghoshal, U. C., 1137W<br />
Ghoumid, J., 843F*, 3157W,<br />
3241W<br />
Ghoussaini, M., 205, 206,<br />
209*<br />
Giacalone, G., 2095T<br />
Giacobini, M., 188<br />
Giacomini, K. M., 246<br />
Giambartolomei, C., 122,<br />
1621T*<br />
Gianfrancesco, F., 2916F<br />
Giannotta, S., 3415T<br />
GIANT Consortium, 108,<br />
1387F, 2074T, 2090F,<br />
2147F, 2210F<br />
Giardina, E., 2160W<br />
Giardine, B., 3545F*<br />
Gibb, A., 3440T<br />
Gibbens, B., 2645F<br />
Gibbon, S., 3327T<br />
Gibbons, P., 3331F<br />
Gibbons, R., 418W*<br />
Gibbs, J. R., 2148W, 2611T<br />
Gibbs, R., 121, 174, 183,<br />
349, 595F, 1520W,<br />
1585T, 1592T, 1599T,<br />
1854F, 2802F, 2880F,<br />
2934F, 3209W, 3597F<br />
Gibbs, R. A., 3, 244, 314,<br />
360, 648T, 1221W,<br />
1231T, 1735W, 1742W,<br />
1757W, 1761W, 2413T,<br />
2577W, 2798T, 2864T,<br />
2881W, 2883F, 2908W,<br />
3576W<br />
Gibbs, R. J., 564W<br />
Gibson, G., 31, 2779W<br />
Gibson, J., 531F, 2072F<br />
Gibson, Q., 602T<br />
Gibson, R., 2537F<br />
Gibson, R. L., 171<br />
Gibson, W., 2797W<br />
Giedd, J., 433F<br />
Giedraitis, V., 434W<br />
Gieger, C., 110, 190, 1942T,<br />
2086T, 2103W, 2160W,<br />
2175W, 2226W, 2568W<br />
Giffen, C., 1218W<br />
Gigarel, N., 72
Gigek, C. O., 1132T, 3421T,<br />
3503T<br />
Giger, T., 561F<br />
Gignoux, C., 3360T<br />
Gignoux, C. R., 158*, 1425T,<br />
3385F<br />
Gigot, N., 2716W, 2729T,<br />
2792T<br />
Gijselinck, I., 2815W<br />
Gil, A., 1968W, 2017T<br />
Gil, G. P., 426W, 2718F<br />
Gil, L., 3732W<br />
Gilad, Y., 2*, 1514W, 2031W,<br />
3251W<br />
Gilbert, D., 75*<br />
Gilbert, J., 2135F, 2637W,<br />
3706W<br />
Gilbert, J. R., 9, 341, 347,<br />
2378F, 2445W, 2572T,<br />
2583W*, 2586W, 2614T<br />
Gilbert-Dussardier, B., 77<br />
Gilbey, M., 1147T<br />
Gilboa, T., 2993T<br />
Gil-da-Silva-Lopes, V.,<br />
1865F, 2270F<br />
Gil-da-Silva-Lopes, V. L.,<br />
959W, 1903T<br />
Gileadi, O., 219<br />
Giles, G., 28, 205<br />
Giles, G. G., 1148F, 1213T,<br />
1214F<br />
Gilfillan, G. D., 3510T<br />
Gilfix, B. M., 673F<br />
Gilissen, C., 97, 100, 125,<br />
160, 214, 672T, 1749W*<br />
Gilissen, C. F. H. A., 1734W<br />
Gilkeson, G. S., 1662T,<br />
1979F, 2046W, 3371W<br />
Gill, D. F., 614T<br />
Gillanders, E., 1543F<br />
Gillanders, E. M., 211<br />
Gillani, N., 1377T, 1928F<br />
Gillani, N. B., 1316W<br />
Gillen, D., 1493W<br />
Gillessen-Kaesbach, G.,<br />
204, 219, 2925F, 2958F<br />
Gilliam, D., 2805F*<br />
Gilliaux, M., 3098F<br />
Gillis, A. J. M., 1122W<br />
Gillis, J., 447F, 3568W<br />
Gillis, L., 79<br />
Gillis, T., 1964F<br />
Gillisen, C., 216<br />
Gillson, C., 1686T<br />
Gilman, R., 1119W<br />
Gilman, R. H., 3325F<br />
Gilmore, B. L., 2636F<br />
Gilmour, K. C., 1748W<br />
Gilsanz, V., 812F<br />
Gimelli, S., 67, 2937F<br />
Gimigliano, A., 2695W<br />
Gindlesperger, A., 3011T*<br />
Ginno, P., 552W<br />
Ginsburg, G. S., 147<br />
Ginty, D. D., 308<br />
Ginzinger, D., 256<br />
Gioia, J., 3717F<br />
Giordano, J. L., 3012T*<br />
Giordano, M., 1153T,<br />
2827W<br />
*Presenting Author<br />
Giorgini, F., 2641T<br />
Giorgio, E., 550W*<br />
Giovannoni, G., 2015F<br />
Giovannucci Uzielli, M. L.,<br />
3114F<br />
Girard, M., 522W, 936T,<br />
2386T, 3121W, 3166F<br />
Girard, S., 3268F, 3401W*<br />
Girard, S. L., 2558F, 2591F<br />
Giraud, S., 1212W<br />
Giri, N., 1196F<br />
Girimaji, S. C., 2776W<br />
Girirajan, S., 12, 14*, 98,<br />
2491T<br />
Girisha, K. M., 3173W<br />
Girling, A., 1257W<br />
Girodon, E., 572W, 1768W,<br />
1874F*<br />
Girodon, F., 2716W<br />
Giste, E., 255<br />
Giudicessi, J. R., 2885T<br />
Giuffre, A., 3669F, 3709F<br />
Giugliani, C., 1851F<br />
Giugliani, R., 685F*, 691F,<br />
747F, 772W, 879W,<br />
1851F, 2425T<br />
Giulianini, F., 51<br />
Giuliano, F., 124<br />
Giurdanella, M. C., 1712T<br />
Giurgea, I., 843F, 894T,<br />
3157W, 3241W<br />
Gjessing, H. K., 213<br />
Gladman, D., 154, 448W,<br />
1952F<br />
Glahn, D., 2061W<br />
Glahn, D. C., 1923W<br />
Glaser, A., 1612T<br />
Glaser, R. L., 3154F<br />
Glaser, T., 2926W<br />
Glasheen, C., 2114F, 2170T<br />
Glash<strong>of</strong>f, R. H., 3332W<br />
Glaspy, J. A., 136<br />
Glass, D., 44, 546W, 583F,<br />
1440T, 2143T<br />
Glass, I., 2789T, 2890W<br />
Glass, M., 727F<br />
Glassford, M., 1860F<br />
Glavač, D., 3381T, 3422T*<br />
Glazer, N. L., 2080T<br />
Gleeson, J., 267<br />
Gleeson, J. G., 3581F<br />
Glenn, G., 132<br />
Glenn, S. B., 529F, 1979F,<br />
2188T<br />
Glentis, S., 1228T<br />
Glessner, J., 2229W, 2492F,<br />
3546W*<br />
Glessner, J. T., 1996T,<br />
2121W, 2389T<br />
Gliedt, T., 3664W<br />
GliomaScan Consortium,<br />
1372F<br />
Global Lipids <strong>Genetics</strong><br />
Consortium, 117<br />
Glodzik, D., 1481W*<br />
Gloeckner, C. J., 86<br />
Glogowski, E., 1841W<br />
Glorieux, F. H., 3169W<br />
Glotzbach, C., 934T<br />
Glover, T., 2879T<br />
SPEAKER AND AUTHOR INDEX 359<br />
Glover, T. W., Session 22,<br />
339<br />
Glunk, V., 3536W<br />
Glusman, G., 195<br />
Gnirke, A., 322, 1725W<br />
Go, M., 1657T<br />
Go, M. J., 49<br />
Goate, A., 2228F, 2582F,<br />
2598W, 2650T<br />
Goate, A. M., 340, 342, 343<br />
Gobert, D., 56<br />
Gocan, H., 849F<br />
Gockel, I., 2088W<br />
Godard, A. L. B., 2655W<br />
Godbole, K., 911W<br />
Goddard, G. H. M., 1329T<br />
Goddard, K. A. B., 1869F*<br />
Goddard, M., 1360F<br />
Goddard, M. E., 108,<br />
1331W<br />
Godefroy, O., 3117W<br />
Godeiro, C., 2642F<br />
Godfraind, C., 1611T<br />
Godfraind, P.-L., 1015T<br />
Godfrey, M., 1856F*<br />
Godi, M., 2827W<br />
Godley, L. A., 3472T<br />
Godson, C., 2307W<br />
Goecks, J., 3547F*<br />
Goel, N., 2592W<br />
Goel, P., 1715T<br />
Goeman, J. J., 542W,<br />
1436W<br />
Goes, F. S., 2180F, 2305T<br />
Goetz, M., 1247F<br />
Goetzman, E., 657F<br />
G<strong>of</strong>f, C. L., 3167W<br />
G<strong>of</strong>f, D. J., 1051T<br />
G<strong>of</strong>frini, P., 2810T<br />
Goin-Kochel, R., 759W*<br />
Goin-Kochel, R. P., 299,<br />
2439W<br />
Goizet, C., 716T*, 2674W<br />
Goj, V., 845F<br />
Gokcumen, O., 3251W,<br />
3310F<br />
Goker-Alpan, O., 693F,<br />
713F, 768W*, 769W<br />
Goksen, D., 3206F<br />
Golalipour, M. G., 1096T<br />
Golan, D., 1797W, 3711F<br />
Golbus, J. R., 1614T, 1683T<br />
Gold, B., 1242W<br />
Gold, J. A., 3068F*<br />
Gold, K. F., 2452T<br />
Gold, N. B., 326<br />
Goldberg, A., 2577W,<br />
3351T*<br />
Goldberg, R., 3<br />
Goldbladtt, M., 1667T<br />
Goldblatt, J., 1216T<br />
Golden, D. M., 968T<br />
Goldenberg, A., 390, 1551T,<br />
2203T*<br />
Goldgar, D., 1492F<br />
Goldgar, D. E., 1067F,<br />
1213T<br />
Goldin, L. R., 30*, 2191T<br />
Goldlust, I. S., 66*<br />
Goldman, D., 2574W<br />
Goldmann, O., 2251T<br />
Goldmuntz, E., 65<br />
Goldschmeding, R., 2848W<br />
Goldschmidt-Clermont, P.,<br />
1644T<br />
Goldsmith, C. L., 1775W*<br />
Goldstein, A., 330, 1076F,<br />
1517W<br />
Goldstein, A. M., 211,<br />
1010F, 1218W*<br />
Goldstein, D., 53, 235<br />
Goldstein, D. B., 203,<br />
2050T, 2335T, 2455T,<br />
2552F, 2875W<br />
Goldstein, J., 2618F, 3644W<br />
Goldstein, J. I., 290*<br />
Goldstein, L. E., 2528F<br />
Goldstein, P., 3529F<br />
Goldwaser, T., 1793W*,<br />
3022T<br />
Golinker, E., 3202F<br />
Golka, K., 1335T<br />
Gollub, J., 493F, 1142F<br />
Golmard, L., 1205F*<br />
Golovleva, I., 1024T<br />
Golozar, A., 1076F*<br />
Golshani, R., 969W<br />
Golub, M. S., 2783T<br />
Golzio, C., 98, 2458T*,<br />
3296W<br />
Gombojav, B., 1654T*<br />
Gomes, C., 913W<br />
Gomes, V., 3364F, 3402T<br />
Gomez, H. T., 926T<br />
Gomez, L., 3509T<br />
Gomez, R., 3373F, 3377W<br />
Gómez-Almaguer, D., 1030T<br />
Gómez-Vázquez, M. J., 48,<br />
3255T<br />
Gomy, I., 3250F<br />
Goncalves, F. T., 2706F*<br />
Goncalves, J., 2982T<br />
Gonçalves, V., 628T<br />
Gonçalves, V. F., 2376W*<br />
Goncalves-Dornelas, H.,<br />
3107W, 3110F<br />
Goncalves Serra, E., 45<br />
Gonder, M. K., 3306T<br />
Gondim, C. S. E., 747F<br />
Gong, F., 909W<br />
Gong, H., 501F<br />
Gong, L., 633T*, 635T<br />
Gong, T.-W., 1878W<br />
Gong, Y., 2210F<br />
Gong, Z., 1369F<br />
Gonggalanzi, G., 3317W<br />
Gonik, M., 2483F<br />
Gonsales, M., 2393F*<br />
Gonsales, M. C., 2233T<br />
Gonsalves, S., 358, 1690T<br />
Gonsalves, S. G., 1696T<br />
Gonzaga-Jauregui, C., 360,<br />
485F, 2798T*<br />
Gonzaga-Jauregui, C. G.,<br />
2881W, 2883F, 2908W<br />
Gonzales, M., 77, 3129W<br />
Gonzalez, A. J., 1627T<br />
González, C. A., 987W<br />
Gonzalez, D., 362, 1750W<br />
Gonzalez, G., 3425T<br />
SPEAKER AND AUTHOR INDEX
360 SPEAKER AND AUTHOR INDEX<br />
Gonzalez, J., 703F, 2940F<br />
Gonzalez, K., 2907F<br />
Gonzalez, K. D., 2698W,<br />
2895F, 3065W*<br />
Gonzalez, M., 57, 1681T,<br />
2615F*, 2820F, 3364F<br />
Gonzaléz, M., 3402T<br />
Gonzalez, P., 521F, 3521T<br />
Gonzalez, R., 3327T<br />
González, R., 2296T<br />
Gonzalez, S., 2495F<br />
González-Andrade, F.,<br />
3364F, 3402T<br />
Gonzalez Berjon, J., 893W<br />
Gonzalez Burchard, E.,<br />
1075T, 3360T, 3380W<br />
Gonzalez-Herrera, L., 2272T*<br />
González-Llano, O., 1030T<br />
González-López, L., 2363F<br />
González-Mercado, A.,<br />
2363F*, 3188F<br />
González-Mercado, M. G.,<br />
3188F*<br />
Gonzalez-Neira, A., 206<br />
Gonzaludo, N., 620T*<br />
Good, B. M., 3584W<br />
Goodall, A. H., 3453T<br />
Goodarzi, M. O., 1916F*,<br />
2080T<br />
Goode, E., 139<br />
Goode, E. L., 210, 1238F,<br />
3451T<br />
Goode, M., 2544W<br />
Goodier, J., 336*<br />
Goodloe, R., 1316W,<br />
1377T*, 1671T, 2041T<br />
Goodman, N., 2643W<br />
Goodrich, J., 537F<br />
Goodrich, J. K., 2029T*<br />
Goodrich, M., 3465T<br />
Goodridge, D., 3713F<br />
Goodship, J. A., 219<br />
Goodwin, A., 3242F*<br />
Goodwin, E. H., 948T<br />
Goodwin, L., 843F<br />
Goossens, M., 572W, 843F,<br />
894T, 1768W, 1796W,<br />
2727F, 3157W, 3241W<br />
Gopalakrishnan, R., 529F,<br />
2188T<br />
Gopie, J., 1788W<br />
Göraler, S., 2107T<br />
Gordeuk, V., 3297T<br />
Gordish-Dressman, H.,<br />
2452T<br />
Gordon, A., 71<br />
Gordon, A. S., 244*, 301<br />
Gordon, C., 126*, 3172F<br />
Gordon, D., 1338T, 1358W,<br />
1359T<br />
Gordon, E. S., 632T<br />
Gordon, L., 245<br />
Gordon, L. B., 2879T<br />
Gordon, L. N., 606T*<br />
Gordon, P., 3141W, 3665F<br />
Gordon, S. D., 2133W<br />
Gordon-Larsen, P., 1467T,<br />
1913F<br />
Gorelenkov, V., 1762W<br />
Gorelik, L., 2561F<br />
*Presenting Author<br />
Gorin, M. B., 1963T<br />
Goring, H. H. H., 533F,<br />
1406W, 2061W<br />
Göring, H. H. H., 1280W,<br />
1282F*, 1458T, 2651F<br />
Goris, A., 2086T<br />
Gorkin, D. U., 258*<br />
Gorman, K., 2234F*<br />
Gormley, P., 1325W<br />
Gornall, H., 2452T<br />
Gorsic, L. K., 614T<br />
Gorvel, J. P., 1949F<br />
Gosendi, M. E., 129<br />
Gospe, S. M., Jr., 167<br />
Goss, G., 135<br />
GoT2D Consortium, 172,<br />
173, 1519F, 2324F<br />
GoT2D Investigators,<br />
1373W, 1389T<br />
Gotlib, J. R., 1017W<br />
Goto, J., 52, 233, 2409W,<br />
2569T<br />
Goto, S., 52<br />
Goto, Y., 234, 1722W<br />
Gotoh, L., 234<br />
Gotta, L., 2520W<br />
Gottipati, S., 183<br />
Gottlieb, B., 398*<br />
Gottschalk, W., 2465F<br />
Götz, A., 327<br />
Goubran-Botros, H., 259<br />
Goudefroye, G., 77<br />
Goudet, P., 1293T<br />
Goudy, S., 2762T<br />
Gougerot-Pocidalo, M.-A.,<br />
2716W<br />
Gould, D. B., 1689T, 2684T<br />
Gould, E., 3724W<br />
Goulet, J.-P., 2266T, 3268F,<br />
3341W<br />
Goumy, C., 894T<br />
Gourraud, P., 2113T, 3330T*<br />
Gourraud, P.-A., 2039F,<br />
2049W, 2350T<br />
Gouttard, S., 2529W<br />
Gouveia, M., 3325F<br />
Gouya, L., 56<br />
Govi, M., 1776W<br />
Govil, M., 1315F*, 2178W<br />
Gowda, H., 3316F<br />
Gowher, A., 329<br />
Gowrisankar, S., 1754W<br />
Goyal, S., 1891T, 2730F*,<br />
3696W<br />
Goyette, P., 1678T, 2319W*<br />
Graber, E., 3033T<br />
Grabowska, E., 2587T<br />
Grabowski, G., 789W<br />
Grabowski, G. A., 161,<br />
690T, 736T, 749F<br />
Grabs, R., 5<br />
Grace, N. M., 1625T<br />
Gracia, G., 1876F<br />
Grad, I., 67<br />
Grad, R., 1852F<br />
Grady, W., 144<br />
Graetz, C., 2058W<br />
Graf, E., 699F, 2557T,<br />
2567F, 2595W, 2917W,<br />
2922F<br />
Graf, J., 200<br />
Grafe, I., 2854W<br />
Graff, M., 1467T, 1913F<br />
Graff-Radford, N., 343<br />
Grafodatskaya, D., 3420T,<br />
3456T*, 3489T<br />
Graham, B., 661F, 676T*,<br />
2395T, 2942T<br />
Graham, B. H., 667F<br />
Graham, J. M., Jr., 3185W<br />
Graham, M., 3331F<br />
Graham, R., 306, 342<br />
Graham, R. R., 2091W<br />
Grahn, R. A., 3252T<br />
Grallert, H., 2116T, 2595W,<br />
3536W<br />
Granberg, C., 2845W<br />
Grandchamp, B., 29, 56,<br />
1062W<br />
Granell, R., 2167T<br />
Grangeiro, C. H. P., 941W,<br />
2813T<br />
Grant, G., 290, 1919F<br />
Grant, R., 118, 3142F<br />
Grant, R. W., 2140T<br />
Grant, S., 2067W, 2121W,<br />
2229W, 2252F<br />
Grant, S. F. A., 812F,<br />
1307W*, 1915T, 1997F<br />
Grarup, N., 2311T, 2317T*,<br />
2347T<br />
Grassh<strong>of</strong>f, U., 3109W<br />
Gratacòs, M., 2303F, 2593T<br />
Grattau, Y., 84<br />
Graubert, T., 1203W<br />
Graubert, T. A., 301, 1408F<br />
Graul-Neumann, L., 2760F<br />
Gravel, S., 3352F*, 3360T,<br />
3361F, 3380W, 3390T,<br />
3563F<br />
Graves, T., 375, 464W, 465F<br />
Graves, T. A., 3296W<br />
Gravitt, P., 1076F<br />
Gray, J. J., 308<br />
Gray, J. W., 984W<br />
Greally, M. T., 100<br />
Greco, D., 100, 1265F,<br />
3631F*<br />
Greco, F., 1776W<br />
Greely, H., Session 20<br />
Green, D., 3688W<br />
Green, E., 3306T<br />
Green, J., 1066T, 1084T<br />
Green, M. R., 1042T<br />
Green, R. C., Session<br />
73, 317, 343, 1781W,<br />
1825W*, 2488T, 3635F<br />
Green, T., 1454W<br />
Greenawalt, D., 1624T<br />
Greenberg, K., 1859F<br />
Greenberg, M. E., 452W,<br />
2613W<br />
Greenberg, S. M., 1689T<br />
Greenblatt, M. S., Session 4<br />
Greene, A. M., 1269W<br />
Greene, C. S., 1501F<br />
Greene, M. H., 210, 213<br />
Green Snyder, L., 2439W<br />
Greenspan, B., 3377W<br />
Greenspan, E., 3377W<br />
Greenwood, C., 1411F<br />
Greenwood, J., 1791W*<br />
Greer, D., 480W<br />
Greer, S. N., 1046F<br />
Greer, T., 876T*, 3154F*<br />
Greger, V., 1729W, 3640W,<br />
3680W<br />
Gregersen, N., 657F<br />
Gregersen, P., 461F<br />
Gregersen, P. K., 306<br />
Gregor, A., 2666T<br />
Gregory, B., 1642T, 3551F<br />
Gregory, B. L., 500W*<br />
Gregory, P. D., 255, 803W<br />
Gregory, S., 1919F, 3541F<br />
Gregory, S. G., 1444F,<br />
1636T, 2340W, 2454W*<br />
Gregoski, M., 1715T<br />
Greisenegger, S., 1603T<br />
Grenier, J.-C., 31, 2266T,<br />
3268F, 3341W<br />
Grenier, J. C., 3260W<br />
Grether, J., 7<br />
Grether, P., 875W, 928T,<br />
956T, 960T<br />
Gretz, N., 1612T<br />
Gribaa, M., 1751W, 2744T<br />
Gribaldo, L., 1877F<br />
Gribble, S., 101, 291<br />
Grice, D. M., 916T<br />
Griebel, T., 567F, 582W<br />
Griesi Oliveira, K., 2414F*<br />
Griffen, C., 1010F<br />
Griffin, H., 751F<br />
Griffith, S., 3644W, 3716W,<br />
3731F<br />
Griffiths, C. E. M., 154<br />
Griffiths, L. R., 1042T,<br />
1912T*, 2916F<br />
Grigorenko, E., 334<br />
Grill, D. E., 1426F<br />
Grillo, E., 2604W<br />
Grimaldi, L., 2095T<br />
Grimholt, R. M., 643T<br />
Grinberg, L. T., 919W<br />
Grindle, S., 1665T<br />
Grioni, S., 1712T<br />
Gripp, K. W., 124<br />
Grisart, B., 3098F<br />
Griskevicius, L., 1208F<br />
Griswold, A. J., 2445W,<br />
2572T*, 2614T<br />
Griswold, B., 1663T<br />
Griswold, B. F., 3231W<br />
Grochowski, C., 2316W<br />
Grocock, R., 1238F, 3663F<br />
Grocock, R. J., 366<br />
Grody, W. W., 130, 315<br />
Groen, J. L., 200<br />
Groen-Blokhuis, M., 2097W<br />
Groenendaal, F., 3164F<br />
Groeneveld, M. P., 33<br />
Groessner-Schreiber, B.,<br />
2058W<br />
Gr<strong>of</strong>, P., 2338T<br />
Gr<strong>of</strong>fen, A., 98<br />
Gr<strong>of</strong>fen, S., 3200F<br />
Grohé, C., 2103W<br />
Gronberg, H., 205, 1148F<br />
Grønskov, K., 363*
Groom, A., 3455T<br />
Groop, L., 47, 2187W<br />
Groop, P.-H., 2307W<br />
Gropman, A., 239<br />
Gropman, A. L., 330<br />
Gros, P., 649T<br />
Gross, M. D., 2337W<br />
Gross, N., 2568W<br />
Gross, V., 2447F<br />
Grossfeld, P., 870T<br />
Grossman, R., 176, 1513F<br />
Grossman, T. R., 804W*<br />
Grossse-Wortmann, L.,<br />
3186F<br />
Groth, J., 3242F<br />
Grotmol, T., 991T<br />
Grove, M. L., 1445W*<br />
Grover, M., 3209W<br />
Groves, A. K., 840F<br />
Grozeva, D., 2576F<br />
GRS Team, 983F<br />
Grubb, J., 786W<br />
Grubb, R., 1012T<br />
Grubert, F., 371, 551F*,<br />
3411W, 3505T<br />
Gruen, J. R., 1973F, 2010W<br />
Grumbt, B., 3539F<br />
Grummel, V., 2086T<br />
Grundberg, E., 44, 583F,<br />
3441T*<br />
Grunenwald, H., 3697F<br />
Grünewald, A., 200, 204,<br />
672T<br />
Grunewald, J., 2103W<br />
Grünfeld, T., 3614W<br />
Grunstad, J., 176, 1513F<br />
Grydholt, J., 3641F, 3662W<br />
Gschwind, A., 415F<br />
GTEx Consortium, 368<br />
Gu, C. C., 1468F<br />
Gu, D., 116*, 2259W<br />
Gu, J., 2721F<br />
Gu, M., 2819T*<br />
Gu, Q., 3168F<br />
Gu, S., 3491T*<br />
Gu, Z., 3309T<br />
Guadalupe, M., 3669F<br />
Guan, M. X., 1628T*<br />
Guan, T., 457F<br />
Guan, W., 1428T*, 1665T<br />
Guan, Y., 1482T*<br />
Guan, Z., 457F, 2623T*<br />
Guarrera, S., 1153T, 1712T<br />
Guaschino, C., 2095T<br />
Guaschino, R., 1153T<br />
Guauque-Olarte, S., 1655T*<br />
Gucev, Z., 33, 845F<br />
Guchelaar, H. J., 243<br />
Gudjonsson, J. E., 154<br />
Guedalia, J., 2993T<br />
Guedet, M. M., 207<br />
Guedj, F., 765W*<br />
Guekunst, K., 1251W<br />
Guella, I., 2459F*, 2469W,<br />
3587F<br />
Guergueltcheva, V., 201,<br />
2948T<br />
Guerra-Junior, G., 478W,<br />
479F<br />
Guerreiro, J. F., 3292F<br />
*Presenting Author<br />
Guerreiro, M., 2876T<br />
Guerreiro, M. M., 2393F<br />
Guerrini, R., 889W<br />
Guethlein, L. A., 3710W<br />
Guettouche, T., 2185T,<br />
3706W*<br />
Guevara-Aguirre, J., 2706F<br />
Guffanti, G., 435F*<br />
Guha, N., 3676W*<br />
Guha, S., 264<br />
Gui, H., 21<br />
Guia-Padilla, M. T., 1805W<br />
Guiblet, W., 3254W*, 3380W<br />
Guidobono, R., 685F<br />
Guidugli, L., 1219T*<br />
Guignoux, C. R., 3380W<br />
Guigo, R., 368, 567F, 582W<br />
Guigò, R., 506W<br />
Guild, C. S., 272<br />
Guilherme, R. S., 3045W<br />
Guillaume, P., 619T<br />
Guillemyn, B., 2225F<br />
Guillen Ahlers, H., 1269W*<br />
Guilmatre, A., 469F*<br />
Guimiot, F., 77<br />
Guiochon-Mantel, A., 894T<br />
Guion-Almeida, M., 2673F<br />
Guion-Almeida, M. L., 813F,<br />
2746W<br />
Guipponi, M., 561F, 2685F,<br />
2877F, 2937F<br />
Guitart, M., 2940F<br />
Gujral, M., 480W<br />
Gül, E., 3132F<br />
Gulab, S., 167<br />
Gullerud, R. E., 1351F<br />
Gulsuner, S., 287*, 2600F,<br />
2924T<br />
Gulsvik, A., 2057F, 2249F<br />
Gulzar, Z., 1167W<br />
Gun, I., 1801W<br />
Gunawardena, S., 1214F<br />
Gunawardena, S. R.,<br />
1206W*<br />
Gunderson, K., 3695F<br />
Gunderson, K. L., 3710W<br />
Gunduz, C., 1025F, 1106F,<br />
1164W, 1166F, 1178F<br />
Gündüz, C., 1172F*<br />
Gunel, M., 1201T, 2924T<br />
Günel, M., 3132F<br />
Gunning, P. W., 410, 2662W,<br />
2796F<br />
Gunter, C., Session 81<br />
Guo, D., 1789W<br />
Guo, D. C., 1743W<br />
Guo, D. E., 589F<br />
Guo, G., 3553F<br />
Guo, H., 453F, 2251T,<br />
3139W<br />
Guo, J., 457F, 1974W*,<br />
2623T<br />
Guo, L., 2721F<br />
Guo, M., 3168F*<br />
Guo, S., 1681T, 1957T<br />
Guo, S. C., 3416T*<br />
Guo, T., 1494T, 1658T<br />
Guo, W., 1559W*, 1659T,<br />
2819T<br />
Guo, X., 1916F<br />
SPEAKER AND AUTHOR INDEX 361<br />
Guo, Y., 1004F, 1606T*,<br />
1659T, 2121W, 3660W*,<br />
3682W, 3724W*<br />
Guo, Y. W., 1110W<br />
Gupta, D., 2739F*<br />
Gupta, K. K., 2293T<br />
Gupta, M., 607T*<br />
Gupta, N., 918T, 1490W,<br />
1677T<br />
Gupta, S., 2803W<br />
Gupta, V., 2739F, 3455T<br />
Gupta Hinch, A., 3360T<br />
Gur, R. C., 2382W, 2514W,<br />
2546F, 2589W, 2651F<br />
Gur, R. E., 2382W, 2514W,<br />
2546F, 2589W, 2651F<br />
Guralnik, J. M., 2148W<br />
Guran, S., 1136F, 2881W<br />
Gurdasani, D., 1507F*,<br />
3412T<br />
Gurkan, A. M., 2329T<br />
Gurnett, C. A., 220, 2860W<br />
Guru, K., 3428T<br />
Gurusiddappa, S., 134<br />
Guruvadoo, L., 3557F<br />
Guryev, V., 459F, 3608W<br />
Gus, R., 879W<br />
Guse, K., 795W<br />
Gusella, J., 2562W<br />
Gusella, J. F., 68, 70, 82,<br />
103, 554W, 1964F,<br />
2643W<br />
Gusella, J. S., 2458T<br />
Gusev, A., 89, 350, 1320T,<br />
1577W*<br />
Gusmao, L., 3364F<br />
Gusmão, L., 3402T<br />
Gustaffsson, S., 108<br />
Gustafsson, M., 3427T<br />
Gustafsson, S., 117,<br />
2070W*, 2076W, 2090F,<br />
2241W<br />
Gustavsson, P., 3245W<br />
Gut, I., 54, 567F, 582W,<br />
2303F, 2326T<br />
Gut, M., 2303F, 2326T<br />
Gutenkunst, R. N., 3354T<br />
Guthery, S., 195<br />
Guthridge, J. M., 549F,<br />
566W<br />
Gutiérrez, A., 1111T, 1127F<br />
Gutierrez, D., 3125W<br />
Gutíerrez, I. A., 1077W*<br />
Gutiérrez, J., 2365T<br />
Gutierrez, K. S., 2106W*<br />
Gutiérrez, O., 2365T<br />
Gutierrez, S., 1798F<br />
Gutierrez-Achury, J., 155*,<br />
1330F<br />
Gutiérrez-Aguirre, H., 1030T<br />
Gutierrez-Arcelus, M., 415F,<br />
561F<br />
Gutin, N., 1021T<br />
Gutman, L., 2411F<br />
Guttman, M., 322<br />
Guttmann, A., 142<br />
Guxens, M., 2097W<br />
Guy, C., 531F, 1212W<br />
Guy, T., 400<br />
Guyant-Maréchal, L., 345<br />
Guymer, R., 1911W<br />
Guyot, M. C., 850F<br />
Guzeldemir, E., 2058W<br />
Guzman, E., 3695F<br />
Guzman, M., 695F, 924T<br />
Guzman, M. A., 785W<br />
Guzman, M. L., 1658T,<br />
2065T<br />
Gwirtzman, H. E., 2637W<br />
Gyapay, G., 2820F<br />
Gylfe, A., 997T<br />
Gyllensten, U., 2366F<br />
Gymrek, M., 333*, 1797W<br />
H<br />
Ha, T., 493F<br />
Haab, B. B., 1186T<br />
Haack, T. B., 699F, 2917W*<br />
Haaf, T., 849F, 3266W<br />
Haagmans, M., 1616T<br />
Haagmans, M. A., 197,<br />
681F<br />
Haan, E. A., 978T<br />
Haas, B. E., 2256W<br />
Haas, J., 2143T<br />
Haas, R., 534W<br />
Haase, V. G., 2434T<br />
Habashi, J. P., 240*<br />
Habegger, L., 41, 280, 551F,<br />
3251W<br />
Habekost, C., 2825T<br />
Haber, B. A., 2316W<br />
Haber, M., 3349F, 3387T*<br />
Haberberger, B., 699F<br />
Haberberger, B. M., 782W*<br />
Haberkorn, M. J., 1649T<br />
Habibian, R., 962T<br />
Habibul, A., 1638T<br />
Hacia, J., 722T<br />
Hack, L. M., 2504F*<br />
Hacker, D., 415F<br />
Hackett, N. R., 2933T,<br />
3399W<br />
Hackmann, K., 1236W,<br />
3224F<br />
Hacohen, N., 528W<br />
Haddad, G., 3307F<br />
Haddad, M., 791W*<br />
Haddad, M. R., 2457W<br />
Hadjidekova, S., 3477T<br />
Hadjidekova, S. P., 923W*<br />
Hadjixen<strong>of</strong>ontos, A., 270,<br />
2039F*, 2049W<br />
Hadj-Rabia, S., 128, 3140F*<br />
Hadley, D., 845F, 2067W*,<br />
2492F, 2872W<br />
Hadzhidekova, S., 3481T<br />
HaemGen Consortium, 383<br />
HaemGen RBC Consortium,<br />
110<br />
Haerian, B., 1113W*<br />
Haerian, M., 1113W<br />
Haertter, S., 617T<br />
Haessler, J., 1925F<br />
Haga, S. B., 147*<br />
Hageman, G. S., Session 7<br />
Hagenah, J., 200<br />
Hager, J., 1640T, 2278T*<br />
SPEAKER AND AUTHOR INDEX
362 SPEAKER AND AUTHOR INDEX<br />
Hagerman, P., 477F*<br />
Hagerman, P. J., 2632T,<br />
2633F, 2634W<br />
Hagerman, R., 770W*<br />
Hagg, S., 2175W<br />
Hägg, S., 119, 1308T,<br />
2074T*, 2076W, 2137T,<br />
2358W<br />
Haggerty, A. A., 968T<br />
Haghighatfard, A., 1718W*<br />
Haghighi, A., 2787F*, 2787F,<br />
2832F, 2856F, 3163W<br />
Haghighi-Kakhki, H.,<br />
2832F*, 2856F<br />
Hagiwara, M., 781W<br />
Hagnefelt, B., 2902W<br />
Hagos, S., 2743W<br />
Hahn, A., 2948T<br />
Hahn, A. F., 201, 3215W<br />
Hahn, A. F. G., 2779W<br />
Hahn, S., 688T, 1787W,<br />
1853F*, 2330F<br />
Hahn, S. E., 1834F<br />
Haider, M., 2267F*<br />
Haigis, R., 1176W, 3686W,<br />
3695F<br />
Haile, R. W., 141, 1067F,<br />
1079F, 1206W<br />
Hailing, J., 2037W<br />
Haiman, C., 205, 356,<br />
1324F, 1608T, 2131T<br />
Haiman, C. A., 48, 1148F,<br />
1150T, 2042F, 2202W<br />
Haimes, E., 1803W<br />
Hainaut, P., 1102T<br />
Haines, J., 1566T, 2041T,<br />
2135F<br />
Haines, J. L., 9, 15, 270,<br />
343, 344, 347, 1286W,<br />
1447F, 1476T, 1489F,<br />
1571W, 1671T, 1887W,<br />
2028W, 2154W, 2240F,<br />
2263T, 2299T, 2318F,<br />
2445W, 2498F, 2508W,<br />
2572T, 2583W, 2586W,<br />
2614T, 2637W, 3275W,<br />
3335W<br />
Hains, D., 450W, 458W<br />
Hajianpour, A., 962T<br />
Hajjar, R. J., 1698T<br />
Hajkova, Z., 752T<br />
Hakeman, M., 419F<br />
Hakenberg, J., 242, 3580W<br />
Hakim, S., 1691T<br />
Hakker, I., 2587T<br />
Hakonarson, H., 319, 812F,<br />
845F, 1307W, 1606T,<br />
1915T, 1996T, 1997F,<br />
2067W, 2121W, 2229W,<br />
2252F, 2389T, 2492F,<br />
2514W, 2546F, 2592W,<br />
2722W, 2785W, 2856F,<br />
2872W, 2892F, 2904F,<br />
3546W, 3561F, 3573F<br />
Hakonarson, H. H., 1992W,<br />
2443T<br />
Halbach, P., 2830W<br />
Halban, P. A., 556W<br />
Halbritter, J., 406, 2850F<br />
Halder, I., 1647T, 2083T*<br />
*Presenting Author<br />
Haldin, C., 520W<br />
Hale, P., 2136W<br />
Haley, C., 1383T<br />
Haley, K., 811F<br />
Halim, S., 1011W<br />
Halime, S., 1402F<br />
Hall, A. L., 2403W<br />
Hall, I. M., 436W*<br />
Hall, J., 2257T*<br />
Hall, J. L., 1665T*<br />
Hall, K., 343, 3663F,<br />
3694W*<br />
Hall, K. P., 366<br />
Hall, M. A., 1316W*<br />
Hall, P., 206, 208, 1150T,<br />
2108F, 2155T<br />
Hall, R. P., 906T<br />
Hall, S., 642T<br />
Hallam, S., 1729W<br />
Haller, G., 2598W*<br />
Haller, T., 1792W, 3353W*<br />
Hallgrímsdóttir, I., 2311T<br />
Hallgrimsson, B., 4<br />
Halligan, B., 587F<br />
Halligan, G., 924T<br />
Hallmayer, J., 2479T<br />
Halme, L., 2023T<br />
Halperin, E., 180, 3360T,<br />
3623F*<br />
Halprein, E., 1797W<br />
Halushka, M. K., 305<br />
Halvardson, J., 3728W<br />
Hamada, H., 1631T<br />
Hämäläinen, E., 2348F,<br />
2898F<br />
Hamamoto, K., 1631T<br />
Hamamy, H., 2937F<br />
Hambleton, I. R., 1906T<br />
Hamdan, F., 2306F<br />
Hamdan, F. F., 2692W,<br />
2790F<br />
Hamdy, F., 1011W<br />
Hamdy, F. C., 1148F<br />
Hamel, B. C., 125<br />
Hamel, B. C. J., 102<br />
Hamel, C., 390, 2679F<br />
Hamel, N., 1262F<br />
Hamet, P., 2994T<br />
Hamid, M., 679F*, 2714T<br />
Hamidovic, A., 2269T<br />
Hamilton, C. M., 1566T*<br />
Hamilton, K., 2586W*,<br />
2637W<br />
Hamilton, K. L., 344, 2498F,<br />
2583W<br />
Hamilton, R. M., 1678T<br />
Hamilton, S., 491F<br />
Hamilton, S. P., 2517W<br />
Hamman, R. F., 1672T,<br />
1673T<br />
Hammann, A., 2716W<br />
Hammarström, L., 2091W<br />
Hammel, P., 1062W<br />
Hammer, M., 285<br />
Hammer, M. F., 2788W,<br />
3354T, 3377W, 3389W<br />
Hammer, R. R., 1849W<br />
Hämmerle, J. M., 2861T<br />
Hammerø, M., 3510T<br />
Hammet, F., 1213T<br />
Hammond, C. J., 335,<br />
2068T, 2138F<br />
Hammond, J. A., 1566T<br />
Hammond, P., 218, 3088F<br />
Hamolsky, D., 1965W<br />
Hamosh, A., 227*<br />
Hampe, J., 580W*<br />
Hampel, H., 1173W*<br />
Hampson, S. C., 2800W<br />
Hampton, O., 3649F<br />
Hampton, T., 1698T<br />
Hamren, S., 2347T<br />
Hamsten, A., 115, 1651T<br />
Hamza, S., 507F<br />
Han, B., 39, 1337W, 1341T,<br />
1480F*, 1657T, 3462T,<br />
3555F, 3623F<br />
Han, B. J., 846F<br />
Han, E., 1535W*<br />
Han, J., 984W, 3461T<br />
Han, J. C., 2702T<br />
Han, K., 947W<br />
Han, K.-H., 2130W<br />
Han, L., 278, 1488T*<br />
Han, M., 2566T, 3223W<br />
Han, S., 1012T, 1243T*,<br />
2497T*<br />
Han, S. S., 1378F*<br />
Han, X., 2623T<br />
Han, X.-Y., 1218W<br />
Han, Y., 1757W, 2934F,<br />
3008T<br />
Han, Y. Y., 3449T<br />
Hanchard, N. A., 1646T,<br />
2158T*<br />
Hancock, D., 2114F<br />
Hancock, D. B., 1566T,<br />
2170T*<br />
Handberg, H., 3641F,<br />
3662W<br />
Hande, M. P., 3034T<br />
Handel, A., 2015F*<br />
Handsaker, R., 322<br />
Handsaker, R. E., 284,<br />
437F*, 1519F<br />
Hanein, S., 324, 390, 522W<br />
Haney, M., 334, 579F,<br />
3658W<br />
Hanis, C. L., 2192F<br />
Hanish, A. E., 2702T<br />
Hankerd, M., 885W<br />
Hankins, J. S., 2331W<br />
Hankinson, J., 2211W<br />
Hankinson, S., 2165F<br />
Hanks, S., 1211F<br />
Hanna, C. W., 2977T, 2986T*<br />
Hanna, G., 2430W*<br />
Hanna, G. L., 3447T<br />
Hanna, M., 1912T, 2581T<br />
Hanna, N., 56<br />
Hannachi, H., 944T<br />
Hannan, G. N., 916T<br />
Hannan, M., 2052W<br />
Hannequin, D., 345<br />
Hannick, L. I., 3332W<br />
Hänninen, S., 541F<br />
Hanscom, C., 68, 70<br />
Hansen, L., 363, 2817F<br />
Hansen, M., 1445W<br />
Hansen, M. R., 2301W<br />
Hansen, N., 999W, 1159T,<br />
1515T<br />
Hansen, N. F., 1690T<br />
Hansen, R., 2491T<br />
Hansen, R. S., 255<br />
Hansen, T., 1624T, 2311T,<br />
2317T, 2347T<br />
Hansikova, H., 752T<br />
Hanson, E., 299, 2439W<br />
Hanson, R., 584W, 1300F,<br />
2038T*<br />
Hanson, R. L., 1953W,<br />
2018F, 2124W<br />
Hansson, O., 47, 2187W<br />
Hantaï, D., 328<br />
Hantash, F. M., 2260T<br />
Hao, H., 822F*<br />
Hao, K., 1369F*, 1624T,<br />
2928F<br />
Hao, L., 1304W, 3345T<br />
Hao, T., 2660F<br />
Hao, Y., 116<br />
Happe, S., 3459T, 3659F,<br />
3669F, 3709F<br />
Hara, K., 2071T*<br />
Hara, T., 468W*<br />
Harafuji, N., 2961F<br />
Harakalova, M., 217, 672T,<br />
2886F<br />
Harari, O., 340, 2228F*<br />
Harbin, S., 2430W<br />
Harbo, H., 2113T<br />
Harbord, R. M., 1626T<br />
Hardcastle, A. J., 3212F<br />
Hardeman, E. C., 410,<br />
2662W, 2796F<br />
Harden, A., 940T<br />
Hardie, R., 3332W<br />
Hardin, J., 75<br />
Hardin, M., 2057F*<br />
Harding, C. O., 774W<br />
Harding, S. P., 2072F<br />
Hardison, M., 314, 1742W<br />
Hardison, M. T., 677F*<br />
Hardison, R. C., 3545F<br />
Hardwick, J., 1369F<br />
Hardwick, R., 438W<br />
Hardy, J., 374, 564W, 2648F<br />
Hardy, O., 3659F<br />
Hardy, R., 2282F<br />
Hare, A., 2381F*, 2523W<br />
Harewood, L., 62, 299<br />
Hariharan, M., 551F<br />
Häring, H., 1624T<br />
Harismendy, O., 395, 1051T<br />
Haritunians, T., 1445W,<br />
1916F, 2153F<br />
Harkin, T. T., 1068W<br />
Harkins, T., 400, 494W,<br />
1242W<br />
Harkins, T. T., 186, 1244F*,<br />
2301W<br />
Härkönen, J., 496W<br />
Harks, I., 2058W<br />
Harlan, M., 1275W<br />
Harlan, W. R., 1566T<br />
Harley, J., 1901F<br />
Harley, J. B., 529F, 1979F,<br />
2046W, 2084F, 2188T,<br />
3371W
Harley, K., 3458T<br />
Härmä, M., 2462F<br />
Harman, E., 1166F<br />
Harmanci, A., 2444F<br />
Harney, L., 132<br />
Haroutunian, V., 3471T<br />
Harper, J. I., 2102F<br />
Harper, S. M., 1756W<br />
Harper, U., 1302T<br />
Harries, L. W., 2148W<br />
Harrington, E., 483F,<br />
2565W<br />
Harrington, E. D., 3617F*<br />
Harrington, P., 139<br />
Harris, A., 509F, 3719F<br />
Harris, C., 2325W*<br />
Harris, D. J., 82<br />
Harris, E., 630T<br />
Harris, H. R., 2077T<br />
Harris, J., 33, 503F<br />
Harris, J. R., 434W, 3510T<br />
Harris, K., 184<br />
Harris, K. M., 1467T<br />
Harris, M., 969W<br />
Harris, P. C., 1909T<br />
Harris, R., 3545F<br />
Harris, T., 1338T, 2080T,<br />
2561F<br />
Harris, T. B., 109, 2116T,<br />
2145W, 2275T<br />
Harrison, B. W., 1821W<br />
Harrison, C., 32<br />
Harrison, C. J., 1024T<br />
Harrison, L., 3494T<br />
Harrison, S., 2845W, 2846T*<br />
Harroche, A., 915W<br />
Harrow, I., 503F<br />
Harrow, J., 506W<br />
Harrow, J. L., 367<br />
Harry, B., 315<br />
Hart, D. J., 2292W<br />
Hart, E., 2098T<br />
Hart, P. S., 322<br />
Hart, R. K., 3548W*<br />
Hart, R. P., 2433W<br />
Hart, S., 1219T<br />
Hartge, P., 1306F, 1372F,<br />
1413T<br />
Hartikainen, J. M., 1114T*,<br />
1125W<br />
Hartl, C., 172, 288<br />
Hartley, J., 954T<br />
Hartley, J. N., 2422T<br />
Hartman, T. J., 1107W<br />
Hartmann, H., 756W<br />
Hartmann, L. C., 1238F<br />
Hartmannova, H., 752T<br />
Hartsfield, J., 2243F*<br />
Hartsfield Jr., J., 1147T<br />
Hartshorne, C., 145, 1810F<br />
Hartshorne, T., 1146W*<br />
Haruki, H., 2823F<br />
Harvard, C., 491F*, 517F<br />
Harvey, E., 3156F<br />
Harvey, H. S., 1849W<br />
Harvey, I., 1065W<br />
Harvey, K. A., 2155T<br />
Har-Zahav, A., 105<br />
Hasan, Q., 1234T, 1893W<br />
Hasegawa, A., 3565F<br />
*Presenting Author<br />
Hasegawa, I., 1321F<br />
Hasegawa, J., 2507F<br />
Hashemzadeh, M., 1143W,<br />
1596T, 1739W, 2008T,<br />
2013W<br />
Hashemzadeh Chaleshtori,<br />
M., 1421W, 2952F<br />
Hashiguchi, A., 2418W,<br />
2601W, 2607W*, 2616W,<br />
2823F<br />
Hashimoto, K., 627T, 963W<br />
Hashimoto, S., 456W, 912T<br />
Hashimoto, T., 2559W<br />
Hashimoto, Y., 2371T<br />
Hashmi, A., 8<br />
Haskins, M., 1081T<br />
Haslag-Min<strong>of</strong>f, J., 1210T<br />
Hasler, R., 582W<br />
Häsler, R., 567F<br />
Haslett, L. J., 162<br />
Haslett, P., 714T, 801W<br />
Hassan, A., 2408F<br />
Hassan, B., 133<br />
Hassanali, N., 44<br />
Hassed, S., 2834T<br />
Hassell, K., 725F<br />
Hassnan, Z., 2743W<br />
Hassold, T., 250<br />
Hastie, N., 1383T<br />
Hastie, N. D., 2366F<br />
Hastings, P. J., 337<br />
Hastings, R., 1874F<br />
Hata, A., 1631T<br />
Hata, K., 3499T<br />
Hatai, Y., 3091W<br />
Hatamnejadian, N., 1961F,<br />
1962W, 2964F<br />
Hatamochi, A., 3230F<br />
Hattersley, A. T., 2704W,<br />
3494T<br />
Hattori, N., 1730W, 2559W,<br />
2619W, 3134F, 3221W<br />
Hattori, S., 2647T<br />
Hatzimanolis, A., 2573F*<br />
Hatzlh<strong>of</strong>er, B. L. D., 2718F<br />
Hauck, S., 3536W<br />
Haudenschild, C., 369,<br />
1249T, 2372F<br />
Hauenstein, N., 2086T<br />
Haug, K. B. F., 643T<br />
Haugarvoll, K., 2451W*<br />
Hauge, C., 921W<br />
Haugen, E., 3459T<br />
Haugen, T. B., 991T<br />
Haughey, N. J., 658T<br />
Haukanes, B. I., 2451W<br />
Haukkala, A., 1835W<br />
Hauner, H., 3536W<br />
Haupt, B., 786W<br />
Hauptschein, R., 1369F<br />
Hause, R. J., Jr., 614T<br />
Hauser, E., 3<br />
Hauser, E. R., 1444F, 1594T,<br />
1636T<br />
Hauser, M., 3, 386, 531F,<br />
2135F<br />
Hauser, M. A., 1887W,<br />
2154W, 2240F, 2263T,<br />
2946F<br />
Hauser, N., 876T<br />
SPEAKER AND AUTHOR INDEX 363<br />
Hauser, N. S., 2839W*<br />
Hauser, S., 2113T, 3330T<br />
Hauser, S. L., 270, 2299T<br />
Hausmann, L. D., 994T,<br />
1405F<br />
Hausser, I., 2869W<br />
Haussler, D., 466W, 1229F,<br />
3557F, 3612W<br />
Hautaniemi, S., 1117T<br />
Havas-Augustin, D., 1660T<br />
Haverfield, E., 2579F<br />
Havulinna, A. S., 1709T<br />
Hawes, A., 1742W<br />
Hawes, A. C., 314, 1735W,<br />
1757W, 1761W<br />
Hawley, N. L., 2159F<br />
Haworth, C. M. A., 2164T<br />
Hawrylycz, M., 2444F<br />
Hawthorne, F., 521F<br />
Hawthorne, F. A., 3521T<br />
Hawwari, A., 3149W, 3155W*<br />
Hay, J., 1841W<br />
Hayano, T., 482W<br />
Hayasaka, K., 3136F<br />
Hayase, T., 1940F*<br />
Hayashi, S., 914T*<br />
Hayashi, Y. K., 755W,<br />
2923W<br />
Hayden, K. E., 414W*<br />
Hayden, M. R., 265<br />
Hayeck, T., 1360F<br />
Hayeems, R., 320, 1872F*,<br />
1873F<br />
Hayeems, R. Z., 142, 1824F<br />
Hayes, J., 3054F, 3089W<br />
Hayes, L., 3076F<br />
Hayes, M., 2098T<br />
Hayes, M. G., 618T, 1447F,<br />
2036F, 3323W<br />
Hayes, V. M., 1085F, 3332W<br />
Hayflick, S. J., Session 10<br />
Haynes, C., 1444F, 1594T,<br />
1636T, 3541F<br />
Hayward, C., 1383T, 2072F<br />
Hayward, N. K., 212<br />
Hazan, F., 1106F, 3206F<br />
Hazlehurst, J., 3211W<br />
Hazra, A., 1073F<br />
Hazucha, M., 2851W<br />
He, C., 1098W, 1969T*,<br />
3483T<br />
He, G., 1174T<br />
He, J., 1324F*, 1465F<br />
He, J. B., 1259F<br />
He, L., 654T, 1174T*, 2419T<br />
He, L.-J., 1218W<br />
He, M., 1758W, 3300T, 3553F<br />
He, P., 1758W<br />
He, Q., 1434T*<br />
He, W., 503F, 2804T<br />
He, X., 722T, 864T, 1144T,<br />
1433W*, 2246F<br />
He, Y., 3308W, 3656W<br />
He, Z., 93*<br />
Headland, C., 3331F<br />
Healey, C. S., 209<br />
Healy, E., 303<br />
Healy, J., 31, 394, 1207T*,<br />
1215W, 3700W<br />
Heanue, T., 308<br />
Heard-Costa, N., 2030F*,<br />
2123F, 2337W<br />
Heath, A. C., 2056T, 2212T<br />
Heath, G., 1238F<br />
Heath, S., 2303F<br />
Heaton, W. H., 3529F<br />
Heba, T., 831F*<br />
Hebbar, P., 3369T<br />
Hebbring, S., 2297F*<br />
Hebbring, S. J., 3326W<br />
Hebert, A. M., 693F*<br />
Hebert, J. M., 633T, 635T<br />
Hebert, L., 458W<br />
Hebson, C., 1679T<br />
Hecht, J., 298, 1908W*,<br />
2325W<br />
Heckbert, S. R., 1585T<br />
Heckenlively, J., 2135F<br />
Heckenlively, J. R., 2183F,<br />
3234F<br />
Heckerman, D., 1379W*,<br />
3468T<br />
Heckman, L., 2807T*<br />
Hedera, P., 2438F<br />
Hedges, D., 524W, 2330F,<br />
3706W<br />
Hedges, D. J., 9, 270,<br />
2572T, 2614T, 3390T<br />
Hedley, P. L., 2699T<br />
Hedman, A., 583F<br />
Hedman, A. K., 44*, 2187W,<br />
3441T<br />
Heesen, L., 236<br />
Heffelfinger, C., 551F, 3313F*<br />
Heffner, L., 3026T<br />
Heffron, T., 3582W<br />
Hefner, K. S., 529F, 2188T<br />
Hegde, M., Session 3, 66<br />
Hegde, M. R., 1758W<br />
Hegele, R., 1688T<br />
Hegele, R. A., 2800W<br />
Hegele, R. G., 1465F<br />
Heguy, A., 998F<br />
Hehir-Kwa, J., 979W<br />
Hehir-Kwa, J. Y., 100, 459F,<br />
955W<br />
Heid, I., Session 7<br />
Heid, I. M., 1954T, 2123F,<br />
2147F<br />
Heidari, N., 416W*<br />
Heide, H., 782W<br />
Heide, S., 890T<br />
Heijmans, B. T., 1436W<br />
Heikkilä, P., 1171T, 1265F<br />
Heikkinen, T., 1006T*,<br />
1117T, 1171T, 1265F<br />
Heil, S., 853F, 2300F<br />
Heilbuth, T. R., 1902W<br />
Heilmann, S., 106*<br />
Heim, K., 275*, 584W, 782W<br />
Heiman, G. A., 261, 2433W,<br />
2602T*<br />
Heimdal, K., 129<br />
Heimer, G., 660T<br />
Hein, A.-M., 3641F<br />
Heinrich, J., 2167T, 2168F,<br />
2226W<br />
Heinrich, J. K., 1033T<br />
Heinzen, E. L., 203, 266<br />
Heise, E., 1853F<br />
SPEAKER AND AUTHOR INDEX
364 SPEAKER AND AUTHOR INDEX<br />
Heiss, G., 174, 1437T,<br />
1661T, 2041T<br />
Heit, J., 1497T*<br />
Heit, J. A., 1375F<br />
Heitmann, M., 3496T<br />
Heitzer, E., 1063T, 1115F*<br />
Hekimgil, M., 1025F<br />
Helderman-van den Enden,<br />
A. T. J. M., 1711T<br />
Helen, R., 2812W<br />
Helfmann, S., 59<br />
Hellebrekers, D. M. E. I.,<br />
2996T*<br />
Hellenthal, G., 181<br />
Heller, R., 236, 2944W<br />
Hellin, A.-C., 925W<br />
Helliwell, T., 33<br />
Hellwege, J. N., 1888T*<br />
Helms, C., 1952F<br />
Helwi, P., 841F<br />
Helzlsouer, K. J., 1822F<br />
Hem, V., 1762W<br />
Hemani, G., 1394W<br />
Hemmelmann, C., 200<br />
Hemmer, B., 2086T<br />
Hemmrich-Stanisak, G.,<br />
2368T*<br />
Hempel, M., 2595W, 2917W<br />
Henders, A. K., 2133W<br />
Hendershot, L., 1847W<br />
Hendershot, T., 1566T<br />
Henderson, A., 126<br />
Henderson, A. J., 2168F<br />
Henderson, B., 205, 1324F<br />
Henderson, B. E., 1148F,<br />
2131T, 2202W<br />
Henderson, J., 1567F,<br />
2102F, 2167T<br />
Henderson, S., 133<br />
Henderson-MacLennan, N.<br />
K., 1658T, 2065T<br />
Hendricks, A., 1518T,<br />
2304W*<br />
Hendrickx, A. T. M., 2996T<br />
Heneghan, M. A., 153<br />
Heng, M. Y., 2423F*<br />
Hengstenberg, C., 3453T<br />
Hengstler, J., 1335T<br />
Henn, B., 3345T<br />
Henn, B. M., Session 6,<br />
186, 371, 3361F, 3368W,<br />
3385F, 3411W<br />
Hennah, W., 252<br />
Henneberg, M., 3344W<br />
Hennekam, E. A. M., 431F<br />
Hennekam, R., 127, 2701W,<br />
2759T<br />
Hennekam, R. C., 681F<br />
Hennekam, R. C. M., 216,<br />
2886F<br />
Henneman, P., 228, 2107T*,<br />
2116T<br />
Hennies, H. C., 2869W<br />
Hennis, A., 1003T<br />
Henrich, V. C., 107*<br />
Henrion, E., 1670T, 2342F,<br />
2558F<br />
Henrion Caude, A., 522W*<br />
Henrique, H., 1108T<br />
Henry, C., 259<br />
*Presenting Author<br />
Henry, P. G., 2539T<br />
Hentati, F., 2537F<br />
Heppe, D. H. M., 1334W,<br />
2169W<br />
Herder, C., 275<br />
Heredia, N., 3690W<br />
Herman, D. S., 1677T<br />
Herman, G., 456W<br />
Herman, S., 1494T<br />
Hermann, M., 2581T<br />
Hermannsson, L., 3573F<br />
Hermansson, M., 541F<br />
Hermetz, K. E., 66<br />
Herms, S., 420W*, 1005W,<br />
3550W<br />
Hernaez, R., 2275T<br />
Hernandez, B. G., 988T*<br />
Hernandez, D. G., 564W,<br />
2148W<br />
Hernandez, K. N., 707F<br />
Hernandez, N., 415F,<br />
2377T*<br />
Hernandez, P., 1646T<br />
Hernandez, R., Session 6,<br />
589F<br />
Hernandez, R. D., 158<br />
Hernandez, W., 40<br />
Hernandez-Escalante, V.,<br />
2272T<br />
Hernandez Fuentes, M.,<br />
2082W<br />
Hernandez-Fuentes, M. P.,<br />
2260T<br />
Hernández-García, A., 834F<br />
Hernández-Garcia, A.,<br />
839F*<br />
Hernández-Hernández, O.,<br />
3124F, 3226F<br />
Hernández-Zamora, E.,<br />
3125W<br />
Hernesniemi, J., 1253F<br />
Herold, C., 106, 1332T*<br />
Heron, D., 127, 889W,<br />
2770W<br />
Héron, D., 131, 3157W<br />
Heron, S. E., 2741T*<br />
Herrera, P., 1119W<br />
Herrera, V., 1714T<br />
Herrera-Sanchez, F., 2272T<br />
Herring, J. A., 221, 1359T<br />
Herrington, D., 1661T<br />
Herrmann, A., 580W<br />
Herrmann, R., 2681T, 2812W<br />
Hersh, C. P., 2249F<br />
Hershberger, R., 1681T<br />
Hershey, G., 578W<br />
Hershman, D. L., 1255T<br />
Hershman, S. G., 326<br />
Hertecant, J., 2740W<br />
Hertz-Picciotto, I., 2491T<br />
Hervás, A., 2578T<br />
Herzenberg, J. E., 2860W<br />
Herzfeld, T., 2416T<br />
Herzog, E., 72<br />
Hesselson, S., 112, 421F,<br />
2140T, 2513F, 3342T,<br />
3383W<br />
Hesselson, S. E., 118<br />
Hessl, D., 770W<br />
Hester, J., 2332T*<br />
Hester, J. M., 2310W<br />
Hestholm, B., 2965W<br />
Hetland, M., 621T<br />
Hetmanski, J. B., 1425T,<br />
1472W, 1512T<br />
Hetrick, K., 2556W, 3644W,<br />
3716W<br />
Hetrick, K. N., 1448W<br />
Hettige, N., 2408F<br />
Heuberger, A., 1189T<br />
Heulens, I., 2527T<br />
Heuzé, Y., 2151W<br />
Hevroni, D., 3656W, 3703F<br />
Hewitt, A. W., 2068T<br />
Hewitt, S. M., 1092W<br />
Hewson, S., 717F<br />
Heydari Sodejani, S.,<br />
2013W*<br />
Heydari Sodjani, S., 1596T*<br />
Heyer, C. M., 1909T<br />
Heyman, M., 1035W, 1126T<br />
Hiatt, J., 10<br />
Hibaoui, Y., 67*<br />
Hibar, D. P., 2054F<br />
Hibbard, M., 1032W<br />
Hibberd, M., 429F<br />
Hiber, M., 392<br />
Hibino, H., 2370W<br />
Hickerton, C., 143<br />
Hickey, F., 1847W<br />
Hickey, L., 477F<br />
Hickey, P., 2741T<br />
Hickey, S., 456W<br />
Hickman, M., 1567F<br />
Hicks, A. A., 86, 110<br />
Hicks, C., 1116W*<br />
Hicks, D. J., 136<br />
Hicks, J., 2854W<br />
Hicks, J. E., 2378F*<br />
Hicks, M., 1649T<br />
Hicks, M. D., 2702T*<br />
Hicks, P., 2332T<br />
Hicks, P. J., 1661T, 2310W<br />
Hicks, S., 1798F, 3549F*<br />
Hidalgo, A., 1030T<br />
Hidalgo-Miranda, A., 1129T<br />
Hiekkala, M. E., 2348F*<br />
Hiekkalinna, T., 1563T*,<br />
2208W, 2399F<br />
Hiemenga, J., 3037W*<br />
Hiene, A., 3662W<br />
Higasa, K., 2409W, 2569T<br />
Higashi, K., 2601W<br />
Higashimoto, K., 3432T,<br />
3519T<br />
Higgins, A., 1494T<br />
Higgins, A. W., 82<br />
Higgs, D. R., 418W<br />
Higgs, J., 330<br />
Higgs, R. H., 1235F<br />
High, K., Session 23<br />
Highland, H. M., 169, 269*,<br />
2192F<br />
Highnam, G., 469F<br />
Hightower, R. C., 1661T<br />
Higuchi, I., 2601W<br />
Higuchi, Y., 2418W, 2601W,<br />
2607W, 2616W*<br />
Hilal, S., 930T<br />
Hilbers, F. M., 1213T<br />
Hilbers, F. S., 27*<br />
Hilbert, P., 3181W, 3216F<br />
Hildebrand, M., 2867T<br />
Hildebrand, M. S., 60,<br />
3228F*<br />
Hildebrandt, F., 406<br />
Hildebrandt, J., 3717F<br />
Hildebrandt, L. L., 2699T<br />
Hildebrandt, M. A. T., 213<br />
Hill, A., 266<br />
Hill, A. V., 2157W<br />
Hill, A. V. S., 1948T<br />
Hill, D. A., 132<br />
Hill, D. E., 2660F<br />
Hill, D. P., 1339F<br />
Hill, H. R., 495F, 2720T<br />
Hill, M., 3018T<br />
Hill, R. S., 8, 266, 452W,<br />
2613W<br />
Hillier, L., 2320T<br />
Hillmer, A. M., 106, 3047W<br />
Hills, L. B., 266<br />
Hilton, C., 2139W<br />
Himes, B., 2166W<br />
Himes, B. E., 622T, 625T,<br />
638T*<br />
Himmelstein, D. S., 1501F*<br />
Hinckley, J., 1889F*<br />
Hindorff, L., 1608T<br />
Hindorff, L. A., 1845W,<br />
1925F, 2042F, 2108F*,<br />
2155T<br />
Hinds, D., 106, 2161T<br />
Hinds, D. A., 114, 498W,<br />
1017W*, 2089T, 2100W,<br />
2115W<br />
Hinek, A., 3186F<br />
Hingorani, A., 1621T<br />
Hinrichs, A., 2582F, 3557F<br />
Hinzpeter, A., 572W*<br />
Hip-Ki, E., 2266T, 3268F,<br />
3341W<br />
Hippolyte, L., 62, 299<br />
Hira, G., 100<br />
Hirai, H., 468W<br />
Hirai, Y., 468W<br />
Hiraki, L. T., 191*<br />
Hirakiyama, A., 2911W<br />
Hirankarn, N., 2006F,<br />
2064W<br />
Hirano, A., 2174F<br />
Hirasawa, T., 2835F<br />
Hirata, M., 1593T<br />
Hirbo, J., 3303T, 3338W<br />
Hirota, T., 2294F*<br />
Hirschhorn, J., 350, 2210F,<br />
3413W<br />
Hirschhorn, J. N., 23, 108,<br />
1677T, 1906T, 1954T,<br />
1960T, 2090F, 2123F,<br />
2131T, 2147F, 2241W,<br />
2307W, 2364W, 3525T<br />
Hirte, H., 1824F<br />
Hirv, K., 3539F<br />
Hishimoto, A., 2380T<br />
Hitayezu, J., 3104F<br />
Hitchen, J., 3668W, 3721F<br />
Hitomi, Y., 53, 2455T*<br />
Hitz, B. C., 3612W<br />
Hixson, J. E., 1932W
Hixson, P., 893W, 898T,<br />
952T<br />
Hixson, R., 1309F<br />
Hjalgrim, H., 1934F, 2055W<br />
Hjermind, L. E., 2765T<br />
Hjorthaug, H. S., 3510T<br />
Ho, A., 2480F<br />
Ho, B. C., 422W<br />
Ho, C. K., 2238W*<br />
Ho, G., 2795T<br />
Ho, J., 2279F, 2280W<br />
Ho, L.-T., 1955F<br />
Ho, P., 2160W<br />
Ho, P. C., 3000T<br />
Ho, V., 1238F<br />
Hoal, E., 2217W, 3385F<br />
Hoal, E. G., 2003F, 2007W<br />
Hoang, N., 1872F, 1873F*<br />
Hoang, V., 1691T<br />
Hoather, T. M., 1105T<br />
Hobbs, C. A., 1459F<br />
Hobel, S., 3587F<br />
Hobson, G., 2664F*<br />
Hobson, G. M., 2793F<br />
Hochreiter, S., 95, 1483F*,<br />
1486F, 2374T<br />
Hocking, T. A., 978T<br />
Hodge, J. C., 103, 1145F*,<br />
2575T<br />
Hodges, K., 853F<br />
Hodges, S., 3690W<br />
Hodgkinson, A., 2266T,<br />
3268F*, 3341W<br />
Hodgkinson, C. A., 2574W<br />
Hodgkinson, K. A., 454W<br />
Hodgkiss, D., 503F<br />
Hodgson-Jensen, L., 1093T<br />
Hoefsloot, E. H., 58<br />
Hoefsloot, L., 65, 1874F<br />
Hoefsloot, L. H., 2925F<br />
Hoeijmakers, J. G. J.,<br />
2448W<br />
Hoekstra, P. J., 2602T<br />
Hoen, P., 582W<br />
H<strong>of</strong>fman, C., 660T<br />
H<strong>of</strong>fman, D., 3582W<br />
H<strong>of</strong>fman, E., 3249W<br />
H<strong>of</strong>fman, G. E., 357,<br />
1355W*<br />
H<strong>of</strong>fman, J., 907W, 1729W*<br />
H<strong>of</strong>fman, J. D., 1286W*<br />
H<strong>of</strong>fman, R., 458W<br />
H<strong>of</strong>fman, R. D., 3275W<br />
H<strong>of</strong>fman, T., 421F, 1741W*,<br />
3383W<br />
H<strong>of</strong>fman, T. J., 246<br />
H<strong>of</strong>fmann, C., 3536W<br />
H<strong>of</strong>fmann, D., 3500T<br />
H<strong>of</strong>fmann, E. M., 1115F<br />
H<strong>of</strong>fmann, G. F., 699F<br />
H<strong>of</strong>fmann, P., 420W, 1005W,<br />
3550W*<br />
H<strong>of</strong>fmann, R. G., 1475W*<br />
H<strong>of</strong>fmann, S., 1612T<br />
H<strong>of</strong>fmann, T., 112, 2513F,<br />
3342T<br />
H<strong>of</strong>fmann, T. J., 7, 118*,<br />
1250F, 1475W, 2140T<br />
H<strong>of</strong>ker, M. H., 523F<br />
Höfler, G., 1115F<br />
*Presenting Author<br />
H<strong>of</strong>man, A., 87, 584W,<br />
1284T, 1334W, 1503T,<br />
2081F, 2105F, 2169W<br />
H<strong>of</strong>man, N., 1616T<br />
H<strong>of</strong>man, O., 356<br />
H<strong>of</strong>mann, A., 2416T<br />
H<strong>of</strong>mann, K., 105<br />
H<strong>of</strong>mann, N., 2330F<br />
H<strong>of</strong>mann, S., 2103W<br />
Hogan, N. S., 1822F<br />
Högel, J., 939W<br />
Hogenesh, J., 2592W<br />
Hogg, C., 809F<br />
Hogg, G., 2973T*, 3023T<br />
Hogg, K., 645T, 3429T*<br />
Hoggart, C., 1387F, 1528F<br />
Högl, B., 2567F, 2568W<br />
Högler, W., 2864T<br />
Hoglund, B. N., 3713F*<br />
Hogue, W. R., 2854W<br />
Hohjoh, H., 799W<br />
Hohmann, J., 2444F<br />
Höhne, K., 2103W<br />
Höhne, W., 2759T, 2861T<br />
Hoiness, R., 1736W<br />
Hoischen, A., 97, 124, 125,<br />
216<br />
Hojati, Z., 892T<br />
Hokanson, J. E., 1672T,<br />
1673T, 2249F, 2346W<br />
Hokken-Koelega, A., 2701W<br />
Hokonohara, T., 2400W<br />
Hokynar, K., 541F*<br />
Holcomb, C. L., 3713F<br />
Holcomb, K., 1272W<br />
Holden, K., 3171W<br />
Holden, K. R., 2826F<br />
Holden, S., 83<br />
Holder, A. M., 834F<br />
Holder, M., 126<br />
Holder, S. E., 298, 2925F<br />
Holder-Espinasse, M.,<br />
889W, 2896W, 3109W,<br />
3172F<br />
Holinski-Feder, E., 758W,<br />
1005W<br />
Hölker, I., 236<br />
Holladay, J., 1021T<br />
Holland, N., 3458T<br />
Hollemon, D., 3020T<br />
Holley, T., 1186T<br />
Holliday, E. G., 2133W<br />
Holloway, A. K., 195<br />
Holloway, L., 2806W<br />
Hollox, E., 438W*, 450W,<br />
3325F<br />
Hollox, E. J., 449F, 2641T<br />
Holm, I., 921W*<br />
Holm, I. A., 1799W, 1836F*,<br />
1843W<br />
Holman, K., 3167W<br />
Holmberg, R., 3011T<br />
Holmes, C., 235<br />
Holmes, S., 2805F<br />
Holmfeldt, L., 31<br />
Holohan, K. N., 2531F*<br />
Holstege, G., 494W<br />
Holstege, H., 494W*<br />
Holt, A., 407<br />
Holt, R. A., 375<br />
SPEAKER AND AUTHOR INDEX 365<br />
Holzinger, E., 1442W*<br />
Homan, E. P., 2854W*<br />
Homuth, G., 275, 2141F<br />
Honda, M., 2496W, 2656T<br />
Honda, Y., 2496W<br />
Honey, E. M., 131<br />
Hong, C., 2117F<br />
Hong, D., 3479T<br />
Hong, E. L., 3612W*<br />
Hong, H., 1830F<br />
Hong, K., 2060F*<br />
Hong, K.-W., 1622T<br />
Hong, L., 2112W<br />
Hong, M., 551F, 1189T,<br />
1990T, 2273F<br />
Hong, S., 2460W*<br />
Hong, X., 3026T<br />
Honig, L., 2547W<br />
Honig, L. S., 2093F, 2410T<br />
Honore Goltz, H., 1857F<br />
Honti, F., 445F<br />
Honzik, T., 752T<br />
Hood, L., 2643W<br />
Hood, L. E., 195<br />
Hood, R. L., 131<br />
Hood, S., 3267T<br />
Hoogenboom, J., 3611F<br />
Hoogerbrugge, N., 27, 1213T<br />
Hoogstraat, M., 400<br />
Hooker, S., 93<br />
Hooli, B., 2520W<br />
Hooper, A., 1680T<br />
Hooper, C., 1119W<br />
Hooper, W. C., 611T<br />
Hoos, M. B., 1711T<br />
Hoover-Fong, J., 227<br />
Hopkin, J. M., 3466T, 3486T<br />
Hopkin, R., 789W<br />
Hopkins, P., 1875F<br />
Hopkins, T. J., 306<br />
Hopp, K., 1909T*<br />
Hoppe, N., 1848W<br />
Hoppe, T., 105, 1939T<br />
Hoppel, C. L., 741F<br />
Hopper, J., 1492F<br />
Hopper, J. L., 141, 1067F,<br />
1079F, 1206W, 1213T<br />
Hoppman-Chaney, N.,<br />
887W<br />
Hops, H., 642T<br />
Hor, H., 2326T*<br />
Horenstein, R. B., 602T<br />
Horike, S., 3497T*, 3498T<br />
Horikoshi, M., 119, 190,<br />
1308T*, 1528F, 2076W,<br />
2137T<br />
Horinek, A., 3437T<br />
Horita, H., 3136F<br />
Horjales-Araujo, E., 2369F*<br />
Hormozdiari, F., 3639F*,<br />
3657F<br />
Horn, D., 298, 2595W<br />
Horn, F., 849F<br />
Horn, H. F., 2914W<br />
Hornemann, T., 758W<br />
Hornyak, M., 2568W<br />
Horovitz, D. D. G., 1877F<br />
Horpaopan, S., 1005W<br />
Horsburgh, K. A., 3333T<br />
Horst, B., 3319F<br />
Horst, D., 3319F<br />
Horst, J., 126, 3319F*<br />
Horst, J. A., 813F<br />
Horsthemke, B., 392,<br />
3496T, 3500T, 3524T<br />
Horvath, A., 1151F<br />
Horvath, G., 750T<br />
Horvath, R., 751F<br />
Horvath, S., 2256W, 2444F,<br />
2479T, 2553W, 2661W,<br />
3474T<br />
Hoseinpour Pheysi, A.,<br />
779W<br />
Hosen, M. J., 833F*,<br />
1790W, 3137W<br />
Hoskins, J., 1199F<br />
Hoskins, L., 1064F<br />
Hosoda, F., 396<br />
Hosokawa, M., 2174F<br />
Hosoki, K., 3056F*<br />
Hosomichi, K., 482W*<br />
Hosono, N., 396, 2174F<br />
Hosoya, T., 663F<br />
Hosseini, M., 1175F*<br />
Hosseini, R., 407<br />
Hosseini, S. M., 2109W*<br />
Hosseinipanah, M., 860T<br />
Hostetter, G., 1186T<br />
Hotate, M., 3091W<br />
Hotte, S., 1824F<br />
Hotte, S. J., 135<br />
Hottenga, J. J., 2175W<br />
Hou, C., 1996T, 2121W<br />
Hou, L., 189*, 2622W*<br />
Hou, X., 1662T, 1971W<br />
Houdayer, C., 1205F<br />
Houldcr<strong>of</strong>t, C., 2163W*<br />
Houlden, H., 2581T<br />
Houlston, R., 1072T, 1531F,<br />
2580W<br />
Hourlier, T., 506W<br />
Housawi, Y., 2785W, 2892F<br />
Houseman, E. A., 3629F<br />
Houshmand, M., 1056W,<br />
1124F, 1175F, 2367W,<br />
2976T, 3197W<br />
Housley, G. D., 2662W<br />
Houston, G. D., 529F, 2188T<br />
Houwing-Duistermaat, J. J.,<br />
2035T<br />
Hovanes, K., 954T, 3054F<br />
Hovatta, I., 2110T*, 2175W,<br />
2399F<br />
Hovatta, O., 807F<br />
Hovelson, D. H., 641T*<br />
Hoven, V., 2006F<br />
Hovingh, G. K., 1604T,<br />
2205W<br />
Hovnik, T., 2688F*, 2710W<br />
Howald, C., 506W*<br />
Howard, A., 3100F<br />
Howard, E., 474W<br />
Howard, K., 2109W<br />
Howard, M., 538W, 2689W<br />
Howard, M. A., 2779W<br />
Howard, P., 122<br />
Howard, T., 2143T<br />
Howard, T. A., 648T, 2331W<br />
Howell, S., 2158T, 2741T<br />
Howells, O. W., 262<br />
SPEAKER AND AUTHOR INDEX
366 SPEAKER AND AUTHOR INDEX<br />
Howerth, E., 2805F<br />
Howie, B., 88<br />
Howson, J., 453F<br />
Hoyer, J., 3235W*<br />
Hoyme, H. E., 3076F<br />
Hozayen, S., 1665T<br />
Hozumi, Y., 1317T<br />
Hrabé de Angelis, M.,<br />
2922F<br />
Hrdlickova, B., 523F<br />
Hrdý, P., 2865F<br />
Hromatka, B. S., 2111F*<br />
Hruska, K., 2579F<br />
Hruska, K. A., 1661T<br />
Hsi, E., 516W*<br />
Hsiao, C., 989F*, 3485T<br />
Hsiao, C. L., 2245T, 3457T*<br />
Hsiao, G., 493F<br />
Hsieh, A., 1557T<br />
Hsieh, A. R., 1380T*, 2245T<br />
Hsieh, C. L., 1214F<br />
Hsieh, M., 2768T*<br />
Hsieh, P. H., 3354T*<br />
Hsieh, W., 3596W*<br />
Hsiung, C., 629T, 989F,<br />
1608T<br />
Hsiung, C.-A., 1955F<br />
Hsiung, S., 3730W<br />
Hsu, C., 508W, 3678W*<br />
Hsu, C. F., 2768T<br />
Hsu, C. J., 2936T<br />
Hsu, C. N., 1439W, 1925F<br />
Hsu, E., 3644W<br />
Hsu, F. C., 123<br />
Hsu, J., 163<br />
Hsu, L., 1437T, 2268W*,<br />
2337W<br />
Hsu, S., 493F, 2571W,<br />
2606F<br />
Hsu, T. Y., 571F<br />
Hsu, Y., 945W, 953W<br />
Hsu, Y.-H., 1334W, 2052W*<br />
Hsueh, W. A., 1916F<br />
Hu, D., 158, 1075T, 1078T*,<br />
1152W, 1576F, 2195F,<br />
3303T<br />
Hu, F., 1357F, 2165F, 2354F<br />
Hu, F. B., 51<br />
Hu, H., 29*, 195*<br />
Hu, H. H., 1062W<br />
Hu, H. J., 3607F<br />
Hu, J., 904T, 2418W, 3561F<br />
Hu, J. J., 2202W<br />
Hu, K., 1905W, 3293W<br />
Hu, L., 1249T<br />
Hu, M., 1004F<br />
Hu, N., 1010F, 1076F,<br />
1218W<br />
Hu, O., 542W<br />
Hu, P., 1459F, 1508W*<br />
Hu, Q., 3428T<br />
Hu, R., 638T<br />
Hu, T., 1453F*, 2571W<br />
Hu, X., 1040F, 2250W,<br />
3553F<br />
Hu, Y., 170, 1036T, 1231T,<br />
1533T*, 1558F, 3355F*,<br />
3551F*<br />
Hu, Y. J., 1437T*<br />
Hu, Z., 984W, 2617T<br />
*Presenting Author<br />
Hua, X., 1511W<br />
Huang, A., 2779W, 3007T*,<br />
3021T<br />
Huang, B., 962T<br />
Huang, C., 516W, 1381F*,<br />
1894T, 2970T<br />
Huang, C.-C., 1666T*<br />
Huang, F.-Y., 2285F<br />
Huang, H., 241, 1403W,<br />
1515T, 1579F*, 1886F,<br />
3569F<br />
Huang, J., 116, 516W,<br />
668T*, 1509T*, 2259W,<br />
3604W<br />
Huang, J.-H., 2970T<br />
Huang, K., 537F, 1491T*,<br />
1917W*<br />
Huang, L., 198, 575F, 651T,<br />
701F, 1900T, 2800W<br />
Huang, M., 989F<br />
Huang, N., 43, 553F, 2982T<br />
Huang, Q., 673F, 1546F*,<br />
1693T<br />
Huang, R. S., 623T<br />
Huang, S., 613T, 1472W,<br />
2251T*<br />
Huang, S. W., 1586T<br />
Huang, T., 3467T<br />
Huang, W., 519F, 616T,<br />
818F, 1945T, 2819T,<br />
3493T, 3552W*, 3682W<br />
Huang, Y., 1662T*, 2181W*,<br />
2237F*, 2251T, 2262W,<br />
2320T, 2343W*, 2467T,<br />
2523W, 2581T, 2849T,<br />
3371W<br />
Huang, Y. A., 803W<br />
Hubbard, T., 367, 464W,<br />
506W<br />
Hübenthal, M., 2368T<br />
Huber, C., 3129W<br />
Huber, J., 941W, 1037F,<br />
1038W<br />
Huber, W., 551F<br />
Hubert, B., 2866W<br />
Hubert, C., 716T<br />
Hubert, P., 2674W<br />
Hubley, L., 1752W<br />
Hubley, R., 195, 3270T<br />
Hubner, N., 2102F<br />
Hucks, D., 136<br />
Huda, M. S. B., 3211W<br />
Huddleston, J., 375, 3296W<br />
Hudgins, L., 869W, 2989T<br />
Hudson, A., 3442T, 3452T<br />
Hudson, B., 3622W<br />
Hudson, B. I., 1638T<br />
Hudson, M. S., 50<br />
Hudson, T., 3478T<br />
Hudson, T. H., 1093T<br />
Hudson, T. J., 135<br />
Hudspith, K., 2939T<br />
Huebner, C., 1868F*<br />
Huen, K., 3458T*<br />
Huentelman, M. J., 2104T,<br />
3215W<br />
Huerta-Chagoya, A., 48<br />
Huerta-Sanchez, E., 3300T*<br />
Huesca, F., 3125W<br />
Huet, F., 2716W, 2792T<br />
Huether, C., 1860F<br />
Huff, C., 385<br />
Huff, C. D., 195, 3297T*,<br />
3378T, 3633F<br />
Hüffmeier, U., 2160W<br />
Hufnagel, R. B., 3194F,<br />
3212F*<br />
Huganir, R., 13, 2566T<br />
Huggins, G., 2083T<br />
Huggins, W., 1566T<br />
Hughes, A. E., 2843T*<br />
Hughes, D., 772W<br />
Hughes, J., 218<br />
Hughes, K., 2974T<br />
Hughes, M., 78<br />
Hughes, P., 529F, 2188T<br />
Hughes, T., 3510T, 3614W<br />
Hughes, T. M., 3275W<br />
Huh, I.-S., 269<br />
Huh, R., 3462T<br />
Huh, W. J., 3395W<br />
Hui, K., 17<br />
Hui, K. Y., 1320T*<br />
Huizing, M., 709F, 711F,<br />
755W, 1702T, 2838F,<br />
3080F<br />
Huizinga, T., 461F<br />
Hukema, R., 513F<br />
Hulick, P. J., 1225T<br />
Hu˚ lková, H., 322<br />
Hull, A. K., 1016F<br />
Hulme, W., 2603F, 3706W<br />
Hulme, W. F., 9, 341, 2318F,<br />
2572T<br />
Hulsh<strong>of</strong>f Pol, H. E., 2526W<br />
Hulsman, M., 1436W<br />
Hultén, M. A., 3032T<br />
Hultman, C., 290, 1325W,<br />
2487W<br />
Hultman, C. M., 2576F,<br />
2618F, 3442T, 3452T<br />
Humbert, M., 2690T<br />
Humbert, M. C., 323<br />
Hume, S., 1052F<br />
Humphray, S., 366, 1238F,<br />
3663F*<br />
Humphrey, M. B., 566W<br />
Humphreys, K., 1934F,<br />
2055W<br />
Humphreys, M. K., 206<br />
Humphreys, P., 701F,<br />
2794W<br />
Humphries, C. E., 341*<br />
Humphries, S. E., 122<br />
Hung, C., 655T, 1905W,<br />
2392T<br />
Hung, C. Y., 297*<br />
Hung, I. H., 828F*<br />
Hung, S., 3708W<br />
Hung, T., 3700W<br />
Hung, Y.-R., 1955F<br />
Hunt, C. A., 262<br />
Hunt, K. A., 155<br />
Hunt, K. J., 1662T<br />
Hunt, L., 1713T<br />
Hunt, P., 250<br />
Hunt, S., 1608T, 1653T,<br />
3669F<br />
Hunter, D., 205, 2165F,<br />
3413W<br />
Hunter, D. G., 2928F<br />
Hunter, D. J., 51, 1148F,<br />
1150T, 1390F<br />
Hunter, E., 36<br />
Hunter, J., 2063F<br />
Hunter, J. E., 3042F*<br />
Hunter, L. A., 2702T<br />
Hunter-Zinck, H., 3288T*<br />
Huntley, M., 1539T<br />
Huntsman, S., 158, 1075T,<br />
1576F<br />
Huo, D., 1003T<br />
Huovari, E., 1006T<br />
Hurba, O., 2831T<br />
Hurd, L. M., 2855T*<br />
Hurd, T. W., 406<br />
Hurle, B., 3306T<br />
Hurles, M., 43, 61, 101*,<br />
252, 291, 364, 453F,<br />
455F, 553F, 560W, 2576F,<br />
2812W, 2982T<br />
Hurtado, M. L., 926T<br />
Hurtado-Hernandez, L.,<br />
1018T*<br />
Husain, S. A., 1278W<br />
Husami, A., 1764W<br />
Huse, K., 580W<br />
Husemoen, L., 2317T<br />
Husgafvel-Pursiainen, K.,<br />
2120F<br />
Husni, J., 2411F<br />
Huso, N., 79, 240<br />
Huson, S. M., 33<br />
Huss, M., 1976F<br />
Hussain, K., 2709F<br />
Hussain, N., 70, 856T<br />
Hussain, W. M., 1100F<br />
Hussein, S., 1031F<br />
Hussin, J., 31*, 2266T,<br />
3260W, 3268F, 3341W<br />
Hussman, J. P., 2572T<br />
Hutchinson, A., 30, 1160F,<br />
1218W<br />
Hutchinson, H., 136<br />
Hutchinson, J., 1081T<br />
Huttner, A., 334<br />
Hutton, H., 3303T<br />
Huyck, K. L., 2056T<br />
Huyghe, J. R., 46*, 1452T<br />
Huynh, M., 267<br />
Huysseune, A., 833F<br />
Hveem, K., 1608T<br />
Hwa, V., 2706F<br />
Hwang, D., 2437T<br />
Hwang, H., 1590T<br />
Hwang, J.-H., 2119T<br />
Hwang, K. B., 3635F<br />
Hwang, S., 1653T*<br />
Hwang, S. J., 3673F<br />
Hwang, Y., 2437T, 3223W<br />
Hwang, Y. S., 3180F<br />
Hwu, C.-M., 1955F*<br />
Hwu, W.-L., 683F<br />
Hwu, W. L., 706T<br />
Hyde, C., 503F<br />
Hyde, C. L., 2804T<br />
Hyde, T., 2444F<br />
Hyland, F., 1232F, 3670W,<br />
3717F<br />
Hyland, P. L., 1010F*
Hyppönen, E., 271, 2097W<br />
Hysi, P. G., 335*, 2068T<br />
Hytonen, M. K., 2517W<br />
Iaconis, D., 2810T<br />
Iacono, W., 1568W<br />
Iacovelli, A. J., 2928F<br />
Iacoviello, L., 1712T<br />
Iakoucheva, L., 480W<br />
Iakoucheva, L. M., 2660F<br />
Ialongo, N., 2541W<br />
Ianakiev, P., 3529F<br />
Iannaccone, A., 1060T<br />
Ianni, B., 1593T<br />
Iannuzzi, M. C., 1895F<br />
Iba, Y., 2697F<br />
Ibarra, B., 2363F<br />
IBC BP Consortium, 1659T<br />
IBC-Lipids Consortium,<br />
1606T<br />
Ibrahim, J., 768W, 769W*<br />
Ibrahim, M., 3303T, 3338W<br />
Ibrahim, S., 167<br />
Ice, J. A., 529F*, 2084F,<br />
2188T<br />
Ichida, K., 663F<br />
Ichihara, Y., 2923W<br />
Ichikawa, M., 233<br />
Ichikawa, N., 2032T<br />
Ichikawa, Y., 52, 2409W<br />
Ickstadt, K., 1335T<br />
ICPCG, 1080W<br />
Ida, K., 2891T, 3051W<br />
Idaghdour, Y., 31, 2266T*,<br />
3260W, 3268F, 3341W<br />
Ide, W. T. S. T., 2394W,<br />
2876T<br />
Idiyatullin, D., 821F<br />
Idoni, B., 2857W<br />
Ieiri, I., 641T<br />
IFAR Collaboration Team,<br />
1069T<br />
Iglesias, A., 3046F<br />
Ignatius, J., 897W<br />
Igo, R. P., Jr., 1295W,<br />
2020T<br />
Iguchi, Y., 2472W<br />
Iida, M., 2174F<br />
Iijima, H., 1980W<br />
Iijima, K., 729F, 781W<br />
Iijima, M., 627T<br />
Iio, K., 3043W<br />
Ikari, K., 2004W, 2287T<br />
Ikeda, K., 2507F<br />
Ikeda, M., 264, 2576F<br />
Ikeda, Y., 2129F<br />
Ikegami, M., 3105W<br />
Ikemura, M., 52<br />
Ikesaki, A., 2656T<br />
Ikezawa, Z., 627T<br />
Ikram, M. A., 1592T<br />
Iles, M. M., 211<br />
Illei, G. G., 2084F<br />
Illig, T., 275, 2226W, 2548T,<br />
3536W<br />
Illson, M. L., 673F<br />
Im, H., 40, 623T*, 1505W<br />
*Presenting Author<br />
I<br />
Im, H. K., 269, 1495F,<br />
2196W<br />
Im, J. H., 571F<br />
Im, K. M., 1242W<br />
Imai, T., 2294F<br />
Imamura, A., 2652W<br />
Imaz-Rosshandler, I., 1129T<br />
Imbriano, P., 34<br />
Imperatore, R., 3492T<br />
Imtiaz, F., 2734W<br />
Inada, T., 2380T<br />
Inagaki, A., 59<br />
Inagaki, H., 475F*<br />
Inamori, Y., 2601W<br />
Inaoka, T., 1327F<br />
Inaoka, Y., 1321F*<br />
Inazawa, J., 914T<br />
Inbar-Feigenberg, M., 3420T<br />
Inchausti, V., 347, 2603F<br />
Incorpora, G., 2780T<br />
Indian Genome Variation<br />
Consortium, 3332W<br />
Indonesia Schizophrenia<br />
<strong>Genetics</strong> Consortium,<br />
2407T<br />
Indrieri, A., 2810T*<br />
Indugula, S. R., 1660T, 2159F<br />
Ingebrigtsen, M., 2965W<br />
Ingelman-Sundberg, M.,<br />
3460T<br />
Ingelsson, E., 108, 115, 117,<br />
1624T, 1707T, 1954T,<br />
1990T, 2074T, 2090F,<br />
2105F, 2123F, 2147F,<br />
2241W, 2358W<br />
Ingelsson, I., 2070W<br />
Ingelsson, M., 434W<br />
Ingersoll, R., 46<br />
Ingham, N. J., 105<br />
Ingles, S. A., 2202W<br />
Ingram, M. A. C., 2769F*<br />
INHANCE Consortium,<br />
1496W<br />
Inherited Neuropathies<br />
Consortium, 1871F<br />
Injeyan, M., 2971T<br />
Injeyan, M. C., 3013T*<br />
Inlow, M., 2531F<br />
Inman, R., 448W<br />
Innes, A. M., 2772F, 3095W,<br />
3127W, 3141W, 3173W<br />
Innes, A. .M., 2800W<br />
Innes, M. I., 3665F<br />
Innis, J. L., 2850F<br />
Innocenti, F., 613T<br />
Inoko, H., 2253W<br />
Inokuchi, T., 724T<br />
Inoue, I., 482W, 2253W,<br />
2349W<br />
Inoue, K., 234*<br />
Inoue, N., 234<br />
Inoue, S., 589F<br />
Inoue, Y., 2656T<br />
International Consortium for<br />
Prostate Cancer<br />
<strong>Genetics</strong>, 28, 986F,<br />
1001F, 1214F<br />
International Consortium<br />
<strong>of</strong> HCV Spontaneous<br />
Resolution, 3393W<br />
SPEAKER AND AUTHOR INDEX 367<br />
International<br />
Craniosynostosis<br />
Consortium, 3070F<br />
International EndoGene<br />
Consortium, GIANT<br />
Consortium, 2077T<br />
International <strong>Genetics</strong> <strong>of</strong><br />
Ankylosing Spondylitis<br />
and Wellcome Trust Case<br />
Control Consortia, 152<br />
International IBD <strong>Genetics</strong><br />
Consortium, 156, 319,<br />
1967F, 2229W<br />
International Multiple<br />
Sclerosis <strong>Genetics</strong><br />
Consortium, 151, 1415W<br />
International Primary<br />
Sclerosing Cholangitis<br />
Study Group and<br />
Immunochip Consortium,<br />
2101T<br />
Introne, W. J., 3080F<br />
Inui, K., 2917W<br />
Ioan, A., 461F<br />
Ioannidis, J. P. A., 109, 1462F<br />
Ionita-Laza, I., 1530T*<br />
Ionita-Lazza, I., 1431T<br />
Iossifov, I., 2587T*<br />
Iovannisci, D., 1352W<br />
Ip, W., 2953W<br />
Iqbal, Z., 41, 472W, 3279T<br />
Iribarren, C., 118, 434W<br />
Irminger, J., 556W<br />
Irvine, A. D., 83<br />
Irving, M., 2896W<br />
Irving, M. D., 780W*<br />
Irwan, I. D., 1934F<br />
Irwanto, A., 1117T, 2112W*<br />
Irwin, M., 2203T<br />
Isaacs, A., 119, 2106W,<br />
2193W*<br />
Isaacs, W., 28, 1001F<br />
Isaacs, W. B., 1080W, 1214F<br />
Isaksson, M., 3685F, 3709F,<br />
3729F<br />
Isasi, R., 1814F*<br />
Iscan, A., 2396F, 2412W<br />
Ishak, G. E., 2772F<br />
Ishida, M., 3508T<br />
Ishigaki, S., 2472W<br />
Ishiguro, H., 2380T<br />
Ishii, M., 559F*<br />
Ishikawa, K., 598W, 2371T*<br />
Ishiko, A., 2911W<br />
Ishiura, H., 52*, 233, 2409W,<br />
2569T<br />
Ishiy, F. A. A., 852F<br />
Ishiyama, I., 1833W*<br />
Ishizu, N., 2559W<br />
Ishizuka, Y., 2009F<br />
Ishpekova, B., 201, 2948T<br />
Isidor, B., 3066F, 3233W*<br />
Iskow, R., 3251W*, 3310F<br />
Ismail, P., 1083W<br />
Isobe, N., 2113T*<br />
Isohanni, M., 252<br />
Isohanni, P., 327<br />
Isomura, M., 1333F*<br />
Israni, A. K., 1428T<br />
Issa, R., 990W*<br />
Issacs, W., 2202W<br />
Istrail, S., 3024T<br />
Italia, M., 2904F<br />
Italia, M. J., 3590W<br />
Italian Autism Network,<br />
2548T, 2659T<br />
Itan, Y., 3599F*<br />
Itirli, G., 1106F<br />
Ito, H., 52<br />
Ito, I., 2647T<br />
Ito, J., 2822T<br />
Ito, K., 1677T<br />
Iuliano, A., 1985F, 3492T<br />
Ivanov, M., 3460T<br />
Ivanova, M., 838F<br />
Ivanovich, J., 132<br />
Ivarsson, A., 1330F<br />
Iwaki, A., 2400W, 2647T<br />
Iwamoto, K., 2435F, 2652W,<br />
3513T<br />
Iwamoto, S., 2009F*<br />
Iwarsson, E., 3032T*, 3245W<br />
Iwasa, H., 2923W<br />
Iwata, A., 52<br />
Iwata, N., 264, 2576F<br />
Iyengar, S. K., 1295W,<br />
2020T<br />
Iyer, A., 3695F*<br />
Izatt, L., 218<br />
Izatt, T., 1240T<br />
Izumi, K., 3058F*<br />
Izumi, Y., 52, 3221W,<br />
3229W<br />
Izumikawa, Y., 2758W<br />
Izzo, G., 439F*<br />
J<br />
Jaal, J., 1140W<br />
Jabado, N., 1182W<br />
Jabbour, F., 890T<br />
Jablonski, K., 249<br />
Jabre, N. A., 749F<br />
Jabs, E. W., 1472W, 2151W,<br />
2928F, 3154F<br />
Jabusch, H.-C., 200<br />
Jacinto, A., 2085W<br />
Jackson, A., 1608T,<br />
3654W*, 3694W<br />
Jackson, A. R., 3433T<br />
Jackson, A. U., 46, 1954T,<br />
2147F<br />
Jackson, J., 433F<br />
Jackson, J. M., 1310W<br />
Jackson, R., 1408F, 1585T,<br />
1925F, 2145W, 2337W<br />
Jackson, R. D., 109, 2336F<br />
Jackson-Cook, C., 3512T<br />
Jacob, C. M., 131<br />
Jacob, C. O., 1979F, 2046W<br />
Jacob, H., Session 3<br />
Jacobs, G., 515F<br />
Jacobs, K., 1154F, 1517W,<br />
3683F<br />
Jacobs, K. B., 30, 213,<br />
1160F, 1372F<br />
Jacobs, K. J., 1218W<br />
Jacobson, E., 2243F<br />
Jacobson, S. G., 2183F<br />
SPEAKER AND AUTHOR INDEX
368 SPEAKER AND AUTHOR INDEX<br />
Jacobsson, B., 3020T,<br />
3028T<br />
Jaconi, M. E., 807F<br />
Jacquemont, S., 62, 127,<br />
299*, 2458T<br />
Jacques, P., 123<br />
Jaddoe, V., 2164T<br />
Jaddoe, V. W. V., 1334W,<br />
2081F, 2162F, 2168F,<br />
2169W<br />
Jaeger, E. B., 1176W*,<br />
3686W<br />
Jaffe, D., 322<br />
Jaffrey, S., 376<br />
Jagadeesh, A., 2411F*<br />
Jaggawantru, S., 756W<br />
Jagomägi, T., 3079W<br />
Jahangirerad, A. J., 1096T<br />
Jahangiri, M., 1584T, 1675T<br />
Jaillard, S., 3170F<br />
Jaimes, G., 3069W<br />
Jain, P., 2556W<br />
Jain, S., 607T<br />
Jakkula, E., 2350T<br />
Jakobs, M., 1616T<br />
Jakobsen, J., 3528W<br />
Jakobsen, L., 126<br />
Jakobsen, R. R., 805F<br />
Jakobsson, M., 3356W<br />
Jakovski, Z., 3286F<br />
Jakubek, Y. A., 3628W*<br />
Jalaluddin Shariff, D., 1719W<br />
Jalil, S. F., 3078F*<br />
Jalkh, N., 2937F<br />
Jamain, S., 259*<br />
Jamal, S. M., 148, 301,<br />
1842F*<br />
Jamar, M., 925W<br />
Jameel, M., 2920W<br />
James, A. H., 2330F<br />
James, A. L., 1465F<br />
James, J., 2284T<br />
James, J. A., 549F, 1979F,<br />
2046W, 2084F<br />
James, P. A., 1224W<br />
James, S. J., 1459F<br />
James, T., 3663F<br />
Jameton, A., 1856F<br />
Jamieson, C. H. M., 1051T<br />
Jamshidi, M., 1117T*<br />
Janas, E., 2922F<br />
Janavicius, R., 1208F*<br />
Janecke, A., 2948T<br />
Janecke, A. R., 201<br />
Janevski, A., 3316F<br />
Jang, H., 1243T, 1657T<br />
Jang, I. J., 641T<br />
Jang, J. Y., 3223W<br />
Jang, W., 3625F<br />
Jang, Y., 1590T<br />
Janicsek, I., 3283F<br />
Jankipersadsing, S. A., 1330F<br />
Jankovic, J., 2581T<br />
Janmohamed, S. G., 745F<br />
Janousek, S. T., 718T<br />
Jansen, R. C., 1284T, 1503T<br />
Jansen Spayd, K., 1245W*,<br />
3687F<br />
Janson, A. A. M., 574W<br />
Janssen, A., 3137W<br />
*Presenting Author<br />
Janssen, I. M., 160<br />
Janssens, A. C., 2105F<br />
Janssens, S., 423F, 2225F<br />
Januszkiewicz-<br />
Lewandowska, D.,<br />
1057T*, 1184F<br />
Japanese Consortium for<br />
Amyotrophic Lateral<br />
Sclerosis Research<br />
(JaCALS), 3221W<br />
Jaquish, C., 2030F<br />
Jardim, L. B., 2424W*,<br />
2609F, 2626T, 2642F,<br />
2825T<br />
Jarhoor, F., 163<br />
Jarinova, O., 1645T<br />
Jaromi, L., 3283F<br />
Jarvela, I., 2181W<br />
Jarvelin, M., 252<br />
Järvelin, M. R., 271, 656T,<br />
1432F, 1528F, 1597T,<br />
1623T, 2162F*, 2164T,<br />
2173T, 2175W, 2366F,<br />
3435T<br />
Jarvik, G., 1447F, 2098T,<br />
3622W<br />
Jarvik, G. P., 170, 618T,<br />
1312F, 1605T, 1828F,<br />
2443T<br />
Järvinen, H. J., 1026W, 1276T<br />
Jarvis, J. P., 632T<br />
Jasinska, A., 2343W<br />
Jasinska, A. J., 2222F,<br />
2262W*, 2320T<br />
Jasmine, F., 1638T, 2025W<br />
Jasso, K., 2365T<br />
Jaswaney, V., 949W<br />
Jauregio, C., 2603F<br />
Javadi, G. H., 1124F<br />
Javed, A., 1556W*, 2631W*,<br />
3570W<br />
Javitz, H. S., 642T<br />
Jaworek, T., 2959W*<br />
Jaworski, J., 2508W, 2614T<br />
Jaworski, J. M., 9, 2572T<br />
Jaworski, M., 2242T*<br />
Jay, A., 3147W<br />
Jay, A. M., 885W<br />
Jay, F., 3356W*<br />
Jayakar, P., 1633T, 3175W<br />
Je, E., 1230W<br />
Jean, C., 1834F<br />
Jeandel, C., 3121W<br />
Jeandidier, B., 973W<br />
Jeanne, M., 1689T*, 2684T<br />
Jeannin, P., 1158W, 2248T,<br />
3137W<br />
Jee, S. H., 1472W<br />
Jeff, J., 1602T*<br />
Jeffrey, J., 3454T<br />
Jeffreys, A. J., 3257W<br />
Jeffries, N., 2247W<br />
Jego, G., 2716W<br />
Jego, L., 2792T<br />
Jelinska, C., 418W<br />
Jena, M., 3262F*<br />
Jenkins, D., 219, 2755W<br />
Jenkins, E., 859W*<br />
Jenkins, E. C., 1986W<br />
Jenkins, G., 603T<br />
Jenkins, G. D., 1426F,<br />
1449T<br />
Jenkins, L., 1748W<br />
Jenkins, M. A., 141, 1067F,<br />
1079F*, 1206W<br />
Jenkins, S. A., 2072F<br />
Jens, J., 785W<br />
Jens, J. K., 2717T<br />
Jensen, E., 1691T<br />
Jensen, K. M., 1867F<br />
Jensen, R., 2041T<br />
Jensen, T. J., 3014T*<br />
Jensen, T. S., 2369F<br />
Jeong, C., 2021F*<br />
Jeong, D. C., 2715F<br />
Jeong, E. K., 2529W<br />
Jeong, J., 1198T, 2313W<br />
Jeong, K., 3459T*<br />
Jepsen, S., 2058W<br />
Jerez, D., 2495F<br />
Jerome-Majewska, L. A.,<br />
831F, 848F<br />
Jessen, J., 2971T, 3196F<br />
Jesus, G., 1977W<br />
Jeter, J. M., 1087T<br />
Jett, C., 3053W<br />
Jewell, S., 368<br />
Jewett, E., 3357T*<br />
Jeyabalan, A., 1884W<br />
Jhala, D., 2731W*<br />
Jhamai, M., 3608W<br />
Jhangiani, S., 360, 2934F*<br />
Jhun, M. A., 2275T<br />
Ji, S.-M., 1622T<br />
Ji, T., 462W<br />
Jia, J., 1088F*, 1199F<br />
Jia, L., 690T<br />
Jia, P., 136, 3554W*, 3620W<br />
Jia, W., 3553F*<br />
Jia, X., 798W, 1934F, 2047T<br />
Jiang, G., 2279F<br />
Jiang, H., 159<br />
Jiang, L., 1221W, 1505W,<br />
3335W<br />
Jiang, M., 411<br />
Jiang, M. M., 2854W<br />
Jiang, M.-M., 2864T<br />
Jiang, P., 2636F<br />
Jiang, Q., 308*<br />
Jiang, R., 1142F, 2481W*<br />
Jiang, T., 3561F<br />
Jiang, X., 260, 2622W<br />
Jiang, Y., 462W, 1963T,<br />
2617T*, 3168F, 3237W<br />
Jiao, S., 1437T<br />
Jiao, W., 135<br />
Jimbo, E. F., 2588F, 3118F<br />
Jimenez, D. E., 3272W<br />
Jin, F. L., 3416T<br />
Jin, H., 1316W, 1377T,<br />
1928F, 3420T<br />
Jin, J., 579F<br />
Jin, L., 443F, 519F, 1499W,<br />
1508W, 2460W, 3265F,<br />
3308W, 3334F, 3355F,<br />
3358F, 3377W, 3379F,<br />
3394T<br />
Jin, M., 1359T<br />
Jin, P., 382, 2477F, 3483T<br />
Jin, S. C., 1472W<br />
Jin, W., 3334F, 3358F*,<br />
3394T<br />
Jin, X., 159*, 480W, 503F,<br />
2617T, 3300T, 3311W<br />
Jin, Y. J., 846F<br />
Jin, Y.-Y., 797W*<br />
Jinawath, N., 2918T*<br />
Jiralerspong, S., 8, 722T<br />
Jirsa, M., 570W<br />
Jo, E. J., 1298W<br />
Jobanputra, V., 957W,<br />
1031F*, 1600T<br />
Jobling, R., 717F*<br />
Jochim, A., 2086T<br />
Jockel, Y., 2058W<br />
Jocson, M., 3522T<br />
Joe, G., 711F<br />
Joecker, A., 3528W, 3641F,<br />
3662W<br />
Joehanes, R., 584W<br />
Joens, C., 547F<br />
Joensuu, T., 2898F<br />
Johannesson, M., 2505W<br />
Johansen, J., 621T<br />
Johansson, A., 2920W<br />
Johansson, B., 1023W,<br />
1024T, 1035W<br />
Johansson, H., 3685F,<br />
3729F*<br />
Johansson, K., 630T<br />
Johansson, L. F., 1619T<br />
Johansson, M., 1012T<br />
Johansson, P., 1259F<br />
Johansson, S., 2451W<br />
Johbanputra, V., 937W<br />
John, E. M., 1003T, 1075T,<br />
1213T, 2202W<br />
John, P., 2398T, 3078F<br />
John, S., Session 26, 3369T<br />
John, S. L., 503F, 2804T<br />
John, V., 1133F<br />
Johnatty, S., 210<br />
Johns, J., 1256F<br />
Johnson, A., 1091F, 1092W,<br />
1267T, 2063F<br />
Johnson, A. D., 174, 301,<br />
584W<br />
Johnson, B. F., 3708W<br />
Johnson, C. A., 403, 2955F<br />
Johnson, C. S., 3428T<br />
Johnson, D., 218, 3129W<br />
Johnson, E., 2114F*, 2650T,<br />
3561F<br />
Johnson, E. O., 1392T,<br />
2170T<br />
Johnson, F. K., 732T*<br />
Johnson, G. C., 2817F<br />
Johnson, G. S., 2805F,<br />
2817F, 2847F*<br />
Johnson, J., 2210F<br />
Johnson, J. A., 626T, 646T<br />
Johnson, J. O., 2611T<br />
Johnson, K., 765W, 1203W,<br />
1774W, 2054F<br />
Johnson, K. J., 3564W<br />
Johnson, K. R., 1878W<br />
Johnson, M., 1280W, 1394W<br />
Johnson, M. G., 1382W*<br />
Johnson, M. P., 533F, 1282F,<br />
1406W, 2061W, 2309F*
Johnson, N. A., 646T,<br />
3318T, 3383W<br />
Johnson, P., 1626T<br />
Johnson, R., 1267T<br />
Johnson, S., 309, 3359W*<br />
Johnson, T., 1400W*,<br />
1595T, 1659T, 2174F<br />
Johnson, T. A., 1552F*,<br />
2051F, 2071T<br />
Johnson, W. G., 2501F<br />
Johnson, Z., 595F<br />
Johnston, C., 3108F<br />
Johnston, J., 358*<br />
Johnston, J. J., 674T, 1696T<br />
Johnstone, L., 2788W<br />
Johnston IV, H. R., 3414W*<br />
John-Williams, K., 2586W,<br />
2637W<br />
Joint Committee <strong>of</strong><br />
NBSTRN Clinical Centers<br />
Workgroup and NCC/RC<br />
Long-Term Follow-Up<br />
Workgroup, 725F<br />
Jokinen, E. P., 1139F<br />
Jondeau, G., 56<br />
Jones, A., 2444F<br />
Jones, C., 113, 177, 186,<br />
1451W, 3664W<br />
Jones, C. M., 157, 1516F<br />
Jones, C. R., 2667F<br />
Jones, D. E., 153<br />
Jones, D. M., 945W<br />
Jones, G., 2292W<br />
Jones, J., 245, 940T<br />
Jones, J. R., 2901F*, 3684W<br />
Jones, K., 3512T<br />
Jones, K. L., 3076F<br />
Jones, K. W., 1142F<br />
Jones, M., 993W, 1092W<br />
Jones, M. A., 1758W*<br />
Jones, M. P. S., 1302T<br />
Jones, M. R., 1916F<br />
Jones, R. B., 614T<br />
Jones, S. J. M., 2772F<br />
Jones, S. M., 2663T<br />
Jones, T. J., 1878W<br />
Jones, W. D., 2896W*<br />
Jongbloed, J. D. H., 1619T,<br />
3650W<br />
Jongen, E., 708T<br />
Jonges, T., 400<br />
Jonsrud, C., 2965W<br />
Jonsson, R., 2084F<br />
Jonveaux, P., 2770W<br />
Joo, J., 1337W, 3555F*<br />
Joober, R., 2402F, 2558F<br />
Jordan, D. M., 3404T<br />
Jordan, J., 2052W<br />
Jordan, L., 1082F<br />
Jordanova, A., 201, 2948T<br />
Jorde, L. B., Session 81,<br />
195, 600F, 1904F, 3297T,<br />
3378T<br />
Jorge, A. A. L., 2706F<br />
Jorge, P., 2417F, 2631W<br />
Jorgensen, J., 1689T<br />
Jorgensen, M., 2262W<br />
Jorgensen, M. J., 2222F<br />
Jørgensen, N., 2041T,<br />
2707W<br />
*Presenting Author<br />
Jørgensen, T., 2317T, 2347T<br />
Jorgenson, E., 2269T,<br />
3655F*<br />
Jorgez, C., 2979T*<br />
Jose, P., 245<br />
Josefsberg, S., 3162F<br />
Joseph, P., 1295W<br />
Joseph, V., 17, 998F, 999W,<br />
1159T*<br />
Joseph-George, A. M.,<br />
3100F<br />
Joset, P., 2595W<br />
Joshi, A. D., 191<br />
Joshi, P., 1383T*<br />
Joshi, S., 3669F<br />
Jossic, F., 77, 403<br />
Jostins, L., 153, 354,<br />
1967F*<br />
Jouan, l., 2306F<br />
Jouan, L., 2342F*<br />
Jouanolle, A. M., 2126F<br />
Jouhilahti, E. M., 1139F*<br />
Joun, D., 1209W, 1246T*,<br />
3278W, 3714W<br />
Jourdain, A.-S., 3172F<br />
Jouzi, M., 3656W, 3703F<br />
Jovanovic, A., 772W<br />
Jowett, J., 1280W<br />
Jowett, J. B., 2308T<br />
Joy, J. B., 375<br />
Joyce, C., 455F<br />
Joyce, P. R., 3440T<br />
Joyner, A., 3670W<br />
Joyner, A. H., 1232F*<br />
Jozaki, K., 3432T, 3519T<br />
Ju, W., 1986W<br />
Ju, Y., 1248W, 1384F<br />
Ju, Y. S., 3259F, 3463T<br />
Juan, G., 1923W<br />
Juang, J., 1608T<br />
Juárez-Velázquez, R.,<br />
1131W, 1141T*<br />
Judkins, T., 1021T<br />
Juengst, E. T., 1848W<br />
Jugurnauth-Little, S., 205,<br />
1011W<br />
Jula, A., 2173T, 2366F<br />
Julian, C. G., 3290W<br />
Julien, C., 2234F, 2945T<br />
Jumper, C., 2197T*<br />
Jun, G., 170, 176, 343, 385,<br />
1448W, 1476T, 1513F*,<br />
1545T, 2308T, 2339F,<br />
2528F*, 3664W<br />
Jun, H. S., 2712F*<br />
Juneblad, K., 2160W<br />
Jung, B., 3135W<br />
Jung, C. W., 1007F, 1103F<br />
Jung, E., 3103W<br />
Jung, H., 1051T<br />
Jung, J., 2828T, 3189W<br />
Jung, J. K., 846F<br />
Jung, Y., 1248W, 2273F*<br />
Junier, T., 3263W<br />
Junkins, H. A., 1566T,<br />
2108F, 2155T*<br />
Juo, S., 511F, 516W, 2357F<br />
Juo, S. H. H., 1586T<br />
Juonala, M., 2120F<br />
Jurado-Medina, L. S., 3362W<br />
SPEAKER AND AUTHOR INDEX 369<br />
Juretic, N., 2343W<br />
Just, J., 1941W<br />
Just, S., 1612T<br />
Justice, A., 1913F*, 2090F,<br />
2123F, 2147F, 2241W,<br />
3359W<br />
Justice, A. E., 1954T<br />
Justice, C. M., 1983W*,<br />
2151W, 3070F<br />
Justice, M., 389, 840F, 850F,<br />
2678T<br />
Juul, A., 2707W<br />
Juusola, J., 3512T<br />
Juyal, R. C., 2941W<br />
Jyothy, A., 224<br />
K<br />
Kääb, S., 86<br />
Kaad, P.-H., 889W<br />
Kaakinen, M., 190, 1432F,<br />
1597T*, 2162F<br />
Kaariainen, H., 1835W*<br />
Kaasik, K., 2667F*<br />
Kabakchiev, B., 42*<br />
Kabashi, E., 2820F<br />
Kabashima, K., 2911W<br />
Kabesch, M., 2102F, 2226W<br />
Kabra, M., 918T, 2844F,<br />
2941W<br />
Kabwama, S., 3494T<br />
Kacevska, M., 3460T<br />
Kachelries, K., 2252F<br />
Kachelries, K. E., 1997F<br />
Kaci, N., 763W<br />
Kaczmarek, L. K., 202<br />
Kadam, N. N., 3010T<br />
Kaderali, L., 1236W<br />
Kadivar, M., 754W<br />
Kadowaki, T., 2071T<br />
Kagami, M., 3499T<br />
Kaganovich, M., 525F*,<br />
604T<br />
Kahali, B., 2090F, 2241W,<br />
2275T<br />
Kähler, A. K., 2576F<br />
Kahn, J. P., 259<br />
Kahn, R. S., 431F, 2526W,<br />
2553W, 2661W, 3474T<br />
Kahn, S., 249<br />
Kahns, L., 3641F, 3662W<br />
Kähönen, M., 2097W, 2120F<br />
Kai, L., 3574W<br />
Kain, S., 3699F<br />
Kaiser, F. J., 204, 2958F<br />
Kaisermann, M., 1858F*<br />
Kaitila, O., 1015T<br />
Kaji, R., 52, 3221W, 3229W<br />
Kakavand, A., 2964F<br />
Kakiuchi, C., 2370W, 2435F,<br />
2652W<br />
Kaklamani, V., 1292W<br />
Kakourou, G., 2995T<br />
Kalari, K., 603T<br />
Kalari, K. R., 1247F<br />
Kaler, S., 235*<br />
Kaler, S. G., Session 10,<br />
791W, 2686W<br />
Kalia, S. S., 1825W<br />
Kalil, J., 1593T<br />
Kalin, N. H., 595F, 2413T<br />
Kalinsky, K., 1255T<br />
Kalish, J., 3082F*<br />
Kalkanoglu-Sivri, H. S.,<br />
702T<br />
Kalkan Ucar, S., 3214F<br />
Kalkwarf, H. J., 812F<br />
Kallela, M., 2348F<br />
Kalli, K. R., 1238F, 3451T<br />
Kallioniemi, A., 1006T<br />
Kals, M., 3079W, 3460T*<br />
Kalscheuer, V. M., 2732T,<br />
3165W<br />
Kalyoncu, S., 3003T<br />
Kamalakaran, S., 3316F<br />
Kamali, N. P., 1675T<br />
Kamamoto, M., 1574W<br />
Kamarainen, O., 1874F<br />
Kamatani, N., 396, 1643T,<br />
2004W, 2174F<br />
Kamatani, Y., 1640T<br />
Kamate, M., 700T, 2803W<br />
Kamaya, M., 559F<br />
Kamberov, E., 3689F<br />
Kamboh, M. I., 343, 1647T,<br />
1672T, 1673T, 2099F,<br />
2125T, 2521T, 3078F<br />
Kambouris, M., 2713W,<br />
2728W, 2899W*, 3140F,<br />
3526W<br />
Kamel-Reid, S., 135<br />
Kamen, D. L., 1662T, 1979F,<br />
3371W<br />
Kaminker, J., 1539T<br />
Kaminska, A., 202, 2536T<br />
Kaminsky, E. B., 917W<br />
Kamio, Y., 2440T<br />
Kamiya, A., 2458T<br />
Kammerer, C., 1641T, 1650T<br />
Kammerer, C. M., 1672T,<br />
1673T, 1920W, 1921T<br />
Kamnasaran, D., 3060F,<br />
3071W, 3232F<br />
Kamp, A., 82<br />
Kamp, T. J., 2885T<br />
Kamphans, T., 3556W*<br />
Kamps, R., 708T<br />
Kamsteeg, E. J., 160, 216,<br />
1734W*<br />
Kamsteeg, E.-J., 214<br />
Kan, M., 93, 2336F, 2337W*<br />
Kan, S.-H., 695F*, 734T<br />
Kan, S.-h., 785W<br />
Kan, S. H., 697F<br />
Kan, Z., 1369F<br />
Kanaan, M., 2772F, 2919F*<br />
Kanafani, S., 3109W<br />
Kanagawa, M., 232<br />
Kaname, T., 2758W*<br />
Kanapin, A., 2939T<br />
Kanavakis, E., 84, 2995T<br />
Kanber, D., 392<br />
Kanchi, K., 1203W<br />
Kandoth, C., 1203W<br />
Kanesky, A., 858T<br />
Kanetsky, P. A., 211, 213<br />
Kang, A., 3223W<br />
Kang, C., 1248W<br />
Kang, E., 39, 1337W*<br />
SPEAKER AND AUTHOR INDEX
370 SPEAKER AND AUTHOR INDEX<br />
Kang, E. Y., 1480F<br />
Kang, H., 662T, 733F*,<br />
1533T, 2769F<br />
Kang, H.-M., 170<br />
Kang, H. M., 108, 154,<br />
172, 177, 1398T, 1446T,<br />
1448W, 1510F*, 1525F,<br />
1545T, 3405W, 3664W<br />
Kang, J., 1248W<br />
Kang, J. H., 1887W, 2154W,<br />
2240F, 2263T<br />
Kang, K., 900T<br />
Kang, L., 3293W*<br />
Kang, M. S., 2093F<br />
Kang, S., 2660F<br />
Kang, S.-H., 898T<br />
Kang, S.-H. L., 432W, 952T,<br />
2395T<br />
Kang, Y., 2225F<br />
Kangas, A. J., 1623T<br />
Kangas, J., 1611T<br />
Kaniecki, K., 1731W<br />
Kanik, A., 1746W<br />
Kannan, R., 3240F<br />
Kannankeril, P. J., 247<br />
Kannengiesser, C., 29<br />
Kanninga, R., 1330F<br />
Kanno, E., 1984T<br />
Kannu, P., 1738W<br />
Kanoni, S., 106, 115*, 3453T<br />
Kant, S., 2701W, 3271F<br />
Kant, S. G., 131, 2925F<br />
Kantarci, S., 315, 950T*<br />
Kantesaria, M., 3370F<br />
Kanthaswamy, S., 595F<br />
Kao, A. H., 2099F<br />
Kao, C., 2229W*, 2492F,<br />
2524T<br />
Kao, L., 350<br />
Kao, L. W. H., 1381F<br />
Kao, W. H., 1932W<br />
Kao, W. H. L., 2210F<br />
Kao, Y., 2392T<br />
Kapalanga, J., 3518T*<br />
Kaper, F., 596W*, 942T,<br />
3619F<br />
Kaphingst, K. A., 316<br />
Kaplan, J., 324, 390, 2320T<br />
Kaplan, J. R., 2222F<br />
Kaplan, L. D., 2185T<br />
Kaplan, R. C., 2080T<br />
Kaplonski, N., 490W<br />
Kapoor, A., 305*<br />
Kapoor, M., 2582F*, 2598W<br />
Kapoor, R., 1134W, 1135T<br />
Kaprio, J., 252, 2022W,<br />
2110T, 2175W, 2256W,<br />
2350T<br />
Kaptoge, S., 109<br />
Kapur, R., 2890W<br />
Karaca, E., 360, 965W,<br />
2719W, 2881W, 2908W*,<br />
3222F<br />
Karacan, I., 2412W<br />
Karaer, K., 3195W<br />
Karafet, T. M., 2788W<br />
Karagas, M. R., 1091F,<br />
1453F<br />
Karagrigoriou, A., 3017T<br />
Karakas, M., 111, 2073W<br />
*Presenting Author<br />
Karaleftheri, M., 2044T,<br />
3396T<br />
Karasik, D., 1334W<br />
Karatas, A. F., 3150F<br />
Karbaschi, M., 1270T*<br />
Karbowski, J., 3709F<br />
Karchin, R., 1731W, 2180F,<br />
2305T<br />
Karczeski, B. A., 3448T<br />
Karczewski, K., 551F, 568W<br />
Karczewski, K. J., 425F,<br />
562W*, 646T<br />
Kardia, S., 113<br />
Karfunkel, D., 2919F<br />
Karim, L., 708T<br />
Karimé, B., 2965W<br />
Karimi, A., 3020T<br />
Kariminejad, A., 2436W<br />
Kariminejad, M., 2436W<br />
Karimipoor, M., 1118F,<br />
1726W<br />
Kariuki, S. N., 2046W*<br />
Karjalainen, J., 108, 523F,<br />
1503T*<br />
Karki, C., 2020T<br />
Karkucak, M., 590W<br />
Karlberg, O., 567F, 3217W,<br />
3427T<br />
Karlin-Neumann, G., 3690W<br />
Karlinsky, L., 3185W<br />
Karlsen, T. H., 2101T<br />
Karlsson, R., 991T*, 1189T,<br />
1990T<br />
Karma, K., 2181W<br />
Karns, R., 1660T<br />
Karolak, J., 934T<br />
Karolchick, D., 3557F<br />
Karolchik, D., 3612W<br />
Karp, D., 1901F, 2284T<br />
Karp, N. A., 105<br />
Karpati, M., 2691F<br />
Karppinen, A., 1253F<br />
Karppinen, J., 1892F<br />
Karssen, L., 2107T<br />
Karssen, L. C., 459F<br />
Kart, H., 980T<br />
Kartmann, H., 86<br />
Karyadi, D. M., 2219F<br />
Karydas, A. M., 2639F<br />
Kasai, K., 2370W, 2435F,<br />
2652W<br />
Kasai, Y., 3724W<br />
Kasapcopur, O., 2841F<br />
Kasapçopur, O., 3132F<br />
Kasarskis, A., 3724W<br />
Kasberger, J., 2269T<br />
Kaschnitz, W., 2570F<br />
Kascsak, R., 2449T<br />
Kase, R., 132<br />
Kashef-Haghighi, D., 397<br />
Kashif, S., 2075F<br />
Kashihara, K., 2559W<br />
Kashimura, A., 598W*<br />
Kashiwagi, K., 1980W<br />
Kasiman, K., 1707T*<br />
Kask, M., 1140W*<br />
Kasowski, M., 551F, 3505T*<br />
Kasper, R. S., 632T<br />
Kastelein, J. J. P., 1604T<br />
Kasten, M., 200<br />
Kasterstein, E., 3002T<br />
Kasuga, H., 663F<br />
Kasvin-Felton, J., 1366F<br />
Kataja, V., 1125W<br />
Kataoka, N., 781W<br />
Kathiresan, S., 115, 117,<br />
170, 280, 350, 1331W,<br />
1677T, 2199W<br />
Katiyar, N., 2491T*, 3542W<br />
Kato, H., 2873T<br />
Kato, K., 1815W, 1848W*<br />
Kato, M., 3136F, 3326W<br />
Kato, N., 3284W<br />
Kato, R., 2963T<br />
Kato, T., 1549F, 2652W,<br />
3513T<br />
Katsanis, N., 3, 13, 98,<br />
310, 386, 2458T, 2955F,<br />
3296W<br />
Katsanis, S. H., 3<br />
Katsuno, M., 2472W<br />
Katsuya, T., 1987T<br />
Kattman, B. L., 1762W<br />
Katz, M., 784W<br />
Katz, M. L., 2805F, 2817F<br />
Katz, M. S., 306<br />
Katz-Jaffe, M. G., 851F*,<br />
2968T<br />
Kaudwell, G., 1304W<br />
Kauff, N., 1841W<br />
Kauffman, T., 1869F<br />
Kauffman, W. B., 1689T<br />
Kauffmann, F., 1461T,<br />
1941W<br />
Kaufman, D., Session 9,<br />
1829W, 2625W<br />
Kaufman, K., 1901F<br />
Kaufman, K. M., 2046W,<br />
3371W<br />
Kaufmann, S., 1238F<br />
Kaukinen, K., 2023T, 2177F<br />
Kaul, N., 1993T<br />
Kaunisto, M. A., 2348F<br />
Kaur, G., 2941W<br />
Kaur, K., 133<br />
Kaur, M., 861W, 3058F<br />
Kaur, N., 1890W*<br />
Kaur, P., 410<br />
Kaur, R., 1891T*<br />
Kaur, S., 1026W<br />
Kaur, V., 50<br />
Kausar, T., 2959W<br />
Kauwe, J. S. K., 340*,<br />
3643F<br />
Kavakli, I. H., 2592W<br />
Kavalla, R., 2056T<br />
Kavitha, H., 1044W<br />
Kawada, A., 3146F<br />
Kawaguchi, T., 2174F<br />
Kawahara, N., 1290T<br />
Kawakami, H., 3229W<br />
Kawakami, K., 309<br />
Kawal, P., 1177T*<br />
Kawame, A., 2697F<br />
Kawame, H., 3043W<br />
Kawamura, H., 2656T<br />
Kawamura, Y., 663F, 2370W<br />
Kawano, Y., 2400W<br />
Kawarai, T., 52<br />
Kawasawa, Y., 2444F<br />
Kawashima, M., 1831W,<br />
2349W, 3301F*<br />
Kay, C., 265<br />
Kay, D. M., 2151W<br />
Kay, J., 230<br />
Kay, T., 2916F<br />
Kaya, H., 590W<br />
Kayabasi, C., 1178F*<br />
Kayama, T., 1549F<br />
Kaye, F. J., 1162T<br />
Kaye, J., 1848W<br />
Kaye, J. A., 2643W<br />
Kayserili, H., 1, 214, 216<br />
Kayserilli, H., 2863W<br />
Kazan, H., 1551T<br />
Kazazian, H. H., 336, 1229F<br />
Kazkaz, L. A., 1490W<br />
Kazma, R., 1250F, 1469W*,<br />
1496W, 3655F<br />
kConFab, 1224W<br />
kConFab, BCFR, 1213T<br />
kConFab Investigators,<br />
AOCS Group, 1492F<br />
Keane, C., 1042T<br />
Kearney, H. M., 958T<br />
Kearns, M., 1506T<br />
Kearns, W. G., 78, 2998T<br />
Keating, B., 1659T, 2063F<br />
Keating, B. J., 1606T<br />
Keating, S., 2971T, 3075W<br />
Keavney, B., 219<br />
Keddache, M., 573F, 690T<br />
Keegan, C. E., 313<br />
Keegan, L. P., 577F<br />
Keen, K., 123<br />
Keenan, B., 380<br />
Keenan, B. T., 2250W,<br />
3417T, 3450T<br />
Keenan, K., 1322W, 2953W<br />
Keene, K., 1971W<br />
Keene, K. L., 1662T<br />
Keeney, J. G., 433F, 835F*<br />
Keerthikumar, S., 3316F<br />
Kefer, N., 515F<br />
Kehdy, F., 1119W, 3325F<br />
Kehl, H. G., 2759T<br />
Kehrer-Sawatzki, H., 939W,<br />
2791W<br />
Keikhaei, B., 2714T<br />
Keil, T., 2102F<br />
Keildson, S., 44, 583F,<br />
2187W*, 3441T<br />
Keinan, A., 183*, 187<br />
Keith, M. E., 1192T*<br />
Kekis, M., 2696T<br />
Kelempisioti, A., 1892F*<br />
Kellam, P., 1507F, 2163W<br />
Keller, A., 186, 515F, 2368T<br />
Keller, M., 2722W<br />
Keller, M. A., 632T<br />
Keller, M. C., 2239T<br />
Kelley, J. L., 285<br />
Kelley, R. I., 105<br />
Kelliher, E., 322<br />
Kellis, M., Session 5, 380,<br />
3291T, 3417T, 3450T<br />
Kelly, E., 1190F<br />
Kelly, J., 953W, 2284T<br />
Kelly, J. A., 529F, 1901F,<br />
1979F, 2188T
Kelly, J. C., 945W<br />
Kelsey, K. T., 3629F<br />
Kelsh, R. N., 363<br />
Kelso, J., 3274F<br />
Kemmotsu, Y., 1631T<br />
Kemp, J., 1567F, 2081F,<br />
2164T<br />
Kemp, J. P., 1318F, 1528F,<br />
1583W, 2169W*<br />
Kempers, M., 128<br />
Kempers, M. J. E., 80,<br />
955W<br />
Kenan, B., 624T<br />
Kendall, F. D., 330<br />
Kendall, J., 2587T<br />
Kendler, K., 3512T<br />
Kendler, K. S., 2500T,<br />
2504F, 2594F, 2599T<br />
Keni, J., 3059W<br />
Kennedy, C., 1729W,<br />
3680W<br />
Kennedy, C. J., 3640W*<br />
Kennedy, D., 784W<br />
Kennedy, J., 628T<br />
Kennedy, J. L., 612T,<br />
2376W, 2608T, 2657F<br />
Kennedy, M. A., 3440T*<br />
Kennedy, R. B., 1426F<br />
Kennedy, S. H., 2133W<br />
Kennedy-Darling, J., 1269W<br />
Kennerknecht, I., 2861T<br />
Kennerson, M., 2742F*<br />
Kenney, M. C., 1963T<br />
Kenny, E., 3362W, 3563F<br />
Kenny, E. E., 293, 3360T*,<br />
3380W, 3390T<br />
Kent, A., 1848W<br />
Kent, J., 414W, 673F,<br />
1280W*, 3612W<br />
Kent, J. W., 1923W<br />
Kent, J. W., Jr., 1406W<br />
Kent, M., 2805F<br />
Kent, W. J., 3557F*<br />
Kenyon, C., Session 26<br />
Keogh, J., 43<br />
Keong, G. T., 1117T<br />
Keppler-Noreuil, K. M., 82,<br />
404<br />
Keravnou, A., 3017T<br />
Kere, J., 154, 1976F, 3631F<br />
Keren, B., 889W, 2770W<br />
Kerkh<strong>of</strong>, M., 2167T<br />
Kerkis, I., 1102T<br />
Kerlikowske, K., 1576F<br />
Kerns, S., 1309F*<br />
Kerr, B., 2852T<br />
Kerr, D., 1072T<br />
Kerr, E., 142<br />
Kerr, K. F., 1661T<br />
Kerr, M., 2821W<br />
Kerscher, T., 2102F<br />
Kershberg, H., 1866F*<br />
Kersten, F. J., 1<br />
Keshavan, R., 440W*<br />
Keshava Prasad, T. S.,<br />
3316F<br />
Kesler, J., 949W<br />
Kesselman, C., 3587F<br />
Kessner, D., 476W<br />
Kessner, D. E., 3626W*<br />
*Presenting Author<br />
Kestelyn, P. G., 2927T<br />
Ketterer, E. A., 2329T<br />
Kettunen, J., 584W, 656T*,<br />
1284T, 1503T, 2110T,<br />
2173T<br />
Keupp, K., 3214F<br />
Keve, S., 784W<br />
Kevelam, S. H., 2848W<br />
Keydar, I., 2875W<br />
Keys, D., 1146W, 1195T,<br />
3725F<br />
Keyser, M., 3671F*<br />
Khabbaz, K., 3469T<br />
Khabour, O., 855W*, 856T<br />
Khachane, A. N., 3442T<br />
Khadem, F., 3501T<br />
Khademian, H., 682T*<br />
Khader, M., 855W<br />
Khaldi, K., 2306F<br />
Khaledifar, A., 1596T<br />
Khalfallah, O., 817F<br />
Khalil, S., 2302T<br />
Khan, B. K., 2639F<br />
Khan, J., 1259F<br />
Khan, J. C., 2072F<br />
Khan, M., 865W<br />
Khan, N., 2680W<br />
Khan, S., 209, 1265F,<br />
2949F*<br />
Khanduzi, S. R. K., 1096T<br />
KhanKhanian, P., 2113T,<br />
3330T<br />
Khanna, H., 2680W<br />
Khanna, R., 732T<br />
Khantane, S., 2674W<br />
Khare, M., 3144F, 3213W*<br />
Kharrazi, M., 3238F<br />
Khatir, A. S., 1615T<br />
Khatri, S. M., 820F<br />
Khazen, G., 3349F<br />
Khazraee, H., 2008T<br />
Khazraei, H., 1421W<br />
Khil, P., 417F, 592W<br />
Kho, A., 811F, 2098T,<br />
3622W<br />
Kho, A. L., 2945T<br />
Kho, J., 165<br />
Kho, M., 1656T*<br />
Khokher, Z., 682T<br />
Kholodov, M., 3582W<br />
Khoo, S. J., 2491T<br />
Khor, C. C., 2094W, 3284W,<br />
3339T<br />
Khosroheidari, M., 1953W<br />
Ki, A., 963W<br />
Kiani, S., 3700W<br />
Kibar, Z., 850F, 1910F,<br />
2075F, 2692W<br />
Kibel, A., 1210T<br />
Kibriya, M., 2025W<br />
Kida, K., 726T<br />
Kida, M., 1092W<br />
Kida, Y., 598W, 599F*<br />
Kidambi, A., 2742F<br />
Kidd, A., 967W<br />
Kidd, J., 285<br />
Kidd, J. M., 371, 3352F,<br />
3361F, 3368W, 3411W<br />
Kidd, K. K., 3313F<br />
Kidd, L., 1339F<br />
SPEAKER AND AUTHOR INDEX 371<br />
Kido, T., 1179W*, 1831W*<br />
Kiefer, A., 1825W<br />
Kiefer, A. K., 106, 114, 626T,<br />
1017W, 1782W, 2087F,<br />
2089T, 2100W, 2115W*,<br />
2127W, 2149T<br />
Kiehl, T.-R., 2428T<br />
Kiel, D. P., 109<br />
Kielbasa, S., 298<br />
Kielty, C., 2852T<br />
Kiemeney, L. A., 106, 431F<br />
Kiemeney, L. A. L. M., 87<br />
Kievit, W., 621T<br />
Kiezun, A., 25*<br />
Kikuchi, H., 2400W, 2923W<br />
Kilambi, K. P., 308<br />
Kilaru, V., 1422T, 3480T<br />
Kilembe, W., 36<br />
Killary, A., 1095W<br />
Kilpeläinen, T. O., 2116T*<br />
Kilpinen, H., 415F<br />
Kim, A., 2723T<br />
Kim, A. S., 838F<br />
Kim, B., 389*, 2518T, 2678T,<br />
3462T<br />
Kim, B. J., 840F<br />
Kim, C., 319, 895W, 896T,<br />
899W, 1915T, 2121W,<br />
2229W, 2252F, 2492F,<br />
2514W, 2785W, 2856F,<br />
2872W, 2892F*, 3573F<br />
Kim, C. A., 2232W, 2863W,<br />
3152F, 3160F, 3184F,<br />
3250F<br />
Kim, C. E., 812F, 1996T,<br />
1997F<br />
Kim, D., 2723T<br />
Kim, D. H., 1007F, 1103F<br />
Kim, D. K., 3223W<br />
Kim, D. S. K., 2443T*<br />
Kim, E., 1608T<br />
Kim, G. H., 698T<br />
Kim, G.-H., 3227W*<br />
Kim, H., 589F, 947W, 1243T,<br />
1384F*, 2117F*, 2117F,<br />
2200T, 2221T, 3103W,<br />
3223W, 3473T, 3485T<br />
Kim, H.-G., 2732T*<br />
Kim, H. S., 3423T<br />
Kim, I.-K.., 385<br />
Kim, I. K., 1305T<br />
Kim, J., 3, 269, 678T, 866T*,<br />
866T, 867W, 947W,<br />
1248W, 1384F, 1385W*,<br />
2151W, 2200T, 2437T,<br />
2518T, 2828T*, 3112F,<br />
3151W, 3178F, 3423T,<br />
3462T, 3473T<br />
Kim, J. C., 706T*, 719F<br />
Kim, J. H., 470W*, 1975T*,<br />
3607F<br />
Kim, J.-I., 1931F<br />
Kim, J. I., 3463T<br />
Kim, J.-M., 3227W<br />
Kim, J.-W., 1007F, 1103F<br />
Kim, J. Y., 846F*<br />
Kim, K., 66, 1656T, 2437T,<br />
3462T<br />
Kim, K. J., 3180F<br />
Kim, K. M., 698T<br />
Kim, M., 900T, 947W,<br />
1230W, 2715F, 3008T,<br />
3461T, 3567F<br />
Kim, M. O., 846F<br />
Kim, P. M., 1551T<br />
Kim, S., 488W, 1007F,<br />
1103F*, 1103F, 2511W,<br />
2518T, 3008T, 3151W,<br />
3461T*<br />
Kim, S.-H., 1007F, 1103F<br />
Kim, S. H., 846F<br />
Kim, S. J., 863W<br />
Kim, S. K., 3014T<br />
Kim, S. Y., 3607F<br />
Kim, T., 1551T<br />
Kim, T. K., 452W<br />
Kim, W., 1338T<br />
Kim, W. R., 2118W*<br />
Kim, W. Y., 1046F<br />
Kim, Y., 488W*, 947W,<br />
999W, 1248W, 1347T*,<br />
1363F, 1396F, 2060F,<br />
2151W, 2468F, 2715F,<br />
2828T, 3178F*, 3444T,<br />
3462T, 3616W<br />
Kim, Y. J., 269<br />
Kim, Y.-M., 3227W<br />
Kim, Y. M., 698T<br />
Kimani, J., 3276T<br />
Kimball, A., 861W<br />
Kimberly, R. P., 306, 1979F,<br />
2046W, 3371W<br />
Kim-Howard, X., 307,<br />
1572T*<br />
Kimmel, M., 3273T, 3549F<br />
Kimonis, V., 1791W, 2151W,<br />
3249W<br />
Kimonis, V. E., 757W, 3144F,<br />
3213W<br />
Kimura, M., 1574W, 2747T*<br />
Kimura, R., 1327F<br />
King, C. R., 2333F<br />
King, J. S., Session 79<br />
King, M.-C., Session 1, 26,<br />
263, 287, 1089W, 1228T,<br />
2600F, 2756T, 1226F,<br />
2929W<br />
King, O. D., 2962W<br />
King, R., 3321T<br />
King, R. A., 261, 2602T<br />
Kingery, M., 239<br />
Kingman, G., 3562W<br />
Kingsbury, Z., 366, 1238F,<br />
3663F<br />
Kingsmore, S. F., Session 73,<br />
366, 2793F, 2894T<br />
Kingston, H., 2852T<br />
Kingwattanakul, P., 2006F<br />
Kini, A., 2492F<br />
Kini, U., 131<br />
Kinnamon, D., 1544W<br />
Kinnamon, D. D., 2603F<br />
Kinney, D., 1746W*<br />
Kinnula, V., 1114T<br />
Kinoshita, S., 2129F<br />
Kinoshita, T., 298<br />
Kinross, C., 3668W*<br />
Kinsella, M., 1043F<br />
Kinsler, V. A., 303*<br />
Kinstlinger, N., 507F<br />
SPEAKER AND AUTHOR INDEX
372 SPEAKER AND AUTHOR INDEX<br />
Kipps, T. J., 395<br />
Kirby, A., 322*, 1725W<br />
Kirby, J., 348<br />
Kircher, M., 3274F<br />
Kirchh<strong>of</strong>f, M., 889W<br />
Kirchh<strong>of</strong>f, T., 208, 1159T<br />
Kirectepe, A. K., 2841F*<br />
Kirel, B., 2704W<br />
Kiridly, J. F., 306<br />
Kirillova, I., 251<br />
Kirk, A., 2779W<br />
Kirk, E., 131<br />
Kirk, E. P., 217<br />
Kirk, K., 1147T<br />
Kirkup, V., 3612W<br />
Kirmani, S., 2575T<br />
Kirmes, I., 849F<br />
Kirov, G., 1325W, 2576F<br />
Kirsanov, K., 1180T*, 1181F<br />
Kirwin, S. M., 2855T<br />
Kiryiya, M., 1638T<br />
Kiryluk, K., 845F<br />
Kishi, F., 1631T<br />
Kishino, H., 2440T<br />
Kishita, Y., 2873T<br />
Kiss, A., 2761W<br />
Kisselev, S., 442W, 1898F<br />
Kissell, D., 1764W<br />
Kitabayashi, N., 1100F<br />
Kitaichi, K., 2647T<br />
Kitajima, H., 3436T*<br />
Kitamura, Y., 2009F<br />
Kitaoka, T., 1684T<br />
Kitchen, R., 2444F<br />
Kitchens, C. S., 2330F<br />
Kitsiou, S., 84, 2937F<br />
Kittles, R. A., 1009T, 2014T*,<br />
2087F, 2202W, 2281T<br />
Kitts, A., 3582W<br />
Kitzis, A., 77<br />
Kitzman, J., 311<br />
Kitzman, J. O., 74*, 94,<br />
1014W<br />
Kivimaki, M., 1621T<br />
Kivirikko, S., 2002T<br />
Kivisild, T., 3322F<br />
Klaften, M., 2922F<br />
Klambauer, G., 1483F,<br />
1486F<br />
Klanderman, B., 638T<br />
Klar, J., 2920W*<br />
Klautau-Guimarães, M. N.,<br />
3375T<br />
Klebe, S., 29<br />
Kleber, M. E., 2116T<br />
Kleefstra, T., 97, 100, 102,<br />
125, 3159W<br />
Klei, L., 553F<br />
Kleiber, M. L., 378<br />
Klein, A. P., 3616W<br />
Klein, B., 2041T<br />
Klein, B. E., 2109W<br />
Klein, C., 200, 204, 672T<br />
Klein, D., 633T, 635T<br />
Klein, E., 2779W<br />
Klein, H.-G., 3539F<br />
Klein, M. L., 2183F<br />
Klein, O. D., 2151W, 3242F<br />
Klein, R., 208, 2041T,<br />
2109W<br />
*Presenting Author<br />
Klein, R. J., 1100F, 1159T<br />
Klein, T. E., 633T, 635T, 646T<br />
Kleinhanz, R., 2220W<br />
Kleinheinz, J., 2759T<br />
Klein-Hitpass, L., 3524T<br />
Kleinman, J., 2444F<br />
Kleinman, J. E., 260, 2622W<br />
Klemm, S., 3037W<br />
Klemm, T., 2328W<br />
Klengel, T., 1422T, 2483F<br />
Klepacka, D., 905W<br />
Klepp, O., 991T<br />
Kleta, R., 199<br />
Klevit, R. E., 2929W<br />
Klimentidis, Y., 1460W<br />
Klimentidis, Y. C., 2201F*<br />
Kline, A. D., 861W*<br />
Kline, J., 1600T<br />
Klinedinst, D., 310<br />
Klink, B., 1236W<br />
Klobus, A. B., 704T<br />
Klocke, B., 3536W<br />
Kloosterman, W., 400, 423F,<br />
459F, 672T<br />
Kloosterman, W. P., 217,<br />
2886F<br />
Kloske, D. A., 1245W,<br />
3527F, 3687F<br />
Kloss-Brandstätter, A.,<br />
3319F<br />
Klotzle, B., 596W, 3451T<br />
Klovins, J., 608T*<br />
Kluck, N., 106<br />
Kluemper, G., 2243F<br />
Kluger, Y., 579F<br />
Klugman, S., 1793W, 3022T<br />
Kluijt, I., 3200F<br />
Klünemann, H. H., 684T<br />
Klungel, O. H., 243, 609T<br />
Kluwe, L., 2791W<br />
Kmoch, S., 322, 752T<br />
Knapp, M., 2088W, 3333T<br />
Knappskog, P. M., 2451W<br />
Knauf, F., 2568W<br />
Knekt, P., 2110T<br />
Knight, J., 154, 628T,<br />
1927T*, 2376W<br />
Knight, J. C., 373, 563F<br />
Knight, S. J., 218<br />
Knight, S. J. L., 219<br />
Knight-Madden, J., 2043W<br />
Knoener, R., 1269W<br />
Knoers, N. V., 217, 3164F<br />
Knoers, N. V. A. M., 216,<br />
2848W, 2886F<br />
Knoll, J. H., 3672W<br />
Knoppers, B. M., 1823W,<br />
1848W<br />
Knower, W., 2038T<br />
Knowler, W., 249<br />
Knowler, W. C., 1300F,<br />
1953W, 2018F, 2124W<br />
Knowles, D., 1440T<br />
Knowles, J., 2444F<br />
Knowles, J. A., 2564F, 3587F<br />
Knowles, J. W., 1624T<br />
Knowles, M., 2953W<br />
Knowles, M. R., 171, 406,<br />
1322W, 2851W<br />
Knowlton, A. A., 1625T<br />
Knowlton, M. N., 2675T<br />
Knudsen, B., 3641F, 3662W<br />
Knutsen, R., 1699T<br />
Knuutila, S., 2888T<br />
Ko, A., 278<br />
Ko, D. C., 2186F*<br />
Ko, J., 877W, 3204F<br />
Ko, J. M., 787W, 3180F*<br />
Ko, W., 3303T<br />
Kobayashi, G. S., 814F*<br />
Kobayashi, K., 232, 2550W,<br />
2963T*, 3513T<br />
Kobayashi, M., 3230F<br />
Kobayashi, Y., 1771W<br />
Kobes, S., 1953W, 2038T,<br />
2124W<br />
Koboldt, D., 1203W, 1210T<br />
Kobor, M., 3734W<br />
Kobrynski, L. J., 2312F<br />
Kobzik, L., 811F<br />
Kocak, M., 3480T<br />
Koch, C., 328<br />
Koch, M., 328<br />
Kochi, Y., 1984T, 2004W<br />
Kockum, I., 1455T, 1939T,<br />
2276F<br />
Kodama, H., 2836W<br />
Kodama, K., 1462F<br />
Kodaman, N., 3388F*<br />
Kodati, V. L., 1893W<br />
Köehler, S., 2725W<br />
Koellinger, P. D., 2505W<br />
Koen, L., 644T<br />
Koenekoop, R., 1779W<br />
Koenen, K., 435F<br />
Koenig, B., Session 25<br />
Koenig, B. A., 1849W<br />
Koenig, M. K., 1761W<br />
Koesterer, R., 2503T<br />
Koestler, D., 3465T<br />
Koestler, D. C., 3451T,<br />
3629F*<br />
Koetters, T., 1965W<br />
Koga, A., 468W<br />
Kogawa, R., 2861T<br />
Kogevinas, M., 1091F<br />
Kogon, B., 1679T<br />
Koh, D. X. R., 3267T<br />
Koh, I., 3462T*<br />
Kohaar, I., 1091F, 1092W*,<br />
1094F<br />
Kohane, I. S., 1769W,<br />
1836F, 1843W, 3635F<br />
Kohda, K., 2370W<br />
Kohda, M., 2873T*, 2923W<br />
Kohl, I., 895W<br />
Kohl, M., 2315F<br />
Kohlbacher, O., 1200W,<br />
1233W<br />
Kohli, A., 493F<br />
Kohli, M. A., 341, 2583W,<br />
2586W, 2637W*<br />
Kohli, M. M., 347<br />
Kohli, S., 1720W<br />
Kohlmann, W., 1783W<br />
Kohno, Y., 2294F<br />
Kohut, A., 3038F<br />
Koiffmann, C., 895W<br />
Koike, A., 2130W, 2349W*,<br />
2496W<br />
Koike, S., 2435F<br />
Koivisto, K., 2350T<br />
Koivunen, P., 3297T<br />
Koizumi, A., 589F<br />
Koizumi, H., 52<br />
Kojima, K., 2588F*<br />
Kojima, M., 2440T<br />
Kojima, R., 559F<br />
Kok, C., 2007W<br />
Kok, J. N., 1436W<br />
Kokabee, L., 1118F*<br />
Kokabee, M., 1118F<br />
Kokocinski, F., 506W<br />
Koks, S., 154<br />
Kokubo, Y., 1730W, 2559W<br />
Kol, N., 2919F<br />
Kolberg, J. A., 2347T<br />
Kolb-Kokocinski, A., 2044T,<br />
3396T<br />
Kolde, R., 1163F<br />
Kolder, I. C. R. M., 35*<br />
Kolek, V., 2103W<br />
Koller, D., 368, 369, 2136W,<br />
2372F<br />
Kolodkin, A. L., 308<br />
Kolomietz, E., 460W<br />
Kolonel, L. N., 2202W<br />
Kolundzija, A. B., 1957T<br />
Komarovsky, D., 3002T<br />
Komorowski, R., 1667T<br />
Komosa, M., 1046F, 1047W,<br />
1050W<br />
Komski, A., 3002T<br />
Kondkar, A., 2997T*<br />
Kondo, E., 2963T<br />
Kondo, S., 2264F<br />
Kondo, T., 1795W<br />
Kondoh, T., 2891T<br />
Kondova, I., 3266W<br />
Kone, A., 2255F<br />
Konecny, G., 3451T<br />
Konen, O., 105<br />
Kong, A., Session 75, 2279F<br />
Kong, B., 1246T, 3278W,<br />
3714W<br />
Kong, B. S. G., 1209W*<br />
Kong, L., 3604W<br />
Kong, S., 3635F*<br />
Kong, S. W., 1769W<br />
Kong, X., 2249F<br />
Konialis, C., 2902W<br />
Konidari, I., 9, 270, 2049W*,<br />
2318F, 2378F, 2508W,<br />
2572T, 2603F, 2614T<br />
Konigorski, S., 3490T<br />
Konkashbaev, A., 2197T,<br />
2333F, 3735F<br />
Konkel, M. K., 3270T*<br />
Konstantopoulou, I., 1191W,<br />
1228T<br />
Kontula, K., 2023T<br />
Koolen, D. A., 97<br />
Koon, S. J., 1909T<br />
Kooner, J. S., 110, 115,<br />
3435T<br />
Kooperberg, C., 170, 1408F,<br />
1437T, 1608T, 1925F,<br />
2131T<br />
Koornh<strong>of</strong>, P., 1808F<br />
Kooshavar, D., 2952F*
Kooy, F., 2527T*<br />
Kopajtich, R., 699F*<br />
Kopp, J., 2073W<br />
Koppelman, G., 2167T,<br />
2168F<br />
Korabecna, M., 3437T*<br />
Koralnik, I. J., 2561F<br />
Koran, M., 2532W*<br />
Korbel, J., 551F<br />
Korbonits, M., 2708T<br />
Korean Autism Genetic<br />
Study Consortium,<br />
2518T<br />
Koreeda, Y., 2601W<br />
Koren, A., 480W<br />
Korenaga, M., 2130W<br />
Korenberg, J., 538W<br />
Korenberg, J. R., 2529W*<br />
Korendowych, E., 2160W<br />
Korf, I., 552W, 3479T<br />
Korinthenberg, R., 2812W<br />
Kormanik, K., 662T*<br />
Kornak, U., 129<br />
Kornberg, Z., 2779W<br />
Korneliussen, T., 2311T,<br />
3312T<br />
Kornreich, R., 1777W,<br />
3724W<br />
Korponay-Szabo, I., 2177F<br />
Kors, J. A., 2193W<br />
Korshunov, A., 1182W<br />
Korzh, V., 3047W<br />
Kos, M. Z., 2589W*, 2651F<br />
Kosaihira, S., 1697T<br />
Kosaki, K., 2882T, 3093W,<br />
3105W<br />
Kosaki, R., 2882T, 3093W*<br />
Koscielska, K. A., 2632T*<br />
Kosho, T., 3043W<br />
Kosho, T., 2697F, 3230F*<br />
Koskelainen, T., 1892F<br />
Koskinen, S., 1835W, 2350T<br />
Kosma, V.-M., 1114T,<br />
1125W<br />
Kosova, B., 1025F<br />
Kosova, G., 2327F*<br />
Kosoy, R., 2360F<br />
Kostem, E., 1386T*<br />
Koster, R., 213<br />
Kostiha, B., 2833W<br />
Kosuga, M., 726T*<br />
Kotecha, U., 1720W, 2754F<br />
Kotecha, U. H., 3236F*<br />
Kote-Jarai, Z., 205, 1011W*,<br />
1109F, 1148F<br />
Kotkiewicz, H., 465F<br />
Kottgen, A., 1932W<br />
Kotti, S., 609T<br />
Koudijs, M., 400<br />
Koumbaris, G., 3017T<br />
Kousi, M., 3<br />
Koutras, C., 2528F<br />
Kovač, J., 2688F<br />
Kovac, V., 714T, 785W<br />
Kovacevic, L., 3286F<br />
Kovacevic, S., 3286F<br />
Kovach, J. L., 2028W,<br />
2318F<br />
Kovacs, B., 520W<br />
Koval, V., 459F, 3608W*<br />
*Presenting Author<br />
Kowall, N., 2437T<br />
Kowalski, T. W., 2270F<br />
Kowgier, M., 2167T*<br />
Kozak, K., 1093T<br />
Kozan, S., 1136F<br />
Kozel, B., 1699T*<br />
Kozhaya, L., 713F<br />
Kozicz, T., 672T<br />
Kozlov, S., 2914W<br />
Kozlowski, P., 1745W<br />
Kozol, R., 2445W<br />
Kozubek, J., 385<br />
Kozyrskyj, A. L., 1465F<br />
Kraaij, R., 3608W<br />
Kraft, P., 191, 205, 318,<br />
356*, 1148F, 1150T,<br />
1331W, 1390F, 3413W<br />
Krahn, T., 3377W<br />
Kraig, E., 1406W<br />
Kraja, A. T., 1641T*, 1650T<br />
Krakow, D., 838F, 2857W,<br />
2874F<br />
Krakow, D. A., 2740W<br />
Kral, A., 2114F<br />
Kral, A. H., 2170T<br />
Kral, B. G., 1652T<br />
Kramer, J., 2598W, 2666T<br />
Kramer, M., 2180F, 2590T,<br />
3316F<br />
Krantz, I., 3038F, 3058F<br />
Krantz, I. D., 861W, 2695W,<br />
2958F<br />
Kranzler, H., 2207F, 2497T<br />
Kranzler, H. R., 2503T,<br />
2621F<br />
Krapels, I. P. C., 1711T*<br />
Krarup, H., 2862F<br />
Krasnow, R., 642T<br />
Kratochvilova, H., 752T<br />
Kratter, I. H., 2643W<br />
Kratz, C., 213<br />
Kratz, C. P., 132<br />
Kraus, C., 3235W<br />
Kraus, W., 3541F<br />
Kraus, W. E., 1444F, 1594T,<br />
1636T<br />
Krause, A., 1794W<br />
Krauss, R., 1442W<br />
Krauss, R. M., 601T, 615T<br />
Krawczak, M., 580W, 1943F,<br />
3364F, 3402T<br />
Krawisz, A., 2479T<br />
Krawitz, P. M., 298*, 3556W<br />
Kreeftmeijer, J., 400<br />
Kreft, M., 2848W<br />
Kreger, K., 1829W<br />
Kreiger, P. A., 33<br />
Kreimer, A., 193*<br />
Kreiner-Møller, E., 2167T<br />
Kremer, H., 1, 58*, 59,<br />
2955F<br />
Kremmer, E., 86<br />
Krepischi, A. C., 891W,<br />
903W, 919W<br />
Krepischi, A. C. V., 439F<br />
Krepkiy, V., 1152W<br />
Kress, W., 2681T<br />
Kretzler, M., 3405W<br />
Kretzschmar, W., 3306T<br />
Krex, D., 1236W<br />
SPEAKER AND AUTHOR INDEX 373<br />
Krieger, H., 1343W, 2352W<br />
Krieger, J. E., 636T, 1629T<br />
Kriek, M., 2701W<br />
Kringen, M. K., 576W, 643T*<br />
Krinsky-McHale, S., 859W<br />
Krintel, S., 621T<br />
Kriouele, Y., 3246F<br />
Krishnamurthi, S., 3139W*<br />
Krishnappa, R. S., 1957T<br />
Krishnaswami, B., 1232F<br />
Kristiansen, K., 2311T<br />
Kristiansen, W., 991T<br />
Kristiansson, K., 252,<br />
2116T, 2132F<br />
Krist<strong>of</strong>fersson, U., 1877F<br />
Krist<strong>of</strong>ice, M., 885W<br />
Kroes, T., 97<br />
Kroetz, D. L., 2258F<br />
Krogh, V., 1712T<br />
Kroisel, P., 126<br />
Kroisel, P. M., 3111W,<br />
3116F*<br />
Krolewski, A. S., 2313W<br />
Krom, Y., 2840T<br />
Kronenberg, F., 1595T,<br />
3319F<br />
Kronenberg, Z., 195, 3633F*<br />
Kronengold, J., 202<br />
Kronick, J., 720T<br />
Kruczek, P., 2966T<br />
Krueger, G. G., 1952F<br />
Krug, T., 2085W<br />
Krüger, U., 298<br />
Kruglyak, S., 596W<br />
Kruisselbrink, T. M., 2906T<br />
Krumbiegel, M., 3235W<br />
Krumina, Z., 672T<br />
Krumm, N., 10, 12*, 93,<br />
2897T<br />
Krumsiek, J., 2226W<br />
Krupp, D., 2340W*<br />
Krupp, L., 1924T<br />
Kruppa, J., 275<br />
Krus, U., 47<br />
Kruse, E., 507F<br />
Kruszka, P., 721F*<br />
Kru˚ tová, M., 2745F<br />
Krylov, V., 2831T<br />
Krystal, J. H., 2621F<br />
Krystkowiak, P., 345<br />
Kryukov, G., 25<br />
Ku, C. R., 739F<br />
Kuang, Q., 1108T<br />
Kuang, Y., 2985T<br />
Kuang, Y. L., 615T<br />
Kubaski, F., 747F*<br />
Kubisch, C., 1, 105<br />
Kubly, V. J., 1909T<br />
Kubo, M., 396, 627T, 1552F,<br />
1631T, 1643T, 2004W,<br />
2051F, 2071T, 2174F,<br />
2294F, 2506T<br />
Kubota, I., 1549F<br />
Kubota, T., 2835F*<br />
Kuchenbaecker, K., 208*<br />
Kuchenbaecker, K. B., 207<br />
Kuchinsky, A., 3588W<br />
Kuchroo, M., 2250W<br />
Kucinskas, V., 920T*<br />
Kučinskas, V., 653T<br />
Kucinskiene, Z., 920T<br />
Kučinskiene · , Z. A., 653T<br />
Kuczynski, E., 3030T<br />
Kudoh, J., 2882T, 2911W*<br />
Kuechler, A., 2760F<br />
Kuersten, S., 585F, 3718W<br />
Kuga, A., 232<br />
Kugathasan, S., 1381F,<br />
2312F<br />
Kuh, D., 2282F<br />
Kuhn, J., 3214F<br />
Kuhn, R., 3557F<br />
Kuipers, E., 2141F<br />
Kuit, B., 809F<br />
Kuivenhoven, J. A., 2205W<br />
Kujala, E., 1835W<br />
Kujala, P., 1000T<br />
Kujala, U. M., 2134T<br />
Kukreti, R., 607T<br />
Kukshal, P., 2382W*<br />
Kukull, W. A., 343<br />
Kukurba, K., 568W<br />
Kukurba, K. R., 527F*<br />
Kulesha, E., 3636W<br />
Kuliev, A., 251*<br />
Kulikowski, L., 896T*, 899W<br />
Kulikowski, L. D., 3045W<br />
Kulkarni, H., 3434T<br />
Kulkarni, R., 2330F<br />
Kulkarni, S., 912T, 1028F<br />
Kulkarni, V., 975W, 3726W<br />
Kulle, B., 1581T<br />
Kuller, L., 2080T<br />
Kullo, I., 2098T, 3622W<br />
Kullo, I. J., 618T, 1312F,<br />
1447F<br />
Kulminski, A., 1991F, 2027F,<br />
2194T*<br />
Kulzer, J. R., 304*<br />
Kumabe, M., 2046W<br />
Kumagai, T., 2748F<br />
Kumanduri, V., 497F<br />
Kumano, K., 233<br />
Kumanovics, A., 495F,<br />
2720T<br />
Kumar, A., 10, 1188W,<br />
1519F*, 2446T, 2776W*<br />
Kumar, A. A., 2046W<br />
Kumar, G., 3442T, 3452T<br />
Kumar, J., 1990T*<br />
Kumar, P., 3316F<br />
Kumar, R., 1177T, 2700F<br />
Kumar, S., 533F*, 1137W,<br />
2308T, 2339F, 2859F*,<br />
3316F*<br />
Kumar, V., 429F, 1330F,<br />
2088W, 2733F*<br />
Kumar, Y., 3701F<br />
Kumaraguruparan, G.,<br />
3558W*<br />
Kumari, M., 1621T<br />
Kumasaka, N., 2174F,<br />
3507T*<br />
Kummar, S., 1068W<br />
Kundaje, A., 3505T<br />
Kuningas, M., 2366F<br />
Kunkel, L. M., 1836F,<br />
2962W<br />
Kunst, H. P. M., 58, 1220F<br />
Kunstmann, E., 2356T<br />
SPEAKER AND AUTHOR INDEX
374 SPEAKER AND AUTHOR INDEX<br />
Kuo, C., 1570F*<br />
Kuo, C. L., 2768T<br />
Kuo, C.-L., 1364W<br />
Kuo, D. S., 2684T<br />
Kuo, J. Z., 130, 2153F<br />
Kuo, P., 2000F, 2524T<br />
Kuo, W., 1249T<br />
Kuo, Y., 3467T<br />
Kupershmidt, I., 1183T,<br />
1190F<br />
Kupert, E. Y., 1454W<br />
Kuracha, M. R., 2731W<br />
Kurahashi, H., 232, 475F<br />
Kural, D., 3395W<br />
Kurapati, R., 3730W<br />
Kurbatova, N., 567F, 582W<br />
Kurdoglu, A. A., 3215W<br />
Kure, S., 1290T<br />
Kurek, M., 2102F<br />
Kurian, M. A., 1773W<br />
Kurihara, I., 76<br />
Kurita, T., 2569T<br />
Kuroda, Y., 2891T, 3051W*<br />
Kuroiwa, Y., 1290T<br />
Kurokawa, M., 233<br />
Kurosawa, K., 1795W,<br />
2758W, 2891T*, 3051W,<br />
3091W, 3094F<br />
Kurppa, K., 2023T, 2177F<br />
Kurtzberg, J., 3<br />
Kury, S., 3066F<br />
Küry, S., 1204T<br />
Kussmann, J., 3101W<br />
Kuster, J., 1958F<br />
Kusters, B., 1220F<br />
Kustra, R., 3490T<br />
Kusumawhardani, A. A. A.<br />
A., 2407T<br />
Kusunoki, N., 729F<br />
Kutalik, Z., 62, 108, 299,<br />
1281T, 1387F*, 2116T<br />
Kutilova, M., 601T<br />
Kutkowska, A., 216<br />
Kutlar, A., 2247W<br />
Kutsche, K., 2810T<br />
Kutta, A., 814F<br />
Kutuk, O., 1746W<br />
Kuusisto, J., 46, 2256W<br />
Kuusisto, K. M., 992F*<br />
Kuwahara, M., 2911W<br />
Kuzawa, C. W., 2036F<br />
Kuzuhara, S., 1730W,<br />
2559W<br />
Kvale, M., 96, 112*, 421F,<br />
2513F, 3342T, 3383W<br />
Kvale, M. N., 118, 2140T<br />
Kvist, U., 3032T<br />
Kwak, Y., 2518T<br />
Kwan, A., 362, 377<br />
Kwan, J., 1093T, 3559F*<br />
Kwan, S., 21<br />
Kwan, T., 256, 569F,<br />
3439T<br />
Kwok, P., 112, 118, 2140T,<br />
2513F, 3342T<br />
Kwok, P. Y., 620T, 1694T,<br />
3383W<br />
Kwok, P.-Y., 421F, 2926W<br />
Kwok, S. K., 3158F<br />
Kwon, A., 947W*, 2715F<br />
*Presenting Author<br />
Kwon, M. S., 1385W<br />
Kwon, O.-S., 1931F<br />
Kwong, A., 177, 981W,<br />
3664W*<br />
Kyaw, E. E. P., 3034T<br />
Kypri, E., 3017T<br />
Kyriakou, S., 3017T<br />
Kyriazopoulou-<br />
Panagiotopoulou, S.,<br />
3505T<br />
L<br />
Laakman, A., 759W<br />
Laakso, A., 1253F<br />
Laakso, E. O., 47<br />
Laakso, M., 46, 88, 1117T,<br />
1608T, 1624T, 2256W,<br />
3455T<br />
Läärä, E., 1597T<br />
Labalme, A., 944T<br />
Labate, A., 2766F, 2780T<br />
Labelle-Dumais, C., 1689T,<br />
2684T<br />
Laberge, A. M., 1733W,<br />
1784W*<br />
Labonte, B., 2482T<br />
Labonté, B., 3470T<br />
Laborde, S., 716T<br />
Labrèze, C., 83<br />
Labrie, V., 3490T*<br />
Labuda, D., 1478W, 2790F<br />
Lacassie, Y., 3057W*<br />
Lacbawan, L., 693F<br />
Lacerenza, D., 550W<br />
Lach, F., 999W<br />
Lachance, J., 283*<br />
Lachance, S., 850F*<br />
La Chance Touchette, P.,<br />
2306F<br />
Lachenko, S., 302<br />
Lacher, M., 1159T<br />
Lackner, C., 1115F<br />
Lackner, K. J., 1669T<br />
Lacombe, D., 124, 473F,<br />
716T, 841F, 3172F<br />
Lacorte, L., 1119W*<br />
Lacoste, C., 2536T<br />
Lacour, A., 1423F*<br />
Lacro, R. V., 82<br />
LaCroix, A. Z., 2145W<br />
Lacroix, J., 778W*<br />
LaDana, C., 3154F<br />
Ladd-Acosta, C., 463F<br />
Ladeira, M. S., 1187F<br />
Ladenvall, C., 2076W,<br />
2187W<br />
Ladner, M., 1589T<br />
Ladouceur, M., 1678T,<br />
1982F, 2319W<br />
Lærum, H., 3614W<br />
LaFauci, G., 2449T<br />
Lafay-Cousin, L., 1052F<br />
Lafek, M., 750T<br />
Laforêt, P., 328<br />
Laframboise, R., 2790F<br />
LaFramboise, T., 1231T<br />
LaFreniere, D., 2474F<br />
Lafrenière, R. G., 2338T<br />
Lagace, F., 2866W<br />
Laganiere, J., 803W<br />
Lage, K., 805F<br />
Lagou, V., 190*, 2106W<br />
Lagström, S., 897W<br />
Lahjouji, F., 2306F<br />
Lahtinen, T., 327<br />
Lai, A., 3707F*<br />
Lai, A. H. M., 2889F<br />
Lai, C. Q., 2024F<br />
Lai, I., 3467T<br />
Lai, J., 2786T<br />
Lai, P. S., 771W*<br />
Lai, S., 177, 1120T*, 1516F,<br />
2198F, 2329T<br />
Lai, Y. C., 667F<br />
Laidre, P., 1140W<br />
Laine, M., 2058W<br />
Laing, S. M., 745F<br />
Laird, C. D., 1580W<br />
Laird, N., 1431T, 1526W,<br />
2346W<br />
Lajonchere, C., 2617T<br />
Lakshman Kumar, B.,<br />
1044W<br />
Lal, D., 2489F<br />
Lalani, S., 898T, 2942T<br />
Lalani, S. R., 229, 432W,<br />
952T, 2395T<br />
Lalanne, E., 9<br />
Laliberte, A., 76<br />
Läll, K., 1792W, 3353W<br />
Lally, C., 611T<br />
Lally, K. P., 834F<br />
Lalonde, E., 752T<br />
Lam, C. S. P., 2080T<br />
Lam, C. T., 680T*<br />
Lam, E. T., 2517W<br />
Lam, L., 3734W<br />
Lam, V., 2279F, 2280W<br />
LaMadrid-Herrmannsfeldt,<br />
M., 530W<br />
Lamantea, E., 164<br />
Lamari, F., 2820F<br />
Lamb, A. N., 886T<br />
Lamb, D., 2979T<br />
Lambert, B., 2179T<br />
Lambert, B. W., 194<br />
Lambert, C., 3303T, 3338W<br />
Lambert, L., 2792T<br />
Lambert, S., 2729T<br />
Lambourne, J. J., 3439T*<br />
Lambrecht, B., 2225F<br />
Lamb Thrush, D., 912T<br />
Lamb Thrush, L., 456W<br />
Lameijer, E., 459F<br />
Lameiras, L., 1778W<br />
Lamghari, H., 2306F<br />
Lammer, E., 75, 1589T<br />
Lammer, E. J., 1352W,<br />
1885T<br />
Lamnissou, K., 3017T<br />
Lamont, R., 910T, 3141W<br />
Lamontagne, M., 1655T,<br />
1947W*<br />
Lamparter, D., 1387F<br />
Lampe, A. K., 218<br />
Lamport, D., 3119W<br />
Lan, F., 1036T<br />
Lancaster, O., 3610W<br />
Lancet, D., 53, 2875W<br />
Landais, E., 3165W<br />
Landan, M., 3242F<br />
Landau, D., 2931F<br />
Lander, E., 322<br />
Landero, D., 2365T<br />
Landes, M., 3698W<br />
Landi, M. T., 1154F*<br />
Landsverk, M., 666T, 677F<br />
Lane, J., 1988F*, 3454T<br />
Laner, A., 1005W<br />
Lang, A. E., 2428T<br />
Lang, P., 1200W, 1233W<br />
Lang, R., 2637W<br />
Langaee, T., 646T<br />
Langberg, C. W., 991T<br />
Langberg, K. A., 2011T<br />
Langdon, Q., 3659F<br />
Lange, C., 1397W, 1536T,<br />
2057F, 2249F, 2346W,<br />
2520W<br />
Lange, E., 28, 1001F<br />
Lange, E. M., 170, 1214F,<br />
1437T, 1467T<br />
Lange, K., 38, 3621F<br />
Lange, L., 350, 1439W,<br />
2210F, 3678W<br />
Lange, L. A., 170*, 1408F,<br />
1437T, 1467T, 2131T,<br />
2336F, 2337W<br />
Langefeld, C. D., 1648T,<br />
1661T, 1888T, 1979F,<br />
2046W, 2143T, 2310W,<br />
3371W<br />
Langevin, L. M., 3095W<br />
Langevitz, P., 783W<br />
Langford, D. J., 1965W*<br />
Langhorst, B., 512W, 3517T<br />
Langhorst, B. W., 3702W,<br />
3715F<br />
Langlois, S., 2480F, 3135W<br />
Langmore, J. P., 3689F*<br />
Lango Allen, H., 2704W,<br />
2935W*<br />
Langouet, M., 202, 2808F*<br />
Langston, J. W., 803W<br />
Lanktree, M. B., 1659T<br />
Lannfelt, L., 434W<br />
Lanoel, A., 83<br />
Lantman - de Valk,<br />
H. M. J., 102<br />
Lao, K., 3696W<br />
Lao, R. Z., 2926W<br />
Lapasset, L., 857W<br />
Lapham, K., 96, 112<br />
Lapierrre, J.-M., 915W<br />
La Porta, M. L., 1060T<br />
Laporte, J., 328*, 2681T<br />
Lappalainen, I., 497F*<br />
Lappalainen, M., 2023T<br />
Lappalainen, T., 561F,<br />
567F*, 582W<br />
Lappe, J. M., 812F, 3081W<br />
Laprise, C., 665F, 778W,<br />
1361W, 1465F, 1941W<br />
Lapunzina, P., 3499T<br />
Laramie, J., 176, 1513F,<br />
1923W, 2308T, 2339F<br />
Largaespada, D., 1229F<br />
Lari, F., 2341T
Lariviere, M., 31<br />
LaRocque-Abramson, K.,<br />
1636T, 2340W<br />
Laron, Z., 2706F<br />
Laros, J. F. J., 2701W,<br />
3586W, 3611F<br />
Larouche, V., 1065W<br />
Larrieu, L., 2947W<br />
Larsen, A., 1050W, 2689W*<br />
Larsen, E. C., 446W<br />
Larsen, l. A., 805F<br />
Larsen, P., 520W<br />
Larson, D., 1210T*, 2325W<br />
Larson, E., 2098T, 3622W<br />
Larson, E. B., 343, 618T,<br />
1312F, 1828F<br />
Larson, M. C., 3451T<br />
Larson, N. B., 1247F*<br />
Larsson, P., 3732W<br />
LaSalle, J. M., 64, 832F,<br />
2783T, 3479T, 3498T<br />
Laslett, L. L., 2292W<br />
La Spada, A. R., 508W,<br />
565F, 2456F, 2628W<br />
Lasseaux, E., 473F<br />
Lasseter, V. K., 2573F<br />
Lassila, O., 1139F<br />
Laššuthová, P., 2745F<br />
Lasyone, C., 3648W*<br />
Laszig, R., 3203W<br />
Latendresse, S., 3512T<br />
Latha, M. M., 1893W*<br />
Lathi, R., 73<br />
Lathrop, G. M., 1952F,<br />
3466T, 3486T<br />
Lathrop, M., 649T, 1158W,<br />
1361W, 1461T, 1941W,<br />
2072F, 2079W, 2248T,<br />
2303F, 3439T<br />
Latos-Bielenska, A., 845F<br />
Latour, F., 1678T, 1982F<br />
Latourelle, J., 1964F<br />
Lattanzi, W., 2235W<br />
Lattig, C., 2705T<br />
Lattig, M. C., 3225W<br />
Lattimer, I., 1173W<br />
Lau, C., 134<br />
Lau, K. W., 138<br />
Lau, K.-W., 1211F<br />
Lau, L., 175, 2617T<br />
Lau, P., 1645T, 2236T<br />
Lau, S., 2102F<br />
Lau, W. W. S., 1419T*<br />
Lau, Y., 2016W, 2064W<br />
Lau, Y.-F. C., 408, 1179W<br />
Lauc, G., 3286F<br />
Laufer, B. I., 378*<br />
Laughlin, C. P., 639T<br />
Laukaitis, C. M., 1087T<br />
Laumen, H., 3536W<br />
Launay, J. M., 259<br />
Laurance, M., 3560W*<br />
Lauren, W., 2490W<br />
Laurent, C., 3658W<br />
Laurent, L. C., 3020T<br />
Laurent, N., 77, 3240F<br />
Laurenti, E., 1193F*<br />
Laureys, A., 2757F<br />
Laurino, M., 144*<br />
Lauritzen, T., 2347T<br />
*Presenting Author<br />
Laury-Andas, J., 1090T<br />
Lauwerys, B., 2284T<br />
Laux, R., 3335W<br />
Laval, G., 3304F<br />
Lavielle, N., 1158W<br />
LaViolette, C., 988T<br />
Laviolette, M., 1947W<br />
Lavy, J., 2302T<br />
Law, J., 3730W<br />
Law, L., 1889F<br />
Law, M. H., 212*<br />
Lawaetz, J., 2707W<br />
Lawani, M. B., 1162T<br />
Lawless, J. F., 1412W<br />
Lawlor, D. A., 1318F,<br />
1626T<br />
Lawrence, E., 2761W*,<br />
2960T<br />
Lawrence, M. S., 402<br />
Lawrenson, K., 210<br />
Lawson, J. W., 2330F<br />
Lawton, S., 143<br />
Lax, S., 1115F<br />
Layman, L., 2984T<br />
Layman, L. C., 2732T<br />
Layrisse, Z., 3390T<br />
Lay-Son, G., 1658T, 2065T<br />
Lazalde, B., 1121F*<br />
Lazar, M., 1727W, 3152F<br />
Lazaruk, K., 75<br />
Lazarus, P., 1016F, 1107W<br />
Lazier, J., 3511T*<br />
Lazor, R., 2877F<br />
Lazzeroni, L. C., 1356T*,<br />
1393F<br />
Le, S., 734T*, 2069F<br />
Le, S. Q., 695F, 697F, 785W<br />
Lea, A., 1820F<br />
Lea, R., 1042T<br />
Lea, R. A., 1912T, 2916F<br />
Leach, C. T., 1406W<br />
Leach, R. J., 2495F<br />
Leal, G. F., 2270F<br />
Leal, M. F., 1008W*, 1132T,<br />
3421T, 3503T<br />
Leal, S., 19, 93<br />
Leal, S. M., 6*, 1554T,<br />
2336F, 2337W<br />
Leão, L., 2434T<br />
Leao, L. L., 3107W<br />
Learned, K., 3557F, 3612W<br />
Leathley, E., 2625W<br />
Lebbé, C., 29<br />
Lebel, K., 1951T<br />
Lebel, R. R., 871W<br />
Le Ber, I., 345, 2638T<br />
LeBlanc, E., 2020T<br />
LeBlanc, M., 1581T*<br />
Lebo, R., 2972T*<br />
Lebon, P., 2452T<br />
Lebon, S., 299<br />
Le Bouar, G., 3170F<br />
Leboyer, M., 259<br />
Lebre, A.-S., 72<br />
Lebron, J., 310<br />
Le Calvez-Klem, F., 1213T<br />
Leccia, M.-T., 29<br />
Lecerf, J.-M., 1607T<br />
Lechno, S., 849F<br />
Leclerc, G., 778W<br />
SPEAKER AND AUTHOR INDEX 375<br />
Le Clerc-Blain, J., 1733W*<br />
Le Cras, T. D., 2136W<br />
Lecroq, T., 3538W<br />
Ledbetter, D. H., 299, 917W,<br />
2439W<br />
Ledda, M., 1281T<br />
Lederer, D., 3216F, 3218F<br />
Ledet, E., 1040F*<br />
Ledevil, C., 2436W<br />
LeDoux, M., 2782W<br />
LeDoux, M. S., 2438F*<br />
Le Dudal, K., 259<br />
Lee, A., 59, 207, 208,<br />
1109F, 1133F<br />
Lee, A. T., 306<br />
Lee, A. V., 3433T<br />
Lee, B., 164, 165, 389, 411,<br />
774W, 795W, 834F, 839F,<br />
840F, 2678T, 2854W,<br />
2934F, 3209W<br />
Lee, B. H., 698T*, 787W,<br />
2864T, 3227W<br />
Lee, B. K., 463F<br />
Lee, B.-N., 3722W*<br />
Lee, C., 10, 34, 400,<br />
494W, 864T, 1249T*,<br />
3103W, 3247W*,<br />
3251W, 3310F<br />
Lee, C. C., 1068W, 1244F<br />
Lee, C. R., 606T<br />
Lee, D., 258, 545F, 2119T,<br />
3008T, 3326W, 3461T<br />
Lee, D. H., 1654T<br />
Lee, D. S., 3463T*<br />
Lee, E., 1248W, 2117F<br />
Lee, E. J., 739F<br />
Lee, E. Y., 863W<br />
Lee, H., 315*, 361, 739F,<br />
1036T, 1657T*, 1685T,<br />
2117F, 2221T*, 3020T,<br />
3485T, 3536W, 3730W<br />
Lee, H.-J., 1622T<br />
Lee, H. M., 2279F<br />
Lee, H.-Y., 2581T*, 2779W,<br />
3656W, 3703F<br />
Lee, I., 2383T<br />
Lee, J., 267*, 442W, 909W,<br />
1061F, 1243T, 1248W,<br />
1291F, 1385W, 1561F*,<br />
1590T, 1650T, 1657T,<br />
1762W, 2117F, 2437T,<br />
2643W*, 2834T*, 3444T,<br />
3462T, 3473T, 3582W,<br />
3625F, 3708W<br />
Lee, J. A., 3109W*<br />
Lee, J.-E., 1656T<br />
Lee, J. E., 641T<br />
Lee, J. G. H., 129<br />
Lee, J.-H., 1964F<br />
Lee, J. H., 82, 194, 897W,<br />
1563T, 1641T, 2093F,<br />
2179T, 2208W*, 2410T,<br />
2547W<br />
Lee, J.-J., 3227W<br />
Lee, J. M., 9, 588W, 1786W,<br />
1787W, 1834F*<br />
Lee, J.-M., 1964F<br />
Lee, J.-O., 964T<br />
Lee, J. S., 787W, 1558F<br />
Lee, J. W., 2715F<br />
Lee, J.-Y., 3227W<br />
Lee, K., 231, 908T, 1654T,<br />
1656T, 2118W, 2119T,<br />
2828T, 3085W, 3635F<br />
Lee, K.-A., 3178F<br />
Lee, K. P. Y., 2640W<br />
Lee, L., 2826F<br />
Lee, M., 263, 900T, 1218W,<br />
1243T, 1474F*, 1590T,<br />
2142W, 2146T, 2156F,<br />
2437T, 2756T, 2921T<br />
Lee, M. H., 528W<br />
Lee, M. K., 26, 287, 1089W,<br />
1226F, 1464T, 1654T,<br />
2600F<br />
Lee, M. N., 528W*<br />
Lee, M. T., 2858T<br />
Lee, N.-C., 683F<br />
Lee, N. C., 706T<br />
Lee, O., 981W<br />
Lee, P. H., 352*<br />
Lee, R., 3696W<br />
Lee, R. K., 2154W, 2240F,<br />
2263T<br />
Lee, S., 846F, 947W,<br />
1230W*, 1248W, 1384F,<br />
1388W*, 1529W*, 1530T,<br />
1931F*, 2334W, 2663T,<br />
2715F, 3085W, 3413W,<br />
3473T, 3605F, 3681F<br />
Lee, S.-J., 2119T*<br />
Lee, S. K., 3423T*<br />
Lee, S. S.-J., Session 9<br />
Lee, S.-T., 1007F, 1103F<br />
Lee, T., 729F, 781W,<br />
2200T<br />
Lee, W., 1248W*, 2437T,<br />
2581T, 3606W<br />
Lee, Y., 40*, 985T, 1894T*,<br />
1905W, 2587T<br />
Lee, Y. A., 2102F<br />
Lee, Y.-A., 1942T<br />
Lee, Y.-H., 1622T<br />
Lee, Y.-J., 2285F<br />
Lee, Y. K., 846F<br />
Lee, Y. M., 2712F<br />
Leeder, J. S., 811F<br />
Lee-Kirsch, M. L., 2102F<br />
Lees, M., 2752W, 2896W<br />
Lees, M. M., 217<br />
Lefeber, D. J., 214, 672T<br />
Lefebvre, A., 3538W<br />
Lefebvre, J.-F., 1478W<br />
Lefever, S., 2927T<br />
Lefevre, J., 1170W<br />
Leffler, E., 285<br />
LeFloch, A., 1768W<br />
Lefol, C., 1212W<br />
Lefort, G., 857W, 936T,<br />
2386T, 2729T, 3121W,<br />
3166F<br />
Legallic, S., 345<br />
Legeai-Mallet, L., 763W<br />
Legendre, M., 77*, 403<br />
Legendre-Guillemin, V., 778W<br />
Legius, E., 1139F<br />
Le G<strong>of</strong>f, C., 127*<br />
Le G<strong>of</strong>f, W., 127<br />
Legrand, G., 1170W<br />
Legro, R. S., 2327F<br />
SPEAKER AND AUTHOR INDEX
376 SPEAKER AND AUTHOR INDEX<br />
Lehesjoki, A.-E., 2898F<br />
Lehman, A., 750T, 3006T*<br />
Lehman, D., 1513F, 2495F<br />
Lehman, D. M., 176, 1923W,<br />
2308T, 2339F<br />
Lehne, B., 1470T<br />
Lehner, T., 2523W, 2560T<br />
Lehr, T., 617T<br />
Lehrach, H., 582W<br />
Lehtimäki, T., 109, 656T,<br />
1623T, 2059T, 2097W,<br />
2120F, 2350T, 2383T<br />
Lehtinen, M. K., 266<br />
Lehtonen, R., 995F<br />
Lei, J., 824F, 1144T<br />
Leiba, H., 3162F<br />
Leidinger, P., 515F<br />
Leigh, M. J., 770W<br />
Leigh, M. W., 2851W<br />
Leighl, N. B., 1108T<br />
Leijsten, N., 979W<br />
Leijsten, N. F. A., 955W<br />
Leikin, S., 222, 2853F<br />
Lein, E., 2444F<br />
Leipzig, J., 391<br />
Leissner, P., 2255F<br />
Leistner-Segal, S., 747F<br />
Leistritz, D. F., 1759W*<br />
Leite, J., 1851F<br />
Leitsalu-Moynihan, L.,<br />
1792W, 1832F*, 3353W<br />
Lejeune, S., 1212W<br />
Lek, M., 280, 295*, 582W<br />
Lekanne dit Deprez, R.,<br />
1616T, 3650W<br />
Lekshami, J., 3400T<br />
Lelis, A. M., 753T*<br />
Lema, G., 283, 3303T, 3338W<br />
Lemaitre, J. M., 857W<br />
Lemanske, R., 536W<br />
Le Marchand, L., 205,<br />
1079F, 2202W<br />
LeMarchand, L., 1067F,<br />
1206W, 1925F<br />
Lemay, P., 2075F*<br />
Le Merrer, M., 324, 915W,<br />
2729T, 3129W<br />
Le Meur, G., 390<br />
Lemieux Perreault, L.-P.,<br />
3401W<br />
Lemire, E., 3127W, 3209W<br />
Lemire, E. G., 2772F<br />
Lemire, M., 1093T, 3478T,<br />
3489T<br />
Lemley, M., Session 20<br />
Lemke, A. A., Session 25<br />
Lemmelä, S., 2120F*<br />
Lemmens, I., 2660F<br />
Lemmers, R. J. L. F., 55<br />
LeMons, C., 774W<br />
Lemos, C., 1296T*, 2736F<br />
Lemos Silveira-Lucas, E., 131<br />
Lemyre, L., 149, 1827W<br />
Lenaers, G., 2679F<br />
Lench, N. J., 1748W, 1773W*<br />
Lencz, T., 17, 264, 3346F,<br />
3366T<br />
Lenders, J. W. M., 1220F<br />
Lenferna de la Motte, P.,<br />
2411F<br />
*Presenting Author<br />
Leng, N., 1249T<br />
Lenk, G. M., 2471F*<br />
Lenkala, D., 623T<br />
Lenkiewitz, E., 1186T<br />
Lennep, C. V., 2676F<br />
Lennington, J., 2854W<br />
Lenz, D. R., 2914W<br />
Lenz, M., 1851F<br />
Lenz, P., 1092W<br />
Lenz, T. L., 3404T*<br />
Lenzini, P. A., 2535W<br />
Leo, P., 152<br />
Leo, P. J., 2053T<br />
Leon, E., 3189W*<br />
Leonard, L., 2316W, 3040F<br />
Léonard, M., 3538W<br />
Leonardi, E., 1755W, 2795T<br />
Leon-Del-Rio, A., 3504T<br />
Leone, M., 2095T, 2804T<br />
Leong, P., 3717F<br />
Leongamornlert, D., 205,<br />
1011W<br />
Leon-Salazar, V., 821F<br />
Leotta, A., 2587T<br />
Leoyklang, P., 709F*<br />
LEPGen Consortium, 2116T<br />
Leppä, V., 252, 2350T*,<br />
2399F<br />
Leppanen, P. H. T., 1976F<br />
Leppert, M. F., 2397W<br />
Leppert, T., 2397W<br />
Leproust, E., 3709F<br />
LeProust, E., 975W, 3459T,<br />
3653F, 3669F, 3726W<br />
Lerach, H., 567F<br />
Lerch, M. M., 2141F<br />
Leren, T. P., 1607T<br />
Lerental, Y., 2691F<br />
Lerer, B., 2564F<br />
Lermioglu, F., 1172F<br />
Lerner, M., 474W<br />
Leroy, B., 77<br />
Leroy, B. P., 539F, 1790W,<br />
2927T<br />
Lesage, S., 29, 2638T*<br />
Lese Martin, C., 13, 299<br />
Leshinsky-Silver, E., 3174F<br />
Leske, M. C., 1003T<br />
Lesko, S. M., 1107W<br />
Leskovac, A., 3286F<br />
Leslie, E., 2325W<br />
Leslie, E. J., 2762T*<br />
Leslie, N., 789W<br />
Leslie, S., 181*<br />
Lesniak, B. P., 2185T<br />
Lesovaya, E., 1180T, 1181F*<br />
Lessage, S., 1982F<br />
Lessard, C. J., 529F,<br />
2084F*, 2188T<br />
Lessard, J. A., 529F, 2084F,<br />
2188T<br />
Lessov-Schlaggar, C. N.,<br />
642T<br />
Lester, T., 218<br />
Lesueur, F., 1213T<br />
Letaif, O., 3184F<br />
Leth, H., 702T<br />
le Tisser, P., 2701W<br />
Letourneau, A., 67, 85,<br />
561F, 807F, 3431T*<br />
Letra, A., 1936T*<br />
Letra, A. M., 1908W<br />
Lettre, G., 350, 1408F,<br />
1906T*, 2063F, 2210F,<br />
2247W, 2319W, 3401W,<br />
3525T<br />
Leung, D., 2849T<br />
Leung, D. G., 2962W<br />
Leung, H.-T., 2072F<br />
Leung, P. C. K., 2977T<br />
Leusink, M., 609T*<br />
Leuzzi, V., 760W<br />
Lev, D., 2447F, 3048F,<br />
3174F<br />
Levade, T., 54, 716T<br />
LeVan, T. D., 3027T<br />
Levandowsky, E., 400,<br />
1068W, 1244F<br />
Levenstein, M., 1269W<br />
Leverenz, J., 2538W<br />
Leverenz, J. B., 2646W<br />
Levert, A., 2558F<br />
Levesque, G., 2528F<br />
Levesque, M. P., 363<br />
Levi, M., 1604T<br />
Levin, A., 1250F<br />
Levin, A. M., 1895F*<br />
Levin, B., 2583W<br />
Levin, H., 1138T<br />
Levin, J. Z., 554W<br />
Levine, D., 3210F<br />
Levine, D. M., 2190W<br />
Levine, J. D., 1965W<br />
Levine, K., 2761W, 2960T<br />
Levine, M. A., 3448T<br />
Levine, R. L., 1017W<br />
Levine, S., 1820F<br />
Levinson, D., 2576F<br />
Levinson, D. F., 369, 2372F,<br />
3658W<br />
Levitas, A., 1588T<br />
Levitt, P., 2444F<br />
Levy, B., 73*, 937W, 957W,<br />
977W, 1031F, 3018T<br />
Levy, D., 584W, 1600T, 1653T,<br />
1659T, 2063F, 2587T<br />
Levy, D. J., 3158F<br />
Levy, J., 2114F<br />
Levy, J. L., 2170T<br />
Levy, N., 328<br />
Levy, R., 10<br />
Levy, S., 494W, 1239W<br />
Levy, S. M., 1464T<br />
Levy Lahad, E., 2991T, 3002T<br />
Levy-Lahad, E., 2447F,<br />
2929W, 2993T<br />
Levy-Mozziconacci, A.,<br />
3129W<br />
Lewandoski, M., 828F<br />
Lewellen, N., 2<br />
Lewinger, J., 1362T<br />
Lewin-Koh, N. J. I., 1539T*<br />
Lewis, A. P., 74, 94<br />
Lewis, B., 2145W<br />
Lewis, B. A., 1295W<br />
Lewis, C. E., 1661T<br />
Lewis, C. M., 348, 1313W,<br />
1329T*, 2509T<br />
Lewis, D., 2034W*<br />
Lewis, D. M., 529F, 2188T<br />
Lewis, I., 3695F<br />
Lewis, J. P., 602T<br />
Lewis, K., 358, 1690T<br />
Lewis, K. L., 1696T<br />
Lewis, M., 3697F<br />
Lewis, M. E. S., 491F<br />
Lewis, M. H., 1731W<br />
Lewis, R., 1900T, 2043W<br />
Lewis, R. A., 3234F<br />
Lewis, S., 447F, 517F<br />
Lewis, S. E., 2725W<br />
Lewis, T., 3182F*<br />
Ley, R. E., 537F, 2029T<br />
Ley, T., 1203W<br />
Leya, J., 865W<br />
Leyva, N., 9, 3124F, 3226F<br />
Leyva, X., 3125W<br />
Li, A., 121, 174, 648T<br />
Li, B., 93, 869W, 2216F*,<br />
2926W, 3273T*, 3275W,<br />
3566W<br />
Li, C., 1493W, 2204F*, 2207F,<br />
2301W, 3275W, 3557F,<br />
3603F, 3604W, 3714W*<br />
Li, C.-Y., 1209W, 1246T,<br />
3278W<br />
Li, D., 1157F, 1681T, 2136W,<br />
2722W, 2856F*, 3237W<br />
Li, F.-Y., 1750W*, 2778F<br />
Li, G., 2080T, 2145W<br />
Li, G.-N., 457F, 2623T<br />
Li, H., 116, 195, 284, 529F,<br />
798W*, 1242W, 1261T,<br />
2084F, 2188T*, 2246F,<br />
2259W, 2477F, 2643W,<br />
3029T, 3293W, 3320W*,<br />
3377W<br />
Li, H.-Y., 3529F<br />
Li, J., 196, 432W, 1404T,<br />
1473T, 1491T, 2053T,<br />
2121W*, 2172W, 2229W,<br />
2237F, 2332T, 2571W,<br />
2879T, 3282T, 3465T*,<br />
3505T, 3534W, 3613F*<br />
Li, J. B., 289, 527F, 543F,<br />
577F<br />
Li, J. Z., 476W, 2135F, 3285T<br />
Li, K., 3281W<br />
Li, K. P., 170<br />
Li, L., 603T*, 888T*, 1086W,<br />
1612T, 1686T, 2230T*,<br />
2680W, 3081W, 3134F,<br />
3483T, 3552W<br />
Li, M., 21*, 399*, 812F,<br />
1027T, 1040F, 1532W,<br />
1555F, 1642T, 1914W*,<br />
2210F, 2444F, 3551F<br />
Li, M. D., 1540F, 2388W,<br />
2390F, 2574W<br />
Li, M. X., 3559F<br />
Li, N., 2544W*<br />
Li, Q., 5*, 159, 1363F,<br />
1512T, 2048F, 2345F,<br />
2419T<br />
Li, Q. B., 2311T<br />
Li, Q. Z., 1901F, 2284T<br />
Li, R., 106, 277, 618T,<br />
1167W, 1311T*, 1312F,<br />
1411F, 1447F, 2098T,<br />
2921T, 3308W, 3667F*
Li, S., 443F, 909W, 1235F,<br />
1365T, 1369F, 2274W*,<br />
2834T, 3394T, 3464T*<br />
Li, T., 2419T, 2494T, 2573F<br />
Li, W., 441F*, 528W, 844F*,<br />
1322W*, 2953W<br />
Li, W. D., 2612F<br />
Li, W. R., 2858T<br />
Li, X., 568W*, 950T, 1322W,<br />
2094W, 2698W, 2895F,<br />
2907F, 3021T, 3065W,<br />
3535F<br />
Li, Y., 1, 154, 159, 323, 377,<br />
382*, 399, 408*, 480W,<br />
564W, 1027T, 1369F,<br />
1427W, 1437T, 1491T,<br />
1524T, 1532W, 1555F,<br />
1627T, 1730W, 1952F,<br />
2251T, 2254T, 2317T,<br />
2347T, 2489F, 2542T,<br />
2559W, 2617T, 2944W,<br />
3134F*, 3221W, 3307F,<br />
3483T, 3490T, 3553F,<br />
3580W<br />
Li, Y. S., 1110W<br />
Li, Z., 974T*, 1304W, 1546F<br />
Lia-Baldini, A.-S., 2694F*<br />
Lianas, L., 157<br />
Liang, B., 490W<br />
Liang, C., 1901F, 2949F<br />
Liang, J., 2251T, 3307F<br />
Liang, J. Q., 1723W<br />
Liang, K. Y., 1472W<br />
Liang, L., 1027T, 1357F,<br />
1390F, 2102F, 3466T*,<br />
3469T, 3486T<br />
Liang, M., 1540F<br />
Liang, S., 1133F<br />
Liang, W., 1240T<br />
Liang, Y., 3300T<br />
Liao, J., 904T, 2094W<br />
Liao, J. C., 2238W<br />
Liao, O. Y., 1054T<br />
Liao, S.-Y., 2122T*<br />
Liao, W., 3708W<br />
Liao, Y., 511F<br />
Liao, Y. C., 1586T*<br />
Libarkin, J., 1861F<br />
Libener, R., 1153T<br />
Liberal, V., 3720W<br />
Liberton, D. K., 2223W<br />
Libiger, O., 24*, 3332W<br />
Li Chang, H. H., 1138T<br />
Lichanska, AM., 1165T<br />
Lichtarge, O., 2854W<br />
Lichtenstein, P., 2509T<br />
Lichter, P. R., 2154W, 2240F,<br />
2263T<br />
Lichter-Konecki, U., 774W<br />
Lichtner, P., 2086T, 2568W<br />
Lichty, A., 3171W<br />
Lidar, M., 783W<br />
Lidereau, R., 1062W,<br />
1212W<br />
Lidral, A., 2325W<br />
Lie, R., 1564F<br />
Lie, R. T., 1472W<br />
Lieber, D. S., 326*<br />
Lieberman, E., 872T, 875W<br />
Lieden, A., 1939T<br />
*Presenting Author<br />
Liendhard, A., 2694F<br />
Lietman, C., 2854W<br />
Lifton, R., Session 74<br />
Lifton, R. P., 845F, 1241F,<br />
2779W, 2915T<br />
Light, N., 569F*<br />
Ligon, K. L., 266<br />
Ligtenberg, M. J. L., 1220F<br />
Liguori, M., 2597F<br />
Lih, C.-J., 1068W*<br />
Lihm, J., 1338T*<br />
Lilien, M. R., 2848W<br />
Liljedahl, U., 3217W, 3427T<br />
Lilley, J. S., 1634T*<br />
Lillquist, Y., 750T<br />
Lim, B., 680T, 877W*, 3204F<br />
Lim, B. C., 3180F<br />
Lim, E., 280, 624T<br />
Lim, E. C. P., 2889F<br />
Lim, E. T., 11*, 2344T,<br />
2613W<br />
Lim, J., 947W, 3008T*,<br />
3461T<br />
Lim, J.-E., 1622T<br />
Lim, J.-H., 964T<br />
Lim, J. W., 55<br />
Lim, M., 1622T<br />
Lim, R., 2482T<br />
Lim, S., 2328W*<br />
Lim, S. N., 3034T<br />
Lim, Y., 552W*<br />
Lima, B. L., 776W*<br />
Lima, M. A. F. D., 2642F<br />
Lima, R. M., 1880F<br />
Limacher, J.-M., 1212W<br />
Limaye, M., 1015T<br />
Limaye, N., 83, 1611T<br />
Limburg, P. J., 1351F<br />
Limem, K., 1751W<br />
Limon, A., 694T<br />
Limotai, C., 2749W<br />
Lin, A., 103, 124, 126<br />
Lin, A. Y., 1054T<br />
Lin, B., 2974T<br />
Lin, C., 1249T, 3695F<br />
Lin, C.-F., 342, 2316W<br />
Lin, C.-L., 2285F<br />
Lin, C. Y., 1368T<br />
Lin, D., 170, 1027T, 2337W<br />
Lin, D. Y., 1434T, 1437T<br />
Lin, G. N., 2660F<br />
Lin, H., 981W*, 2556W,<br />
3467T*<br />
Lin, I.-H., 610T<br />
Lin, J., 96, 112<br />
Lin, L., 382, 2543F<br />
Lin, M., 1894T, 1905W<br />
Lin, M.-W., 610T*, 1955F<br />
Lin, R., 511F<br />
Lin, S., 1272W, 2419T,<br />
2610W, 3326W, 3467T<br />
Lin, S.-W., 1010F<br />
Lin, W., 985T, 1410T, 1894T<br />
Lin, X., 1529W, 1530T,<br />
2122T, 2334W<br />
Lin, Y., 1235F, 2053T<br />
Lin, Y. C., 2245T<br />
Lin, Y. H., 2936T*<br />
Lin, Y.-Y., 214<br />
Lin, Z., 2478W*, 2921T*<br />
SPEAKER AND AUTHOR INDEX 377<br />
Linares, N., 659F<br />
Lincecum, T., 3698W<br />
Lincoln, P., 804W<br />
Lincoln, S., 1513F, 1923W,<br />
2308T, 2339F<br />
Lincoln, S. E., 176<br />
Lind, J. M., 1705T, 1862F*<br />
Lind, L., 2070W<br />
Lind, P. A., 2212T, 2505W*<br />
Lindberg, M. L., 436W<br />
Lindblad-Toh, K., 322<br />
Linden, D., 684T<br />
Lindenbaum, P., 1204T<br />
Linder, H., 2331W<br />
Linderoth, T., 3312T<br />
Lindfors, K., 2023T<br />
Lindgren, A. M., 70, 284,<br />
862T<br />
Lindgren, C. M., 44, 173,<br />
269, 583F, 1308T, 1954T,<br />
2070W, 2076W, 2077T,<br />
2090F, 2123F, 2147F,<br />
2187W, 2324F, 3435T<br />
Lindhurst, M. J., 33*<br />
Lindor, N. M., 141, 1058F*,<br />
1067F, 1079F, 1206W,<br />
3564W<br />
Lindo-Samanamud, S.,<br />
2453F*<br />
Lindquist, K., 1250F*<br />
Lindsay, F., 2497T<br />
Lindsay, M., 81<br />
Lindsay, M. E., 79, 80<br />
Lindsay, S., 43, 61<br />
Lindstrand, A., 2955F*<br />
Lindstrom, S., 191, 205,<br />
318, 356, 1150T<br />
Linehan, W. M., 1242W<br />
Ling, H., 46, 1254W, 1452T,<br />
1512T, 2556W, 3716W<br />
Ling-Fung, P., 2926W<br />
Linker, S., 524W*<br />
Linn, A., 316<br />
Linnankivi, T., 2888T<br />
Linneberg, A., 2317T<br />
Linnertz, C., 2465F<br />
Lins, T. C. L., 1880F,<br />
3272W*<br />
Lins, T. S., 2706F<br />
Linton, M. F., 1634T<br />
Lioi, M. B., 2629T<br />
Lionel, A., 98, 2570F<br />
Lionel, A. C., 2575T*, 3086F,<br />
3095W<br />
Liou, B., 161<br />
Liou, H., 2392T<br />
Lipinski, S., 2103W<br />
Lipkin, S. L., 1159T<br />
Li-Pook-Than, J., 1505W,<br />
2322W<br />
Lippert, C., 1379W, 3468T<br />
Lipshultz, L., 2979T<br />
Lipska, B. K., 260, 2622W<br />
Lipson, S., 168<br />
Liptak, G. S., 1254W<br />
Lira, R. P. C., 2751F<br />
Lis, J. T., 415F<br />
Lisoňová, J., 2745F<br />
Lissowska, J., 1117T<br />
Listerman, I., 96, 112<br />
Listgarten, J., 1379W,<br />
3468T*<br />
Litscher, S. J., 710T<br />
Little, J., 149, 1827W<br />
Littleton, K. R., 50<br />
Littman, E., 78<br />
Littman, J., 999W<br />
Littrell, J., 441F<br />
Litzelman, K., 1267T<br />
Litzler, J., 3240F<br />
Liu, A., 536W<br />
Liu, C., 412W*, 486W,<br />
1585T, 1896W*, 1974W,<br />
2196W, 2197T, 2561F,<br />
3520T<br />
Liu, C. T., 2030F<br />
Liu, D., 1370W*<br />
Liu, E., 1330F<br />
Liu, E. Y., 1427W, 1555F*<br />
Liu, G., 1016F, 1108T,<br />
3210F<br />
Liu, H., 1257W, 1291F,<br />
2721F*<br />
Liu, J., 368, 602T, 910T*,<br />
924T*, 1117T, 1930T,<br />
2055W, 2112W, 2275T<br />
Liu, J. B., 2985T<br />
Liu, J. J., 1934F<br />
Liu, J. Z., 153*, 2101T,<br />
2163W<br />
Liu, K., 1371T, 2649W<br />
Liu, L., 1433W, 1520W*,<br />
1777W<br />
Liu, M., 1198T<br />
Liu, M.-J., 3029T<br />
Liu, N., 1410T*, 1460W<br />
Liu, P., 61*, 63, 512W, 824F,<br />
1511W*, 3483T, 3517T,<br />
3702W, 3715F*<br />
Liu, R., 2969T<br />
Liu, S., 326, 489F*, 1925F,<br />
2489F, 3428T<br />
Liu, T., 1070F<br />
Liu, V. C. H., 2066F<br />
Liu, W., 314, 613T*, 1735W,<br />
1742W, 1757W, 1761W,<br />
2802F*<br />
Liu, X., 123, 174, 349,<br />
442W*, 864T, 1182W*,<br />
1369F, 1546F, 1693T*,<br />
3026T, 3339T*<br />
Liu, X. L., 1930T<br />
Liu, X. S., 1907F<br />
Liu, Y., 13, 386, 544W,<br />
1019F*, 1098W, 1491T,<br />
1642T*, 2052W, 2145W,<br />
2154W, 2172W, 2240F,<br />
2263T, 2556W, 3551F<br />
Liu, Y. J., 2053T<br />
Liu, Y.-Z., 2172W<br />
Liu, Y. Z., 2053T<br />
Liu, Z., 1357F*, 1644T,<br />
2020T, 3495T, 3587F<br />
Livermore Auer, P., 19*<br />
Livingston, R., 530W<br />
Livneh, A., 783W<br />
Lizano, E., 567F<br />
Llewellyn, K. J., 757W*<br />
Lloreta, J., 1091F<br />
Lloyd, D., 3703F<br />
SPEAKER AND AUTHOR INDEX
378 SPEAKER AND AUTHOR INDEX<br />
Lloyd, D. L., 219*<br />
Lloyd-Evans, E., 162<br />
Lo, C.-L., 829F<br />
Lo, F., 1894T<br />
Lo, K., 601T, 1249T<br />
Lo, K. S., 1906T, 3525T*<br />
Lo, Y., 1521T*<br />
Loane, E., 1897T<br />
Lobina, M., 177, 1516F,<br />
2329T, 3664W<br />
Lobo, D. S. S., 2608T*<br />
Local Genome Diversity<br />
Studies Consortium,<br />
3315T<br />
Locke, A. E., 108, 173, 269,<br />
1954T, 2069F, 2090F,<br />
2123F*, 2147F, 2241W<br />
Lockhart, D. J., 732T, 1684T<br />
Lockhart, N., 1845W<br />
Lockwood, C., 3030T<br />
Locus Development, Inc.,<br />
1766W, 1771W, 3548W,<br />
3692W<br />
Loddo, S., 881W, 943W,<br />
2777T*<br />
Loeschner, A., 2483F<br />
Loeuillet, L., 77, 403<br />
Loeys, B., 79, 80*, 1617T,<br />
1679T, 2387F<br />
L<strong>of</strong>tus, S. K., 258<br />
Logan, A. C., 1112F<br />
Loget, P., 77, 3129W, 3170F<br />
Logronio, C., 3331F*<br />
Logsdon, B. A., 1408F*<br />
Logue, M., 343<br />
Logue, M. W., 2563T*<br />
Loguercio, S., 3584W<br />
Lohi, H., 2213F, 2517W,<br />
2913F<br />
Löhle, E., 2829F, 3203W<br />
Lohman, G., 3517T, 3715F<br />
Lohmann, D., 392<br />
Lohmann, J., 2160W<br />
Lohmann, K., 200*, 204<br />
Lohmueller, K., 182, 281<br />
Lohmueller, K. E., 1573F,<br />
2311T*, 3305W<br />
Lohn, Z., 1846W*<br />
Lohnau, T., 204<br />
Loi, A., 157<br />
Loi, H., 3730W<br />
Lok, K. H., 1662T<br />
Loke, J., 409*, 1185W<br />
Loken, E., 2594F<br />
Loken, E. K., 2599T*<br />
Lokki, M. L., 3258T<br />
Lolkema, M., 400<br />
Lomas, D., 2057F<br />
Lomas, D. A., 2249F<br />
Lomax, M. I., 1878W<br />
London, S., 536W<br />
Londono, D., 1358W*,<br />
1359T<br />
Londsdale, J., 368<br />
Long, J., 3612W<br />
Long, Q., 1457W<br />
Long Life Family Study,<br />
2040W<br />
Longman, C., 2812W<br />
Longo, A., 824F, 3492T<br />
*Presenting Author<br />
Longo, N., 660T, 689F<br />
Longstreth, W. T., 1592T<br />
Lonie, A., 1213T, 3679F<br />
Lönnerholm, G., 3427T<br />
Lonnqvist, J., 252<br />
Lonsberry, V., 3683F<br />
Loo, A., 3006T<br />
Loo, S. K., 639T<br />
Loogers, L., 307<br />
Looijenga, L. H. J., 1122W*,<br />
1273T<br />
Loomes, K. M., 2316W<br />
Loomis, E., 477F, 2634W<br />
Loomis, E. W., 2633F*<br />
Loomis, S., 1887W, 2263T*<br />
Loomis, S. J., 2154W,<br />
2240F<br />
Loos, B. G., 2058W<br />
Loos, R. J., 2116T, 2131T<br />
Loos, R. J. F., 43, 108,<br />
1954T, 2090F, 2123F,<br />
2147F, 2241W, 2282F,<br />
2359T<br />
Lopes, A., 1778W, 2982T<br />
Lopes, F., 913W<br />
Lopes-Cendes, I., 514W,<br />
2233T, 2393F, 2394W,<br />
2609F*, 2653T, 2655W,<br />
2876T, 3578W<br />
Lopez, A., 1141T, 3035W<br />
Lopez, E., 2716W, 2770W*,<br />
2792T<br />
Lopez, I., 1779W<br />
Lopez, J., 3582W<br />
Lopez, J. P., 2338T, 2482T*<br />
Lopez, O. L., 2125T, 2521T<br />
Lopez Camarillo, C., 1048T<br />
López-Hernández, G.,<br />
1131W, 1141T<br />
Lopez Parra, A. M., 3364F,<br />
3402T<br />
Loplumlert, J., 2749W<br />
Loranger, K., 1059W<br />
Lord, G., 2082W<br />
Lord, H., 218<br />
Lorenco, L. G., 3421T<br />
Lorente, B., 1<br />
Lorenz-Depiereux, B.,<br />
2693T, 2922F*<br />
Lorenzo, C., 1888T<br />
Lorenzo, F. R., 3297T<br />
Lorey, F., 362<br />
Lorget, F., 763W*<br />
Lori, A., 2383T*, 2384F<br />
Loring, E., 2915T<br />
Lo Rizzo, C., 2604W<br />
Lortz, A., 3088F<br />
Löscher, W., 2948T<br />
Löscher, W. N., 201<br />
Losfeld, M. E., 1758W<br />
Lossie, A. C., 829F*<br />
Lotery, A. J., 2072F, 2843T<br />
Lott, P., 552W, 3479T<br />
Lotta, L., 2880F<br />
Lou, H., 443F*, 1242W,<br />
3334F, 3394T<br />
Lou, X., 1460W*<br />
Lou, Y., 1232F, 3456T<br />
Loucoubar, C., 2079W,<br />
2248T*<br />
Louie, K., 3429T<br />
Louie, T., 171<br />
Louie, Y., 3182F<br />
Louis, E., 442W, 2377T<br />
Louis, E. D., 1898F<br />
Loureiro, L. J., 2820F<br />
Lourenco, C., 2425T*<br />
Lourenço, C., 895W<br />
Lourenço, L. G., 3503T<br />
Lourenço, N. C. V., 1727W<br />
Louro, I. D., 182, 1573F<br />
Loutrel, J., 3530W<br />
Love, T. W., 2087F<br />
Lovecchio, J., 1133F<br />
Lovelette-Hernandez, A.,<br />
1754W<br />
Lovell, A., 789W<br />
Lovestone, S., 3471T<br />
Lovick, N., 145*, 1810F<br />
Lovicu, M., 847F<br />
Loviglio, M. N., 775W, 3256F*<br />
Low, P. S., 771W<br />
Low, S., 2506T*<br />
Low, S.-K., 2133W<br />
Lowe, J., 553F<br />
Lowe, J. K., 2478W, 2518T,<br />
2551T*, 2658W<br />
Lowman, G., 3698W<br />
Lowndes, S., 982T*<br />
Lowrance, W., 1328W<br />
Loyola, B., 3076F<br />
Lozano, M. C., 2705T*<br />
Lozanovski, V. J., 845F<br />
LSFC Consortium, 665F<br />
Lu, A., 2415W*<br />
Lu, A. T., 2056T<br />
Lu, C., 1203W, 2606F,<br />
2759T<br />
Lu, D., 2721F, 3334F, 3394T<br />
Lu, F., 1251W, 3648W<br />
Lu, H., 2698W, 2895F,<br />
3065W, 3535F, 3681F<br />
Lu, H. M., 2698W, 2895F,<br />
3065W, 3535F<br />
Lu, I., 1736W<br />
Lu, J., 2934F, 3209W,<br />
3597F*<br />
Lu, J. T., 2864T<br />
Lu, L., 28, 1661T<br />
Lu, Q., 638T, 2251T<br />
Lu, W., 82<br />
Lu, X., 116, 134*, 909W,<br />
2259W<br />
Lu, X.-J., 2970T<br />
Lu, X. L., 1974W<br />
Lu, Y., 5, 1249T, 1511W,<br />
1582F, 2048F*, 2345F,<br />
2868F<br />
Lu, Y. C., 2936T<br />
Lu, Y. E., 1298W<br />
Lu, Z., 247<br />
Lu, Z.-L., 2970T<br />
Lua, R., 2854W<br />
Luan, J., 1553W*, 2282F<br />
Luan, J. A., 1365T<br />
Lublingh<strong>of</strong>f, N., 2829F*<br />
Luc, G., 1607T<br />
Luccarini, C., 205<br />
Lucchiari, S., 1751W<br />
Lucena-Araujo, A. R., 1045T<br />
Ludmila Serafim, A. L. S.,<br />
3099W*<br />
Ludtke, A., 3033T*<br />
Ludwig, D., 96, 118, 230,<br />
2513F<br />
Ludwig, K., 1512T<br />
Ludwig-Kubinski, A., 1269W<br />
Ludwin, S., 671F<br />
Luedeke, M., 1080W<br />
Lugo-Trampe, A., 1030T<br />
Lugtenburg, I. C., 3611F<br />
Luiselli, D., 3322F<br />
Lujic, S., 1705T<br />
Luk, J., 1369F<br />
Luke, A., 1959W<br />
Luke, M. M., 1603T*<br />
Lukina, E., 773W<br />
Lukong, J., 1958F<br />
Luksan, O., 570W*<br />
Lulli, P., 760W<br />
Lum, P. Y., 2220W, 3618W<br />
Lumayag, S., 520W<br />
Lumley, T., 1346W, 1585T<br />
Lund, A. M., 737F<br />
Lund, J., 2699T<br />
Lund, L., 1845W<br />
Lundholm, C., 1707T<br />
Lundmark, P., 569F<br />
Lunetta, K., 1571W, 2165F<br />
Lunetta, K. L., 343, 1476T,<br />
2336F<br />
Lunnon, K., 3471T<br />
Luo, G., 3698W<br />
Luo, L., 20, 1401T*<br />
Luo, M., 490W, 1777W*,<br />
3276T*<br />
Luo, R., 553F*<br />
Luo, S., 1167W<br />
Luo, X., 521F<br />
Luo, Y., 354*<br />
Luoma, L. M., 2474F*<br />
Lupien, M., 188<br />
Lupoli, S., 2095T<br />
Lupski, J., 360*, 777W,<br />
2542T, 2934F<br />
Lupski, J. R., 61, 63, 229,<br />
314, 337, 428W, 430W,<br />
432W, 433F, 485F, 898T,<br />
1735W, 1742W, 1761W,<br />
2470T, 2798T, 2881W,<br />
2883F, 2908W, 2955F<br />
Lupton, S. J., 1705T<br />
Luscombe, S., 454W<br />
Lusis, A., 1337W<br />
Lusis, A. J., 39<br />
Luthra, K., 555F<br />
Lutz, C., 983F<br />
Lutz, F., 2646W<br />
Lutz, M., 2465F<br />
Lutz, M. W., 637T*, 1382W<br />
Lutz, R., 2951T<br />
Luu, S., 832F, 2571W<br />
Luukkonen, T. M., 897W*<br />
Luz del Rosario, M., 167<br />
Lvova, M., 3653F<br />
Ly, C., 2742F<br />
Ly, V., 490W<br />
Lybarger, D. J., 1346W<br />
Lyle, P., 136<br />
Lyle, R., 434W, 3510T*
Lynch, D. C., 3127W*<br />
Lynch, J., 262<br />
Lyon, E., Session 3, 1752W,<br />
3220F<br />
Lyon, G., 3561F*<br />
Lyonnet, S., 126, 522W,<br />
843F, 915W, 3172F<br />
Lyons, L. A., 3252T*<br />
Lyons, R., 177<br />
Lyons, R. H., 2329T, 2850F<br />
Lysell, J., 2276F<br />
Lyssenko, V., 190<br />
Lyu, S., 900T<br />
Lyytinen, H., 1976F<br />
M<br />
Ma, B., 2587T, 3469T*<br />
Ma, C., 1352W, 1389T*,<br />
1510F, 1885T, 2419T,<br />
2489F<br />
Ma, J., 31, 593F*, 1399F,<br />
2819T<br />
Ma, J. Z., 2388W, 2390F,<br />
2574W<br />
Ma, L., 183, 187*, 1936T,<br />
2251T<br />
Ma, R., 2280W<br />
Ma, R. C. W., 2279F*<br />
Ma, X., 462W, 1235F<br />
Ma, Y., 1198T*, 1772W*<br />
Ma, Z., 3696W*<br />
Maas, J., 2581T<br />
Maas, R. L., 82<br />
Maas, S., 2932W<br />
Maayan, H., 788W<br />
Mäbert, K., 2920W<br />
Mabuchi, F., 1980W*<br />
Macaranas, O., 803W<br />
MacArthur, D., 41, 567F<br />
MacArthur, D. G., 280*, 295,<br />
582W<br />
MacArthur, J. A. L., 2108F,<br />
2155T, 3732W*<br />
Macaya, D., 1676T<br />
MacBean, E., 1825W<br />
Macciardi, F., 2459F,<br />
2469W, 2564F*, 3587F<br />
Maccioni, L., 2001W<br />
MacCluer, J., 1280W<br />
MacCluer, J. W., 2061W<br />
MacDonald, H., 3143W<br />
MacDonald, I., 1802F<br />
MacDonald, J. R., 460W<br />
MacDonald, M. E., 1964F,<br />
2643W<br />
MacDougall, M., 2759T<br />
Mace, A., 62, 299<br />
Macek, M., 2102F<br />
Macera, M. J., 937W,<br />
957W*, 1031F<br />
MacGregor, S., 212, 2068T,<br />
2133W, 2190W<br />
Macgregor, S., 388*, 2077T<br />
Mach, C., 2770W<br />
Mach, M., 3116F<br />
Machado, C. O. F., 2654F<br />
Machado, J. C., 1747W<br />
Machida, J., 1574W*, 2747T<br />
*Presenting Author<br />
Machiela, M. J., 1390F*<br />
Machielsen, G. C., 955W<br />
Machielsen, T., 979W<br />
Macias-García, B., 1030T<br />
Maciel, P., 913W<br />
Maciel-Guerra, A. T., 478W,<br />
479F<br />
Maciewicz, R. A., 2292W<br />
Macintyre, G., 2474F<br />
Macip, S., 1270T<br />
Mack, W., 3415T<br />
Mackay, D. J. G., 3494T<br />
MacKenzie, A. E., 2800W<br />
MacKenzie, J., 671F<br />
Mackenzie, W. G., 2855T,<br />
3150F<br />
Mackey, D. A., 2068T<br />
Mackey, J. R., 1297F<br />
Mackey, K., 658T<br />
Mackie Ogilvie, C., 906T<br />
MacKinnon, S., 2928F<br />
Macleod, J., 1567F<br />
MacLeod, S. L., 1459F<br />
MacMillan, A., 966T<br />
Mac Neal, M., 129, 2761W<br />
MacNee, W., 2249F<br />
Macpherson, J. M., 498W,<br />
1223F, 3386W<br />
Macpherson, M., 179<br />
Macrae, F., 1130F<br />
Macri, J., 2243F<br />
Macri, V. S., 1585T<br />
Madan, S., 2864T<br />
Madan-Khetarpal, S., 129,<br />
904T, 1744W<br />
Madden, P. A. F., 2056T,<br />
2212T<br />
Maddren, M., 3612W<br />
Madhoun, M., 3098F<br />
Madhusoodanan, J., 1183T*<br />
Madjunkova, S., 2983T<br />
Madore, A.-M., 1941W<br />
Madore, S., 966T<br />
Madrigal, I., 2624F, 2630F,<br />
2940F, 3217W*<br />
Madsen, J., 266<br />
Maeda, K., 52, 2823F<br />
Maeda, S., 2051F, 2071T<br />
Maeda, T., 1833W, 3432T*,<br />
3519T<br />
Mäenpää, H., 1253F<br />
Maer, A., 2973T, 3023T<br />
Maes, H. H., 2277W<br />
Maestrale, G. B., 2062T<br />
Maffei, P., 2702T, 2703F<br />
Maffeo, C., 775W<br />
Maga, M., 821F<br />
Magadi Gopalaiah, V., 523F*<br />
Magalhaes, W., 3562W*<br />
Magalhaes, W. C. S., 3325F<br />
Magaña, J. J., 3124F, 3226F<br />
Maganzini, D., 3680W<br />
Magdelaine, C., 2694F<br />
Mage, D. T., 86<br />
Mager-Heckel, A. M., 329<br />
Magi, R., 108, 2123F,<br />
2144F<br />
Mägi, R., 119, 190, 1308T,<br />
1954T, 2076W*, 2137T,<br />
2147F<br />
SPEAKER AND AUTHOR INDEX 379<br />
MAGIC (Meta-Analyses<br />
<strong>of</strong> Glucose and<br />
Insulin-Related<br />
Traits Consortium)<br />
Investigators, 2106W<br />
Maglio, C., 1271F<br />
Magliocca, S., 2916F<br />
Maglott, D., Session 77,<br />
1762W, 3582W, 3625F*,<br />
3732W<br />
Magnani, C., 1153T<br />
Magnani, J. W., 1585T<br />
Magnani, M., 760W<br />
Magnus, P., 3028T<br />
Magnusson, P. K. E., 991T,<br />
2105F, 2505W, 3442T,<br />
3452T<br />
Magot, A., 3066F<br />
Magoulas, P., 300<br />
Magoulas, P. L., 952T<br />
Magri, S., 2764W<br />
Magrini, V. J., 2587T<br />
Maguire, J., 290<br />
Maguire, M., 497F<br />
Magyari, L., 3283F<br />
Mahadevan, S., 3495T<br />
Mahajan, A., 49*, 119, 169,<br />
190, 1308T, 2070W,<br />
2076W, 2116T, 2137T<br />
Mahajan, V. B., 2750T*<br />
Mahamdallie, S. S., 1211F*<br />
Mahaney, M., 1280W<br />
Mahaney, M. C., 2308T,<br />
2309F, 3434T<br />
Mahaut, C., 127<br />
Mahdavi, M., 1718W,<br />
2964F*<br />
Mahdieh, N., 57<br />
Maher, B. H., 2916F<br />
Maher, B. S., 2500T, 2504F<br />
Maher, E. R., 2955F<br />
Mahesh, A., 1719W<br />
Mahmood, H., 2570F<br />
Mahomva, C., 1845W<br />
Mahon, L., 876T<br />
Mahon, P. B., 2391W*<br />
Mai, M. Q., 1723W<br />
Mai, P. L., 210, 1064F*<br />
Maia, S., 3019T<br />
Maiburg, M. C., 3164F<br />
Maier, A. B., 1436W<br />
Maier, C., 28, 1001F,<br />
1080W*, 1214F<br />
Maier, W., 3203W<br />
Maiers, M., 3330T<br />
Maiese, D. R., 1566T<br />
Maili, L., 1908W<br />
Maillard, A., 62, 299<br />
Maillet, P., 1268F<br />
Maisenbacher, M. K., 73<br />
Maiti, A., 1572T<br />
Maiti, A. K., 307*<br />
Maiti, R., 3582W, 3625F<br />
Maitland-van der Zee,<br />
A.-H., 609T<br />
Maiwald, S., 1604T<br />
Majewski, J., 701F, 706T,<br />
752T, 2790F, 2794W,<br />
3595F<br />
Majid, S., 2743W*<br />
Majounie, E., 2648F*<br />
Majumder, P. P., 3343F<br />
Mak, A., 1694T*<br />
Mak, S. K., 803W<br />
Makareeva, E., 222, 2853F<br />
Makarov, V., 1530T<br />
Mäki, M., 2023T, 2177F<br />
Makino, S., 373, 563F*,<br />
1574W<br />
Makishima, S., 2009F<br />
Makita, Y., 2758W<br />
Makkapati, V., 3316F<br />
Makke, B. J., 2249F<br />
Makowski, C., 2917W<br />
Makri, A., 5<br />
Makrythanasis, P., 84, 561F,<br />
2937F*, 3431T<br />
Maksymowych, W., 448W<br />
Malan, V., 889W, 915W*,<br />
3172F<br />
Malarstig, A., 503F<br />
Malasky, M., 30, 1218W,<br />
1517W<br />
Malats, N., 1091F<br />
Maldonado-Rodríguez, M.,<br />
3124F<br />
Malecki, M., 1020W, 3015T*<br />
Malecki, R., 1020W*, 3015T<br />
Malek, J. A., 2933T, 3399W<br />
Malerba, G., 1361W,<br />
2548T*, 2659T<br />
Maleszewski, J. J., 2906T<br />
Maleva, I., 2983T<br />
Malfait, F., 128, 129, 2225F*<br />
Malheiro, A., 1762W<br />
Malhotra, A., 2124W*<br />
Malhotra, A. K., 264<br />
Malhotra, D., 480W, 2576F<br />
Malhotra, N., 2967T<br />
Malicdan, M. C., 755W*,<br />
2870T<br />
Malig, M., 12, 14, 278, 375<br />
Malik, J. M., 3078F<br />
Malik, N. A., 2920W<br />
Malik, R., 1313W<br />
Malinowski, A., 3013T<br />
Malinowski, J., 2042F*<br />
Maliszewski, K., 432W<br />
Malki, N., 1707T<br />
Malkin, D., 1055F, 3142F<br />
Malladi, V., 3612W<br />
Mallarino, C., 1876F<br />
Mallempati, K., 2951T<br />
Maller, J., 176, 1513F<br />
Malley, J. D., 1363F<br />
Mallick, S., 3372T<br />
Mallott, J. M., 362*<br />
Malloy, M. J., 1694T<br />
Malloy-Diniz, L., 2404T<br />
Mallya, K. S., 639T<br />
Maloney, K. A., 384<br />
Malta, F. S. V., 182, 1573F<br />
Maltête, D., 345<br />
Malukiewicz, J., 3251W<br />
Malvehy, J., 1053W<br />
Malzac, P., 2792T<br />
Mamaeva, O., 2759T<br />
Mamaï, O., 1751W, 2744T*<br />
Mamarabadi, M., 3197W<br />
Mambelli, L. I., 1102T*<br />
SPEAKER AND AUTHOR INDEX
380 SPEAKER AND AUTHOR INDEX<br />
Mamchoui, K., 2840T<br />
Mampilly, G., 911W<br />
Mampilly, T., 911W<br />
Mamula, K. A., 1649T<br />
Manabe, R., 2891T<br />
Manak, J., 422W<br />
Manak, J. R., 419F<br />
Mancardi, G., 2095T<br />
Manchia, M., 2342F<br />
Mancini, G., 124<br />
Mancini, G. M. S., 214, 405*<br />
Mancini-DiNardo, D.,<br />
1021T*<br />
Manco-Johnson, M. J.,<br />
2330F<br />
Mandal, D., 28, 1040F,<br />
1081T*, 1214F, 1454W<br />
Mandal, R. K., 1123T<br />
Mandegar, M. A., 1620T<br />
Mandel, J.-L., 1800F*<br />
Mandell, J., 1226F<br />
Mandell, J. B., 1089W<br />
Mandelman, D., 3719F<br />
Mandl, K. D., 1836F<br />
Mane, S., 2444F<br />
Maneval, D. R., 1304W<br />
Manganelli, G., 2629T<br />
Mangino, M., 1653T, 2116T,<br />
2175W<br />
Mangold, E., 1512T, 2102F<br />
Mangolin, R., 2373W<br />
Mangravite, L., 615T<br />
Manhart, A., 3319F<br />
Manickam, K., 103, 456W<br />
Maniezzo, N. M., 1187F<br />
Manjarrez-Orduño, N., 306*<br />
Manjunath, S. H., 824F<br />
Mankodi, A., 711F<br />
Manley, W., 2426F*<br />
Manlhiot, C., 1704T<br />
Manly, J., 343<br />
Mann, G. J., 212<br />
Mann, K., 906T<br />
Mann, M., 2010W<br />
Mann, S. S., 2072F<br />
Mann, T., 3710W<br />
Mannens, M., 1616T<br />
Mannens, M. M., 681F<br />
Mannens, M. M. A. M.,<br />
3650W<br />
Mannermaa, A., 1114T,<br />
1125W<br />
Mannhalter, C., 1603T<br />
Mannick, K., 299<br />
Mannik, K., 62<br />
Männikkö, M., 1892F<br />
Manning, A., 249, 269, 1151F<br />
Manning, A. K., 48, 50, 173,<br />
176*, 1373W<br />
Manning, J., 2255F<br />
Manning, M., 3053W<br />
Mannini, L., 2695W<br />
Manoharan, A. P., 2091W<br />
Manokhina, I., 1760W*<br />
Manoli, I., 674T*, 721F,<br />
738T, 2683W<br />
Manolio, T., 1447F<br />
Manolio, T. A., 2155T<br />
Manouvrier-Hanu, S., 3172F<br />
Manrique, C. P., 2049W<br />
*Presenting Author<br />
Manschreck, C., 998F, 1159T<br />
Mansfield, B. C., 2712F<br />
Mansoori, M. M., 1096T<br />
Mansoori Derakhsham, S.,<br />
779W<br />
Mansour, S., 127, 129<br />
Mansouri, M., 3246F<br />
Mantero, F., 2708T<br />
Mantha, K., 378<br />
Mantripragada, K. K., 2405F*<br />
Manuck, T., 1904F<br />
Manuel Gonzalez, J., 506W<br />
Manyam, S. R., 2351F*<br />
Manzaneda, F., 2033F<br />
Manzaneda, J., 2033F<br />
Manzardo, A., 3089W<br />
Manzi, S., 2099F<br />
Manzi, S. F., 634T*<br />
Manzoni, M., 3256F<br />
Mao, J., 3029T<br />
Mao, J.-H., 984W<br />
Mao, L., 2910F<br />
Mao, M., 1369F, 2684T*<br />
Mao, R., 689F, 3637F<br />
Mao, X., 3604W<br />
Maples, B., 3360T, 3361F,<br />
3380W, 3563F*<br />
Mapua, C., 2466W<br />
Mapua, C. A., 2473T<br />
Maqsood, M. I., 2959W<br />
Mar, L., 145, 1810F*<br />
Maragh, S., 818F*<br />
Maranda, B., 2790F<br />
Maranian, M. J., 209<br />
Marano, L. A., 3277F*<br />
Maranville, J., 248*<br />
Maranville, J. C., 2021F<br />
Marasca, G., 685F<br />
Marasco, E., 306<br />
Maray, T., 3336T<br />
Marazita, M., 2034W,<br />
2325W, 3609F<br />
Marazita, M. L., 1315F,<br />
1464T, 1472W, 1474F,<br />
1512T, 1936T, 1937F,<br />
2142W, 2156F, 2178W,<br />
3028T<br />
Marble, M., 124<br />
Marca, V., 2453F<br />
Marcelli, M., 113, 177, 186,<br />
1451W, 1516F<br />
March, M. E., 1996T*<br />
Marchan, R., 1335T<br />
Marchand, L., 5, 141<br />
Marchani, E., 1918T*<br />
Marchegiani, S. M., 2938W*<br />
Marchetti, F., 984W<br />
Marchini, J., 90, 91, 1484W,<br />
3360T, 3384T<br />
Marcia, L., 823F, 847F*<br />
Marcinkowska, M., 1745W*<br />
Marder, K., 442W, 2547W<br />
Mardis, E., 1203W, 1210T<br />
Mardis, E. R., 244, 2587T<br />
Marduel, M., 1607T<br />
Marenholz, I., 2102F<br />
Mares, J. A., 2020T<br />
Margadant, C., 2848W<br />
Margalioth, E. J., 2991T,<br />
2993T<br />
Margaritte-Jeannin, P.,<br />
1361W, 1461T, 1941W,<br />
2079W<br />
Margolis, R. L., 2644T<br />
Margraf, R. L., 2720T,<br />
2951T*, 3638W<br />
Margulies, D. M., 1769W,<br />
1799W, 1836F, 1843W<br />
Margulies, E., 3663F<br />
Mari, B., 513F, 817F<br />
Mari, F., 2604W<br />
Mari, J. J., 2533T, 2534F<br />
Mariage, L., 3216F<br />
Mariani, J., 334<br />
Maric, I., 1259F<br />
Mariette, X., 2084F<br />
Marinelli, M., 2164T<br />
Marini, J. C., 222, 2853F<br />
Marini, M. G., 2001W<br />
Marini, N., 75<br />
Marion, M., 2143T<br />
Marion, M. C., 1979F<br />
Marion, V., 2887W<br />
Mariot, V., 2840T<br />
Mariotti, C., 2764W<br />
Maris, J. M., 2203T<br />
Maristany, M., 2578T<br />
Marjan, E., 1108T<br />
Marjanovic, D., 3286F<br />
Marjoram, P., 2153F<br />
Mark, K., 14<br />
Markaki, Y., 3500T<br />
Markello, T., 359, 2610W,<br />
2870T<br />
Markello, T. C., 2938W,<br />
3543F<br />
Markianos, K., 8, 452W,<br />
2811F, 3219W<br />
Markowitz-Shulman, A., 670T<br />
Marks, H., 2945T<br />
Markunas, C., 1919F*<br />
Markus, B., 2931F<br />
Markus, H. S., 1313W<br />
Markward, N. J., 642T<br />
Marle, N., 2729T, 2792T<br />
Marles, S., 491F<br />
Marlin, R., 32, 1222T<br />
Marlin, S., 126, 127, 2727F<br />
Marlton, P., 1042T<br />
Marmol, B., 977W<br />
Marmoset Genome<br />
Sequencing and Analysis<br />
Consortium, 3270T<br />
Marongiu, M., 547F, 823F*,<br />
847F, 1516F, 2001W<br />
Maroo, A., 3616W<br />
Maro<strong>of</strong>ian, R., 3201W<br />
Marostica, A., 2659T<br />
Marosy, B., 3704W,<br />
3716W*, 3731F, 3733F<br />
Maroun, L. E., 2411F<br />
Marqueling, A. L., 2926W<br />
Marques, A. A., 1037F<br />
Marques, F. A., 1880F*<br />
Marques, I., 2631W<br />
Marques, J. H., 3184F<br />
Marques, W., Jr., 2425T<br />
Márquez-Luna, C., 48<br />
Marrero, A. R., 994T,<br />
1405F*, 1946F<br />
Marrosu, M. G., 157<br />
Marruso, G., 2812W<br />
Marschall, C., 3539F<br />
Marsh, C. B., 626T<br />
Marshall, C. R., 175, 460W,<br />
2575T, 2932W, 3086F,<br />
3095W<br />
Marshall, J. D., 2702T<br />
Marshall, K., 2158T, 2782W<br />
Marshall, P., 1848W<br />
Marsidi, A., 1682T<br />
Marsit, C., 3465T<br />
Marsit, C. J., 3629F<br />
Martell, S., 2977T<br />
Martelli, L., 941W*<br />
Martemyanov, K., 2801T<br />
Marth, G., 41, 3606W<br />
Martin, A. L., 916T*<br />
Martin, A. R., 371*, 3411W<br />
Martin, B., 10, 3213W<br />
Martin, C., 713F*<br />
Martin, C. L., Session 77,<br />
917W<br />
Martin, E., 1544W, 1681T,<br />
2820F, 3170F<br />
Martin, E. R., 344, 347,<br />
1571W, 1957T, 2445W,<br />
2498F, 2508W, 2572T,<br />
2583W, 2586W, 2603F,<br />
2614T, 2637W, 3390T<br />
Martin, H. C., 2939T*<br />
Martin, J., 2046W<br />
Martin, L., 39, 3177W<br />
Martin, L. M., 1790W<br />
Martin, M., 2217W<br />
Martín, M. G., 296<br />
Martin, N. G., 106, 212, 351,<br />
2054F, 2056T, 2133W,<br />
2175W, 2212T*<br />
Martin, P., 2231F*<br />
Martin, T., 1152W<br />
Martinaud, O., 345<br />
Martin-Coignard, D., 3129W<br />
Martinelli, B., 691F<br />
Martinelli, V., 624T, 2095T,<br />
2781F<br />
Martinelli Boneschi, F.,<br />
624T*, 2095T<br />
Martinet, D., 299<br />
Martinez, A., 3242F<br />
Martinez, D., 2614T<br />
Martinez, F., 536W<br />
Martinez, J., 864T, 3074F*<br />
Martinez, J. C., 951W<br />
Martinez, R. J., 3390T<br />
Martinez, S., 501F<br />
Martinez-Agosto, J. A., 361<br />
Martinez-Barbera, J., 2701W<br />
Martinez-Barrios, E., 1053W<br />
Martinez-Cruzado, J. C.,<br />
3315T, 3360T, 3380W<br />
Martínez-Cruzado, J. C.,<br />
3254W, 3363T<br />
Martinez-Jarreta, B., 3364F<br />
Martínez-Jarreta, B., 3402T<br />
Martinez-Lopez, M. C.,<br />
2019W<br />
Martinez-Perez, A., 1651T<br />
Martinovic, J., 77, 894T,<br />
3129W
Martins, A. S., 2655W<br />
Martins, M., 1979F*, 2150F,<br />
2655W<br />
Martins, M. T., 852F<br />
Martins-da-Silva, A., 1296T<br />
Martinuzzi, A., 2799F<br />
Martis, S., 652T*<br />
Martos-Moreno, G. A.,<br />
2711T<br />
Marullo, L., 119, 190, 1308T,<br />
2076W, 2137T<br />
Maruyama, H., 3229W<br />
Marvelle, A. F., 1627T<br />
Marwaha, R., 3207W<br />
Marx, R., 2677W<br />
Mary, P., 3700W<br />
März, W., 1595T<br />
Marziali, A., 1264T*<br />
Marzouka, N., 1881W<br />
Masaki, N., 2130W<br />
Maschio, A., 113, 177,<br />
1451W, 1516F, 2001W,<br />
2329T*, 3664W<br />
Mash, D., 368, 2637W<br />
Mash, D. C., 341<br />
Mashevich, M., 858T<br />
Maskeri, B., 1515T<br />
Maslanski, B., 3002T<br />
Maslen, C., 1349W, 1700T*<br />
Maslen, C. L., 1743W,<br />
2069F<br />
Masliah, J., 124<br />
Mason, C., 2610W, 3464T<br />
Mason, C. E., 376*, 1818F<br />
Mason, E., 675F<br />
Mason, T., 1926W<br />
Mason-Suares, H., 338<br />
Masotti, C., 813F<br />
Masri, A., 2937F<br />
Massam, H., 1500T<br />
Massé, K., 841F*<br />
Massey, S., 3254W<br />
Massicotte, C., 2790F<br />
Massie, M. J., 1841W<br />
Massimi, L., 2235W<br />
Massingham, L., 765W<br />
Mastronardi, M., 3689F<br />
Masuda, A., 2472W<br />
Masuho, I., 2801T<br />
Masuno, M., 1795W, 2891T,<br />
3051W<br />
Masurel-Paulet, A., 2792T<br />
Masys, D. R., 1312F<br />
Mata, I., 2538W*<br />
Matanovic, A., 2102F<br />
Matar, C., 3241W<br />
Mateo Leach, I., 110<br />
Materna-Kiryluk, A., 845F<br />
Matharoo, K., 1703T<br />
Mathavan, S., 3047W<br />
Matheny, J., 384<br />
Mathern, G., 267<br />
Matheus, G., 3171W<br />
Mathews, C., 1480F<br />
Mathews, D., 1826F*<br />
Mathews, V., 931W<br />
Mathias, R. A., 158, 171,<br />
1425T, 1558F, 1710T,<br />
1900T, 2043W, 2346W<br />
Mathiesen, R., 2982T<br />
*Presenting Author<br />
Mathieson, I., 16, 3279T,<br />
3298F*<br />
Mathieu, F., 259<br />
Mathieu, J., 2900T<br />
Mathieu, M., 3117W<br />
Mathieu, P., 1655T<br />
Mathieu-Dramard, M.,<br />
3109W<br />
Matias, R., 2466W<br />
Matise, T., 2041T, 2216F<br />
Matise, T. C., 1359T, 2042F,<br />
3558W, 3566W<br />
Matisoo-Smith, E., 3349F<br />
Matisoo-Smith, E. A.,<br />
3333T*<br />
Matoba, N., 2873T,<br />
2923W*<br />
Matoo, S., 1961F*, 1962W<br />
Matos, A. H. B., 2655W*<br />
Matsson, H., 1976F*<br />
Matsubara, Y., 1290T<br />
Matsuda, F., 2004W,<br />
2361W<br />
Matsuda, H., 2697F<br />
Matsui, T., 2174F<br />
Matsuishi, T., 724T<br />
Matsukawa, T., 233*<br />
Matsumoto, A., 2588F,<br />
3118F*<br />
Matsumoto, M., 1447F<br />
Matsumoto, N., 1290T,<br />
2822T, 2878W*, 3136F,<br />
3230F<br />
Matsumoto, T., 2174F<br />
Matsumura, Y., 1327F<br />
Matsunaga, T., 2882T<br />
Matsunami, N., 2397W*<br />
Matsuo, H., 663F*, 2371T<br />
Matsuo, M., 781W<br />
Matsushita, H., 2687T<br />
Matsushita, M., 2549F<br />
Matsuura, E., 2601W<br />
Matsuura, K., 2130W<br />
Matta, J., 996W, 1074W<br />
Matte, U., 691F, 2825T<br />
Matteini, A. M., 2040W<br />
Matteson, P., 2216F<br />
Matteson, P. G., 2426F<br />
Mattheisen, M., 1536T,<br />
2520W<br />
Matthiessen, M., 2057F<br />
Matthijs, G., Session 20<br />
Mattiello, A., 1712T<br />
Mattiske, T., 2640W<br />
Mättö, J., 2023T<br />
Matullo, G., 1153T, 1712T<br />
Matvienko, M., 3528W,<br />
3641F*, 3662W<br />
Matyakhina, L., 332<br />
Mauermann, O., 1115F<br />
Maues de Paula, A., 328<br />
Maugard, C., 1212W<br />
Maurat, E., 716T<br />
Maurer, M., 2681T<br />
Maurer, M. A., 1255T<br />
Maurer-Morelli, C. V., 1903T,<br />
2373W, 2394W, 2655W,<br />
3578W<br />
Maury, P., 2945T<br />
Maussion, G., 3470T*<br />
SPEAKER AND AUTHOR INDEX 381<br />
Mautner, V.-F., 2791W<br />
Mavrothalassitis, G., 218<br />
Mawatari, Y., 2130W<br />
Maxfield, A. B., 820F<br />
Maxfield, K., 3671F<br />
Maxwell, A. P., 2307W<br />
Maxwell, T. J., 272*, 340<br />
May, A., 3619F<br />
May, A. P., 2301W<br />
May, M., 2806W<br />
May, T., 1837W<br />
Mayani, R., 3558W<br />
Mayen, D., 928T, 956T<br />
Mayén, D. G., 875W, 960T<br />
Mayer, F., 691F<br />
Mayer, J., 2778F<br />
Mayerle, J., 2141F<br />
Mayeux, R., 343, 344,<br />
1476T, 1571W, 2040W,<br />
2093F, 2410T, 2498F<br />
Mayhew, C. N., 736T<br />
Mayne, K., 385, 1305T<br />
Mayo, K., 340<br />
Mayo, P., 1286W, 1316W,<br />
1377T, 1671T, 1713T<br />
Mayo, V., 9, 2445W<br />
Mayr, J., 782W<br />
Mayr, J. A., 699F, 2917W<br />
Mayr, M., 3723F<br />
Maystadt, I., 214, 2810T,<br />
3181W, 3216F, 3218F*<br />
Mazery, AC., 104<br />
Mazloom, A., 3016T<br />
Mazloom, A. R., 3014T<br />
Mazor, M., 2738T<br />
Mazur, D., 3698W<br />
Mazzetti, P., 2453F<br />
Mazzeu, J., 2863W*<br />
Mazzeu, J. F., 903W, 961W<br />
Mazzilli, M. C., 1330F<br />
Mazzini, L., 2775F<br />
Mazzola, L. M., 3702W<br />
Mazzucatto, l. F., 3099W<br />
McAdoo, S., 3018T<br />
McAteer, J., 249<br />
McBride, D., 3694W<br />
McBride, K., 1680T*<br />
McBride, K. L., 1646T<br />
McCabe, E. R. B., 1867F<br />
McCabe, L., 1867F<br />
Mccafferty, S., 2703F<br />
McCaleb, M., 804W<br />
McCall, S., 3622W<br />
McCallie, B. R., 851F,<br />
2968T*<br />
McCallion, A. S., 79, 258,<br />
545F, 818F<br />
McCandless, S. E., 741F*,<br />
774W<br />
McCann, B., 1965W<br />
McCann, L., 651T<br />
McCarroll, S., 290, 350,<br />
480W, 1325W, 2487W,<br />
2618F<br />
McCarroll, S. A., 280, 284,<br />
437F, 1519F<br />
McCarthy, L. C., 649T<br />
McCarthy, M., 368, 583F,<br />
1440T, 1513F, 2097W,<br />
2162F<br />
McCarthy, M. I., 44, 119,<br />
176, 280, 582W, 1308T,<br />
1519F, 1954T, 2076W,<br />
2123F, 2137T, 2147F,<br />
2324F, 3435T, 3441T,<br />
3575F<br />
McCarthy, S., 455F, 1518T,<br />
2590T*<br />
McCarty, C., 2098T, 3622W<br />
McCarty, C. A., 618T, 1312F,<br />
1447F, 2154W, 2240F,<br />
2263T<br />
McCauley, J., 151*<br />
McCauley, J. L., 270, 2039F,<br />
2049W, 2299T, 3390T<br />
McClain, L. L., 2125T*<br />
McClaren, B. J., 143<br />
McClay, J. L., 3442T, 3452T<br />
McClellan, B., 1316W,<br />
1377T, 1928F, 2037W<br />
McClellan, B., Jr., 1671T<br />
McClellan, J., 263, 2600F<br />
McClellan, R., 3065W<br />
McCole, R. B., 444W*<br />
McCombie, W. R., 2180F,<br />
2305T, 2587T, 2590T,<br />
3316F<br />
McConnachie, A., 1626T<br />
McConnell, J. C., 3419T<br />
McConnell, M. J., 436W<br />
McCord, R., 255<br />
McCormick, C., 369, 2372F<br />
McCormick, J. B., 1849W*,<br />
2048F, 2345F<br />
McCracken, J. T., 639T<br />
McCuaig, C., 778W<br />
McCulloch, C. E., 589F<br />
McCullough, A. E., 1186T<br />
McDade-Walker, D., 3705F<br />
McDaniel, L., 370<br />
McDavid, A., 2098T<br />
McDonagh, E. M., 633T,<br />
635T*<br />
McDonald, J., 1058F<br />
McDonald, K., 3<br />
McDonald, K. K., 2946F*<br />
McDonald, M., 2057F<br />
McDonald, M. N., 2249F*<br />
McDonald, M. T., 3<br />
McDonald-McGinn, D., 65,<br />
1494T, 3038F*<br />
McDonnell, N., 1663T<br />
McDonnell, N. B., 3231W<br />
McDonnell, S., 1214F<br />
McDonnell, S. K., 986F,<br />
3564W<br />
McElhinny, T., 1861F<br />
McElligott, J., 949W<br />
McElroy, J., 3030T<br />
McElroy, S., 605T, 2516F<br />
McEntagart, M., 2896W<br />
McEvoy, B., 2223W<br />
McEvoy, B. P., 2366F<br />
McEvoy, M., 2133W<br />
McEwen, J. E., 1845W<br />
McEwen, R., 503F<br />
McFadden, D. E., 2986T<br />
McGarvey, S. T., 2159F<br />
McGeachie, M. J., 625T*<br />
McGee, S., 2901F<br />
SPEAKER AND AUTHOR INDEX
382 SPEAKER AND AUTHOR INDEX<br />
McGehee, S., 1702T<br />
McGhee, S., 1658T, 2065T<br />
McGillivary, B., 491F<br />
McGinley, C., 1869F<br />
McGlynn, K., 213<br />
McGough, J. J., 639T<br />
McGovern, D. P., 1381F,<br />
2319W<br />
McGowan, B., 3211W<br />
McGowan, M., 2761W<br />
McGowan, R., 126, 127<br />
McGowan, S., 219<br />
McGowan, S. J., 218, 2746W<br />
McGrath, J., 2486F, 2573F<br />
McGrath, J. A., 2461T<br />
McGrath, J. M., 2576F<br />
McGregor, T. L., 247, 631T<br />
McGue, M., 1568W<br />
McGuffin, P., 2509T<br />
McGuffog, L., 207, 208<br />
McGuire, A., Session 25<br />
McGuire, A. L., 430W,<br />
1797W, 1798F<br />
McGuire, M., 904T<br />
McGuire, M. M., 993W*<br />
McGuire, P. J., 669F<br />
McGuire, S. E., 3433T<br />
McGuire, W., 96<br />
McHenry, T., 1936T<br />
McHugh, N., 2160W<br />
McInerney, P., 3697F*<br />
McInnes, B., 1052F<br />
McIntosh, I., 3331F<br />
McIver, Z., 1259F<br />
McKay, F., 1748W<br />
McKay, G. J., 1897T*<br />
McKay, J., 1012T<br />
McKay, J. D., 1496W<br />
McKean, D., 340<br />
McKee, A. C., 2528F<br />
McKeigue, P., 1481W,<br />
1895F<br />
McKenna, A., 25<br />
McKenney, A., 2033F<br />
McKenzie, C. A., 1906T,<br />
2158T<br />
McKenzie, K., 303<br />
McKeon, M., 1687T<br />
McKew, J., 711F, 1702T<br />
McKinney, A., 456W, 912T<br />
McKinnon, M., 3135W*<br />
McKnight, A. J., 2307W<br />
McKnight, D., 2579F<br />
McLaren, P. J., 2050T*<br />
McLaren, W. M., 3732W<br />
McLaughlin, H. M., 2470T<br />
McLaughlin, J., 1061F,<br />
1803W*<br />
McLaughlin, S., 1244F,<br />
3717F<br />
McLean, C., 483F, 3617F<br />
McLean, C. Y., 2565W*<br />
Mclellan, M., 1203W<br />
McLennan, G., 3014T<br />
McLeod, D. R., 2800W<br />
Mcleod, H., 241<br />
McLeod, H. L., 626T<br />
McMahon, F. J., 260, 261,<br />
2622W<br />
McMahon, K. L., 2054F<br />
*Presenting Author<br />
McMahon, S. B., 503F<br />
McManus, R., 2160W,<br />
2283W<br />
McMaster, M. L., 30, 2191T<br />
McMillin, M. J., 2740W<br />
McMullen, I., 46<br />
McMullen, I. A., 1452T<br />
McNally, E. M., 1614T*,<br />
1683T<br />
McNamara, S., 171<br />
McNeil, D. W., 1464T,<br />
1474F, 2034W, 2142W,<br />
2156F, 2178W<br />
McNeill, N. H., 1684T<br />
McPherson, J. D., 135,<br />
1093T, 1227W, 1256F,<br />
1279T<br />
McPherson, J. R., 2889F<br />
McPherson, R., 1645T,<br />
2236T<br />
McQueen, M. B., 2239T<br />
McQuillan, R., 1383T,<br />
1481W, 2366F<br />
McSweeney, K. M., 339,<br />
2879T*<br />
McTague, A., 1773W<br />
McVean, G., 16, 285, 472W,<br />
3279T, 3298F<br />
McVicar, K., 3119W<br />
McWilliams, R., 603T<br />
Md-Zain, B. M., 3267T<br />
Meaburn, E. L., 3487T<br />
Mead, M., 2325W<br />
Meader, S., 445F*<br />
Means, D., 868T<br />
Mearin, M. L., 1330F<br />
Mechanic, L., 1543F<br />
Mechawar, N., 2482T,<br />
3470T<br />
Meck, J., 332<br />
Mecklin, J.-P., 1026W,<br />
1276T<br />
Meda, S., 2532W<br />
Medeira, A., 3165W<br />
Medeiros, P., 2289W<br />
Medeiros, P. F. V., 747F,<br />
2642F<br />
Medina, E., 2251T<br />
Medina, M., 1442W<br />
Medina, M. W., 601T, 615T<br />
Medina-Gomez, C., 2169W<br />
Medina Gomez, M. C.,<br />
1334W*<br />
Medland, S. E., 351*, 2054F,<br />
2056T, 2505W<br />
Medne, L., 1702T, 1781W,<br />
2884W<br />
Medrano-Hernández, A.,<br />
1131W<br />
Meduri, D., 583F<br />
Meduri, E., 44, 3441T,<br />
3453T<br />
Meehan, B., 1182W<br />
Meek, I., 3138F*<br />
Meese, E., 515F<br />
Mefford, H., 2890W<br />
Mefford, H. C., 10, 2789T,<br />
2897T<br />
Mefford, J., 1548T*, 2258F<br />
Mefford, J. A., 1250F<br />
Megarbane, A., 84, 2692W,<br />
2937F, 3241W<br />
Meguro-Horike, M., 3497T,<br />
3498T*<br />
Mehaffey, M. G., 1068W<br />
Mehdi, S. Q., 3322F<br />
Mehdipour, P., 1169F<br />
Mehravar, E., 682T<br />
Mehrdad, K., 777W<br />
Mehrotra, P., 2926W<br />
Mehrtashfar, S., 1615T*<br />
Mehta, A., 492W, 2603F<br />
Mehta, A. B., 772W<br />
Mehta, D., 1422T, 2483F*<br />
Mehta, G., 3558W<br />
Mehta, G. R., 3692W*<br />
Mehta, L., 3033T, 3145W*<br />
Mehta, S., 3172F<br />
Mehta, S. G., 3213W<br />
Mehta, T. Y., 2731W<br />
Mei, H., 459F, 652T, 958T*,<br />
3488T<br />
Mei, J., 159, 2617T<br />
Mei, R., 369, 2372F<br />
Meigs, J. B., 269, 1346W,<br />
2080T, 2106W, 2337W<br />
Meijer, I. A., 2591F<br />
Meijers-Heijboer, H., 98,<br />
494W, 3200F<br />
Meikle, P. J., 2308T<br />
Meire, F., 539F<br />
Meirelles, O., 276, 1391W*<br />
Meisinger, C., 2595W<br />
Meisler, M. H., 2463W, 2471F<br />
Meissner, A., 380, 2107T,<br />
3450T<br />
Meitinger, T., 86, 275, 567F,<br />
582W, 699F, 782W,<br />
2567F, 2568W, 2595W,<br />
2917W<br />
Mejia, L., 2705T<br />
Mejias, R., 2566T<br />
Mejia-Santana, H., 442W<br />
Mekonnen, E., 3322F<br />
Melaragno, M., 896T, 899W,<br />
3131W<br />
Melaragno, M. I., 2533T,<br />
2534F, 3045W*<br />
Melbye, M., 1528F, 3028T<br />
Melegh, B., 3283F*<br />
Melegh, B. I., 3283F<br />
Melen, E., 2167T, 2168F<br />
Melendez, C., 3377W<br />
Meléndez, R., 875W, 960T<br />
Melin, B. S., 1372F<br />
Melki, J., 54*, 1796W<br />
Mellgren, G., 3536W<br />
Mellgren, S. I., 2965W<br />
Mello, M., 2404T<br />
Mellone, S., 2827W<br />
Mells, G. F., 153<br />
Melnick, A., 3464T<br />
Melnyk, S., 1459F, 3697F<br />
Melo, M. B., 426W, 2286W,<br />
2718F*, 2751F<br />
Melone, M., 2950W<br />
Meloni, A., 823F, 2001W<br />
Meloni, I., 2604W<br />
Meloni, V., 899W<br />
Melton, P. E., 1406W, 2061W*<br />
Meltz Steinberg, K., 375*<br />
Melzer, D., 2148W<br />
Memari, Y., 503F<br />
Members <strong>of</strong> Groupe<br />
d’Étude des Tumeurs<br />
Endocrines, 1293T<br />
Members <strong>of</strong> Mouse<br />
<strong>Genetics</strong> Project, 2725W<br />
Menaa, F., 426W<br />
Menard, A., 438W<br />
Menashe, I., 446W*<br />
Mencarelli, M. A., 2604W<br />
Menchón, J. M., 2593T<br />
Mencikova, A., 2831T<br />
Menck, C. F., 814F<br />
Mendell, J., Session 76<br />
Mendell, N. R., 1338T<br />
Mendes-Júnior, C., 3261T<br />
Mendes-Junior, C. T.,<br />
3277F, 3280F<br />
Mendes-Júnior, C. T., 3375T<br />
Mendez, F. L., 3389W*<br />
Mendez-Dominguez, N.,<br />
2272T<br />
Mendez-Ramírez, N., 1030T<br />
Mendola, A., 1611T<br />
Mendonça, F., 1968W,<br />
2017T<br />
Mendoza, L., 1049F<br />
Mendoza, R., 3196F<br />
Mendoza-Constantino, S.<br />
P., 875W<br />
Mendoza-Londono, R., 103,<br />
1738W, 3100F*, 3106F,<br />
3183W<br />
Mendus, D., 2773W<br />
Menelaou, A., 91*<br />
Menendez, I., 3125W<br />
Meneses-Morales, I., 3504T<br />
Meng, W., 2843T<br />
Meng, Y., 2307W*<br />
Mengel-From, J., 2244W,<br />
2295W<br />
Menghini, D., 3087W<br />
Mengrelis, K., 2752W<br />
Menke-Pluymers, M.,<br />
1788W<br />
Menni, C., 503F, 2138F<br />
Menon, R., 2572T, 3030T<br />
Mensenkamp, A. R., 1220F*<br />
Mentch, F., 319, 2229W,<br />
2252F, 2872W, 3573F<br />
Mentch, F. D., 1997F,<br />
2121W, 2546F<br />
Menten, B., 98, 423F, 2387F<br />
Mentzen, W., 1516F<br />
Menzin, A., 1133F<br />
Meola, N., 2950W<br />
Merath, K., 1667T*<br />
Mercado, D., 2043W<br />
Mercado, T., 1036T<br />
Mercedes de la Cruz, F.,<br />
3363T<br />
Mercer, F., 3708W<br />
Mercer, K. B., 1422T, 2420F,<br />
2483F, 3480T<br />
Mercier, E., 447F*, 517F,<br />
3568W<br />
Mercier, S., 2893W, 3066F*,<br />
3170F
Mercimek- Mahmutoglu,<br />
S., 717F<br />
Merck-Laval-UBC-Groningen<br />
Lung eQTL Consortium,<br />
1947W<br />
Merckx, D. M. L., 2448W<br />
Meredith, G., 3717F*<br />
Mergener, R., 879W<br />
Merico, D., 2617T<br />
Mericq, V., 131<br />
Merideth, M. A., 2838F<br />
Merkies, I. S. J., 2448W<br />
Merkoulovitch, A., 460W<br />
Merla, G., 84, 775W,<br />
3087W*, 3256F<br />
Merner, N., 1898F<br />
Merrick, C., 1082F*<br />
Merrill, A. E., 838F, 2857W<br />
Merrill, D., 1195T<br />
Merrill, J. T., 1979F, 2046W<br />
Merrill, L., 512W, 3517T<br />
Merriman, B., 2779W<br />
Mersha, T., 578W*<br />
Mertz, E. L., 222<br />
Mervis, C. B., 3482T<br />
Mesa, R. A., 1017W<br />
Meskel, D., 3303T, 3338W<br />
Meslin, E. M., 1848W<br />
Messaed, C., 2842W<br />
Messiaen, L., 1139F, 2791W<br />
Messika-Zeitoun, D., 1655T<br />
Messinger, Y., 132<br />
Mester, J., 1144T<br />
MetaXpress Consortium,<br />
275<br />
Metay, C., 1796W<br />
Métay, C., 894T<br />
Metayer, C., 2268W<br />
Metcalf, J. L., 1046F<br />
Metcalfe, S. A., 143*<br />
Metlapally, R., 2328W,<br />
3521T*<br />
Metrustry, S., 2292W<br />
Metrustry, S. J., 2171F*<br />
Metsepalu, A., 1284T,<br />
1503T<br />
Metspalu, A., 109, 584W,<br />
1163F, 1792W, 1832F,<br />
2144F, 2165F, 2175W,<br />
2366F, 3079W, 3353W,<br />
3460T<br />
Metspalu, E., 3286F<br />
Metzker, M. L., 244<br />
Meugnier, E., 2278T<br />
Meulenbelt, I., 584W<br />
Meurer, L., 691F<br />
Mewes, H. W., 86<br />
Mexal, S., 1736W, 3535F,<br />
3681F<br />
Meyer, A., 1117T, 3425T<br />
Meyer, B. F., 2676F<br />
Meyer, D., 3292F<br />
Meyer, E., 1773W<br />
Meyer, F., 691F<br />
Meyer, I., 2751F<br />
Meyer, K., 376<br />
Meyer, K. B., 209<br />
Meyer, M., 1441F<br />
Meyer, N., 2867T<br />
Meyer, N. C., 2301W<br />
*Presenting Author<br />
Meyers, J. L., 2022W*<br />
Meyers, K. J., 2020T<br />
Meyers, L., 3557F<br />
Meyle, J., 2058W<br />
Meyn, M. S., 1046F*,<br />
1047W, 1050W<br />
Meyn, S., 1055F<br />
Meza, C., 1336F<br />
Mezey, J. G., 1355W, 2933T,<br />
3399W<br />
Mhaidat, N., 856T<br />
Mhanni, A., 954T<br />
Mhanni, A. A., 2422T, 2772F<br />
MHC Disease Research<br />
Group, 3258T<br />
Mhiri, C., 2820F<br />
Mhlanga-Mutangadura, T.,<br />
2847F<br />
Miano, M. G., 505F, 2629T<br />
Mias, G. I., 1505W*<br />
Micale, C., 3680W<br />
Micale, L., 775W*, 3087W,<br />
3256F<br />
Miceli-Richard, C., 2084F<br />
Micha, D., 809F<br />
Michaeel, A., 3210F<br />
Michaelides, M., 3212F<br />
Michaeli-Yossef, Y., 3048F<br />
Michaelson, J., 480W*<br />
Michaelson-Cohen, R.,<br />
2929W<br />
Michailidou, K., 206*, 209,<br />
210, 1150T<br />
Michaud, J., 2075F, 2794W<br />
Michaud, J. L., 2692W,<br />
2790F<br />
Michaux, D., 1205F<br />
Michealraj, A., 2941W<br />
Michel, L., 29<br />
Michel, M., 642T<br />
Micheli, R., 760W<br />
Michelini, K., 2<br />
Michelis, L. D., 2958F<br />
Michels, V. V., 1695T<br />
Michelson, M., 3048F<br />
Michelson-Kerman, M.,<br />
3174F*<br />
Michetti, F., 2235W<br />
Michiorri, S., 71<br />
Michot, C., 127<br />
Micliavacca, M. P., 2485T<br />
Middha, S., 1214F, 1695T,<br />
3564W*<br />
Middlebrooks, C. D., 253*<br />
Middleton, M., 133<br />
Middleton, S., 242<br />
Mieczkowski, P., 3659F<br />
Miele, L., 1116W<br />
Migita, O., 2620T<br />
Migliavacca, E., 62*, 84,<br />
415F, 3256F<br />
Migliavacca, M., 3131W*<br />
Migliavacca, M. P., 2484W<br />
Mignot, C., 2770W<br />
Mignot, C. C., 2431T*, 2441F<br />
Mignot, E., 2543F<br />
Mihovilovic, M., 2465F<br />
Mikhailov, A., 2398T, 2570F<br />
Miklos, D. B., 1112F<br />
Mikula, M., 2260T*<br />
SPEAKER AND AUTHOR INDEX 383<br />
Mila, M., 2624F*, 2630F,<br />
2940F, 3217W<br />
Milan, G., 1985F, 2702T<br />
Milani, L., 3460T<br />
Milani, P., 2775F<br />
Milanova, V., 3477T<br />
Milas, M., 1144T<br />
Milburn, J., 142<br />
Miles, S., 96<br />
Miles-Mason, E., 168<br />
Milewicz, D., 1789W<br />
Milewicz, D. M., 1743W<br />
Milgram, R., 1303F<br />
Milgrom, R., 2875W<br />
Milh, M., 2536T*<br />
Mili, A., 1751W*<br />
Mili, F., 611T*<br />
Milic Rasic, V., 201, 2948T<br />
Mill, J., 3471T*, 3476T,<br />
3487T<br />
Millan, J., 2947W<br />
Millar, K., 3075W*<br />
Millen, A. E., 2020T<br />
Miller, B., 2249F<br />
Miller, B. L., 2639F<br />
Miller, D. G., 55*, 2224T<br />
Miller, E., 1674T<br />
Miller, E. M., 2698W<br />
Miller, F. A., 142, 1824F<br />
Miller, F. W., 434W<br />
Miller, J., 2904F, 3590W,<br />
3717F<br />
Miller, J. K., 1279T*<br />
Miller, L. L., 1973F, 2010W<br />
Miller, M., 2953W<br />
Miller, M. A., 494W, 1239W<br />
Miller, M. R., 1322W<br />
Miller, N., 3490T<br />
Miller, N. A., 366, 2793F,<br />
2894T<br />
Miller, N. H., 1983W<br />
Miller, P., 1107W<br />
Miller, R. A., 818F<br />
Miller, S., 1937F*<br />
Miller, S. I., 2186F<br />
Miller, W., 3545F<br />
Millikan, R. C., 2202W<br />
Millonig, J., 2216F, 2467T<br />
Millonig, J. H., 2426F, 3566W<br />
Mills, J. L., 2151W<br />
Mills, P. B., 167<br />
Mills, R., 147<br />
Mills, R. E., 3251W<br />
Mills, T., 2157W<br />
Millson, A., 3220F*<br />
Millwood, I. Y., 2162F<br />
Milne, R. L., 206<br />
Milner, L. C., 1804F*<br />
Milon, J., 3170F<br />
Milosavljevic, A., 432W,<br />
3433T<br />
Milstone, L., 2915T<br />
Milz, E., 3214F<br />
Mimori, T., 2004W<br />
Mimouni-Bloch, A., 731F<br />
Min, B., 933W*, 3204F<br />
Min, J., 583F<br />
Min, J. L., 1522F*<br />
Min, W., 947W<br />
Mina, D., 2728W<br />
Minakuchi, T., 2768T<br />
Minakuchi, Y., 2835F<br />
Minari, J., 1815W*<br />
Minatoya, K., 2697F<br />
Miner, T., 2325W<br />
Ming, J. E., 819F, 2884W<br />
Mingroni-Netto, R. C., 891W<br />
Miniati, D., 816F<br />
Minillo, R. M., 2484W<br />
Minna, J., 1454W<br />
Minor, L. B., 2301W<br />
Minot, D., 2770W<br />
Minster, R. L., 1920W,<br />
1921T, 2159F*<br />
Minto, M., 3717F<br />
Minx, P., 2320T<br />
Miny, P., 3044F, 3109W<br />
Miousse, I. R., 719F<br />
Mira, M., 1899W<br />
Mira, M. T., 1978T, 2289W,<br />
2475W<br />
Mirabelli, D., 1153T<br />
Miralles, M., 2379W<br />
Miranda, D., 2404T<br />
Miranda, D. M., 1902W,<br />
2385W<br />
Miranda, M. L., 1636T<br />
Mirante, T., 2766F, 2774T<br />
Mirel, D., 356, 1447F,<br />
1490W, 2098T<br />
Mirel, D. B., 1960T<br />
Miri Nargesi, M., 1083W*<br />
Mirkin, S., 402<br />
Mirkov, S., 613T<br />
Miro, X., 105<br />
Mirocha, J., 753T<br />
Miron, I., 3013T<br />
Mirsattari, S. M., 2779W<br />
Miryounesi, M., 1169F,<br />
2987T*<br />
Mirzozoda, K., 1898F*,<br />
2410T<br />
Misawa, K., 3565F*<br />
Mishra, A., 764W, 1287T,<br />
1288F, 1587T*, 1598T<br />
Misner, K. J., 1242W<br />
Misra, A., 555F<br />
Misra, S., 1188W<br />
Missmer, S. A., 2077T,<br />
2133W<br />
Missoni, S., 1660T<br />
Mistri, M., 700T*<br />
Mistri, M. A., 2803W<br />
Mistry, P. K., 768W, 769W<br />
Mitchell, A., 1665T<br />
Mitchell, A. A., 2576F<br />
Mitchell, A. D., 2218T<br />
Mitchell, B. D., 602T<br />
Mitchell, E. B., 2575T<br />
Mitchell, F., 239<br />
Mitchell, G., 1224W, 1492F<br />
Mitchell, J. A., 1307W<br />
Mitchell, M. E., 3020T<br />
Mitchell, P., 2068T, 2094W<br />
Mitchell, S., 1713T*<br />
Mitchison, H. M., 216, 809F<br />
Mitrovic, Z., 201, 2948T<br />
Mitsui, J., 52, 233, 2409W,<br />
2569T<br />
Mitsunaga, E., 1505W<br />
SPEAKER AND AUTHOR INDEX
384 SPEAKER AND AUTHOR INDEX<br />
Mitsunaga, S., 2253W<br />
Mitsuuchi, F. N., 2751F<br />
Mittal, B., 1137W, 1188W,<br />
1587T, 1598T*, 2293T,<br />
3271F<br />
Mittal, K., 2398T, 2525F*<br />
Mittal, R. D., 1123T*,<br />
1134W, 1135T<br />
Mittal, S., 2967T<br />
Mittal, T., 1587T, 1598T<br />
Mittelman, D., 469F<br />
Mittelstadt, S. D., 696T<br />
Mitterling, T., 2567F<br />
Mittleman, M. A., 3469T<br />
Miura, K., 2748F<br />
Miwa, A., 729F<br />
Miya, F., 396<br />
Miyachi, H., 1574W, 2747T<br />
Miyada, G., 3699F<br />
Miyadera, H., 1994F*<br />
Miyagawa, T., 2496W, 2656T*<br />
Miyahara, R., 1998W*,<br />
1999T<br />
Miyakawa, S., 2911W<br />
Miyakawa, T., 2550W,<br />
2647T<br />
Miyake, K., 2835F<br />
Miyake, M., 3146F<br />
Miyake, N., 1290T, 2822T,<br />
2878W, 3136F, 3230F<br />
Miyamoto, R., 3229W*<br />
Miyamura, H., 475F<br />
Miyano, S., 396<br />
Miyatake, S., 1290T*<br />
Mizokami, M., 2130W,<br />
3682W<br />
Mizrahi-Man, O., 2031W<br />
Mizumoto, S., 2861T, 3230F<br />
Mizuno, S., 1795W, 2758W,<br />
2891T, 3043W, 3094F*<br />
Mizuno, Y., 2873T<br />
Mizuochi, T., 724T<br />
Mizusawa, H., 2371T<br />
Mizutani, S., 3091W<br />
Mladenov, E., 3500T, 3524T<br />
Mlikotic, A., 785W<br />
Mlynarski, W., 2703F<br />
Mo, F., 491F<br />
Moalem, S., 3156F*<br />
Moayyeri, A., 2138F<br />
Moazami, N., 1056W<br />
Mobasheri, M., 1169F<br />
Mochel, F., 2539T*<br />
Mochida, G. H., 8<br />
Moctezuma-Meza, C.,<br />
1168T<br />
Modarressi, M. H., 1169F,<br />
2987T<br />
Modig, L., 1970F<br />
Moe, T., 3034T<br />
Moen, E. L., 3472T*<br />
Moeschler, J., 3176F*<br />
M<strong>of</strong>fatt, M. F., 1361W,<br />
2102F, 3466T, 3469T,<br />
3486T<br />
Moggio, M., 1776W<br />
Moghadam, M., 1615T<br />
Moghaddam, M., 1961F,<br />
1962W, 2964F<br />
Moghaddasi, M., 3197W<br />
*Presenting Author<br />
Mohamdi, H., 1158W<br />
Mohamed, A. N., 885W<br />
Mohamed-Hadley, A.,<br />
1992W, 2492F*<br />
Mohammad, A., 1061F<br />
Mohammadi, M., 679F<br />
Mohammadi Fatideh, M. J.,<br />
3083W<br />
Mohammed, N., 1352W,<br />
1589T<br />
Mohammed, S., 3211W<br />
Mohammed, S. N., 218<br />
Mohan, G., 2776W<br />
Mohan, R., 481F<br />
Mohan, V., 878T*<br />
Mohila, C. A., 834F<br />
Mohlke, K. L., 46, 117, 292,<br />
304, 1427W, 1608T,<br />
1627T, 1954T, <strong>2012</strong>F,<br />
2090F, 2123F, 2147F,<br />
2241W<br />
Mohr, D. W., 79, 1254W<br />
Mohsen, A.-W., 662T, 733F<br />
Moi, P., 2001W<br />
Mokhonova, E., 1685T<br />
Mokhtarani, M., 774W<br />
Mokrejsova, M., 3437T<br />
Molck, M. C., 959W*<br />
Mole, D., 509F<br />
Molecular <strong>Genetics</strong><br />
<strong>of</strong> Schizophrenia<br />
Consortium, 2576F<br />
Molenda, A., 1257W<br />
Molfetta, G. A., 1037F*,<br />
1038W, 2813T<br />
Molina, B., 875W, 928T,<br />
960T, 976T, 1048T<br />
Molina, F., 2685F<br />
Molina, J., 2672T<br />
Molina, L., 2685F<br />
Molina-Gomes, D., 890T<br />
Molineros, J., 3253F*<br />
Mollema, N., 2625W*<br />
Møller, LB., 702T<br />
Moller, M., 2217W<br />
Möller, M., 2007W*, 3385F<br />
Mollet, I., 47<br />
Møllgård, K., 805F<br />
Mollon, J., 2082W<br />
Mollon, J. E., 1470T*<br />
Momčilovič, D., 2438F<br />
Momigliano-Richiardi, P.,<br />
2827W<br />
Momin, S., 1108T<br />
Momma, K., 755W<br />
Momohara, S., 2004W,<br />
2287T<br />
Momoi, M. Y., 2588F, 3118F<br />
Monare, L. R., 1085F<br />
Moncaster, J. A., 2528F<br />
Moncla, A., 2792T<br />
Monda, K. L., 2131T<br />
Mondal, A. K., 2011T<br />
Mondal, K., 2312F<br />
Mondesert, B., 1678T<br />
Mongini, T., 1776W<br />
Mongrain, I., 3401W<br />
Moninger, T. O., 404<br />
Monk, D., 3499T<br />
Monlleó, I. L., 479F, 2270F<br />
Monlong, J., 567F<br />
Monnot, S., 72<br />
Monos, D., 2904F<br />
Monos, D. S., 1915T<br />
Mønsted, S., 3641F, 3662W<br />
Montaño, A., 786W<br />
Montazer Zohori, M.,<br />
2013W<br />
Monte, T. L., 2424W, 2626T<br />
Monteiro, A. N. A., 1156T<br />
Montenegro, M. A., 2393F<br />
Monterrubio-Ledezma, C.<br />
E., 3188F<br />
Montesclaros, L., 3690W<br />
Montgomery, C. G., 529F,<br />
1895F, 2084F, 2188T<br />
Montgomery, G., 1072T,<br />
2165F<br />
Montgomery, G. W., 212,<br />
351, 2054F, 2056T,<br />
2077T, 2133W, 2212T<br />
Montgomery, S., 568W,<br />
2372F<br />
Montgomery, S. B., 369,<br />
371, 527F, 547F, 561F,<br />
3411W<br />
Monti, E., 3256F<br />
Montiel, M., 951W, 3074F<br />
Montine, T., 2498F*, 2538W<br />
Montine, T. J., 2646W<br />
Montpetit, A., 277<br />
Montsar<strong>of</strong>f, S. Z., 195<br />
Moody, H., 1773W<br />
Moog, U., 300, 2403W,<br />
2595W, 3111W<br />
Mook, O., 1616T*, 3650W<br />
Mook, O. R., 681F<br />
Mookherjee, S., 2680W*<br />
Mook-Kanamori, D., 2162F<br />
Mook-Kanamori, D. O., 228<br />
Moon, J., 866T, 867W,<br />
3112F*, 3473T*<br />
Moon, J. W., 3423T<br />
Moon, S.-U., 2834T<br />
Moore, A. T., 2072F, 3212F<br />
Moore, B., 195, 3561F<br />
Moore, B. T., 3081W<br />
Moore, C., 3542W<br />
Moore, C. B., 3624W*<br />
Moore, D. T., 1245W, 3527F,<br />
3687F<br />
Moore, G. E., 303, 2752W,<br />
2755W, 3501T, 3508T<br />
Moore IV, H. E., 2543F<br />
Moore, J., 3465T<br />
Moore, J. C., 2433W<br />
Moore, J. H., 188, 1339F*,<br />
1453F, 3275W<br />
Moore, L., 1012T<br />
Moore, L. E., 1092W<br />
Moore, L. G., 3290W<br />
Moore, M., 2148W<br />
Moore, R., 3642W*<br />
Moore, S., 2945T<br />
Moore, S. J., 454W<br />
Moorman, A. V., 1024T<br />
Moors, T., 774W<br />
Moortgat, S., 3181W, 3216F,<br />
3218F<br />
Moosavi, A., 1726W*<br />
Mooser, V., 106, 1281T<br />
Mootha, V. K., 326<br />
Mora, L., 3035W*<br />
Mora, T., 597F<br />
Morad, T., 1165T<br />
Moradi Chaleshtori, M., 892T*<br />
Moraes, E., 2404T<br />
Moraes, M. O., 2289W<br />
Morais, S., 2818W<br />
Morales, A., 1681T*<br />
Morales, L., 1074W<br />
Morales, M. A., 1770W<br />
Moralli, D., 509F<br />
Moran, J., 1325W, 2487W<br />
Moran, J. L., 290, 2618F<br />
Moran, K., 140<br />
Morandi, L., 1776W<br />
Morava, E., 672T*<br />
Morcet, J., 2126F<br />
Moreau, A., 1784W, 2234F<br />
Moreau, C., 1478W<br />
Moreau, M., 2114F, 2170T<br />
Morehouse, R., 107<br />
Moreira, B. C., 2434T<br />
Moreira, M., 896T, 899W<br />
Moreira-Filho, C., 899W<br />
Moreland, L. W., 2047T<br />
Morell, R. J., 2724F<br />
Morello, R., 2854W<br />
Moreno, L., 2325W<br />
Moreno, L. M., 1564F, 1937F<br />
Moreno, O., 951W, 3049W<br />
Moreno, S., 259<br />
Moreno, T., Session 9,<br />
1825W<br />
Moreno-De-Luca, A., 2439W*<br />
Moreno-De-Luca, D., 13,<br />
917W<br />
Moreno-Estrada, A., 186,<br />
3352F, 3380W<br />
Moreno Estrada, A., 2033F,<br />
3360T, 3390T*<br />
Moreno-Garcia, M., 848F*<br />
Moreno-Macías, H., 48<br />
Moretti, E., 3050F<br />
Morfopoulou, S., 3600W*<br />
Morford, L., 1147T*, 2243F<br />
Morgan, A. T., 3228F<br />
Morgan, C. T., 1705T<br />
Morgan, D., 385<br />
Morgan, D. J., 1305T<br />
Morgan, J., 983F<br />
Morgan, T., 730T*, 3030T<br />
Mori, K., 2129F<br />
Mori, M., 2873T<br />
Morice-Picard, F., 473F<br />
Morigaki, R., 52<br />
Morimoto, M., 2849T*<br />
Morimura, T., 234<br />
Morin, C., 778W<br />
Morin, G., 3117W<br />
Morino, H., 3229W<br />
Morioka, I., 729F<br />
Morisaki, H., 2697F*<br />
Morisaki, T., 2697F<br />
Morishita, S., 2409W, 2569T<br />
Morissette, R., 1663T*<br />
Morita, M. E., 2394W<br />
Morita, S., 1290T<br />
Moriuchi, H., 1999T
Moriyama, N., 3136F<br />
Moriyama, Y., 2873T<br />
Morizono, H., 669F<br />
Morizono, T., 2051F, 2174F<br />
Morken, M. A., 304<br />
Morlan, J., 1198T<br />
Morleo, M., 2810T<br />
Morley, K., 101, 364<br />
Morley, K. I., 35, 291<br />
Morley, M., 535F<br />
Moroi, S., 2135F, 2154W<br />
Moroi, S. E., 2240F, 2263T<br />
Morren, M.-A., 2926W<br />
Morris, A., 119, 2077T<br />
Morris, A. D., 609T<br />
Morris, A. P., 49, 111*, 169,<br />
190, 269, 1308T, 1954T,<br />
2070W, 2073W, 2076W,<br />
2123F, 2133W, 2137T,<br />
2147F<br />
Morris, C. A., 3482T<br />
Morris, D., 2590T<br />
Morris, D. L., 3382F<br />
Morris, J. A., 37*<br />
Morris, M. A., 1874F<br />
Morris, N., 1376W<br />
Morris, N. J., 1575T<br />
Morris, R. W., 1626T, 3390T<br />
Morrison, A., 349, 1346W<br />
Morrison, A. C., 121, 174*,<br />
1585T<br />
Morrison, B. E., 508W, 565F<br />
Morrison, C., 3428T<br />
Morrison, H., 4<br />
Morrison, J., 1477F*<br />
Morrison, K. E., 348<br />
Morrison, M., 385<br />
Morrison, M. A., 1305T,<br />
2183F<br />
Morrison, S. M., 1859F*<br />
Morrissey, K. M., 246<br />
Morrow, B., 1494T, 1658T,<br />
3531F<br />
Morrow, E. M., 8, 452W<br />
Morse, M., 1869F<br />
Mortensen, A. H., 1878W<br />
Mortier, G., 79, 98<br />
Mortier, G. R., 80, 298,<br />
3129W<br />
Mortlock, D. P., 837F, 3275W<br />
Morton, C., 2562W<br />
Morton, C. C., 68, 70, 82,<br />
284, 554W, 862T, 2056T<br />
MOSAIC and GenISIS<br />
Investigators, 1507F<br />
Mosca, S., 3095W*<br />
Mosca-Boidron, A.-L.,<br />
2729T, 2770W, 2792T<br />
Moseley, K., 237<br />
Moser, A., 722T<br />
Moser, K. L., 1979F, 2046W<br />
Moser, M., 368<br />
Moser, T., 1, 59<br />
Moser Sivils, K., 529F,<br />
2084F, 2188T<br />
Moses, D., 2916F<br />
Moses, E., 1280W<br />
Moses, E. K., 1282F,<br />
1406W, 2061W, 2309F<br />
Moskovtsev, S., 2982T<br />
*Presenting Author<br />
Moskowitz, I. P., 82<br />
Mosley, J. D., 1345F*<br />
Mosley, T. H., 1592T<br />
Mosnier, J. F., 1204T<br />
Mosor, M., 1184F<br />
Moss, A., 2804T<br />
Mosser, J., 2126F*, 2893W,<br />
3170F<br />
Mostacciuolo, M. L.,<br />
1732W, 2799F<br />
Mostafavi, S., 369, 2372F*<br />
Mostile, G., 2763F<br />
Mota, F. M., 2288F<br />
Motahari, B., 1056W,<br />
1124F*<br />
Motahari, M. M., 3163W<br />
Mota-Vieira, L., 2288F,<br />
2814F*<br />
Motazacker, M. M., 2205W*<br />
Motghare, P., 307<br />
Motley, C., 133<br />
Motovalibashi, M., 1421W<br />
Motoya, S., 2174F<br />
Motoyoshi, Y., 3091W<br />
Mott, R., 355<br />
Motti, J. M. B., 3362W<br />
Motulsky, A. G., 1605T<br />
Mou, Y., 1251W<br />
Mouanoutoua, M., 1146W,<br />
1195T<br />
Mouassess, F., 1490W<br />
Mouga, S., 2417F, 2502W<br />
Mougou-Zerelli, S., 403,<br />
944T<br />
Moult, J., 499F<br />
Moulton, K., 3700W<br />
Mouly, V., 2840T<br />
Mountain, J., Session 9,<br />
179, 1825W<br />
Mountain, J. L., 114, 626T*,<br />
1017W, 1782W, 1838F,<br />
2087F, 2089T, 2100W,<br />
2111F, 2115W, 2149T,<br />
3386W<br />
Mourah, S., 29<br />
Mouri, K., 2380T<br />
Mouritzen, P., 1194W*<br />
Mousavy Gharavy, S.,<br />
2701W<br />
Moustafa, K., 259<br />
Mouton, S., 104<br />
Moutsianas, L., 169<br />
Mouzaya, F., 3349F<br />
Movva, S., 1720W, 2754F*<br />
Mowat, D., 843F, 3167W<br />
Mowery-Rushton, P. A.,<br />
3101W*<br />
Mowrey, P., 953W<br />
Mowrey, P. N., 945W<br />
Mowry, E., 1289W, 1301W,<br />
1414F*<br />
Moy, T. F., 1652T<br />
Moy, W., 1282F<br />
Moya, P. R., 261*<br />
Moylan, C., 531F<br />
Moysés, M., 3131W<br />
Mozaffar, T., 3213W<br />
Mrkonjic, M., 3478T<br />
Mrowietz, U., 154<br />
Msilaty-Gross, S., 731F<br />
SPEAKER AND AUTHOR INDEX 385<br />
Mucaki, E. J., 3672W<br />
Mucci, T., 3033T<br />
Muchmore, B., 1155W<br />
Mudd, P. N., Jr., 732T<br />
Muddashetty, R., 540W<br />
Mudgal, P., 2332T<br />
Mudge, J. M., 367*<br />
Mueller, D., 628T<br />
Mueller, D. M., 326<br />
Mueller, K. L., 1973F, 3735F<br />
Mueller, U., 2416T*<br />
Mugge, S., 2493W<br />
Muglia, L., 3030T<br />
Mugnaini, E., 2427W<br />
Mugneret, F., 2729T<br />
Mugniery, E., 763W<br />
Muhammad, E., 1588T*<br />
Mühleisen, T. W., 259<br />
Muilu, J., 3610W<br />
Muir, K. R., 2292W<br />
Mujahid, S., 3211W<br />
Mukaddes, N. M., 8<br />
Mukerji, M., 3332W<br />
Mukhatira, P., 3656W,<br />
3703F<br />
Mukherjee, S., 17, 264*,<br />
342, 1514W<br />
Mukherjee Dey, S., 1097F<br />
Mukhopadhyay, N., 253,<br />
1315F, 2178W*<br />
Mulas, A., 113, 157, 177,<br />
547F, 1451W, 1516F,<br />
2198F, 2329T<br />
Mulchandani, S., 3082F<br />
Mulder, F., 431F<br />
Mulder, L., 3310F<br />
Mulle, J., 2069F<br />
Mulle, J. G., 66, 1349W,<br />
2312F, 2576F*<br />
Mullegama, S. V., 103*<br />
Mullen, L., 1256F<br />
Muller, A., 684T, 1949F<br />
Müller, B. F., 782W<br />
Müller, C., 275, 1669T,<br />
2759T<br />
Muller, R., 3720W*<br />
Muller, S., 3316F<br />
Müller, T., 201, 2948T<br />
Müller, U., 2581T<br />
Muller, Y. L., 1300F*<br />
Muller-Cohn, J., 3720W<br />
Müller-Myshok, B., 2483F,<br />
2568W<br />
Müller-Quernheim, J.,<br />
2103W<br />
Mullighan, C. M., 31<br />
Mulliken, J. B., 83<br />
Mulliken, N., 1015T<br />
Mullikin, J., 358, 1515T,<br />
3306T<br />
Mullikin, J. C., 1690T,<br />
1696T, 2938W<br />
Mullin, K., 2520W<br />
Mullinax, B., 975W<br />
Mullins, J. G., 262, 2821W<br />
Mullins, M., 626T, 2087F<br />
Mullins, M. E., 2127W*<br />
Mullins, R. F., 2215T<br />
Mulukutla, .S., 2083T<br />
Mulvihill, J., 1875F*<br />
Mumm, S., 2864T<br />
Mumoli, L., 2780T<br />
Mumy, A., 1092W, 1094F,<br />
1155W*<br />
Munafo, D., 512W*, 3517T<br />
Munafo, D. B., 3702W,<br />
3715F<br />
Münchau, A., 200<br />
Munchel, S., 596W, 1238F<br />
Mundlos, S., 298<br />
Mundorff, J., 1958F<br />
Mundwiller, E., 2820F<br />
Mungall, C. J., 2725W<br />
Munger, R., 1564F<br />
Munger, R. G., 1472W,<br />
3643F<br />
Munhoz, R. P., 2475W<br />
Munier, P., 522W<br />
Munir, K., 1746W<br />
Muniz, Y. C. N., 994T*,<br />
1405F, 1946F<br />
Munnich, A., 72, 104, 126,<br />
127, 202, 324, 325, 329,<br />
390, 403, 522W, 763W,<br />
915W, 2808F, 3129W,<br />
3172F, 3240F<br />
Muñoz, X., 987W<br />
Muñoz-Montero, S., 1129T<br />
Munroe, P. B., 1659T<br />
Munshi, A., 224*<br />
Munson, J., 2406W<br />
Munson, P., 584W<br />
Munson, P. J., 260<br />
Muntoni, F., 2812W<br />
Munzel, T., 1669T<br />
Munzy, D., 2908W<br />
Muona, M., 2898F*<br />
Mur, A., 3217W<br />
Murabito, J., 2165F<br />
Murabito, J. M., 2336F<br />
Murakami, T., 2836W<br />
Murakami, Y., 298, 2559W<br />
Murali, R., 998F, 999W<br />
Murali, S. G., 710T<br />
Muramatsu, Y., 3094F<br />
Murata, K., 2130W<br />
Murata, M., 2619W<br />
Murayama, K., 2873T<br />
Murayama, S., 52, 2409W<br />
Murdoch, B., 250<br />
Murdock, D., 2802F<br />
Murdock, D. G., 1713T<br />
Mureau, M., 1788W<br />
Murgia, A., 1755W, 2795T<br />
Murgia, F., 2062T, 2128T*<br />
Muroya, K., 1795W, 2891T<br />
Murphy, A., 2014T<br />
Murphy, A. B., 1009T<br />
Murphy, D. L., 261<br />
Murphy, H., 127<br />
Murphy, K. G., 1834F<br />
Murphy, P., 3125W<br />
Murphy, S., 531F<br />
Murphy, T., 750T<br />
Murphy Bollinger, J., 1829W*<br />
Murray, A., 1021T, 2148W,<br />
2165F<br />
Murray, D., 1854F*<br />
Murray, J., 1882T, 2325W,<br />
3030T, 3537F<br />
SPEAKER AND AUTHOR INDEX
386 SPEAKER AND AUTHOR INDEX<br />
Murray, J. C., 74, 94, 1344T,<br />
1472W, 1512T, 1564F,<br />
1937F, 2762T, 3028T<br />
Murray, R. F., Jr., 1821W<br />
Murray, S., 983F<br />
Murray, S. S., 2274W<br />
Murray, T., 1472W, 2043W<br />
Murtha, A., 3<br />
Murtha, M., 2605T<br />
Murty, V. V., 1031F<br />
Murugan, A., 597F*<br />
Musani, S., 178, 350, 2063F,<br />
2210F<br />
Musani, S. K., 2275T*<br />
Muscat, J. E., 1016F,<br />
1107W<br />
Musci, T., 2978T*<br />
Mushar<strong>of</strong>f, S., 3352F,<br />
3361F*<br />
Mushiroda, T., 627T<br />
Musio, A., 2695W*<br />
Musk, A. W., 1465F<br />
Musolf, A., 1359T*<br />
Mussini, J. M., 3066F<br />
Musson, D., 784W<br />
Mussotter, T., 939W*<br />
Mustalahti, K., 2177F<br />
Mustapha, M., 1878W,<br />
2773W*<br />
Mustill, W., 2966T*<br />
Mutai, H., 2882T<br />
Mutarelli, M., 2950W<br />
Mutesa, L., 925W*, 3104F<br />
MuTHER Consortium, 44,<br />
583F, 1440T, 2187W<br />
Muthusamy, B., 3316F<br />
Muthuswamy, S., 2446T*<br />
Muti, C., 56<br />
Muto, K., 1819W, 1830F*,<br />
1833W<br />
Muzny, D., 174, 183, 360,<br />
1585T, 1599T, 1742W,<br />
2798T, 2880F*, 2934F,<br />
3597F<br />
Muzny, D. M., 3, 314, 595F,<br />
648T, 1221W, 1735W,<br />
1757W, 1761W, 2413T,<br />
2883F<br />
Muzzio, M., 293, 3362W*,<br />
3380W<br />
Mychaleckyj, J., 1971W,<br />
2210F<br />
Mychaleckyj, J. C., 1662T,<br />
2313W<br />
Myerburg, R. J., 86<br />
Myers, A., 380<br />
Myers, L., 80<br />
Myers, M., 1059W*<br />
Myers, R. H., 1964F, 2116T,<br />
2227T, 2643W<br />
Myers, R. M., 2556W<br />
Myers, S., 181, 3360T<br />
Myers, S. M., 2439W<br />
Myhre, R., 3028T<br />
Myking, S., 3028T<br />
Myllymäki, M., 3297T<br />
Myouzen, K., 2004W*<br />
Myres, N., 3321T*, 3340F,<br />
3365W<br />
Mysliwiec, V., 2221T<br />
*Presenting Author<br />
Mysore, J. S., 1964F<br />
Myung, C., 2849T<br />
N<br />
Naab, T., 1242W<br />
Näbauer, M., 86<br />
Nabbout, R., 202<br />
Nabika, T., 1333F<br />
Nacak, M., 1402F, 1935W,<br />
1938W*<br />
Nadeau, K., 2322W<br />
Nadel, L., 2529W<br />
Nadel, M., 3656W, 3703F<br />
Nadif, R., 1461T*<br />
Nading, E., 2328W<br />
Nadji, A., 2150F<br />
Naeem, T., 2920W<br />
Naess, K., 672T<br />
Nafisi, S., 2436W<br />
Nag, A., 335, 2068T*<br />
Nagai, A., 1833W<br />
Nagai, J., 3051W<br />
Nagai, T., 1631T<br />
Nagamani, S., 165, 3209W<br />
Nagamani, S. S. C., 433F<br />
Naganawa, M., 914T<br />
Nagao, T., 2747T<br />
Nagappa, J., 2411F<br />
Nagaraja, R., 276, 2001W<br />
Nagaraju, K., 2452T<br />
Nagasaki, M., 396<br />
Nagashima, T., 2264F<br />
Nagaswamy, U., 648T<br />
Naggert, J., 2702T<br />
Nagy, A., 3463T<br />
Nagy, M., 3364F, 3402T<br />
Nagy, Z., 2767W<br />
Nah, H.-D., 2856F<br />
Nahab, F., 347, 2603F<br />
Nahum, O., 977W<br />
Naides, S. J., 2260T<br />
Naidich, T. P., 168<br />
Naidoo, D., 615T<br />
Naidu, S., 3065W<br />
Naim Bushra, M., 930T<br />
Naing, B. T., 1697T<br />
Nair, R. P., 154, 1952F<br />
Nair, S., 2731W<br />
Naito, Y., 3221W<br />
Naitza, S., 1516F, 2198F<br />
Naj, A., 2637W<br />
Naj, A. C., 342, 344*, 2498F,<br />
2583W, 2586W<br />
Najfeld, V., 3488T<br />
Najmabadi, H., 2301W<br />
Naka, I., 1327F*<br />
Nakabayashi, K., 3499T*<br />
Nakachi, Y., 2873T<br />
Nakada, T. A., 1632T<br />
Nakagama, H., 396<br />
Nakagawa, H., 396<br />
Nakagawa, M., 52<br />
Nakahira, K., 475F<br />
Nakahori, Y., 3337F<br />
Nakamori, M., 2824W<br />
Nakamura, H., 396, 1998W,<br />
1999T<br />
Nakamura, M., 663F<br />
Nakamura, R., 3221W<br />
Nakamura, T., 663F, 1317T,<br />
1549F, 2607W, 2616W,<br />
2823F, 3043W<br />
Nakamura, Y., 396, 627T,<br />
1277F, 1552F, 1631T,<br />
1643T, 2004W, 2051F,<br />
2133W, 2174F, 2506T<br />
Nakano, K., 396<br />
Nakano, M., 2129F*<br />
Nakano, N., 2559W<br />
Nakaoka, H., 2253W*<br />
Nakashima, H., 663F<br />
Nakatome, M., 1321F<br />
Nakayama, A., 663F<br />
Nakayama, J., 3230F<br />
Nakayama, K., 2009F<br />
Nakhla, M., 1108T<br />
Näkki, A., 2134T*<br />
Nalbandian, A., 757W,<br />
3213W, 3249W*<br />
Naley, M., 133<br />
Nalls, M., 2063F<br />
Nalls, M. A., 2148W, 2611T<br />
Naluai, A. T., 1970F<br />
Naluai-Cecchini, T., 940T<br />
Nam, M., 866T, 867W*,<br />
3112F<br />
Namavar, Y., 197<br />
Nampoothiri, S., 3240F<br />
Nance, T., 527F<br />
Nancy, A., 931W<br />
Nanda, V., 2216F<br />
Nanko, S., 2652W<br />
Napierala, D., 2854W<br />
Napoletano, S., 71<br />
Napolitano, F., 3631F<br />
Narayanan, D., 2224T<br />
Narayanan, V., 3215W<br />
Narimatsu, H., 1549F<br />
Naritomi, K., 2758W<br />
Narkis, G., 2931F<br />
Narod, S., 1061F<br />
Naruto, T., 2891T, 3051W<br />
Narzisi, G., 2587T<br />
Nascimento, D. R., 2655W<br />
Nascimento, L., 1899W*<br />
Nascimento, L. M., 1978T<br />
Nash, D., 3671F<br />
Nashi, E., 306<br />
Naslavsky, M. S., 1727W*<br />
Nasonkin, I., 827F<br />
Nass, R. D., 3113W<br />
Nassar, N., 231<br />
Nasser, M., 3157W*, 3241W<br />
Nassir, R., 2360F<br />
Nasuti, A., 2300F<br />
Nath, S., 1572T, 3253F<br />
Nath, S. K., 307, 2351F,<br />
2731W<br />
Nath, S. R., 764W*<br />
Nathanson, K. L., 213,<br />
1003T<br />
Nathanson, L., 341<br />
Nato, A. Q., 2216F, 3558W,<br />
3566W*<br />
Natoli, J., 1866F<br />
Nätynki, M., 1611T<br />
Naughton, B., 483F, 3386W,<br />
3617F<br />
Naughton, B. T., 179, 498W,<br />
1223F*, 1620T, 1838F<br />
Navarrete, J., 694T*<br />
Navarrete Meneses, M. P.,<br />
872T, 1022F*<br />
Navarrete-Meneses, P.,<br />
1131W<br />
Navarro, B., 3266W<br />
Navarro, L., 3706W<br />
Navarro, P., 1383T, 1481W<br />
Naviaux, R., 534W<br />
Navin, N., 1258T<br />
Navon, O., 3623F<br />
Navon, R., 3588W<br />
Nayak, G., 2663T*, 2724F<br />
Nayak, R., 1506T*<br />
Nayak, U., 1662T<br />
Naydenov, C., 2151W<br />
Nayernia, K., 2987T<br />
Nazarenko, I., 678T, 2926W<br />
Nazemi, A., 1083W<br />
NCI Breast and Prostate<br />
Cancer Cohort<br />
Consortium, 1390F<br />
Ndumele, C. E., 272<br />
Neal, C. O. S., 1310W*<br />
Neal, D., 1011W<br />
Neal, D. E., 1148F<br />
Neale, B. M., 280, 290,<br />
1523W, 2618F*<br />
Neale, G. A., 2331W<br />
Neary, J., 2651F<br />
Neas, L., 1636T<br />
Nebel, A., 515F, 1943F,<br />
2103W, 2295W, 2303F<br />
Neben, C. L., 2857W*<br />
Nebert, D. W., 487F,<br />
2800W<br />
Nedelea, F. M., 2728W<br />
Neel, B. G., 135<br />
Neeradha, C., 911W<br />
Nees, S. N., 845F<br />
Neff, F., 2922F<br />
Neff, M. W., 2517W<br />
Neff, T., 1237T<br />
Negretto, C., 896T, 899W<br />
Negroni, E., 2840T<br />
Neidich, J. A., 1736W<br />
NEIGHBOR Consortium,<br />
2135F, 2263T<br />
NEIGHBOR Consortium<br />
Investigators, 386<br />
Neill, N. J., 884T<br />
Neison, M., 1491T<br />
Neiswanger, K., 1315F<br />
Neitz, J., 3212F<br />
Neitz, M., 3212F<br />
Neitzel, L., 819F<br />
Nekrutenko, A., 3547F<br />
Nelakuditi, V., 1683T, 1737W<br />
Nelen, M., 1749W, 3650W<br />
Nelen, M. R., 1734W<br />
Nelis, M., 2937F<br />
Nelissen, F., 2696T<br />
Nelson, A., 3340F<br />
Nelson, B., 12, 825F<br />
Nelson, C., 767W, 1595T,<br />
1698T, 3453T<br />
Nelson, C. P., 119, 1308T,<br />
2076W, 2175W
Nelson, H. H., 1229F<br />
Nelson, M., 294, 1686T,<br />
2087F<br />
Nelson, M. R., 476W, 641T,<br />
649T, 3282T, 3406T<br />
Nelson, R., 3671F<br />
Nelson, S., 1447F<br />
Nelson, S. F., 296, 315,<br />
361, 471F, 1685T, 2874F,<br />
3666W<br />
Nelson-Moseke, A. C.,<br />
1087T*<br />
Nelson-Williams, C., 1241F,<br />
2779W<br />
Nemat-Gorgani, N., 3710W<br />
Nematollahi-Mahani, A.,<br />
413F<br />
Nemesure, B., 1003T<br />
Neogi, A., 1719W*<br />
Neph, S., 255<br />
Nerella, S., 3442T, 3452T<br />
Neri, M., 1153T<br />
Nerkizian, N., 3700W<br />
Neshan, M., 2976T<br />
Nesheva, D. V., 923W<br />
Ness, A. R., 1583W<br />
Nessa, A., 2359T<br />
Nestadt, G., 2391W, 2573F,<br />
2576F<br />
Nesterova, M., 1151F<br />
Nestle, F., 583F<br />
Nestle, F. O., 2138F<br />
Nestrasil, I., 714T*, 785W,<br />
801W<br />
Nethander, M., 2080T<br />
Neto, J. L., 2736F<br />
Netterville, J. L., 136<br />
Netto, C. B. O., 696T<br />
Neuberger, J. M., 153<br />
Neuhaus, J., 1965W<br />
Neuhausen, S. L., 1213T<br />
Neuh<strong>of</strong>f, N., 1976F<br />
Neumann, L. C., 3500T*<br />
Neuwirth, C., 1618T<br />
Nevado, J. B., 1610T*<br />
Nevalainen, E. M., 2213F*<br />
Nevanlinna, H., 209, 997T,<br />
1006T, 1117T, 1171T,<br />
1265F<br />
Neveling, K., 58, 100,<br />
1734W, 1749W<br />
Neves, C. T., 1880F<br />
Nevruz, O., 1136F<br />
Newberg, J., 2979T<br />
Newburger, D., 397<br />
Newby, L. K., 1444F<br />
Newcomb, P., 144, 1206W<br />
Newcomb, P. A., 141,<br />
1067F, 1079F<br />
Newcomer, D., 3731F<br />
Newhouse, S., 2580W<br />
Newlin, A. C., 1225T<br />
Newman, A., 2165F<br />
Newman, A. B., 1920W,<br />
1921T, 2040W<br />
Newman, D. L., 1966T<br />
Newman, W. G., 2852T<br />
Newport, D. J., 2384F<br />
Newschaffer, C., 463F<br />
Newsome, J., 1009T, 2014T<br />
*Presenting Author<br />
Newton, A., 3682W<br />
Newton, K., 2098T<br />
Newton Bishop, J. A., 211<br />
Newton-Cheh, C., 1585T,<br />
1677T<br />
Ney, D. M., 710T<br />
Nezarati, M., 124<br />
Ng, B. G., 1758W<br />
Ng, C., 136<br />
Ng, C. L., 2066F<br />
Ng, D., 358, 1690T, 1696T*<br />
Ng, D. P. C., 1757W<br />
Ng, E., 563F<br />
Ng, E. H. Y., 3000T<br />
Ng, K., 135, 1227W<br />
Ng, M., 178, 2280W, 2332T<br />
Ng, M. C., 2131T<br />
Ng, M. C. Y., 1648T, 1879T,<br />
2310W<br />
Ng, P., 735F, 1556W<br />
Ng, P. C., 1792W, 3353W<br />
Ng, S., 26<br />
Ng, W.-F., 2084F<br />
Ngeow, J., 1144T*<br />
Ngom, A., 3490T<br />
Ngu, M. S., 3267T<br />
Nguyen, C., 757W<br />
Nguyen, D., 379, 3730W<br />
Nguyen, D. V., 770W<br />
Nguyen, H. H., 396<br />
Nguyen, K.-D. H., 121*<br />
Nguyen, N. D., 2176T<br />
Nguyen, S. C., 2176T*<br />
Nguyen, T. M., 2539T<br />
Nguyen, T. V., 2176T<br />
Nguyen, V., 3007T<br />
Nguyen-Dumont, T., 1213T,<br />
3679F<br />
Nguyen-Nielsen, M., 1565W*<br />
NHLBI Exome Sequencing<br />
Project, 6, 12, 19, 170,<br />
1692T, 2336F, 2337W<br />
NHLBI Exome Sequencing<br />
Project, Exome<br />
Sequencing Project<br />
Blood Counts Project<br />
Team, 1408F<br />
NHLBI Exome Sequencing<br />
Project - Early Onset<br />
Myocardial Infarction, 120<br />
NHLBI GO Exome<br />
Sequencing Project,<br />
1437T<br />
NHLBI Personal Genomics<br />
Project Team and NHLBI<br />
Exome Sequencing<br />
Project, 301<br />
Nho, K., 2511W<br />
Ni, P., 3300T<br />
Ni, T., 586W<br />
NIAID Center for HIV/AIDS<br />
Vaccine Immunology<br />
(CHAVI), 2335T<br />
Niangaly, A., 2255F<br />
Nica, A., 44, 583F<br />
Nica, A. C., 556W*<br />
NICE Study Group, 3020T<br />
Nicholas, T., 494W, 1239W<br />
Nichol Edamura, K., 2696T<br />
Nicholl, J. K., 978T<br />
SPEAKER AND AUTHOR INDEX 387<br />
Nicholls, K., 745F*, 772W<br />
Nicholls, S. G., 149, 150,<br />
1827W*<br />
Nichols, A. H. G., 1084T*<br />
Nichols, W. C., 2136W<br />
Nicholson, G., 52, 2470T,<br />
2742F<br />
Nicholson, G. A., 2816T<br />
Nickerson, D., 93, 223<br />
Nickerson, D. A., 10, 12,<br />
170, 171, 244, 301, 601T,<br />
1408F, 1605T, 2443T,<br />
2740W<br />
Nickerson, M., 1242W,<br />
2833W*<br />
Nicolae, D. L., 368, 2196W,<br />
2197T, 2333F<br />
Nicolaides, K., 3508T<br />
Nicolaou, N., 2848W<br />
Nicolas, G., 345*<br />
Nicolato, R., 2404T<br />
Nicoletti, A., 2763F<br />
Nicolini, H., 2495F<br />
Nicolson, S. C. N., 2443T<br />
Nicosia, S., 1061F<br />
Nicouleau, M., 390<br />
NIDDK and International<br />
IBD <strong>Genetics</strong> Consortia,<br />
2319W<br />
NIDDK IBD <strong>Genetics</strong><br />
Consortium, 42<br />
Nidey, N., 1937F<br />
Nie, J., 1086W<br />
Nieberle, I., 3539F<br />
Niehaus, D., 644T<br />
Nielsen, F., 1238F<br />
Nielsen, J. E., 2765T<br />
Nielsen, P., 3528W<br />
Nielsen, R., 182, 281,<br />
1573F, 2311T, 2317T,<br />
2347T, 3289F, 3300T,<br />
3305W, 3311W, 3312T<br />
Nielsen, S. J., 1194W<br />
Nielsen, T. T., 2765T<br />
Nielson, C. M., 109<br />
Niemelä, M., 1253F<br />
Niemi, A.-K., 744T*<br />
Nieminen, K. M., 1125W*<br />
Nieminen, T. T., 1276T*<br />
Nieminen-von Wendt, T.,<br />
2399F<br />
Nienhuis, J., 2430W<br />
Nieuwint, A., 98<br />
Nievergelt, C. M., 2375F<br />
Nieves-Colon, M. A., 3363T*<br />
Niewold, T. B., 1979F,<br />
2046W<br />
Nigrin, D. J., 1836F<br />
NIH Intramural Sequencing<br />
Center, 3306T<br />
Nii, T., 2647T<br />
Niikawa, N., 3056F<br />
Niinimaki, J., 1892F<br />
Niizeki, H., 2911W<br />
Nijman, I., 400<br />
Nijman, I. J., 217, 2886F<br />
Nika, M., 2135F<br />
Nikamo, P., 2276F*<br />
Nikiforov, T., 3698W<br />
Nikkel, S. M., 131*<br />
Nikkilä, J., 1099T<br />
Nikkola, E., 2256W<br />
Nikodinovic, J., 201, 2948T<br />
Nikolaev, S. I., 3263W*<br />
Nikolaus, S., 2368T<br />
Nikolova, D., 3477T<br />
Nikopensius, T., 3079W*<br />
Nikpay, M., 2236T*<br />
Nillesen, W., 215<br />
Nillesen, W. M., 125<br />
Niloufar, B., 2037W<br />
Nimgaonkar, V. L., 2382W,<br />
2589W, 2651F<br />
Nimmo, G., 722T<br />
Ning, X.-H., 3281W<br />
Nino, D., 2189F<br />
Nippert, I., 1877F*<br />
Niranjan, T., 2566T*, 2806W<br />
Nirmala Sadasivam, S.,<br />
2988T<br />
Nisbet, J., 44, 583F, 3441T<br />
NISC Comparative<br />
Sequencing <strong>Program</strong>,<br />
1690T, 1983W, 2938W<br />
NISC Comparative<br />
Sequencing <strong>Program</strong>,<br />
NHGRI, NIH Intramural<br />
Sequencing Center, 1261T<br />
NISC Comparative<br />
Sequencing <strong>Program</strong>,<br />
NIH, 2470T<br />
Nishi, E., 3043W*, 3094F<br />
Nishida, A., 781W*<br />
Nishida, N., 2130W*,<br />
2349W, 3301F<br />
Nishikawa, T., 1795W, 2891T<br />
Nishimori, I., 2768T<br />
Nishimoto, H. K., 2732T<br />
Nishimura, C., 419F<br />
Nishimura, D. Y., 404<br />
Nishimura, F., 2370W,<br />
2652W*<br />
Nishimura, T., 2771T<br />
Nishina, S., 3093W<br />
Nishino, I., 755W, 2409W,<br />
2923W<br />
Nishino, S., 2667F<br />
Nishioka, K., 3134F<br />
Nishioka, M., 2435F*<br />
Nishioka, T., 2619W<br />
Nishita, D., 642T<br />
Nishiyama, K., 3136F<br />
Nishiyama, S., 475F<br />
Nishiyama, T., 1574W,<br />
2440T*<br />
Nishizawa, D., 2507F*<br />
Nishizawa, H., 475F<br />
Nitschke, P., 104, 202,<br />
324, 325, 329, 390, 403,<br />
2808F<br />
Nitschke, Y., 2759T<br />
Nitzberg, M., 493F<br />
Niu, B., 457F, 1974W, 2623T<br />
Niu, D., 3467T<br />
Niu, G., 557F<br />
Niu, H., 242<br />
Niu, Q., 1003T<br />
Niu, T., 2172W*<br />
Niu, Z., 314, 1735W,<br />
1742W, 1761W*, 3493T<br />
SPEAKER AND AUTHOR INDEX
388 SPEAKER AND AUTHOR INDEX<br />
Niyazov, D., 3036F*<br />
Nizou, A., 2694F<br />
Nizzari, M., 3680W<br />
Njølstad, I., 1608T<br />
No, D., 682T<br />
Noack, B., 2058W<br />
Nobel, A., 368<br />
Noble, J., 3454T<br />
Nobuta, K., 1249T<br />
Noethen, M. M., 420W,<br />
1512T<br />
Noguchi, K., 2559W<br />
Noguchi, S., 755W<br />
Nohutcu, R., 2058W<br />
Nolan, J. J., 1624T<br />
Nolan, J. M., 1897T<br />
Nolent, F., 54<br />
Nolin, S., 2449T<br />
Nolta, J. A., 1625T<br />
Nolte, D., 2416T<br />
Nomura, M., 2264F*, 2647T<br />
Nomura, N., 2748F<br />
Nomura, Y., 3230F<br />
Nonaka, I., 755W<br />
Noonan, D., 1589T<br />
Noonan, J. P., Session 5<br />
Noor, A., 2525F, 3106F<br />
Noori Daloii, M. R., 2952F<br />
Noponen, N., 1892F<br />
Noppola-Hemmi, J., 1976F<br />
Norberg, S., 3695F, 3710W<br />
Nord, A., 263<br />
Nord, A. S., 4, 254, 407*<br />
Nord, K. H., 1024T<br />
Nordborg, M., 2320T<br />
Nordenskjöld, A., 3245W<br />
Nordenskjöld, E., 3245W<br />
Nordenskjöld, M., 1035W,<br />
1126T, 1939T<br />
Nordgren, A., 1035W,<br />
1126T, 3245W<br />
Nordlund, J., 3427T<br />
Nordmark, G., 2084F<br />
Nordstrom, L., 1186T<br />
Noreau, A., 2591F*<br />
Norman, P. J., 3390T, 3710W<br />
Normanno, N., 1060T*<br />
Norrgrann, P., 1563T<br />
Norris, J., 1330F<br />
Norris, J. M., 1888T<br />
Norsworthy, P., 1618T<br />
North, H., 2411F<br />
North, K., 1608T, 3299W<br />
North, K. E., 170, 1437T,<br />
1467T, 1599T, 1913F,<br />
1925F, 1954T, 2073W,<br />
2090F, 2123F, 2131T*,<br />
2145W, 2147F, 2337W<br />
North, K. N., 295<br />
North <strong>American</strong> Brain<br />
Expression Consortium<br />
and UK Brain Expression<br />
Consortium, 564W<br />
Northrop, L., 957W<br />
Northrop, L. E., 937W*<br />
Norton, M. E., 2978T, 3020T<br />
Norton, N., 1681T<br />
Norwitz, E., 3030T<br />
Noskova, L., 752T<br />
Nothen, M. M., 2102F<br />
*Presenting Author<br />
Nöthen, M. M., 106, 1005W,<br />
1976F, 2088W, 2557T<br />
Nothnagel, M., 580W,<br />
2058W, 2103W, 3364F*,<br />
3402T<br />
Notini, A. J., 1273T<br />
Noto, C. S., 2533T<br />
Noto, K., 3321T, 3365W*<br />
Nouira, R., 2744T<br />
Nouvian, R., 2685F<br />
Novak, B., 3459T, 3669F,<br />
3709F<br />
Novak, S., 2114F<br />
Novak, S. P., 2170T<br />
Novelli, A., 881W, 943W,<br />
2777T, 3050F<br />
Novelli, G., 2160W<br />
Novembre, J., 180, 185,<br />
476W, 1491T, 3282T,<br />
3302W, 3406T, 3626W<br />
Noveski, P., 2983T<br />
Novikov, I., 1303F<br />
Novo-Filho, G., 896T, 899W<br />
Novokmet, N., 1660T<br />
Novosad, P., 2865F<br />
Nowaczyk, M., 124<br />
Nowaczyk, M. J. M., 131,<br />
300*, 701F<br />
Nowak, J., 1057T, 1184F*<br />
Nowak, S., 423F<br />
Nowell, K., 759W<br />
Nowicka, K., 1057T, 1184F<br />
Nozaki, Y., 3118F<br />
nPOD-Virus Group, 3600W<br />
Nsubuga, R., 3412T<br />
Ntalla, I., 2097W, 3396T<br />
Ntzani, E. E., 109<br />
Nucci, A., 2653T<br />
Nuccitelli, A., 71<br />
Nuernberg, G., 105, 2909T<br />
Nuernberg, P., 105, 2909T<br />
Nukina, N., 2768T<br />
Numabe, H., 1816F*<br />
Numata, Y., 234<br />
Nunes, D. H., 1946F<br />
Nunes, H. F., 2291F*<br />
Nunes, K., 3292F*<br />
Nunes, M. E., Session 79,<br />
3158F*<br />
Nunes, V., 2703F<br />
Nuñez, A. F., 926T<br />
Nunez, C., 1330F, 3364F<br />
Núñez, C., 3402T<br />
Nuñez, G., 1320T<br />
Nuñez-Zenteno, A., 650T<br />
Nuotio, M.-L., 2132F*<br />
Nurmi, E. L., 639T*<br />
Nurminen, R., 995F*, 997T<br />
Nürnberg, G., 1, 2930T,<br />
2944W, 3214F<br />
Nürnberg, P., 1, 2759T,<br />
2812W, 2861T, 2869W,<br />
2930T, 2944W, 3214F<br />
Nurse, J. C., 3725F<br />
Nusbaum, C., 322<br />
Nusbaum, S., 915W<br />
Nuytemans, K., 347*, 2603F<br />
Nwebube, N., 3518T<br />
Nyambo, T., 283, 3303T,<br />
3338W<br />
Nyberg, F., 609T, 1970F<br />
Nyegaard, M., 2699T*<br />
Nygaard, M., 2295W*<br />
Nygaard Ravn, M., 3641F,<br />
3662W<br />
Nyholt, D. R., 106, 2056T,<br />
2133W*, 2175W<br />
Nyström, M., 982T<br />
O<br />
Oakhill, K., 1257W<br />
Obayashi, M., 2371T<br />
Ober, C., 278, 536W,<br />
2031W, 2982T, 3398T<br />
Oberfield, S. E., 812F<br />
Oberg, A. L., 1426F<br />
Oberman, B., 1303F<br />
Oberoi, S., 3242F<br />
Obisesan, T. O., 317<br />
O’Bleness, M., 433F, 465F*<br />
O’Bra, S., 3238F<br />
Obraztsova, O., 2005T<br />
O’Brien, D. P., 2805F, 2847F<br />
O’Brien, J. E., 2463W*<br />
O’Bryhim, B. E., 1989W*<br />
Obuchi, M., 2656T<br />
Occhi, G., 2708T*<br />
Ochoa, J., 970T<br />
Ochoa, S., 3063W*<br />
Ochs-Balcom, H., 1086W<br />
Ochs-Balcom, H. M., 2360F<br />
Ockeloen, C. W., 100,<br />
3159W*<br />
O’Connell, J., 1484W*,<br />
2210F<br />
O’Connell, J. R., Session<br />
27, 602T<br />
O’Connell, M. A., 577F<br />
O’Connor, I., 2620T<br />
O’Connor, M., 1740W<br />
Oda, T., 232<br />
O’Day, D., 2789T*<br />
O’Day, D. R., 10<br />
Oddoux, C., 3345T, 3395W,<br />
3397W*<br />
Odeberg, J., 1651T<br />
Odefrey, F., 3679F<br />
Odefrey, F. A., 1213T<br />
Odent, S., 2893W, 3170F*<br />
Odenthal-Hesse, L.,<br />
3257W*<br />
Odom, D., Session 5<br />
O’Donnell, C., 584W, 586W,<br />
1408F<br />
O’Donnell, C. J., 170, 174,<br />
349, 1445W, 1585T,<br />
1599T*, 1677T<br />
O’Donovan, M., 1325W<br />
O’Donovan, M. C., 2576F<br />
O’Dushlaine, C., 290, 333,<br />
2487W*<br />
O’Dushlaine, C., 2618F<br />
O’Dushlaine, C. T., 2576F<br />
Oehl-Jaschkowitz, B.,<br />
3111W<br />
Oei, L., 109*<br />
Oepkes, D., 3020T<br />
Oertel, W., 2568W<br />
Oestergaard, E., 702T*<br />
Oeth, P., 2973T, 3016T*,<br />
3023T<br />
Oetjens, M. T., 647T*<br />
O’Fallon, B. D., 225*<br />
Offenhäuser, N., 1<br />
Offit, K., 17, 27, 207, 208,<br />
998F, 999W, 1159T,<br />
1841W<br />
Ofverholm, I., 1126T*<br />
Ogaki, K., 2559W, 3221W*<br />
Ogata, H., 663F, 3499T<br />
Oghalai, J. S., 840F<br />
Ogundiran, T. O., 1003T<br />
Ogunniyi, A., 1959W<br />
Oguzkan Balci, S., 1402F*,<br />
1935W, 1938W<br />
Oh, B., 1622T*<br />
Oh, E., 13<br />
Oh, E. C., 2458T<br />
Oh, F., 1691T<br />
Oh, G., 628T<br />
Oh, H., 2665W*<br />
Oh, J., 1230W<br />
Oh, K., 3223W<br />
Oh, S., 690T, 3567F*<br />
O’Hanlon, T. P., 434W<br />
O’Hare, J., 893W<br />
Ohashi, J., 1327F, 1994F,<br />
3301F<br />
Ohh, M., 1046F<br />
Ohler, U., 586W<br />
Ohlsson, C., 2080T, 2116T<br />
Ohmen, J., 2184W*<br />
Ohmen, J. D., 2104T<br />
Ohmura, K., 2004W<br />
Ohno, K., 2472W*<br />
Ohno, M., 548W*, 558W,<br />
598W<br />
Ohta, T., 3056F<br />
Ohtake, A., 2873T<br />
O’Huallachain, M., 425F*<br />
Oien, N. C., 3<br />
Oikkonen, J., 2181W<br />
Oikonomopoulos, S., 509F<br />
Oiso, N., 3146F*<br />
Oitmaa, E., 1140W<br />
Ojeda, F., 1669T<br />
Ojha, B. K., 1177T<br />
Oji, V., 2869W<br />
Okabe, T., 800W*<br />
Okada, J., 724T<br />
Okada, K., 1815W, 2440T,<br />
2550W<br />
Okada, T., 799W<br />
Okada, Y., 111, 1490W*,<br />
2004W<br />
Okada-Hatakeyama, M.,<br />
2264F<br />
Okamoto, N., 1290T, 2697F,<br />
2758W, 3102F*<br />
Okamoto, Y., 777W*,<br />
2418W, 2607W, 2616W<br />
Okamura-Ikeda, K., 8<br />
Okano, H., 2911W<br />
Okano, T., 2833W<br />
Okazaki, Y., 2652W, 2873T,<br />
2923W<br />
Okochi, S., 1130F<br />
Okou, D. T., 2312F*
Oksenberg, J., 2113T, 3330T<br />
Oksenberg, J. R., 270,<br />
1924T, 2299T<br />
Okuyama, T., 726T, 2911W<br />
Oláh, E., 3070F<br />
Olatubosun, A., 496W<br />
O’Laughlin, M., 1210T<br />
Oldgren, J., 617T, 619T<br />
O’Leary, J., 2974T<br />
Oleksyk, T., 3254W<br />
Oleksyk, T. K., 3315T,<br />
3360T, 3380W<br />
Olender, T., 53, 2875W<br />
Oler, J. A., 2413T<br />
Olin, A. C., 1970F<br />
Oliphant, A., 2978T, 3020T<br />
Oliva, R., 2624F<br />
Oliveira, B. A., 2417F*,<br />
2502W<br />
Oliveira, E. P. L., 514W<br />
Oliveira, F. A., 2233T<br />
Oliveira, F. M., 1045T*<br />
Oliveira, G., 1239W, 2261F,<br />
2417F, 2502W<br />
Oliveira, J. P., 3122F<br />
Oliveira, K. G., 2654F<br />
Oliveira, L. F. S., 2434T<br />
Oliveira, M., 896T, 899W<br />
Oliveira, M. B., 2286W*,<br />
2291F, 2718F<br />
Oliveira, R. J., 1880F<br />
Oliveira, S., 3261T*<br />
Oliveira, S. A., 1977W,<br />
2085W, 2150F<br />
Oliveira, S. F., 961W, 3324T,<br />
3375T<br />
Oliver, J., 3703F<br />
Oliver, J. S., 3529F, 3656W*<br />
Oliver, K. L., 2898F<br />
Oliver, P. L., 2649W*<br />
Oliver, T., 940T<br />
Olivier, M., 441F, 587F,<br />
1269W, 1667T<br />
Oljira, T., 3322F<br />
Ollert, M., 2922F<br />
Ollila, H. M., 2462F*<br />
Olm-Shipman, A. J., 2265W,<br />
2670F<br />
Olopade, O. I., 1003T<br />
Olsen, A. O., 3510T<br />
Olsen, N., 1901F, 2284T<br />
Olson, J. E., 3564W<br />
Olson, L., 247, 1447F,<br />
2263T<br />
Olson, L. M., 2154W, 2240F<br />
Olson, T. M., 1695T<br />
Olsson, L., 1023W*<br />
Olsson, T., 1455T, 2561F<br />
Olstad, O. K., 576W<br />
Omar, S., 3303T, 3338W<br />
Omarjee, A., 126<br />
Omay, Z., 1201T<br />
Omdal, R., 2084F<br />
Omi, N., 2129F<br />
Omran, H., 2850F, 2955F<br />
Önal-Akan, A., 2869W<br />
Onat, O. E., 2924T*<br />
Onay, H., 2719W, 3206F*,<br />
3222F<br />
Öncel Torun, Z., 3195W*<br />
*Presenting Author<br />
Oncescu, A., 3009T, 3067W<br />
Onda, H., 2675T<br />
O’Neill, C., 763W, 784W<br />
O’Neill, F. A., 2500T, 2594F,<br />
2599T<br />
Onengut-Gumuscu, S.,<br />
1299T<br />
Oner, O., 8<br />
Ong, F. S., 130*<br />
Ong, J., 3669F<br />
Ong, K., 2165F<br />
Ong, K. K., 2282F<br />
Ong, R. T. H., 3284W, 3339T<br />
Ongaco, C., 2139W<br />
Ongen, H., 401*, 556W,<br />
561F<br />
Onkamo, P., 2181W<br />
Onland-Moret, N. C., 609T<br />
Onouchi, Y., 1631T*, 1643T<br />
Onoufriadis, A., 809F*<br />
Ontiveros, A., 2495F<br />
Ooi, C., 3574W<br />
Oonk, A. M. M., 58<br />
Oostdijk, W., 2701W<br />
Oosterveld, M. J. S., 2848W<br />
Oosterwijk, J. C., 27<br />
Oostra, B., 2107T<br />
Oostra, B. A., 2193W<br />
Oostrik, J., 58<br />
Opdal, M. S., 643T<br />
Openshaw, P. J., 1507F<br />
Oph<strong>of</strong>f, R. A., 431F, 2526W,<br />
2553W, 2661W, 3474T*<br />
Opocher, G., 2708T<br />
Oppelt, P., 3153W<br />
Oppeneer, T., 763W<br />
Oppenheimer, S., 3264T,<br />
3267T<br />
Oppo, M., 113, 157, 177<br />
OPTIMED Consortium,<br />
608T<br />
O’Rahilly, S., 33, 43, 45, 583F<br />
Orange, J. S., 2722W<br />
Ordonez, J., 2495F<br />
Ordovas, J. M., 2024F<br />
Ordulu, Z., 68, 70*<br />
O’Reilly, D. D., 454W<br />
O’Reilly, P., 1432F, 2162F<br />
O’Reilly, P. F., 2164T<br />
O’Reilly, R., 2585F<br />
Orellana, C., 103<br />
Organ, C., 2561F<br />
Ori, A. P. S., 2661W<br />
O’Rielly, D., 448W*<br />
Orioli, A., 415F<br />
Orlando, S., 255<br />
Orl<strong>of</strong>f, M., 1144T<br />
Ormond, K., Session 25<br />
Ormond, K. E., 1844F<br />
Ormshaw, E., 3167W<br />
Ornitz, D. M., 828F<br />
Ornt<strong>of</strong>t, T. F., 401<br />
O’Roak, B. J., 10*, 93, 278,<br />
2789T, 2897T<br />
Oron-Karni, V., 2919F<br />
Orosco, L., 956T<br />
O’Rourke, M., 853F<br />
Orr, H. T., 2625W, 2769F<br />
Orr, N., 1150T<br />
Orrù, V., 1516F<br />
SPEAKER AND AUTHOR INDEX 389<br />
Orr-Urtreger, A., 63, 704T<br />
Orta Correia, F., 1968W<br />
Orta Gomes, F., 2017T<br />
Ortega, G., 3226F<br />
Ortega, M., 2049W<br />
Ortega, O., 2453F<br />
Ortega, V., 868T<br />
Ortega Del Vecchyo, D.,<br />
3302W*, 3621F<br />
Ortega-Gutierrez, F. A., 650T<br />
Ortel, T. L., 2330F<br />
Ortiz, R., 1141T<br />
Ortiz, V., 526W<br />
Ortiz Brüchle, N., 3111W<br />
Ortiz-López, R., 1030T<br />
Ortiz-Orozco, R., 650T<br />
Ortiz-Tello, P., 2033F*, 3390T<br />
Ortmann, W., 2091W<br />
Ortoz, R., 1049F<br />
Orwoll, E., 109<br />
Orwoll, E. S., 2375F<br />
Ory, D., 684T<br />
Osaka, H., 234, 2836W,<br />
3136F<br />
Osann, K., 1791W<br />
Osann, K. E., 3213W<br />
Osawa, M., 1321F, 2963T<br />
Osborne, K., 399<br />
Osborne, L. R., 2665W,<br />
3482T<br />
Oshiro, M. M., 3712W<br />
Oshlack, A., 3484T<br />
Osimani, S., 124<br />
Osimo, E., 2564F<br />
Osoegawa, K., 1589T*<br />
Osorio, A., 1213T<br />
Ospina, L. H., 2790F<br />
Ossowski, S., 2303F, 2326T,<br />
2593T, 2940F, 3661F*<br />
Ossowsky, V., 2018F<br />
Ostell, J., 1762W, 3625F<br />
Oster, B., 401<br />
Østergaard, E., 363<br />
Ostergren, J. E., 1849W<br />
Ostrander, E. A., 28, 1001F,<br />
1214F, 2219F*<br />
Ostrer, H., 17, 409, 1185W,<br />
1309F, 2078F, 3345T,<br />
3395W*, 3397W<br />
Ostrosky, P., 1049F<br />
Ostrovnaya, I., 999W<br />
Ostrovsky, J., 534W, 2943F<br />
Oswald, G., 80<br />
Oswald, M., 1133F<br />
Ota, S., 475F<br />
Ota, V. K., 2533T*, 2534F<br />
Otieno, F., 2722W, 2856F<br />
Otieno, F. G., 2872W<br />
Otsuka, A., 2911W<br />
Ott, J., 1892F<br />
Otterud, B., 2397W<br />
Ottman, R., 203<br />
Otto, E. A., 406, 2850F*<br />
Otto, P. A., 874T<br />
Ottoboni, L., 2250W<br />
Ottolini, B., 449F*<br />
Ou, J., 553F, 2479T<br />
Ouahla, M., 2674W<br />
Oualkacha, K., 1411F*<br />
Ouazzani, O., 2306F<br />
Ouchi, K., 1631T<br />
Oud, M., 324<br />
Oud, M. M., 216<br />
Oufadem, M., 3172F<br />
Ouguerram, K., 1607T<br />
Ouled Amar Bencheikh, B.,<br />
2306F*, 2342F<br />
Õunap, K., 3151W<br />
Ounissi-Benkalha1, H., 5<br />
Ousager, L. B., 2760F<br />
Outeiro, T. F., 2641T<br />
Ouwehand, W., 110<br />
Ouwehand, W. H.,<br />
Session 22, 383,<br />
1604T, 3453T<br />
Ouwenga, R., 3398T<br />
Ouzhuluobu, O., 3317W<br />
Ovarian Cancer Association<br />
Consortium, 1156T<br />
Ovcharenko, I., 407, 545F<br />
Overgaard, M. T., 2699T<br />
Ovetsky, M., 1762W<br />
Owen, M., 1325W<br />
Owen, M. J., 2405F, 2576F<br />
Owen, N., 730T<br />
Owen, R., 876T, 3522T<br />
Owens, C., 3142F<br />
Owings, A., 3373F<br />
Owings, A. C., 3329W,<br />
3377W<br />
Oyama, F., 548W, 558W*,<br />
559F, 598W, 599F<br />
Oyarzo, A., 2672T<br />
Oystreck, D. T., 2928F<br />
Oza, A., 1824F<br />
Ozaki, A., 2656T<br />
Ozaki, K., 1631T, 1643T*<br />
Ozaksit, G., 594W<br />
Ozbek, U., 22*, 2396F,<br />
2412W*<br />
Ozcelik, H., 1500T<br />
Ozcelik, T., 287, 2924T<br />
Ozdemir, O., 2412W<br />
Ozdemir, T., 3222F*<br />
Ozdemir, T. R., 1106F<br />
Ozeki, T., 627T*<br />
Ozel, A. B., 2135F*<br />
Ozelius, L., 17<br />
Ozelius, L. J., 2801T<br />
Ozen, M., 2908W<br />
Ozenberger, B. A., 1845W*<br />
Ozer, O., 3424T*, 3426T<br />
Ozhan, N., 1025F<br />
Ozilou, C., 915W<br />
Ozkan, E., 3201W<br />
Ozkilic, M., 3475T*<br />
Ozkinay, C., 1106F<br />
Ozkinay, F., 965W, 1106F,<br />
2719W*, 3206F, 3222F<br />
Özkinay, F., 3214F<br />
Oz-Levi, D., 53*, 2875W<br />
Ozmore, J., 3176F<br />
P<br />
Pääbo, S., 3274F, 3372T<br />
Paananen, J., 46<br />
Paardekooper Overman,<br />
J., 215<br />
SPEAKER AND AUTHOR INDEX
390 SPEAKER AND AUTHOR INDEX<br />
Paavola-Sakki, P., 2023T<br />
Pabón-Peña, C., 3669F<br />
Pabst, S., 2103W<br />
Pacanaro, A. N., 3045W<br />
Pacheco, J., 1312F<br />
Pacheco, J. A., 618T<br />
Pacheco Torres, A., 996W*<br />
Paciolla, M., 505F<br />
Pack, A., 2592W<br />
Padbury, J., 76, 3024T*<br />
Padgett, R. A., Session 24<br />
Padilla, C. D., 1805W*,<br />
1877F<br />
Padilla, S., 1805W<br />
Padioleau, I., 561F<br />
Padmanaban, A., 3705F<br />
Padmanabhan, S., 1626T<br />
Padoan, M., 1153T<br />
Padula, A., 2629T<br />
Padyukov, L., 1934F, 1981T,<br />
2103W, 2160W, 2276F<br />
Paelinck, B., 1617T<br />
Paetau, A., 1253F<br />
Paez, P., 3115W*<br />
Paff, T., 809F<br />
Pagan, C., 259<br />
Pagani, L., 3322F*, 3377W<br />
Page, D., 2297F<br />
Page, E., 1109F<br />
Page, G., 2114F<br />
Page, G. P., 1392T*, 2170T<br />
Pagliarani, S., 1751W<br />
Pagnamenta, A. T., 2939T<br />
Pagon, R. A., 1753W<br />
Pai, A., 2<br />
Pai, A. A., 3251W<br />
Paila, U. D., 3632W*<br />
Painter, J. N., 2056T<br />
Painter, J. P., 2133W<br />
Paisan-Ruiz, C., 2866W<br />
Paithankar, S., 3433T<br />
Paiva, C., 2288F<br />
Pajukanta, P., 2256W<br />
Pak, H., 1590T<br />
Pakalapati, G., 434W<br />
Pakstis, A. J., 3313F<br />
Pal, A., 802W<br />
Pal, D. K., 1531F, 2580W<br />
Pal, T., 1061F*<br />
Pala, M., 547F*, 2001W<br />
Palacios, B., 526W<br />
Palacios, M. G., 3084F*<br />
Palamara, G., 2780T<br />
Palamara, P., 3346F, 3366T*<br />
Palamara, P. F., 17, 3345T<br />
Palejev, D., 334<br />
Palha, T., 3364F, 3402T<br />
Palin, K., 3396T<br />
Pall, H., 348<br />
Pallas, M. C., 3725F*<br />
Paller, A. S., 2915T<br />
Pallesi-Pocachard, E.,<br />
889W*, 2674W<br />
Pallone, N. L., 742T*<br />
Palma, M. G., 926T<br />
Palmas, W., 1661T<br />
Palmeiro, A., 1778W<br />
Palmer, C., 1082F, 2131T<br />
Palmer, C. D., 3525T<br />
Palmer, C. N. A., 115, 609T<br />
*Presenting Author<br />
Palmer, D., 735F<br />
Palmer, L., 1153T<br />
Palmer, L. J., 2167T<br />
Palmer, N., 269<br />
Palmer, N. D., 1661T,<br />
1879T*, 1888T, 2275T,<br />
2310W<br />
Palmer, R., 126, 1773W<br />
Palmer, S. E., 330<br />
Palmer, S. J., 410*, 2662W,<br />
2796F<br />
Palmfeldt, J., 657F<br />
Palomaki, G. E., 3016T<br />
Palomares, M., 1658T,<br />
2065T<br />
Palotie, A., 252, 656T,<br />
897W, 1325W, 1709T,<br />
2059T, 2134T, 2344T,<br />
2348F, 2350T, 2399F,<br />
2898F<br />
Palou, J., 1053W<br />
Pals, G., 809F<br />
Palser, A. L., 2163W<br />
Paltiel, O., 1159T<br />
Paltoo, D., 2247W<br />
Pan, H., 1566T, 1772W<br />
Pan, J., 2838F<br />
Pan, S., 1601T<br />
Pan, W. H., 3430T<br />
Pan, X., 443F, 3394T<br />
Panchal, A., 1256F<br />
Panckeri, K., 853F<br />
Pandey, A., 3316F<br />
Pandey, M. K., 749F*<br />
Pandey, R., 1992W, 1997F,<br />
2252F*<br />
Pandite, L. N., 651T<br />
Pandor, A., 762W*<br />
Panettieri Jr., R. A., 638T<br />
Pang, A., 3506T*<br />
Pang, C. P., 1972T<br />
Pang, H., 531F<br />
Pang, Z., 2433W<br />
Pangalos, C., 2902W*<br />
Pan-Hammarström, Q.,<br />
2091W<br />
Panhuis, T. M., <strong>2012</strong>F<br />
Panicker, V., 1216T<br />
Panico, S., 1712T<br />
Panigrahi, A., 3316F<br />
Panigrahi, G., 2635T*<br />
Panigrahi, I., 3207W*<br />
Pankow, J. S., 1925F,<br />
2337W<br />
Pannosian, S., 2872W<br />
Pannuti, A., 1116W<br />
Panossian, S., 1997F,<br />
2252F, 2785W, 2892F,<br />
2904F<br />
Panoutsopoulou, K., 2044T,<br />
2097W, 2292W*, 3396T<br />
Pantel, K., 1115F<br />
Panzer, J. A., 330<br />
Pao, W., 136, 3620W<br />
Papadogiannakis, N.,<br />
3245W<br />
Papageorgiou, E. A.,<br />
3017T<br />
Papanicolaou, G., 350,<br />
2063F, 2210F<br />
Papanicolaou, G. J., 2131T,<br />
2247W, 3299W<br />
Papasian, C. J., 2053T<br />
Papenhausen, P., 949W<br />
Papillon-Cavanagh, S.,<br />
2790F<br />
Papp, A. C., 609T<br />
Pappas, J. G., 3113W*<br />
Pappatà, S., 1985F<br />
Paprotka, T., 3701F<br />
Paquette, A. M., 3314W<br />
Paquette, J., 3618W*<br />
Paquis, V., 2703F<br />
Paraki, I., 218<br />
Parboosingh, J., 1052F,<br />
3173W<br />
Parboosingh, J. S., 2800W,<br />
3095W, 3127W, 3141W,<br />
3665F<br />
Parc, Y., 1170W<br />
Pardi, E., 2708T<br />
Pardo, L., 98<br />
Pare, G., 617T*<br />
Paré, P. D., 1465F<br />
Paredes, R., 1141T<br />
Paredes-Aguilera, R.,<br />
1131W<br />
Parent, P., 1728W<br />
Parets, S. E., 2384F*<br />
Pareyson, D., 2781F<br />
Parfenov, M. G., 1677T<br />
Parfrey, P., 1066T, 1084T<br />
Parham, P., Session 80,<br />
3390T, 3710W<br />
Pariente, J., 345<br />
Parikh, A., 3097W<br />
Parikh, H., 1088F, 1199F*<br />
Parikh, S., 330<br />
Parikshak, N., 2444F<br />
Parimi, N., 2375F<br />
Parisi, V., 881W, 943W*,<br />
2777T<br />
Parisot, P., 77<br />
Park, A., 1590T, 2042F<br />
Park, B. L., 1975T<br />
Park, C., 1931F<br />
Park, C. S., 1975T<br />
Park, D. J., 1213T, 3679F*<br />
Park, H., 1155W<br />
Park, H. C., 3223W*<br />
Park, I., 1248W, 3462T<br />
Park, J., 947W, 1190F,<br />
1306F, 1450F*, 1657T,<br />
2715F, 3444T<br />
Park, J. E., 1465F<br />
Park, J.-H., 1007F*<br />
Park, K. H., 1305T<br />
Park, K.-H., 385<br />
Park, L., 2499W<br />
Park, M., 2518T<br />
Park, N., 2260T, 2547W<br />
Park, S., 126, 900T, 2518T,<br />
3008T, 3103W, 3461T,<br />
3473T<br />
Park, S. H., 3423T<br />
Park, S. J., 863W<br />
Park, S.-Y., 1622T<br />
Park, T., 1385W<br />
Park, W., 933W, 2723T*,<br />
3204F, 3223W<br />
Park, Y. S., 344, 2508W*<br />
Parker, D., 386<br />
Parker, H. G., 2219F<br />
Parker, M. M., 1425T*,<br />
1512T, 3616W<br />
Parker, T., 3210F<br />
Parker, V. E. R., 33<br />
Parkes, M., 2314T<br />
Parkhurst, E., 1866F<br />
Parkinson, H., 2108F<br />
Parkinson, K., 2703F<br />
Parkinson, N., 3142F<br />
Parkinson’s Disease<br />
<strong>Genetics</strong> Study Group,<br />
2638T<br />
Parks, J. C., 2968T<br />
Park-Simon, T. W., 1117T<br />
Parla, J., 2180F, 2305T,<br />
2587T<br />
Parlamee, N., 17<br />
Parmalee, N., 1898F,<br />
2547W*<br />
Parman, Y., 201, 2948T<br />
Parmar, A. S., 2023T*<br />
Parnaik, R., 361<br />
Parnell, L., 2024F*<br />
Parnham, A., 2916F<br />
Parodi, C., 1589T<br />
Parra, E., 49<br />
Parra, M., 1736W*<br />
Parracciani, D., 2128T<br />
Parrado, A. R., 2520W*<br />
Parrini, E., 889W<br />
Parsons, J., 530W<br />
Parsons, M. J., 818F<br />
Parsons, M. T., 1067F<br />
Parsons, R., 1255T<br />
Partanen, J., 2023T<br />
Partlow, J. N., 8<br />
Parts, L., 44, 583F, 1440T<br />
Partyka, G., 1867F<br />
Parvari, R., 1588T, 2738T*<br />
Parveen, F., 2992T*<br />
Pasalar, P., 1083W<br />
Pasaniuc, B., 89*, 284, 350,<br />
1331W, 1577W<br />
Pasca, S., 2479T<br />
Pasche, B., 1292W<br />
Paschon, D. E., 803W<br />
Pasco, Y., 270, 2603F<br />
Pasco, Y. M., 2572T<br />
Pascoal, V. D. B., 2655W<br />
Pasko, D., 2116T<br />
Paskulin, G., 2434T<br />
Pasmanik-Chor, M., 105<br />
Pasquale, L. R., 51, 1887W,<br />
2135F, 2154W*, 2240F,<br />
2263T<br />
Pasquale, R., 1060T<br />
Pasquali, A., 2548T<br />
Pasquali, M., 686T<br />
Pasquier, L., 3157W<br />
Passan, S., 1342F*<br />
Passini, M., 793W<br />
Passos-Bueno, M. R., 439F,<br />
813F, 814F, 852F, 2414F,<br />
2654F, 2673F, 2687T,<br />
2746W, 3070F, 3152F<br />
Passtoors, W. M., 1436W<br />
Pasternack, D., 1279T
Pasternack, S., 1005W<br />
Pastinen, T., 256, 394,<br />
569F, 649T, 705F, 1207T,<br />
1215W, 3439T, 3466T,<br />
3514T<br />
Pastore, N., 735F*<br />
Pastores, G. M., 768W,<br />
769W, 772W, 773W<br />
Pastorino, R., 2039F<br />
Pastura, P., 2136W<br />
Pasutharnchat, N., 2749W<br />
Pasutto, F., 2160W<br />
Patel, A., 61, 229, 430W,<br />
432W, 893W, 898T*,<br />
952T, 2403W<br />
Patel, C., 2230T<br />
Patel, C. J., 1462F*<br />
Patel, D., 1108T<br />
Patel, H., 3400T<br />
Patel, K., 503F<br />
Patel, M., 750T<br />
Patel, P., 2778F*<br />
Patel, P. J., 1472W<br />
Patel, S. R., 646T<br />
Patel, V. C., 2312F<br />
Patel, Y., 3471T<br />
Paternoster, L., 1528F,<br />
2102F<br />
Paterson, A., 2376W,<br />
2499W<br />
Paterson, A. D., 2109W<br />
Pathak, J., 1351F<br />
Patil, S., 1841W<br />
Patin, E., 3368W<br />
Patino, A., 951W<br />
Patiño, A., 3074F<br />
Patney, H. L., 1649T<br />
Pato, C., 2564F<br />
Pato, M., 2564F<br />
Paton, W., 222<br />
Patrinos, G. P., 3610W<br />
Patry, L., 2692W, 2790F<br />
Patsalis, P., 3017T*<br />
Patsopoulos, N. A., 624T<br />
Patterson, A., 2281T<br />
Patterson, B., 1847W<br />
Patterson, D. G., 2504F<br />
Patterson, M. C., 684T<br />
Patterson, N., 89, 178, 350,<br />
1331W, 1360F, 2210F,<br />
3372T, 3407W<br />
Patti, E., 2095T<br />
Pattnaik, B., 2830W<br />
Patto, J. V., 1977W<br />
Pauciulo, M. W., 2136W*<br />
Paul, D. S., 110, 383<br />
Paul, S. M., 1965W<br />
Paul-Gilloteaux, P., 842F<br />
Pauls, D., 1480F<br />
Paulsson, K., 1023W, 1024T<br />
Paulus, W., 2568W<br />
Paunio, T., 252, 2462F<br />
Pauws, E., 2752W, 2859F<br />
Pavan, W. J., 258<br />
Pavanello, R. C. M., 1727W<br />
Pavlidis, P., 447F, 491F,<br />
517F, 2482T, 3568W*<br />
Pavlovic, A., 1601T<br />
Pawel, B., 924T<br />
Pawitan, Y., 2074T<br />
*Presenting Author<br />
Pawlikowska, L., 589F<br />
Paxinos, E., 3682W, 3724W<br />
Paxinos, E. E., 36<br />
Payet, M., 2729T<br />
Payette, Y., 2266T, 3341W<br />
Payne, F., 33, 45*<br />
Payne, T. J., 2388W, 2390F,<br />
2574W<br />
Paynter, N. P., 51<br />
Pazos, A., 3388F<br />
Pazourkova, E., 3437T<br />
Pearce, K. E., 1145F<br />
Pearce, M. S., 3419T<br />
Pearlman, A., 409, 1185W*,<br />
3345T<br />
Pearson, C., 2635T, 3026T<br />
Pearson, C. E., 2696T,<br />
2824W<br />
Pearson, K., 3238F<br />
Pearson, L., 2083T<br />
Pearson, L. N., 2223W<br />
Pearson, N., 1558F, 1561F<br />
Pearson, N. M., 2871F<br />
Pearson, R. D., 172, 1519F<br />
Peckins, S., 3264T<br />
Peco-Antic, A., 216<br />
Peden, J., 1238F<br />
Pedersen, A. G., 2241W<br />
Pedersen, E. B., 2329T<br />
Pedersen, I. S., 2862F<br />
Pedersen, J. K., 1323T<br />
Pedersen, L., 1565W<br />
Pedersen, N. L., 434W,<br />
2105F, 2175W<br />
Pedersen, O., 1624T, 2116T,<br />
2311T, 2317T, 2347T<br />
Pediatric Imaging<br />
Neurocognition <strong>Genetics</strong><br />
Study, 1973F<br />
Pedram, M., 2714T<br />
Pedrazzoli, J., Jr., 1187F<br />
Pedroso, J. L., 2642F<br />
Peebles, D., 3508T<br />
Pe’er, I., Session 75, 17*,<br />
193, 264, 353, 1231T,<br />
1320T, 3345T, 3346F,<br />
3366T<br />
Peete, J., 493F<br />
Peeters, E. A. J., 214<br />
Peeters, H., 925W<br />
Peeters, K., 201, 2948T<br />
Pegoraro, E., 1732W, 2799F<br />
Pehlivan, D., 337, 360,<br />
777W, 2881W*, 2908W,<br />
2955F<br />
Pehlivan, S., 1402F, 1935W,<br />
1938W<br />
Pehlivan, Y., 2881W<br />
Pei, Y. F., 2053T, 3534W<br />
Pei, Y.-F., 2172W<br />
Peissig, P., 618T, 1312F,<br />
3622W<br />
Peitz, M., 236<br />
Pelak, K., 53, 2335T<br />
Peleg, L., 2691F*<br />
Pellegata, N., 2708T<br />
Pellegrini, M., 2479T<br />
Pellegrino, C., 2674W<br />
Pellegrino, R., 2492F,<br />
2592W*<br />
SPEAKER AND AUTHOR INDEX 391<br />
Peller, L., 674T<br />
Peller, L. C., 1696T<br />
Pellerin, P., 2002T<br />
Pellestor, F., 857W*, 936T<br />
Pellico, M. T., 775W<br />
Pellitteri-Hahn, M., 587F<br />
Peloso, G., 279<br />
Peloso, G. M., 117, 170<br />
Pelte, M. F., 67<br />
Peltekova, V., 1093T*<br />
Peltoketo, H., 1099T<br />
Peltomäki, P., 1026W,<br />
1276T<br />
Peltonen, J., 1139F<br />
Peltonen, S., 1139F<br />
Pelttari, L. M., 997T*<br />
Peluso, I., 2950W<br />
Peluso, P., 477F<br />
Pemberton, T., 2778F<br />
Pemberton, T. J., 3285T<br />
Pemov, A., 1261T*<br />
Peña, J. A., 3375T<br />
Pena, S. D. J., 3110F<br />
Peñaherrera, M. S., 3429T<br />
Penalva, L., 585F<br />
Penchaszadeh, V., 1877F<br />
Pendergrass, S. A., 226*,<br />
625T, 1316W, 2258F,<br />
3542W, 3624W<br />
Peng, B., 1543F*, 1554T<br />
Peng, C., 3596W<br />
Peng, G., 3589F<br />
Peng, J., 763W<br />
Peng, Q., 1263W*<br />
Peng, S., 3596W<br />
Peng, W., 586W, 3285T<br />
Peng, X., 3698W*<br />
Peng, X. H., 3081W<br />
Peng, Y., 3317W<br />
Peng, Z., 1369F<br />
Penland, C. M., 1731W<br />
Penn, J., 688T<br />
Pennacchio, L. A., 4, 254,<br />
407<br />
Pennell, C., 2097W, 2164T<br />
Penninger, J., 110<br />
Pennings, R. J. E., 58<br />
Pennington, J., 3530W<br />
Pennington, J. W., 3590W<br />
Pennison, M. J., 1292W*<br />
Penny, D. J., 1646T<br />
Pensato, V., 2775F<br />
Penzes, P., 263<br />
Peoples, A., 480W<br />
Pepalyte · , I., 653T, 920T<br />
Peppard, P. E., 2543F<br />
Pepperkok, R., 1630T<br />
Peralta, J., 1280W, 2589W<br />
Peralta, J. M., 1923W,<br />
2308T, 2309F, 2339F<br />
Perche, O., 3246F<br />
Perdomo, S., 3115W<br />
Perea-Díaz, F. J., 2363F<br />
Perego, U. A., 3340F<br />
Pereira, A., 1593T<br />
Pereira, A. C., 636T, 1629T,<br />
3160F, 3184F<br />
Pereira, C. S., 941W<br />
Pereira, E. T., 2642F<br />
Pereira, F. A., 840F<br />
Pereira, F. S., 2825T*<br />
Pereira, I. A., 1405F<br />
Pereira, L., 1343W*, 3325F<br />
Pereira, L. C., 2352W<br />
Pereira, L. V., 776W<br />
Pereira, P., 2404T*<br />
Pereira, P. D., 479F<br />
Pereira, R. W., 1202F,<br />
1880F, 2223W, 3272W<br />
Pereira, S., 70<br />
Pereira, S. L., 2932W<br />
Pereira Filho, S. A. C.,<br />
2751F<br />
Pereira-Latini, A. C., 2289W<br />
Pereira- Leal, J. B., 2261F<br />
Perera, M., 646T<br />
Perera, N., 1108T<br />
Perez, A., 2540F*, 3131W<br />
Perez, A.-B., 895W<br />
Perez, A. B. A., 2484W,<br />
2485T<br />
Pérez, C., 2300F<br />
Perez, I. C., 2837T<br />
Perez, M. J., 77, 3129W<br />
Perez, R. J. M., 3039W<br />
Perez, S., 827F<br />
Perez-Jurado, L., 84<br />
Perez-Jurado, L. A., 2711T*,<br />
3084F, 3208F<br />
Perez-Nuño, M., 650T<br />
Perez-Quiñones, M. L.,<br />
3363T<br />
Perez Siles, G., 2742F<br />
Perez-Stable, E., 1075T<br />
Perez-Vera, P., 1141T,<br />
3040F<br />
Pérez-Vera, P., 872T, 1022F,<br />
1131W<br />
Pergadia, M. L., 2212T<br />
Pericak-Vance, M., 492W,<br />
1571W, 3706W<br />
Pericak-Vance, M. A.,<br />
Session 7, 9, 15, 270,<br />
341, 342, 343, 344, 347,<br />
588W, 1476T, 1489F,<br />
1644T, 1834F, 2028W,<br />
2049W, 2154W, 2185T,<br />
2240F, 2263T, 2299T,<br />
2318F, 2330F, 2445W,<br />
2498F, 2508W, 2572T,<br />
2583W, 2586W, 2614T,<br />
2637W, 3335W<br />
Perin, J., 2904F<br />
Perin, J. C., 2943F<br />
Periyasamy, G., 2967T<br />
Perlberg, S., 2447F,<br />
2991T<br />
Perls, T., 2040W<br />
Permaul, J., 1852F<br />
Perola, M., 656T, 1253F,<br />
1436W, 1563T, 2059T,<br />
2132F, 2175W, 2366F,<br />
2462F<br />
Perrault, I., 324*, 390<br />
Perrier, R., 910T, 1052F<br />
Perrin, M., 2126F<br />
Perry, B. J., 845F<br />
Perry, G. H., 3251W<br />
Perry, J. R. B., 111, 2073W,<br />
2165F*<br />
SPEAKER AND AUTHOR INDEX
392 SPEAKER AND AUTHOR INDEX<br />
Perry, R., 2648F<br />
Pers, T., 2090F<br />
Pers, T. H., 2241W*<br />
Persani, L., 2701W<br />
Perseu, L., 2001W<br />
Persico, I., 2062T*<br />
Person, R., 1742W<br />
Person, R. E., 314<br />
Perszyk, A., 687F*, 740T,<br />
743F, 3239W<br />
Pertesi, M., 1213T<br />
Perucha, E., 2082W<br />
Perusse, L., 2116T<br />
Pescarini, J., 1343W,<br />
2352W*<br />
Pescatore, A., 505F<br />
Pesce, L. L., 1614T<br />
Peskett, E., 2752W, 2859F<br />
Peskind, E., 340<br />
Peskind, E. R., 2646W<br />
Pessah, I. N., 2491T<br />
Petanovski, Z., 2983T<br />
Petek, E., 2570F<br />
Petek, L. M., 55, 2224T<br />
Peter, B., 2432F*, 3300T,<br />
3311W<br />
Peter, B. J., 971W<br />
Peter, I., 17, 1320T, 1777W,<br />
2151W, 2576F, 3488T<br />
Peter, J., 2205W<br />
Peterlin, B., 3001T<br />
Peterlongo, P., 27<br />
Peters, A., 275, 2226W,<br />
2568W<br />
Peters, J. A., 1064F<br />
Peters, M. J., 584W*, 1284T,<br />
1503T, 2141F<br />
Peters, U., 1437T, 1608T,<br />
1925F, 2337W<br />
Peterschmitt, M. J., 773W*<br />
Petersen, A., 2862F<br />
Petersen, B., 3583F<br />
Petersen, B.-S., 2315F*<br />
Petersen, D. C., 1085F,<br />
3332W*<br />
Petersen, G., 603T, 1088F,<br />
1161W, 1199F, 1267T<br />
Petersen, M. B., 2862F<br />
Petersen, O. B., 3148F<br />
Peterson, L., 2220W<br />
Peterson, R. E., 2277W*<br />
Petit, F., 3172F<br />
Petkovich, M., 2926W<br />
Petkovič Ramadža, D., 214<br />
Petraroli, R., 1060T<br />
Petrek, M., 2103W<br />
Petri, A., 2827W<br />
Petri, M., 1979F<br />
Petridi, S., 809F<br />
Petrikin, J. E., 366<br />
Petrill, S. A., 2544W<br />
Petronis, A., 377, 3490T<br />
Petropoulos, C., 3682W<br />
Petrosino, J., 3600W<br />
Petrosyan, P., 3587F<br />
Petru, E., 1115F<br />
Petrulis, M., 1879T<br />
Pettersen, B. J., 73<br />
Petukhova, G., 417F, 592W<br />
Petukhova, L., 2182T*<br />
*Presenting Author<br />
Petzl-Erler, M. L., 1405F<br />
Pevsner, J., 3374W<br />
Peyrard-Janvid, M., 1976F<br />
Pezanowski, D., 924T<br />
Pezzolesi, M. G., 2313W*<br />
Pfeifer, S., 285<br />
Pfeiffer, R. M., 1314T<br />
Pfeiffer, W., 494W, 1239W<br />
Pfeufer, A., 86*<br />
Pfister, S., 1182W<br />
Pflückhahn, U., 1200W,<br />
1233W<br />
Pfundt, R., 100, 102, 214,<br />
955W, 979W*, 2848W<br />
PGen Study Group, 1825W<br />
Phadke, S. R., 2739F<br />
Pham, J., 952T<br />
Pham, L., 3699F<br />
Pham, P., 1742W, 1757W,<br />
1761W, 3576W<br />
Pham, P. A., 314, 1735W<br />
Phan, L., 3582W, 3625F<br />
Phan, V., 78<br />
Phanstiel, D. H., 416W<br />
Pharoah, P., 139, 1150T<br />
Pharoah, P. D. P., 206, 209,<br />
210, 1156T<br />
Phelan, C. M., 1156T<br />
Phelan, K., 907W, 3052F*<br />
Phelan, M., 3699F*<br />
Phelps, I. G., 10, 2772F,<br />
2789T<br />
Philip, G. K., 1224W<br />
Philippe, C., 2792T<br />
Phillips, D. L., 3344W<br />
Phillips III, J. A., 2732T<br />
Phillips, J., 730T<br />
Phillips, K., 949W<br />
Phillips, M., 788W, 3401W<br />
Phillips, S. L., 107<br />
Phouanenavong, S., 407<br />
Piard, J., 3199W*<br />
Piaza, A. C. S., 514W<br />
Piazuelo, M. B., 3388F<br />
Piazzon, F., 896T<br />
Piazzon, F. B., 899W*,<br />
3045W<br />
Pibarot, P., 1655T<br />
Picanço, C. G., 941W<br />
Picard, A., 983F<br />
Piccolini, E., 1153T<br />
Piccolo, P., 735F<br />
Picher, M. M., 59<br />
Pichler, M., 1115F<br />
Pichot, C. S., 3433T<br />
Pickering, D. L., 968T*<br />
Pickett, H., 210<br />
Pickle, L., 3717F<br />
Pickrell, J. K., 3367F*<br />
Pic-Taylor, A., 903W*<br />
Pidsley, R., 3476T*<br />
Piehl, F., 2561F<br />
Piehler, A. P., 576W, 643T<br />
Pierard, G. E., 129<br />
Pierce, B., Session 21,<br />
1638T, 2025W*<br />
Pierce, E. A., 1756W, 2943F,<br />
3653F<br />
Pierce, J., 3587F<br />
Pierce, R., 2221T<br />
Pierce, S. B., 2929W*<br />
Pieri, P. C., 2863W<br />
Pierquin, G., 925W<br />
Pietiläinen, K. H., 2256W<br />
Pietiläinen, O., 252*, 2399F<br />
Pietrement, C., 324<br />
Pietrzykowski, A. Z., 507F*<br />
Pignatti, P. F., 1361W,<br />
2548T, 2659T<br />
Piherova, L., 752T<br />
Pihko, H., 327<br />
Pihur, V., 305<br />
Pike, K., 13<br />
Pilarski, R., 1197W*<br />
Pillai, N. E., 3339T<br />
Pillalamarri, V., 68, 70<br />
Pillers, D., 2830W, 3287W*<br />
Pilling, L., 584W<br />
Pilorge, M., 901W<br />
Pilu, R., 157<br />
Pilz, D., 124<br />
Pimenta, G., 2404T<br />
Pimlott, N., 1852F<br />
Pina, R., 3019T<br />
Pina Neto, J. M., 3099W<br />
Pinder, C. L., 3382F<br />
Pineda, M., 684T<br />
Pineda, T., 703F, 3190F*<br />
Pineda, V. V., 2456F<br />
Pineda Alvarez, D., 332<br />
Ping, W., 2879T<br />
Pingault, V., 2727F<br />
Pinner, J. R., 3167W<br />
Pinney, S. M., 1454W<br />
Pinnkas, P., 3671F<br />
Pino-Yanes, M., 2296T*<br />
Pinto, D., 2577W*, 2620T<br />
Pinto, E. M., 2706F<br />
Pinto, F. R., 2373W<br />
Piotrowski, A., 434W<br />
Piper, J., 436W<br />
Pipiras, E., 973W*, 2784F<br />
Pique-Regi, R., 2<br />
Pirags, V., 608T<br />
Piras, M. G., 177, 547F,<br />
1516F, 2198F, 2329T<br />
Piras, R., 157, 847F<br />
Pirastu, M., 2062T, 2128T<br />
Pirastu, N., 1484W, 2128T,<br />
2366F<br />
Piravej, K., 2749W<br />
Pires, F., 1170W<br />
Piri, N., 2832F<br />
Pirim, D., 1672T*<br />
Pirinen, M., 1340W, 2157W<br />
Pirooznia, M., 2180F, 2305T<br />
Piryaei, F., 754W*, 754W,<br />
2367W*, 2367W<br />
Pischler, C., 3116F<br />
Piscopo, I., 808F<br />
Piscopo, M., 3492T<br />
Pishotta, F., 2537F<br />
Piskol, R., 289*, 527F<br />
Pistis, G., 1451W*<br />
Pitchappan, R., 3377W<br />
Piteau, S. J., 671F*<br />
Pitman, T., 658T<br />
Pitstick, L., 2670F<br />
Pittaway, J., 780W<br />
Pitzalis, D., 113<br />
Pitzalis, M., 157, 177, 186,<br />
3664W<br />
Piveta, C. S. C., 479F*<br />
Pivnick, E., 3119W<br />
Pizzo, M., 2950W<br />
Place, E., 534W, 2943F<br />
Place, E. M., 1756W<br />
Plagnol, V., 122, 453F,<br />
1621T, 2072F, 2812W,<br />
3600W<br />
Plajzer-Frick, I., 407<br />
Planchon, A., 401, 556W,<br />
561F<br />
Plaseska-Karanfilska, D.,<br />
2983T*<br />
Plaster, C., 3322F<br />
Platt, A., 185*<br />
Platt, D., 1640T, 3349F<br />
Platt, F. M., 162<br />
Platt, S. R., 2805F<br />
Platzer, M., 580W, 1236W<br />
Plazzer, J. P., 1130F<br />
Plebani, A., 760W<br />
Plecko, B., 756W<br />
Plenge, R. M., 625T, 1490W,<br />
2047T, 2199W, 2210F,<br />
2258F<br />
Pleshko, N., 826F<br />
Plessis, G., 3109W<br />
Pletnikova, O., 2648F<br />
Plitnik, T., 2586W<br />
Plomin, R., 2164T, 3487T<br />
Plon, S. E., 134, 314, 430W,<br />
1221W*, 1735W, 1742W,<br />
1761W, 1798F, 3549F<br />
Plona, T., 13<br />
Plongthongkum, N., 3474T<br />
Plotsky, Y., 1165T<br />
Plourde, F., 1065W*<br />
Plowe, C., 2255F<br />
Plumari, M., 2781F<br />
Plumb, I., 1193F<br />
Plummer, F., 3276T<br />
Plummer, F. A., 490W<br />
Plunkett, K., 952T<br />
Plunkett III, G., 3671F<br />
Pluye, P., 1852F<br />
Pluzhnikov, A., 2333F, 3735F<br />
PMG Awareness<br />
Organization, Inc., 3239W<br />
Pochet, N., 322<br />
Poddie, F., 157<br />
Podolsky, R., 3418T<br />
Poduri, A., 266*<br />
Poeta, L., 2629T*<br />
Pogue, R., 1202F, 1880F<br />
Pogue-Geile, M. F., 2589W,<br />
2651F<br />
Poh, W. T., 3339T<br />
Pohl, E., 1, 3214F<br />
Poidevin, M., 2477F<br />
Poirot, B., 1205F<br />
Pokholok, D., 3695F<br />
Polak, P., 402, 1550W*<br />
Poland, G. A., 1426F<br />
Polasek, O., 1383T<br />
Polenakovic, M., 3481T<br />
Poletta, F., 1936T<br />
Pollack, S., 350, 1331W,<br />
1360F, 2210F, 3413W
Pollack-Berti, A., 3671F<br />
Pollak, M. N., 2080T<br />
Pollak, M. R., 284<br />
Pollard, K. S., Session 5,<br />
195<br />
Pollett, A., 1093T<br />
Polley, S., 450W*<br />
Polli, R., 1755W, 2795T*<br />
Pollin, T., 249<br />
Pollin, T. I., 1671T, 3027T<br />
Poll-The, B. T., 197, 2909T<br />
Polonikov, A. V., 2271W<br />
Polsinelli, G., 2408F<br />
Polverino, A., 1985F, 3492T*<br />
Polyak, E., 534W, 2943F<br />
Polychronakos, C., 5, 277,<br />
1915T<br />
Polzin, K. O., 1286W<br />
Pomilla, C., 3412T<br />
Ponciano-Jackson, D.,<br />
1302T<br />
Pond, A., 3648W<br />
Pond, A. C., 1251W*<br />
Pond, S., 1684T<br />
Pons-Estel, B., 2046W<br />
Pontes, T. B., 1132T, 3503T<br />
Pont-Kingdon, G., 1752W*,<br />
3182F<br />
Pook, M., 761W<br />
Pooley, K. A., 210<br />
Poon, R., 1369F<br />
Popadin, K., 85*, 3263W<br />
Pope, B. J., 1213T, 3679F<br />
Pope, K., 131<br />
Pope, R. M., 323<br />
Poplin, R., 41, 288<br />
Popov, J., 2260T<br />
Popovic, M., 3395W<br />
Poppe, B., 423F<br />
Popper, T., 1108T<br />
Porchet, N., 3172F<br />
Porcu, E., 157, 2198F*<br />
Porcu, L., 2001W<br />
Porkka-Heiskanen, T., 2462F<br />
Porreca, G., 1729W<br />
Porreca, G. J., 3640W,<br />
3680W*<br />
Porreca, G. P., 3693F<br />
Portas, L., 2062T, 2128T<br />
Portela, L. V. C., 2424W<br />
Porter, F. D., 162<br />
Porter, M., 969W*, 3530W<br />
Porter-Gill, P., 1091F,<br />
1092W, 1094F*<br />
Portlock, C., 1159T<br />
Pospiech, H., 1099T<br />
Post, W., 1662T<br />
Post, W. S., 301<br />
Posthuma, D., 98<br />
Postiglione, A., 1985F<br />
Potash, J. B., 369, 2180F,<br />
2305T, 2372F, 2391W<br />
Potkin, S., 3587F<br />
Potkin, S. G., 2469W, 2564F<br />
Potocki, L., Session 28<br />
Potter, B. K., 142, 149, 150,<br />
1827W<br />
Potter, C., 3419T*<br />
Pottier, C., 345<br />
Pottinger, S., 2139W<br />
*Presenting Author<br />
Potts, A., 247<br />
Pouget, J., 328<br />
Poulain, P., 3170F<br />
Poulin, M., 3425T*<br />
Poulizac, P., 716T<br />
Poulou, M., 2995T<br />
Pourahmad, R., 1596T<br />
Pourcain, B. S., 1528F<br />
Pourjafari, B., 860T<br />
Pour-Jafari, H., 860T*<br />
Povysil, G., 1483F, 1486F*<br />
Powell, A., 3694W<br />
Powell, B., 876T, 1221W,<br />
3601F*<br />
Powell, C., 2090F, 2241W,<br />
2328W<br />
Powell, H., 2302T<br />
Powell, J., 778W, 1199F,<br />
3471T<br />
Powell, S., 2542T<br />
Powell, W., 3498T<br />
Powell, W. T., 64*<br />
Power, R. A., 2509T*<br />
Powers, N. R., 1973F,<br />
2010W*<br />
Pöyhönen, M., 897W<br />
Pöyhönen, R., 327<br />
Poznik, G. D., 3368W*<br />
Pozzi, E., 790W<br />
Prabhu, S., 353*<br />
PRACTICAL Consortium,<br />
205, 1148F<br />
Prada, C., 789W*<br />
Pradhan, S., 3702W<br />
Pradhan, V., 1572T<br />
Prado, D. M., 3187W<br />
Prado, W., 1119W<br />
Prahalad, S., 2143T<br />
Prakash, G., 2293T*<br />
Prakash, S. K., 1743W*<br />
Prakruthi, P., 1108T<br />
Pramathan, T., 160<br />
Pramstaller, P. P., 86, 2080T,<br />
2366F<br />
Pranculis, A., 653T*, 920T<br />
Prandini, P., 2548T, 2659T<br />
Pras, E., 53, 783W, 2875W<br />
Prasad, A., 175, 2575T,<br />
2620T<br />
Prasad, K., 2589W, 2651F<br />
Prasad, R., 481F, 802W*<br />
Prasanna, S., 1701T<br />
Prasun, P., 3147W*<br />
Pratt, H., 1969T<br />
Pratt, J. G., 1566T<br />
Pratto, F., 592W*<br />
Prawitt, D., 3496T<br />
Prchal, J. T., 3297T<br />
Predazzi, I., 1668T*<br />
Predazzi, I. M., 1634T<br />
Preethi, T., 878T<br />
Pregizer, S., 837F<br />
Preil, M. L., 2869W<br />
Prenni, J., 1189T, 1990T<br />
Prera, E., 2753T*<br />
Prescott, C. A., 2504F<br />
Prescott, K., 129<br />
Prescott, T., 2926W<br />
Pressey, J. G., 1186T<br />
Presson, A. P., 1867F*<br />
SPEAKER AND AUTHOR INDEX 393<br />
Preto, P., 2393F<br />
Pretorius, M., 606T<br />
PreventCD Group, 1330F<br />
Previtali, S., 2948T<br />
Previtali, S. C., 201<br />
Pribadi, M., 2639F<br />
Price, A., 284, 350, 1360F*,<br />
2199W, 2210F, 3310F,<br />
3413W<br />
Price, A. L., 89, 1331W,<br />
1577W, 3407W<br />
Price, E., 3734W*<br />
Price, J., 2668W<br />
Price, S., 131<br />
Price, T. S., 3487T<br />
Price, V., 167<br />
Priebe, L., 420W<br />
Priest, J. R., 1065W<br />
Prieto, J. C., 3049W<br />
Prieto Rivera, J. C., 3077W<br />
Prieur-Gaston, E., 3538W<br />
Prill, R. J., 3569F*<br />
Priller, J., 684T<br />
Primorac, D., 3286F<br />
Prince, A., 1809W*<br />
Prince, J., 1189T, 1990T<br />
Prince, S., 762W<br />
Prins, B. P., 111, 2073W<br />
Prinz, M., 1591T<br />
Pristauz, G., 1115F<br />
Pritchard, J., 2, 273, 368<br />
Pritchard, J. K., 3367F<br />
Priya, R. R., 2183F*<br />
Probst, F., 898T<br />
Procter, M., 689F*<br />
Prodam, F., 2827W<br />
Pr<strong>of</strong>fitt, J. M., 2309F<br />
Prokisch, H., 275, 584W,<br />
699F, 782W, 2917W<br />
Prokopenko, I., 119, 190,<br />
269, 1308T, 1528F,<br />
2076W, 2106W, 2137T*<br />
Prokunina-Olsson, L.,<br />
510W, 1091F, 1092W,<br />
1094F, 1097F, 1155W<br />
Prom-Wormley, E. C.,<br />
2277W<br />
Proost, D., 1617T<br />
Prosper, B., 842F<br />
Prost, S., 3333T<br />
PROTECT Group, 205<br />
Provenzale, J., 785W<br />
Province, M. A., Session 8,<br />
18, 1641T, 1650T, 1661T,<br />
2093F<br />
Provost, S., 2402F<br />
Prucha, H., 86<br />
Prust, M., 2452T<br />
Przeworski, M., 285<br />
Przybylo, J., 1159T<br />
Psaty, B., 174, 349, 584W,<br />
1599T<br />
Psaty, B. M., 170, 1284T,<br />
1503T, 1585T, 2080T<br />
Psoni, S., 2937F<br />
Psychiatric Genomics<br />
Consortium, 2512T<br />
Psychiatric Genomics<br />
Consortium: ADHD<br />
Subgroup, 2515T<br />
Psychiatric GWAS<br />
Consortium, 2526W<br />
Psychiatric GWAS<br />
Consortium -<br />
Schizophrenia & Autism<br />
Working Group, 352<br />
Psychogios, A., 1682T*<br />
Ptacek, L. J., 2423F, 2581T,<br />
2667F, 2779W<br />
Pu, S., 1872F, 1873F<br />
Puck, J., 362<br />
Puckelwartz, M. J., 1614T,<br />
1683T*<br />
Puddu, A., 847F<br />
Puebla, A. M., 1077W,<br />
1111T, 1127F*, 1128W<br />
Puechberty, J., 857W, 936T,<br />
2386T, 2729T, 3121W,<br />
3166F<br />
Puel, A., 365<br />
Puel, J. L., 2685F<br />
Puente, X. S., 2578T<br />
Puffenberger, E. G., 1052F,<br />
2800W<br />
Puga, A. C., 773W<br />
Pugash, D., 3006T<br />
Puggal, M., 2247W<br />
Pugh, E., 1447F, 2098T,<br />
2556W<br />
Pugh, E. W., 46, 1452T*,<br />
1512T<br />
Pugh, T. J., 1754W<br />
Pugliese, A., 3600W<br />
Puglisi, M. A., 2235W<br />
Puig, A., 2940F<br />
Puig, O., 1252T<br />
Puig, S., 1053W<br />
Puig-Butille, J. A., 1053W<br />
Pulford, D., 630T<br />
Pulijaal, V., 3012T<br />
Pulit, S., 1585T<br />
Pulit, S. L., 1692T*<br />
Pullinger, C. R., 1694T<br />
Pulver, A., 2387F, 2461T,<br />
2486F<br />
Pulver, A. E., 2573F, 2576F<br />
Punaro, M., 2143T<br />
Pupacdi, B., 2918T, 3570W*<br />
Pupavac, M., 848F<br />
Puppala, S., 2339F<br />
Purcell, S., 280, 290, 1325W,<br />
1447F, 2487W, 2618F<br />
Purcell, S. M., 22, 2577W<br />
Purchase, T. R., 454W<br />
Purdie, C., 1082F<br />
Purdon, S., 2474F<br />
Purdue, M., 1012T, 1413T<br />
Purdue, M. P., 1091F<br />
Purdy, M., 3730W<br />
Purevdorj, I., 3248F<br />
Purevdorj, M., 3248F<br />
Puri, M., 3463T<br />
Puri, R., 1720W*, 2754F,<br />
3236F<br />
Purrazzella, J., 391<br />
Purser, S., 2474F<br />
Pursley, A., 952T<br />
Pursley, A. N., 898T<br />
Puschmann, A., 2438F<br />
Pussila, M., 982T<br />
SPEAKER AND AUTHOR INDEX
394 SPEAKER AND AUTHOR INDEX<br />
Putheti, P., 2260T<br />
Putonti, C., 591F<br />
Putoux, A., 3240F*<br />
Puts, D. A., 2223W<br />
Puttonen, S., 2462F<br />
Puura, K., 2383T<br />
Pyatt, R., 98<br />
Pyatt, R. E., 103, 456W, 912T<br />
Pyle, A., 751F*<br />
Pylkäs, K., 1099T<br />
Pyridoxine Dependent<br />
Epilepsy Consortium,<br />
756W<br />
Q<br />
Qaadri, K., 3571F*<br />
Qahar, Z., 2909T<br />
Qazi, A., 1093T<br />
Qi, L., 51, 1357F, 1954T,<br />
2123F, 2147F, 2354F,<br />
2360F*<br />
Qi, Q., 51, 1357F, 2354F*<br />
Qi, X., 3317W<br />
Qi, Y., 1772W<br />
Qi, Z., 963W<br />
Qiao, D., 1536T*<br />
Qiao, Y., 447F, 491F, 517F*<br />
Qiao, Y.-L., 1010F<br />
Qiao, Y. L., 1076F<br />
Qin, D. Q., 1723W<br />
Qin, H., 1404T*, 3572W*<br />
Qin, J., 3237W<br />
Qin, N., 1032W*<br />
Qin, P., 3334F*, 3394T<br />
Qin, S., 654T*<br />
Qin, W., 2407T<br />
Qin, X., 386<br />
Qin, Z., 1558F, 3265F<br />
Qing, G., 3378T<br />
Qiu, C., 1252T<br />
Qiu, F., 1295W<br />
Qiu, H., 2121W, 2546F,<br />
3573F*<br />
Qiu, K., 3553F<br />
Qiu, R., 74, 94<br />
Qiu, W., 536W<br />
Qiu, X., 1108T<br />
Q-MEGA and AMFS<br />
Investigators, 212<br />
Qoqandi, M. A., 1738W<br />
Qu, H., 5<br />
Qu, H. Q., 1915T, 2048F,<br />
2345F*<br />
Qu, K., 1198T<br />
Qu, L., 812F<br />
Qu, Y., 680T<br />
Quach, H., 1289W, 1301W*,<br />
1455T, 1924T, 3304F*,<br />
3454T<br />
Quaio, C. R. D. C., 2232W,<br />
3152F, 3160F*<br />
Quarles, J. M., 2189F<br />
Quartararo, J., 2810T<br />
Quattrone, A., 2763F, 2766F,<br />
2774T<br />
Quaye, L., 2138F*<br />
Quaynor, S., 2984T*<br />
Queiroz, L. S., 514W<br />
*Presenting Author<br />
Quentric, M., 2002T*<br />
Quertermous, T., 1624T<br />
Quesenberry, C., 96<br />
Quezado, M., 2786T<br />
Quh, H., 255<br />
Qui, H., 2229W<br />
Quiezi, R., 3072F<br />
Quillen, E. E., 2223W,<br />
2308T, 2589W, 2651F*<br />
Quindipan, C., 1721W*<br />
Quinlan, A., 12, 1971W<br />
Quinlan, A. R., 3632W<br />
Quinlan, J., 3260W<br />
Quinlan, P., 1082F<br />
Quinn, B., 161<br />
Quinn, E., 2283W, 2581T<br />
Quinn, J., 1274F, 2538W<br />
Quinn, J. F., 2421W, 2510F*<br />
Quintana, M. A., 1435F*<br />
Quintana-Murci, L., Session<br />
6, 3304F, 3368W, 3599F<br />
Quintero, F., 315<br />
Quintero-Rivera, F., 82*<br />
Quinti, I., 760W<br />
Quon, G., 3468T<br />
R<br />
Raabe-Meyer, G., 3111W<br />
Rabai, E., 2767W<br />
Rabban, J., 1059W<br />
Rabe, K., 1161W<br />
Rabès, J.-P., 1607T<br />
Rabiller, D., 3705F<br />
Rabin, K., 134<br />
Rabinowitz, M., 73, 3018T*<br />
Rabionet, R., 84, 2326T,<br />
2940F*<br />
Raby, B., 536W<br />
Rachel, R. A., 824F<br />
Racher, H., 3665F*<br />
Rachiglio, A. M., 1060T<br />
Racimo, F., 3274F*<br />
Racine, B., 1543F<br />
Raczy, C., 3663F<br />
Radecki, J., 3681F*<br />
Radek, A., 585F, 3718W<br />
Rademacher, K., 3496T<br />
Rademakers, R., 2639F<br />
Radfar, L., 529F, 2188T<br />
Radhakrishna, U., 2351F,<br />
2731W<br />
Radhakrishnan, A., 110<br />
Radice, P., 27<br />
Radom-Aizik, S., 3249W<br />
Radovich, M., 1098W<br />
Radwan, Z. H., 1673T*<br />
Raedler, A., 2368T<br />
Rafaels, N., 2043W<br />
Rafaels, N. M., 1900T*<br />
Rafati, S., 1949F<br />
Rafeeq, M., 2663T<br />
Raff, J., 3323W*<br />
Raffan, E., 45<br />
Raffel, L. J., 1916F<br />
Rafi, S. K., 2265W*<br />
Rafiq, M. A., 2398T*<br />
Ragge, N. K., 3161W*<br />
Raggio, C., 826F, 3128F<br />
Raghav, S., 415F<br />
Raghavendra, R., 1295W<br />
Raghuraman, S., 3433T<br />
Ragon, C., 2729T, 2792T<br />
Ragoussis, I., 3161W<br />
Ragoussis, J., 509F<br />
Rahi, J. S., 335<br />
Rahimian, G., 1143W, 1739W<br />
Rahimov, F., 2962W*<br />
Rahman, A., 1070F<br />
Rahman, N., 138, 213, 1211F<br />
Rahman, P., 154, 448W,<br />
454W, 1952F<br />
Rahman, R., 3661F<br />
Rahmioglu, N., 2077T*<br />
Rahmouni, K., 2671W<br />
Rahrmann, E., 1229F<br />
Rai, E., 1901F*, 2284T<br />
Raia, M., 1908W<br />
Raible, D. W., 3296W<br />
Raichel Jacob, R., 1044W<br />
Raijas, P., 2181W<br />
Raik, E., 932T<br />
Raiman, J., 3196F<br />
Raime, K., 1140W<br />
Raimo, S., 505F<br />
Rainwater, D. L., 3434T<br />
Raitakari, O., 656T, 1623T,<br />
2059T, 2097W, 2120F<br />
Raitakari, O. T., 2116T,<br />
2173T, 2366F<br />
Raivio, T., 2707W<br />
Raj, P., 1901F, 2284T<br />
Raj, S., 764W, 1287T*,<br />
1288F, 1294F, 1883F<br />
Raj, S. M., 357*<br />
Raj, T., 2250W*, 3310F<br />
Rajab, A., 1877F<br />
Rajadhyaksha, A., 1633T<br />
Rajagopalan, R., 1605T,<br />
3369T*<br />
Rajagopalan, R. R., 2443T<br />
Rajaraman, P., 1372F<br />
Rajasimha, H., 1774W<br />
Rajasimha, H. K., 2183F<br />
Rajbhandary, R., 344,<br />
1571W, 2498F, 2583W,<br />
2586W, 2637W<br />
Rajcan-Separovic, E., 491F,<br />
517F, 2977T<br />
Rajender, S., 1950W*<br />
Rajendram, R., 3456T<br />
Rajendran, S., 339<br />
Rajive, K., 29<br />
Rajkovic, A., 904T, 971W,<br />
993W, 1744W, 2042F<br />
Rajput, A., 346<br />
Rajput, A. H., 346<br />
Rajput, M. L., 346<br />
Rak, J., 1182W<br />
Rakovic, A., 204<br />
Ralph, P., 282*<br />
Ralston, J. D., 1828F<br />
Ramachandran, D., 1349W,<br />
2069F*, 2312F<br />
Ramachandran, S., 3361F,<br />
3370F*<br />
Ramachandran, V., 1584T<br />
Ramagopalan, S., 2015F<br />
Ramakrishnan, R., 3652W<br />
Ramallo, V., 3362W<br />
Ramanan, V., 2531F<br />
Ramanan, V. K., 2511W*<br />
Ramanathan, S., 3068F,<br />
3191W*<br />
Ramani, R., 3213W<br />
Ramasamy, A., 374, 564W*<br />
Ramaswami, G., 289,<br />
543F*, 577F<br />
Ramazi, S., 1421W*<br />
Ramazi, S. H., 892T<br />
Ramensky, V., 1480F, 2343W<br />
Ramesar, R., 762W<br />
Ramezani, M., 754W<br />
Ramirez, A. R., 647T<br />
Ramirez, C. T., 2467T*<br />
Ramirez, F., 81*, 767W,<br />
815F, 1698T<br />
Ramirez, J., 613T<br />
Ramirez, M., 2495F, 3669F<br />
Ramírez, R., 1127F<br />
Ramirez-Garcia, S. A.,<br />
3187W<br />
Ramirez-Solis, R., 105<br />
Ramke, J., 1305T<br />
Rammamoorthy, S., 261<br />
Rammensee, H. G., 1200W,<br />
1233W<br />
Rammohan, K. W., 2049W<br />
Ramocki, M. B., 229, 299,<br />
337<br />
Ramos, A., 1111T, 1127F,<br />
1128W*<br />
Ramos, E., 241*<br />
Ramos, E. M., 1566T,<br />
1964F*<br />
Ramos, E. S., 941W<br />
Ramos, F., 3019T<br />
Ramos, L., 3019T<br />
Ramos, P., 1186T*<br />
Ramos, P. S., 3371W*<br />
Ramos, S., 928T*<br />
Ramos, Y. F., 584W<br />
Rampersaud, E., 1681T,<br />
2185T<br />
Ramsay, E., 138, 1211F<br />
Ramsay, P., 1455T, 3454T<br />
Ramsay, P. P., 1289W,<br />
1301W<br />
Ramsey, S., 456W, 912T<br />
Ramsey-Goldman, R.,<br />
1979F, 2099F<br />
Ramsing, M., 3148F<br />
Ramsook, S. S., 9<br />
Ramu, A., 2982T<br />
Ramus, S., 139<br />
Ramus, S. J., 1156T*<br />
Ramzan, K., 2734W*,<br />
2743W<br />
Rana, S., 362<br />
Ranade, S., 3659F<br />
Ranatunga, D., 96, 230,<br />
2513F, 3342T<br />
Ranatunga, D. K., 118,<br />
2140T<br />
Ranchalis, J., 1605T<br />
Ranciaro, A., 3303T,<br />
3338W<br />
Randall, J., 108<br />
Randolph, L., 728T*
Raney, B., 3557F<br />
Rangel, C., 526W<br />
Rangel-Escareño, C.,<br />
1129T*, 3255T<br />
Rangrej, J., 1093T<br />
Rank, D., 477F<br />
Rankin, K. J., 2639F<br />
Rantapää-Dahlqvist, S.,<br />
461F<br />
Rantus, J. A., 2572T<br />
Ranum, L. P. W., 2645F<br />
Rao, A. R., 471F*<br />
Rao, D., 2063F<br />
Rao, J. U., 1220F<br />
Rao, K. P., 1234T<br />
Rao, K. R. S. S., 2351F<br />
Rao, M., 1456F*<br />
Rao, M. V., 2731W<br />
Rao, N., 873W<br />
Rao, P., 134<br />
Rao, P. N., 1029W<br />
Raouf, R., 1877F<br />
Raoul, O., 915W<br />
Rapoport, J., 433F, 2479T,<br />
2558F, 2584T<br />
Raposo, A., 2814F<br />
Raposo, J., 3019T<br />
Rappaport, E., 534W, 2904F<br />
Rappold, G., 2595W<br />
Rappold, G. A., 1612T*<br />
Rashkin, S., 641T<br />
Rasi, C., 434W<br />
Raska, P., 3409W*<br />
Raskin, S., 870T*, 2475W,<br />
2609F, 3055W<br />
Raskind, W., 2406W, 2432F<br />
Raskind, W. H., 2549F*<br />
Rasmussen, F., 2965W<br />
Rasmussen, M., 2965W,<br />
3148F*<br />
Rasmussen, S. A., 1867F<br />
Rasmussen-Torvik, L. J.,<br />
2116T<br />
Rasolonjatovo, I., 3694W<br />
Rasool, M., 2920W<br />
Rassenti, L., 395<br />
Rastetter, A., 2820F<br />
Ratain, M., 613T<br />
Ratan, A., 3545F<br />
Ratan, R., 2437T<br />
Ratbi, I., 708T<br />
Ratcliffe, P., 509F<br />
Rath, L., 1309F<br />
Rath, M., 532W*<br />
Rathkolb, B., 2922F<br />
Ratié, L., 2893W<br />
Ratjen, F., 142<br />
Ratnamala, U., 2351F,<br />
2731W<br />
Rattanasopha, S., 1944W<br />
Ratti, A., 2775F<br />
Rauch, A., 2356T, 2595W,<br />
3240F<br />
Rauch, F., 3169W<br />
Rauen, K., 99, 300, 3139W<br />
Rauen, K. A., 1274F, 3242F<br />
Rauhala, H., 1000T<br />
Rau-Murthy, R., 998F,<br />
999W, 1159T, 1841W<br />
Rauramaa, R., 1608T<br />
*Presenting Author<br />
Rautanen, A., 1948T,<br />
2157W*<br />
Rautenstrauss, B., 61,<br />
758W*<br />
Rava, R., 3021T<br />
Raval, R. P., 1130F*<br />
Raveendrababu, M., 2731W<br />
Raveendran, M., 595F*,<br />
2413T<br />
Ravi, H., 3669F<br />
Ravi, R., 3376F<br />
Ravichandran, A., 2328W<br />
Ravichandran, K., 861W<br />
Ravindran, P., 3574W*<br />
Ravnan, J. B., 884T, 3101W<br />
Ravnik-Glavač, M., 3422T<br />
Rawat, A., 3207W<br />
Ray, A., 1356T, 1393F*<br />
Ray, F. A., 948T*<br />
Ray, P. N., 2554T, 2905W<br />
Raychaudhuri, S., 1907F*,<br />
2047T, 2199W, 2210F,<br />
2250W<br />
Rayford, W., 1040F<br />
Raymond, D., 2801T<br />
Raymond, P., 843F<br />
Raymond, V., 1951T<br />
Rayner, N. W., 2044T, 3575F*<br />
Rayner, W., 3396T<br />
Raz, T., 3700W*<br />
Raz, V., 542W<br />
Raza, M. H., 1956W*, 1958F<br />
Razak, A., 1824F<br />
Razavi, F., 2770W<br />
Raznahan, A., 433F<br />
Razzaghian, H. R., 434W<br />
Real, F. X., 1091F<br />
Realini, T., 2154W, 2240F<br />
Reardon, W., 2925F<br />
Rebbeck, T., 283<br />
Rebbeck, T. R., 1003T,<br />
1307W<br />
Rebeiro, P., 2554T<br />
Rebelo, A., 2668W*<br />
Rebollo Mesa, I., 2082W<br />
Receveur, A., 3117W<br />
Rech, R., 2805F<br />
Recker, R. R., 3081W<br />
Reddel, R., 210<br />
Reddy, K., 2696T, 3059W*<br />
Reddy, M., 3717F<br />
Reddy, S. U., 3455T<br />
Rede Neurogenética, 2642F<br />
Redett, R. J., 1472W<br />
Redl, D., 2800W<br />
Redler, S., 106<br />
Redline, S., 2375F<br />
Reed, B., 3717F<br />
Reed, D., 2135F<br />
Reed, R., 784W<br />
Reed, X., 545F*<br />
Reeder, A., 1737W<br />
Rees, E., 1325W<br />
Rees, M. I., 262, 2821W*<br />
Reese, M., 3602W<br />
Reese, M. G., 195, 1770W<br />
Reeves, K., 2300F<br />
Reeves, R., 310<br />
Reeves, R. H., 1349W,<br />
2069F<br />
SPEAKER AND AUTHOR INDEX 395<br />
Regalado, E., 1789W*<br />
Regan, E. A., 2249F<br />
Regan, J., 3690W<br />
Regan, L., 3508T<br />
Regazzo, D., 2708T<br />
Regev, A., 322, 528W<br />
Register, T. C., 1661T<br />
REGISTRY Investigators <strong>of</strong><br />
EHDN, 2641T<br />
Regla-Nava, J. A., 2363F<br />
Rego, E. M., 1045T<br />
Rehermann, B., 1155W<br />
Rehm, H. L., Session 77,<br />
1677T, 1754W<br />
Rehnström, K., 252, 2344T*,<br />
2399F<br />
Rei, N., 1977W<br />
Reich, D., 178, 284, 333,<br />
350, 3347W, 3372T<br />
Reid, J., 349, 360, 1742W,<br />
2798T, 2880F, 2934F,<br />
3597F<br />
Reid, J. G., 314, 1592T,<br />
1735W, 1757W, 1761W,<br />
2883F, 3576W*<br />
Reid, K., 309<br />
Reid, K. P., 3267T<br />
Reid, M., 1906T, 2158T<br />
Reider, M. J., 171<br />
Reilly, E., 1860F<br />
Reilly, M., 1642T, 3551F<br />
Reilly, M. P., 115<br />
Reilly, P., 617T, 619T<br />
Reinateo, S., 100<br />
Reinders, M., 494W<br />
Reinders, M. J. T., 1436W<br />
Reindollar, R. H., 2732T<br />
Reiner, A. P., 170, 1408F,<br />
1437T, 1913F, 2063F,<br />
2131T, 2337W<br />
Reiner, G., 534W<br />
Reiner, J., 917W*<br />
Reinhard, C., 1369F<br />
Reinhard, C. R., 1235F<br />
Reinhart-Mercer, L., 3335W<br />
Reinholdt, L., 983F<br />
Reinier, F., 113, 157, 177,<br />
186, 547F, 1451W<br />
Reinmaa, E., 1284T, 1503T<br />
Reinscheidt, A., 3550W<br />
Reis, A., 154, 2160W*,<br />
2356T, 2557T, 2595W,<br />
2666T, 3235W<br />
Reis, G. S., 1902W*<br />
Reis, L. A. M., 514W<br />
Reis, L. M., 2903T*<br />
Reis, S., 1647T, 2083T<br />
Reish, O., 858T*<br />
Reisi, S., 2013W<br />
Reiss, J., 1869F<br />
Reiter, L. T., 3119W<br />
Reitz, C., 343*<br />
Rejto, P., 1369F<br />
Relton, C. L., 3419T, 3455T<br />
Rembowska, J., 1057T<br />
Remmers, C., 263<br />
Remmert, C. S., 313<br />
Ren, B., 3509T<br />
Ren, H., 1779W<br />
Ren, W., 3025T<br />
Renard, M., 128, 2225F<br />
Renaud, D. L., 718T*<br />
Renbaum, P., 2991T, 3002T<br />
Renda, Y., 54<br />
Rendeiro, P., 1778W<br />
Rendon, A., 110, 383<br />
Renieri, A., 2604W<br />
Renkema, K. Y., 2848W*<br />
Renkens, I., 217, 2886F<br />
Renkonen-Sinisalo, L.,<br />
1026W<br />
Rennard, S., 2249F<br />
Renner, S., 3153W<br />
Rennert, H., 3210F<br />
Rennert, O. M., 3506T<br />
Rensen, J. H. M., 102<br />
Renteria, M. E., 2054F*<br />
Renton, A. E., 2611T*, 2648F<br />
Renwick, A., 138, 1211F<br />
Repetto, G. M., 1658T*,<br />
2065T<br />
Repici, M., 2641T<br />
Repnikova, E. A., 103<br />
Repo, S., 499F<br />
Reppell, M., 3406T*<br />
Represa, A., 889W, 2674W<br />
Reprogen Consortium,<br />
2165F<br />
Requa, M., 3649F*<br />
Reshmi, S., 456W, 912T<br />
Ressler, K. J., 1422T, 2420F,<br />
2483F, 3480T<br />
Restagno, G., 2611T<br />
Restrepo, D., 835F<br />
Restrepo, N., 2041T*<br />
Retterer, K., 2579F<br />
Reuther, J., 1095W*<br />
REVEAL Study Group,<br />
1781W<br />
Reveille, J., 1291F<br />
Revilla, F., 2538W<br />
Rewers, M., 1330F<br />
Rex-Haffner, M., 2483F<br />
Reyes, A., 1022F<br />
Reyes-Carmona, S., 3504T<br />
Reyes-León, A., 1131W*,<br />
1141T<br />
Reyes-Romero, M. A.,<br />
1121F<br />
Reyhani, N., 982T<br />
Reymond, A., 299, 415F*,<br />
506W, 2458T, 3256F,<br />
3674W<br />
Reynolds, A., 463F<br />
Reynolds, J. M., 502W*<br />
Reynolds, R. J., 2047T*<br />
Rezaian, I., 3490T<br />
Reznik-Wolf, H., 53<br />
Rhead, B., 3557F<br />
Rhee, H., 1248W<br />
Rheumatoid Arthritis<br />
Consortium for<br />
Immunochip, 2231F<br />
Rhoda, C., 853F<br />
Rhodenizer, D., 1758W<br />
Rhodes, B., 2005T<br />
Rhodes, K., 1237T<br />
Rhodes, M., 3717F<br />
Rhodes, S., 2026T*,<br />
2538W<br />
SPEAKER AND AUTHOR INDEX
396 SPEAKER AND AUTHOR INDEX<br />
Rhodus, N., 2084F<br />
Rhodus, N. L., 529F, 2188T<br />
Rial-Sebbag, E., 1811W,<br />
1817W*<br />
Rianthavorn, P., 2006F<br />
Riazuddin, S., 1956W,<br />
2663T, 2724F, 2959W,<br />
3212F<br />
Riba, L., 2256W<br />
Ribas, A., 136<br />
Ribeiro, E. M., 2270F, 2642F<br />
Ribeiro, M. L., 1187F*,<br />
3502T<br />
Ribeiro, R. T., 167<br />
Ribeiro-Bicudo, L., 3072F*<br />
Ribeiro-dos-Santos, A.,<br />
3364F, 3402T<br />
Ribeiro-dos-Santos, A. K.,<br />
1629T<br />
Riboldi, G., 2775F<br />
Riboli, E., 987W<br />
Riby, J., 2055W, 3623F<br />
Ricceri, F., 1712T<br />
Ricci, E., 1776W<br />
Ricci, G., 1776W<br />
Riccio, A., 3496T<br />
Riccio Oliveira, R., 2043W<br />
Rice, G., 2452T<br />
Rice, J., 2114F<br />
Rice, J. P., 2170T<br />
Rice, K., 174, 2080T<br />
Rice, L., 741F<br />
Rich, S., 453F, 1408F, 1971W<br />
Rich, S. S., 117, 170, 1299T,<br />
1585T, 1662T, 2313W<br />
Rich, T., 1197W<br />
Richard, C., 714T, 801W<br />
Richard, G., 330, 332,<br />
1676T, 1765W, 2579F*<br />
Richard, P., 2436W<br />
Richard, S., 1212W<br />
Richards, A., 544W<br />
Richards, A. L., 370<br />
Richards, B., 1411F<br />
Richards, J., 391, 2135F<br />
Richards, J. B., 106, 109,<br />
277*, 649T, 1311T, 1595T<br />
Richards, J. E., 2154W,<br />
2240F, 2263T<br />
Richards, S., Session 3<br />
Richardson, A. S., 1467T<br />
Richardson, K., 2024F<br />
Richer, C., 394, 1207T,<br />
1215W<br />
Richieri-Costa, A., 2673F,<br />
2746W, 2863W, 3072F<br />
Richmond, R. C., 1583W*<br />
Richmond, S., 1528F<br />
Richmond, T., 3688W<br />
Richter, A., 1733W<br />
Richter, M. A., 612T<br />
Richter, S. J., 107<br />
Richter, U., 327<br />
Richterová, R., 2865F*<br />
Richtsmeier, J. T., 2151W<br />
Ricks-Santi, L., 1926W<br />
Rico, A., 1060T<br />
Rideout, A., 2480F, 3143W<br />
Rider, D., 1267T<br />
Rider, E., 196, 2389T, 3198F<br />
*Presenting Author<br />
Rider, L. G., 434W<br />
Ridge, P. G., 340<br />
Ridge, P. G., Jr., 3643F*<br />
Ridker, P. M., 51, 109, 609T,<br />
2056T<br />
Ried, J. S., 119, 190, 1308T,<br />
2076W, 2137T, 2226W*<br />
Rieder, C. R. M., 2424W,<br />
2626T<br />
Rieder, M. J., 530W*,<br />
1605T<br />
Riegel, M., 879W*<br />
Rieger, G., 1957T<br />
Riegert-Johnson, D. L.,<br />
1058F<br />
Riemenschneider, M.,<br />
3577F*<br />
Riemer, C., 3545F<br />
Riemersma, M., 214<br />
Riess, O., 1200W, 1233W,<br />
2595W<br />
Riethdorf, S., 1115F<br />
Riethmaier, D., 332<br />
Riethman, H., 861W<br />
Rieu, P. N., 83<br />
Riffaud, L., 3170F<br />
Riffault, A., 1062W<br />
Rijlaarsdam, M. A., 1122W<br />
Riley, B. P., 2500T, 2504F,<br />
2594F, 2599T<br />
Riley, G., 3582W, 3625F<br />
Riley-Gillis, B., 1252T*<br />
Rimm, E. B., 51<br />
Rimmer, A., 2939T<br />
Rimoin, D. L., 130<br />
Rinaldi, D., 2539T<br />
Rinckleb, A. E., 1080W<br />
Rincon-Sanchez, A. R.,<br />
3187W<br />
Rine, J., 75<br />
Rinella, E., 2078F*<br />
Ring, S., 1528F, 1567F,<br />
2081F<br />
Ring, S. M., 560W, 1318F,<br />
1583W, 1973F, 2010W,<br />
2169W<br />
Rinkel, G. J. E., 87<br />
Rinne, T. K., 955W<br />
Rio, M., 104*, 843F, 915W<br />
Rio Deiros, D., 595F<br />
Rion, J. R., 2260T<br />
Rioux, J., 3330T, 3401W<br />
Rioux, J. D., 1381F, 1678T,<br />
1982F, 2319W, 3382F<br />
Ripatti, S., 117, 119, 190,<br />
252, 656T, 1284T, 1308T,<br />
1503T, 1623T, 1709T,<br />
2076W, 2110T, 2137T,<br />
2173T, 2350T, 2399F<br />
Ripke, S., 352, 2487W,<br />
2509T, 2512T*, 2526W<br />
Rippey, C., 263*<br />
Ririe, M., 3189W<br />
Risacher, S. L., 2511W,<br />
2531F<br />
RISC Consortium, 3455T<br />
Risch, H., 1061F<br />
Risch, N., 7*, 96, 112, 118,<br />
230, 279, 421F, 620T,<br />
2140T, 3342T, 3383W<br />
Risch, R., 2513F<br />
Rischmueller, M., 2084F<br />
Riska, S. M., 986F<br />
Rissanen, A., 2256W<br />
Ristaldi, M. S., 2001W<br />
Ristoska-Bojkovska, N.,<br />
845F<br />
Ritchie, M., 1442W, 1602T,<br />
2041T, 2098T<br />
Ritchie, M. D., 226, 618T,<br />
625T, 1312F, 1316W,<br />
1447F*, 2042F, 2258F,<br />
2491T, 3542W, 3624W<br />
Ritchie, W., 1664T<br />
Ritter, D., 1221W<br />
Rittinger, O., 297<br />
Ritz, B., 2026T, 2538W<br />
Rivadeneira, F., 87, 109,<br />
584W, 1284T, 1334W,<br />
1503T, 2053T, 2081F,<br />
2105F, 2169W<br />
Rivard, L., 1678T<br />
Rivas, M., 176, 269, 1513F<br />
Rivas, M. A., 169, 173,<br />
567F, 582W*, 1948T,<br />
2319W, 2324F<br />
Rivera, I., 3315T<br />
Rivera, S., 770W<br />
Rivera-Luna, R., 1131W<br />
Riviello, J. J., 266<br />
Rivier, F., 3121W, 3166F<br />
Rivière, J. B., 124<br />
Rizzo, G., 71<br />
Rizzu, P., 98<br />
Roa, B., 1021T<br />
Roach, J. C., 195, 2643W<br />
Robb, L., 1678T<br />
Robbins, J., 2360F<br />
Robbins, J. A., 2145W<br />
Roberson, D., 3683F<br />
Roberts, A. E., 82<br />
Roberts, A. L., 2005T*<br />
Roberts, D., 3459T, 3669F,<br />
3709F<br />
Roberts, J., 3054F*, 3089W<br />
Roberts, J. M., 1884W<br />
Roberts, J. S., Session 9,<br />
317, 1781W, 1825W<br />
Roberts, K., 3644W<br />
Roberts, M. E., 1058F<br />
Roberts, R., 115<br />
Roberts, W., 175, 3086F,<br />
3456T<br />
Robertson, J., 549F<br />
Robertson, K. R., 2517W<br />
Robertson, M., 967W<br />
Robertson, N., 3575F<br />
Robertson, N. G., 862T<br />
Robertson, S., 3006T,<br />
3100F<br />
Robichaux, A., 3036F<br />
Robins, H., 530W<br />
Robinson, A., 3704W,<br />
3716W, 3731F, 3733F*<br />
Robinson, D., 3161W<br />
Robinson, J., 322, 2020T<br />
Robinson, P. C., 152<br />
Robinson, P. N., 298, 2725W<br />
Robinson, R., 385, 1305T<br />
Robinson, W., 3734W<br />
Robinson, W. P., 2977T,<br />
2986T, 3429T, 3445T<br />
Robson, C. D., 2928F<br />
Robson, M., 998F, 1159T,<br />
1275W, 1841W<br />
Robson, P. J., 1297F<br />
Robyr, D., 550W, 3431T<br />
Roca, A., 3254W<br />
Rocha, C. S., 514W, 2394W,<br />
2655W, 2876T, 3578W*<br />
Rocha, J., 2223W, 3318T<br />
Rocha, K. M., 3152F<br />
Rocha, R. M., 1217F<br />
Roche, O., 324, 390<br />
Rocke, D. M., 1625T<br />
Rockett, K., 2157W<br />
Rockwood, S., 983F*<br />
Roda, R. H., 2470T<br />
Roddy, T. P., 1605T<br />
Rodegher, M., 624T, 2095T<br />
Roden, D., 806F, 1602T,<br />
3622W<br />
Roden, D. M., 247, 618T,<br />
647T, 1312F, 1345F<br />
Roden, M., 275<br />
Rodenburg, R., 672T<br />
Rodgers, L., 2587T<br />
Rødningen, O., 3096F<br />
Rodolico, C., 1776W<br />
Rodrgio, A., 3326W<br />
Rodrigues, A. L., 2814F<br />
Rodrigues, M., 1119W,<br />
3562W<br />
Rodrigues, M. R., 3325F<br />
Rodrigues Jr., V., 1593T<br />
Rodrigues-Peres, R. M.,<br />
1033T*<br />
Rodriguez, A., 1048T,<br />
1049F*, 1432F, 2336F,<br />
2337W<br />
Rodriguez, D., 522W,<br />
3708W<br />
Rodriguez, E., 1939T,<br />
2226W<br />
Rodríguez, E., 1942T<br />
Rodriguez, M., 2495F,<br />
2660F<br />
Rodriguez, M. H., 3020T<br />
Rodriguez, S., 1626T,<br />
2427W<br />
Rodriguez, S. P., 926T<br />
Rodriguez de Alba Freiria,<br />
M., 1874F<br />
Rodriguez-Fernandez, I. A.,<br />
361<br />
Rodriguez-Flores, J. L.,<br />
2933T, 3380W, 3399W*<br />
Rodriguez-Florez, J. L.,<br />
3315T<br />
Rodriguez-Revenga, L.,<br />
2624F, 2630F*, 3217W<br />
Rodríguez-Santiago, B.,<br />
3208F*<br />
Rodriquez, C., 3290W<br />
Roe, A., 3022T<br />
Roe, D., 1087T<br />
Roe, G., 3557F<br />
Roeder, K., 268, 1433W,<br />
1520W, 2560T, 2577W<br />
Roelens, F., 423F
Roenspie, S., 2632T<br />
Roepman, R., 216<br />
Roethlisberger, B., 3044F<br />
Roetzer, K., 2570F<br />
Roewer, L., 3364F, 3402T*<br />
Rogaeva, E., 2428T<br />
Rogan, P. K., 3672W*<br />
Rogatto, S. R., 1217F<br />
Roger, J., 827F<br />
Roger, J. E., 830F*<br />
Rogério, F., 514W<br />
Rogers, C., 3185W<br />
Rogers, J., 595F, 2413T<br />
Rogers, K., 3150F<br />
Rogers, R. C., 2772F, 3052F<br />
Roh, S., 2117F<br />
Rohde, K., 1361W<br />
Rohena, L., 3046F<br />
ROHgen, 2366F<br />
Rohlfs, R. V., 182*, 1573F<br />
Rohrer, M. D., 529F, 2188T<br />
Rojas, J., 2365T<br />
Rojas, J. D., 2990T<br />
Rojas, M., 1851F<br />
Rojas, X., 3115W<br />
Rojas-Martínez, A., 1030T<br />
Rojas Martínez, J., 3077W*<br />
Rojo-Contreras, J., 2363F<br />
Rokas, A., 3275W<br />
Rolfs, A., 704T<br />
Rolinski, B., 782W<br />
Rollins, B., 2459F<br />
Roma, C., 1060T<br />
Roma, G., 1237T<br />
Romalho, A. S., 1731W<br />
Roman, S., 1237T<br />
Roman, T. S., 1627T*<br />
Romana, S., 915W<br />
Romanelli, V., 3499T<br />
Romano, A., 1949F*<br />
Romano, C., 100<br />
Romano, L., 401, 556W,<br />
561F<br />
Romano-Palumbo, L., 415F<br />
Romanos, J., 155, 1330F*<br />
Romano-Silva, M., 2385W*,<br />
2404T<br />
Romeo, M., 624T<br />
Romeo, S., 427F, 1271F*<br />
Romero, A., 3064F*<br />
Romero, F. E. P., 3039W<br />
Romero, J. A., 3708W*<br />
Romero, V., 2660F<br />
Romero-Gallo, J., 3388F<br />
Romigh, T., 1144T<br />
Romitti, P., 1564F<br />
Romitti, P. A., 2151W,<br />
3070F<br />
Romm, J., 1448W, 2114F,<br />
2139W*, 2170T, 3704W,<br />
3716W, 3733F<br />
Romm, J. M., 46, 1452T<br />
Rommens, J., 2953W<br />
Rommens, J. M., 1322W,<br />
1731W, 2905W<br />
Ronaghi, M., 596W, 1167W,<br />
3695F, 3710W<br />
Ronald, A., 3487T<br />
Roncarolo, M.-G.,<br />
Session 23<br />
*Presenting Author<br />
Ron El, R., 3002T<br />
Ronemus, M., 1600T, 2587T<br />
Ronen, R., 3307F*<br />
Roney, E., 63<br />
Rønning, V., 921W<br />
Ronninger, M., 1981T,<br />
2103W<br />
Ronowicz, A., 434W<br />
Rook, M. B., 217<br />
Roomere, H., 1140W<br />
Rooryck, C., 473F<br />
Roos, F., 3685F*, 3709F,<br />
3729F<br />
Root, H., 1050W*<br />
Rope, A. F., 3220F<br />
Ropers, H. H., 2732T<br />
Röpke, A., 2595W<br />
Rosa, F., 1153T, 1712T<br />
Rosa, R. L., 2220W<br />
Rosana, K. M., 2223W<br />
Rosand, J., 1689T<br />
Rosario, M., 979W, 1749W<br />
Rosati, G., 157<br />
Roscioli, T., 214*, 298,<br />
2151W, 3070F<br />
Rose, C., 2143T<br />
Rose, J., 2541W<br />
Rose, J. W., 2397W<br />
Rose, L., 2056T<br />
Rose, L. M., 51<br />
Rose, R., 2566T<br />
Rose, R. J., 2022W<br />
Rosembloom, A. L., 2706F<br />
Rosen, A., 1330F<br />
Rosen, B., 1061F<br />
Rosenbaum, H., 748T*,<br />
773W<br />
Rosenbaum, J., 2587T<br />
Rosenberg, C., 439F, 891W,<br />
903W, 919W, 961W<br />
Rosenberg, D. R., 3447T<br />
Rosenberg, N., 3357T<br />
Rosenberg, N. A., 1534F,<br />
3285T, 3351T<br />
Rosenberg, P., 1012T<br />
Rosenberg, P. S., 1378F<br />
Rosenberg, T., 363<br />
Rosenberg-Belmaker, L.,<br />
334<br />
Rosenblatt, D., 719F*<br />
Rosenblatt, D. S., 673F,<br />
705F, 706T, 848F<br />
Rosenbloom, B., 768W,<br />
769W<br />
Rosenbloom, K., 3612W<br />
Rosenfeld, J., 66, 68, 98,<br />
870T, 2979T<br />
Rosenfeld, J. A., 41, 103,<br />
274*, 805F, 884T, 902T,<br />
1818F*, 2395T, 3055W,<br />
3101W<br />
Rosenfeld, R. G., 2706F<br />
Rosenman, K. D., 1915T<br />
Rosenstein, B., 1309F<br />
Rosenstiel, P., 515F, 567F,<br />
582W, 2103W, 2303F<br />
Rosenthal, E., 1021T<br />
Rosenthal, E. A., 1605T*<br />
Rosenthal, J., 1783W<br />
Rosenthal, S. L., 2521T*<br />
SPEAKER AND AUTHOR INDEX 397<br />
Roses, A., 2465F<br />
Roses, A. D., 637T, 1382W<br />
Rosinski, J., 242<br />
Ross, A., 217<br />
Ross, J., 2525F<br />
Ross, J. W., 2717T<br />
Ross, L. H., 773W<br />
Ross, M., 1291F, 3694W<br />
Ross, T., 494W, 1244F<br />
Ross-Adams, H., 1011W<br />
Rossello, F., 1273T<br />
Rosser, T., 2069F<br />
Rossi, A., 943W, 3190F<br />
Rossi, C., 2786T<br />
Rossi, M., 124, 2399F*<br />
Rossier, E., 3109W<br />
Rossman, M., 1915T<br />
Rostı, R. O., 3195W<br />
Roter, A. H., 972T<br />
Roth, F. P., 2660F<br />
Roth, J., 924T<br />
Roth, L. A., 158<br />
Roth, M. P., 2126F, 3073W<br />
Rothhammer, F., 3327T<br />
Röthlisberger, B., 3109W<br />
Rothman, N., 1012T, 1091F,<br />
1092W<br />
Rothschild, C., 1796W<br />
Rothschild, H., 1081T,<br />
1454W<br />
Rothwell, P. M., 1313W<br />
Rotig, A., 72, 325, 329<br />
Rötig, A., 699F, 782W<br />
Rotimi, C., 241, 1515T,<br />
1886F, 1959W, 3533F<br />
Rottbauer, W., 86, 1612T<br />
Rotter, J., 350<br />
Rotter, J. I., 130, 1445W,<br />
1661T, 1662T, 1916F,<br />
2080T, 2153F, 2210F,<br />
2337W<br />
Rotunno, M., 30, 1218W,<br />
1517W, 2191T*<br />
Rouault, A., 473F<br />
Rouault, T. A., Session 10<br />
Roubertie, A., 2536T<br />
Roughley, P., 3169W<br />
Rouhani, F., 3507T<br />
Rouleau, C., 77<br />
Rouleau, E., 1062W,<br />
1212W*<br />
Rouleau, G., 1480F, 1670T,<br />
1898F, 2306F, 2338T,<br />
2816T, 3268F<br />
Rouleau, G. A., 2342F,<br />
2402F, 2558F, 2591F,<br />
2692W, 2790F, 3401W<br />
Roulstone, S., 2164T<br />
Roume, J., 56, 3129W<br />
Rousseau, F., 1840F<br />
Rousseau, M., 5<br />
Roux, A. F., 2947W*<br />
Roux, AF., 1874F<br />
Roux, K. J., 2914W<br />
Rovelet-Lecrux, A., 345<br />
Rovin, B., 458W<br />
Rowan, D., 786W<br />
Rowe, M., 2347T<br />
Rowell, S., 96<br />
Rowland, R. R. R., 2717T<br />
Rowley, S. M., 1224W<br />
Rowsey, R., 250*<br />
Roy, A., 314<br />
Royce, T., 942T, 3710W<br />
Roy-Gagnon, M.-H., 1478W<br />
Roze, V., 2770W<br />
Rozel, C., 3170F<br />
Rozell, B., 2427W<br />
Rozen, S., 2328W, 2889F<br />
Rozenzhak, S., 395<br />
Rozet, J., 390*<br />
Rozet, J.-M., 324<br />
Rozowsky, J., 551F<br />
Ruan, M. Z. C., 795W*<br />
Ruark, E., 138*, 1211F<br />
Ruau, D., 2230T<br />
Rubel, M. A., 3251W<br />
Rubens, C. E., 74, 94<br />
Rubenstein, J. L. R., 407<br />
Rubenstein, K., 2549F<br />
Rubenstein, L. M., 261<br />
Rubenstein, R., 2579F<br />
Rubicz, R., 1406W*<br />
Rubin, E. M., 4, 407<br />
Rubin, M. A., 1100F<br />
Rubini, M., 2002T<br />
Rubinstein, W., 3582W<br />
Rubinstein, W. S., 1762W*,<br />
3625F<br />
Ruchirawat, M., 3570W<br />
Ruczinksi, I., 350<br />
Ruczinski, I., 1076F, 1472W,<br />
1512T, 1558F, 1900T,<br />
2043W, 3609F*<br />
Rudaitis, V., 1208F<br />
Rudan, I., 1383T, 2366F<br />
Rudan, P., 1660T<br />
Rudd, D., 422W, 2493W*<br />
Rudd, M. K., 66, 338, 938T<br />
Ruden, M., 1009T, 2014T<br />
Rudenskaja, G., 2930T<br />
Ruderfer, D., 1325W<br />
Ruderfer, D. M., 2512T<br />
Rudge, S., 33<br />
Rudnev, D., 3582W<br />
Rudnicki, D. D., 2644T<br />
Rudser, K., 714T<br />
Rudy, G., 3579F*<br />
Rueda, L., 3490T<br />
Rueedi, R., 1281T*<br />
Ruef, B. J., 2725W<br />
Ruff, D., 1209W, 1246T,<br />
3278W, 3714W<br />
Ruffini, E., 1153T<br />
Ruggiero, L., 1776W<br />
Rugo, H., 1965W<br />
Ruhe, A. L., 2517W<br />
Ruigrok, Y. M., 87<br />
Ruivenkamp, C., 2701W,<br />
3650W<br />
Ruiz, N., 3121W<br />
Ruiz, R. G., 926T<br />
Ruíz-Flores, P., 1030T<br />
Ruiz-Linares, A., 1480F,<br />
3327T, 3360T, 3380W<br />
Ruiz-Ortiz, L., 2272T<br />
Ruiz-Pallares, N., 3166F<br />
Ruiz-Rodriguez, C. T.,<br />
3254W<br />
Rukova, B., 3477T*, 3481T<br />
SPEAKER AND AUTHOR INDEX
398 SPEAKER AND AUTHOR INDEX<br />
Rukova, B. B., 923W<br />
Rule, J., 3602W<br />
Rummel, S., 1002W, 1780W*<br />
Rump, A., 1236W, 2595W,<br />
3224F*<br />
Rundek, T., 1635T, 1638T<br />
Runyon, S., 2322W<br />
Runz, H., 1630T*<br />
Ruparel, K., 2514W<br />
Rupchock, A., 1786W*,<br />
1787W, 1853F<br />
Rupert, J. L., 1760W<br />
Rüschendorf, F., 2102F<br />
Russel, R., 1011W<br />
Russell, A., 1770W, 3602W*<br />
Russell, J. A., 1632T<br />
Russell, J. F., 2779W*<br />
Russell, M. B., 2804T<br />
Russell, M. L., 1186T<br />
Russin, J., 3415T<br />
Russo, A., 1153T, 1712T*<br />
Russo, A. D., 2424W, 2626T<br />
Rustin, P., 3241W<br />
Rusu, C., 124<br />
Rusyn, I., 368<br />
Ruth, B., 2904F, 3590W<br />
Rüther, U., 3524T<br />
Rutherford, N. J., 2639F<br />
Rutledge, D. N., 3408T<br />
Rutsch, F., 2759T*<br />
Rutschow, D., 645T<br />
Ruvolo, M., 975W*<br />
Ruzzo, E., 53<br />
Ruzzo, E. K., 203*, 2455T,<br />
2875W<br />
Ryan, A. W., 2160W, 2283W<br />
Ryan, C., 1856F<br />
Ryan, K., 602T<br />
Ryan, M., 2143T, 2742F<br />
Rybicki, B. A., 1250F, 1895F,<br />
2202W<br />
Ryckman, K., 1882T, 3537F<br />
Ryckman, K. K., 1344T*<br />
Ryder, E., 105<br />
Ryder, M., 1021T<br />
Rykiel, G., 240<br />
Rynes, E., 402<br />
Ryten, M., 374, 564W<br />
Rytkönen, K. M., 2462F<br />
Ryu, D., 3418T<br />
Ryu, E., 1351F*<br />
Ryu, H., 2437T, 3008T<br />
Ryu, M., 3461T<br />
Ryvkin, M., 1714T<br />
Rzadzinska, A. K., 1<br />
Rzhetskaya, M., 3323W<br />
S<br />
Sá, J., 1778W, 2755W, 3019T<br />
Sá, M. J. N., 3122F*<br />
Saad, A., 944T, 1751W,<br />
2744T<br />
Saada, N., 314, 1735W,<br />
1742W, 1757W, 1761W<br />
Saadi, A., 2808F<br />
Saadi, I., 2265W, 2670F<br />
Sääf, A., 1939T<br />
Saag, M., 3079W<br />
*Presenting Author<br />
Saal, H. M., 3194F<br />
Saarela, J., 2134T, 2350T,<br />
2888T<br />
Saavalainen, P., 2023T,<br />
2177F<br />
Saba, B., 1593T<br />
Sabatelli, M., 2611T<br />
Sabater-Lleal, M., 1651T<br />
Sabatti, C., 421F*, 431F,<br />
3342T, 3383W<br />
Sabbaghian, N., 1065W,<br />
1262F<br />
Saberi, A. H., 679F, 2714T<br />
Sabeti, P., Session 80<br />
Sabo, A., 3, 648T, 3597F<br />
Sabolic, V., 2777T<br />
Saboohi, S., 3083W<br />
Sabourin, J.-C., 32<br />
Sabova, L., 849F<br />
Sabrautzki, S., 2922F<br />
Sacaglia, F., 898T<br />
Sacco, R., 1638T<br />
Sacco, R. L., 1635T<br />
Saccone, N., 2114F, 2650T<br />
Saccone, N. L., 2170T<br />
Sacerdote, C., 1712T<br />
Sachs, N., 2848W<br />
Sacks, G., 2993T*<br />
Sacks, S., 1470T, 2260T<br />
Sacks, S. H., 2082W<br />
Sadan, S., 660T<br />
Sadasivam, M. N., 2988T<br />
Sadee, W., 609T<br />
Sadeghin, T., 239<br />
Sadeghpour, A., 3<br />
Sadetzki, S., 783W, 1303F<br />
Sadia, S., 2959W<br />
Sadighi Akha, E., 218,<br />
2939T<br />
Sadim, M., 1292W<br />
Sadler, B., 2650T*<br />
Sadler, M., 96<br />
Sadowski, H., 3649F<br />
Saeb, F., 2976T<br />
Saed, S., 2756T<br />
Saeed, S. R., 2302T<br />
Saenen, J., 1617T<br />
Saenz, M., 3133W<br />
Saez, M., 794W<br />
Safatle, H. P. N., 903W,<br />
961W<br />
Safavi, S., 1024T*<br />
Saffery, R., 3484T<br />
Saffrey, P., 366, 3663F<br />
Safina, N. P., 366<br />
Safra, N., 2778F<br />
Saggar, A., 1675T<br />
Saggar, A. K., 2896W<br />
Saghbini, M., 3649F<br />
Sagreiya, H., 646T<br />
Sahin, A., 2979T<br />
Sahin, F. I., 594W, 1013F,<br />
3003T, 3243W*, 3424T,<br />
3426T<br />
Sahlin, E., 3245W<br />
Sahoo, T., 876T<br />
Saiag, P., 1062W<br />
Sai Babu, M., 224<br />
Sailani, M. R., 84*, 3431T<br />
Sailani, S. R., 67<br />
Saillour, V., 31, 394, 1207T,<br />
1215W, 3268F<br />
Saini, S., 1890W, 2733F,<br />
2735T*<br />
Saip, A., 2098T<br />
Saip, S., 2450F<br />
Saisanit, C., 242<br />
Saisanit, S., 3580W*<br />
Saith, S., 2465F<br />
Saito, K., 2963T<br />
Saito, M., 2588F<br />
Saito, T., 3051W<br />
Saito, T. L., 2569T<br />
Saitoh, S., 2822T*, 3056F<br />
Saitsu, H., 1290T, 2822T,<br />
3136F*<br />
Saitta, S., 65*, 1721W,<br />
3038F<br />
Sajan, S., 2389T<br />
Saji, T., 1631T<br />
Sajuthi, S., 3371W<br />
Sakabe, J., 2911W<br />
Sakaguchi, M., 558W, 559F,<br />
598W, 599F<br />
Sakaguti, M., 548W<br />
Sakai, S., 2440T<br />
Sakamoto, L. H. T., 1202F<br />
Sakamoto, M., 1147T<br />
Sakiyama, Y., 2418W,<br />
2601W<br />
Sako, W., 52<br />
Sakoda, L., 230, 2513F<br />
Sakoda, L. C., 2140T*<br />
Sakowski, L., 2664F<br />
Sakurada, Y., 1980W<br />
Sakurai, Y., 663F<br />
Sala, A., 3364F, 3402T<br />
Sala, N., 987W<br />
Salako, B., 1959W<br />
Salam, M. T., 2168F<br />
Salama, M., 3637F<br />
Salama, M. E., 3297T<br />
Salamanca-Gomez, F. A.,<br />
1168T<br />
Salari, K., Session 28<br />
Salarini, D. Z., 2642F<br />
Salas, C., 872T, 1141T,<br />
3040F*<br />
Salas, E., 1111T, 1127F,<br />
1128W<br />
Salas-Labadía, C., 1131W<br />
Salazar, A. M., 1049F<br />
Salazar, D., 712T<br />
Salazar-Dávalos, I. M.,<br />
3187W, 3188F<br />
Salazar-Páramo, M., 2363F<br />
Salazar-Riojas, R., 1030T<br />
Salbert, B. A., 1759W<br />
Sale, M., 178, 1971W<br />
Sale, M. M., 123, 1662T,<br />
3371W<br />
Saleh, M., 649T<br />
Saleheen, D., 115<br />
Saleh-Gohari, N., 2787F,<br />
2832F<br />
Salehi, Z., 3083W<br />
Salehi-Ashtiani, K., 2660F<br />
Salehzade, F., 2856F<br />
Salek, R., 1281T<br />
Salem, R. M., 23*, 2307W<br />
Salem, S., 2971T<br />
Salerno, B., 2078F<br />
Saletore, Y., 376<br />
Salgado, M., 1977W<br />
Salhi, A., 129, 1949F<br />
Salhi, H., 77<br />
Salhi, N., 1268F<br />
Salhi, S., 325*<br />
Salido, E., 981W<br />
Salie, M., 2217W*<br />
Salifoglu, H., 590W*<br />
Saligan, L., 3485T<br />
Salih, M., 324, 2997T<br />
Salimzadeh, L., 1143W,<br />
1739W*<br />
Salit, J., 2933T, 3399W<br />
Salit, M., 3647F<br />
Sallinen, S.-L., 992F<br />
Salloum, A., 3349F<br />
Salo, P., 1253F*, 2175W<br />
Salomaa, V., 656T, 1709T,<br />
1835W, 2110T, 2116T,<br />
2132F, 2173T, 2462F<br />
Salomão, H., 870T, 2289W*,<br />
3055W<br />
Salomons, G. S., 681F<br />
Salonen, R., 897W<br />
Salonga, E. G., 2975T<br />
Salvarinova, R., 750T<br />
Salvatore, J. E., 2022W<br />
Salvetat, N., 2685F<br />
Salviati, L., 2909T<br />
Salvoro, C., 1732W<br />
Sam, M., 1256F<br />
Samango-Sprouse, C., 239*<br />
Samani, N. J., 115, 1659T,<br />
2035T, 2175W, 3453T<br />
Samarov, D., 3647F<br />
Sambrook, J. G., 1604T<br />
Sambyal, V., 1703T<br />
Sammeth, M., 567F, 582W<br />
Samocha, K. E., 1523W*<br />
Samonigg, H., 1115F<br />
Sampaio, M., 1593T<br />
Sampath, P., 2312F<br />
Sample, M., 3622W<br />
Sampson, B., 1591T<br />
Sampson, J., 1160F, 1306F<br />
Sampson, K., 2411F<br />
Sampson, M. G., 845F,<br />
3405W*<br />
Samuel, J., 978T<br />
Samuels, D. C., 72, 3275W<br />
Samuels, M. E., 2790F<br />
Samuels, M.-E., 2692W,<br />
2945T<br />
Sanabria, D., 3225W<br />
Sanada, H., 245<br />
Sanapareddy, N., 242<br />
Sanchez, G., 2311T<br />
Sanchez, R. L., 3175W*<br />
Sanchez, S., 956T, 2055W<br />
Sánchez, S., 875W, 960T*,<br />
976T<br />
Sánchez-García, F., 2296T<br />
Sanchez-Huerta, E., 3311W<br />
Sanchez-Lara, P. A., 300,<br />
2151W<br />
Sánchez-López, J. Y.,<br />
2363F
Sánchez-Machín, I., 2296T<br />
Sánchez-Palacios, A., 2296T<br />
Sand, S. R., 1071W<br />
Sanders, A., 3373F<br />
Sanders, A. R., 1282F,<br />
1957T*, 2576F<br />
Sanders, D. N., 2805F<br />
Sanders, J. L., 1920W*,<br />
2040W<br />
Sanders, S., 13, 553F,<br />
1433W, 2605T<br />
Sanders, S. J., 2478W<br />
Sanders, T. N., 1822F<br />
Sandford, A. J., 1465F<br />
Sandford, R. N., 153<br />
Sandholm, N., 2307W<br />
Sandholt, C. H., 2317T,<br />
2347T<br />
Sandhu, M., 117<br />
Sandhu, M. S., 1507F<br />
Sandi, C., 761W*<br />
Sandi, M., 761W<br />
Sandin, S., 1707T<br />
Sandling, J. K., 44, 3441T<br />
Sandmann, H., 3528W<br />
Sandoval, K., 3380W<br />
Sandoval, L., 682T<br />
Sandoval Mendoza, K.,<br />
2033F<br />
Sandstrom, R., 255<br />
Sandulache, V., 1120T<br />
Sanger, W. G., 968T<br />
Sanghera, D., 474W<br />
Sanghera, D. K., 1933T<br />
Sanghi, D., 764W, 1287T,<br />
1288F, 1294F*, 1883F<br />
Sangkuhl, K., 633T, 635T<br />
Sanguansermsri, S., 3319F<br />
Sanidad, M. A., 945W<br />
Sankararaman, S., 3372T*,<br />
3407W<br />
Sanlaville, D., 944T, 3117W<br />
San Luciano, M., 2801T<br />
San Martin, W. B., 926T<br />
Sanna, S., Session 27, 110,<br />
113, 157, 177, 186, 547F,<br />
1391W, 1451W, 1516F,<br />
2001W, 2198F, 2329T,<br />
3664W<br />
Sanna-Cherchi, S., 845F*<br />
San Nicolas, H., 2627F<br />
Sansbury, F. H., 2704W*<br />
Sanseau, P., 649T<br />
Santago, Y., 255<br />
Santana, J., 2300F<br />
Santangelo, S., 352<br />
Santani, A. B., 2904F*<br />
Santaniello, A., 2113T<br />
Sante, T., 423F<br />
Santen, G. W. E., 55<br />
Santiago, K. M., 1217F<br />
Santibanez, J., 2934F<br />
Santibanez-Koref, M., 751F<br />
Santillan, D. A., 74, 94<br />
Santillan, M. K., 74, 94<br />
Santoni, F., 84, 85, 2877F,<br />
2937F, 3431T<br />
Santoro, F., 1949F<br />
Santoro, L., 1776W<br />
Santoro, M., 2464T*<br />
*Presenting Author<br />
Santoro, M. L., 2533T,<br />
2534F<br />
Santoro, S., 1847W*<br />
Santos, D., 2736F*<br />
Santos, E. J. M., 3292F<br />
Santos, F., 3377W<br />
Santos, J., 492W<br />
Santos, J. C., 1187F, 3502T*<br />
Santos, L. C., 1132T*<br />
Santos, M. M., 2085W<br />
Santos, M. N. N., 2718F<br />
Santos, N., 3364F, 3402T<br />
Santos, P. A. C., 961W*<br />
Santos, P. C. J. L., 636T*<br />
Santos, R., 2417F, 2631W,<br />
3362W<br />
Santos, R. O., 2394W*<br />
Santos, S., 2642F, 3364F,<br />
3402T<br />
Santos, S. A., 941W<br />
Santos, S. C. L., 2596T*<br />
Santos, S. E., 1629T<br />
Santos da Cunha, B., 131<br />
Santos Filho, A. F., 2534F<br />
Sapkota, Y., 1297F*<br />
Sapp, J. C., 33, 674T<br />
Saraceni, C., 2915T<br />
Saraga, M., 845F<br />
Saraidaridis, J., 3703F<br />
Saraiva, J., 2755W, 3019T*<br />
Saraiva-Pereira, M. L.,<br />
2424W, 2626T, 2642F<br />
Sarantaus, L., 982T<br />
Sarasin, A., 1496W<br />
Saraswathy, R., 929W*<br />
Sarca, G. J., 2954T<br />
Sarda, P., 857W, 936T,<br />
2386T*, 2729T, 3047W,<br />
3121W, 3166F<br />
SardiNIA Project, 3664W<br />
Sargan, D. R., 1105T<br />
Sariadaridis, J., 3656W<br />
Sarian, L. O. Z., 1033T<br />
Sarin, A., 1308T<br />
Sarin, A.-P., 119, 2076W,<br />
2137T, 2173T<br />
Sarkar Roy, N., 3343F<br />
Sarmady, M., 2904F<br />
Sarmiento, M., 951W<br />
Sarnowski, C., 1361W*,<br />
2079W<br />
Sarrel, K., 998F, 999W,<br />
1159T<br />
Sarroza, D., 1759W<br />
Sarto, E., 2764W, 2781F<br />
Sarto, G. E., 2020T<br />
Sartor, M. A., 34<br />
Sartor, O., 1040F<br />
Sarukhanov, A., 838F,<br />
2857W<br />
Sasada, T., 2380T<br />
Sasago, K., 1631T<br />
Sasaki, H., 2697F<br />
Sasaki, M., 1697T<br />
Sasaki, R., 1730W, 2559W<br />
Sasaki, T., 2370W, 2496W,<br />
2652W, 2911W<br />
Sasarman, F., 2771T<br />
Sasikala, K., 1044W<br />
Sasner, M., 983F<br />
SPEAKER AND AUTHOR INDEX 399<br />
Sass, J. O., 737F<br />
Sassi, C., 2611T<br />
Sasson, A., 2904F<br />
Satake, W., 2619W*<br />
Sathanoori, M., 904T<br />
Sato, D., 2575T, 2620T<br />
Sato, M., 1830F<br />
Sato, N., 2371T, 2507F<br />
Sato, R., 2129F<br />
Sato, Y., 1631T, 1722W*,<br />
3337F*<br />
Satoh, F., 1321F<br />
Satta, S., 2001W<br />
Sattar, N., 1626T<br />
Satten, G. A., 1349W*<br />
Satterthwaite, T., 2514W<br />
Saugier-Veber, P., 3117W<br />
Saunders, A. M., 637T<br />
Saunders, C. J., 366*,<br />
2793F, 2894T<br />
Saunders, E., 205, 1011W,<br />
1109F<br />
Saunders, P., 1729W,<br />
3680W<br />
Saunders, P. C., 3640W<br />
Saunders-Pullman, R.,<br />
2801T<br />
Saunier, S., 324, 403<br />
Saute, J., 2609F<br />
Saute, J. A., 2626T*<br />
Saute, J. A. M., 2424W<br />
Sauthier, P., 2842W<br />
Savad, S., 1169F, 2987T<br />
Savage, D. B., 33, 45<br />
Savage, M., 3018T<br />
Savage, S. A., 1064F, 1196F*<br />
Savage, S. K., 1799W,<br />
1836F, 1843W*<br />
Saville, B., 247<br />
Savio, A., 3478T*<br />
Savitzki, D., 199<br />
Saw, S. M., 2094W<br />
Saw, W. Y., 3284W*<br />
Sawa, A., 2458T, 2461T<br />
Sawada, T., 1984T<br />
Sawai, H., 2130W<br />
Sawyer, S. L., 3141W*<br />
Saxena, A., 2353T<br />
Saxena, R., 1720W, 1988F<br />
Saydam, G., 1164W, 1178F<br />
Sayer, J. A., 2676F<br />
Saykin, A. J., 2511W, 2531F<br />
Sbardellati, A., 823F<br />
Sboner, A., 2444F<br />
Scafe, C., 3670W, 3717F<br />
Scaglia, F., 163, 759W,<br />
2942T<br />
Scaletsky, I. C. A., 1187F<br />
Scalf, M., 1269W<br />
Scambler, P., 216<br />
Scambler, P. J., 2955F<br />
Scanlan, N. L., 1138T<br />
Scaparo, R. M., 941W<br />
Scarano, G., 3129W<br />
Scaroni, C., 2708T<br />
Scarpini, E., 2095T<br />
Scarselli, G., 3114F<br />
Scelo, G., 1012T<br />
Schaaf, C., 759W<br />
Schaaf, C. P., 2403W<br />
Schaafsma, G. C. P., 3611F<br />
Schaarschmidt, H., 2102F<br />
Schachar, R. J., 2499W<br />
Schacherer, C., 1291F<br />
Schackert, G., 1236W<br />
Schadt, E., 583F, 1621T,<br />
3724W<br />
Schadt, E. E., 1624T,<br />
2220W<br />
Schaefer, A. S., 2058W*<br />
Schaefer, C., 96*, 112, 118,<br />
230, 421F, 620T, 1289W,<br />
1301W, 1414F, 1455T,<br />
2140T, 2513F, 3342T,<br />
3383W<br />
Schaefer, E., 2887W<br />
Schaefer, M., 36<br />
Schaeffer, P., 2642F<br />
Schafer, C. M., 268*<br />
Schäfer, Z., 86<br />
Schaffer, A. A., 1958F*<br />
Schaffer, L. G., 805F<br />
Schaibley, V. M., 476W*<br />
Schaid, D., 28, 1001F,<br />
1214F<br />
Schaid, D. J., 986F, 1449T*,<br />
1497T, 3564W<br />
Schalkwyk, L., 3471T,<br />
3476T<br />
Schalkwyk, L. C., 3487T<br />
Schanen, N. C., 2783T,<br />
3119W<br />
Schanze, I., 2666T<br />
Schara, U., 2681T<br />
Scharer, C., 3310F<br />
Scharer, G., 451F*<br />
Scharer, G. H., 2884W<br />
Scharer, O. D., 2696T<br />
Scharf, J., 1480F<br />
Scharfe, C., 3691F<br />
Scharpf, R. B., 3609F<br />
Scharschmidt, B., 662T<br />
Scharschmidt, B. F., 774W<br />
Schatz, M. C., 2587T<br />
Schaub, F. X., 1162T<br />
Schauer, S., 1236W<br />
Schaumberg, D., 385<br />
Schaumberg, D. A., 1305T<br />
Schawb, M., 3362W<br />
Schecter, S. C., 816F*<br />
Scheel, M., 314, 1735W,<br />
1742W, 1757W, 1761W<br />
Scheet, P., 1041W*, 1258T,<br />
1542T<br />
Scheetz, T. E., 60<br />
Scheffer, H., 97, 243, 621T,<br />
1734W, 1749W<br />
Scheffer, I. E., 203, 2741T,<br />
2897T, 3228F<br />
Schein, J., 375<br />
Scheinfeldt, L., 3338W<br />
Scheinfeldt, L. B., 3303T*<br />
Scheinhardt, M. O., 1669T<br />
Schekman, R., Session 26<br />
Schell, M., 86<br />
Schellenberg, G., 343,<br />
1476T, 1520W, 1571W,<br />
2498F<br />
Schellenberg, G. D., 342,<br />
344, 2316W, 2577W<br />
SPEAKER AND AUTHOR INDEX
400 SPEAKER AND AUTHOR INDEX<br />
Schenck, A., 2595W, 2666T<br />
Schendel, D., 463F<br />
Schepers, D., 79, 80<br />
Scherag, A., 108, 2090F<br />
Scherer, S., 98, 1688T,<br />
2525F<br />
Scherer, S. E., 60, 244<br />
Scherer, S. W., 175, 460W,<br />
2570F, 2575T, 2617T,<br />
2620T, 2932W, 3086F,<br />
3095W, 3456T<br />
Scheuerle, A., 1761W<br />
Schiettecatte, F., 227<br />
Schieve, L., 463F<br />
Schiffman, J., 2982T<br />
Schiffman, R., 2786T<br />
Schiffmann, R., 772W,<br />
1684T*<br />
Schildkraut, J., 1061F<br />
Schildkraut, J. M., 1156T<br />
Schilhabel, M., 3224F<br />
Schillert, A., 200, 275,<br />
1443T, 1669T<br />
Schimpf-Linzenbold, S.,<br />
3126F<br />
Schindeler, K., 3143W<br />
Schlagenhauf, U., 2058W<br />
Schlegel, P. N., 2982T<br />
Schlesinger, D., 919W,<br />
1727W<br />
Schlessinger, D., 113, 177,<br />
276, 547F, 847F, 1391W,<br />
1516F, 2001W, 2198F<br />
Schleutker, J., 28, 992F,<br />
995F, 997T, 1000T,<br />
1001F, 1006T, 1214F,<br />
1302T<br />
Schliekelman, P., 2206T*<br />
Schlitt, T., 1470T, 2804T<br />
Schl<strong>of</strong>f, D., 885W<br />
Schmahmann, J. D., 326<br />
Schmid, B., 2103W<br />
Schmidlen, T. J., 632T<br />
Schmidt, A., 200<br />
Schmidt, B., 1965W<br />
Schmidt, C., 2135F<br />
Schmidt, E., 2427W<br />
Schmidt, E. M., 117<br />
Schmidt, J., 493F*, 1582F,<br />
2786T<br />
Schmidt, J. L., 2452T*<br />
Schmidt, M., 1544W*,<br />
2614T<br />
Schmidt, M. A., 9<br />
Schmidt, M. K., 206, 1117T,<br />
1150T<br />
Schmidtke, J., 1763W*,<br />
1868F, 1877F<br />
Schmidts, M., 216*, 809F<br />
Schmitt, B., 675F<br />
Schmitt, C. A., 2222F*<br />
Schmitt, C. P., 231<br />
Schmitz, C., 3449T<br />
Schmitz, K., 2811F, 3219W<br />
Schmitz-Abe, K., 8<br />
Schmitz-Abe, K. E., 452W*<br />
Schnabel, R. B., 1669T<br />
Schnabel, R. D., 2847F<br />
Schned, A., 1091F<br />
Schned, A. R., 1092W<br />
*Presenting Author<br />
Schneider, A., 770W, 810F,<br />
857W, 936T, 2386T,<br />
3004T, 3121W, 3166F,<br />
3179W*<br />
Schneider, B., 1098W<br />
Schneider, B. G., 3388F<br />
Schneider, E., 3266W<br />
Schneider, J. A., 3417T,<br />
3450T<br />
Schneider, K. U., 1612T<br />
Schneider, S., 1119W<br />
Schneider, V., 464W<br />
Schneiderat, P., 2961F<br />
Schnetz-Boutaud, N., 15,<br />
1286W, 1316W, 1377T,<br />
1671T, 1713T<br />
Schnizel, A., 3240F<br />
Schnutgen, F., 825F<br />
Schoenberger, J., 1021T<br />
Schoenmaker, N., 2701W<br />
Schoenwolf, G. C., 828F<br />
Sch<strong>of</strong>ield, P., 198<br />
Schonberg, S., 953W<br />
Schoolcraft, W. B., 851F,<br />
2968T<br />
Schoonderwoerd, K., 708T<br />
Schorderet, D. F., 854F<br />
Schork, N. J., 24, 146,<br />
1319W, 1839W, 2274W,<br />
3332W<br />
Schormair, B., 2567F*,<br />
2568W<br />
Schorn, M., 3717F<br />
Schorry, E., 3177W*<br />
Schoser, B., 2944W<br />
Schoumans, J., 1035W<br />
Schrader, B. J., 1714T<br />
Schrader, K., 999W, 1841W<br />
Schrader, K. A., 998F*, 1159T<br />
Schraders, M., 58, 214<br />
Schrauwen, I., 59*, 2104T<br />
Schreiber, E., 3684W<br />
Schreiber, S., 200, 515F,<br />
567F, 580W, 582W,<br />
1942T, 1943F, 2058W,<br />
2103W, 2295W, 2303F,<br />
2314T, 2315F, 2368T<br />
Schreml, J., 236, 3214F*<br />
Schrock, E., 1236W*, 3224F<br />
Schrodi, S., 2297F, 3287W,<br />
3326W<br />
Schroeder, C., 1200W,<br />
1233W*<br />
Schroeder, D., 3479T*<br />
Schroeder, J., 3671F<br />
Schroer, R. J., 2826F<br />
Schroyer, R., 745F<br />
Schu, M., 385, 2563T<br />
Schubert, C. R., 2613W,<br />
2928F<br />
Schuberth, C., 1630T<br />
Schuck, R. N., 606T<br />
Schuckit, M., 2582F<br />
Schuele, B., 803W*<br />
Schuemann, B., 622T<br />
Schuh, A., 133<br />
Schuh, A. F. S., 2424W,<br />
2626T<br />
Schüle, R., 2820F, 2930T<br />
Schülke, M., 699F<br />
Schuller-Faccini, L., 3031T<br />
Schully, S. D., 1845W<br />
Schulte, E. C., 2568W*<br />
Schulte-Körne, G., 1976F<br />
Schultz, E. S., 2167T<br />
Schultz, K., 1589T<br />
Schultz, K. A., 132<br />
Schultz, R. A., 3101W<br />
Schultze, J., 2416T<br />
Schulz, B., 129<br />
Schulze, A., 675F<br />
Schumacher, F., 205, 213<br />
Schumacher, F. R., 1148F<br />
Schumacher, J., 1976F,<br />
2088W, 2557T<br />
Schuman, J. S., 2154W,<br />
2240F, 2263T<br />
Schunkert, H., 115, 3453T<br />
Schupf, N., 859W, 1920W<br />
Schurmann, C., 275, 1284T,<br />
2141F*<br />
Schürmann, M., 2103W<br />
Schürmann, P., 1117T<br />
Schurr, E., 1374T, 2003F<br />
Schurr, T., 3373F*<br />
Schurr, T. G., 3329W, 3377W<br />
Schuurs-Hoeijmakers, J. H.<br />
M., 100, 160, 672T<br />
Schwab, R. B., 1051T<br />
Schwab, S. G., 2407T<br />
Schwaderer, A., 458W<br />
Schwartz, A. G., 1454W<br />
Schwartz, C., 2566T,<br />
2806W, 3196F<br />
Schwartz, C. M., 3185W<br />
Schwartz, D. A., 3466T<br />
Schwartz, I. V. D., 696T<br />
Schwartz, J., 3469T<br />
Schwartz, P. J., 86<br />
Schwartz, R., 839F, 3376F<br />
Schwartz, S., 103, 949W*<br />
Schwartz, S. G., 2028W,<br />
2318F<br />
Schwartz, S. M., 213<br />
Schwartz, T., 1239W<br />
Schwartzentruber, J.,<br />
160, 198, 701F, 2790F,<br />
2794W<br />
Schwarz, E., 686T<br />
Schwarzacher, T., 449F<br />
Schwarze, U., 1759W<br />
Schwarzmayr, T., 2595W<br />
Schwei, T., 3671F<br />
Schweiger, M., 3224F<br />
Schwender, H., 1335T*,<br />
1430W, 1472W, 3609F<br />
Schwenk, W. F., 718T<br />
Schwenn, M., 1091F,<br />
1092W<br />
Scionti, I., 1776W*<br />
Sciortino, S., 96, 112, 118,<br />
230*, 620T, 2140T, 2513F<br />
Sciurba, F. C., 129<br />
Scliar, M., 3325F<br />
Sc<strong>of</strong>ield, R. H., 529F, 1979F,<br />
2084F, 2188T<br />
Scolari, F., 845F<br />
Scollen, S., 503F, 2804T<br />
Scollon, S., 1798F*<br />
Scotet, V., 1728W<br />
Scott, A., 2325W<br />
Scott, A. F., 79, 1254W*,<br />
1472W, 1512T, 3609F<br />
Scott, C. E., 33<br />
Scott, C. R., 668T, 727F*,<br />
3281W<br />
Scott, D., 389, 432W<br />
Scott, D. A., 834F*, 839F,<br />
840F, 2678T<br />
Scott, H., 2685F<br />
Scott, J., 2974T<br />
Scott, J. A., 2157W<br />
Scott, J. K., 375<br />
Scott, J. N., 2800W<br />
Scott, K., 2135F<br />
Scott, L. J., 34, 46, 1389T<br />
Scott, M., 1566T<br />
Scott, R., 1686T, 2755W<br />
Scott, R. H., 1773W<br />
Scott, R. J., 916T, 2133W<br />
Scott, R. T., 2968T<br />
Scott, R. T., Jr., 2999T<br />
Scott, S. A., 652T, 958T,<br />
1777W, 3488T<br />
Scott, W., 489F, 492W<br />
Scott, W. K., Session 27,<br />
347, 1489F, 2028W,<br />
2318F*, 2378F, 2603F,<br />
3335W<br />
Scrivner, S., 3133W<br />
Scurr, I. J., 217<br />
Scutti, A., 2300F*<br />
Seal, R., 3651F<br />
Seal, S., 138, 1211F<br />
Sealy, I., 37<br />
Searby, C. C., 323, 404,<br />
2215T, 2671W<br />
Searle, S. M. J., 506W<br />
Sebat, J., 480W, 2576F,<br />
2660F<br />
Sebert, S., 1432F, 2162F<br />
Sebire, G., 2790F<br />
Sebire, N. J., 303<br />
Sebro, R., 279*<br />
Secolin, R., 514W, 2394W,<br />
2876T<br />
Sedaghati Khayat, B.,<br />
1961F, 1962W, 2964F<br />
Sedaka, N. M., 2702T<br />
Sedel, F., 684T<br />
Sedova, M., 3717F<br />
Seebohm, G., 86<br />
Seeley, A. H., 313*<br />
Seeman, P., 2745F<br />
Sefiani, A., 708T, 2937F,<br />
3246F<br />
Segal, B., 2084F<br />
Segal, B. M., 529F, 2188T<br />
Segal, D. J., 1625T*<br />
Segal, H., 1313W<br />
Segal, M., 589F<br />
Segal, M. M., 3581F*<br />
Segel, R., 2447F*<br />
Segers, P., 2225F<br />
Segone, A. M., 1085F<br />
Segref, A., 105<br />
Segura-Puimedón, M.,<br />
3084F<br />
Segurel, L., 285*<br />
Sehar, N., 2075F
Sehmi, J., 110<br />
Sehnert, A., 3021T<br />
Sehrawat, B. S., 1297F<br />
Seibler, P., 204<br />
Seidman, C., 1677T<br />
Seidman, J. G., 1677T<br />
Seifert, D., 3266W<br />
Seifert, M., 822F, 827F,<br />
3536W<br />
Seik Soon, K., 2496W<br />
Seipp, M. T., 495F*<br />
Seixas, S., 3306T<br />
Sekar, R. B., 305<br />
Seki, A., 1685T, 2911W<br />
Seki, Y., 724T<br />
Sekine, T., 3134F<br />
Sekowska, M., 44, 3441T<br />
Seldin, M. F., 2360F<br />
Self, M., 853F, 2300F<br />
Selhub, J., 123<br />
Selinski, S., 1335T<br />
Selkirk, C. G., 1225T*<br />
Selleck, S. B., 2491T<br />
Selleri, L., 365<br />
Sellers, M., 2411F<br />
Sellers, T., 1061F<br />
Sellers, T. A., 1156T<br />
Selmer, K., 3096F*<br />
Sels, J.-W., 1711T<br />
Selvi, N., 1025F*<br />
Semaka, A., 265*<br />
Semenza, G. L., 3297T<br />
Semina, E. V., 2903T<br />
Seminara, D., 28, 1214F<br />
Semple, R. K., 33, 45<br />
Semsarian, C., 1664T<br />
Sen, S., 158, 260<br />
Senac, J., 738T<br />
Sénac, J. S., 2683W*<br />
Senders, C., 2151W<br />
Senegaglia, A. C., 2475W<br />
Seneviratne, C., 2390F<br />
Sengstag, T., 2891T<br />
Sengupta, S., 117, 1429F*<br />
Senman, L., 3456T<br />
Sens, M. M., 1946F<br />
Senter, L., 1740W<br />
Seo, D., 1644T*<br />
Seo, E.-J., 964T<br />
Seo, J., 1248W, 1384F<br />
Seo, J. S., 467F, 1931F,<br />
3259F, 3463T<br />
Seo, M., 933W<br />
Seo, S., 233, 323*, 1267T,<br />
2215T, 2671W, 2690T<br />
Seok, J., 1112F<br />
Seok, S.-C., 2523W<br />
Seok, Y., 863W*<br />
Seoud, M., 2981T<br />
Seow, A., 1934F<br />
Separovic, E., 447F<br />
Sepe, R. M., 735F<br />
Seppala, E., 2213F<br />
Seppälä, I., 2120F<br />
Sepuri, N. B., 3630W<br />
Sequeira, A., 2459F<br />
Sequeiros, J., 1296T, 1964F,<br />
2736F, 2818W<br />
Sergi, C., 3060F*, 3071W<br />
Serin, A., 1201T<br />
*Presenting Author<br />
Serjeant, G., 1906T<br />
Serra, C., 1091F<br />
Serra, D., 2062T<br />
Serra-Juhe, C., 84<br />
Serre, V., 127, 325, 329,<br />
390, 1607T<br />
Sertie, A. L., 2654F<br />
Service, S., 2222F, 2343W<br />
Servidei, S., 54<br />
Sesboué, R., 32<br />
Sese, J., 2550W, 3513T<br />
Seshadri, S., 123, 1592T,<br />
2528F<br />
Sessa, M., 71<br />
Sesta, M., 2766F<br />
Sestan, N., 2444F<br />
Setchell, K. D. R., 161<br />
Sethuraman, A., 3682W*<br />
Setia, S., 1447F<br />
Seto, A., 2381F<br />
Setoodeh, A., 2787F<br />
Settin, A., 1922F<br />
Severi, G., 205, 1148F,<br />
1214F<br />
Severin, E., 2954T*, 3005T,<br />
3009T, 3067W<br />
Sewry, C., 2812W<br />
Sexton, D. P., 314, 1735W,<br />
1757W, 1761W, 3576W<br />
Seyahi, E., 3475T<br />
Seyedhassani, S., 2976T*<br />
Seynaeve, C., 1788W<br />
Seyrantepe, V., 2669T*<br />
Sezerman, O. U., 2450F<br />
Sgardioli, I., 1865F<br />
Sgardioli, I. C., 959W<br />
Sha, Q., 1409W*<br />
Sha, S. J., 2639F<br />
Shaaban, S., 2928F<br />
Shabalin, A. A., 564W<br />
Shabbeer, J., 1714T<br />
Shachar, S. B., 63<br />
Shadravan, F., 3410T*<br />
Shafer, A., 3459T<br />
Shaffer, C. L., 3388F<br />
Shaffer, J., 22, 2034W<br />
Shaffer, J. R., 1464T, 1474F,<br />
2142W*, 2156F, 2178W<br />
Shaffer, L. G., 66, 68, 103,<br />
274, 884T, 902T, 934T,<br />
2395T, 3101W<br />
Shafiee, N. M., 2150F<br />
Shah, A. S., 3231W<br />
Shah, B., 346, 2537F<br />
Shah, E., 1009T, 2014T,<br />
2281T*<br />
Shah, K., 1591T, 1701T*,<br />
1863F*<br />
Shah, K. H., 130<br />
Shah, M., 3717F<br />
Shah, R., 1701T<br />
Shah, S., 998F, 999W*,<br />
1159T, 1841W<br />
Shah, S. H., 1444F, 1594T,<br />
1636T<br />
Shahak, E., 3202F<br />
Shahbazi, M., 3163W<br />
Shahbazi, M. S., 1096T*<br />
Shahid, H., 2072F<br />
Shahin, H., 2756T*, 2772F<br />
SPEAKER AND AUTHOR INDEX 401<br />
Shahmirzadi, L., 1844F*<br />
Shahram, F., 2150F<br />
Shaikh, R. S., 2959W<br />
Shaikh, T., 451F<br />
Shaikh, T. H., 819F, 2884W<br />
Shakir, K., 280<br />
Sham, P., 21<br />
Sham, P. C., 109, 1930T,<br />
2066F, 2494T, 2932W,<br />
3559F<br />
Shameer, K., 1312F*<br />
Shami, P., 3637F<br />
Shamloo, B., 3475T<br />
Shams, S., 440W<br />
Shamsi, M., 2967T*<br />
Shan, Y., 3300T<br />
Shanahan, K., 326<br />
Shang, J., 3168F, 3237W<br />
Shang, Q., 2419T<br />
Shankar, S., 745F, 772W,<br />
1679T<br />
Shanmugam, A., 2625W<br />
Shanmugham, A., 2579F<br />
Shannon, M., 1209W,<br />
1246T, 3278W, 3714W<br />
Shannon, N., 324<br />
Shannon, P., 2971T, 3013T,<br />
3075W<br />
Shao, D., 3625F<br />
Shao, H., 159<br />
Shao, X., 1414F, 1415W*<br />
Shao, Y., 1185W, 1309F,<br />
2078F, 3582W<br />
Shapero, M., Session 76,<br />
3730W*<br />
Shapira, I., 1133F*<br />
Shapiro, A., 1889F<br />
Shapiro, E., 714T, 715F,<br />
801W<br />
Shapiro, E. G., 785W<br />
Sharaha, U., 2756T<br />
Shariati, G., 2714T*<br />
Shariati, G. R., 679F<br />
Sharifi, R., 3201W*<br />
Sharififard, B., 2714T<br />
Sharma, H., 481F*<br />
Sharma, K., 13<br />
Sharma, K. L., 1188W*<br />
Sharma, M., 555F*<br />
Sharma, N., 2801T<br />
Sharma, N. K., 2011T<br />
Sharma, P., 918T*<br />
Sharma, R., 2353T*<br />
Sharma, R. K., 2353T<br />
Sharma, S., 221*, 811F*,<br />
1439W, 2844F*, 3678W<br />
Sharma, V. P., 218<br />
Sharp, A., 84, 3431T, 3516T*<br />
Sharp, A. J., 469F, 3488T<br />
Sharp, S. J., 1553W<br />
Shaw, C., 893W, 898T,<br />
952T, 2542T<br />
Shaw, C. A., 229, 430W,<br />
432W, 2189F<br />
Shaw, C. E., 348<br />
Shaw, D. W. W., 2530T<br />
Shaw, G., 75, 1589T<br />
Shaw, G. M., 1352W, 1885T<br />
Shaw, N. J., 2864T<br />
Shaw, P., 135<br />
Shaw, P. J., 348<br />
Shchelochkov, O., 165, 389,<br />
1882T, 2678T<br />
Shchelochkov, O. A., 840F,<br />
1344T<br />
Shchetynsky, K., 1981T*<br />
Shea, P., 2050T<br />
Shea, P. R., 2335T*<br />
Shearer, E., 60*, 2867T<br />
Shears, D., 217, 2939T<br />
Shechter, N., 783W<br />
Sheehan, P., 3484T<br />
Sheehan, S., 184*<br />
Sheehan, V., 2331W<br />
Sheehan, V. A., 648T*<br />
Sheets, K., 3<br />
Sheffer, I., 2542T<br />
Sheffield, J., 3395W<br />
Sheffield, V., 1588T, 2690T<br />
Sheffield, V. C., 323, 387,<br />
404, 2215T, 2671W,<br />
2738T, 2750T<br />
Sheikh, F., 1155W<br />
Shekar, M., 1183T, 1190F<br />
Shekari Khaniani, M., 779W<br />
Shekhtman, E., 3582W<br />
Sheldon, M., 2433W<br />
Shell, E., 493F<br />
Shelton, G. D., 2681T<br />
Shelton, J., 602T<br />
Shelton, S. E., 2413T<br />
Shen, C., 1249T<br />
Shen, C. L., 2985T<br />
Shen, E., 2444F<br />
Shen, H., 2053T, 2172W<br />
Shen, H. C., 210<br />
Shen, J., 159, 294, 876T,<br />
934T<br />
Shen, L., 230, 1289W,<br />
1301W, 1414F, 1455T,<br />
2140T, 2511W, 2513F*,<br />
2531F<br />
Shen, M., 1945T<br />
Shen, P., 3691F*<br />
Shen, R., 3695F, 3697F<br />
Shen, Y., 554W, 1255T*,<br />
1482T, 2606F, 2660F,<br />
2732T, 3627F<br />
Shendure, J., Session 72,<br />
Session 74, Session 81,<br />
26, 311, 1014W, 2337W,<br />
2789T, 2897T, 3721F<br />
Shendure, J. A., Session 72,<br />
10, 74, 94<br />
Shepard, P., 395<br />
Shephard, R. E., 1664T<br />
Shepherd, F. A., 1108T<br />
Shepherd, J., 1576F<br />
Shepherd, J. A., 812F<br />
Sheppard, B., 463F*<br />
Sher, K., 1566T<br />
Sherafat Kazemzadeh, R.,<br />
2702T<br />
Sheridan, E., 214<br />
Sheridan, M. B., 935W*<br />
Sherman, M., 1117T<br />
Sherman, M. E., 1150T<br />
Sherman, S., 940T<br />
Sherman, S. L., 253,<br />
1349W, 2069F, 3042F<br />
SPEAKER AND AUTHOR INDEX
402 SPEAKER AND AUTHOR INDEX<br />
Sherr, E., 196, 3198F<br />
Sherr, E. H., 299, 2389T<br />
Sherridan, E., 3173W<br />
Sherrill, J. B., 829F<br />
Sherry, S., 3582W*, 3592W,<br />
3625F<br />
Sherva, R., 2488T*, 2503T<br />
Sherwood, A., 530W<br />
Shete, S., 1298W, 1578T<br />
Sheth, F., 700T, 3400T<br />
Sheth, F. J., 911W*, 2803W<br />
Sheth, J., 700T, 911W, 3400T<br />
Sheth, J. J., 2731W, 2803W*<br />
Sheth, V., 1244F, 3717F<br />
Sheu, W., 1608T<br />
Sheu, W. H.-H., 1955F<br />
Shevah, O., 2706F<br />
Shevchenko, Y., 330<br />
Shevell, M. I., 2790F<br />
Shi, A., 532W<br />
Shi, B., 1472W<br />
Shi, H., 3317W<br />
Shi, J., 616T, 1154F, 1199F,<br />
3493T*<br />
Shi, L., 836F, 2151W, 3415T<br />
Shi, M., 551F, 1416T*<br />
Shi, Y., 159, 480W, 486W,<br />
503F, 2617T, 3595F<br />
Shianna, K., 53<br />
Shianna, K. V., 203, 2050T,<br />
2335T<br />
Shibata, A., 729F, 1574W,<br />
2472W, 2647T, 2747T,<br />
3634W*<br />
Shibata, H., 2400W<br />
Shibata, K., 1549F*<br />
Shibata, T., 396<br />
Shibuya, T., 396<br />
Shieh, J. T. C., 501F, 1687T,<br />
3247W<br />
Shield, J. P. H., 3494T<br />
Shiffman, S., 39<br />
Shigemizu, D., 2051F*<br />
Shigeta, R., 493F<br />
Shih, A., 2617T<br />
Shih, S., 1905W<br />
Shikishima, C., 3513T<br />
Shilon-Hadass, A., 660T<br />
Shim, S., 900T*<br />
Shima, J., 1190F<br />
Shimada, A., 3192F*<br />
Shimada, T., 1697T<br />
Shimbo, H., 2836W<br />
Shimizu, A., 2882T*, 2911W<br />
Shimizu, J., 2409W<br />
Shimizu, T., 663F<br />
Shimmin, L. C., 1932W<br />
Shimojima, K., 1290T,<br />
3102F<br />
Shimojo, N., 2294F<br />
Shimozato, K., 1574W,<br />
2747T<br />
Shin, C. S., 2053T<br />
Shin, D., 1590T*<br />
Shin, E., 908T*, 1590T,<br />
2834T<br />
Shin, H. D., 1975T<br />
Shin, J., 1248W, 2437T*<br />
Shin, J. Y., 3463T<br />
Shin, S.-Y., 44, 583F<br />
*Presenting Author<br />
Shin, Y.-B., 1622T<br />
Shink, E., 1951T<br />
Shinka, T., 3337F<br />
Shinomiya, N., 663F<br />
Shinomura, Y., 2174F<br />
Shinya, K., 2507F<br />
Shiohama, A., 2911W<br />
Shiohara, T., 627T<br />
Shirai, T., 1815W<br />
Shiraishi, H., 2822T<br />
Shirakata, Y., 627T<br />
Shirakawa, O., 2380T<br />
Shirakihara, T., 396<br />
Shirazi, M., 957W, 3730W<br />
Shiri, R., 2120F<br />
Shirley, B., 3672W<br />
Shirley, M., 3374W<br />
Shirmardi, A., 2013W<br />
Shiroiwa, K., 2380T<br />
Shirota, R., 1277F<br />
Shirzad, H., 1143W, 1739W<br />
Shiu, C., 1557T<br />
Shiue, C., 413F*<br />
Shivatzki, S., 2914W<br />
Shmueli, D., 2447F<br />
Shmygelska, A., 483F*,<br />
3617F<br />
Shneebaum, N., 2447F<br />
Shoda, H., 1984T<br />
Shoedel, J., 509F<br />
Shoemark, A., 809F<br />
Shohat, M., 105, 3185W<br />
Shohet, J., 134<br />
Shomron, N., 2919F<br />
Shortreed, M., 1269W<br />
Shotelersuk, V., 709F,<br />
1944W*, 2006F, 2749W<br />
Shou, W., 616T*, 3493T<br />
Shoubridge, C., 2629T,<br />
2640W*<br />
Shoubridge, E. A., 2771T<br />
Shoukry, M., 407<br />
Shoval, Y., 199<br />
Shprintzen, R., 1494T<br />
Shrader, J., 711F<br />
Shrestha, D., 864T<br />
Shridhar, V., 1238F, 3451T<br />
Shriner, D., 241, 1515T,<br />
3412T, 3533F<br />
Shringarpure, S., 3605F<br />
Shringarpure, S. S., 3391W*<br />
Shriver, C. D., 1002W,<br />
1780W<br />
Shriver, M., 1850W, 2083T<br />
Shriver, M. D., 2223W*,<br />
3290W, 3318T, 3360T,<br />
3380W<br />
Shtir, C., 453F*<br />
Shu, Y., 1362T*<br />
Shugart, Y., 1527T<br />
Shugart, Y. Y., 1559W,<br />
3572W<br />
Shukla, A., 1232F<br />
Shukla, K. P., 2186F<br />
Shukla, N. K., 1278W<br />
Shukla, R., 918T<br />
Shukla, R. K., 3271F*<br />
Shuldiner, A., 249<br />
Shuldiner, A. R., 602T<br />
Shulman, J., 2488T<br />
Shuman, C., 320, 1872F,<br />
1873F<br />
Shungin, D., 1954T, 2123F,<br />
2147F<br />
Shvetsova, T., 1245W,<br />
3687F<br />
Shy, M., 1871F<br />
Shyong Tai, E., 2041T<br />
Siasi, E., 2980T*<br />
Sibigtroth, C., 784W<br />
Siciliano, G., 1776W<br />
Sicotte, H., 1247F<br />
Sidders, B., 503F<br />
Siddiqui, K., 3149W<br />
Siderowf, A., 2538W<br />
Sidore, C., 113, 157, 177*,<br />
186, 276, 1451W, 1516F,<br />
1568W, 2001W, 2198F,<br />
2329T, 3664W<br />
Sidow, A., 397*<br />
Sidransky, E., Session 10<br />
Sie, D., 494W<br />
Siebel, S., 1702T*<br />
Sieber, O., 1072T<br />
Sieberg, R., 1666T<br />
Siegbahn, A., 617T, 619T<br />
Siegel, P., 1182W<br />
Siegesmund, K., 200<br />
Siegfried, J. D., 1767W<br />
Siegler, I. C., 1594T, 2481W<br />
Siegmund, D., 3675F*<br />
Sierra, F. P., 926T<br />
Siervogel, R. M., 2146T<br />
Siffredi, V., 62<br />
Siffroi, J.-P., 2674W<br />
SIGMA Type 2 Diabetes<br />
Consortium, 48<br />
Sigmon, D. F., 1229F<br />
Signorello, L. B., 2202W<br />
Sigurjonsson, S., 73<br />
Sik, A., 2767W<br />
Sikdar, N., 1097F*<br />
Sikela, J., 465F<br />
Sikela, J. M., Session 22,<br />
433F, 835F<br />
Sikela, M., 433F<br />
Sikka, N., 1644T<br />
Sikkema-Raddatz, B., 1619T<br />
Siklosi, K. R., 1731W*<br />
Sikora, M., 186*<br />
Sikron, F., 783W<br />
Silander, K., 2462F<br />
Silani, V., 2775F<br />
Silao, C. L. T., 707F*<br />
Silas, J. C., 2988T*<br />
Silberbach, M., 1743W<br />
Silberg, J. L., 2277W<br />
Siles, J., 728T<br />
Sill, H., 1115F<br />
Sillanpää, M. J., 1597T<br />
Sillé, F. C. M., 1104W*,<br />
2055W<br />
Sillence, D. O., 3167W<br />
Siltanen, S., 1000T*<br />
Silva, A. C. S., 1902W<br />
Silva, A. G., 891W<br />
Silva, C., 2193W<br />
Silva, E., 324, 390<br />
Silva, F., 2624F<br />
Silva, I. D. C. G., 1008W<br />
Silva, J., 913W, 2668W<br />
Silva, L., 1851F<br />
Silva, L. C. S., 2642F<br />
Silva, M. J., 2718F<br />
Silva, R. M., 1315F, 1936T<br />
Silva, W. A., Jr., 1037F,<br />
1038W, 2813T<br />
Silva, W. L., 2289W<br />
Silva-Zollezzi, I., 3255T<br />
Silveira, S., 1651T<br />
Silveira Lucas, L., 131<br />
Silver, D. L., 2455T<br />
Silverberg, M. S., 42, 1381F,<br />
2319W<br />
Silverman, D. T., 1091F,<br />
1092W<br />
Silverman, E. K., 1425T,<br />
2057F, 2249F, 2346W<br />
Silverman, I., 1642T, 3551F<br />
Silverman, W., 859W<br />
Silverstein, C., 1685T<br />
Silvestri, G., 385, 1305T,<br />
1779W, 1897T<br />
Sim, X., 169, 173*, 269,<br />
1510F<br />
Simanivanh, T., 953W<br />
Simarci, A., 3125W<br />
Simard, J., 207, 208, 1150T,<br />
2635T<br />
Simeonov, D., 2610W<br />
Simino, J., 1637T*<br />
Simioni, M., 959W, 1903T*<br />
Simkin, L., 2003F<br />
Simmons, L. E., 74, 94<br />
Simms, R. J., 2676F<br />
Simões, A. L., 3277F, 3280F<br />
Simões, B. P., 1045T<br />
Simões, R. T., 994T<br />
Simola, K. O. J., 897W<br />
Simon, A. J., 2691F<br />
Simon, D., 841F<br />
Simon, K., 2561F<br />
Simon, M., 127, 3213W<br />
Simon, M. S., 1003T<br />
Simon, T., 609T<br />
Simon, V., 3310F<br />
Simonelli, F., 2950W<br />
Simonic, I., 98, 3109W,<br />
3172F<br />
Simonson, M. A., 2239T*<br />
Simonson, T. S., 3297T,<br />
3378T<br />
Simons VIP Consortium,<br />
and 16p11.2 European<br />
Consortium, 299<br />
Simosky, J. K., 772W<br />
Simpfendorfer, K. R., 306<br />
Simpson, A., 2211W<br />
Simpson, C. L., 1302T,<br />
1454W*<br />
Simpson, D., 1779W<br />
Simpson, M. A., 780W,<br />
2804T, 2896W, 2925F*<br />
Simpson, P., 1475W<br />
Sims, D. J., 1068W<br />
Sims, K., 1684T<br />
Sims, K. B., 326<br />
Simsir, A., 1106F<br />
Sincan, M., 359, 3543F<br />
Sinclair, E., 3454T
Sinclair, S., 750T<br />
Sindeaux, R. H. M., 2475W*<br />
Sindhi, M., 2075F<br />
Sing, C., 183<br />
Sing, C. F., 187<br />
Singer, A., 3048F, 3162F*,<br />
3174F<br />
Singer, C., 347, 2603F<br />
Singh, A. P., 3627F*<br />
Singh, D., 666T, 2737W*<br />
Singh, G., 3618W<br />
Singh, J., 1920W, 1921T*<br />
Singh, J. R., 2735T<br />
Singh, K., 1950W, 2154W,<br />
2240F, 2263T, 2700F<br />
Singh, K. E., 1071W<br />
Singh, L., 2988T<br />
Singh, L. N., 1696T<br />
Singh, N., 2967T<br />
Singh, R., 2988T, 3316F<br />
Singh, S., 2585F<br />
Singh, S. K., 481F<br />
Singh, S. M., 378<br />
Singh, V., 1134W*<br />
Singhi, P., 167<br />
Singleton, A. B., 564W,<br />
2148W, 2648F<br />
Sinha, G., 2663T<br />
Siniard, A. L., 3215W<br />
Sinicina, I., 86<br />
Sinicropi, D., 1198T<br />
Sinke, R. J., 1619T, 2886F<br />
Sin Lo, K. S., 2319W<br />
Sinnett, D., 31, 394, 1207T,<br />
1215W, 3268F<br />
Sinning, C. R., 1669T<br />
Sinnott, R., 2703F<br />
Sinnwell, J., 1247F<br />
Sinnwell, J. P., 1449T, 1497T<br />
Sinopoli, V., 2499W<br />
Sipeky, Cs., 3283F<br />
Sirén, I., 2110T<br />
Sirewanda, K., 3196F<br />
Siriwan, P., 1944W<br />
Siriwardena, K., 720T*<br />
Sirmaci, A., 57<br />
Sironi, M., 438W<br />
Sirotkin, K., 3582W, 3625F<br />
Siscovick, D., 350, 1346W,<br />
2210F, 2337W<br />
Sisk, R. A., 3212F<br />
Siskind, C., 1871F<br />
Sismani, C., 3017T<br />
Sistermans, E., 98, 494W,<br />
3200F<br />
Sisto, D., 2541W<br />
Sistonen, P., 2023T<br />
SISu Consortium, 2344T<br />
Sitaram, U., 931W<br />
Sitaraman, S., 732T, 745F<br />
Sites, E., 3177W<br />
Sitlani, C., 1346W, 1585T<br />
Siu, L., 135<br />
Siu, L. L., 1824F<br />
Siu, M., 3694W<br />
Siu, V. M., 1138T<br />
Siva, A., 2429F, 2450F<br />
Sivakumaran, T. A., 1764W*<br />
Sivapalaratnam, S., 1604T,<br />
1606T<br />
*Presenting Author<br />
Sivaramakrishna<br />
Rachakonda, P., 29<br />
Sivils, K. M., 2284T<br />
Sivley, M., 2532W<br />
Sizer, E., 645T<br />
Sjödin, P., 3356W<br />
Sjöholm, K., 1271F<br />
Sjöstrand, C., 2804T<br />
Sjöström, L., 427F, 1271F<br />
Skalitzky, C., 3688W<br />
Skarnes, W. C., 2725W<br />
Skarpås, B., 3729F<br />
Skeie, J. M., 2750T<br />
Skibola, C., 3623F<br />
Skibola, C. F., 1104W,<br />
2055W<br />
Skinner, C., 2806W, 2826F,<br />
3185W<br />
Skinner, H., 1267T<br />
Skinner, M., 2220W<br />
Skipper, L., 497F<br />
Sklar, P., 290, 1325W,<br />
2487W, 2576F, 2577W,<br />
2618F<br />
Sk<strong>of</strong>f, R., 2664F<br />
Skogstad, A., 2965W<br />
Skol, A. D., 2046W<br />
Skotheim, R. I., 213<br />
Skov, R. L., 1323T<br />
Skovbo, P., 2862F<br />
Skovbo, S., 1565W<br />
Skovby, F., 2765T<br />
Skupien, J., 2313W<br />
Skuse, D., 2383T<br />
Sladek, R., 176, 1513F,<br />
1923W, 2308T, 2339F<br />
Sladkova, J., 752T<br />
Slagboom, E., 2080T<br />
Slagboom, P. E., 1436W,<br />
2035T, 2175W<br />
Slager, S., 1150T<br />
Slama, A., 325<br />
Slate, N. G., 326<br />
Slater, A., 1491T<br />
Slavin, T., 3085W*<br />
Slavotinek, A., 810F, 869W,<br />
2926W*, 3162F<br />
Slawik, H., 2567F<br />
Slean, M., 2635T<br />
Slean, M. M., 2696T*<br />
Sleiman, P. M. A., 1996T,<br />
2121W, 2514W*, 2546F,<br />
2785W, 2892F<br />
Slepushkina, N., 1263W<br />
Slezer, R., 3688W<br />
Slifer, S., 2614T<br />
Slifer, S. H., 9, 2572T<br />
Slim, R., 2842W*, 2981T<br />
Sliwerska, E., 3368W<br />
Sload, J., 652T<br />
Sloan, C., 3612W<br />
Sloan, J., 721F, 738T<br />
Sloan, J. L., 664T*, 674T<br />
Sloper, L., 1663T<br />
Sloper, L. J., 3231W<br />
Slotta, D., 3582W<br />
Slovak, M. L., 945W<br />
Smagulova, F., 417F, 592W<br />
Smaldone, S., 815F*<br />
Small, G. W., 2637W<br />
SPEAKER AND AUTHOR INDEX 403<br />
Small, K., 583F*<br />
Small, K. S., 44, 3441T<br />
Smaoui, N., 330, 1676T,<br />
1765W*<br />
Smart, C., 210<br />
Smedby, K. E., 1934F,<br />
2055W<br />
Smedley, D. P., 2725W*<br />
Smeets, D. F. C. M., 955W<br />
Smeets, H., 708T*, 796W<br />
Smeets, H. J. M., 1711T,<br />
2448W, 2996T<br />
Smeitink, J. A. M., 672T<br />
Smets, K., 2820F<br />
Smiles, A. M., 2313W<br />
Smit, A. F. A., 195, 3270T<br />
Smit, M., 3200F<br />
Smith, A., 701F, 2794W<br />
Smith, A. C. M., 3080F<br />
Smith, A. J. P., 122*<br />
Smith, A. K., 1422T, 2384F,<br />
2483F, 3480T*<br />
Smith, A. V., 2275T<br />
Smith, B. N., 348*<br />
Smith, C., 374, 564W, 1538W<br />
Smith, C. D., 3213W<br />
Smith, C. L., 2675T<br />
Smith, C. T., 3349F<br />
Smith, D., 453F<br />
Smith, E. A., 2047T<br />
Smith, E. N., 395*, 1659T,<br />
2274W<br />
Smith, E. S., 1653T<br />
Smith, G., 671F, 3663F<br />
Smith, G. D., Session 21,<br />
560W, 1528F<br />
Smith, J., 93, 2740W<br />
Smith, J. D., 170, 244<br />
Smith, K., 568W, 2444F<br />
Smith, K. R., 2741T<br />
Smith, L. M., 1269W<br />
Smith, M. A. C., 1008W,<br />
1132T, 2533T, 2534F,<br />
3421T, 3503T<br />
Smith, M. W., 13<br />
Smith, N. L., 1408F<br />
Smith, R., 886T, 3471T,<br />
3636W<br />
Smith, R. A., 34<br />
Smith, R. J. H., 60, 419F,<br />
2301W, 2867T, 3228F<br />
Smith, R. L., 968T<br />
Smith, R. P., 246*<br />
Smith, S., 1186T<br />
Smith, S. C., 1661T<br />
Smith, S. M., 1537F*<br />
Smith, U., 1624T<br />
Smith, W., 774W*<br />
Smithson, S., 2896W<br />
Smithson, S. F., 217<br />
Smogorzewska, A., 999W<br />
Smolarek, T., 3177W<br />
Snegovskikh, V., 3030T<br />
Snell, Q. O., 3643F<br />
Snella, E. M., 2717T<br />
Snieder, H., 2282F<br />
Snijders, A. M., 984W<br />
Snipes, G., 777W<br />
Sniukiene, V., 745F, 772W<br />
Snopkowski, C., 2260T<br />
Snyder, D., 3644W<br />
Snyder, M., 425F, 525F,<br />
551F, 562W, 581F, 604T,<br />
1505W, 1601T, 2322W,<br />
3361F, 3368W, 3505T<br />
Snyder, M. P., 371, 416W,<br />
3313F, 3411W<br />
Snyder, M. W., 74, 94*<br />
So, E., 544W<br />
So, I., 2437T<br />
So, J., 2657F*<br />
So, M. T., 1930T, 2066F<br />
So, W., 2280W<br />
So, W. Y., 2279F<br />
Soares, F., 1151F, 3325F<br />
Soares, R. A. G., 636T<br />
Soares-Souza, G., 1119W<br />
Soares-Souza, G. B.,<br />
3325F<br />
Soave, D., 2953W*<br />
Sobel, E. M., 38<br />
Soblet, J., 83*, 1611T<br />
Sobol, M., 2920W<br />
Sobota, R., 2255F*<br />
Sobral, J., 2150F<br />
Sobreira, C., 2425T<br />
Sobreira, N., 227, 889W,<br />
2387F*, 3131W<br />
Sobue, G., 52, 2472W,<br />
3221W<br />
Socci, N., 998F<br />
Sochett, E., 3100F<br />
Soden, S. E., 366, 2793F,<br />
2894T<br />
Söderberg, S., 2070W<br />
Soejima, H., 3499T, 3519T<br />
Soens, Z. T., 430W<br />
Soerensen, M., 2244W*,<br />
2295W<br />
Soezima, H., 3432T<br />
SOFFOET, 77<br />
Sohail, A., 2959W<br />
Sohn, W. J., 846F<br />
Sohn, Y., 3103W*<br />
Sohn, Y. B., 787W<br />
Soi, S., 3303T, 3338W*<br />
Soini, Y., 1114T<br />
Soininen, P., 1623T<br />
Solanki, N., 1779W<br />
Solberg, A., 991T<br />
Soldano, K., 1919F, 2340W<br />
Sole, G., 1516F<br />
Solé, G., 716T<br />
Soler, C. V., 2233T*<br />
Soliman, N. A., 2850F<br />
Sollier, C., 1182W<br />
Solnick, J. V., 449F<br />
Solomon, T., 1966T*<br />
Solot, C. B. S., 2443T<br />
Solovieff, N., 1325W*<br />
Solovieva, S., 2120F<br />
Solski, J. A., 2816T<br />
Solverson, P., 710T<br />
Solyom, S., 1229F*<br />
Somasundaram, P., 2056T<br />
Somerharju, P., 541F<br />
Sommargren, M., 1766W*<br />
Sommen, M., 59<br />
Sommers, J. A., 2692W<br />
Son, N., 1590T<br />
SPEAKER AND AUTHOR INDEX
404 SPEAKER AND AUTHOR INDEX<br />
Søndergaard, M. T., 2699T<br />
Song, C. X., 3483T<br />
Song, G., 1762W<br />
Song, H., 139*<br />
Song, I. W., 2858T*<br />
Song, J., 1657T<br />
Song, J. I., 3673F<br />
Song, K., 106, 2273F, 3020T*<br />
Song, L., 159<br />
Song, O., 1675T<br />
Song, P., 3553F<br />
Song, S., 3567F<br />
Song, Y., 182, 557F*, 1259F,<br />
2020T, 2246F, 2254T<br />
Song, Y. M., 1654T, 2118W<br />
Song, Y.-M., 1656T, 2119T<br />
Song, Y. S., 184<br />
Song, Z., 3275W<br />
Sonnenberg, A., 2848W<br />
Sood, R., 664T, 824F,<br />
1983W<br />
Soodyall, H., 3377W<br />
Soo-Jin Lee, S., 1844F<br />
Sooknanan, R., 3668W,<br />
3721F*<br />
Soon, W., 416W<br />
Soong, B.-W., 2581T<br />
Sopher, B. L., 2628W<br />
Soplepmann, J., 1140W<br />
Soppet, D., 13<br />
Sorant, A. J. M., 1347T,<br />
1396F<br />
Soranzo, N., 44, 110, 383,<br />
503F, 583F, 1604T,<br />
2082W<br />
Sorarù, G., 1732W, 2775F<br />
Sorbrino, A., 957W<br />
Sørensen, T., 1528F<br />
Sørensen, T. I. A., 2116T,<br />
3028T<br />
Soresina, A. R., 760W<br />
Soria, J. M., 1651T*<br />
Sorosina, M., 624T, 2095T<br />
Sorrentino, G., 1985F<br />
Sorrentino, P., 1985F<br />
Sosa, D., 1048T, 1049F<br />
Sosa, M. X., 13, 308<br />
Sosman, J., 136<br />
Sosnay, P. R., 1731W<br />
Sotiriou, C., 3017T<br />
Sotiroska, V., 2983T<br />
Sotomaior, V. S., 870T,<br />
2475W, 3055W<br />
Sotoodehnia, N., 1585T<br />
Soubeyrand, S., 1645T<br />
Soubrier, F., 1170W<br />
Soucy, P., 207<br />
Soufir, N., 29, 1062W*<br />
Soulier, A., 1817W<br />
Sousa, A., 1296T, 2736F<br />
Sousa, I., 1977W*, 2085W<br />
Sousa, R., 3122F<br />
Sousa, S., 913W, 1747W,<br />
3019T<br />
Sousa, S. B., 2755W*<br />
Soussi-Yanicostas, N., 843F<br />
Soutar, A., 1618T<br />
South, S., 3088F<br />
Southam, L., 2044T, 3396T<br />
Southern, M. R., 1162T<br />
*Presenting Author<br />
Southey, M., 1213T*<br />
Southey, M. C., 27, 3679F<br />
Southgate, L., 2804T*<br />
Souto, J. C., 1651T<br />
Souza, D. O. G., 2424W<br />
Souza, G., 3562W<br />
Souza, G. N., 2424W, 2626T<br />
Souza, I. R., 994T, 1405F,<br />
1946F<br />
Souza, J., 870T, 959W,<br />
2270F, 2746W, 3055W<br />
Souza, L. T., 2270F<br />
Souzeau, E., 1785W*<br />
Sovath, S., 2973T, 3023T<br />
Sovio, U., 2162F<br />
Sovová, J., 322<br />
Spacek, D., 525F, 604T*,<br />
3505T<br />
Spacilova, J., 752T<br />
Spadafora, P., 2597F<br />
Spaeth, J. M., 125<br />
Spaich, C., 3111W<br />
Spain, S. L., 154, 1927T<br />
Spalding, J. D., 497F<br />
Spangler, J., 1244F<br />
Sparagana, S., 3108F<br />
Sparén, P., 1707T<br />
Sparks, A. B., 3020T<br />
Sparks, K., 3211W<br />
Sparso, T., 2311T<br />
Sparsø, T., 2317T, 2347T<br />
Speck-Martins, C. E., 2596T<br />
Spector, E., 451F<br />
Spector, T., 109, 583F,<br />
1440T, 2165F, 2171F,<br />
2292W, 3453T<br />
Spector, T. D., 44, 277,<br />
335, 503F, 546W, 1216T,<br />
1311T, 2029T, 2138F,<br />
2175W, 2359T, 3441T<br />
Speed, D., 1394W*<br />
Speed, W. C., 3313F<br />
Spehlmann, M., 2368T<br />
Speicher, M. R., 1063T,<br />
1115F, 3116F<br />
Speleman, F., 423F<br />
Speliotes, E. K., 1954T,<br />
2090F, 2123F, 2147F,<br />
2210F*, 2241W, 2275T<br />
Spence, S. J., 299<br />
Spencer, C., 2157W<br />
Spencer, C. C. A., 1340W*<br />
Spencer, K., 2041T<br />
Spencer, K. L., 2042F<br />
Spencer, M., 1685T<br />
Spengler, S., 3111W*<br />
Sperber, S. M., 3163W*<br />
Sperl, W., 699F, 782W<br />
Sperle, K., 2664F<br />
Spertus, J. A., 2535W<br />
Speziani, F., 1871F*, 2930T<br />
Spiegelman, D., 1670T,<br />
2306F, 2338T, 2342F,<br />
2558F, 2591F<br />
Spier, I., 1005W<br />
Spindola, L. M. N., 2534F*<br />
Spinella, J., 394*<br />
Spinella, J.-F., 31, 3268F<br />
Spinella, J. F., 1207T,<br />
1215W<br />
Spinner, N., 3082F<br />
Spinner, N. B., 2316W,<br />
3040F<br />
Spiro, J. E., 299, 2439W<br />
Spitali, P., 574W*<br />
Spizzichino, L., 71<br />
Spraggs, C., 630T<br />
Spraggs, C. F., 651T<br />
Sprissler, R., 2788W<br />
Spritz, R. A., Session 80<br />
Sprott, K. M., 1171T<br />
Sprowl, J., 3007T, 3021T<br />
Spruill, I. J., 1662T<br />
Spurdle, A. B., Session 4,<br />
1067F<br />
Spurrell, C. H., 26*, 1089W,<br />
1226F<br />
Spyrou, C., 3017T<br />
Squire, K. M., 3666W*<br />
Srichomthong, C., 709F,<br />
1944W, 2006F<br />
Sriha, B., 2744T<br />
Srikanth, A., 2491T<br />
Srikanth, S. M., 3316F<br />
Srinivasan, A., 3007T,<br />
3021T*<br />
Srinivasan, M., 975W<br />
Srinivasan, R., 362<br />
Srinivasan, S., 2943F<br />
Srinivasan, S. R., 2274W<br />
Sriram, G., 2238W<br />
Sritharan, K., 2525F<br />
Srivastava, A., 931W,<br />
1587T, 1598T, 3465T<br />
Srivastava, A. K., 2826F*,<br />
2837T<br />
Srivastava, D., 195<br />
Srivastava, G., 380, 3450T<br />
Srivastava, G. P., 3417T*<br />
Srivastava, N., 1134W<br />
Srivastava, P., 1135T*<br />
Srivastava, R., 1287T,<br />
1294F, 1883F<br />
Srivastava, R. N., 1288F*<br />
Srivastava, V. M., 931W*<br />
Srour, M., 2790F*<br />
Staats, S., 3377W<br />
Stack, C. A., 632T<br />
Stacpoole, P. W., 164<br />
Stade, B., 3583F*<br />
Stadler, Z., 998F, 1159T,<br />
1841W<br />
Staggs, R., 1665T<br />
Stahl, E., 350, 2199W*<br />
Stahl, E. A., 625T, 1331W,<br />
2210F, 2258F<br />
Ståhle, M., 2276F<br />
Stainier, D., Session 26<br />
Stajich, J., 1919F, 2946F<br />
Stalker, H., 3126F<br />
Stalker, J., 216<br />
St-Amant, M., 1065W<br />
Stamato, T., 1142F<br />
Stamatoyannopoulos, J.,<br />
3459T<br />
Stamatoyannopoulos, J. A.,<br />
255*, 402<br />
Stambolian, D., 2183F<br />
Stambouli, D., 2728W<br />
Stan, A., 2954T<br />
Stanaway, I. B., 10<br />
Stanaway, I. B. S., 2443T<br />
Stančáková, A., 46<br />
Stanek, E. J., 1714T<br />
Staneva, R., 3477T, 3481T*<br />
Stanford, J., 28, 1001F<br />
Stanford, J. L., 1214F,<br />
2202W<br />
Stangier, K., 3701F*<br />
Stanhope, S., 1395T*<br />
Stanier, P., 303, 2752W*,<br />
3501T<br />
Stankiewicz, P., 229, 430W,<br />
432W, 485F, 952T, 2395T,<br />
2403W<br />
Stankiewicz, P. T., Session 22<br />
Stanley, K., 2003F<br />
Stanton, J., 3333T<br />
Staples, J., 223*<br />
Stapleton, E., 239<br />
Stark, A. L., 614T*<br />
Starker, L. F., 1241F<br />
Stassinopoulos, A., 3720W<br />
State, M., 13, 553F, 1433W,<br />
2478W, 2605T<br />
State, M. W., 2560T, 2577W,<br />
2602T<br />
Stathaki, E., 2937F<br />
Staufenbiel, I., 2058W<br />
Stavropoulos, D. J., 103,<br />
3100F, 3106F, 3183W<br />
Stavropoulos, J., 1872F,<br />
1873F<br />
Stavropoulou, A., 1228T*<br />
Stavropoulou, A. V., 1191W<br />
Steck, A. K., 1330F<br />
Steckley, J. L., 2779W<br />
Steel, K. P., 1, 105, 2302T<br />
Steele, L., 2905W*<br />
Steele, P. D., 1759W<br />
Steele, T., 3340F<br />
Steenpass, L., 392*<br />
Steensbjerre Moller, R.,<br />
889W<br />
Stefan, M., 573F*<br />
Stefani, M. M. A., 2475W<br />
Stefanick, M. L., 2145W<br />
Stefanidis, C. J., 2850F<br />
Stefanova, I., 219<br />
Stefanovic, V., 3481T<br />
Stefanowicz, D., 1465F<br />
Stefansson, H., 106, 252<br />
Stefansson, K., 106, 583F,<br />
2165F, 2317T<br />
Steffann, J., 72*<br />
Steger, M., 782W<br />
Stegger, M., 1323T<br />
Stein, C. M., 1295W*<br />
Stein, J., 75<br />
Stein, J. L., 2054F<br />
Stein, L., 135<br />
Stein, L. D., 1093T<br />
Steinbeisser, H., 1612T<br />
Steinberg, J., 2476T*<br />
Steinberg, S. J., 3448T<br />
Steinfeld, I., 3588W<br />
Steinmann, K., 299<br />
Stejskal, D., 2865F<br />
Stemming, J., 1680T<br />
Stemple, D., 363
Stemple, D. L., 37, 214<br />
Stenroos, E. S., 2501F<br />
Stephan, D. A., 2301W<br />
Stephan, M., 2740W<br />
Stephans, J., 1198T<br />
Stephens, J., 383<br />
Stephens, J. C., 503F,<br />
1604T, 2804T<br />
Stephens, K., 1753W<br />
Stephens, M., 273, 1463W,<br />
1514W, 1580W<br />
Stephenson, M., 2977T<br />
Stephenson, R., 1328W<br />
Stergiakouli, E., 2081F<br />
Steri, M., 1516F*, 2198F<br />
Stern, M. C., 1075T<br />
Stern, M.-H., 1205F<br />
Sternberg, C. N., 651T<br />
Stevanin, G., 2820F*<br />
Stevanovic, S., 1233W<br />
Stevens, A. J., 3440T<br />
Stevens, C., 8, 290, 322,<br />
2319W<br />
Stevens, C. R., 2613W<br />
Stevens, E., 3374W*<br />
Stevens, J., 412W, 486W,<br />
532W, 851F, 1146W,<br />
2397W<br />
Stevens, K., 615T<br />
Stevens, V., 1012T<br />
Stevens, V. L., 1390F<br />
Stevenson, D., 3177W,<br />
3189W<br />
Stevenson, D. A., 3076F<br />
Stevenson, R., 3185W<br />
Stevison, L., 285<br />
Stevnsner, T., 2244W<br />
Steward, M., 3310F<br />
Stewart, A., 126<br />
Stewart, C. L., 2914W<br />
Stewart, D. R., 132*, 1261T<br />
Stewart, E. A., 1145F, 2056T<br />
Stewart, F., 512W, 3517T<br />
Stewart, F. J., 218, 3702W*,<br />
3715F<br />
Stewart, H., 2939T<br />
Stewart, R., 1269W<br />
Stewart, W., 1407T*<br />
St. George-Hyslop, P.,<br />
2528F<br />
Stiasny-Kolster, K., 2568W<br />
Stiburkova, B., 2831T*<br />
Stiby, A. I., 1567F*<br />
Sticht, H., 2595W<br />
Stieler, K., 2760F<br />
Stienen, D., 1005W<br />
Stieren, J., 3671F<br />
Still, C., 2078F<br />
Stimpson, K. M., 69*<br />
Stitzel, M. L., 304<br />
Stitziel, N., 2199W<br />
St. Jean, P. L., 476W, 3406T<br />
St. Luke’s Dementia Study<br />
Group, 2466W, 2473T<br />
Stobdan, T., 3307F<br />
Stock, F., 2869W<br />
Stock, R., 1309F<br />
Stöcker, T., 1335T, 1430W*<br />
Stockler, S., 750T*, 756W<br />
Stockley, T., 3183W<br />
*Presenting Author<br />
Stockley, T. L., 2905W<br />
Stockton, D., 885W, 3147W<br />
Stockton, D. W., 2678T<br />
Stoddard, G., 1904F<br />
Stoeger, R., 1580W<br />
Stoessl, A. J., 346<br />
Stoetzel, C., 2887W<br />
St<strong>of</strong>anko, M., 3107W, 3110F<br />
Stojanov, P., 402<br />
Stok, M., 796W<br />
Stokes, P., 3700W<br />
Stokes, T., 3011T<br />
Stoler, J., 2151W<br />
Stoletzki, N., 402<br />
Stolk, L., 2141F<br />
Stoll, C., 3073W*<br />
Stoll, M., 3577F<br />
Stolle, C., 2904F<br />
Stolte- Dijkstra, I., 127<br />
Stone, A., 3306T<br />
Stone, A. C., 3251W<br />
Stone, B., 3527F<br />
Stone, D. U., 529F, 2188T<br />
Stone, E. M., 387, 2750T<br />
Stone, K. L., 2375F<br />
Stone, N., 1309F<br />
Stoppa-Lyonnet, D., 1205F<br />
Storey-Montalvo, G., 2272T<br />
Storm, K., 2757F<br />
Stormo, C., 576W*<br />
Storniolo, A. M., 1098W<br />
Stowe, Z. N., 2384F<br />
St. Pourcain, B., 1318F,<br />
1567F, 1583W, 2081F,<br />
2164T*, 2169W<br />
Strachan, E., 434W<br />
Strader, L. C., 1566T<br />
Straka, R., 1641T<br />
Stram, D., 1324F<br />
Stram, D. O., 1292W,<br />
2202W<br />
Strandgren, C., 2427W<br />
Stranecky, V., 752T<br />
Stranger, B., 3310F<br />
Stranger, B. E., 584W,<br />
1907F, 2250W<br />
Strassburger, D., 3002T<br />
Strasser, D. S., 684T<br />
Strauch, K., 190, 275,<br />
2226W<br />
Strauss, D., 1159T<br />
Strawbridge, R., 2147F<br />
Strawbridge, R. J., 1954T,<br />
2123F<br />
Stray, S. M., 1089W, 1226F<br />
Stray-Pedersen, A., 360,<br />
2908W<br />
Strazza Júnior, P. S., 3280F<br />
Strecker, M., 954T<br />
Strecker, V., 782W<br />
Street, C., 382<br />
Streeter, I., 3636W<br />
Strengman, E., 2553W,<br />
2661W<br />
Strick, R., 3153W<br />
Strickland, A., 2668W<br />
Strike, L., 2054F<br />
Stringham, H. M., 46<br />
Strissel, P., 3153W<br />
Strohecker, B., 3698W<br />
SPEAKER AND AUTHOR INDEX 405<br />
Strom, C. M., 2260T, 3522T<br />
Strom, S. S., 2202W<br />
Strom, T., 567F, 582W,<br />
2557T<br />
Strom, T. B., 2260T<br />
Strom, T. M., 699F, 2567F,<br />
2595W, 2693T, 2917W,<br />
2922F<br />
Strome, E. D., 384<br />
Strong, E., 3482T*<br />
Strong, K. A., 1837W*<br />
Strong, L., 1197W<br />
Strong, L. C., 1221W<br />
Strother, D., 1052F<br />
Stroud, D., 806F<br />
Stroud, T., 884T<br />
Strovel, E., 1729W<br />
Strug, L., 2953W<br />
Strug, L. J., 1322W, 1531F*,<br />
2580W<br />
Strunz, C. M. C., 636T<br />
Strutz-Seebohm, N., 86<br />
Stuart, A., 3672W<br />
Stuart, P. E., 154, 1952F<br />
Stuart, S., 1167W<br />
Stückler, F., 2226W<br />
Stuckless, S., 1066T*<br />
Studer, M., 808F<br />
Study AT1001-013 Principal<br />
Investigators, 732T<br />
Study <strong>of</strong> Osteoporotic<br />
Fractures and<br />
Osteoporotic Fractures<br />
in Men Study Groups,<br />
2375F<br />
Stuenkel, A. J., 1767W*<br />
Stuffrein-Roberts, S., 3440T<br />
Stuhrmann-Spangenberg,<br />
M., 1868F<br />
Sturm, M., 1200W, 1233W<br />
Sturtz, F., 2694F<br />
Sturzeneker, R., 2434T<br />
Stutz, M., 210<br />
Stutzman, F., 2887W<br />
Styrkarsdottir, U., 109<br />
Su, A. I., 3584W*<br />
Su, B., 3317W*<br />
Su, C., 2761W<br />
Su, C.-T., 129<br />
Su, D., 1322W, 2953W<br />
Su, H., 1010F, 1218W<br />
Su, J., 1183T, 2999T<br />
Su, M., 2000F*, 2116T<br />
Su, S., 3418T<br />
Su, W., 989F<br />
Su, Z., 136<br />
Suárez, E., 3315T<br />
Suchi, S., 1765W<br />
Suchiman, H. E. D., 2035T<br />
Suchy, S. F., 330<br />
Suchy-Dicey, A., 584W,<br />
1284T, 1503T<br />
Suda, L., 3044F<br />
Sudbrak, R., 567F, 582W<br />
Sudlow, C. L., 1313W<br />
Sudman, M., 2143T*<br />
Sudmant, P. H., 278, 375,<br />
3296W<br />
Sudo, A., 2822T<br />
Suematsu, M., 2911W<br />
Suemoto, C. K., 919W<br />
Suen, Y. K., 3491T<br />
Suenaga, T., 1631T<br />
Sugahar, K., 2861T<br />
Sugahara, K., 3230F<br />
Sugahara, Y., 548W, 558W,<br />
559F, 599F<br />
Sugalski, R., 433F<br />
Sugano, S., 2619W, 2923W<br />
Sugawara, H., 3513T<br />
Sugawara, Y., 3091W<br />
Sugier, P.-E., 2079W*, 2248T<br />
Sugimoto, K., 1987T<br />
Sugimura, H., 2507F<br />
Sugino, S., 1940F<br />
Sugiyama, M., 2130W,<br />
3682W<br />
Suh, J. Y., 846F<br />
Suhl, J., 540W*<br />
Suhre, K., 228, 2226W<br />
Sui, D., 1291F<br />
Sukhadia, S., 2316W<br />
Suktitipat, B., 1347T,<br />
1396F*, 1690T<br />
Sukumar, A. T., 3251W<br />
Sul, J., 1341T*, 3555F<br />
Sul, J. H., 3623F<br />
Sulcova, V., 3522T<br />
Sule, G., 2864T, 3209W*<br />
Sule, N., 2542T*<br />
Sulem, P., 2317T<br />
Sulis, M. L., 1031F<br />
Sullivan, A. K., 2362T*<br />
Sullivan, B. A., 69, 384*<br />
Sullivan, J., 147<br />
Sullivan, K., 953W, 2778F<br />
Sullivan, L. L., 69, 384<br />
Sullivan, L. S., 3234F<br />
Sullivan, P., 235, 280,<br />
1325W, 2487W<br />
Sullivan, P. F., 290, 1350T,<br />
2468F, 2522F, 2576F,<br />
2618F, 3442T, 3452T,<br />
3659F<br />
Sulonen, A.-M., 2888T*<br />
Sulovari, A., 1339F<br />
Sultan, K., 1133F<br />
Sultan, M., 567F, 582W<br />
Sultana, R., 2697F<br />
Sumanas, S., 2724F<br />
Sumi, S., 2440T<br />
Summar, M., 670T<br />
Summerer, M., 3319F<br />
Sumner, C., 512W, 3517T,<br />
3715F<br />
Sumner, C. J., 3702W<br />
Sun, C., 1625T, 2561F<br />
Sun, G., 1660T, 2159F,<br />
2206T, 3561F, 3619F<br />
Sun, H., 314, 1417F*, 1735W,<br />
1742W, 1757W, 1761W<br />
Sun, J., 3<br />
Sun, L., 798W, 1322W,<br />
1412W, 2109W, 2376W,<br />
2819T, 2953W<br />
Sun, M., 2458T<br />
Sun, N., 2433W*<br />
Sun, P., 1061F<br />
Sun, Q., 165, 537F, 2080T,<br />
2116T<br />
SPEAKER AND AUTHOR INDEX
406 SPEAKER AND AUTHOR INDEX<br />
Sun, S., 1101W, 3585F*,<br />
3593F<br />
Sun, W., 1027T, 1560T*,<br />
2260T, 3522T<br />
Sun, X., 246, 2644T*<br />
Sun, Y., 78, 161*, 690T,<br />
736T, 2063F, 2701W<br />
Sun, Z., 2617T<br />
Sunaga, D. Y., 814F, 2414F<br />
Sundararajan, R., 803W<br />
Sundaresan, V., 2773W<br />
Sunde, L., 3148F<br />
Sunderam, U., 362<br />
Sundramoorthy, A., 880T*<br />
Sundsbak, J. L., 1909T<br />
Sung, H., 1396F, 1690T*,<br />
2584T<br />
Sung, J., 1384F, 1654T,<br />
1656T, 2118W, 2119T,<br />
3259F<br />
Sung, K., 1369F<br />
Sung, S., 900T<br />
Sung, Y., 1608T, 2063F,<br />
2117F<br />
Sung, Y. J., 2116T<br />
Sunkin, S., 2444F*<br />
Sunyaev, S., 402*, 2199W,<br />
2209T, 3310F<br />
Sunyaev, S. R., 1550W,<br />
3404T<br />
Sunyer, J., 2167T, 2168F<br />
Suomalainen, A., 327<br />
Superko, H. R., 1714T*<br />
Superti-Furga, A., 3190F<br />
Suphapeetiporn, K., 709F,<br />
1944W, 2006F*, 2749W<br />
Sur, A. L., 1805W<br />
Surakka, I., 119*, 190,<br />
1308T, 2076W, 2110T,<br />
2137T, 2175W<br />
Surdulescu, G., 503F<br />
Surti, U., 904T*, 971W,<br />
993W, 1744W<br />
Suskin, B., 3022T*<br />
Susswein, L., 688T<br />
Sutcliffe, C., 1316W, 1377T,<br />
1602T, 1671T, 1928F,<br />
2037W<br />
Sutcliffe, J., 1520W<br />
Sutcliffe, J. S., 268, 2577W<br />
Sutera-Sardo, J., 2536T<br />
Suthanthiran, M., 2260T<br />
Suther, R., 3207W<br />
Sutherland, M., 853F<br />
Sutton, V. R., 33, 227<br />
Suvarnan, L., 2234F<br />
Suver, C., 2220W<br />
Suvisaari, J., 252<br />
Suzuk, Y., 2294F<br />
Suzuki, A., 531F, 1984T*,<br />
2004W<br />
Suzuki, A. M., 2654F*<br />
Suzuki, H., 663F, 1631T<br />
Suzuki, M., 475F, 2440T<br />
Suzuki, N., 2882T<br />
Suzuki, S., 2440T<br />
Suzuki, T., 1317T*, 2823F<br />
Suzuki, Y., 1631T, 2174F,<br />
2264F, 2619W, 2923W<br />
Svaneby, D., 1565W<br />
*Presenting Author<br />
Svensson, P., 2369F<br />
Svensson, P.-J., 3245W<br />
Svetkey, L. P., 147<br />
Svidzinski, A. E., 3324T*<br />
Svirski, R., 2691F<br />
Swami, S., 585F<br />
Swaminathan, K., 3726W<br />
Swaminathan, S., 2531F<br />
Swamy, S., 596W<br />
Swan, G. E., 642T<br />
Swan, H., 1835W<br />
Swanson, D. M., 1397W*<br />
Swanson, W., 3306T<br />
Swaroop, A., 385, 822F,<br />
824F, 827F, 830F, 1774W,<br />
2135F, 2183F, 2680W<br />
Swedish Schizophrenia<br />
Consortium, 2487W,<br />
3442T, 3452T<br />
Swedish Schizophrenia<br />
Consortium, ARRA<br />
Autism Sequencing<br />
Consortium, 290<br />
Sweeney, T., 397<br />
Sweetman, L., 1684T<br />
Swenson, J., 3182F<br />
Swerdlow, A., 2165F<br />
Swertz, M. A., 3610W<br />
Swierczek, S., 3297T<br />
Swift, C., 1684T<br />
Swindell, E. C., 1908W<br />
Swindle, K., 1983W<br />
Swinkels, D. S., 306<br />
Swinkels, M. E., 217<br />
Swoboda, K. J., 2581T,<br />
2951T<br />
Sw<strong>of</strong>ford, D. L., 1382W<br />
Syed, F., 3718W*<br />
Syed, S., 83<br />
Symer, D. E., Session 24<br />
Symoens, S., 129, 2225F<br />
Symons, R. C. A., 1989W<br />
Syngelaki, A., 3508T<br />
Syn<strong>of</strong>zik, M., 2797W<br />
Syoji, K., 2619W<br />
Sysoeva, E., 773W<br />
Sysol, J. R., 2683W<br />
Syvänen, A.-C., 567F,<br />
569F, 582W, 617T, 619T,<br />
1624T, 3217W, 3427T<br />
Szabo, C., 1219T<br />
Szafranski, K., 580W,<br />
1236W<br />
Szafranski, P., 432W, 2395T*<br />
Szak, S., 2561F<br />
Szatkiewicz, J. P., 1350T*<br />
Szatmari, P., 175, 2620T*,<br />
3086F<br />
Szekely, A., 334<br />
Szelinger, S., 3215W*<br />
Szepetowski, P., 2581T<br />
Szeto, D., 1605T<br />
Szigeti, K., 2489F*, 2542T<br />
Szkotnicki, L., 3648W<br />
Szkotnicki, L. T., 1251W<br />
Sznajer, Y., 124<br />
Sznewajs, A., 3198F*<br />
Szperl, A., 1330F<br />
Szpiech, Z. A., 3285T*<br />
Szporn, A., 3145W<br />
Szulkin, R., 1189T*<br />
Szulwach, K., 382<br />
Szulwach, K. E., 3483T*<br />
Szuto, A., 2342F, 2591F<br />
Szu Tu, C., 346, 2537F<br />
Szymanska, K., 403<br />
Szymanski, M., 2461T,<br />
2486F<br />
Szymczak, S., 1363F*,<br />
1512T, 1669T, 3591F<br />
T<br />
T1DGC, 1299T<br />
T2D-GENES, 176<br />
T2D-GENES Consortium,<br />
169, 269<br />
Taal, H. R., 2081F, 2162F<br />
Tabara, Y., 2361W*<br />
Tabatabai, Z. L., 408<br />
Tabatabaiefar, M. A., 59<br />
Taber, T., 693F, 713F<br />
Tabet, A. C., 901W*<br />
Tabor, H. K., Session 25,<br />
74, 94, 148, 171, 301*,<br />
1842F<br />
Taboulet, F., 1811W<br />
Tabuteau, S., 716T<br />
Tachdjian, G., 894T<br />
Tachmazidou, I., 2044T,<br />
3396T, 3412T*<br />
Tackney, J., 3323W<br />
Tag, J., 1295W<br />
Taggart, R. T., 3523T*<br />
Taghikhani, A., 1143W,<br />
1739W<br />
Taghizadeh, M., 779W*<br />
Tagliaferri, R., 3631F<br />
Taguri, M., 1290T<br />
Tahar Yacoubi, M., 403<br />
Taher, L., 407, 545F<br />
Taherian, N., 1065W<br />
Tahir Turanli, E., 2429F,<br />
2450F, 2841F, 3475T<br />
Tahmasebifar, A. T., 1096T<br />
Tai, E. S., 2094W<br />
Taibah, K., 2734W<br />
Taira, M., 2409W*<br />
Taja, L., 2365T<br />
Takada, L., 2639F<br />
Takada, T., 663F<br />
Takada, Y., 663F<br />
Takagi, S., 2569T<br />
Takahashi, A., 627T, 1631T,<br />
2004W, 2174F, 2506T<br />
Takahashi, H., 396<br />
Takahashi, K., 1998W,<br />
1999T<br />
Takahashi, M., 799W*<br />
Takahashi, Y., 52, 233,<br />
2409W, 2569T*<br />
Takamura, T., 1888T<br />
Takanari, H., 217<br />
Takanohashi, A., 2452T<br />
Takao, K., 2550W, 2647T<br />
Takashima, H., 2418W*,<br />
2601W, 2607W, 2616W,<br />
2823F<br />
Takata, R. I., 2596T<br />
Takazoe, M., 2174F<br />
Takeda, S., 232<br />
Takenouchi, T., 3093W<br />
Takeshima, Y., 729F, 781W<br />
Takeuchi, G., 2747T<br />
Talajic, M., 1678T<br />
Talasar, A., 1167W<br />
Talbot, K., 2470T<br />
Talebizadeh, Z., 2379W*<br />
Talebzadeh, F., 860T<br />
Talim, B., 751F, 2945T<br />
Talkowski, M., 70, 98,<br />
2562W<br />
Talkowski, M. E., 68*, 103,<br />
554W, 862T, 2458T<br />
Tallila, J., 252<br />
Talmud, P. J., 122, 2175W<br />
Talseth-Palmer, B. A., 916T<br />
Tal-Singer, R., 2249F<br />
Talwar, D., 2788W<br />
Talwar, P., 2967T<br />
Tam, A., 3085W<br />
Tam, C., 2279F, 2280W*<br />
Tam, K., 142<br />
Tam, P. H., 3123W<br />
Tam, P. K. H., 408, 1930T,<br />
2066F, 2932W<br />
Tam, S., 2660F<br />
Tam, T., 675F<br />
Tamada, I., 3192F<br />
Tamakoshi, A., 1833W<br />
Tamari, M., 2294F<br />
Tamaru, S., 2873T<br />
Tambets, K., 3286F*<br />
Tamburrini, G., 2235W<br />
Tamhankar, P., 2803W<br />
Tamiya, G., 1317T, 1549F<br />
Tamm, R., 2144F*<br />
Tammaro, R., 808F, 2810T<br />
Tammela, T. L., 995F, 1000T,<br />
1302T<br />
Tammesoo, M. L., 1832F<br />
Tampakeras, M., 2608T<br />
Tamraz, B., 335<br />
Tamura, A., 3221W<br />
Tan, A., 1446T*<br />
Tan, A. G., 2094W<br />
Tan, C., 1737W, 3090F<br />
Tan, C. S., 2561F<br />
Tan, D. E. K., 1934F<br />
Tan, E. C., 2889F, 3034T*<br />
Tan, G., 3200F<br />
Tan, M. H., 527F<br />
Tan, P., 2889F<br />
Tan, Q., 1365T, 2244W,<br />
2295W<br />
Tan, W., 1242W<br />
Tan, X., 2251T, 3089W,<br />
3648W<br />
Tan, X. X., 1251W<br />
Tan, Y., 1618T, 3210F*<br />
Tanabe, O., 52<br />
Tanaka, H., 396, 2174F,<br />
2697F, 2822T<br />
Tanaka, K., 2133W<br />
Tanaka, M., 233<br />
Tanaka, T., 1391W, 1631T,<br />
1643T, 2080T, 2116T<br />
Tanaka, Y., 2130W<br />
Tanck, M. W., 1604T
Tandon, A., 350, 3433T<br />
Tandy, S. L., 1767W<br />
Taner, N., 380<br />
Tanese, K., 2911W<br />
Tang, C. S., 2161T*, 2323T<br />
Tang, C. S. M., 1930T, 2066F<br />
Tang, F., 491F<br />
Tang, G., 893W*<br />
Tang, H., 159, 421F, 581F,<br />
646T, 1157F, 1408F,<br />
1504F, 2223W, 2634W,<br />
3318T, 3342T, 3383W<br />
Tang, L., 589F<br />
Tang, L. F., 362<br />
Tang, L. Y., 2985T<br />
Tang, M., 2973T, 3023T*<br />
Tang, P., 2254T<br />
Tang, P. L. F., 1694T<br />
Tang, W., 510W*, 1091F,<br />
1092W, 1094F, 1097F,<br />
1155W<br />
Tang, X., 2237F<br />
Tang, Y., 1591T*<br />
Tang, Z., 170, 966T*<br />
Tang, Z.-Z., 1010F<br />
Tang, Z. Z., 1076F<br />
Taniguchi, A., 2004W,<br />
2032T*, 2287T, 3221W<br />
Taniguchi, H., 8<br />
Taniguchi, M., 232*<br />
Taniguchi, T., 137<br />
Taniguchi, Y., 2458T<br />
Tanioka, F., 2507F<br />
Tanizawa, Y., 2679F<br />
Tanna, U., 3378T<br />
Tan-Sindhunata, G. M. B.,<br />
214<br />
Tantau, J., 77<br />
Tantisira, K., 623T, 638T<br />
Tantisira, K. G., 622T, 625T,<br />
811F, 2166W<br />
Tantravahi, U., 765W<br />
Tanzer, A., 506W<br />
Tanzi, R. E., Session 10,<br />
2520W<br />
Tao, J., 411<br />
Tao, K., 1783W<br />
Tao, R., 73<br />
Tapia-Guerrero, Y., 3124F*<br />
Tapscott, S., 2840T<br />
Tapscott, S. J., 55<br />
Tarabishy, Y., 1238F<br />
Tarantino, P., 2763F, 2766F,<br />
2774T, 2780T*<br />
Tarasova, L., 608T<br />
Tarassov, I., 329<br />
Tarazona, E., 3562W<br />
Tarazona-Santos, E.,<br />
1119W, 3325F*<br />
Tardif, J., 665F*<br />
Tardif, J.-C., 3401W<br />
Tardón, A., 1091F<br />
Tare, A., 1988F<br />
Tarekegn, A., 3322F<br />
Tarini, B. A., 313<br />
Tario, J. D., 3523T<br />
Tariq, M., 1674T*, 2920W<br />
Tariq, N., 2959W<br />
Tariq, S., 160<br />
Tarlé, R. G., 1978T*<br />
*Presenting Author<br />
Tarn, C., 853F*, 2300F<br />
Tarnopolsky, M., 2554T<br />
Taroni, F., 2764W, 2775F,<br />
2781F*<br />
Tarrier, B., 1568W, 2329T,<br />
2850F, 3664W<br />
Tartaglia, M., 215<br />
Tarway, M., 1097F<br />
Tasan, M., 2660F<br />
Taschner, P., 3586W*<br />
Taschner, P. E. M., 3610W,<br />
3611F<br />
Tascón-Peñaranda, E. P.,<br />
3315T, 3363T<br />
Tashiro, K., 724T, 2129F<br />
Tashtosh, R., 1881W<br />
Tasic, V., 845F<br />
Taskiran, E., 219<br />
Tasseva, G., 2755W<br />
Tassone, F., 2491T, 2634W<br />
Tat, M., 1167W<br />
Tata, S., 3569F<br />
Tatar, A., 1326T<br />
Tatè, R., 2810T<br />
Tatonetti, N., 646T<br />
Tatum, Z., 3611F<br />
Taub, M., 2461T, 2566T<br />
Taub, M. A., 1512T<br />
Taub, P. J., 2151W<br />
Tauer, U., 2917W<br />
Tavano, C., 3677F<br />
Tavares, A., 691F<br />
Tavares, P., 1778W*<br />
Tavares, V. L. R., 813F*<br />
Tavendale, R., 1082F<br />
Tavernier, J., 2660F<br />
Taviaux, S., 857W, 936T,<br />
2386T<br />
Tavormina, J., 76<br />
Tavtigian, S. V., Session<br />
4, 195, 1067F, 1213T,<br />
1783W*<br />
Tawamie, H., 2557T<br />
Tawil, R., 55, 2840T<br />
Tawk, M., 54<br />
Tay, S. K. H., 771W<br />
Tay, W. T., 2094W<br />
Tayama, C., 3499T<br />
Tayel, S., 930T*<br />
Taylor, A., 1257W<br />
Taylor, H. A., 1677T<br />
Taylor, H. G., 1295W<br />
Taylor, J., 967W, 2939T,<br />
2989T*, 3547F<br />
Taylor, J. C., 133*, 211<br />
Taylor, J. F., 2847F<br />
Taylor, J. G., 1259F<br />
Taylor, J. S., 1272W*<br />
Taylor, K. C., 2145W*<br />
Taylor, K. D., 1445W, 1916F,<br />
2153F<br />
Taylor, K. M., 2796F<br />
Taylor, K. T., 2131T<br />
Taylor, L., 142<br />
Taylor, M., 1318F*<br />
Taylor, N., 1109F<br />
Taylor, P., 315, 2874F*<br />
Taylor, P. L., 1836F<br />
Taylor, P. R., 1010F, 1076F,<br />
1218W<br />
SPEAKER AND AUTHOR INDEX 407<br />
Taylor, S., 218<br />
Taylor, S. P., 1685T<br />
Tayo, B., 1959W*, 2063F<br />
Teckman, J., 735F<br />
Tedeschi, G., 2095T<br />
Tedeschi, H., 514W<br />
Teer, J. K., 1690T, 1696T<br />
Teerlink, C., 1001F*, 1149W<br />
Tegg, E., 932T*<br />
Teglas, S., 107<br />
TeGrootenhuis, L. T., 2301W<br />
Teh, M. S., 3267T<br />
Teichgraeber, J. F., 1908W<br />
Teilum, M. W., 1194W<br />
Teimori, H., 892T<br />
Teive, H. A., 2475W<br />
Teive, H. A. G., 2609F<br />
Teixeira, P., 1593T<br />
Tejasvi, T., 154, 1952F<br />
Tejeda, L., 507F<br />
Tejero, E., 526W<br />
Tekin, M., 57*, 297, 2719W,<br />
2772F, 3125W<br />
Tembe, W., 1240T<br />
te Meerman, G. J., 1284T,<br />
1503T<br />
Temel, S., 1708T*<br />
Temple, I. K., 3494T*<br />
Templeton, A. K., 566W<br />
Temtamy, S., 2937F<br />
Teng, W., 2721F<br />
Teng, Y., 655T*<br />
Tengström, M., 1114T<br />
Tengvall-Linder, M., 1939T<br />
ten Kate, S., 3159W<br />
Tenniswood, M., 1192T<br />
Teo, Y., 1418W<br />
Teo, Y. Y., 2094W, 3284W,<br />
3339T<br />
Tepperberg, J., 949W<br />
Terai, M., 1631T<br />
Teramo, K., 3030T<br />
Terao, C., 2004W, 2361W<br />
Terdiman, J., 1059W<br />
Terhal, P., 217<br />
Terhal, P. A., 2848W, 2886F<br />
Terhorst, L., 1884W<br />
Terk, M., 1309F<br />
Ter Kuile, M., 1788W<br />
Terrier, B., 177<br />
Terry, J. G., 1913F<br />
Terry, M. B., 1213T<br />
Terwilliger, J. D., 194,<br />
897W, 1563T, 2179T*,<br />
2208W<br />
Terwisscha van Scheltinga,<br />
A. F., 2526W*<br />
Terzi, Y. K., 594W, 1013F,<br />
3003T, 3243W, 3424T,<br />
3426T*<br />
Terzioglu, G., 2429F<br />
Tesar, V., 3437T<br />
Tesarova, M., 699F, 752T*<br />
Teslovich, T. M., 46, 169*,<br />
176, 269, 1513F, 1923W,<br />
2308T, 2339F<br />
Tesmer, T., 3689F<br />
Tessari, M., 2696T<br />
Testa, F., 2950W<br />
Tester, D. J., 2885T, 2906T*<br />
Tétreault, M., 2797W,<br />
2900T*<br />
Teumer, A., 275, 584W,<br />
1284T, 1503T, 2080T*<br />
Texas Alzheimer Research<br />
and Care Consortium,<br />
2489F<br />
Teyssier, J.-R., 2729T<br />
Tezcanli Kaymaz, B., 1025F<br />
Tezenas du Montcel, S.,<br />
2545T*<br />
Thacker, M. M., 33<br />
Thackray, L., 3600W<br />
Thair, S. A., 1632T*<br />
Thakkar, P., 865W<br />
Thakur, M. L., 797W<br />
Thangaraj, K., 1950W,<br />
2967T, 2988T<br />
Thangavel, A., 3369T<br />
Thappa, B., 802W<br />
Thareja, G., 3369T<br />
Thauvin-Robinet, C., 403,<br />
2716W, 2729T, 2770W,<br />
2792T<br />
Theda, C., 3484T*<br />
Thedens, D. R., 404<br />
Theis, F. J., 2226W<br />
Theis, J. L., 1695T*<br />
Thekkoot, D. M., 2717T<br />
Thelma, B. K., 2382W,<br />
2941W*<br />
Thenral, S. G., 2941W<br />
Theodore, D., 630T<br />
Thera, M., 2255F<br />
Theusch, E., 601T, 615T*<br />
ThevaDas, K., 1625T<br />
Thevenon, J., 1293T*,<br />
2716W, 2770W, 2792T<br />
Thézé, N., 841F<br />
Thibert, R., 3119W<br />
Thibodeau, S., 28, 1001F,<br />
1267T<br />
Thibodeau, S. N., 986F,<br />
1067F, 1080W, 1206W,<br />
1214F*, 3564W<br />
Thiebaud, P., 841F<br />
Thiede, A., 849F<br />
Thiel, C. T., 2356T*<br />
Thiele, H., 105, 2759T, 2861T,<br />
2869W, 2930T, 2944W<br />
Thiering, E., 2162F<br />
Thiesen, M., 3579F<br />
Thiffault, I., 2771T*<br />
Thilbeault, K. S., 434W<br />
Thiruvahindrapuram, B., 175<br />
Thiselton, D. L., 2500T<br />
Thistlethwaite, P. A., 1051T<br />
Thobois, S., 2638T<br />
’t Hoen, P. A. C., 228, 542W,<br />
567F, 574W<br />
Thoenes, M., 236<br />
Thoeng, A. D., 2816T<br />
Thomale, J., 3524T<br />
Thomas, A., 2181W, 3508T<br />
Thomas, A. C., 303, 3501T*<br />
Thomas, A. W., 658T<br />
Thomas, B., 295, 1248W<br />
Thomas, C. E., 2241W<br />
Thomas, D., 1232F, 1569T*,<br />
3717F<br />
SPEAKER AND AUTHOR INDEX
408 SPEAKER AND AUTHOR INDEX<br />
Thomas, E., 1618T<br />
Thomas, E. R. A., 2005T<br />
Thomas, J., 368<br />
Thomas, K., 2492F<br />
Thomas, K. A., 2121W<br />
Thomas, K. B., 1251W,<br />
3648W<br />
Thomas, L., 29<br />
Thomas, L. I., 727F<br />
Thomas, M. A., 3141W,<br />
3511T<br />
Thomas, M. G., 3322F<br />
Thomas, M. K., 50<br />
Thomas, P., 2262W<br />
Thomas, R. G., 2405F<br />
Thomas, R. H., 262,<br />
2821W<br />
Thomas, S., 403*, 456W,<br />
3240F<br />
Thomasse, Y. E. M., 2909T<br />
Thomassen, G., 3614W<br />
Thompson, A., 45, 1082F,<br />
1088F, 2620T<br />
Thompson, B., 300<br />
Thompson, B. A., 1067F*,<br />
1274F*<br />
Thompson, C., 346, 2537F<br />
Thompson, C. L., Session<br />
76, 1086W<br />
Thompson, E. A., Session 75<br />
Thompson, E. R., 1224W*<br />
Thompson, J., 3529F,<br />
3637F, 3656W, 3703F*<br />
Thompson, J. R., 115<br />
Thompson, M. D., 298<br />
Thompson, M. K., 3314W<br />
Thompson, N. E., 1821W*<br />
Thompson, P. M., 2054F<br />
Thompson, S., 2143T,<br />
3303T, 3338W<br />
Thompson, Z., 1061F<br />
Thomson, N., 3528W,<br />
3662W*<br />
Thorburn, D. R., 326<br />
Thorgeirsson, S., 1199F<br />
Thorisson, G. A., 3610W<br />
Thorland, E. C., 66<br />
Thorleifsson, G., 109, 119,<br />
1308T, 2076W, 2137T<br />
Thorn, C. F., 633T, 635T<br />
Thornton, A. M., 26, 1089W,<br />
1226F, 2600F<br />
Thornton, C., 2824W<br />
Thornton, T., 1424W*<br />
Thornton-Thompson, S.,<br />
3449T<br />
Thornton-Wells, T., 1925F,<br />
2532W<br />
Thornton-Wells, T. A.,<br />
2401T, 3275W<br />
Thorsteinsdottir, U., 115,<br />
2165F, 2317T<br />
Thrush, D. L., 103<br />
Thun, M., 1012T, 1091F,<br />
1154F<br />
Thurman, R. E., 255, 402<br />
Thusberg, J., 496W<br />
Thyagarajan, B., 1921T<br />
Tian, A., 3695F<br />
Tian, C., 2915T<br />
*Presenting Author<br />
Tian, L., 2722W*, 2856F,<br />
2872W, 3561F, 3710W<br />
Tian, Q., 2053T<br />
Tian, S., 1269W<br />
Tian, Y., 553F, 2479T*<br />
Tibben, A., 1788W*<br />
Tibbetts, C., 1165T<br />
Tibbo, P., 2474F<br />
Tibboel, D., 834F<br />
Ticca, A., 2039F<br />
Tice, R., 3490T<br />
TIC <strong>Genetics</strong> Team, 2602T<br />
Ticozzi, N., 2775F<br />
TIDE BC, Treatable<br />
Intellectual Disability<br />
Endeavor in British<br />
Columbia, 750T<br />
Tidhar, R., 2869W<br />
Tidyman, W. E., 3242F<br />
Tiemeier, H., 431F, 2105F,<br />
2164T<br />
Tien, L., 2785W, 2892F<br />
Tienari, P., 2350T<br />
Tien Yin, W., 2041T<br />
Tieva, A., 1026W*<br />
Tiffin, N., 1808F<br />
Tifft, C., 359, 2870T<br />
Tifft, C. J., 2938W, 3543F<br />
Tikhomirov, A., 2333F*<br />
Tikkanen, E., 1709T*<br />
Tiller, G., 1866F<br />
Tilley, M. K., 3616W<br />
Tilling, K., 1583W<br />
Tillis, C., 3036F<br />
Tillman, V., 2703F<br />
Tillmann, H., 531F<br />
Tillmans, L. S., 986F<br />
Tiloca, C., 2775F<br />
Tim, R. C., 3014T<br />
Timman, R., 1788W<br />
Timmerman, V., 201, 2948T<br />
Timmermans, J., 80<br />
Timmers, H. J. L. M., 1220F<br />
Timms, L., 1093T, 1256F*<br />
Timpano, K. R., 261<br />
Timpson, N., 1567F, 2097W,<br />
2164T<br />
Timpson, N. J., 1318F,<br />
1528F, 1583W, 1626T,<br />
2081F*, 2162F, 2169W<br />
Timur, Z., 2669T<br />
Tin, A., 1932W*<br />
Tinat, J., 32, 1222T*<br />
Tincheva, R. S., 923W<br />
Tindall, E. A., 1085F*<br />
Ting, W., 1894T<br />
Tingaud, A., 841F<br />
Tinker, L., 2020T<br />
Tinker, S. W., 253<br />
Tinschert, S., 2403W<br />
Tintle, N., 1371T*<br />
Tiomkin, M., 788W<br />
Tipney, H., 649T<br />
Tipton, l., 249<br />
Tiraboschi, E., 1976F<br />
Tirado, C. A., 873W, 970T*<br />
Tiranti, V., 2810T<br />
Tirapo, C., 1205F<br />
Tiret, L., 2681T<br />
Tirri, D., 2377T<br />
Tischfield, J., 2582F<br />
Tischfield, J. A., 261,<br />
2433W, 2602T<br />
Tischkowitz, M., 1257W*<br />
Tischler, T., 2904F<br />
Tishk<strong>of</strong>f, S., 283, 518W,<br />
3306T<br />
Tishk<strong>of</strong>f, S. A., 3303T,<br />
3338W<br />
Title, A., 3506T<br />
Titus, T., 2916F<br />
Tivey, A., 101, 291, 364<br />
Tiwari, A., 628T<br />
Tiwari, H., 1410T, 3443T<br />
Tiwari, H. K., 434W<br />
Tiziano, F. D., 54<br />
Tjernagel, J., 299<br />
To, K., 2254T<br />
To, M. N., 2384F<br />
Tobias, E., 126<br />
Tobias, J. H., 1528F, 2169W<br />
Tobin, K., 2523W<br />
Tobler, K. J., 2998T*<br />
Toburen, D., 3677F<br />
Tochigi, M., 2370W<br />
Toda, T., 232, 2550W,<br />
2619W, 2963T, 3513T<br />
Todd, E., 3232F, 3244F*<br />
Todd, J., 453F<br />
Todorovic, S., 201<br />
Toes, R., 461F<br />
T<strong>of</strong>anelli, S., 3377W<br />
T<strong>of</strong>fey, D., 2218T<br />
Toga, A. W., 3587F<br />
Tohonen, V., 807F<br />
Toi, A., 3075W<br />
Toji, L., 966T<br />
Tokarz, S., 2830W, 3287W<br />
Tokita, Y., 1574W, 2747T<br />
Tokuda, Y., 2129F<br />
Tokunaga, K., 1994F,<br />
2130W, 2349W, 2496W,<br />
2656T, 3301F<br />
Tokunaga, S., 2418W,<br />
2607W, 2616W, 2823F*<br />
Tokuzawa, Y., 2873T<br />
Toland, A., 1740W*<br />
Toland, A. E., 1274F<br />
Toledo, R. C., 3324T<br />
Toledo, R. C. P., 3375T*<br />
Tolentino, C., 2136W<br />
Toliat, M. R., 2861T<br />
Tolmie, J., 127<br />
Tolstrup, N., 1194W<br />
Toma, A. M., 1528F<br />
Toma, C., 2578T*<br />
Toma, J., 3682W<br />
Tomaselli, G. F., 305<br />
Tomasini, L., 334<br />
Tomatsu, S., 786W*<br />
Tomblin, J. B., 1973F, 3735F<br />
Tomczuk, M., 2675T<br />
Tomelleri, G., 1776W<br />
Tomer, Y., 573F<br />
Tominaga, M., 2891T,<br />
3094F<br />
Tomiuk, M., 954T<br />
Tomiyama, H., 1730W*,<br />
2559W, 2619W, 3134F,<br />
3221W<br />
Tomizawa, K., 2822T<br />
Tomlinson, I., 133, 1072T,<br />
1531F, 2580W<br />
Tomlinson, J. W., 3211W<br />
Tomlinson, M. W., 3020T<br />
Tommerup, N., 805F<br />
Tommiska, J., 2707W*<br />
Toncheva, D., 3477T, 3481T<br />
Toncheva, D. I., 923W<br />
Tonduti, D., 2786T<br />
Tonekaboni, S. H., 3197W<br />
Toneva, I., 3636W<br />
Tong, C., 2721F<br />
Tong, C. H., 1603T<br />
Tong, L., 2025W<br />
Tong, S., 238<br />
Tong, X., 1540F<br />
Tong, X.-Z., 166<br />
Tonge, P., 3463T<br />
Tongkobpetch, S., 709F,<br />
1944W, 2006F<br />
Toniolo, D., 2165F, 2366F<br />
Tönjes, A., 2080T<br />
Toome, K., 1140W<br />
Topacio, D., 1237T<br />
Topaloglu, H., 54, 201, 751F,<br />
2945T, 2948T<br />
Topcuoglu, N., 1025F<br />
Topete -Gonzalez, L. R.,<br />
3187W<br />
TOPIC Study, 243<br />
Topol, E. J., 146, 1239W,<br />
1839W<br />
Topp, S., 348<br />
Topper, S., 1737W*<br />
Topuz, F., 1746W<br />
Torabi Dalivandan, S.,<br />
3083W*<br />
Toralles, M. B. P., 2642F<br />
Torchia, B., 902T*<br />
Torelli, S., 2812W<br />
Torgerson, D. G., 158<br />
Toriello, H., 3037W<br />
Torii, C., 2882T, 3093W,<br />
3105W<br />
Tornador, C., 2303F, 2593T<br />
Tornes, L., 2049W<br />
Torniainen, M., 252<br />
Toro, C., 359, 2610W,<br />
2870T, 3543F<br />
Toro, J. R., 766W, 1012T*<br />
Toro-Ramos, A. J., 2433W<br />
Torres, F. R., 514W, 2876T*<br />
Torres, J. M., 2192F*<br />
Torres, L., 875W, 956T,<br />
1049F<br />
Torres, M., 2153F<br />
Torres, M. M., 2456F<br />
Torres, N., 526W<br />
Torres, T. T., 813F<br />
Torres, V. E., 1909T<br />
Torres-López, J., 1168T<br />
Torres Maldonado, L. C.,<br />
1048T*<br />
Torri, F., 2459F, 2469W,<br />
2564F, 3587F*<br />
Torrico, B., 2578T<br />
Torstenson, E., 1489F,<br />
3275W, 3603F*<br />
Tortorella, G., 2766F
Torun, D., 590W, 1136F*,<br />
3195W<br />
Tosca, L., 894T<br />
Toscanini, U., 3364F, 3402T<br />
Tosi, L. L., 33<br />
Tosi, M., 1222T<br />
Tosolini, L., 1607T<br />
Toth, C. L., 162<br />
Totoki, Y., 396<br />
Tou, B., 894T<br />
Touho, H., 1290T<br />
Touitou, I., 3121W, 3166F<br />
Toung, J., 544W<br />
Toung, J. M., 370<br />
Touraine, R., 84, 127<br />
Tournaire, M., 936T, 3121W,<br />
3166F<br />
Tournev, I., 201, 2948T<br />
Tournier, I., 32*, 1222T<br />
Toussaint, W., 2225F<br />
Toutain, A., 403<br />
Toutain, J., 473F<br />
Touvana, E., 3017T<br />
Tovar, A. R., 526W<br />
Towne, B., 2146T*<br />
Towne, C., 1729W, 3680W<br />
Townsend, A., 1840F,<br />
1846W<br />
Toy, T., 315<br />
Toyama, Y., 2287T<br />
Toyoada, A., 2835F<br />
Toyoda, C., 2559W<br />
Toyoda, H., 2496W<br />
Tozer, E., 3698W<br />
Trabetti, E., 2548T, 2659T<br />
Trabzuni, D., 374, 564W<br />
Trachtenberg, E., 1589T<br />
Tracy, K. L., 1856F<br />
Tracy, R. P., 170, 1408F<br />
Traeger-Synodinos, J.,<br />
2995T<br />
Tragante, V., 1606T<br />
Tragante do O., V., 1659T*<br />
Trager, E., 2135F<br />
Trainer, A. H., 1224W<br />
Tran, A. N., 1126T<br />
Tran, B., 135<br />
Tran, C. K., 1691T<br />
Tran, K., 532W<br />
Tran, N., 2262W, 2320T,<br />
2343W, 2661W<br />
Tran, N. H., 1998W, 1999T<br />
Tran, P., 3694W<br />
Tran, T., 688T<br />
Tranah, G. J., 2375F<br />
Tran Mau-Them, F., 3166F<br />
Tran-Viet, K., 2328W, 3521T<br />
Traupe, H., 2160W, 2869W<br />
Trautmann, U., 2356T<br />
Travaglini, L., 943W, 2777T<br />
Traylor, M., 1313W*<br />
Traynor, B. J., 2611T, 2648F<br />
Treacy, R., 1257W<br />
Treadwell, M., 145, 1810F<br />
Trebušak Podkrajšek, K.,<br />
2688F, 2710W*<br />
Trecroci, F., 2597F*<br />
Trede, N., 365<br />
Treff, N., 2968T<br />
Treff, N. R., 2999T*<br />
*Presenting Author<br />
Tregidgo, C., 3694W<br />
Treherne, A., 766W*<br />
Treloar, S. A., 2056T, 2133W<br />
Trembath, R. C., 154,<br />
1927T, 2804T, 2896W,<br />
2925F<br />
Trembath, R. T., 780W<br />
Trenkwalder, C., 2568W<br />
Trent, J. M., 1186T, 1240T<br />
Treskes, M., 2205W<br />
Tretli, S., 991T<br />
Trevisan, C. P., 1776W<br />
Triche, E., 76<br />
Trifiro, M., 398<br />
Triggs-Raine, B., 2772F<br />
Trimble, V., 2283W<br />
Trindade-Filho, A., 3261T<br />
Trinh, C., 532W<br />
Trinh, J., 346, 2537F*<br />
Trinh, Q., 1093T<br />
Trinh, X. M., 1998W<br />
Trinidad, S. B., 1828F<br />
Trip, M. D., 1604T<br />
Tripodis, Y., 2488T<br />
Tristán, A., 2578T<br />
Trivellin, G., 2708T<br />
Troakes, C., 3471T, 3476T<br />
Troge, J., 2587T<br />
Trojanowski, J., 2538W<br />
Tromp, G., 1447F<br />
Trompet, S., 109<br />
Troncoso, J. C., 2648F<br />
Trost, J., 1021T<br />
Trost, M., 1545T*, 3664W<br />
Trost, M. K., 276<br />
Troup, C., 3690W<br />
Troyanskaya, O. G., 1501F<br />
Troyer, D., 2717T<br />
Trubetskoy, V. V., 1495F*<br />
Trucco, G., 993W<br />
Truitt, B., 1295W, 2020T<br />
Trujillano, D., 2303F, 2593T*<br />
Trujillo, A. M., 3499T<br />
Trujillo, C., 222<br />
Trujillo, I., 3504T*<br />
Trump, D. L., 3428T<br />
Tryka, K. A., 1566T<br />
Trynka, G., 155, 461F,<br />
1330F, 1907F, 2088W<br />
TSA Consortium for<br />
<strong>Genetics</strong>, The<br />
International OCD<br />
Foundation <strong>Genetics</strong><br />
Collaborative, 3540W<br />
Tsafantakis, E., 2044T, 3396T<br />
Tsai, A., 905W*<br />
Tsai, A. C.-H., 432W, 898T<br />
Tsai, E. A.-L., 2316W*<br />
Tsai, H., 2571W, 3026T*<br />
Tsai, M., 2606F, 3376F*<br />
Tsai, P., 511F<br />
Tsai, P.-T., 1955F<br />
Tsai, Y., 989F<br />
Tsai, Y. Y., 1156T<br />
TSAICG, 1480F<br />
TSAICG, IOCFGC, TS GWAS<br />
Consortium, 2519F<br />
Tsakok, T., 2138F<br />
Tsalamlal, A., 29<br />
Tsalenko, A., 3588W*<br />
SPEAKER AND AUTHOR INDEX 409<br />
Tsaliki, E., 3017T<br />
Tsan, M., 3697F<br />
Tsang, K. M., 2421W*<br />
Tsang, M., 3238F*<br />
Tsang, P., 975W<br />
Tsang, S. H., Session 78,<br />
393<br />
Tsao, B. P., 1979F, 2046W<br />
Tsao, D., 3522T<br />
Tsao, J. W., 2702T<br />
Tsao, M.-S., 1108T<br />
Tsaprouni, L., 583F, 3453T<br />
TSB LifeTech Consortium,<br />
133<br />
Tsernikova, N., 1308T,<br />
2076W<br />
Tsetskhladze, Z., 309*<br />
Tsilidis, K. K., 109, 1390F<br />
Tsimiklis, H., 1213T<br />
Tsironi, E. E., 385, 1305T<br />
Tsitlaidou, M., 1228T<br />
’t Slot, R., 400<br />
Tso, S.-C., 2742F<br />
Tsoi, L. C., 154*, 1952F<br />
Tsongalis, G., 3465T<br />
Tsoutsman, T., 1664T<br />
Tsuda, K., 548W, 558W<br />
Tsui, E., 1034F<br />
Tsuji, S., 52, 233, 2349W,<br />
2409W, 2569T<br />
Tsukahara, M., 2758W<br />
Tsukahara, S., 1980W<br />
Tsukikawa, M., 534W,<br />
2943F<br />
Tsuneda, S. S., 2876T<br />
Tsunemi, T., 565F*, 2456F<br />
Tsung, E., 3670W<br />
Tsunoda, T., 396, 1552F,<br />
1631T, 1643T, 2004W,<br />
2051F, 2071T, 2174F,<br />
3565F<br />
Tsuruda, L., 763W, 784W<br />
Tsurusaki, Y., 2822T, 2878W<br />
Tsz-Wai Pang, R., 2796F<br />
Tu, W., 1969T<br />
Tucker, M., 1012T, 1160F,<br />
1517W<br />
Tucker, M. A., 30, 1010F,<br />
1218W<br />
Tufano, J. T., 1828F<br />
Tuff, J. F., 490W*<br />
Tufik, S., 2592W<br />
Tuggle, C. K., 2717T<br />
Tukiainen, T., 656T, 2173T*<br />
Tully, R., 3582W, 3625F<br />
Tully, R. E., 3732W<br />
Tumini, S., 2777T<br />
Tumino, R., 1712T<br />
Tunca, Y., 590W<br />
Tuncer, F. N., 2396F*,<br />
2412W<br />
Tung, J., 1514W<br />
Tung, J. Y., 106, 114, 626T,<br />
1017W, 1782W, 1838F*,<br />
2089T, 2100W, 2111F,<br />
2115W, 2127W, 2149T<br />
Tuomilehto, J., 1608T<br />
Tupler, R., 1776W<br />
Turbon, D., 3364F<br />
Turbón, D., 3402T<br />
Turecek, F., 727F<br />
Turecki, G., 2338T, 2482T,<br />
3470T<br />
Turk, W., 3276T<br />
Turnbull, C., 213<br />
Turner, A., 1645T*, 1774W<br />
Turner, B., 3528W<br />
Turner, C., 2935W<br />
Turner, C. L. S., 217<br />
Turner, E., 10, 2740W<br />
Turner, E. H., 170<br />
Turner, I., 3279T<br />
Turner, I. H. C., 472W*<br />
Turner, K., 935W<br />
Turner, S., 3228F<br />
Turner, T., 13*<br />
Turnherr, S., 415F<br />
Turnpenny, P., 2935W<br />
Tursi, R. M., 2572T<br />
Turunen, U., 2023T<br />
Tuschl, K., 167*<br />
Tusie-Luna, T., 2256W<br />
Tuulio-Henriksson, A., 252<br />
Tüysüz, B., 3132F*<br />
Tuzov, N., 1562W*<br />
Tuzovic, L., 3046F*<br />
Tweddale, B., 2785W,<br />
2892F, 2904F<br />
Twigg, S. R., 219<br />
Twigg, S. R. F., 218*, 2746W<br />
Tybjærg-Hansen, A.,<br />
Session 21<br />
Tylavsky, F. A., 3480T<br />
Tyler, R. C., 2903T<br />
Tyler, S., 490W<br />
Tyler-Smith, C., 41, 3322F,<br />
3377W<br />
Tymrakiewicz, M., 205,<br />
1011W<br />
Tynan, J., 2973T, 3023T<br />
Tyndale, R. F., 642T<br />
Tynninen, O., 1253F<br />
Tyrer, J., 210<br />
Tyrrell, J., 2148W<br />
Tyynismaa, H., 327<br />
Tzadok, M., 660T<br />
Tzeng, J., 1538W*<br />
Tzeng, J. Y., 1350T<br />
Tzetis, M., 2995T<br />
Tziotzios, C., 33<br />
Tzoulis, C., 2451W<br />
U<br />
U., L., 3395W, 3397W<br />
Uda, M., 110, 113, 847F,<br />
2001W<br />
Udagawa, Y., 475F<br />
Udar, N., 1176W, 1963T,<br />
3686W*<br />
Udd, B., 2945T<br />
Uddin, M., 435F, 448W,<br />
454W*<br />
Udelsman, R., 1241F<br />
Udpa, N., 1471F*, 3307F<br />
Uebe, S., 2160W, 2557T<br />
Uebelhoer, M., 1611T*<br />
Ueffing, M., 86<br />
Uehara, D. T., 891W, 914T<br />
SPEAKER AND AUTHOR INDEX
410 SPEAKER AND AUTHOR INDEX<br />
Uehara, N., 2873T<br />
Ueki, M., 1549F<br />
Ueno, M., 2129F<br />
Ueno, Y., 1549F<br />
Ugolini, D., 1153T<br />
Ugur Iseri, S. A., 2396F,<br />
2412W<br />
Uher, R., 2509T<br />
Uhl, G., 2541W*<br />
Uhlhaas, S., 1005W<br />
Uhlmann, W. R., 317<br />
Uhrich, S., 668T<br />
Uicab-Pool, G., 2272T<br />
Uitterlinden, A., 2366F,<br />
3608W<br />
Uitterlinden, A. G., 87, 109,<br />
431F, 584W, 1284T,<br />
1334W, 1503T, 1659T,<br />
2053T, 2081F, 2105F,<br />
2141F, 2165F, 2169W<br />
UK10K, 809F<br />
UK10K, UKIBDGC, 354<br />
UK10K Cohorts Goup,<br />
1411F<br />
UK10K Consortium, 45,<br />
216, 1518T, 2812W<br />
UK10K Consortium Cohorts<br />
Group, 1522F, 3645F<br />
UK10K Statistics Group,<br />
2304W<br />
UK Brain Expression<br />
Consortium, 374<br />
UK <strong>Genetics</strong> Prostate Cancer<br />
Study Collaborators,<br />
PRACTICAL Consortium,<br />
1011W<br />
Ukkola-Vuoti, L., 2181W<br />
UK PBC Consortium and<br />
Wellcome Trust Case<br />
Control Consortium 3,<br />
153<br />
Ukraintseva, S., 2027F*,<br />
2194T<br />
Ulivi, S., 1484W, 2128T<br />
Ullmann, R., 2732T<br />
Ullmer, B., 3270T<br />
Ulloa, R., 57<br />
Ullrich, N., 3177W<br />
Ulmer, M., 386*, 2135F<br />
Ulz, P., 1115F<br />
Um, S., 1591T<br />
Umana, L. A., 1646T*<br />
Umar, M., 1137W*<br />
Umbach, D. M., 1416T<br />
Umbarger, M., 1729W,<br />
3680W<br />
Umbarger, M. A., 3640W,<br />
3693F*<br />
Umekage, T., 2370W<br />
Umeno, J., 2174F<br />
Umesh, A., 1190F<br />
Umicevic Mirkov, M., 621T*<br />
Underhill, H. R., 2530T*<br />
Underhill, P., 3321T<br />
Underhill, P. A., 186, 3368W<br />
Undlien, D. E., 3510T,<br />
3614W<br />
Unger, S., 129, 3075W<br />
Unique Rare Chromosome<br />
Support, 66<br />
*Presenting Author<br />
United Kingdom and<br />
Ireland Renal Transplant<br />
Consortium, the<br />
Wellcome Trust<br />
Case-Control<br />
Consortium 3, 2082W<br />
Uno, S., 2133W<br />
Unutmaz, D., 713F<br />
Upadhyay, R., 1137W<br />
Uppal, S. S., 2267F<br />
Upsall, E., 3695F<br />
Upton, S., 3176F<br />
Urano, F., 2472W<br />
Urano, W., 2032T<br />
Urban, A., 551F, 579F, 2372F<br />
Urban, A. E., 334*, 369,<br />
425F, 3658W<br />
Urban, Z., 129, 820F*,<br />
2761W<br />
Urbanek, M., 2327F<br />
Urdal, P., 643T<br />
Urnov, F. D., 255, 803W<br />
Uro-Coste, E., 2945T<br />
Urquhart, J., 2852T<br />
Urraca, N., 3119W*<br />
Urru, M., 113, 177<br />
Urru, M. F., 1451W, 1516F<br />
Ursini, M. V., 505F, 2629T<br />
Urtatiz, O., 3225W*<br />
Usala, G., 2001W<br />
Useche, F., 3459T<br />
Usher-Ridge, B., 1785W<br />
Utami, K. H., 3047W*<br />
Utiramerur, S., 1232F,<br />
3670W<br />
Utsumi, Y., 663F<br />
Utz, J., 1855F*<br />
Uwineza, A., 3104F*<br />
Uyama, E., 2409W<br />
Uyar Bozkurt, S., 2429F<br />
Uyenoyama, M., 3392T*<br />
Uyguner, O., 1<br />
Uysal, H., 2924T<br />
Uzumcu, A., 1<br />
Uzun, A., 76*, 3024T<br />
V<br />
Vaags, A., 2525F<br />
Vaags, A. K., 2575T, 3086F<br />
Vaccargiu, S., 2128T<br />
Vaccarino, F., 334<br />
Vaché, C., 2947W<br />
Vachin, P., 72<br />
Vachon, C., 1150T<br />
Vacic, V., 3346F<br />
Vadapalli, A., 971W*<br />
Vadasz, E., 2414F, 2654F<br />
Vadlamudi, S., 1627T,<br />
<strong>2012</strong>F<br />
Værum, M., 3641F, 3662W<br />
Vago, P., 894T<br />
Vaidla, K., 1140W<br />
Vaidya, D., 1652T, 1710T*<br />
Vaidya, S., 1234T*<br />
Vaidyanathan, R., 585F*,<br />
3718W<br />
Vainz<strong>of</strong>, M., 1727W<br />
Vairo, F., 696T*<br />
Vairo, F. P., 1217F<br />
Vaitsiakhovich, T., 1332T<br />
Vakil, H., 130<br />
Valabregue, R., 2539T<br />
Valdes, A., 2292W<br />
Valdes, A. M., 2171F,<br />
2341T*<br />
Valdés-Mas, R., 2578T<br />
Valente, A. L., 1002W*<br />
Valente, E. M., 943W, 2777T<br />
Valentini, M., 157, 1516F<br />
Valenzano, K. J., 732T<br />
Valenzuela, I., 2930T, 3208F<br />
Väliaho, J., 496W<br />
Valladares, O., 342, 2316W<br />
Vallance, H., 750T<br />
Vallant, E., 3116F<br />
Vallat, J. M., 328<br />
Valle, A. C., 2655W<br />
Valle, D., Session 28,<br />
Session 74, 227, 520W,<br />
2387F, 2461T, 2486F,<br />
2566T, 2573F, 3131W<br />
Vallender, E., 595F<br />
Valles-Ayoub, Y., 682T<br />
Vallier, L., 3507T<br />
Valsesia, A., 84<br />
Valverde, K., 1781W<br />
van Aalst, J., 2756T<br />
Vanakker, O., 128, 129, 423F<br />
Vanakker, O. M., 833F,<br />
1790W, 3137W*<br />
van Amstel, J. K. P., 2886F*<br />
van Asperen, C. J., 27<br />
Vanasse, M., 2900T<br />
van Attikum, H., 27<br />
Van Baaren, J. M., 588W<br />
van Beek, R., 955W, 979W<br />
van Beelen, E., 58<br />
van Bers, M., 58<br />
van Beusekom, E., 214<br />
van Bever, Y., 980T<br />
Van Binsbergen, E., 423F<br />
van Bokhoven, H., 100, 102,<br />
125, 160, 214, 2863W<br />
van Bon, B. W. M., 97, 100,<br />
103, 124, 125<br />
Van Booven, D., 9, 3706W<br />
Van Broeckhoven, C., 2815W<br />
van Buggenhout, G., 925W<br />
Van Camp, G., 59, 2104T<br />
Van Cauwenbergh, C., 539F<br />
Vance, D. D., 2185T*<br />
Vance, J., 492W, 2603F*,<br />
2668W, 2755W<br />
Vance, J. M., 270, 347,<br />
588W, 1871F, 2185T,<br />
2330F, 2470T<br />
van Dam, R., 2358W<br />
Van Dam, R., 2165F<br />
Van Damme, P., 201, 2948T<br />
Van Damme, T., 129<br />
van de Bunt, M., 2324F<br />
Van de Heyning, P. H.,<br />
2104T<br />
van de Kamp, J., 98<br />
van de Laar, M. A. F., 621T<br />
van den Akker, E. B.,<br />
1436W*<br />
van den Akker, W. M., 160<br />
Van den Berg, L. H., 431F<br />
Vandenberg, M., 2805F<br />
van den Berg, M. P., 1619T<br />
van den Bergen, J. C.,<br />
574W<br />
van den Boogaard, M. J.,<br />
2886F<br />
van den Boom, D., 2973T,<br />
3014T, 3016T, 3023T<br />
van den Bosch, B., 708T<br />
van den Bree, M. B., 2405F<br />
van den Broek, S., 1117T<br />
Van Den Eeden, S., 96<br />
van den Eijnde, R., 574W<br />
van den Elzen, C., 214<br />
van den Ende, J., 3193W*<br />
van den Heuvel, L., 2909T<br />
van den Linden, H., 2642F<br />
van den Oord, E. J. C. G.,<br />
3442T, 3452T<br />
Van den Veyver, I. B., 2802F,<br />
3495T<br />
Van den Wijngaard, A.,<br />
1711T, 3650W<br />
Van der Aa, N., 127, 423F,<br />
2527T, 2757F, 3193W<br />
van der Brug, M., 1539T<br />
van der Burgt, I., 215<br />
van der Harst, P., 110, 383,<br />
609T, 1659T, 2175W<br />
van der Heyden, M. A. G.,<br />
217<br />
Vander Horn, P., 3698W<br />
van de Rijn, M., 1054T<br />
van der Klauw, M. M.,<br />
2282F<br />
van der Laan, M., 1415W<br />
van der Maarel, S., 2840T*<br />
van der Maarel, S. M., 55,<br />
542W<br />
Van der Merwe, L., 3385F<br />
van der Merwe, L., 2007W,<br />
2217W<br />
van der Most, P. J., 2282F<br />
van der Schouw, Y. T.,<br />
1659T<br />
van der Smagt, J. J., 217<br />
van der Stoep, N., 3650W*<br />
van der Valk, R. J. P., 2168F*<br />
van der Veken, L. T., 3164F*<br />
van der Velde-Visser, S.,<br />
160<br />
Vanderver, A., 2452T,<br />
2786T*, 2797W<br />
van der Vleuten, C. J., 83<br />
van der Vliet, P. J., 55<br />
van der Voorn, 3200F<br />
van der Zee, J., 2815W*<br />
van der Zwaag, B., 2848W,<br />
3650W<br />
van der Zwan, Y., 1122W<br />
van de Vondervoort, I.,<br />
100, 160<br />
van de Warrenburg, B. P., 160<br />
van de Warrenburg, B. P. C.,<br />
1734W<br />
Vandeweyer, G., 1617T<br />
van de Zwan, Y., 1273T<br />
van Diemen, C. C., 1330F<br />
Van Dijck, P., 2948T
van Dijk, F., 459F<br />
Van Driest, S. L., 247*, 631T<br />
Vandrovcova, J., 1618T*<br />
van Duijn, C., Session 27,<br />
1592T, 2080T, 2107T<br />
van Duijn, C. M., 2175W,<br />
2193W, 2366F<br />
van Eerde, A. M., 2848W<br />
Van Eijk, K. R., 431F,<br />
2553W*, 3474T<br />
van Engelen, B., 2840T<br />
VanErp, T., 2564F<br />
van Erp, T. G. M., 2469W*<br />
Van Essen, T., 127<br />
Van Eyk, J., 80<br />
Vangapandu, V., 2979T<br />
van Gassen, K. L. I., 1220F<br />
van Gessel, S., 979W<br />
van Gessel, S. L. J., 955W<br />
Van Ghelue, M., 2965W*<br />
van Gilst, W. H., 609T,<br />
2175W<br />
Vangipuram, M., 803W<br />
Van Goor, F., 1731W<br />
van Haaften, G., 217*,<br />
2886F<br />
van Haelst, M. M., 217,<br />
2886F<br />
van Haren, N. E. M., 2526W<br />
van Harssel, J. J. T., 217<br />
van Hasselt, P., 672T<br />
van Heel, D., 155<br />
van Heel, D. A., 1330F<br />
van Helden, P., 2003F<br />
van Helden, P. D., 2007W<br />
van Heumen, C., 3159W<br />
Van Hirtum-Das, M., 1721W<br />
van Ho<strong>of</strong>t, P., 3316F<br />
Van Hout, C. V., 3269W*<br />
Vanhoutte, L., 2225F<br />
Vanhove, C., 2225F<br />
Van Hove, J. L., 2884W<br />
Van Hul, E., 2757F<br />
van Iperen, E. P. A., 1604T*,<br />
1606T<br />
Vanita, V., 1342F, 1890W,<br />
1891T, 2726T, 2730F,<br />
2735T, 2737W<br />
Van Itallie, C. M., 2663T<br />
van Karnebeek, C., 750T,<br />
756W*<br />
van Klinken, J., 2107T<br />
van Kogelenberg, M., 101,<br />
291, 364*<br />
van Koningsbruggen, S.,<br />
681F*<br />
Van Laarhoven, P., 819F*<br />
Van Laer, L., 79, 80, 1617T*<br />
Van Laere, K., 2527T<br />
Van Langenhove, T., 2815W<br />
van Lieshout, S., 217, 400,<br />
2886F<br />
VanLoy, C., 1237T<br />
Van Luchene, R., 3007T<br />
Van Maldergem, L., 129,<br />
3165W*, 3199W<br />
van Marrewijk, C. J., 243<br />
van Meurs, J. B. J., 584W,<br />
1284T, 1334W, 1503T<br />
Vannier, A., 2877F, 2937F<br />
*Presenting Author<br />
Van Oers, N., 2949F<br />
van Ommen, G., 582W<br />
van Ommen, G. J., 567F<br />
van Rahden, V., 2810T<br />
Van Ravenswaaij, C.,<br />
65, 124<br />
van Reeuwijk, J., 214<br />
van Riel, P. C. L., 621T<br />
van Rooij, F. J. A., 111,<br />
2073W<br />
van Rooij, J., 3608W<br />
van Slegtenhorst, M.,<br />
3650W<br />
van Spaendonck-Zwarts, K.<br />
Y., 1619T, 2909T<br />
van ’t H<strong>of</strong>, F. N. G., 87*<br />
Van Til, N., 796W<br />
van Tintelen, J. P., 1619T,<br />
2909T<br />
van Trotsenburg, A. S. P.,<br />
2701W<br />
van Tuil, M., 2886F<br />
van Vliet-Ostaptchouk, J.,<br />
2282F*<br />
Vanwijck, R., 2002T<br />
van Wyk, C., 1794W<br />
van Zutven, L. J. C. M., 980T<br />
van Zuydam, N. R., 609T<br />
van Zwet, E. W., 1436W<br />
van Zyl, S., 1085F<br />
Varadan, V., 3316F<br />
Vardarajan, B., 343, 1476T*<br />
Vardarajan, B. N., 2563T<br />
Varga, R. E., 2930T<br />
Vargas, E., 3290W<br />
Vargas, F. R., 2642F<br />
Vargas, G., 1119W<br />
Varilo, T., 252, 897W<br />
Varley, K. E., 1245W, 3527F,<br />
3687F<br />
Varma, R., 2153F<br />
Varner, M., 1904F<br />
Varret, M., 1607T*<br />
Varvil, T., 2397W<br />
Vasan, R. S., 1677T, 2080T<br />
Vaschalde, Y., 345<br />
Vasco, D. A., 3326W*<br />
Vasconcellos, J. F., 2655W<br />
Vasconcellos, J. P. C.,<br />
2286W, 2291F<br />
Vasenkova, I. A., 1245W,<br />
3687F*<br />
Vasey, S., 630T<br />
Vasishta, R., 802W<br />
Vasli, N., 2681T<br />
Vasquez, L., 2974T<br />
Vasseur, C., 1768W*<br />
Vassilev, L., 242<br />
Vasta, V., 688T<br />
Vasudevan, R., 1083W<br />
Vatanavicharn, N., 712T<br />
Vats, S., 1703T*<br />
Vatta, M., 314, 1735W,<br />
1742W, 1761W<br />
Vattathil, S., 1041W, 1258T*<br />
Vaughan, B., 3636W<br />
Vaughan, T. L., 2190W<br />
Vaughn, C. B., 1086W*<br />
Vaula, G., 550W<br />
Vaur, D., 32<br />
SPEAKER AND AUTHOR INDEX 411<br />
Vawter, M. P., 2459F,<br />
2469W, 2564F, 3587F<br />
Vaysse, A., 1158W, 2079W,<br />
2248T<br />
Vaz, F., 672T<br />
Vazquez, A. I., 2201F<br />
Vear, S., 247<br />
Veatch, O. J., 15*<br />
Veble, A., 3001T<br />
Vecchio-Pagán, B., 1450F<br />
Vece, T. J., 2883F<br />
Vedantam, S., 108, 2090F,<br />
2241W<br />
Vedes, J., 1977W<br />
Vedrenne, V., 329*<br />
Veenma, D., 834F<br />
Veeramah, K. R., 2788W*,<br />
3354T<br />
Vega, J. N., 2401T*<br />
Veillet, J., 54<br />
Vekemans, M., 77, 403,<br />
915W, 3172F, 3240F<br />
Velagaleti, G., 868T*<br />
Velasco, H., 703F*, 3069W,<br />
3190F<br />
Velazquez-Hernandez, N.,<br />
1121F<br />
Velázquez-Pérez, L., 3124F<br />
Velders, F., 2164T<br />
Veldink, J. H., 431F<br />
Veleri, S., 824F*, 827F<br />
Velez Edwards, D. R.,<br />
2131T, 3299W<br />
Velez-Ruiz, G., 2470T<br />
Velissariou, V., 3017T<br />
Velsher, L., 320, 1872F,<br />
1873F<br />
Veltman, I., 216<br />
Veltman, J., Session 73<br />
Veltman, J. A., 58, 97, 100,<br />
102, 160, 214, 672T,<br />
1749W<br />
Venâncio, M., 3019T<br />
Venceslá, A., 987W<br />
Venditti, C. P., 664T, 669F,<br />
674T, 721F, 738T, 2683W<br />
Venegas, A., 951W, 3074F<br />
Venegas, V., 1251W, 3648W<br />
Venema, A., 542W<br />
Venkat, A., 285<br />
Venkatesan, S., 1456F<br />
Venkateswara Rao, A., 224<br />
Venn, O., 285, 3279T*<br />
Vennemann, M., 86<br />
Venselaar, H., 215, 217<br />
Venter, P. A., 1085F<br />
Ventura, A., Session 76<br />
Ventura, M., 74, 94<br />
Venturini, C., 335, 2068T<br />
Vepsäläinen, S., 2348F<br />
Vera, M., 697F*, 734T<br />
Verbeek, A. L. M., 243<br />
VerBerkmoes, N., 2826F<br />
Verbitsky, M., 845F<br />
Vercelli, L., 1776W<br />
Verchere, C., 3006T<br />
Verdin, H., 2832F, 2927T*<br />
Verdu, P., 3351T<br />
Vergara, C., 1900T<br />
Vergara, C. I., 2043W*<br />
Vergin, C., 2719W<br />
Vergult, S., 98, 423F*<br />
Verheijen, F. W., 405<br />
Verhoeven, A., 2107T<br />
Verioes, A., 2887W<br />
Verkarre, V., 1212W<br />
Verloes, A., 124*, 127, 218,<br />
901W<br />
Verma, A., 1316W<br />
Verma, I. C., 1720W, 1877F,<br />
2754F, 3236F<br />
Verma, J., 1720W<br />
Verma, S., 440W<br />
Vermaas, E., 3694W<br />
Vermaat, M., 3586W, 3611F<br />
Vermeer, S., 160, 1734W<br />
Vermeesch, J., 894T<br />
Vermeire, S., 2319W<br />
Vermeulen, S. H., 87, 106,<br />
243, 621T<br />
Vernalis, M. N., 1649T<br />
Vernet, G., 2255F<br />
Vernon, H., 2915T<br />
Vernon-Smith, A., 109<br />
Vernot, B., 283<br />
Verrow, S., 3654W<br />
Verschuuren, J. J. G. M.,<br />
574W<br />
Verstuyft, C., 609T<br />
Verwaijen, P., 681F<br />
Verweij, N., 110<br />
Verwer, L., 98<br />
Vesa, J., 3144F<br />
Vestbo, J., 2249F<br />
Vester, A., 2470T<br />
Vetrini, F., 735F<br />
Vezain, M., 32<br />
Vézina, H., 1478W<br />
Vial, C., 1658T, 2065T*<br />
Vialard, F., 890T*<br />
Viale, A., 998F, 1159T<br />
Viali, S., 2159F<br />
Viana, J., 3476T<br />
Viana, M. M., 3107W,<br />
3110F*<br />
Vianna, G. S., 2434T<br />
Vianna-Morgante, A. M.,<br />
874T, 882T, 2863W,<br />
3250F<br />
Viatte, S., 2231F<br />
Vicari, S., 84, 3087W<br />
Vicente, A. M., 1968W,<br />
2017T, 2261F, 2417F,<br />
2502W<br />
Vidal, H., 2278T<br />
Vidal, M., 2660F<br />
Vidal, R., 394, 1207T,<br />
1215W*<br />
Vidal, V., 1204T<br />
Vieira, A. R., 1315F, 1936T<br />
Vieira, F., 3312T<br />
Vieira, F. G., 3289F*<br />
Vieira, M. L., 2288F<br />
Vieira, T., 1851F*, 1865F*<br />
Vieira, T. P., 959W<br />
Vieland, V. J., 2181W,<br />
2467T, 2523W*<br />
Vierkant, R. A., 3451T<br />
Vigeland, M., 1547W*<br />
Vigneron, J., 2770W<br />
SPEAKER AND AUTHOR INDEX
412 SPEAKER AND AUTHOR INDEX<br />
Vigouroux, A., 2957T<br />
Vigueras, R. M., 2365T<br />
Vihinen, M., 496W*, 992F,<br />
3610W<br />
Vihola, A., 2945T<br />
Viikari, J., 2097W, 2120F<br />
Viikari-Juntura, E., 2120F<br />
Vijai, J., 208, 1841W<br />
Vijayalakshmy, J., 911W<br />
Vijayarangakannan, P., 291,<br />
455F*<br />
Vijzelaar, R., 652T<br />
Vikkula, M., 83, 1015T,<br />
1611T, 2002T, 3156F<br />
Vikman, P., 47<br />
Vikram, N., 555F<br />
Vila, L. M., 1979F<br />
Vilain, E., 315, 361, 950T<br />
Vilar, M., 3373F<br />
Vilar, M. G., 3329W, 3377W<br />
Vilarino-Guell, C., 346*,<br />
2537F<br />
Vilboux, T., 3080F*<br />
Vilhelmsen, K., 363<br />
Vilhjalmsson, B., 350,<br />
1331W*, 1360F, 2199W,<br />
2210F<br />
Villa, E. C., 2495F<br />
Villamarin, R., 3625F<br />
Villamarin-Salomon, R.,<br />
3582W<br />
Villani, A. C., 528W<br />
Villanueva, C., 2845W<br />
Villanueva Dávalos, V.,<br />
2033F<br />
Villar, J., 2296T<br />
Villar, V., 245<br />
Villard, L., 2457W, 2536T,<br />
3165W<br />
Villarreal-Quiroga, P., 1030T<br />
Villarroel, C., 875W, 976T<br />
Ville, D., 2536T<br />
Ville, Y., 72, 77, 403<br />
Villela, D., 919W*<br />
Villems, R., 3286F<br />
Vilo, J., 1163F<br />
Vilske, S., 1006T<br />
Vimaleswaran, K. S., 271*<br />
Viñas, M., 2940F<br />
Vinasco, T., 3069W*<br />
Vincent, J., 2525F<br />
Vincent, J. B., 2398T,<br />
2570F*, 2575T<br />
Vincent, M., 1267T, 3121W*<br />
Vincent, Q., 1361W<br />
Vincenzi, O. C., 1037F,<br />
1038W*<br />
Vinci, M., 3114F<br />
Vinckenbosch, N., 3311W<br />
Vineis, P., 1712T<br />
Vinette, K. M., 2855T<br />
Vink, C., 3159W<br />
Vinkler, C., 3048F*, 3162F,<br />
3174F<br />
Vinod, B., 2113T<br />
Vinson, A., 2218T*<br />
Vinther-Jensen, T., 2765T<br />
Viñuela, A., 546W<br />
Viola, M., 2811F<br />
Viqaruddin, M., 3149W<br />
*Presenting Author<br />
Virani, S., 1688T<br />
Virdis, F., 1516F<br />
Virmond, M. L. C., 2289W<br />
Virmouni, S., 761W<br />
Virtamo, J., 1012T, 1091F<br />
Visakorpi, T., 1000T<br />
Viscardi, R. M., 3027T<br />
Viscidi, R. P., 2561F<br />
Visel, A., 4, 254, 407<br />
Vishwabandya, A., 931W<br />
Visitacion, M., 3669F<br />
Visitacion, M. R., 3709F*<br />
Viskochil, D., 3177W<br />
Visscher, P., 1360F, 2090F,<br />
2200T<br />
Visscher, P. M., 108, 351,<br />
1331W, 2366F<br />
Visser, G., 681F<br />
Visser, J., 2165F<br />
Vissers, L. E. L. M., 97, 100,<br />
102, 160, 214, 215, 672T,<br />
1749W, 2925F<br />
Vista, E. S., 529F, 2188T<br />
Viswanathan, A. C., 2068T<br />
Viswanathan, K., 1901F<br />
Vitale, C., 1985F<br />
Vitale, E., 1985F*, 3492T<br />
Vitart, V., 1383T, 1481W<br />
Vite, C. H., 785W<br />
Vitello, A., 100<br />
Vitiello, G., 943W<br />
Vittori, A., 2641T*<br />
Vivekandandan, S., 3316F<br />
Vives, L., 10, 278<br />
Vlasschaert, M., 460W<br />
Vlassov, A. V., 3723F<br />
Vlummens, P., 129<br />
Vnencak-Jones, C. L., 136<br />
Vo, D., 585F, 893W<br />
Vockler, J. S., 3558W<br />
Vockley, J., 657F*, 662T,<br />
733F<br />
Voegele, C., 1213T<br />
Voelkerding, K. V., 2720T,<br />
2951T, 3638W, 3643F<br />
Voest, E., 400<br />
Vogel, I., 3148F<br />
Vogel, J., 506W<br />
Vogel, K. J., 1225T<br />
Vogel, M., 3650W<br />
Vogel, S. N., 3027T<br />
Vogel, T. W., 404<br />
Vogel, W., 1080W<br />
Voglino, F., 1153T, 1712T<br />
Vogt, G., 3599F<br />
Vogt, J., 939W, 2791W*<br />
Vogt, S., 1005W, 3109W<br />
Voight, B. F., Session 21<br />
Voinea, S., 1439W, 3678W<br />
Voineagu, I., 553F<br />
Voit, T., 2812W<br />
Volar, M., 1093T<br />
Volders, P. G. A., 1711T<br />
Völker, U., 275<br />
Völker-Albert, M. C., 27<br />
Vollenweider, P., 1281T,<br />
2165F<br />
Vollrath, D., 2154W, 2240F,<br />
2263T<br />
Volpi, E., 509F<br />
Volpini, V., 2627F*<br />
Volta, M., 3471T<br />
Völzke, H., 584W, 1954T,<br />
2123F, 2147F<br />
Von Allmen, G., 2395T<br />
von Dadelszen, P., 3429T,<br />
3445T<br />
Vondracek, P., 2812W<br />
VonHoldt, B., 2219F<br />
von Kleist-Retzow, J. C.,<br />
2944W<br />
Von Kuster, G., 3545F<br />
Vonsattel, J. P., 2547W<br />
Vooder, T., 1163F<br />
Voorhees, J. J., 154, 1952F<br />
Voorhoeve, E., 98*<br />
Voorman, A., 174<br />
Vorgia, E., 218<br />
Vorstman, J. A. S., 431F<br />
Vos, Y. J., 1619T*<br />
Võsa, U., 1163F<br />
Vosatka, A., 2220W<br />
Voshol, P., 2701W<br />
Voss, K., 383<br />
Vrabec, K., 3381T<br />
Vranas, M., 2699T<br />
Vreeswijk, M. P. G., 27<br />
Vrettou, C., 2995T<br />
Vrielynck, P., 3218F<br />
Vriend, G., 217<br />
Vrieze, S., 1568W<br />
Vrijenhoek, T., 1870F*<br />
Vrints, C., 1617T<br />
Vu, A., 1147T<br />
Vu, B. J., 803W<br />
Vu, T., 14, 1716W<br />
Vuillaume, M. L., 473F<br />
Vuillemenot, B., 784W*<br />
Vuillot, A., 126<br />
Vulto-van Silfhout, A. T., 97,<br />
100, 125*, 160<br />
Vyhlidal, C., 811F<br />
Vyse, T. J., 306, 2005T,<br />
2046W, 3382F<br />
W<br />
Wachihi, C., 3276T<br />
Wacholder, S., 1413T<br />
Wacklin, P., 2023T<br />
Wada, T., 2836W*<br />
Waddell, L. B., 295<br />
Wade, K. H., 1626T*<br />
Wadelius, C., 617T, 619T<br />
Wadelius, M., 617T, 619T<br />
Waeber, G., 1281T<br />
Waetjen, L. E., 2360F<br />
Wafa, A., 1922F<br />
Waffern, F., 3076F<br />
Wagemaker, G., 796W<br />
Wagenknecht, L. E., 1661T,<br />
2275T<br />
Waggoner, D. J., 3398T<br />
Wagman, C., 2007W<br />
Wagner, E., 1098W*, 1969T<br />
Wagner, J., 1850W*<br />
Wagner, J. K., 2223W<br />
Wagner, K., 3116F<br />
Wagner, K. R., 2962W<br />
Wagner, M., 2143T<br />
Wagner, P., 638T<br />
Wahl, C., 2965W<br />
Wahlberg, P., 3427T*<br />
Wahlfors, T., 995F, 1000T,<br />
1302T<br />
Wahlgren, C. F., 1939T<br />
Wahren-Herlenius, M., 2084F<br />
Waide, E. H., 2717T<br />
Wain, K. E., 1058F<br />
Wainstein, T., 1794W*<br />
Waisfisz, Q., 3200F, 3650W<br />
Waite, L., 434W, 1608T,<br />
3443T<br />
Wakabayashi, Y., 586W*<br />
Wakahiro, M., 196, 2389T<br />
Wakamatsu, N., 2748F<br />
Wakefield, D. B., 3449T<br />
Wakefield, J., 294<br />
Wakefield, S., 658T<br />
Wakelam, M. J. O., 33<br />
Wakeland, B., 1901F, 2949F<br />
Wakeland, E., 2284T*,<br />
2949F<br />
Wakeland, E. K., 1901F<br />
Walcott, F., 1064F<br />
Walczak, A., 597F<br />
Waldan, I., 1498F<br />
Waldek, S., 772W<br />
Waldispuehl-Geigl, J.,<br />
1115F<br />
Waldman, I. D., 2515T*<br />
Wali, N., 37<br />
Walia, A., 3370F<br />
Walia, A. T., 3329W<br />
Walia, G. K., 3455T<br />
Walker, C., 940T*, 3479T<br />
Walker, D., 2516F<br />
Walker, D. L., 605T<br />
Walker, H., 953W<br />
Walker, J. A., 3270T<br />
Walker, M., 1624T, 2116T,<br />
3455T<br />
Walker, N., 453F<br />
Walker, R., 374, 564W<br />
Walker, S., 175*, 2575T,<br />
2617T, 2620T<br />
Wall, J., 285<br />
Wall, J. D., 3354T<br />
Wall, S. A., 218, 2151W<br />
Wallace, A., 2054F<br />
Wallace, D., Session 56<br />
Wallace, D. C., 3653F<br />
Wallace, J., 1667T, 3542W<br />
Wallace, J. R., 3624W<br />
Wallace, M., 1261T<br />
Wallace, P. K., 3523T<br />
Wallace, R., 2020T<br />
Wallasch<strong>of</strong>ski, H., 275,<br />
2080T<br />
Wallenhorst, E., 953W<br />
Wallentin, L., 617T, 619T<br />
Waller, K., 1736W<br />
Walley, K. R., 1632T<br />
Wallum, H., 2509T<br />
Walrafen, P., 3522T<br />
Walsh, C. A., 8, 266, 452W,<br />
2613W<br />
Walsh, D., 2500T, 2504F,<br />
2594F, 2599T
Walsh, J., 1216T<br />
Walsh, M., 889W<br />
Walsh, T., 26, 263, 287,<br />
1089W, 1226F*, 1228T,<br />
2600F, 2756T, 2929W<br />
Walston, J., 1920W<br />
Walter, K., 61, 1518T<br />
Walter, L., 96, 112, 118,<br />
230, 620T, 2513F<br />
Walter, M., 236, 575F,<br />
1200W<br />
Walter, M. A., 1951T<br />
Walter, M. C., 2961F<br />
Walter, P. J., 1398T*<br />
Walters, K. A., 2523W<br />
Walters, L., 456W*<br />
Walters, N., 506W<br />
Walters, R., 1067F<br />
Walther, D., 2541W<br />
Walther, S., 140<br />
Walton, K., 32<br />
Walz, K., 794W, 2672T,<br />
2837T*<br />
Wambebe, C., 3303T,<br />
3338W<br />
Wan, E., 2057F, 2249F<br />
Wan, J., 2511W<br />
Wan, W., 3495T<br />
Wanamaker, S. A., 2660F<br />
Wand, G. S., 2391W<br />
Wanderley, H. Y., 2642F<br />
Wang, A., 3213W<br />
Wang, B., 462W, 519F,<br />
616T, 2203T, 3620W<br />
Wang, B.-J., 3029T<br />
Wang, C., 398, 864T,<br />
1010F, 1112F, 1170W,<br />
1218W<br />
Wang, C. C., 3379F<br />
Wang, D., 1591T, 2221T,<br />
2251T, 3428T, 3485T*<br />
Wang, D. Y., 1887W<br />
Wang, E., Session 24<br />
Wang, E., 2978T<br />
Wang, F., 457F, 1779W*,<br />
1974W, 1997F, 2252F,<br />
2623T, 2721F, 2910F,<br />
3684W<br />
Wang, G., 19, 93, 1369F,<br />
1554T*, 2028W, 2318F,<br />
2337W, 3026T<br />
Wang, G. L., 1974W<br />
Wang, G.-L., 457F<br />
Wang, G. T., 2336F<br />
Wang, H., 255, 458W*,<br />
511F, 1472W, 1779W,<br />
1905W, 2910F, 2921T<br />
Wang, H. M., 2245T*<br />
Wang, I., 544W*<br />
Wang, I. X., 370<br />
Wang, J., 159, 462W,<br />
480W, 503F, 683F*,<br />
962T*, 1235F, 1369F,<br />
1578T*, 1650T, 1685T*,<br />
1750W, 2184W, 2311T,<br />
2317T, 2347T, 2390F,<br />
2452T, 2582F, 2617T,<br />
3168F, 3237W*, 3300T,<br />
3311W, 3334F, 3428T,<br />
3561F<br />
*Presenting Author<br />
Wang, J. C., 3416T<br />
Wang, J.-H., 457F*,<br />
2623T<br />
Wang, J. H., 1974W<br />
Wang, J. J., 2094W<br />
Wang, J. M., 462W<br />
Wang, K., 1889F, 2872W,<br />
3415T, 3532W, 3561F,<br />
3660W<br />
Wang, L., 116, 123, 347,<br />
492W*, 603T, 1010F,<br />
1218W, 1247F, 1291F,<br />
1635T, 1638T, 1974W,<br />
2185T, 2259W, 2583W,<br />
2603F<br />
Wang, L. L., 1034F<br />
Wang, L.-S., 342*, 343,<br />
2316W<br />
Wang, L. S., 1571W<br />
Wang, M., 314, 1292W,<br />
1735W, 1742W, 1757W,<br />
1761W, 2331W, 2617T,<br />
2880F, 2934F, 3308W*<br />
Wang, M. H., 1466W*<br />
Wang, M. Q., 1910F<br />
Wang, M.-S., 457F<br />
Wang, P., 1499W*<br />
Wang, P. H., 3730W<br />
Wang, Q., 206, 308, 2114F,<br />
2170T, 2494T, 3000T*,<br />
3582W, 3620W<br />
Wang, R., 1359T, 2461T,<br />
2486F, 2573F, 2895F<br />
Wang, S., 549F*, 566W,<br />
1417F, 1666T, 2388W,<br />
2390F, 2574W*, 3358F<br />
Wang, S.-N., 3029T<br />
Wang, S. R., 1960T*<br />
Wang, T., 889W, 1333F,<br />
1494T, 1608T, 2566T,<br />
2661W, 2806W*, 3016T,<br />
3097W, 3474T<br />
Wang, W., 319, 1555F,<br />
2229W, 3561F, 3589F*,<br />
3691F<br />
Wang, X., 207, 257*, 909W,<br />
1219T, 1367W*, 1418W*,<br />
1460W, 1464T, 1474F,<br />
1672T, 1673T, 1774W*,<br />
2034W, 2099F, 2125T,<br />
2142W, 2156F*, 2158T,<br />
2178W, 2189F, 2521T,<br />
2802F, 2834T, 2880F,<br />
2921T, 3026T, 3078F,<br />
3418T, 3486T*, 3619F*,<br />
3652W<br />
Wang, X. B., 1647T*<br />
Wang, X. T., 3416T<br />
Wang, X.-W., 457F, 2623T<br />
Wang, Y., 133, 507F,<br />
511F*, 657F, 864T*,<br />
1004F, 1146W, 1291F,<br />
1986W, 2279F, 2280W,<br />
2357F*, 2511W, 2617T,<br />
2721F, 3029T, 3081W*,<br />
3311W, 3317W, 3355F,<br />
3493T<br />
Wang, Y.-H., 2824W<br />
Wang, Y. P., 2053T<br />
Wang, Y. S., 972T*, 1586T<br />
SPEAKER AND AUTHOR INDEX 413<br />
Wang, Z., 213, 245, 519F*,<br />
616T, 1010F, 1088F,<br />
1160F*, 1259F*, 1420F*,<br />
2587T, 2819T, 3657F*<br />
Wang, Z.-G., 457F<br />
Wang, Z. G., 2985T*<br />
Wang-Sattler, R., 2226W,<br />
2548T<br />
Waqar, F., 1673T<br />
Warburton, D., 957W,<br />
1600T*<br />
Warby, S., 2543F*<br />
Ward, E., 3113W<br />
Ward, L., 1216T<br />
Ward, L. D., 3291T*<br />
Ward, M., 3625F<br />
Ward, M. H., 3582W<br />
Ward, P., 1742W<br />
Ward, P. A., 1735W, 1761W<br />
Ward-Caviness, C. K.,<br />
1636T*<br />
Ware, R. E., 648T, 2331W<br />
Ware, S., 1674T, 2698W<br />
Wareham, N. J., 43, 1553W,<br />
1626T, 1686T, 2282F,<br />
2359T<br />
Warman Chardon, J., 198*<br />
Warner, A., 249<br />
Warner, J., 549F<br />
Warner, N., 1320T<br />
Warnich, L., 644T<br />
Warnke, A., 1976F<br />
Warraich, S., 2816T<br />
Warram, J. H., 2313W<br />
Warren, L., 1686T<br />
Warren, P., 2904F<br />
Warren, R., 2217W<br />
Warren, R. L., 375<br />
Warren, S., 540W, 2464T<br />
Warren, S. T., 2576F<br />
Warren, W., 2262W, 2320T*,<br />
2343W<br />
Warrington, N., 2164T<br />
Warrington, N. M., 2162F<br />
Wary, C., 2539T<br />
Washington, A. V., 3315T<br />
Wassel, C. L., 170, 1661T<br />
Wasserscheid, J., 2262W<br />
Wasserstein, M. P., 958T<br />
Wassif, C. A., 162*<br />
Wassink, T., 2493W<br />
Wassink, T. H., 422W*<br />
Wasson, K., 1822F*<br />
Waszak, S., 415F, 551F<br />
Wat, J. J., 834F<br />
Wat, M., 839F<br />
Wat, M. J., 834F<br />
Watanabe, A., 1697T*,<br />
2400W<br />
Watanabe, H., 3221W<br />
Watanabe, R., 1362T<br />
Watanabe, R. M., 46<br />
Watanabe, Y., 724T*, 842F*,<br />
2727F<br />
Watanabe-Makino, K., 396<br />
Waterham, H. R., 681F<br />
Waters, A., 199<br />
Waters, C., 442W<br />
Waters, J. P., 2312F<br />
Waters, W., 978T<br />
Waterworth, D., 1686T*<br />
Waterworth, D. M., 649T<br />
Watkins, D., 673F, 705F,<br />
706T, 719F<br />
Watkins, H., 115<br />
Watkins, J. C., 3389W<br />
Watkins, L., 3644W*<br />
Watkins, W. S., 195, 600F,<br />
3378T<br />
Watman, N., 773W<br />
Watrin, E., 2958F<br />
Watrin, F., 2457W<br />
Watson, C. T., 375<br />
Watson, H., 2043W<br />
Watson, M., 3530W<br />
Watson, R., 83<br />
Watson, S. J., 2163W<br />
Watt, G., 1626T<br />
Watt, J., 967W<br />
Watt, S., 135<br />
Wattanasirichaigoon, D.,<br />
2755W, 2918T<br />
Watts, A. C., 287, 2600F*<br />
Watts, G. J., 3213W<br />
Watts, G. S., 3712W*<br />
Waubant, E., 1924T<br />
Waxman, S. G., 2448W<br />
Wayne, R. K., 2219F<br />
Weale, M. E., 374*, 564W,<br />
1470T, 1927T, 2082W,<br />
2804T, 3348T<br />
Weaver, D. T., 1171T<br />
Webb, A. A., 2517W<br />
Webb, A. E., 66<br />
Webb, B. D., 2928F*<br />
Webb, B. T., 2277W, 2500T,<br />
2504F, 2594F*<br />
Webb, S., 315<br />
Webber, C., 445F, 2476T<br />
Weber, C., 456W, 912T<br />
Weber, T. K., 1130F<br />
Webster, A. R., 2072F<br />
Webster, J., 2301W<br />
Webster, T., 493F, 1582F<br />
Weckselblatt, B., 938T*<br />
Wedel, R., 203<br />
Weedon, M., 2709F,<br />
2935W<br />
Weedon, M. N., 108, 1624T,<br />
2148W<br />
Weeks, D. E., 22, 1464T,<br />
1474F, 1963T, 2142W,<br />
2156F, 2159F, 2178W<br />
Weersma, R., 461F<br />
Wegmann, D., 476W, 3406T<br />
Wehby, G. L., 1564F*,<br />
1937F<br />
Wehrens, X., 667F<br />
Wei, C., 1995W<br />
Wei, J., 1259F, 1736W,<br />
3065W<br />
Wei, J. J., 2698W, 2895F*<br />
Wei, L., 31, 2237F, 2605T,<br />
3604W<br />
Wei, P., 1157F*<br />
Wei, Q., 1291F<br />
Wei, X. C., 3141W<br />
Wei, Z., 319*, 2121W,<br />
2229W, 3561F<br />
Weichenthal, M., 154<br />
SPEAKER AND AUTHOR INDEX
414 SPEAKER AND AUTHOR INDEX<br />
Weidinger, S., 1939T, 1942T,<br />
2102F, 2226W<br />
Weihbrecht, K., 323,<br />
2690T*<br />
Weinberg, C. R., 1416T<br />
Weinberg, S., 1937F<br />
Weinberg, S. M., 1315F<br />
Weinberger, D., 2444F<br />
Weiner, A., 2673F<br />
Weinreb, R. N., 2154W,<br />
2240F, 2263T<br />
Weinshilboum, R., 1247F<br />
Weinstein, D. A., 2712F<br />
Weinstein, G., 123<br />
Weinstein, P., 611T<br />
Weinstein, S., 1012T<br />
Weinstock, G., 2325W,<br />
2343W<br />
Weinstock, G. M., 2262W,<br />
2320T<br />
Weir, B., 294<br />
Weir, J., 3663F<br />
Weir, J. C., 366<br />
Weir, J. M., 2308T<br />
Weis, J., 2681T<br />
Weis, M., 222, 2853F<br />
Weis, M. A., 2854W<br />
Weisburd, J., 1338T<br />
Weisenberger, D., 3415T<br />
Weisfeld-Adams, J. D.,<br />
168*, 958T<br />
Weiss, J., 2833W, 3020T<br />
Weiss, K. M., 194*, 1563T,<br />
2179T, 2208W<br />
Weiss, L., 99<br />
Weiss, L. A., 1274F, 2421W,<br />
2555F, 3242F<br />
Weiss, L. W., 2510F<br />
Weiss, M., 53, 98<br />
Weiss, M. M., 3200F*,<br />
3650W<br />
Weiss, R., 538W*<br />
Weiss, S., 536W<br />
Weiss, S. M., 1225T<br />
Weiss, S. T., 622T, 623T,<br />
638T, 811F, 2166W<br />
Weissglas, D., 2256W*<br />
Weissman, M. M., 369,<br />
2372F<br />
Weissman, S., 334, 425F,<br />
551F, 579F<br />
Weissman, S. M., 1225T<br />
Weitzel, J., 321<br />
Weitzel, J. N., 1071W,<br />
1219T<br />
Weksberg, R., 1872F, 1873F,<br />
3420T*, 3447T, 3456T,<br />
3482T, 3489T<br />
Welch, R. P., 34*<br />
Welch, S., 135, 1824F<br />
Welford, R., 684T<br />
Wellcome Trust Case Control<br />
Consortium, 1466W<br />
Wellcome Trust Case<br />
Control Consortium<br />
(WTCCC2), 1313W<br />
Wells, D. W., 1242W<br />
Wells, J. M., 2189F<br />
Wells, R. S., 3329W, 3349F<br />
Wells, S., 3377W*<br />
*Presenting Author<br />
Welsh-Bohmer, K., 2465F<br />
Welter, D., 2108F<br />
Wen, F., 549F, 566W*<br />
Wen, J., 2977T*<br />
Wen, R., 2668W<br />
Wen, S., 3495T*<br />
Wen, X., 273, 1429F,<br />
1463W*<br />
Wen, Y., 399<br />
Wencel, M., 3144F<br />
Wendland, J., 260, 2622W<br />
Wendland, J. R., 261<br />
Wendschlag, A., 515F<br />
Wendt, D., 763W<br />
Wendt, J., 3688W<br />
Wendt, K. S., 2958F<br />
Weng, Y., 1689T, 3467T<br />
Weng, Z., 397<br />
Wenger, D. A., 2805F<br />
Wenger, N., 611T<br />
Wennerström, A., 3258T*<br />
Wentworth, B., 767W,<br />
1698T<br />
Wentzel, S., 309<br />
Wenz, M., 3708W<br />
Werling, D. M., 2551T,<br />
2658W*<br />
Werneck, R., 1899W<br />
Werneck, R. I., 1978T<br />
Wernig, M., Session 78<br />
Wernovsky, G. W., 2443T<br />
Wert, K. J., 393*<br />
Wertelecki, W., 302*<br />
Wesfeld-Adams, J. D.,<br />
3145W<br />
Weslow-Schmidt, J., 912T<br />
Wessman, M., 2348F<br />
West, A. B., 1235F<br />
West, C., 1965W<br />
West, J. D., 2511W, 2531F<br />
West, R., 397<br />
West, R. B., 1054T<br />
Westbroek, W., 199<br />
Westbrook, J., 1771W*<br />
Westbrook, M. J., 631T<br />
Westendorp, R., 2080T<br />
Westerfield, M., 2725W<br />
Westerman, M. P., 434W<br />
Westgate, K., 2359T<br />
Westh<strong>of</strong>, E., 522W<br />
Westlake, C., 1088F<br />
Weston, N., 2098T<br />
Westra, H., 584W, 1284T*,<br />
1503T<br />
Westra, H.-J., 523F, 1621T,<br />
2088W<br />
Weterman, M. A. J., 2909T*<br />
Wettrell, G., 2699T<br />
Wever, O. R., 3363T<br />
Wevers, R. A., 160, 167,<br />
672T<br />
Wey, G., 730T<br />
Weyant, R., 2034W, 3406T<br />
Weyant, R. J., 1464T, 1474F,<br />
2142W, 2156F, 2178W<br />
Whalen, M. B., 1516F<br />
Wheaton, D. K., 3234F<br />
Wheelan, S., 1229F<br />
Wheeler, B., 1306F<br />
Wheeler, D., 2880F<br />
Wheeler, D. A., 1221W,<br />
1231T<br />
Wheeler, E., 43*<br />
Wheeler, M., 1601T, 2292W,<br />
3232F<br />
Wheeler, W., 1010F<br />
Wheeler, W. A., 1372F<br />
Whelan, F., 639T<br />
Whigham, B., 386<br />
Whincup, P. H., 1626T<br />
Whirl-Carrillo, M., 633T,<br />
635T<br />
Whitacre, J., 3697F<br />
White, C., 2184W<br />
White, C. C., 1599T<br />
White, H., 454W<br />
White, J., 2701W<br />
White, J. G., 2838F<br />
White, J. K., 105<br />
White, K. P., 614T<br />
White, M., 245*<br />
White, P., 2904F, 3530W<br />
White, P. S., 3590W*<br />
White, R., 37<br />
White, R. S., 1989W<br />
White, S., 506W, 1911W,<br />
2801T<br />
White, S. J., 1122W, 1273T*<br />
White, S. M., 131, 2925F<br />
White, W., 1715T<br />
Whitehead, P., 2330F*,<br />
2508W, 2637W<br />
Whitehead, P. L., 9, 270,<br />
2028W, 2049W, 2318F,<br />
2445W, 2572T, 2583W,<br />
2586W, 2614T<br />
Whitehead, P. W., 341<br />
Whitehouse, A., 2164T<br />
Whitehouse, P. J., 317<br />
Whiteman, D., 2190W<br />
Whitfield, J. B., 2212T<br />
Whiting, R., 784W<br />
Whitley, C., 714T, 715F<br />
Whitley, C. B., 801W*<br />
Whitley, W., 1855F<br />
Whitmer, R., 96<br />
Whitsel, E., 2337W<br />
Whittaker, J., 1257W, 1387F<br />
Whittemore, A., 1001F<br />
Whittemore, A. S., 1214F<br />
Whittington, D., 1854F<br />
Whyte, J., 1133F<br />
Whyte, M. P., 2864T<br />
Wibrand, F., 702T<br />
Wichmann, H.-E., 1942T,<br />
2103W, 2160W, 2226W<br />
Wickstrom, E., 797W<br />
Widagdo, J., 2796F<br />
Widen, E., 2059T, 2134T<br />
Widén, E., 2097W<br />
Wide Pissetti, C., 1593T<br />
Wie, J., 2437T<br />
Wieacker, P., 2595W<br />
Wieben, E., 1247F<br />
Wieczorek, D., 2356T,<br />
2595W<br />
Wiedau-Pazos, M., 2661W<br />
Wiederkehr, M., 415F<br />
Wiegand, M., 2567F<br />
Wiegant, W. W., 27<br />
Wieland, T., 567F, 582W,<br />
2567F, 2595W*, 2917W,<br />
2922F<br />
Wiemels, J., 2268W<br />
Wienker, T. F., 3550W<br />
Wieselquist, L., 1820F<br />
Wieskamp, N., 1749W<br />
Wiesner, G., 3097W<br />
Wiest, J. S., 1454W<br />
Wigg, K., 3509T<br />
Wiggs, J., 2135F<br />
Wiggs, J. L., 1887W,<br />
2154W, 2240F, 2263T<br />
Wigler, M., 1600T, 2587T<br />
Wigner, C., 935W<br />
Wiitala, K., 3331F<br />
Wijburg, F. A., 681F<br />
Wijdicks, M., 3688W*<br />
Wijmenga, C., 155, 461F,<br />
523F, 1284T, 1330F,<br />
1503T, 2088W<br />
Wijmenga, S. S., 2696T<br />
Wijsman, E., 1541W<br />
Wijsman, E. M., 1605T,<br />
2406W, 2549F<br />
Wiklund, F., 28, 205, 991T,<br />
1001F, 1148F, 1189T,<br />
1214F, 1990T<br />
Wilcox, A., 1564F<br />
Wilcox, A. J., 1472W<br />
Wilcox, E. R., 2724F<br />
Wilcox, W., 753T<br />
Wilcox, W. R., 712T<br />
Wild, P. S., 275, 1669T<br />
Wild, S., 1481W<br />
Wild, S. H., 1383T<br />
Wilde, J., 2958F, 3725F<br />
Wilde, S., 1669T<br />
Wildenauer, D. B., 2407T*<br />
Wildenauer, M. D. B., 2407T<br />
Wilder, J. A., 988T, 3314W*<br />
Wildman, D., 435F<br />
Wildsoet, C. F., 3521T<br />
Wiley, G., 1901F<br />
Wiley, G. B., 549F<br />
Wiley, L., 312*, 2321F<br />
Wiley, V., 166<br />
Wilfong, A. A., 2395T<br />
Wilhelmsen, K., 2489F, 2542T<br />
Wilhelmsen, K. C., 231<br />
Wiliams, N. M., 2405F<br />
Wilichowski, E., 758W<br />
Wilk, A., 44, 3441T<br />
Wilke, M., 696T<br />
Wilke, R. A., 647T<br />
Wilkens, A., 2904F, 3038F,<br />
3082F<br />
Wilkens, L., 2042F<br />
Wilker, E., 3469T<br />
Wilkie, A. O. M., 218, 219,<br />
2151W, 2746W, 3070F<br />
Wilkins-Haug, L. E., 70<br />
Wilkinson, R., 3332W<br />
Wilkinson, S., 3720W<br />
Willaert, A., 833F<br />
Willard, H. F., 147<br />
Willard, M., 1369F<br />
Willard, M. D., 1235F*<br />
Willatt, L., 3109W<br />
Willems, M., 3166F*
Willems, S. M., 1308T,<br />
2076W, 2116T, 2137T<br />
Willemsen, M. A., 100, 160,<br />
214<br />
Willemsen, M. A. A. P., 125,<br />
1734W<br />
Willemsen, M. H., 97, 100,<br />
102*<br />
Willemsen, R., 513F<br />
Willems van Dijk, K., 228,<br />
2107T<br />
Willenborg, C., 115, 119,<br />
1308T, 2076W<br />
Willer, C., 117*<br />
Willer, C. J., 170, 2090F<br />
Willer, J., 2458T<br />
Willer, J. R., 3<br />
Willer, T., 2812W<br />
Williams, A., 178, 3360T<br />
Williams, A. H., 1979F<br />
Williams, A. L., 48*<br />
Williams, B., 1765W<br />
Williams, C., 3126F*<br />
Williams, D. C., 2517W<br />
Williams, F. M. K., 503F<br />
Williams, G., 132<br />
Williams, H., 1325W<br />
Williams, I. M., 162<br />
Williams, J., III, 3020T<br />
Williams, K. L., 2816T*<br />
Williams, M. S., 3581F<br />
Williams, P. M., 1068W<br />
Williams, R. B., 1594T,<br />
2481W<br />
Williams, R. C., 1348F*<br />
Williams, S., 1668T, 3388F<br />
Williams, S. M., 245, 606T,<br />
1634T, 2572T, 3275W*<br />
Williams, S. R., 123*<br />
Williams, T. C., 3713F<br />
Williams, T. N., 2157W<br />
Williams-Blangero, S.,<br />
1280W<br />
Williamson, A. L., 1073F<br />
Williamson, D., 530W<br />
Williamson, K., 3072F<br />
Williford, B., 949W<br />
Willing, M. C., 220<br />
Willis, A., 314, 1735W,<br />
1742W, 1761W<br />
Willis-Owen, S. A. G.,<br />
3466T, 3469T, 3486T<br />
Willsey, A. J., 375, 2605T<br />
Willuweit, S., 3364F, 3402T<br />
Wilnai, Y., 3053W*<br />
Wilson, A. F., 1347T, 1396F,<br />
1690T, 1983W, 2151W,<br />
3070F<br />
Wilson, B. J., 149*, 150,<br />
1827W, 1852F<br />
Wilson, J., 350, 1481W<br />
Wilson, J. F., 1383T, 2366F*<br />
Wilson, J. G., 170, 178, 284,<br />
1408F, 1677T, 2210F,<br />
2337W<br />
Wilson, K., 3388F<br />
Wilson, L., 126<br />
Wilson, L. C., 217, 218<br />
Wilson, M., 334<br />
Wilson, M. J., 3290W<br />
*Presenting Author<br />
Wilson, N. R., 2670F*<br />
Wilson, R., 465F, 809F,<br />
1203W, 1210T, 2325W,<br />
2343W<br />
Wilson, R. K., 375, 2320T,<br />
2587T, 3296W<br />
Wilson, R. R., 3158F<br />
Wilson, S., 247, 1316W,<br />
1928F*<br />
Wilson, S. G., 1216T*<br />
Wilson, T. E., 339<br />
Wilson, W., 3053W<br />
Wilson Sayres, M., 281*<br />
Wiltshire, S., 119, 1308T,<br />
2076W, 2137T<br />
Wimmer, K., 2791W<br />
Win, A. K., 141*, 1079F<br />
Winarni, T. I., 770W<br />
Winata, C. L., 3047W<br />
Winberg, J., 3245W*<br />
Winchester, L., 509F<br />
Winckler, W., 368<br />
Windham, G., 7, 463F<br />
Windpassinger, C., 2570F,<br />
2575T, 3456T<br />
Wineburg, M., 966T<br />
Wineinger, N. E., 434W,<br />
1319W*<br />
Winge, M. C. G., 1939T*<br />
Wingo, T., 2477F<br />
Winham, S., 605T<br />
Winham, S. J., 2516F*<br />
Wininger, F., 784W<br />
Wininger, F. A., 2817F<br />
Winkelmann, J., 2086T,<br />
2567F, 2568W<br />
Winkler, C. A., 2073W, 3315T<br />
Winkler, R., 732T, 772W<br />
Winkler, R. E., 745F<br />
Winkler, S., 200<br />
Winkler, T., 1308T, 2076W<br />
Winkler, T. W., 108, 119,<br />
1954T, 2090F, 2123F,<br />
2147F*<br />
Winn, J., 1440T<br />
Winn, V. D., 3232F<br />
Winney, B., 181<br />
Winquist, E., 135, 1824F<br />
Winqvist, R., 1099T*<br />
Winsvold, B. S., 2348F<br />
Winterh<strong>of</strong>f, B. J., 3451T<br />
Winters, A. H., 3027T*<br />
Wirth, B., 236*<br />
Wirth, R., 2944W<br />
Wise, C., 221, 2143T<br />
Wise, C. A., 1359T, 3108F<br />
Wiseman, R., 1671T<br />
Wiseman, R. W., 595F<br />
Wisjman, E., 1918T<br />
Wisnieski, F., 1132T, 3421T,<br />
3503T*<br />
Wisotzkey, R., 1190F*<br />
Wissinger, B., 3126F<br />
Wissink-Lindhout, W. M.,<br />
102<br />
Wiszniewska, J., 61, 314,<br />
898T, 1742W, 1757W<br />
Wiszniewski, W., 360,<br />
777W, 2798T, 2883F*,<br />
2908W<br />
SPEAKER AND AUTHOR INDEX 415<br />
Wit, J., 2701W<br />
Wit, J. M., 131<br />
Wither, J. E., 3382F<br />
Withers, M., 61<br />
Witherspoon, D. J., 600F*,<br />
3378T<br />
With<strong>of</strong>f, S., 523F<br />
Witkowski, A. M., 33<br />
Witmer, P. D., 520W<br />
Witonsky, D., 248<br />
Witte, D. R., 2317T, 2347T<br />
Witte, J., 75, 1469W, 1548T<br />
Witte, J. S., 1250F, 1352W,<br />
1501F, 1885T, 2202W,<br />
2258F<br />
Witte, T., 2084F<br />
Wittemore, A., 28<br />
Wittig, I., 699F, 782W<br />
Wittwer, C., 673F<br />
Wittwer, C. T., 495F<br />
Witwicki, R. M., 62, 415F<br />
Wo, M., 3204F<br />
Wodak, S., 320, 1872F,<br />
1873F<br />
Wohler, E., 2918T<br />
Wohlleber, E., 2595W,<br />
3109W<br />
Wojcik, G. L., 3393W*<br />
Wojczynski, M. K., 1913F<br />
Wokke, B., 574W<br />
Wold, H., 921W<br />
Wolf, D., 2788W<br />
Wolf, E., 2922F<br />
Wolf, I., 1063T<br />
Wolf, J., 1152W<br />
Wolf, L., 3185W<br />
Wolf, P. A., 123, 2528F<br />
Wolf, W. A., 1799W<br />
Wolfbauer, G., 1605T<br />
Wolfe, L. A., 2938W<br />
Wolfe, R., 2996T<br />
Wolffenbuttel, B. H. R., 2282F<br />
Wolfgeher, D., 1614T, 1683T<br />
Wolfner, M. F., 2214W<br />
Wolk, F., 59<br />
Wöllner, K., 1005W<br />
Wollnik, B., 1*, 2944W,<br />
3070F, 3214F<br />
Wollstein, G., 2154W,<br />
2240F, 2263T<br />
Woloszynska-Read, A.,<br />
3428T*<br />
Wolyniec, P., 2461T, 2486F,<br />
2573F, 2576F<br />
Won, H.-H., 1007F, 1103F<br />
Won, M., 3695F<br />
Won, M. S., 3710W*<br />
Wong, A., 2282F<br />
Wong, A. C. Y., 2662W<br />
Wong, B., 493F<br />
Wong, C., 1338T<br />
Wong, C. C. Y., 3487T*<br />
Wong, D., 3161W, 3518T,<br />
3591F*<br />
Wong, D. A., 315, 680T<br />
Wong, E., 2494T*<br />
Wong, E. H. M., 1930T,<br />
2066F, 2932W<br />
Wong, H. M., 3123W<br />
Wong, K., 256, 2786T<br />
Wong, K. C. C., 3466T,<br />
3469T, 3486T<br />
Wong, K. K. Y., 1930T<br />
Wong, L., 245, 677F, 3209W<br />
Wong, L.-C., 683F<br />
Wong, L. J., 666T<br />
Wong, L.-J., 1750W<br />
Wong, L. P., 3339T<br />
Wong, M., 3612W<br />
Wong, P., 2573F<br />
Wong, R. C. C., 3100F<br />
Wong, S., 64<br />
Wong, S. H., 143<br />
Wong, S.-S., 1235F<br />
Wong, S. S., 614T<br />
Wong, T. Y., 429F, 2094W<br />
Wong, Z., 28<br />
Wong-Ley, L. E., 650T*<br />
Woo, C., 412W, 486W,<br />
3520T*<br />
Woo, M., 877W<br />
Woo, S., 3673F*<br />
Woo, Y., 3444T<br />
Wood, A., 1513F<br />
Wood, A. R., 108, 176,<br />
1923W, 2148W*, 2241W,<br />
2308T, 2339F<br />
Wood, B. M., 1781W<br />
Wood, G. C., 2078F<br />
Wood, N., 2581T<br />
Wood, S., 262<br />
Wooderchak-Donahue,<br />
W., 225<br />
Woodruff, T., 250<br />
Woods, J., 133<br />
Woods, R., 832F, 2262W<br />
Wood-Siverio, C., 2538W<br />
Woodward, S., 3321T, 3340F<br />
Woodward, S. R., 3365W<br />
Woollard, W. J., 2896W,<br />
2925F<br />
Woolstenhulme, N., 1021T<br />
Workalemahu, T., 51, 108,<br />
1954T, 2123F, 2147F<br />
Worley, M., Jr., 1272W<br />
Wormley, B., 2500T, 2594F<br />
Worrall, B. B., 123<br />
Wortmann, S., 672T<br />
Woulfe, J., 2794W<br />
Wouters, E., 2249F<br />
Wouters, M. M., 2088W<br />
Woyciechowski, S., 65<br />
Wragg, C., 2935W<br />
Wraith, J. E., 684T<br />
Wratten, N., 2467T<br />
Wrazien, S., 3530W<br />
Wren, J. D., 549F<br />
Wren, Y., 2164T<br />
Wright, A., 413F, 1481W<br />
Wright, A. F., 1383T, 2072F,<br />
2366F<br />
Wright, C., 101, 291, 364,<br />
2637W<br />
Wright, C. B., 1635T, 2583W<br />
Wright, F., 368, 2953W<br />
Wright, F. A., 171, 1322W,<br />
1532W<br />
Wright, G., 644T<br />
Wright, G. E. B., 1808F*<br />
Wright, M., 1803W, 3651F<br />
SPEAKER AND AUTHOR INDEX
416 SPEAKER AND AUTHOR INDEX<br />
Wright, M. F., 631T<br />
Wright, M. J., 2054F<br />
Wright, W., 1776W<br />
Writzl, K., 61, 3001T*<br />
WTCCC2, 2068T<br />
WTCCC2, Genetic Analysis<br />
<strong>of</strong> Psoriasis Consortium,<br />
I-chip for Psoriasis<br />
Consortium, 1927T<br />
Wu, B., 2696T<br />
Wu, C., 1027T, 2042F, 3584W<br />
Wu, C. C., 1298W*, 2936T<br />
Wu, C.-T., 444W<br />
Wu, D., 2027F<br />
Wu, G., 1502W*<br />
Wu, H., 382, 864T, 1338T<br />
Wu, J., 816F, 1314T*,<br />
1723W, 1954T, 2123F,<br />
2147F, 3604W<br />
Wu, J. Y., 2858T<br />
Wu, J.-Y., 2092T<br />
Wu, K., 623T<br />
Wu, K. H. C., 3167W*<br />
Wu, L., 581F*, 1161W*,<br />
1162T, 2000F<br />
Wu, M., 1262F*<br />
Wu, M. C., 1532W<br />
Wu, Q., 2073W<br />
Wu, S., 1838F, 2149T*, 2874F<br />
Wu, S. W., 2438F<br />
Wu, S. Y., 1003T, 2053T<br />
Wu, T., 1472W*, 2721F,<br />
3317W<br />
Wu, W., 1904F*, 3378T<br />
Wu, W. T., 2985T<br />
Wu, X., 213, 1684T, 3168F,<br />
3237W<br />
Wu, X.-F., 3281W<br />
Wu, Y., 1546F, 1608T*,<br />
1894T, 2617T, 3168F,<br />
3237W<br />
Wu, Y. L., 458W<br />
Wu, Z., 668T, 2492F<br />
Wu-Chou, Y. H., 1472W,<br />
1512T<br />
Wulur, I. H., 1235F<br />
Wunderink, M., 955W, 979W<br />
Wurfel, M. M., 1408F<br />
Würtz, P., 1623T*<br />
Wuyts, W., 2757F*<br />
Wyatt, A., 3161W<br />
Wyatt, C. R., 2717T<br />
Wynn, J., 3046F<br />
Wyrobek, A. J., 984W*<br />
X<br />
Xavier, A. C., 959W<br />
Xavier, J., 2150F*<br />
Xavier, J. M., 1977W,<br />
2085W<br />
Xavier, R. J., 2319W<br />
Xe, Q., 457F<br />
Xerri, O., 390<br />
Xi, L., 2804T<br />
Xi, Q. J., 82<br />
Xia, B., 1099T<br />
Xia, F., 314*, 1742W<br />
Xia, H., 1930T<br />
*Presenting Author<br />
Xia, J., 136, 3620W*<br />
Xia, K., 2251T, 2617T<br />
Xia, M., 242, 3490T<br />
Xia, Q., 2121W<br />
Xia, R., 1041W<br />
Xia, Y., 2227T<br />
Xian, M., 2251T<br />
Xiang, A. H., 1916F<br />
Xiang, K., 3317W<br />
Xiang, Q., 244, 457F<br />
Xiao, C., 3592W*<br />
Xiao, F., 1399F*<br />
Xiao, J., 2438F, 2782W*<br />
Xiao, M., 3025T*, 3649F<br />
Xiao, P., 3081W<br />
Xiao, T., 810F<br />
Xiao, W., 1112F, 1199F,<br />
3485T<br />
Xie, C., 3604W*<br />
Xie, F., 1945T<br />
Xie, H., 1974W, 3168F<br />
Xie, L. Y., 3442T, 3452T<br />
Xie, P., 2621F*<br />
Xie, Q., 2623T<br />
Xie, W., 1546F, 1624T,<br />
1693T, 2935W, 3509T<br />
Xie, Y. Y., 1110W<br />
Xifara, D., 16*<br />
Xing, C., 1368T*<br />
Xing, E., 1388W, 3605F*<br />
Xing, E. P., 2152T, 3391W<br />
Xing, J., 195, 600F, 1904F,<br />
3297T, 3378T*<br />
Xing, Q., 2419T*<br />
Xing, Y., 2636F<br />
Xiong, L., 1670T, 2402F*,<br />
2558F<br />
Xiong, M., 20*, 92, 192,<br />
1401T, 1499W, 1508W,<br />
1527T, 2460W<br />
Xiong, X., 1010F<br />
Xu, C., 651T, 1972T, 2495F*<br />
Xu, G. L., 3483T<br />
Xu, H., 1511W, 1864F*,<br />
1907F, 3334F, 3418T*<br />
Xu, J., 28, 986F, 1001F,<br />
1080W, 1214F, 1369F,<br />
1491T, 1648T, 1661T,<br />
2274W, 2332T, 2879T,<br />
3285T, 3425T<br />
Xu, J. B., 3416T<br />
Xu, K., 2785W, 2892F<br />
Xu, L., 2237F<br />
Xu, N., 1255T<br />
Xu, Q., 2617T<br />
Xu, S., 443F, 520W*, 909W*,<br />
3334F, 3358F, 3394T*<br />
Xu, T., 532W, 3723F<br />
Xu, W., 909W, 1108T, 2819T<br />
Xu, X., 1100F*, 1255T,<br />
2617T, 2935W<br />
Xu, Y., 161, 1298W<br />
Xu, Y.-H., 690T<br />
Xu, Y. H., 2667F<br />
Xu, Y.-Q., 2970T*<br />
Xu, Y. Q., 836F<br />
Xu, Z., 2477F*, 3231W*<br />
Xue, C., 170<br />
Xue, F., 1365T<br />
Xue, X., 2080T<br />
Xue, Y., 41, 130, 3377W<br />
Xue, Z., 641T, 651T*<br />
Xumerle, L., 2548T<br />
Y<br />
Yadak, R., 796W<br />
Yadavalli, A. D., 3630W*<br />
Yaghootkar, H., 1284T,<br />
1503T, 2148W<br />
Yagi, M., 729F*, 781W<br />
Yagmurdur, M. C., 3426T<br />
Yagnik, G., 2151W*<br />
Yahya, Z., 3034T<br />
Yahyavi, M., 810F*, 2926W<br />
Yakhini, Z., 3588W<br />
Yakir, B., 3675F<br />
Yakubovskaya, M., 1180T,<br />
1181F<br />
Yamada, K., 2748F<br />
Yamada, R., 1984T, 2004W<br />
Yamada, T., 2174F<br />
Yamada, Y., 2748F*<br />
Yamagata, S., 2550W<br />
Yamagata, T., 2588F, 3118F<br />
Yamagata, Z., 1819W*,<br />
1833W, 1980W<br />
Yamagata University<br />
Genomic Cohort<br />
Consortium, 1549F<br />
Yamaguchi, S., 1574W,<br />
2747T<br />
Yamakage, M., 1940F<br />
Yamamoto, E. H., 2876T<br />
Yamamoto, G. L., 2232W,<br />
3152F, 3184F, 3250F*<br />
Yamamoto, K., 1574W,<br />
1984T, 2004W, 3436T<br />
Yamamoto, M., 2619W<br />
Yamamoto, N., 1815W<br />
Yamamoto, R., 234<br />
Yamamoto, T., 233, 1290T,<br />
3102F<br />
Yamanaka, H., 2004W,<br />
2032T, 2287T<br />
Yamanaka, I., 2697F<br />
Yamano, A., 2748F<br />
Yamanouchi, Y., 1795W*,<br />
2891T<br />
Yamaoka, M., 2130W<br />
Yamasaki, M., 2496W*<br />
Yamashita, C., 1730W,<br />
2559W<br />
Yamashita, H., 1549F<br />
Yamauchi, A., 3337F<br />
Yamauchi, N., 52<br />
Yamazaki, K., 2174F*<br />
Yamazaki, T., 2873T<br />
Yammine, T., 2692W<br />
Yamrom, B., 2587T<br />
Yan, A., 3730W<br />
Yan, C.-Y., 1216T<br />
Yan, J., 1465F<br />
Yan, K., 1475W<br />
Yan, L., 2489F, 3293W,<br />
3425T, 3428T<br />
Yan, Q., 2445W<br />
Yan, S., 1524T*, 3265F,<br />
3379F*<br />
Yan, W., 1986W<br />
Yanagi, K., 2758W<br />
Yanagi, T., 724T<br />
Yanagihara, I., 475F<br />
Yandell, M., 195, 3561F,<br />
3633F<br />
Yanek, L. R., 1652T*, 1710T<br />
Yang, B. Z., 2497T<br />
Yang, C., 2204F, 2207F*<br />
Yang, F., 438W<br />
Yang, H., 531F, 1249T,<br />
1391W, 1905W*, 2617T<br />
Yang, H. C., 3430T<br />
Yang, I., 3466T<br />
Yang, J., 108, 1331W,<br />
1360F, 2016W*, 2090F,<br />
2200T*, 2388W*, 2574W,<br />
3370F, 3470T<br />
Yang, J. P., 2482T<br />
Yang, K., 1071W<br />
Yang, L., 3667F<br />
Yang, M., 1540F<br />
Yang, M. Y., 80<br />
Yang, P., 989F, 1454W<br />
Yang, Q., 123<br />
Yang, R., 1517W*<br />
Yang, S., 2273F, 3330T<br />
Yang, S. P., 658T<br />
Yang, T., 411, 583F<br />
Yang, T.-P., 44, 3453T<br />
Yang, W., 180*, 586W,<br />
1468F*, 1929W, 2016W,<br />
2064W*, 3657F<br />
Yang, X., 116, 159, 864T,<br />
2220W*, 2660F<br />
Yang, X.-H., 2969T, 2970T<br />
Yang, Y., 314, 821F, 864T,<br />
985T, 1735W*, 1742W,<br />
1757W, 1761W, 1972T,<br />
2921T, 3488T*<br />
Yang, Z., 2390F*, 2574W,<br />
3317W<br />
Yanicostas, C., 843F<br />
Yanikkaya Demirel, G., 2429F<br />
Yannoukakos, D., 1191W,<br />
1228T<br />
Yano, K., 2287T<br />
Yano, S., 237*<br />
Yanovitch, T., 2328W<br />
Yanovski, J. A., 2702T<br />
Yao, W., 1249T<br />
Yao, Y., 2584T, 2917W<br />
Yap, Z., 216<br />
Yarnall, J. M., 1329T<br />
Yarnykh, V. L., 2530T<br />
Yaron, O., 2919F<br />
Yaron, Y., 704T<br />
Yasari Mazandarani, A.,<br />
1961F, 1962W*<br />
Yashin, A., 1991F, 2027F,<br />
2194T<br />
Yaspan, B., 15, 1887W,<br />
2135F<br />
Yaspan, B. L., 2154W,<br />
2240F*, 2263T<br />
Yasuda, C. L., 2394W<br />
Yasufumi, O., 3519T*<br />
Yasui, D. H., 64, 2783T*,<br />
3498T<br />
Yasukawa, K., 1631T
Yasunami, M., 1998W,<br />
1999T*<br />
Yates, J. C., 2249F<br />
Yates, J. R. W., 2072F<br />
Yato, S., 3221W<br />
Yatsenko, S., 904T<br />
Yatsenko, S. A., 971W,<br />
1744W*<br />
Yatsuka-Kanesaki, Y.,<br />
2923W<br />
YAtsuki, H., 3432T<br />
Yatsuki, H., 3519T<br />
Yau, M., 2812W<br />
Yazarlou, F., 1169F<br />
Yazdani, R., 448W<br />
Yazici, H., 3475T<br />
Ye, C., 322, 528W, 1341T<br />
Ye, K., 459F*, 2587T, 3309T*<br />
Ye, L., 859W, 1699T<br />
Ye, X., 1472W, 2151W, 2928F<br />
Ye, Z., 1626T, 2297F, 3326W<br />
Yeager, M., 30, 213, 1012T,<br />
1154F, 1160F, 1218W,<br />
1242W, 1372F, 1517W,<br />
3683F<br />
Yeakley, J., 1176W<br />
Yee, J. K., 695F<br />
Yee, M. C., 293, 371, 3361F,<br />
3362W, 3368W, 3411W<br />
Yeetong, P., 2749W*<br />
Yeh, E., 2687T<br />
Yeh, T., 666T<br />
Yeheskel, A., 2919F<br />
Yehuda, D., 1159T<br />
Yemelyanov, A., 1181F<br />
Yen, T., 3596W<br />
Yendle, S. C., 2897T<br />
Yeo, A., 641T<br />
Yeo, G. S. H., 3034T<br />
Yeoh, K. H., 2491T<br />
Yeow, V., 1472W<br />
Yerges-Armstrong, L. M.,<br />
602T, 2275T<br />
Yerko, V., 2482T<br />
Yesilyurt, A., 2881W<br />
Yeung, W. S. B., 3000T<br />
Yevtushok, L., 302<br />
Yi, K., 2251T<br />
Yi, L., 2686W*<br />
Yi, N., 1292W, 1410T, 3613F<br />
Yi, X., 3300T<br />
Yigit, E., 512W, 3517T,<br />
3702W, 3715F<br />
Yilmaz, E., 2058W<br />
Yilmaz, N., 594W*<br />
Yilmaz, S., 594W, 1164W,<br />
1166F, 3132F<br />
Yilmaz Celik, Z., 1013F*,<br />
3424T, 3426T<br />
Yilmaz Susluer, S., 1178F<br />
Yilmaz Süslüer, S., 1172F<br />
Yim, P., 412W<br />
Yim, P. W., 486W*<br />
Yim, S., 3103W<br />
Yim, S. H., 3607F<br />
Yin, A. H., 1723W<br />
Yin, B., 1757W<br />
Yin, H. W. H., 1034F*<br />
Yin, J., 477F, 2152T*, 3605F<br />
Yin, X., 660T, 1585T<br />
*Presenting Author<br />
Yip, B. H. K., 2066F<br />
Yip, W., 1431T*<br />
Yiu, E., 2742F<br />
Yiu, M., 963W*<br />
Ylaya, K., 1092W<br />
Ylstra, B., 494W<br />
Yntema, H., 215*<br />
Yntema, H. G., 97, 102,<br />
125, 1749W<br />
Yntema, J. B., 216<br />
Yokota, T., 232, 729F<br />
Yokoyama, E., 875W, 976T,<br />
2365T<br />
Yokoyama, J. S., 2517W*,<br />
2639F<br />
Yolken, R., 1406W<br />
Yonath, H., 783W*<br />
Yoneda, M., 245<br />
Yonezawa, A., 2917W<br />
Yoo, H., 2518T*<br />
Yoo, H. W., 698T, 787W*<br />
Yoo, H.-W., 964T, 3227W<br />
Yoo, N., 1230W<br />
Yoo, S., 1248W<br />
Yoo, Y., 1384F<br />
Yoon, E. J., 1338T<br />
Yoon, G., 2554T*<br />
Yoon, J., 1243T, 3462T<br />
Yoon, O. K., 571F*<br />
Yoon, S., 866T, 867W,<br />
3112F<br />
York, T., 3512T*<br />
York, T. P., 1717W<br />
Yoshida, A., 2697F<br />
Yoshida, L. M., 1998W,<br />
1999T<br />
Yoshida, M., 52, 2349W,<br />
2380T*<br />
Yoshida, S., 2287T*<br />
Yoshida, Y., 1333F<br />
Yoshihashi, H., 3105W*,<br />
3192F<br />
Yoshikawa, A., 2370W*,<br />
2652W<br />
Yoshikawa, T., 1631T<br />
Yoshimatsu, H., 2917W<br />
Yoshimura, A., 2418W,<br />
2601W, 2607W, 2616W,<br />
2823F<br />
Yoshimura, J., 2409W,<br />
2569T<br />
Yoshino, H., 52, 2559W,<br />
3134F, 3221W<br />
Yoshino, M., 724T<br />
Yoshinori, T., 3136F<br />
Yoshizawa, G., 1815W<br />
Yoshizawa, J., 1317T<br />
Yosunkaya, E., 2912T*<br />
You, G., 3473T<br />
You, M., 1454W<br />
Young, A., 1515T, 2042F<br />
Young, B. M., 1162T<br />
Young, C., 1869F<br />
Young, D., 2480F<br />
Young, J., 794W*, 1072T,<br />
2672T<br />
Young, J. E., 2628W<br />
Young, J. I., 347, 2837T<br />
Young, J. P., 141, 1067F<br />
Young, K. L., 1467T*<br />
SPEAKER AND AUTHOR INDEX 417<br />
Young, L. J., 2383T<br />
Young, S. P., 168<br />
Young, T., 521F*, 2328W,<br />
2543F<br />
Young, T. L., 454W, 2068T,<br />
3521T<br />
Young, W. L., 589F<br />
Youngblom, J., 145, 1810F<br />
Younkin, S., 3609F<br />
Yourdkhani, H., 3083W<br />
Yourshaw, M., 296*, 315<br />
Yousaf, R., 2663T, 2724F*<br />
Yousefi, P., 3458T<br />
Yousif, F., 1256F<br />
Yrigollen, C. M., 2634W*<br />
Yu, C., 601T*, 2550W<br />
Yu, C. C., 232, 3513T*<br />
Yu, C. E., 2646W<br />
Yu, C. S., 3730W<br />
Yu, C. Y., Session 22, 458W<br />
Yu, D., 1027T, 1480F,<br />
2519F*<br />
Yu, F., 174, 331*, 3576W<br />
Yu, H., 1731W, 2884W*,<br />
3479T<br />
Yu, I., 346<br />
Yu, J., 148*, 174, 963W,<br />
1004F, 1842F, 1930T,<br />
2251T, 2617T<br />
Yu, J. H., 301<br />
Yu, K., 1010F<br />
Yu, L., 1359T<br />
Yu, L.-H., 234<br />
Yu, M., 516W, 1666T<br />
Yu, S., 978T<br />
Yu, T., 2003F*<br />
Yu, T. W., 8*, 452W, 2613W<br />
Yu, X., 3585F, 3593F*<br />
Yu, Z., 389, 834F, 839F,<br />
1493W*, 1969T, 2678T<br />
Yuan, A., 3533F<br />
Yuan, D., 2251T<br />
Yuan, G., 3659F<br />
Yuan, H., 2868F*<br />
Yuan, J., 2601W*<br />
Yuan, Q., 2234F<br />
Yuan, Y., 1269W<br />
Yudk<strong>of</strong>f, M., 534W<br />
Yue, Y., 1235F<br />
Yuen, R., 175<br />
Yuen, R. K., 460W*, 2617T<br />
Yuen, R. K. C., 3445T<br />
Yuksel, A., 2908W<br />
Yum, S., 3673F<br />
Yum, S. W., 330<br />
Yun, J., 3103W<br />
Yund, B., 714T<br />
Yurovsky, A., 561F<br />
Yusuf, S., 617T, 619T<br />
Yuvarani, S., 931W<br />
Yuzyuk, T., 686T*<br />
Z<br />
Zabetian, C., 2538W<br />
Zaccarioto, T. R., 2751F<br />
Zachariadis, V., 1035W*<br />
Zack, D. J., 2154W, 2240F,<br />
2263T<br />
Zackai, E., 65, 1494T,<br />
2904F, 3082F, 3151W<br />
Zackai, E. H., 819F, 2884W,<br />
3038F<br />
Zackai, E. Z., 2443T<br />
Zada, G., 3415T<br />
Zaenglein, A., 2761W<br />
Zaghlool, A., 3728W*<br />
Zaghloul, N., 310<br />
Zagury, J.-F., 90<br />
Zahavich, L., 1704T*<br />
Zahid, S., 1579F<br />
Zahnleiter, D., 2356T<br />
Zahra, R., 508W<br />
Zahrate, M., 324<br />
Zahrieh, D., 768W, 769W<br />
Zai, C., 628T*, 2376W<br />
Zai, G., 612T*<br />
Zaidi, S., 2542T<br />
Zaitlen, N., 89, 350*,<br />
1331W, 1360F, 1577W<br />
Zakariyah, A., 831F<br />
Zakharia, F., 3352F, 3360T,<br />
3380W*, 3390T, 3563F<br />
Zaki, M. J., 3570W<br />
Zaki, M. S., 167, 2937F<br />
Zakov, S., 1043F*<br />
Zaldivar, F., 3144F<br />
Zalloua, P., 1640T, 3349F,<br />
3377W<br />
Zalloua, P. A., 3387T<br />
Zamani, A. R., 860T<br />
Zamanyan, A., 3587F<br />
Zamarron-Licona, E.,<br />
2019W*<br />
Zambruno, G., 2760F<br />
Zamir, I. M., 731F*<br />
Zampella, J., 1260W*<br />
Zampetaki, A., 3723F*<br />
Zampieri, S., 2809W<br />
Zamudio, R., 1119W, 3325F<br />
Zamudio, R. M., 926T<br />
Zamzuraida, A. S., 3267T<br />
Zanardo, E., 896T, 899W<br />
Zand, D., 2915T<br />
Zandi, P. P., 2180F, 2305T,<br />
2391W<br />
Zandi, S., 1093T<br />
Zandoná, A., 896T<br />
Zandoná-Teixeira, A., 899W<br />
Zanetti, G., 157<br />
Zaneveld, J., 1779W,<br />
2910F*<br />
Zang, W., 573F<br />
Zang, Z. J., 2889F<br />
Zaniew, M., 845F<br />
Zanke, B., 377, 3478T<br />
Zanke, B. W., 1093T, 3489T<br />
Zanlonghi, X., 390<br />
Zanni, G., 943W, 2777T<br />
Zannis-Hadjopoulos, M.,<br />
2824W<br />
Zapata, G., 1646T<br />
Zapata, G. E., 2189F<br />
Zappia, M., 2763F<br />
Zara, I., 157*, 186<br />
Zaragkoulias, A., 218<br />
Zaragoza, M. V., 1691T*<br />
Zarante, A., 3041W, 3049W*<br />
Zarante, I., 1876F*, 3035W<br />
SPEAKER AND AUTHOR INDEX
418 SPEAKER AND AUTHOR INDEX<br />
Zarate, Y., 3171W*<br />
Zarbakhsh, B., 1726W<br />
Zarina, L., 608T<br />
Zariwala, M. A., 2851W*<br />
Zariwala, M. B., 406<br />
Zaslav, A., 1036T*<br />
Zattara, H., 1212W<br />
Zatyka, M., 2767W<br />
Zatz, M., 1727W, 1776W<br />
Zavala, J., 2495F<br />
Zavala-Castro, J., 2272T<br />
Zavaleta, M. J., 960T<br />
Zaveri, H., 840F*, 2678T<br />
Zawistowski, M., 476W,<br />
1371T, 3406T<br />
Zayed, H., 2643W<br />
Zaykin, D., 1364W*, 1570F<br />
Zazo Seco, C., 58, 59<br />
Zbar, B., 1242W<br />
Zechi-Ceide, R., 2673F<br />
Zechi-Ceide, R. M., 813F,<br />
2746W<br />
Zechner, U., 849F, 3266W*<br />
Zeegers, D., 3034T<br />
Zeesman, S., 300<br />
Zeevi, D. A., 2991T, 3002T*<br />
Zeggini, E., 2044T*, 2097W,<br />
2292W, 2522F, 3396T,<br />
3408T<br />
Zehnder, J. L., 1017W<br />
Zeidler, C., 1868F<br />
Zeien, G., 422W<br />
Zeinali, S., 1726W, 3197W<br />
Zeissig, S., 2315F, 2368T<br />
Zeissig, Y., 2315F<br />
Zelante, L., 775W<br />
Zeldin, D. C., 606T<br />
Zeledòn, M., 2486F<br />
Zeledón, M., 2461T*<br />
Zelenetz, A., 1159T<br />
Zelenika, D., 2072F<br />
Zelh<strong>of</strong>, A. C., 2966T<br />
Zeligson, S., 2447F, 2991T<br />
Zelinski, T., 2772F<br />
Zeller, T., 275, 1669T*<br />
Zellers, A. D., 1806F*<br />
Zeman, J., 752T<br />
Zembutsu, H., 2133W<br />
Zemel, B. S., 812F*<br />
Zen, P., 2434T<br />
Zender, G., 1680T<br />
Zender, G. A., 1646T<br />
Zeng, C., 245, 2251T<br />
Zeng, L., 3415T<br />
Zeng, Q., 1292W<br />
Zeng, R., 2805F, 2817F*<br />
Zeng, W., 2698W*, 2895F,<br />
2907F, 3065W<br />
Zeng, Z., 1464T, 1474F,<br />
2034W, 2156F<br />
Zerdoumi, Y., 1090T<br />
Zeringer, E., 3684W<br />
Zerres, K., 3111W<br />
Zethelius, B., 2358W<br />
Zettermann, K., 3729F<br />
Zeuner, K. E., 200<br />
Zevallos, J., 1120T<br />
Zeviani, M., 164, 699F,<br />
782W, 2810T<br />
*Presenting Author<br />
Zha, Z., 1256F<br />
Zhai, J., 1232F<br />
Zhan, S. H., 2772F<br />
Zhan, X., 641T, 1510F,<br />
1525F*, 1568W, 2183F<br />
Zhan, Y., 1582F*<br />
Zhang, B., 503F*, 2403W,<br />
2804T<br />
Zhang, C., 1369F, 2080T,<br />
2644T<br />
Zhang, C. K., 189<br />
Zhang, D., 221, 3438T<br />
Zhang, F., 63, 138, 1004F,<br />
2112W, 2668W<br />
Zhang, G., 487F*, 1027T*,<br />
1239W, 1660T<br />
Zhang, H., 893W, 1434T,<br />
2121W, 2184W, 2314T,<br />
3317W, 3582W<br />
Zhang, H. S., 803W<br />
Zhang, H. X., 2985T<br />
Zhang, J., 31, 821F, 888T,<br />
1003T, 2251T, 2921T,<br />
3595F*<br />
Zhang, J. G., 1473T*,<br />
2053T, 3534W<br />
Zhang, K., 283, 519F,<br />
1292W, 1410T, 1764W,<br />
1779W, 2154W, 2240F,<br />
2260T, 2263T, 2910F,<br />
3474T, 3493T, 3594W*,<br />
3646W<br />
Zhang, L., 255, 999W,<br />
1159T, 1275W*, 2053T*,<br />
2172W, 2981T, 3097W*<br />
Zhang, M., 1972T<br />
Zhang, N., 3675F<br />
Zhang, P., 1534F*<br />
Zhang, Q., 18*, 33, 404,<br />
1004F, 1203W, 1369F,<br />
1457W*, 2040W<br />
Zhang, R., 577F*<br />
Zhang, R. Z., 1930T<br />
Zhang, S., 1409W, 2206T<br />
Zhang, S. Y., 3599F<br />
Zhang, T., 135, 457F,<br />
1974W, 2623T<br />
Zhang, T. X., 1472W<br />
Zhang, V., 1750W, 3209W<br />
Zhang, V.-W., 683F<br />
Zhang, W., 49, 110, 161,<br />
1320T, 2292W, 3472T,<br />
3719F<br />
Zhang, X., 159, 462W,<br />
836F, 2016W, 2064W,<br />
2254T, 2868F, 3317W,<br />
3472T<br />
Zhang, Y., 334, 579F*, 600F,<br />
836F*, 1723W*, 1995W,<br />
2016W, 2064W, 2215T*,<br />
2721F, 3474T, 3545F<br />
Zhang, Z., 377, 421F, 457F,<br />
534W*, 2063F*, 3058F,<br />
3438T, 3670W<br />
Zhao, G., 1777W, 3600W<br />
Zhao, H., 189, 1201T,<br />
1283W, 1635T, 2204F,<br />
2207F, 2478W, 2497T,<br />
2503T, 2621F, 3237W<br />
Zhao, H. Z., 1974W<br />
Zhao, J., 192*, 1527T<br />
Zhao, J. H., 1365T*, 1553W,<br />
2359T<br />
Zhao, J.-H., 2282F<br />
Zhao, K., 3254W<br />
Zhao, M., 1101W*, 2237F,<br />
3606W*<br />
Zhao, T., 2999T<br />
Zhao, W., 171<br />
Zhao, X., 1367W<br />
Zhao, X.-L., 1986W<br />
Zhao, Y., 134, 544W, 557F,<br />
2721F, 3631F<br />
Zhao, Z., 136*, 1101W,<br />
2418W, 3554W, 3620W<br />
Zheng, H., 480W, 1369F,<br />
3265F*, 3355F, 3645F*<br />
Zheng, H. F., 109<br />
Zheng, H.-F., 2187W<br />
Zheng, P., 1463W<br />
Zheng, S., 28, 888T<br />
Zheng, S. L., 1080W<br />
Zheng, W., 2202W, 2644T<br />
Zheng, X., 294*, 2098T<br />
Zheng, Y., 1003T*, 1972T<br />
Zheng, Z., 2178W<br />
Zheng, Z. H., 836F<br />
Zheng Bradley, H., 3636W<br />
Zhernakova, A., 461F*, 523F<br />
Zhernakova, D. V., 523F<br />
Zhi, D., 1410T, 1460W,<br />
1502W, 3594W, 3646W*<br />
Zhong, H., 3317W, 3574W<br />
Zhong, J., 242*, 2337W<br />
Zhong, N., 1613T, 1864F,<br />
1877F, 1986W*, 2355W,<br />
2969T, 2970T, 3025T,<br />
3029T<br />
Zhong, W., 1930T<br />
Zhou, B., 458W, 1591T,<br />
2617T<br />
Zhou, D., 3307F, 3438T*<br />
Zhou, E., 1251W<br />
Zhou, F., 3553F<br />
Zhou, H., 38*, 214, 1369F,<br />
1866F, 3621F<br />
Zhou, J., 54, 241, 1515T,<br />
1526W*, 1886F, 2254T<br />
Zhou, J. H., 1986W<br />
Zhou, L., 1540F<br />
Zhou, Q., 3553F<br />
Zhou, S., 1670T*, 2402F<br />
Zhou, S. L., 836F<br />
Zhou, T., 798W<br />
Zhou, X., 462W*, 1514W*,<br />
2254T, 2868F<br />
Zhou, Y., 864T, 1019F<br />
Zhou, Z., 2297F<br />
Zhou, Z.-N., 3281W<br />
Zhu, C., 349*, 2419T<br />
Zhu, D., 2419T<br />
Zhu, G., 174, 2212T<br />
Zhu, H., 557F<br />
Zhu, J., 368, 586W, 1107W,<br />
1540F, 1777W, 2220W,<br />
2910F, 3123W<br />
Zhu, J.-Z., 1613T, 2355W*<br />
Zhu, L., 864T<br />
Zhu, Q., 3251W, 3310F*<br />
Zhu, W.-Z., 3281W<br />
Zhu, X., 350, 369, 579F,<br />
1376W, 1460W, 1466W,<br />
1659T, 1959W, 2063F,<br />
2210F, 2372F, 3658W*<br />
Zhu, X. Z., 2053T<br />
Zhu, Y., 4, 20, 92, 192, 254,<br />
382, 1004F*, 1527T*<br />
Zhu, Z., 2251T<br />
Zhu, Z.-H., 1540F<br />
Zhu, Z.-Q., 457F<br />
Zhu, Z.-X., 1540F*<br />
Zhukov, O., 2260T<br />
Zhurov, A., 1528F<br />
Ziccardi, W., 591F*<br />
Zickus, M., 1667T<br />
Zidan, J., 3336T<br />
Zieba, J., 838F*<br />
Ziebell, S., 422W<br />
Ziegler, A., 200, 275,<br />
1443T*, 1669T<br />
Ziegler, J., 1979F<br />
Ziegler, J. T., 1888T<br />
Ziegler, R. G., 2202W<br />
Ziehe, M., 3524T<br />
Zielenski, J., 1731W<br />
Ziemek, D., 503F<br />
Ziff, J. L., 2302T*<br />
Zigman, W., 859W<br />
Zilka, M., 123, 3704W*,<br />
3716W, 3731F, 3733F<br />
Zill, O., 311*<br />
Zillges, H., 3373F<br />
Zillikens, M. C., 1334W,<br />
1954T, 2123F, 2147F,<br />
2169W<br />
Zimdahl-Gelling, H., 617T<br />
Zimmerman, E., 948T<br />
Zimmerman, J., 1292W<br />
Zimmerman, S. L., 3194F*<br />
Zimmerman-Bier, B., 2381F<br />
Zimmermann, A. F., 1405F<br />
Zimmermann, K., 236<br />
Zimon, M., 201, 2948T*<br />
Zimprich, A., 2568W<br />
Zimran, A., 746T, 773W,<br />
788W*<br />
Zink, A., 186<br />
Zink, A. M., 1005W, 2595W,<br />
3109W<br />
Ziolkowska-Suchanek, I.,<br />
1184F<br />
Zissel, G., 2103W<br />
Ziv, E., 1075T, 1078T,<br />
1152W, 1576F, 2080T,<br />
2195F*<br />
Zivony-Elboum, Y., 199<br />
Zlatopolsky, Z., 251<br />
Zode, G. S., 387*<br />
Zody, M. C., 437F<br />
Zoellner, S., 1542T<br />
Zoghbi, H., 2807T<br />
Zoghbi, H. Y., 2769F<br />
Zoledziewska, M., 113,<br />
157, 177, 1451W, 1516F,<br />
3664W<br />
Zöllner, S., 476W, 1521T,<br />
1534F, 3285T, 3406T
Zondervan, K. T., 44,<br />
583F, 2056T, 2077T,<br />
2133W<br />
Zongaro, S., 513F*<br />
Zook, J. M., 3647F*<br />
Zou, H., 1359T<br />
Zou, J. Z., 1974W<br />
Zou, R., 198<br />
Zu, T., 2645F*<br />
Zuccherato, L. W., 3325F<br />
*Presenting Author<br />
Zuchelli, M., 807F<br />
Zuchner, S., 57, 347,<br />
1681T, 1871F, 2470T,<br />
2583W, 2586W, 2603F,<br />
2615F, 2668W, 2820F,<br />
2930T<br />
Züchner, S., 201, 2637W,<br />
2948T<br />
Zuckerman, B., 3026T<br />
Zufferey, F., 62, 299<br />
SPEAKER AND AUTHOR INDEX 419<br />
Zumbo, P., 376, 1818F,<br />
2610W<br />
Zúñiga, G. M., 1111T<br />
Zupan, A., 3381T*<br />
Zusevics, K. L., 1837W<br />
Zusi, C., 2548T, 2659T*<br />
Zuvich, R. L., 631T<br />
Zvi, T., 704T<br />
Zvulunov, A., 2810T<br />
Zwaigenbaum, L., 175<br />
Zweemer, R., 400<br />
Zweier, C., 2595W, 2666T*<br />
Zweig, A., 3557F, 3612W<br />
Zweynert, S., 3364F,<br />
3402T<br />
Zwick, M. E., 1349W, 2069F,<br />
2312F<br />
Zwiefelh<strong>of</strong>er, T., 3014T<br />
Zwinderman, A. H., 1604T<br />
Zymak-Zakutnia, N., 302<br />
SPEAKER AND AUTHOR INDEX
<strong>ASHG</strong> <strong>2012</strong> MOBILE APP<br />
Download the <strong>ASHG</strong> <strong>2012</strong> Mobile App to your smartphone (iOS, Android, and<br />
Blackberry platforms).<br />
The mobile App brings the meeting to your fingertips wherever you go. Once the App<br />
has been downloaded, you do not need an Internet connection to view information.<br />
See ad on page 422.<br />
RECORDED PRESENTATIONS AVAILABLE AFTER THE MEETING<br />
Invited Sessions, Award Presentations, and the Plenary Sessions will be<br />
recorded and posted on the Web site after the meeting.<br />
These recordings are free to meeting registrants.<br />
Visit the <strong>ASHG</strong> Web site in early December to view these presentations.<br />
During the meeting, attendees are encouraged to post thoughts on exciting scientific<br />
or clinical advances heard at a session or workshop and on challenges that<br />
the field will face by using hashtag #<strong>ASHG</strong><strong>2012</strong> or by posting on the <strong>ASHG</strong><br />
Facebook page. The posts will be monitored and may be discussed at the Closing<br />
Symposium on Saturday.<br />
Twitter: @<strong>Genetics</strong> <strong>Society</strong>, use #<strong>ASHG</strong><strong>2012</strong><br />
Facebook: https://www.facebook.com/<strong>Genetics</strong><strong>Society</strong><br />
Follow <strong>ASHG</strong> on Twitter before and during the week <strong>of</strong> the <strong>2012</strong> Meeting to get the latest<br />
updates, tips, news, and announcements.
The Heart <strong>of</strong> the Exhibit Hall<br />
Get Answers at the <strong>ASHG</strong> Membership booth<br />
Meet your Editors at the <strong>American</strong> Journal <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong> booth<br />
Learn about Boston, the destination for <strong>ASHG</strong> 2013<br />
Meet <strong>Society</strong> Leadership<br />
Sit down in our seating area<br />
Recharge your electronics<br />
Network Net with colleagues<br />
Central
YOUR GUIDE TO THE <strong>ASHG</strong><br />
<strong>2012</strong> MOBILE APP<br />
info search exhibitors Contacts notes<br />
continuing<br />
education<br />
twitter schedule MAPS notifications
during the <strong>ASHG</strong> Meeting in San Francisco.<br />
• Apply for ACMG membership during the <strong>ASHG</strong> meeting and SAVE $125<br />
on ACMG membership and event registration.<br />
• Enter drawings for a Kindle Fire and a 2013 ACMG Annual Meeting<br />
Registration!<br />
• Check out the Live Online Learning Center and much more!<br />
Plan Now<br />
to Attend!<br />
Don’t Miss Out!<br />
Stop by the<br />
<strong>American</strong> College <strong>of</strong> Medical <strong>Genetics</strong><br />
and Genomics (ACMG) Booth 318<br />
Mark Your Calendar<br />
• Detailed program, registration, and hotel information<br />
available October <strong>2012</strong> at www.ACMGmeeting.net<br />
• Abstract submission opens: October <strong>2012</strong><br />
• Abstract submission deadline: Friday,<br />
December 7, <strong>2012</strong><br />
2013 ACMG <strong>Genetics</strong> Review Course<br />
• June 2013 •<br />
Info Coming Soon at www.ACMG.net
ESHG 2013<br />
Paris, France, June 8 – 11, 2013<br />
European <strong>Human</strong> <strong>Genetics</strong> Conference<br />
www.eshg.org/eshg2013<br />
This international conference (now in its 46 th year) is a forum for all workers<br />
in human and medical genetics to review advances and develop research<br />
collaborations. The conference has become one <strong>of</strong> the premier events in<br />
the fi eld <strong>of</strong> human genetics with over 2.500 delegates, more than 100<br />
oral presentations, 16 workshops, and 8 educational sessions. The<br />
ESHG conference is where the latest developments in human<br />
genetics are discussed, and where pr<strong>of</strong>essionals from all parts<br />
<strong>of</strong> human genetics meet.<br />
Abstract submission deadline:<br />
February 15, 2013
Natera Introduces Next Generation<br />
Non-Invasive Prenatal Testing<br />
Natera can detect more<br />
chromosomal abnormalities than<br />
other non-invasive tests<br />
• NIPT from Natera provides twice<br />
the disease detection and is the<br />
only test to detect X and Y<br />
chromosome abnormalities<br />
• Natera’s Parental Support<br />
is the only technology with<br />
consistently high detection<br />
accuracy across all five<br />
chromosomes [>99%]:<br />
13, 18, 21, X, and Y.<br />
Natera also <strong>of</strong>fers the following:<br />
• Noninvasive Prenatal Paternity Testing<br />
• Products <strong>of</strong> Conception (POC) Molecular Karyotype<br />
• Preimplantation Genetic Diagnosis (PGD)<br />
• Natera One Multi-Disease Carrier Screening<br />
Contact Mollie Larson at mlarson@natera.com to learn more or to<br />
have kits sent directly to your <strong>of</strong>fice.<br />
Visit us at bOOTh 504<br />
62nd Annual Meeting <strong>of</strong> the <strong>American</strong><br />
<strong>Society</strong> <strong>of</strong> human <strong>Genetics</strong><br />
November 7–9, <strong>2012</strong><br />
www.natera.com | 1-877-476-4743
Let’s talk about NGS and data overload.
NGS is a great discovery tool. But if you’re using it for<br />
validation, you’re wasting valuable time. The Sequenom<br />
MassARRAY® System* gives you the specifi city and<br />
sensitivity you need for research. A proven platform with<br />
over 1,500 peer reviewed publications including GWAS<br />
validation, it delivers accurate results in a matter <strong>of</strong><br />
days. So what did you just fi nd? An essential research<br />
validation tool that pays for itself.<br />
*The MassARRAY System is for Research Use Only. Not for use in diagnostic procedures.
Rich<br />
multimedia<br />
and interactive<br />
features<br />
A new,<br />
innovative<br />
website<br />
Precision<br />
search,<br />
relevant<br />
content<br />
1 network. 1 website.<br />
JAMA and<br />
9 specialty<br />
Archives<br />
Journals<br />
Access the new online home <strong>of</strong> JAMA and the entire JAMA Network.<br />
The JAMA Network website <strong>of</strong>fers fully integrated access to the research, reviews, and<br />
perspectives that shape the future <strong>of</strong> medicine. Spanning all 10 <strong>of</strong> The JAMA Network<br />
journals, it equips you with the medical insights that matter most to your practice.<br />
Join the experts at jamanetwork.com<br />
Please visit us in booth #1201<br />
200 new<br />
articles<br />
every week
PGM for genes. Proton for genomes.<br />
Sequencing for all.<br />
Powered by fast, simple, scalable semiconductor chips,<br />
the Ion PGM Sequencer introduced an entirely new approach<br />
to sequencing, making it dramatically faster and more accessible.<br />
The new Ion Proton Sequencer will go even further. With chip<br />
densities up to 1,000-fold greater than the Ion PGM Sequencer,<br />
the Ion Proton Sequencer will put whole-genome sequencing<br />
within reach <strong>of</strong> every lab.<br />
Visit Life Technologies at booth #601 at <strong>ASHG</strong><br />
or look for the Ion Bus in the Exhibit Hall<br />
Get fast, affordable benchtop sequencing at<br />
lifetechnologies.com/ionsequencing<br />
For research use only. Not intended for any animal or human therapeutic or diagnostic use. The content provided herein may relate to<br />
products that have not been <strong>of</strong>ficially released and is subject to change without notice ©<strong>2012</strong> Life Technologies Corporation. All rights<br />
reserved. The trademarks mentioned herein are the property <strong>of</strong> Life Technologies Corporation or their respective owners. CO03380 0712
The Definitive Evolution <strong>of</strong> Genotyping<br />
Axiom ® Genotyping Solution. Survival <strong>of</strong> the fittest.<br />
Axiom Genotyping Solution is the most powerful genotyping workflow delivering superior coverage<br />
<strong>of</strong> populations, disease genes, and rare variants at an affordable price.<br />
n Unique GWAS, replication, and fine-mapping content on one array<br />
n Unrivaled coverage <strong>of</strong> the exome, disease genes, and functional regions<br />
n Cost-effective custom array design with 100% SNP conversion<br />
Axiom Genotyping Solution adapts to the needs <strong>of</strong> your research—coverage and flexibility like never before.<br />
Contact your Affymetrix representative today or visit www.affymetrix.com/genotype.<br />
Wednesday, Nov. 7, 12:45 – 2:15 PM<br />
Room 302, Esplanade Level (South),<br />
Moscone Center<br />
Enabling the Genome Generation #1:<br />
population-optimized strategies and genotyping<br />
solutions for expanding our understanding <strong>of</strong> the<br />
genetic variations in complex diseases<br />
Join our luncheon seminars:<br />
Coverage<br />
90%<br />
85%<br />
80%<br />
75%<br />
70%<br />
Axiom ® World Array 4<br />
Competing Array<br />
MAF >1%<br />
Thursday, Nov. 8, 12:45 – 2:15 PM<br />
Room 307, Esplanade Level (South),<br />
Moscone Center<br />
Enabling the Genome Generation #2:<br />
next-generation cytogenetics solution for<br />
constitutional and cancer research applications<br />
Box lunch will be provided. First come, first served.<br />
Visit booths #918/920, #925/927. ©Affymetrix, Inc. All rights reserved. “For Research Use Only. Not for use in diagnostic procedures.”<br />
MAF >5%